𐋇¦how¦ ¦do¦ ¦covid¦ - ¦19¦
𐋇 ¦vaccines¦ ¦work¦ ?
𐋇 ¦december¦ ¦2020¦
𐋇 ¦vaccines¦ ¦work¦ ¦by¦ ¦pre par ing¦ ¦a¦ ¦person¦ ▁’▁ ¦s¦ ¦immune¦ ¦system¦ ▁( ¦the¦ ¦body¦ ▁’▁ ¦s¦ ¦nat ural¦ ¦def en ces¦ )▁ ¦to¦ ¦reco gn ise¦ ¦and¦ ¦def end¦ ¦ it s el f¦ ¦against¦ ¦a¦ ¦specific¦ ¦disease¦ .
𐋇 ¦bu il ding¦ ¦immun ity¦
𐋇 ¦most¦ ¦research¦ ¦on¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦invol ves¦ ¦gener ating¦ ¦resp on ses¦ ¦to¦ ¦all¦ ¦or¦ ¦par t¦ ¦of¦ ¦a¦ ¦protein¦ ¦that¦ ¦is¦ ¦uni q ue¦ ¦to¦ ¦the¦ ¦virus¦ ¦that¦ ¦ca u ses¦ ¦covid¦ - ¦19¦ .
𐋇¦when¦ ¦a¦ ¦person¦ ¦rece ives¦ ¦the¦ ¦vaccine¦ ,▁ ¦it¦ ¦will¦ ¦t ri gg er¦ ¦an¦ ¦immune¦ ¦response¦ .
𐋇 ¦most¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦requir e¦ ¦two¦ ¦doses¦ ¦to¦ ¦bu i ld¦ ¦immun ity¦ .
𐋇¦if¦ ¦the¦ ¦person¦ ¦is¦ ¦infected¦ ¦by¦ ¦the¦ ¦virus¦ ¦later¦ ¦on¦ ,▁ ¦the¦ ¦immune¦ ¦system¦ ¦reco gn i ses¦ ¦the¦ ¦virus¦ .
𐋇¦the¦ ¦system¦ ¦is¦ ¦then¦ ¦pre p ared¦ ¦to¦ ¦att ack¦ ¦the¦ ¦virus¦ .
𐋇¦how¦ ¦do¦ ¦the¦ ¦vaccines¦ ¦b ou gh t¦ ¦by¦ ¦the¦ ¦european¦ ¦comm i ssion¦ ¦work¦ ?
𐋇¦n uc le ic¦ ¦ac id¦ ¦vaccines¦ ▁( ¦m r na¦ )
𐋇 ¦bi on te ch¦ ▁/▁ ¦p f iz er¦ ▁ | ▁ ¦mod er na¦ ▁ | ▁ ¦cur e v a c¦
𐋇¦this¦ ¦typ e¦ ¦of¦ ¦vaccine¦ ¦conta ins¦ ¦par t¦ ¦of¦ ¦the¦ ▁ ‘ ▁ ¦in str uc tions¦ ▁’▁ ¦from¦ ¦the¦ ¦virus¦ ¦that¦ ¦ca u ses¦ ¦covid¦ - ¦19¦ .
𐋇¦this¦ ¦all ow s¦ ¦the¦ ¦body¦ ▁’▁ ¦s¦ ¦ own¦ ¦ce lls¦ ¦to¦ ¦make¦ ¦a¦ ¦protein¦ ¦that¦ ¦is¦ ¦uni q ue¦ ¦to¦ ¦the¦ ¦virus¦ .
𐋇¦the¦ ¦person¦ ▁’▁ ¦s¦ ¦immune¦ ¦system¦ ¦reco gn i ses¦ ¦that¦ ¦this¦ ¦uni q ue¦ ¦protein¦ ¦should¦ ¦not¦ ¦be¦ ¦in¦ ¦the¦ ¦body¦ ¦and¦ ¦resp on ds¦ ¦by¦ ¦produc ing¦ ¦nat ural¦ ¦def en ces¦ ¦against¦ ¦infection¦ ¦by¦ ¦covid¦ - ¦19¦ .
𐋇 ¦protein¦ - ¦based¦ ¦vaccines¦
𐋇 ¦sa no f i¦ ▁/▁ ¦g s k¦
𐋇¦this¦ ¦typ e¦ ¦of¦ ¦vaccine¦ ¦conta ins¦ ¦fra g ments¦ ¦of¦ ¦a¦ ¦protein¦ ¦that¦ ¦is¦ ¦uni q ue¦ ¦to¦ ¦the¦ ¦virus¦ .
𐋇¦these¦ ¦are¦ ¦en ough¦ ¦for¦ ¦the¦ ¦person¦ ▁’▁ ¦s¦ ¦immune¦ ¦system¦ ¦to¦ ¦reco gn ise¦ ¦that¦ ¦the¦ ¦uni q ue¦ ¦protein¦ ¦should¦ ¦not¦ ¦be¦ ¦in¦ ¦the¦ ¦body¦ ¦and¦ ¦to¦ ¦resp on d¦ ¦by¦ ¦produc ing¦ ¦nat ural¦ ¦def en ces¦ ¦against¦ ¦infection¦ ¦by¦ ¦covid¦ - ¦19¦ .
𐋇 ¦viral¦ ¦v ector¦ ¦vaccines¦
𐋇 ¦astrazeneca¦ ▁ ¦jo h ns on¦ ▁ & ▁ ¦jo h ns on¦
𐋇¦this¦ ¦typ e¦ ¦of¦ ¦vaccine¦ ¦u ses¦ ¦a¦ ¦different¦ ,▁ ¦h arm less¦ ¦virus¦ ¦to¦ ¦de li ver¦ ¦the¦ ▁ ‘ ▁ ¦in str uc tions¦ ▁’▁ ¦from¦ ¦the¦ ¦virus¦ ¦that¦ ¦ca u ses¦ ¦covid¦ - ¦19¦ .
𐋇¦this¦ ¦all ow s¦ ¦the¦ ¦body¦ ▁’▁ ¦s¦ ¦ own¦ ¦ce lls¦ ¦to¦ ¦make¦ ¦the¦ ¦protein¦ ¦uni q ue¦ ¦to¦ ¦the¦ ¦covid¦ - ¦19¦ ¦virus¦ .
𐋇¦the¦ ¦person¦ ▁’▁ ¦s¦ ¦immune¦ ¦system¦ ¦reco gn i ses¦ ¦that¦ ¦this¦ ¦uni q ue¦ ¦protein¦ ¦should¦ ¦not¦ ¦be¦ ¦in¦ ¦the¦ ¦body¦ ¦and¦ ¦resp on ds¦ ¦by¦ ¦produc ing¦ ¦nat ural¦ ¦def en ces¦ ¦against¦ ¦infection¦ ¦by¦ ¦covid¦ - ¦19¦ .
𐋇¦if¦ ¦the¦ ¦vaccinated¦ ¦person¦ ¦is¦ ¦later¦ ¦exp osed¦ ¦to¦ ¦the¦ ¦covid¦ - ¦19¦ ¦virus¦ ,▁ ¦their¦ ¦nat ural¦ ¦def en ces¦ ¦are¦ ¦able¦ ¦to¦ ¦reco gn ise¦ ¦the¦ ¦protein¦ ¦in¦ ¦covid¦ - ¦19¦ .
𐋇¦the¦ ¦body¦ ▁’▁ ¦s¦ ¦def en ces¦ ¦are¦ ¦rea dy¦ ¦to¦ ¦k ill¦ ¦the¦ ¦virus¦ ,▁ ¦and¦ ¦to¦ ¦prevent¦ ¦it¦ ¦from¦ ¦ent ering¦ ¦ce lls¦ ¦or¦ ¦sprea ding¦ ¦further¦ .
𐋇 ¦more¦ ¦information¦ ¦on¦ ¦covid¦ - ¦19¦ ¦vacc ination¦
𐋇¦for¦ ¦more¦ ¦information¦ ¦about¦ ¦the¦ ¦vacc ination¦ ¦pr ogra m me¦ ¦in¦ ¦your¦ ¦country¦ ,▁ ¦se e¦ ¦the¦ ¦ec dc¦ ¦vaccine¦ ¦s ch ed ul er¦ ¦and¦ ¦visit¦ ¦the¦ ¦offic ial¦ ¦we b si tes¦ ¦on¦ ¦vacc ination¦ ¦of¦ ¦the¦ ¦countries¦ ¦of¦ ¦the¦ ¦european¦ ¦un ion¦ ¦and¦ ¦the¦ ¦european¦ ¦ec onomic¦ ¦a rea¦ .
𐋇 ¦vaccines¦ ¦protect¦ ¦people¦ ¦and¦ ¦comm un ities¦ ¦against¦ ¦d ea d ly¦ ¦diseases¦ .
𐋇¦they¦ ¦have¦ ¦e rad ic ated¦ ¦s ma ll p o x¦ ,▁ ¦and¦ ¦vir t ually¦ ¦e li min ated¦ ¦other¦ ¦diseases¦ ¦like¦ ¦po li o¦ .
𐋇 ¦vacc ination¦ ¦bu il ds¦ ¦up¦ ¦a¦ ¦person¦ ▁’▁ ¦s¦ ¦def en ces¦ ¦to¦ ¦common¦ ¦diseases¦ ¦that¦ ¦they¦ ¦are¦ ¦exp osed¦ ¦to¦
𐋇 ¦being¦ ¦vaccinated¦ ¦prev ents¦ ¦people¦ ¦from¦ ¦c at c hing¦ ¦the¦ ¦disease¦ ¦in¦ ¦the¦ ¦v ast¦ ¦ma j or ity¦ ¦of¦ ¦cases¦ .
𐋇¦in¦ ¦some¦ ¦cases¦ ,▁ ¦a¦ ¦person¦ ¦can¦ ¦still¦ ¦get¦ ¦a¦ ¦disease¦ ¦after¦ ¦being¦ ¦vaccinated¦ .
𐋇¦the¦ ¦symptoms¦ ,▁ ¦however¦ ,▁ ¦are¦ ¦m il der¦ ¦and¦ ¦reco ve ry¦ ¦is¦ ¦f as ter¦ .
𐋇¦some¦ ¦of¦ ¦the¦ ¦diseases¦ ¦that¦ ¦vaccines¦ ¦protect¦ ¦against¦
𐋇 ¦he p at itis¦ ¦b ¦
𐋇 ¦human¦
𐋇¦p ap il lo ma vir us¦
𐋇 ¦infection¦
( 𐋇¦h p v ¦ )
𐋇 ¦influenza¦
𐋇 ¦me as les¦ ,
𐋇¦m um ps¦ ¦and¦
𐋇 ¦r ub e ll a¦
𐋇 ¦po li o¦
𐋇¦t et an us¦
𐋇¦t ub erc u lo sis¦
𐋇 ¦bet ter¦ ¦for¦ ¦e veryone¦
𐋇¦a¦ ¦vaccinated¦ ¦person¦ ¦is¦ ¦less¦ ¦likely¦ ¦to¦ ¦p ass¦ ¦on¦ ¦an¦ ¦infectious¦ ¦disease¦ ¦to¦ ¦others¦ .▁ 𐋇 ¦so¦ ,▁ ¦people¦ ¦who¦ ¦get¦ ¦vaccinated¦ ¦can¦ ¦help¦ ¦protect¦ ¦those¦ ¦who¦ ¦cannot¦ ¦be¦ ¦vaccinated¦ ¦the m s el ves¦ .
𐋇¦this¦ ¦inclu des¦ ¦bab ies¦ ,▁ ¦children¦ ,▁ ¦ ol der¦ ¦people¦ ¦and¦ ¦people¦ ¦with¦ ¦w ea k¦ ¦immune¦ ¦sys tems¦ ¦such¦ ¦as¦ ¦cance r¦ ¦patients¦ .
𐋇¦these¦ ¦grou ps¦ ¦be ne f i t¦ ¦from¦ ¦others¦ ¦getting¦ ¦vaccinated¦ ,▁ ¦because¦ ¦the¦ ¦disease¦ ¦then¦ ¦cannot¦ ¦spread¦ ¦in¦ ¦the¦ ¦community¦ .
𐋇 ¦me as les¦
𐋇 ¦community¦
𐋇 ¦immun ity¦
𐋇¦a¦ ¦high¦ ¦number¦ ¦of¦ ¦vacc in ations¦ ¦is¦ ¦required¦ ¦to¦ ¦help¦ ¦cre ate¦ ¦this¦ ¦community¦ ¦immun ity¦ .
𐋇¦when¦ ¦a¦ ¦high¦ ¦number¦ ¦of¦ ¦people¦ ¦are¦ ¦vaccinated¦ ,▁ ¦cha ins¦ ¦of¦ ¦infections¦ ¦are¦ ¦sto pp ed¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦according¦ ¦to¦ ¦the¦ ¦european¦ ¦centre¦ ¦for¦ ¦disease¦ ¦pre vention¦ ¦and¦ ¦control¦ ▁( ¦ec dc¦ )▁ ¦9 5¦ %▁ ¦of¦ ¦people¦ ¦need¦ ¦to¦ ¦vacc in ate¦ ¦against¦ ¦me as les¦ ¦to¦ ¦prevent¦ ¦further¦ ¦spread¦ ¦in¦ ¦the¦ ¦community¦ .
¦5¦ %▁ ¦not¦ ¦vaccinated¦
¦9 5¦ %▁ ¦vaccinated¦
𐋇 ¦reduc ing¦ ¦the¦ ¦b ur d en¦ ¦on¦ ¦people¦
𐋇¦by¦ ¦h el p ing¦ ¦keep¦ ¦more¦ ¦people¦ ¦healthy¦ ,▁ ¦vacc ination¦ ¦h el ps¦ ¦reduce¦ ¦the¦ ¦social¦ ¦and¦ ¦p s y ch ological¦ ¦t ol l¦ ¦of¦ ¦illness¦ ¦on¦ ¦people¦ ¦and¦ ¦le ss ens¦ ¦the¦ ¦b ur d en¦ ¦on¦ ¦hosp it als¦ ¦and¦ ¦healthcare¦ ¦sys tems¦ .
𐋇¦this¦ ¦me ans¦ ¦that¦ ¦res o ur ces¦ ¦can¦ ¦go¦ ¦to¦ ¦fi gh ting¦ ¦other¦ ¦diseases¦ ,▁ ¦such¦ ¦as¦ ¦cance r¦ ¦or¦ ¦al z he im er¦ ▁’▁ ¦s¦ .
𐋇¦s ma ll p o x¦
𐋇 ¦th an ks¦ ¦to¦ ¦vacc ination¦ ,▁ ¦s ma ll p o x¦ ¦has¦ ¦been¦ ¦comp le tely¦ ¦w ip ed¦ ¦out¦ .
𐋇¦it¦ ¦was¦ ¦o nce¦ ¦a¦ ¦common¦ ¦disease¦ ¦that¦ ¦ki lled¦ ¦a¦ ¦thir d¦ ¦of¦ ¦people¦ ¦who¦ ¦contr ac ted¦ ¦it¦ .
𐋇¦the¦ ¦last¦ ¦case¦ ¦of¦ ¦nat ur ally¦ ¦contr ac ted¦ ¦s ma ll p o x¦ ¦was¦ ¦in¦ ¦19 7 7¦ ¦and¦ ¦it¦ ¦was¦ ¦e rad ic ated¦ ¦in¦ ¦19 8 0¦ .
𐋇 ¦po li o¦ ¦is¦ ¦an¦ ¦infectious¦ ¦disease¦ ¦mo st ly¦ ¦contr ac ted¦ ¦by¦ ¦children¦ .
¦1¦ ¦person¦ ¦in¦ ¦2 00¦ ¦develop s¦ ¦inc ur able¦ ¦par al y sis¦ ¦after¦ ¦infection¦ .
𐋇¦a¦ ¦vaccine¦ ¦was¦ ¦developed¦ ¦in¦ ¦19 5 5¦ ¦and¦ ¦wid ely¦ ¦int ro duc ed¦ .
𐋇¦as¦ ¦of¦ ¦2020¦ ,▁ ¦the¦ ¦only¦ ¦rem aining¦ ¦cases¦ ¦of¦ ¦po li o¦ ¦have¦ ¦been¦ ¦found¦ ¦in¦ ¦pa k ist an¦ ¦and¦ ¦a f gh an ist an¦ .
𐋇¦the¦ ¦me as les¦ ¦virus¦ ¦was¦ ¦identified¦ ¦in¦ ¦19 5 4¦ ¦and¦ ¦a¦ ¦vaccine¦ ¦was¦ ¦int ro duc ed¦ ¦in¦ ¦19 6 3¦ .
𐋇 ¦th an ks¦ ¦to¦ ¦vacc ination¦ ,▁ ¦between¦ ¦20 00¦ ¦and¦ ¦20 1 8¦ ,▁ ¦global¦ ¦deaths¦ ¦from¦ ¦me as les¦ ¦f ell¦ ¦by¦ ¦7 3¦ % .
¦23¦ ¦million¦ ¦deaths¦ ¦were¦ ¦prev ented¦ .
𐋇¦the¦ ¦amer ic a s¦ ¦have¦ ¦been¦ ¦me as les¦ - ¦fre e¦ ¦since¦ ¦20 0 2¦ .
𐋇¦however¦ ,▁ ¦out b rea ks¦ ¦of¦ ¦me as les¦ ¦still¦ ¦occur ¦ ¦in¦ ¦several¦ ¦european¦ ¦countries¦ ¦because¦ ¦vacc ination¦ ¦co ver age¦ ¦is¦ ¦i ns u ff ici ent¦ ¦in¦ ¦c er tain¦ ¦areas¦ .
𐋇¦p ut¦ ¦an¦ ¦end¦ ¦to¦ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ .
𐋇¦the¦ ¦european¦ ¦comm i ssion¦ ¦is¦ ¦bu il ding¦ ¦one¦ ¦of¦ ¦the¦ ¦b ro a d est¦ ¦p ort f o li o s¦ ¦of¦ ¦different¦ ¦vaccines¦ ¦that¦ ¦are¦ ¦safe¦ ,▁ ¦effective¦ ¦and¦ ¦aff or d able¦ .
𐋇¦the¦ ¦comm i ssion¦ ¦sec ur ed¦ ¦doses¦ ¦of¦ ¦si x¦ ¦of¦ ¦the¦ ¦most¦ ¦pr om ising¦ ¦vaccines¦ ¦so¦ ¦fa r¦ .
𐋇 ¦more¦ ¦may¦ ¦come¦ .
𐋇¦some¦ ¦of¦ ¦these¦ ¦f ut ure¦ ¦vaccines¦ ¦are¦ ¦based¦ ¦on¦ ¦new¦ ¦techn ol og ies¦ ,▁ ¦so¦ ¦we¦ ¦can¦ ¦develop ¦ ¦and¦ ¦produc e¦ ¦them¦ ¦rap id ly¦ ¦in¦ ¦the¦ ¦face¦ ¦of¦ ¦the¦ ¦emergency¦ .
𐋇¦they¦ ¦are¦ ¦also¦ ¦based¦ ¦on¦ ¦different¦ ¦techn ol og ies¦ ,▁ ¦to¦ ¦imp ro ve¦ ¦our¦ ¦chan ces¦ ¦of¦ ¦f in ding¦ ¦effective¦ ¦ on es¦ ¦rap id ly¦ .
𐋇 ¦vaccines¦ ¦only¦ ¦go¦ ¦on¦ ¦the¦ ¦mark et¦ ¦after¦ ¦a¦ ¦th or ough¦ ¦and¦ ¦r ig o ro us¦ ¦ev a lu ation¦ ¦to¦ ¦pro ve¦ ¦they¦ ¦are¦ ¦safe¦ ¦for¦ ¦all¦ .
𐋇 ¦o nce¦ ¦author i sed¦ ,▁ ¦the¦ ¦vaccines¦ ¦are¦ ¦made¦ ¦available¦ ¦to¦ ¦eu¦ ¦countries¦ ¦at¦ ¦the¦ ¦same¦ ¦time¦ ¦and¦ ¦at¦ ¦the¦ ¦same¦ ¦conditions¦ .
𐋇 ¦so¦ ¦fa r¦ ,▁ ¦the¦ ¦comm i ssion¦ ¦has¦ ¦sec ur ed¦ ¦up¦ ¦to¦ ¦4¦ . ¦4¦ ¦bi ll ion¦ ¦doses¦ ¦bi on te ch¦ ▁/▁ ¦p f iz er¦ ¦up¦ ¦to¦ ¦2¦ . ¦4¦ ¦mod er na¦ ¦up¦ ¦to¦ ¦4 6 0¦ ¦million¦ ¦doses¦ ¦bi ll ion¦ ¦doses¦
𐋇 ¦o ption¦ ¦to¦ ¦p ur ch ase¦ ¦9 00¦ ¦million¦ ¦doses¦
𐋇¦to¦ ¦be¦ ¦effective¦ ,▁ ¦most¦ ¦vaccines¦ ¦are¦ ¦likely¦ ¦to¦ ¦need¦ ¦two¦ ¦doses¦ ¦per¦ ¦person¦ .
𐋇¦we¦ ¦have¦ ¦sec ur ed¦ ¦su ff ici ent¦ ¦doses¦ ¦of¦ ¦vaccines¦ ¦for¦ ¦eu¦ ¦c itiz ens¦ .
𐋇 ¦vacc ination¦ ¦is¦ ¦v o lu nt ary¦ .
𐋇¦e ur ope¦ ¦is¦ ¦inv es ting¦ ¦in¦ ¦vaccines¦ ¦not¦ ¦only¦ ¦for¦ ¦e ur op e ans¦ .
𐋇 ¦eu¦ ¦countries¦ ¦may¦ ¦d on ate¦ ¦vaccine¦ ¦doses¦ ¦to¦ ¦v ul n er able¦ ¦countries¦ ¦in¦ ¦the¦ ¦ne i gh bo ur h ood¦ ¦and¦ ¦be y on d¦ .
𐋇¦the¦ ¦european¦ ¦comm i ssion¦ ¦has¦ ¦gr an ted¦ ¦mark e ting¦ ¦author is ations¦ ¦to¦ ¦the¦ ¦bi on te ch p f iz er¦ ,▁ ¦mod er na¦ ,▁ ¦astrazeneca¦ ¦and¦ ¦jo h ns on¦ ▁ & ▁ ¦jo h ns on¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦based¦ ¦on¦ ¦positive¦ ¦sc ie nt if ic¦ ¦op in i ons¦ ¦by¦ ¦the¦ ¦european¦ ¦medic ines¦ ¦a ge ncy¦ .
𐋇¦the¦ ¦first¦ ¦european¦ ¦c itiz ens¦ ¦were¦ ¦vaccinated¦ ¦at¦ ¦the¦ ¦end¦ ¦of¦ ¦december¦ ¦2020¦ ,▁ ¦during¦ ¦the¦ ¦eu¦ ¦vacc ination¦ ¦days¦ .
𐋇 ¦and¦ ¦are¦ ¦you¦ ¦having¦ ¦any¦ ¦of¦ ¦the¦ ¦following¦ ¦symptoms¦ ¦with¦ ¦your¦ ¦chest¦ ¦pain¦
𐋇 ¦and¦ ¦are¦ ¦you¦ ¦having¦ ¦a¦ ¦r un n y¦ ¦nose¦ ?
𐋇 ¦and¦ ¦does¦ ¦this¦ ¦pain¦ ¦mo ve¦ ¦from¦ ¦your¦ ¦chest¦ ?
𐋇 ¦and¦ ¦dr ink¦ ¦lo ts¦ ¦of¦ ¦f lu i ds¦
𐋇 ¦and¦ ¦sh e¦ ¦is¦ ¦s ort a¦ ¦have¦ ¦the¦ ¦same¦ ¦symptoms¦
𐋇 ¦and¦ ¦t ell¦ ¦ me¦ ¦what¦ ¦symptoms¦ ¦are¦ ¦you¦ ¦having¦ ¦n ow¦ ?
𐋇 ¦and¦ ¦your¦ ¦symptoms¦ ¦do¦ ¦not¦ ¦go¦ ¦away¦ ¦in¦ ¦five¦ ¦days¦
𐋇 ¦any¦ ¦sh ar p¦ ¦pain¦ ¦on¦ ¦your¦ ¦le f t¦ ¦ side¦ ¦of¦ ¦your¦ ¦chest¦ ?
𐋇 ¦are¦ ¦you¦ ¦having¦ ¦any¦ ¦diffic ult y¦ ¦brea thing¦ ¦n ow¦
𐋇 ¦be si des¦ ¦the¦ ¦di ab e tes¦ ¦do¦ ¦you¦ ¦have¦ ¦other¦ ¦prob le ms¦ ¦or¦ ¦important¦ ¦diseases¦ ?
𐋇¦but¦ ¦if¦ ¦you¦ ¦have¦ ¦the¦ ¦cough¦
𐋇 ¦cause¦ ¦they¦ ' ¦r e¦ ¦having¦ ¦a¦ ¦cough¦
𐋇¦do¦ ¦you¦ ¦have¦ ¦any¦ ¦blood¦ ¦pre ss ure¦ ¦prob le m¦ ¦as¦ ¦fa r¦ ¦as¦ ¦you¦ ¦know¦ ?
𐋇¦do¦ ¦your¦ ¦rel at ives¦ ¦have¦ ¦the¦ ¦same¦ ¦symptoms¦
𐋇 ¦have¦ ¦a¦ ¦d ry¦ ¦cough¦ ¦a¦ ¦cold¦ ¦and¦ ¦r un n y¦ ¦nose¦ ¦v o mi ting¦ ¦di arr he a¦
𐋇 ¦i¦ ¦d on¦ ' ¦t¦ ¦th ink¦ ¦i¦ ¦have¦ ¦high¦ ¦blood¦ ¦pre ss ure¦
𐋇 ¦i¦ ¦feel¦ ¦a¦ ¦pain¦ ¦in¦ ¦the¦ ¦chest¦ ¦h er e¦ ¦in¦ ¦the¦ ¦f r on t¦ ¦par t¦ ¦of¦ ¦the¦ ¦chest¦
𐋇 ¦i¦ ¦had¦ ¦a¦ ¦sh ort¦ ¦sh ar p¦ ¦pain¦ ¦in¦ ¦m y¦ ¦chest¦
𐋇 ¦i¦ ¦have¦ ¦h ay¦ ¦fever¦ ¦th ough¦ ¦to o¦
𐋇 ¦i¦ ¦have¦ ¦made¦ ¦on¦ ¦the¦ ¦body¦ ¦around¦ ¦the¦ ¦chest¦ ¦a rea¦ ?
𐋇 ¦i¦ ¦se e¦ ¦it¦ ¦go ing¦ ¦from¦ ¦the¦ ¦center¦ ¦of¦ ¦your¦ ¦chest¦ ¦go ing¦ ¦up¦ ¦to¦ ¦your¦ ¦n eck¦
𐋇¦it¦ ¦h ur ts¦ ¦in¦ ¦the¦ ¦chest¦
𐋇¦it¦ ¦is¦ ¦occur r ing¦ ¦r ight¦ ¦in¦ ¦the¦ ¦m id d le¦ ¦of¦ ¦m y¦ ¦chest¦
𐋇¦it¦ ¦is¦ ¦r ight¦ ¦in¦ ¦the¦ ¦center¦ ¦of¦ ¦m y¦ ¦chest¦
𐋇¦it¦ ¦so un ds¦ ¦like¦ ¦you¦ ¦j ust¦ ¦may¦ ¦have¦ ¦the¦ ¦gard en¦ ¦vari et y¦ ¦cold¦ ¦or¦ ¦a¦ ¦flu¦
𐋇 ¦i¦ ¦will¦ ¦s end¦ ¦you¦ ¦an¦ ¦ im age¦
𐋇 ¦i¦ ¦will¦ ¦s end¦ ¦you¦ ¦an¦ ¦ im age¦ ¦on¦ ¦your¦ ¦scre en¦
𐋇 ¦most¦ ¦of¦ ¦the¦ ¦time¦ ¦it¦ ¦is¦ ¦this¦ ¦typ e¦ ¦of¦ ¦chest¦ ¦pain¦
𐋇¦m y¦ ¦s is ter¦ ¦has¦ ¦similar¦ ¦symptoms¦
𐋇¦n ow¦ ¦i¦ ¦s end¦ ¦you¦ ¦an¦ ¦ im age¦
𐋇 ¦or¦ ¦if¦ ¦you¦ ¦have¦ ¦high¦ ¦blood¦ ¦pre ss ure¦
𐋇 ¦so¦ ¦your¦ ¦chest¦ ¦pain¦ ¦star ted¦ ¦this¦ ¦m or ning¦
𐋇¦the¦ ¦fever¦ ¦star ted¦ ¦two¦ ¦days¦ ¦ag o¦
𐋇¦the¦ ¦m us c le¦ ¦pa ins¦ ¦with¦ ¦the¦ ¦h ay¦ ¦fever¦
𐋇 ¦well¦ ¦from¦ ¦m y¦ ¦po in t¦ ¦of¦ ¦v ie w¦ ¦it¦ ¦is¦ ¦a¦ ¦l it t le¦ ¦flu¦
𐋇 ¦well¦ ¦ma d am¦ ¦from¦ ¦l ist ening¦ ¦to¦ ¦your¦ ¦symptoms¦ ¦it¦ ¦so un ds¦ ¦like¦ ¦you¦ ' ¦ ve¦ ¦g ot¦ ¦one¦ ¦of¦ ¦the¦ ¦flu¦ ¦viruses¦
𐋇¦you¦ ¦are¦ ¦prob ab ly¦ ¦having¦ ¦chest¦ ¦pain¦
𐋇 ¦pre li min ary¦ ¦estim ates¦ ¦of¦ ¦the¦ ¦prev al ence¦ ¦of¦ ¦s el ected¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦among¦ ¦patients¦ ¦with¦ ¦coronavirus¦ ¦disease¦ ¦2019¦ ▁ — ▁ ¦united¦ ¦states¦ ,▁ ¦february¦ ¦12¦ ▁–▁ ¦march¦ ¦2 8¦ ,▁ ¦2020¦
𐋇¦on¦ ¦march¦ ¦11¦ ,▁ ¦2020¦ ,▁ ¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ¦decl ared¦ ¦coronavirus¦ ¦disease¦ ¦2019¦ ▁( ¦covid¦ - ¦19¦ )▁ ¦a¦ ¦pandemic¦ .
𐋇¦as¦ ¦of¦ ¦march¦ ¦2 8¦ ,▁ ¦2020¦ ,▁ ¦a¦ ¦total¦ ¦of¦ ¦5 7 1¦ , ¦6 7 8¦ ¦confirmed¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦and¦ ¦26¦ , ¦4 9 4¦ ¦deaths¦ ¦have¦ ¦been¦ ¦reported¦ ¦worldwide¦ .
𐋇 ¦rep orts¦ ¦from¦ ¦china¦ ¦and¦ ¦italy¦ ¦su gg est¦ ¦that¦ ¦risk¦ ¦fa ctors¦ ¦for¦ ¦severe¦ ¦disease¦ ¦include¦ ¦ ol der¦ ¦age¦ ¦and¦ ¦the¦ ¦pres ence¦ ¦of¦ ¦at¦ ¦least¦ ¦one¦ ¦of¦ ¦several¦ ¦underlying¦ ¦health¦ ¦conditions¦ .
𐋇 ¦u¦ . ¦s¦ .▁ ¦ ol der¦ ¦ad ul ts¦ ,▁ ¦including¦ ¦those¦ ¦a ged¦ ▁ ≥ ▁ ¦6 5¦ ¦years¦ ¦and¦ ¦partic ul arly¦ ¦those¦ ¦a ged¦ ▁ ≥ ▁ ¦8 5¦ ¦years¦ ,▁ ¦also¦ ¦app ear¦ ¦to¦ ¦be¦ ¦at¦ ¦higher¦ ¦risk¦ ¦for¦ ¦severe¦ ¦covid¦ - ¦19¦ ▁–▁ ¦associated¦ ¦out c omes¦ ;▁ ¦however¦ ,▁ ¦data¦ ¦d esc rib ing¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦among¦ ¦u¦ . ¦s¦ .▁ ¦covid¦ - ¦19¦ ¦patients¦ ¦have¦ ¦not¦ ¦y et¦ ¦been¦ ¦reported¦ .
𐋇¦as¦ ¦of¦ ¦march¦ ¦2 8¦ ,▁ ¦2020¦ ,▁ ¦u¦ . ¦s¦ .▁ ¦states¦ ¦and¦ ¦ter r it or ies¦ ¦have¦ ¦reported¦ ¦1 2 2¦ , ¦6 5 3¦ ¦u¦ . ¦s¦ .▁ ¦covid¦ - ¦19¦ ¦cases¦ ¦to¦ ¦c dc¦ ,▁ ¦including¦ ¦7¦ , ¦1 6 2¦ ▁( ¦5¦ . ¦8¦ % )▁ ¦for¦ ¦wh om¦ ¦data¦ ¦on¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦and¦ ¦other¦ ¦known¦ ¦risk¦ ¦fa ctors¦ ¦for¦ ¦severe¦ ¦out c omes¦ ¦from¦ ¦respiratory¦ ¦infections¦ ¦were¦ ¦reported¦ .
𐋇 ¦among¦ ¦these¦ ¦7¦ , ¦1 6 2¦ ¦cases¦ ,▁ ¦2¦ , ¦6 9 2¦ ▁( ¦3 7¦ . ¦6¦ % )▁ ¦patients¦ ¦had¦ ¦one¦ ¦or¦ ¦more¦ ¦underlying¦ ¦health¦ ¦c ond ition¦ ¦or¦ ¦risk¦ ¦fa ct or¦ ,▁ ¦and¦ ¦4¦ , ¦4 7 0¦ ▁( ¦6 2¦ . ¦4¦ % )▁ ¦had¦ ¦n one¦ ¦of¦ ¦these¦ ¦conditions¦ ¦reported¦ .
𐋇¦the¦ ¦per ce nt age¦ ¦of¦ ¦covid¦ - ¦19¦ ¦patients¦ ¦with¦ ¦at¦ ¦least¦ ¦one¦ ¦underlying¦ ¦health¦ ¦c ond ition¦ ¦or¦ ¦risk¦ ¦fa ct or¦ ¦was¦ ¦higher¦ ¦among¦ ¦those¦ ¦requir ing¦ ¦in tens ive¦ ¦care¦ ¦uni t¦ ▁( ¦ ic u¦ )▁ ¦ad mi ssion¦ ▁( ¦3 5 8¦ ¦of¦ ¦4 5 7¦ ,▁ ¦7 8¦ % )▁ ¦and¦ ¦those¦ ¦requir ing¦ ¦hosp it al iz ation¦ ¦without¦ ¦ ic u¦ ¦ad mi ssion¦ ▁( ¦7 3 2¦ ¦of¦ ¦1¦ , ¦0 3 7¦ ,▁ ¦7 1¦ % )▁ ¦than¦ ¦that¦ ¦among¦ ¦those¦ ¦who¦ ¦were¦ ¦not¦ ¦hosp i tali zed¦ ▁( ¦1¦ , ¦3 8 8¦ ¦of¦ ¦5¦ , ¦1 4 3¦ ,▁ ¦2 7¦ % ).
𐋇¦the¦ ¦most¦ ¦comm on ly¦ ¦reported¦ ¦conditions¦ ¦were¦ ¦di ab e tes¦ ¦me ll it us¦ ,▁ ¦ch r on ic¦ ¦lu ng¦ ¦disease¦ ,▁ ¦and¦ ¦car di ov as c ular¦ ¦disease¦ .
𐋇¦these¦ ¦pre li min ary¦ ¦fi nd ings¦ ¦su gg est¦ ¦that¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦pers ons¦ ¦with¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦or¦ ¦other¦ ¦reco gn i zed¦ ¦risk¦ ¦fa ctors¦ ¦for¦ ¦severe¦ ¦out c omes¦ ¦from¦ ¦respiratory¦ ¦infections¦ ¦app ear¦ ¦to¦ ¦be¦ ¦at¦ ¦a¦ ¦higher¦ ¦risk¦ ¦for¦ ¦severe¦ ¦disease¦ ¦from¦ ¦covid¦ - ¦19¦ ¦than¦ ¦are¦ ¦pers ons¦ ¦without¦ ¦these¦ ¦conditions¦ .
𐋇 ¦data¦ ¦from¦ ¦laboratory¦ - ¦confirmed¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦reported¦ ¦to¦ ¦c dc¦ ¦from¦ ¦50¦ ¦states¦ ,▁ ¦four¦ ¦u¦ . ¦s¦ .▁ ¦ter r it or ies¦ ¦and¦ ¦aff i li ated¦ ¦ is l an ds¦ ,▁ ¦the¦ ¦di stric t¦ ¦of¦ ¦co lu mb ia¦ ,▁ ¦and¦ ¦new¦ ¦y or k¦ ¦city¦ ¦with¦ ¦february¦ ¦12¦ ▁–▁ ¦march¦ ¦2 8¦ ,▁ ¦2020¦ ¦o ns et¦ ¦d ates¦ ¦were¦ ¦anal y zed¦ .
𐋇 ¦cases¦ ¦among¦ ¦pers ons¦ ¦rep at ri ated¦ ¦to¦ ¦the¦ ¦united¦ ¦states¦ ¦from¦ ¦wuhan¦ ,▁ ¦china¦ ,▁ ¦and¦ ¦the¦ ¦d ia m on d¦ ¦pri nc ess¦ ¦c ru ise¦ ¦s hi p¦ ¦were¦ ¦ex c lu ded¦ .
𐋇¦for¦ ¦cases¦ ¦with¦ ¦mi ss ing¦ ¦o ns et¦ ¦d ates¦ ,▁ ¦date¦ ¦of¦ ¦o ns et¦ ¦was¦ ¦estim ated¦ ¦by¦ ¦sub t r ac ting¦ ¦4¦ ¦days¦ ▁( ¦me di an¦ ¦int erv al¦ ¦from¦ ¦s y m pt om¦ ¦o ns et¦ ¦to¦ ¦spec im en¦ ¦colle ction¦ ¦date¦ ¦among¦ ¦cases¦ ¦with¦ ¦known¦ ¦d ates¦ ¦in¦ ¦these¦ ¦data¦ )▁ ¦from¦ ¦the¦ ¦ ear li est¦ ¦spec im en¦ ¦colle ction¦ .
𐋇 ¦public¦ ¦health¦ ¦de pa rt ments¦ ¦reported¦ ¦cases¦ ¦to¦ ¦c dc¦ ¦using¦ ¦a¦ ¦sta nd ar di zed¦ ¦case¦ ¦report¦ ¦for m¦ ¦that¦ ¦ca pt ures¦ ¦information¦ ▁( ¦y es¦ ,▁ ¦no¦ ,▁ ¦or¦ ¦un k n own¦ )▁ ¦on¦ ¦the¦ ¦following¦ ¦conditions¦ ¦and¦ ¦pote ntial¦ ¦risk¦ ¦fa ctors¦ :▁ 𐋇 ¦ch r on ic¦ ¦lu ng¦ ¦disease¦ ▁( ¦inclu s ive¦ ¦of¦ ¦as th m a¦ ,▁ ¦ch r on ic¦ ¦ob str uc tive¦ ¦p ul m on ary¦ ¦disease¦ ▁ [ ¦c op d¦ ] ,▁ ¦and¦ ¦e m ph y se m a¦ ) ;▁ ¦di ab e tes¦ ¦me ll it us¦ ;▁ ¦car di ov as c ular¦ ¦disease¦ ;▁ ¦ch r on ic¦ ¦r en al¦ ¦disease¦ ;▁ ¦ch r on ic¦ ¦li ver¦ ¦disease¦ ;▁ ¦immun oc o mp ro mi sed¦ ¦c ond ition¦ ;▁ ¦ne ur ol og ic¦ ¦dis or der¦ ,▁ ¦ne u ro de v el op me ntal¦ ,▁ ¦or¦ ¦in te ll ect ual¦ ¦dis a bility¦ ;▁ ¦pregn a ncy¦ ;▁ ¦current¦ ¦s mo king¦ ¦st at us¦ ;▁ ¦f orm er¦ ¦s mo king¦ ¦st at us¦ ;▁ ¦or¦ ¦other¦ ¦ch r on ic¦ ¦disease¦ .
𐋇 ¦data¦ ¦reported¦ ¦to¦ ¦c dc¦ ¦are¦ ¦pre li min ary¦ ¦and¦ ¦can¦ ¦be¦ ¦up d ated¦ ¦by¦ ¦health¦ ¦de pa rt ments¦ ¦over¦ ¦time¦ ;▁ ¦crit ical¦ ¦data¦ ¦e le ments¦ ¦might¦ ¦be¦ ¦mi ss ing¦ ¦at¦ ¦the¦ ¦time¦ ¦of¦ ¦in it ial¦ ¦report¦ ;▁ ¦th us¦ ,▁ ¦this¦ ¦anal y sis¦ ¦is¦ ¦d esc r ip tive¦ ,▁ ¦and¦ ¦no¦ ¦st at ist ical¦ ¦comp ar is ons¦ ¦could¦ ¦be¦ ¦made¦ .
𐋇¦the¦ ¦p erc en ta ges¦ ¦of¦ ¦patients¦ ¦of¦ ¦all¦ ¦a ges¦ ¦with¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦who¦ ¦were¦ ¦not¦ ¦hosp i tali zed¦ ,▁ ¦hosp i tali zed¦ ¦without¦ ¦ ic u¦ ¦ad mi ssion¦ ,▁ ¦and¦ ¦hosp i tali zed¦ ¦with¦ ¦ ic u¦ ¦ad mi ssion¦ ¦were¦ ¦c al c ul ated¦ .
𐋇¦p erc en ta ges¦ ¦of¦ ¦hosp it al iz ations¦ ¦with¦ ¦and¦ ¦without¦ ¦ ic u¦ ¦ad mi ssion¦ ¦were¦ ¦estim ated¦ ¦for¦ ¦pers ons¦ ¦a ged¦ ▁ ≥ ▁ ¦19¦ ¦years¦ ¦with¦ ¦and¦ ¦without¦ ¦underlying¦ ¦health¦ ¦conditions¦ .
𐋇¦this¦ ¦par t¦ ¦of¦ ¦the¦ ¦anal y sis¦ ¦was¦ ¦limi ted¦ ¦to¦ ¦pers ons¦ ¦a ged¦ ▁ ≥ ▁ ¦19¦ ¦years¦ ¦because¦ ¦of¦ ¦the¦ ¦sm all¦ ¦sampl e¦ ¦s iz e¦ ¦of¦ ¦cases¦ ¦in¦ ¦children¦ ¦with¦ ¦reported¦ ¦underlying¦ ¦health¦ ¦conditions¦ ▁( ¦ n¦ ▁ = ▁ ¦3 2¦ ).
𐋇¦to¦ ¦acc o un t¦ ¦for¦ ¦mi ss ing¦ ¦data¦ ¦among¦ ¦these¦ ¦pre li min ary¦ ¦rep orts¦ ,▁ ¦r an ges¦ ¦were¦ ¦estim ated¦ ¦with¦ ¦a¦ ¦lower¦ ¦ bo un d¦ ¦including¦ ¦cases¦ ¦with¦ ¦both¦ ¦known¦ ¦and¦ ¦un k n own¦ ¦st at us¦ ¦for¦ ¦hosp it al iz ation¦ ¦with¦ ¦and¦ ¦without¦ ¦ ic u¦ ¦ad mi ssion¦ ¦as¦ ¦the¦ ¦de no min at or¦ ¦and¦ ¦an¦ ¦u pp er¦ ¦ bo un d¦ ¦using¦ ¦only¦ ¦cases¦ ¦with¦ ¦known¦ ¦out c ome¦ ¦st at us¦ ¦as¦ ¦the¦ ¦de no min at or¦ .
𐋇 ¦because¦ ¦of¦ ¦sm all¦ ¦sampl e¦ ¦s iz e¦ ¦and¦ ¦mi ss ing¦ ¦data¦ ¦on¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦among¦ ¦covid¦ - ¦19¦ ¦patients¦ ¦who¦ ¦d ied¦ ,▁ ¦case¦ - ¦fat ality¦ ¦r ates¦ ¦for¦ ¦pers ons¦ ¦with¦ ¦and¦ ¦without¦ ¦underlying¦ ¦conditions¦ ¦were¦ ¦not¦ ¦estim ated¦ .
𐋇¦as¦ ¦of¦ ¦march¦ ¦2 8¦ ,▁ ¦2020¦ ,▁ ¦a¦ ¦total¦ ¦of¦ ¦1 2 2¦ , ¦6 5 3¦ ¦laboratory¦ - ¦confirmed¦ ¦covid¦ - ¦19¦ ¦cases¦ ▁( ¦f ig ure¦ )▁ ¦and¦ ¦2¦ , ¦1 1 2¦ ¦deaths¦ ¦were¦ ¦reported¦ ¦to¦ ¦c dc¦ .
𐋇 ¦case¦ ¦report¦ ¦for ms¦ ¦were¦ ¦sub m it ted¦ ¦to¦ ¦c dc¦ ¦for¦ ¦7 4¦ , ¦4 3 9¦ ▁( ¦6 0¦ . ¦7¦ % )▁ ¦cases¦ .
𐋇 ¦data¦ ¦on¦ ¦pres ence¦ ¦or¦ ¦ab s ence¦ ¦of¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦and¦ ¦other¦ ¦reco gn i zed¦ ¦risk¦ ¦fa ctors¦ ¦for¦ ¦severe¦ ¦out c omes¦ ¦from¦ ¦respiratory¦ ¦infections¦ ▁( ¦i¦ . ¦ e¦ . ,▁ ¦s mo king¦ ¦and¦ ¦pregn a ncy¦ )▁ ¦were¦ ¦available¦ ¦for¦ ¦7¦ , ¦1 6 2¦ ▁( ¦5¦ . ¦8¦ % )▁ ¦patients¦ ▁( ¦t able¦ ¦1¦ ).
𐋇 ¦appro xi ma tely¦ ¦one¦ ¦thir d¦ ¦of¦ ¦these¦ ¦patients¦ ▁( ¦2¦ , ¦6 9 2¦ ,▁ ¦3 7¦ . ¦6¦ % ),▁ ¦had¦ ¦at¦ ¦least¦ ¦one¦ ¦underlying¦ ¦c ond ition¦ ¦or¦ ¦risk¦ ¦fa ct or¦ .
𐋇 ¦di ab e tes¦ ¦me ll it us¦ ▁( ¦7 8 4¦ ,▁ ¦10¦ . ¦9¦ % ),▁ ¦ch r on ic¦ ¦lu ng¦ ¦disease¦ ▁( ¦6 5 6¦ ,▁ ¦9¦ . ¦2¦ % ),▁ ¦and¦ ¦car di ov as c ular¦ ¦disease¦ ▁( ¦6 4 7¦ ,▁ ¦9¦ . ¦ 0¦ % )▁ ¦were¦ ¦the¦ ¦most¦ ¦fre qu e ntly¦ ¦reported¦ ¦conditions¦ ¦among¦ ¦all¦ ¦cases¦ .
𐋇 ¦among¦ ¦4 5 7¦ ¦ ic u¦ ¦ad m is si ons¦ ¦and¦ ¦1¦ , ¦0 3 7¦ ¦non¦ - ¦ ic u¦ ¦hosp it al iz ations¦ ,▁ ¦3 5 8¦ ▁( ¦7 8¦ % )▁ ¦and¦ ¦7 3 2¦ ▁( ¦7 1¦ % ),▁ ¦resp ect ively¦ ¦occur r ed¦ ¦among¦ ¦pers ons¦ ¦with¦ ¦one¦ ¦or¦ ¦more¦ ¦reported¦ ¦underlying¦ ¦health¦ ¦c ond ition¦ .
𐋇¦in¦ ¦contr ast¦ ,▁ ¦1¦ , ¦3 8 8¦ ¦of¦ ¦5¦ , ¦1 4 3¦ ▁( ¦2 7¦ % )▁ ¦covid¦ - ¦19¦ ¦patients¦ ¦who¦ ¦were¦ ¦not¦ ¦hosp i tali zed¦ ¦were¦ ¦reported¦ ¦to¦ ¦have¦ ¦at¦ ¦least¦ ¦one¦ ¦underlying¦ ¦health¦ ¦c ond ition¦ .
𐋇 ¦among¦ ¦patients¦ ¦a ged¦ ▁ ≥ ▁ ¦19¦ ¦years¦ ,▁ ¦the¦ ¦per ce nt age¦ ¦of¦ ¦non¦ - ¦ ic u¦ ¦hosp it al iz ations¦ ¦was¦ ¦higher¦ ¦among¦ ¦those¦ ¦with¦ ¦underlying¦ ¦health¦ ¦conditions¦ ▁( ¦2 7¦ . ¦3¦ % ▁–▁ ¦2 9¦ . ¦8¦ % )▁ ¦than¦ ¦among¦ ¦those¦ ¦without¦ ¦underlying¦ ¦health¦ ¦conditions¦ ▁( ¦7¦ . ¦2¦ % ▁–▁ ¦7¦ . ¦8¦ % ) ;▁ ¦the¦ ¦per ce nt age¦ ¦of¦ ¦cases¦ ¦that¦ ¦res ul ted¦ ¦in¦ ¦an¦ ¦ ic u¦ ¦ad mi ssion¦ ¦was¦ ¦also¦ ¦higher¦ ¦for¦ ¦those¦ ¦with¦ ¦underlying¦ ¦health¦ ¦conditions¦ ▁( ¦13¦ . ¦3¦ % ▁–▁ ¦14¦ . ¦5¦ % )▁ ¦than¦ ¦those¦ ¦without¦ ¦these¦ ¦conditions¦ ▁( ¦2¦ . ¦2¦ % ▁–▁ ¦2¦ . ¦4¦ % ) ▁( ¦t able¦ ¦2¦ ).
𐋇 ¦sm all¦ ¦nu mbers¦ ¦of¦ ¦covid¦ - ¦19¦ ¦patients¦ ¦a ged¦ ▁ & ▁ ¦l t¦ ;▁ ¦19¦ ¦years¦ ¦were¦ ¦reported¦ ¦to¦ ¦be¦ ¦hosp i tali zed¦ ▁( ¦4 8¦ )▁ ¦or¦ ¦ad m it ted¦ ¦to¦ ¦an¦ ¦ ic u¦ ▁( ¦e ight¦ ).
𐋇¦in¦ ¦contr ast¦ ,▁ ¦3 3 5¦ ¦patients¦ ¦a ged¦ ▁ & ▁ ¦l t¦ ;▁ ¦19¦ ¦years¦ ¦were¦ ¦not¦ ¦hosp i tali zed¦ ¦and¦ ¦1¦ , ¦3 4 2¦ ¦had¦ ¦mi ss ing¦ ¦data¦ ¦on¦ ¦hosp it al iz ation¦ .
𐋇 ¦among¦ ¦all¦ ¦covid¦ - ¦19¦ ¦patients¦ ¦with¦ ¦co mpl et e¦ ¦information¦ ¦on¦ ¦underlying¦ ¦conditions¦ ¦or¦ ¦risk¦ ¦fa ctors¦ ,▁ ¦1 8 4¦ ¦deaths¦ ¦occur r ed¦ ▁( ¦all¦ ¦among¦ ¦patients¦ ¦a ged¦ ▁ ≥ ▁ ¦19¦ ¦years¦ ) ;▁ ¦1 7 3¦ ¦deaths¦ ▁( ¦9 4¦ % )▁ ¦were¦ ¦reported¦ ¦among¦ ¦patients¦ ¦with¦ ¦at¦ ¦least¦ ¦one¦ ¦underlying¦ ¦c ond ition¦ .
𐋇 ¦among¦ ¦1 2 2¦ , ¦6 5 3¦ ¦u¦ . ¦s¦ .▁ ¦covid¦ - ¦19¦ ¦cases¦ ¦reported¦ ¦to¦ ¦c dc¦ ¦as¦ ¦of¦ ¦march¦ ¦2 8¦ ,▁ ¦2020¦ ,▁ ¦7¦ , ¦1 6 2¦ ▁( ¦5¦ . ¦8¦ % )▁ ¦patients¦ ¦had¦ ¦data¦ ¦available¦ ¦per t aining¦ ¦to¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦or¦ ¦pote ntial¦ ¦risk¦ ¦fa ctors¦ ;▁ ¦among¦ ¦these¦ ¦patients¦ ,▁ ¦higher¦ ¦p erc en ta ges¦ ¦of¦ ¦patients¦ ¦with¦ ¦underlying¦ ¦conditions¦ ¦were¦ ¦ad m it ted¦ ¦to¦ ¦the¦ ¦hospital¦ ¦and¦ ¦to¦ ¦an¦ ¦ ic u¦ ¦than¦ ¦patients¦ ¦without¦ ¦reported¦ ¦underlying¦ ¦conditions¦ .
𐋇¦these¦ ¦results¦ ¦are¦ ¦cons ist ent¦ ¦with¦ ¦fi nd ings¦ ¦from¦ ¦china¦ ¦and¦ ¦italy¦ ,▁ ¦which¦ ¦su gg est¦ ¦that¦ ¦patients¦ ¦with¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦and¦ ¦risk¦ ¦fa ctors¦ ,▁ ¦including¦ ,▁ ¦but¦ ¦not¦ ¦limi ted¦ ¦to¦ ,▁ ¦di ab e tes¦ ¦me ll it us¦ ,▁ ¦h y p er tens ion¦ ,▁ ¦c op d¦ ,▁ ¦corona ry¦ ¦ar te ry¦ ¦disease¦ ,▁ ¦ce re b r ov as c ular¦ ¦disease¦ ,▁ ¦ch r on ic¦ ¦r en al¦ ¦disease¦ ,▁ ¦and¦ ¦s mo king¦ ,▁ ¦might¦ ¦be¦ ¦at¦ ¦higher¦ ¦risk¦ ¦for¦ ¦severe¦ ¦disease¦ ¦or¦ ¦death¦ ¦from¦ ¦covid¦ - ¦19¦ .
𐋇¦this¦ ¦anal y sis¦ ¦was¦ ¦limi ted¦ ¦by¦ ¦sm all¦ ¦nu mbers¦ ¦and¦ ¦mi ss ing¦ ¦data¦ ¦because¦ ¦of¦ ¦the¦ ¦b ur d en¦ ¦pl ac ed¦ ¦on¦ ¦rep orting¦ ¦health¦ ¦de pa rt ments¦ ¦with¦ ¦rap id ly¦ ¦r ising¦ ¦case¦ ¦cou nts¦ ,▁ ¦and¦ ¦these¦ ¦fi nd ings¦ ¦might¦ ¦ch ange¦ ¦as¦ ¦ad di tional¦ ¦data¦ ¦bec ome¦ ¦available¦ .
𐋇¦it¦ ¦is¦ ¦not¦ ¦y et¦ ¦known¦ ¦wh ether¦ ¦the¦ ¦se ver ity¦ ¦or¦ ¦level¦ ¦of¦ ¦control¦ ¦of¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦aff ects¦ ¦the¦ ¦risk¦ ¦for¦ ¦severe¦ ¦disease¦ ¦associated¦ ¦with¦ ¦covid¦ - ¦19¦ .
𐋇 ¦many¦ ¦of¦ ¦these¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦are¦ ¦common¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ :▁ 𐋇 ¦based¦ ¦on¦ ¦self¦ - ¦reported¦ ¦20 1 8¦ ¦data¦ ,▁ ¦the¦ ¦prev al ence¦ ¦of¦ ¦diagn osed¦ ¦di ab e tes¦ ¦among¦ ¦u¦ . ¦s¦ .▁ ¦ad ul ts¦ ¦was¦ ¦10¦ . ¦1¦ % ,▁ ¦and¦ ¦the¦ ¦u¦ . ¦s¦ .▁ ¦age¦ - ¦ad j us ted¦ ¦prev al ence¦ ¦of¦ ¦all¦ ¦typ es¦ ¦of¦ ¦h ear t¦ ¦disease¦ ▁( ¦ex c lu ding¦ ¦h y p er tens ion¦ ¦without¦ ¦other¦ ¦h ear t¦ ¦disease¦ )▁ ¦was¦ ¦10¦ . ¦6¦ %▁ ¦in¦ ¦20 1 7¦ .
𐋇¦the¦ ¦age¦ - ¦ad j us ted¦ ¦prev al ence¦ ¦of¦ ¦c op d¦ ¦among¦ ¦u¦ . ¦s¦ .▁ ¦ad ul ts¦ ¦is¦ ¦5¦ . ¦9¦ % ,▁ ¦and¦ ¦in¦ ¦20 1 8¦ ,▁ ¦the¦ ¦u¦ . ¦s¦ .▁ ¦estim ated¦ ¦prev al ence¦ ¦of¦ ¦current¦ ¦as th m a¦ ¦among¦ ¦pers ons¦ ¦of¦ ¦all¦ ¦a ges¦ ¦was¦ ¦7¦ . ¦9¦ % .
𐋇¦c dc¦ ¦contin ues¦ ¦to¦ ¦develop ¦ ¦and¦ ¦up d ate¦ ¦res o ur ces¦ ¦for¦ ¦pers ons¦ ¦with¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦to¦ ¦reduce¦ ¦the¦ ¦risk¦ ¦of¦ ¦ac qu ir ing¦ ¦covid¦ - ¦19¦ .
𐋇¦the¦ ¦estim ated¦ ¦higher¦ ¦prev al ence¦ ¦of¦ ¦these¦ ¦conditions¦ ¦among¦ ¦those¦ ¦in¦ ¦this¦ ¦early¦ ¦group¦ ¦of¦ ¦u¦ . ¦s¦ .▁ ¦covid¦ - ¦19¦ ¦patients¦ ¦and¦ ¦the¦ ¦pote nt ially¦ ¦higher¦ ¦risk¦ ¦for¦ ¦more¦ ¦severe¦ ¦disease¦ ¦from¦ ¦covid¦ - ¦19¦ ¦associated¦ ¦with¦ ¦the¦ ¦pres ence¦ ¦of¦ ¦underlying¦ ¦conditions¦ ¦high l ight¦ ¦the¦ ¦imp ort ance¦ ¦of¦ ¦covid¦ - ¦19¦ ¦pre vention¦ ¦in¦ ¦pers ons¦ ¦with¦ ¦underlying¦ ¦conditions¦ .
𐋇¦the¦ ¦fi nd ings¦ ¦in¦ ¦this¦ ¦report¦ ¦are¦ ¦sub j ect¦ ¦to¦ ¦at¦ ¦least¦ ¦si x¦ ¦limi t ations¦ .
𐋇 ¦first¦ ,▁ ¦these¦ ¦data¦ ¦are¦ ¦pre li min ary¦ ,▁ ¦and¦ ¦the¦ ¦anal y sis¦ ¦was¦ ¦limi ted¦ ¦by¦ ¦mi ss ing¦ ¦data¦ ¦related¦ ¦to¦ ¦the¦ ¦health¦ ¦department¦ ¦rep orting¦ ¦b ur d en¦ ¦associated¦ ¦with¦ ¦rap id ly¦ ¦r ising¦ ¦case¦ ¦cou nts¦ ¦and¦ ¦del ays¦ ¦in¦ ¦co mpl et ion¦ ¦of¦ ¦information¦ ¦requir ing¦ ¦medical¦ ¦ch ar t¦ ¦re v ie w¦ ;▁ ¦these¦ ¦fi nd ings¦ ¦might¦ ¦ch ange¦ ¦as¦ ¦ad di tional¦ ¦data¦ ¦bec ome¦ ¦available¦ .
𐋇 ¦information¦ ¦on¦ ¦underlying¦ ¦conditions¦ ¦was¦ ¦only¦ ¦available¦ ¦for¦ ¦7¦ , ¦1 6 2¦ ▁( ¦5¦ . ¦8¦ % )▁ ¦of¦ ¦1 2 2¦ , ¦6 5 3¦ ¦cases¦ ¦reported¦ ¦to¦ ¦c dc¦ .
𐋇¦it¦ ¦cannot¦ ¦be¦ ¦ass u med¦ ¦that¦ ¦those¦ ¦with¦ ¦mi ss ing¦ ¦information¦ ¦are¦ ¦similar¦ ¦to¦ ¦those¦ ¦with¦ ¦data¦ ¦on¦ ¦e it her¦ ¦hosp it al iz ations¦ ¦or¦ ¦underlying¦ ¦health¦ ¦conditions¦ .
𐋇 ¦second¦ ,▁ ¦these¦ ¦data¦ ¦are¦ ¦sub j ect¦ ¦to¦ ¦b ia s¦ ¦in¦ ¦out c ome¦ ¦as c er ta in ment¦ ¦because¦ ¦of¦ ¦sh ort¦ ¦follow¦ - ¦up¦ ¦time¦ .
𐋇¦some¦ ¦out c omes¦ ¦might¦ ¦be¦ ¦under e st im ated¦ ,▁ ¦and¦ ¦long¦ - ¦ter m¦ ¦out c omes¦ ¦cannot¦ ¦be¦ ¦ass es sed¦ ¦in¦ ¦this¦ ¦anal y sis¦ .
𐋇 ¦thir d¦ ,▁ ¦because¦ ¦of¦ ¦the¦ ¦limi ted¦ ¦a v ai la bility¦ ¦of¦ ¦testing¦ ¦in¦ ¦many¦ ¦j ur is d ic tions¦ ¦during¦ ¦this¦ ¦period¦ ,▁ ¦this¦ ¦anal y sis¦ ¦is¦ ¦likely¦ ¦b ia sed¦ ¦t ow ard¦ ¦more¦ ¦severe¦ ¦cases¦ ,▁ ¦and¦ ¦fi nd ings¦ ¦might¦ ¦ch ange¦ ¦as¦ ¦testing¦ ¦bec omes¦ ¦more¦ ¦wid esp r ead¦ .
𐋇 ¦fo ur th¦ ,▁ ¦because¦ ¦of¦ ¦the¦ ¦d esc r ip tive¦ ¦nat ure¦ ¦of¦ ¦these¦ ¦data¦ ,▁ ¦att ack¦ ¦r ates¦ ¦among¦ ¦pers ons¦ ¦with¦ ¦and¦ ¦without¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦could¦ ¦not¦ ¦be¦ ¦comp ared¦ ,▁ ¦and¦ ¦th us¦ ¦the¦ ¦risk¦ ¦di ff er ence¦ ¦of¦ ¦severe¦ ¦disease¦ ¦with¦ ¦covid¦ - ¦19¦ ¦between¦ ¦these¦ ¦grou ps¦ ¦could¦ ¦not¦ ¦be¦ ¦estim ated¦ .
𐋇¦f if th¦ ,▁ ¦no¦ ¦co nc lu si ons¦ ¦could¦ ¦be¦ ¦d ra w n¦ ¦about¦ ¦underlying¦ ¦conditions¦ ¦that¦ ¦were¦ ¦not¦ ¦inclu ded¦ ¦in¦ ¦the¦ ¦case¦ ¦report¦ ¦for m¦ ¦or¦ ¦about¦ ¦different¦ ¦conditions¦ ¦that¦ ¦were¦ ¦reported¦ ¦in¦ ¦a¦ ¦si ng le¦ ,▁ ¦u mb re ll a¦ ¦ca te g ory¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦as th m a¦ ¦and¦ ¦c op d¦ ¦were¦ ¦inclu ded¦ ¦in¦ ¦a¦ ¦ch r on ic¦ ¦lu ng¦ ¦disease¦ ¦ca te g ory¦ .
𐋇¦f in ally¦ ,▁ ¦for¦ ¦some¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦and¦ ¦risk¦ ¦fa ctors¦ ,▁ ¦including¦ ¦ne ur ol og ic¦ ¦dis or d ers¦ ,▁ ¦ch r on ic¦ ¦li ver¦ ¦disease¦ ,▁ ¦being¦ ¦a¦ ¦current¦ ¦s mo k er¦ ,▁ ¦and¦ ¦pregn a ncy¦ ,▁ ¦fe w¦ ¦severe¦ ¦out c omes¦ ¦were¦ ¦reported¦ ;▁ ¦the re f ore¦ ,▁ ¦co nc lu si ons¦ ¦cannot¦ ¦be¦ ¦d ra w n¦ ¦about¦ ¦the¦ ¦risk¦ ¦for¦ ¦severe¦ ¦covid¦ - ¦19¦ ¦among¦ ¦pers ons¦ ¦in¦ ¦these¦ ¦grou ps¦ .
𐋇 ¦pers ons¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ¦with¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦app ear¦ ¦to¦ ¦be¦ ¦at¦ ¦higher¦ ¦risk¦ ¦for¦ ¦more¦ ¦severe¦ ¦covid¦ - ¦19¦ ,▁ ¦cons ist ent¦ ¦with¦ ¦fi nd ings¦ ¦from¦ ¦other¦ ¦countries¦ .
𐋇 ¦pers ons¦ ¦with¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦who¦ ¦have¦ ¦symptoms¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦including¦ ¦fever¦ ,▁ ¦cough¦ ,▁ ¦or¦ ¦sh ort ness¦ ¦of¦ ¦brea th¦ ,▁ ¦should¦ ¦imm ed ia tely¦ ¦contact¦ ¦their¦ ¦health¦ ¦care¦ ¦provid er¦ .
𐋇¦these¦ ¦pers ons¦ ¦should¦ ¦take¦ ¦ste ps¦ ¦to¦ ¦protect¦ ¦the m s el ves¦ ¦from¦ ¦covid¦ - ¦19¦ ,▁ ¦through¦ ¦washing¦ ¦their¦ ¦hands¦ ;▁ ¦cl ea ning¦ ¦and¦ ¦disinf ecting¦ ¦high¦ - ¦tou ch¦ ¦sur fa ces¦ ;▁ ¦and¦ ¦social¦ ¦distancing¦ ,▁ ¦including¦ ¦sta ying¦ ¦at¦ ¦home¦ ,▁ ¦a v oi ding¦ ¦cr ow ds¦ ,▁ ¦ga ther ings¦ ,▁ ¦and¦ ¦travel¦ ,▁ ¦and¦ ¦a v oi ding¦ ¦contact¦ ¦with¦ ¦pers ons¦ ¦who¦ ¦are¦ ¦ ill¦ .
𐋇¦m ai nt aining¦ ¦at¦ ¦least¦ ¦a¦ ¦30¦ - ¦day¦ ¦supp ly¦ ¦of¦ ¦medic ation¦ ,▁ ¦a¦ ¦2¦ - ¦week¦ ¦supp ly¦ ¦of¦ ¦food¦ ¦and¦ ¦other¦ ¦ne cess ities¦ ,▁ ¦and¦ ¦k n ow l ed ge¦ ¦of¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ¦are¦ ¦recommended¦ ¦for¦ ¦those¦ ¦with¦ ¦underlying¦ ¦health¦ ¦conditions¦ .
𐋇 ¦all¦ ¦pers ons¦ ¦should¦ ¦take¦ ¦ste ps¦ ¦to¦ ¦protect¦ ¦the m s el ves¦ ¦from¦ ¦covid¦ - ¦19¦ ¦and¦ ¦to¦ ¦protect¦ ¦others¦ .
𐋇 ¦all¦ ¦pers ons¦ ¦who¦ ¦are¦ ¦ ill¦ ¦should¦ ¦stay¦ ¦home¦ ,▁ ¦ex cep t¦ ¦to¦ ¦get¦ ¦medical¦ ¦care¦ ;▁ ¦should¦ ¦not¦ ¦go¦ ¦to¦ ¦work¦ ;▁ ¦and¦ ¦should¦ ¦stay¦ ¦away¦ ¦from¦ ¦others¦ .
𐋇¦this¦ ¦is¦ ¦especially¦ ¦important¦ ¦for¦ ¦those¦ ¦who¦ ¦work¦ ¦with¦ ¦pers ons¦ ¦with¦ ¦underlying¦ ¦conditions¦ ¦or¦ ¦who¦ ¦o ther w ise¦ ¦are¦ ¦at¦ ¦high¦ ¦risk¦ ¦for¦ ¦severe¦ ¦out c omes¦ ¦from¦ ¦covid¦ - ¦19¦ .
𐋇 ¦community¦ ¦m it ig ation¦ ¦stra te g ies¦ ,▁ ¦which¦ ¦ ai m¦ ¦to¦ ¦sl ow¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦are¦ ¦important¦ ¦to¦ ¦protect¦ ¦all¦ ¦pers ons¦ ¦from¦ ¦covid¦ - ¦19¦ ,▁ ¦especially¦ ¦pers ons¦ ¦with¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦and¦ ¦other¦ ¦pers ons¦ ¦at¦ ¦risk¦ ¦for¦ ¦severe¦ ¦covid¦ - ¦19¦ ▁–▁ ¦associated¦ ¦disease¦ ▁( ¦h t t ps¦ :▁ / ▁/▁ ¦w w w¦ . ¦c dc¦ . ¦g ov ¦ ▁/▁ ¦coronavirus¦ ▁/▁ ¦2019¦ - ¦n cov ¦ ▁/▁ ¦d ow n lo a ds¦ ▁/▁ ¦community¦ - ¦m it ig ation¦ - ¦stra te g y¦ . ¦p d f¦ ).
𐋇 ¦what¦ ¦is¦ ¦al rea dy¦ ¦known¦ ¦about¦ ¦this¦ ¦t op ic¦ ?
𐋇 ¦publ ished¦ ¦rep orts¦ ¦from¦ ¦china¦ ¦and¦ ¦italy¦ ¦su gg est¦ ¦that¦ ¦risk¦ ¦fa ctors¦ ¦for¦ ¦severe¦ ¦covid¦ - ¦19¦ ¦disease¦ ¦include¦ ¦underlying¦ ¦health¦ ¦conditions¦ ,▁ ¦but¦ ¦data¦ ¦d esc rib ing¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦among¦ ¦u¦ . ¦s¦ .▁ ¦covid¦ - ¦19¦ ¦patients¦ ¦have¦ ¦not¦ ¦y et¦ ¦been¦ ¦reported¦ .
𐋇 ¦what¦ ¦is¦ ¦ad ded¦ ¦by¦ ¦this¦ ¦report¦ ?
𐋇 ¦based¦ ¦on¦ ¦pre li min ary¦ ¦u¦ . ¦s¦ .▁ ¦data¦ ,▁ ¦pers ons¦ ¦with¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦such¦ ¦as¦ ¦di ab e tes¦ ¦me ll it us¦ ,▁ ¦ch r on ic¦ ¦lu ng¦ ¦disease¦ ,▁ ¦and¦ ¦car di ov as c ular¦ ¦disease¦ ,▁ ¦app ear¦ ¦to¦ ¦be¦ ¦at¦ ¦higher¦ ¦risk¦ ¦for¦ ¦severe¦ ¦covid¦ - ¦19¦ ▁–▁ ¦associated¦ ¦disease¦ ¦than¦ ¦pers ons¦ ¦without¦ ¦these¦ ¦conditions¦ .
𐋇 ¦what¦ ¦are¦ ¦the¦ ¦i mpl ications¦ ¦for¦ ¦public¦ ¦health¦ ¦pract ice¦ ?
𐋇 ¦stra te g ies¦ ¦to¦ ¦protect¦ ¦all¦ ¦pers ons¦ ¦and¦ ¦especially¦ ¦those¦ ¦with¦ ¦underlying¦ ¦health¦ ¦conditions¦ ,▁ ¦including¦ ¦social¦ ¦distancing¦ ¦and¦ ¦hand w as hing¦ ,▁ ¦should¦ ¦be¦ ¦imp le m ented¦ ¦by¦ ¦all¦ ¦comm un ities¦ ¦and¦ ¦all¦ ¦pers ons¦ ¦to¦ ¦help¦ ¦sl ow¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇¦e mer g ence¦ ¦of¦ ¦a¦ ¦novel¦ ¦coronavirus¦ ▁( ¦covid¦ - ¦19¦ ) :▁ 𐋇 ¦prot oc o l¦ ¦for¦ ¦ext ending¦ ¦surveillance¦ ¦used¦ ¦by¦ ¦the¦ ¦ro y al¦ ¦colle ge¦ ¦of¦ ¦general¦ ¦practi tion ers¦ ¦research¦ ¦and¦ ¦surveillance¦ ¦centre¦ ¦and¦ ¦public¦ ¦health¦ ¦e ng land¦
𐋇¦the¦ ¦ro y al¦ ¦colle ge¦ ¦of¦ ¦general¦ ¦practi tion ers¦ ▁( ¦r c g p¦ )▁ ¦research¦ ¦and¦ ¦surveillance¦ ¦centre¦ ▁( ¦ rs c¦ )▁ ¦and¦ ¦public¦ ¦health¦ ¦e ng land¦ ▁( ¦ph e¦ )▁ ¦have¦ ¦s uc cess f ul ly¦ ¦wor ked¦ ¦t og ether¦ ¦on¦ ¦the¦ ¦surveillance¦ ¦of¦ ¦influenza¦ ¦and¦ ¦other¦ ¦infectious¦ ¦diseases¦ ¦for¦ ¦over¦ ¦50¦ ¦years¦ ,▁ ¦including¦ ¦three¦ ¦prev ious¦ ¦p an de m ics¦ .
𐋇 ¦with¦ ¦the¦ ¦e mer g ence¦ ¦of¦ ¦the¦ ¦international¦ ¦outbreak¦ ¦of¦ ¦the¦ ¦coronavirus¦ ¦infection¦ ▁( ¦covid¦ - ¦19¦ ),▁ ¦a¦ ¦uk¦ ¦national¦ ¦appro a ch¦ ¦to¦ ¦conta in ment¦ ¦has¦ ¦been¦ ¦ es ta bl ished¦ ¦to¦ ¦test¦ ¦people¦ ¦suspected¦ ¦of¦ ¦exp osure¦ ¦to¦ ¦covid¦ - ¦19¦ .
𐋇 ¦at¦ ¦the¦ ¦same¦ ¦time¦ ¦and¦ ¦separ a tely¦ ,▁ ¦the¦ ¦r c g p¦ ¦ rs c¦ ▁’▁ ¦s¦ ¦surveillance¦ ¦has¦ ¦been¦ ¦ex te nded¦ ¦to¦ ¦monit or¦ ¦the¦ ¦temp or al¦ ¦and¦ ¦ ge ogra ph ical¦ ¦d ist rib ution¦ ¦of¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦in¦ ¦the¦ ¦community¦ ¦as¦ ¦well¦ ¦as¦ ¦ass ess¦ ¦the¦ ¦eff ec ti ve ness¦ ¦of¦ ¦the¦ ¦conta in ment¦ ¦stra te g y¦ .
𐋇¦the¦ ¦ ai ms¦ ¦of¦ ¦this¦ ¦study¦ ¦are¦ ¦to¦ ¦sur ve il¦ ¦covid¦ - ¦19¦ ¦in¦ ¦both¦ ¦as ymptomatic¦ ¦p op ul ations¦ ¦and¦ ¦a mb ul atory¦ ¦cases¦ ¦with¦ ¦respiratory¦ ¦infections¦ ,▁ ¦as c er tain¦ ¦both¦ ¦the¦ ¦rate¦ ¦and¦ ¦p at t er n¦ ¦of¦ ¦covid¦ - ¦19¦ ¦spread¦ ,▁ ¦and¦ ¦ass ess¦ ¦the¦ ¦eff ec ti ve ness¦ ¦of¦ ¦the¦ ¦conta in ment¦ ¦pol ic y¦ .
𐋇¦the¦ ¦r c g p¦ ¦ rs c¦ ,▁ ¦a¦ ¦n et w or k¦ ¦of¦ ¦over¦ ¦5 00¦ ¦general¦ ¦practi ces¦ ¦in¦ ¦e ng land¦ ,▁ ¦ext r ac t¦ ¦p se ud on y mi zed¦ ¦data¦ ¦w ee k ly¦ .
𐋇¦this¦ ¦ex te nded¦ ¦surveillance¦ ¦comp ri ses¦ ¦of¦ ¦five¦ ¦comp on ents¦ : ▁( ¦1¦ )▁ ¦recor ding¦ ¦in¦ ¦medical¦ ¦recor ds¦ ¦of¦ ¦an yone¦ ¦suspected¦ ¦to¦ ¦have¦ ¦or¦ ¦who¦ ¦has¦ ¦been¦ ¦exp osed¦ ¦to¦ ¦covid¦ - ¦19¦ .
𐋇 ¦comp ut eri zed¦ ¦medical¦ ¦recor ds¦ ¦supp li ers¦ ¦have¦ ¦within¦ ¦a¦ ¦week¦ ¦of¦ ¦re qu est¦ ¦cre ated¦ ¦new¦ ¦co des¦ ¦to¦ ¦support¦ ¦this¦ .
( ¦2¦ )▁ ¦ex tens ion¦ ¦of¦ ¦current¦ ¦vir ological¦ ¦surveillance¦ ¦and¦ ¦testing¦ ¦people¦ ¦with¦ ¦influenza¦ - ¦like¦ ¦illness¦ ¦or¦ ¦lower¦ ¦respiratory¦ ¦trac t¦ ¦infections¦ ▁( ¦l rt i¦ )▁ — ▁ ¦with¦ ¦the¦ ¦ca ve at¦ ¦that¦ ¦people¦ ¦suspected¦ ¦to¦ ¦have¦ ¦or¦ ¦who¦ ¦have¦ ¦been¦ ¦exp osed¦ ¦to¦ ¦covid¦ - ¦19¦ ¦should¦ ¦be¦ ¦ref er r ed¦ ¦to¦ ¦the¦ ¦national¦ ¦conta in ment¦ ¦path w ay¦ ¦and¦ ¦not¦ ¦se en¦ ¦in¦ ¦pr imary¦ ¦care¦ .
( ¦3¦ )▁ ¦ser ology¦ ¦sampl e¦ ¦colle ction¦ ¦across¦ ¦all¦ ¦age¦ ¦grou ps¦ .
𐋇¦this¦ ¦will¦ ¦be¦ ¦an¦ ¦ext r a¦ ¦blood¦ ¦sampl e¦ ¦ta k en¦ ¦from¦ ¦people¦ ¦who¦ ¦are¦ ¦att ending¦ ¦their¦ ¦general¦ ¦pract ice¦ ¦for¦ ¦a¦ ¦s ch ed ul ed¦ ¦blood¦ ¦test¦ .
𐋇¦the¦ ¦100¦ ¦general¦ ¦practi ces¦ ¦cur re ntly¦ ¦under ta king¦ ¦an n ual¦ ¦influenza¦ ¦vir ology¦ ¦surveillance¦ ¦will¦ ¦be¦ ¦invol v ed¦ ¦in¦ ¦the¦ ¦ex te nded¦ ¦vir ological¦ ¦and¦ ¦ser ological¦ ¦surveillance¦ .
( ¦4¦ )▁ ¦coll ecting¦ ¦con v al esc ent¦ ¦ser um¦ ¦samples¦ .
𐋇¦we¦ ¦have¦ ¦the¦ ¦o pp ort un ity¦ ¦to¦ ¦ esc al ate¦ ¦the¦ ¦data¦ ¦ext ra ction¦ ¦to¦ ¦t w ice¦ ¦w ee k ly¦ ¦if¦ ¦nee ded¦ .
𐋇 ¦sw ab s¦ ¦and¦ ¦ser a¦ ¦will¦ ¦be¦ ¦anal y zed¦ ¦in¦ ¦ph e¦ ¦ref er ence¦ ¦la bor at or ies¦ .
𐋇 ¦general¦ ¦pract ice¦ ¦clinical¦ ¦system¦ ¦provid ers¦ ¦have¦ ¦int ro duc ed¦ ¦an¦ ¦emergency¦ ¦new¦ ¦s et¦ ¦of¦ ¦clinical¦ ¦co des¦ ¦to¦ ¦support¦ ¦covid¦ - ¦19¦ ¦surveillance¦ .
𐋇 ¦ad di tion ally¦ ,▁ ¦practi ces¦ ¦partic ip ating¦ ¦in¦ ¦current¦ ¦vir ology¦ ¦surveillance¦ ¦are¦ ¦n ow¦ ¦ta king¦ ¦samples¦ ¦for¦ ¦covid¦ - ¦19¦ ¦surveillance¦ ¦from¦ ¦low¦ - ¦risk¦ ¦patients¦ ¦pres en ting¦ ¦with¦ ¦l r ti s¦ .
𐋇 ¦within¦ ¦the¦ ¦first¦ ¦2¦ ¦weeks¦ ¦of¦ ¦s et u p¦ ¦of¦ ¦this¦ ¦surveillance¦ ,▁ ¦we¦ ¦have¦ ¦identified¦ ¦3¦ ¦cases¦ :▁ ¦1¦ ¦through¦ ¦the¦ ¦new¦ ¦co ding¦ ¦system¦ ,▁ ¦the¦ ¦other¦ ¦2¦ ¦through¦ ¦the¦ ¦ex te nded¦ ¦vir ology¦ ¦sampl ing¦ .
𐋇¦we¦ ¦have¦ ¦rap id ly¦ ¦con ver ted¦ ¦the¦ ¦ es ta bl ished¦ ¦national¦ ¦r c g p¦ ¦ rs c¦ ¦influenza¦ ¦surveillance¦ ¦system¦ ¦into¦ ¦one¦ ¦that¦ ¦can¦ ¦test¦ ¦the¦ ¦eff ec ti ve ness¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦conta in ment¦ ¦pol ic y¦ .
𐋇¦the¦ ¦ex te nded¦ ¦surveillance¦ ¦has¦ ¦al rea dy¦ ¦se en¦ ¦the¦ ¦use¦ ¦of¦ ¦new¦ ¦co des¦ ¦with¦ ¦3¦ ¦cases¦ ¦reported¦ .
𐋇 ¦rap id¦ ¦sh ar ing¦ ¦of¦ ¦this¦ ¦prot oc o l¦ ¦should¦ ¦en able¦ ¦sc ie nt if ic¦ ¦crit i q ue¦ ¦and¦ ¦sh ared¦ ¦learning¦ .
𐋇¦the¦ ¦ro y al¦ ¦colle ge¦ ¦of¦ ¦general¦ ¦practi tion ers¦ ▁( ¦r c g p¦ )▁ ¦research¦ ¦and¦ ¦surveillance¦ ¦centre¦ ▁( ¦ rs c¦ )▁ ¦is¦ ¦a¦ ¦n et w or k¦ ¦of¦ ¦general¦ ¦practi ces¦ ▁( ¦g ps¦ )▁ ¦with¦ ¦a¦ ¦na tion ally¦ ¦rep re se nt ative¦ ¦population¦ ¦that¦ ¦provid es¦ ¦p se ud on y mi zed¦ ¦data¦ ¦for¦ ¦w ee k ly¦ ¦surveillance¦ ¦of¦ ¦infectious¦ ¦diseases¦ .
𐋇¦the¦ ¦disease¦ ¦surveillance¦ ¦pr ogra m¦ ¦is¦ ¦comm is si o ned¦ ¦by¦ ¦public¦ ¦health¦ ¦e ng land¦ ▁( ¦ph e¦ )▁ ¦and¦ ¦cov ers¦ ¦3 7¦ ¦infectious¦ ¦diseases¦ ,▁ ¦including¦ ¦influenza¦ .
𐋇¦the¦ ¦r c g p¦ ¦ rs c¦ ¦and¦ ¦ph e¦ ¦have¦ ¦an¦ ¦ es ta bl ished¦ ¦coll a bor ation¦ ¦of¦ ¦over¦ ¦50¦ ¦years¦ ¦in¦ ¦influenza¦ ¦and¦ ¦respiratory¦ ¦disease¦ ¦surveillance¦ ¦and¦ ¦are¦ ¦n ow¦ ¦in¦ ¦their¦ ¦5 3 r d¦ ¦se as on¦ ¦of¦ ¦surveillance¦ ¦and¦ ¦anal y sis¦ .
𐋇¦the¦ ¦r c g p¦ ¦ rs c¦ ¦ext r ac ts¦ ¦p se ud on y mi zed¦ ¦data¦ ¦from¦ ¦a¦ ¦na tion ally¦ ¦rep re se nt ative¦ ¦sampl e¦ ¦of¦ ¦over¦ ¦5 00¦ ¦ ur b an¦ ¦and¦ ¦n on ur b an¦ ¦g ps¦ ¦each¦ ¦week¦ ¦cov ering¦ ¦a¦ ¦population¦ ¦of¦ ¦over¦ ¦4¦ ¦million¦ .
𐋇 ¦data¦ ¦from¦ ¦these¦ ¦practi ces¦ ¦are¦ ¦reported¦ ¦online¦ ¦in¦ ¦a¦ ¦w ee k ly¦ ¦retur n¦ ,▁ ¦which¦ ¦inclu des¦ ¦monit or ing¦ ¦w ee k ly¦ ¦r ates¦ ¦of¦ ¦influenza¦ - ¦like¦ ¦illness¦ ▁( ¦ il i¦ )▁ ¦and¦ ¦other¦ ¦comm un ic able¦ ¦and¦ ¦respiratory¦ ¦diseases¦ ¦in¦ ¦e ng land¦ .
𐋇¦we¦ ¦also¦ ¦produc e¦ ¦an¦ ¦an n ual¦ ¦report¦ .
𐋇¦the¦ ¦r c g p¦ ¦ rs c¦ ¦data¦ ¦s et¦ ¦inclu des¦ ¦all¦ ¦co ded¦ ¦data¦ ¦and¦ ¦all¦ ¦pr esc rib ed¦ ¦i tems¦ ¦including¦ ¦vaccine¦ ¦exp osure¦ .
𐋇¦the¦ ¦r c g p¦ ¦ rs c¦ ¦con duc ts¦ ¦vir ology¦ ¦surveillance¦ ¦each¦ ¦influenza¦ ¦se as on¦ ,▁ ¦with¦ ¦100¦ ¦g ps¦ ¦partic ip ating¦ ¦in¦ ¦the¦ ¦2019¦ - ¦2020¦ ¦se as on¦ ▁( ¦f ig ure¦ ¦1¦ ).
𐋇¦these¦ ¦vir ology¦ ¦sampl ing¦ ¦practi ces¦ ¦are¦ ¦also¦ ¦rec ru i ted¦ ¦to¦ ¦be¦ ¦na tion ally¦ ¦rep re se nt ative¦ ▁( ¦f ig ure¦ ¦1¦ ).
𐋇 ¦g ps¦ ¦take¦ ¦n as o ph ar y n ge al¦ ¦sw ab s¦ ¦from¦ ¦pers ons¦ ¦sh owing¦ ¦acute¦ ¦respiratory¦ ¦illness¦ ¦within¦ ¦7¦ ¦days¦ ¦of¦ ¦the¦ ¦o ns et¦ ¦of¦ ¦symptoms¦ .
𐋇¦n as o ph ar y n ge al¦ ¦sw ab s¦ ¦are¦ ¦ta k en¦ ¦from¦ ¦children¦ ¦y ou nger¦ ¦than¦ ¦5¦ ¦years¦ ¦sh owing¦ ¦symptoms¦ ¦of¦ ¦acute¦ ¦br on ch itis¦ ¦or¦ ¦b ro nc hi ol itis¦ .
𐋇 ¦ad di tion ally¦ ,▁ ¦n as o ph ar y n ge al¦ ¦samples¦ ¦are¦ ¦ta k en¦ ¦from¦ ¦an yone¦ ¦5¦ ¦years¦ ¦and¦ ¦ ol der¦ ¦sh owing¦ ¦acute¦ ¦o ns et¦ ¦of¦ ¦ il i¦ ¦and¦ ¦respiratory¦ ¦s y n ct ial¦ ¦virus¦ .
𐋇 ¦sw ab s¦ ¦are¦ ¦tested¦ ¦at¦ ¦the¦ ¦ph e¦ ¦respiratory¦ ¦virus¦ ¦uni t¦ ¦for¦ ¦influenza¦ ¦to¦ ¦monit or¦ ¦p os it iv ity¦ ¦r ates¦ ¦and¦ ¦c ir c ul ating¦ ¦stra ins¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦for¦ ¦me as ur ing¦ ¦vaccine¦ ¦eff ec ti ve ness¦ .
𐋇¦the¦ ¦r c g p¦ ¦ rs c¦ ¦s uc cess f ul ly¦ ¦con duc ted¦ ¦a¦ ¦p il ot¦ ¦coll ecting¦ ¦ser ological¦ ¦samples¦ ¦from¦ ¦ad ul ts¦ ¦and¦ ¦l in king¦ ¦them¦ ¦to¦ ¦a¦ ¦pa ti ent¦ ▁’▁ ¦s¦ ¦medical¦ ¦recor ds¦ ¦during¦ ¦the¦ ¦20 1 8¦ - ¦2019¦ ¦influenza¦ ¦se as on¦ .
𐋇¦this¦ ¦p il ot¦ ¦was¦ ¦in¦ ¦coll a bor ation¦ ¦with¦ ¦the¦ ¦ph e¦ ¦se ro e p ide mi ology¦ ¦uni t¦ ¦and¦ ¦ad ded¦ ¦to¦ ¦the¦ ¦res id ual¦ ¦blood¦ ¦samples¦ ¦sub m it ted¦ ¦to¦ ¦ph e¦ ¦by¦ ¦national¦ ¦health¦ ¦service¦ ▁( ¦n h s¦ )▁ ¦la bor at or ies¦ .
𐋇 ¦ser ology¦ ¦can¦ ¦provide¦ ¦important¦ ¦information¦ ¦about¦ ¦b ac k g ro un d¦ ¦population¦ ¦immun ity¦ ,▁ ¦and¦ ¦sen ti ne l¦ ¦n et w or ks¦ ¦can¦ ¦provide¦ ¦a¦ ¦me ch an is m¦ ¦for¦ ¦sys te m at ic¦ ¦data¦ ¦colle ction¦ ¦and¦ ¦l in k age¦ ¦to¦ ¦medical¦ ¦recor ds¦ ¦and¦ ¦health¦ ¦out c omes¦ .
𐋇¦the¦ ¦ser ology¦ ¦p il ot¦ ¦has¦ ¦dem on str ated¦ ¦the¦ ¦a bility¦ ¦of¦ ¦the¦ ¦n et w or k¦ ¦to¦ ¦coll ect¦ ¦ser ology¦ ¦samples¦ ¦in¦ ¦ad ul ts¦ .
𐋇 ¦with¦ ¦the¦ ¦covid¦ - ¦19¦ ¦outbreak¦ ,▁ ¦ph e¦ ¦and¦ ¦r c g p¦ ¦ rs c¦ ¦have¦ ¦ad ap ted¦ ¦ex is ting¦ ¦influenza¦ ¦surveillance¦ ¦to¦ ¦monit or¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦the¦ ¦community¦ ,▁ ¦and¦ ¦this¦ ¦prot oc o l¦ ¦s ets¦ ¦out¦ ¦the¦ ¦ba sis¦ ¦for¦ ¦that¦ ¦coll a bor ation¦ .
𐋇¦the¦ ¦pr imary¦ ¦national¦ ¦stra te g y¦ ¦for¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦is¦ ¦conta in ment¦ ,▁ ¦with¦ ¦patients¦ ¦who¦ ¦are¦ ¦at¦ ¦high¦ ¦risk¦ ¦mana ged¦ ¦v ia¦ ¦the¦ ¦te le ph one¦ ¦help¦ ¦system¦ ¦n h s 1 1 1¦ ¦and¦ ¦the¦ ¦ph e¦ ¦health¦ ¦prote ction¦ ¦t ea ms¦ ,▁ ¦but¦ ¦the¦ ¦r c g p¦ ¦ rs c¦ ¦surveillance¦ ¦is¦ ¦ent ir ely¦ ¦separ ate¦ .
𐋇¦the¦ ¦r c g p¦ ¦ rs c¦ ,▁ ¦by¦ ¦ext ending¦ ¦its¦ ¦ es ta bl ished¦ ¦work¦ ,▁ ¦will¦ ¦provide¦ ¦vir ological¦ ¦and¦ ¦ser ological¦ ¦surveillance¦ ¦to¦ ¦monit or¦ ¦the¦ ¦temp or al¦ ¦and¦ ¦ ge ogra ph ical¦ ¦d ist rib ution¦ ¦of¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦in¦ ¦the¦ ¦community¦ ,▁ ¦and¦ ¦ass ess¦ ¦the¦ ¦eff ec ti ve ness¦ ¦of¦ ¦the¦ ¦conta in ment¦ ¦stra te g y¦ .
𐋇¦we¦ ¦would¦ ¦not¦ ¦be¦ ¦wor king¦ ¦in¦ ¦isolation¦ ¦on¦ ¦this¦ ¦research¦ .
𐋇¦we¦ ¦will¦ ¦share¦ ¦the¦ ¦prot oc o l¦ ¦with¦ ¦uk¦ ¦coll ea g ues¦ ¦and¦ ¦the¦ ¦i¦ - ¦mo ve¦ ¦cons or ti um¦ ¦who¦ ¦have¦ ¦rece ntly¦ ¦ob ta ined¦ ¦eu¦ ¦h or iz on¦ ¦2020¦ ¦f un ding¦ ¦from¦ ¦the¦ ¦st re am¦ ▁ “ ¦ad v a ncing¦ ¦k n ow l ed ge¦ ¦for¦ ¦the¦ ¦clinical¦ ¦and¦ ¦public¦ ¦health¦ ¦response¦ ¦to¦ ¦the¦ ¦novel¦ ¦coronavirus¦ ¦epidemic¦ ▁ ” .
𐋇¦it¦ ¦is¦ ¦anti c ip ated¦ ¦that¦ ¦g re at¦ ¦eff ic ie nc ies¦ ¦in¦ ¦pro j ect¦ ¦mana ge ment¦ ¦will¦ ¦result¦ ¦through¦ ¦this¦ ¦coll a bor ation¦ ¦than¦ ¦that¦ ¦ob ta ined¦ ¦from¦ ¦countries¦ ¦ac ting¦ ¦al one¦ .
𐋇¦the¦ ¦ ai m¦ ¦of¦ ¦this¦ ¦study¦ ¦is¦ ¦to¦ ¦ident if y¦ ¦wh ether¦ ¦there¦ ¦is¦ ¦u nd et ected¦ ¦community¦ ¦transmission¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦estim ate¦ ¦population¦ ¦s us cep ti bility¦ ,▁ ¦and¦ ¦monit or¦ ¦the¦ ¦temp or al¦ ¦and¦ ¦ ge ogra ph ical¦ ¦d ist rib ution¦ ¦of¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦in¦ ¦the¦ ¦community¦ .
𐋇¦the¦ ¦ob j ect ives¦ ¦of¦ ¦this¦ ¦study¦ ¦are¦ ¦as¦ ¦fo ll ow s¦ :
𐋇¦to¦ ¦monit or¦ ¦the¦ ¦b ur d en¦ ¦of¦ ¦suspected¦ ¦covid¦ - ¦19¦ ¦activ ity¦ ¦in¦ ¦the¦ ¦community¦ ¦through¦ ¦pr imary¦ ¦care¦ ¦surveillance¦ ¦and¦ ¦clinical¦ ¦co ding¦ ¦of¦ ¦possible¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦ref er r ed¦ ¦into¦ ¦the¦ ¦conta in ment¦ ¦path w ay¦
𐋇¦to¦ ¦provide¦ ¦vir ological¦ ¦evidence¦ ¦on¦ ¦the¦ ¦pres ence¦ ¦and¦ ¦ext ent¦ ¦of¦ ¦u nd et ected¦ ¦community¦ ¦transmission¦ ¦of¦ ¦covid¦ - ¦19¦ ¦and¦ ¦monit or¦ ¦p os it iv ity¦ ¦r ates¦ ¦among¦ ¦individuals¦ ¦pres en ting¦ ¦ il i¦ ¦or¦ ¦acute¦ ¦respiratory¦ ¦trac t¦ ¦infections¦ ¦to¦ ¦pr imary¦ ¦care¦
𐋇¦to¦ ¦estim ate¦ ¦ba se line¦ ¦s us cep ti bility¦ ¦to¦ ¦covid¦ - ¦19¦ ¦in¦ ¦the¦ ¦community¦ ¦and¦ ¦estim ate¦ ¦both¦ ¦s ymptomatic¦ ¦and¦ ¦as ymptomatic¦ ¦exp osure¦ ¦r ates¦ ¦in¦ ¦the¦ ¦population¦ ¦through¦ ¦ser op re v al ence¦ ¦monit or ing¦
𐋇¦to¦ ¦p il ot¦ ¦imp le me nt ation¦ ¦of¦ ¦a¦ ¦s che me¦ ¦for¦ ¦colle ction¦ ¦of¦ ¦con v al esc ent¦ ¦ser a¦ ¦with¦ ¦antibo dy¦ ¦pro f i les¦ ¦among¦ ¦re covered¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦dis ch ar ged¦ ¦to¦ ¦the¦ ¦community¦
𐋇¦we¦ ¦int end¦ ¦to¦ ¦ca pt ure¦ ¦the¦ ¦following¦ .
𐋇 ¦clinical¦ ¦work lo ad¦ ¦related¦ ¦to¦ ¦rep orts¦ ¦of¦ ¦covid¦ - ¦19¦ ¦using¦ ¦the¦ ¦co des¦ ¦cre ated¦ ¦to¦ ¦f la g¦ ¦cases¦ ,▁ ¦those¦ ¦being¦ ¦ass es sed¦ ¦and¦ ¦where¦ ¦the¦ ¦infection¦ ¦is¦ ¦loc ated¦ ¦are¦ ¦ex c lu ded¦ ▁( ¦f ig ures¦ ¦2¦ - ▁ ​ ▁ - ¦4 4¦ )
𐋇 ¦fo re ign¦ ¦countries¦ ¦visi ted¦ ¦in¦ ¦the¦ ¦last¦ ¦2 8¦ ¦days¦
𐋇 ¦ex is ting¦ ¦co des¦ ¦that¦ ¦may¦ ¦have¦ ¦ ut il ity¦ ▁( ¦t ab les¦ ¦1¦ - ▁ ​ ▁ - ¦3¦ )▁ . ¦3¦ ).
𐋇 ¦many¦ ¦g ps¦ ¦and¦ ¦pr imary¦ ¦care¦ ¦t ea ms¦ ¦may¦ ¦not¦ ¦re al iz e¦ ¦that¦ ¦important¦ ¦re le v ant¦ ¦data¦ ¦can¦ ¦be¦ ¦co ded¦ .
𐋇¦there¦ ¦is¦ ¦also¦ ¦the¦ ¦pote ntial¦ ¦during¦ ¦any¦ ¦pandemic¦ ¦to¦ ¦monit or¦ ¦the¦ ¦eff ec ti ve ness¦ ¦of¦ ¦any¦ ¦transmission¦ ¦control¦ ¦measures¦ .
𐋇 ¦re li able¦ ¦co ding¦ ¦of¦ ¦l et t ers¦ ¦and¦ ¦test¦ ¦results¦ ¦that¦ ¦will¦ ¦sh ow¦ ¦an¦ ¦infection¦ ¦has¦ ¦bec ome¦ ¦e it her¦ ¦confirmed¦ ¦or¦ ¦ex c lu ded¦
𐋇¦the¦ ¦met ho ds¦ ¦will¦ ¦follow¦ ¦the¦ ¦appro a ch¦ ¦used¦ ¦in¦ ¦the¦ ¦current¦ ¦influenza¦ ¦surveillance¦ ¦system¦ ¦and¦ ¦rec ent¦ ¦ser ology¦ ¦study¦ ,▁ ¦and¦ ¦inclu des¦ ¦five¦ ¦comp on ents¦ : ▁( ¦1¦ )▁ ¦pr imary¦ ¦care¦ ¦clinical¦ ¦surveillance¦ ; ▁( ¦2¦ )▁ ¦vir ological¦ ¦surveillance¦ ; ▁( ¦3¦ )▁ ¦population¦ ¦ser ological¦ ¦surveillance¦ ; ▁( ¦4¦ )▁ ¦con v al esc ent¦ ¦ser a¦ ¦in¦ ¦cases¦ ;▁ ¦and¦ ▁( ¦5¦ )▁ ¦data¦ ¦cur ation¦ .
𐋇¦the¦ ¦n h s¦ ¦u ses¦ ¦the¦ ¦sys te ma ti zed¦ ¦no me nc l at ure¦ ¦of¦ ¦medic ine¦ ¦clinical¦ ¦ter ms¦ ▁( ¦s no med¦ ¦c t¦ )▁ ¦system¦ ¦of¦ ¦co ding¦ ,▁ ¦which¦ ¦is¦ ¦n orm ally¦ ¦only¦ ¦up d ated¦ ¦t w ice¦ ¦an n ually¦ .
𐋇¦there¦ ¦was¦ ¦ad ded¦ ¦comp le x ity¦ ¦as¦ ¦some¦ ¦comp ut eri zed¦ ¦medical¦ ¦recor d¦ ▁( ¦c m r¦ )▁ ¦supp li ers¦ ¦use¦ ¦the¦ ¦r ead¦ ¦co ding¦ ¦sys tems¦ ▁( ¦r ead¦ ¦clinical¦ ¦ter ms¦ ¦ ve rs ion¦ ¦3¦ ▁–▁ ¦ ct v 3¦ ),▁ ¦which¦ ¦is¦ ¦no¦ ¦lo nger¦ ¦up d ated¦ .
𐋇 ¦ad di tion ally¦ ,▁ ¦there¦ ¦were¦ ¦no¦ ¦clinical¦ ¦co des¦ ¦to¦ ¦recor d¦ ¦covid¦ - ¦19¦ ¦in¦ ¦early¦ ¦february¦ ¦2020¦ .
𐋇 ¦the re f ore¦ ,▁ ¦the¦ ¦two¦ ¦ma in¦ ¦gp¦ ¦system¦ ¦supp li ers¦ ¦ad ded¦ ¦the¦ ¦five¦ ¦ter ms¦ ¦sh own¦ ¦in¦ ¦t able¦ ¦4¦ ¦as¦ ¦system¦ - ¦w ide¦ ¦local¦ ¦co des¦ .
𐋇¦a¦ ¦uk¦ ¦emergency¦ ¦re le ase¦ ¦of¦ ¦s no med¦ ¦c t¦ ¦con cep ts¦ ¦for¦ ¦covid¦ - ¦19¦ ¦was¦ ¦also¦ ¦sub se qu e ntly¦ ¦made¦ ¦available¦ ¦across¦ ¦all¦ ¦c m r¦ ¦sys tems¦ ▁( ¦t able¦ ¦4¦ ).
𐋇¦the¦ ¦in te nt ion¦ ¦is¦ ¦that¦ ¦these¦ ¦will¦ ¦e vent ually¦ ¦be¦ ¦ma pp ed¦ ¦to¦ ¦the¦ ¦new¦ ¦s no med¦ ¦c t¦ ¦con cep ts¦ ¦as¦ ¦they¦ ¦bec ome¦ ¦available¦ ,▁ ¦all owing¦ ¦recor ding¦ ¦of¦ ¦re le v ant¦ ¦data¦ ▁( ¦mult im ed ia¦ ¦app en di x¦ ¦1¦ ).
𐋇¦the¦ ¦k e y¦ ¦requir e ments¦ ¦for¦ ¦this¦ ¦re le ase¦ ¦were¦ ¦the¦ ¦a bility¦ ¦to¦ ¦co de¦ ▁( ¦t able¦ ¦4¦ )▁ ¦a¦ ¦case¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦exp osure¦ ¦to¦ ¦risk¦ ¦of¦ ¦infection¦ ▁( ¦travel¦ ¦to¦ ¦an¦ ¦a rea¦ ¦where¦ ¦there¦ ¦may¦ ¦be¦ ¦a¦ ¦higher¦ ¦risk¦ ),▁ ¦contact¦ ¦with¦ ¦an yone¦ ¦infected¦ ¦with¦ ¦covid¦ - ¦19¦ ,▁ ¦a¦ ¦report¦ ¦that¦ ¦a¦ ¦person¦ ¦had¦ ¦been¦ ¦tested¦ ¦for¦ ¦covid¦ - ¦19¦ ,▁ ¦and¦ ¦that¦ ¦the¦ ¦disease¦ ¦had¦ ¦been¦ ¦ex c lu ded¦ ▁( ¦likely¦ ¦a¦ ¦negative¦ ¦test¦ ).
𐋇¦in¦ ¦add ition¦ ,▁ ¦practi ces¦ ¦are¦ ¦n ow¦ ¦able¦ ¦to¦ ¦co de¦ ¦any¦ ¦fo re ign¦ ¦travel¦ ¦under ta k en¦ ,▁ ¦including¦ ¦the¦ ¦a bility¦ ¦to¦ ¦recor d¦ ¦visi ts¦ ¦to¦ ¦mult ip le¦ ¦countries¦ ▁( ¦imp le m ented¦ ¦february¦ ¦8¦ ,▁ ¦2020¦ ).
𐋇¦f ig ures¦ ¦2¦ - ▁ ​ ▁ - ¦4 4¦ ¦sh ow¦ ¦the¦ ¦e mi s¦ ¦we b ¦ ¦imp le me nt ation¦ .
𐋇 ¦cur re ntly¦ ,▁ ¦vir ology¦ ¦samples¦ ¦for¦ ¦influenza¦ ¦surveillance¦ ¦are¦ ¦acc o mp an ied¦ ¦by¦ ¦a¦ ¦sta nd ard¦ ¦re qu est¦ ¦for m¦ .
𐋇¦for¦ ¦covid¦ - ¦19¦ ,▁ ¦we¦ ¦will¦ ¦cre ate¦ ¦a¦ ¦new¦ ¦re qu est¦ ¦for m¦ ¦that¦ ¦will¦ ¦recor d¦ :
𐋇 ¦date¦ ¦of¦ ¦o ns et¦ ¦of¦ ¦symptoms¦
𐋇 ¦diagn o sis¦ ¦of¦ ¦any¦ ¦of¦ ¦the¦ ¦following¦ :
𐋇 ¦acute¦ ¦br on ch itis¦ ▁/▁ ¦b ro nc hi ol itis¦ ¦in¦ ¦those¦ ¦y ou nger¦ ¦than¦ ¦five¦ ¦years¦
𐋇 ¦lower¦ ¦respiratory¦ ¦trac t¦ ¦infection¦ ▁( ¦l rt i¦ )
𐋇¦h ist ory¦ ¦of¦ ¦fever¦ ▁( ¦ y¦ ▁/▁ ¦ n¦ ) ;▁ ¦me as ur ed¦ ▁( ¦ y¦ ▁/▁ ¦ n¦ ) ;▁ ¦if¦ ¦y es¦ ,▁ ¦level¦
𐋇 ¦sh ort ness¦ ¦of¦ ¦brea th¦ ▁( ¦ y¦ ▁/▁ ¦ n¦ ),▁ ¦if¦ ¦me as ur ed¦ :▁ 𐋇 ¦o x yg en¦ ¦s at ur ation¦ ¦and¦ ¦respiratory¦ ¦rate¦
𐋇 ¦rec ent¦ ¦travel¦ ▁( ¦ y¦ ▁/▁ ¦ n¦ ) ;▁ ¦if¦ ¦y es¦ ,▁ ¦countries¦ ¦visi ted¦ ¦in¦ ¦last¦ ¦14¦ ¦days¦
𐋇 ¦contact¦ ¦with¦ ¦a¦ ¦na med¦ ¦person¦ ¦with¦ ¦confirmed¦ ¦covid¦ - ¦19¦ ▁( ¦ y¦ ▁/▁ ¦ n¦ )▁ ¦with¦ ¦a¦ ¦fre e¦ ¦te xt¦ ¦comm ent¦ ¦about¦ ¦the¦ ¦level¦ ¦of¦ ¦ce rt ai nt y¦
𐋇¦these¦ ¦co des¦ ¦will¦ ¦be¦ ¦grou p ed¦ ¦o nt ol og ically¦ ¦into¦ ▁ “ ¦def in ite¦ ▁ ” , “ ▁ ¦prob able¦ ▁ ” ,▁ “ ¦possible¦ ▁ ” ,▁ ¦and¦ “ ▁ ¦not¦ ¦a¦ ¦case¦ ▁ ” ▁ ¦using¦ ¦our¦ ¦sta nd ard¦ ¦appro a ch¦ ¦to¦ ¦grou p ing¦ ¦co des¦ ▁( ¦t able¦ ¦5¦ ),▁ ¦which¦ ¦has¦ ¦been¦ ¦used¦ ¦previously¦ ¦across¦ ¦disease¦ ¦areas¦ .
𐋇¦the¦ ¦r c g p¦ ¦ rs c¦ ¦def in ition¦ ¦for¦ ¦ il i¦ ¦is¦ ¦sh own¦ ¦in¦ ¦mult im ed ia¦ ¦app en di x¦ ¦2¦ .
𐋇 ¦public¦ ¦pre se nt ation¦ ¦of¦ ¦data¦ ¦using¦ ¦an¦ ¦ob s erv atory¦ ¦and¦ ¦d as h bo ards¦
𐋇¦we¦ ¦will¦ ¦develop ¦ ¦an¦ ¦ob s erv atory¦ ¦to¦ ¦pres ent¦ ¦data¦ ¦na tion ally¦ ¦and¦ ¦a¦ ¦d as h bo ard¦ ¦for¦ ¦fe ed b ack¦ ¦to¦ ¦practi ces¦ ¦about¦ ¦their¦ ¦data¦ ¦qu ality¦ ¦and¦ ¦colle ction¦ ¦of¦ ¦vir ology¦ ¦and¦ ¦ser ology¦ ¦samples¦ .
𐋇¦this¦ ¦is¦ ¦based¦ ¦on¦ ¦co ding¦ ¦d esc rib ed¦ ¦in¦ ¦t able¦ ¦4¦ .
𐋇 ¦def in ite¦ ¦case¦ ¦will¦ ¦be¦ ¦pres ented¦ ¦on¦ ¦our¦ ¦d as h bo ard¦ ¦as¦ ▁ “ ¦cases¦ ▁ ” ▁ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇 ¦possible¦ ¦cases¦ ¦will¦ ¦be¦ ¦pres ented¦ ¦as¦ ▁ “ ¦under¦ ¦in ve st ig ation¦ ▁ ” ▁( ¦in ve st ig ating¦ ).
“ ¦not¦ ¦a¦ ¦case¦ ▁ ” ▁ ¦will¦ ¦be¦ ¦pres ented¦ ¦as¦ “ ▁ ¦ex c lu ded¦ ▁ ” .
𐋇 ¦online¦ ¦data¦ ¦has¦ ¦been¦ ¦ es ta bl ished¦ ¦within¦ ¦the¦ ¦in it ial¦ ¦fe w¦ ¦weeks¦ ¦in¦ ¦the¦ ¦covid¦ - ¦19¦ ¦ob s erv atory¦ ▁( ¦f ig ure¦ ¦5¦ ),▁ ¦indic ating¦ ¦the¦ ¦over all¦ ¦number¦ ¦of¦ ¦patients¦ ¦and¦ ¦rate¦ ¦per¦ ¦10¦ , ¦000¦ ¦patients¦ ¦of¦ ¦cases¦ ¦confirmed¦ ¦or¦ ¦under¦ ¦in ve st ig ation¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦where¦ ¦the¦ ¦virus¦ ¦is¦ ¦ex c lu ded¦ .
𐋇¦we¦ ¦have¦ ¦the¦ ¦o ption¦ ¦to¦ ¦mo ve¦ ¦to¦ ¦t w ice¦ ¦w ee k ly¦ ¦surveillance¦ ¦rep orts¦ ¦with¦ ¦a¦ ¦sc ope¦ ¦to¦ ¦ch ange¦ ¦this¦ ¦to¦ ¦daily¦ ¦rep orting¦ .
𐋇¦we¦ ¦will¦ ¦continue¦ ¦vir ology¦ ¦sampl ing¦ ¦from¦ ¦our¦ ¦sen ti ne l¦ ¦practi ces¦ ,▁ ¦r at her¦ ¦than¦ ¦disc o nt in u ing¦ ¦as¦ ¦se as on al¦ ¦influenza¦ ¦decl ines¦ .
𐋇 ¦ad di tion ally¦ ,▁ ¦we¦ ¦will¦ ¦rec ru i t¦ ¦more¦ ¦surveillance¦ ¦practi ces¦ .
𐋇¦the¦ ¦r c g p¦ ¦ rs c¦ ¦vir ology¦ ¦practi ces¦ ¦will¦ ¦ ai m¦ ¦to¦ ¦under ta ke¦ ¦2 00¦ - ¦3 00¦ ¦n as o ph ar y n ge al¦ ¦sw ab s¦ ¦per¦ ¦week¦ ¦across¦ ¦the¦ ¦r c g p¦ ¦ rs c¦ ¦sen ti ne l¦ ¦n et w or k¦ ,▁ ¦coll ecting¦ ¦spec im ens¦ ¦across¦ ¦all¦ ¦age¦ ¦b an ds¦ .
𐋇¦in¦ ¦add ition¦ ¦to¦ ¦the¦ ¦inclu s ion¦ ¦crit er ia¦ ¦for¦ ¦influenza¦ ¦vir ology¦ ¦surveillance¦ ▁( ¦ il i¦ ,▁ ¦acute¦ ¦br on ch itis¦ ▁/▁ ¦b ro nc hi ol itis¦ ),▁ ¦partic ip ating¦ ¦practi ces¦ ¦will¦ ¦take¦ ¦n as o ph ar y n ge al¦ ¦sw ab ¦ ¦samples¦ ¦from¦ ¦any¦ ¦people¦ ¦sh owing¦ ¦acute¦ ¦symptoms¦ ¦of¦ ¦l rt i¦ ¦if¦ ¦the¦ ¦o ns et¦ ¦of¦ ¦symptoms¦ ¦is¦ ¦within¦ ¦7¦ ¦days¦ .
𐋇 ¦r c g p¦ ¦ rs c¦ ¦research¦ ¦offic ers¦ ¦and¦ ¦pract ice¦ ¦l ia is on¦ ¦staff¦ ¦will¦ ¦mana ge¦ ¦practi ces¦ ¦to¦ ¦a ch ie ve¦ ¦a¦ ¦total¦ ¦national¦ ¦sampl e¦ ¦of¦ ¦2 00¦ - ¦3 00¦ ¦sw ab s¦ ¦per¦ ¦week¦ .
𐋇¦this¦ ¦could¦ ¦be¦ ¦increased¦ ¦if¦ ¦ph e¦ ¦mod el ers¦ ¦requir e¦ ¦more¦ ¦samples¦ .
𐋇 ¦samples¦ ¦from¦ ¦each¦ ¦pract ice¦ ¦would¦ ¦be¦ ¦spread¦ ¦across¦ ¦the¦ ¦following¦ ¦age¦ ¦grou ps¦ :▁ & ▁ ¦l t¦ ;▁ ¦5¦ ¦years¦ ,▁ ¦5¦ - ¦1 7¦ ¦years¦ ,▁ ¦18¦ - ¦6 4¦ ¦years¦ ,▁ ¦and¦ ¦6 5¦ ¦years¦ ¦and¦ ¦ ol der¦
𐋇 ¦samples¦ ▁( ¦sw ab s¦ ¦or¦ ¦ser um¦ )▁ ¦coll ected¦ ¦will¦ ¦be¦ ¦s ent¦ ¦v ia¦ ¦pre pa id¦ ¦en v el op es¦ ¦ad dr es sed¦ ¦to¦ ¦the¦ ¦appr op ri ate¦ ¦ph e¦ ¦laboratory¦ ¦for¦ ¦anal y sis¦ .
𐋇 ¦all¦ ¦samples¦ ¦coll ected¦ ¦will¦ ¦be¦ ¦tested¦ ¦for¦ ¦the¦ ¦pres ence¦ ¦of¦ ¦influenza¦ ¦and¦ ¦covid¦ - ¦19¦ .
𐋇 ¦ad di tion ally¦ ,▁ ¦ph e¦ ¦will¦ ¦r et r os p ect ively¦ ¦test¦ ¦any¦ ¦influenza¦ ¦vir ology¦ ¦samples¦ ¦coll ected¦ ¦between¦ ¦early¦ ¦and¦ ¦m id¦ - ¦february¦ ¦2020¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇 ¦practi ces¦ ¦will¦ ¦still¦ ¦follow¦ ¦the¦ ¦ph e¦ ¦prot oc o l¦ ¦for¦ ¦covid¦ - ¦19¦ ¦with¦ ¦resp ect¦ ¦to¦ ¦people¦ ¦at¦ ¦risk¦ ¦of¦ ¦infection¦ ¦who¦ ¦should¦ ¦be¦ ¦sign p os ted¦ ¦down¦ ¦the¦ ¦conta in ment¦ ¦path w ay¦ ,▁ ¦r at her¦ ¦than¦ ¦ph ys ically¦ ¦att end¦ ¦their¦ ¦pract ice¦ .
𐋇 ¦direct¦ ¦testing¦ ¦of¦ ¦those¦ ¦who¦ ¦att end¦ ¦sur ge ry¦ ¦rema ins¦ ¦p erm it ted¦ ,▁ ¦but¦ ¦we¦ ¦have¦ ¦also¦ ¦ro lled¦ ¦out¦ ¦self¦ - ¦sw ab b ing¦ ¦at¦ ¦home¦ .
𐋇 ¦su mm ary¦ ¦of¦ ¦proc es ses¦ ¦are¦ ¦detail ed¦ ¦in¦ ¦mult im ed ia¦ ¦app en di x¦ ¦3¦ .
𐋇¦e veryone¦ ¦with¦ ¦an¦ ¦ il i¦ ¦or¦ ¦a¦ ¦respiratory¦ ¦illness¦ ¦who¦ ¦contac ts¦ ¦a¦ ¦gp¦ ▁( ¦e g¦ ,▁ ¦ph on es¦ ¦for¦ ¦an¦ ¦appointment¦ )▁ ¦should¦ ¦be¦ ¦as ked¦ ¦spec if ically¦ ¦about¦ ¦rec ent¦ ¦travel¦ ¦to¦ ¦china¦ ¦and¦ ¦other¦ ¦countries¦ ¦f la g ged¦ ¦in¦ ¦current¦ ¦ph e¦ ¦advice¦ ,▁ ¦or¦ ¦if¦ ¦they¦ ¦have¦ ¦had¦ ¦contact¦ ¦with¦ ¦other¦ ¦people¦ ¦with¦ ¦covid¦ - ¦19¦ .
𐋇¦if¦ ¦these¦ ¦scre ening¦ ¦en qu ir ies¦ ¦are¦ ¦positive¦ ,▁ ¦the¦ ¦pa ti ent¦ ¦would¦ ¦be¦ ¦ad vi sed¦ ¦to¦ ¦not¦ ¦come¦ ¦to¦ ¦the¦ ¦pract ice¦ ¦but¦ ¦inst ead¦ ¦to¦ ¦follow¦ ¦the¦ ¦ph e¦ ¦f l ow¦ ¦s he et¦ .
𐋇¦this¦ ¦can¦ ¦be¦ ¦by¦ ¦a¦ ¦rece ption¦ ¦or¦ ¦cl in ici an¦ ¦staff¦ ,▁ ¦dep ending¦ ¦on¦ ¦ind iv id ual¦ ¦pract ice¦ ¦prot oc o l¦ .
𐋇¦these¦ ¦ca lls¦ ¦should¦ ¦be¦ ¦co ded¦ ¦into¦ ¦the¦ ¦gp¦ ¦c m r¦ ¦system¦ ¦and¦ ¦can¦ ¦be¦ ¦reported¦ ¦as¦ ¦par t¦ ¦of¦ ¦the¦ ¦r c g p¦ ¦ rs c¦ ¦w ee k ly¦ ¦retur n¦ .
𐋇¦we¦ ¦have¦ ¦developed¦ ¦tr aining¦ ¦m at er ial¦ ¦to¦ ¦support¦ ¦this¦ ¦co ding¦ ▁( ¦mult im ed ia¦ ¦app en di x¦ ¦4¦ ).
𐋇¦these¦ ¦include¦ ¦pro mp t¦ ¦c ards¦ ¦for¦ :
𐋇 ¦pract ice¦ ¦rece ption¦ ¦or¦ ¦t ri age¦ ¦staff¦ :▁ 𐋇¦for¦ ¦co ding¦ ¦of¦ ¦any¦ ¦patients¦ ¦ca lling¦ ¦the¦ ¦pract ice¦ ¦with¦ ¦symptoms¦ ¦of¦ ¦acute¦ ¦respiratory¦ ¦infection¦ ¦with¦ ¦a¦ ¦h ist ory¦ ¦of¦ ¦travel¦ ¦to¦ ¦important¦ ¦areas¦ ¦based¦ ¦on¦ ¦ph e¦ ¦advice¦
𐋇 ¦admin i str ative¦ ¦staff¦ ¦or¦ ¦cl in ici ans¦ ¦who¦ ¦co de¦ :▁ 𐋇¦to¦ ¦e nc o ur age¦ ¦cons ist ent¦ ¦co ding¦ ¦of¦ ¦results¦ ¦for¦ ¦any¦ ¦suspected¦ ¦cases¦ ,▁ ¦including¦ ¦co ding¦ ¦of¦ ¦negative¦ ¦results¦ ¦for¦ ¦ex c l us ion¦
𐋇 ¦practi ces¦ ¦partic ip ating¦ ¦in¦ ¦vir ology¦ ¦surveillance¦ ¦will¦ ¦o pp ort un ist ically¦ ¦coll ect¦ ¦blood¦ ¦samples¦ ¦from¦ ¦patients¦ ¦c om ing¦ ¦into¦ ¦the¦ ¦pract ice¦ ¦for¦ ¦a¦ ¦ro ut ine¦ ¦blood¦ ¦test¦ .
𐋇 ¦patients¦ ¦who¦ ¦att end¦ ¦their¦ ¦pract ice¦ ¦for¦ ¦a¦ ¦ro ut ine¦ ¦blood¦ ¦test¦ ¦will¦ ¦be¦ ¦as ked¦ ¦to¦ ¦provide¦ ¦an¦ ¦ad di tional¦ ¦sampl e¦ ¦for¦ ¦ser ology¦ .
𐋇¦we¦ ¦have¦ ¦con duc ted¦ ¦in it ial¦ ¦s ear ches¦ ¦within¦ ¦the¦ ¦r c g p¦ ¦ rs c¦ ¦d at ab ase¦ ¦to¦ ¦l ook¦ ¦at¦ ¦the¦ ¦number¦ ¦of¦ ¦f ul l¦ ¦blood¦ ¦co un t¦ ▁( ¦f b c¦ )▁ ¦results¦ ¦and¦ ¦over all¦ ¦r ates¦ ¦in¦ ¦ad ul ts¦ ¦and¦ ¦children¦ ▁( ¦f ig ures¦ ¦6¦ - ▁ ​ ▁ - ¦9¦ )▁ . ¦9¦ ).
𐋇 ¦an¦ ¦f b c¦ ¦is¦ ¦one¦ ¦of¦ ¦the¦ ¦most¦ ¦common¦ ¦tests¦ ¦per for med¦ ,▁ ¦and¦ ¦we¦ ¦h ope¦ ¦this¦ ¦will¦ ¦give¦ ¦an¦ ¦appro x im ate¦ ¦indic ation¦ ¦of¦ ¦over all¦ ¦nu mbers¦ ¦of¦ ¦blood¦ ¦tests¦ ¦per for med¦ .
𐋇¦the¦ ¦sampl ing¦ ¦rate¦ ,▁ ¦per¦ ¦100¦ , ¦000¦ ¦patients¦ ¦was¦ ¦high est¦ ¦for¦ ¦children¦ ¦15¦ - ¦1 7¦ ¦years¦ ¦of¦ ¦age¦ ¦and¦ ¦6 0¦ ¦year¦ ¦or¦ ¦ ol der¦ ¦in¦ ¦ad ul ts¦ ,▁ ¦with¦ ¦the¦ ¦l ow est¦ ¦r ates¦ ¦in¦ ¦children¦ ¦ 0¦ - ¦4¦ ¦years¦ ¦of¦ ¦age¦ ¦and¦ ¦18¦ - ¦2 9¦ ¦years¦ ¦of¦ ¦age¦ ¦in¦ ¦ad ul ts¦ ▁( ¦f ig ures¦ ¦6¦ - ▁ ​ ▁ - ¦9 9¦ ).
𐋇¦we¦ ¦will¦ ¦provide¦ ¦1 0 00¦ ¦ser ology¦ ¦ba se line¦ ¦samples¦ ¦across¦ ¦all¦ ¦a ges¦ ¦that¦ ¦ref l ect¦ ¦the¦ ¦v ar ying¦ ¦r ates¦ ¦of¦ ¦att end ance¦ ¦by¦ ¦age¦ .
𐋇 ¦ad di tion ally¦ ,▁ ¦we¦ ¦will¦ ¦test¦ ¦if¦ ¦we¦ ¦can¦ ¦ob tain¦ ¦these¦ ¦all¦ ¦from¦ ¦vir ology¦ ¦practi ces¦ ¦to¦ ¦en h ance¦ ¦the¦ ¦y ie ld¦ .
𐋇¦a¦ ¦g ood¦ ¦ ge ogra ph ical¦ ¦spread¦ ¦is¦ ¦important¦ ,▁ ¦so¦ ¦ph e¦ ¦can¦ ¦ad v ise¦ ¦on¦ ¦areas¦ ¦where¦ ¦ser ology¦ ¦will¦ ¦most¦ ¦u se f ul ly¦ ¦be¦ ¦coll ected¦ .
𐋇¦this¦ ¦will¦ ¦be¦ ¦fo ll owed¦ ¦by¦ ¦8 00¦ ¦samples¦ ¦mon th ly¦ .
𐋇¦the¦ ¦sampl e¦ ¦will¦ ¦be¦ ¦stra t if ied¦ ¦with¦ ¦2 00¦ ¦spec im ens¦ ¦for¦ ¦pre p an de m ic¦ ¦sur ve y¦ ▁( ¦100¦ ¦for¦ ¦mon th ly¦ )▁ ¦in¦ ¦the¦ ¦following¦ ¦age¦ ¦grou ps¦ :▁ & ▁ ¦l t¦ ;▁ ¦5¦ ¦years¦ ,▁ ¦5¦ - ¦1 7¦ ¦years¦ ,▁ ¦18¦ - ¦6 4¦ ¦years¦ ,▁ ¦and¦ ¦6 5¦ ¦years¦ ¦or¦ ¦ ol der¦ .
𐋇¦the¦ ¦y ou nger¦ ¦patients¦ ,▁ ¦in¦ ¦many¦ ¦practi ces¦ ¦y ou nger¦ ¦than¦ ¦14¦ ¦years¦ ,▁ ¦and¦ ¦in¦ ¦ne arly¦ ¦all¦ ¦for¦ ¦children¦ ¦y ou nger¦ ¦than¦ ¦8¦ ¦years¦ ¦will¦ ¦requir e¦ ¦p e di at r ic¦ ¦ser ology¦ ¦surveillance¦ .
𐋇¦we¦ ¦will¦ ¦develop ¦ ¦a¦ ¦new¦ ¦re qu est¦ ¦for m¦ ¦for¦ ¦practi ces¦ ¦to¦ ¦ca pt ure¦ ¦rec ent¦ ¦travel¦ ¦and¦ ¦exp osure¦ ¦to¦ ¦covid¦ - ¦19¦ .
𐋇¦we¦ ¦will¦ ¦p il ot¦ ¦a¦ ¦s che me¦ ¦for¦ ¦coll ecting¦ ¦con v al esc ent¦ ¦ser ology¦ ¦from¦ ¦people¦ ¦with¦ ¦confirmed¦ ¦cases¦ ¦and¦ ¦who¦ ¦have¦ ¦had¦ ¦an¦ ¦acute¦ ¦vir ology¦ ¦sampl e¦ ¦at¦ ¦the¦ ¦time¦ ¦of¦ ¦their¦ ¦infection¦ .
𐋇¦this¦ ¦is¦ ¦to¦ ¦ident if y¦ ¦a¦ ¦car ri er¦ ¦state¦ ¦in¦ ¦patients¦ ¦who¦ ¦have¦ ¦re covered¦ ¦from¦ ¦the¦ ¦virus¦ ¦but¦ ¦may¦ ¦continue¦ ¦sh ed ding¦ ¦the¦ ¦virus¦ .
𐋇¦if¦ ¦there¦ ¦are¦ ¦a¦ ¦sm all¦ ¦number¦ ¦of¦ ¦cases¦ ,▁ ¦this¦ ¦may¦ ¦ass ist¦ ¦in¦ ¦develop ing¦ ¦a¦ ¦test¦ ¦ki t¦ ¦for¦ ¦patients¦ ¦to¦ ¦take¦ ¦to¦ ¦their¦ ¦ own¦ ¦gp¦ ¦and¦ ¦ex pl ore¦ ¦its¦ ¦ac cep ta bility¦ ¦to¦ ¦patients¦ .
𐋇¦if¦ ¦there¦ ¦are¦ ¦a¦ ¦large¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦na tion ally¦ ,▁ ¦con v al esc ent¦ ¦samples¦ ¦could¦ ¦be¦ ¦coll ected¦ ¦from¦ ¦r c g p¦ ¦ rs c¦ ¦practi ces¦ ¦where¦ ¦there¦ ¦are¦ ¦confirmed¦ ¦cases¦ ,▁ ¦with¦ ¦the¦ ¦a bility¦ ¦to¦ ¦l ink¦ ¦to¦ ¦the¦ ¦f ul l¦ ¦medical¦ ¦recor d¦ .
𐋇¦this¦ ¦proc ess¦ ¦may¦ ¦include¦ ¦chec king¦ ¦p se ud on y mi zed¦ ¦n h s¦ ¦nu mbers¦ ¦for¦ ¦positive¦ ¦individuals¦ ¦at¦ ¦r c g p¦ ¦ rs c¦ ¦practi ces¦ ,▁ ¦chec king¦ ¦current¦ ¦ph e¦ ¦gu id ance¦ ¦reg ar ding¦ ¦consid er ations¦ ¦of¦ ¦inf ec ti o us ness¦ ¦for¦ ¦confirmed¦ ¦cases¦ ,▁ ¦and¦ ¦off ering¦ ¦the¦ ¦pa ti ent¦ ¦an¦ ¦appointment¦ ¦following¦ ¦the¦ ¦previously¦ ¦m en tion ed¦ ¦proc ess¦ .
𐋇¦this¦ ¦needs¦ ¦to¦ ¦be¦ ¦ca re f ul ly¦ ¦co or d in ated¦ ¦na tion ally¦ ¦across¦ ¦the¦ ¦n et w or k¦ ¦and¦ ¦may¦ ¦requir e¦ ¦ph e¦ ¦to¦ ¦e ns ure¦ ¦individuals¦ ¦are¦ ¦not¦ ¦contac ted¦ ¦by¦ ¦mult ip le¦ ¦a ge nc ies¦ .
𐋇 ¦r c g p¦ ¦ rs c¦ ¦could¦ ¦provide¦ ¦a¦ ¦u se ful¦ ¦st ru ct ure¦ ¦to¦ ¦chan ne l¦ ¦the¦ ¦in it ial¦ ¦contact¦ ¦o nce¦ ¦ph e¦ ¦has¦ ¦made¦ ¦a¦ ¦re qu est¦ .
𐋇¦the¦ ¦r c g p¦ ¦ rs c¦ ¦practi ces¦ ¦partic ip ating¦ ¦in¦ ¦the¦ ¦an n ual¦ ¦influenza¦ ¦vir ology¦ ¦surveillance¦ ¦have¦ ¦star ted¦ ¦sampl ing¦ ¦from¦ ¦patients¦ ¦sh owing¦ ¦symptoms¦ ¦of¦ ¦a¦ ¦l rt i¦ .
𐋇 ¦all¦ ¦samples¦ ¦received¦ ¦are¦ ¦being¦ ¦tested¦ ¦for¦ ¦influenza¦ ¦and¦ ¦covid¦ - ¦19¦ .
𐋇¦the¦ ¦r c g p¦ ¦ rs c¦ ¦will¦ ¦ex pl ore¦ ¦w ays¦ ¦to¦ ¦coll ect¦ ¦con v al esc ent¦ ¦samples¦ ¦from¦ ¦any¦ ¦patients¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ ¦through¦ ¦the¦ ¦ex tens ion¦ ¦of¦ ¦the¦ ¦vir ological¦ ¦surveillance¦ .
𐋇 ¦from¦ ¦the¦ ¦star t¦ ,▁ ¦we¦ ¦will¦ ¦be¦ ¦ca re f ul ly¦ ¦cur ating¦ ¦data¦ ¦to¦ ¦e ns ure¦ ¦that¦ ¦it¦ ¦can¦ ¦be¦ ¦used¦ ¦for¦ ¦f ut ure¦ ¦st u dies¦ .
𐋇 ¦our¦ ¦clinical¦ ¦data¦ ¦will¦ ¦be¦ ¦l in ked¦ ¦to¦ ¦vir ology¦ .
𐋇¦we¦ ¦will¦ ¦cur ate¦ ¦our¦ ¦data¦ ¦using¦ ¦the¦ ¦fi nd able¦ ,▁ ¦acc es si ble¦ ,▁ ¦inter op er able¦ ,▁ ¦re us able¦ ¦pri nc ip les¦ .
𐋇¦to¦ ¦facil it ate¦ ¦this¦ ¦our¦ ¦data¦ ¦s et¦ ¦is¦ ¦l is ted¦ ¦with¦ ¦health¦ ¦data¦ ¦research¦ ¦uk¦ ¦and¦ ¦the¦ ¦european¦ ¦health¦ ¦data¦ ¦evidence¦ ¦n et w or k¦ .
𐋇¦the¦ ¦st at ist ical¦ ¦met ho d ology¦ ¦is¦ ¦in¦ ¦support¦ ¦of¦ ¦a¦ ¦pol ic y¦ ¦appro a ch¦ ¦to¦ ¦wid esp r ead¦ ¦disease¦ ¦outbreak¦ ,▁ ¦where¦ ¦so¦ - ¦called¦ ¦n on ph ar ma ce ut ical¦ ¦int erv en tions¦ ▁( ¦n p i s¦ )▁ ¦are¦ ¦used¦ ¦to¦ ¦resp on d¦ ¦to¦ ¦an¦ ¦e mer ging¦ ¦pandemic¦ ¦to¦ ¦produc e¦ ¦disease¦ ¦supp re ssion¦ .
𐋇¦this¦ ¦pol ic y¦ ¦ ai ms¦ ¦to¦ ¦reduce¦ ¦contact¦ ¦r ates¦ ¦in¦ ¦the¦ ¦population¦ ¦and¦ ¦the re b y¦ ¦reduce¦ ¦transmission¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦to¦ ¦imp le ment¦ ¦this¦ ¦the¦ ¦uk¦ ¦government¦ ¦has¦ ¦rece ntly¦ ¦a rt ic ul ated¦ ¦the¦ ¦d es ir e¦ ¦to¦ ¦imp le ment¦ ¦population¦ ¦self¦ - ¦isolation¦ ¦measures¦ .
𐋇¦by¦ ¦t ar ge ting¦ ¦the¦ ¦rep ro d u ction¦ ¦number¦ ▁( ¦ r¦ ) ▁( ¦the¦ ¦a ver age¦ ¦number¦ ¦of¦ ¦sec ond ary¦ ¦cases¦ ¦each¦ ¦case¦ ¦gener ates¦ )▁ ¦and¦ ¦a im ing¦ ¦to¦ ¦reduce¦ ¦the¦ ¦ r¦ ¦to¦ ¦b el ow¦ ¦1¦ ,▁ ¦the¦ ¦pol ic y¦ ¦s ee ks¦ ¦to¦ ¦reduce¦ ¦case¦ ¦nu mbers¦ ¦to¦ ¦low¦ ¦le v els¦ ¦or¦ ▁( ¦as¦ ¦se en¦ ¦in¦ ¦prev ious¦ ¦out b rea ks¦ ¦with¦ ¦severe¦ ¦acute¦ ¦respiratory¦ ¦syndrome¦ ¦and¦ ¦e b ol a¦ )▁ ¦to¦ ¦e li min ate¦ ¦human¦ - ¦to¦ - ¦human¦ ¦transmission¦ .
𐋇¦as¦ ¦the¦ ¦exp eri ence¦ ¦from¦ ¦the¦ ¦20 0 9¦ ¦h 1 n 1¦ ¦pandemic¦ ¦has¦ ¦sh own¦ ,▁ ¦n p i s¦ ¦can¦ ¦be¦ ¦a¦ ¦cr uc ial¦ ¦comp on ent¦ ¦of¦ ¦pandemic¦ ¦m it ig ation¦ .
𐋇 ¦k e y¦ ¦to¦ ¦the¦ ¦f oc us¦ ¦of¦ ¦our¦ ¦study¦ ¦will¦ ¦be¦ ¦the¦ ¦estim ation¦ ¦of¦ ¦p ea k¦ ¦cases¦ ¦in¦ ¦the¦ ¦population¦ ¦and¦ ¦contin ual¦ ¦monit or ing¦ ¦by¦ ¦data¦ ¦colle ction¦ ¦and¦ ¦mo de lling¦ ¦the¦ ¦pote ntial¦ ¦gr ow th¦ ¦and¦ ¦e mer g ence¦ ¦of¦ ¦sub se qu ent¦ ¦p ea ks¦ ¦in¦ ¦new¦ ¦cases¦ ¦as¦ ¦social¦ ¦distancing¦ ¦measures¦ ¦are¦ ¦re la x ed¦ .
𐋇¦there¦ ¦has¦ ¦al rea dy¦ ¦been¦ ¦publ ic ation¦ ¦of¦ ¦important¦ ¦disease¦ ¦e p ide mi ological¦ ¦measures¦ ¦concer ning¦ ¦the¦ ¦outbreak¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦main land¦ ¦china¦ .
𐋇¦a¦ ¦further¦ ¦f u nd a me ntal¦ ¦me as ure¦ ¦in¦ ¦pandemic¦ ¦d y na m ics¦ ¦is¦ ¦the¦ ¦le ng th¦ ¦of¦ ¦time¦ ¦from¦ ¦infection¦ ¦to¦ ¦when¦ ¦a¦ ¦person¦ ¦is¦ ¦infectious¦ ¦to¦ ¦others¦ ¦and¦ ¦the¦ ¦me an¦ ¦d ur ation¦ ¦of¦ ¦inf ec ti o us ness¦ .
𐋇¦these¦ ¦fa ctors¦ ,▁ ¦if¦ ¦estim ated¦ ¦acc u ra tely¦ ,▁ ¦will¦ ¦give¦ ¦g ood¦ ¦pr ed ic tions¦ ¦for¦ ¦the¦ ¦likely¦ ¦le ng th¦ ¦of¦ ¦the¦ ¦pandemic¦ ,▁ ¦the¦ ¦f in al¦ ¦number¦ ¦of¦ ¦infected¦ ¦cases¦ .
𐋇¦we¦ ¦int end¦ ¦to¦ ¦app ly¦ ¦appro x im ate¦ ¦ba y e si an¦ ¦inf er ence¦ ▁( ¦ab c¦ )▁ ¦to¦ ▁( ¦p os si b ly¦ ¦sp at ially¦ ¦he te ro ge ne o us¦ )▁ ¦s us cep ti ble¦ - ¦exp osed¦ - ▁ ¦infectious¦ - ¦rem oved¦ ▁( ¦se i r¦ )▁ ¦sto ch a st ic¦ ¦epidemic¦ ¦mod els¦ .
𐋇 ¦such¦ ¦techn i q ues¦ ¦are¦ ¦high ly¦ ¦p ara ll el iz able¦ ¦and¦ ¦have¦ ¦been¦ ¦s uc cess f ul ly¦ ¦app l ied¦ ¦to¦ ¦many¦ ¦fi el ds¦ ¦including¦ ¦disease¦ ¦transmission¦ ¦mo de lling¦ .
𐋇¦they¦ ¦are¦ ¦partic ul arly¦ ¦su i ted¦ ¦to¦ ¦s itu ations¦ ¦where¦ ¦li k e li h ood¦ ¦f u nc tions¦ ¦are¦ ¦ab s ent¦ ¦and¦ ¦where¦ ¦more¦ ¦tra di tional¦ ¦appro a ches¦ ¦such¦ ¦as¦ ¦mark ov ¦ ¦cha in¦ ¦mo nt e¦ ¦car l o¦ ¦are¦ ¦imp ra ct ical¦ .
𐋇 ¦such¦ ¦an¦ ¦appro a ch¦ ¦has¦ ¦been¦ ¦dem on str ated¦ ¦to¦ ¦work¦ ¦eff ect ively¦ ¦on¦ ¦the¦ ¦as p r en¦ ¦surveillance¦ ¦data¦ ,▁ ¦a¦ ¦n et w or k¦ ¦of¦ ¦sen ti ne l¦ ¦g ps¦ ¦and¦ ¦n ur se¦ ¦practi tion ers¦ ¦who¦ ¦report¦ ¦de ide nt if ied¦ ¦information¦ ¦on¦ ¦i li s¦ ¦and¦ ¦other¦ ¦conditions¦ ,▁ ¦where¦ ¦i ss ues¦ ¦such¦ ¦as¦ ¦mi ss ing¦ ¦data¦ ¦and¦ ¦the¦ ¦need¦ ¦to¦ ¦mo de l¦ ¦the¦ ¦ob s erv ation¦ ¦proc ess¦ ¦ it s el f¦ ¦has¦ ¦been¦ ¦s uc cess f ul ly¦ ¦ad dr es sed¦ .
𐋇¦f ur th erm ore¦ ,▁ ¦p ea ks¦ ¦in¦ ¦new¦ ¦cases¦ ¦have¦ ¦been¦ ¦estim ated¦ ¦by¦ ¦d ist rib u tional¦ ¦met ho ds¦ .
𐋇 ¦estim ates¦ ¦of¦ ¦the¦ ¦p ara m et ers¦ ¦of¦ ¦the¦ ¦se i r¦ ¦mo de l¦ ¦are¦ ¦tra ct able¦ ¦on¦ ¦large¦ ¦data¦ ¦s ets¦ ¦because¦ ¦of¦ ¦p ara ll el iz a bility¦ ,▁ ¦and¦ ¦these¦ ¦met ho ds¦ ¦have¦ ¦been¦ ¦imp le m ented¦ ¦in¦ ¦several¦ ¦ r¦ ¦li b r ar ies¦ ;▁ ¦we¦ ¦int end¦ ¦to¦ ¦use¦ ¦the¦ ¦li b r ar ies¦ ¦ab se i r¦ ▁( ¦dep o si ted¦ ¦on¦ ¦g i th ub ¦ :▁ 𐋇¦h t t ps¦ :▁ / ▁/▁ ¦t in y ur l¦ . ¦c om¦ ▁/▁ ¦v qu 3 5 c j ¦ )▁ ¦and¦ ¦ab ct o ols¦ ▁( ¦h t t ps¦ :▁ / ▁/▁ ¦t in y ur l¦ . ¦c om¦ ▁/▁ ¦t f j a v z 4¦ )▁ ¦to¦ ¦estim ate¦ ¦epidemic¦ ¦measures¦ ¦on¦ ¦a¦ ¦w ee k ly¦ ¦ba sis¦ .
𐋇 ¦since¦ ¦we¦ ¦are¦ ¦f it ting¦ ¦an¦ ¦si r¦ - ¦epidemic¦ ¦mo de l¦ ¦in¦ ¦the¦ ¦ab c¦ ¦ro ut ine¦ ,▁ ¦we¦ ¦anti c ip ate¦ ¦that¦ ¦our¦ ¦results¦ ¦will¦ ¦be¦ ¦r ob ust¦ ¦against¦ ¦w ee k ly¦ ¦case¦ ¦data¦ ¦cont aining¦ ¦rel at ively¦ ¦sm all¦ ¦cou nts¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦se e¦ ¦for¦ ¦the¦ ¦ab c¦ ¦met ho d ology¦ ¦app l ied¦ ¦to¦ ¦the¦ ¦tr ist an¦ ¦d a¦ ¦c un h a¦ ¦common¦ ¦cold¦ ¦data¦ ¦from¦ ¦19 6 7¦ ,▁ ¦where¦ ¦cou nts¦ ¦of¦ ¦i¦ ▁( ¦number¦ ¦of¦ ¦infectious¦ ¦cases¦ )▁ ¦and¦ ¦ r¦ ▁( ¦number¦ ¦of¦ ¦re covered¦ ¦cases¦ )▁ ¦are¦ ¦in¦ ¦the¦ ¦t ens¦ ¦at¦ ¦most¦ .
𐋇¦f in ally¦ ,▁ ¦in¦ ¦add ition¦ ¦to¦ ¦the¦ ¦a bo ve¦ ¦met ho d ology¦ ¦we¦ ¦will¦ ¦e mploy ¦ ¦the¦ ¦k a pl an¦ - ¦me i er¦ ¦met ho d¦ ¦with¦ ¦two¦ ¦out c omes¦ ▁( ¦death¦ ¦and¦ ¦reco ve ry¦ )▁ ¦to¦ ¦estim ate¦ ¦the¦ ¦case¦ ¦fat ality¦ ¦ra ti o¦ .
𐋇¦this¦ ¦appro a ch¦ ¦is¦ ¦in de p end ent¦ ¦of¦ ¦the¦ ¦ab c¦ ¦met ho d ology¦ ¦and¦ ¦will¦ ¦all ow¦ ¦comp ar is ons¦ ¦between¦ ¦estim ates¦ ¦from¦ ¦the¦ ¦two¦ ¦mo de lling¦ ¦appro a ches¦ ¦to¦ ¦j ud ge¦ ¦r ob u st ness¦ ¦of¦ ¦results¦ .
𐋇 ¦r c g p¦ ¦ rs c¦ ▁’▁ ¦s¦ ¦surveillance¦ ¦with¦ ¦ph e¦ ¦is¦ ¦def ined¦ ¦as¦ ¦health¦ ¦prote ction¦ ¦under¦ ¦regul ation¦ ¦3¦ ¦of¦ ¦the¦ ¦health¦ ¦service¦ ▁( ¦control¦ ¦of¦ ¦pa ti ent¦ ¦information¦ )▁ ¦regul ations¦ ¦20 0 2¦ .
𐋇¦this¦ ¦has¦ ¦been¦ ¦confirmed¦ ¦by¦ ¦ph e¦ ▁’▁ ¦s¦ ¦c al d ic ot t¦ ¦gu ar di an¦ ▁’▁ ¦s¦ ¦off ice¦ .
𐋇¦we¦ ¦do¦ ¦not¦ ¦se e¦ ¦any¦ ¦increased¦ ¦risk¦ ¦to¦ ¦practi ces¦ ¦or¦ ¦practi tion ers¦ ¦ta king¦ ¦par t¦ ¦in¦ ¦this¦ ¦surveillance¦ .
𐋇 ¦infection¦ ¦pre vention¦ ¦and¦ ¦control¦ ¦advice¦ ¦will¦ ¦follow¦ ¦ext ant¦ ¦national¦ ¦gu id ance¦ .
𐋇 ¦any¦ ¦cases¦ ¦identified¦ ¦will¦ ¦be¦ ¦mana ged¦ ¦according¦ ¦to¦ ¦the¦ ¦ph e¦ ▁/▁ ¦n h s¦ ¦gu id ance¦ ¦in¦ ¦for ce¦ ¦at¦ ¦the¦ ¦time¦ ,▁ ¦including¦ ¦advice¦ ¦for¦ ¦identified¦ ¦contac ts¦ .
𐋇¦however¦ ,▁ ¦our¦ ¦tr aining¦ ¦will¦ ¦include¦ ¦re mi nd ers¦ ¦about¦ ¦safe¦ ¦hand l ing¦ ¦of¦ ¦spec im ens¦ ¦and¦ ¦re v is ion¦ ¦of¦ ¦infection¦ ¦control¦ ¦measures¦ ¦anti c ip ated¦ ¦to¦ ¦be¦ ¦high¦ ¦in¦ ¦our¦ ¦practi ces¦ .
𐋇¦it¦ ¦is¦ ¦a¦ ¦k e y¦ ¦par t¦ ¦of¦ ¦regul ation¦ ¦12¦ ¦about¦ ¦safe¦ ¦care¦ ¦and¦ ¦treatment¦ ,▁ ¦perio d ically¦ ¦i ns p ected¦ ¦by¦ ¦the¦ ¦care¦ ¦qu ality¦ ¦comm i ssion¦ .
𐋇 ¦travel¦ ¦h ist ory¦ ¦and¦ ¦clinical¦ ¦d esc ri pt ors¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦infections¦
𐋇¦the¦ ¦r c g p¦ ¦ rs c¦ ¦practi ces¦ ¦have¦ ¦been¦ ¦ad vi sed¦ ¦on¦ ¦the¦ ¦clinical¦ ¦co ding¦ ¦that¦ ¦has¦ ¦been¦ ¦made¦ ¦available¦ ¦for¦ ¦covid¦ - ¦19¦ ¦across¦ ¦all¦ ¦c m r¦ ¦sys tems¦ .
𐋇¦this¦ ¦inclu des¦ ¦information¦ ¦on¦ ¦co ding¦ ¦of¦ ¦clinical¦ ¦d esc ri pt ors¦ ▁( ¦t able¦ ¦4¦ )▁ ¦and¦ ¦any¦ ¦rec ent¦ ¦travel¦ ¦h ist ory¦ .
𐋇¦ es ta bl is h ment¦ ¦of¦ ¦ex te nded¦ ¦vir ology¦ ¦sampl ing¦
𐋇¦the¦ ¦r c g p¦ ¦ rs c¦ ¦practi ces¦ ¦partic ip ating¦ ¦in¦ ¦the¦ ¦an n ual¦ ¦influenza¦ ¦vir ology¦ ¦surveillance¦ ¦have¦ ¦star ted¦ ¦sampl ing¦ ¦from¦ ¦patients¦ ¦sh owing¦ ¦symptoms¦ ¦of¦ ¦l rt i¦ .
𐋇 ¦all¦ ¦samples¦ ¦received¦ ¦are¦ ¦being¦ ¦tested¦ ¦for¦ ¦influenza¦ ¦and¦ ¦covid¦ - ¦19¦ .
𐋇¦this¦ ¦has¦ ¦l ed¦ ¦to¦ ¦in it ial¦ ¦early¦ ¦ident ific ation¦ ¦of¦ ¦b ac k g ro un d¦ ¦spread¦ ¦in¦ ¦low¦ - ¦risk¦ ¦patients¦ .
𐋇¦as¦ ¦of¦ ¦march¦ ¦7¦ ,▁ ¦2020¦ ,▁ ¦the¦ ¦surveillance¦ ¦system¦ ¦has¦ ¦detected¦ ¦2¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦low¦ - ¦risk¦ ¦patients¦ ¦with¦ ¦no¦ ¦h ist ory¦ ¦of¦ ¦travel¦ ¦through¦ ¦ex te nded¦ ¦vir ological¦ ¦sampl ing¦ .
𐋇¦this¦ ¦prot oc o l¦ ¦d esc rib es¦ ¦how¦ ¦we¦ ¦have¦ ¦ad ap ted¦ ¦a¦ ¦national¦ ¦influenza¦ ¦surveillance¦ ¦system¦ ¦to¦ ¦monit or¦ ¦community¦ ¦spread¦ ¦of¦ ¦an¦ ¦u ne x p ected¦ ¦infection¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇¦we¦ ¦have¦ ¦rap id ly¦ ¦cre ated¦ ¦and¦ ¦inc or p or ated¦ ¦new¦ ¦co des¦ ¦to¦ ¦all ow¦ ¦data¦ ¦recor ding¦ ,▁ ¦and¦ ¦are¦ ¦coll ecting¦ ¦data¦ ¦to¦ ¦monit or¦ ¦the¦ ¦eff ec ti ve ness¦ ¦of¦ ¦conta in ment¦ ¦stra te g ies¦ .
𐋇 ¦through¦ ¦this¦ ¦surveillance¦ ,▁ ¦we¦ ¦int end¦ ¦to¦ ¦f ind¦ ¦out¦ ¦more¦ ¦about¦ ¦the¦ ¦e p ide mi ology¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦a mb ul atory¦ ¦care¦ .
𐋇¦in¦ ¦partic ular¦ ,▁ ¦its¦ ¦rate¦ ¦of¦ ¦spread¦ ,▁ ¦both¦ ¦temp or al¦ ¦and¦ ¦ ge ogra ph ical¦ .
𐋇 ¦our¦ ¦testing¦ ¦of¦ ¦low¦ - ¦risk¦ ¦patients¦ ¦will¦ ¦also¦ ¦in for m¦ ¦wh ether¦ ¦the¦ ¦conta in ment¦ ¦stra te g y¦ ¦that¦ ¦is¦ ¦based¦ ¦on¦ ¦vir ology¦ ¦testing¦ ¦of¦ ¦high¦ - ¦risk¦ ¦patients¦ ¦and¦ ¦their¦ ¦contac ts¦ ¦pl us¦ ¦self¦ - ¦isolation¦ ¦is¦ ¦effective¦ .
𐋇 ¦conta in ment¦ ¦should¦ ¦sl ow¦ ¦the¦ ¦spread¦ ,▁ ¦and¦ ¦there¦ ¦may¦ ¦be¦ ¦be ne f i ts¦ ¦in¦ ¦the¦ ¦mana ge ment¦ ¦of¦ ¦spread¦ ¦from¦ ¦int en se¦ ¦surveillance¦ .
𐋇¦however¦ ,▁ ¦there¦ ¦may¦ ¦come¦ ¦a¦ ¦po in t¦ ¦at¦ ¦which¦ ¦the¦ ¦virus¦ ¦sprea ds¦ ¦more¦ ¦wid ely¦ ¦into¦ ¦the¦ ¦population¦ ,▁ ¦as¦ ¦has¦ ¦happ e ned¦ ¦in¦ ¦italy¦ .
𐋇 ¦surveillance¦ ¦of¦ ¦low¦ - ¦risk¦ ¦patients¦ ¦should¦ ¦in for m¦ ¦when¦ ¦we¦ ¦rea ch¦ ¦this¦ ¦ti pping¦ ¦po in t¦ ¦and¦ ¦when¦ ¦infection¦ ¦r ates¦ ¦star t¦ ¦to¦ ¦re mi t¦ .
𐋇¦the¦ ¦e p ide mi ology¦ ¦of¦ ¦covid¦ - ¦19¦ ¦rema ins¦ ¦e mer g ent¦ .
𐋇¦the¦ ¦regi str ation¦ - ¦based¦ ¦nat ure¦ ¦of¦ ¦uk¦ ¦pr imary¦ ¦care¦ ¦me ans¦ ¦that¦ ¦we¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦cre ate¦ ¦a¦ ¦co mpl et e¦ ¦p i ct ure¦ ¦of¦ ¦the¦ ¦c um ul ative¦ ¦inc idence¦ ¦and¦ ¦d ur ation¦ .
𐋇¦the¦ ¦surveillance¦ ¦system¦ ¦should¦ ¦be¦ ¦able¦ ¦to¦ ¦ident if y¦ ¦areas¦ ¦where¦ ¦covid¦ - ¦19¦ ¦spread¦ ¦is¦ ¦ta king¦ ¦place¦ ¦that¦ ¦might¦ ¦be¦ ¦su it able¦ ¦for¦ ¦trials¦ ¦of¦ ¦anti vir al¦ ¦ ther ap y¦ .
𐋇¦we¦ ¦could¦ ¦also¦ ¦follow¦ ¦up¦ ¦on¦ ¦the¦ ¦eff ec ti ve ness¦ ¦or¦ ¦any¦ ¦ad ver se¦ ¦re ac tions¦ ¦to¦ ¦these¦ ¦medic ines¦ ¦or¦ ¦vacc in ations¦ .
𐋇¦f in ally¦ ,▁ ¦early¦ ¦de te ction¦ ¦of¦ ¦a¦ ¦confirmed¦ ¦covid¦ - ¦19¦ ¦case¦ ¦has¦ ¦ex e mpl if ied¦ ¦the¦ ¦rap id¦ ¦imp le me nt ation¦ ¦of¦ ¦this¦ ¦en h a nc ed¦ ¦surveillance¦ ¦in¦ ¦the¦ ¦national¦ ¦n et w or k¦ .
𐋇 ¦safety¦ ¦of¦ ¦practi ces¦ ¦is¦ ¦our¦ ¦pr imary¦ ¦concer n¦ .
𐋇¦the¦ ¦r c g p¦ ¦ rs c¦ ¦has¦ ¦op er ated¦ ¦for¦ ¦over¦ ¦50¦ ¦years¦ ¦and¦ ¦has¦ ¦been¦ ¦invol v ed¦ ¦in¦ ¦coll ecting¦ ¦samples¦ ¦to¦ ¦monit or¦ ¦disease¦ ¦and¦ ¦vaccine¦ ¦eff ec ti ve ness¦ ¦through¦ ¦the¦ ¦ho ng¦ ¦ko ng¦ ¦flu¦ ¦pandemic¦ ¦of¦ ¦19 6 8¦ ▁/▁ ¦6 9¦ ,▁ ¦the¦ ¦r us si an¦ ¦flu¦ ¦of¦ ¦19 7 7¦ ▁/▁ ¦7 8¦ ,▁ ¦and¦ ¦the¦ ¦20 0 9¦ ¦sw ine¦ ¦flu¦ ¦pandemic¦ .
𐋇¦we¦ ¦are¦ ¦not¦ ¦a w are¦ ¦of¦ ¦any¦ ¦increased¦ ¦risk¦ ¦to¦ ¦pract ice¦ ¦staff¦ ¦or¦ ¦other¦ ¦patients¦ ¦from¦ ¦invol ve ment¦ ¦in¦ ¦surveillance¦ .
𐋇 ¦pandemic¦ ¦pre par ed ness¦ ¦is¦ ¦par t¦ ¦of¦ ¦the¦ ¦ro le¦ ¦of¦ ¦the¦ ¦r c g p¦ ¦ rs c¦ .
𐋇¦it¦ ¦is¦ ¦pla u si ble¦ ¦that¦ ¦en h a nc ed¦ ¦co ding¦ ¦of¦ ¦information¦ ¦from¦ ¦contac ts¦ ¦with¦ ¦the¦ ¦practi ces¦ ¦in¦ ¦r c g p¦ ¦ rs c¦ ¦will¦ ¦reduce¦ ¦the¦ ¦li k e li h ood¦ ¦of¦ ¦people¦ ¦who¦ ¦may¦ ¦be¦ ¦suspected¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦being¦ ¦br ou gh t¦ ¦to¦ ¦the¦ ¦sur ge ry¦ ¦i na d ver te ntly¦ .
𐋇 ¦where¦ ¦cases¦ ¦are¦ ¦detected¦ ¦u ne x p ect ed ly¦ ,▁ ¦it¦ ¦is¦ ¦prob ab ly¦ ¦h el p ful¦ ¦for¦ ¦that¦ ¦pa ti ent¦ ,▁ ¦their¦ ¦contac ts¦ ,▁ ¦and¦ ¦the¦ ¦pract ice¦ ¦to¦ ¦know¦ .
𐋇¦the¦ ¦impac t¦ ¦on¦ ¦practi ces¦ ¦has¦ ¦been¦ ¦to¦ ¦close¦ ¦for¦ ¦a¦ ¦day¦ ,▁ ¦if¦ ¦a¦ ¦case¦ ¦is¦ ¦found¦ ,▁ ¦for¦ ¦d ee p¦ ¦cl ea ning¦ ¦and¦ ¦then¦ ¦reop en¦ .
𐋇¦the¦ ¦pri nc ip al¦ ¦limi t ations¦ ¦of¦ ¦our¦ ¦system¦ ¦are¦ ¦the¦ ¦number¦ ¦of¦ ¦data¦ ¦p oi nts¦ .
𐋇¦we¦ ¦are¦ ¦coll ecting¦ ¦ser ology¦ ¦and¦ ¦vir ology¦ ¦data¦ ¦from¦ ¦100¦ ¦si tes¦ ,▁ ¦which¦ ¦cov ers¦ ¦a¦ ¦sm all¦ ¦group¦ ¦of¦ ¦the¦ ¦population¦ .
𐋇¦this¦ ¦has¦ ¦been¦ ¦s at is fa ct ory¦ ¦for¦ ¦monit or ing¦ ¦influenza¦ ,▁ ¦but¦ ¦we¦ ¦are¦ ¦not¦ ¦c er tain¦ ¦if¦ ¦this¦ ¦is¦ ¦a¦ ¦su ff ic ie ntly¦ ¦large¦ ¦sampl e¦ ¦for¦ ¦the¦ ¦covid¦ - ¦19¦ ¦outbreak¦ .
𐋇 ¦our¦ ¦si tes¦ ▁( ¦surveillance¦ ¦practi ces¦ )▁ ¦are¦ ¦cur re ntly¦ ¦fi x ed¦ ,▁ ¦and¦ ¦it¦ ¦could¦ ¦be¦ ¦h el p ful¦ ¦to¦ ¦be¦ ¦able¦ ¦to¦ ¦rap id ly¦ ¦ on bo ard¦ ¦practi ces¦ ¦in¦ ¦regi ons¦ ¦where¦ ¦there¦ ¦are¦ ¦more¦ ¦cases¦ .
𐋇 ¦cur re ntly¦ ,▁ ¦we¦ ¦will¦ ¦be¦ ¦rep orting¦ ¦w ee k ly¦ .
𐋇 ¦our¦ ¦ex is ting¦ ¦system¦ ¦can¦ ¦be¦ ¦en h a nc ed¦ ¦to¦ ¦t w ice¦ ¦w ee k ly¦ ,▁ ¦but¦ ¦ma y b e¦ ¦daily¦ ¦or¦ ¦ho ur ly¦ ¦data¦ ¦should¦ ¦be¦ ¦our¦ ¦current¦ ¦appro a ch¦ .
𐋇 ¦o pp ort un ist ic¦ ¦sampl ing¦ ¦for¦ ¦ser ology¦ ¦in¦ ¦children¦ ¦y ou nger¦ ¦than¦ ¦10¦ ¦years¦ ¦might¦ ¦be¦ ¦limi ted¦ ¦due¦ ¦to¦ ¦the¦ ¦over all¦ ¦reduc ed¦ ¦rate¦ ¦of¦ ¦blood¦ ¦tests¦ ¦in¦ ¦children¦ .
𐋇¦the¦ ¦ex te nded¦ ¦surveillance¦ ¦using¦ ¦the¦ ¦r c g p¦ ¦ rs c¦ - ¦ph e¦ ¦n et w or k¦ ¦for¦ ¦the¦ ¦e mer g ent¦ ¦covid¦ - ¦19¦ ¦outbreak¦ ¦has¦ ¦been¦ ¦ es ta bl ished¦ ¦rap id ly¦ .
𐋇¦the¦ ¦mo de l¦ ¦of¦ ¦getting¦ ¦the¦ ¦appr op ri ate¦ ¦inf orm at ics¦ ¦to¦ ¦en able¦ ¦ca pt ure¦ ¦of¦ ¦the¦ ¦required¦ ¦data¦ ¦has¦ ¦al rea dy¦ ¦been¦ ¦a¦ ¦s uc c ess¦ ,▁ ¦with¦ ¦data¦ ¦recor ding¦ ¦star ting¦ ¦the¦ ¦week¦ ¦the¦ ¦co des¦ ¦were¦ ¦cre ated¦ .
𐋇¦in¦ ¦add ition¦ ,▁ ¦mod if ying¦ ¦the¦ ¦ex is ting¦ ¦surveillance¦ ¦system¦ ¦to¦ ¦coll ect¦ ¦population¦ ¦data¦ ¦in¦ ¦a¦ ¦par al le l¦ ¦way¦ ¦has¦ ¦also¦ ¦been¦ ¦effective¦ .
𐋇¦however¦ ,▁ ¦we¦ ¦are¦ ¦at¦ ¦pres ent¦ ¦u ns ure¦ ¦as¦ ¦to¦ ¦wh ether¦ ¦the¦ ¦sc a le¦ ¦of¦ ¦this¦ ¦surveillance¦ ¦provid es¦ ¦su ff ici ent¦ ¦data¦ ¦to¦ ¦dr ive¦ ¦local¦ ¦conta in ment¦ ¦stra te g ies¦ ¦or¦ ¦if¦ ¦rep orting¦ ¦inf re qu e ntly¦ ¦me ets¦ ¦the¦ ¦need¦ ¦of¦ ¦our¦ ¦information¦ ¦age¦ .
𐋇 ¦national¦ ¦b as k et b all¦ ¦associ ation¦ ¦susp ends¦ ¦se as on¦ ¦due¦ ¦to¦ ¦covid¦ - ¦19¦ ¦concer ns¦
𐋇¦on¦ ¦w ed n es day¦ ,▁ ¦the¦ ¦united¦ ¦states¦ ' ▁ ¦national¦ ¦b as k et b all¦ ¦associ ation¦ ▁( ¦n b a¦ )▁ ¦susp e nded¦ ¦its¦ ¦pro f es si on al¦ ¦b as k et b all¦ ¦se as on¦ ¦due¦ ¦to¦ ¦concer ns¦ ¦reg ar ding¦ ¦covid¦ - ¦19¦ .
𐋇¦the¦ ¦n b a¦ ' ¦s¦ ¦dec is ion¦ ¦fo ll owed¦ ¦a¦ ¦u ta h ¦ ¦j a z z ¦ ¦pla y er¦ ¦testing¦ ¦positive¦ ¦for¦ ¦the¦ ¦covid¦ - ¦19¦ ¦virus¦ .
𐋇¦the¦ ¦n b a¦ ¦d id¦ ¦not¦ ¦re le ase¦ ¦the¦ ¦ident ity¦ ¦of¦ ¦the¦ ¦pla y er¦ ¦in¦ ¦qu e st ion¦ ¦in¦ ¦its¦ ¦an no un ce ment¦ .
𐋇¦they¦ ¦d id¦ ¦s ay¦ ¦h e¦ ¦was¦ ¦not¦ ¦pres ent¦ ¦at¦ ¦ch es ap ea ke¦ ¦en er g y¦ ¦a re na¦ ¦in¦ ¦o k la h om a¦ ¦city¦ ,▁ ¦where¦ ¦the¦ ¦u ta h ¦ ¦j a z z ¦ ¦were¦ ¦to¦ ¦pl ay¦ ¦against¦ ¦the¦ ¦o k la h om a¦ ¦city¦ ¦th un der¦ .
𐋇 ¦according¦ ¦to¦ ¦its¦ ¦pr ess¦ ¦re le ase¦ ,▁ ¦the¦ ¦n b a¦ ¦was¦ ▁" ¦susp ending¦ ¦ga me¦ ¦pl ay¦ ¦following¦ ¦the¦ ¦co nc l us ion¦ ¦of¦ ▁ [ ¦w ed n es day¦ ' ¦s¦ ] ▁ ¦s ch ed u le¦ ¦of¦ ¦ga m es¦ ¦until¦ ¦further¦ ¦n ot ice¦ . "
𐋇¦the¦ ¦j a z z ¦ ' ¦s¦ ¦ga me¦ ¦was¦ ¦cance lled¦ ,▁ ¦as¦ ¦was¦ ¦another¦ ¦n b a¦ ¦ga me¦ ¦w ed n es day¦ ¦between¦ ¦the¦ ¦s ac ra me nt o¦ ¦k ings¦ ¦and¦ ¦the¦ ¦new¦ ¦or le ans¦ ¦p el ic ans¦ .
𐋇 ¦other¦ ¦ga m es¦ ¦s ch ed ul ed¦ ¦for¦ ¦w ed n es day¦ ¦were¦ ¦still¦ ¦he ld¦ ,▁ ¦according¦ ¦to¦ ¦n b c¦ ¦new s¦ .
𐋇¦the¦ ¦united¦ ¦states¦ ' ▁ ¦other¦ ¦major¦ ¦b as k et b all¦ ¦organiz ation¦ ,▁ ¦the¦ ¦national¦ ¦colle g i ate¦ ¦a th l et ic¦ ¦associ ation¦ ,▁ ¦which¦ ¦ ru ns¦ ¦colle ge¦ ¦b as k et b all¦ ,▁ ¦has¦ ¦cance lled¦ ¦its¦ ¦ own¦ ¦to ur na ment¦ ,▁ ¦march¦ ¦ma d ness¦ ,▁ ¦for¦ ¦both¦ ¦m en¦ ' ¦s¦ ¦and¦ ¦women¦ ' ¦s¦ ¦lea g ues¦ .
𐋇 ¦according¦ ¦to¦ ¦jo h ns¦ ¦h op k ins¦ ¦univers ity¦ ,▁ ¦as¦ ¦of¦ ¦w ed n es day¦ ,▁ ¦there¦ ¦were¦ ¦at¦ ¦least¦ ¦1¦ , ¦2 7 9¦ ¦confirmed¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ .
𐋇¦c n b c¦ ¦reported¦ ¦there¦ ¦were¦ ¦at¦ ¦least¦ ¦1 1 8¦ , ¦3 8 1¦ ¦cases¦ ¦worldwide¦ .
𐋇 ¦us¦ ¦pres ident¦ ¦tr um p¦ ¦decl ar es¦ ¦covid¦ - ¦19¦ ¦national¦ ¦emergency¦
𐋇¦on¦ ¦f ri day¦ ,▁ ¦united¦ ¦states¦ ¦pres ident¦ ¦do na ld¦ ¦tr um p¦ ¦decl ared¦ ¦a¦ ¦national¦ ¦emergency¦ ¦in¦ ¦response¦ ¦to¦ ¦the¦ ¦o ng o ing¦ ¦coronavirus¦ ¦outbreak¦ .
𐋇¦the¦ ¦mo ve¦ ¦ca me¦ ¦two¦ ¦days¦ ¦after¦ ¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ¦decl ared¦ ¦the¦ ¦outbreak¦ ,▁ ¦which¦ ¦ca u ses¦ ¦the¦ ¦covid¦ - ¦19¦ ¦disease¦ ,▁ ¦to¦ ¦be¦ ¦a¦ ¦pandemic¦ .
𐋇¦the¦ ¦mo ve¦ ¦g ives¦ ¦the¦ ¦f ed er al¦ ¦government¦ ¦acc ess¦ ¦to¦ ¦around¦ ¦us¦ ▁ $ ¦50¦ ¦bi ll ion¦ ¦in¦ ¦ext r a¦ ¦f un ding¦ ¦to¦ ¦co mb at¦ ¦the¦ ¦pandemic¦ ,▁ ¦according¦ ¦to¦ ¦n b c¦ ¦new s¦ .
𐋇¦the¦ ¦proc la m ation¦ ¦spec if ically¦ ¦said¦ ▁" ¦the¦ ¦covid¦ - ¦19¦ ¦outbreak¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ¦con st itu tes¦ ¦a¦ ¦national¦ ¦emergency¦ "▁ ¦and¦ ¦said¦ ¦the¦ ¦national¦ ¦emergency¦ ¦beg an¦ ¦on¦ ¦march¦ ¦1¦ ,▁ ¦al m ost¦ ¦two¦ ¦weeks¦ ¦before¦ ¦the¦ ¦proc la m ation¦ ¦ it s el f¦ .
𐋇¦the¦ ¦united¦ ¦states¦ ¦department¦ ¦of¦ ¦health¦ ¦and¦ ¦human¦ ¦services¦ ¦decl ared¦ ¦the¦ ¦outbreak¦ ¦a¦ ▁" ¦public¦ ¦health¦ ¦emergency¦ "▁ ¦on¦ ¦january¦ ¦3 1¦ .
𐋇 ¦tr um p¦ ¦d id¦ ¦not¦ ¦place¦ ¦the¦ ¦f ed er al¦ ¦emergency¦ ¦mana ge ment¦ ¦a ge ncy¦ ▁( ¦fe m a¦ )▁ ¦in¦ ¦ch ar ge¦ ¦of¦ ¦the¦ ¦government¦ ' ¦s¦ ¦response¦ ¦to¦ ¦covid¦ - ¦19¦ ,▁ ¦which¦ ¦pol it ic o¦ ¦reported¦ ¦le f t¦ ¦some¦ ¦exp er ts¦ ¦in¦ ¦dis as ter¦ ¦mana ge ment¦ ¦dis a pp o in ted¦ .
𐋇 ¦pol it ic o¦ ¦qu o ted¦ ¦ti m¦ ¦m an ning¦ ,▁ ¦f orm erly¦ ¦a¦ ¦dep ut y¦ ¦admin i str at or¦ ¦at¦ ¦fe m a¦ ,▁ ¦as¦ ¦sa ying¦ ▁" ¦fe m a¦ ¦has¦ ¦an¦ ¦important¦ ¦ro le¦ ¦in¦ ¦co or d in ating¦ ¦the¦ ¦l arg er¦ ¦response¦ ¦to¦ ¦the¦ ¦c ri sis¦ "▁ ¦and¦ ▁" [ ¦i¦ ] ▁ ¦ f¦ ¦there¦ ' ¦s¦ ¦an¦ ¦emergency¦ ,▁ ¦fe m a¦ ¦needs¦ ¦to¦ ¦be¦ ¦invol v ed¦ . "
𐋇 ¦tr um p¦ ¦made¦ ¦the¦ ¦dec is ion¦ ¦under¦ ¦pro vi si ons¦ ¦of¦ ¦the¦ ¦national¦ ¦e mer ge nc ies¦ ¦ac t¦ ,▁ ¦a mo ng s t¦ ¦other¦ ¦gover ning¦ ¦author ities¦ .
𐋇¦the¦ ¦tr um p¦ ¦admin i str ation¦ ¦also¦ ¦announced¦ ¦other¦ ¦eff orts¦ ¦in¦ ¦response¦ ¦to¦ ¦covid¦ - ¦19¦ ,▁ ¦including¦ ¦wai ving¦ ¦the¦ ¦inter est¦ ¦it¦ ¦coll ects¦ ¦on¦ ¦f ed er al¦ ¦st ud ent¦ ¦lo ans¦ ¦and¦ ¦incre as ing¦ ¦u¦ . ¦s¦ .▁ ¦stra te g ic¦ ¦o il¦ ¦res er ve¦ ¦o il¦ ¦p ur ch a ses¦ .
𐋇 ¦impac t¦ ¦of¦ ¦the¦ ¦2019¦ ▁–▁ ¦20¦ ¦coronavirus¦ ¦pandemic¦ ¦on¦ ¦education¦
𐋇¦the¦ ¦2019¦ ▁–▁ ¦20¦ ¦coronavirus¦ ¦pandemic¦ ¦has¦ ¦affected¦ ¦e duc a tional¦ ¦sys tems¦ ¦worldwide¦ ,▁ ¦lea ding¦ ¦to¦ ¦the¦ ¦wid esp r ead¦ ¦closures¦ ¦of¦ ¦schools¦ ¦and¦ ¦univers ities¦ .
𐋇¦as¦ ¦of¦ ¦8¦ ¦april¦ ¦2020¦ ,▁ ¦appro xi ma tely¦ ¦1¦ . ¦7 1 6¦ ¦bi ll ion¦ ¦lear n ers¦ ¦have¦ ¦been¦ ¦affected¦ ¦due¦ ¦to¦ ¦school¦ ¦closures¦ ¦in¦ ¦response¦ ¦to¦ ¦covid¦ - ¦19¦ .
𐋇 ¦according¦ ¦to¦ ¦un esc o¦ ¦monit or ing¦ ,▁ ¦1 8 8¦ ¦countries¦ ¦have¦ ¦imp le m ented¦ ¦na tion w ide¦ ¦closures¦ ¦and¦ ¦5¦ ¦have¦ ¦imp le m ented¦ ¦local¦ ¦closures¦ ,▁ ¦impac ting¦ ¦about¦ ¦9 9¦ . ¦4¦ %▁ ¦of¦ ¦the¦ ¦world¦ ' ¦s¦ ¦st ud ent¦ ¦population¦ .
𐋇¦on¦ ¦23¦ ¦march¦ ¦2020¦ ,▁ ¦ca mb r id ge¦ ¦international¦ ¦ex a min ations¦ ▁( ¦c i e¦ )▁ ¦rel ea sed¦ ¦a¦ ¦sta te ment¦ ¦an n ou ncing¦ ¦the¦ ¦cance ll ation¦ ¦of¦ ¦ca mb r id ge¦ ¦ ig c se¦ ,▁ ¦ca mb r id ge¦ ¦ o¦ ¦level¦ ,▁ ¦ca mb r id ge¦ ¦international¦ ¦as¦ ▁ & ▁ ¦a m p¦ ;▁ ¦a¦ ¦level¦ ,▁ ¦ca mb r id ge¦ ¦a ice¦ ¦di pl om a¦ ,▁ ¦and¦ ¦ca mb r id ge¦ ¦pr e¦ - ¦u¦ ¦ex a min ations¦ ¦for¦ ¦the¦ ¦may¦ ▁/▁ ¦june¦ ¦2020¦ ¦ser ies¦ ¦across¦ ¦all¦ ¦countries¦ .
𐋇 ¦international¦ ¦b ac c a la u re ate¦ ¦ex a ms¦ ¦have¦ ¦also¦ ¦been¦ ¦cance lled¦ . ¦school¦ ¦closures¦ ¦impac t¦ ¦not¦ ¦only¦ ¦students¦ ,▁ ¦t ea ch ers¦ ,▁ ¦and¦ ¦fa m il ies¦ ,▁ ¦but¦ ¦have¦ ¦fa r¦ - ¦re ac hing¦ ¦ec onomic¦ ¦and¦ ¦s oc i et al¦ ¦con se qu en ces¦ .
𐋇 ¦school¦ ¦closures¦ ¦in¦ ¦response¦ ¦to¦ ¦covid¦ - ¦19¦ ¦have¦ ¦sh ed¦ ¦l ight¦ ¦on¦ ¦v ar ious¦ ¦social¦ ¦and¦ ¦ec onomic¦ ¦i ss ues¦ ,▁ ¦including¦ ¦st ud ent¦ ¦de b t¦ ,▁ ¦d ig it al¦ ¦learning¦ ,▁ ¦food¦ ¦i ns ec ur ity¦ ,▁ ¦and¦ ¦ho me le ss ness¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦acc ess¦ ¦to¦ ¦ch ild c are¦ ,▁ ¦health¦ ¦care¦ ,▁ ¦ho us ing¦ ,▁ ¦inter n et¦ ,▁ ¦and¦ ¦dis a bility¦ ¦services¦ .
𐋇¦the¦ ¦impac t¦ ¦was¦ ¦more¦ ¦severe¦ ¦for¦ ¦dis a d v an ta ged¦ ¦children¦ ¦and¦ ¦their¦ ¦fa m il ies¦ ,▁ ¦ca us ing¦ ¦inter ru p ted¦ ¦learning¦ ,▁ ¦comp ro mi sed¦ ¦n ut r ition¦ ,▁ ¦ch ild c are¦ ¦prob le ms¦ ,▁ ¦and¦ ¦con se qu ent¦ ¦ec onomic¦ ¦c ost¦ ¦to¦ ¦fa m il ies¦ ¦who¦ ¦could¦ ¦not¦ ¦work¦ . ¦in¦ ¦response¦ ¦to¦ ¦school¦ ¦closures¦ ,▁ ¦un esc o¦ ¦recommended¦ ¦the¦ ¦use¦ ¦of¦ ¦dista nce¦ ¦learning¦ ¦pr ogra mm es¦ ¦and¦ ¦open¦ ¦e duc a tional¦ ¦app l ications¦ ¦and¦ ¦pl at for ms¦ ¦that¦ ¦schools¦ ¦and¦ ¦t ea ch ers¦ ¦can¦ ¦use¦ ¦to¦ ¦rea ch¦ ¦lear n ers¦ ¦re mo tely¦ ¦and¦ ¦limi t¦ ¦the¦ ¦dis ru ption¦ ¦of¦ ¦education¦ .
𐋇 ¦eff orts¦ ¦to¦ ¦ste m¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ ¦through¦ ¦non¦ - ¦ph ar ma ce ut ical¦ ¦int erv en tions¦ ¦and¦ ¦prev en tive¦ ¦measures¦ ¦such¦ ¦as¦ ¦social¦ - ¦distancing¦ ¦and¦ ¦self¦ - ¦isolation¦ ¦have¦ ¦pro mp ted¦ ¦the¦ ¦wid esp r ead¦ ¦cl osure¦ ¦of¦ ¦pr imary¦ ,▁ ¦sec ond ary¦ ,▁ ¦and¦ ¦ter ti ary¦ ¦sc ho ol ing¦ ¦in¦ ¦over¦ ¦100¦ ¦countries¦ . ¦prev ious¦ ¦out b rea ks¦ ¦of¦ ¦infectious¦ ¦diseases¦ ¦have¦ ¦pro mp ted¦ ¦wid esp r ead¦ ¦school¦ ¦clos ings¦ ¦around¦ ¦the¦ ¦world¦ ,▁ ¦with¦ ¦v ar ying¦ ¦le v els¦ ¦of¦ ¦eff ec ti ve ness¦ .
𐋇¦m at he m at ical¦ ¦mo de lling¦ ¦has¦ ¦sh own¦ ¦that¦ ¦transmission¦ ¦of¦ ¦an¦ ¦outbreak¦ ¦may¦ ¦be¦ ¦de la y ed¦ ¦by¦ ¦clos ing¦ ¦schools¦ .
𐋇¦however¦ ,▁ ¦eff ec ti ve ness¦ ¦dep ends¦ ¦on¦ ¦the¦ ¦contac ts¦ ¦children¦ ¦main tain¦ ¦outside¦ ¦of¦ ¦school¦ .
𐋇 ¦school¦ ¦closures¦ ¦may¦ ¦be¦ ¦effective¦ ¦when¦ ¦en ac ted¦ ¦pr om pt ly¦ .
𐋇¦if¦ ¦school¦ ¦closures¦ ¦occur ¦ ¦l ate¦ ¦rel ative¦ ¦to¦ ¦an¦ ¦outbreak¦ ,▁ ¦they¦ ¦are¦ ¦less¦ ¦effective¦ ¦and¦ ¦may¦ ¦not¦ ¦have¦ ¦any¦ ¦impac t¦ ¦at¦ ¦all¦ .
𐋇 ¦ad di tion ally¦ ,▁ ¦in¦ ¦some¦ ¦cases¦ ,▁ ¦the¦ ¦reop ening¦ ¦of¦ ¦schools¦ ¦after¦ ¦a¦ ¦period¦ ¦of¦ ¦cl osure¦ ¦has¦ ¦res ul ted¦ ¦in¦ ¦increased¦ ¦infection¦ ¦r ates¦ .
𐋇¦as¦ ¦closures¦ ¦t end¦ ¦to¦ ¦occur ¦ ¦co nc ur re ntly¦ ¦with¦ ¦other¦ ¦int erv en tions¦ ¦such¦ ¦as¦ ¦public¦ ¦ga th ering¦ ¦b ans¦ ,▁ ¦it¦ ¦can¦ ¦be¦ ¦diffic ul t¦ ¦to¦ ¦me as ure¦ ¦the¦ ¦specific¦ ¦impac t¦ ¦of¦ ¦school¦ ¦closures¦ . ¦during¦ ¦the¦ ¦19 1 8¦ - ¦19 1 9¦ ¦influenza¦ ¦pandemic¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦school¦ ¦closures¦ ¦and¦ ¦public¦ ¦ga th ering¦ ¦b ans¦ ¦were¦ ¦associated¦ ¦with¦ ¦lower¦ ¦total¦ ¦m ort ality¦ ¦r ates¦ .
𐋇¦c ities¦ ¦that¦ ¦imp le m ented¦ ¦such¦ ¦int erv en tions¦ ¦ ear li er¦ ¦had¦ ¦g rea ter¦ ¦del ays¦ ¦in¦ ¦re ac hing¦ ¦p ea k¦ ¦m ort ality¦ ¦r ates¦ .
𐋇 ¦schools¦ ¦closed¦ ¦for¦ ¦a¦ ¦me di an¦ ¦d ur ation¦ ¦of¦ ¦4¦ ¦weeks¦ ¦according¦ ¦to¦ ¦a¦ ¦study¦ ¦of¦ ¦4 3¦ ¦us¦ ¦c ities¦ ' ▁ ¦response¦ ¦to¦ ¦the¦ ¦sp an ish¦ ¦flu¦ .
𐋇 ¦school¦ ¦closures¦ ¦were¦ ¦sh own¦ ¦to¦ ¦reduce¦ ¦m or b id ity¦ ¦from¦ ¦the¦ ¦a si an¦ ¦flu¦ ¦by¦ ¦9 0¦ %▁ ¦during¦ ¦the¦ ¦19 5 7¦ ▁–▁ ¦5 8¦ ¦outbreak¦ ,▁ ¦and¦ ¦up¦ ¦to¦ ¦50¦ %▁ ¦in¦ ¦cont ro lling¦ ¦influenza¦ ¦in¦ ¦the¦ ¦us¦ ,▁ ¦20 0 4¦ ▁–▁ ¦20 0 8¦ . ¦mult ip le¦ ¦countries¦ ¦s uc cess f ul ly¦ ¦sl owed¦ ¦the¦ ¦spread¦ ¦of¦ ¦infection¦ ¦through¦ ¦school¦ ¦closures¦ ¦during¦ ¦the¦ ¦20 0 9¦ ¦h 1 n 1¦ ¦flu¦ ¦pandemic¦ .
𐋇 ¦school¦ ¦closures¦ ¦in¦ ¦the¦ ¦city¦ ¦of¦ ¦o it a¦ ,▁ ¦j ap an¦ ,▁ ¦were¦ ¦found¦ ¦to¦ ¦have¦ ¦s uc cess f ul ly¦ ¦dec rea sed¦ ¦the¦ ¦number¦ ¦of¦ ¦infected¦ ¦students¦ ¦at¦ ¦the¦ ¦p ea k¦ ¦of¦ ¦infection¦ ;▁ ¦however¦ ¦clos ing¦ ¦schools¦ ¦was¦ ¦not¦ ¦found¦ ¦to¦ ¦have¦ ¦sign ific a ntly¦ ¦dec rea sed¦ ¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦infected¦ ¦students¦ .
𐋇 ¦mand atory¦ ¦school¦ ¦closures¦ ¦and¦ ¦other¦ ¦social¦ ¦distancing¦ ¦measures¦ ¦were¦ ¦associated¦ ¦with¦ ¦a¦ ¦2 9¦ %▁ ¦to¦ ¦3 7¦ %▁ ¦reduc t ion¦ ¦in¦ ¦influenza¦ ¦transmission¦ ¦r ates¦ .
𐋇 ¦early¦ ¦school¦ ¦closures¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ¦de la y ed¦ ¦the¦ ¦p ea k¦ ¦of¦ ¦the¦ ¦20 0 9¦ ¦h 1 n 1¦ ¦flu¦ ¦pandemic¦ .
𐋇¦d esp ite¦ ¦the¦ ¦over all¦ ¦s uc c ess¦ ¦of¦ ¦clos ing¦ ¦schools¦ ,▁ ¦a¦ ¦study¦ ¦of¦ ¦school¦ ¦closures¦ ¦in¦ ¦mi ch ig an¦ ¦found¦ ¦that¦ ▁" ¦di stric t¦ ¦level¦ ¦re ac tive¦ ¦school¦ ¦closures¦ ¦were¦ ¦i ne ff ective¦ . "▁ 𐋇 ¦during¦ ¦the¦ ¦sw ine¦ ¦flu¦ ¦outbreak¦ ¦in¦ ¦20 0 9¦ ¦in¦ ¦the¦ ¦uk¦ ,▁ ¦in¦ ¦an¦ ¦a rt ic le¦ ¦t it l ed¦ ▁" ¦cl osure¦ ¦of¦ ¦schools¦ ¦during¦ ¦an¦ ¦influenza¦ ¦pandemic¦ "▁ ¦publ ished¦ ¦in¦ ¦the¦ ¦la nc et¦ ¦infectious¦ ¦diseases¦ ,▁ ¦a¦ ¦group¦ ¦of¦ ¦e p ide mi ol og i sts¦ ¦ end or sed¦ ¦the¦ ¦cl osure¦ ¦of¦ ¦schools¦ ¦in¦ ¦order¦ ¦to¦ ¦inter ru p t¦ ¦the¦ ¦co ur se¦ ¦of¦ ¦the¦ ¦infection¦ ,▁ ¦sl ow¦ ¦further¦ ¦spread¦ ¦and¦ ¦bu y¦ ¦time¦ ¦to¦ ¦research¦ ¦and¦ ¦produc e¦ ¦a¦ ¦vaccine¦ .
𐋇 ¦having¦ ¦st ud ied¦ ¦prev ious¦ ¦influenza¦ ¦p an de m ics¦ ¦including¦ ¦the¦ ¦19 1 8¦ ¦flu¦ ¦pandemic¦ ,▁ ¦the¦ ¦influenza¦ ¦pandemic¦ ¦of¦ ¦19 5 7¦ ¦and¦ ¦the¦ ¦19 6 8¦ ¦flu¦ ¦pandemic¦ ,▁ ¦they¦ ¦reported¦ ¦on¦ ¦the¦ ¦ec onomic¦ ¦and¦ ¦work for ce¦ ¦eff ect¦ ¦school¦ ¦cl osure¦ ¦would¦ ¦have¦ ,▁ ¦partic ul arly¦ ¦with¦ ¦a¦ ¦large¦ ¦per ce nt age¦ ¦of¦ ¦do ctors¦ ¦and¦ ¦n ur ses¦ ¦being¦ ¦women¦ ,▁ ¦of¦ ¦wh om¦ ¦h al f¦ ¦had¦ ¦children¦ ¦under¦ ¦the¦ ¦age¦ ¦of¦ ¦16¦ .
𐋇¦they¦ ¦also¦ ¦l oo ked¦ ¦at¦ ¦the¦ ¦d y na m ics¦ ¦of¦ ¦the¦ ¦spread¦ ¦of¦ ¦influenza¦ ¦in¦ ¦fra nce¦ ¦during¦ ¦fre n ch¦ ¦school¦ ¦h ol id ays¦ ¦and¦ ¦no ted¦ ¦that¦ ¦cases¦ ¦of¦ ¦flu¦ ¦dro pp ed¦ ¦when¦ ¦schools¦ ¦closed¦ ¦and¦ ¦r e¦ - ¦e mer ged¦ ¦when¦ ¦they¦ ¦r e¦ - ¦op e ned¦ .
𐋇¦they¦ ¦no ted¦ ¦that¦ ¦when¦ ¦t ea ch ers¦ ¦in¦ ¦ is ra e l¦ ¦w ent¦ ¦on¦ ¦st ri ke¦ ¦during¦ ¦the¦ ¦flu¦ ¦se as on¦ ¦of¦ ¦19 9 9¦ ▁–▁ ¦20 00¦ ,▁ ¦visi ts¦ ¦to¦ ¦do ctors¦ ¦and¦ ¦the¦ ¦number¦ ¦of¦ ¦respiratory¦ ¦infections¦ ¦dro pp ed¦ ¦by¦ ¦more¦ ¦than¦ ¦a¦ ¦f if th¦ ¦and¦ ¦more¦ ¦than¦ ¦two¦ ¦f if ths¦ ¦resp ect ively¦ .
𐋇¦for¦ ¦schools¦ ¦and¦ ¦ch ild c are¦ ¦facil ities¦ ,▁ ¦the¦ ¦u¦ . ¦s¦ .▁ ¦ce nt ers¦ ¦for¦ ¦disease¦ ¦control¦ ¦and¦ ¦pre vention¦ ¦recomm ends¦ ¦sh ort¦ - ¦ter m¦ ¦cl osure¦ ¦to¦ ¦clean¦ ¦or¦ ¦disinf ect¦ ¦if¦ ¦an¦ ¦infected¦ ¦person¦ ¦has¦ ¦been¦ ¦in¦ ¦a¦ ¦school¦ ¦bu il ding¦ ¦reg ar d less¦ ¦of¦ ¦community¦ ¦spread¦ .
𐋇¦when¦ ¦there¦ ¦is¦ ¦min im al¦ ¦to¦ ¦mod er ate¦ ¦community¦ ¦transmission¦ ,▁ ¦social¦ ¦distancing¦ ¦stra te g ies¦ ¦can¦ ¦be¦ ¦imp le m ented¦ ¦such¦ ¦as¦ ¦cance lling¦ ¦f ie ld¦ ¦t ri ps¦ ,▁ ¦as se m bl ies¦ ,▁ ¦and¦ ¦other¦ ¦large¦ ¦ga ther ings¦ ¦such¦ ¦as¦ ¦ph ys ical¦ ¦education¦ ¦or¦ ¦ch oi r¦ ¦cl as ses¦ ¦or¦ ¦me als¦ ¦in¦ ¦a¦ ¦ca f et er ia¦ ,▁ ¦incre as ing¦ ¦the¦ ¦sp ace¦ ¦between¦ ¦d es ks¦ ,▁ ¦sta gg ering¦ ¦arr iv al¦ ¦and¦ ¦dis mi ss al¦ ¦times¦ ,▁ ¦limi ting¦ ¦n on es se ntial¦ ¦visi t ors¦ ,▁ ¦and¦ ¦using¦ ¦a¦ ¦separ ate¦ ¦health¦ ¦off ice¦ ¦loc ation¦ ¦for¦ ¦children¦ ¦with¦ ¦flu¦ - ¦like¦ ¦symptoms¦ .
𐋇¦when¦ ¦there¦ ¦is¦ ¦sub s ta ntial¦ ¦transmission¦ ¦in¦ ¦the¦ ¦local¦ ¦community¦ ,▁ ¦in¦ ¦add ition¦ ¦to¦ ¦social¦ ¦distancing¦ ¦stra te g ies¦ ,▁ ¦ex te nded¦ ¦school¦ ¦dis mi ss als¦ ¦may¦ ¦be¦ ¦consid ered¦ .
𐋇¦on¦ ¦26¦ ¦january¦ ,▁ ¦china¦ ¦inst itu ted¦ ¦measures¦ ¦to¦ ¦con tain¦ ¦the¦ ¦covid¦ - ¦19¦ ¦outbreak¦ ¦which¦ ¦inclu ded¦ ¦ext ending¦ ¦the¦ ¦sp r ing¦ ¦fe st iv al¦ ¦ho li day¦ ¦to¦ ¦con tain¦ ¦the¦ ¦outbreak¦ .
𐋇 ¦univers ities¦ ¦and¦ ¦schools¦ ¦around¦ ¦the¦ ¦country¦ ¦closed¦ .
𐋇¦on¦ ¦23¦ ¦february¦ ,▁ ¦iran¦ ' ¦s¦ ¦min ist ry¦ ¦of¦ ¦health¦ ¦announced¦ ¦the¦ ¦cl osure¦ ¦of¦ ¦univers ities¦ ,▁ ¦higher¦ ¦e duc a tional¦ ¦inst itu tions¦ ¦and¦ ¦schools¦ ¦in¦ ¦several¦ ¦c ities¦ ¦and¦ ¦pr ov in ces¦ .
𐋇¦on¦ ¦3¦ ¦march¦ ,▁ ¦un esc o¦ ¦rel ea sed¦ ¦the¦ ¦first¦ ¦global¦ ¦nu mbers¦ ¦on¦ ¦school¦ ¦closures¦ ¦and¦ ¦affected¦ ¦students¦ .
𐋇¦it¦ ¦reported¦ ¦that¦ ¦13¦ ¦countries¦ ¦had¦ ¦en ac ted¦ ¦prev en tive¦ ¦measures¦ ¦including¦ ¦the¦ ¦temp or ary¦ ¦cl osure¦ ¦of¦ ¦schools¦ ¦and¦ ¦univers ities¦ ,▁ ¦impac ting¦ ¦2 9 0¦ . ¦5¦ ¦million¦ ¦students¦ ¦around¦ ¦the¦ ¦world¦ .
𐋇¦in¦ ¦rea ction¦ ,▁ ¦un esc o¦ ¦called¦ ¦on¦ ¦countries¦ ¦to¦ ¦support¦ ¦affected¦ ¦students¦ ¦and¦ ¦fa m il ies¦ ¦and¦ ¦facil it ate¦ ¦large¦ - ¦sc a le¦ ¦inclu s ive¦ ¦dista nce¦ ¦learning¦ ¦pr ogra mm es¦ .
𐋇¦on¦ ¦4¦ ¦march¦ ,▁ ¦the¦ ¦i tali an¦ ¦government¦ ¦or d ered¦ ¦the¦ ¦f ul l¦ ¦cl osure¦ ¦of¦ ¦all¦ ¦schools¦ ¦and¦ ¦univers ities¦ ¦na tion w ide¦ ¦as¦ ¦italy¦ ¦rea ched¦ ¦100¦ ¦deaths¦ .
𐋇¦in¦ ¦do ing¦ ¦so¦ ,▁ ¦italy¦ ¦bec a me¦ ¦one¦ ¦of¦ ¦2 2¦ ¦countries¦ ¦on¦ ¦three¦ ¦contin ents¦ ¦which¦ ¦had¦ ¦announced¦ ¦or¦ ¦imp le m ented¦ ¦school¦ ¦closures¦ .
𐋇¦on¦ ¦5¦ ¦march¦ ,▁ ¦the¦ ¦ma j or ity¦ ¦of¦ ¦lear n ers¦ ¦affected¦ ¦by¦ ¦covid¦ - ¦19¦ ¦emergency¦ ¦measures¦ ¦were¦ ¦loc ated¦ ¦in¦ ¦china¦ ,▁ ¦with¦ ¦2 3 3¦ ¦million¦ ¦lear n ers¦ ¦affected¦ ,▁ ¦fo ll owed¦ ¦by¦ ¦j ap an¦ ¦at¦ ¦16¦ . ¦5¦ ¦million¦ ¦and¦ ¦iran¦ ¦at¦ ¦14¦ . ¦5¦ ¦million¦ .
𐋇¦by¦ ¦10¦ ¦march¦ ,▁ ¦one¦ ¦in¦ ¦five¦ ¦students¦ ¦worldwide¦ ¦was¦ ▁" ¦sta ying¦ ¦away¦ ¦from¦ ¦school¦ ¦due¦ ¦to¦ ¦the¦ ¦covid¦ - ¦19¦ ¦c ri sis¦ "▁ ¦while¦ ¦another¦ ¦one¦ ¦in¦ ¦four¦ ¦was¦ ¦b arr ed¦ ¦from¦ ¦higher¦ ¦education¦ ¦inst itu tions¦ .
𐋇¦on¦ ¦13¦ ¦march¦ ,▁ ¦gover n ments¦ ¦in¦ ¦4 9¦ ¦countries¦ ¦announced¦ ¦or¦ ¦imp le m ented¦ ¦school¦ ¦closures¦ ,▁ ¦including¦ ¦3 9¦ ¦countries¦ ¦which¦ ¦closed¦ ¦schools¦ ¦na tion w ide¦ ¦and¦ ¦2 2¦ ¦countries¦ ¦with¦ ¦loc a li sed¦ ¦school¦ ¦closures¦ .
𐋇¦by¦ ¦16¦ ¦march¦ ,▁ ¦this¦ ¦f ig ure¦ ¦increased¦ ¦from¦ ¦4 9¦ ¦to¦ ¦7 3¦ ¦countries¦ ¦according¦ ¦to¦ ¦un esc o¦ .
𐋇¦by¦ ¦19¦ ¦march¦ ,▁ ¦50¦ %▁ ¦of¦ ¦students¦ ¦worldwide¦ ¦were¦ ¦affected¦ ¦by¦ ¦school¦ ¦closures¦ ,▁ ¦cor r esp on ding¦ ¦to¦ ¦na tion w ide¦ ¦closures¦ ¦in¦ ¦1 0 2¦ ¦countries¦ ¦and¦ ¦local¦ ¦closures¦ ¦in¦ ¦11¦ ¦countries¦ ¦aff ecting¦ ¦8 5 0¦ ¦million¦ ¦children¦ ¦and¦ ¦y ou th¦ .
𐋇¦by¦ ¦20¦ ¦march¦ ,▁ ¦over¦ ¦7 0¦ %▁ ¦of¦ ¦the¦ ¦world¦ ' ¦s¦ ¦lear n ers¦ ¦were¦ ¦impac ted¦ ¦by¦ ¦closures¦ ,▁ ¦with¦ ¦1 2 4¦ ¦country¦ - ¦w ide¦ ¦school¦ ¦closures¦ .
𐋇¦on¦ ¦23¦ ¦march¦ ,▁ ¦all¦ ¦n ig eri an¦ ¦school¦ ¦were¦ ¦found¦ ¦to¦ ¦have¦ ¦been¦ ¦closed¦ ¦down¦ ¦by¦ ¦n ig eri an¦ ¦government¦ ,▁ ¦mark ets¦ ¦as¦ ¦well¦ ¦as¦ ¦comp an ies¦ ¦were¦ ¦closed¦ ¦down¦ ¦and¦ ¦children¦ ¦were¦ ¦for b id d en¦ ¦by¦ ¦par ents¦ ¦to¦ ¦ste p¦ ¦out¦ ¦of¦ ¦their¦ ¦h omes¦ .
𐋇¦on¦ ¦26¦ ¦march¦ ,▁ ¦all¦ ¦new¦ ¦z ea land¦ ¦schools¦ ¦and¦ ¦univers ities¦ ¦have¦ ¦been¦ ¦closed¦ ¦down¦ ¦across¦ ¦the¦ ¦country¦ .
𐋇¦the¦ ¦government¦ ¦has¦ ¦imp osed¦ ¦a¦ ¦two¦ - ¦week¦ ¦ho li day¦ ,▁ ¦all owing¦ ¦schools¦ ¦to¦ ¦trans ition¦ ¦to¦ ¦for ms¦ ¦of¦ ¦d ist ant¦ ¦te ac hing¦ ¦as¦ ¦so on¦ ¦as¦ ¦possible¦ .
𐋇 ¦univers ities¦ ¦have¦ ¦closed¦ ¦for¦ ¦one¦ ¦week¦ ,▁ ¦but¦ ¦res u med¦ ¦with¦ ¦online¦ ¦te ac hing¦ ¦a f t er w ards¦ .
𐋇 ¦other¦ ¦school¦ ¦services¦ ¦remain¦ ¦open¦ ,▁ ¦but¦ ¦te ac hing¦ ¦is¦ ¦re stric ted¦ ¦to¦ ¦d ist ant¦ ¦learning¦ .
𐋇¦by¦ ¦2 7¦ ¦march¦ ,▁ ¦ne arly¦ ¦9 0¦ ¦p erc ent¦ ¦of¦ ¦the¦ ¦world¦ ' ¦s¦ ¦st ud ent¦ ¦population¦ ¦was¦ ¦out¦ ¦of¦ ¦cl ass¦ .
𐋇 ¦regi ons¦ ¦with¦ ¦schools¦ ¦rem aining¦ ¦open¦ ¦inclu ded¦ ¦t ai w an¦ ,▁ ¦si ng ap ore¦ ,▁ ¦a u str al ia¦ ,▁ ¦sw ed en¦ ,▁ ¦and¦ ¦some¦ ¦u¦ . ¦s¦ .▁ ¦states¦ .
𐋇¦by¦ ¦2 9¦ ¦march¦ ,▁ ¦more¦ ¦than¦ ¦1¦ . ¦5¦ ¦bi ll ion¦ ¦children¦ ¦and¦ ¦other¦ ¦students¦ ¦were¦ ¦affected¦ ¦by¦ ¦na tion w ide¦ ¦school¦ ¦closures¦ .
𐋇 ¦others¦ ¦were¦ ¦dis ru p ted¦ ¦by¦ ¦loc a li zed¦ ¦closures¦ .
𐋇 ¦until¦ ¦april¦ ¦6¦ ,▁ ¦h ol id ays¦ ¦were¦ ¦ex te nded¦ ¦in¦ ¦all¦ ¦sec ond ary¦ ¦schools¦ ¦of¦ ¦t ur k m en ist an¦ .
𐋇 ¦an¦ ¦order¦ ¦sign ed¦ ¦by¦ ¦the¦ ¦min ist ry¦ ¦of¦ ¦education¦ ¦as¦ ¦a¦ ¦pre vent ative¦ ¦me as ure¦ ¦ ai ms¦ ¦to¦ ¦prevent¦ ¦the¦ ¦spread¦ ¦of¦ ¦respiratory¦ ¦diseases¦ ¦in¦ ¦con ne ction¦ ¦with¦ ¦the¦ ¦who¦ ¦coronavirus¦ ¦pandemic¦ .
¦10¦ ¦countries¦ ¦have¦ ¦loc a li sed¦ ¦schools¦ ¦closures¦ ,▁ ¦un esc o¦ ¦estim ates¦ ¦4 7 3¦ , ¦9 3 3¦ , ¦3 5 6¦ ¦lear n ers¦ ¦are¦ ¦pote nt ially¦ ¦at¦ ¦risk¦ ▁( ¦pr e¦ - ¦pr imary¦ ¦to¦ ¦u pp er¦ - ¦sec ond ary¦ ¦education¦ )▁ ¦and¦ ¦7 7¦ , ¦9 3 8¦ , ¦9 0 4¦ ¦lear n ers¦ ¦are¦ ¦pote nt ially¦ ¦at¦ ¦risk¦ ¦in¦ ¦ter ti ary¦ ¦education¦ .
𐋇¦n ot e¦ :▁ 𐋇¦f ig ures¦ ¦cor r esp on d¦ ¦to¦ ¦total¦ ¦number¦ ¦of¦ ¦lear n ers¦ ¦en ro lled¦ ¦at¦ ¦pr e¦ - ¦pr imary¦ ,▁ ¦pr imary¦ ,▁ ¦lower¦ - ¦sec ond ary¦ ,▁ ¦and¦ ¦u pp er¦ - ¦sec ond ary¦ ¦le v els¦ ¦of¦ ¦education¦ ▁ [ ¦ is c ed¦ ¦le v els¦ ¦ 0¦ ¦to¦ ¦3¦ ] ,▁ ¦as¦ ¦well¦ ¦as¦ ¦at¦ ¦ter ti ary¦ ¦education¦ ¦le v els¦ ▁ [ ¦ is c ed¦ ¦le v els¦ ¦5¦ ¦to¦ ¦8¦ ] ▁ ¦who¦ ¦could¦ ¦be¦ ¦affected¦ ¦should¦ ¦loc a li sed¦ ¦closures¦ ¦bec ome¦ ¦cou nt r y w ide¦ .
𐋇 ¦en r ol ment¦ ¦f ig ures¦ ¦based¦ ¦on¦ ¦l at est¦ ¦un esc o¦ ¦inst it ute¦ ¦of¦ ¦st at ist ics¦ ¦data¦ .
𐋇 ¦school¦ ¦closures¦ ¦in¦ ¦response¦ ¦to¦ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ ¦have¦ ¦sh ed¦ ¦a¦ ¦l ight¦ ¦on¦ ¦nu me ro us¦ ¦i ss ues¦ ¦aff ecting¦ ¦acc ess¦ ¦to¦ ¦education¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦b ro a der¦ ¦s oc i o¦ - ¦ec onomic¦ ¦i ss ues¦ .
𐋇¦as¦ ¦of¦ ¦march¦ ¦12¦ ,▁ ¦more¦ ¦than¦ ¦3 7 0¦ ¦million¦ ¦children¦ ¦and¦ ¦y ou th¦ ¦are¦ ¦not¦ ¦att ending¦ ¦school¦ ¦because¦ ¦of¦ ¦temp or ary¦ ¦or¦ ¦in de f in ite¦ ¦country¦ ¦w ide¦ ¦school¦ ¦closures¦ ¦mand ated¦ ¦by¦ ¦gover n ments¦ ¦in¦ ¦an¦ ¦att e mp t¦ ¦to¦ ¦sl ow¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇¦as¦ ¦of¦ ¦2 9¦ ¦march¦ ,▁ ¦ne arly¦ ¦9 0¦ %▁ ¦of¦ ¦the¦ ¦world¦ ' ¦s¦ ¦lear n ers¦ ¦were¦ ¦impac ted¦ ¦by¦ ¦closures¦ . ¦even¦ ¦when¦ ¦school¦ ¦closures¦ ¦are¦ ¦temp or ary¦ ,▁ ¦it¦ ¦c arr ies¦ ¦high¦ ¦social¦ ¦and¦ ¦ec onomic¦ ¦co sts¦ .
𐋇¦the¦ ¦dis ru p tions¦ ¦they¦ ¦cause¦ ¦aff ect¦ ¦people¦ ¦across¦ ¦comm un ities¦ ,▁ ¦but¦ ¦their¦ ¦impac t¦ ¦is¦ ¦more¦ ¦severe¦ ¦for¦ ¦dis a d v an ta ged¦ ¦children¦ ¦and¦ ¦their¦ ¦fa m il ies¦ ¦including¦ ¦inter ru p ted¦ ¦learning¦ ,▁ ¦comp ro mi sed¦ ¦n ut r ition¦ ,▁ ¦ch ild c are¦ ¦prob le ms¦ ¦and¦ ¦con se qu ent¦ ¦ec onomic¦ ¦c ost¦ ¦to¦ ¦fa m il ies¦ ¦who¦ ¦cannot¦ ¦work¦ .
𐋇 ¦wor king¦ ¦par ents¦ ¦are¦ ¦more¦ ¦likely¦ ¦to¦ ¦m is s¦ ¦work¦ ¦when¦ ¦schools¦ ¦close¦ ¦in¦ ¦order¦ ¦to¦ ¦take¦ ¦care¦ ¦of¦ ¦their¦ ¦children¦ ,▁ ¦inc ur r ing¦ ¦w age¦ ¦l os s¦ ¦in¦ ¦many¦ ¦inst an ces¦ ¦and¦ ¦ne g at ively¦ ¦impac ting¦ ¦produc t iv ity¦ .
𐋇 ¦loc a li sed¦ ¦school¦ ¦closures¦ ¦place¦ ¦b ur d ens¦ ¦on¦ ¦schools¦ ¦as¦ ¦par ents¦ ¦and¦ ¦off ici als¦ ¦r ed ir ect¦ ¦children¦ ¦to¦ ¦schools¦ ¦that¦ ¦are¦ ¦open¦ .
𐋇 ¦women¦ ¦often¦ ¦rep r es ent¦ ¦a¦ ¦large¦ ¦share¦ ¦of¦ ¦health¦ - ¦care¦ ¦workers¦ ¦and¦ ¦often¦ ¦cannot¦ ¦att end¦ ¦work¦ ¦because¦ ¦of¦ ¦ch ild c are¦ ¦o bl ig ations¦ ¦that¦ ¦result¦ ¦from¦ ¦school¦ ¦closures¦ .
𐋇¦this¦ ¦me ans¦ ¦that¦ ¦many¦ ¦medical¦ ¦pro f es si on als¦ ¦are¦ ¦not¦ ¦at¦ ¦the¦ ¦facil ities¦ ¦where¦ ¦they¦ ¦are¦ ¦most¦ ¦nee ded¦ ¦during¦ ¦a¦ ¦health¦ ¦c ri sis¦ .
𐋇¦l ack¦ ¦of¦ ¦acc ess¦ ¦to¦ ¦techn ology¦ ¦or¦ ¦f ast¦ ,▁ ¦re li able¦ ¦inter n et¦ ¦acc ess¦ ¦can¦ ¦prevent¦ ¦students¦ ¦in¦ ¦r ural¦ ¦areas¦ ¦and¦ ¦from¦ ¦dis a d v an ta ged¦ ¦fa m il ies¦ .
𐋇¦l ack¦ ¦of¦ ¦acc ess¦ ¦to¦ ¦techn ology¦ ¦or¦ ¦g ood¦ ¦inter n et¦ ¦con n ect iv ity¦ ¦is¦ ¦an¦ ¦ob st ac le¦ ¦to¦ ¦contin u ed¦ ¦learning¦ ,▁ ¦especially¦ ¦for¦ ¦students¦ ¦from¦ ¦dis a d v an ta ged¦ ¦fa m il ies¦ .
𐋇¦in¦ ¦response¦ ¦to¦ ¦school¦ ¦closures¦ ¦caused¦ ¦by¦ ¦covid¦ - ¦19¦ ,▁ ¦un esc o¦ ¦recomm ends¦ ¦the¦ ¦use¦ ¦of¦ ¦dista nce¦ ¦learning¦ ¦pr ogra mm es¦ ¦and¦ ¦open¦ ¦e duc a tional¦ ¦app l ications¦ ¦and¦ ¦pl at for ms¦ ¦that¦ ¦schools¦ ¦and¦ ¦t ea ch ers¦ ¦can¦ ¦use¦ ¦to¦ ¦rea ch¦ ¦lear n ers¦ ¦re mo tely¦ ¦and¦ ¦limi t¦ ¦the¦ ¦dis ru ption¦ ¦of¦ ¦education¦ . ¦to¦ ¦a id¦ ¦in¦ ¦sl owing¦ ¦the¦ ¦transmission¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦h u nd re ds¦ ¦of¦ ¦li b r ar ies¦ ¦have¦ ¦temp o ra ri ly¦ ¦closed¦ .
𐋇¦in¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦nu me ro us¦ ¦major¦ ¦c ities¦ ¦announced¦ ¦public¦ ¦li b r ary¦ ¦closures¦ ,▁ ¦including¦ ¦lo s¦ ¦an ge les¦ ,▁ ¦s an¦ ¦fra nc is c o¦ ,▁ ¦se at t le¦ ,▁ ¦and¦ ¦new¦ ¦y or k¦ ¦city¦ ,▁ ¦aff ecting¦ ¦2 21¦ ¦li b r ar ies¦ .
𐋇¦for¦ ¦students¦ ¦without¦ ¦inter n et¦ ¦at¦ ¦home¦ ,▁ ¦this¦ ¦inc rea ses¦ ¦the¦ ¦diffic ult y¦ ¦of¦ ¦k ee p ing¦ ¦up¦ ¦with¦ ¦dista nce¦ ¦learning¦ .
𐋇 ¦school¦ ¦closures¦ ¦p u ts¦ ¦a¦ ¦stra in¦ ¦on¦ ¦par ents¦ ¦and¦ ¦gu ar di ans¦ ¦to¦ ¦provide¦ ¦ch ild c are¦ ¦and¦ ¦mana ge¦ ¦dista nce¦ ¦learning¦ ¦while¦ ¦children¦ ¦are¦ ¦out¦ ¦of¦ ¦school¦ .
𐋇¦in¦ ¦the¦ ¦ab s ence¦ ¦of¦ ¦al t er n ative¦ ¦op tions¦ ,▁ ¦wor king¦ ¦par ents¦ ¦often¦ ¦lea ve¦ ¦children¦ ¦al one¦ ¦when¦ ¦schools¦ ¦close¦ ¦and¦ ¦this¦ ¦can¦ ¦l ead¦ ¦to¦ ¦r is k y¦ ¦be h a vi o ur s¦ ,▁ ¦including¦ ¦increased¦ ¦influ ence¦ ¦of¦ ¦p e er¦ ¦pre ss ure¦ ¦and¦ ¦sub st ance¦ ¦ab use¦ .
𐋇 ¦many¦ ¦children¦ ¦worldwide¦ ¦r ely¦ ¦on¦ ¦fre e¦ ¦or¦ ¦disc o un ted¦ ¦me als¦ ¦at¦ ¦schools¦ .
𐋇¦when¦ ¦schools¦ ¦close¦ ,▁ ¦n ut r ition¦ ¦is¦ ¦comp ro mi sed¦ . ¦n ut r ition¦ ¦pl ays¦ ¦a¦ ¦crit ical¦ ¦ro le¦ ¦in¦ ¦co gn i tive¦ ¦development¦ ¦and¦ ¦ac a de m ic¦ ¦per f orm ance¦ ¦for¦ ¦children¦ . ¦in¦ ¦w as hi ng t on¦ ¦state¦ ,▁ ¦around¦ ¦4 5¦ %▁ ¦of¦ ¦the¦ ¦states¦ ¦1¦ . ¦1¦ ¦million¦ ¦students¦ ¦en ro lled¦ ¦in¦ ¦tra di tional¦ ¦public¦ ¦and¦ ¦ch ar ter¦ ¦schools¦ ¦qu al if y¦ ¦for¦ ¦sub si di sed¦ ¦school¦ ¦me als¦ .
𐋇 ¦at¦ ¦least¦ ¦5 2 0¦ , ¦000¦ ¦students¦ ¦and¦ ¦their¦ ¦fa m il ies¦ ¦may¦ ¦be¦ ¦affected¦ ¦by¦ ¦food¦ ¦i ns ec ur ity¦ ¦as¦ ¦a¦ ¦result¦ ¦of¦ ¦school¦ ¦closures¦ . ¦school¦ ¦l un ch¦ ¦pr ogra mm es¦ ¦are¦ ¦the¦ ¦second¦ - ¦bi gg est¦ ¦anti ¦ - ¦h u nger¦ ¦in i ti ative¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ¦after¦ ¦food¦ ¦sta m ps¦ .
𐋇 ¦every¦ ¦year¦ ,▁ ¦ne arly¦ ¦30¦ ¦million¦ ¦children¦ ¦r ely¦ ¦on¦ ¦schools¦ ¦to¦ ¦provide¦ ¦fre e¦ ¦or¦ ¦low¦ - ¦c ost¦ ¦me als¦ ¦including¦ ¦brea k f ast¦ ,▁ ¦l un ch¦ ,▁ ¦s n ac ks¦ ,▁ ¦and¦ ¦even¦ ¦d in n er¦ . ¦in¦ ¦al ab a m a¦ ,▁ ¦where¦ ¦state¦ - ¦w ide¦ ¦school¦ ¦closures¦ ¦as¦ ¦of¦ ¦18¦ ¦march¦ ¦have¦ ¦affected¦ ¦over¦ ¦7 2 0¦ , ¦000¦ ¦students¦ ,▁ ¦the¦ ¦state¦ ¦su p eri nt end ent¦ ¦announced¦ ¦that¦ ¦staff¦ ¦in¦ ¦schools¦ ¦dis p r op or tion a tely¦ ¦affected¦ ¦by¦ ¦po ve rt y¦ ¦would¦ ¦cre ate¦ ¦me al¦ ¦d ist rib ution¦ ¦n et w or ks¦ ¦to¦ ¦provide¦ ¦food¦ ¦for¦ ¦students¦ ¦who¦ ¦r ely¦ ¦on¦ ¦school¦ ¦l un ches¦ .
𐋇 ¦school¦ ¦closures¦ ¦ne g at ively¦ ¦impac t¦ ¦st ud ent¦ ¦learning¦ ¦out c omes¦ .
𐋇 ¦sc ho ol ing¦ ¦provid es¦ ¦essential¦ ¦learning¦ ¦and¦ ¦when¦ ¦schools¦ ¦close¦ ,▁ ¦children¦ ¦and¦ ¦y ou th¦ ¦are¦ ¦dep r iv ed¦ ¦o pp ort un ities¦ ¦for¦ ¦gr ow th¦ ¦and¦ ¦development¦ .
𐋇¦the¦ ¦dis a d v an ta ges¦ ¦are¦ ¦dis p r op or tion ate¦ ¦for¦ ¦under¦ - ¦pri vi le ged¦ ¦lear n ers¦ ¦who¦ ¦t end¦ ¦to¦ ¦have¦ ¦fe w er¦ ¦e duc a tional¦ ¦o pp ort un ities¦ ¦be y on d¦ ¦school¦ . ¦st ud ent¦ ¦dro p¦ - ¦out¦ ¦r ates¦ ¦t end¦ ¦to¦ ¦increase¦ ¦as¦ ¦an¦ ¦eff ect¦ ¦of¦ ¦school¦ ¦closures¦ ¦due¦ ¦to¦ ¦the¦ ¦cha ll en ge¦ ¦of¦ ¦e ns ur ing¦ ¦all¦ ¦students¦ ¦retur n¦ ¦to¦ ¦school¦ ¦o nce¦ ¦school¦ ¦closures¦ ¦ ends¦ .
𐋇¦this¦ ¦is¦ ¦especially¦ ¦tr ue¦ ¦of¦ ¦prot r ac ted¦ ¦closures¦ . ¦schools¦ ¦are¦ ¦hub s¦ ¦of¦ ¦social¦ ¦activ ity¦ ¦and¦ ¦human¦ ¦inter a ction¦ .
𐋇¦when¦ ¦schools¦ ¦are¦ ¦closed¦ ,▁ ¦many¦ ¦children¦ ¦and¦ ¦y ou th¦ ¦m is s¦ ¦out¦ ¦of¦ ¦on¦ ¦social¦ ¦contact¦ ¦that¦ ¦is¦ ¦essential¦ ¦to¦ ¦learning¦ ¦and¦ ¦development¦ . ¦when¦ ¦schools¦ ¦close¦ ¦par ents¦ ¦are¦ ¦often¦ ¦as ked¦ ¦to¦ ¦facil it ate¦ ¦the¦ ¦learning¦ ¦of¦ ¦children¦ ¦at¦ ¦home¦ ¦and¦ ¦can¦ ¦st ru gg le¦ ¦to¦ ¦per for m¦ ¦this¦ ¦t as k¦ .
𐋇¦this¦ ¦is¦ ¦especially¦ ¦tr ue¦ ¦for¦ ¦par ents¦ ¦with¦ ¦limi ted¦ ¦education¦ ¦and¦ ¦res o ur ces¦ .
𐋇 ¦pote ntial¦ ¦impac ts¦ ¦of¦ ¦school¦ ¦closures¦ ¦and¦ ¦re li ance¦ ¦on¦ ¦dista nce¦ ¦learning¦ ¦are¦ ¦not¦ ¦ad dr es sed¦ ¦in¦ ¦f ed er al¦ ¦ac ts¦ ¦of¦ ¦le g is l ation¦ ¦at¦ ¦this¦ ¦time¦ .
𐋇¦f ormal¦ ¦education¦ ▁ — ▁ ¦as¦ ¦o pp osed¦ ¦to¦ ¦inf ormal¦ ¦education¦ ¦or¦ ¦non¦ - ¦f ormal¦ ¦education¦ ▁ — ▁ ¦t ends¦ ¦to¦ ¦ref er¦ ¦to¦ ¦schools¦ ,▁ ¦colle ges¦ ,▁ ¦univers ities¦ ¦and¦ ¦tr aining¦ ¦inst itu tions¦ .
𐋇¦a¦ ¦19 7 4¦ ¦report¦ ¦by¦ ¦the¦ ¦world¦ ¦b an k¦ ¦def ined¦ ¦f ormal¦ ¦education¦ ¦as¦ ¦the¦ ¦following¦ :▁ 𐋇¦f ormal¦ ¦education¦ :▁ 𐋇¦the¦ ¦hi er ar ch ically¦ ¦st ru ct ur ed¦ ,▁ ¦ch r on ol og ically¦ ¦g ra ded¦ ▁ ‘ ▁ ¦education¦ ¦system¦ ▁ ’ ,▁ ¦r un ning¦ ¦from¦ ¦pr imary¦ ¦school¦ ¦through¦ ¦the¦ ¦univers ity¦ ¦and¦ ¦including¦ ,▁ ¦in¦ ¦add ition¦ ¦to¦ ¦general¦ ¦ac a de m ic¦ ¦st u dies¦ ,▁ ¦a¦ ¦vari et y¦ ¦of¦ ¦spec ia li sed¦ ¦pr ogra mm es¦ ¦and¦ ¦inst itu tions¦ ¦for¦ ¦f ul l¦ - ¦time¦ ¦techn ical¦ ¦and¦ ¦pro f es si on al¦ ¦tr aining¦ . ¦the¦ ¦ma j or ity¦ ¦of¦ ¦data¦ ¦coll ected¦ ¦on¦ ¦the¦ ¦number¦ ¦of¦ ¦students¦ ¦and¦ ¦lear n ers¦ ¦impac ted¦ ¦by¦ ¦covid¦ - ¦19¦ ¦has¦ ¦been¦ ¦c al c ul ated¦ ¦based¦ ¦on¦ ¦the¦ ¦cl osure¦ ¦of¦ ¦f ormal¦ ¦education¦ ¦sys tems¦ .
𐋇¦the¦ ¦un esc o¦ ¦inst it ute¦ ¦for¦ ¦st at ist ics¦ ¦provid es¦ ¦f ig ures¦ ¦on¦ ¦students¦ ¦impac ted¦ ¦by¦ ¦covid¦ - ¦19¦ ¦cor r esp on ding¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦lear n ers¦ ¦en ro lled¦ ¦at¦ ¦pr e¦ - ¦pr imary¦ ,▁ ¦pr imary¦ ,▁ ¦lower¦ - ¦sec ond ary¦ ,▁ ¦and¦ ¦u pp er¦ - ¦sec ond ary¦ ¦le v els¦ ¦of¦ ¦education¦ ▁ [ ¦ is c ed¦ ¦le v els¦ ¦ 0¦ ¦to¦ ¦3¦ ] ,▁ ¦as¦ ¦well¦ ¦as¦ ¦at¦ ¦ter ti ary¦ ¦education¦ ¦le v els¦ ▁ [ ¦ is c ed¦ ¦le v els¦ ¦5¦ ¦to¦ ¦8¦ ] .
𐋇 ¦early¦ ¦ch ild h ood¦ ¦e duc a tional¦ ¦pr ogra mm es¦ ¦are¦ ¦us ually¦ ¦d es ig ned¦ ¦for¦ ¦children¦ ¦b el ow¦ ¦the¦ ¦age¦ ¦of¦ ¦3¦ ¦and¦ ¦may¦ ¦ref er¦ ¦to¦ ¦pr esc ho ols¦ ,▁ ¦n ur se ry¦ ¦schools¦ ,▁ ¦ki nd er g a rt ens¦ ,▁ ¦and¦ ¦some¦ ¦day¦ ¦care¦ ¦pr ogra mm es¦ .
𐋇 ¦while¦ ¦many¦ ¦pr imary¦ ¦and¦ ¦sec ond ary¦ ¦schools¦ ¦have¦ ¦closed¦ ¦around¦ ¦the¦ ¦world¦ ¦due¦ ¦to¦ ¦covid¦ - ¦19¦ ,▁ ¦measures¦ ¦impac ting¦ ¦early¦ ¦ch ild h ood¦ ¦e duc a tional¦ ¦pr ogra mm es¦ ¦have¦ ¦vari ed¦ .
𐋇¦in¦ ¦some¦ ¦countries¦ ¦and¦ ¦ter r it or ies¦ ,▁ ¦pr esc ho ols¦ ¦and¦ ¦day¦ ¦car es¦ ¦are¦ ¦consid ered¦ ¦ne cess ary¦ ¦services¦ ¦and¦ ¦have¦ ¦not¦ ¦closed¦ ¦in¦ ¦t an de m¦ ¦with¦ ¦b ro a der¦ ¦school¦ ¦cl osure¦ ¦measures¦ . ¦in¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦the¦ ¦w as hi ng t on¦ ¦state¦ ¦department¦ ¦of¦ ¦children¦ ,▁ ¦y ou th¦ ,▁ ¦and¦ ¦fa m il ies¦ ¦e nc ou ra ged¦ ¦child¦ ¦care¦ ¦and¦ ¦early¦ ¦learning¦ ¦centr es¦ ¦to¦ ¦stay¦ ¦open¦ .
𐋇¦some¦ ¦school¦ ¦di stric ts¦ ¦may¦ ¦off er¦ ¦al t er n ative¦ ¦child¦ ¦care¦ ¦op tions¦ ,▁ ¦pri or it ising¦ ¦the¦ ¦children¦ ¦of¦ ¦first¦ ¦resp ond ers¦ ¦and¦ ¦healthcare¦ ¦workers¦ .
𐋇¦the¦ ¦gover n or¦ ¦of¦ ¦m ar y land¦ ¦mand ated¦ ¦that¦ ¦specific¦ ¦child¦ ¦care¦ ¦services¦ ¦remain¦ ¦open¦ ¦for¦ ¦the¦ ¦children¦ ¦of¦ ¦emergency¦ ¦pers on ne l¦ ¦while¦ ¦w as hi ng t on¦ ¦state¦ ¦and¦ ¦ca li for n ia¦ ¦have¦ ¦le f t¦ ¦it¦ ¦to¦ ¦the¦ ¦disc r et ion¦ ¦of¦ ¦care¦ ¦provid ers¦ .
𐋇 ¦ca li for n ia¦ ¦gover n or¦ ¦ga v in¦ ¦new s om¦ ¦exp la ined¦ ¦hi s¦ ¦state¦ ' ¦s¦ ¦p os ition¦ ,▁ ¦sa ying¦ ▁ “ ¦we¦ ¦need¦ ¦our¦ ¦child¦ ¦care¦ ¦facil ities¦ ,▁ ¦our¦ ¦da y c are¦ ¦ce nt ers¦ ,▁ ¦to¦ ¦op er ate¦ ¦to¦ ¦ab s or b ¦ ¦the¦ ¦impac t¦ ¦of¦ ¦these¦ ¦school¦ ¦closures¦ .▁ ”
𐋇 ¦co lo rad o¦ ¦has¦ ¦e nc ou ra ged¦ ¦the¦ ¦development¦ ¦of¦ ▁" ¦t oo l¦ ¦ki ts¦ "▁ ¦for¦ ¦par ents¦ ¦to¦ ¦use¦ ¦at¦ ¦home¦ ¦to¦ ¦e m ul ate¦ ¦the¦ ¦le ss ons¦ ¦children¦ ¦would¦ ¦have¦ ¦received¦ ¦in¦ ¦their¦ ¦early¦ ¦learning¦ ¦pr ogra mm es¦ . ¦in¦ ¦j ap an¦ ,▁ ¦pri me¦ ¦minister¦ ¦sh in z o¦ ¦ab e¦ ¦closed¦ ¦all¦ ¦schools¦ ¦th r ou g ho ut¦ ¦the¦ ¦country¦ ¦until¦ ¦april¦ ¦8¦ ,▁ ¦however¦ ,▁ ¦children¦ ' ¦s¦ ¦da y c are¦ ¦facil ities¦ ¦were¦ ¦ex c lu ded¦ .
𐋇¦in¦ ¦early¦ ¦march¦ ,▁ ¦five¦ ¦ad ul ts¦ ¦associated¦ ¦with¦ ¦a¦ ¦nu rs ing¦ ¦facil ity¦ ¦for¦ ¦pres ch oo l¦ ¦children¦ ¦in¦ ¦k ob e¦ ¦tested¦ ¦positive¦ ¦for¦ ¦coronavirus¦ .
𐋇 ¦after¦ ¦testing¦ ¦over¦ ¦one¦ ¦h un dr ed¦ ¦children¦ ¦at¦ ¦the¦ ¦facil ity¦ ,▁ ¦a¦ ¦pres ch oo l¦ ¦st ud ent¦ ¦was¦ ¦found¦ ¦to¦ ¦be¦ ¦c arr ying¦ ¦the¦ ¦virus¦ .
𐋇 ¦pr imary¦ ¦or¦ ¦e le me nt ary¦ ¦education¦ ¦typ ically¦ ¦con si sts¦ ¦of¦ ¦the¦ ¦first¦ ¦four¦ ¦to¦ ¦se v en¦ ¦years¦ ¦of¦ ¦f ormal¦ ¦education¦ .
𐋇¦the¦ ¦international¦ ¦b ac c a la u re ate¦ ¦organiz ation¦ ▁( ¦i b o¦ )▁ ¦cance l ed¦ ¦the¦ ¦ex a min ations¦ ¦for¦ ¦its¦ ¦di pl om a¦ ¦pr ogra m me¦ ¦and¦ ¦ca re er¦ - ¦related¦ ¦pr ogra m me¦ ¦ca nd id ates¦ ¦s ch ed ul ed¦ ¦between¦ ¦30¦ ¦april¦ ¦and¦ ¦2 2¦ ¦may¦ ¦2020¦ ,▁ ¦rep ort ed ly¦ ¦aff ecting¦ ¦more¦ ¦than¦ ¦2 00¦ , ¦000¦ ¦students¦ ¦worldwide¦ .
𐋇¦the¦ ¦i b o¦ ¦stated¦ ¦that¦ ¦it¦ ¦would¦ ¦a w ard¦ ¦ca nd id ates¦ ¦their¦ ¦d ip lo ma s¦ ¦or¦ ¦ce rt ific ates¦ ¦based¦ ¦on¦ ▁" ¦their¦ ¦co ur se w or k¦ "▁ ¦and¦ ▁" ¦the¦ ¦ es ta bl ished¦ ¦as se ss ment¦ ¦exp e rt ise¦ ,▁ ¦r ig or¦ ,▁ ¦and¦ ¦qu ality¦ ¦control¦ ¦al rea dy¦ ¦bu il t¦ ¦into¦ ¦the¦ ¦pr ogra m me¦ . "
𐋇 ¦ter ti ary¦ ¦education¦ ,▁ ¦also¦ ¦known¦ ¦as¦ ¦higher¦ ¦education¦ ,▁ ¦ref ers¦ ¦to¦ ¦the¦ ¦non¦ - ¦comp ul s ory¦ ¦e duc a tional¦ ¦le v els¦ ¦that¦ ¦follow¦ ¦co mpl et ion¦ ¦of¦ ¦sec ond ary¦ ¦school¦ ¦or¦ ¦high¦ ¦school¦ .
𐋇 ¦ter ti ary¦ ¦education¦ ¦is¦ ¦n orm ally¦ ¦ta k en¦ ¦to¦ ¦include¦ ¦under g rad u ate¦ ¦and¦ ¦po st g rad u ate¦ ¦education¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦v oc a tional¦ ¦education¦ ¦and¦ ¦tr aining¦ .
𐋇 ¦individuals¦ ¦who¦ ¦co mpl et e¦ ¦ter ti ary¦ ¦education¦ ¦gener ally¦ ¦receive¦ ¦ce rt ific ates¦ ,▁ ¦d ip lo ma s¦ ,▁ ¦or¦ ¦ac a de m ic¦ ¦de g re es¦ .
𐋇 ¦under g rad u ate¦ ¦education¦ ¦is¦ ¦education¦ ¦con duc ted¦ ¦after¦ ¦sec ond ary¦ ¦education¦ ¦and¦ ¦pri or¦ ¦to¦ ¦p ost¦ - ¦g rad u ate¦ ¦education¦ ,▁ ¦for¦ ¦which¦ ¦the¦ ¦lear n er¦ ¦is¦ ¦typ ically¦ ¦a w ar ded¦ ¦a¦ ¦ba ch el or¦ ' ¦s¦ ¦de g re e¦ .
𐋇 ¦students¦ ¦en ro lled¦ ¦in¦ ¦higher¦ ¦education¦ ¦pr ogra mm es¦ ¦at¦ ¦colle ges¦ ,▁ ¦univers ities¦ ,▁ ¦and¦ ¦community¦ ¦colle ges¦ ¦are¦ ¦often¦ ¦ref e re ed¦ ¦to¦ ¦in¦ ¦countries¦ ¦such¦ ¦as¦ ¦united¦ ¦states¦ ¦as¦ ▁" ¦colle ge¦ ¦students¦ . "▁ 𐋇¦the¦ ¦cl osure¦ ¦of¦ ¦colle ges¦ ¦and¦ ¦univers ities¦ ¦has¦ ¦wid esp r ead¦ ¦i mpl ications¦ ¦for¦ ¦students¦ ,▁ ¦f ac ult y¦ ,▁ ¦admin i str at ors¦ ,▁ ¦and¦ ¦the¦ ¦inst itu tions¦ ¦the m s el ves¦ .
𐋇 ¦colle ges¦ ¦and¦ ¦univers ities¦ ¦across¦ ¦the¦ ¦united¦ ¦states¦ ¦have¦ ¦been¦ ¦called¦ ¦up on¦ ¦to¦ ¦i ss ue¦ ¦ref un ds¦ ¦to¦ ¦students¦ ¦for¦ ¦the¦ ¦c ost¦ ¦of¦ ¦t u ition¦ ¦and¦ ¦ro om¦ ¦and¦ ¦ bo ard¦ .
𐋇¦in¦ ¦the¦ ¦united¦ ¦states¦ ¦of¦ ¦amer ica¦ ,▁ ¦colle ges¦ ¦and¦ ¦univers ities¦ ¦op er ate¦ ¦as¦ ▁" ¦min i¦ - ¦c ities¦ "▁ ¦which¦ ¦gener ate¦ ¦sign ific ant¦ ¦re v en ue¦ ¦for¦ ¦c ities¦ ,▁ ¦states¦ ,▁ ¦and¦ ¦regi ons¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦pri nc et on¦ ¦univers ity¦ ¦cont rib u ted¦ ▁ $ ¦1¦ . ¦5 8¦ ¦bi ll ion¦ ¦us d¦ ¦to¦ ¦the¦ ¦new¦ ¦j er se y¦ ¦ec on om y¦ ¦and¦ ¦students¦ ¦sp ent¦ ¦about¦ ▁ $ ¦6 0¦ ¦million¦ ¦in¦ ¦off ¦ - ¦ca mp us¦ ¦sp ending¦ .
𐋇 ¦colle ge¦ ¦and¦ ¦univers ity¦ ¦closures¦ ¦have¦ ¦a¦ ¦do min o¦ ¦eff ect¦ ¦on¦ ¦ec on om ies¦ ¦with¦ ¦fa r¦ - ¦re ac hing¦ ¦i mpl ications¦ . ¦according¦ ¦to¦ ¦li nd a¦ ¦b il m es¦ ¦of¦ ¦the¦ ¦h ar v ard¦ ¦k en ne dy¦ ¦school¦ , ▁" ¦local¦ ¦h ot els¦ ,▁ ¦res ta u ra nts¦ ,▁ ¦ca f es¦ ,▁ ¦sho ps¦ ,▁ ¦ca r¦ ¦re ntal¦ ¦a ge nc ies¦ ¦and¦ ¦other¦ ¦local¦ ¦b us in es ses¦ ¦ob tain¦ ¦a¦ ¦sign ific ant¦ ¦share¦ ¦of¦ ¦an n ual¦ ¦re v en ue¦ ¦from¦ ¦g rad u ation¦ ¦week¦ ¦and¦ ¦colle ge¦ ¦re un i ons¦ . . .
𐋇¦these¦ ¦comm un ities¦ ¦will¦ ¦su ff er¦ ¦a¦ ¦l ot¦ ¦of¦ ¦ec onomic¦ ¦da m age¦ ¦if¦ ¦the¦ ¦colle ges¦ ¦remain¦ ¦closed¦ ¦at¦ ¦that¦ ¦time¦ . ▁" 𐋇 ¦sm all¦ ¦t ow ns¦ ¦which¦ ¦r ely¦ ¦on¦ ¦colle ge¦ ¦students¦ ¦to¦ ¦support¦ ¦the¦ ¦local¦ ¦ec on om y¦ ¦and¦ ¦provide¦ ¦l ab ou r¦ ¦to¦ ¦local¦ ¦b us in es ses¦ ¦are¦ ¦especially¦ ¦impac ted¦ ¦by¦ ¦school¦ ¦closures¦ ¦and¦ ¦the¦ ¦ex o d us¦ ¦of¦ ¦students¦ ¦from¦ ¦ca mp us¦ .
𐋇¦in¦ ¦i th ac a¦ ,▁ ¦new¦ ¦y or k¦ ,▁ ¦cor n ell¦ ¦univers ity¦ ¦students¦ ¦sp ent¦ ¦at¦ ¦least¦ ▁ $ ¦4¦ ¦million¦ ¦a¦ ¦week¦ ¦in¦ ¦to mp k ins¦ ¦county¦ .
𐋇¦in¦ ¦the¦ ¦w a ke¦ ¦of¦ ¦cor n ell¦ ' ¦s¦ ¦dec is ion¦ ¦to¦ ¦keep¦ ¦students¦ ¦home¦ ¦following¦ ¦sp r ing¦ ¦brea k¦ ¦and¦ ¦trans ition¦ ¦to¦ ¦vir t ual¦ ¦inst ru ction¦ ,▁ ¦the¦ ¦ma y or¦ ¦of¦ ¦i th ac a¦ ¦called¦ ¦for¦ ▁" ¦immediate¦ ¦and¦ ¦for ce ful¦ ¦f ed er al¦ ¦a ction¦ ▁ — ▁ ¦we¦ ¦will¦ ¦se e¦ ¦a¦ ¦h or r if ic¦ ¦ec onomic¦ ¦impac t¦ ¦as¦ ¦a¦ ¦result¦ ¦of¦ ¦cor n ell¦ ¦univers ity¦ ¦clos ing¦ . "
𐋇 ¦un esc o¦ ¦is¦ ¦sh ar ing¦ ¦10¦ ¦recomm end ations¦ ¦during¦ ¦this¦ ¦period¦ :
𐋇 ¦ex a m ine¦ ¦the¦ ¦rea di ness¦ ¦and¦ ¦c ho ose¦ ¦the¦ ¦most¦ ¦re le v ant¦ ¦to ols¦ :▁ 𐋇 ¦dec ide¦ ¦on¦ ¦the¦ ¦use¦ ¦high¦ - ¦techn ology¦ ¦and¦ ¦low¦ - ¦techn ology¦ ¦so lu tions¦ ¦based¦ ¦on¦ ¦the¦ ¦rel ia bility¦ ¦of¦ ¦local¦ ¦p ower¦ ¦supp l ies¦ ,▁ ¦inter n et¦ ¦con n ect iv ity¦ ,▁ ¦and¦ ¦d ig it al¦ ¦s k i lls¦ ¦of¦ ¦t ea ch ers¦ ¦and¦ ¦students¦ .
𐋇¦this¦ ¦could¦ ¦r ange¦ ¦through¦ ¦in te g r ated¦ ¦d ig it al¦ ¦learning¦ ¦pl at for ms¦ ,▁ ¦v ide o¦ ¦le ss ons¦ ,▁ ¦mo oc s¦ ,▁ ¦to¦ ¦b ro a d c as ting¦ ¦through¦ ¦ra di o s¦ ¦and¦ ¦t v s¦ .
𐋇¦e ns ure¦ ¦inclu s ion¦ ¦of¦ ¦the¦ ¦dista nce¦ ¦learning¦ ¦pr ogra mm es¦ :▁ 𐋇 ¦imp le ment¦ ¦measures¦ ¦to¦ ¦e ns ure¦ ¦that¦ ¦students¦ ¦including¦ ¦those¦ ¦with¦ ¦dis ab il ities¦ ¦or¦ ¦from¦ ¦low¦ - ¦inc ome¦ ¦b ac k g ro un ds¦ ¦have¦ ¦acc ess¦ ¦to¦ ¦dista nce¦ ¦learning¦ ¦pr ogra mm es¦ ,▁ ¦if¦ ¦only¦ ¦a¦ ¦limi ted¦ ¦number¦ ¦of¦ ¦them¦ ¦have¦ ¦acc ess¦ ¦to¦ ¦d ig it al¦ ¦de vi ces¦ .
𐋇 ¦consid er¦ ¦temp o ra ri ly¦ ¦de ce nt r al ising¦ ¦such¦ ¦de vi ces¦ ¦from¦ ¦comp u ter¦ ¦l ab s¦ ¦to¦ ¦fa m il ies¦ ¦and¦ ¦support¦ ¦them¦ ¦with¦ ¦inter n et¦ ¦con n ect iv ity¦ .
𐋇 ¦protect¦ ¦data¦ ¦priv acy¦ ¦and¦ ¦data¦ ¦sec ur ity¦ :▁ 𐋇 ¦ass ess¦ ¦data¦ ¦sec ur ity¦ ¦when¦ ¦up lo a ding¦ ¦data¦ ¦or¦ ¦e duc a tional¦ ¦res o ur ces¦ ¦to¦ ¦we b ¦ ¦s pa ces¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦when¦ ¦sh ar ing¦ ¦them¦ ¦with¦ ¦other¦ ¦or g an is ations¦ ¦or¦ ¦individuals¦ .
𐋇¦e ns ure¦ ¦that¦ ¦the¦ ¦use¦ ¦of¦ ¦app l ications¦ ¦and¦ ¦pl at for ms¦ ¦does¦ ¦not¦ ¦ vi ol ate¦ ¦students¦ ▁’▁ ¦data¦ ¦priv acy¦ .
𐋇 ¦pri or itiz e¦ ¦so lu tions¦ ¦to¦ ¦ad dr ess¦ ¦p s y ch os oc ial¦ ¦cha ll en ges¦ ¦before¦ ¦te ac hing¦ :▁ 𐋇¦m ob il iz e¦ ¦available¦ ¦to ols¦ ¦to¦ ¦con n ect¦ ¦schools¦ ,▁ ¦par ents¦ ,▁ ¦t ea ch ers¦ ,▁ ¦and¦ ¦students¦ ¦with¦ ¦each¦ ¦other¦ .
𐋇 ¦cre ate¦ ¦comm un ities¦ ¦to¦ ¦e ns ure¦ ¦reg ular¦ ¦human¦ ¦inter ac tions¦ ,▁ ¦en able¦ ¦social¦ ¦car ing¦ ¦measures¦ ,▁ ¦and¦ ¦ad dr ess¦ ¦possible¦ ¦p s y ch os oc ial¦ ¦cha ll en ges¦ ¦that¦ ¦students¦ ¦may¦ ¦face¦ ¦when¦ ¦they¦ ¦are¦ ¦isol ated¦ .
𐋇 ¦pl an¦ ¦the¦ ¦study¦ ¦s ch ed u le¦ ¦of¦ ¦the¦ ¦dista nce¦ ¦learning¦ ¦pr ogra mm es¦ :▁ 𐋇 ¦or g an ise¦ ¦disc us si ons¦ ¦with¦ ¦sta k e h ol d ers¦ ¦to¦ ¦ex a m ine¦ ¦the¦ ¦possible¦ ¦d ur ation¦ ¦of¦ ¦school¦ ¦closures¦ ¦and¦ ¦dec ide¦ ¦wh ether¦ ¦the¦ ¦dista nce¦ ¦learning¦ ¦pr ogra m me¦ ¦should¦ ¦f oc us¦ ¦on¦ ¦te ac hing¦ ¦new¦ ¦k n ow l ed ge¦ ¦or¦ ¦en h ance¦ ¦students¦ ▁’▁ ¦k n ow l ed ge¦ ¦of¦ ¦pri or¦ ¦le ss ons¦ .
𐋇 ¦pl an¦ ¦the¦ ¦s ch ed u le¦ ¦dep ending¦ ¦on¦ ¦the¦ ¦s itu ation¦ ¦of¦ ¦the¦ ¦affected¦ ¦z on es¦ ,▁ ¦level¦ ¦of¦ ¦st u dies¦ ,▁ ¦needs¦ ¦of¦ ¦students¦ ¦needs¦ ,▁ ¦and¦ ¦a v ai la bility¦ ¦of¦ ¦par ents¦ .
𐋇¦c ho ose¦ ¦the¦ ¦appr op ri ate¦ ¦learning¦ ¦met ho d ol og ies¦ ¦based¦ ¦on¦ ¦the¦ ¦st at us¦ ¦of¦ ¦school¦ ¦closures¦ ¦and¦ ¦home¦ - ¦based¦ ¦qu ara nt ines¦ .
𐋇 ¦avoid¦ ¦learning¦ ¦met ho d ol og ies¦ ¦that¦ ¦requir e¦ ¦face¦ - ¦to¦ - ¦face¦ ¦comm un ic ation¦ .
𐋇 ¦provide¦ ¦support¦ ¦to¦ ¦t ea ch ers¦ ¦and¦ ¦par ents¦ ¦on¦ ¦the¦ ¦use¦ ¦of¦ ¦d ig it al¦ ¦to ols¦ :▁ 𐋇 ¦or g an ise¦ ¦br ief¦ ¦tr aining¦ ¦or¦ ¦or ie nt ation¦ ¦s es si ons¦ ¦for¦ ¦t ea ch ers¦ ¦and¦ ¦par ents¦ ¦as¦ ¦well¦ ,▁ ¦if¦ ¦monit or ing¦ ¦and¦ ¦facil it ation¦ ¦are¦ ¦nee ded¦ .
𐋇 ¦help¦ ¦t ea ch ers¦ ¦to¦ ¦pre p are¦ ¦the¦ ¦b as ic¦ ¦s et t ings¦ ¦such¦ ¦as¦ ¦so lu tions¦ ¦to¦ ¦the¦ ¦use¦ ¦of¦ ¦inter n et¦ ¦data¦ ¦if¦ ¦they¦ ¦are¦ ¦required¦ ¦to¦ ¦provide¦ ¦live¦ ¦st rea m ing¦ ¦of¦ ¦le ss ons¦ .
𐋇¦ bl end¦ ¦appr op ri ate¦ ¦appro a ches¦ ¦and¦ ¦limi t¦ ¦the¦ ¦number¦ ¦of¦ ¦app l ications¦ ¦and¦ ¦pl at for ms¦ :▁ 𐋇¦ bl end¦ ¦to ols¦ ¦or¦ ¦m ed ia¦ ¦that¦ ¦are¦ ¦available¦ ¦for¦ ¦most¦ ¦students¦ ,▁ ¦both¦ ¦for¦ ¦s y n ch ro no us¦ ¦comm un ic ation¦ ¦and¦ ¦le ss ons¦ ,▁ ¦and¦ ¦for¦ ¦as y n ch ro no us¦ ¦learning¦ .
𐋇 ¦avoid¦ ¦over lo a ding¦ ¦students¦ ¦and¦ ¦par ents¦ ¦by¦ ¦as king¦ ¦them¦ ¦to¦ ¦d ow n lo ad¦ ¦and¦ ¦test¦ ¦to o¦ ¦many¦ ¦app l ications¦ ¦or¦ ¦pl at for ms¦ .
𐋇 ¦develop ¦ ¦dista nce¦ ¦learning¦ ¦ ru les¦ ¦and¦ ¦monit or¦ ¦students¦ ▁’▁ ¦learning¦ ¦proc ess¦ :▁ 𐋇 ¦def ine¦ ¦the¦ ¦ ru les¦ ¦with¦ ¦par ents¦ ¦and¦ ¦students¦ ¦on¦ ¦dista nce¦ ¦learning¦ .
𐋇¦d es ign¦ ¦f orm ative¦ ¦qu es tions¦ ,▁ ¦tests¦ ,▁ ¦or¦ ¦exerc i ses¦ ¦to¦ ¦monit or¦ ¦clos ely¦ ¦students¦ ▁’▁ ¦learning¦ ¦proc ess¦ .
𐋇¦t ry¦ ¦to¦ ¦use¦ ¦to ols¦ ¦to¦ ¦support¦ ¦sub mi ssion¦ ¦of¦ ¦students¦ ▁’▁ ¦fe ed b ack¦ ¦and¦ ¦avoid¦ ¦over lo a ding¦ ¦par ents¦ ¦by¦ ¦re qu es ting¦ ¦them¦ ¦to¦ ¦sc an¦ ¦and¦ ¦s end¦ ¦students¦ ▁’▁ ¦fe ed b ack¦
𐋇 ¦def ine¦ ¦the¦ ¦d ur ation¦ ¦of¦ ¦dista nce¦ ¦learning¦ ¦uni ts¦ ¦based¦ ¦on¦ ¦students¦ ▁’▁ ¦self¦ - ¦regul ation¦ ¦s k i lls¦ :▁ 𐋇 ¦keep¦ ¦a¦ ¦co h er ent¦ ¦t im ing¦ ¦according¦ ¦to¦ ¦the¦ ¦level¦ ¦of¦ ¦the¦ ¦students¦ ▁’▁ ¦self¦ - ¦regul ation¦ ¦and¦ ¦met ac o gn i tive¦ ¦ab il ities¦ ¦especially¦ ¦for¦ ¦li ve st rea m ing¦ ¦cl as ses¦ .
𐋇 ¦pre f er ab ly¦ ,▁ ¦the¦ ¦uni t¦ ¦for¦ ¦pr imary¦ ¦school¦ ¦students¦ ¦should¦ ¦not¦ ¦be¦ ¦more¦ ¦than¦ ¦20¦ ¦min u tes¦ ,▁ ¦and¦ ¦no¦ ¦lo nger¦ ¦than¦ ¦4 0¦ ¦min u tes¦ ¦for¦ ¦sec ond ary¦ ¦school¦ ¦students¦ .
𐋇 ¦cre ate¦ ¦comm un ities¦ ¦and¦ ¦en h ance¦ ¦con ne ction¦ :▁ 𐋇 ¦cre ate¦ ¦comm un ities¦ ¦of¦ ¦t ea ch ers¦ ,▁ ¦par ents¦ ,▁ ¦and¦ ¦school¦ ¦mana g ers¦ ¦to¦ ¦ad dr ess¦ ¦sen se¦ ¦of¦ ¦lo ne li ness¦ ¦or¦ ¦h el p le ss ness¦ ,▁ ¦facil it ate¦ ¦sh ar ing¦ ¦of¦ ¦exp eri ence¦ ¦and¦ ¦disc u ssion¦ ¦on¦ ¦c op ing¦ ¦stra te g ies¦ ¦when¦ ¦f ac ing¦ ¦learning¦ ¦diffic ult ies¦ .
¦2 9 0¦ ¦million¦ ¦students¦ ¦out¦ ¦of¦ ¦school¦ ¦due¦ ¦to¦ ¦covid¦ - ¦19¦ :▁ 𐋇 ¦un esc o¦ ¦rel ea ses¦ ¦first¦ ¦global¦ ¦nu mbers¦ ¦and¦ ¦m ob il iz es¦ ¦response¦ ,▁ ¦un esc o¦ .
𐋇¦w he rea s¦ ¦on¦ ¦march¦ ¦4¦ ,▁ ¦2020¦ ,▁ ¦i¦ ¦proc l ai med¦ ¦a¦ ¦state¦ ¦of¦ ¦emergency¦ ¦to¦ ¦ex ist¦ ¦in¦ ¦ca li for n ia¦ ¦as¦ ¦a¦ ¦result¦ ¦of¦ ¦the¦ ¦th re at¦ ¦of¦ ¦covid¦ - ¦19¦ ;
𐋇 ¦and¦ ¦w he rea s¦ ¦in¦ ¦a¦ ¦sh ort¦ ¦period¦ ¦of¦ ¦time¦ ,▁ ¦covid¦ - ¦19¦ ¦has¦ ¦rap id ly¦ ¦spread¦ ¦th r ou g ho ut¦ ¦ca li for n ia¦ ,▁ ¦ne cess it ating¦ ¦up d ated¦ ¦and¦ ¦more¦ ¦st ri ng ent¦ ¦gu id ance¦ ¦from¦ ¦f ed er al¦ ,▁ ¦state¦ ,▁ ¦and¦ ¦local¦ ¦public¦ ¦health¦ ¦off ici als¦ ;
𐋇 ¦and¦ ¦w he rea s¦ ¦for¦ ¦the¦ ¦pres erv ation¦ ¦of¦ ¦public¦ ¦health¦ ¦and¦ ¦safety¦ ¦th r ou g ho ut¦ ¦the¦ ¦ent ir e¦ ¦state¦ ¦of¦ ¦ca li for n ia¦ ,▁ ¦i¦ ¦f ind¦ ¦it¦ ¦ne cess ary¦ ¦for¦ ¦all¦ ¦ca li for n i ans¦ ¦to¦ ¦he ed¦ ¦the¦ ¦state¦ ¦public¦ ¦health¦ ¦dir ect ives¦ ¦from¦ ¦the¦ ¦department¦ ¦of¦ ¦public¦ ¦health¦ .
𐋇¦n ow¦ ,▁ ¦the re f ore¦ ,▁ ¦i¦ ,▁ ¦ga v in¦ ¦new s om¦ ,▁ ¦gover n or¦ ¦of¦ ¦the¦ ¦state¦ ¦of¦ ¦ca li for n ia¦ ,▁ ¦in¦ ¦acc or d ance¦ ¦with¦ ¦the¦ ¦author ity¦ ¦v ested¦ ¦in¦ ¦ me¦ ¦by¦ ¦the¦ ¦state¦ ¦con st it ution¦ ¦and¦ ¦st at u tes¦ ¦of¦ ¦the¦ ¦state¦ ¦of¦ ¦ca li for n ia¦ ,▁ ¦and¦ ¦in¦ ¦partic ular¦ ,▁ ¦government¦ ¦co de¦ ¦sec tions¦ ¦8 5 6 7¦ ,▁ ¦8 6 2 7¦ ,▁ ¦and¦ ¦8 6 6 5¦ ¦do¦ ¦he re b y¦ ¦i ss ue¦ ¦the¦ ¦following¦ ¦order¦ ¦to¦ ¦bec ome¦ ¦effective¦ ¦imm ed ia tely¦ :
𐋇¦it¦ ¦is¦ ¦he re b y¦ ¦or d ered¦ ¦that¦ :
¦1¦ )▁ ¦to¦ ¦pres er ve¦ ¦the¦ ¦public¦ ¦health¦ ¦and¦ ¦safety¦ ,▁ ¦and¦ ¦to¦ ¦e ns ure¦ ¦the¦ ¦healthcare¦ ¦de li ve ry¦ ¦system¦ ¦is¦ ¦c ap able¦ ¦of¦ ¦ser ving¦ ¦all¦ ,▁ ¦and¦ ¦pri or itiz ing¦ ¦those¦ ¦at¦ ¦the¦ ¦high est¦ ¦risk¦ ¦and¦ ¦v ul ne ra bility¦ ,▁ ¦all¦ ¦res id ents¦ ¦are¦ ¦dir ected¦ ¦to¦ ¦imm ed ia tely¦ ¦he ed¦ ¦the¦ ¦current¦ ¦state¦ ¦public¦ ¦health¦ ¦dir ect ives¦ ,▁ ¦which¦ ¦i¦ ¦or d ered¦ ¦the¦ ¦department¦ ¦of¦ ¦public¦ ¦health¦ ¦to¦ ¦develop ¦ ¦for¦ ¦the¦ ¦current¦ ¦sta te w ide¦ ¦st at us¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇 ¦those¦ ¦dir ect ives¦ ¦are¦ ¦cons ist ent¦ ¦with¦ ¦the¦ ¦march¦ ¦19¦ ,▁ ¦2020¦ ,▁ ¦me mo ra nd um¦ ¦on¦ ¦ident ific ation¦ ¦of¦ ¦essential¦ ¦crit ical¦ ¦inf ra st ru ct ure¦ ¦workers¦ ¦during¦ ¦covid¦ - ¦19¦ ¦response¦ ,▁ ¦found¦ ¦at¦ :▁ 𐋇¦h t t ps¦ :▁ / ▁/▁ ¦cov id 1 9¦ . ¦c a¦ . ¦g ov ¦ ▁ / .
𐋇 ¦order¦ ¦of¦ ¦the¦ ¦state¦ ¦public¦ ¦health¦ ¦offic er¦
𐋇¦to¦ ¦protect¦ ¦public¦ ¦health¦ ,▁ ¦i¦ ¦as¦ ¦state¦ ¦public¦ ¦health¦ ¦offic er¦ ¦and¦ ¦dir ector¦ ¦of¦ ¦the¦ ¦ca li for n ia¦ ¦department¦ ¦of¦ ¦public¦ ¦health¦ ¦order¦ ¦all¦ ¦individuals¦ ¦li ving¦ ¦in¦ ¦the¦ ¦state¦ ¦of¦ ¦ca li for n ia¦ ¦to¦ ¦stay¦ ¦home¦ ¦or¦ ¦at¦ ¦their¦ ¦place¦ ¦of¦ ¦res idence¦ ¦ex cep t¦ ¦as¦ ¦nee ded¦ ¦to¦ ¦main tain¦ ¦contin u ity¦ ¦of¦ ¦op er ations¦ ¦of¦ ¦the¦ ¦f ed er al¦ ¦crit ical¦ ¦inf ra st ru ct ure¦ ¦se ctors¦ ,▁ ¦as¦ ¦out l ined¦ ¦at¦ ¦h t t ps¦ :▁ / ▁/▁ ¦w w w¦ . ¦c is a¦ . ¦g ov ¦ ▁/▁ ¦crit ical¦ - ¦inf ra st ru ct ure¦ - ¦se ctors¦ .
𐋇¦in¦ ¦add ition¦ ,▁ ¦and¦ ¦in¦ ¦cons ult ation¦ ¦with¦ ¦the¦ ¦dir ector¦ ¦of¦ ¦the¦ ¦gover n or¦ ' ¦s¦ ¦off ice¦ ¦of¦ ¦emergency¦ ¦services¦ ,▁ ¦i¦ ¦may¦ ¦de si gn ate¦ ¦ad di tional¦ ¦se ctors¦ ¦as¦ ¦crit ical¦ ¦in¦ ¦order¦ ¦to¦ ¦protect¦ ¦the¦ ¦health¦ ¦and¦ ¦well¦ - ¦being¦ ¦of¦ ¦all¦ ¦ca li for n i ans¦ .
𐋇¦p u rs u ant¦ ¦to¦ ¦the¦ ¦author ity¦ ¦under¦ ¦the¦ ¦health¦ ¦and¦ ¦safety¦ ¦co de¦ ¦1 2 0 1 2 5¦ ,▁ ¦1 2 0 1 4 0¦ ,▁ ¦1 3 1 0 8 0¦ ,▁ ¦1 2 0 1 3 0¦ ▁( ¦ c¦ ),▁ ¦1 2 0 1 3 5¦ ,▁ ¦1 2 0 1 4 5¦ ,▁ ¦1 2 0 1 7 5¦ ¦and¦ ¦1 2 0 1 5 0¦ ,▁ ¦this¦ ¦order¦ ¦is¦ ¦to¦ ¦go¦ ¦into¦ ¦eff ect¦ ¦imm ed ia tely¦ ¦and¦ ¦sh all¦ ¦stay¦ ¦in¦ ¦eff ect¦ ¦until¦ ¦further¦ ¦n ot ice¦ .
𐋇¦the¦ ¦f ed er al¦ ¦government¦ ¦has¦ ¦identified¦ ¦16¦ ¦crit ical¦ ¦inf ra st ru ct ure¦ ¦se ctors¦ ¦wh ose¦ ¦ass ets¦ ,▁ ¦sys tems¦ ,▁ ¦and¦ ¦n et w or ks¦ ,▁ ¦wh ether¦ ¦ph ys ical¦ ¦or¦ ¦vir t ual¦ ,▁ ¦are¦ ¦consid ered¦ ¦so¦ ¦v it al¦ ¦to¦ ¦the¦ ¦united¦ ¦states¦ ¦that¦ ¦their¦ ¦inc ap ac it ation¦ ¦or¦ ¦de st ru ction¦ ¦would¦ ¦have¦ ¦a¦ ¦de b il it ating¦ ¦eff ect¦ ¦on¦ ¦sec ur ity¦ ,▁ ¦ec onomic¦ ¦sec ur ity¦ ,▁ ¦public¦ ¦health¦ ¦or¦ ¦safety¦ ,▁ ¦or¦ ¦any¦ ¦co mb ination¦ ¦the re o f¦ .
𐋇 ¦i¦ ¦order¦ ¦that¦ ¦ca li for n i ans¦ ¦wor king¦ ¦in¦ ¦these¦ ¦16¦ ¦crit ical¦ ¦inf ra st ru ct ure¦ ¦se ctors¦ ¦may¦ ¦continue¦ ¦their¦ ¦work¦ ¦because¦ ¦of¦ ¦the¦ ¦imp ort ance¦ ¦of¦ ¦these¦ ¦se ctors¦ ¦to¦ ¦ca li for n i ans¦ ' ▁ ¦health¦ ¦and¦ ¦well¦ - ¦being¦ .
𐋇¦this¦ ¦order¦ ¦is¦ ¦being¦ ¦issued¦ ¦to¦ ¦protect¦ ¦the¦ ¦public¦ ¦health¦ ¦of¦ ¦ca li for n i ans¦ .
𐋇¦the¦ ¦ca li for n ia¦ ¦department¦ ¦of¦ ¦public¦ ¦health¦ ¦l oo ks¦ ¦to¦ ¦ es ta bl ish¦ ¦cons is te ncy¦ ¦across¦ ¦the¦ ¦state¦ ¦in¦ ¦order¦ ¦to¦ ¦e ns ure¦ ¦that¦ ¦we¦ ¦m it ig ate¦ ¦the¦ ¦impac t¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇 ¦our¦ ¦go al¦ ¦is¦ ¦si mp le¦ ,▁ ¦we¦ ¦w ant¦ ¦to¦ ¦b end¦ ¦the¦ ¦cur ve¦ ,▁ ¦and¦ ¦dis ru p t¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦the¦ ¦supp ly¦ ¦cha in¦ ¦must¦ ¦continue¦ ,▁ ¦and¦ ¦ca li for n i ans¦ ¦must¦ ¦have¦ ¦acc ess¦ ¦to¦ ¦such¦ ¦ne cess ities¦ ¦as¦ ¦food¦ ,▁ ¦pr esc r ip tions¦ ,▁ ¦and¦ ¦health¦ ¦care¦ .
𐋇¦when¦ ¦people¦ ¦need¦ ¦to¦ ¦lea ve¦ ¦their¦ ¦h omes¦ ¦or¦ ¦places¦ ¦of¦ ¦res idence¦ ,▁ ¦wh ether¦ ¦to¦ ¦ob tain¦ ¦or¦ ¦per for m¦ ¦the¦ ¦f u nc tions¦ ¦a bo ve¦ ,▁ ¦or¦ ¦to¦ ¦o ther w ise¦ ¦facil it ate¦ ¦author i zed¦ ¦ne cess ary¦ ¦activ ities¦ ,▁ ¦they¦ ¦should¦ ¦at¦ ¦all¦ ¦times¦ ¦pract ice¦ ¦social¦ ¦distancing¦ .
¦2¦ )▁ ¦the¦ ¦healthcare¦ ¦de li ve ry¦ ¦system¦ ¦sh all¦ ¦pri or itiz e¦ ¦services¦ ¦to¦ ¦ser ving¦ ¦those¦ ¦who¦ ¦are¦ ¦the¦ ¦s ick est¦ ¦and¦ ¦sh all¦ ¦pri or itiz e¦ ¦res o ur ces¦ ,▁ ¦including¦ ¦personal¦ ¦prot ective¦ ¦equipment¦ ,▁ ¦for¦ ¦the¦ ¦provid ers¦ ¦provid ing¦ ¦direct¦ ¦care¦ ¦to¦ ¦them¦ .
¦3¦ )▁ ¦the¦ ¦off ice¦ ¦of¦ ¦emergency¦ ¦services¦ ¦is¦ ¦dir ected¦ ¦to¦ ¦take¦ ¦ne cess ary¦ ¦ste ps¦ ¦to¦ ¦e ns ure¦ ¦comp li ance¦ ¦with¦ ¦this¦ ¦order¦ .
¦4¦ )▁ ¦this¦ ¦order¦ ¦sh all¦ ¦be¦ ¦en for ce able¦ ¦p u rs u ant¦ ¦to¦ ¦ca li for n ia¦ ¦la w¦ ,▁ ¦including¦ ,▁ ¦but¦ ¦not¦ ¦limi ted¦ ¦to¦ ,▁ ¦government¦ ¦co de¦ ¦se ction¦ ¦8 6 6 5¦ .
𐋇¦it¦ ¦is¦ ¦further¦ ¦or d ered¦ ¦that¦ ¦as¦ ¦so on¦ ¦as¦ ¦he rea f ter¦ ¦possible¦ ,▁ ¦this¦ ¦order¦ ¦be¦ ¦f il ed¦ ¦in¦ ¦the¦ ¦off ice¦ ¦of¦ ¦the¦ ¦sec r et ary¦ ¦of¦ ¦state¦ ¦and¦ ¦that¦ ¦wid esp r ead¦ ¦publ ic ity¦ ¦and¦ ¦n ot ice¦ ¦be¦ ¦giv en¦ ¦of¦ ¦this¦ ¦order¦ .
𐋇¦this¦ ¦order¦ ¦is¦ ¦not¦ ¦in te nded¦ ¦to¦ ,▁ ¦and¦ ¦does¦ ¦not¦ ,▁ ¦cre ate¦ ¦any¦ ¦ ri gh ts¦ ¦or¦ ¦be ne f i ts¦ ,▁ ¦sub st an tive¦ ¦or¦ ¦proc ed ural¦ ,▁ ¦en for ce able¦ ¦at¦ ¦la w¦ ¦or¦ ¦in¦ ¦e qu ity¦ ,▁ ¦against¦ ¦the¦ ¦state¦ ¦of¦ ¦ca li for n ia¦ ,▁ ¦its¦ ¦a ge nc ies¦ ,▁ ¦de pa rt ments¦ ,▁ ¦ent ities¦ ,▁ ¦offic ers¦ ,▁ ¦e mploy e es¦ ,▁ ¦or¦ ¦any¦ ¦other¦ ¦person¦ .
𐋇¦in¦ ¦w it ness¦ ¦w he re o f¦ ¦i¦ ¦have¦ ¦he re u nt o¦ ¦s et¦ ¦m y¦ ¦hand¦ ¦and¦ ¦caused¦ ¦the¦ ¦g re at¦ ¦se al¦ ¦of¦ ¦the¦ ¦state¦ ¦of¦ ¦ca li for n ia¦ ¦to¦ ¦be¦ ¦aff i x ed¦ ¦this¦ ¦19 th¦ ¦day¦ ¦of¦ ¦march¦ ¦2020¦ .
𐋇¦the¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦virus¦ ¦is¦ ¦the¦ ¦cause¦ ¦of¦ ¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ ¦disease¦ ¦2019¦ ),▁ ¦a¦ ¦conta g ious¦ ¦respiratory¦ ¦disease¦ ¦that¦ ¦was¦ ¦first¦ ¦identified¦ ¦in¦ ¦december¦ ¦2019¦ ,▁ ¦in¦ ¦wuhan¦ ,▁ ¦hub e i¦ ,▁ ¦china¦ .
𐋇¦the¦ ¦disease¦ ¦is¦ ¦a¦ ¦typ e¦ ¦of¦ ¦coronavirus¦ ,▁ ¦the¦ ¦same¦ ¦family¦ ¦that¦ ¦inclu des¦ ¦sars¦ ,▁ ¦mers¦ ,▁ ¦and¦ ¦some¦ ¦vari et ies¦ ¦of¦ ¦the¦ ¦common¦ ¦cold¦ .
𐋇¦it¦ ¦was¦ ¦decl ared¦ ¦a¦ ¦pandemic¦ ¦by¦ ¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ▁( ¦who¦ )▁ ¦on¦ ¦11¦ ¦march¦ ¦2020¦ .
𐋇 ¦while¦ ¦much¦ ¦about¦ ¦covid¦ - ¦19¦ ¦is¦ ¦still¦ ¦un k n own¦ ,▁ ¦pre li min ary¦ ¦data¦ ¦su g ge sts¦ ¦that¦ ¦it¦ ¦is¦ ¦more¦ ¦vir ul ent¦ ¦and¦ ¦conta g ious¦ ¦than¦ ¦the¦ ¦se as on al¦ ¦flu¦ ,▁ ¦and¦ ¦less¦ ¦vir ul ent¦ ¦but¦ ¦more¦ ¦conta g ious¦ ¦than¦ ¦sars¦ ¦and¦ ¦mers¦ .
𐋇¦ ol der¦ ¦people¦ ¦and¦ ¦those¦ ¦with¦ ¦underlying¦ ¦conditions¦ ¦are¦ ¦the¦ ¦most¦ ¦at¦ ¦risk¦ ¦of¦ ¦ser ious¦ ¦co mpl ications¦ ¦including¦ ¦death¦ .
𐋇 ¦due¦ ¦to¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦disease¦ ,▁ ¦you¦ ¦are¦ ¦ad vi sed¦ ¦not¦ ¦to¦ ¦travel¦ ¦un less¦ ¦ne cess ary¦ ,▁ ¦to¦ ¦avoid¦ ¦being¦ ¦infected¦ ,▁ ¦qu ara nt ined¦ ,▁ ¦or¦ ¦stra nded¦ ¦by¦ ¦chan ging¦ ¦restrictions¦ ¦and¦ ¦cance lled¦ ¦f li gh ts¦ .
𐋇 ¦avoid¦ ¦cr ow ded¦ ¦places¦ ¦w he ne ver¦ ¦possible¦ .
𐋇¦this¦ ¦is¦ ¦not¦ ¦j ust¦ ¦to¦ ¦protect¦ ¦you¦ ,▁ ¦but¦ ¦also¦ ¦those¦ ¦you¦ ¦come¦ ¦in¦ ¦contact¦ ¦with¦ .
𐋇¦as¦ ¦it¦ ¦happ ens¦ ,▁ ¦you¦ ¦prob ab ly¦ ¦ar en¦ ' ¦t¦ ¦mi ss ing¦ ¦much¦ ¦by¦ ¦sta ying¦ ¦home¦ ,▁ ¦as¦ ¦many¦ ¦att r ac tions¦ ¦around¦ ¦the¦ ¦world¦ ¦are¦ ¦clos ing¦ ¦their¦ ¦do ors¦ ¦to¦ ¦avoid¦ ¦sprea ding¦ ¦the¦ ¦disease¦ .
𐋇¦if¦ ¦you¦ ¦do¦ ¦need¦ ¦to¦ ¦travel¦ ,▁ ¦take¦ ¦pr ec a u tions¦ ¦as¦ ¦you¦ ¦would¦ ¦for¦ ¦other¦ ¦infections¦ :▁ 𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦fre qu e ntly¦ ,▁ ¦avoid¦ ¦to uc hing¦ ¦your¦ ¦face¦ ,▁ ¦cough¦ ¦and¦ ¦s n ee z e¦ ¦into¦ ¦your¦ ¦el b ow¦ ¦or¦ ¦a¦ ¦ti ss ue¦ ,▁ ¦and¦ ¦avoid¦ ¦contact¦ ¦with¦ ¦sick¦ ¦people¦ .
𐋇 ¦before¦ ¦tra v el ing¦ ,▁ ¦r ead¦ ¦up¦ ¦on¦ ¦the¦ ¦ex tens ive¦ ¦and¦ ¦f ast¦ - ¦chan ging¦ ¦arr ay¦ ¦of¦ ¦travel¦ ¦restrictions¦ ¦that¦ ¦have¦ ¦been¦ ¦imp osed¦ ¦around¦ ¦the¦ ¦world¦ .
𐋇 ¦after¦ ¦travel¦ ,▁ ¦monit or¦ ¦your¦ ¦health¦ ¦and¦ ¦consid er¦ ¦self¦ - ¦isolation¦ ¦for¦ ¦two¦ ¦weeks¦ ¦to¦ ¦avoid¦ ¦transm it ting¦ ¦the¦ ¦disease¦ ¦to¦ ¦others¦ .
𐋇 ¦trans p ort ation¦ ¦from¦ ¦long¦ - ¦dista nce¦ ¦p as se nger¦ ¦f li gh ts¦ ¦to¦ ¦local¦ ¦bu ses¦ ¦has¦ ¦been¦ ¦cur tail ed¦ ¦or¦ ¦comp le tely¦ ¦sh ut¦ ¦down¦ ¦in¦ ¦many¦ ¦countries¦ ¦due¦ ¦to¦ ¦low¦ ¦dem and¦ ¦or¦ ¦government¦ ¦or d ers¦ .
𐋇 ¦many¦ ¦international¦ ¦and¦ ¦regi on al¦ ¦ bor d ers¦ ¦are¦ ¦closed¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦away¦ ¦from¦ ¦home¦ ,▁ ¦and¦ ¦especially¦ ¦if¦ ¦you¦ ¦are¦ ¦in¦ ¦another¦ ¦country¦ ,▁ ¦consid er¦ ¦retur ning¦ ¦home¦ ¦as¦ ¦so on¦ ¦as¦ ¦possible¦ ;▁ ¦this¦ ¦may¦ ¦get¦ ¦even¦ ¦more¦ ¦diffic ul t¦ ¦as¦ ¦restrictions¦ ¦continue¦ ¦to¦ ¦ch ange¦ .
𐋇¦in¦ ¦some¦ ¦cases¦ ¦it¦ ¦may¦ ¦si mp ly¦ ¦not¦ ¦be¦ ¦possible¦ ,▁ ¦even¦ ¦if¦ ¦you¦ ' ¦r e¦ ¦healthy¦ ¦and¦ ¦me et¦ ¦the¦ ¦le g al¦ ¦requir e ments¦ ¦for¦ ¦ent ry¦ .
𐋇¦if¦ ¦you¦ ¦can¦ ' ¦t¦ ¦f ind¦ ¦a¦ ¦way¦ ¦b ack¦ ¦to¦ ¦your¦ ¦country¦ ,▁ ¦contact¦ ¦your¦ ¦n ear est¦ ¦e mb a ss y¦ ¦or¦ ¦cons ul ate¦ ¦for¦ ¦ass ist ance¦ .
𐋇¦they¦ ¦may¦ ¦be¦ ¦able¦ ¦to¦ ¦organiz e¦ ¦an¦ ¦ev ac u ation¦ ,▁ ¦ident if y¦ ¦non¦ - ¦regul arly¦ ¦s ch ed ul ed¦ ¦f li gh ts¦ ,▁ ¦or¦ ¦give¦ ¦you¦ ¦an¦ ¦emergency¦ ¦lo an¦ ¦to¦ ¦p ay¦ ¦for¦ ¦transport¦ .
𐋇¦in¦ ¦case¦ ¦they¦ ¦can¦ ' ¦t¦ ,▁ ¦make¦ ¦pre par ations¦ ¦in¦ ¦case¦ ¦you¦ ¦need¦ ¦to¦ ¦stay¦ ¦where¦ ¦you¦ ¦are¦ ¦for¦ ¦an¦ ¦ex te nded¦ ¦period¦ .
𐋇¦if¦ ¦you¦ ¦do¦ ¦f ind¦ ¦a¦ ¦way¦ ¦b ack¦ ¦home¦ ,▁ ¦be¦ ¦pre p ared¦ ¦that¦ ¦it¦ ¦may¦ ¦be¦ ¦exp e ns ive¦ ,▁ ¦inc on v en i ent¦ ,▁ ¦and¦ ¦have¦ ¦un us ual¦ ¦restrictions¦ ▁( ¦such¦ ¦as¦ ¦no¦ ¦chec ked¦ ¦ba gg age¦ ).
𐋇¦as¦ ¦of¦ ¦early¦ ¦april¦ ¦2020¦ ,▁ ¦the¦ ¦number¦ ¦of¦ ¦confirmed¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦is¦ ¦appro ac hing¦ ¦one¦ ¦million¦ .
𐋇 ¦th ough¦ ¦the¦ ¦disease¦ ¦star ted¦ ¦in¦ ¦main land¦ ¦china¦ ,▁ ¦it¦ ¦has¦ ¦spread¦ ¦around¦ ¦the¦ ¦world¦ ¦and¦ ¦china¦ ¦has¦ ¦fe w er¦ ¦confirmed¦ ¦cases¦ ¦and¦ ¦deaths¦ ¦than¦ ¦several¦ ¦other¦ ¦countries¦ .
𐋇¦e ur ope¦ ¦is¦ ¦the¦ ¦new¦ ¦e p ic en ter¦ ¦of¦ ¦the¦ ¦pandemic¦ .
𐋇 ¦all¦ ¦but¦ ¦a¦ ¦hand ful¦ ¦of¦ ¦countries¦ ¦have¦ ¦reported¦ ¦at¦ ¦least¦ ¦one¦ ¦case¦ ,▁ ¦with¦ ¦the¦ ¦high est¦ ¦nu mbers¦ ¦of¦ ¦reported¦ ¦cases¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦s pa in¦ ,▁ ¦italy¦ ,▁ ¦g erm an y¦ ,▁ ¦fra nce¦ ,▁ ¦main land¦ ¦china¦ ,▁ ¦iran¦ ,▁ ¦and¦ ¦the¦ ¦united¦ ¦ki ng d om¦ .
𐋇 ¦local¦ ¦transmission¦ ¦is¦ ¦ es ta bl ished¦ ¦in¦ ¦many¦ ¦countries¦ ¦in¦ ¦all¦ ¦major¦ ¦in h ab i ted¦ ¦regi ons¦ ¦of¦ ¦the¦ ¦world¦ ¦ex cep t¦ ¦some¦ ¦p ac if ic¦ ¦ is land¦ ¦n ations¦ .
( 𐋇 ¦se e¦ ¦up d ates¦ ¦from¦ ¦the¦ ¦who¦ . )
𐋇¦the¦ ¦f ul l¦ ¦ext ent¦ ¦of¦ ¦the¦ ¦spread¦ ¦is¦ ¦u nc er tain¦ ,▁ ¦due¦ ¦in¦ ¦par t¦ ¦to¦ ¦limi ted¦ ¦testing¦ .
𐋇 ¦many¦ ¦countries¦ ¦are¦ ¦exp er ie ncing¦ ¦a¦ ¦severe¦ ¦sh ort age¦ ¦of¦ ¦test¦ ¦ki ts¦ ,▁ ¦and¦ ¦the¦ ¦author ities¦ ¦have¦ ¦not¦ ¦been¦ ¦able¦ ¦to¦ ¦test¦ ¦e ver y bo dy¦ ¦who¦ ¦is¦ ¦at¦ ¦high¦ ¦risk¦ ,▁ ¦so¦ ¦the¦ ¦re al¦ ¦number¦ ¦of¦ ¦cases¦ ¦is¦ ¦prob ab ly¦ ¦much¦ ¦higher¦ ¦than¦ ¦the¦ ¦offic ial¦ ¦one¦ .
𐋇 ¦countries¦ ¦also¦ ¦di ff er¦ ¦in¦ ¦their¦ ¦testing¦ ¦and¦ ¦rep orting¦ ¦practi ces¦ ,▁ ¦so¦ ¦comp ar is ons¦ ¦of¦ ¦the¦ ¦number¦ ¦of¦ ¦reported¦ ¦cases¦ ¦do¦ ¦not¦ ¦t ell¦ ¦the¦ ¦f ul l¦ ¦st ory¦ ¦of¦ ¦how¦ ¦the¦ ¦epidemic¦ ¦has¦ ¦pr og r es sed¦ ¦in¦ ¦different¦ ¦areas¦ .
𐋇¦the¦ ¦virus¦ ¦is¦ ¦transm it ted¦ ¦through¦ ¦respiratory¦ ¦dro pl ets¦ ¦and¦ ¦through¦ ¦ob j ects¦ .
𐋇¦the¦ ¦coronavirus¦ ¦is¦ ¦a¦ ¦rel at ively¦ ¦large¦ ¦virus¦ ,▁ ¦m ea ning¦ ¦it¦ ¦is¦ ¦not¦ ¦t ru ly¦ ¦air bor n e¦ :▁ 𐋇¦it¦ ¦will¦ ¦s et t le¦ ¦down¦ ¦in¦ ¦respiratory¦ ¦dro pl ets¦ .
𐋇 ¦sta ying¦ ¦two¦ ¦met r es¦ ▁( ¦si x¦ ¦fe et¦ )▁ ¦away¦ ¦from¦ ¦other¦ ¦people¦ ¦is¦ ¦us ually¦ ¦en ough¦ ¦to¦ ¦prevent¦ ¦transmission¦ ¦through¦ ¦this¦ ¦ro ute¦ .
𐋇 ¦transmission¦ ¦from¦ ¦ob j ects¦ ¦can¦ ¦happ en¦ ,▁ ¦for¦ ¦example¦ ,▁ ¦if¦ ¦someone¦ ¦s n ee z es¦ ,▁ ¦tou ches¦ ¦a¦ ¦do or k n ob ¦ ,▁ ¦and¦ ¦then¦ ¦other¦ ¦people¦ ¦tou ch¦ ¦the¦ ¦do or k n ob ¦ ¦and¦ ¦then¦ ¦tou ch¦ ¦their¦ ¦fa ces¦ .
𐋇¦the¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦virus¦ ¦may¦ ¦last¦ ¦on¦ ¦car d bo ard¦ ¦for¦ ¦up¦ ¦to¦ ¦24¦ ¦hours¦ ¦and¦ ¦on¦ ¦pla st ic¦ ¦for¦ ¦up¦ ¦to¦ ¦3¦ ¦days¦ .
𐋇 ¦transmission¦ ¦v ia¦ ¦the¦ ¦f ec al¦ ▁–▁ ¦or al¦ ¦ro ute¦ ¦may¦ ¦also¦ ¦be¦ ¦possible¦ .
𐋇 ¦evidence¦ ¦su g ge sts¦ ¦that¦ ¦covid¦ - ¦19¦ ¦is¦ ¦conta g ious¦ ¦even¦ ¦without¦ ¦symptoms¦ ,▁ ¦th ough¦ ¦to¦ ¦what¦ ¦ext ent¦ ¦is¦ ¦still¦ ¦being¦ ¦in ve st ig ated¦ .
𐋇 ¦common¦ ¦symptoms¦ ¦include¦ ¦a¦ ¦fever¦ ,▁ ¦d ry¦ ¦cough¦ ,▁ ¦and¦ ¦fat ig ue¦ .
𐋇 ¦other¦ ¦less¦ ¦common¦ ¦symptoms¦ ¦include¦ ¦sh ort ness¦ ¦of¦ ¦brea th¦ ,▁ ¦a¦ ¦s ore¦ ¦th ro at¦ ,▁ ¦h ea d a ch e¦ ,▁ ¦m us c le¦ ¦pain¦ ,▁ ¦or¦ ¦sp ut um¦ ¦produc t ion¦ .
𐋇¦some¦ ¦patients¦ ¦have¦ ¦very¦ ¦mild¦ ¦symptoms¦ ,▁ ¦similar¦ ¦to¦ ¦a¦ ¦cold¦ .
𐋇 ¦ser ious¦ ¦co mpl ications¦ ¦include¦ ¦pneumonia¦ ,▁ ¦acute¦ ¦respiratory¦ ¦di str ess¦ ¦syndrome¦ ,▁ ¦and¦ ¦mult i¦ - ¦or g an¦ ¦fa il ure¦ ¦lea ding¦ ¦to¦ ¦dis a bility¦ ¦or¦ ¦death¦ .
𐋇 ¦about¦ ¦8 0¦ %▁ ¦of¦ ¦infections¦ ¦result¦ ¦in¦ ¦mild¦ ¦symptoms¦ ,▁ ¦while¦ ¦the¦ ¦rem aining¦ ¦may¦ ¦result¦ ¦in¦ ¦hosp it al iz ation¦ .
𐋇 ¦case¦ ¦fat ality¦ ¦rate¦ ¦is¦ ¦estim ated¦ ¦at¦ ¦1¦ - ¦3¦ %▁ ¦of¦ ¦infected¦ ¦individuals¦ ,▁ ¦most¦ ¦of¦ ¦wh om¦ ¦are¦ ¦el d erly¦ ¦with¦ ¦underlying¦ ¦health¦ ¦conditions¦ .
𐋇¦the¦ ¦fat ality¦ ¦rate¦ ¦is¦ ¦much¦ ¦higher¦ ¦for¦ ¦those¦ ¦over¦ ¦7 0¦ ¦but¦ ¦sign ific a ntly¦ ¦lower¦ ¦for¦ ¦those¦ ¦under¦ ¦4 0¦ .
𐋇 ¦those¦ ¦most¦ ¦at¦ ¦risk¦ ¦of¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦and¦ ¦ser ious¦ ¦co mpl ications¦ ¦are¦ ¦the¦ ¦el d erly¦ ¦and¦ ¦those¦ ¦with¦ ¦w ea k e ned¦ ¦immune¦ ¦sys tems¦ ¦or¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦like¦ ¦car di ov as c ular¦ ¦disease¦ ,▁ ¦di ab e tes¦ ,▁ ¦h y p er tens ion¦ ,▁ ¦ch r on ic¦ ¦respiratory¦ ¦disease¦ ,▁ ¦and¦ ¦cance r¦ .
𐋇 ¦not¦ ¦many¦ ¦cases¦ ¦are¦ ¦reported¦ ¦in¦ ¦children¦ ¦and¦ ¦most¦ ¦of¦ ¦these¦ ¦are¦ ¦mild¦ ¦or¦ ¦mod er ate¦ ,▁ ¦th ough¦ ¦a¦ ¦sign ific ant¦ ¦fra ction¦ ¦do¦ ¦get¦ ¦pneumonia¦ .
𐋇 ¦occ u pa tion ally¦ ,▁ ¦health¦ ¦care¦ ¦workers¦ ¦have¦ ¦higher¦ ¦risk¦ ¦comp ared¦ ¦to¦ ¦others¦ ¦with¦ ¦c lu st ers¦ ¦of¦ ¦disease¦ ¦among¦ ¦workers¦ ¦and¦ ¦in¦ ¦health¦ ¦care¦ ¦s et t ings¦ .
𐋇¦the¦ ¦time¦ ¦between¦ ¦being¦ ¦exp osed¦ ¦to¦ ¦the¦ ¦virus¦ ¦and¦ ¦the¦ ¦e mer g ence¦ ¦of¦ ¦symptoms¦ ▁( ¦inc ub ation¦ ¦period¦ )▁ ¦is¦ ¦typ ically¦ ¦between¦ ¦2¦ ¦and¦ ¦14¦ ¦days¦ ,▁ ¦th ough¦ ¦there¦ ¦has¦ ¦been¦ ¦one¦ ¦reported¦ ¦case¦ ¦in¦ ¦china¦ ¦where¦ ¦symptoms¦ ¦app e ared¦ ¦2 7¦ ¦days¦ ¦after¦ ¦exp osure¦ .
𐋇¦as¦ ¦of¦ ¦february¦ ¦2020¦ ,▁ ¦the¦ ¦period¦ ¦of¦ ¦inf ec ti o us ness¦ ¦is¦ ¦un k n own¦ ,▁ ¦but¦ ¦is¦ ¦likely¦ ¦most¦ ¦sign ific ant¦ ¦when¦ ¦people¦ ¦are¦ ¦s ymptomatic¦ .
𐋇¦there¦ ¦is¦ ¦evidence¦ ¦of¦ ¦transmission¦ ¦from¦ ¦people¦ ¦who¦ ¦d on¦ ' ¦t¦ ¦have¦ ¦symptoms¦ ,▁ ¦al th ough¦ ¦to¦ ¦what¦ ¦ext ent¦ ¦is¦ ¦still¦ ¦being¦ ¦in ve st ig ated¦ .
𐋇¦it¦ ¦is¦ ¦u nc l ear¦ ¦wh ether¦ ¦it¦ ¦is¦ ¦possible¦ ¦to¦ ¦be¦ ¦re in f ected¦ ¦with¦ ¦the¦ ¦virus¦ ¦after¦ ¦re cov ering¦ ¦from¦ ¦it¦ ¦the¦ ¦first¦ ¦time¦ ¦around¦ .
𐋇 ¦long¦ - ¦ter m¦ ¦eff ects¦ ¦for¦ ¦people¦ ¦who¦ ¦have¦ ¦re covered¦ ¦remain¦ ¦u nc l ear¦ ,▁ ¦but¦ ¦there¦ ¦is¦ ¦evidence¦ ¦of¦ ¦reduc ed¦ ¦lu ng¦ ¦c ap ac ity¦ ¦in¦ ¦some¦ ¦re covered¦ ¦patients¦ .
𐋇 ¦testing¦ ¦for¦ ¦the¦ ¦virus¦ ¦us ually¦ ¦con si sts¦ ¦of¦ ¦a¦ ¦sw ab ¦ ¦i ns er ted¦ ¦through¦ ¦the¦ ¦nose¦ ¦or¦ ¦a¦ ¦th ro at¦ ¦sw ab ¦ ¦which¦ ¦is¦ ¦anal y sed¦ ¦in¦ ¦a¦ ¦laboratory¦ ¦for¦ ¦the¦ ¦virus¦ .
𐋇¦the¦ ¦current¦ ▁" ¦go ld¦ ¦sta nd ard¦ "▁ ¦test¦ ¦invol ves¦ ¦ext r ac ting¦ ¦the¦ ¦gen et ic¦ ¦m at er ial¦ ¦from¦ ¦the¦ ¦sampl e¦ ¦and¦ ¦anal ys ing¦ ¦it¦ ¦for¦ ¦known¦ ¦gen et ic¦ ¦mark ers¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦ es ta bl ished¦ ¦test¦ ¦as se ss ing¦ ¦for¦ ¦the¦ ¦virus¦ ¦or¦ ¦antibo dies¦ ¦in¦ ¦the¦ ¦blood¦ ,▁ ¦al th ough¦ ¦tests¦ ¦are¦ ¦being¦ ¦developed¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦test¦ ¦to¦ ¦ es ta bl ish¦ ¦immun ity¦ ¦to¦ ¦the¦ ¦virus¦ .
𐋇 ¦many¦ ¦gover n ments¦ ¦around¦ ¦the¦ ¦world¦ ¦have¦ ¦ad vi sed¦ ¦their¦ ¦c itiz ens¦ ¦not¦ ¦to¦ ¦travel¦ ¦un ne cess a ri ly¦ ¦a m id¦ ¦the¦ ¦pandemic¦ .
𐋇 ¦lo ts¦ ¦of¦ ¦air l ines¦ ¦and¦ ¦p ac k age¦ ¦h ol id ays¦ ¦are¦ ¦ma king¦ ¦it¦ ¦e as y¦ ¦for¦ ¦you¦ ¦by¦ ¦wai ving¦ ¦cance ll ation¦ ¦and¦ ¦ch ange¦ ¦fe es¦ .
𐋇 ¦partic ul arly¦ ¦avoid¦ ¦c ru ise¦ ¦s hi p¦ ¦travel¦ .
𐋇¦ ol der¦ ¦tra v el ers¦ ¦and¦ ¦those¦ ¦with¦ ¦underlying¦ ¦health¦ ¦conditions¦ ¦are¦ ¦most¦ ¦at¦ ¦risk¦ ¦and¦ ¦should¦ ¦avoid¦ ¦travel¦ ¦that¦ ¦p u ts¦ ¦them¦ ¦at¦ ¦risk¦ ,▁ ¦such¦ ¦as¦ ¦long¦ ¦pl an e¦ ¦f li gh ts¦ ,▁ ¦visi ts¦ ¦to¦ ¦cr ow ded¦ ¦places¦ ,▁ ¦and¦ ¦especially¦ ¦c ru i ses¦ ,▁ ¦even¦ ¦outside¦ ¦of¦ ¦se ver ely¦ ¦affected¦ ¦areas¦ .
𐋇¦in¦ ¦affected¦ ¦areas¦ ,▁ ¦most¦ ¦exp er ts¦ ¦recomm end¦ ¦a¦ ¦pract ice¦ ¦known¦ ¦as¦ ¦social¦ ¦distancing¦ .
𐋇¦this¦ ¦me ans¦ ¦min im ising¦ ¦contact¦ ¦with¦ ¦others¦ ¦by¦ ¦k ee p ing¦ ¦a¦ ¦dista nce¦ ¦of¦ ¦si x¦ ¦fe et¦ ¦or¦ ¦two¦ ¦meters¦ ¦from¦ ¦them¦ ¦and¦ ¦a v oi ding¦ ¦ga th ering¦ ¦t og ether¦ ¦in¦ ¦grou ps¦ .
𐋇¦some¦ ¦areas¦ ¦per mi t¦ ¦sm all¦ ¦grou ps¦ ;▁ ¦others¦ ¦pro hi b i t¦ ¦all¦ ¦group¦ ¦ga ther ings¦ .
𐋇 ¦measures¦ ¦you¦ ¦are¦ ¦e nc ou ra ged¦ ¦to¦ ¦take¦ ¦include¦ ¦wor king¦ ¦from¦ ¦home¦ ¦w he ne ver¦ ¦possible¦ ,▁ ¦a v oi ding¦ ¦cr ow ds¦ ¦and¦ ¦a v oi ding¦ ¦lea ving¦ ¦your¦ ¦home¦ ¦un less¦ ¦ab s o lu tely¦ ¦ne cess ary¦ .
𐋇¦if¦ ¦you¦ ¦must¦ ¦go¦ ¦out¦ ,▁ ¦t ry¦ ¦to¦ ¦stay¦ ¦at¦ ¦least¦ ¦2¦ ¦meters¦ ▁( ¦6¦ ¦fe et¦ )▁ ¦away¦ ¦from¦ ¦other¦ ¦people¦ .
𐋇¦in¦ ¦many¦ ¦places¦ ¦these¦ ¦measures¦ ¦are¦ ¦required¦ .
𐋇 ¦follow¦ ¦h yg ien e¦ ¦practi ces¦ ¦like¦ ¦for¦ ¦flu¦ ¦pre vention¦ .
𐋇 ¦fre qu e ntly¦ ¦wash¦ ¦your¦ ¦hands¦ ¦with¦ ¦so a p¦ ¦and¦ ¦w ar m¦ ¦water¦ ,▁ ¦and¦ ¦then¦ ¦d ry¦ ¦your¦ ¦hands¦ ¦on¦ ¦a¦ ¦clean¦ ¦to we l¦ .
𐋇¦as¦ ¦coronaviruses¦ ¦are¦ ¦en v el op ed¦ ¦viruses¦ ,▁ ¦washing¦ ¦your¦ ¦hands¦ ¦with¦ ¦so a p¦ ¦ki lls¦ ¦the¦ ¦virus¦ ¦by¦ ¦dis ru p ting¦ ¦the¦ ¦mo st ly¦ ¦f at¦ - ¦based¦ ¦viral¦ ¦en v el ope¦ .
𐋇 ¦effective¦ ¦hand¦ ¦washing¦ ¦requir es¦ ¦r ub b ing¦ ¦your¦ ¦hands¦ ¦for¦ ¦at¦ ¦least¦ ¦20¦ ¦sec on ds¦ .
𐋇 ¦dr ying¦ ¦your¦ ¦w as h ed¦ ¦hands¦ ¦ph ys ically¦ ¦re mo ves¦ ¦some¦ ¦g er ms¦ ¦from¦ ¦your¦ ¦s k in¦ ▁( ¦so¦ ¦d on¦ ' ¦t¦ ¦s k i p¦ ¦that¦ ¦ste p¦ ,▁ ¦and¦ ¦d on¦ ' ¦t¦ ¦share¦ ¦t ow els¦ ).
𐋇¦if¦ ¦so a p¦ ¦and¦ ¦water¦ ¦are¦ ¦not¦ ¦available¦ ,▁ ¦then¦ ¦use¦ ¦a¦ ▁ & ▁ ¦g t¦ ;▁ ¦6 0¦ %▁ ¦al c o ho l¦ - ¦based¦ ¦hand¦ ¦s an itiz er¦ .
𐋇 ¦al c o ho l¦ ¦is¦ ¦a¦ ¦qu ick¦ ¦g er m¦ - ¦ki ll er¦ ,▁ ¦but¦ ¦it¦ ' ¦s¦ ¦not¦ ¦qu ite¦ ¦inst ant¦ ,▁ ¦so¦ ¦this¦ ¦still¦ ¦requir es¦ ¦the¦ ¦same¦ ¦20¦ ¦sec on ds¦ ¦of¦ ¦r ub b ing¦ ¦your¦ ¦hands¦ ¦t og ether¦ ,▁ ¦ma king¦ ¦sure¦ ¦that¦ ¦every¦ ¦si ng le¦ ¦sc ra p¦ ¦of¦ ¦s k in¦ ¦g ets¦ ¦w et¦ ,▁ ¦and¦ ¦then¦ ¦you¦ ¦have¦ ¦to¦ ¦wai t¦ ¦about¦ ¦another¦ ¦min ute¦ ,▁ ¦for¦ ¦the¦ ¦al c o ho l¦ ¦to¦ ¦comp le tely¦ ¦d ry¦ .
𐋇 ¦avoid¦ ¦to uc hing¦ ¦your¦ ¦ey es¦ ,▁ ¦nose¦ ¦and¦ ¦mouth¦ ¦with¦ ¦your¦ ¦hands¦ .
𐋇 ¦most¦ ¦people¦ ¦tou ch¦ ¦their¦ ¦fa ces¦ ¦every¦ ¦fe w¦ ¦min u tes¦ ,▁ ¦all¦ ¦day¦ ¦long¦ .
𐋇¦t ry¦ ¦to¦ ¦do¦ ¦this¦ ¦less¦ ,▁ ¦and¦ ¦t ry¦ ¦to¦ ¦wash¦ ¦your¦ ¦hands¦ ¦before¦ ¦to uc hing¦ ¦your¦ ¦face¦ .
𐋇 ¦also¦ ,▁ ¦t ry¦ ¦to¦ ¦avoid¦ ¦to uc hing¦ ¦sur fa ces¦ ¦you¦ ¦d on¦ ' ¦t¦ ¦have¦ ¦to¦ ¦tou ch¦ ¦in¦ ¦the¦ ¦first¦ ¦place¦ ,▁ ¦at¦ ¦least¦ ¦with¦ ¦your¦ ¦b are¦ ¦hands¦ .
𐋇 ¦cough¦ ¦and¦ ¦s n ee z e¦ ¦into¦ ¦your¦ ¦el b ow¦ ¦or¦ ¦a¦ ¦ti ss ue¦ ,▁ ¦and¦ ¦then¦ ¦imm ed ia tely¦ ¦th r ow¦ ¦away¦ ¦the¦ ¦ti ss ue¦ ¦and¦ ¦wash¦ ¦your¦ ¦hands¦ .
𐋇¦d on¦ ' ¦t¦ ¦st and¦ ¦or¦ ¦si t¦ ¦n ear¦ ¦people¦ ¦who¦ ¦might¦ ¦be¦ ¦sick¦ .
𐋇¦stay¦ ¦at¦ ¦least¦ ¦one¦ ¦me ter¦ ▁–▁ ¦and¦ ¦ ide ally¦ ¦two¦ ¦meters¦ ▁( ¦si x¦ ¦fe et¦ ) ▁–▁ ¦away¦ .
𐋇¦as¦ ¦a¦ ¦qu ick¦ ¦way¦ ¦to¦ ¦ey e b all¦ ¦this¦ ¦dista nce¦ ,▁ ¦i ma g ine¦ ¦that¦ ¦you¦ ¦and¦ ¦the¦ ¦other¦ ¦person¦ ¦both¦ ¦rea ched¦ ¦your¦ ¦hands¦ ¦t ow ards¦ ¦each¦ ¦other¦ .
𐋇 ¦could¦ ¦you¦ ¦tou ch¦ ¦the¦ ¦other¦ ¦person¦ ' ¦s¦ ¦hand¦ ¦without¦ ¦ta king¦ ¦a¦ ¦ste p¦ ¦t ow ards¦ ¦that¦ ¦person¦ ?
𐋇¦if¦ ¦the¦ ¦a ns w er¦ ¦is¦ ¦y es¦ ,▁ ¦then¦ ¦you¦ ' ¦r e¦ ¦to o¦ ¦close¦ .
𐋇 ¦clean¦ ¦ob j ects¦ ¦and¦ ¦sur fa ces¦ ¦that¦ ¦a¦ ¦l ot¦ ¦of¦ ¦people¦ ¦tou ch¦ ,▁ ¦such¦ ¦as¦ ¦do or k n ob s¦ ,▁ ¦ph on es¦ ,▁ ¦and¦ ¦te le v is ion¦ ¦re mo tes¦ ¦with¦ ¦reg ular¦ ¦hou se ho ld¦ ¦c le an er¦ .
𐋇 ¦disinf ect¦ ¦the¦ ¦sur fa ces¦ ¦with¦ ¦a¦ ¦su it able¦ ¦disinf ect ant¦ ,▁ ¦such¦ ¦as¦ ¦di lu ted¦ ¦hou se ho ld¦ ¦ bl ea ch¦ .
𐋇¦stay¦ ¦home¦ ¦when¦ ¦you¦ ¦are¦ ¦sick¦ ,▁ ¦and¦ ¦avoid¦ ¦contact¦ ¦with¦ ¦other¦ ¦people¦ ¦until¦ ¦your¦ ¦symptoms¦ ¦are¦ ¦g one¦ .
𐋇¦do¦ ¦not¦ ¦share¦ ¦personal¦ ¦i tems¦ ¦that¦ ¦come¦ ¦into¦ ¦contact¦ ¦with¦ ¦s al iv a¦ ,▁ ¦such¦ ¦as¦ ¦t oo th b r us h es¦ ,▁ ¦e ating¦ ¦u tens il s¦ ,▁ ¦dr in ks¦ ,▁ ¦water¦ ¦b ot t les¦ ,▁ ¦and¦ ¦t ow els¦ .
𐋇¦the¦ ¦pract ice¦ ¦of¦ ¦ser ving¦ ¦yourself¦ ¦from¦ ¦a¦ ¦common¦ ¦pl ate¦ ¦with¦ ¦your¦ ¦ own¦ ¦ch op st ic ks¦ ,▁ ¦common¦ ¦in¦ ¦china¦ ,▁ ¦should¦ ¦be¦ ¦a v oi ded¦ .
𐋇 ¦g re et¦ ¦people¦ ¦without¦ ¦to uc hing¦ ¦them¦ .
𐋇 ¦avoid¦ ¦h u g s¦ ,▁ ¦k is ses¦ ,▁ ¦hand s h a k es¦ ,▁ ¦f ist¦ ¦b um ps¦ ,▁ ¦and¦ ¦any¦ ¦other¦ ¦contact¦ .
𐋇¦if¦ ¦it¦ ' ¦s¦ ¦imp os si ble¦ ¦to¦ ¦avoid¦ ¦contact¦ ,▁ ¦then¦ ¦wash¦ ¦your¦ ¦hands¦ ¦both¦ ¦before¦ ¦and¦ ¦after¦ .
𐋇¦it¦ ¦w on¦ ' ¦t¦ ¦protect¦ ¦you¦ ¦from¦ ¦the¦ ¦coronavirus¦ ,▁ ¦but¦ ¦it¦ ¦will¦ ¦part ially¦ ¦protect¦ ¦you¦ ¦from¦ ¦the¦ ¦flu¦ ,▁ ¦which¦ ¦rema ins¦ ¦a¦ ¦g rea ter¦ ¦risk¦ ¦than¦ ¦covid¦ - ¦19¦ ¦in¦ ¦many¦ ¦areas¦ .
𐋇¦this¦ ¦also¦ ¦sa ves¦ ¦you¦ ¦from¦ ¦un ne cess ary¦ ¦wor ry¦ ¦if¦ ¦you¦ ¦get¦ ¦the¦ ¦flu¦ ¦and¦ ¦th ink¦ ¦it¦ ¦might¦ ¦be¦ ¦the¦ ¦coronavirus¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦el d erly¦ ¦or¦ ¦o ther w ise¦ ¦in¦ ¦a¦ ¦high¦ - ¦risk¦ ¦group¦ ¦and¦ ¦can¦ ¦be¦ ¦vaccinated¦ ¦for¦ ¦pneumonia¦ ,▁ ¦get¦ ¦that¦ ¦vacc ination¦ .
𐋇¦it¦ ¦w on¦ ' ¦t¦ ¦protect¦ ¦you¦ ¦from¦ ¦viral¦ ¦pneumonia¦ ¦from¦ ¦covid¦ - ¦19¦ ,▁ ¦but¦ ¦some¦ ¦covid¦ - ¦19¦ ¦patients¦ ¦have¦ ¦d ied¦ ¦of¦ ¦ba ct er ial¦ ¦pneumonia¦ ¦that¦ ¦att ac ked¦ ¦their¦ ¦w ea k e ned¦ ¦lu ng s¦ ,▁ ¦so¦ ¦a¦ ¦pneumonia¦ ¦vacc ination¦ ¦could¦ ¦sa ve¦ ¦your¦ ¦l ife¦ .
𐋇¦w earing¦ ¦masks¦ ¦is¦ ¦recommended¦ ¦for¦ ¦those¦ ¦who¦ ¦are¦ ¦suspected¦ ¦of¦ ¦c arr ying¦ ¦of¦ ¦disease¦ ¦and¦ ¦those¦ ¦who¦ ¦are¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ ¦those¦ ¦infected¦ .
𐋇¦for¦ ¦those¦ ¦who¦ ¦are¦ ¦as ymptomatic¦ ,▁ ¦the¦ ¦who¦ ¦does¦ ¦not¦ ¦recomm end¦ ¦masks¦ ,▁ ¦th ough¦ ¦some¦ ¦national¦ ¦gover n ments¦ ¦do¦ .
𐋇¦w earing¦ ¦a¦ ¦mask¦ ¦of¦ ¦some¦ ¦k ind¦ ¦is¦ ¦required¦ ¦in¦ ¦some¦ ¦countries¦ ¦and¦ ¦c ities¦ ¦in¦ ¦an¦ ¦eff ort¦ ¦to¦ ¦reduce¦ ¦community¦ ¦transmission¦ .
𐋇¦there¦ ¦are¦ ¦worldwide¦ ¦sh or ta ges¦ ¦of¦ ¦sur g ical¦ ¦masks¦ .
𐋇¦if¦ ¦you¦ ¦do¦ ¦wear¦ ¦a¦ ¦mask¦ ,▁ ¦make¦ ¦sure¦ ¦to¦ ¦use¦ ¦it¦ ¦cor r ect ly¦ .
𐋇¦the¦ ¦mask¦ ¦should¦ ¦cover¦ ¦your¦ ¦nose¦ ¦and¦ ¦mouth¦ ¦and¦ ¦fi t¦ ¦without¦ ¦ga ps¦ .
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦before¦ ¦p ut ting¦ ¦on¦ ¦the¦ ¦mask¦ ¦and¦ ¦avoid¦ ¦to uc hing¦ ¦the¦ ¦mask¦ ¦while¦ ¦w earing¦ ¦it¦ .
𐋇¦if¦ ¦you¦ ¦do¦ ¦tou ch¦ ¦it¦ ,▁ ¦wash¦ ¦your¦ ¦hands¦ ¦imm ed ia tely¦ ¦a f t er w ards¦ .
𐋇¦when¦ ¦the¦ ¦mask¦ ¦bec omes¦ ¦da m p¦ ,▁ ¦disc ard¦ ¦and¦ ¦re pl ace¦ ¦it¦ .
𐋇 ¦re mo ve¦ ¦it¦ ¦from¦ ¦the¦ ¦b ack¦ ,▁ ¦th r ow¦ ¦it¦ ¦away¦ ,▁ ¦and¦ ¦then¦ ¦wash¦ ¦your¦ ¦hands¦ .
𐋇 ¦re me mber¦ ¦that¦ ¦masks¦ ¦are¦ ¦not¦ ¦a¦ ¦sub st it ute¦ ¦for¦ ¦g ood¦ ¦h yg ien e¦ :▁ 𐋇 ¦continue¦ ¦to¦ ¦wash¦ ¦your¦ ¦hands¦ ¦fre qu e ntly¦ .
𐋇¦d on¦ ' ¦t¦ ¦st oc k¦ ¦up¦ ¦on¦ ¦masks¦ ¦if¦ ¦you¦ ¦d on¦ ' ¦t¦ ¦need¦ ¦them¦ .
𐋇 ¦mask¦ ¦sh or ta ges¦ ¦me an¦ ¦that¦ ¦healthcare¦ ¦workers¦ ¦are¦ ¦having¦ ¦tr ou ble¦ ¦getting¦ ¦a¦ ¦ho ld¦ ¦of¦ ¦masks¦ ,▁ ¦which¦ ¦p u ts¦ ¦e veryone¦ ¦at¦ ¦risk¦ .
𐋇 ¦that¦ ¦inclu des¦ ¦n 9 5¦ ¦resp ir at ors¦ ,▁ ¦which¦ ¦are¦ ¦not¦ ¦recommended¦ ¦for¦ ¦the¦ ¦general¦ ¦public¦ ▁–▁ ¦these¦ ¦are¦ ¦spec i al ist¦ ¦equipment¦ ¦which¦ ¦must¦ ¦be¦ ¦f it ted¦ ¦to¦ ¦be¦ ¦o pt im ally¦ ¦effective¦ .
𐋇 ¦lea ve¦ ¦them¦ ¦for¦ ¦healthcare¦ ¦workers¦ .
𐋇 ¦avoid¦ ¦cr ow ded¦ ¦areas¦ ,▁ ¦especially¦ ¦e nc l osed¦ ¦areas¦ ¦without¦ ¦much¦ ¦air ¦ ¦c ir c ul ation¦ ,▁ ¦such¦ ¦as¦ ¦conf er en ces¦ ,▁ ¦per f orm an ces¦ ,▁ ¦shopping¦ ¦ma lls¦ ,▁ ¦public¦ ¦trans p ort ation¦ ,▁ ¦and¦ ¦rel ig ious¦ ¦services¦ .
𐋇 ¦events¦ ¦which¦ ¦invol ve¦ ¦a¦ ¦large¦ ¦sc a le¦ ¦ga th ering¦ ¦of¦ ¦people¦ ,▁ ¦from¦ ¦rel ig ious¦ ¦p il g ri ma ges¦ ¦to¦ ¦m us ic¦ ¦concer ts¦ ,▁ ¦are¦ ¦being¦ ¦cance l ed¦ ¦worldwide¦ ,▁ ¦in¦ ¦an¦ ¦eff ort¦ ¦to¦ ¦con tain¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇 ¦to ur ist¦ ¦att r ac tions¦ ,▁ ¦b us in es ses¦ ,▁ ¦and¦ ¦trans p ort ation¦ ¦may¦ ¦be¦ ¦closed¦ ,▁ ¦especially¦ ¦in¦ ¦affected¦ ¦countries¦ .
𐋇¦some¦ ¦cance l ed¦ ¦events¦ ,▁ ¦especially¦ ¦per f orm an ces¦ ,▁ ¦sp orting¦ ¦events¦ ,▁ ¦and¦ ¦cl as ses¦ ,▁ ¦are¦ ¦being¦ ¦m oved¦ ¦online¦ ,▁ ¦which¦ ¦me ans¦ ¦you¦ ¦can¦ ¦exp eri ence¦ ¦them¦ ¦without¦ ¦tra v el ing¦ .
𐋇 ¦at¦ ¦p et ro l¦ ▁/▁ ¦ga s¦ ¦st ations¦ ,▁ ¦use¦ ¦g lo ves¦ ¦or¦ ¦w ip e¦ ¦down¦ ¦the¦ ¦hand le¦ ¦with¦ ¦a¦ ¦disinf ect ant¦ ¦w ip e¦ ¦if¦ ¦you¦ ¦can¦ .
𐋇 ¦after¦ ¦fi lling¦ ¦up¦ ,▁ ¦clean¦ ¦your¦ ¦hands¦ ¦with¦ ¦hand¦ ¦s an itiz er¦ .
𐋇¦the¦ ¦u¦ . ¦s¦ .▁ ¦and¦ ¦ca na di an¦ ¦gover n ments¦ ¦recomm end¦ ¦a v oi ding¦ ¦travel¦ ¦by¦ ¦c ru ise¦ ¦s hi p¦ .
𐋇 ¦infections¦ ¦spread¦ ¦ ea si ly¦ ¦on¦ ¦ bo ard¦ ,▁ ¦and¦ ¦medical¦ ¦care¦ ¦is¦ ¦limi ted¦ .
𐋇 ¦a m id¦ ¦a¦ ¦c ru ise¦ ¦s hi p¦ ¦outbreak¦ ,▁ ¦qu ara nt ines¦ ¦and¦ ¦d oc king¦ ¦are¦ ¦cha ll en ging¦ ¦part ly¦ ¦due¦ ¦to¦ ¦the¦ ¦large¦ ¦number¦ ¦of¦ ¦people¦ ¦a bo ard¦ .
𐋇 ¦even¦ ¦c ru ise¦ ¦s hi ps¦ ¦without¦ ¦confirmed¦ ¦cases¦ ¦have¦ ¦been¦ ¦d en ied¦ ¦per mi ssion¦ ¦to¦ ¦d oc k¦ ¦due¦ ¦to¦ ¦virus¦ ¦f ear s¦ ,▁ ¦and¦ ¦in¦ ¦the¦ ¦high¦ - ¦pro f i le¦ ¦case¦ ¦of¦ ¦the¦ ¦d ia m on d¦ ¦pri nc ess¦ ¦in¦ ¦j ap an¦ ,▁ ¦h u nd re ds¦ ¦of¦ ¦people¦ ¦were¦ ¦infected¦ ¦on¦ ¦the¦ ¦s hi p¦ .
𐋇¦if¦ ¦you¦ ¦b el ie ve¦ ¦you¦ ¦may¦ ¦be¦ ¦infected¦ ,▁ ¦call¦ ¦a¦ ¦hospital¦ ¦or¦ ¦local¦ ¦emergency¦ ¦medical¦ ¦services¦ ¦inst ead¦ ¦of¦ ¦go ing¦ ¦in¦ ¦person¦ ¦to¦ ¦avoid¦ ¦inf ecting¦ ¦others¦ .
𐋇 ¦me nt ion¦ ¦your¦ ¦symptoms¦ ¦and¦ ¦travel¦ ¦h ist ory¦ .
𐋇 ¦wear¦ ¦a¦ ¦medical¦ ¦mask¦ ¦and¦ ¦follow¦ ¦the¦ ¦in str uc tions¦ ¦of¦ ¦author ities¦ ¦and¦ ¦do ctors¦ .
𐋇 ¦se e¦ ¦also¦ :▁ 𐋇¦f l ight¦ ¦and¦ ¦health¦
𐋇¦on¦ ¦a¦ ¦pl an e¦ ,▁ ¦follow¦ ¦the¦ ¦same¦ ¦h yg ien e¦ ¦practi ces¦ ¦as¦ ¦an y w h er e¦ ¦el se¦ :▁ 𐋇 ¦wash¦ ¦hands¦ ¦fre qu e ntly¦ ,▁ ¦or¦ ¦use¦ ¦al c o ho l¦ - ¦based¦ ¦hand¦ ¦s an itiz er¦ ¦if¦ ¦it¦ ' ¦s¦ ¦not¦ ¦con v en i ent¦ ¦to¦ ¦lea ve¦ ¦your¦ ¦se at¦ ,▁ ¦and¦ ¦avoid¦ ¦to uc hing¦ ¦your¦ ¦face¦ .
𐋇 ¦res ear ch ers¦ ¦have¦ ¦found¦ ¦that¦ ¦p as se ng ers¦ ¦in¦ ¦w i nd ow¦ ¦s ea ts¦ ¦have¦ ¦less¦ ¦risk¦ ¦of¦ ¦contact¦ ¦with¦ ¦sick¦ ¦people¦ .
𐋇¦t ry¦ ¦to¦ ¦b ook¦ ¦a¦ ¦w i nd ow¦ ¦se at¦ ,▁ ¦and¦ ¦avoid¦ ¦mo ving¦ ¦around¦ ¦the¦ ¦c ab in¦ ¦during¦ ¦the¦ ¦f l ight¦ .
𐋇 ¦after¦ ¦washing¦ ¦your¦ ¦hands¦ ¦and¦ ¦before¦ ¦s it ting¦ ¦down¦ ,▁ ¦use¦ ¦disinf ect ant¦ ¦w ip es¦ ¦to¦ ¦w ip e¦ ¦down¦ ¦the¦ ¦a rea¦ ¦around¦ ¦your¦ ¦se at¦ .
𐋇¦w ip e¦ ¦h ard¦ ¦sur fa ces¦ ,▁ ¦and¦ ¦if¦ ¦your¦ ¦se at¦ ¦is¦ ¦le at her¦ ¦you¦ ¦can¦ ¦w ip e¦ ¦that¦ ¦to o¦ .
𐋇¦d on¦ ' ¦t¦ ¦w ip e¦ ¦a¦ ¦c lo th¦ ¦se at¦ ,▁ ¦as¦ ¦the¦ ¦mo ist ure¦ ¦can¦ ¦make¦ ¦transmission¦ ¦ ea si er¦ .
𐋇¦when¦ ¦using¦ ¦disinf ect ant¦ ¦w ip es¦ ,▁ ¦follow¦ ¦the¦ ¦in str uc tions¦ ¦on¦ ¦the¦ ¦p ac k a ging¦ .
𐋇 ¦and¦ ¦re me mber¦ ,▁ ¦viruses¦ ¦en ter¦ ¦through¦ ¦your¦ ¦mouth¦ ,▁ ¦nose¦ ,▁ ¦and¦ ¦ey es¦ ▁–▁ ¦w ip ing¦ ¦down¦ ¦the¦ ¦a rea¦ ¦do es n¦ ' ¦t¦ ¦h ur t¦ ,▁ ¦but¦ ¦it¦ ' ¦s¦ ¦not¦ ¦a¦ ¦sub st it ute¦ ¦for¦ ¦prop er¦ ¦h yg ien e¦ .
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦and¦ ¦avoid¦ ¦to uc hing¦ ¦your¦ ¦face¦ .
𐋇 ¦and¦ ¦use¦ ¦a¦ ¦ti ss ue¦ ¦to¦ ¦tou ch¦ ¦the¦ ¦tou ch¦ ¦scre en¦ ¦or¦ ¦other¦ ¦contr ols¦ .
𐋇¦when¦ ¦using¦ ¦the¦ ¦la v atory¦ ,▁ ¦use¦ ¦p ap er¦ ¦t ow els¦ ¦to¦ ¦t ur n¦ ¦off ¦ ¦the¦ ¦fa uc et¦ ¦and¦ ¦open¦ ¦the¦ ¦ door¦ ,▁ ¦then¦ ¦th r ow¦ ¦them¦ ¦away¦ .
𐋇 ¦air l ines¦ ¦in¦ ¦affected¦ ¦areas¦ ¦are¦ ¦ta king¦ ¦ste ps¦ ¦to¦ ¦reduce¦ ¦transmission¦ ¦and¦ ¦keep¦ ¦p as se ng ers¦ ¦safe¦ .
𐋇¦for¦ ¦inst ance¦ ,▁ ¦these¦ ¦may¦ ¦include¦ ¦cl ea ning¦ ¦facil ities¦ ¦more¦ ¦fre qu e ntly¦ ,▁ ¦all owing¦ ¦f l ight¦ ¦att end a nts¦ ¦to¦ ¦wear¦ ¦masks¦ ,▁ ¦and¦ ¦ser ving¦ ¦pre p ac k a ged¦ ¦inst ead¦ ¦of¦ ¦fre s h ly¦ ¦he ated¦ ¦me als¦ .
𐋇¦if¦ ¦a¦ ¦group¦ ¦of¦ ¦p as se ng ers¦ ¦is¦ ¦con n ecting¦ ¦from¦ ¦an¦ ¦a rea¦ ¦with¦ ¦a¦ ¦severe¦ ¦outbreak¦ ,▁ ¦the¦ ¦f l ight¦ ¦att end a nts¦ ¦may¦ ¦be¦ ¦able¦ ¦to¦ ¦se at¦ ¦them¦ ¦away¦ ¦from¦ ¦the¦ ¦r est¦ ¦of¦ ¦the¦ ¦p as se ng ers¦ ▁( ¦and¦ ¦if¦ ¦you¦ ¦were¦ ¦rece ntly¦ ¦in¦ ¦a¦ ¦high¦ - ¦risk¦ ¦a rea¦ ,▁ ¦consid er¦ ¦te lling¦ ¦the¦ ¦f l ight¦ ¦att end a nts¦ ¦for¦ ¦this¦ ¦re as on¦ ).
𐋇¦you¦ ¦may¦ ¦be¦ ¦pro hi b i ted¦ ¦from¦ ¦chan ging¦ ¦s ea ts¦ ¦on¦ ¦the¦ ¦f l ight¦ .
𐋇¦this¦ ¦is¦ ¦so¦ ¦that¦ ,▁ ¦if¦ ¦someone¦ ¦on¦ ¦the¦ ¦f l ight¦ ¦t ur ns¦ ¦out¦ ¦to¦ ¦be¦ ¦infected¦ ,▁ ¦the¦ ¦author ities¦ ¦can¦ ¦tr ack¦ ¦down¦ ¦the¦ ¦people¦ ¦who¦ ¦were¦ ¦s it ting¦ ¦n ear¦ ¦them¦ ¦for¦ ¦testing¦ ¦or¦ ¦quarantine¦ .
𐋇¦covid¦ - ¦19¦ ¦is¦ ¦tre ated¦ ¦by¦ ¦rel ie ving¦ ¦symptoms¦ ¦and¦ ¦prev en ting¦ ¦co mpl ications¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦vaccine¦ ¦or¦ ¦specific¦ ¦treatment¦ ¦for¦ ¦the¦ ¦novel¦ ¦coronavirus¦ .
𐋇 ¦research¦ ¦into¦ ¦a¦ ¦vaccine¦ ¦or¦ ¦specific¦ ¦anti vir al¦ ¦drug¦ ¦is¦ ¦under w ay¦ .
𐋇¦there¦ ¦are¦ ¦a¦ ¦vari et y¦ ¦of¦ ¦trials¦ ¦using¦ ¦h iv ¦ ¦medic ations¦ ¦and¦ ¦other¦ ¦novel¦ ¦anti vir al¦ ¦medic ations¦ ¦for¦ ¦treatment¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇 ¦mild¦ ¦symptoms¦ ¦may¦ ¦be¦ ¦rel ie v ed¦ ¦by¦ ¦ta king¦ ¦p ara ce ta mo l¦ ▁( ¦a ce ta mi no ph en¦ ).
𐋇¦if¦ ¦you¦ ¦are¦ ¦infected¦ ¦with¦ ¦covid¦ - ¦19¦ ,▁ ¦countries¦ ¦will¦ ¦isol ate¦ ¦you¦ ¦until¦ ¦several¦ ¦cons ecu tive¦ ¦tests¦ ¦for¦ ¦covid¦ - ¦19¦ ¦are¦ ¦negative¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦been¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ ¦someone¦ ¦infected¦ ¦with¦ ¦covid¦ - ¦19¦ ,▁ ¦many¦ ¦countries¦ ¦will¦ ¦quarantine¦ ¦you¦ ¦for¦ ¦14¦ ¦days¦ ¦since¦ ¦the¦ ¦last¦ ¦exp osure¦ ¦and¦ ¦monit or¦ ¦you¦ ¦for¦ ¦signs¦ ¦and¦ ¦symptoms¦ .
𐋇¦some¦ ¦countries¦ ¦will¦ ¦also¦ ¦test¦ ¦you¦ ¦even¦ ¦if¦ ¦you¦ ¦d on¦ ' ¦t¦ ¦have¦ ¦symptoms¦ .
𐋇¦in¦ ¦many¦ ¦countries¦ ,▁ ¦the¦ ¦healthcare¦ ¦system¦ ¦has¦ ¦been¦ ¦ str et ched¦ ¦to¦ ¦the¦ ¦po in t¦ ¦of¦ ¦not¦ ¦being¦ ¦able¦ ¦to¦ ¦hand le¦ ¦the¦ ¦s he er¦ ¦number¦ ¦of¦ ¦patients¦ ,▁ ¦and¦ ¦there¦ ¦is¦ ¦a¦ ¦ch ance¦ ¦you¦ ¦may¦ ¦be¦ ¦ref u sed¦ ¦treatment¦ ¦due¦ ¦to¦ ¦the¦ ¦l ack¦ ¦of¦ ¦available¦ ¦medical¦ ¦staff¦ ,▁ ¦supp l ies¦ ¦or¦ ¦equipment¦ .
𐋇 ¦many¦ ¦countries¦ ¦have¦ ¦sh ut¦ ¦down¦ ¦or¦ ¦se ver ely¦ ¦limi ted¦ ¦f li gh ts¦ ,▁ ¦s hi ps¦ ,▁ ¦and¦ ¦ bor der¦ ¦c ro ss ings¦ ,▁ ¦especially¦ ¦to¦ ¦and¦ ¦from¦ ¦affected¦ ¦areas¦ .
𐋇 ¦even¦ ¦more¦ ¦countries¦ ¦have¦ ¦imp osed¦ ¦restrictions¦ ¦on¦ ¦ar ri ving¦ ¦tra v el ers¦ ,▁ ¦e it her¦ ¦b arr ing¦ ¦ent ry¦ ▁( ¦ma y b e¦ ¦with¦ ¦an¦ ¦ex ce ption¦ ¦for¦ ¦local¦ ¦c itiz ens¦ ¦and¦ ¦p erm an ent¦ ¦res id ents¦ )▁ ¦or¦ ¦requir ing¦ ¦you¦ ¦to¦ ¦be¦ ¦qu ara nt ined¦ ,▁ ¦typ ically¦ ¦for¦ ¦14¦ ¦days¦ .
𐋇 ¦even¦ ¦if¦ ¦a¦ ¦mand atory¦ ¦quarantine¦ ¦is¦ ¦not¦ ¦imp osed¦ ,▁ ¦you¦ ¦may¦ ¦be¦ ¦as ked¦ ¦to¦ ▁" ¦self¦ - ¦quarantine¦ "▁ ¦by¦ ¦sta ying¦ ¦at¦ ¦home¦ ¦and¦ ¦not¦ ¦inter ac ting¦ ¦with¦ ¦other¦ ¦people¦ .
𐋇¦the¦ ¦most¦ ¦severe¦ ¦restrictions¦ ¦are¦ ¦on¦ ¦tra ve ll ers¦ ¦who¦ ¦have¦ ¦rece ntly¦ ¦been¦ ¦to¦ ¦affected¦ ¦areas¦ ,▁ ¦but¦ ¦inc rea si ng ly¦ ¦many¦ ¦countries¦ ¦are¦ ¦app l ying¦ ¦them¦ ¦to¦ ¦inc om ing¦ ¦tra ve ll ers¦ ¦over all¦ .
𐋇¦some¦ ¦countries¦ ¦have¦ ¦even¦ ¦pro hi b i ted¦ ¦all¦ ¦or¦ ¦al m ost¦ ¦all¦ ¦fo re i gn ers¦ ¦from¦ ¦ent ry¦ ¦or¦ ¦limi ted¦ ¦the¦ ¦a bility¦ ¦of¦ ¦local¦ ¦c itiz ens¦ ¦and¦ ¦res id ents¦ ¦to¦ ¦lea ve¦ .
𐋇 ¦what¦ ¦are¦ ¦the¦ ¦affected¦ ¦areas¦ ?
𐋇 ¦well¦ ,▁ ¦this¦ ¦is¦ ¦a¦ ¦f ast¦ - ¦chan ging¦ ¦s itu ation¦ ,▁ ¦and¦ ¦each¦ ¦country¦ ▁/▁ ¦reg ion¦ ▁/▁ ¦organiz ation¦ ¦has¦ ¦its¦ ¦ own¦ ¦l ist¦ ¦of¦ ¦what¦ ¦areas¦ ¦are¦ ¦sub j ect¦ ¦to¦ ¦restrictions¦ .
𐋇¦the¦ ¦city¦ ¦of¦ ¦wuhan¦ ¦is¦ ¦on¦ ¦every¦ ¦l ist¦ ¦and¦ ¦the¦ ¦r est¦ ¦of¦ ¦main land¦ ¦china¦ ¦is¦ ¦on¦ ¦most¦ .
𐋇 ¦other¦ ¦areas¦ ¦that¦ ¦are¦ ¦often¦ ¦inclu ded¦ :▁ 𐋇¦f r ance¦ ,▁ ¦g erm an y¦ ,▁ ¦ho ng¦ ¦ko ng¦ ,▁ ¦iran¦ ,▁ ¦italy¦ ,▁ ¦j ap an¦ ,▁ ¦m ac a u¦ ,▁ ¦si ng ap ore¦ ,▁ ¦south¦ ¦ko rea¦ ,▁ ¦s pa in¦ ,▁ ¦t ai w an¦ ,▁ ¦the¦ ¦united¦ ¦ki ng d om¦ ,▁ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦the¦ ¦s che ng en¦ ¦a rea¦ ¦as¦ ¦a¦ ¦w ho le¦ ,▁ ¦and¦ ¦s om et im es¦ ¦v ar ious¦ ¦others¦ .
𐋇¦some¦ ¦countries¦ ¦have¦ ¦imp osed¦ ¦restrictions¦ ¦based¦ ¦on¦ ¦c itiz e ns hi p¦ ¦or¦ ¦res ide ncy¦ ¦from¦ ¦se ver ely¦ ¦affected¦ ¦areas¦ .
𐋇¦a¦ ¦detail ed¦ ¦l ist¦ ¦of¦ ¦ent ry¦ ¦restrictions¦ ¦is¦ ¦main ta ined¦ ¦by¦ ¦the¦ ¦i at a¦ .
𐋇¦it¦ ¦do es n¦ ' ¦t¦ ¦cover¦ ¦all¦ ¦the¦ ¦restrictions¦ ,▁ ¦but¦ ¦it¦ ' ¦s¦ ¦still¦ ¦u se ful¦ .
𐋇 ¦keep¦ ¦up¦ ¦to¦ ¦date¦ ▁ — ▁ ¦the¦ ¦outbreak¦ ¦and¦ ¦the¦ ¦travel¦ ¦restrictions¦ ¦are¦ ¦chan ging¦ ¦rap id ly¦ .
𐋇¦for¦ ¦travel¦ ¦in¦ ¦the¦ ¦n ear¦ ¦f ut ure¦ ,▁ ¦consid er¦ ¦ma king¦ ¦ref u nd able¦ ¦res erv ations¦ ¦in¦ ¦case¦ ¦the¦ ¦chan ging¦ ¦s itu ation¦ ¦for ces¦ ¦you¦ ¦to¦ ¦ch ange¦ ¦your¦ ¦pl ans¦ .
𐋇 ¦avoid¦ ¦bu ying¦ ¦t ick ets¦ ¦with¦ ¦a¦ ¦con ne ction¦ ¦in¦ ¦an¦ ¦affected¦ ¦a rea¦ ▁–▁ ¦even¦ ¦chan ging¦ ¦pl an es¦ ¦can¦ ¦make¦ ¦you¦ ¦sub j ect¦ ¦to¦ ¦restrictions¦ .
𐋇¦f li gh ts¦ ¦may¦ ¦get¦ ¦cance l ed¦ ¦with¦ ¦l it t le¦ ¦n ot ice¦ ,▁ ¦e it her¦ ¦due¦ ¦to¦ ¦the¦ ¦disease¦ ' ¦s¦ ¦spread¦ ¦and¦ ¦e ver¦ - ¦chan ging¦ ¦ent ry¦ ¦restrictions¦ ,▁ ¦or¦ ¦si mp ly¦ ¦because¦ ¦fe w er¦ ¦people¦ ¦are¦ ¦f l ying¦ ¦and¦ ¦air l ines¦ ¦are¦ ¦having¦ ¦tr ou ble¦ ¦fi lling¦ ¦s ea ts¦ .
𐋇¦you¦ ¦might¦ ¦also¦ ¦be¦ ¦de la y ed¦ ¦for¦ ¦hours¦ ¦up on¦ ¦arr iv al¦ ¦wai ting¦ ¦for¦ ¦temp erat ure¦ ¦chec ks¦ ¦and¦ ¦related¦ ¦proc ed ures¦ ¦and¦ ¦p ap er w or k¦ ,▁ ¦or¦ ¦even¦ ¦get¦ ¦qu ara nt ined¦ ¦for¦ ¦two¦ ¦weeks¦ .
𐋇 ¦be¦ ¦pre p ared¦ ¦for¦ ¦the¦ ¦p os si bility¦ ¦of¦ ¦dis ru ption¦ ¦to¦ ¦your¦ ¦travel¦ ¦pl ans¦ ,▁ ¦especially¦ ¦if¦ ¦tra v el ing¦ ¦inter na tion ally¦ .
𐋇 ¦even¦ ¦if¦ ¦you¦ ' ¦r e¦ ¦n ow h er e¦ ¦n ear¦ ¦affected¦ ¦areas¦ ¦there¦ ' ¦s¦ ¦a¦ ¦risk¦ ¦that¦ ¦you¦ ' ¦l l¦ ¦have¦ ¦to¦ ¦stay¦ ¦at¦ ¦the¦ ¦de st ination¦ ¦lo nger¦ ¦than¦ ¦pl an ned¦ ¦if¦ ¦you¦ ' ¦ ve¦ ¦sh ared¦ ¦a¦ ¦bu il ding¦ ¦or¦ ¦v es se l¦ ¦with¦ ¦an¦ ¦infected¦ ¦person¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦in¦ ¦l ate¦ ¦february¦ ¦an¦ ¦i tali an¦ ¦doctor¦ ¦on¦ ¦v ac ation¦ ¦in¦ ¦co st a¦ ¦a de j e¦ ▁( ¦c an ary¦ ¦ is l an ds¦ )▁ ¦was¦ ¦diagn osed¦ ¦with¦ ¦covid¦ - ¦19¦ ,▁ ¦and¦ ¦as¦ ¦a¦ ¦result¦ ¦all¦ ¦the¦ ¦gu e sts¦ ¦in¦ ¦the¦ ¦ho te l¦ ¦h e¦ ¦sta y ed¦ ¦at¦ ¦were¦ ¦qu ara nt ined¦ .
𐋇 ¦loc k d ow ns¦ ¦and¦ ¦other¦ ¦inter n al¦ ¦restrictions¦
𐋇¦some¦ ¦countries¦ ¦and¦ ¦regi ons¦ ,▁ ¦especially¦ ¦se ver ely¦ ¦affected¦ ¦ on es¦ ,▁ ¦are¦ ¦imp le m en ting¦ ¦emergency¦ ¦loc k d ow ns¦ ¦and¦ ¦restrictions¦ ¦on¦ ¦people¦ ' ¦s¦ ¦movements¦ ¦and¦ ¦activ ities¦ ,▁ ¦even¦ ¦for¦ ¦those¦ ¦who¦ ¦ha v en¦ ' ¦t¦ ¦rece ntly¦ ¦been¦ ¦ab ro ad¦ .
𐋇¦these¦ ¦include¦ ¦the¦ ¦temp or ary¦ ¦re i nt ro d u ction¦ ¦of¦ ¦some¦ ¦ bor der¦ ¦contr ols¦ ,▁ ¦restrictions¦ ¦on¦ ¦travel¦ ¦within¦ ¦the¦ ¦country¦ ,▁ ¦clos ing¦ ¦or¦ ¦limi ting¦ ¦service¦ ¦at¦ ¦res ta u ra nts¦ ¦and¦ ¦other¦ ¦ es ta bl is h ments¦ ,▁ ¦b an ning¦ ¦large¦ ¦public¦ ¦events¦ ,▁ ¦and¦ ¦in¦ ¦the¦ ¦most¦ ¦severe¦ ¦cases¦ ¦pro hi b i ting¦ ¦people¦ ¦from¦ ¦lea ving¦ ¦the¦ ¦house¦ ¦ex cep t¦ ¦for¦ ¦essential¦ ¦re as ons¦ .
𐋇 ¦be y on d¦ ¦government¦ ¦restrictions¦ ,▁ ¦ind iv id ual¦ ¦ es ta bl is h ments¦ ¦are¦ ¦sh ut ting¦ ¦their¦ ¦do ors¦ ¦and¦ ¦cance lling¦ ¦events¦ ¦to¦ ¦t ry¦ ¦to¦ ¦reduce¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦in¦ ¦china¦ ,▁ ¦there¦ ¦are¦ ¦ex tens ive¦ ¦restrictions¦ ¦on¦ ¦trans p ort ation¦ ¦and¦ ¦activ ity¦ ,▁ ¦which¦ ¦v ary¦ ¦wid ely¦ ¦by¦ ¦pro vi nce¦ ,▁ ¦city¦ ,▁ ¦and¦ ¦even¦ ¦by¦ ¦di stric t¦ ¦or¦ ¦ vi ll age¦ .
𐋇 ¦many¦ ¦gover n ments¦ ¦recomm end¦ ¦against¦ ¦tra v el ing¦ ¦to¦ ¦china¦ ¦at¦ ¦this¦ ¦time¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦no¦ ¦c ho ice¦ ,▁ ¦do¦ ¦your¦ ¦research¦ ¦and¦ ¦get¦ ¦up¦ - ¦to¦ - ¦date¦ ¦information¦ ¦about¦ ¦the¦ ¦local¦ ¦s itu ation¦ ¦w he re ver¦ ¦you¦ ¦are¦ ¦go ing¦ .
𐋇 ¦people¦ ¦who¦ ¦have¦ ¦tra v el ed¦ ¦to¦ ¦hub e i¦ ¦face¦ ¦partic ul arly¦ ¦severe¦ ¦restrictions¦ .
𐋇 ¦ex a mp les¦ ¦of¦ ¦restrictions¦ ¦that¦ ¦you¦ ¦may¦ ¦e nc o un ter¦ ¦in¦ ¦some¦ ¦par ts¦ ¦of¦ ¦china¦ ▁( ¦this¦ ¦is¦ ¦not¦ ¦an¦ ¦ex h a us tive¦ ¦l ist¦ ) :
¦14¦ - ¦day¦ ¦quarantine¦ ,▁ ¦self¦ - ¦quarantine¦ ,▁ ¦or¦ ¦covid¦ - ¦19¦ ¦test¦ ¦up on¦ ¦arr iv al¦ ¦from¦ ¦other¦ ¦par ts¦ ¦of¦ ¦china¦ ¦or¦ ¦from¦ ¦other¦ ¦countries¦ ,▁ ¦at¦ ¦your¦ ¦exp en se¦
𐋇 ¦qu es tions¦ ¦about¦ ¦your¦ ¦travel¦ ¦and¦ ¦medical¦ ¦h ist ory¦ ▁( ¦l ying¦ ¦can¦ ¦get¦ ¦you¦ ¦years¦ ¦in¦ ¦pr is on¦ )
𐋇 ¦mand atory¦ ¦regi str ation¦ ¦using¦ ¦an¦ ¦online¦ ¦or¦ ¦p ap er¦ ¦for m¦
𐋇 ¦requir e ment¦ ¦to¦ ¦wear¦ ¦a¦ ¦face¦ ¦mask¦ ¦in¦ ¦public¦
𐋇 ¦people¦ ¦who¦ ¦have¦ ¦been¦ ¦outside¦ ¦of¦ ¦china¦ ¦within¦ ¦14¦ ¦days¦ ¦not¦ ¦all owed¦ ¦into¦ ¦public¦ ¦places¦ ¦like¦ ¦ma lls¦
𐋇 ¦sho ps¦ ¦only¦ ¦ac cep t¦ ¦m ob i le¦ ¦pa y ments¦ ,▁ ¦not¦ ¦c as h ¦
𐋇 ¦res ta u ra nts¦ ,▁ ¦trans p ort ation¦ ¦and¦ ¦other¦ ¦ es ta bl is h ments¦ ¦ref us ing¦ ¦service¦ ¦to¦ ¦non¦ - ¦chinese¦ ¦c itiz ens¦
𐋇 ¦many¦ ¦for ms¦ ¦of¦ ¦trans p ort ation¦ ¦reduc ed¦ ¦or¦ ¦sh ut¦ ¦down¦
𐋇 ¦mand atory¦ ¦re al¦ - ¦na me¦ ¦regi str ation¦ ¦for¦ ¦public¦ ¦trans i t¦ ¦c ards¦
𐋇 ¦acc ess¦ ¦in¦ ¦and¦ ¦out¦ ¦of¦ ¦a¦ ¦t own¦ ,▁ ¦ vi ll age¦ ,▁ ¦or¦ ¦city¦ ¦comp le tely¦ ¦ bl oc ked¦
𐋇 ¦non¦ - ¦res ident¦ ¦visi t ors¦ ¦pro hi b i ted¦ ¦from¦ ¦ent ering¦ ¦a pa rt ment¦ ¦comp le x es¦
𐋇 ¦only¦ ¦all owed¦ ¦to¦ ¦go¦ ¦outside¦ ¦o nce¦ ¦every¦ ¦two¦ ¦days¦ ¦to¦ ¦get¦ ¦supp l ies¦
𐋇¦b us in es ses¦ ,▁ ¦activ ities¦ ,▁ ¦and¦ ¦att r ac tions¦ ¦closed¦
𐋇¦b us in es ses¦ ¦need¦ ¦local¦ ¦government¦ ¦per mi ssion¦ ¦to¦ ¦r e¦ - ¦open¦
𐋇 ¦res ta u ra nts¦ ▁( ¦if¦ ¦they¦ ¦are¦ ¦even¦ ¦open¦ )▁ ¦requir e¦ ¦a¦ ¦min im um¦ ¦dista nce¦ ¦between¦ ¦c u st om ers¦
𐋇 ¦se lling¦ ¦sub s ta nd ard¦ ¦face¦ ¦masks¦ ¦has¦ ¦a¦ ¦ma x im um¦ ¦se nt ence¦ ¦of¦ ¦l ife¦ ¦imp r is on ment¦
𐋇¦as¦ ¦of¦ ¦m id¦ - ¦march¦ ¦2020¦ ,▁ ¦e ur ope¦ ¦is¦ ¦the¦ ¦e p ic en ter¦ ¦of¦ ¦the¦ ¦epidemic¦ ,▁ ¦and¦ ¦many¦ ¦european¦ ¦countries¦ ¦have¦ ¦closed¦ ¦their¦ ¦ bor d ers¦ ¦to¦ ¦international¦ ¦travel¦ ▁-▁ ¦only¦ ¦ bor der¦ ¦comm ut ers¦ ¦and¦ ¦fre ight¦ ¦are¦ ¦all owed¦ ¦to¦ ¦c ross¦ .
𐋇 ¦also¦ ¦b us in es ses¦ ¦other¦ ¦than¦ ¦food¦ ¦st or es¦ ¦and¦ ¦ph arm ac ies¦ ¦are¦ ¦closed¦ ,▁ ¦and¦ ¦public¦ ¦transport¦ ¦has¦ ¦been¦ ¦reduc ed¦ ¦or¦ ¦sto pp ed¦ .
𐋇¦in¦ ¦the¦ ¦wor s t¦ ¦affected¦ ¦countries¦ ¦including¦ ¦italy¦ ,▁ ¦s pa in¦ ¦and¦ ¦fra nce¦ ,▁ ¦loc k d ow ns¦ ¦like¦ ¦in¦ ¦china¦ ¦in¦ ¦january¦ ,▁ ¦have¦ ¦been¦ ¦imp le m ented¦ .
𐋇¦as¦ ¦well¦ ¦the¦ ¦eu¦ ¦has¦ ¦closed¦ ¦its¦ ¦out er¦ ¦ bor d ers¦ .
𐋇¦covid¦ - ¦19¦ ¦is¦ ¦prev al ent¦ ¦also¦ ¦in¦ ¦n or th¦ ¦amer ica¦ .
𐋇¦the¦ ¦ bor d ers¦ ¦between¦ ¦ca na d a¦ ,▁ ¦the¦ ¦u¦ . ¦s¦ . ,▁ ¦and¦ ¦me x ic o¦ ¦are¦ ¦closed¦ ¦to¦ ¦non¦ - ¦essential¦ ¦travel¦ ,▁ ¦and¦ ¦in¦ ¦many¦ ¦areas¦ ¦b ans¦ ¦on¦ ¦bi g¦ ¦ga ther ings¦ ¦are¦ ¦in¦ ¦eff ect¦ ▁( ¦this¦ ¦me ans¦ ¦places¦ ¦like¦ ¦res ta u ra nts¦ ¦are¦ ¦closed¦ ,▁ ¦and¦ ¦events¦ ¦are¦ ¦cance l ed¦ ).
𐋇 ¦nu me ro us¦ ¦state¦ ,▁ ¦county¦ ,▁ ¦and¦ ¦m un ic ip al¦ ¦j ur is d ic tions¦ ¦have¦ ¦issued¦ ¦stay¦ - ¦at¦ - ¦home¦ ¦or d ers¦ ¦that¦ ¦requir e¦ ¦all¦ ¦n on es se ntial¦ ¦b us in es ses¦ ¦to¦ ¦close¦ .
𐋇 ¦with¦ ¦lo ts¦ ¦of¦ ¦f li gh ts¦ ¦cance l ed¦ ,▁ ¦w ar n ings¦ ¦issued¦ ,▁ ¦and¦ ¦restrictions¦ ¦imp osed¦ ,▁ ¦f l ying¦ ¦in¦ ¦the¦ ¦time¦ ¦of¦ ¦coronavirus¦ ¦can¦ ¦be¦ ¦a¦ ¦cha ll en ge¦ .
𐋇¦some¦ ¦r ou tes¦ ¦are¦ ¦not¦ ¦possible¦ .
𐋇 ¦others¦ ¦will¦ ¦requir e¦ ¦more¦ ¦inc on v en i ent¦ ¦con n ec tions¦ ¦than¦ ¦us ual¦ ▁ — ▁ ¦mult ip le¦ ¦sto ps¦ ¦and¦ ¦long¦ ¦wai ts¦ ¦between¦ ¦f li gh ts¦ .
𐋇¦in¦ ¦some¦ ¦cases¦ ¦that¦ ¦me ans¦ ¦more¦ ¦exp e ns ive¦ ¦t ick ets¦ .
𐋇¦on¦ ¦the¦ ¦other¦ ¦hand¦ ,▁ ¦the¦ ¦g ood¦ ¦new s¦ ¦is¦ ¦that¦ ¦many¦ ¦f li gh ts¦ ¦are¦ ¦ che ap er¦ ¦than¦ ¦us ual¦ ¦due¦ ¦to¦ ¦dec rea sed¦ ¦dem and¦ ,▁ ¦and¦ ¦there¦ ' ¦s¦ ¦a¦ ¦dec ent¦ ¦ch ance¦ ¦you¦ ' ¦l l¦ ¦get¦ ¦an¦ ¦e m pt y¦ ¦se at¦ ¦ne xt¦ ¦to¦ ¦you¦ .
𐋇 ¦bu i ld¦ ¦in¦ ¦ext r a¦ ¦time¦ ¦for¦ ¦your¦ ¦con n ec tions¦ ,▁ ¦especially¦ ¦if¦ ¦trans f er r ing¦ ¦from¦ ¦an¦ ¦international¦ ¦f l ight¦ ¦to¦ ¦a¦ ¦do me st ic¦ ¦f l ight¦ ¦and¦ ¦especially¦ ¦if¦ ¦your¦ ¦ it in er ary¦ ¦invol ves¦ ¦a¦ ¦country¦ ¦that¦ ' ¦s¦ ¦s eri o us ly¦ ¦affected¦ .
𐋇 ¦scre en ings¦ ,▁ ¦temp erat ure¦ ¦chec ks¦ ,▁ ¦ext r a¦ ¦p ap er w or k¦ ,▁ ¦and¦ ¦the¦ ¦associated¦ ¦wai ting¦ ¦around¦ ¦can¦ ¦ad d¦ ¦min u tes¦ ¦or¦ ¦hours¦ ¦before¦ ¦you¦ ' ¦r e¦ ¦all owed¦ ¦to¦ ¦continue¦ ¦on¦ ¦your¦ ¦jo ur ne y¦ .
𐋇¦you¦ ¦may¦ ¦f ind¦ ¦it¦ ¦h ar der¦ ¦than¦ ¦us ual¦ ¦to¦ ¦bu y¦ ¦a¦ ¦t ick et¦ ¦to¦ ¦or¦ ¦from¦ ¦a¦ ¦de st ination¦ ¦sub j ect¦ ¦to¦ ¦w ar n ings¦ ¦and¦ ¦restrictions¦ .
𐋇¦this¦ ¦is¦ ¦a¦ ¦re al¦ ¦concer n¦ ¦if¦ ¦you¦ ' ¦r e¦ ¦tr ying¦ ¦to¦ ¦get¦ ¦out¦ ¦of¦ ¦an¦ ¦affected¦ ¦a rea¦ .
𐋇¦for¦ ¦inst ance¦ ,▁ ¦most¦ ¦a gg re g at ors¦ ¦are¦ ¦not¦ ¦se lling¦ ¦t ick ets¦ ¦from¦ ¦china¦ ¦to¦ ¦the¦ ¦united¦ ¦states¦ ▁( ¦pres um ab ly¦ ¦to¦ ¦avoid¦ ¦fa lling¦ ¦a f ou l¦ ¦of¦ ¦restrictions¦ ¦and¦ ¦being¦ ¦on¦ ¦the¦ ¦h ook¦ ¦for¦ ¦a¦ ¦p as se nger¦ ' ¦s¦ ¦f l ight¦ ¦out¦ ).
𐋇¦to¦ ¦bu y¦ ¦a¦ ¦t ick et¦ ¦for¦ ¦an¦ ¦ it in er ary¦ ¦like¦ ¦this¦ ,▁ ¦you¦ ¦may¦ ¦have¦ ¦to¦ ¦contact¦ ¦the¦ ¦air line¦ ¦or¦ ¦use¦ ¦a¦ ¦le ss er¦ - ¦known¦ ¦a gg re g at or¦ .
𐋇 ¦another¦ ¦p os si bility¦ ¦is¦ ¦to¦ ¦bu y¦ ¦two¦ ¦separ ate¦ ¦t ick ets¦ ▁( ¦for¦ ¦inst ance¦ ,▁ ¦a¦ ¦t ick et¦ ¦from¦ ¦china¦ ¦to¦ ¦ca m bo d ia¦ ¦and¦ ¦a¦ ¦second¦ ¦t ick et¦ ¦from¦ ¦ca m bo d ia¦ ¦to¦ ¦the¦ ¦u¦ . ¦s¦ . ),▁ ¦but¦ ¦be¦ ¦ca re ful¦ ¦you¦ ¦w on¦ ' ¦t¦ ¦get¦ ¦qu ara nt ined¦ ¦or¦ ¦l ose¦ ¦your¦ ¦lu gg age¦ ¦in¦ ¦between¦ .
𐋇 ¦con n ecting¦ ¦f li gh ts¦ ¦can¦ ¦be¦ ¦a¦ ¦prob le m¦ .
𐋇¦the¦ ¦risk¦ ¦of¦ ¦getting¦ ¦st uc k¦ ¦in¦ ¦the¦ ¦con ne ction¦ ¦city¦ ¦is¦ ¦higher¦ ¦than¦ ¦us ual¦ ¦r ight¦ ¦n ow¦ ,▁ ¦due¦ ¦to¦ ¦del ays¦ ¦for¦ ¦scre ening¦ ¦and¦ ¦testing¦ ¦as¦ ¦well¦ ¦as¦ ¦ex tens ive¦ ¦cance ll ations¦ .
𐋇 ¦con n ecting¦ ¦in¦ ¦an¦ ¦affected¦ ¦a rea¦ ¦may¦ ¦l ead¦ ¦to¦ ¦ent ry¦ ¦restrictions¦ ¦later¦ ¦on¦ ,▁ ¦and¦ ¦if¦ ¦you¦ ' ¦ ve¦ ¦been¦ ¦in¦ ¦an¦ ¦affected¦ ¦a rea¦ ¦rece ntly¦ ¦some¦ ¦countries¦ ¦w on¦ ' ¦t¦ ¦even¦ ¦l et¦ ¦you¦ ¦ch ange¦ ¦pl an es¦ .
𐋇¦on¦ ¦c er tain¦ ¦ it in er ar ies¦ ¦there¦ ¦is¦ ¦a¦ ¦risk¦ ¦of¦ ¦getting¦ ¦qu ara nt ined¦ ¦so me w h er e¦ ¦a lo ng¦ ¦the¦ ¦way¦ .
𐋇 ¦so¦ ¦b ook¦ ¦a¦ ¦direct¦ ¦f l ight¦ ¦if¦ ¦you¦ ¦can¦ ,▁ ¦and¦ ¦if¦ ¦not¦ ,▁ ¦th ink¦ ¦ca re f ul ly¦ ¦about¦ ¦where¦ ¦to¦ ¦con n ect¦ .
𐋇¦in¦ ¦u nc er tain¦ ¦times¦ ,▁ ¦pl ans¦ ¦can¦ ¦ch ange¦ .
𐋇 ¦many¦ ¦e mb a ss ies¦ ¦and¦ ¦cons ul ates¦ ¦have¦ ¦ev ac u ated¦ ¦n on es se ntial¦ ¦staff¦ ,▁ ¦and¦ ¦some¦ ¦have¦ ¦sh ut¦ ¦down¦ ¦op er ations¦ ¦comp le tely¦ .
𐋇 ¦emergency¦ ¦ass ist ance¦ ¦should¦ ¦still¦ ¦be¦ ¦available¦ ,▁ ¦th ough¦ ¦it¦ ' ¦s¦ ¦possible¦ ¦you¦ ¦may¦ ¦have¦ ¦to¦ ¦contact¦ ¦a¦ ¦further¦ - ¦away¦ ¦cons ul ate¦ ¦if¦ ¦your¦ ¦local¦ ¦one¦ ¦has¦ ¦sh ut¦ ¦down¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦been¦ ¦stra nded¦ ¦due¦ ¦to¦ ¦the¦ ¦pandemic¦ ,▁ ¦your¦ ¦n ear est¦ ¦cons ul ate¦ ¦may¦ ¦be¦ ¦able¦ ¦to¦ ¦help¦ ¦you¦ ¦f ind¦ ¦a¦ ¦f l ight¦ ¦home¦ ,▁ ¦arr ange¦ ¦an¦ ¦emergency¦ ¦lo an¦ ¦so¦ ¦you¦ ¦can¦ ¦bu y¦ ¦a¦ ¦t ick et¦ ,▁ ¦or¦ ¦provide¦ ¦an¦ ¦emergency¦ ¦pa ss p ort¦ .
𐋇 ¦at¦ ¦the¦ ¦very¦ ¦least¦ ¦they¦ ¦can¦ ¦keep¦ ¦you¦ ¦in for med¦ ¦about¦ ¦the¦ ¦local¦ ¦s itu ation¦ ¦and¦ ¦n ot if y¦ ¦you¦ ¦about¦ ¦rece ntly¦ ¦int ro duc ed¦ ¦travel¦ ¦requir e ments¦ ¦and¦ ¦restrictions¦ .
𐋇 ¦or d in ary¦ ¦cons ular¦ ¦services¦ ¦such¦ ¦as¦ ¦v is a¦ ¦and¦ ¦pa ss p ort¦ ¦pro cess ing¦ ¦may¦ ¦be¦ ¦susp e nded¦ ¦or¦ ¦re stric ted¦ ¦to¦ ¦ ur g ent¦ ¦need¦ ,▁ ¦dep ending¦ ¦on¦ ¦the¦ ¦loc ation¦ ¦and¦ ¦the¦ ¦cons ul ate¦ .
𐋇 ¦al th ough¦ ¦some¦ ¦people¦ ¦call¦ ¦the¦ ¦disease¦ ▁" ¦wuhan¦ ¦pneumonia¦ " ▁( ¦ 武 汉 ¦ ▁( ¦ 漢 ¦ )▁ ¦ 肺 炎 ¦ ▁/▁ ¦ 武 肺 ¦ ),▁ " ¦wuhan¦ ¦disease¦ " ,▁ ¦or¦ ▁" ¦chinese¦ ¦virus¦ " ,▁ ¦the¦ ¦use¦ ¦of¦ ¦these¦ ¦ter ms¦ ¦is¦ ¦consid ered¦ ¦r ac ist¦ ¦in¦ ¦china¦ ¦and¦ ¦by¦ ¦many¦ ¦people¦ ¦of¦ ¦chinese¦ ¦orig in¦ .
𐋇¦it¦ ¦is¦ ¦still¦ ¦common¦ ¦to¦ ¦ref er¦ ¦the¦ ¦disease¦ ¦as¦ ▁" ¦wuhan¦ ¦pneumonia¦ "▁ ¦or¦ ▁" ¦chinese¦ ¦virus¦ "▁ ¦in¦ ¦places¦ ¦like¦ ¦ho ng¦ ¦ko ng¦ ¦and¦ ¦t ai w an¦ .
𐋇¦to¦ ¦be¦ ¦safe¦ ,▁ ¦use¦ ¦loc ation¦ - ¦ne ut r al¦ ¦ter ms¦ ¦when¦ ¦ref er r ing¦ ¦to¦ ¦the¦ ¦disease¦ ,▁ ¦such¦ ¦as¦ ▁" ¦covid¦ - ¦19¦ " , ▁" ¦novel¦ ¦coronavirus¦ " ,▁ ¦or¦ ¦j ust¦ ▁" ¦the¦ ¦virus¦ "▁ ¦or¦ ▁" ¦the¦ ¦pandemic¦ " .
𐋇 ¦partic ul arly¦ ¦in¦ ¦develop ing¦ ¦countries¦ ¦where¦ ¦la w¦ ¦en for ce ment¦ ¦are¦ ¦po or ly¦ ¦tra ined¦ ,▁ ¦en for ce ment¦ ¦of¦ ¦cur f e w¦ ,▁ ¦lockdown¦ ¦or¦ ¦stay¦ - ¦at¦ - ¦home¦ ¦or d ers¦ ¦are¦ ¦often¦ ¦br ut al¦ ,▁ ¦often¦ ¦using¦ ¦for ces¦ ¦not¦ ¦prop or tion ate¦ ¦against¦ ¦cr ow ds¦ .
𐋇 ¦comp ly¦ ¦with¦ ¦these¦ ¦or d ers¦ ,▁ ¦and¦ ¦avoid¦ ¦cr ow ds¦ ¦in¦ ¦public¦ .
𐋇¦as¦ ¦a¦ ¦result¦ ¦of¦ ¦the¦ ¦coronavirus¦ ¦pandemic¦ ,▁ ¦ x e no ph ob ia¦ ¦has¦ ¦r is en¦ ¦in¦ ¦many¦ ¦countries¦ ,▁ ¦pri ma ri ly¦ ¦but¦ ¦not¦ ¦ex c l us ively¦ ¦t ar ge ting¦ ¦people¦ ¦per ce iv ed¦ ¦to¦ ¦be¦ ¦chinese¦ .
𐋇¦there¦ ¦has¦ ¦been¦ ¦a¦ ¦worldwide¦ ¦sp i ke¦ ¦in¦ ¦r ac ist¦ ¦inc id ents¦ ¦t ar ge ting¦ ¦people¦ ¦of¦ ¦e ast¦ ¦a si an¦ ¦orig in¦ ,▁ ¦including¦ ¦in¦ ¦major¦ ¦c ities¦ ¦such¦ ¦as¦ ¦new¦ ¦y or k¦ ,▁ ¦l ond on¦ ¦and¦ ¦s an¦ ¦fra nc is c o¦ .
𐋇¦in¦ ¦ho ng¦ ¦ko ng¦ ,▁ ¦si no ph ob ia¦ ,▁ ¦which¦ ¦was¦ ¦al rea dy¦ ¦high¦ ¦to¦ ¦beg in¦ ¦with¦ ,▁ ¦has¦ ¦in tens if ied¦ ¦as¦ ¦a¦ ¦result¦ ¦of¦ ¦the¦ ¦pandemic¦ ,▁ ¦with¦ ¦the¦ ¦result¦ ¦that¦ ¦many¦ ¦sho ps¦ ¦and¦ ¦res ta u ra nts¦ ¦are¦ ¦n ow¦ ¦d en ying¦ ¦service¦ ¦to¦ ¦main land¦ ¦chinese¦ ¦c u st om ers¦ ¦and¦ ¦b an ning¦ ¦mand ar in¦ ¦sp ea k ers¦ ¦from¦ ¦their¦ ¦pre mi ses¦ ▁( ¦with¦ ¦the¦ ¦ex ce ption¦ ¦of¦ ¦t ai w a ne se¦ ).
𐋇 ¦le v els¦ ¦of¦ ¦ x e no ph ob ia¦ ¦have¦ ¦also¦ ¦r is en¦ ¦in¦ ¦e ast¦ ¦as ia¦ ,▁ ¦with¦ ¦some¦ ¦res ta u ra nts¦ ¦and¦ ¦other¦ ¦b us in es ses¦ ¦in¦ ¦j ap an¦ ¦and¦ ¦china¦ ¦ref us ing¦ ¦service¦ ¦to¦ ¦fo re ign¦ ¦c u st om ers¦ .
𐋇¦in¦ ¦china¦ ,▁ ¦there¦ ¦have¦ ¦been¦ ¦inc id ents¦ ¦of¦ ¦fo re i gn ers¦ ¦being¦ ¦ref u sed¦ ¦r oo ms¦ ¦by¦ ¦ho te l¦ ¦staff¦ ,▁ ¦and¦ ¦fo re ign¦ ¦res id ents¦ ,▁ ¦partic ul arly¦ ¦ bl ack¦ ¦people¦ ,▁ ¦being¦ ¦k ic ked¦ ¦out¦ ¦of¦ ¦their¦ ¦a pa rt ments¦ ¦on¦ ¦sh ort¦ ¦n ot ice¦ ¦by¦ ¦their¦ ¦la nd l or ds¦ .
𐋇 ¦sour ces¦ ¦for¦ ¦further¦ ¦information¦ ¦on¦ ¦the¦ ¦coronavirus¦ ¦outbreak¦ ¦include¦ :
𐋇¦the¦ ¦us¦ ¦government¦ ¦ce nt ers¦ ¦for¦ ¦disease¦ ¦control¦ ¦and¦ ¦pre vention¦
𐋇 ¦european¦ ¦centre¦ ¦for¦ ¦disease¦ ¦pre vention¦ ¦and¦ ¦control¦ ▁( ¦daily¦ ¦up d ates¦ )
𐋇 ¦united¦ ¦ki ng d om¦ ¦government¦ , ▁-▁ ¦fo re ign¦ ¦and¦ ¦comm on we al th¦ ¦off ice¦ ¦advice¦ ¦for¦ ¦tra ve ll ers¦
𐋇 ¦an¦ ¦online¦ ¦ma p¦ ¦and¦ ¦d as h bo ard¦ ¦from¦ ¦the¦ ¦jo h n¦ ¦h op k ins¦ ¦univers ity¦ ¦center¦ ¦for¦ ¦sys tems¦ ¦sc i ence¦ ¦and¦ ¦e ng i ne ering¦ ¦with¦ ¦live¦ ¦up d ates¦
𐋇 ¦part ial¦ ¦li sts¦ ¦of¦ ¦ent ry¦ ¦restrictions¦ ¦from¦ ¦i at a¦ ¦and¦ ¦the¦ ¦new¦ ¦y or k¦ ¦times¦
𐋇¦a¦ ¦vari et y¦ ¦of¦ ¦m is in f orm ation¦ ¦and¦ ¦cons p ir acy¦ ¦the or ies¦ ¦about¦ ¦the¦ ¦virus¦ ¦are¦ ¦being¦ ¦pro mo ted¦ ¦online¦ ¦and¦ ¦even¦ ¦by¦ ¦some¦ ¦government¦ ¦off ici als¦ ,▁ ¦so¦ ¦be¦ ¦ca re ful¦ ¦which¦ ¦sour ces¦ ¦you¦ ¦ch eck¦ ¦for¦ ¦information¦ .
𐋇¦e ns ure¦ ¦that¦ ¦all¦ ¦information¦ ¦and¦ ¦advice¦ ¦you¦ ¦receive¦ ¦has¦ ¦been¦ ¦b ac ked¦ ¦by¦ ¦rep ut able¦ ¦do ctors¦ ¦and¦ ¦sc ien ti sts¦ .
𐋇¦in¦ ¦a¦ ¦c ri sis¦ ,▁ ¦it¦ ' ¦s¦ ¦nat ural¦ ¦to¦ ¦w ant¦ ¦to¦ ¦keep¦ ¦following¦ ¦the¦ ¦l at est¦ ¦up d ates¦ ,▁ ¦but¦ ¦it¦ ¦may¦ ¦be¦ ¦bet ter¦ ¦for¦ ¦your¦ ¦me ntal¦ ¦health¦ ¦to¦ ¦mod er ate¦ ¦the¦ ¦a mo un t¦ ¦of¦ ¦new s¦ ¦that¦ ¦you¦ ¦l ook¦ ¦at¦ ,▁ ¦and¦ ¦st ick¦ ¦to¦ ¦re li able¦ ¦new s¦ ¦sour ces¦ .
𐋇¦if¦ ¦you¦ ¦n orm ally¦ ¦w at ch¦ ¦the¦ ¦new s¦ ¦t w ice¦ ¦per¦ ¦day¦ ¦then¦ ¦st ick¦ ¦to¦ ¦this¦ ¦s ch ed u le¦ ¦and¦ ¦do¦ ¦so me thing¦ ¦el se¦ ,▁ ¦r at her¦ ¦than¦ ¦having¦ ¦the¦ ¦24¦ - ¦hou r¦ ¦new s¦ ¦on¦ ¦contin u o us ly¦ .
𐋇¦b ¦ ' ¦bat¦ ¦sars¦ - ¦like¦ ¦coronavirus¦ ¦w iv 1¦ ▁( ¦bat¦ ¦s l¦ - ¦cov¦ - ¦w iv 1¦ ),▁ ¦also¦ ¦s om et im es¦ ¦called¦ ¦sars¦ - ¦like¦ ¦coronavirus¦ ¦w iv 1¦ ,▁ ¦is¦ ¦a¦ ¦stra in¦ ¦of¦ ¦severe¦ ¦acute¦ ¦respiratory¦ ¦syndrome¦ - ¦related¦ ¦coronavirus¦ ▁( ¦sa rs r¦ - ¦cov¦ )▁ ¦isol ated¦ ¦from¦ ¦chinese¦ ¦ ru f o us¦ ¦ho rs es ho e¦ ¦bats¦ ▁( ¦r hi no lo ph us¦ ¦s in ic us¦ ).
𐋇 ¦like¦ ¦all¦ ¦coronaviruses¦ ,▁ ¦vir i ons¦ ¦cons ist¦ ¦of¦ ¦si ng le¦ - ¦stra nded¦ ¦positive¦ - ¦sen se¦ ¦rna¦ ¦e nc l osed¦ ¦within¦ ¦an¦ ¦en v el ope¦ .
𐋇¦the¦ ¦disc o ve ry¦ ¦conf ir ms¦ ¦that¦ ¦bats¦ ¦are¦ ¦the¦ ¦nat ural¦ ¦res erv oi r¦ ¦of¦ ¦sars¦ - ¦cov¦ .
𐋇 ¦ph y l ogen et ic¦ ¦anal y sis¦ ¦sh ow s¦ ¦the¦ ¦p os si bility¦ ¦of¦ ¦direct¦ ¦transmission¦ ¦of¦ ¦sars¦ ¦from¦ ¦bats¦ ¦to¦ ¦humans¦ ¦without¦ ¦the¦ ¦inter me di ary¦ ¦chinese¦ ¦c iv ets¦ ,▁ ¦as¦ ¦previously¦ ¦b el ie v ed¦ .
𐋇¦b ¦ ' ¦covid¦ - ¦19¦ ¦drug¦ ¦development¦ ¦is¦ ¦the¦ ¦research¦ ¦proc ess¦ ¦to¦ ¦develop ¦ ¦a¦ ¦pre vent ative¦ ¦vaccine¦ ¦or¦ ¦ ther ap e ut ic¦ ¦pr esc ri ption¦ ¦drug¦ ¦that¦ ¦would¦ ¦al le vi ate¦ ¦the¦ ¦se ver ity¦ ¦of¦ ¦2019¦ - ¦20¦ ¦coronavirus¦ ¦disease¦ ▁( ¦covid¦ - ¦19¦ ).
𐋇¦the¦ ¦international¦ ¦clinical¦ ¦trials¦ ¦reg ist ry¦ ¦pl at for m¦ ¦of¦ ¦the¦ ¦who¦ ¦recor ded¦ ¦5 3 6¦ ¦clinical¦ ¦st u dies¦ ¦to¦ ¦develop ¦ ¦p ost¦ - ¦infection¦ ¦ ther ap ies¦ ¦for¦ ¦covid¦ - ¦19¦ ¦infections¦ ,▁ ¦with¦ ¦nu me ro us¦ ¦ es ta bl ished¦ ¦anti vir al¦ ¦comp o un ds¦ ¦for¦ ¦tre ating¦ ¦other¦ ¦infections¦ ¦under¦ ¦clinical¦ ¦research¦ ¦to¦ ¦be¦ ¦rep ur p osed¦ .
𐋇¦in¦ ¦march¦ ,▁ ¦the¦ ¦who¦ ¦in i ti ated¦ ¦the¦ ▁" ¦s ol id ar ity¦ ¦tr ial¦ "▁ ¦in¦ ¦10¦ ¦countries¦ ,▁ ¦en ro lling¦ ¦t ho us an ds¦ ¦of¦ ¦people¦ ¦infected¦ ¦with¦ ¦covid¦ - ¦19¦ ¦to¦ ¦ass ess¦ ¦treatment¦ ¦eff ects¦ ¦of¦ ¦four¦ ¦ex is ting¦ ¦anti vir al¦ ¦comp o un ds¦ ¦with¦ ¦the¦ ¦most¦ ¦pr om ise¦ ¦of¦ ¦eff ic acy¦ .
𐋇¦a¦ ¦d y na m ic¦ ,▁ ¦sys te m at ic¦ ¦re v ie w¦ ¦was¦ ¦ es ta bl ished¦ ¦in¦ ¦april¦ ¦2020¦ ¦to¦ ¦tr ack¦ ¦the¦ ¦pr og r ess¦ ¦of¦ ¦reg ist ered¦ ¦clinical¦ ¦trials¦ ¦for¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦and¦ ¦ ther ap e ut ic¦ ¦drug¦ ¦ca nd id ates¦ . ¦vaccine¦ ¦and¦ ¦drug¦ ¦development¦ ¦is¦ ¦a¦ ¦mult is te p¦ ¦proc ess¦ ,▁ ¦typ ically¦ ¦requir ing¦ ¦more¦ ¦than¦ ¦five¦ ¦years¦ ¦to¦ ¦ass ure¦ ¦safety¦ ¦and¦ ¦eff ic acy¦ ¦of¦ ¦the¦ ¦new¦ ¦comp o un d¦ .
𐋇 ¦drug¦ ¦development¦ ¦is¦ ¦the¦ ¦proc ess¦ ¦of¦ ¦bringing¦ ¦a¦ ¦new¦ ¦infectious¦ ¦disease¦ ¦vaccine¦ ¦or¦ ¦ ther ap e ut ic¦ ¦drug¦ ¦to¦ ¦the¦ ¦mark et¦ ¦o nce¦ ¦a¦ ¦l ead¦ ¦comp o un d¦ ¦has¦ ¦been¦ ¦identified¦ ¦through¦ ¦the¦ ¦proc ess¦ ¦of¦ ¦drug¦ ¦disc o ve ry¦ .
𐋇¦it¦ ¦inclu des¦ ¦laboratory¦ ¦research¦ ¦on¦ ¦m ic ro or g an is ms¦ ¦and¦ ¦anim als¦ ,▁ ¦f il ing¦ ¦for¦ ¦regul atory¦ ¦st at us¦ ,▁ ¦such¦ ¦as¦ ¦v ia¦ ¦the¦ ¦f d a¦ ,▁ ¦for¦ ¦an¦ ¦in ve st ig a tional¦ ¦new¦ ¦drug¦ ¦to¦ ¦in i ti ate¦ ¦clinical¦ ¦trials¦ ¦on¦ ¦humans¦ ,▁ ¦and¦ ¦may¦ ¦include¦ ¦the¦ ¦ste p¦ ¦of¦ ¦ob t aining¦ ¦regul atory¦ ¦appr ov al¦ ¦with¦ ¦a¦ ¦new¦ ¦drug¦ ¦app l ic ation¦ ¦to¦ ¦mark et¦ ¦the¦ ¦drug¦ .
𐋇 ¦development¦ ¦of¦ ¦a¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦or¦ ¦ ther ap e ut ic¦ ¦anti vir al¦ ¦drug¦ ¦beg ins¦ ¦with¦ ¦m at c hing¦ ¦a¦ ¦ che m ical¦ ¦con cep t¦ ¦to¦ ¦the¦ ¦pote ntial¦ ¦pro ph y la ct ic¦ ¦me ch an is m¦ ¦of¦ ¦the¦ ¦f ut ure¦ ¦vaccine¦ ¦or¦ ¦anti vir al¦ ¦activ ity¦ ¦in¦ ¦v iv o¦ .
𐋇 ¦new¦ ¦ che m ical¦ ¦ent ities¦ ▁( ¦n ces¦ ,▁ ¦also¦ ¦known¦ ¦as¦ ¦new¦ ¦m ol ec ular¦ ¦ent ities¦ ¦or¦ ¦n m es¦ )▁ ¦are¦ ¦comp o un ds¦ ¦that¦ ¦e mer ge¦ ¦from¦ ¦the¦ ¦proc ess¦ ¦of¦ ¦drug¦ ¦disc o ve ry¦ ¦to¦ ¦spec if y¦ ¦a¦ ¦vaccine¦ ¦or¦ ¦anti vir al¦ ¦ca nd id ate¦ .
𐋇¦these¦ ¦have¦ ¦pr om ising¦ ¦activ ity¦ ¦against¦ ¦a¦ ¦bi ological¦ ¦t arg et¦ ¦related¦ ¦to¦ ¦covid¦ - ¦19¦ ¦disease¦ .
𐋇 ¦at¦ ¦the¦ ¦beg in ning¦ ¦of¦ ¦vaccine¦ ¦or¦ ¦drug¦ ¦development¦ ,▁ ¦l it t le¦ ¦is¦ ¦known¦ ¦about¦ ¦the¦ ¦safety¦ ,▁ ¦to x ic ity¦ ,▁ ¦ph arm ac o k in et ics¦ ,▁ ¦and¦ ¦met ab ol is m¦ ¦of¦ ¦the¦ ¦ nce¦ ¦in¦ ¦humans¦ .
𐋇¦it¦ ¦is¦ ¦the¦ ¦f un ction¦ ¦and¦ ¦o bl ig ation¦ ¦of¦ ¦drug¦ ¦development¦ ¦to¦ ¦ass ess¦ ¦all¦ ¦of¦ ¦these¦ ¦p ara m et ers¦ ¦pri or¦ ¦to¦ ¦human¦ ¦clinical¦ ¦trials¦ ¦to¦ ¦pro ve¦ ¦safety¦ ¦and¦ ¦eff ic acy¦ .
𐋇¦a¦ ¦further¦ ¦major¦ ¦ob j ective¦ ¦of¦ ¦drug¦ ¦development¦ ¦is¦ ¦to¦ ¦recomm end¦ ¦the¦ ¦d ose¦ ¦and¦ ¦s ch ed u le¦ ¦for¦ ¦the¦ ¦first¦ ¦use¦ ¦in¦ ¦a¦ ¦human¦ ¦clinical¦ ¦tr ial¦ ▁( " ¦first¦ - ¦in¦ - ¦human¦ "▁ [ ¦fi h ¦ ] ▁ ¦or¦ ¦first¦ ¦human¦ ¦d ose¦ ▁ [ ¦f h d¦ ] ,▁ ¦previously¦ ¦also¦ ¦known¦ ¦as¦ ▁" ¦first¦ - ¦in¦ - ¦m an¦ "▁ [ ¦fi m¦ ] ).
𐋇¦in¦ ¦add ition¦ ,▁ ¦drug¦ ¦development¦ ¦must¦ ¦ es ta bl ish¦ ¦the¦ ¦ph ys ic o che m ical¦ ¦prop e rt ies¦ ¦of¦ ¦the¦ ¦ nce¦ :▁ 𐋇 ¦its¦ ¦ che m ical¦ ¦ma k e u p¦ ,▁ ¦sta bility¦ ,▁ ¦and¦ ¦so lu bility¦ .
𐋇¦m an u fa ct ur ers¦ ¦must¦ ¦o pt im iz e¦ ¦the¦ ¦proc ess¦ ¦they¦ ¦use¦ ¦to¦ ¦make¦ ¦the¦ ¦ che m ical¦ ¦so¦ ¦they¦ ¦can¦ ¦sc a le¦ ¦up¦ ¦from¦ ¦a¦ ¦medic in al¦ ¦ che m ist¦ ¦produc ing¦ ¦mi ll ig ra ms¦ ,▁ ¦to¦ ¦m an u fa ct ur ing¦ ¦on¦ ¦the¦ ¦k il ogra m¦ ¦and¦ ¦t on¦ ¦sc a le¦ .
𐋇¦they¦ ¦further¦ ¦ex a m ine¦ ¦the¦ ¦produc t¦ ¦for¦ ¦su i ta bility¦ ¦to¦ ¦p ac k age¦ ¦as¦ ¦c ap s u les¦ ,▁ ¦ta bl ets¦ ,▁ ¦a er os o l¦ ,▁ ¦int ra m us c ular¦ ¦in j ect able¦ ,▁ ¦sub c u ta ne o us¦ ¦in j ect able¦ ,▁ ¦or¦ ¦int ra ve no us¦ ¦f orm ul ations¦ .
𐋇¦t og ether¦ ,▁ ¦these¦ ¦proc es ses¦ ¦are¦ ¦known¦ ¦in¦ ¦pr ec l in ical¦ ¦and¦ ¦clinical¦ ¦development¦ ¦as¦ ¦ che m ist ry¦ ,▁ ¦m an u fa ct ur ing¦ ,▁ ¦and¦ ¦control¦ ▁( ¦c m c¦ )▁ . ¦many¦ ¦as p ects¦ ¦of¦ ¦drug¦ ¦development¦ ¦f oc us¦ ¦on¦ ¦s at is f ying¦ ¦the¦ ¦regul atory¦ ¦requir e ments¦ ¦of¦ ¦drug¦ ¦li ce ns ing¦ ¦author ities¦ .
𐋇¦these¦ ¦gener ally¦ ¦con st it ute¦ ¦tests¦ ¦d es ig ned¦ ¦to¦ ¦det erm ine¦ ¦the¦ ¦major¦ ¦to x ic ities¦ ¦of¦ ¦a¦ ¦novel¦ ¦comp o un d¦ ¦pri or¦ ¦to¦ ¦first¦ ¦use¦ ¦in¦ ¦humans¦ .
𐋇¦the¦ ¦ca na di an¦ ¦government¦ ¦announced¦ ¦c a¦ ▁ $ ¦2 7 5¦ ¦million¦ ¦in¦ ¦f un ding¦ ¦for¦ ¦9 6¦ ¦research¦ ¦pro j ects¦ ¦on¦ ¦medical¦ ¦cou nt er me as ures¦ ¦against¦ ¦covid¦ - ¦19¦ ,▁ ¦including¦ ¦nu me ro us¦ ¦vaccine¦ ¦ca nd id ates¦ ¦at¦ ¦ca na di an¦ ¦univers ities¦ ,▁ ¦with¦ ¦pl ans¦ ¦to¦ ¦ es ta bl ish¦ ¦a¦ ▁" ¦vaccine¦ ¦b an k¦ "▁ ¦of¦ ¦new¦ ¦vaccines¦ ¦for¦ ¦imp le me nt ation¦ ¦if¦ ¦another¦ ¦coronavirus¦ ¦outbreak¦ ¦occur s¦ .
𐋇 ¦clinical¦ ¦tr ial¦ ¦pr ogra ms¦ ¦invol ve¦ ¦three¦ ,▁ ¦mult ip le¦ - ¦year¦ ¦sta ges¦ ¦t ow ard¦ ¦produc t¦ ¦appr ov al¦ ,▁ ¦and¦ ¦a¦ ¦fo ur th¦ ,▁ ¦p ost¦ - ¦appr ov al¦ ¦st age¦ ¦for¦ ¦o ng o ing¦ ¦safety¦ ¦monit or ing¦ ¦of¦ ¦the¦ ¦vaccine¦ ¦or¦ ¦drug¦ ¦ ther ap y¦ :
𐋇 ¦ph ase¦ ¦i¦ ¦trials¦ ,▁ ¦us ually¦ ¦in¦ ¦healthy¦ ¦v ol un te ers¦ ,▁ ¦det erm ine¦ ¦safety¦ ¦and¦ ¦d os ing¦ .
𐋇 ¦ph ase¦ ¦i i¦ ¦trials¦ ¦are¦ ¦used¦ ¦to¦ ¦ es ta bl ish¦ ¦an¦ ¦in it ial¦ ¦rea ding¦ ¦of¦ ¦eff ic acy¦ ¦and¦ ¦further¦ ¦ex pl ore¦ ¦safety¦ ¦in¦ ¦sm all¦ ¦nu mbers¦ ¦of¦ ¦people¦ ¦having¦ ¦the¦ ¦disease¦ ¦t ar ge ted¦ ¦by¦ ¦the¦ ¦ nce¦ .
𐋇 ¦ph ase¦ ¦i i i¦ ¦trials¦ ¦are¦ ¦large¦ ,▁ ¦p iv ot al¦ ¦trials¦ ¦to¦ ¦det erm ine¦ ¦safety¦ ¦and¦ ¦eff ic acy¦ ¦in¦ ¦su ff ic ie ntly¦ ¦large¦ ¦nu mbers¦ ¦of¦ ¦people¦ ¦with¦ ¦the¦ ¦covid¦ - ¦19¦ ¦infection¦ .
𐋇¦if¦ ¦safety¦ ¦and¦ ¦eff ic acy¦ ¦are¦ ¦a de qu a tely¦ ¦pr oved¦ ,▁ ¦clinical¦ ¦testing¦ ¦may¦ ¦sto p¦ ¦at¦ ¦this¦ ¦ste p¦ ¦and¦ ¦the¦ ¦ nce¦ ¦ad v an ces¦ ¦to¦ ¦the¦ ¦new¦ ¦drug¦ ¦app l ic ation¦ ▁( ¦ nd a¦ )▁ ¦st age¦ ¦to¦ ¦beg in¦ ¦mark e ting¦ .
𐋇 ¦ph ase¦ ¦ iv ¦ ¦trials¦ ¦are¦ ¦p ost¦ - ¦appr ov al¦ ¦trials¦ ¦that¦ ¦may¦ ¦be¦ ¦a¦ ¦c ond ition¦ ¦att a ched¦ ¦by¦ ¦the¦ ¦f d a¦ ,▁ ¦also¦ ¦called¦ ¦p ost¦ - ¦mark et¦ ¦surveillance¦ ¦st u dies¦ .
𐋇¦in¦ ¦add ition¦ ¦to¦ ¦the¦ ¦tests¦ ¦required¦ ¦to¦ ¦mo ve¦ ¦a¦ ¦novel¦ ¦vaccine¦ ¦or¦ ¦anti vir al¦ ¦drug¦ ¦into¦ ¦the¦ ¦cl in ic¦ ¦for¦ ¦the¦ ¦first¦ ¦time¦ ,▁ ¦m an u fa ct ur ers¦ ¦must¦ ¦e ns ure¦ ¦that¦ ¦any¦ ¦long¦ - ¦ter m¦ ¦or¦ ¦ch r on ic¦ ¦to x ic ities¦ ¦are¦ ¦well¦ - ¦def ined¦ ,▁ ¦including¦ ¦eff ects¦ ¦on¦ ¦sys tems¦ ¦not¦ ¦previously¦ ¦monit or ed¦ ▁( ¦fe rt il ity¦ ,▁ ¦rep ro d u ction¦ ,▁ ¦immune¦ ¦system¦ ,▁ ¦among¦ ¦others¦ ).
𐋇¦in¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦this¦ ¦proc ess¦ ¦is¦ ¦called¦ ¦a¦ ▁" ¦new¦ ¦drug¦ ¦app l ic ation¦ "▁ ¦or¦ ¦ nd a¦ .
𐋇¦a¦ ¦clinical¦ ¦tr ial¦ ¦d es ign¦ ¦in¦ ¦pr og r ess¦ ¦may¦ ¦be¦ ¦mod if ied¦ ¦as¦ ¦an¦ ▁" ¦ad ap tive¦ ¦d es ign¦ "▁ ¦if¦ ¦acc um ul ating¦ ¦data¦ ¦in¦ ¦the¦ ¦tr ial¦ ¦provide¦ ¦early¦ ¦in si gh ts¦ ¦about¦ ¦positive¦ ¦or¦ ¦negative¦ ¦eff ic acy¦ ¦of¦ ¦the¦ ¦treatment¦ .
𐋇¦the¦ ¦global¦ ¦s ol id ar ity¦ ¦and¦ ¦european¦ ¦disc o ve ry¦ ¦trials¦ ¦of¦ ¦hosp i tali zed¦ ¦people¦ ¦with¦ ¦severe¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦app ly¦ ¦ad ap tive¦ ¦d es ign¦ ¦to¦ ¦rap id ly¦ ¦al ter¦ ¦tr ial¦ ¦p ara m et ers¦ ¦as¦ ¦results¦ ¦from¦ ¦the¦ ¦four¦ ¦exp eri me ntal¦ ¦ ther ap e ut ic¦ ¦stra te g ies¦ ¦e mer ge¦ .
𐋇 ¦ad ap tive¦ ¦d es ig ns¦ ¦within¦ ¦o ng o ing¦ ¦ph ase¦ ¦i i¦ - ¦i i i¦ ¦clinical¦ ¦trials¦ ¦on¦ ¦ca nd id ate¦ ¦ ther ap e ut ics¦ ¦may¦ ¦sh ort en¦ ¦tr ial¦ ¦d ur ations¦ ¦and¦ ¦use¦ ¦fe w er¦ ¦sub j ects¦ ,▁ ¦p os si b ly¦ ¦exp e di ting¦ ¦dec i si ons¦ ¦for¦ ¦early¦ ¦t erm ination¦ ¦or¦ ¦s uc c ess¦ ,▁ ¦and¦ ¦co or d in ating¦ ¦d es ign¦ ¦chan ges¦ ¦for¦ ¦a¦ ¦specific¦ ¦tr ial¦ ¦across¦ ¦its¦ ¦international¦ ¦loc ations¦ .
𐋇 ¦most¦ ¦novel¦ ¦drug¦ ¦ca nd id ates¦ ▁( ¦n ces¦ )▁ ¦fa il¦ ¦during¦ ¦drug¦ ¦development¦ ,▁ ¦e it her¦ ¦because¦ ¦they¦ ¦have¦ ¦un ac ce pt able¦ ¦to x ic ity¦ ¦or¦ ¦because¦ ¦they¦ ¦si mp ly¦ ¦do¦ ¦not¦ ¦pro ve¦ ¦eff ic acy¦ ¦on¦ ¦the¦ ¦t ar ge ted¦ ¦disease¦ ,▁ ¦as¦ ¦sh own¦ ¦in¦ ¦ph ase¦ ¦i i¦ - ¦i i i¦ ¦clinical¦ ¦trials¦ .
𐋇¦the¦ ¦high¦ ¦fa il ure¦ ¦r ates¦ ¦associated¦ ¦with¦ ¦ph ar ma ce ut ical¦ ¦development¦ ¦are¦ ¦ref er r ed¦ ¦to¦ ¦as¦ ¦an¦ ▁" ¦att r ition¦ ¦rate¦ " ,▁ ¦requir ing¦ ¦dec i si ons¦ ¦during¦ ¦the¦ ¦early¦ ¦sta ges¦ ¦of¦ ¦drug¦ ¦development¦ ¦to¦ ▁" ¦k ill¦ "▁ ¦pro j ects¦ ¦early¦ ¦to¦ ¦avoid¦ ¦co st ly¦ ¦fa il ures¦ .
𐋇 ¦one¦ ¦20 1 0¦ ¦study¦ ¦ass es sed¦ ¦both¦ ¦c ap i tali zed¦ ¦and¦ ¦out¦ - ¦of¦ - ¦p oc k et¦ ¦co sts¦ ¦for¦ ¦bringing¦ ¦a¦ ¦si ng le¦ ¦new¦ ¦drug¦ ¦to¦ ¦mark et¦ ¦as¦ ¦about¦ ¦us¦ ▁ $ ¦1¦ . ¦8¦ ¦bi ll ion¦ ¦and¦ ▁ $ ¦8 7 0¦ ¦million¦ ,▁ ¦resp ect ively¦ .
𐋇¦a¦ ¦me di an¦ ¦c ost¦ ¦estim ate¦ ¦of¦ ¦20 1 5¦ - ¦16¦ ¦trials¦ ¦for¦ ¦development¦ ¦of¦ ¦10¦ ¦anti ¦ - ¦cance r¦ ¦d ru g s¦ ¦was¦ ▁ $ ¦6 4 8¦ ¦million¦ .
𐋇¦in¦ ¦a¦ ¦20 1 6¦ ¦re v ie w¦ ¦of¦ ¦1 0 6¦ ¦drug¦ ¦ca nd id ates¦ ¦ass es sed¦ ¦through¦ ¦clinical¦ ¦trials¦ ,▁ ¦the¦ ¦total¦ ¦c ap it al¦ ¦exp end it ure¦ ¦for¦ ¦a¦ ¦m an u fa ct ur er¦ ¦having¦ ¦a¦ ¦drug¦ ¦appr oved¦ ¦through¦ ¦s uc cess ful¦ ¦ph ase¦ ¦i i i¦ ¦trials¦ ¦was¦ ▁ $ ¦2¦ . ¦6¦ ¦bi ll ion¦ ▁( ¦in¦ ¦20 1 3¦ ¦do ll ar s¦ ),▁ ¦an¦ ¦a mo un t¦ ¦incre as ing¦ ¦at¦ ¦an¦ ¦an n ual¦ ¦rate¦ ¦of¦ ¦8¦ . ¦5¦ % .
𐋇 ¦se v en¦ ¦trials¦ ¦were¦ ¦ev a lu ating¦ ¦rep ur p osed¦ ¦d ru g s¦ ¦al rea dy¦ ¦appr oved¦ ¦to¦ ¦tre at¦ ¦m al ar ia¦ ,▁ ¦including¦ ¦four¦ ¦st u dies¦ ¦on¦ ¦h y d ro x y ch lo ro qu ine¦ ¦or¦ ¦ch lo ro qu ine¦ ¦ph os ph ate¦ .
𐋇 ¦rep ur p osed¦ ¦anti vir al¦ ¦d ru g s¦ ¦make¦ ¦up¦ ¦most¦ ¦of¦ ¦the¦ ¦chinese¦ ¦research¦ ,▁ ¦with¦ ¦9¦ ¦ph ase¦ ¦i i i¦ ¦trials¦ ¦on¦ ¦rem de si vi r¦ ¦across¦ ¦several¦ ¦countries¦ ¦due¦ ¦to¦ ¦report¦ ¦by¦ ¦the¦ ¦end¦ ¦of¦ ¦april¦ .
𐋇¦l ed¦ ¦by¦ ¦the¦ ¦b ill¦ ¦and¦ ¦me li nd a¦ ¦g ates¦ ¦f ou nd ation¦ ¦with¦ ¦part n ers¦ ¦inv es ting¦ ¦us¦ ▁ $ ¦1 2 5¦ ¦million¦ ¦and¦ ¦co or d in ating¦ ¦with¦ ¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ,▁ ¦the¦ ¦covid¦ - ¦19¦ ¦ ther ap e ut ics¦ ¦acc el erat or¦ ¦beg an¦ ¦in¦ ¦march¦ ,▁ ¦facil it ating¦ ¦drug¦ ¦development¦ ¦res ear ch ers¦ ¦to¦ ¦rap id ly¦ ¦ident if y¦ ,▁ ¦ass ess¦ ,▁ ¦develop ¦ ,▁ ¦and¦ ¦sc a le¦ ¦up¦ ¦pote ntial¦ ¦tre at ments¦ .
𐋇¦the¦ ¦covid¦ - ¦19¦ ¦clinical¦ ¦research¦ ¦co al ition¦ ¦for med¦ ¦to¦ ¦co or d in ate¦ ¦and¦ ¦exp ed ite¦ ¦results¦ ¦from¦ ¦international¦ ¦clinical¦ ¦trials¦ ¦on¦ ¦the¦ ¦most¦ ¦pr om ising¦ ¦p ost¦ - ¦infection¦ ¦tre at ments¦ .
𐋇¦in¦ ¦early¦ ¦2020¦ ,▁ ¦nu me ro us¦ ¦ es ta bl ished¦ ¦anti vir al¦ ¦comp o un ds¦ ¦for¦ ¦tre ating¦ ¦other¦ ¦infections¦ ¦were¦ ¦being¦ ¦rep ur p osed¦ ¦or¦ ¦developed¦ ¦in¦ ¦new¦ ¦clinical¦ ¦research¦ ¦eff orts¦ ¦to¦ ¦al le vi ate¦ ¦the¦ ¦illness¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇¦for¦ ¦an¦ ¦al rea dy¦ - ¦appr oved¦ ¦drug¦ ▁( ¦such¦ ¦as¦ ¦h y d ro x y ch lo ro qu ine¦ ¦for¦ ¦m al ar ia¦ ),▁ ¦ph ase¦ ¦i i i¦ - ¦ iv ¦ ¦trials¦ ¦det erm ine¦ ¦in¦ ¦h u nd re ds¦ ¦to¦ ¦t ho us an ds¦ ¦of¦ ¦covid¦ - ¦19¦ - ¦infected¦ ¦people¦ ¦the¦ ¦possible¦ ¦ex te nded¦ ¦use¦ ¦of¦ ¦an¦ ¦al rea dy¦ - ¦appr oved¦ ¦drug¦ ¦for¦ ¦tre ating¦ ¦covid¦ - ¦19¦ ¦infection¦ .
𐋇¦as¦ ¦of¦ ¦early¦ ¦april¦ ¦2020¦ ,▁ ¦1 0 3¦ ¦ca nd id ate¦ ¦ ther ap e ut ics¦ ¦were¦ ¦in¦ ¦pr ec l in ical¦ ¦or¦ ¦a¦ ¦st age¦ ¦of¦ ¦ph ase¦ ¦i¦ - ¦ iv ¦ ¦development¦ ,▁ ¦with¦ ¦tr ial¦ ¦results¦ ¦for¦ ¦2 9¦ ¦drug¦ ¦ca nd id ates¦ ¦exp ected¦ ¦during¦ ¦april¦ .
𐋇¦in¦ ¦march¦ ,▁ ¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ▁( ¦who¦ )▁ ¦la un ched¦ ¦the¦ ¦co or d in ated¦ ▁" ¦s ol id ar ity¦ ¦tr ial¦ "▁ ¦in¦ ¦10¦ ¦countries¦ ¦to¦ ¦rap id ly¦ ¦ass ess¦ ¦in¦ ¦t ho us an ds¦ ¦of¦ ¦covid¦ - ¦19¦ ¦infected¦ ¦people¦ ¦the¦ ¦pote ntial¦ ¦eff ic acy¦ ¦of¦ ¦ex is ting¦ ¦anti vir al¦ ¦and¦ ¦anti ¦ - ¦inf la mm atory¦ ¦ag ents¦ ¦not¦ ¦y et¦ ¦ev a lu ated¦ ¦spec if ically¦ ¦for¦ ¦covid¦ - ¦19¦ ¦illness¦ .
𐋇¦do¦ ¦any¦ ¦of¦ ¦the¦ ¦d ru g s¦ ¦reduce¦ ¦m ort ality¦ ?
𐋇¦do¦ ¦any¦ ¦of¦ ¦the¦ ¦d ru g s¦ ¦reduce¦ ¦the¦ ¦time¦ ¦a¦ ¦pa ti ent¦ ¦is¦ ¦hosp i tali zed¦ ?
𐋇¦do¦ ¦the¦ ¦tre at ments¦ ¦aff ect¦ ¦the¦ ¦need¦ ¦for¦ ¦people¦ ¦with¦ ¦covid¦ - ¦19¦ - ¦in duc ed¦ ¦pneumonia¦ ¦to¦ ¦be¦ ¦ ventil ated¦ ¦or¦ ¦main ta ined¦ ¦in¦ ¦in tens ive¦ ¦care¦ ?
𐋇 ¦could¦ ¦such¦ ¦d ru g s¦ ¦be¦ ¦used¦ ¦to¦ ¦min im iz e¦ ¦the¦ ¦illness¦ ¦of¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦in¦ ¦healthcare¦ ¦staff¦ ¦and¦ ¦people¦ ¦at¦ ¦high¦ ¦risk¦ ¦of¦ ¦develop ing¦ ¦severe¦ ¦illness¦ ? ▁ 𐋇 ¦en ro lling¦ ¦people¦ ¦with¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦is¦ ¦si mpl if ied¦ ¦by¦ ¦using¦ ¦data¦ ¦ent r ies¦ ,▁ ¦including¦ ¦in for med¦ ¦cons ent¦ ,▁ ¦on¦ ¦a¦ ¦who¦ ¦we b s ite¦ .
𐋇 ¦after¦ ¦the¦ ¦tr ial¦ ¦staff¦ ¦det erm ines¦ ¦the¦ ¦d ru g s¦ ¦available¦ ¦at¦ ¦the¦ ¦hospital¦ ,▁ ¦the¦ ¦who¦ ¦we b s ite¦ ¦ra nd om iz es¦ ¦the¦ ¦hosp i tali zed¦ ¦sub j ect¦ ¦to¦ ¦one¦ ¦of¦ ¦the¦ ¦tr ial¦ ¦d ru g s¦ ¦or¦ ¦to¦ ¦the¦ ¦hospital¦ ¦sta nd ard¦ ¦of¦ ¦care¦ ¦for¦ ¦tre ating¦ ¦covid¦ - ¦19¦ .
𐋇¦the¦ ¦tr ial¦ ¦ph ys ici an¦ ¦recor ds¦ ¦and¦ ¦sub mi ts¦ ¦follow¦ - ¦up¦ ¦information¦ ¦about¦ ¦the¦ ¦sub j ect¦ ¦st at us¦ ¦and¦ ¦treatment¦ ,▁ ¦comp le ting¦ ¦data¦ ¦in p ut¦ ¦v ia¦ ¦the¦ ¦who¦ ¦s ol id ar ity¦ ¦we b s ite¦ .
𐋇¦a¦ ¦global¦ ¦safety¦ ¦monit or ing¦ ¦ bo ard¦ ¦of¦ ¦who¦ ¦ph ys ici ans¦ ¦ex a m ine¦ ¦int eri m¦ ¦results¦ ¦to¦ ¦ass ist¦ ¦dec i si ons¦ ¦on¦ ¦safety¦ ¦and¦ ¦eff ec ti ve ness¦ ¦of¦ ¦the¦ ¦tr ial¦ ¦d ru g s¦ ,▁ ¦and¦ ¦al ter¦ ¦the¦ ¦tr ial¦ ¦d es ign¦ ¦or¦ ¦recomm end¦ ¦an¦ ¦effective¦ ¦ ther ap y¦ .
𐋇¦a¦ ¦similar¦ ¦we b ¦ - ¦based¦ ¦study¦ ¦to¦ ¦s ol id ar ity¦ ,▁ ¦called¦ ▁" ¦disc o ve ry¦ " ,▁ ¦was¦ ¦in i ti ated¦ ¦in¦ ¦march¦ ¦across¦ ¦se v en¦ ¦countries¦ ¦by¦ ¦i ns er m¦ ▁( ¦pa ri s¦ ,▁ ¦fra nce¦ )▁ . ¦during¦ ¦march¦ ,▁ ¦f un ding¦ ¦for¦ ¦the¦ ¦s ol id ar ity¦ ¦tr ial¦ ¦rea ched¦ ¦us¦ ▁ $ ¦1 0 8¦ ¦million¦ ¦from¦ ¦20 3¦ , ¦000¦ ¦individuals¦ ,▁ ¦organiz ations¦ ¦and¦ ¦gover n ments¦ ,▁ ¦with¦ ¦4 5¦ ¦countries¦ ¦invol v ed¦ ¦in¦ ¦fi na ncing¦ ¦or¦ ¦tr ial¦ ¦mana ge ment¦ .
𐋇 ¦nu me ro us¦ ¦ca nd id ate¦ ¦d ru g s¦ ¦under¦ ¦study¦ ¦as¦ ▁" ¦supp or tive¦ "▁ ¦tre at ments¦ ¦to¦ ¦rel ie ve¦ ¦disc om f ort¦ ¦during¦ ¦illness¦ ,▁ ¦such¦ ¦as¦ ¦ ns ai ds¦ ¦or¦ ¦b ro nc ho d il at ors¦ ,▁ ¦are¦ ¦not¦ ¦inclu ded¦ ¦in¦ ¦the¦ ¦t able¦ ¦b el ow¦ .
𐋇 ¦others¦ ¦in¦ ¦early¦ - ¦st age¦ ¦ph ase¦ ¦i i¦ ¦trials¦ ¦or¦ ¦nu me ro us¦ ¦treatment¦ ¦ca nd id ates¦ ¦in¦ ¦ph ase¦ ¦i¦ ¦trials¦ ,▁ ¦are¦ ¦also¦ ¦ex c lu ded¦ .
𐋇 ¦drug¦ ¦ca nd id ates¦ ¦in¦ ¦ph ase¦ ¦i¦ - ¦i i¦ ¦trials¦ ¦have¦ ¦a¦ ¦low¦ ¦rate¦ ¦of¦ ¦s uc c ess¦ ▁( ¦under¦ ¦12¦ % )▁ ¦to¦ ¦p ass¦ ¦through¦ ¦all¦ ¦tr ial¦ ¦ph a ses¦ ¦to¦ ¦ga in¦ ¦e vent ual¦ ¦appr ov al¦ .
𐋇¦h y d ro x y ch lo ro qu ine¦ ¦is¦ ¦more¦ ¦comm on ly¦ ¦available¦ ¦than¦ ¦ch lo ro qu ine¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ .
𐋇 ¦al th ough¦ ¦several¦ ¦countries¦ ¦use¦ ¦ch lo ro qu ine¦ ¦or¦ ¦h y d ro x y ch lo ro qu ine¦ ¦for¦ ¦treatment¦ ¦of¦ ¦pers ons¦ ¦hosp i tali zed¦ ¦with¦ ¦covid¦ - ¦19¦ ,▁ ¦as¦ ¦of¦ ¦march¦ ¦2020¦ ¦the¦ ¦drug¦ ¦has¦ ¦not¦ ¦been¦ ¦f orm ally¦ ¦appr oved¦ ¦through¦ ¦clinical¦ ¦trials¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ .
𐋇 ¦ch lo ro qu ine¦ ¦has¦ ¦been¦ ¦recommended¦ ¦by¦ ¦chinese¦ ,▁ ¦south¦ ¦ko re an¦ ¦and¦ ¦i tali an¦ ¦health¦ ¦author ities¦ ¦for¦ ¦the¦ ¦treatment¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦al th ough¦ ¦these¦ ¦a ge nc ies¦ ¦and¦ ¦the¦ ¦us¦ ¦c dc¦ ¦no ted¦ ¦contr ai nd ications¦ ¦for¦ ¦people¦ ¦with¦ ¦h ear t¦ ¦disease¦ ¦or¦ ¦di ab e tes¦ .
𐋇 ¦both¦ ¦d ru g s¦ ¦have¦ ¦ex tens ive¦ ¦inter ac tions¦ ¦with¦ ¦pr esc ri ption¦ ¦d ru g s¦ ,▁ ¦aff ecting¦ ¦the¦ ¦ ther ap e ut ic¦ ¦d ose¦ ¦and¦ ¦disease¦ ¦m it ig ation¦ .
𐋇¦some¦ ¦people¦ ¦have¦ ¦all er g ic¦ ¦re ac tions¦ ¦to¦ ¦these¦ ¦d ru g s¦ . ¦on¦ ¦12¦ ¦april¦ ,▁ ¦a¦ ¦pre li min ary¦ ¦clinical¦ ¦tr ial¦ ¦con duc ted¦ ¦at¦ ¦a¦ ¦hospital¦ ¦in¦ ¦b ra z il¦ ¦was¦ ¦sto pp ed¦ ¦when¦ ¦several¦ ¦people¦ ¦giv en¦ ¦high¦ ¦doses¦ ¦of¦ ¦ch lo ro qu ine¦ ¦for¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦developed¦ ¦ir re g ular¦ ¦h ear t¦ ¦r ates¦ ,▁ ¦ca us ing¦ ¦11¦ ¦deaths¦ .
𐋇 ¦chinese¦ ¦clinical¦ ¦trials¦ ¦in¦ ¦wuhan¦ ¦and¦ ¦sh en z h en¦ ¦cl ai med¦ ¦to¦ ¦sh ow¦ ¦that¦ ¦fa v ip i ra vi r¦ ¦was¦ ▁" ¦c le arly¦ ¦effective¦ " .
𐋇 ¦of¦ ¦3 5¦ ¦patients¦ ¦in¦ ¦sh en z h en¦ ¦tested¦ ¦negative¦ ¦in¦ ¦a¦ ¦me di an¦ ¦of¦ ¦4¦ ¦days¦ ,▁ ¦while¦ ¦the¦ ¦le ng th¦ ¦of¦ ¦illness¦ ¦was¦ ¦11¦ ¦days¦ ¦in¦ ¦the¦ ¦4 5¦ ¦patients¦ ¦who¦ ¦d id¦ ¦not¦ ¦receive¦ ¦it¦ .
𐋇¦in¦ ¦a¦ ¦study¦ ¦con duc ted¦ ¦in¦ ¦wuhan¦ ¦on¦ ¦2 4 0¦ ¦patients¦ ¦with¦ ¦pneumonia¦ ¦h al f¦ ¦were¦ ¦giv en¦ ¦fa v ip i ra vi r¦ ¦and¦ ¦h al f¦ ¦received¦ ¦ um if e no vi r¦ .
𐋇¦the¦ ¦ter m¦ ▁" ¦pr ec l in ical¦ ¦research¦ "▁ ¦is¦ ¦def ined¦ ¦by¦ ¦laboratory¦ ¦st u dies¦ ¦in¦ ¦v it r o¦ ¦and¦ ¦in¦ ¦v iv o¦ ,▁ ¦indic ating¦ ¦a¦ ¦beg in ning¦ ¦st age¦ ¦for¦ ¦development¦ ¦of¦ ¦a¦ ¦vaccine¦ ,▁ ¦anti vir al¦ ¦or¦ ¦mon oc l on al¦ ¦antibo dy¦ ¦ ther ap y¦ ,▁ ¦such¦ ¦as¦ ¦exp eri ments¦ ¦to¦ ¦det erm ine¦ ¦effective¦ ¦doses¦ ¦and¦ ¦to x ic ity¦ ,▁ ¦before¦ ¦a¦ ¦ca nd id ate¦ ¦comp o un d¦ ¦is¦ ¦ad v a nc ed¦ ¦for¦ ¦safety¦ ¦and¦ ¦eff ic acy¦ ¦ev a lu ation¦ ¦in¦ ¦humans¦ .
𐋇¦some¦ ¦anti b i ot ics¦ ¦may¦ ¦be¦ ¦rep ur p osed¦ ¦as¦ ¦covid¦ - ¦19¦ ¦tre at ments¦ :
𐋇¦in¦ ¦march¦ ¦2020¦ ,▁ ¦the¦ ¦ma in¦ ¦prote ase¦ ¦of¦ ¦the¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦virus¦ ¦was¦ ¦identified¦ ¦as¦ ¦a¦ ¦t arg et¦ ¦for¦ ¦p ost¦ - ¦infection¦ ¦d ru g s¦ .
𐋇¦this¦ ¦en z y me¦ ¦is¦ ¦essential¦ ¦to¦ ¦the¦ ¦host¦ ¦c ell¦ ¦to¦ ¦rep ro duc e¦ ¦the¦ ¦ rib on uc le ic¦ ¦ac id¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦to¦ ¦f ind¦ ¦the¦ ¦en z y me¦ ,▁ ¦sc ien ti sts¦ ¦used¦ ¦the¦ ¦gen ome¦ ¦publ ished¦ ¦by¦ ¦chinese¦ ¦res ear ch ers¦ ¦in¦ ¦january¦ ¦2020¦ ¦to¦ ¦isol ate¦ ¦the¦ ¦ma in¦ ¦prote ase¦ .
𐋇¦as¦ ¦a¦ ¦pote ntial¦ ¦co mb ination¦ ¦ ther ap y¦ ,▁ ¦they¦ ¦are¦ ¦used¦ ¦t og ether¦ ¦in¦ ¦two¦ ¦ph ase¦ ¦i i i¦ ¦ar ms¦ ¦of¦ ¦the¦ ¦2020¦ ¦global¦ ¦s ol id ar ity¦ ¦pro j ect¦ ¦on¦ ¦covid¦ - ¦19¦ .
𐋇¦a¦ ¦pre li min ary¦ ¦study¦ ¦in¦ ¦china¦ ¦of¦ ¦co mb ined¦ ¦l op i na vi r¦ ¦and¦ ¦r it o na vi r¦ ¦found¦ ¦no¦ ¦eff ect¦ ¦in¦ ¦people¦ ¦hosp i tali zed¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇¦it¦ ¦is¦ ¦u nc l ear¦ ¦y et¦ ¦wh ether¦ ¦conditions¦ ¦ar ising¦ ¦during¦ ¦pregn a ncy¦ ¦including¦ ¦di ab e tes¦ ,▁ ¦car d ia c¦ ¦fa il ure¦ ,▁ ¦h y p erc o a g u la bility¦ ¦or¦ ¦h y p er tens ion¦ ¦might¦ ¦rep r es ent¦ ¦ad di tional¦ ¦risk¦ ¦fa ctors¦ ¦for¦ ¦pre gnant¦ ¦people¦ ¦as¦ ¦they¦ ¦do¦ ¦for¦ ¦n on p re gnant¦ ¦people¦ . ¦from¦ ¦the¦ ¦limi ted¦ ¦data¦ ¦available¦ ,▁ ¦ ve rt ical¦ ¦transmission¦ ¦during¦ ¦the¦ ¦thir d¦ ¦tr im es ter¦ ¦prob ab ly¦ ¦does¦ ¦not¦ ¦occur ¦ ,▁ ¦or¦ ¦only¦ ¦occur s¦ ¦very¦ ¦r ar ely¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦data¦ ¦y et¦ ¦on¦ ¦early¦ ¦pregn a ncy¦ .
𐋇¦l it t le¦ ¦evidence¦ ¦e xi sts¦ ¦to¦ ¦per mi t¦ ¦any¦ ¦s ol id¦ ¦co nc lu si ons¦ ¦about¦ ¦the¦ ¦nat ure¦ ¦of¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦in¦ ¦pregn a ncy¦ .
𐋇¦a¦ ¦case¦ ¦ser ies¦ ¦of¦ ¦4 3¦ ¦women¦ ¦from¦ ¦new¦ ¦y or k¦ ¦who¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ ¦sh owed¦ ¦similar¦ ¦p at t er ns¦ ¦to¦ ¦non¦ - ¦pre gnant¦ ¦ad ul ts¦ :▁ ¦8 6¦ %▁ ¦had¦ ¦mild¦ ¦disease¦ ,▁ ¦9¦ . ¦3¦ %▁ ¦had¦ ¦severe¦ ¦disease¦ ¦and¦ ¦4¦ . ¦7¦ %▁ ¦developed¦ ¦crit ical¦ ¦disease¦ .
𐋇¦f et al¦ ¦di str ess¦ ¦was¦ ¦reported¦ ¦in¦ ¦two¦ .
𐋇¦n one¦ ¦of¦ ¦the¦ ¦women¦ ¦developed¦ ¦severe¦ ¦covid¦ - ¦19¦ ¦pneumonia¦ ¦or¦ ¦d ied¦ .
𐋇 ¦all¦ ¦of¦ ¦them¦ ¦had¦ ¦live¦ ¦b ir th¦ ¦pregn a nc ies¦ ¦and¦ ¦no¦ ¦severe¦ ¦ne on at al¦ ¦as ph y x ia¦ ¦was¦ ¦ob s erv ed¦ .
𐋇¦the¦ ¦samples¦ ¦of¦ ¦b re ast¦ ¦m il k¦ ,▁ ¦a m n i ot ic¦ ¦f lu id¦ ,▁ ¦cor d¦ ¦blood¦ ¦and¦ ¦ne on at al¦ ¦th ro at¦ ¦sw ab ¦ ¦were¦ ¦tested¦ ¦for¦ ¦sars¦ - ¦cov¦ - ¦2¦ ,▁ ¦and¦ ¦all¦ ¦results¦ ¦were¦ ¦negative¦ . ¦in¦ ¦another¦ ¦study¦ ¦on¦ ¦15¦ ¦pre gnant¦ ¦women¦ ,▁ ¦ma j or ity¦ ¦of¦ ¦the¦ ¦patients¦ ¦pres ented¦ ¦with¦ ¦fever¦ ¦and¦ ¦cough¦ ,▁ ¦while¦ ¦laboratory¦ ¦tests¦ ¦y i el ded¦ ¦l y m ph oc y t op en ia¦ ¦in¦ ¦12¦ ¦patients¦ .
𐋇 ¦comp u ted¦ ¦t om ogra ph y¦ ¦fi nd ings¦ ¦of¦ ¦these¦ ¦patients¦ ¦were¦ ¦cons ist ent¦ ¦with¦ ¦prev ious¦ ¦rep orts¦ ¦of¦ ¦non¦ - ¦pre gnant¦ ¦patients¦ ,▁ ¦cons is ting¦ ¦of¦ ¦grou n d¦ - ¦gl ass¦ ¦op ac ities¦ ¦at¦ ¦early¦ ¦st age¦ .
𐋇 ¦follow¦ - ¦up¦ ¦i ma ges¦ ¦after¦ ¦de li ve ry¦ ¦sh owed¦ ¦no¦ ¦pr og re ssion¦ ¦of¦ ¦pneumonia¦ . ¦m ed ia¦ ¦rep orts¦ ¦indic ate¦ ¦that¦ ¦over¦ ¦100¦ ¦women¦ ¦with¦ ¦covid¦ - ¦19¦ ¦might¦ ¦have¦ ¦del iv ered¦ ,▁ ¦and¦ ¦in¦ ¦march¦ ¦2020¦ ,▁ ¦no¦ ¦m at er n al¦ ¦deaths¦ ¦were¦ ¦reported¦ .
𐋇 ¦their¦ ¦gu id el ines¦ ¦th us¦ ¦ad v ise¦ ¦that¦ ¦any¦ ¦pre gnant¦ ¦person¦ ¦ad m it ted¦ ¦to¦ ¦hospital¦ ¦with¦ ¦a¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦should¦ ¦receive¦ ¦at¦ ¦least¦ ¦10¦ ¦days¦ ¦of¦ ¦pro ph y la ct ic¦ ¦low¦ - ¦m ol ec ular¦ - ¦we ight¦ ¦he par in¦ ¦after¦ ¦being¦ ¦dis ch ar ged¦ ¦from¦ ¦the¦ ¦hospital¦ .
𐋇¦there¦ ¦are¦ ¦no¦ ¦data¦ ¦y et¦ ¦concer ning¦ ¦the¦ ¦i mpl ications¦ ¦of¦ ¦covid¦ - ¦19¦ ¦infections¦ ¦for¦ ¦l ab ou r¦ .
𐋇 ¦one¦ ¦inf ant¦ ¦g ir l¦ ¦ bor n¦ ¦to¦ ¦a¦ ¦m ot her¦ ¦with¦ ¦covid¦ - ¦19¦ ¦had¦ ¦e le v ated¦ ¦ ig m¦ ¦le v els¦ ¦two¦ ¦hours¦ ¦after¦ ¦b ir th¦ ,▁ ¦su gg es ting¦ ¦that¦ ¦sh e¦ ¦had¦ ¦been¦ ¦infected¦ ¦in¦ ¦ ut er o¦ ¦and¦ ¦supp orting¦ ¦the¦ ¦p os si bility¦ ¦of¦ ¦ ve rt ical¦ ¦transmission¦ ¦in¦ ¦some¦ ¦cases¦ .
𐋇¦a¦ ¦sm all¦ ¦study¦ ¦invol ving¦ ¦6¦ ¦confirmed¦ ¦covid¦ - ¦19¦ ¦mo th ers¦ ¦sh owed¦ ¦no¦ ¦indic ation¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦19¦ ¦in¦ ¦their¦ ¦new bor ns¦ ' ▁ ¦th ro a ts¦ ¦or¦ ¦ser um¦ ¦but¦ ¦antibo dies¦ ¦were¦ ¦pres ent¦ ¦in¦ ¦ne on at al¦ ¦blood¦ ¦ser a¦ ¦samples¦ ,▁ ¦including¦ ¦ ig m¦ ¦in¦ ¦two¦ ¦of¦ ¦the¦ ¦in fa nts¦ .
𐋇¦this¦ ¦is¦ ¦not¦ ¦us ually¦ ¦p as sed¦ ¦from¦ ¦m ot her¦ ¦to¦ ¦f et us¦ ¦so¦ ¦further¦ ¦research¦ ¦is¦ ¦required¦ ¦to¦ ¦know¦ ¦wh ether¦ ¦the¦ ¦virus¦ ¦cr os sed¦ ¦the¦ ¦pla ce nt a¦ ¦or¦ ¦wh ether¦ ¦pl ac en ta s¦ ¦of¦ ¦women¦ ¦in¦ ¦the¦ ¦study¦ ¦were¦ ¦da ma ged¦ ¦or¦ ¦ab n ormal¦ .
𐋇 ¦since¦ ¦covid¦ - ¦19¦ ¦sh ow s¦ ¦s im il ar ities¦ ¦to¦ ¦sars¦ - ¦cov¦ ¦and¦ ¦mers¦ - ¦cov¦ ,▁ ¦it¦ ¦is¦ ¦likely¦ ¦that¦ ¦their¦ ¦eff ect¦ ¦on¦ ¦pregn a ncy¦ ¦are¦ ¦similar¦ .
𐋇 ¦four¦ ¦of¦ ¦se v en¦ ¦had¦ ¦first¦ ¦tr im es ter¦ ¦m is c ar ri age¦ ,▁ ¦two¦ ¦of¦ ¦five¦ ¦had¦ ¦f et al¦ ¦gr ow th¦ ¦re st ri ction¦ ¦in¦ ¦the¦ ¦second¦ ¦tr im es ter¦ ,▁ ¦and¦ ¦four¦ ¦of¦ ¦five¦ ¦had¦ ¦pr et er m¦ ¦b ir th¦ .
𐋇¦n one¦ ¦of¦ ¦the¦ ¦new bor ns¦ ¦were¦ ¦infected¦ ¦with¦ ¦sars¦ - ¦cov¦ .
𐋇¦a¦ ¦report¦ ¦of¦ ¦t en¦ ¦cases¦ ¦of¦ ¦mers¦ - ▁ ¦cov¦ ¦infection¦ ¦in¦ ¦pregn a ncy¦ ¦in¦ ¦sa ud i¦ ¦ar ab ia¦ ¦sh owed¦ ¦that¦ ¦the¦ ¦clinical¦ ¦pre se nt ation¦ ¦is¦ ¦vari able¦ ,▁ ¦from¦ ¦mild¦ ¦to¦ ¦severe¦ ¦infection¦ .
𐋇¦the¦ ¦out c ome¦ ¦was¦ ¦fa v or able¦ ¦in¦ ¦a¦ ¦ma j or ity¦ ¦of¦ ¦the¦ ¦cases¦ ,▁ ¦but¦ ¦the¦ ¦inf ant¦ ¦death¦ ¦rate¦ ¦was¦ ¦2 7¦ %▁ . ¦a¦ ¦rec ent¦ ¦re v ie w¦ ¦su gg ested¦ ¦that¦ ¦covid¦ - ¦19¦ ¦app e ared¦ ¦to¦ ¦be¦ ¦less¦ ¦le th al¦ ¦to¦ ¦mo th ers¦ ¦and¦ ¦in fa nts¦ ¦than¦ ¦sars¦ ¦and¦ ¦mers¦ ¦but¦ ¦that¦ ¦there¦ ¦may¦ ¦be¦ ¦an¦ ¦increased¦ ¦risk¦ ¦of¦ ¦pr et er m¦ ¦b ir th¦ ¦after¦ ¦2 8¦ ¦weeks¦ ' ▁ ¦ ge st ation¦ .
𐋇¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ¦and¦ ¦ce nt ers¦ ¦for¦ ¦disease¦ ¦control¦ ¦and¦ ¦pre vention¦ ¦of¦ ¦the¦ ¦united¦ ¦states¦ ¦ad vi ses¦ ¦pre gnant¦ ¦women¦ ¦to¦ ¦do¦ ¦the¦ ¦same¦ ¦th ings¦ ¦as¦ ¦the¦ ¦general¦ ¦public¦ ¦to¦ ¦avoid¦ ¦infection¦ ,▁ ¦such¦ ¦as¦ ¦cov ering¦ ¦cough¦ ,▁ ¦avoid¦ ¦inter ac ting¦ ¦with¦ ¦sick¦ ¦people¦ ,▁ ¦cl ea ning¦ ¦hands¦ ¦with¦ ¦so a p¦ ¦and¦ ¦water¦ ¦or¦ ¦s an itiz er¦ .
𐋇¦a¦ ¦sur ve y¦ ¦con duc ted¦ ¦in¦ ¦sh an gh a i¦ ¦among¦ ¦pre gnant¦ ¦women¦ ¦in¦ ¦different¦ ¦t ri me st ers¦ ¦of¦ ¦pregn a ncy¦ ¦identified¦ ¦a¦ ¦st ro ng¦ ¦dem and¦ ¦for¦ ¦online¦ ¦acc ess¦ ¦to¦ ¦health¦ ¦information¦ ¦and¦ ¦services¦ .
𐋇 ¦people¦ ¦exp ecting¦ ¦their¦ ¦first¦ ¦baby¦ ¦were¦ ¦more¦ ¦w i lling¦ ¦to¦ ¦have¦ ¦online¦ ¦cons ult ation¦ ¦and¦ ¦gu id ance¦ ¦than¦ ¦who¦ ¦had¦ ¦previously¦ ¦giv en¦ ¦b ir th¦ . ¦the¦ ¦r c o g¦ ¦and¦ ¦r c m¦ ¦recomm end¦ ¦that¦ ¦in¦ - ¦person¦ ¦app oi nt ments¦ ¦be¦ ¦def er r ed¦ ¦by¦ ¦7¦ ¦days¦ ¦after¦ ¦the¦ ¦star t¦ ¦of¦ ¦symptoms¦ ¦of¦ ¦covid¦ - ¦19¦ ¦or¦ ¦14¦ ¦days¦ ¦if¦ ¦another¦ ¦person¦ ¦in¦ ¦the¦ ¦hou se ho ld¦ ¦has¦ ¦symptoms¦ .
𐋇 ¦fever¦ ¦sub se qu e ntly¦ ¦developed¦ ¦in¦ ¦three¦ ¦as ymptomatic¦ ¦patients¦ .
𐋇 ¦one¦ ¦pa ti ent¦ ¦who¦ ¦had¦ ¦tested¦ ¦negative¦ ¦sub se qu e ntly¦ ¦bec a me¦ ¦s ymptomatic¦ ¦po st pa rt um¦ ¦and¦ ¦tested¦ ¦positive¦ ¦three¦ ¦days¦ ¦after¦ ¦the¦ ¦in it ial¦ ¦negative¦ ¦test¦ .
𐋇¦the¦ ¦do ctors¦ ¦con duc ting¦ ¦the¦ ¦scre ening¦ ¦recommended¦ ¦that¦ ¦in¦ ¦order¦ ¦to¦ ¦reduce¦ ¦infection¦ ¦and¦ ¦all oc ate¦ ¦ pp e¦ ,▁ ¦due¦ ¦to¦ ¦high¦ ¦nu mbers¦ ¦of¦ ¦patients¦ ¦pres en ting¦ ¦as¦ ¦as ymptomatic¦ ,▁ ¦univers al¦ ¦scre ening¦ ¦of¦ ¦pre gnant¦ ¦patients¦ ¦should¦ ¦be¦ ¦con duc ted¦ .
𐋇¦they¦ ¦also¦ ¦su gg est¦ ¦that¦ ¦people¦ ¦with¦ ¦suspected¦ ¦or¦ ¦confirmed¦ ¦covid¦ - ¦19¦ ¦should¦ ¦have¦ ¦contin u o us¦ ¦el ect r on ic¦ ¦f et al¦ ¦monit or ing¦ .
𐋇¦the¦ ¦use¦ ¦of¦ ¦b ir thing¦ ¦po ols¦ ¦is¦ ¦not¦ ¦recommended¦ ¦for¦ ¦suspected¦ ¦or¦ ¦confirmed¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦due¦ ¦to¦ ¦the¦ ¦risk¦ ¦of¦ ¦infection¦ ¦v ia¦ ¦fa e ces¦ .
𐋇¦in¦ ¦the¦ ¦uk¦ ,▁ ¦offic ial¦ ¦recomm end ations¦ ¦state¦ ¦that¦ ¦pr ec a u tion ary¦ ¦separ ation¦ ¦of¦ ¦a¦ ¦m ot her¦ ¦and¦ ¦a¦ ¦healthy¦ ¦baby¦ ¦should¦ ¦not¦ ¦be¦ ¦under ta k en¦ ¦li gh t ly¦ ¦and¦ ¦that¦ ¦they¦ ¦should¦ ¦be¦ ¦k e p t¦ ¦t og ether¦ ¦in¦ ¦the¦ ¦po st pa rt um¦ ¦period¦ ¦where¦ ¦ne on at al¦ ¦care¦ ¦is¦ ¦not¦ ¦required¦ . ¦l it erat ure¦ ¦from¦ ¦china¦ ¦recommended¦ ¦separ ation¦ ¦of¦ ¦infected¦ ¦mo th ers¦ ¦from¦ ¦bab ies¦ ¦for¦ ¦14¦ ¦days¦ .
𐋇¦in¦ ¦the¦ ¦us¦ ¦there¦ ¦is¦ ¦also¦ ¦the¦ ¦recomm end ation¦ ¦that¦ ¦new bor ns¦ ¦and¦ ¦mo th ers¦ ¦should¦ ¦be¦ ¦temp o ra ri ly¦ ¦separ ated¦ ¦until¦ ¦transmission¦ - ¦based¦ ¦pr ec a u tions¦ ¦are¦ ¦disc o nt in u ed¦ ,▁ ¦and¦ ¦that¦ ¦where¦ ¦this¦ ¦is¦ ¦not¦ ¦possible¦ ¦the¦ ¦new bor n¦ ¦should¦ ¦be¦ ¦k e p t¦ ¦2¦ ¦met r es¦ ¦away¦ ¦from¦ ¦the¦ ¦m ot her¦ .
𐋇¦b ¦ ' ¦covid¦ - ¦19¦ ¦surveillance¦ ¦invol ves¦ ¦monit or ing¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦coronavirus¦ ¦disease¦ ¦in¦ ¦order¦ ¦to¦ ¦ es ta bl ish¦ ¦the¦ ¦p at t er ns¦ ¦of¦ ¦disease¦ ¦pr og re ssion¦ .
𐋇¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ▁( ¦who¦ )▁ ¦recomm ends¦ ¦ac tive¦ ¦surveillance¦ ,▁ ¦with¦ ¦f oc us¦ ¦of¦ ¦case¦ ¦f in ding¦ ,▁ ¦testing¦ ¦and¦ ¦contact¦ ¦trac ing¦ ¦in¦ ¦all¦ ¦transmission¦ ¦s ce na ri o s¦ .
𐋇¦covid¦ - ¦19¦ ¦surveillance¦ ¦is¦ ¦exp ected¦ ¦to¦ ¦monit or¦ ¦e p ide mi ological¦ ¦tr ends¦ ,▁ ¦rap id ly¦ ¦det ect¦ ¦new¦ ¦cases¦ ,▁ ¦and¦ ¦based¦ ¦on¦ ¦this¦ ¦information¦ ,▁ ¦provide¦ ¦e p ide mi ological¦ ¦information¦ ¦to¦ ¦con duc t¦ ¦risk¦ ¦as se ss ment¦ ¦and¦ ¦gu ide¦ ¦disease¦ ¦pre par ed ness¦ .
𐋇 ¦syndr om ic¦ ¦surveillance¦ ¦is¦ ¦d one¦ ¦based¦ ¦on¦ ¦the¦ ¦symptoms¦ ¦of¦ ¦an¦ ¦ind iv id ual¦ ¦that¦ ¦cor r esp on ds¦ ¦to¦ ¦covid¦ - ¦19¦ .
𐋇¦as¦ ¦of¦ ¦march¦ ¦2020¦ ,▁ ¦the¦ ¦who¦ ¦recomm ends¦ ¦the¦ ¦following¦ ¦case¦ ¦def in i tions¦ :
𐋇 ¦prob able¦ ¦case¦ : ▁" 𐋇¦a¦ ¦susp ect¦ ¦case¦ ¦for¦ ¦wh om¦ ¦testing¦ ¦for¦ ¦the¦ ¦covid¦ - ¦19¦ ¦virus¦ ¦is¦ ¦inc o nc l us ive¦ "▁ ¦or¦ ▁" ¦a¦ ¦susp ect¦ ¦case¦ ¦for¦ ¦wh om¦ ¦testing¦ ¦could¦ ¦not¦ ¦be¦ ¦per for med¦ ¦for¦ ¦any¦ ¦re as on¦ " .
𐋇 ¦confirmed¦ ¦case¦ : ▁" 𐋇¦a¦ ¦person¦ ¦with¦ ¦laboratory¦ ¦conf ir m ation¦ ¦of¦ ¦covid¦ - ¦19¦ ¦infection¦ ,▁ ¦ir r esp ective¦ ¦of¦ ¦clinical¦ ¦signs¦ ¦and¦ ¦symptoms¦ " .
𐋇 ¦direct¦ ¦ph ys ical¦ ¦contact¦ ¦with¦ ¦a¦ ¦prob able¦ ¦or¦ ¦confirmed¦ ¦case¦ ;
𐋇 ¦direct¦ ¦care¦ ¦for¦ ¦a¦ ¦pa ti ent¦ ¦with¦ ¦prob able¦ ¦or¦ ¦confirmed¦ ¦covid¦ - ¦19¦ ¦disease¦ ¦without¦ ¦using¦ ¦prop er¦ ¦personal¦ ¦prot ective¦ ¦equipment¦ ;
𐋇 ¦other¦ ¦s itu ations¦ ¦as¦ ¦indic ated¦ ¦by¦ ¦local¦ ¦risk¦ ¦as se ss ments¦ ▁" . ¦who¦ ¦recomm ends¦ ¦rep orting¦ ¦of¦ ¦prob able¦ ¦and¦ ¦confirmed¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦within¦ ¦4 8¦ ¦hours¦ ¦of¦ ¦ident ific ation¦ .
𐋇¦the¦ ¦countries¦ ¦should¦ ¦report¦ ¦on¦ ¦a¦ ¦case¦ - ¦by¦ - ¦case¦ ¦ba sis¦ ¦as¦ ¦fa r¦ ¦as¦ ¦possible¦ ,▁ ¦but¦ ¦in¦ ¦case¦ ¦of¦ ¦limi t ation¦ ¦in¦ ¦res o ur ces¦ ,▁ ¦a gg re g ate¦ ¦w ee k ly¦ ¦rep orting¦ ¦is¦ ¦also¦ ¦possible¦ .
𐋇¦some¦ ¦organiz ations¦ ¦have¦ ¦cre ated¦ ¦cr ow d s o ur c ed¦ ¦app s¦ ¦for¦ ¦syndr om ic¦ ¦surveillance¦ ,▁ ¦where¦ ¦people¦ ¦can¦ ¦report¦ ¦their¦ ¦symptoms¦ ¦to¦ ¦help¦ ¦res ear ch ers¦ ¦ma p¦ ¦areas¦ ¦with¦ ¦con ce nt r ation¦ ¦of¦ ¦covid¦ - ¦19¦ ¦symptoms¦ .
𐋇 ¦vir ological¦ ¦surveillance¦ ¦is¦ ¦d one¦ ¦by¦ ¦using¦ ¦m ol ec ular¦ ¦tests¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇 ¦who¦ ¦has¦ ¦publ ished¦ ¦res o ur ces¦ ¦for¦ ¦la bor at or ies¦ ¦on¦ ¦how¦ ¦to¦ ¦per for m¦ ¦testing¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇¦in¦ ¦the¦ ¦european¦ ¦un ion¦ ,▁ ¦laboratory¦ ¦confirmed¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦are¦ ¦reported¦ ¦within¦ ¦24¦ ¦hours¦ ¦of¦ ¦ident ific ation¦ .
𐋇 ¦at¦ ¦least¦ ¦24¦ ¦countries¦ ¦have¦ ¦ es ta bl ished¦ ¦d ig it al¦ ¦surveillance¦ ¦of¦ ¦their¦ ¦c itiz ens¦ .
𐋇¦the¦ ¦d ig it al¦ ¦surveillance¦ ¦techn ol og ies¦ ¦include¦ ¦app s¦ ,▁ ¦loc ation¦ ¦data¦ ¦and¦ ¦el ect r on ic¦ ¦ta g s¦ .
𐋇¦the¦ ¦center¦ ¦for¦ ¦disease¦ ¦control¦ ¦and¦ ¦pre vention¦ ¦in¦ ¦us a¦ ¦trac ks¦ ¦the¦ ¦travel¦ ¦information¦ ¦of¦ ¦individuals¦ ¦using¦ ¦air line¦ ¦p as se nger¦ ¦data¦ .
𐋇¦in¦ ¦ho ng¦ ¦ko ng¦ ,▁ ¦author ities¦ ¦are¦ ¦requir ing¦ ¦a¦ ¦br ac el et¦ ¦and¦ ¦an¦ ¦app¦ ¦for¦ ¦all¦ ¦tra ve ll ers¦ .
𐋇¦a¦ ¦g ps¦ ¦app¦ ¦is¦ ¦used¦ ¦to¦ ¦tr ack¦ ¦the¦ ¦loc ations¦ ¦of¦ ¦individuals¦ ¦in¦ ¦south¦ ¦ko rea¦ ¦to¦ ¦e ns ure¦ ¦against¦ ¦quarantine¦ ¦brea ch¦ ,▁ ¦s ending¦ ¦al er ts¦ ¦to¦ ¦the¦ ¦us er¦ ¦and¦ ¦to¦ ¦author ities¦ ¦if¦ ¦people¦ ¦lea ve¦ ¦de si gn ated¦ ¦areas¦ .
𐋇¦in¦ ¦si ng ap ore¦ ,▁ ¦individuals¦ ¦have¦ ¦to¦ ¦report¦ ¦their¦ ¦loc ations¦ ¦with¦ ¦ph ot ogra ph ic¦ ¦pr oo f¦ .
𐋇 ¦th ai land¦ ¦is¦ ¦using¦ ¦an¦ ¦app¦ ¦and¦ ¦si m¦ ¦c ards¦ ¦for¦ ¦all¦ ¦tra v el ers¦ ¦to¦ ¦en for ce¦ ¦their¦ ¦quarantine¦ .
𐋇 ¦human¦ ¦ ri gh ts¦ ¦organiz ations¦ ¦have¦ ¦crit ici zed¦ ¦some¦ ¦of¦ ¦these¦ ¦measures¦ ,▁ ¦as king¦ ¦the¦ ¦gover n ments¦ ¦not¦ ¦to¦ ¦use¦ ¦the¦ ¦pandemic¦ ¦as¦ ¦a¦ ¦cover¦ ¦to¦ ¦int ro duc e¦ ¦inv as ive¦ ¦d ig it al¦ ¦surveillance¦ .
𐋇¦b ¦ ' ¦coronaviruses¦ ¦are¦ ¦a¦ ¦group¦ ¦of¦ ¦related¦ ¦viruses¦ ¦that¦ ¦cause¦ ¦diseases¦ ¦in¦ ¦ma mm als¦ ¦and¦ ¦b ir ds¦ .
𐋇¦in¦ ¦humans¦ ,▁ ¦coronaviruses¦ ¦cause¦ ¦respiratory¦ ¦trac t¦ ¦infections¦ ¦that¦ ¦can¦ ¦r ange¦ ¦from¦ ¦mild¦ ¦to¦ ¦le th al¦ .
𐋇 ¦mild¦ ¦i ll n es ses¦ ¦include¦ ¦some¦ ¦cases¦ ¦of¦ ¦the¦ ¦common¦ ¦cold¦ ▁( ¦which¦ ¦has¦ ¦other¦ ¦possible¦ ¦ca u ses¦ ,▁ ¦pr ed o mi na ntly¦ ¦r hi no vi ru ses¦ ),▁ ¦while¦ ¦more¦ ¦le th al¦ ¦vari et ies¦ ¦can¦ ¦cause¦ ¦sars¦ ,▁ ¦mers¦ ,▁ ¦and¦ ¦covid¦ - ¦19¦ .
𐋇 ¦symptoms¦ ¦in¦ ¦other¦ ¦spec ies¦ ¦v ary¦ :▁ 𐋇¦in¦ ¦ch ick ens¦ ,▁ ¦they¦ ¦cause¦ ¦an¦ ¦u pp er¦ ¦respiratory¦ ¦trac t¦ ¦disease¦ ,▁ ¦while¦ ¦in¦ ¦c ow s¦ ¦and¦ ¦p ig s¦ ¦they¦ ¦cause¦ ¦di arr he a¦ .
𐋇¦there¦ ¦are¦ ¦y et¦ ¦to¦ ¦be¦ ¦vaccines¦ ¦or¦ ¦anti vir al¦ ¦d ru g s¦ ¦to¦ ¦prevent¦ ¦or¦ ¦tre at¦ ¦human¦ ¦coronavirus¦ ¦infections¦ .
𐋇 ¦coronaviruses¦ ¦con st it ute¦ ¦the¦ ¦sub fa mi ly¦ ¦or th oc o ro na vi ri na e¦ ,▁ ¦in¦ ¦the¦ ¦family¦ ¦corona vir id a e¦ ,▁ ¦order¦ ¦n id o vi ra les¦ ,▁ ¦and¦ ¦re al m¦ ¦ ri bo vir ia¦ .
𐋇¦they¦ ¦are¦ ¦en v el op ed¦ ¦viruses¦ ¦with¦ ¦a¦ ¦positive¦ - ¦sen se¦ ¦si ng le¦ - ¦stra nded¦ ¦rna¦ ¦gen ome¦ ¦and¦ ¦a¦ ¦n uc le oc ap s id¦ ¦of¦ ¦h el ical¦ ¦s y mm et ry¦ .
𐋇¦the¦ ¦gen ome¦ ¦s iz e¦ ¦of¦ ¦coronaviruses¦ ¦r an ges¦ ¦from¦ ¦appro xi ma tely¦ ¦26¦ ¦to¦ ¦3 2¦ ¦k il ob a ses¦ ,▁ ¦one¦ ¦of¦ ¦the¦ ¦l arg est¦ ¦among¦ ¦rna¦ ¦viruses¦ .
𐋇¦they¦ ¦have¦ ¦ch ara ct er ist ic¦ ¦cl ub ¦ - ¦sh ap ed¦ ¦sp i k es¦ ¦that¦ ¦pro j ect¦ ¦from¦ ¦their¦ ¦sur f ace¦ ,▁ ¦which¦ ¦in¦ ¦el ect r on¦ ¦m ic r ogra ph s¦ ¦cre ate¦ ¦an¦ ¦ im age¦ ¦re min is c ent¦ ¦of¦ ¦the¦ ¦so la r¦ ¦corona ¦ ¦from¦ ¦which¦ ¦their¦ ¦na me¦ ¦d er ives¦ .
𐋇 ¦coronaviruses¦ ¦were¦ ¦first¦ ¦dis covered¦ ¦in¦ ¦the¦ ¦19 3 0 s¦ ¦when¦ ¦an¦ ¦acute¦ ¦respiratory¦ ¦infection¦ ¦of¦ ¦do me st ic ated¦ ¦ch ick ens¦ ¦was¦ ¦sh own¦ ¦to¦ ¦be¦ ¦caused¦ ¦by¦ ¦infectious¦ ¦br on ch itis¦ ¦virus¦ ▁( ¦i b v ¦ ).
𐋇¦in¦ ¦the¦ ¦19 4 0 s¦ ,▁ ¦two¦ ¦more¦ ¦anim al¦ ¦coronaviruses¦ ,▁ ¦mo use¦ ¦he p at itis¦ ¦virus¦ ▁( ¦m h v ¦ )▁ ¦and¦ ¦transm is si ble¦ ¦ga st ro e nt er itis¦ ¦virus¦ ▁( ¦t ge v ¦ ),▁ ¦were¦ ¦isol ated¦ . ¦human¦ ¦coronaviruses¦ ¦were¦ ¦dis covered¦ ¦in¦ ¦the¦ ¦19 6 0 s¦ .
𐋇¦the¦ ¦ ear li est¦ ¦ on es¦ ¦st ud ied¦ ¦were¦ ¦from¦ ¦human¦ ¦patients¦ ¦with¦ ¦the¦ ¦common¦ ¦cold¦ ,▁ ¦which¦ ¦were¦ ¦later¦ ¦na med¦ ¦human¦ ¦coronavirus¦ ¦22 9 e¦ ¦and¦ ¦human¦ ¦coronavirus¦ ¦ oc 4 3¦ .
𐋇¦they¦ ¦were¦ ¦first¦ ¦i ma ged¦ ¦by¦ ¦sc ot t ish¦ ¦vir ol og ist¦ ¦june¦ ¦al me id a¦ ¦at¦ ¦s t¦ .▁ ¦t ho ma s¦ ¦hospital¦ ¦in¦ ¦l ond on¦ .
𐋇 ¦other¦ ¦human¦ ¦coronaviruses¦ ¦have¦ ¦since¦ ¦been¦ ¦identified¦ ,▁ ¦including¦ ¦sars¦ - ¦cov¦ ¦in¦ ¦20 0 3¦ ,▁ ¦hcov¦ ¦n l 6 3¦ ¦in¦ ¦20 0 4¦ ,▁ ¦h k u 1¦ ¦in¦ ¦20 0 5¦ ,▁ ¦mers¦ - ¦cov¦ ¦in¦ ¦20 1 2¦ ,▁ ¦and¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦in¦ ¦2019¦ .
𐋇 ¦most¦ ¦of¦ ¦these¦ ¦have¦ ¦invol v ed¦ ¦ser ious¦ ¦respiratory¦ ¦trac t¦ ¦infections¦ .
𐋇¦the¦ ¦na me¦ ¦was¦ ¦first¦ ¦used¦ ¦in¦ ¦19 6 8¦ ¦by¦ ¦an¦ ¦inf ormal¦ ¦group¦ ¦of¦ ¦vir ol og i sts¦ ¦in¦ ¦the¦ ¦jo ur n al¦ ¦nat ure¦ ¦to¦ ¦de si gn ate¦ ¦the¦ ¦new¦ ¦family¦ ¦of¦ ¦viruses¦ .
𐋇¦the¦ ¦na me¦ ¦ref ers¦ ¦to¦ ¦the¦ ¦ch ara ct er ist ic¦ ¦app ear ance¦ ¦of¦ ¦vir i ons¦ ▁( ¦the¦ ¦inf ective¦ ¦for m¦ ¦of¦ ¦the¦ ¦virus¦ )▁ ¦by¦ ¦el ect r on¦ ¦m ic r os c op y¦ ,▁ ¦which¦ ¦have¦ ¦a¦ ¦f r in ge¦ ¦of¦ ¦large¦ ,▁ ¦b ul bo us¦ ¦sur f ace¦ ¦pro j ec tions¦ ¦cre ating¦ ¦an¦ ¦ im age¦ ¦re min is c ent¦ ¦of¦ ¦a¦ ¦cr own¦ ¦or¦ ¦of¦ ¦a¦ ¦so la r¦ ¦corona ¦ .
𐋇¦this¦ ¦m or ph ology¦ ¦is¦ ¦cre ated¦ ¦by¦ ¦the¦ ¦viral¦ ¦sp i ke¦ ¦p e pl om ers¦ ,▁ ¦which¦ ¦are¦ ¦prote ins¦ ¦on¦ ¦the¦ ¦sur f ace¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇 ¦coronaviruses¦ ¦are¦ ¦large¦ ¦p le om or ph ic¦ ¦s ph er ical¦ ¦partic les¦ ¦with¦ ¦b ul bo us¦ ¦sur f ace¦ ¦pro j ec tions¦ .
𐋇¦the¦ ¦en v el ope¦ ¦of¦ ¦the¦ ¦virus¦ ¦in¦ ¦el ect r on¦ ¦m ic r ogra ph s¦ ¦app ear s¦ ¦as¦ ¦a¦ ¦dis ti nc t¦ ¦p ai r¦ ¦of¦ ¦el ect r on¦ ¦d en se¦ ¦s he lls¦ . ¦the¦ ¦viral¦ ¦en v el ope¦ ¦con si sts¦ ¦of¦ ¦a¦ ¦l ip id¦ ¦bi la y er¦ ¦where¦ ¦the¦ ¦me mb r an e¦ ▁( ¦ m¦ ),▁ ¦en v el ope¦ ▁( ¦ e¦ )▁ ¦and¦ ¦sp i ke¦ ▁( ¦s¦ )▁ ¦st ru ct ural¦ ¦prote ins¦ ¦are¦ ¦an ch or ed¦ .
𐋇¦the¦ ¦l ip id¦ ¦bi la y er¦ ¦en v el ope¦ ,▁ ¦me mb r an e¦ ¦prote ins¦ ,▁ ¦and¦ ¦n uc le oc ap s id¦ ¦protect¦ ¦the¦ ¦virus¦ ¦when¦ ¦it¦ ¦is¦ ¦outside¦ ¦the¦ ¦host¦ ¦c ell¦ .
𐋇 ¦coronaviruses¦ ¦con tain¦ ¦a¦ ¦positive¦ - ¦sen se¦ ,▁ ¦si ng le¦ - ¦stra nded¦ ¦rna¦ ¦gen ome¦ .
𐋇¦the¦ ¦gen ome¦ ¦s iz e¦ ¦for¦ ¦coronaviruses¦ ¦r an ges¦ ¦from¦ ¦26¦ . ¦4¦ ¦to¦ ¦3 1¦ . ¦7¦ ¦k il ob a ses¦ .
𐋇¦the¦ ¦gen ome¦ ¦s iz e¦ ¦is¦ ¦one¦ ¦of¦ ¦the¦ ¦l arg est¦ ¦among¦ ¦rna¦ ¦viruses¦ .
𐋇¦the¦ ¦open¦ ¦rea ding¦ ¦fra m es¦ ¦1 a¦ ¦and¦ ¦1 b ¦ ,▁ ¦which¦ ¦occ u p y¦ ¦the¦ ¦first¦ ¦two¦ - ¦thir ds¦ ¦of¦ ¦the¦ ¦gen ome¦ ,▁ ¦e nc o de¦ ¦the¦ ¦re pl ic ase¦ ▁/▁ ¦trans c ri pt ase¦ ¦pol y p ro te in¦ .
𐋇¦the¦ ¦re pl ic ase¦ ▁/▁ ¦trans c ri pt ase¦ ¦pol y p ro te in¦ ¦self¦ ¦cl ea ves¦ ¦to¦ ¦for m¦ ¦n on st ru ct ural¦ ¦prote ins¦ . ¦the¦ ¦later¦ ¦rea ding¦ ¦fra m es¦ ¦e nc o de¦ ¦the¦ ¦four¦ ¦major¦ ¦st ru ct ural¦ ¦prote ins¦ :▁ 𐋇 ¦sp i ke¦ ,▁ ¦en v el ope¦ ,▁ ¦me mb r an e¦ ,▁ ¦and¦ ¦n uc le oc ap s id¦ .
𐋇 ¦inter s p er sed¦ ¦between¦ ¦these¦ ¦rea ding¦ ¦fra m es¦ ¦are¦ ¦the¦ ¦rea ding¦ ¦fra m es¦ ¦for¦ ¦the¦ ¦ac cess ory¦ ¦prote ins¦ .
𐋇¦the¦ ¦number¦ ¦of¦ ¦ac cess ory¦ ¦prote ins¦ ¦and¦ ¦their¦ ¦f un ction¦ ¦is¦ ¦uni q ue¦ ¦dep ending¦ ¦on¦ ¦the¦ ¦specific¦ ¦coronavirus¦ .
𐋇 ¦infection¦ ¦beg ins¦ ¦when¦ ¦the¦ ¦viral¦ ¦sp i ke¦ ▁( ¦s¦ )▁ ¦gl y c op ro te in¦ ¦att a ches¦ ¦to¦ ¦its¦ ¦comp le me nt ary¦ ¦host¦ ¦c ell¦ ¦rece pt or¦ .
𐋇 ¦after¦ ¦att a ch ment¦ ,▁ ¦a¦ ¦prote ase¦ ¦of¦ ¦the¦ ¦host¦ ¦c ell¦ ¦cl ea ves¦ ¦and¦ ¦activ ates¦ ¦the¦ ¦rece pt or¦ - ¦att a ched¦ ¦sp i ke¦ ¦protein¦ .
𐋇 ¦dep ending¦ ¦on¦ ¦the¦ ¦host¦ ¦c ell¦ ¦prote ase¦ ¦available¦ ,▁ ¦cl ea v age¦ ¦and¦ ¦activ ation¦ ¦all ow s¦ ¦the¦ ¦virus¦ ¦to¦ ¦en ter¦ ¦the¦ ¦host¦ ¦c ell¦ ¦by¦ ¦ end oc y t o sis¦ ¦or¦ ¦direct¦ ¦f us ion¦ ¦of¦ ¦the¦ ¦viral¦ ¦en ve lo p¦ ¦with¦ ¦the¦ ¦host¦ ¦me mb r an e¦ . ¦on¦ ¦ent ry¦ ¦into¦ ¦the¦ ¦host¦ ¦c ell¦ ,▁ ¦the¦ ¦virus¦ ¦partic le¦ ¦is¦ ¦u nc o ated¦ ,▁ ¦and¦ ¦its¦ ¦gen ome¦ ¦ent ers¦ ¦the¦ ¦c ell¦ ¦c y t o pl as m¦ .
𐋇¦the¦ ¦host¦ ¦ rib os ome¦ ¦trans l ates¦ ¦the¦ ¦in it ial¦ ¦over la pping¦ ¦open¦ ¦rea ding¦ ¦fra me¦ ¦of¦ ¦the¦ ¦virus¦ ¦gen ome¦ ¦and¦ ¦for ms¦ ¦a¦ ¦long¦ ¦pol y p ro te in¦ .
𐋇¦the¦ ¦pol y p ro te in¦ ¦has¦ ¦its¦ ¦ own¦ ¦prot ea ses¦ ¦which¦ ¦cl ea ve¦ ¦the¦ ¦pol y p ro te in¦ ¦into¦ ¦mult ip le¦ ¦n on st ru ct ural¦ ¦prote ins¦ .
𐋇¦a¦ ¦number¦ ¦of¦ ¦the¦ ¦n on st ru ct ural¦ ¦prote ins¦ ¦co al es ce¦ ¦to¦ ¦for m¦ ¦a¦ ¦mult i¦ - ¦protein¦ ¦re pl ic ase¦ - ¦trans c ri pt ase¦ ¦comp le x¦ ▁( ¦ rt c¦ ).
𐋇¦the¦ ¦ma in¦ ¦re pl ic ase¦ - ¦trans c ri pt ase¦ ¦protein¦ ¦is¦ ¦the¦ ¦rna¦ - ¦dep end ent¦ ¦rna¦ ¦pol y mer ase¦ ▁( ¦r dr p¦ ).
𐋇¦it¦ ¦is¦ ¦dir ect ly¦ ¦invol v ed¦ ¦in¦ ¦the¦ ¦re pl ic ation¦ ¦and¦ ¦trans c ri ption¦ ¦of¦ ¦rna¦ ¦from¦ ¦an¦ ¦rna¦ ¦ str and¦ .
𐋇¦the¦ ¦other¦ ¦n on st ru ct ural¦ ¦prote ins¦ ¦in¦ ¦the¦ ¦comp le x¦ ¦ass ist¦ ¦in¦ ¦the¦ ¦re pl ic ation¦ ¦and¦ ¦trans c ri ption¦ ¦proc ess¦ .
𐋇¦the¦ ¦ex o rib on uc le ase¦ ¦n on st ru ct ural¦ ¦protein¦ ,▁ ¦for¦ ¦inst ance¦ ,▁ ¦provid es¦ ¦ext r a¦ ¦f id el ity¦ ¦to¦ ¦re pl ic ation¦ ¦by¦ ¦provid ing¦ ¦a¦ ¦pr oo f rea ding¦ ¦f un ction¦ ¦which¦ ¦the¦ ¦rna¦ - ¦dep end ent¦ ¦rna¦ ¦pol y mer ase¦ ¦l ac ks¦ . ¦one¦ ¦of¦ ¦the¦ ¦ma in¦ ¦f u nc tions¦ ¦of¦ ¦the¦ ¦comp le x¦ ¦is¦ ¦to¦ ¦re pl ic ate¦ ¦the¦ ¦viral¦ ¦gen ome¦ .
𐋇 ¦r dr p¦ ¦dir ect ly¦ ¦me di ates¦ ¦the¦ ¦s y nt he sis¦ ¦of¦ ¦negative¦ - ¦sen se¦ ¦ ge nomic¦ ¦rna¦ ¦from¦ ¦the¦ ¦positive¦ - ¦sen se¦ ¦ ge nomic¦ ¦rna¦ .
𐋇¦this¦ ¦is¦ ¦fo ll owed¦ ¦by¦ ¦the¦ ¦re pl ic ation¦ ¦of¦ ¦positive¦ - ¦sen se¦ ¦ ge nomic¦ ¦rna¦ ¦from¦ ¦the¦ ¦negative¦ - ¦sen se¦ ¦ ge nomic¦ ¦rna¦ .
𐋇¦the¦ ¦other¦ ¦important¦ ¦f un ction¦ ¦of¦ ¦the¦ ¦comp le x¦ ¦is¦ ¦to¦ ¦trans c rib e¦ ¦the¦ ¦viral¦ ¦gen ome¦ .
𐋇 ¦r dr p¦ ¦dir ect ly¦ ¦me di ates¦ ¦the¦ ¦s y nt he sis¦ ¦of¦ ¦negative¦ - ¦sen se¦ ¦sub ge nomic¦ ¦rna¦ ¦m ol ecu les¦ ¦from¦ ¦the¦ ¦positive¦ - ¦sen se¦ ¦ ge nomic¦ ¦rna¦ .
𐋇¦this¦ ¦is¦ ¦fo ll owed¦ ¦by¦ ¦the¦ ¦trans c ri ption¦ ¦of¦ ¦these¦ ¦negative¦ - ¦sen se¦ ¦sub ge nomic¦ ¦rna¦ ¦m ol ecu les¦ ¦to¦ ¦their¦ ¦cor r esp on ding¦ ¦positive¦ - ¦sen se¦ ¦m r na s¦ .
𐋇¦the¦ ¦re pl ic ated¦ ¦positive¦ - ¦sen se¦ ¦ ge nomic¦ ¦rna¦ ¦bec omes¦ ¦the¦ ¦gen ome¦ ¦of¦ ¦the¦ ¦pr ogen y¦ ¦viruses¦ .
𐋇¦the¦ ¦m r na s¦ ¦are¦ ¦gen e¦ ¦trans c r ip ts¦ ¦of¦ ¦the¦ ¦last¦ ¦thir d¦ ¦of¦ ¦the¦ ¦virus¦ ¦gen ome¦ ¦after¦ ¦the¦ ¦in it ial¦ ¦over la pping¦ ¦rea ding¦ ¦fra me¦ .
𐋇¦these¦ ¦m r na s¦ ¦are¦ ¦trans l ated¦ ¦by¦ ¦the¦ ¦host¦ ' ¦s¦ ¦ rib os omes¦ ¦into¦ ¦the¦ ¦st ru ct ural¦ ¦prote ins¦ ¦and¦ ¦a¦ ¦number¦ ¦of¦ ¦ac cess ory¦ ¦prote ins¦ .
𐋇 ¦rna¦ ¦trans l ation¦ ¦occur s¦ ¦in side¦ ¦the¦ ¦ end o pl as m ic¦ ¦r et ic ul um¦ .
𐋇¦the¦ ¦viral¦ ¦st ru ct ural¦ ¦prote ins¦ ¦s¦ ,▁ ¦ e¦ ,▁ ¦and¦ ¦ m¦ ¦mo ve¦ ¦a lo ng¦ ¦the¦ ¦sec r et ory¦ ¦path w ay¦ ¦into¦ ¦the¦ ¦g ol g i¦ ¦int erm ediate¦ ¦comp a rt ment¦ .
𐋇¦there¦ ,▁ ¦the¦ ¦ m¦ ¦prote ins¦ ¦direct¦ ¦most¦ ¦protein¦ - ¦protein¦ ¦inter ac tions¦ ¦required¦ ¦for¦ ¦as se mb ly¦ ¦of¦ ¦viruses¦ ¦following¦ ¦its¦ ¦b in ding¦ ¦to¦ ¦the¦ ¦n uc le oc ap s id¦ .
𐋇 ¦pr ogen y¦ ¦viruses¦ ¦are¦ ¦then¦ ¦rel ea sed¦ ¦from¦ ¦the¦ ¦host¦ ¦c ell¦ ¦by¦ ¦ex oc y t o sis¦ ¦through¦ ¦sec r et ory¦ ¦v es ic les¦ .
𐋇¦the¦ ¦inter a ction¦ ¦of¦ ¦the¦ ¦coronavirus¦ ¦sp i ke¦ ¦protein¦ ¦with¦ ¦its¦ ¦comp le ment¦ ¦host¦ ¦c ell¦ ¦rece pt or¦ ¦is¦ ¦centr al¦ ¦in¦ ¦det er mi ning¦ ¦the¦ ¦ti ss ue¦ ¦tr op is m¦ ,▁ ¦inf ect iv ity¦ ,▁ ¦and¦ ¦spec ies¦ ¦r ange¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦the¦ ¦sars¦ ¦coronavirus¦ ,▁ ¦for¦ ¦example¦ ,▁ ¦inf ects¦ ¦human¦ ¦ce lls¦ ¦by¦ ¦att ac hing¦ ¦to¦ ¦the¦ ¦a ng i o tens in¦ - ¦con ver ting¦ ¦en z y me¦ ¦2¦ ▁( ¦a ce 2¦ )▁ ¦rece pt or¦ .
𐋇¦the¦ ¦sc ie nt if ic¦ ¦na me¦ ¦for¦ ¦coronavirus¦ ¦is¦ ¦or th oc o ro na vi ri na e¦ ¦or¦ ¦corona vi ri na e¦ .
𐋇 ¦coronaviruses¦ ¦be lo ng¦ ¦to¦ ¦the¦ ¦family¦ ¦of¦ ¦corona vir id a e¦ ,▁ ¦order¦ ¦n id o vi ra les¦ ,▁ ¦and¦ ¦re al m¦ ¦ ri bo vir ia¦ .
𐋇 ¦gen us¦ ¦bet ac o ro na vir us¦ ;▁ ¦typ e¦ ¦spec ies¦ :▁ 𐋇¦m ur ine¦ ¦coronavirus¦
𐋇 ¦spec ies¦ :▁ 𐋇 ¦bet ac o ro na vir us¦ ¦1¦ ▁( ¦b ov ine¦ ¦coronavirus¦ ,▁ ¦human¦ ¦coronavirus¦ ¦ oc 4 3¦ ),▁ ¦human¦ ¦coronavirus¦ ¦h k u 1¦ ,▁ ¦m ur ine¦ ¦coronavirus¦ ,▁ ¦p ip ist re ll us¦ ¦bat¦ ¦coronavirus¦ ¦h k u 5¦ ,▁ ¦ro us et t us¦ ¦bat¦ ¦coronavirus¦ ¦h k u 9¦ ,▁ ¦severe¦ ¦acute¦ ¦respiratory¦ ¦syndrome¦ - ¦related¦ ¦coronavirus¦ ▁( ¦sars¦ - ¦cov¦ ,▁ ¦sars¦ - ¦cov¦ - ¦2¦ ),▁ ¦t y l on y ct eri s¦ ¦bat¦ ¦coronavirus¦ ¦h k u 4¦ ,▁ ¦m id d le¦ ¦e ast¦ ¦respiratory¦ ¦syndrome¦ - ¦related¦ ¦coronavirus¦ ,▁ ¦h ed ge ho g¦ ¦coronavirus¦ ¦1¦ ▁( ¦ eri cov ¦ )
𐋇 ¦spec ies¦ :▁ 𐋇 ¦be lu g a¦ ¦wh a le¦ ¦coronavirus¦ ¦sw 1¦ ,▁ ¦infectious¦ ¦br on ch itis¦ ¦virus¦
𐋇¦the¦ ¦most¦ ¦rec ent¦ ¦common¦ ¦an ce st or¦ ▁( ¦m r c a¦ )▁ ¦of¦ ¦all¦ ¦coronaviruses¦ ¦is¦ ¦estim ated¦ ¦to¦ ¦have¦ ¦ex is ted¦ ¦as¦ ¦rece ntly¦ ¦as¦ ¦8 0 00¦ ¦b ce¦ ,▁ ¦al th ough¦ ¦some¦ ¦mod els¦ ¦place¦ ¦the¦ ¦common¦ ¦an ce st or¦ ¦as¦ ¦fa r¦ ¦b ack¦ ¦as¦ ¦5 5¦ ¦million¦ ¦years¦ ¦or¦ ¦more¦ ,▁ ¦i mpl ying¦ ¦long¦ ¦ter m¦ ¦co e v ol ution¦ ¦with¦ ¦bat¦ ¦and¦ ¦a vi an¦ ¦spec ies¦ .
𐋇¦the¦ ¦most¦ ¦rec ent¦ ¦common¦ ¦an ce st or¦ ¦of¦ ¦the¦ ¦al ph ac o ro na vir us¦ ¦ line¦ ¦has¦ ¦been¦ ¦pl ac ed¦ ¦at¦ ¦about¦ ¦2 4 00¦ ¦b ce¦ ,▁ ¦the¦ ¦bet ac o ro na vir us¦ ¦ line¦ ¦at¦ ¦3 3 00¦ ¦b ce¦ ,▁ ¦the¦ ¦ga mm ac o ro na vir us¦ ¦ line¦ ¦at¦ ¦2 8 00¦ ¦b ce¦ ,▁ ¦and¦ ¦the¦ ¦del t ac o ro na vir us¦ ¦ line¦ ¦at¦ ¦about¦ ¦30 00¦ ¦b ce¦ .
𐋇¦the¦ ¦large¦ ¦number¦ ¦of¦ ¦host¦ ¦bat¦ ¦and¦ ¦a vi an¦ ¦spec ies¦ ,▁ ¦and¦ ¦their¦ ¦global¦ ¦r ange¦ ,▁ ¦has¦ ¦e na bl ed¦ ¦ex tens ive¦ ¦ev ol ution¦ ¦and¦ ¦dis se m ination¦ ¦of¦ ¦coronaviruses¦ . ¦many¦ ¦human¦ ¦coronavirus¦ ¦have¦ ¦their¦ ¦orig in¦ ¦in¦ ¦bats¦ .
𐋇 ¦more¦ ¦rece ntly¦ ,▁ ¦al p ac a¦ ¦coronavirus¦ ¦and¦ ¦human¦ ¦coronavirus¦ ¦22 9 e¦ ¦di ver ged¦ ¦so me ti me¦ ¦before¦ ¦19 6 0¦ .
𐋇 ¦mers¦ - ¦cov¦ ¦e mer ged¦ ¦in¦ ¦humans¦ ¦from¦ ¦bats¦ ¦through¦ ¦the¦ ¦int erm ediate¦ ¦host¦ ¦of¦ ¦ca m els¦ .
𐋇 ¦mers¦ - ¦cov¦ ,▁ ¦al th ough¦ ¦related¦ ¦to¦ ¦several¦ ¦bat¦ ¦coronavirus¦ ¦spec ies¦ ,▁ ¦app ear s¦ ¦to¦ ¦have¦ ¦di ver ged¦ ¦from¦ ¦these¦ ¦several¦ ¦ce nt ur ies¦ ¦ag o¦ .
𐋇¦the¦ ¦most¦ ¦clos ely¦ ¦related¦ ¦bat¦ ¦coronavirus¦ ¦and¦ ¦sars¦ - ¦cov¦ ¦di ver ged¦ ¦in¦ ¦19 8 6¦ .
𐋇¦a¦ ¦possible¦ ¦pa th¦ ¦of¦ ¦ev ol ution¦ ,▁ ¦of¦ ¦sars¦ ¦coronavirus¦ ¦and¦ ¦k e en¦ ¦bat¦ ¦coronaviruses¦ ,▁ ¦su g ge sts¦ ¦that¦ ¦sars¦ ¦related¦ ¦coronaviruses¦ ¦co e v ol v ed¦ ¦in¦ ¦bats¦ ¦for¦ ¦a¦ ¦long¦ ¦time¦ .
𐋇¦in¦ ¦the¦ ¦1 7 9 0 s¦ ,▁ ¦e qu ine¦ ¦coronavirus¦ ¦di ver ged¦ ¦from¦ ¦the¦ ¦b ov ine¦ ¦coronavirus¦ ¦after¦ ¦a¦ ¦c ross¦ - ¦spec ies¦ ¦j um p¦ .
𐋇 ¦later¦ ¦in¦ ¦the¦ ¦1 8 9 0 s¦ ,▁ ¦human¦ ¦coronavirus¦ ¦ oc 4 3¦ ¦di ver ged¦ ¦from¦ ¦b ov ine¦ ¦coronavirus¦ ¦after¦ ¦another¦ ¦c ross¦ - ¦spec ies¦ ¦sp il lo ver¦ ¦ev ent¦ .
𐋇¦it¦ ¦is¦ ¦spec ul ated¦ ¦that¦ ¦the¦ ¦flu¦ ¦pandemic¦ ¦of¦ ¦1 8 9 0¦ ¦may¦ ¦have¦ ¦been¦ ¦caused¦ ¦by¦ ¦this¦ ¦sp il lo ver¦ ¦ev ent¦ ,▁ ¦and¦ ¦not¦ ¦by¦ ¦the¦ ¦influenza¦ ¦virus¦ ,▁ ¦because¦ ¦of¦ ¦the¦ ¦related¦ ¦t im ing¦ ,▁ ¦ne ur ological¦ ¦symptoms¦ ,▁ ¦and¦ ¦un k n own¦ ¦ca us ative¦ ¦ag ent¦ ¦of¦ ¦the¦ ¦pandemic¦ .
𐋇 ¦human¦ ¦coronavirus¦ ¦ oc 4 3¦ ¦be si des¦ ¦ca us ing¦ ¦respiratory¦ ¦infections¦ ¦is¦ ¦also¦ ¦suspected¦ ¦of¦ ¦pla ying¦ ¦a¦ ¦ro le¦ ¦in¦ ¦ne ur ological¦ ¦diseases¦ .
𐋇¦in¦ ¦the¦ ¦19 5 0 s¦ ,▁ ¦the¦ ¦human¦ ¦coronavirus¦ ¦ oc 4 3¦ ¦beg an¦ ¦to¦ ¦di ver ge¦ ¦into¦ ¦its¦ ¦pres ent¦ ¦gen ot y p es¦ .
𐋇 ¦ph y lo ge nt ically¦ ,▁ ¦mo use¦ ¦he p at itis¦ ¦virus¦ ▁( ¦m ur ine¦ ¦coronavirus¦ ),▁ ¦which¦ ¦inf ects¦ ¦the¦ ¦mo use¦ ' ¦s¦ ¦li ver¦ ¦and¦ ¦the¦ ¦centr al¦ ¦n erv o us¦ ¦system¦ ,▁ ¦is¦ ¦related¦ ¦to¦ ¦human¦ ¦coronavirus¦ ¦ oc 4 3¦ ¦and¦ ¦b ov ine¦ ¦coronavirus¦ .
𐋇 ¦human¦ ¦coronavirus¦ ¦h k u 1¦ ,▁ ¦like¦ ¦the¦ ¦a for e m en tion ed¦ ¦viruses¦ ,▁ ¦also¦ ¦has¦ ¦its¦ ¦orig ins¦ ¦in¦ ¦ro d ents¦ .
𐋇 ¦coronaviruses¦ ¦v ary¦ ¦sign ific a ntly¦ ¦in¦ ¦risk¦ ¦fa ct or¦ .
𐋇¦some¦ ¦can¦ ¦k ill¦ ¦more¦ ¦than¦ ¦30¦ %▁ ¦of¦ ¦those¦ ¦infected¦ ,▁ ¦such¦ ¦as¦ ¦mers¦ - ¦cov¦ ,▁ ¦and¦ ¦some¦ ¦are¦ ¦rel at ively¦ ¦h arm less¦ ,▁ ¦such¦ ¦as¦ ¦the¦ ¦common¦ ¦cold¦ .
𐋇 ¦coronaviruses¦ ¦can¦ ¦cause¦ ¦c ol ds¦ ¦with¦ ¦major¦ ¦symptoms¦ ,▁ ¦such¦ ¦as¦ ¦fever¦ ,▁ ¦and¦ ¦a¦ ¦s ore¦ ¦th ro at¦ ¦from¦ ¦sw o ll en¦ ¦ad en oi ds¦ .
𐋇 ¦coronaviruses¦ ¦can¦ ¦cause¦ ¦pneumonia¦ ▁( ¦e it her¦ ¦direct¦ ¦viral¦ ¦pneumonia¦ ¦or¦ ¦sec ond ary¦ ¦ba ct er ial¦ ¦pneumonia¦ )▁ ¦and¦ ¦br on ch itis¦ ▁( ¦e it her¦ ¦direct¦ ¦viral¦ ¦br on ch itis¦ ¦or¦ ¦sec ond ary¦ ¦ba ct er ial¦ ¦br on ch itis¦ ).
𐋇¦the¦ ¦human¦ ¦coronavirus¦ ¦dis covered¦ ¦in¦ ¦20 0 3¦ ,▁ ¦sars¦ - ¦cov¦ ,▁ ¦which¦ ¦ca u ses¦ ¦severe¦ ¦acute¦ ¦respiratory¦ ¦syndrome¦ ▁( ¦sars¦ ),▁ ¦has¦ ¦a¦ ¦uni q ue¦ ¦path ogen e sis¦ ¦because¦ ¦it¦ ¦ca u ses¦ ¦both¦ ¦u pp er¦ ¦and¦ ¦lower¦ ¦respiratory¦ ¦trac t¦ ¦infections¦ . ¦si x¦ ¦spec ies¦ ¦of¦ ¦human¦ ¦coronaviruses¦ ¦are¦ ¦known¦ ,▁ ¦with¦ ¦one¦ ¦spec ies¦ ¦sub di vi ded¦ ¦into¦ ¦two¦ ¦different¦ ¦stra ins¦ ,▁ ¦ma king¦ ¦se v en¦ ¦stra ins¦ ¦of¦ ¦human¦ ¦coronaviruses¦ ¦al t og ether¦ .
𐋇 ¦four¦ ¦of¦ ¦these¦ ¦coronaviruses¦ ¦contin ually¦ ¦c ir c ul ate¦ ¦in¦ ¦the¦ ¦human¦ ¦population¦ ¦and¦ ¦produc e¦ ¦the¦ ¦gener ally¦ ¦mild¦ ¦symptoms¦ ¦of¦ ¦the¦ ¦common¦ ¦cold¦ ¦in¦ ¦ad ul ts¦ ¦and¦ ¦children¦ ¦worldwide¦ :▁ - ¦ oc 4 3¦ ,▁ - ¦h k u 1¦ ,▁ ¦hcov¦ - ¦22 9 e¦ ,▁ - ¦n l 6 3¦ .
𐋇 ¦coronaviruses¦ ¦cause¦ ¦about¦ ¦15¦ %▁ ¦of¦ ¦comm ons¦ ¦c ol ds¦ .
𐋇¦the¦ ¦ma j or ity¦ ¦of¦ ¦c ol ds¦ ¦are¦ ¦caused¦ ¦by¦ ¦r hi no vi ru ses¦ .
𐋇¦the¦ ¦four¦ ¦mild¦ ¦coronaviruses¦ ¦have¦ ¦a¦ ¦se as on al¦ ¦inc idence¦ ¦occur r ing¦ ¦in¦ ¦the¦ ¦w in ter¦ ¦mon ths¦ ¦in¦ ¦temp er ate¦ ¦cl im ates¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦pre f er ence¦ ¦t ow ards¦ ¦a¦ ¦partic ular¦ ¦se as on¦ ¦in¦ ¦tr op ical¦ ¦cl im ates¦ .
𐋇 ¦four¦ ¦human¦ ¦coronaviruses¦ ¦produc e¦ ¦symptoms¦ ¦that¦ ¦are¦ ¦gener ally¦ ¦mild¦ :
𐋇¦the¦ ¦virus¦ ¦was¦ ¦offic ially¦ ¦na med¦ ¦the¦ ¦sars¦ ¦coronavirus¦ ▁( ¦sars¦ - ¦cov¦ ).
𐋇 ¦more¦ ¦than¦ ¦8¦ , ¦000¦ ¦people¦ ¦were¦ ¦infected¦ ,▁ ¦about¦ ¦t en¦ ¦p erc ent¦ ¦of¦ ¦wh om¦ ¦d ied¦ .
𐋇¦in¦ ¦se p te mber¦ ¦20 1 2¦ ,▁ ¦a¦ ¦new¦ ¦typ e¦ ¦of¦ ¦coronavirus¦ ¦was¦ ¦identified¦ ,▁ ¦in it ially¦ ¦called¦ ¦novel¦ ¦coronavirus¦ ¦20 1 2¦ ,▁ ¦and¦ ¦n ow¦ ¦offic ially¦ ¦na med¦ ¦m id d le¦ ¦e ast¦ ¦respiratory¦ ¦syndrome¦ ¦coronavirus¦ ▁( ¦mers¦ - ¦cov¦ ).
𐋇¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ¦issued¦ ¦a¦ ¦global¦ ¦alert¦ ¦so on¦ ¦after¦ .
𐋇¦the¦ ¦who¦ ¦up d ate¦ ¦on¦ ¦2 8¦ ¦se p te mber¦ ¦20 1 2¦ ¦said¦ ¦the¦ ¦virus¦ ¦d id¦ ¦not¦ ¦s ee m¦ ¦to¦ ¦p ass¦ ¦ ea si ly¦ ¦from¦ ¦person¦ ¦to¦ ¦person¦ .
𐋇¦however¦ ,▁ ¦on¦ ¦12¦ ¦may¦ ¦20 1 3¦ ,▁ ¦a¦ ¦case¦ ¦of¦ ¦human¦ - ¦to¦ - ¦human¦ ¦transmission¦ ¦in¦ ¦fra nce¦ ¦was¦ ¦confirmed¦ ¦by¦ ¦the¦ ¦fre n ch¦ ¦min ist ry¦ ¦of¦ ¦social¦ ¦aff a ir s¦ ¦and¦ ¦health¦ .
𐋇¦in¦ ¦add ition¦ ,▁ ¦cases¦ ¦of¦ ¦human¦ - ¦to¦ - ¦human¦ ¦transmission¦ ¦were¦ ¦reported¦ ¦by¦ ¦the¦ ¦min ist ry¦ ¦of¦ ¦health¦ ¦in¦ ¦t un is ia¦ .
𐋇 ¦two¦ ¦confirmed¦ ¦cases¦ ¦invol v ed¦ ¦people¦ ¦who¦ ¦s ee med¦ ¦to¦ ¦have¦ ¦ca u gh t¦ ¦the¦ ¦disease¦ ¦from¦ ¦their¦ ¦l ate¦ ¦fat her¦ ,▁ ¦who¦ ¦bec a me¦ ¦ ill¦ ¦after¦ ¦a¦ ¦visit¦ ¦to¦ ¦ q a ta r¦ ¦and¦ ¦sa ud i¦ ¦ar ab ia¦ .
𐋇¦d esp ite¦ ¦this¦ ,▁ ¦it¦ ¦app ear s¦ ¦the¦ ¦virus¦ ¦had¦ ¦tr ou ble¦ ¦sprea ding¦ ¦from¦ ¦human¦ ¦to¦ ¦human¦ ,▁ ¦as¦ ¦most¦ ¦individuals¦ ¦who¦ ¦are¦ ¦infected¦ ¦do¦ ¦not¦ ¦trans mi t¦ ¦the¦ ¦virus¦ .
𐋇¦the¦ ¦f in al¦ ¦na me¦ ¦for¦ ¦the¦ ¦virus¦ ¦is¦ ¦m id d le¦ ¦e ast¦ ¦respiratory¦ ¦syndrome¦ ¦coronavirus¦ ▁( ¦mers¦ - ¦cov¦ ).
𐋇¦the¦ ¦only¦ ¦u¦ . ¦s¦ .▁ ¦cases¦ ▁( ¦both¦ ¦sur v iv ed¦ )▁ ¦were¦ ¦recor ded¦ ¦in¦ ¦may¦ ¦20 1 4¦ . ¦in¦ ¦may¦ ¦20 1 5¦ ,▁ ¦an¦ ¦outbreak¦ ¦of¦ ¦mers¦ - ¦cov¦ ¦occur r ed¦ ¦in¦ ¦the¦ ¦rep u bl ic¦ ¦of¦ ¦ko rea¦ ,▁ ¦when¦ ¦a¦ ¦m an¦ ¦who¦ ¦had¦ ¦tra v el ed¦ ¦to¦ ¦the¦ ¦m id d le¦ ¦e ast¦ ,▁ ¦visi ted¦ ¦four¦ ¦hosp it als¦ ¦in¦ ¦the¦ ¦se ou l¦ ¦a rea¦ ¦to¦ ¦tre at¦ ¦hi s¦ ¦illness¦ .
𐋇¦this¦ ¦caused¦ ¦one¦ ¦of¦ ¦the¦ ¦l arg est¦ ¦out b rea ks¦ ¦of¦ ¦mers¦ - ¦cov¦ ¦outside¦ ¦the¦ ¦m id d le¦ ¦e ast¦ .
𐋇¦as¦ ¦of¦ ¦december¦ ¦2019¦ ,▁ ¦2¦ , ¦4 6 8¦ ¦cases¦ ¦of¦ ¦mers¦ - ¦cov¦ ¦infection¦ ¦had¦ ¦been¦ ¦confirmed¦ ¦by¦ ¦laboratory¦ ¦tests¦ ,▁ ¦8 5 1¦ ¦of¦ ¦which¦ ¦were¦ ¦fat al¦ ,▁ ¦a¦ ¦m ort ality¦ ¦rate¦ ¦of¦ ¦appro xi ma tely¦ ¦3 4¦ . ¦5¦ % .
𐋇¦in¦ ¦december¦ ¦2019¦ ,▁ ¦a¦ ¦pneumonia¦ ¦outbreak¦ ¦was¦ ¦reported¦ ¦in¦ ¦wuhan¦ ,▁ ¦china¦ .
𐋇¦on¦ ¦3 1¦ ¦december¦ ¦2019¦ ,▁ ¦the¦ ¦outbreak¦ ¦was¦ ¦trac ed¦ ¦to¦ ¦a¦ ¦novel¦ ¦stra in¦ ¦of¦ ¦coronavirus¦ ,▁ ¦which¦ ¦was¦ ¦giv en¦ ¦the¦ ¦int eri m¦ ¦na me¦ ¦2019¦ - ¦n cov ¦ ¦by¦ ¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ▁( ¦who¦ ),▁ ¦later¦ ¦re na med¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦by¦ ¦the¦ ¦international¦ ¦comm it te e¦ ¦on¦ ¦ta x on om y¦ ¦of¦ ¦viruses¦ .
𐋇¦some¦ ¦res ear ch ers¦ ¦have¦ ¦su gg ested¦ ¦the¦ ¦h u an an¦ ¦s ea f ood¦ ¦wh ol es a le¦ ¦mark et¦ ¦may¦ ¦not¦ ¦be¦ ¦the¦ ¦orig in al¦ ¦sour ce¦ ¦of¦ ¦viral¦ ¦transmission¦ ¦to¦ ¦humans¦ . ¦as¦ ¦of¦ ¦1 7¦ ¦april¦ ¦2020¦ ,▁ ¦there¦ ¦have¦ ¦been¦ ¦at¦ ¦least¦ ¦1 5 3¦ , ¦8 2 2¦ ¦confirmed¦ ¦deaths¦ ¦and¦ ¦more¦ ¦than¦ ¦2¦ , ¦2 4 0¦ , ¦19 1¦ ¦confirmed¦ ¦cases¦ ¦in¦ ¦the¦ ¦coronavirus¦ ¦pneumonia¦ ¦pandemic¦ .
𐋇¦the¦ ¦wuhan¦ ¦stra in¦ ¦has¦ ¦been¦ ¦identified¦ ¦as¦ ¦a¦ ¦new¦ ¦stra in¦ ¦of¦ ¦bet ac o ro na vir us¦ ¦from¦ ¦group¦ ¦2 b ¦ ¦with¦ ¦appro xi ma tely¦ ¦7 0¦ %▁ ¦gen et ic¦ ¦s im il ar ity¦ ¦to¦ ¦the¦ ¦sars¦ - ¦cov¦ .
𐋇¦the¦ ¦virus¦ ¦has¦ ¦a¦ ¦9 6¦ %▁ ¦s im il ar ity¦ ¦to¦ ¦a¦ ¦bat¦ ¦coronavirus¦ ,▁ ¦so¦ ¦it¦ ¦is¦ ¦wid ely¦ ¦suspected¦ ¦to¦ ¦orig in ate¦ ¦from¦ ¦bats¦ ¦as¦ ¦well¦ .
𐋇¦the¦ ¦pandemic¦ ¦has¦ ¦res ul ted¦ ¦in¦ ¦travel¦ ¦restrictions¦ ¦and¦ ¦na tion w ide¦ ¦loc k d ow ns¦ ¦in¦ ¦several¦ ¦countries¦ .
𐋇 ¦coronaviruses¦ ¦have¦ ¦been¦ ¦reco gn i zed¦ ¦as¦ ¦ca us ing¦ ¦path ological¦ ¦conditions¦ ¦in¦ ¦v et er in ary¦ ¦medic ine¦ ¦since¦ ¦the¦ ¦19 3 0 s¦ .
𐋇 ¦ex cep t¦ ¦for¦ ¦a vi an¦ ¦infectious¦ ¦br on ch itis¦ ,▁ ¦the¦ ¦major¦ ¦related¦ ¦diseases¦ ¦have¦ ¦main ly¦ ¦an¦ ¦in te st in al¦ ¦loc ation¦ .
𐋇 ¦coronaviruses¦ ¦pri ma ri ly¦ ¦inf ect¦ ¦the¦ ¦u pp er¦ ¦respiratory¦ ¦and¦ ¦ga st ro in te st in al¦ ¦trac t¦ ¦of¦ ¦ma mm als¦ ¦and¦ ¦b ir ds¦ .
𐋇¦they¦ ¦also¦ ¦cause¦ ¦a¦ ¦r ange¦ ¦of¦ ¦diseases¦ ¦in¦ ¦f ar m¦ ¦anim als¦ ¦and¦ ¦do me st ic ated¦ ¦p ets¦ ,▁ ¦some¦ ¦of¦ ¦which¦ ¦can¦ ¦be¦ ¦ser ious¦ ¦and¦ ¦are¦ ¦a¦ ¦th re at¦ ¦to¦ ¦the¦ ¦f arm ing¦ ¦ind u st ry¦ .
𐋇¦in¦ ¦ch ick ens¦ ,▁ ¦the¦ ¦infectious¦ ¦br on ch itis¦ ¦virus¦ ▁( ¦i b v ¦ ),▁ ¦a¦ ¦coronavirus¦ ,▁ ¦t arg ets¦ ¦not¦ ¦only¦ ¦the¦ ¦respiratory¦ ¦trac t¦ ¦but¦ ¦also¦ ¦the¦ ¦ ur ogen it al¦ ¦trac t¦ .
𐋇¦the¦ ¦virus¦ ¦can¦ ¦spread¦ ¦to¦ ¦different¦ ¦or g ans¦ ¦th r ou g ho ut¦ ¦the¦ ¦ch ick en¦ .
𐋇 ¦ec on om ically¦ ¦sign ific ant¦ ¦coronaviruses¦ ¦of¦ ¦f ar m¦ ¦anim als¦ ¦include¦ ¦p or c ine¦ ¦coronavirus¦ ▁( ¦transm is si ble¦ ¦ga st ro e nt er itis¦ ¦coronavirus¦ ,▁ ¦t ge¦ )▁ ¦and¦ ¦b ov ine¦ ¦coronavirus¦ ,▁ ¦which¦ ¦both¦ ¦result¦ ¦in¦ ¦di arr he a¦ ¦in¦ ¦y ou ng¦ ¦anim als¦ .
𐋇 ¦fe line¦ ¦coronavirus¦ :▁ 𐋇 ¦two¦ ¦for ms¦ ,▁ ¦fe line¦ ¦ent er ic¦ ¦coronavirus¦ ¦is¦ ¦a¦ ¦path og en¦ ¦of¦ ¦min or¦ ¦clinical¦ ¦sign ific ance¦ ,▁ ¦but¦ ¦sp on ta ne o us¦ ¦m ut ation¦ ¦of¦ ¦this¦ ¦virus¦ ¦can¦ ¦result¦ ¦in¦ ¦fe line¦ ¦infectious¦ ¦per it on itis¦ ▁( ¦fi p¦ ),▁ ¦a¦ ¦disease¦ ¦associated¦ ¦with¦ ¦high¦ ¦m ort ality¦ .
𐋇¦s im il arly¦ ,▁ ¦there¦ ¦are¦ ¦two¦ ¦typ es¦ ¦of¦ ¦coronavirus¦ ¦that¦ ¦inf ect¦ ¦f er r ets¦ :▁ 𐋇¦f er r et¦ ¦ent er ic¦ ¦coronavirus¦ ¦ca u ses¦ ¦a¦ ¦ga st ro in te st in al¦ ¦syndrome¦ ¦known¦ ¦as¦ ¦e p iz o ot ic¦ ¦c at arr h al¦ ¦ent er itis¦ ▁( ¦e ce¦ ),▁ ¦and¦ ¦a¦ ¦more¦ ¦le th al¦ ¦sys te m ic¦ ¦ ve rs ion¦ ¦of¦ ¦the¦ ¦virus¦ ▁( ¦like¦ ¦fi p¦ ¦in¦ ¦ca ts¦ )▁ ¦known¦ ¦as¦ ¦f er r et¦ ¦sys te m ic¦ ¦coronavirus¦ ▁( ¦f s c¦ ).
𐋇¦there¦ ¦are¦ ¦two¦ ¦typ es¦ ¦of¦ ¦c an ine¦ ¦coronavirus¦ ▁( ¦c cov ¦ ),▁ ¦one¦ ¦that¦ ¦ca u ses¦ ¦mild¦ ¦ga st ro in te st in al¦ ¦disease¦ ¦and¦ ¦one¦ ¦that¦ ¦has¦ ¦been¦ ¦found¦ ¦to¦ ¦cause¦ ¦respiratory¦ ¦disease¦ .
𐋇 ¦mo use¦ ¦he p at itis¦ ¦virus¦ ▁( ¦m h v ¦ )▁ ¦is¦ ¦a¦ ¦coronavirus¦ ¦that¦ ¦ca u ses¦ ¦an¦ ¦epidemic¦ ¦m ur ine¦ ¦illness¦ ¦with¦ ¦high¦ ¦m ort ality¦ ,▁ ¦especially¦ ¦among¦ ¦c ol on ies¦ ¦of¦ ¦laboratory¦ ¦m ice¦ .
𐋇¦s ia lo d ac r y o a d en itis¦ ¦virus¦ ▁( ¦s d a v ¦ )▁ ¦is¦ ¦high ly¦ ¦infectious¦ ¦coronavirus¦ ¦of¦ ¦laboratory¦ ¦ra ts¦ ,▁ ¦which¦ ¦can¦ ¦be¦ ¦transm it ted¦ ¦between¦ ¦individuals¦ ¦by¦ ¦direct¦ ¦contact¦ ¦and¦ ¦ind ir ect ly¦ ¦by¦ ¦a er os o l¦ .
𐋇¦some¦ ¦stra ins¦ ¦of¦ ¦m h v ¦ ¦cause¦ ¦a¦ ¦pr og re ss ive¦ ¦dem y el in ating¦ ¦en ce ph al itis¦ ¦in¦ ¦m ice¦ ¦which¦ ¦has¦ ¦been¦ ¦used¦ ¦as¦ ¦a¦ ¦m ur ine¦ ¦mo de l¦ ¦for¦ ¦mult ip le¦ ¦sc le ro sis¦ .
𐋇 ¦sign ific ant¦ ¦research¦ ¦eff orts¦ ¦have¦ ¦been¦ ¦f oc u sed¦ ¦on¦ ¦el uc id ating¦ ¦the¦ ¦viral¦ ¦path ogen e sis¦ ¦of¦ ¦these¦ ¦anim al¦ ¦coronaviruses¦ ,▁ ¦especially¦ ¦by¦ ¦vir ol og i sts¦ ¦inter ested¦ ¦in¦ ¦v et er in ary¦ ¦and¦ ¦z o on ot ic¦ ¦diseases¦ .
𐋇¦p or c ine¦ ¦coronavirus¦ ▁( ¦transm is si ble¦ ¦ga st ro e nt er itis¦ ¦coronavirus¦ ¦of¦ ¦p ig s¦ ,▁ ¦t ge v ¦ ).
𐋇¦b ov ine¦ ¦coronavirus¦ ▁( ¦b c v ¦ ),▁ ¦resp on si ble¦ ¦for¦ ¦severe¦ ¦pro f use¦ ¦ent er itis¦ ¦in¦ ¦of¦ ¦y ou ng¦ ¦c al ves¦ .
𐋇 ¦fe line¦ ¦coronavirus¦ ▁( ¦f cov ¦ )▁ ¦ca u ses¦ ¦mild¦ ¦ent er itis¦ ¦in¦ ¦ca ts¦ ¦as¦ ¦well¦ ¦as¦ ¦severe¦ ¦fe line¦ ¦infectious¦ ¦per it on itis¦ ▁( ¦other¦ ¦vari a nts¦ ¦of¦ ¦the¦ ¦same¦ ¦virus¦ ).
𐋇¦the¦ ¦two¦ ¦typ es¦ ¦of¦ ¦c an ine¦ ¦coronavirus¦ ▁( ¦c cov ¦ ) ▁( ¦one¦ ¦ca us ing¦ ¦ent er itis¦ ,▁ ¦the¦ ¦other¦ ¦found¦ ¦in¦ ¦respiratory¦ ¦diseases¦ ).
𐋇¦t ur k e y¦ ¦coronavirus¦ ▁( ¦t c v ¦ )▁ ¦ca u ses¦ ¦ent er itis¦ ¦in¦ ¦t ur k e y s¦ .
𐋇¦f er r et¦ ¦ent er ic¦ ¦coronavirus¦ ¦ca u ses¦ ¦e p iz o ot ic¦ ¦c at arr h al¦ ¦ent er itis¦ ¦in¦ ¦f er r ets¦ .
𐋇¦f er r et¦ ¦sys te m ic¦ ¦coronavirus¦ ¦ca u ses¦ ¦fi p¦ - ¦like¦ ¦sys te m ic¦ ¦syndrome¦ ¦in¦ ¦f er r ets¦ .
𐋇 ¦r ab b i t¦ ¦ent er ic¦ ¦coronavirus¦ ¦ca u ses¦ ¦acute¦ ¦ga st ro in te st in al¦ ¦disease¦ ¦and¦ ¦di arr he a¦ ¦in¦ ¦y ou ng¦ ¦european¦ ¦r ab b i ts¦ .
𐋇¦p or c ine¦ ¦epidemic¦ ¦di arr he a¦ ¦virus¦ ▁( ¦p ed¦ ¦or¦ ¦p ed v ¦ ),▁ ¦has¦ ¦e mer ged¦ ¦around¦ ¦the¦ ¦world¦ .
𐋇 ¦about¦ ¦how¦ ¦long¦ ¦have¦ ¦these¦ ¦symptoms¦ ¦been¦ ¦go ing¦ ¦on¦ ?
𐋇 ¦and¦ ¦all¦ ¦chest¦ ¦pain¦ ¦should¦ ¦be¦ ¦tre ated¦ ¦this¦ ¦way¦ ¦especially¦ ¦with¦ ¦your¦ ¦age¦
𐋇 ¦and¦ ¦a lo ng¦ ¦with¦ ¦a¦ ¦fever¦
𐋇 ¦and¦ ¦also¦ ¦needs¦ ¦to¦ ¦be¦ ¦chec ked¦ ¦your¦ ¦ch ol es te ro l¦ ¦blood¦ ¦pre ss ure¦
𐋇 ¦and¦ ¦are¦ ¦you¦ ¦having¦ ¦a¦ ¦fever¦ ¦n ow¦ ?
𐋇 ¦and¦ ¦are¦ ¦you¦ ¦having¦ ¦this¦ ¦chest¦ ¦pain¦ ¦n ow¦ ?
𐋇 ¦and¦ ¦be si des¦ ¦do¦ ¦you¦ ¦have¦ ¦diffic ult y¦ ¦brea thing¦
𐋇 ¦and¦ ¦can¦ ¦you¦ ¦t ell¦ ¦ me¦ ¦what¦ ¦other¦ ¦symptoms¦ ¦are¦ ¦you¦ ¦having¦ ¦a lo ng¦ ¦with¦ ¦this¦ ?
𐋇 ¦and¦ ¦how¦ ¦high¦ ¦has¦ ¦your¦ ¦fever¦ ¦been¦
𐋇 ¦and¦ ¦i¦ ¦have¦ ¦a¦ ¦cough¦ ¦to o¦
𐋇 ¦and¦ ¦i¦ ¦have¦ ¦a¦ ¦l it t le¦ ¦cold¦ ¦and¦ ¦a¦ ¦cough¦
𐋇 ¦and¦ ¦i¦ ' ¦ m¦ ¦re ally¦ ¦having¦ ¦some¦ ¦b ad¦ ¦chest¦ ¦pain¦ ¦to day¦
𐋇 ¦and¦ ¦is¦ ¦this¦ ¦the¦ ¦r ight¦ ¦time¦ ¦for¦ ¦your¦ ¦h ay¦ ¦fever¦
𐋇 ¦and¦ ¦it¦ ¦get¦ ¦the¦ ¦chest¦ ¦pain¦
𐋇 ¦and¦ ¦i¦ ¦th ink¦ ¦i¦ ¦have¦ ¦a¦ ¦l it t le¦ ¦bi t¦ ¦of¦ ¦a¦ ¦fever¦
𐋇 ¦and¦ ¦i¦ ¦w ant¦ ¦you¦ ¦to¦ ¦d esc rib e¦ ¦where¦ ¦the¦ ¦chest¦ ¦pain¦ ¦is¦
𐋇 ¦and¦ ¦they¦ ' ¦r e¦ ¦having¦ ¦some¦ ¦fe v ers¦ ¦as¦ ¦well¦
𐋇 ¦and¦ ¦with¦ ¦your¦ ¦h ist ory¦ ¦of¦ ¦di ab e tes¦
𐋇 ¦and¦ ¦you¦ ¦know¦ ¦it¦ ¦fe els¦ ¦like¦ ¦m y¦ ¦chest¦ ¦is¦ ¦like¦ ¦g on na¦ ¦cr us h ¦
𐋇 ¦and¦ ¦you¦ ¦know¦ ¦people¦ ¦cough¦ ¦on¦ ¦ me¦ ¦all¦ ¦the¦ ¦time¦
𐋇 ¦and¦ ¦you¦ ' ¦r e¦ ¦having¦ ¦chest¦ ¦pain¦
𐋇 ¦and¦ ¦you¦ ¦said¦ ¦this¦ ¦is¦ ¦a¦ ¦pre ss ure¦ ¦in¦ ¦your¦ ¦chest¦
𐋇 ¦an yone¦ ¦in¦ ¦the¦ ¦family¦ ¦have¦ ¦a¦ ¦h ear t¦ ¦prob le m¦ ¦h ear t¦ ¦disease¦ ¦h ear t¦ ¦att ack¦ ¦high¦ ¦ch ol es te ro l¦ ¦high¦ ¦blood¦ ¦pre ss ure¦
𐋇 ¦any¦ ¦other¦ ¦symptoms¦ ¦or¦ ¦prob le ms¦ ¦that¦ ¦you¦ ¦n ot ice¦ ¦with¦ ¦the¦ ¦m us c le¦ ¦a ches¦ ?
𐋇 ¦are¦ ¦there¦ ¦other¦ ¦people¦ ¦sick¦ ¦as¦ ¦you¦ ¦at¦ ¦home¦ ¦with¦ ¦your¦ ¦same¦ ¦symptoms¦ ?
𐋇 ¦are¦ ¦you¦ ¦having¦ ¦any¦ ¦other¦ ¦symptoms¦ ?
𐋇 ¦are¦ ¦you¦ ¦having¦ ¦any¦ ¦sh ort ness¦ ¦of¦ ¦brea th¦ ?
𐋇 ¦are¦ ¦you¦ ¦still¦ ¦having¦ ¦the¦ ¦chest¦ ¦pain¦
𐋇 ¦because¦ ¦this¦ ¦is¦ ¦flu¦ ¦se as on¦
𐋇¦but¦ ¦also¦ ¦we¦ ¦sho ul d n¦ ' ¦t¦ ¦be¦ ¦p ut¦ ¦a side¦ ¦for¦ ¦the¦ ¦h ear t¦ ¦car d ia c¦ ¦orig in¦ ¦chest¦ ¦pain¦
𐋇¦but¦ ¦a¦ ¦more¦ ¦important¦ ¦prob le m¦ ¦n ow¦ ¦is¦ ¦this¦ ¦chest¦ ¦pain¦
𐋇¦but¦ ¦i¦ ¦have¦ ¦diffic ult y¦ ¦brea thing¦
𐋇¦but¦ ¦i¦ ¦know¦ ¦l ot¦ ¦of¦ ¦people¦ ¦cough¦ ¦on¦ ¦ me¦
𐋇¦but¦ ¦we¦ ¦need¦ ¦to¦ ¦tre at¦ ¦every¦ ¦chest¦ ¦pain¦ ¦with¦ ¦the¦ ¦ ut m ost¦ ¦s eri o us ness¦
𐋇¦but¦ ¦you¦ ' ¦r e¦ ¦brea thing¦ ¦all¦ ¦r ight¦ ¦r ight¦ ¦n ow¦ ¦r ight¦ ?
𐋇 ¦cause¦ ¦of¦ ¦this¦ ¦chest¦ ¦pain¦ ¦i¦ ¦t ot ally¦ ¦for g ot¦
𐋇 ¦does¦ ¦it¦ ¦feel¦ ¦like¦ ¦so me bo dy¦ ¦s qu ee z ing¦ ¦your¦ ¦chest¦
𐋇¦do¦ ¦still¦ ¦feel¦ ¦like¦ ¦sh ort ness¦ ¦of¦ ¦brea th¦
𐋇¦do¦ ¦they¦ ¦comp la in¦ ¦of¦ ¦being¦ ¦sick¦ ¦similar¦ ¦symptoms¦ ?
𐋇¦do¦ ¦you¦ ¦have¦ ¦any¦ ¦other¦ ¦ch r on ic¦ ¦like¦ ¦high¦ ¦blood¦ ¦pre ss ure¦ ¦or¦ ¦an y thing¦ ¦like¦ ¦that¦ ?
𐋇¦do¦ ¦you¦ ¦have¦ ¦any¦ ¦other¦ ¦diseases¦ ¦ch r on ic¦ ¦medical¦ ¦prob le ms¦ ¦like¦ ¦di ab e tes¦ ?
𐋇¦do¦ ¦you¦ ¦have¦ ¦any¦ ¦sh ort ness¦ ¦of¦ ¦brea th¦ ¦with¦ ¦that¦ ¦chest¦ ¦pain¦ ?
𐋇¦do¦ ¦you¦ ¦have¦ ¦high¦ ¦blood¦ ¦pre ss ure¦ ?
𐋇¦do¦ ¦you¦ ¦have¦ ¦some¦ ¦sh ort ness¦ ¦of¦ ¦brea th¦ ¦go es¦ ¦with¦ ¦that¦ ?
𐋇¦do¦ ¦you¦ ¦know¦ ¦what¦ ¦symptoms¦ ¦sh e¦ ¦was¦ ¦having¦ ?
𐋇¦do¦ ¦you¦ ¦se e¦ ¦the¦ ¦ im age¦ ?
𐋇 ¦dr ink¦ ¦p le nt y¦ ¦of¦ ¦f lu i ds¦ ¦to day¦
𐋇¦however¦ ¦i¦ ¦take¦ ¦tests¦ ¦for¦ ¦the¦ ¦di ab e tes¦
𐋇¦however¦ ¦sh e¦ ¦has¦ ¦symptoms¦ ¦qu ite¦ ¦similar¦ ¦to¦ ¦m ine¦
𐋇¦how¦ ¦high¦ ¦is¦ ¦your¦ ¦fever¦ ?
𐋇¦how¦ ▁' ¦s¦ ¦your¦ ¦blood¦ ¦pre ss ure¦ ?
𐋇¦if¦ ¦you¦ ¦continue¦ ¦to¦ ¦have¦ ¦high¦ ¦fe v ers¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦a¦ ¦fever¦ ¦of¦ ¦a¦ ¦h un dr ed¦ ¦and¦ ¦two¦ ¦or¦ ¦higher¦
𐋇¦if¦ ¦you¦ ¦th ink¦ ¦that¦ ¦your¦ ¦symptoms¦ ¦or¦ ¦prob le ms¦ ¦w arr ant¦ ¦a¦ ¦bet ter¦ ¦l ook¦
𐋇 ¦i¦ ¦g ot¦ ¦a¦ ¦fever¦ ¦y e st er day¦
𐋇 ¦i¦ ¦g ot¦ ¦a¦ ¦sl ight¦ ¦fever¦ ¦to o¦
𐋇 ¦i¦ ¦had¦ ¦a¦ ¦fever¦ ¦y e st er day¦
𐋇 ¦i¦ ¦have¦ ¦a¦ ¦sh ar p¦ ¦pain¦ ¦h er e¦ ¦in¦ ¦the¦ ¦chest¦
𐋇 ¦i¦ ¦have¦ ¦some¦ ¦diffic ult y¦ ¦brea thing¦ ¦to o¦
𐋇 ¦i¦ ' ¦l l¦ ¦s end¦ ¦you¦ ¦an¦ ¦ im age¦
𐋇 ¦i¦ ' ¦ m¦ ¦having¦ ¦some¦ ¦chest¦ ¦pain¦ ¦to day¦
𐋇 ¦i¦ ' ¦ m¦ ¦j ust¦ ¦having¦ ¦some¦ ¦h ea d a ches¦ ¦and¦ ¦some¦ ¦fever¦ ¦to day¦
𐋇¦in¦ ¦m y¦ ¦op in ion¦ ¦it¦ ¦is¦ ¦flu¦
𐋇¦in¦ ¦m y¦ ¦op in ion¦ ¦this¦ ¦is¦ ¦a¦ ¦l it t le¦ ¦flu¦
𐋇 ¦is¦ ¦it¦ ¦like¦ ¦some¦ ¦h ea v y¦ ¦h ea v y¦ ¦person¦ ¦s it ting¦ ¦on¦ ¦your¦ ¦chest¦ ?
𐋇¦it¦ ¦all¦ ¦star ted¦ ¦with¦ ¦the¦ ¦h ea d a ches¦ ¦and¦ ¦with¦ ¦the¦ ¦fever¦ ¦about¦ ¦the¦ ¦same¦ ¦time¦
𐋇¦it¦ ¦h ur ts¦ ¦in¦ ¦the¦ ¦m id d le¦ ¦of¦ ¦m y¦ ¦chest¦
𐋇¦it¦ ¦is¦ ¦a¦ ¦pre ss ure¦ ¦like¦ ¦chest¦ ¦pain¦
𐋇¦it¦ ¦is¦ ¦in¦ ¦m y¦ ¦chest¦
𐋇¦it¦ ¦is¦ ¦in¦ ¦the¦ ¦center¦ ¦of¦ ¦m y¦ ¦chest¦
𐋇¦it¦ ¦is¦ ¦in¦ ¦the¦ ¦center¦ ¦of¦ ¦the¦ ¦chest¦
𐋇 ¦i¦ ' ¦ ve¦ ¦g ot¦ ¦pain¦ ¦in¦ ¦m y¦ ¦chest¦
𐋇 ¦i¦ ' ¦ ve¦ ¦very¦ ¦concer ned¦ ¦of¦ ¦this¦ ¦chest¦ ¦pain¦
𐋇 ¦i¦ ¦w ant¦ ¦you¦ ¦to¦ ¦t ell¦ ¦ me¦ ¦in¦ ¦d esc rib ing¦ ¦this¦ ¦chest¦ ¦pain¦
𐋇 ¦like¦ ¦high¦ ¦blood¦ ¦pre ss ure¦ ¦or¦ ¦di ab e tes¦
𐋇 ¦like¦ ¦r ight¦ ¦in¦ ¦the¦ ¦center¦ ¦of¦ ¦the¦ ¦chest¦
𐋇¦n ow¦ ¦for¦ ¦the¦ ¦fever¦ ¦you¦ ¦can¦ ¦take¦ ¦a¦ ¦ta ch ip i ri na¦ ¦s we et¦
𐋇¦n ow¦ ¦m ary¦ ¦how¦ ¦many¦ ¦days¦ ¦have¦ ¦you¦ ¦had¦ ¦the¦ ¦symptoms¦
𐋇¦n ow¦ ¦you¦ ¦said¦ ¦you¦ ¦have¦ ¦a¦ ¦chest¦ ¦pain¦
𐋇 ¦occ a si on ally¦ ¦i¦ ¦have¦ ¦some¦ ¦chest¦ ¦pain¦
𐋇 ¦o k ay¦ ¦are¦ ¦you¦ ¦having¦ ¦any¦ ¦other¦ ¦symptoms¦ ¦a lo ng¦ ¦with¦ ¦this¦ ¦other¦ ¦than¦ ¦j ust¦ ¦the¦ ¦pain¦
𐋇 ¦or¦ ¦so me bo dy¦ ¦s it ting¦ ¦on¦ ¦your¦ ¦chest¦ ?
𐋇 ¦pr et t y¦ ¦much¦ ¦the¦ ¦same¦ ¦with¦ ¦the¦ ¦fever¦ ¦and¦ ¦the¦ ¦cough¦ ¦h ea d a ch e¦ ¦and¦ ¦m us c le¦ ¦pa ins¦
𐋇 ¦r ight¦ ¦in¦ ¦the¦ ¦m id d le¦ ¦of¦ ¦m y¦ ¦chest¦
𐋇 ¦sh ow¦ ¦ me¦ ¦on¦ ¦this¦ ¦ im age¦ ¦where¦ ¦you¦ ¦feel¦ ¦the¦ ¦pain¦
𐋇 ¦since¦ ¦you¦ ¦have¦ ¦a¦ ¦fever¦
𐋇 ¦so¦ ¦do¦ ¦you¦ ¦th ink¦ ¦that¦ ¦some¦ ¦of¦ ¦these¦ ¦symptoms¦ ¦could¦ ¦be¦ ¦related¦ ¦to¦ ¦being¦ ¦pre gnant¦ ?
𐋇 ¦so¦ ¦your¦ ¦children¦ ¦are¦ ¦having¦ ¦some¦ ¦of¦ ¦the¦ ¦same¦ ¦symptoms¦ ?
𐋇¦t ell¦ ¦ me¦ ¦about¦ ¦your¦ ¦chest¦ ¦pain¦
𐋇¦the¦ ¦fever¦ ¦inc rea ses¦ ¦at¦ ¦n ight¦
𐋇¦the¦ ¦fever¦ ¦i¦ ' ¦ ve¦ ¦had¦ ¦for¦ ¦the¦ ¦last¦ ¦two¦ ¦days¦
𐋇¦the¦ ¦fever¦ ¦star ted¦ ¦to¦ ¦increase¦ ¦last¦ ¦n ight¦
𐋇¦this¦ ¦is¦ ¦doctor¦ ¦p or ter¦ ¦in¦ ¦the¦ ¦emergency¦ ¦ro om¦ ¦t ri age¦ ¦center¦
𐋇 ¦well¦ ¦can¦ ¦you¦ ¦t ell¦ ¦ me¦ ¦a¦ ¦l it t le¦ ¦bi t¦ ¦more¦ ¦about¦ ¦your¦ ¦chest¦ ¦pain¦ ?
𐋇 ¦well¦ ¦i¦ ¦feel¦ ¦a¦ ¦pain¦ ¦in¦ ¦the¦ ¦f r on t¦ ¦of¦ ¦m y¦ ¦body¦ ¦h er e¦ ¦in¦ ¦m y¦ ¦chest¦
𐋇 ¦well¦ ¦i¦ ' ¦ ve¦ ¦been¦ ¦having¦ ¦a¦ ¦st ro ng¦ ¦pain¦ ¦in¦ ¦m y¦ ¦chest¦
𐋇 ¦well¦ ¦when¦ ¦i¦ ¦have¦ ¦that¦ ¦pain¦ ¦in¦ ¦m y¦ ¦chest¦
𐋇 ¦what¦ ¦ki nd a¦ ¦pain¦ ¦do¦ ¦you¦ ¦have¦ ¦in¦ ¦your¦ ¦chest¦ ?
𐋇¦when¦ ¦this¦ ¦chest¦ ¦pain¦ ¦star ted¦ ?
𐋇 ¦where¦ ¦do¦ ¦you¦ ¦have¦ ¦the¦ ¦pain¦ ¦in¦ ¦the¦ ¦chest¦ ?
𐋇 ¦where¦ ¦you¦ ¦feel¦ ¦this¦ ¦chest¦ ¦pain¦ ¦ ee l¦ ¦this¦ ¦chest¦ ¦t¦
𐋇¦you¦ ¦feel¦ ¦like¦ ¦ti gh t ness¦ ¦on¦ ¦your¦ ¦chest¦
𐋇¦you¦ ¦know¦ ¦i¦ ¦g ot¦ ¦di ab e tes¦ ¦and¦ ¦st u f f¦
𐋇¦you¦ ¦said¦ ¦you¦ ' ¦r e¦ ¦having¦ ¦this¦ ¦chest¦ ¦pain¦
𐋇 ¦rap id ly¦ ¦incre as ing¦ ¦c um ul ative¦ ¦inc idence¦ ¦of¦ ¦coronavirus¦ ¦disease¦ ▁( ¦covid¦ - ¦19¦ )▁ ¦in¦ ¦the¦ ¦european¦ ¦un ion¦ ▁/▁ ¦european¦ ¦ec onomic¦ ¦a rea¦ ¦and¦ ¦the¦ ¦united¦ ¦ki ng d om¦ ,▁ ¦1¦ ¦january¦ ¦to¦ ¦15¦ ¦march¦ ¦2020¦
𐋇¦the¦ ¦c um ul ative¦ ¦inc idence¦ ¦of¦ ¦coronavirus¦ ¦disease¦ ▁( ¦covid¦ - ¦19¦ )▁ ¦cases¦ ¦is¦ ¦sh owing¦ ¦similar¦ ¦tr ends¦ ¦in¦ ¦european¦ ¦un ion¦ ▁/▁ ¦european¦ ¦ec onomic¦ ¦a rea¦ ¦countries¦ ¦and¦ ¦the¦ ¦united¦ ¦ki ng d om¦ ¦conf ir m ing¦ ¦that¦ ,▁ ¦while¦ ¦at¦ ¦a¦ ¦different¦ ¦st age¦ ¦dep ending¦ ¦on¦ ¦the¦ ¦country¦ ,▁ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ ¦is¦ ¦pr og re ss ing¦ ¦rap id ly¦ ¦in¦ ¦all¦ ¦countries¦ .
𐋇 ¦based¦ ¦on¦ ¦the¦ ¦exp eri ence¦ ¦from¦ ¦italy¦ ,▁ ¦countries¦ ,▁ ¦hosp it als¦ ¦and¦ ¦in tens ive¦ ¦care¦ ¦uni ts¦ ¦should¦ ¦increase¦ ¦their¦ ¦pre par ed ness¦ ¦for¦ ¦a¦ ¦sur ge¦ ¦of¦ ¦patients¦ ¦with¦ ¦covid¦ - ¦19¦ ¦who¦ ¦will¦ ¦requir e¦ ¦healthcare¦ ,▁ ¦and¦ ¦in¦ ¦partic ular¦ ¦in tens ive¦ ¦care¦ .
𐋇¦on¦ ¦3 1¦ ¦december¦ ¦2019¦ ,▁ ¦a¦ ¦cl us ter¦ ¦of¦ ¦pneumonia¦ ¦cases¦ ¦of¦ ¦un k n own¦ ¦a e ti ology¦ ¦was¦ ¦reported¦ ¦in¦ ¦wuhan¦ ,▁ ¦hub e i¦ ¦pro vi nce¦ ,▁ ¦china¦ .
𐋇¦on¦ ¦9¦ ¦january¦ ¦2020¦ ,▁ ¦the¦ ¦china¦ ¦center¦ ¦for¦ ¦disease¦ ¦control¦ ¦and¦ ¦pre vention¦ ¦reported¦ ¦the¦ ¦ca us ative¦ ¦ag ent¦ ¦as¦ ¦being¦ ¦a¦ ¦novel¦ ¦coronavirus¦ ¦n ow¦ ¦ref er r ed¦ ¦to¦ ¦as¦ ¦severe¦ ¦acute¦ ¦respiratory¦ ¦syndrome¦ ¦coronavirus¦ ¦2¦ ▁( ¦sars¦ - ¦cov¦ - ¦2¦ ).
𐋇 ¦since¦ ,▁ ¦the¦ ¦illness¦ ¦res ul ting¦ ¦from¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦infection¦ ¦has¦ ¦been¦ ¦na med¦ ¦coronavirus¦ ¦disease¦ ▁( ¦covid¦ - ¦19¦ ).
𐋇 ¦evidence¦ ¦to¦ ¦date¦ ¦is¦ ¦that¦ ¦c a¦ ¦8 0¦ %▁ ¦of¦ ¦individuals¦ ¦with¦ ¦covid¦ - ¦19¦ ¦have¦ ¦a¦ ¦mild¦ ¦disease¦ ,▁ ¦i¦ . ¦ e¦ .▁ ¦a¦ ¦respiratory¦ ¦trac t¦ ¦infection¦ ¦with¦ ¦or¦ ¦without¦ ¦pneumonia¦ ,▁ ¦and¦ ¦most¦ ¦of¦ ¦these¦ ¦reco ver¦ .
𐋇¦in¦ ¦c a¦ ¦14¦ %▁ ¦cases¦ ,▁ ¦covid¦ - ¦19¦ ¦develop s¦ ¦into¦ ¦a¦ ¦more¦ ¦severe¦ ¦disease¦ ¦requir ing¦ ¦hosp it al is ation¦ ¦while¦ ¦the¦ ¦rem aining¦ ¦6¦ %▁ ¦cases¦ ¦exp eri ence¦ ¦crit ical¦ ¦illness¦ ¦requir ing¦ ¦in tens ive¦ ¦care¦ .
𐋇¦the¦ ¦m ort ality¦ ¦of¦ ¦patients¦ ¦hosp i tali sed¦ ¦due¦ ¦to¦ ¦covid¦ - ¦19¦ ¦is¦ ¦c a¦ ¦4¦ % .
𐋇¦in¦ ¦this¦ ¦study¦ ,▁ ¦we¦ ¦ass ess¦ ¦the¦ ¦tr ends¦ ¦in¦ ¦the¦ ¦c um ul ative¦ ¦inc idence¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦each¦ ¦european¦ ¦un ion¦ ▁/▁ ¦european¦ ¦ec onomic¦ ¦a rea¦ ▁( ¦eu¦ ▁/▁ ¦ ee a¦ )▁ ¦country¦ ¦and¦ ¦the¦ ¦united¦ ¦ki ng d om¦ ▁( ¦uk¦ )▁ ¦and¦ ¦comp are¦ ¦them¦ ¦to¦ ¦that¦ ¦of¦ ¦hub e i¦ ¦pro vi nce¦ ,▁ ¦china¦ .
𐋇¦we¦ ¦also¦ ¦comp are¦ ¦the¦ ¦current¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦in¦ ¦eu¦ ▁/▁ ¦ ee a¦ ¦countries¦ ¦and¦ ¦the¦ ¦uk¦ ¦with¦ ¦that¦ ¦in¦ ¦italy¦ ¦during¦ ¦3 1¦ ¦january¦ ▁–▁ ¦15¦ ¦march¦ ¦2020¦ .
𐋇¦covid¦ - ¦19¦ ¦cases¦ ¦in¦ ¦eu¦ ▁/▁ ¦ ee a¦ ¦countries¦ ¦and¦ ¦the¦ ¦uk¦
𐋇 ¦sub se qu ent¦ ¦to¦ ¦china¦ ,▁ ¦covid¦ - ¦19¦ ¦under w ent¦ ¦further¦ ¦ ge ogra ph ical¦ ¦spread¦ ¦and¦ ¦the¦ ¦d y na m ic¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ ¦in¦ ¦the¦ ¦r est¦ ¦of¦ ¦the¦ ¦world¦ ¦cur re ntly¦ ¦fo ll ow s¦ ¦that¦ ¦of¦ ¦this¦ ¦country¦ .
𐋇¦on¦ ¦11¦ ¦march¦ ¦2020¦ ,▁ ¦the¦ ¦dir ector¦ ¦general¦ ¦of¦ ¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ▁( ¦who¦ )▁ ¦decl ared¦ ¦covid¦ - ¦19¦ ¦a¦ ¦pandemic¦ .
𐋇¦in¦ ¦the¦ ¦5¦ ¦march¦ ¦i ss ue¦ ¦of¦ ¦e ur os ur ve i ll ance¦ ¦2020¦ ,▁ ¦sp it er i¦ ¦ et¦ ¦ al¦ .▁ ¦reported¦ ¦on¦ ¦the¦ ¦first¦ ¦european¦ ¦confirmed¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦according¦ ¦to¦ ¦the¦ ¦who¦ ¦case¦ ¦def in ition¦ .
𐋇¦in¦ ¦the¦ ¦eu¦ ▁/▁ ¦ ee a¦ ,▁ ¦the¦ ¦first¦ ¦three¦ ¦confirmed¦ ¦cases¦ ¦were¦ ¦reported¦ ¦by¦ ¦fra nce¦ ¦on¦ ¦24¦ ¦january¦ ¦2020¦ ¦in¦ ¦pers ons¦ ¦retur ning¦ ¦from¦ ¦wuhan¦ ,▁ ¦hub e i¦ ¦pro vi nce¦ ,▁ ¦china¦ .
𐋇¦as¦ ¦at¦ ¦15¦ ¦march¦ ¦2020¦ ,▁ ¦covid¦ - ¦19¦ ¦cases¦ ¦had¦ ¦been¦ ¦detected¦ ¦in¦ ¦all¦ ¦30¦ ¦eu¦ ▁/▁ ¦ ee a¦ ¦countries¦ ¦and¦ ¦the¦ ¦united¦ ¦ki ng d om¦ ▁( ¦uk¦ ),▁ ¦w he re b y¦ ¦between¦ ¦3 1¦ ¦december¦ ¦2019¦ ¦and¦ ¦that¦ ¦date¦ ¦inclu ded¦ ,▁ ¦3 9¦ , ¦7 6 8¦ ¦cases¦ ¦and¦ ¦1¦ , ¦7 2 7¦ ¦deaths¦ ¦had¦ ¦been¦ ¦reported¦ ,▁ ¦with¦ ¦1 7¦ , ¦7 5 0¦ ¦cases¦ ¦and¦ ¦1¦ , ¦4 4 1¦ ¦deaths¦ ¦from¦ ¦italy¦ ¦al one¦ .
𐋇 ¦ob t aining¦ ¦c um ul ative¦ ¦number¦ ¦and¦ ¦c um ul ative¦ ¦inc idence¦ ¦of¦ ¦covid¦ - ¦19¦ ¦cases¦
𐋇 ¦at¦ ¦the¦ ¦european¦ ¦centre¦ ¦for¦ ¦disease¦ ¦pre vention¦ ¦and¦ ¦control¦ ▁( ¦ec dc¦ ),▁ ¦the¦ ¦notified¦ ¦covid¦ - ¦19¦ ¦case¦ ¦cou nts¦ ¦in¦ ¦each¦ ¦country¦ ¦worldwide¦ ,▁ ¦ob ta ined¦ ¦from¦ ¦only¦ ¦offic ial¦ ¦sour ces¦ ¦such¦ ¦as¦ ¦the¦ ¦countries¦ ▁’▁ ¦min ist ry¦ ¦of¦ ¦health¦ ,▁ ¦national¦ ¦and¦ ¦regi on al¦ ¦health¦ ¦author ities¦ ¦and¦ ¦the¦ ¦who¦ ,▁ ¦are¦ ¦up d ated¦ ¦each¦ ¦day¦ ¦at¦ ¦8¦ :▁ ¦ 00¦ ¦a¦ . ¦ m¦ .
𐋇¦these¦ ¦data¦ ¦were¦ ¦used¦ ¦for¦ ¦as se ss ing¦ ¦the¦ ¦tr ends¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦eu¦ ▁/▁ ¦ ee a¦ ¦and¦ ¦the¦ ¦uk¦ ,▁ ¦and¦ ¦comp ar ing¦ ¦them¦ ¦to¦ ¦that¦ ¦in¦ ¦italy¦ .
𐋇¦as¦ ¦a¦ ¦pro x y¦ ¦of¦ ¦the¦ ¦prev al ence¦ ¦of¦ ¦ac tive¦ ¦covid¦ - ¦19¦ ¦cases¦ ,▁ ¦we¦ ¦c al c ul ated¦ ¦the¦ ¦14¦ - ¦day¦ ¦t ru nc ated¦ ¦c um ul ative¦ ¦inc idence¦ ¦of¦ ¦covid¦ - ¦19¦ ¦cases¦ ,▁ ¦th us¦ ¦ta king¦ ¦into¦ ¦acc o un t¦ ¦the¦ ¦nat ural¦ ¦co ur se¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦in¦ ¦each¦ ¦eu¦ ▁/▁ ¦ ee a¦ ¦country¦ ¦and¦ ¦the¦ ¦uk¦ ,▁ ¦during¦ ¦the¦ ¦1¦ ¦january¦ ▁–▁ ¦15¦ ¦march¦ ¦2020¦ ¦period¦ .
𐋇¦we¦ ¦also¦ ¦pres ented¦ ¦the¦ ¦c um ul ative¦ ¦number¦ ¦of¦ ¦notified¦ ¦cases¦ ¦of¦ ¦each¦ ¦country¦ ¦as¦ ¦at¦ ¦15¦ ¦march¦ ¦2020¦ ¦8¦ :▁ ¦ 00¦ ¦a¦ . ¦ m¦ .▁ ¦comp ared¦ ¦with¦ ¦that¦ ¦of¦ ¦italy¦ ¦for¦ ¦the¦ ¦3 1¦ ¦january¦ ▁–▁ ¦15¦ ¦march¦ ¦2020¦ ¦period¦ .
𐋇 ¦tr ends¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦eu¦ ▁/▁ ¦ ee a¦ ¦countries¦ ¦and¦ ¦the¦ ¦uk¦
𐋇¦the¦ ¦tr ends¦ ¦in¦ ¦the¦ ¦14¦ - ¦day¦ ¦t ru nc ated¦ ¦c um ul ative¦ ¦inc idence¦ ¦of¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦in¦ ¦eu¦ ▁/▁ ¦ ee a¦ ¦countries¦ ¦and¦ ¦the¦ ¦uk¦ ¦gener ally¦ ¦fo ll owed¦ ¦that¦ ¦of¦ ¦hub e i¦ ¦pro vi nce¦ ▁( ¦china¦ ) ▁( ¦f ig ure¦ ¦1¦ ).
𐋇¦for¦ ¦the¦ ¦eu¦ ▁/▁ ¦ ee a¦ ¦and¦ ¦the¦ ¦uk¦ ¦over all¦ ,▁ ¦the¦ ¦c um ul ative¦ ¦inc idence¦ ¦of¦ ¦covid¦ - ¦19¦ ¦star ted¦ ¦to¦ ¦increase¦ ¦around¦ ¦ 21¦ ¦february¦ ¦and¦ ¦then¦ ¦increased¦ ¦sh ar p ly¦ ¦around¦ ¦2 8¦ ¦february¦ ¦2020¦ ▁( ¦supp le me nt ary¦ ¦m at er ial¦ ).
𐋇¦this¦ ¦was¦ ¦mo st ly¦ ¦dr iv en¦ ¦by¦ ¦the¦ ¦rap id¦ ¦increase¦ ¦in¦ ¦the¦ ¦number¦ ¦of¦ ¦reported¦ ¦cases¦ ¦from¦ ¦italy¦ ,▁ ¦but¦ ¦all¦ ¦other¦ ¦eu¦ ▁/▁ ¦ ee a¦ ¦countries¦ ¦and¦ ¦the¦ ¦uk¦ ¦sh owed¦ ¦similar¦ ¦incre as ing¦ ¦tr ends¦ ¦of¦ ¦the¦ ¦c um ul ative¦ ¦inc idence¦ ¦of¦ ¦covid¦ - ¦19¦ ▁( ¦supp le me nt ary¦ ¦m at er ial¦ ).
𐋇¦f ig ure¦ ¦2¦ ¦sh ow s¦ ¦the¦ ¦c um ul ative¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦cases¦ ,▁ ¦in¦ ¦eu¦ ▁/▁ ¦ ee a¦ ¦countries¦ ¦and¦ ¦the¦ ¦uk¦ ¦comp ared¦ ¦with¦ ¦that¦ ¦in¦ ¦italy¦ ¦for¦ ¦the¦ ¦3 1¦ ¦january¦ ▁–▁ ¦15¦ ¦march¦ ¦2020¦ ¦period¦ .
𐋇¦it¦ ¦high li gh ts¦ ¦that¦ ,▁ ¦as¦ ¦at¦ ¦15¦ ¦march¦ ¦8¦ :▁ ¦ 00¦ ¦a¦ . ¦ m¦ . ,▁ ¦15¦ ¦other¦ ¦eu¦ ▁/▁ ¦ ee a¦ ¦countries¦ ¦and¦ ¦the¦ ¦uk¦ ¦had¦ ¦al rea dy¦ ¦reported¦ ¦a¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦comp ar able¦ ¦to¦ ¦that¦ ¦of¦ ¦italy¦ ¦j ust¦ ¦3¦ ¦weeks¦ ¦pri or¦ ¦or¦ ¦less¦ .
𐋇 ¦our¦ ¦results¦ ¦indic ate¦ ¦that¦ ¦the¦ ¦number¦ ¦of¦ ¦notified¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦is¦ ¦rap id ly¦ ¦incre as ing¦ ¦in¦ ¦the¦ ¦eu¦ ▁/▁ ¦ ee a¦ ¦and¦ ¦the¦ ¦uk¦ .
𐋇¦the¦ ¦ob s erv ed¦ ¦tr ends¦ ¦in¦ ¦the¦ ¦c um ul ative¦ ¦inc idence¦ ¦of¦ ¦covid¦ - ¦19¦ ¦su gg est¦ ¦that¦ ¦the¦ ¦pandemic¦ ¦is¦ ¦pr og re ss ing¦ ¦at¦ ¦a¦ ¦comp ar able¦ ¦sp e ed¦ ¦in¦ ¦all¦ ¦countries¦ .
𐋇¦this¦ ¦is¦ ¦d esp ite¦ ¦countries¦ ¦being¦ ¦at¦ ¦different¦ ¦sta ges¦ ,▁ ¦vari ations¦ ¦in¦ ¦national¦ ¦public¦ ¦health¦ ¦resp on ses¦ ,▁ ¦and¦ ¦p os si b ly¦ ¦different¦ ¦case¦ ¦def in i tions¦ ¦in¦ ¦countries¦ ¦and¦ ¦different¦ ¦prot oc ols¦ ¦for¦ ¦s el ecting¦ ¦patients¦ ¦that¦ ¦must¦ ¦be¦ ¦tested¦ ¦for¦ ¦conf ir m ation¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦including¦ ¦c at ch¦ - ¦up¦ ¦testing¦ .
𐋇 ¦early¦ ¦march¦ ¦2020¦ ,▁ ¦do ctors¦ ¦in¦ ¦the¦ ¦affected¦ ¦regi ons¦ ¦of¦ ¦italy¦ ¦d esc rib ed¦ ¦a¦ ¦s itu ation¦ ¦in¦ ¦which¦ ¦c a¦ ¦10¦ %▁ ¦of¦ ¦patients¦ ¦with¦ ¦covid¦ - ¦19¦ ¦required¦ ¦in tens ive¦ ¦care¦ ¦and¦ ¦m ed ia¦ ¦sour ces¦ ¦reported¦ ¦that¦ ¦hosp it als¦ ¦and¦ ¦in tens ive¦ ¦care¦ ¦uni ts¦ ¦in¦ ¦these¦ ¦regi ons¦ ¦had¦ ¦al rea dy¦ ¦rea ched¦ ¦their¦ ¦ma x im um¦ ¦c ap ac ity¦ .
𐋇 ¦data¦ ¦on¦ ¦ad mi ssion¦ ¦of¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦in¦ ¦a¦ ¦hospital¦ ¦and¦ ▁/▁ ¦or¦ ¦an¦ ¦in tens ive¦ ¦care¦ ¦uni t¦ ¦are¦ ¦cur re ntly¦ ¦available¦ ¦at¦ ¦eu¦ ▁/▁ ¦ ee a¦ ¦level¦ ¦for¦ ¦only¦ ¦6¦ %▁ ¦and¦ ¦1¦ %▁ ¦cases¦ ,▁ ¦resp ect ively¦ ▁( ¦data¦ ¦not¦ ¦sh own¦ ).
𐋇¦they¦ ¦should¦ ,▁ ¦however¦ ,▁ ¦be¦ ¦coll ected¦ ¦in¦ ¦a¦ ¦sys te m at ic¦ ¦f as h ion¦ ¦to¦ ¦comp le ment¦ ¦current¦ ¦surveillance¦ ¦data¦ ¦that¦ ¦f oc us¦ ¦on¦ ¦the¦ ¦number¦ ¦of¦ ¦reported¦ ¦cases¦ ¦and¦ ¦the¦ ¦number¦ ¦of¦ ¦deaths¦ .
𐋇¦a¦ ¦study¦ ¦per for med¦ ¦in¦ ¦20 1 0¦ ▁–▁ ¦11¦ ¦sh owed¦ ¦a¦ ¦large¦ ¦vari ation¦ ¦in¦ ¦the¦ ¦a v ai la bility¦ ¦of¦ ¦in tens ive¦ ¦care¦ ¦and¦ ¦int erm ediate¦ ¦care¦ ¦be ds¦ ¦in¦ ¦e ur ope¦ ,▁ ¦r an ging¦ ¦from¦ ¦2 9¦ . ¦2¦ ¦in¦ ¦g erm an y¦ ¦to¦ ¦4¦ . ¦2¦ ¦be ds¦ ¦per¦ ¦100¦ , ¦000¦ ¦population¦ ¦in¦ ¦p ort u g al¦ .
𐋇¦this¦ ¦me ans¦ ¦that¦ ¦countries¦ ¦may¦ ¦have¦ ¦more¦ ¦or¦ ¦less¦ ¦res o ur ces¦ ¦than¦ ¦italy¦ ▁( ¦12¦ . ¦5¦ ¦in tens ive¦ ¦care¦ ¦and¦ ¦int erm ediate¦ ¦care¦ ¦be ds¦ ¦per¦ ¦100¦ , ¦000¦ ¦population¦ ¦in¦ ¦20 1 0¦ ▁–▁ ¦11¦ ).
𐋇 ¦mo de lling¦ ¦s ce na ri o s¦ ¦related¦ ¦to¦ ¦healthcare¦ ¦c ap ac ity¦ ¦s at ur ation¦ ,▁ ¦with¦ ¦estim ates¦ ¦for¦ ¦each¦ ¦eu¦ ▁/▁ ¦ ee a¦ ¦country¦ ¦and¦ ¦the¦ ¦uk¦ ¦of¦ ¦the¦ ¦prev al ence¦ ¦of¦ ¦hosp i tali sed¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦associated¦ ¦with¦ ¦a¦ ▁ & ▁ ¦g t¦ ;▁ ¦9 0¦ %▁ ¦risk¦ ¦of¦ ¦ex c ee ding¦ ¦in tens ive¦ ¦care¦ ¦b ed¦ ¦c ap ac ity¦ ,▁ ¦are¦ ¦provid ed¦ ¦in¦ ¦the¦ ¦si x th¦ ¦up d ate¦ ¦of¦ ¦the¦ ¦ec dc¦ ¦rap id¦ ¦risk¦ ¦as se ss ment¦ ¦on¦ ¦covid¦ - ¦19¦ .
𐋇 ¦since¦ ¦cases¦ ¦have¦ ¦so¦ ¦fa r¦ ¦c lu st ered¦ ¦in¦ ¦c er tain¦ ¦regi ons¦ ¦in¦ ¦eu¦ ▁/▁ ¦ ee a¦ ¦countries¦ ¦and¦ ¦the¦ ¦uk¦ ,▁ ¦and¦ ¦hosp it als¦ ¦and¦ ¦in tens ive¦ ¦care¦ ¦uni ts¦ ¦us ually¦ ¦ser ve¦ ¦a¦ ¦def ined¦ ¦regi on al¦ ¦c at ch ment¦ ¦population¦ ,▁ ¦information¦ ¦about¦ ¦cases¦ ¦and¦ ¦in tens ive¦ ¦care¦ ¦be ds¦ ¦should¦ ¦pre f er ab ly¦ ¦be¦ ¦made¦ ¦available¦ ¦at¦ ¦the¦ ¦no me nc l at ure¦ ¦of¦ ¦ter r it or ial¦ ¦uni ts¦ ¦for¦ ¦st at ist ics¦ ¦2¦ ▁( ¦nu ts¦ - ¦2¦ )▁ ¦level¦ .
𐋇¦the¦ ¦exp eri ence¦ ¦from¦ ¦italy¦ ¦and¦ ¦the¦ ¦current¦ ¦tr ends¦ ¦in¦ ¦other¦ ¦countries¦ ¦sh ow¦ ¦that¦ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ ¦is¦ ¦pr og re ss ing¦ ¦rap id ly¦ ¦in¦ ¦the¦ ¦eu¦ ▁/▁ ¦ ee a¦ ¦and¦ ¦the¦ ¦uk¦ .
𐋇 ¦countries¦ ,▁ ¦hosp it als¦ ¦and¦ ¦in tens ive¦ ¦care¦ ¦uni ts¦ ¦should¦ ¦th us¦ ¦pre p are¦ ¦the m s el ves¦ ¦for¦ ¦a¦ ¦s ce na ri o¦ ¦of¦ ¦s us ta ined¦ ¦community¦ ¦transmission¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦and¦ ¦an¦ ¦increase¦ ¦in¦ ¦the¦ ¦number¦ ¦of¦ ¦patients¦ ¦with¦ ¦covid¦ - ¦19¦ ¦requir ing¦ ¦healthcare¦ ,▁ ¦and¦ ¦in¦ ¦partic ular¦ ¦in tens ive¦ ¦care¦ ,▁ ¦such¦ ¦as¦ ¦the¦ ¦one¦ ¦occur r ing¦ ¦in¦ ¦the¦ ¦affected¦ ¦regi ons¦ ¦of¦ ¦italy¦ .
𐋇¦as¦ ¦po in ted¦ ¦out¦ ¦in¦ ¦the¦ ¦rec ent¦ ¦ec dc¦ ¦rap id¦ ¦risk¦ ¦as se ss ment¦ ,▁ ¦a¦ ¦rap id¦ ,▁ ¦pro ac tive¦ ¦and¦ ¦comp re he ns ive¦ ¦appro a ch¦ ¦is¦ ¦essential¦ ¦to¦ ¦del ay¦ ¦the¦ ¦spread¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ,▁ ¦with¦ ¦a¦ ¦sh if t¦ ¦from¦ ¦a¦ ¦conta in ment¦ ¦to¦ ¦a¦ ¦m it ig ation¦ ¦appro a ch¦ ,▁ ¦as¦ ¦the¦ ¦anti c ip ated¦ ¦rap id¦ ¦increase¦ ¦in¦ ¦the¦ ¦number¦ ¦of¦ ¦cases¦ ¦may¦ ¦not¦ ¦provide¦ ¦dec is ion¦ ¦ma k ers¦ ¦and¦ ¦hosp it als¦ ¦en ough¦ ¦time¦ ¦to¦ ¦comp re h end¦ ,▁ ¦ac cep t¦ ¦and¦ ¦ad ap t¦ ¦their¦ ¦response¦ ¦acc or di ng ly¦ ¦if¦ ¦not¦ ¦imp le m ented¦ ¦a h ead¦ ¦of¦ ¦time¦ .
𐋇¦the¦ ¦rap id¦ ¦risk¦ ¦as se ss ment¦ ¦also¦ ¦li sts¦ ¦the¦ ¦public¦ ¦health¦ ¦measures¦ ¦to¦ ¦m it ig ate¦ ¦the¦ ¦impac t¦ ¦of¦ ¦the¦ ¦pandemic¦ .
𐋇¦there¦ ¦is¦ ¦a¦ ¦sh ort¦ ¦w i nd ow¦ ¦of¦ ¦o pp ort un ity¦ ¦during¦ ¦which¦ ¦countries¦ ¦have¦ ¦the¦ ¦p os si bility¦ ¦to¦ ¦further¦ ¦increase¦ ¦their¦ ¦control¦ ¦eff orts¦ ¦to¦ ¦sl ow¦ ¦down¦ ¦the¦ ¦spread¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦and¦ ¦dec re ase¦ ¦the¦ ¦pre ss ure¦ ¦on¦ ¦healthcare¦ .
𐋇 ¦fa il ing¦ ¦this¦ ,▁ ¦it¦ ¦is¦ ¦likely¦ ¦that¦ ¦the¦ ¦healthcare¦ ¦sys tems¦ ¦of¦ ¦other¦ ¦eu¦ ▁/▁ ¦ ee a¦ ¦countries¦ ¦will¦ ¦face¦ ¦a¦ ¦sur ge¦ ¦of¦ ¦patients¦ ¦that¦ ¦requir e¦ ¦in tens ive¦ ¦care¦ ¦within¦ ¦the¦ ¦c om ing¦ ¦days¦ ¦or¦ ¦weeks¦ .
𐋇¦the¦ ¦outbreak¦ ¦of¦ ¦coronavirus¦ ¦disease¦ ¦2019¦ ▁( ¦covid¦ - ¦19¦ ),▁ ¦caused¦ ¦by¦ ¦severe¦ ¦acute¦ ¦respiratory¦ ¦syndrome¦ ▁( ¦sars¦ )▁ ¦coronavirus¦ ¦2¦ ▁( ¦sars¦ - ¦cov¦ - ¦2¦ ),▁ ¦has¦ ¦th us¦ ¦fa r¦ ¦ki lled¦ ¦over¦ ¦3¦ , ¦000¦ ¦people¦ ¦and¦ ¦infected¦ ¦over¦ ¦8 0¦ , ¦000¦ ¦in¦ ¦china¦ ¦and¦ ¦el se w h er e¦ ¦in¦ ¦the¦ ¦world¦ ,▁ ¦res ul ting¦ ¦in¦ ¦ca ta st ro ph e¦ ¦for¦ ¦humans¦ .
𐋇 ¦similar¦ ¦to¦ ¦its¦ ¦h om ol og o us¦ ¦virus¦ ,▁ ¦sars¦ - ¦cov¦ ,▁ ¦which¦ ¦caused¦ ¦sars¦ ¦in¦ ¦t ho us an ds¦ ¦of¦ ¦people¦ ¦in¦ ¦20 0 3¦ ,▁ ¦sars¦ - ¦cov¦ - ¦2¦ ¦might¦ ¦also¦ ¦be¦ ¦transm it ted¦ ¦from¦ ¦the¦ ¦bats¦ ¦and¦ ¦ca u ses¦ ¦similar¦ ¦symptoms¦ ¦through¦ ¦a¦ ¦similar¦ ¦me ch an is m¦ .
𐋇¦however¦ ,▁ ¦covid¦ - ¦19¦ ¦has¦ ¦lower¦ ¦se ver ity¦ ¦and¦ ¦m ort ality¦ ¦than¦ ¦sars¦ ¦but¦ ¦is¦ ¦much¦ ¦more¦ ¦trans mi ss ive¦ ¦and¦ ¦aff ects¦ ¦more¦ ¦el d erly¦ ¦individuals¦ ¦than¦ ¦y ou th¦ ¦and¦ ¦more¦ ¦m en¦ ¦than¦ ¦women¦ .
𐋇¦in¦ ¦response¦ ¦to¦ ¦the¦ ¦rap id ly¦ ¦incre as ing¦ ¦number¦ ¦of¦ ¦publ ications¦ ¦on¦ ¦the¦ ¦e mer ging¦ ¦disease¦ ,▁ ¦this¦ ¦a rt ic le¦ ¦att e mp ts¦ ¦to¦ ¦provide¦ ¦a¦ ¦t im ely¦ ¦and¦ ¦comp re he ns ive¦ ¦re v ie w¦ ¦of¦ ¦the¦ ¦sw if t ly¦ ¦develop ing¦ ¦research¦ ¦sub j ect¦ .
𐋇¦we¦ ¦will¦ ¦cover¦ ¦the¦ ¦b as ics¦ ¦about¦ ¦the¦ ¦e p ide mi ology¦ ,▁ ¦e ti ology¦ ,▁ ¦vir ology¦ ,▁ ¦diagn o sis¦ ,▁ ¦treatment¦ ,▁ ¦pr og no sis¦ ,▁ ¦and¦ ¦pre vention¦ ¦of¦ ¦the¦ ¦disease¦ .
𐋇 ¦al th ough¦ ¦many¦ ¦qu es tions¦ ¦still¦ ¦requir e¦ ¦a ns w ers¦ ,▁ ¦we¦ ¦h ope¦ ¦that¦ ¦this¦ ¦re v ie w¦ ¦h el ps¦ ¦in¦ ¦the¦ ¦under st an ding¦ ¦and¦ ¦e rad ic ation¦ ¦of¦ ¦the¦ ¦th re at ening¦ ¦disease¦ .
𐋇¦the¦ ¦sp r ing¦ ¦fe st iv al¦ ¦on¦ ¦january¦ ¦2 5¦ ,▁ ¦2020¦ ¦has¦ ¦bec ome¦ ¦an¦ ¦un p r ec ed ented¦ ¦and¦ ¦un for g et t able¦ ¦me m ory¦ ¦to¦ ¦all¦ ¦chinese¦ ¦who¦ ¦were¦ ¦ ur ged¦ ¦to¦ ¦stay¦ ¦ind o ors¦ ¦for¦ ¦all¦ ¦the¦ ¦ho li day¦ ¦and¦ ¦for¦ ¦many¦ ¦weeks¦ ¦after¦ ¦due¦ ¦to¦ ¦the¦ ¦outbreak¦ ¦of¦ ¦a¦ ¦novel¦ ¦viral¦ ¦disease¦ .
𐋇¦the¦ ¦virus¦ ¦is¦ ¦high ly¦ ¦h om ol og o us¦ ¦to¦ ¦the¦ ¦coronavirus¦ ▁( ¦cov¦ )▁ ¦that¦ ¦caused¦ ¦an¦ ¦outbreak¦ ¦of¦ ¦severe¦ ¦acute¦ ¦respiratory¦ ¦syndrome¦ ▁( ¦sars¦ )▁ ¦in¦ ¦20 0 3¦ ;▁ ¦th us¦ ,▁ ¦it¦ ¦was¦ ¦na med¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦by¦ ¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ▁( ¦who¦ )▁ ¦on¦ ¦february¦ ¦11¦ ,▁ ¦2020¦ ,▁ ¦and¦ ¦the¦ ¦associated¦ ¦disease¦ ¦was¦ ¦na med¦ ¦cov¦ ¦disease¦ - ¦19¦ ▁( ¦covid¦ - ¦19¦ ).
𐋇¦the¦ ¦epidemic¦ ¦star ted¦ ¦in¦ ¦wuhan¦ ,▁ ¦china¦ ,▁ ¦and¦ ¦qu ick ly¦ ¦spread¦ ¦th r ou g ho ut¦ ¦the¦ ¦ent ir e¦ ¦country¦ ¦and¦ ¦to¦ ¦n ear¦ ¦50¦ ¦others¦ ¦all¦ ¦over¦ ¦the¦ ¦world¦ .
𐋇¦as¦ ¦of¦ ¦march¦ ¦2¦ ,▁ ¦2020¦ ,▁ ¦the¦ ¦virus¦ ¦has¦ ¦res ul ted¦ ¦in¦ ¦over¦ ¦8 0¦ , ¦000¦ ¦confirmed¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦with¦ ¦more¦ ¦than¦ ¦4 0¦ , ¦000¦ ¦patients¦ ¦dis ch ar ged¦ ¦and¦ ¦over¦ ¦3¦ , ¦000¦ ¦patients¦ ¦who¦ ¦d ied¦ .
𐋇 ¦who¦ ¦w ar ns¦ ¦that¦ ¦covid¦ - ¦19¦ ¦is¦ ▁ “ ¦public¦ ¦e ne m y¦ ¦number¦ ¦1¦ ▁ ” ▁ ¦and¦ ¦pote nt ially¦ ¦more¦ ¦p ow er ful¦ ¦than¦ ¦ter r or is m¦ .
𐋇 ¦according¦ ¦to¦ ¦p ub med¦ ▁( ¦h t t ps¦ :▁ / ▁/▁ ¦w w w¦ . ¦ nc b i¦ . ¦n l m¦ . ¦n i h ¦ . ¦g ov ¦ ▁/▁ ¦p ub med¦ ▁ / ),▁ ¦in¦ ¦less¦ ¦than¦ ¦two¦ ¦mon ths¦ ,▁ ¦over¦ ¦2 00¦ ¦p ap ers¦ ¦have¦ ¦been¦ ¦publ ished¦ ¦on¦ ¦covid¦ - ¦19¦ ¦including¦ ¦its¦ ¦vir ology¦ ,▁ ¦e p ide mi ology¦ ,▁ ¦e ti ology¦ ,▁ ¦diagn o sis¦ ,▁ ¦and¦ ¦treatment¦ ¦since¦ ¦the¦ ¦first¦ ¦report¦ ¦on¦ ¦january¦ ¦7¦ ,▁ ¦2020¦ ¦that¦ ¦det erm ined¦ ¦the¦ ¦se qu ence¦ ¦of¦ ¦the¦ ¦virus¦ ¦isol ated¦ ¦from¦ ¦mult ip le¦ ¦patients¦ .
𐋇¦this¦ ¦re v ie w¦ ¦att e mp ts¦ ¦to¦ ¦su mm ar iz e¦ ¦the¦ ¦research¦ ¦pr og r ess¦ ¦in¦ ¦the¦ ¦new¦ ¦and¦ ¦sw if t ly¦ ¦develop ing¦ ¦sub j ect¦ ¦a rea¦ .
𐋇¦w he ne ver¦ ¦possible¦ ,▁ ¦we¦ ¦will¦ ¦t ry¦ ¦to¦ ¦comp are¦ ¦covid¦ - ¦19¦ ¦with¦ ¦sars¦ ¦and¦ ¦another¦ ¦cov¦ - ¦caused¦ ¦disease¦ ,▁ ¦m id d le¦ ¦e ast¦ ¦respiratory¦ ¦syndrome¦ ▁( ¦mers¦ ,▁ ¦an¦ ¦outbreak¦ ¦in¦ ¦20 1 2¦ ).
𐋇¦we¦ ¦will¦ ¦also¦ ¦disc us s¦ ¦what¦ ¦we¦ ¦have¦ ¦lear ned¦ ¦so¦ ¦fa r¦ ¦reg ar ding¦ ¦the¦ ¦pre vention¦ ¦and¦ ¦pr og no sis¦ ¦of¦ ¦the¦ ¦disease¦ ¦as¦ ¦well¦ ¦as¦ ¦some¦ ¦rem aining¦ ¦y et¦ ¦ ur g ent¦ ¦qu es tions¦ .
𐋇 ¦covs¦ ¦have¦ ¦been¦ ¦tra di tion ally¦ ¦consid ered¦ ¦n on le th al¦ ¦path og ens¦ ¦to¦ ¦humans¦ ,▁ ¦main ly¦ ¦ca us ing¦ ¦appro xi ma tely¦ ¦15¦ %▁ ¦of¦ ¦common¦ ¦c ol ds¦ ¦4¦ .
𐋇¦however¦ ,▁ ¦in¦ ¦this¦ ¦ce nt u ry¦ ,▁ ¦we¦ ¦have¦ ¦e nc ou nt ered¦ ¦high ly¦ ¦path ogen ic¦ ¦human¦ ¦covs¦ ¦t w ice¦ ,▁ ¦i¦ . ¦ e¦ . ,▁ ¦sars¦ - ¦cov¦ ¦and¦ ¦mers¦ - ¦cov¦ ,▁ ¦which¦ ¦caused¦ ¦an¦ ¦outbreak¦ ¦orig in ally¦ ¦in¦ ¦china¦ ¦in¦ ¦20 0 3¦ ¦and¦ ¦sa ud i¦ ¦ar ab ia¦ ¦in¦ ¦20 1 2¦ ,▁ ¦resp ect ively¦ ,▁ ¦and¦ ¦so on¦ ¦spread¦ ¦to¦ ¦many¦ ¦other¦ ¦countries¦ ¦with¦ ¦h or ri ble¦ ¦m or b id ity¦ ¦and¦ ¦m ort ality¦ .
𐋇 ¦the re f ore¦ ,▁ ¦the¦ ¦current¦ ¦covid¦ - ¦19¦ ¦is¦ ¦the¦ ¦thir d¦ ¦cov¦ ¦outbreak¦ ¦in¦ ¦the¦ ¦recor ded¦ ¦h ist ory¦ ¦of¦ ¦humans¦ .
𐋇¦as¦ ¦sh own¦ ¦in¦ ¦fi g¦ .▁ ​ ▁ ¦fi g¦ . ¦1¦ , ¦1¦ ,▁ ¦c lu st ers¦ ¦of¦ ¦pneumonia¦ ¦that¦ ¦had¦ ¦un k n own¦ ¦orig ins¦ ¦were¦ ¦first¦ ¦reported¦ ¦from¦ ¦wuhan¦ ¦on¦ ¦december¦ ¦3 1¦ ,▁ ¦2019¦ ¦to¦ ¦the¦ ¦china¦ ¦national¦ ¦health¦ ¦comm i ssion¦ .
𐋇 ¦se v en¦ ¦days¦ ¦later¦ ¦the¦ ¦se qu ence¦ ¦of¦ ¦the¦ ¦cov¦ ¦was¦ ¦rel ea sed¦ .
𐋇¦on¦ ¦january¦ ¦15¦ ,▁ ¦2020¦ ¦the¦ ¦first¦ ¦fat al¦ ¦case¦ ¦from¦ ¦wuhan¦ ¦was¦ ¦reported¦ .
𐋇 ¦me an w hi le¦ ,▁ ¦the¦ ¦epidemic¦ ¦rap id ly¦ ¦spread¦ ¦to¦ ¦the¦ ¦ne i gh bor ing¦ ¦c ities¦ ,▁ ¦pr ov in ces¦ ,▁ ¦and¦ ¦countries¦ .
𐋇¦on¦ ¦january¦ ¦20¦ ,▁ ¦the¦ ¦infection¦ ¦of¦ ¦health¦ - ¦care¦ ¦provid ers¦ ¦was¦ ¦reported¦ ,▁ ¦su gg es ting¦ ¦that¦ ¦human¦ - ¦to¦ - ¦human¦ ¦transmission¦ ¦was¦ ¦possible¦ .
𐋇¦on¦ ¦january¦ ¦23¦ ,▁ ¦the¦ ¦city¦ ¦of¦ ¦wuhan¦ ¦was¦ ¦loc ked¦ ¦down¦ ¦with¦ ¦all¦ ¦its¦ ¦public¦ ¦trans p ort ation¦ ¦sto pp ed¦ .
𐋇¦on¦ ¦january¦ ¦24¦ ¦the¦ ¦first¦ ¦clinical¦ ¦study¦ ¦on¦ ¦the¦ ¦disease¦ ¦reported¦ ¦that¦ ,▁ ¦out¦ ¦of¦ ¦4 1¦ ¦patients¦ ¦with¦ ¦confirmed¦ ¦cases¦ ,▁ ¦only¦ ¦ 21¦ ¦had¦ ¦direct¦ ¦contact¦ ¦with¦ ¦the¦ ¦wuhan¦ ¦s ea f ood¦ ¦mark et¦ ¦that¦ ¦was¦ ¦consid ered¦ ¦the¦ ¦star ting¦ ¦s ite¦ ¦of¦ ¦the¦ ¦infection¦ ¦from¦ ¦an¦ ¦un k n own¦ ¦anim al¦ ¦sour ce¦ .
𐋇¦on¦ ¦january¦ ¦30¦ ,▁ ¦who¦ ¦decl ared¦ ¦the¦ ¦outbreak¦ ¦a¦ ¦global¦ ¦health¦ ¦emergency¦ .
𐋇¦by¦ ¦the¦ ¦time¦ ¦of¦ ¦this¦ ¦report¦ ,▁ ¦the¦ ¦disease¦ ¦has¦ ¦al rea dy¦ ¦spread¦ ¦th r ou g ho ut¦ ¦china¦ ¦and¦ ¦n ear¦ ¦50¦ ¦other¦ ¦countries¦ ¦all¦ ¦over¦ ¦the¦ ¦world¦ ▁( ¦fi g¦ .▁ ​ ▁( ¦fi g¦ . ¦2¦ )▁ . ¦2¦ ).
𐋇¦as¦ ¦the¦ ¦s itu ation¦ ¦is¦ ¦rap id ly¦ ¦ev ol ving¦ ,▁ ¦the¦ ¦f in al¦ ¦sc ope¦ ¦and¦ ¦se ver ity¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦remain¦ ¦to¦ ¦be¦ ¦det erm ined¦ .
𐋇¦on¦ ¦february¦ ¦11¦ ,▁ ¦2020¦ ,▁ ¦a¦ ¦mult i¦ - ¦center¦ ¦study¦ ¦on¦ ¦8¦ , ¦8 6 6¦ ¦patients¦ ¦including¦ ¦4¦ , ¦0 21¦ ¦confirmed¦ ¦covid¦ - ¦19¦ ¦patients¦ ¦pres ented¦ ¦a¦ ¦more¦ ¦up d ated¦ ¦ il lu str ation¦ ¦of¦ ¦the¦ ¦epidemic¦ ¦as¦ ¦fo ll ow s¦ ▁( ¦h t t ps¦ :▁ / ▁/▁ ¦m p¦ . ¦we i x in¦ . ¦ q q ¦ . ¦c om¦ ▁/▁ ¦s¦ ▁/▁ ¦ ul b i¦ - ¦h x¦ ¦ _ ¦ ¦r h p x a 1 q h a 2 b h d a¦ ).
𐋇 ¦sars¦ - ¦cov¦ - ¦2¦ ¦infected¦ ¦people¦ ¦of¦ ¦all¦ ¦a ges¦ ,▁ ¦but¦ ¦main ly¦ ¦at¦ ¦the¦ ¦age¦ ¦of¦ ¦30¦ - ¦6 5¦ .
𐋇 ¦al m ost¦ ¦h al f¦ ▁( ¦4 7¦ . ¦7¦ % )▁ ¦of¦ ¦the¦ ¦infected¦ ¦individuals¦ ¦were¦ ¦over¦ ¦50¦ ¦years¦ ¦o ld¦ ,▁ ¦very¦ ¦fe w¦ ¦were¦ ¦under¦ ¦20¦ ,▁ ¦and¦ ¦only¦ ¦14¦ ¦infected¦ ¦individuals¦ ¦were¦ ¦under¦ ¦the¦ ¦age¦ ¦of¦ ¦10¦ .
𐋇 ¦sars¦ - ¦cov¦ - ¦2¦ ¦infected¦ ¦more¦ ¦m en¦ ▁( ¦ 0¦ . ¦3 1¦ ▁/▁ ¦100¦ , ¦000¦ )▁ ¦than¦ ¦women¦ ▁( ¦ 0¦ . ¦2 7¦ ▁/▁ ¦100¦ , ¦000¦ ).
𐋇¦covid¦ - ¦19¦ ¦ex pa nded¦ ¦in¦ ¦c lu st ers¦ ¦main ly¦ ¦in¦ ¦and¦ ¦around¦ ¦hub e i¦ .
𐋇¦covid¦ - ¦19¦ ¦t ook¦ ¦an¦ ¦a ver age¦ ¦of¦ ¦5¦ ▁( ¦2¦ - ¦9¦ )▁ ¦days¦ ¦from¦ ¦o ns et¦ ¦to¦ ¦diagn o sis¦ .
𐋇¦the¦ ¦a ver age¦ ¦inc ub ation¦ ¦period¦ ¦was¦ ¦4¦ . ¦8¦ ▁( ¦3¦ . ¦ 0¦ - ¦7¦ . ¦2¦ )▁ ¦days¦ .
𐋇¦the¦ ¦a ver age¦ ¦time¦ ¦from¦ ¦o ns et¦ ¦to¦ ¦death¦ ¦was¦ ¦9¦ . ¦5¦ ▁( ¦4¦ . ¦8¦ - ¦13¦ )▁ ¦days¦ .
𐋇¦the¦ ¦b as ic¦ ¦rep ro duc tive¦ ¦number¦ ▁( ¦r 0¦ )▁ ¦was¦ ¦3¦ . ¦7 7¦ ▁( ¦9 5¦ %▁ ¦c i¦ :▁ ¦3¦ . ¦5 1¦ - ¦4¦ . ¦0 5¦ ),▁ ¦and¦ ¦the¦ ¦ad j us ted¦ ¦r 0¦ ¦was¦ ¦2¦ . ¦23¦ - ¦4¦ . ¦8 2¦ .
𐋇¦the¦ ¦number¦ ¦of¦ ¦infected¦ ¦people¦ ¦increased¦ ¦exp o ne nt ially¦ ¦before¦ ¦23¦ ¦j an¦ .▁ ¦2020¦ ,▁ ¦m at c hing¦ ¦the¦ ¦time¦ ¦of¦ ¦ma ss ive¦ ¦trans p ort ation¦ ¦before¦ ¦the¦ ¦sp r ing¦ ¦fe st iv al¦ ¦in¦ ¦china¦ .
𐋇¦the¦ ¦m ort ality¦ ¦of¦ ¦patients¦ ¦with¦ ¦confirmed¦ ¦cases¦ ¦was¦ ¦1¦ . ¦4 4¦ % ▁( ¦9 5¦ %▁ ¦c i¦ :▁ ¦1¦ . ¦10¦ - ¦1¦ . ¦8 6¦ % ),▁ ¦and¦ ¦the¦ ¦ad j us ted¦ ¦m ort ality¦ ¦of¦ ¦all¦ ¦the¦ ¦patients¦ ¦was¦ ¦3¦ . ¦0 6¦ % ▁( ¦9 5¦ %▁ ¦c i¦ :▁ ¦2¦ . ¦0 2¦ - ¦4¦ . ¦5 9¦ % ).
𐋇 ¦three¦ ¦major¦ ¦risk¦ ¦fa ctors¦ ¦for¦ ¦covid¦ - ¦19¦ ¦were¦ ¦se x¦ ▁( ¦ma le¦ ),▁ ¦age¦ ▁( ≥ ▁ ¦6 0¦ ),▁ ¦and¦ ¦severe¦ ¦pneumonia¦ .
𐋇 ¦covs¦ ¦are¦ ¦a¦ ¦sub fa mi ly¦ ¦of¦ ¦large¦ ¦and¦ ¦en v el op ed¦ ¦viruses¦ ¦cont aining¦ ¦a¦ ¦si ng le¦ ¦ str and¦ ¦of¦ ¦sen se¦ ¦rna¦ .
𐋇¦they¦ ¦can¦ ¦be¦ ¦di vi ded¦ ¦into¦ ¦four¦ ¦gener a¦ ,▁ ¦i¦ . ¦ e¦ . ,▁ ¦al ph a¦ ,▁ ¦bet a¦ ,▁ ¦ga mm a¦ ,▁ ¦and¦ ¦del t a¦ ,▁ ¦of¦ ¦which¦ ¦al ph a¦ - ▁ ¦and¦ ¦bet a¦ - ¦covs¦ ¦are¦ ¦known¦ ¦to¦ ¦inf ect¦ ¦humans¦ .
𐋇¦the¦ ¦en v el ope¦ ¦sp i ke¦ ▁( ¦s¦ )▁ ¦gl y c op ro te in¦ ¦b in ds¦ ¦to¦ ¦its¦ ¦ce ll ular¦ ¦rece pt ors¦ ¦a ng i o tens in¦ - ¦con ver ting¦ ¦en z y me¦ ¦2¦ ▁( ¦a ce 2¦ )▁ ¦and¦ ¦d ip e pt id y l¦ ¦p e pt id ase¦ ¦4¦ ▁( ¦d pp 4¦ )▁ ¦for¦ ¦sars¦ - ¦cov¦ ¦and¦ ¦mers¦ - ¦cov¦ ,▁ ¦resp ect ively¦ ,▁ ¦and¦ ¦then¦ ¦me mb r an e¦ ¦f us ion¦ ¦occur s¦ .
𐋇¦the¦ ¦viral¦ ¦rna¦ ¦gen ome¦ ¦is¦ ¦rel ea sed¦ ¦into¦ ¦the¦ ¦c y t o pl as m¦ ;▁ ¦after¦ ¦re pl ic ation¦ ¦of¦ ¦the¦ ¦viral¦ ¦gen ome¦ ,▁ ¦ ge nomic¦ ¦rna¦ ¦acc o mp an ied¦ ¦by¦ ¦en v el ope¦ ¦gl y c op ro te ins¦ ¦and¦ ¦n uc le oc ap s id¦ ¦prote ins¦ ¦for ms¦ ¦vir ion¦ - ¦cont aining¦ ¦v es ic les¦ ,▁ ¦which¦ ¦then¦ ¦f use¦ ¦with¦ ¦the¦ ¦pl as m a¦ ¦me mb r an e¦ ¦to¦ ¦re le ase¦ ¦the¦ ¦virus¦ .
𐋇¦the¦ ¦first¦ ¦ ge nomic¦ ¦se qu ence¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦was¦ ¦reported¦ ¦on¦ ¦january¦ ¦10¦ ,▁ ¦2020¦ .
𐋇 ¦sars¦ - ¦cov¦ - ¦2¦ ¦was¦ ¦found¦ ¦to¦ ¦be¦ ¦a¦ ¦new¦ ¦typ e¦ ¦of¦ ¦bet a¦ - ¦cov¦ ¦with¦ ¦more¦ ¦than¦ ¦9 9¦ . ¦9 8¦ %▁ ¦gen et ic¦ ¦ident ity¦ ¦among¦ ¦10¦ ¦se qu e nc ed¦ ¦samples¦ ¦coll ected¦ ¦from¦ ¦the¦ ¦orig in al¦ ¦s ite¦ ¦of¦ ¦the¦ ¦outbreak¦ ,▁ ¦the¦ ¦h u an an¦ ¦s ea f ood¦ ¦mark et¦ ¦in¦ ¦wuhan¦ .
𐋇 ¦sars¦ - ¦cov¦ - ¦2¦ ¦is¦ ¦gen et ically¦ ¦more¦ ¦similar¦ ¦to¦ ¦sars¦ - ¦cov¦ ¦than¦ ¦to¦ ¦mers¦ - ¦cov¦ .
𐋇 ¦through¦ ¦transmission¦ ¦el ect r on¦ ¦m ic r os c op y¦ ,▁ ¦sars¦ - ¦cov¦ - ¦2¦ ¦partic les¦ ¦were¦ ¦found¦ ¦in¦ ¦ ult ra th in¦ ¦sec tions¦ ¦of¦ ¦human¦ ¦air w ay¦ ¦e p it he li um¦ .
𐋇 ¦human¦ ¦a ce 2¦ ¦was¦ ¦found¦ ¦to¦ ¦be¦ ¦a¦ ¦rece pt or¦ ¦for¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦as¦ ¦well¦ ¦as¦ ¦sars¦ - ¦cov¦ .
𐋇¦however¦ ,▁ ¦the¦ ¦s¦ ¦protein¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦b in ds¦ ¦to¦ ¦human¦ ¦a ce 2¦ ¦more¦ ¦w ea k ly¦ ¦than¦ ¦that¦ ¦of¦ ¦sars¦ - ¦cov¦ ,▁ ¦which¦ ¦is¦ ¦c oi nc ident¦ ¦with¦ ¦the¦ ¦f ac t¦ ¦that¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦ca u ses¦ ¦less¦ ¦severe¦ ¦infection¦ ¦in¦ ¦patients¦ ¦than¦ ¦sars¦ - ¦cov¦ .
𐋇 ¦sars¦ - ¦cov¦ - ¦2¦ ¦can¦ ¦also¦ ¦for m¦ ¦a¦ ¦novel¦ ¦sh ort¦ ¦protein¦ ¦e nc o ded¦ ¦by¦ ¦or f 3 b ¦ ¦and¦ ¦a¦ ¦sec re ted¦ ¦protein¦ ¦e nc o ded¦ ¦by¦ ¦or f 8¦ .
𐋇¦the¦ ¦or f 3 b ¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦may¦ ¦pl ay¦ ¦a¦ ¦ro le¦ ¦in¦ ¦the¦ ¦viral¦ ¦path ogen ic ity¦ ¦and¦ ¦in hi b i t¦ ¦the¦ ¦exp re ssion¦ ¦of¦ ¦ if n β ¦ ;▁ ¦however¦ ,▁ ¦or f 8¦ ¦does¦ ¦not¦ ¦con tain¦ ¦any¦ ¦known¦ ¦f u nc tional¦ ¦do ma in¦ ¦or¦ ¦mo ti f¦ .
𐋇¦on¦ ¦february¦ ¦18¦ ,▁ ¦2020¦ ,▁ ¦z ho u¦ ,▁ ¦ et¦ ¦ al¦ . ,▁ ¦reported¦ ¦the¦ ¦cr y o¦ - ¦e m¦ ¦st ru ct ure¦ ¦of¦ ¦the¦ ¦f ul l¦ - ¦le ng th¦ ¦human¦ ¦a ce 2¦ ¦at¦ ¦2¦ . ¦9¦ ¦ å ¦ ¦res ol ution¦ ¦in¦ ¦comp le x¦ ¦with¦ ¦the¦ ¦a min o¦ ¦ac id¦ ¦trans p or ter¦ ¦b 0 at 1¦ .
𐋇¦they¦ ¦found¦ ¦that¦ ¦the¦ ¦comp le x¦ ,▁ ¦which¦ ¦had¦ ¦open¦ ¦and¦ ¦closed¦ ¦conf orm ations¦ ,▁ ¦was¦ ¦as se m bl ed¦ ¦as¦ ¦a¦ ¦d im er¦ ¦and¦ ¦the¦ ¦a ce 2¦ - ¦b 0 at 1¦ ¦comp le x¦ ¦can¦ ¦b ind¦ ¦two¦ ¦s¦ ¦prote ins¦ ,▁ ¦which¦ ¦provid es¦ ¦evidence¦ ¦for¦ ¦cov¦ ¦reco gn ition¦ ¦and¦ ¦infection¦ .
𐋇¦b 0 at 1¦ ¦may¦ ¦bec ome¦ ¦a¦ ¦ ther ap e ut ic¦ ¦t arg et¦ ¦for¦ ¦drug¦ ¦scre ening¦ ¦to¦ ¦supp r ess¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦infection¦ .
𐋇¦the¦ ¦orig in¦ ¦and¦ ¦int erm ediate¦ ¦host¦
𐋇¦it¦ ¦has¦ ¦been¦ ¦known¦ ¦that¦ ¦both¦ ¦sars¦ - ¦cov¦ ¦and¦ ¦mers¦ - ¦cov¦ ¦orig in ated¦ ¦from¦ ¦bats¦ ¦and¦ ¦were¦ ¦transm it ted¦ ¦to¦ ¦humans¦ ¦v ia¦ ¦c iv et¦ ¦ca ts¦ ¦and¦ ¦ca m els¦ ,▁ ¦resp ect ively¦ .
𐋇 ¦through¦ ¦a¦ ¦ph y l ogen et ic¦ ¦comp ar is on¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦with¦ ¦other¦ ¦covs¦ ,▁ ¦bats¦ ¦were¦ ¦consid ered¦ ¦the¦ ¦n ative¦ ¦host¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦as¦ ¦the¦ ¦new¦ ¦virus¦ ¦is¦ ¦9 6¦ %▁ ¦ident ical¦ ¦to¦ ¦two¦ ¦sars¦ - ¦like¦ ¦covs¦ ¦from¦ ¦bats¦ ¦called¦ ¦bat¦ - ¦s l¦ - ¦cov z x 4 5¦ ¦and¦ ¦bat¦ - ¦s l¦ - ¦cov z x 21¦ .
𐋇¦however¦ ,▁ ¦what¦ ¦int erm ediate¦ ¦host¦ ¦h el p ed¦ ¦the¦ ¦virus¦ ¦c ross¦ ¦the¦ ¦spec ies¦ ¦b ar ri er¦ ¦to¦ ¦inf ect¦ ¦humans¦ ¦rema ins¦ ¦un k n own¦ ,▁ ¦and¦ ¦the¦ ¦transmission¦ ¦ro ute¦ ¦is¦ ¦y et¦ ¦to¦ ¦be¦ ¦el uc id ated¦ .
𐋇 ¦j i¦ ,▁ ¦ et¦ ¦ al¦ . ,▁ ¦prop osed¦ ¦s na k es¦ ¦as¦ ¦a¦ ¦car ri er¦ ¦of¦ ¦the¦ ¦virus¦ ¦from¦ ¦bats¦ ¦to¦ ¦humans¦ ¦which¦ ¦invol v ed¦ ¦h om ol og o us¦ ¦reco mb ination¦ ¦within¦ ¦the¦ ¦s¦ ¦protein¦ .
𐋇 ¦according¦ ¦to¦ ¦a¦ ¦study¦ ,▁ ¦res ear ch ers¦ ¦in¦ ¦gu a ng z ho u¦ ,▁ ¦china¦ ,▁ ¦su gg ested¦ ¦that¦ ¦pa ngol ins¦ ▁-▁ ¦long¦ - ¦s n ou ted¦ ,▁ ¦ ant¦ - ¦e ating¦ ¦ma mm als¦ ¦often¦ ¦used¦ ¦in¦ ¦tra di tional¦ ¦chinese¦ ¦medic ine¦ ▁-▁ ¦are¦ ¦the¦ ¦pote ntial¦ ¦int erm ediate¦ ¦host¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦based¦ ¦on¦ ¦9 9¦ %▁ ¦gen et ic¦ ¦h om ology¦ ¦in¦ ¦a¦ ¦cov¦ ¦dis covered¦ ¦in¦ ¦pa ngol ins¦ ¦and¦ ¦sars¦ - ¦cov¦ - ¦2¦ .
𐋇¦however¦ ,▁ ¦1¦ %▁ ¦di ff er ence¦ ¦spread¦ ¦all¦ ¦over¦ ¦two¦ ¦gen omes¦ ¦is¦ ¦still¦ ¦a¦ ¦bi g¦ ¦di ff er ence¦ ;▁ ¦th us¦ ,▁ ¦co nc l us ive¦ ¦results¦ ¦for¦ ¦co nc r et e¦ ¦evidence¦ ¦are¦ ¦a w ai ted¦ ▁( ¦fi g¦ .▁ ​ ▁( ¦fi g¦ . ¦3 3¦ ).
𐋇¦the¦ ¦ph ys ic o che m ical¦ ¦prop e rt ies¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦are¦ ¦l arg ely¦ ¦not¦ ¦y et¦ ¦known¦ .
𐋇 ¦sars¦ - ¦cov¦ ¦and¦ ¦mers¦ - ¦cov¦ ¦can¦ ¦sur v ive¦ ¦in¦ ¦v it r o¦ ¦for¦ ¦4 8¦ ¦hours¦ ¦in¦ ¦a¦ ¦d ry¦ ¦en vir on ment¦ ¦and¦ ¦up¦ ¦to¦ ¦5¦ ¦days¦ ¦under¦ ¦20¦ ▁ ° ▁ ¦ c¦ ¦and¦ ¦4 0¦ %▁ - ¦50¦ %▁ ¦h um id ity¦ .
𐋇 ¦sars¦ - ¦cov¦ - ¦2¦ ¦may¦ ¦po ss ess¦ ¦similar¦ ¦prop e rt ies¦ .
𐋇¦it¦ ¦has¦ ¦been¦ ¦reported¦ ¦that¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦is¦ ¦sen si tive¦ ¦to¦ ¦ ult ra vi ol et¦ ¦r ays¦ ¦and¦ ¦he at¦ ¦at¦ ¦5 6¦ ▁ ° ▁ ¦ c¦ ¦for¦ ¦30¦ ¦min u tes¦ ;▁ ¦ ether¦ ,▁ ¦7 5¦ %▁ ¦e th a no l¦ ,▁ ¦ch l or ine¦ - ¦cont aining¦ ¦disinf ect ant¦ ,▁ ¦per ac et ic¦ ¦ac id¦ ,▁ ¦ch lo ro for m¦ ,▁ ¦and¦ ¦other¦ ¦fat t y¦ ¦s ol v ents¦ ,▁ ¦but¦ ¦not¦ ¦ch l or he x id ine¦ ,▁ ¦can¦ ¦eff ect ively¦ ¦i na ct iv ate¦ ¦the¦ ¦virus¦ .
𐋇¦the¦ ¦ent ir e¦ ¦human¦ ¦population¦ ¦gener ally¦ ¦l ac ks¦ ¦immun ity¦ ¦to¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦and¦ ¦h ence¦ ¦is¦ ¦s us cep ti ble¦ ¦to¦ ¦the¦ ¦novel¦ ¦virus¦ .
𐋇 ¦cur re ntly¦ ,▁ ¦no¦ ¦detail ed¦ ¦study¦ ¦has¦ ¦been¦ ¦reported¦ ¦reg ar ding¦ ¦the¦ ¦immun ological¦ ¦response¦ ¦to¦ ¦sars¦ - ¦cov¦ - ¦2¦ .
𐋇 ¦th us¦ ,▁ ¦we¦ ¦can¦ ¦only¦ ¦ref er¦ ¦to¦ ¦prev ious¦ ¦st u dies¦ ¦on¦ ¦other¦ ¦covs¦ ,▁ ¦especially¦ ¦sars¦ - ¦cov¦ ¦and¦ ¦mers¦ - ¦cov¦ ▁( ¦fi g¦ .▁ ​ ▁( ¦fi g¦ . ¦4¦ )▁ . ¦4¦ ).
𐋇¦in¦ ¦general¦ ,▁ ¦after¦ ¦a¦ ¦virus¦ ¦inv a des¦ ¦the¦ ¦host¦ ,▁ ¦it¦ ¦is¦ ¦first¦ ¦reco gn i zed¦ ¦by¦ ¦the¦ ¦host¦ ¦in n ate¦ ¦immune¦ ¦system¦ ¦through¦ ¦p at t er n¦ ¦reco gn ition¦ ¦rece pt ors¦ ▁( ¦pr r s¦ )▁ ¦including¦ ¦ c¦ - ¦typ e¦ ¦l ect in¦ - ¦like¦ ¦rece pt ors¦ ,▁ ¦t ol l¦ - ¦like¦ ¦rece pt or¦ ▁( ¦t l r¦ ),▁ ¦no d¦ - ¦like¦ ¦rece pt or¦ ▁( ¦n l r¦ ),▁ ¦and¦ ¦ ri g¦ - ¦i¦ - ¦like¦ ¦rece pt or¦ ▁( ¦r l r¦ ).
𐋇 ¦through¦ ¦different¦ ¦path w ays¦ ,▁ ¦the¦ ¦virus¦ ¦ind u ces¦ ¦the¦ ¦exp re ssion¦ ¦of¦ ¦inf la mm atory¦ ¦fa ctors¦ ,▁ ¦m at ur ation¦ ¦of¦ ¦d en dr it ic¦ ¦ce lls¦ ,▁ ¦and¦ ¦s y nt he sis¦ ¦of¦ ¦typ e¦ ¦i¦ ¦inter f er ons¦ ▁( ¦ if ns¦ )▁ ¦which¦ ¦limi t¦ ¦the¦ ¦sprea ding¦ ¦of¦ ¦the¦ ¦virus¦ ¦and¦ ¦acc el er ate¦ ¦m ac ro ph age¦ ¦ph a g oc y t o sis¦ ¦of¦ ¦viral¦ ¦anti g ens¦ .
𐋇¦however¦ ,▁ ¦the¦ ¦ n¦ ¦protein¦ ¦of¦ ¦sars¦ - ¦cov¦ ¦can¦ ¦help¦ ¦the¦ ¦virus¦ ¦ esc ap e¦ ¦from¦ ¦the¦ ¦immune¦ ¦resp on ses¦ .
𐋇 ¦so on¦ ,▁ ¦the¦ ¦ad ap tive¦ ¦immune¦ ¦response¦ ¦jo ins¦ ¦the¦ ¦f ight¦ ¦against¦ ¦the¦ ¦virus¦ .
𐋇 ¦t¦ ¦l y m ph oc y tes¦ ¦including¦ ¦c d 4¦ ▁ + ▁ ¦and¦ ¦c d 8¦ ▁ + ▁ ¦t¦ ¦ce lls¦ ¦pl ay¦ ¦an¦ ¦important¦ ¦ro le¦ ¦in¦ ¦the¦ ¦def en se¦ .
𐋇¦c d 4¦ ▁ + ▁ ¦t¦ ¦ce lls¦ ¦st im ul ate¦ ¦b ¦ ¦ce lls¦ ¦to¦ ¦produc e¦ ¦virus¦ - ¦specific¦ ¦antibo dies¦ ,▁ ¦and¦ ¦c d 8¦ ▁ + ▁ ¦t¦ ¦ce lls¦ ¦dir ect ly¦ ¦k ill¦ ¦virus¦ - ¦infected¦ ¦ce lls¦ .
𐋇 ¦t¦ ¦h el p er¦ ¦ce lls¦ ¦produc e¦ ¦pro in f la mm atory¦ ¦c y t o k ines¦ ¦to¦ ¦help¦ ¦the¦ ¦def ending¦ ¦ce lls¦ .
𐋇¦however¦ ,▁ ¦cov¦ ¦can¦ ¦in hi b i t¦ ¦t¦ ¦c ell¦ ¦f u nc tions¦ ¦by¦ ¦in duc ing¦ ¦ ap o pt o sis¦ ¦of¦ ¦t¦ ¦ce lls¦ .
𐋇¦the¦ ¦h um or al¦ ¦immun ity¦ ¦including¦ ¦comp le ments¦ ¦such¦ ¦as¦ ¦c 3 a¦ ¦and¦ ¦c 5 a¦ ¦and¦ ¦antibo dies¦ ¦is¦ ¦also¦ ¦essential¦ ¦in¦ ¦co mb ating¦ ¦the¦ ¦viral¦ ¦infection¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦antibo dies¦ ¦isol ated¦ ¦from¦ ¦a¦ ¦re covered¦ ¦pa ti ent¦ ¦ne ut ra li zed¦ ¦mers¦ - ¦cov¦ .
𐋇¦on¦ ¦the¦ ¦other¦ ¦hand¦ ,▁ ¦an¦ ¦over rea ction¦ ¦of¦ ¦the¦ ¦immune¦ ¦system¦ ¦gener ates¦ ¦a¦ ¦large¦ ¦number¦ ¦of¦ ¦fre e¦ ¦ rad ic als¦ ¦loc ally¦ ¦that¦ ¦can¦ ¦cause¦ ¦severe¦ ¦da ma ges¦ ¦to¦ ¦the¦ ¦lu ng s¦ ¦and¦ ¦other¦ ¦or g ans¦ ,▁ ¦and¦ ,▁ ¦in¦ ¦the¦ ¦wor s t¦ ¦s ce na ri o¦ ,▁ ¦mult i¦ - ¦or g an¦ ¦fa il ure¦ ¦and¦ ¦even¦ ¦death¦ .
𐋇¦the¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦infection¦ ,▁ ¦fe at ur ed¦ ¦by¦ ¦c lu st ering¦ ¦o ns et¦ ,▁ ¦is¦ ¦more¦ ¦likely¦ ¦to¦ ¦aff ect¦ ¦el d erly¦ ¦people¦ ¦with¦ ¦c om or b id ities¦ ¦and¦ ¦pre gnant¦ ¦women¦ .
𐋇¦it¦ ¦is¦ ¦common¦ ¦that¦ ¦for¦ ¦people¦ ¦who¦ ¦are¦ ¦exp osed¦ ¦to¦ ¦a¦ ¦large¦ ¦number¦ ¦of¦ ¦viruses¦ ¦or¦ ¦wh ose¦ ¦immune¦ ¦f u nc tions¦ ¦are¦ ¦comp ro mi sed¦ ,▁ ¦they¦ ¦have¦ ¦higher¦ ¦ch ance¦ ¦to¦ ¦be¦ ¦infected¦ ¦than¦ ¦others¦ .
𐋇¦the¦ ¦estim ated¦ ¦me an¦ ¦inc ub ation¦ ¦period¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦is¦ ¦1¦ - ¦14¦ ¦days¦ ,▁ ¦mo st ly¦ ¦3¦ - ¦7¦ ¦days¦ ¦based¦ ¦on¦ ¦a¦ ¦study¦ ¦of¦ ¦the¦ ¦first¦ ¦4 2 5¦ ¦cases¦ ¦in¦ ¦wuhan¦ .
𐋇¦however¦ ,▁ ¦a¦ ¦study¦ ¦on¦ ¦1¦ , ¦0 9 9¦ ¦cases¦ ¦dem on str ates¦ ¦that¦ ¦the¦ ¦inc ub ation¦ ¦period¦ ¦was¦ ¦3¦ ¦days¦ ¦on¦ ¦a ver age¦ ¦and¦ ¦r an ged¦ ¦from¦ ¦ 0¦ ¦to¦ ¦24¦ ¦days¦ .
𐋇¦a¦ ¦more¦ ¦rec ent¦ ¦study¦ ,▁ ¦as¦ ¦d esc rib ed¦ ¦a bo ve¦ ,▁ ¦dem on str ates¦ ¦that¦ ¦the¦ ¦inc ub ation¦ ¦period¦ ¦was¦ ¦4¦ . ¦8¦ ▁( ¦3¦ . ¦ 0¦ - ¦7¦ . ¦2¦ )▁ ¦days¦ ¦based¦ ¦on¦ ¦the¦ ¦dem ogra ph y¦ ¦of¦ ¦8¦ , ¦8 6 6¦ ¦cases¦ .
𐋇¦it¦ ¦is¦ ¦very¦ ¦important¦ ¦for¦ ¦health¦ ¦author ities¦ ¦to¦ ¦ad j ust¦ ¦the¦ ¦effective¦ ¦quarantine¦ ¦time¦ ¦based¦ ¦on¦ ¦the¦ ¦most¦ ¦acc ur ate¦ ¦inc ub ation¦ ¦period¦ ,▁ ¦th us¦ ¦prev en ting¦ ¦infected¦ ¦but¦ ¦s y m pt om less¦ ¦people¦ ¦from¦ ¦transm it ting¦ ¦the¦ ¦virus¦ ¦to¦ ¦others¦ .
𐋇¦as¦ ¦a¦ ¦common¦ ¦pract ice¦ ,▁ ¦individuals¦ ¦exp osed¦ ¦to¦ ,▁ ¦or¦ ¦infected¦ ¦by¦ ,▁ ¦the¦ ¦virus¦ ¦are¦ ¦us ually¦ ¦required¦ ¦to¦ ¦be¦ ¦qu ara nt ined¦ ¦for¦ ¦14¦ ¦days¦ .
𐋇 ¦should¦ ¦the¦ ¦quarantine¦ ¦time¦ ¦be¦ ¦ex te nded¦ ¦to¦ ¦24¦ ¦days¦ ?
𐋇 ¦fever¦ ¦is¦ ¦often¦ ¦the¦ ¦major¦ ¦and¦ ¦in it ial¦ ¦s y m pt om¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦which¦ ¦can¦ ¦be¦ ¦acc o mp an ied¦ ¦by¦ ¦no¦ ¦s y m pt om¦ ¦or¦ ¦other¦ ¦symptoms¦ ¦such¦ ¦as¦ ¦d ry¦ ¦cough¦ ,▁ ¦sh ort ness¦ ¦of¦ ¦brea th¦ ,▁ ¦m us c le¦ ¦a ch e¦ ,▁ ¦d iz z i ness¦ ,▁ ¦h ea d a ch e¦ ,▁ ¦s ore¦ ¦th ro at¦ ,▁ ¦r h in or r he a¦ ,▁ ¦chest¦ ¦pain¦ ,▁ ¦di arr he a¦ ,▁ ¦na u se a¦ ,▁ ¦and¦ ¦v o mi ting¦ .
𐋇¦some¦ ¦patients¦ ¦exp er ie nc ed¦ ¦d ys p ne a¦ ¦and¦ ▁/▁ ¦or¦ ¦h y p o x e m ia¦ ¦one¦ ¦week¦ ¦after¦ ¦the¦ ¦o ns et¦ ¦of¦ ¦the¦ ¦disease¦ .
𐋇¦in¦ ¦severe¦ ¦cases¦ ,▁ ¦patients¦ ¦qu ick ly¦ ¦pr og r es sed¦ ¦to¦ ¦develop ¦ ¦acute¦ ¦respiratory¦ ¦syndrome¦ ,▁ ¦se pt ic¦ ¦sh oc k¦ ,▁ ¦met ab ol ic¦ ¦ac id o sis¦ ,▁ ¦and¦ ¦co a g u lo pa th y¦ .
𐋇 ¦patients¦ ¦with¦ ¦fever¦ ¦and¦ ▁/▁ ¦or¦ ¦respiratory¦ ¦symptoms¦ ¦and¦ ¦acute¦ ¦fever¦ ,▁ ¦even¦ ¦without¦ ¦p ul m on ary¦ ¦i ma ging¦ ¦ab n orm al ities¦ ,▁ ¦should¦ ¦be¦ ¦scre e ned¦ ¦for¦ ¦the¦ ¦virus¦ ¦for¦ ¦early¦ ¦diagn o sis¦ .
𐋇¦a¦ ¦dem ogra ph ic¦ ¦study¦ ¦in¦ ¦l ate¦ ¦december¦ ¦of¦ ¦2019¦ ¦sh owed¦ ¦that¦ ¦the¦ ¦p erc en ta ges¦ ¦of¦ ¦the¦ ¦symptoms¦ ¦were¦ ¦9 8¦ %▁ ¦for¦ ¦fever¦ ,▁ ¦7 6¦ %▁ ¦for¦ ¦d ry¦ ¦cough¦ ,▁ ¦5 5¦ %▁ ¦for¦ ¦d ys p ne a¦ ,▁ ¦and¦ ¦3¦ %▁ ¦for¦ ¦di arr he a¦ ;▁ ¦8¦ %▁ ¦of¦ ¦the¦ ¦patients¦ ¦required¦ ¦ ventil ation¦ ¦support¦ .
𐋇 ¦similar¦ ¦fi nd ings¦ ¦were¦ ¦reported¦ ¦in¦ ¦two¦ ¦rec ent¦ ¦st u dies¦ ¦of¦ ¦a¦ ¦family¦ ¦cl us ter¦ ¦and¦ ¦a¦ ¦cl us ter¦ ¦caused¦ ¦by¦ ¦transmission¦ ¦from¦ ¦an¦ ¦as ymptomatic¦ ¦ind iv id ual¦ .
𐋇¦c om par ab ly¦ ,▁ ¦a¦ ¦dem ogra ph ic¦ ¦study¦ ¦in¦ ¦20 1 2¦ ¦sh owed¦ ¦that¦ ¦mers¦ - ¦cov¦ ¦patients¦ ¦also¦ ¦had¦ ¦fever¦ ▁( ¦9 8¦ % ),▁ ¦d ry¦ ¦cough¦ ▁( ¦4 7¦ % ),▁ ¦and¦ ¦d ys p ne a¦ ▁( ¦5 5¦ % )▁ ¦as¦ ¦their¦ ¦ma in¦ ¦symptoms¦ .
𐋇¦however¦ ,▁ ¦8 0¦ %▁ ¦of¦ ¦them¦ ¦required¦ ¦ ventil ation¦ ¦support¦ ,▁ ¦much¦ ¦more¦ ¦than¦ ¦covid¦ - ¦19¦ ¦patients¦ ¦and¦ ¦cons ist ent¦ ¦with¦ ¦the¦ ¦higher¦ ¦le th ality¦ ¦of¦ ¦mers¦ ¦than¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇 ¦di arr he a¦ ▁( ¦26¦ % )▁ ¦and¦ ¦s ore¦ ¦th ro at¦ ▁( ¦ 21¦ % )▁ ¦were¦ ¦also¦ ¦ob s erv ed¦ ¦with¦ ¦mers¦ ¦patients¦ .
𐋇¦in¦ ¦sars¦ ¦patients¦ ,▁ ¦it¦ ¦has¦ ¦been¦ ¦dem on str ated¦ ¦that¦ ¦fever¦ ▁( ¦9 9¦ %▁ - ¦100¦ % ),▁ ¦d ry¦ ¦cough¦ ▁( ¦2 9¦ %▁ - ¦7 5¦ % ),▁ ¦d ys p ne a¦ ▁( ¦4 0¦ %▁ - ¦4 2¦ % ),▁ ¦di arr he a¦ ▁( ¦20¦ - ¦2 5¦ % ),▁ ¦and¦ ¦s ore¦ ¦th ro at¦ ▁( ¦13¦ - ¦2 5¦ % )▁ ¦were¦ ¦the¦ ¦major¦ ¦symptoms¦ ¦and¦ ¦ ventil ation¦ ¦support¦ ¦was¦ ¦required¦ ¦for¦ ¦appro xi ma tely¦ ¦14¦ %▁ - ¦20¦ %▁ ¦of¦ ¦the¦ ¦patients¦ .
𐋇¦by¦ ¦february¦ ¦14¦ ,▁ ¦the¦ ¦m ort ality¦ ¦of¦ ¦covid¦ - ¦19¦ ¦was¦ ¦2¦ %▁ ¦when¦ ¦the¦ ¦confirmed¦ ¦cases¦ ¦rea ched¦ ¦6 6¦ , ¦5 7 6¦ ¦gl ob ally¦ .
𐋇¦c om par ab ly¦ ,▁ ¦the¦ ¦m ort ality¦ ¦of¦ ¦sars¦ ¦by¦ ¦no ve mber¦ ¦20 0 2¦ ¦was¦ ¦10¦ %▁ ¦of¦ ¦8¦ , ¦0 9 6¦ ¦confirmed¦ ¦cases¦ .
𐋇¦for¦ ¦mers¦ ,▁ ¦based¦ ¦on¦ ¦a¦ ¦dem ogra ph ic¦ ¦study¦ ¦in¦ ¦june¦ ¦20 1 2¦ ,▁ ¦the¦ ¦m ort ality¦ ¦was¦ ¦3 7¦ %▁ ¦of¦ ¦2¦ , ¦4 9 4¦ ¦confirmed¦ ¦cases¦ .
𐋇 ¦an¦ ¦ ear li er¦ ¦study¦ ¦reported¦ ¦that¦ ¦the¦ ¦r 0¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦was¦ ¦as¦ ¦high¦ ¦as¦ ¦6¦ . ¦4 7¦ ¦with¦ ¦a¦ ¦9 5¦ %▁ ¦conf idence¦ ¦int erv al¦ ▁( ¦c i¦ )▁ ¦of¦ ¦5¦ . ¦7 1¦ - ¦7¦ . ¦23¦ ,▁ ¦w he rea s¦ ¦the¦ ¦r 0¦ ¦of¦ ¦sars¦ - ¦cov¦ ¦only¦ ¦r an ged¦ ¦from¦ ¦2¦ ¦to¦ ¦4¦ .
𐋇¦a¦ ¦comp ar is on¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦with¦ ¦mers¦ - ¦cov¦ ¦and¦ ¦s ar a¦ - ¦cov¦ ¦reg ar ding¦ ¦their¦ ¦symptoms¦ ,▁ ¦m ort ality¦ ,▁ ¦and¦ ¦r 0¦ ¦is¦ ¦pres ented¦ ¦in¦ ¦t able¦ ▁ ​ ▁ ¦t ab le 1¦ . ¦1¦ .
𐋇¦the¦ ¦a bo ve¦ ¦f ig ures¦ ¦su gg est¦ ¦that¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦has¦ ¦a¦ ¦higher¦ ¦a bility¦ ¦to¦ ¦spread¦ ¦than¦ ¦mers¦ - ¦cov¦ ¦and¦ ¦sars¦ - ¦cov¦ ,▁ ¦but¦ ¦it¦ ¦is¦ ¦less¦ ¦le th al¦ ¦than¦ ¦the¦ ¦l at ter¦ ¦two¦ .
𐋇 ¦th us¦ ,▁ ¦it¦ ¦is¦ ¦much¦ ¦more¦ ¦cha ll en ging¦ ¦to¦ ¦control¦ ¦the¦ ¦epidemic¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦than¦ ¦those¦ ¦of¦ ¦mers¦ - ¦cov¦ ¦and¦ ¦sars¦ - ¦cov¦ .
𐋇¦c lu st ered¦ ¦o ns et¦ ¦often¦ ¦happ ens¦ ¦in¦ ¦the¦ ¦same¦ ¦family¦ ¦or¦ ¦from¦ ¦the¦ ¦same¦ ¦ga th ering¦ ¦or¦ ¦ ve h ic le¦ ¦such¦ ¦as¦ ¦a¦ ¦c ru ise¦ ¦s hi p¦ .
𐋇 ¦patients¦ ¦often¦ ¦have¦ ¦a¦ ¦h ist ory¦ ¦of¦ ¦travel¦ ¦or¦ ¦res idence¦ ¦in¦ ¦wuhan¦ ¦or¦ ¦other¦ ¦affected¦ ¦areas¦ ¦or¦ ¦contact¦ ¦with¦ ¦infected¦ ¦individuals¦ ¦or¦ ¦patients¦ ¦in¦ ¦the¦ ¦rec ent¦ ¦two¦ ¦weeks¦ ¦before¦ ¦the¦ ¦o ns et¦ .
𐋇¦however¦ ,▁ ¦it¦ ¦has¦ ¦been¦ ¦reported¦ ¦that¦ ¦people¦ ¦can¦ ¦car ry¦ ¦the¦ ¦virus¦ ¦without¦ ¦symptoms¦ ¦lo nger¦ ¦than¦ ¦two¦ ¦weeks¦ ¦and¦ ¦cur ed¦ ¦patients¦ ¦dis ch ar ged¦ ¦from¦ ¦hosp it als¦ ¦can¦ ¦car ry¦ ¦the¦ ¦virus¦ ¦ag a in¦ ,▁ ¦which¦ ¦s ends¦ ¦out¦ ¦an¦ ¦al ar m¦ ¦to¦ ¦increase¦ ¦the¦ ¦time¦ ¦for¦ ¦quarantine¦ .
𐋇 ¦patients¦ ¦have¦ ¦normal¦ ¦or¦ ¦reduc ed¦ ¦number¦ ¦of¦ ¦p eri ph er al¦ ¦wh ite¦ ¦blood¦ ¦ce lls¦ ▁( ¦especially¦ ¦l y m ph oc y tes¦ )▁ ¦at¦ ¦the¦ ¦early¦ ¦st age¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦l y m ph op en ia¦ ¦with¦ ¦wh ite¦ ¦blood¦ ¦c ell¦ ¦co un t¦ ▁ & ▁ ¦l t¦ ;▁ ¦4¦ ▁ × ▁ ¦1 0 9¦ ▁/▁ ¦ l¦ ¦including¦ ¦l y m ph oc y t e¦ ¦co un t¦ ▁ & ▁ ¦l t¦ ;▁ ¦1¦ ▁ × ▁ ¦1 0 9¦ ▁/▁ ¦ l¦ ,▁ ¦and¦ ¦e le v ated¦ ¦as pa rt ate¦ ¦a min ot ra ns f er ase¦ ¦le v els¦ ¦and¦ ¦vir e m ia¦ ¦were¦ ¦found¦ ¦in¦ ¦1¦ , ¦0 9 9¦ ¦covid¦ - ¦19¦ ¦patients¦ .
𐋇¦the¦ ¦le v els¦ ¦of¦ ¦li ver¦ ¦and¦ ¦m us c le¦ ¦en z y m es¦ ¦and¦ ¦m y og l ob in¦ ¦were¦ ¦increased¦ ¦in¦ ¦the¦ ¦blood¦ ¦of¦ ¦some¦ ¦patients¦ ,▁ ¦and¦ ¦ c¦ - ¦re ac tive¦ ¦protein¦ ¦and¦ ¦ er y th r oc y t e¦ ¦se di me nt ation¦ ¦were¦ ¦increased¦ ¦in¦ ¦the¦ ¦blood¦ ¦of¦ ¦most¦ ¦patients¦ .
𐋇¦in¦ ¦patients¦ ¦with¦ ¦severe¦ ¦cases¦ ,▁ ¦the¦ ¦level¦ ¦of¦ ¦ d¦ - ¦d im er¦ ,▁ ¦a¦ ¦fi b r in¦ ¦de g rad ation¦ ¦produc t¦ ¦pres ent¦ ¦in¦ ¦the¦ ¦blood¦ ,▁ ¦was¦ ¦e le v ated¦ ,▁ ¦and¦ ¦l y m ph oc y t e¦ ¦co un t¦ ¦was¦ ¦pr og re ss ively¦ ¦reduc ed¦ .
𐋇 ¦ab n orm al ities¦ ¦in¦ ¦chest¦ ¦ra di ogra ph y¦ ¦are¦ ¦found¦ ¦in¦ ¦most¦ ¦covid¦ - ¦19¦ ¦patients¦ ¦and¦ ¦fe at ur ed¦ ¦by¦ ¦b il at er al¦ ¦p at ch y¦ ¦sh a d ow s¦ ¦or¦ ¦grou n d¦ ¦gl ass¦ ¦op ac ity¦ ¦in¦ ¦the¦ ¦lu ng s¦ .
𐋇 ¦patients¦ ¦often¦ ¦develop ¦ ¦an¦ ¦ at y p ical¦ ¦pneumonia¦ ,▁ ¦acute¦ ¦lu ng¦ ¦in j u ry¦ ,▁ ¦and¦ ¦acute¦ ¦respiratory¦ ¦di str ess¦ ¦syndrome¦ ▁( ¦ ards¦ ).
𐋇¦when¦ ¦ ards¦ ¦happ ens¦ ,▁ ¦u nc o nt ro lled¦ ¦inf la mm ation¦ ,▁ ¦f lu id¦ ¦acc um ul ation¦ ,▁ ¦and¦ ¦pr og re ss ive¦ ¦fi b ro sis¦ ¦se ver ely¦ ¦comp r om ise¦ ¦the¦ ¦ga s¦ ¦ex ch ange¦ .
𐋇¦d ys f un ction¦ ¦of¦ ¦typ e¦ - ¦i¦ ¦and¦ ¦typ e¦ - ¦i i¦ ¦p ne um oc y tes¦ ¦dec rea ses¦ ¦the¦ ¦sur fa ct ant¦ ¦level¦ ¦and¦ ¦inc rea ses¦ ¦sur f ace¦ ¦ tens ion¦ ,▁ ¦th us¦ ¦reduc ing¦ ¦the¦ ¦a bility¦ ¦of¦ ¦the¦ ¦lu ng s¦ ¦to¦ ¦exp and¦ ¦and¦ ¦he i gh t ening¦ ¦the¦ ¦risk¦ ¦of¦ ¦lu ng¦ ¦coll ap se¦ .
𐋇 ¦the re f ore¦ ,▁ ¦the¦ ¦wor s t¦ ¦chest¦ ¦ra di ogra ph ic¦ ¦fi nd ings¦ ¦often¦ ¦par al le l¦ ¦the¦ ¦most¦ ¦severe¦ ¦ext ent¦ ¦of¦ ¦the¦ ¦disease¦ .
𐋇¦on¦ ¦february¦ ¦18¦ ,▁ ¦2020¦ ,▁ ¦the¦ ¦first¦ ¦path ological¦ ¦anal y sis¦ ¦of¦ ¦covid¦ - ¦19¦ ¦dem on str ated¦ ¦the¦ ¦d es qu a m ation¦ ¦of¦ ¦p ne um oc y tes¦ ,▁ ¦h y a line¦ ¦me mb r an e¦ ¦f orm ation¦ ,▁ ¦and¦ ¦inter st it ial¦ ¦l y m ph oc y t e¦ ¦inf il t r ation¦ ,▁ ¦and¦ ¦mult in uc le ated¦ ¦s y nc y t ial¦ ¦ce lls¦ ¦in¦ ¦the¦ ¦lu ng s¦ ¦of¦ ¦a¦ ¦pa ti ent¦ ¦who¦ ¦d ied¦ ¦of¦ ¦the¦ ¦disease¦ ,▁ ¦cons ist ent¦ ¦with¦ ¦the¦ ¦path ology¦ ¦of¦ ¦viral¦ ¦infection¦ ¦and¦ ¦ ards¦ ¦and¦ ¦similar¦ ¦to¦ ¦that¦ ¦of¦ ¦sars¦ ¦and¦ ¦mers¦ ¦patients¦ .
𐋇¦the¦ ¦de te ction¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦rna¦ ¦v ia¦ ¦re ver se¦ - ¦trans c ri pt ase¦ ¦pol y mer ase¦ ¦cha in¦ ¦rea ction¦ ▁( ¦r t¦ - ¦p c r¦ )▁ ¦was¦ ¦used¦ ¦as¦ ¦the¦ ¦major¦ ¦crit er ia¦ ¦for¦ ¦the¦ ¦diagn o sis¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇¦however¦ ,▁ ¦due¦ ¦to¦ ¦the¦ ¦high¦ ¦f al se¦ - ¦negative¦ ¦rate¦ ,▁ ¦which¦ ¦may¦ ¦acc el er ate¦ ¦the¦ ¦epidemic¦ ,▁ ¦clinical¦ ¦m an if e st ations¦ ¦star ted¦ ¦to¦ ¦be¦ ¦used¦ ¦for¦ ¦diagn o sis¦ ▁( ¦which¦ ¦no¦ ¦lo nger¦ ¦s ol ely¦ ¦rel ied¦ ¦on¦ ¦r t¦ - ¦p c r¦ )▁ ¦in¦ ¦china¦ ¦on¦ ¦february¦ ¦13¦ ,▁ ¦2020¦ .
𐋇¦a¦ ¦similar¦ ¦s itu ation¦ ¦also¦ ¦occur r ed¦ ¦with¦ ¦the¦ ¦diagn o sis¦ ¦of¦ ¦sars¦ .
𐋇 ¦the re f ore¦ ,▁ ¦a¦ ¦co mb ination¦ ¦of¦ ¦disease¦ ¦h ist ory¦ ,▁ ¦clinical¦ ¦m an if e st ations¦ ,▁ ¦laboratory¦ ¦tests¦ ,▁ ¦and¦ ¦ra di ological¦ ¦fi nd ings¦ ¦is¦ ¦essential¦ ¦and¦ ¦imp er ative¦ ¦for¦ ¦ma king¦ ¦an¦ ¦effective¦ ¦diagn o sis¦ .
𐋇¦on¦ ¦february¦ ¦14¦ ,▁ ¦2020¦ ,▁ ¦the¦ ¦fe ng¦ ¦z h a ng¦ ¦group¦ ¦d esc rib ed¦ ¦a¦ ¦prot oc o l¦ ¦of¦ ¦using¦ ¦the¦ ¦cr is p r¦ - ¦based¦ ¦sh er l oc k¦ ¦techn i q ue¦ ¦to¦ ¦det ect¦ ¦sars¦ - ¦cov¦ - ¦2¦ ,▁ ¦which¦ ¦det ects¦ ¦s y n th et ic¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦rna¦ ¦fra g ments¦ ¦at¦ ¦20¦ ▁ × ▁ ¦10¦ - ¦18¦ ¦mo l¦ ▁/▁ ¦ l¦ ¦to¦ ¦2 00¦ ▁ × ▁ ¦10¦ - ¦18¦ ¦mo l¦ ▁/▁ ¦ l¦ ▁( ¦10¦ - ¦100¦ ¦c op ies¦ ¦per¦ ¦m ic ro li ter¦ ¦of¦ ¦in p ut¦ )▁ ¦using¦ ¦a¦ ¦d ip st ick¦ ¦in¦ ¦less¦ ¦than¦ ¦an¦ ¦hou r¦ ¦without¦ ¦requir ing¦ ¦e la bor ate¦ ¦inst ru me nt ation¦ .
𐋇¦h op e f ul ly¦ ,▁ ¦the¦ ¦new¦ ¦techn i q ue¦ ¦can¦ ¦d ra m at ically¦ ¦en h ance¦ ¦the¦ ¦se ns it iv ity¦ ¦and¦ ¦con v en i ence¦ ¦if¦ ¦ ver if ied¦ ¦in¦ ¦clinical¦ ¦samples¦ .
𐋇 ¦due¦ ¦to¦ ¦the¦ ¦l ack¦ ¦of¦ ¦exp eri ence¦ ¦with¦ ¦the¦ ¦novel¦ ¦cov¦ ,▁ ¦ph ys ici ans¦ ¦can¦ ¦main ly¦ ¦provide¦ ¦supp or tive¦ ¦care¦ ¦to¦ ¦covid¦ - ¦19¦ ¦patients¦ ,▁ ¦while¦ ¦att e mp ting¦ ¦a¦ ¦vari et y¦ ¦of¦ ¦ ther ap ies¦ ¦that¦ ¦have¦ ¦been¦ ¦used¦ ¦or¦ ¦prop osed¦ ¦before¦ ¦for¦ ¦the¦ ¦treatment¦ ¦of¦ ¦other¦ ¦covs¦ ¦such¦ ¦as¦ ¦sars¦ - ¦cov¦ ¦and¦ ¦mers¦ - ¦cov¦ ¦and¦ ¦other¦ ¦viral¦ ¦diseases¦ ▁( ¦t able¦ ▁ ​ ▁( ¦t ab le 2¦ )▁ . ¦2¦ ).
𐋇¦these¦ ¦ ther ap ies¦ ¦include¦ ¦current¦ ¦and¦ ¦pote ntial¦ ¦tre at ments¦ ¦with¦ ¦anti vir al¦ ¦d ru g s¦ ,▁ ¦immun os u pp re ss a nts¦ ,▁ ¦st er oi ds¦ ,▁ ¦pl as m a¦ ¦from¦ ¦re covered¦ ¦patients¦ ,▁ ¦chinese¦ ¦medic ine¦ ,▁ ¦and¦ ¦p s y ch ological¦ ¦support¦ .
𐋇 ¦even¦ ¦pl as m a¦ ¦from¦ ¦re covered¦ ¦patients¦ ¦was¦ ¦prop osed¦ ¦to¦ ¦be¦ ¦used¦ ¦for¦ ¦treatment¦ .
𐋇 ¦ph ar ma ce ut ical¦ ¦comp an ies¦ ¦are¦ ¦r ac ing¦ ¦to¦ ¦develop ¦ ¦antibo dies¦ ¦and¦ ¦vaccines¦ ¦against¦ ¦the¦ ¦virus¦ .
𐋇 ¦sars¦ - ¦cov¦ - ¦2¦ ¦main ly¦ ¦att ac ks¦ ¦the¦ ¦lu ng s¦ ¦in¦ ¦the¦ ¦beg in ning¦ ¦and¦ ¦prob ab ly¦ ¦also¦ ¦att ac ks¦ ,▁ ¦to¦ ¦a¦ ¦le ss er¦ ¦de g re e¦ ,▁ ¦other¦ ¦or g ans¦ ¦that¦ ¦exp r ess¦ ¦a ce 2¦ ,▁ ¦such¦ ¦as¦ ¦the¦ ¦ga st ro in te st in al¦ ¦system¦ ¦and¦ ¦the¦ ¦k id ne y s¦ .
𐋇 ¦ne ve rt he less¦ ,▁ ¦respiratory¦ ¦d ys f un ction¦ ¦and¦ ¦fa il ure¦ ¦are¦ ¦the¦ ¦major¦ ¦th re at¦ ¦to¦ ¦the¦ ¦patients¦ ¦and¦ ¦the¦ ¦major¦ ¦cause¦ ¦of¦ ¦death¦ .
𐋇 ¦th us¦ ,▁ ¦respiratory¦ ¦support¦ ¦is¦ ¦crit ical¦ ¦to¦ ¦rel ie ve¦ ¦the¦ ¦symptoms¦ ¦and¦ ¦sa ve¦ ¦l ives¦ ¦and¦ ¦inclu des¦ ¦general¦ ¦o x yg en¦ ¦ ther ap y¦ ,▁ ¦high¦ - ¦f l ow¦ ¦o x yg en¦ ,▁ ¦n on in v as ive¦ ¦ ventil ation¦ ,▁ ¦and¦ ¦inv as ive¦ ¦me ch an ical¦ ¦ ventil ation¦ ¦dep ending¦ ¦on¦ ¦the¦ ¦se ver ity¦ ¦of¦ ¦the¦ ¦disease¦ .
𐋇 ¦patients¦ ¦with¦ ¦severe¦ ¦respiratory¦ ¦symptoms¦ ¦have¦ ¦to¦ ¦be¦ ¦supp or ted¦ ¦by¦ ¦ext r ac or p o re al¦ ¦me mb r an e¦ ¦o x yg en ation¦ ▁( ¦ec m o¦ ),▁ ¦a¦ ¦mod if ied¦ ¦car di op ul m on ary¦ ¦b y p ass¦ ¦techn i q ue¦ ¦used¦ ¦for¦ ¦the¦ ¦treatment¦ ¦of¦ ¦l ife¦ - ¦th re at ening¦ ¦car d ia c¦ ¦or¦ ¦respiratory¦ ¦fa il ure¦ .
𐋇¦in¦ ¦add ition¦ ,▁ ¦the¦ ¦main t en ance¦ ¦of¦ ¦el ect r ol y t e¦ ¦b al ance¦ ,▁ ¦the¦ ¦pre vention¦ ¦and¦ ¦treatment¦ ¦of¦ ¦sec ond ary¦ ¦infection¦ ¦and¦ ¦se pt ic¦ ¦sh oc k¦ ,▁ ¦and¦ ¦the¦ ¦prote ction¦ ¦of¦ ¦the¦ ¦f u nc tions¦ ¦of¦ ¦the¦ ¦v it al¦ ¦or g ans¦ ¦are¦ ¦also¦ ¦essential¦ ¦for¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦patients¦ .
𐋇¦it¦ ¦has¦ ¦been¦ ¦known¦ ¦that¦ ¦a¦ ¦c y t o k ine¦ ¦st or m¦ ¦results¦ ¦from¦ ¦an¦ ¦over rea ction¦ ¦of¦ ¦the¦ ¦immune¦ ¦system¦ ¦in¦ ¦sars¦ ¦and¦ ¦mers¦ ¦patients¦ .
𐋇¦c y t o k ine¦ ¦st or m¦ ¦is¦ ¦a¦ ¦for m¦ ¦of¦ ¦sys te m ic¦ ¦inf la mm atory¦ ¦response¦ ¦fe at ur ed¦ ¦by¦ ¦the¦ ¦re le ase¦ ¦of¦ ¦a¦ ¦ser ies¦ ¦of¦ ¦c y t o k ines¦ ¦including¦ ¦t n f α ¦ ,▁ ¦ il¦ - ¦1 β ¦ ,▁ ¦ il¦ - ¦2¦ ,▁ ¦ il¦ - ¦6¦ ,▁ ¦ if n α ¦ ,▁ ¦ if n β ¦ ,▁ ¦ if n γ ¦ ,▁ ¦and¦ ¦m c p¦ - ¦1¦ .
𐋇¦these¦ ¦c y t o k ines¦ ¦ind u ce¦ ¦immune¦ ¦ce lls¦ ¦to¦ ¦re le ase¦ ¦a¦ ¦v ast¦ ¦number¦ ¦of¦ ¦fre e¦ ¦ rad ic als¦ ¦which¦ ¦are¦ ¦the¦ ¦major¦ ¦cause¦ ¦of¦ ¦ ards¦ ¦and¦ ¦mult ip le¦ ¦or g an¦ ¦fa il ure¦ .
𐋇 ¦immun os u pp re ssion¦ ¦is¦ ¦essential¦ ¦in¦ ¦the¦ ¦treatment¦ ¦of¦ ¦c y t o k ine¦ ¦st or ms¦ ,▁ ¦especially¦ ¦in¦ ¦severe¦ ¦patients¦ .
𐋇¦c ort ic o st er oi ds¦ ¦and¦ ¦t oc il iz um ab ¦ ,▁ ¦an¦ ¦anti ¦ - ¦ il 6¦ ¦mon oc l on al¦ ¦antibo dy¦ ,▁ ¦have¦ ¦been¦ ¦used¦ ¦to¦ ¦tre at¦ ¦c y t o k ine¦ ¦st or m¦ .
𐋇 ¦other¦ ¦immun os u pp re ssion¦ ¦tre at ments¦ ¦for¦ ¦c y t o k ine¦ ¦st or m¦ ¦include¦ ¦the¦ ¦mod ul ation¦ ¦of¦ ¦t¦ ¦c ell¦ - ¦dir ected¦ ¦immune¦ ¦response¦ ;▁ ¦the¦ ¦ bl oc k a de¦ ¦of¦ ¦ if n¦ - ¦ γ ¦ ,▁ ¦ il¦ - ¦1¦ ,▁ ¦and¦ ¦t n f¦ ;▁ ¦j a k¦ ¦in hi b ition¦ ;▁ ¦ bl in at um om ab ¦ ;▁ ¦supp re ss or¦ ¦of¦ ¦c y t o k ine¦ ¦sign al ing¦ ¦4¦ ;▁ ¦and¦ ¦h d a c¦ ¦in hi b it ors¦ .
𐋇 ¦st er oi ds¦ ,▁ ¦as¦ ¦immun os u pp re ss a nts¦ ,▁ ¦were¦ ¦wid ely¦ ¦used¦ ¦in¦ ¦the¦ ¦treatment¦ ¦of¦ ¦sars¦ ¦to¦ ¦reduce¦ ¦the¦ ¦se ver ity¦ ¦of¦ ¦inf la mm atory¦ ¦da m age¦ .
𐋇¦however¦ ,▁ ¦st er oi ds¦ ¦at¦ ¦high¦ ¦d os a ges¦ ¦were¦ ¦not¦ ¦be ne f ic ial¦ ¦to¦ ¦severe¦ ¦lu ng¦ ¦in j u ry¦ ¦in¦ ¦sars¦ ¦and¦ ¦covid¦ - ¦19¦ ¦patients¦ .
𐋇 ¦inst ead¦ ,▁ ¦they¦ ¦may¦ ¦cause¦ ¦severe¦ ¦ side¦ ¦eff ects¦ ,▁ ¦especially¦ ¦a v as c ular¦ ¦ os te on ec ro sis¦ ,▁ ¦d ra m at ically¦ ¦aff ecting¦ ¦the¦ ¦pr og no sis¦ .
𐋇 ¦ne ve rt he less¦ ,▁ ¦sh ort¦ ¦co ur ses¦ ¦of¦ ¦c ort ic o st er oi ds¦ ¦at¦ ¦low¦ - ¦to¦ - ¦mod er ate¦ ¦doses¦ ¦have¦ ¦been¦ ¦recommended¦ ¦to¦ ¦be¦ ¦used¦ ¦p ru de ntly¦ ¦for¦ ¦crit ically¦ ¦ ill¦ ¦covid¦ - ¦19¦ ¦patients¦ .
𐋇 ¦at¦ ¦the¦ ¦time¦ ¦of¦ ¦w ri ting¦ ,▁ ¦no¦ ¦effective¦ ¦anti vir al¦ ¦ ther ap y¦ ¦has¦ ¦been¦ ¦confirmed¦ .
𐋇¦however¦ ,▁ ¦int ra ve no us¦ ¦admin i str ation¦ ¦with¦ ¦rem de si vi r¦ ,▁ ¦a¦ ¦n uc le ot ide¦ ¦anal o g¦ ,▁ ¦has¦ ¦been¦ ¦found¦ ¦to¦ ¦be¦ ¦eff ic ac ious¦ ¦in¦ ¦an¦ ¦amer ic an¦ ¦pa ti ent¦ ¦with¦ ¦covid¦ - ¦19¦ .
𐋇 ¦rem de si vi r¦ ¦is¦ ¦a¦ ¦novel¦ ¦anti vir al¦ ¦drug¦ ¦developed¦ ¦by¦ ¦g il ead¦ ¦in it ially¦ ¦for¦ ¦the¦ ¦treatment¦ ¦of¦ ¦diseases¦ ¦caused¦ ¦by¦ ¦e b ol a¦ ¦and¦ ¦m ar l b ur g¦ ¦viruses¦ .
𐋇 ¦later¦ ,▁ ¦rem de si vi r¦ ¦also¦ ¦dem on str ated¦ ¦possible¦ ¦in hi b ition¦ ¦of¦ ¦other¦ ¦si ng le¦ ¦stra nded¦ ¦rna¦ ¦viruses¦ ¦including¦ ¦mers¦ ¦and¦ ¦sars¦ ¦viruses¦ .
𐋇 ¦based¦ ¦on¦ ¦these¦ ,▁ ¦g il ead¦ ¦has¦ ¦provid ed¦ ¦the¦ ¦comp o un d¦ ¦to¦ ¦china¦ ¦to¦ ¦con duc t¦ ¦a¦ ¦p ai r¦ ¦of¦ ¦trials¦ ¦on¦ ¦sars¦ - ¦cov¦ - ¦2¦ - ¦infected¦ ¦individuals¦ ,▁ ¦and¦ ¦the¦ ¦results¦ ¦are¦ ¦high ly¦ ¦anti c ip ated¦ .
𐋇¦in¦ ¦add ition¦ ,▁ ¦b ar ic it in b ¦ ,▁ ¦inter f er on¦ - ¦ α ¦ ,▁ ¦l op i na vi r¦ ▁/▁ ¦r it o na vi r¦ ,▁ ¦and¦ ¦ rib a vir in¦ ¦have¦ ¦been¦ ¦su gg ested¦ ¦as¦ ¦pote ntial¦ ¦ ther ap ies¦ ¦for¦ ¦patients¦ ¦with¦ ¦acute¦ ¦respiratory¦ ¦symptoms¦ .
𐋇 ¦di arr he a¦ ,▁ ¦na u se a¦ ,▁ ¦v o mi ting¦ ,▁ ¦li ver¦ ¦da m age¦ ,▁ ¦and¦ ¦other¦ ¦ad ver se¦ ¦re ac tions¦ ¦can¦ ¦occur ¦ ¦following¦ ¦co mb ined¦ ¦ ther ap y¦ ¦with¦ ¦l op i na vi r¦ ▁/▁ ¦r it o na vi r¦ .
𐋇¦the¦ ¦inter a ction¦ ¦of¦ ¦these¦ ¦tre at ments¦ ¦with¦ ¦other¦ ¦d ru g s¦ ¦used¦ ¦in¦ ¦the¦ ¦patients¦ ¦should¦ ¦be¦ ¦monit or ed¦ ¦ca re f ul ly¦ .
𐋇 ¦pl as m a¦ ¦from¦ ¦re covered¦ ¦patients¦ ¦and¦ ¦antibo dy¦ ¦gener ation¦
𐋇¦the¦ ¦colle ction¦ ¦of¦ ¦the¦ ¦blood¦ ¦from¦ ¦patients¦ ¦who¦ ¦re covered¦ ¦from¦ ¦a¦ ¦conta g ious¦ ¦disease¦ ¦to¦ ¦tre at¦ ¦other¦ ¦patients¦ ¦su ff ering¦ ¦from¦ ¦the¦ ¦same¦ ¦disease¦ ¦or¦ ¦to¦ ¦protect¦ ¦healthy¦ ¦individuals¦ ¦from¦ ¦c at c hing¦ ¦the¦ ¦disease¦ ¦has¦ ¦a¦ ¦long¦ ¦h ist ory¦ .
𐋇 ¦in de ed¦ ,▁ ¦re covered¦ ¦patients¦ ¦often¦ ¦have¦ ¦a¦ ¦rel at ively¦ ¦high¦ ¦level¦ ¦of¦ ¦antibo dies¦ ¦against¦ ¦the¦ ¦path og en¦ ¦in¦ ¦their¦ ¦blood¦ .
𐋇 ¦antibo dies¦ ¦are¦ ¦an¦ ¦immun og l ob ul in¦ ▁( ¦i g¦ )▁ ¦produc ed¦ ¦by¦ ¦b ¦ ¦l y m ph oc y tes¦ ¦to¦ ¦f ight¦ ¦path og ens¦ ¦and¦ ¦other¦ ¦fo re ign¦ ¦ob j ects¦ ¦and¦ ¦they¦ ¦reco gn iz e¦ ¦uni q ue¦ ¦m ol ecu les¦ ¦in¦ ¦the¦ ¦path og ens¦ ¦and¦ ¦ne ut r al iz e¦ ¦them¦ ¦dir ect ly¦ .
𐋇 ¦based¦ ¦on¦ ¦this¦ ,▁ ¦pl as m a¦ ¦was¦ ¦coll ected¦ ¦from¦ ¦the¦ ¦blood¦ ¦of¦ ¦a¦ ¦group¦ ¦of¦ ¦patients¦ ¦who¦ ¦re covered¦ ¦from¦ ¦covid¦ - ¦19¦ ¦and¦ ¦was¦ ¦in j ected¦ ¦into¦ ¦10¦ ¦s eri o us ly¦ ¦ ill¦ ¦patients¦ .
𐋇 ¦their¦ ¦symptoms¦ ¦imp r oved¦ ¦within¦ ¦24¦ ¦hours¦ ,▁ ¦acc o mp an ied¦ ¦by¦ ¦reduc ed¦ ¦inf la mm ation¦ ¦and¦ ¦viral¦ ¦lo a ds¦ ¦and¦ ¦imp r oved¦ ¦o x yg en¦ ¦s at ur ation¦ ¦in¦ ¦the¦ ¦blood¦ .
𐋇¦however¦ ,▁ ¦ ver ific ation¦ ¦and¦ ¦cl ar ific ation¦ ¦are¦ ¦ne cess ary¦ ¦to¦ ¦prop ose¦ ¦the¦ ¦met ho d¦ ¦for¦ ¦large¦ - ¦sc a le¦ ¦use¦ ¦before¦ ¦specific¦ ¦ ther ap ies¦ ¦are¦ ¦not¦ ¦y et¦ ¦developed¦ .
𐋇¦in¦ ¦add ition¦ ,▁ ¦giv en¦ ¦the¦ ¦ ther ap e ut ic¦ ¦eff ects¦ ,▁ ¦some¦ ¦dis a d v an ta ges¦ ¦associated¦ ¦with¦ ¦the¦ ¦pl as m a¦ ¦should¦ ¦be¦ ¦consid ered¦ ¦ca re f ul ly¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦antibo dies¦ ¦can¦ ¦over st im ul ate¦ ¦the¦ ¦immune¦ ¦response¦ ¦and¦ ¦cause¦ ¦c y t o k ine¦ ¦re le ase¦ ¦syndrome¦ ,▁ ¦which¦ ¦is¦ ¦pote nt ially¦ ¦a¦ ¦l ife¦ - ¦th re at ening¦ ¦to x ic ity¦ .
𐋇¦the¦ ¦con ce nt r ation¦ ¦of¦ ¦antibo dies¦ ¦in¦ ¦the¦ ¦blood¦ ¦is¦ ¦us ually¦ ¦low¦ ,▁ ¦and¦ ¦the¦ ¦dem and¦ ¦for¦ ¦the¦ ¦pl as m a¦ ¦is¦ ¦large¦ ¦to¦ ¦tre at¦ ¦crit ically¦ ¦ ill¦ ¦patients¦ .
𐋇¦it¦ ¦is¦ ¦diffic ul t¦ ¦to¦ ¦develop ¦ ¦and¦ ¦produc e¦ ¦specific¦ ¦antibo dies¦ ¦rap id ly¦ ¦en ough¦ ¦to¦ ¦f ight¦ ¦against¦ ¦a¦ ¦global¦ ¦epidemic¦ .
𐋇 ¦th us¦ ,▁ ¦it¦ ¦is¦ ¦more¦ ¦crit ical¦ ¦and¦ ¦pract ical¦ ¦to¦ ¦isol ate¦ ¦b ¦ ¦ce lls¦ ¦from¦ ¦re covered¦ ¦patients¦ ¦and¦ ¦ident if y¦ ¦the¦ ¦gen et ic¦ ¦co des¦ ¦e nc o ding¦ ¦effective¦ ¦antibo dies¦ ¦or¦ ¦scre en¦ ¦for¦ ¦effective¦ ¦antibo dies¦ ¦against¦ ¦essential¦ ¦prote ins¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦this¦ ¦way¦ ,▁ ¦we¦ ¦can¦ ¦rea di ly¦ ¦sc a le¦ ¦up¦ ¦the¦ ¦produc t ion¦ ¦of¦ ¦the¦ ¦antibo dies¦ .
𐋇¦t c m¦ ¦has¦ ¦been¦ ¦used¦ ¦to¦ ¦tre at¦ ¦a¦ ¦vari et y¦ ¦of¦ ¦diseases¦ ¦in¦ ¦china¦ ¦for¦ ¦t ho us an ds¦ ¦of¦ ¦years¦ .
𐋇¦however¦ ,▁ ¦its¦ ¦eff ects¦ ¦l arg ely¦ ¦r ely¦ ¦on¦ ¦a¦ ¦co mb ination¦ ¦of¦ ¦mult ip le¦ ¦comp on ents¦ ¦in¦ ¦a¦ ¦f orm ul a¦ ¦that¦ ¦vari es¦ ¦dep ending¦ ¦on¦ ¦the¦ ¦diagn o sis¦ ¦of¦ ¦a¦ ¦disease¦ ¦based¦ ¦on¦ ¦the¦ ¦the or ies¦ ¦of¦ ¦t c m¦ .
𐋇 ¦most¦ ¦of¦ ¦the¦ ¦effective¦ ¦comp on ents¦ ¦remain¦ ¦un k n own¦ ¦or¦ ¦are¦ ¦v a g ue¦ ¦as¦ ¦it¦ ¦is¦ ¦diffic ul t¦ ¦to¦ ¦ext r ac t¦ ¦and¦ ¦ ver if y¦ ¦such¦ ¦comp on ents¦ ¦or¦ ¦their¦ ¦o pt im al¦ ¦co mb in ations¦ .
𐋇 ¦cur re ntly¦ ,▁ ¦due¦ ¦to¦ ¦the¦ ¦l ack¦ ¦of¦ ¦effective¦ ¦and¦ ¦specific¦ ¦ ther ap y¦ ¦for¦ ¦covid¦ - ¦19¦ ,▁ ¦t c m¦ ¦has¦ ¦bec ome¦ ¦one¦ ¦of¦ ¦the¦ ¦major¦ ¦al t er n ative¦ ¦tre at ments¦ ¦for¦ ¦patients¦ ¦with¦ ¦l ight¦ ¦to¦ ¦mod er ate¦ ¦symptoms¦ ¦or¦ ¦for¦ ¦those¦ ¦who¦ ¦have¦ ¦re covered¦ ¦from¦ ¦severe¦ ¦sta ges¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦sh u¦ ¦fe ng¦ ¦j i e¦ ¦d u¦ ¦c ap s u les¦ ¦and¦ ¦li an¦ ¦h u a¦ ¦ q ing¦ ¦w en¦ ¦c ap s u les¦ ¦were¦ ¦found¦ ¦to¦ ¦be¦ ¦effective¦ ¦for¦ ¦covid¦ - ¦19¦ ¦treatment¦ .
𐋇 ¦to p¦ ¦c ure¦ ¦r ates¦ ¦in¦ ¦the¦ ¦treatment¦ ¦of¦ ¦covid¦ - ¦19¦ ¦patients¦ ¦were¦ ¦ob s erv ed¦ ¦in¦ ¦several¦ ¦pr ov in ces¦ ¦in¦ ¦china¦ ¦that¦ ¦used¦ ¦t c m¦ ¦in¦ ¦8 7¦ %▁ ¦of¦ ¦their¦ ¦patients¦ ,▁ ¦including¦ ¦ga ns u¦ ▁( ¦6 3¦ . ¦7¦ % ),▁ ¦n i ng x ia¦ ▁( ¦50¦ % ),▁ ¦and¦ ¦h un an¦ ▁( ¦50¦ % ),▁ ¦w he rea s¦ ¦hub e i¦ ¦pro vi nce¦ ,▁ ¦which¦ ¦used¦ ¦t c m¦ ¦in¦ ¦only¦ ¦appro xi ma tely¦ ¦30¦ %▁ ¦of¦ ¦its¦ ¦covid¦ - ¦19¦ ¦patients¦ ,▁ ¦had¦ ¦the¦ ¦l ow est¦ ¦c ure¦ ¦rate¦ ▁( ¦13¦ % ).
𐋇¦however¦ ,▁ ¦this¦ ¦is¦ ¦qu ite¦ ¦a¦ ¦r ough¦ ¦comp ar is on¦ ¦as¦ ¦many¦ ¦other¦ ¦impac t¦ ¦fa ctors¦ ¦such¦ ¦as¦ ¦the¦ ¦number¦ ¦and¦ ¦se ver ity¦ ¦of¦ ¦the¦ ¦patients¦ ¦should¦ ¦be¦ ¦inclu ded¦ ¦in¦ ¦the¦ ¦ev a lu ation¦ .
𐋇¦on¦ ¦february¦ ¦18¦ ,▁ ¦2020¦ ,▁ ¦b ol i¦ ¦z h a ng¦ ¦and¦ ¦c ow or k ers¦ ¦publ ished¦ ¦a¦ ¦study¦ ¦to¦ ¦comp are¦ ¦we st er n¦ ¦medic ine¦ ▁( ¦w m¦ )▁ ¦treatment¦ ¦al one¦ ¦with¦ ¦co mb ined¦ ¦treatment¦ ¦of¦ ¦w m¦ ¦and¦ ¦t c m¦ .
𐋇¦they¦ ¦found¦ ¦that¦ ¦the¦ ¦times¦ ¦nee ded¦ ¦for¦ ¦body¦ ¦temp erat ure¦ ¦reco ve ry¦ ,▁ ¦s y m pt om¦ ¦dis a pp ear ance¦ ,▁ ¦and¦ ¦hosp it al iz ation¦ ¦were¦ ¦rem ar k ab ly¦ ¦sh or ter¦ ¦in¦ ¦the¦ ¦w m¦ ▁ + ▁ ¦t c m¦ ¦group¦ ¦than¦ ¦in¦ ¦the¦ ¦w m¦ ¦only¦ ¦group¦ .
𐋇 ¦most¦ ¦imp re ss ively¦ ,▁ ¦the¦ ¦rate¦ ¦for¦ ¦s ymptomatic¦ ¦wor s ening¦ ▁( ¦from¦ ¦l ight¦ ¦to¦ ¦severe¦ )▁ ¦was¦ ¦rem ar k ab ly¦ ¦lower¦ ¦for¦ ¦the¦ ¦w m¦ ▁ + ▁ ¦t c m¦ ¦group¦ ¦than¦ ¦for¦ ¦the¦ ¦w m¦ ¦only¦ ¦group¦ ▁( ¦7¦ . ¦4¦ %▁ ¦ ve rs us¦ ¦4 6¦ . ¦2¦ % )▁ ¦and¦ ¦the¦ ¦m ort ality¦ ¦was¦ ¦lower¦ ¦in¦ ¦the¦ ¦w m¦ ▁ + ▁ ¦t c m¦ ¦group¦ ¦than¦ ¦w m¦ ¦only¦ ¦group¦ ▁( ¦8¦ . ¦8¦ %▁ ¦ ve rs us¦ ¦3 9¦ % ).
𐋇 ¦ne ve rt he less¦ ,▁ ¦the¦ ¦eff ic acy¦ ¦and¦ ¦safety¦ ¦of¦ ¦t c m¦ ¦still¦ ¦a w ai t¦ ¦more¦ ¦well¦ - ¦cont ro lled¦ ¦trials¦ ¦at¦ ¦l arg er¦ ¦sc a les¦ ¦and¦ ¦in¦ ¦more¦ ¦ce nt ers¦ .
𐋇¦it¦ ¦would¦ ¦also¦ ¦be¦ ¦int r ig u ing¦ ¦to¦ ¦ch ara ct er iz e¦ ¦the¦ ¦me ch an is m¦ ¦of¦ ¦ac tions¦ ¦and¦ ¦cl ar if y¦ ¦the¦ ¦effective¦ ¦comp on ents¦ ¦of¦ ¦t c m¦ ¦tre at ments¦ ¦or¦ ¦their¦ ¦co mb in ations¦ ¦if¦ ¦possible¦ .
𐋇 ¦patients¦ ¦with¦ ¦suspected¦ ¦or¦ ¦confirmed¦ ¦covid¦ - ¦19¦ ¦mo st ly¦ ¦exp eri ence¦ ¦g re at¦ ¦f ear¦ ¦of¦ ¦the¦ ¦high ly¦ ¦conta g ious¦ ¦and¦ ¦even¦ ¦fat al¦ ¦disease¦ ,▁ ¦and¦ ¦qu ara nt ined¦ ¦people¦ ¦also¦ ¦exp eri ence¦ ¦ bor ed om¦ ,▁ ¦lo ne li ness¦ ,▁ ¦and¦ ¦a nger¦ .
𐋇¦f ur th erm ore¦ ,▁ ¦symptoms¦ ¦of¦ ¦the¦ ¦infection¦ ¦such¦ ¦as¦ ¦fever¦ ,▁ ¦h y p o x ia¦ ,▁ ¦and¦ ¦cough¦ ¦as¦ ¦well¦ ¦as¦ ¦ad ver se¦ ¦eff ects¦ ¦of¦ ¦the¦ ¦tre at ments¦ ¦such¦ ¦as¦ ¦i ns om n ia¦ ¦caused¦ ¦by¦ ¦c ort ic o st er oi ds¦ ¦can¦ ¦l ead¦ ¦to¦ ¦more¦ ¦an xi et y¦ ¦and¦ ¦me ntal¦ ¦di str ess¦ .
𐋇¦in¦ ¦the¦ ¦early¦ ¦ph ase¦ ¦of¦ ¦the¦ ¦sars¦ ¦outbreak¦ ,▁ ¦a¦ ¦r ange¦ ¦of¦ ¦p s y c hi at r ic¦ ¦m or b id ities¦ ¦including¦ ¦pers ist ent¦ ¦dep re ssion¦ ,▁ ¦an xi et y¦ ,▁ ¦p an ic¦ ¦att ac ks¦ ,▁ ¦p s y ch om ot or¦ ¦ex c i te ment¦ ,▁ ¦p s y ch ot ic¦ ¦symptoms¦ ,▁ ¦de li ri um¦ ,▁ ¦and¦ ¦even¦ ¦su ic id ality¦ ¦were¦ ¦reported¦ .
𐋇 ¦mand atory¦ ¦contact¦ ¦trac ing¦ ¦and¦ ¦quarantine¦ ,▁ ¦as¦ ¦a¦ ¦par t¦ ¦of¦ ¦the¦ ¦public¦ ¦health¦ ¦resp on ses¦ ¦to¦ ¦the¦ ¦covid¦ - ¦19¦ ¦outbreak¦ ,▁ ¦can¦ ¦make¦ ¦people¦ ¦more¦ ¦an x ious¦ ¦and¦ ¦gu il t y¦ ¦about¦ ¦the¦ ¦eff ects¦ ¦of¦ ¦the¦ ¦conta g ion¦ ,▁ ¦quarantine¦ ,▁ ¦and¦ ¦st ig m a¦ ¦on¦ ¦their¦ ¦fa m il ies¦ ¦and¦ ¦f ri ends¦ .
𐋇 ¦th us¦ ,▁ ¦me ntal¦ ¦health¦ ¦care¦ ¦should¦ ¦be¦ ¦provid ed¦ ¦to¦ ¦covid¦ - ¦19¦ ¦patients¦ ,▁ ¦suspected¦ ¦individuals¦ ,▁ ¦and¦ ¦people¦ ¦in¦ ¦contact¦ ¦with¦ ¦them¦ ¦as¦ ¦well¦ ¦as¦ ¦the¦ ¦general¦ ¦public¦ ¦who¦ ¦are¦ ¦in¦ ¦need¦ .
𐋇¦the¦ ¦p s y ch ological¦ ¦support¦ ¦should¦ ¦include¦ ¦the¦ ¦ es ta bl is h ment¦ ¦of¦ ¦mult id is c i pl in ary¦ ¦me ntal¦ ¦health¦ ¦t ea ms¦ ,▁ ¦cl ear¦ ¦comm un ications¦ ¦with¦ ¦reg ular¦ ¦and¦ ¦acc ur ate¦ ¦up d ates¦ ¦about¦ ¦the¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦outbreak¦ ¦and¦ ¦treatment¦ ¦pl ans¦ ¦and¦ ¦the¦ ¦use¦ ¦of¦ ¦pro f es si on al¦ ¦el ect r on ic¦ ¦de vi ces¦ ¦and¦ ¦app l ications¦ ¦to¦ ¦avoid¦ ¦close¦ ¦contact¦ ¦with¦ ¦each¦ ¦other¦ .
𐋇 ¦effective¦ ¦vaccines¦ ¦are¦ ¦essential¦ ¦for¦ ¦inter ru p ting¦ ¦the¦ ¦cha in¦ ¦of¦ ¦transmission¦ ¦from¦ ¦anim al¦ ¦res erv o ir s¦ ¦and¦ ¦infected¦ ¦humans¦ ¦to¦ ¦s us cep ti ble¦ ¦ho sts¦ ¦and¦ ¦are¦ ¦often¦ ¦comp le me nt ary¦ ¦to¦ ¦anti vir al¦ ¦treatment¦ ¦in¦ ¦the¦ ¦control¦ ¦of¦ ¦e p ide m ics¦ ¦caused¦ ¦by¦ ¦e mer ging¦ ¦viruses¦ .
𐋇 ¦eff orts¦ ¦have¦ ¦been¦ ¦made¦ ¦to¦ ¦develop ¦ ¦s¦ ¦protein¦ - ¦based¦ ¦vaccines¦ ¦to¦ ¦gener ate¦ ¦long¦ - ¦ter m¦ ¦and¦ ¦p ot ent¦ ¦ne ut r al iz ing¦ ¦antibo dies¦ ¦and¦ ▁/▁ ¦or¦ ¦prot ective¦ ¦immun ity¦ ¦against¦ ¦sars¦ - ¦cov¦ .
𐋇 ¦live¦ - ¦att en u ated¦ ¦vaccines¦ ¦have¦ ¦been¦ ¦ev a lu ated¦ ¦in¦ ¦anim al¦ ¦mod els¦ ¦for¦ ¦sars¦ .
𐋇¦however¦ ,▁ ¦the¦ ¦in¦ ¦v iv o¦ ¦eff ic acy¦ ¦of¦ ¦these¦ ¦vaccine¦ ¦ca nd id ates¦ ¦in¦ ¦el d erly¦ ¦individuals¦ ¦and¦ ¦le th al¦ - ¦cha ll en ge¦ ¦mod els¦ ¦and¦ ¦their¦ ¦prote ction¦ ¦against¦ ¦z o on ot ic¦ ¦virus¦ ¦infection¦ ¦have¦ ¦y et¦ ¦to¦ ¦be¦ ¦det erm ined¦ ¦before¦ ¦a¦ ¦clinical¦ ¦study¦ ¦is¦ ¦in i ti ated¦ .
𐋇¦this¦ ¦is¦ ¦prob ab ly¦ ¦because¦ ¦sars¦ ¦d ied¦ ¦down¦ ¦1 7¦ ¦years¦ ¦ag o¦ ¦and¦ ¦no¦ ¦new¦ ¦case¦ ¦has¦ ¦been¦ ¦reported¦ ¦since¦ .
𐋇¦in¦ ¦contr ast¦ ,▁ ¦sp o rad ic¦ ¦cases¦ ¦and¦ ¦c lu st ers¦ ¦of¦ ¦mers¦ ¦continue¦ ¦to¦ ¦occur ¦ ¦in¦ ¦the¦ ¦m id d le¦ ¦e ast¦ ¦and¦ ¦spread¦ ¦to¦ ¦other¦ ¦regi ons¦ ¦ owing¦ ¦to¦ ¦the¦ ¦pers ist ence¦ ¦of¦ ¦z o on ot ic¦ ¦sour ces¦ ¦in¦ ¦en de m ic¦ ¦areas¦ .
𐋇 ¦vacc ination¦ ¦stra te g ies¦ ¦have¦ ¦been¦ ¦developed¦ ¦for¦ ¦mers¦ ¦by¦ ¦using¦ ¦i na ct iv ated¦ ¦virus¦ ,▁ ¦d na¦ ¦pl as mi ds¦ ,▁ ¦viral¦ ¦ ve ctors¦ ,▁ ¦na no pa rt ic les¦ ,▁ ¦virus¦ - ¦like¦ ¦partic les¦ ¦and¦ ¦reco mb in ant¦ ¦protein¦ ¦sub un i ts¦ ¦and¦ ¦some¦ ¦have¦ ¦been¦ ¦ev a lu ated¦ ¦in¦ ¦anim al¦ ¦mod els¦ .
𐋇¦the¦ ¦development¦ ¦of¦ ¦a¦ ¦safe¦ ¦and¦ ¦effective¦ ¦vaccine¦ ¦against¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦for¦ ¦non¦ - ¦immune¦ ¦individuals¦ ¦is¦ ¦an¦ ¦ ur g ent¦ ¦and¦ ¦crit ical¦ ¦t as k¦ ¦for¦ ¦cont ro lling¦ ¦the¦ ¦o ng o ing¦ ¦epidemic¦ .
𐋇¦however¦ ,▁ ¦it¦ ¦is¦ ¦cha ll en ging¦ ¦to¦ ¦over c ome¦ ¦the¦ ¦diffic ult y¦ ¦because¦ ¦of¦ ¦the¦ ¦long¦ ¦period¦ ¦of¦ ¦time¦ ▁( ¦a ve ra ged¦ ¦18¦ ¦mon ths¦ )▁ ¦nee ded¦ ¦for¦ ¦vaccine¦ ¦development¦ ¦and¦ ¦the¦ ¦d y na m ic¦ ¦vari ations¦ ¦of¦ ¦covs¦ .
𐋇¦as¦ ¦a¦ ¦novel¦ ¦disease¦ ,▁ ¦covid¦ - ¦19¦ ¦has¦ ¦j ust¦ ¦star ted¦ ¦to¦ ¦m an if est¦ ¦its¦ ¦f ul l¦ ¦clinical¦ ¦co ur se¦ ¦th r ou g ho ut¦ ¦t ho us an ds¦ ¦of¦ ¦patients¦ .
𐋇¦in¦ ¦most¦ ¦cases¦ ,▁ ¦patients¦ ¦can¦ ¦reco ver¦ ¦g rad ually¦ ¦without¦ ¦se qu e la e¦ .
𐋇¦however¦ ,▁ ¦similar¦ ¦to¦ ¦sars¦ ¦and¦ ¦mers¦ ,▁ ¦covid¦ - ¦19¦ ¦is¦ ¦also¦ ¦associated¦ ¦with¦ ¦high¦ ¦m or b id ity¦ ¦and¦ ¦m ort ality¦ ¦in¦ ¦patients¦ ¦with¦ ¦severe¦ ¦cases¦ .
𐋇 ¦the re f ore¦ ,▁ ¦bu il ding¦ ¦a¦ ¦pr og no sis¦ ¦mo de l¦ ¦for¦ ¦the¦ ¦disease¦ ¦is¦ ¦essential¦ ¦for¦ ¦health¦ - ¦care¦ ¦a ge nc ies¦ ¦to¦ ¦pri or itiz e¦ ¦their¦ ¦services¦ ,▁ ¦especially¦ ¦in¦ ¦res o ur ce¦ - ¦con st ra ined¦ ¦areas¦ .
𐋇 ¦based¦ ¦on¦ ¦clinical¦ ¦st u dies¦ ¦reported¦ ¦th us¦ ¦fa r¦ ,▁ ¦the¦ ¦following¦ ¦fa ctors¦ ¦may¦ ¦aff ect¦ ¦or¦ ¦be¦ ¦associated¦ ¦with¦ ¦the¦ ¦pr og no sis¦ ¦of¦ ¦covid¦ - ¦19¦ ¦patients¦ ▁( ¦t able¦ ▁ ​ ▁( ¦t ab le 3 3¦ ) :
𐋇 ¦age¦ :▁ 𐋇 ¦age¦ ¦was¦ ¦the¦ ¦most¦ ¦important¦ ¦fa ct or¦ ¦for¦ ¦the¦ ¦pr og no sis¦ ¦of¦ ¦sars¦ ,▁ ¦which¦ ¦is¦ ¦also¦ ¦tr ue¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇¦covid¦ - ¦19¦ ¦main ly¦ ¦happ e ned¦ ¦at¦ ¦the¦ ¦age¦ ¦of¦ ¦30¦ - ¦6 5¦ ¦with¦ ¦4 7¦ . ¦7¦ %▁ ¦of¦ ¦those¦ ¦patients¦ ¦being¦ ¦over¦ ¦50¦ ¦in¦ ¦a¦ ¦study¦ ¦of¦ ¦8¦ , ¦8 6 6¦ ¦cases¦ ¦as¦ ¦d esc rib ed¦ ¦a bo ve¦ .
𐋇 ¦patients¦ ¦who¦ ¦required¦ ¦in tens ive¦ ¦care¦ ¦were¦ ¦more¦ ¦likely¦ ¦to¦ ¦have¦ ¦underlying¦ ¦c om or b id ities¦ ¦and¦ ¦co mpl ications¦ ¦and¦ ¦were¦ ¦sign ific a ntly¦ ¦ ol der¦ ¦than¦ ¦those¦ ¦who¦ ¦d id¦ ¦not¦ ▁( ¦at¦ ¦the¦ ¦me di an¦ ¦age¦ ¦of¦ ¦6 6¦ ¦ ve rs us¦ ¦5 1¦ ),▁ ¦su gg es ting¦ ¦age¦ ¦as¦ ¦a¦ ¦pr og no st ic¦ ¦fa ct or¦ ¦for¦ ¦the¦ ¦out c ome¦ ¦of¦ ¦covid¦ - ¦19¦ ¦patients¦ .
𐋇 ¦se x¦ :▁ 𐋇 ¦sars¦ - ¦cov¦ - ¦2¦ ¦has¦ ¦infected¦ ¦more¦ ¦m en¦ ¦than¦ ¦women¦ ▁( ¦ 0¦ . ¦3 1¦ ▁/▁ ¦100¦ , ¦000¦ ¦ ve rs us¦ ¦ 0¦ . ¦2 7¦ ▁/▁ ¦100¦ , ¦000¦ ),▁ ¦as¦ ¦d esc rib ed¦ ¦a bo ve¦ .
𐋇¦c om or b id ities¦ ¦and¦ ¦co mpl ications¦ :▁ 𐋇 ¦patients¦ ¦with¦ ¦covid¦ - ¦19¦ ¦who¦ ¦requir e¦ ¦in tens ive¦ ¦care¦ ¦are¦ ¦more¦ ¦likely¦ ¦to¦ ¦su ff er¦ ¦from¦ ¦acute¦ ¦car d ia c¦ ¦in j u ry¦ ¦and¦ ¦arr h y th m ia¦ .
𐋇 ¦car d ia c¦ ¦events¦ ¦were¦ ¦also¦ ¦the¦ ¦ma in¦ ¦re as on¦ ¦for¦ ¦death¦ ¦in¦ ¦sars¦ ¦patients¦ .
𐋇¦it¦ ¦has¦ ¦been¦ ¦reported¦ ¦that¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦can¦ ¦also¦ ¦b ind¦ ¦to¦ ¦a ce 2¦ - ¦positive¦ ¦c ho la ng i oc y tes¦ ,▁ ¦which¦ ¦might¦ ¦l ead¦ ¦to¦ ¦li ver¦ ¦d ys f u nc tions¦ ¦in¦ ¦covid¦ - ¦19¦ ¦patients¦ .
𐋇¦it¦ ¦is¦ ¦wor th¦ ¦no ting¦ ¦that¦ ¦age¦ ¦and¦ ¦underlying¦ ¦disease¦ ¦are¦ ¦st ro ng ly¦ ¦cor r el ated¦ ¦and¦ ¦might¦ ¦inter f er e¦ ¦with¦ ¦each¦ ¦other¦ .
𐋇 ¦ab n ormal¦ ¦laboratory¦ ¦fi nd ings¦ :▁ 𐋇¦the¦ ¦ c¦ - ¦re ac tive¦ ¦protein¦ ▁( ¦cr p¦ )▁ ¦level¦ ¦in¦ ¦blood¦ ¦ref l ects¦ ¦the¦ ¦se ver ity¦ ¦of¦ ¦inf la mm ation¦ ¦or¦ ¦ti ss ue¦ ¦in j u ry¦ ¦and¦ ¦has¦ ¦been¦ ¦prop osed¦ ¦to¦ ¦be¦ ¦a¦ ¦pote ntial¦ ¦pr og no st ic¦ ¦fa ct or¦ ¦for¦ ¦disease¦ ,▁ ¦response¦ ¦to¦ ¦ ther ap y¦ ,▁ ¦and¦ ¦ ult im ate¦ ¦reco ve ry¦ .
𐋇¦the¦ ¦cor r el ation¦ ¦of¦ ¦cr p¦ ¦level¦ ¦to¦ ¦the¦ ¦se ver ity¦ ¦and¦ ¦pr og no sis¦ ¦of¦ ¦covid¦ - ¦19¦ ¦has¦ ¦also¦ ¦been¦ ¦prop osed¦ .
𐋇¦in¦ ¦add ition¦ ,▁ ¦e le v ated¦ ¦la ct ate¦ ¦de h y dr ogen ase¦ ▁( ¦l d h ¦ ),▁ ¦as pa rt ate¦ ¦a min ot ra ns f er ase¦ ▁( ¦ ast¦ ),▁ ¦al an ine¦ ¦a min ot ra ns f er ase¦ ▁( ¦al t¦ ),▁ ¦and¦ ¦cre at ine¦ ¦k in ase¦ ▁( ¦c k¦ )▁ ¦may¦ ¦also¦ ¦help¦ ¦pr ed ic t¦ ¦the¦ ¦out c ome¦ .
𐋇¦these¦ ¦en z y m es¦ ¦are¦ ¦exp r es sed¦ ¦ex tens ively¦ ¦in¦ ¦mult ip le¦ ¦or g ans¦ ,▁ ¦especially¦ ¦in¦ ¦the¦ ¦h ear t¦ ¦and¦ ¦li ver¦ ,▁ ¦and¦ ¦are¦ ¦rel ea sed¦ ¦during¦ ¦ti ss ue¦ ¦da m age¦ .
𐋇 ¦th us¦ ,▁ ¦they¦ ¦are¦ ¦tra di tional¦ ¦mark ers¦ ¦for¦ ¦h ear t¦ ¦or¦ ¦li ver¦ ¦d ys f u nc tions¦ .
𐋇 ¦major¦ ¦clinical¦ ¦symptoms¦ :▁ 𐋇 ¦chest¦ ¦ra di ogra ph y¦ ¦and¦ ¦temp or al¦ ¦pr og re ssion¦ ¦of¦ ¦clinical¦ ¦symptoms¦ ¦should¦ ¦be¦ ¦consid ered¦ ¦t og ether¦ ¦with¦ ¦the¦ ¦other¦ ¦i ss ues¦ ¦for¦ ¦the¦ ¦pre di ction¦ ¦of¦ ¦out c omes¦ ¦and¦ ¦co mpl ications¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇 ¦use¦ ¦of¦ ¦st er oi ds¦ :▁ 𐋇¦as¦ ¦d esc rib ed¦ ¦a bo ve¦ ,▁ ¦st er oi ds¦ ¦are¦ ¦immun os u pp re ss ant¦ ¦comm on ly¦ ¦used¦ ¦as¦ ¦an¦ ¦ad j u nc tive¦ ¦ ther ap y¦ ¦for¦ ¦infectious¦ ¦diseases¦ ¦to¦ ¦reduce¦ ¦the¦ ¦se ver ity¦ ¦of¦ ¦inf la mm atory¦ ¦da m age¦ .
𐋇 ¦since¦ ¦a¦ ¦high¦ ¦d os age¦ ¦of¦ ¦c ort ic o st er oi ds¦ ¦was¦ ¦wid ely¦ ¦used¦ ¦in¦ ¦severe¦ ¦sars¦ ¦patients¦ ,▁ ¦many¦ ¦sur v iv ors¦ ¦su ff ered¦ ¦from¦ ¦a v as c ular¦ ¦ os te on ec ro sis¦ ¦with¦ ¦l ife¦ - ¦long¦ ¦dis a bility¦ ¦and¦ ¦po or¦ ¦l ife¦ ¦qu ality¦ .
𐋇 ¦th us¦ ,▁ ¦if¦ ¦nee ded¦ ,▁ ¦st er oi ds¦ ¦should¦ ¦be¦ ¦used¦ ¦at¦ ¦low¦ ¦d os age¦ ¦and¦ ¦for¦ ¦a¦ ¦sh ort¦ ¦time¦ ¦in¦ ¦covid¦ - ¦19¦ ¦patients¦ .
𐋇 ¦me ntal¦ ¦ str ess¦ :▁ 𐋇¦as¦ ¦d esc rib ed¦ ¦a bo ve¦ ,▁ ¦during¦ ¦the¦ ¦covid¦ - ¦19¦ ¦outbreak¦ ¦many¦ ¦patients¦ ¦have¦ ¦su ff ered¦ ¦from¦ ¦ext ra or d in ary¦ ¦ str ess¦ ¦as¦ ¦they¦ ¦often¦ ¦ end ur ed¦ ¦long¦ ¦perio ds¦ ¦of¦ ¦quarantine¦ ¦and¦ ¦ext re me¦ ¦un ce rt ai nt y¦ ¦and¦ ¦w it n es sed¦ ¦the¦ ¦death¦ ¦of¦ ¦close¦ ¦family¦ ¦me mbers¦ ¦and¦ ¦fe ll ow¦ ¦patients¦ .
𐋇¦it¦ ¦is¦ ¦imp er ative¦ ¦to¦ ¦provide¦ ¦p s y ch ological¦ ¦cou ns el ing¦ ¦and¦ ¦long¦ - ¦ter m¦ ¦support¦ ¦to¦ ¦help¦ ¦these¦ ¦patients¦ ¦reco ver¦ ¦from¦ ¦the¦ ¦ str ess¦ ¦and¦ ¦retur n¦ ¦to¦ ¦normal¦ ¦l ife¦ .
𐋇 ¦according¦ ¦to¦ ¦dem ogra ph ic¦ ¦st u dies¦ ¦so¦ ¦fa r¦ ,▁ ¦covid¦ - ¦19¦ ¦s ee ms¦ ¦to¦ ¦have¦ ¦different¦ ¦e p ide mi ological¦ ¦fe at ures¦ ¦from¦ ¦sars¦ .
𐋇¦in¦ ¦add ition¦ ¦to¦ ¦re pl ic ating¦ ¦in¦ ¦the¦ ¦lower¦ ¦respiratory¦ ¦trac t¦ ,▁ ¦sars¦ - ¦cov¦ - ¦2¦ ¦can¦ ¦eff ic ie ntly¦ ¦re pl ic ate¦ ¦in¦ ¦the¦ ¦u pp er¦ ¦respiratory¦ ¦trac t¦ ¦and¦ ¦ca u ses¦ ¦mild¦ ¦or¦ ¦no¦ ¦symptoms¦ ¦in¦ ¦the¦ ¦early¦ ¦ph ase¦ ¦of¦ ¦infection¦ ,▁ ¦similar¦ ¦to¦ ¦other¦ ¦covs¦ ¦that¦ ¦cause¦ ¦common¦ ¦c ol ds¦ .
𐋇 ¦the re f ore¦ ,▁ ¦infected¦ ¦patients¦ ¦at¦ ¦the¦ ¦early¦ ¦ph ase¦ ¦or¦ ¦inc ub ation¦ ¦period¦ ¦can¦ ¦produc e¦ ¦a¦ ¦large¦ ¦a mo un t¦ ¦of¦ ¦virus¦ ¦during¦ ¦daily¦ ¦activ ities¦ ,▁ ¦ca us ing¦ ¦g re at¦ ¦diffic ult y¦ ¦for¦ ¦the¦ ¦control¦ ¦of¦ ¦the¦ ¦epidemic¦ .
𐋇¦however¦ ,▁ ¦the¦ ¦transmission¦ ¦of¦ ¦sars¦ - ¦cov¦ ¦was¦ ¦consid ered¦ ¦to¦ ¦occur ¦ ¦when¦ ¦the¦ ¦patients¦ ¦are¦ ¦se ver ely¦ ¦ ill¦ ,▁ ¦while¦ ¦most¦ ¦transmission¦ ¦d id¦ ¦not¦ ¦happ en¦ ¦at¦ ¦the¦ ¦early¦ ¦ph ase¦ .
𐋇 ¦th us¦ ,▁ ¦the¦ ¦current¦ ¦outbreak¦ ¦of¦ ¦covid¦ - ¦19¦ ¦is¦ ¦much¦ ¦more¦ ¦severe¦ ¦and¦ ¦diffic ul t¦ ¦to¦ ¦control¦ ¦than¦ ¦the¦ ¦outbreak¦ ¦of¦ ¦sars¦ .
𐋇 ¦g re at¦ ¦eff orts¦ ¦are¦ ¦cur re ntly¦ ¦under w ay¦ ¦in¦ ¦china¦ ¦including¦ ¦the¦ ¦lockdown¦ ¦of¦ ¦wuhan¦ ¦and¦ ¦sur ro un ding¦ ¦c ities¦ ¦and¦ ¦contin u o us¦ ¦quarantine¦ ¦of¦ ¦al m ost¦ ¦the¦ ¦ent ir e¦ ¦population¦ ¦in¦ ¦h op es¦ ¦of¦ ¦inter ru p ting¦ ¦the¦ ¦transmission¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ .
𐋇 ¦al th ough¦ ¦these¦ ¦ac tions¦ ¦have¦ ¦been¦ ¦d ra m at ically¦ ¦da ma ging¦ ¦the¦ ¦ec on om y¦ ¦and¦ ¦other¦ ¦se ctors¦ ¦of¦ ¦the¦ ¦country¦ ,▁ ¦the¦ ¦number¦ ¦of¦ ¦new¦ ¦patients¦ ¦is¦ ¦dec li ning¦ ,▁ ¦indic ating¦ ¦the¦ ¦sl ow d own¦ ¦of¦ ¦the¦ ¦epidemic¦ .
𐋇¦the¦ ¦most¦ ¦o pt im ist ic¦ ¦estim ate¦ ¦is¦ ¦that¦ ¦the¦ ¦outbreak¦ ¦will¦ ¦end¦ ¦by¦ ¦march¦ ¦and¦ ¦the¦ ¦d ow ns w ing¦ ¦ph ase¦ ¦will¦ ¦last¦ ¦for¦ ¦3¦ - ¦4¦ ¦mon ths¦ .
𐋇¦however¦ ,▁ ¦some¦ ¦other¦ ¦exp er ts¦ ¦are¦ ¦not¦ ¦that¦ ¦o pt im ist ic¦ .
𐋇 ¦pa u l¦ ¦h un ter¦ ,▁ ¦ et¦ ¦ al¦ . ,▁ ¦estim ated¦ ¦that¦ ¦covid¦ - ¦19¦ ,▁ ¦which¦ ¦s ee ms¦ ¦sub s ta nt ially¦ ¦more¦ ¦infectious¦ ¦than¦ ¦sars¦ ,▁ ¦will¦ ¦not¦ ¦end¦ ¦in¦ ¦2020¦ .
𐋇 ¦ir a¦ ¦lo ng in i¦ ,▁ ¦ et¦ ¦ al¦ . ,▁ ¦ es ta bl ished¦ ¦a¦ ¦mo de l¦ ¦to¦ ¦pr ed ic t¦ ¦the¦ ¦out c ome¦ ¦of¦ ¦the¦ ¦epidemic¦ ¦and¦ ¦su gg ested¦ ¦that¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦could¦ ¦inf ect¦ ¦two¦ - ¦thir ds¦ ¦of¦ ¦the¦ ¦global¦ ¦population¦ .
𐋇¦a¦ ¦ca na di an¦ ¦group¦ ¦reported¦ ¦that¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦was¦ ¦detected¦ ¦in¦ ¦both¦ ¦m id¦ - ¦t ur b in ate¦ ¦and¦ ¦th ro at¦ ¦sw ab s¦ ¦of¦ ¦patients¦ ¦who¦ ¦re covered¦ ¦and¦ ¦le f t¦ ¦the¦ ¦hospital¦ ¦2¦ ¦weeks¦ ¦ ear li er¦ ,▁ ¦which¦ ¦indic ates¦ ¦that¦ ¦the¦ ¦new ly¦ ¦identified¦ ¦virus¦ ¦could¦ ¦bec ome¦ ¦a¦ ¦c y c l ical¦ ¦e p is o de¦ ¦similar¦ ¦to¦ ¦influenza¦ .
𐋇¦however¦ ,▁ ¦pr om ising¦ ¦signs¦ ¦have¦ ¦occur r ed¦ ¦in¦ ¦china¦ ¦based¦ ¦on¦ ¦the¦ ¦dec li ning¦ ¦number¦ ¦of¦ ¦new¦ ¦cases¦ ,▁ ¦indic ating¦ ¦the¦ ¦current¦ ¦stra te g ies¦ ¦might¦ ¦have¦ ¦been¦ ¦wor king¦ .
𐋇¦e b ol a¦ ¦was¦ ¦orig in ally¦ ¦pr ed ic ted¦ ¦to¦ ¦cause¦ ¦up¦ ¦to¦ ¦a¦ ¦million¦ ¦cases¦ ¦with¦ ¦h al f¦ ¦a¦ ¦million¦ ¦deaths¦ .
𐋇¦however¦ ,▁ ¦v ia¦ ¦ stric t¦ ¦quarantine¦ ¦and¦ ¦isolation¦ ,▁ ¦the¦ ¦disease¦ ¦has¦ ¦e vent ually¦ ¦been¦ ¦p ut¦ ¦under¦ ¦control¦ .
𐋇¦it¦ ¦is¦ ¦possible¦ ,▁ ¦similar¦ ¦to¦ ¦sars¦ - ¦cov¦ ,▁ ¦that¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦might¦ ¦bec ome¦ ¦w ea k er¦ ¦in¦ ¦inf ect iv ity¦ ¦and¦ ¦e vent ually¦ ¦di e¦ ¦down¦ ¦or¦ ¦bec ome¦ ¦a¦ ¦less¦ ¦path ogen ic¦ ¦virus¦ ¦c o¦ - ¦ex ist ent¦ ¦with¦ ¦humans¦ .
𐋇¦a¦ ¦comp ar is on¦ ¦of¦ ¦the¦ ¦epidemic¦ ¦of¦ ¦covid¦ - ¦19¦ ¦with¦ ¦that¦ ¦of¦ ¦sars¦ ¦and¦ ¦mers¦ ¦is¦ ¦provid ed¦ ¦b el ow¦ ▁( ¦fi g¦ .▁ ​ ▁( ¦fi g¦ . ¦5 5¦ ).
𐋇 ¦sars¦ - ¦cov¦ - ¦2¦ ¦is¦ ¦high ly¦ ¦transm it t able¦ ¦through¦ ¦cou g hing¦ ¦or¦ ¦sneezing¦ ,▁ ¦and¦ ¦p os si b ly¦ ¦also¦ ¦through¦ ¦direct¦ ¦contact¦ ¦with¦ ¦m at eri als¦ ¦conta min ated¦ ¦by¦ ¦the¦ ¦virus¦ .
𐋇¦the¦ ¦virus¦ ¦was¦ ¦also¦ ¦found¦ ¦in¦ ¦fe ces¦ ,▁ ¦which¦ ¦r ai ses¦ ¦a¦ ¦new¦ ¦p os si bility¦ ¦of¦ ¦fe ces¦ - ¦to¦ - ¦mouth¦ ¦transmission¦ .
𐋇¦a¦ ¦rec ent¦ ¦study¦ ¦on¦ ¦1 3 8¦ ¦cases¦ ¦reported¦ ¦that¦ ¦4 1¦ %▁ ¦of¦ ¦the¦ ¦cases¦ ¦were¦ ¦p os si b ly¦ ¦caused¦ ¦by¦ ¦n os oc om ial¦ ¦infections¦ ,▁ ¦including¦ ¦1 7¦ ¦patients¦ ¦with¦ ¦other¦ ¦pri or¦ ¦diseases¦ ¦and¦ ¦4 0¦ ¦health¦ - ¦care¦ ¦provid ers¦ .
𐋇 ¦th us¦ ,▁ ¦g re at¦ ¦pr ec a ution¦ ¦should¦ ¦be¦ ¦used¦ ¦to¦ ¦protect¦ ¦humans¦ ,▁ ¦especially¦ ¦health¦ - ¦care¦ ¦provid ers¦ ,▁ ¦social¦ ¦workers¦ ,▁ ¦family¦ ¦me mbers¦ ,▁ ¦coll ea g ues¦ ,▁ ¦and¦ ¦even¦ ¦b ys ta nd ers¦ ¦in¦ ¦contact¦ ¦with¦ ¦patients¦ ¦or¦ ¦infected¦ ¦people¦ .
𐋇¦the¦ ¦first¦ ¦ line¦ ¦of¦ ¦def en se¦ ¦that¦ ¦could¦ ¦be¦ ¦used¦ ¦to¦ ¦lower¦ ¦the¦ ¦risk¦ ¦of¦ ¦infection¦ ¦is¦ ¦through¦ ¦w earing¦ ¦face¦ ¦masks¦ ;▁ ¦both¦ ¦the¦ ¦use¦ ¦of¦ ¦sur g ical¦ ¦masks¦ ¦and¦ ¦n 9 5¦ ¦resp ir at or¦ ¦masks¦ ▁( ¦ser ies¦ ▁ # ▁ ¦1 8 6 0 s¦ )▁ ¦h el ps¦ ¦control¦ ¦the¦ ¦spread¦ ¦of¦ ¦viruses¦ .
𐋇 ¦sur g ical¦ ¦face¦ ¦masks¦ ¦prevent¦ ¦li qu id¦ ¦dro pl ets¦ ¦from¦ ¦a¦ ¦pote nt ially¦ ¦infected¦ ¦ind iv id ual¦ ¦from¦ ¦tra v el ing¦ ¦through¦ ¦the¦ ¦air ¦ ¦or¦ ¦st ic king¦ ¦o nt o¦ ¦sur fa ces¦ ¦of¦ ¦m at eri als¦ ,▁ ¦where¦ ¦they¦ ¦could¦ ¦be¦ ¦p as sed¦ ¦on¦ ¦to¦ ¦others¦ .
𐋇¦however¦ ,▁ ¦only¦ ¦n 9 5¦ ▁( ¦ser ies¦ ▁ # ▁ ¦1 8 6 0 s¦ )▁ ¦masks¦ ¦can¦ ¦protect¦ ¦against¦ ¦the¦ ¦in h al ation¦ ¦of¦ ¦vir i ons¦ ¦as¦ ¦sm all¦ ¦as¦ ¦10¦ ¦to¦ ¦8 0¦ ¦n m¦ ,▁ ¦with¦ ¦only¦ ¦5¦ %▁ ¦of¦ ¦the¦ ¦vir i ons¦ ¦being¦ ¦able¦ ¦to¦ ¦p en et r ate¦ ¦comp le tely¦ ;▁ ¦sars¦ - ¦cov¦ - ¦2¦ ¦is¦ ¦similar¦ ¦to¦ ¦sars¦ - ¦cov¦ ¦in¦ ¦s iz e¦ ¦and¦ ¦both¦ ¦are¦ ¦appro xi ma tely¦ ¦8 5¦ ¦n m¦ .
𐋇 ¦since¦ ¦partic les¦ ¦can¦ ¦p en et r ate¦ ¦even¦ ¦five¦ ¦sur g ical¦ ¦masks¦ ¦st ac ked¦ ¦t og ether¦ ,▁ ¦health¦ - ¦care¦ ¦provid ers¦ ¦in¦ ¦direct¦ ¦contact¦ ¦with¦ ¦patients¦ ¦must¦ ¦wear¦ ¦n 9 5¦ ▁( ¦ser ies¦ ▁ # ▁ ¦1 8 6 0 s¦ )▁ ¦masks¦ ¦but¦ ¦not¦ ¦sur g ical¦ ¦masks¦ .
𐋇¦in¦ ¦add ition¦ ¦to¦ ¦masks¦ ,▁ ¦health¦ - ¦care¦ ¦provid ers¦ ¦should¦ ¦wear¦ ¦f it ted¦ ¦isolation¦ ¦g ow ns¦ ¦in¦ ¦order¦ ¦to¦ ¦further¦ ¦reduce¦ ¦contact¦ ¦with¦ ¦viruses¦ .
𐋇 ¦viruses¦ ¦can¦ ¦also¦ ¦inf ect¦ ¦an¦ ¦ind iv id ual¦ ¦through¦ ¦the¦ ¦ey es¦ .
𐋇¦on¦ ¦january¦ ¦2 2¦ ,▁ ¦2020¦ ,▁ ¦a¦ ¦doctor¦ ¦was¦ ¦infected¦ ¦with¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦al th ough¦ ¦h e¦ ¦w ore¦ ¦an¦ ¦n 9 5¦ ¦mask¦ ;▁ ¦the¦ ¦virus¦ ¦might¦ ¦have¦ ¦ent ered¦ ¦hi s¦ ¦body¦ ¦through¦ ¦hi s¦ ¦inf la mm atory¦ ¦ey es¦ .
𐋇 ¦th us¦ ,▁ ¦health¦ - ¦care¦ ¦provid ers¦ ¦should¦ ¦also¦ ¦wear¦ ¦trans par ent¦ ¦face¦ ¦s hi el ds¦ ¦or¦ ¦go gg les¦ ¦while¦ ¦wor king¦ ¦with¦ ¦patients¦ .
𐋇¦for¦ ¦the¦ ¦general¦ ¦public¦ ¦in¦ ¦affected¦ ¦or¦ ¦pote nt ially¦ ¦affected¦ ¦areas¦ ,▁ ¦it¦ ¦is¦ ¦high ly¦ ¦su gg ested¦ ¦that¦ ¦e ver y bo dy¦ ¦wash¦ ¦their¦ ¦hands¦ ¦with¦ ¦disinf ect ant¦ ¦so a ps¦ ¦more¦ ¦often¦ ¦than¦ ¦us ual¦ ,▁ ¦t ry¦ ¦to¦ ¦stay¦ ¦ind o ors¦ ¦for¦ ¦self¦ - ¦quarantine¦ ¦and¦ ¦limi t¦ ¦contact¦ ¦with¦ ¦pote nt ially¦ ¦infected¦ ¦individuals¦ .
𐋇 ¦three¦ ¦fe et¦ ¦is¦ ¦consid ered¦ ¦an¦ ¦appr op ri ate¦ ¦dista nce¦ ¦for¦ ¦people¦ ¦to¦ ¦stay¦ ¦away¦ ¦from¦ ¦a¦ ¦pa ti ent¦ .
𐋇¦these¦ ¦ac tions¦ ¦are¦ ¦effective¦ ¦met ho ds¦ ¦to¦ ¦lower¦ ¦the¦ ¦risk¦ ¦of¦ ¦infection¦ ¦as¦ ¦well¦ ¦as¦ ¦prevent¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇 ¦al th ough¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦ca me¦ ¦as¦ ¦a¦ ¦new¦ ¦virus¦ ¦to¦ ¦the¦ ¦human¦ ¦world¦ ,▁ ¦its¦ ¦high¦ ¦h om ology¦ ¦to¦ ¦sars¦ - ¦cov¦ ¦as¦ ¦reported¦ ¦on¦ ¦7¦ ¦january¦ ¦2020¦ ¦should¦ ¦have¦ ¦caused¦ ¦high¦ ¦alert¦ ¦to¦ ¦china¦ ¦based¦ ¦on¦ ¦ her¦ ¦d ee p¦ ¦me m ory¦ ¦of¦ ¦the¦ ¦sars¦ ¦outbreak¦ ¦in¦ ¦20 0 3¦ .
𐋇¦however¦ ,▁ ¦not¦ ¦until¦ ¦19¦ ¦january¦ ¦2020¦ ¦d id¦ ¦the¦ ¦dir ector¦ ¦of¦ ¦the¦ ¦center¦ ¦of¦ ¦disease¦ ¦control¦ ¦of¦ ¦wuhan¦ ¦c om f ort¦ ¦the¦ ¦c itiz ens¦ ¦by¦ ¦sa ying¦ ¦that¦ ¦the¦ ¦novel¦ ¦virus¦ ¦has¦ ¦low¦ ¦conta g i o us ness¦ ¦and¦ ¦limi ted¦ ¦rep ro duc t iv ity¦ ¦from¦ ¦human¦ ¦to¦ ¦human¦ ¦and¦ ¦that¦ ¦it¦ ¦is¦ ¦not¦ ¦a¦ ¦prob le m¦ ¦to¦ ¦prevent¦ ¦and¦ ¦con tain¦ ¦the¦ ¦disease¦ .
𐋇¦this¦ ¦me ss age¦ ¦rem ar k ab ly¦ ¦re la x ed¦ ¦the¦ ¦al ar m¦ ¦of¦ ¦the¦ ¦public¦ ,▁ ¦especially¦ ¦when¦ ¦the¦ ¦ent ir e¦ ¦country¦ ¦was¦ ¦pre par ing¦ ¦for¦ ¦the¦ ¦sp r ing¦ ¦fe st iv al¦ ,▁ ¦and¦ ¦the¦ ¦crit ical¦ ¦time¦ ¦was¦ ¦m is sed¦ ¦to¦ ¦con tain¦ ¦the¦ ¦disease¦ ¦at¦ ¦its¦ ¦min im al¦ ¦sc a le¦ ¦in¦ ¦wuhan¦ .
𐋇¦the¦ ¦disease¦ ¦control¦ ¦a ge nc ies¦ ¦in¦ ¦china¦ ¦may¦ ¦take¦ ¦this¦ ¦h ard¦ ¦le ss on¦ ¦and¦ ¦make¦ ¦crit ical¦ ¦imp ro ve ments¦ ¦in¦ ¦the¦ ¦f ut ure¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦these¦ ¦a ge nc ies¦ ¦should¦ ¦be¦ ▁( ¦1¦ )▁ ¦more¦ ¦ca re ful¦ ¦when¦ ¦ma king¦ ¦public¦ ¦an no un ce ments¦ ¦as¦ ¦every¦ ¦wor d¦ ¦cou nts¦ ¦to¦ ¦c itiz ens¦ ¦and¦ ¦can¦ ¦ch ange¦ ¦their¦ ¦att itu de¦ ¦and¦ ¦dec i si ons¦ ; ▁( ¦2¦ )▁ ¦more¦ ¦sen si tive¦ ¦and¦ ¦re ac tive¦ ¦to¦ ¦un us ual¦ ¦information¦ ¦from¦ ¦cl in ics¦ ¦r at her¦ ¦than¦ ¦wai ting¦ ¦for¦ ¦f ormal¦ ¦rep orts¦ ¦from¦ ¦do ctors¦ ¦or¦ ¦off ici als¦ ; ▁( ¦3¦ )▁ ¦more¦ ¦re stric tive¦ ¦to¦ ¦con tain¦ ¦a¦ ¦pote ntial¦ ¦epidemic¦ ¦at¦ ¦its¦ ¦early¦ ¦st age¦ ¦r at her¦ ¦than¦ ¦att e mp ting¦ ¦to¦ ¦c om f ort¦ ¦the¦ ¦public¦ ;▁ ¦and¦ ▁( ¦4¦ )▁ ¦more¦ ¦often¦ ¦to¦ ¦i ss ue¦ ¦t ar ge ted¦ ¦and¦ ¦effective¦ ¦d ri lls¦ ¦to¦ ¦increase¦ ¦the¦ ¦public¦ ' ¦s¦ ¦a w a re ness¦ ¦about¦ ¦epidemic¦ ¦diseases¦ ¦and¦ ¦to¦ ¦test¦ ¦and¦ ¦imp ro ve¦ ¦the¦ ¦response¦ ¦system¦ ¦of¦ ¦the¦ ¦s oc i et y¦ ¦perio d ically¦ .
𐋇¦the¦ ¦outbreak¦ ¦of¦ ¦covid¦ - ¦19¦ ¦caused¦ ¦by¦ ¦the¦ ¦novel¦ ¦virus¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦star ted¦ ¦in¦ ¦the¦ ¦end¦ ¦of¦ ¦december¦ ¦2019¦ .
𐋇¦in¦ ¦less¦ ¦than¦ ¦two¦ ¦mon ths¦ ,▁ ¦it¦ ¦has¦ ¦spread¦ ¦all¦ ¦over¦ ¦china¦ ¦and¦ ¦n ear¦ ¦50¦ ¦other¦ ¦countries¦ ¦gl ob ally¦ ¦at¦ ¦the¦ ¦time¦ ¦of¦ ¦this¦ ¦w ri ting¦ .
𐋇 ¦since¦ ¦the¦ ¦virus¦ ¦is¦ ¦very¦ ¦similar¦ ¦to¦ ¦sars¦ - ¦cov¦ ¦and¦ ¦the¦ ¦symptoms¦ ¦are¦ ¦also¦ ¦similar¦ ¦between¦ ¦covid¦ - ¦19¦ ¦and¦ ¦sars¦ ,▁ ¦the¦ ¦outbreak¦ ¦of¦ ¦covid¦ - ¦19¦ ¦has¦ ¦cre ated¦ ¦a¦ ¦sen se¦ ¦of¦ ¦sars¦ ¦rec ur r ing¦ .
𐋇¦however¦ ,▁ ¦there¦ ¦are¦ ¦some¦ ¦rem ar k able¦ ¦di ff er en ces¦ ¦between¦ ¦covid¦ - ¦19¦ ¦and¦ ¦sars¦ ,▁ ¦which¦ ¦are¦ ¦essential¦ ¦for¦ ¦cont aining¦ ¦the¦ ¦epidemic¦ ¦and¦ ¦tre ating¦ ¦the¦ ¦patients¦ .
𐋇¦covid¦ - ¦19¦ ¦aff ects¦ ¦more¦ ¦el d erly¦ ¦individuals¦ ¦than¦ ¦y ou th¦ ¦and¦ ¦more¦ ¦m en¦ ¦than¦ ¦women¦ ,▁ ¦and¦ ¦the¦ ¦se ver ity¦ ¦and¦ ¦death¦ ¦rate¦ ¦are¦ ¦also¦ ¦higher¦ ¦in¦ ¦el d erly¦ ¦ind iv id ual¦ ¦than¦ ¦in¦ ¦y ou th¦ .
𐋇 ¦sars¦ ¦has¦ ¦higher¦ ¦m ort ality¦ ¦than¦ ¦covid¦ - ¦19¦ ▁( ¦10¦ . ¦9 1¦ %▁ ¦ ve rs us¦ ¦1¦ . ¦4 4¦ % ).
𐋇¦covid¦ - ¦19¦ ¦patients¦ ¦trans mi t¦ ¦the¦ ¦virus¦ ¦even¦ ¦when¦ ¦they¦ ¦are¦ ¦s y m pt om less¦ ¦w he rea s¦ ¦sars¦ ¦patients¦ ¦do¦ ¦so¦ ¦us ually¦ ¦when¦ ¦they¦ ¦are¦ ¦se ver ely¦ ¦ ill¦ ,▁ ¦which¦ ¦ca u ses¦ ¦much¦ ¦g rea ter¦ ¦diffic ult y¦ ¦to¦ ¦con tain¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ ¦than¦ ¦sars¦ .
𐋇¦this¦ ¦part ially¦ ¦exp la ins¦ ¦wh y¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦spread¦ ¦much¦ ¦f as ter¦ ¦and¦ ¦b ro a der¦ ¦than¦ ¦sars¦ - ¦cov¦ .
𐋇¦the¦ ¦reg ular¦ ¦rna¦ ¦ass ay¦ ¦for¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦can¦ ¦be¦ ¦negative¦ ¦in¦ ¦some¦ ¦covid¦ - ¦19¦ ¦patients¦ .
𐋇¦on¦ ¦the¦ ¦other¦ ¦hand¦ ,▁ ¦cur ed¦ ¦patients¦ ¦can¦ ¦be¦ ¦positive¦ ¦for¦ ¦the¦ ¦virus¦ ¦ag a in¦ .
𐋇¦these¦ ¦fi nd ings¦ ¦d ra m at ically¦ ¦increase¦ ¦the¦ ¦risk¦ ¦of¦ ¦virus¦ ¦sprea ding¦ .
𐋇 ¦giv en¦ ¦such¦ ¦rap id¦ ¦pr og r ess¦ ¦in¦ ¦research¦ ¦on¦ ¦covid¦ - ¦19¦ ,▁ ¦several¦ ¦crit ical¦ ¦i ss ues¦ ¦remain¦ ¦to¦ ¦be¦ ¦s ol v ed¦ ,▁ ¦as¦ ¦fo ll ow s¦ :
𐋇 ¦where¦ ¦d id¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦come¦ ¦from¦ ?
𐋇 ¦al th ough¦ ¦9 6¦ %▁ ¦gen et ic¦ ¦ho mo lo g¦ ¦was¦ ¦found¦ ¦between¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦and¦ ¦two¦ ¦bat¦ ¦sars¦ - ¦like¦ ¦covs¦ ,▁ ¦we¦ ¦still¦ ¦cannot¦ ¦co nc lu de¦ ¦that¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦is¦ ¦from¦ ¦bats¦ .
𐋇 ¦what¦ ¦anim al¦ ¦was¦ ¦the¦ ¦int erm ediate¦ ¦spec ies¦ ¦to¦ ¦trans mi t¦ ¦the¦ ¦virus¦ ¦from¦ ¦the¦ ¦orig in al¦ ¦host¦ ,▁ ¦s ay¦ ¦bats¦ ,▁ ¦to¦ ¦humans¦ ?
𐋇 ¦without¦ ¦k n owing¦ ¦a ns w ers¦ ¦to¦ ▁ # ▁ ¦1¦ ¦and¦ ¦2¦ ,▁ ¦we¦ ¦cannot¦ ¦eff ic ie ntly¦ ¦c ut¦ ¦the¦ ¦transmission¦ ,▁ ¦and¦ ¦the¦ ¦outbreak¦ ¦can¦ ¦rel ap se¦ ¦at¦ ¦any¦ ¦time¦ .
𐋇 ¦al th ough¦ ¦m ol ec ular¦ ¦mod el ing¦ ¦and¦ ¦bi o che m ical¦ ¦ass ays¦ ¦have¦ ¦dem on str ated¦ ¦that¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦b in ds¦ ¦to¦ ¦a ce 2¦ ,▁ ¦how¦ ¦ex a ct ly¦ ¦does¦ ¦the¦ ¦virus¦ ¦en ter¦ ¦the¦ ¦air w ay¦ ¦ce lls¦ ¦and¦ ¦cause¦ ¦sub se qu ent¦ ¦path ological¦ ¦chan ges¦ ?
𐋇 ¦does¦ ¦the¦ ¦virus¦ ¦also¦ ¦b ind¦ ¦a ce 2¦ - ¦exp re ss ing¦ ¦ce lls¦ ¦in¦ ¦other¦ ¦or g ans¦ ?
𐋇 ¦without¦ ¦cl ear¦ ¦a ns w ers¦ ¦to¦ ¦these¦ ¦qu es tions¦ ,▁ ¦we¦ ¦cannot¦ ¦a ch ie ve¦ ¦f ast¦ ¦and¦ ¦acc ur ate¦ ¦diagn o sis¦ ¦and¦ ¦effective¦ ¦treatment¦ .
𐋇¦how¦ ¦long¦ ¦will¦ ¦the¦ ¦epidemic¦ ¦last¦ ?
𐋇¦how¦ ¦is¦ ¦the¦ ¦virus¦ ¦gen et ically¦ ¦ev ol ving¦ ¦during¦ ¦transmission¦ ¦among¦ ¦humans¦ ?
𐋇 ¦will¦ ¦it¦ ¦bec ome¦ ¦a¦ ¦pandemic¦ ¦worldwide¦ ,▁ ¦di e¦ ¦down¦ ¦like¦ ¦sars¦ ¦or¦ ¦rel ap se¦ ¦perio d ically¦ ¦like¦ ¦the¦ ¦flu¦ ?
𐋇¦it¦ ¦is¦ ¦essential¦ ¦but¦ ¦may¦ ¦take¦ ¦some¦ ¦time¦ ¦to¦ ¦s ear ch¦ ¦for¦ ¦a ns w ers¦ ¦to¦ ¦the¦ ¦a bo ve¦ ¦and¦ ¦many¦ ¦other¦ ¦qu es tions¦ .
𐋇¦however¦ ,▁ ¦with¦ ¦wh a te ver¦ ¦exp en se¦ ¦it¦ ¦may¦ ¦dem and¦ ,▁ ¦we¦ ¦have¦ ¦no¦ ¦other¦ ¦c ho ice¦ ¦but¦ ¦to¦ ¦sto p¦ ¦the¦ ¦epidemic¦ ¦as¦ ¦so on¦ ¦as¦ ¦possible¦ ¦and¦ ¦br ing¦ ¦our¦ ¦l ife¦ ¦b ack¦ ¦to¦ ¦normal¦ .
𐋇 ¦z o on ot ic¦ ¦orig ins¦ ¦of¦ ¦human¦ ¦coronaviruses¦
𐋇¦m ut ation¦ ¦and¦ ¦ad a pt ation¦ ¦have¦ ¦dr iv en¦ ¦the¦ ¦c o¦ - ¦ev ol ution¦ ¦of¦ ¦coronaviruses¦ ▁( ¦covs¦ )▁ ¦and¦ ¦their¦ ¦ho sts¦ ,▁ ¦including¦ ¦human¦ ¦be ings¦ ,▁ ¦for¦ ¦t ho us an ds¦ ¦of¦ ¦years¦ .
𐋇 ¦before¦ ¦20 0 3¦ ,▁ ¦two¦ ¦human¦ ¦covs¦ ▁( ¦hcovs¦ )▁ ¦were¦ ¦known¦ ¦to¦ ¦cause¦ ¦mild¦ ¦illness¦ ,▁ ¦such¦ ¦as¦ ¦common¦ ¦cold¦ .
𐋇¦the¦ ¦out b rea ks¦ ¦of¦ ¦severe¦ ¦acute¦ ¦respiratory¦ ¦syndrome¦ ▁( ¦sars¦ )▁ ¦and¦ ¦the¦ ¦m id d le¦ ¦e ast¦ ¦respiratory¦ ¦syndrome¦ ▁( ¦mers¦ )▁ ¦have¦ ¦f li pp ed¦ ¦the¦ ¦co in¦ ¦to¦ ¦re ve al¦ ¦how¦ ¦de v a st ating¦ ¦and¦ ¦l ife¦ - ¦th re at ening¦ ¦an¦ ¦hcov¦ ¦infection¦ ¦could¦ ¦be¦ .
𐋇¦the¦ ¦e mer g ence¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦in¦ ¦centr al¦ ¦china¦ ¦at¦ ¦the¦ ¦end¦ ¦of¦ ¦2019¦ ¦has¦ ¦th r us ted¦ ¦covs¦ ¦into¦ ¦the¦ ¦sp ot l ight¦ ¦ag a in¦ ¦and¦ ¦sur p ri sed¦ ¦us¦ ¦with¦ ¦its¦ ¦high¦ ¦transm is si bility¦ ¦but¦ ¦reduc ed¦ ¦path ogen ic ity¦ ¦comp ared¦ ¦to¦ ¦its¦ ¦s is ter¦ ¦sars¦ - ¦cov¦ .
¦19 1 8¦ ¦flu¦
𐋇 ¦acute¦ ¦br on ch itis¦
𐋇 ¦acute¦ ¦respiratory¦ ¦disease¦
𐋇¦ ai ds¦
𐋇 ¦air bor n e¦ ¦dro pl ets¦
𐋇 ¦air w ay¦
𐋇 ¦al c o ho l¦ - ¦based¦
𐋇 ¦al c o ho l¦ - ¦based¦ ¦hand¦ ¦r ub ¦
𐋇 ¦al c o ho l¦ - ¦based¦ ¦hand¦ ¦s an itiz er¦
𐋇 ¦al ve o la r¦ ¦disease¦
𐋇 ¦an¦ ¦epidemic¦
𐋇 ¦an n ual¦ ¦flu¦
𐋇 ¦anti ¦ - ¦inf la mm atory¦ ¦drug¦
𐋇 ¦anti vir al¦ ¦drug¦
𐋇 ¦anti vir al¦ ¦treatment¦
𐋇 ¦ass ay¦
𐋇 ¦as ymptomatic¦
𐋇 ¦a vi an¦ ¦flu¦
𐋇¦ bl ack¦ ¦pla g ue¦
𐋇 ¦blood¦ ¦pre ss ure¦
𐋇 ¦body¦ ¦f lu id¦
𐋇 ¦brea thing¦
𐋇¦b ub on ic¦ ¦pla g ue¦
𐋇¦c 1 9¦
𐋇¦c v 1 9¦
𐋇 ¦case¦ ¦fat ality¦ ¦rate¦
𐋇 ¦ca us ative¦ ¦ag ent¦
𐋇¦c dc¦
𐋇¦ che m ical¦ ¦disinf e ction¦
𐋇 ¦chest¦ ¦ x¦ - ¦r ay¦
𐋇 ¦clinical¦ ¦diagn o sis¦
𐋇 ¦clinical¦ ¦tr ial¦
𐋇 ¦close¦ ¦contact¦
𐋇¦c vir us¦
𐋇 ¦ch r on ic¦ ¦respiratory¦ ¦disease¦
𐋇 ¦common¦ ¦cold¦
𐋇 ¦common¦ ¦flu¦
𐋇 ¦comm un ic able¦ ¦disease¦
𐋇 ¦community¦ ¦spread¦
𐋇 ¦community¦ ¦transmission¦
𐋇 ¦comp ro mi sed¦ ¦immune¦ ¦system¦
𐋇 ¦conta g ion¦
𐋇 ¦conta g ious¦
𐋇 ¦conta g i o us ness¦
𐋇 ¦corona ¦
𐋇 ¦corona ¦ ¦virus¦
𐋇 ¦corona ¦ ¦virus¦ ¦epidemic¦
𐋇 ¦corona ¦ ¦virus¦ ¦outbreak¦
𐋇 ¦corona ¦ ¦virus¦ ¦sc are¦
𐋇 ¦coronavirus¦
𐋇 ¦coronavirus¦ ¦cases¦
𐋇 ¦coronavirus¦ ¦outbreak¦
𐋇 ¦coronavirus¦ ¦pandemic¦
𐋇 ¦coronavirus¦ ¦sc are¦
𐋇 ¦cough¦
𐋇 ¦cough¦ ¦e ti qu et t e¦
𐋇 ¦cou g hing¦
𐋇 ¦cov¦ ¦19¦
𐋇 ¦cov 1 9¦
𐋇¦covid¦
𐋇¦covid¦ - ¦19¦ ¦c ri sis¦
𐋇¦covid¦ - ¦19¦
𐋇 ¦cov id 1 9¦
𐋇¦covid¦ - ¦19¦ ¦epidemic¦
𐋇¦covid¦ - ¦19¦ ¦outbreak¦
𐋇¦covid¦ - ¦19¦ ¦pandemic¦
𐋇¦covid¦ ¦19¦
𐋇 ¦current¦ ¦c ri sis¦
𐋇 ¦current¦ ¦health¦ ¦c ri sis¦
𐋇 ¦current¦ ¦outbreak¦
𐋇 ¦current¦ ¦pandemic¦
𐋇¦c v ¦
𐋇¦c v ¦ - ¦19¦
𐋇¦d ea d ly¦
𐋇¦d ea d ly¦ ¦virus¦
𐋇 ¦death¦ ¦rate¦
𐋇 ¦death¦ ¦t ol l¦
𐋇 ¦dec on ta min ate¦
𐋇 ¦det ect able¦
𐋇 ¦det er g ent¦
𐋇 ¦diffic ult y¦ ¦brea thing¦
𐋇 ¦di ab e tes¦
𐋇 ¦diagn os able¦ ¦disease¦
𐋇 ¦diagn o st ic¦ ¦prot oc o l¦
𐋇 ¦diagn o st ic¦ ¦testing¦
𐋇 ¦disease¦ ¦ it s el f¦
𐋇 ¦disease¦ ¦outbreak¦
𐋇 ¦disinf ect ant¦
𐋇 ¦dis p os able¦
𐋇 ¦dro pl et¦ ¦transmission¦
𐋇 ¦dro pl ets¦
𐋇¦d ry¦ ¦cough¦
𐋇¦d ry¦ ¦sur f ace¦ ¦conta m ination¦
𐋇¦e b ol a¦
𐋇 ¦effective¦ ¦treatment¦
𐋇 ¦el ect r on¦ ¦m ic r os c ope¦
𐋇 ¦emergency¦ ¦department¦
𐋇 ¦epidemic¦
𐋇 ¦epidemic¦ ¦cur ve¦
𐋇 ¦epidemic¦ ¦p ea k¦
𐋇¦e p ide mi ol og ist¦
𐋇 ¦exp osure¦
𐋇 ¦ext re me¦ ¦ca ution¦
𐋇 ¦ey e¦ ¦prote ction¦
𐋇 ¦face¦ ¦mask¦
𐋇 ¦face¦ ¦masks¦
𐋇 ¦family¦ ¦cl us ter¦
𐋇 ¦fat ality¦ ¦rate¦
𐋇¦f ec al¦ ¦conta m ination¦
𐋇 ¦fever¦
𐋇¦f l at t en¦ ¦the¦ ¦infection¦ ¦cur ve¦
𐋇 ¦flu¦
𐋇 ¦food¦ ¦safety¦
𐋇¦f orm al de h y de¦
𐋇 ¦ga st ro e nt er itis¦
𐋇 ¦g erm ic ide¦
𐋇 ¦global¦ ¦pandemic¦
𐋇 ¦global¦ ¦w arm ing¦
𐋇 ¦g ood¦ ¦respiratory¦ ¦h yg ien e¦
𐋇 ¦gu a ng d o ng¦
𐋇¦h 1 n 1¦
𐋇¦h 1 n 1¦ ¦virus¦
𐋇 ¦hand¦ ¦disinf ect ant¦
𐋇 ¦hand¦ ¦s an itiz er¦
𐋇 ¦health¦ ¦care¦ ¦provid er¦
𐋇 ¦health¦ ¦c ri sis¦
𐋇 ¦health¦ ¦pl an¦ ¦car ri er¦
𐋇 ¦health¦ ¦services¦
𐋇¦h ear t¦ ¦fa il ure¦
𐋇 ¦high¦ ¦fever¦
𐋇¦h iv ¦
𐋇 ¦hosp it al iz e¦
𐋇 ¦hou se ho ld¦ ¦ bl ea ch¦
𐋇 ¦hub e i¦
𐋇¦h y dr og en¦ ¦per o x ide¦
𐋇¦h yg ien e¦
𐋇 ¦immune¦ ¦system¦
𐋇 ¦immun ity¦
𐋇 ¦immun oc o mp ro mi sed¦
𐋇 ¦immun ol og ist¦
𐋇 ¦inc ub ation¦
𐋇 ¦inc ub ation¦ ¦period¦
𐋇 ¦ind ir ect¦ ¦contact¦
𐋇 ¦inf ect¦
𐋇 ¦infection¦
𐋇 ¦infectious¦
𐋇 ¦inf ect iv ity¦
𐋇 ¦influenza¦
𐋇 ¦in it ial¦ ¦transmission¦ ¦ev ent¦
𐋇 ¦in tens ive¦ ¦care¦ ¦equipment¦
𐋇 ¦int erm ediate¦ ¦host¦
𐋇 ¦int ra ut er ine¦
𐋇 ¦int ub ation¦
𐋇 ¦isolation¦
𐋇¦ is op ro pa no l¦
𐋇 ¦laboratory¦ ¦test¦ ¦ki t¦
𐋇 ¦laboratory¦ ¦testing¦
𐋇¦l ack¦ ¦of¦ ¦testing¦
𐋇¦l ack¦ ¦of¦ ¦tests¦
𐋇¦l at est¦ ¦up d ates¦
𐋇 ¦li ver¦ ¦fa il ure¦
𐋇 ¦local¦ ¦public¦ ¦health¦ ¦author ity¦
𐋇 ¦lockdown¦
𐋇 ¦lu ng s¦
𐋇 ¦masks¦
𐋇 ¦me as les¦
𐋇 ¦me ch an ical¦ ¦ ventil ation¦
𐋇¦m ed ia¦ ¦co ver age¦
𐋇 ¦medical¦ ¦care¦
𐋇 ¦mers¦
𐋇 ¦mers¦ ¦cov¦
𐋇¦m ic r ob i ol og ist¦
𐋇 ¦mild¦ ¦cough¦
𐋇¦m ort ality¦ ¦rate¦
𐋇 ¦mult i¦ - ¦or g an¦ ¦fa il ure¦
𐋇¦n as al¦ ¦con ge st ion¦
𐋇 ¦ne ut r al¦ ¦det er g ent¦
𐋇 ¦new¦ ¦normal¦
𐋇 ¦novel¦ ¦corona ¦ ¦virus¦
𐋇 ¦novel¦ ¦coronavirus¦
𐋇 ¦novel¦ ¦coronavirus¦ ¦outbreak¦
𐋇 ¦novel¦ ¦virus¦
𐋇 ¦online¦ ¦medical¦ ¦cons ult ation¦
𐋇 ¦o ns et¦
𐋇 ¦outbreak¦
𐋇 ¦outbreak¦ ¦rea di ness¦
𐋇 ¦over all¦ ¦case¦ ¦fat ality¦
𐋇 ¦pandemic¦
𐋇 ¦pa ngol in¦
𐋇 ¦path og en¦
𐋇 ¦path ology¦
𐋇 ¦pa ti ent¦ ¦care¦ ¦equipment¦
𐋇 ¦personal¦ ¦prot ective¦ ¦equipment¦
𐋇 ¦person¦ - ¦to¦ - ¦person¦ ¦transmission¦
𐋇 ¦ph le g m¦
𐋇 ¦ph ys ical¦ ¦contact¦
𐋇 ¦pla g ue¦
𐋇 ¦pneumonia¦
𐋇¦p ne um on ia s¦
𐋇 ¦positive¦ ¦test¦
𐋇 ¦pr ec a ution¦
𐋇 ¦pr ec a u tion ary¦
𐋇 ¦pr e¦ - ¦ex is ting¦ ¦c ond ition¦
𐋇 ¦pre par ed ness¦
𐋇 ¦pr og no sis¦
𐋇 ¦protect¦ ¦m ys el f¦
𐋇 ¦protect¦ ¦others¦
𐋇 ¦protect¦ ¦yourself¦
𐋇 ¦prot ective¦ ¦measures¦
𐋇 ¦public¦ ¦health¦ ¦c ri sis¦
𐋇¦p ul m on ary¦ ¦ti ss ue¦ ¦da m age¦
𐋇 ¦quarantine¦
𐋇 ¦rap id¦ ¦risk¦ ¦as se ss ment¦
𐋇 ¦rea g ent¦
𐋇 ¦reg ular¦ ¦flu¦
𐋇 ¦re in f e ction¦
𐋇 ¦r en al¦ ¦disease¦
𐋇 ¦r en al¦ ¦fa il ure¦
𐋇 ¦resp ir at or¦
𐋇 ¦respiratory¦
𐋇 ¦respiratory¦ ¦disease¦
𐋇 ¦respiratory¦ ¦di str ess¦
𐋇 ¦respiratory¦ ¦dro pl ets¦
𐋇 ¦respiratory¦ ¦h yg ien e¦
𐋇 ¦respiratory¦ ¦illness¦
𐋇 ¦respiratory¦ ¦syndrome¦
𐋇 ¦respiratory¦ ¦trac t¦ ¦disease¦
𐋇 ¦restrictions¦
𐋇 ¦res ur ge¦
𐋇 ¦rna¦
𐋇 ¦r ub e ol a¦
𐋇 ¦r un n y¦ ¦nose¦
𐋇 ¦sars¦
𐋇 ¦sars¦ - ¦cov¦ - ¦2¦
𐋇 ¦sars¦ - ¦cov¦
𐋇 ¦sars¦ - ¦related¦ ¦coronavirus¦
𐋇 ¦se as on al¦ ¦flu¦
𐋇 ¦se as on al¦ ¦influenza¦
𐋇 ¦sec r et ion¦
𐋇 ¦self¦ - ¦quarantine¦
𐋇 ¦se p sis¦
𐋇 ¦se pt ic¦ ¦sh oc k¦
𐋇 ¦severe¦ ¦acute¦ ¦respiratory¦ ¦syndrome¦
𐋇 ¦sh ort ness¦ ¦of¦ ¦brea th¦
𐋇¦s ick e ned¦
𐋇¦s ick ness¦
𐋇¦s n ee z e¦
𐋇¦s n ee z es¦
𐋇 ¦sneezing¦
𐋇 ¦social¦ ¦distancing¦
𐋇¦s ore¦ ¦th ro at¦
𐋇 ¦sp an ish¦ ¦flu¦
𐋇 ¦spec im en¦ ¦colle ction¦
𐋇 ¦spread¦
𐋇 ¦sp ut um¦
𐋇 ¦st ig m at is ation¦
𐋇 ¦supp or tive¦
𐋇 ¦sur f ace¦
𐋇 ¦sur fa ces¦
𐋇 ¦suspected¦ ¦infection¦
𐋇 ¦sw ab ¦
𐋇 ¦sw ine¦ ¦flu¦
𐋇¦s y m pt om¦
𐋇¦s ymptomatic¦
𐋇 ¦symptoms¦
𐋇¦t ar ge ted¦ ¦disinf e ction¦
𐋇 ¦test¦ ¦ki t¦
𐋇 ¦testing¦ ¦ er r or¦
𐋇 ¦ti ss ue¦ ¦da m age¦
𐋇¦t p¦ ¦sh ort age¦
𐋇 ¦to il et¦ ¦p ap er¦ ¦sh ort age¦
𐋇 ¦tou ch¦
𐋇 ¦to uc hing¦
𐋇 ¦transm is si bility¦
𐋇 ¦transm is si ble¦
𐋇 ¦transmission¦
𐋇 ¦transmission¦ ¦pote ntial¦
𐋇 ¦typ ical¦ ¦flu¦
𐋇 ¦underlying¦ ¦disease¦
𐋇 ¦up d ates¦
𐋇 ¦vaccine¦
𐋇 ¦vaccines¦
𐋇¦ ventil ation¦
𐋇¦ ventil at or¦
𐋇¦ ventil at ors¦
𐋇 ¦viral¦ ¦infection¦
𐋇 ¦viral¦ ¦outbreak¦
𐋇 ¦viral¦ ¦pandemic¦
𐋇 ¦viral¦ ¦pneumonia¦
𐋇¦ vi rt ual¦ ¦care¦
𐋇 ¦vir ul ence¦
𐋇 ¦virus¦ ¦ it s el f¦
𐋇 ¦virus¦ ¦outbreak¦
𐋇 ¦virus¦ ¦sc are¦
𐋇 ¦virus¦ ¦sprea ds¦
𐋇 ¦virus¦ ¦stra in¦
𐋇 ¦viral¦ ¦transmission¦
𐋇 ¦v iv id¦ - ¦19¦
𐋇 ¦washing¦ ¦hands¦
𐋇 ¦washing¦ ¦ on es¦ ¦hands¦
𐋇 ¦wash¦ ¦your¦ ¦hands¦
𐋇 ¦wh ite¦ ¦blood¦ ¦c ell¦ ¦co un t¦
𐋇 ¦wid esp r ead¦ ¦transmission¦
𐋇 ¦wor king¦ ¦from¦ ¦home¦
𐋇¦w f h ¦
𐋇 ¦wuhan¦
𐋇 ¦hcov¦ ¦infection¦ ¦is¦ ¦a¦ ¦z oo no sis¦ ¦and¦ ¦under st an ding¦ ¦the¦ ¦z o on ot ic¦ ¦orig ins¦ ¦of¦ ¦hcovs¦ ¦would¦ ¦ser ve¦ ¦us¦ ¦well¦ .
𐋇 ¦most¦ ¦hcovs¦ ¦orig in ated¦ ¦from¦ ¦bats¦ ¦where¦ ¦they¦ ¦are¦ ¦non¦ - ¦path ogen ic¦ .
𐋇¦the¦ ¦int erm ediate¦ ¦res erv oi r¦ ¦ho sts¦ ¦of¦ ¦some¦ ¦hcovs¦ ¦are¦ ¦also¦ ¦known¦ .
𐋇 ¦ident if ying¦ ¦the¦ ¦anim al¦ ¦ho sts¦ ¦has¦ ¦direct¦ ¦i mpl ications¦ ¦in¦ ¦the¦ ¦pre vention¦ ¦of¦ ¦human¦ ¦diseases¦ .
𐋇 ¦in ve st ig ating¦ ¦cov¦ - ¦host¦ ¦inter ac tions¦ ¦in¦ ¦anim als¦ ¦might¦ ¦also¦ ¦d er ive¦ ¦important¦ ¦i ns ight¦ ¦on¦ ¦cov¦ ¦path ogen e sis¦ ¦in¦ ¦humans¦ .
𐋇¦in¦ ¦this¦ ¦re v ie w¦ ,▁ ¦we¦ ¦pres ent¦ ¦an¦ ¦over v ie w¦ ¦of¦ ¦the¦ ¦ex is ting¦ ¦k n ow l ed ge¦ ¦about¦ ¦the¦ ¦se v en¦ ¦hcovs¦ ,▁ ¦with¦ ¦a¦ ¦f oc us¦ ¦on¦ ¦the¦ ¦h ist ory¦ ¦of¦ ¦their¦ ¦disc o ve ry¦ ¦as¦ ¦well¦ ¦as¦ ¦their¦ ¦z o on ot ic¦ ¦orig ins¦ ¦and¦ ¦inter s p ec ies¦ ¦transmission¦ .
𐋇 ¦imp or ta ntly¦ ,▁ ¦we¦ ¦comp are¦ ¦and¦ ¦contr ast¦ ¦the¦ ¦different¦ ¦hcovs¦ ¦from¦ ¦a¦ ¦pers p ective¦ ¦of¦ ¦virus¦ ¦ev ol ution¦ ¦and¦ ¦gen ome¦ ¦reco mb ination¦ .
𐋇¦the¦ ¦current¦ ¦cov¦ ¦disease¦ ¦2019¦ ▁( ¦covid¦ - ¦19¦ )▁ ¦epidemic¦ ¦is¦ ¦disc us sed¦ ¦in¦ ¦this¦ ¦con te xt¦ .
𐋇¦in¦ ¦add ition¦ ,▁ ¦the¦ ¦requir e ments¦ ¦for¦ ¦s uc cess ful¦ ¦host¦ ¦sw it ches¦ ¦and¦ ¦the¦ ¦i mpl ications¦ ¦of¦ ¦virus¦ ¦ev ol ution¦ ¦on¦ ¦disease¦ ¦se ver ity¦ ¦are¦ ¦also¦ ¦high li gh ted¦ .
𐋇 ¦coronaviruses¦ ▁( ¦covs¦ )▁ ¦be lo ng¦ ¦to¦ ¦the¦ ¦family¦ ¦corona vir id a e¦ ,▁ ¦which¦ ¦comp ri ses¦ ¦a¦ ¦group¦ ¦of¦ ¦en v el op ed¦ ,▁ ¦positive¦ - ¦sen sed¦ ,▁ ¦si ng le¦ - ¦stra nded¦ ¦rna¦ ¦viruses¦ .
𐋇¦these¦ ¦viruses¦ ¦h ar bo ur ing¦ ¦the¦ ¦l arg est¦ ¦gen ome¦ ¦of¦ ¦26¦ ¦to¦ ¦3 2¦ ¦k il ob a ses¦ ¦a mo ng s t¦ ¦rna¦ ¦viruses¦ ¦were¦ ¦ter med¦ ▁ “ ¦covs¦ ▁ ” ▁ ¦because¦ ¦of¦ ¦their¦ ¦cr own¦ - ¦like¦ ¦m or ph ology¦ ¦under¦ ¦el ect r on¦ ¦m ic r os c ope¦ .
𐋇 ¦st ru ct ur ally¦ ,▁ ¦covs¦ ¦have¦ ¦non¦ - ¦se g m ented¦ ¦gen omes¦ ¦that¦ ¦share¦ ¦a¦ ¦similar¦ ¦organiz ation¦ .
𐋇 ¦appro xi ma tely¦ ¦two¦ ¦thir ds¦ ¦of¦ ¦the¦ ¦gen ome¦ ¦con tain¦ ¦two¦ ¦large¦ ¦over la pping¦ ¦open¦ ¦rea ding¦ ¦fra m es¦ ▁( ¦or f 1 a¦ ¦and¦ ¦or f 1 b ¦ ),▁ ¦which¦ ¦are¦ ¦trans l ated¦ ¦into¦ ¦the¦ ¦ pp 1 a¦ ¦and¦ ¦ pp 1 ab ¦ ¦re pl ic ase¦ ¦pol y p ro te ins¦ .
𐋇¦the¦ ¦pol y p ro te ins¦ ¦are¦ ¦further¦ ¦proc es sed¦ ¦to¦ ¦gener ate¦ ¦16¦ ¦non¦ - ¦st ru ct ural¦ ¦prote ins¦ ,▁ ¦de si gn ated¦ ¦ ns p 1¦ ▁ ~ ▁ ¦16¦ .
𐋇¦the¦ ¦rem aining¦ ¦p ort ion¦ ¦of¦ ¦the¦ ¦gen ome¦ ¦conta ins¦ ¦or f s¦ ¦for¦ ¦the¦ ¦st ru ct ural¦ ¦prote ins¦ ,▁ ¦including¦ ¦sp i ke¦ ▁( ¦s¦ ),▁ ¦en v el ope¦ ▁( ¦ e¦ ),▁ ¦me mb r an e¦ ▁( ¦ m¦ )▁ ¦and¦ ¦n uc le op ro te in¦ ▁( ¦ n¦ ).
𐋇¦a¦ ¦number¦ ¦of¦ ¦li ne age¦ - ¦specific¦ ¦ac cess ory¦ ¦prote ins¦ ¦are¦ ¦also¦ ¦e nc o ded¦ ¦by¦ ¦different¦ ¦l in ea ges¦ ¦of¦ ¦covs¦ .
𐋇 ¦based¦ ¦on¦ ¦the¦ ¦di ff er ence¦ ¦in¦ ¦protein¦ ¦se qu en ces¦ ,▁ ¦covs¦ ¦are¦ ¦c la ss if ied¦ ¦into¦ ¦four¦ ¦gener a¦ ▁( ¦al ph a¦ - ¦cov¦ ,▁ ¦bet a¦ - ¦cov¦ ,▁ ¦ga mm a¦ - ¦cov¦ ¦and¦ ¦del t a¦ - ¦cov¦ ),▁ ¦among¦ ¦which¦ ¦the¦ ¦bet a¦ - ¦cov¦ ¦gener a¦ ¦conta ins¦ ¦most¦ ¦hcovs¦ ¦and¦ ¦is¦ ¦sub di vi ded¦ ¦into¦ ¦four¦ ¦l in ea ges¦ ▁( ¦a¦ ,▁ ¦b ¦ ,▁ ¦ c¦ ¦and¦ ¦ d¦ ).
𐋇 ¦ph y l ogen et ic¦ ¦evidence¦ ¦has¦ ¦sh own¦ ¦that¦ ¦bats¦ ¦and¦ ¦ro d ents¦ ¦ser ve¦ ¦as¦ ¦the¦ ¦gen e¦ ¦sour ce¦ ¦of¦ ¦most¦ ¦al ph a¦ - ¦covs¦ ¦and¦ ¦bet a¦ - ¦covs¦ ,▁ ¦while¦ ¦b ir ds¦ ¦are¦ ¦the¦ ¦ma in¦ ¦res erv oi r¦ ¦of¦ ¦ga mm a¦ - ¦covs¦ ¦and¦ ¦del t a¦ - ¦covs¦ .
𐋇¦for¦ ¦t ho us an ds¦ ¦of¦ ¦years¦ ,▁ ¦covs¦ ¦have¦ ¦cons ta ntly¦ ¦cr os sed¦ ¦spec ies¦ ¦b ar ri ers¦ ¦and¦ ¦some¦ ¦have¦ ¦e mer ged¦ ¦as¦ ¦important¦ ¦human¦ ¦path og ens¦ .
𐋇¦to¦ ¦date¦ ,▁ ¦se v en¦ ¦human¦ ¦covs¦ ▁( ¦hcovs¦ )▁ ¦are¦ ¦known¦ .
𐋇 ¦among¦ ¦them¦ ¦hcov¦ - ¦22 9 e¦ ¦and¦ ¦hcov¦ - ¦n l 6 3¦ ¦are¦ ¦al ph a¦ - ¦covs¦ .
𐋇¦the¦ ¦other¦ ¦five¦ ¦bet a¦ - ¦covs¦ ¦include¦ ¦hcov¦ - ¦ oc 4 3¦ ,▁ ¦hcov¦ - ¦h k u 1¦ ,▁ ¦severe¦ ¦acute¦ ¦respiratory¦ ¦syndrome¦ ¦coronavirus¦ ▁( ¦sars¦ - ¦cov¦ ),▁ ¦m id d le¦ ¦e ast¦ ¦respiratory¦ ¦syndrome¦ ¦coronavirus¦ ▁( ¦mers¦ - ¦cov¦ )▁ ¦and¦ ¦sars¦ - ¦cov¦ - ¦2¦ .
𐋇 ¦hcov¦ - ¦22 9 e¦ ,▁ ¦hcov¦ - ¦ oc 4 3¦ ,▁ ¦hcov¦ - ¦h k u 1¦ ¦and¦ ¦hcov¦ - ¦n l 6 3¦ ¦us ually¦ ¦cause¦ ¦mild¦ ¦symptoms¦ ,▁ ¦like¦ ¦common¦ ¦cold¦ ¦and¦ ▁/▁ ¦or¦ ¦di arr he a¦ .
𐋇¦in¦ ¦contr ast¦ ,▁ ¦sars¦ - ¦cov¦ ,▁ ¦mers¦ - ¦cov¦ ¦and¦ ¦the¦ ¦new ly¦ - ¦identified¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦are¦ ¦high ly¦ ¦path ogen ic¦ ,▁ ¦ca us ing¦ ¦severe¦ ¦lower¦ ¦respiratory¦ ¦trac t¦ ¦infection¦ ¦in¦ ¦rel at ively¦ ¦more¦ ¦patients¦ ¦with¦ ¦a¦ ¦higher¦ ¦ch ance¦ ¦to¦ ¦develop ¦ ¦acute¦ ¦respiratory¦ ¦di str ess¦ ¦syndrome¦ ▁( ¦ ards¦ )▁ ¦and¦ ¦ext r ap ul m on ary¦ ¦m an if e st ations¦ .
𐋇¦the¦ ¦first¦ ¦hcov¦ - ¦22 9 e¦ ¦stra in¦ ,▁ ¦b 8 1 4¦ ,▁ ¦was¦ ¦isol ated¦ ¦from¦ ¦the¦ ¦n as al¦ ¦dis ch ar ge¦ ¦of¦ ¦patients¦ ¦with¦ ¦common¦ ¦cold¦ ¦in¦ ¦m id¦ - ¦19 6 0 s¦ .
𐋇 ¦since¦ ¦then¦ ,▁ ¦more¦ ¦k n ow l ed ge¦ ¦was¦ ¦acc um ul ated¦ ¦through¦ ¦ex tens ive¦ ¦st u dies¦ ¦on¦ ¦hcov¦ - ¦22 9 e¦ ¦and¦ ¦hcov¦ - ¦ oc 4 3¦ ,▁ ¦both¦ ¦of¦ ¦which¦ ¦cause¦ ¦self¦ - ¦limi ting¦ ¦symptoms¦ .
𐋇 ¦in de ed¦ ,▁ ¦the¦ ¦con cep t¦ ¦had¦ ¦been¦ ¦wid ely¦ ¦ac cep ted¦ ¦that¦ ¦infection¦ ¦with¦ ¦hcovs¦ ¦is¦ ¦gener ally¦ ¦h arm less¦ ¦until¦ ¦the¦ ¦outbreak¦ ¦of¦ ¦sars¦ .
𐋇¦the¦ ¦sars¦ ¦outbreak¦ ¦occur r ed¦ ¦in¦ ¦20 0 3¦ ¦is¦ ¦one¦ ¦of¦ ¦the¦ ¦most¦ ¦de v a st ating¦ ¦in¦ ¦current¦ ¦h ist ory¦ ,▁ ¦inf ecting¦ ¦over¦ ¦8¦ , ¦000¦ ¦people¦ ¦with¦ ¦a¦ ¦c ru de¦ ¦case¦ ¦fat ality¦ ¦of¦ ¦appro xi ma tely¦ ¦10¦ % .
𐋇¦t en¦ ¦years¦ ¦later¦ ,▁ ¦the¦ ¦m id d le¦ ¦e ast¦ ¦respiratory¦ ¦syndrome¦ ▁( ¦mers¦ )▁ ¦outbreak¦ ¦res ul ted¦ ¦in¦ ¦a¦ ¦pers ist ent¦ ¦epidemic¦ ¦in¦ ¦the¦ ¦ar ab i an¦ ¦p en i ns ul a¦ ¦with¦ ¦sp o rad ic¦ ¦sprea ding¦ ¦to¦ ¦the¦ ¦r est¦ ¦of¦ ¦the¦ ¦world¦ .
𐋇¦the¦ ¦2019¦ ¦novel¦ ¦hcov¦ ▁( ¦2019¦ - ¦n cov ¦ ),▁ ¦which¦ ¦has¦ ¦sub se qu e ntly¦ ¦been¦ ¦re na med¦ ¦sars¦ - ¦cov¦ - ¦2¦ ,▁ ¦is¦ ¦the¦ ¦ca us ative¦ ¦ag ent¦ ¦of¦ ¦the¦ ¦o ng o ing¦ ¦epidemic¦ ¦of¦ ¦coronavirus¦ ¦disease¦ ¦2019¦ ▁( ¦covid¦ - ¦19¦ ),▁ ¦which¦ ¦has¦ ¦cl ai med¦ ¦more¦ ¦than¦ ¦3¦ , ¦1 2 0¦ ¦l ives¦ ¦and¦ ¦infected¦ ¦more¦ ¦than¦ ¦9 1¦ , ¦000¦ ¦people¦ ¦as¦ ¦of¦ ¦march¦ ¦3¦ ,▁ ¦2020¦ .
𐋇¦the¦ ¦al ar m¦ ¦has¦ ¦been¦ ¦r in ging¦ ¦and¦ ¦the¦ ¦world¦ ¦has¦ ¦to¦ ¦pre p are¦ ¦for¦ ¦the¦ ¦c om ing¦ ¦pandemic¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ .
𐋇 ¦all¦ ¦se v en¦ ¦hcovs¦ ¦have¦ ¦a¦ ¦z o on ot ic¦ ¦orig in¦ ¦from¦ ¦bats¦ ,▁ ¦m ice¦ ¦or¦ ¦do me st ic¦ ¦anim als¦ .
𐋇 ¦mult ip le¦ ¦l ines¦ ¦of¦ ¦evidence¦ ¦support¦ ¦an¦ ¦ev o lu tion ary¦ ¦orig in¦ ¦of¦ ¦all¦ ¦hcovs¦ ¦from¦ ¦bats¦ ,▁ ¦where¦ ¦viruses¦ ¦are¦ ¦well¦ ¦ad ap ted¦ ¦and¦ ¦non¦ - ¦path ogen ic¦ ¦but¦ ¦sh ow¦ ¦g re at¦ ¦gen et ic¦ ¦di ve rs ity¦ .
𐋇¦the¦ ¦covid¦ - ¦19¦ ¦epidemic¦ ¦has¦ ¦pres ented¦ ¦en or mo us¦ ¦medical¦ ,▁ ¦sc ie nt if ic¦ ,▁ ¦social¦ ¦and¦ ¦m or al¦ ¦cha ll en ges¦ ¦to¦ ¦china¦ ¦and¦ ¦the¦ ¦world¦ .
𐋇 ¦trac ing¦ ¦the¦ ¦z o on ot ic¦ ¦orig ins¦ ¦of¦ ¦hcovs¦ ¦provid es¦ ¦a¦ ¦fra me w or k¦ ¦to¦ ¦under st and¦ ¦the¦ ¦nat ural¦ ¦h ist ory¦ ,▁ ¦d ri ving¦ ¦for ce¦ ¦and¦ ¦re st ri ction¦ ¦fa ctors¦ ¦of¦ ¦spec ies¦ ¦j u mp ing¦ .
𐋇¦this¦ ¦might¦ ¦also¦ ¦gu ide¦ ¦or¦ ¦facil it ate¦ ¦the¦ ¦s ear ch¦ ¦for¦ ¦the¦ ¦res erv oi r¦ ,▁ ¦int erm ediate¦ ¦and¦ ¦a mpl if ying¦ ¦anim al¦ ¦host¦ ▁( ¦s¦ )▁ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ,▁ ¦with¦ ¦important¦ ¦i mpl ications¦ ¦in¦ ¦the¦ ¦pre vention¦ ¦of¦ ¦f ut ure¦ ¦sp i ll ov ers¦ .
𐋇¦in¦ ¦this¦ ¦re v ie w¦ ¦we¦ ¦pres ent¦ ¦an¦ ¦over v ie w¦ ¦of¦ ¦the¦ ¦z o on ot ic¦ ¦orig ins¦ ,▁ ¦inter s p ec ies¦ ¦transmission¦ ¦and¦ ¦path ogen e sis¦ ¦of¦ ¦hcovs¦ .
𐋇 ¦partic ul arly¦ ,▁ ¦we¦ ¦high l ight¦ ¦and¦ ¦disc us s¦ ¦the¦ ¦common¦ ¦the me¦ ¦that¦ ¦pa re ntal¦ ¦viruses¦ ¦of¦ ¦hcovs¦ ¦are¦ ¦typ ically¦ ¦non¦ - ¦path ogen ic¦ ¦in¦ ¦their¦ ¦nat ural¦ ¦res erv oi r¦ ¦ho sts¦ ¦but¦ ¦bec ome¦ ¦path ogen ic¦ ¦after¦ ¦inter s p ec ies¦ ¦transmission¦ ¦to¦ ¦a¦ ¦new¦ ¦host¦ .
𐋇¦we¦ ¦also¦ ¦re v ie w¦ ¦the¦ ¦tr end¦ ¦of¦ ¦hcov¦ ¦ev ol ution¦ ¦in¦ ¦which¦ ¦the¦ ¦increase¦ ¦in¦ ¦transm is si bility¦ ¦often¦ ¦c omes¦ ¦with¦ ¦the¦ ¦dec re ase¦ ¦in¦ ¦path ogen ic ity¦ .
𐋇¦the¦ ¦out c ome¦ ¦of¦ ¦the¦ ¦o ng o ing¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦outbreak¦ ¦is¦ ¦also¦ ¦disc us sed¦ ¦in¦ ¦this¦ ¦con te xt¦ .
𐋇 ¦anim al¦ ¦covs¦ ¦have¦ ¦been¦ ¦known¦ ¦since¦ ¦l ate¦ ¦19 3 0 s¦ .
𐋇 ¦before¦ ¦the¦ ¦first¦ ¦isolation¦ ¦of¦ ¦hcov¦ - ¦22 9 e¦ ¦stra in¦ ¦b 8 1 4¦ ¦from¦ ¦the¦ ¦n as al¦ ¦dis ch ar ge¦ ¦of¦ ¦patients¦ ¦who¦ ¦had¦ ¦contr ac ted¦ ¦common¦ ¦cold¦ ,▁ ¦different¦ ¦covs¦ ¦had¦ ¦been¦ ¦isol ated¦ ¦in¦ ¦v ar ious¦ ¦infected¦ ¦anim als¦ ,▁ ¦including¦ ¦t ur k e y¦ ,▁ ¦mo use¦ ,▁ ¦c ow¦ ,▁ ¦p i g¦ ,▁ ¦c at¦ ¦and¦ ¦do g¦ .
𐋇¦in¦ ¦the¦ ¦p ast¦ ¦dec a des¦ ,▁ ¦se v en¦ ¦hcovs¦ ¦have¦ ¦been¦ ¦identified¦ .
𐋇¦a¦ ¦br ief¦ ¦su mm ary¦ ¦of¦ ¦the¦ ¦h ist ory¦ ¦of¦ ¦hcov¦ ¦disc o ve ry¦ ¦in¦ ¦ch r on ological¦ ¦order¦ ▁( ¦t able¦ ▁ ​ ▁ ¦1¦ )▁ ¦would¦ ¦be¦ ¦inf orm ative¦ ¦and¦ ¦in str uc tive¦ .
𐋇¦the¦ ¦first¦ ¦hcov¦ - ¦22 9 e¦ ¦stra in¦ ¦was¦ ¦isol ated¦ ¦from¦ ¦the¦ ¦respiratory¦ ¦trac t¦ ¦of¦ ¦patients¦ ¦with¦ ¦u pp er¦ ¦respiratory¦ ¦trac t¦ ¦infection¦ ¦in¦ ¦the¦ ¦year¦ ¦of¦ ¦19 6 6¦ ,▁ ¦and¦ ¦was¦ ¦sub se qu e ntly¦ ¦ad ap ted¦ ¦to¦ ¦gr ow¦ ¦in¦ ¦w i¦ - ¦3 8¦ ¦lu ng¦ ¦c ell¦ ¦l ines¦ .
𐋇 ¦patients¦ ¦infected¦ ¦with¦ ¦hcov¦ - ¦22 9 e¦ ¦pres ented¦ ¦with¦ ¦common¦ ¦cold¦ ¦symptoms¦ ,▁ ¦including¦ ¦h ea d a ch e¦ ,▁ ¦sneezing¦ ,▁ ¦ma la ise¦ ¦and¦ ¦s ore¦ - ¦th ro at¦ ,▁ ¦with¦ ¦fever¦ ¦and¦ ¦cough¦ ¦se en¦ ¦in¦ ¦10¦ ▁ ~ ▁ ¦20¦ %▁ ¦cases¦ .
𐋇 ¦later¦ ¦in¦ ¦19 6 7¦ ,▁ ¦hcov¦ - ¦ oc 4 3¦ ¦was¦ ¦isol ated¦ ¦from¦ ¦or g an¦ ¦c ult ure¦ ¦and¦ ¦sub se qu ent¦ ¦ser ial¦ ¦pa ss age¦ ¦in¦ ¦b ra ins¦ ¦of¦ ¦s uc k l ing¦ ¦m ice¦ .
𐋇¦the¦ ¦clinical¦ ¦fe at ures¦ ¦of¦ ¦hcov¦ - ¦ oc 4 3¦ ¦infection¦ ¦app ear¦ ¦to¦ ¦be¦ ¦similar¦ ¦to¦ ¦those¦ ¦caused¦ ¦by¦ ¦hcov¦ - ¦22 9 e¦ ,▁ ¦which¦ ¦are¦ ¦s y m pt om at ically¦ ¦ind is ti ng u is h able¦ ¦from¦ ¦infection¦ ¦with¦ ¦other¦ ¦respiratory¦ ¦trac t¦ ¦path og ens¦ ¦such¦ ¦as¦ ¦influenza¦ ¦a¦ ¦viruses¦ ¦and¦ ¦r hi no vi ru ses¦ .
𐋇 ¦both¦ ¦hcov¦ - ¦22 9 e¦ ¦and¦ ¦hcov¦ - ¦ oc 4 3¦ ¦are¦ ¦d ist rib u ted¦ ¦gl ob ally¦ ,▁ ¦and¦ ¦they¦ ¦t end¦ ¦to¦ ¦be¦ ¦pr ed o mi na ntly¦ ¦transm it ted¦ ¦during¦ ¦the¦ ¦se as on¦ ¦of¦ ¦w in ter¦ ¦in¦ ¦temp er ate¦ ¦cl im ate¦ .
𐋇 ¦gener ally¦ ,▁ ¦the¦ ¦inc ub ation¦ ¦time¦ ¦of¦ ¦these¦ ¦two¦ ¦viruses¦ ¦is¦ ¦less¦ ¦than¦ ¦one¦ ¦week¦ ,▁ ¦fo ll owed¦ ¦by¦ ¦an¦ ¦appro xi ma tely¦ ¦2¦ - ¦week¦ ¦illness¦ .
𐋇 ¦according¦ ¦to¦ ¦a¦ ¦human¦ ¦v ol un te er¦ ¦study¦ ,▁ ¦healthy¦ ¦individuals¦ ¦infected¦ ¦with¦ ¦hcov¦ - ¦22 9 e¦ ¦developed¦ ¦mild¦ ¦common¦ ¦cold¦ .
𐋇 ¦only¦ ¦a¦ ¦fe w¦ ¦immun oc o mp ro mi sed¦ ¦patients¦ ¦ex hi b i ted¦ ¦severe¦ ¦lower¦ ¦respiratory¦ ¦trac t¦ ¦infection¦ .
𐋇 ¦sars¦ ,▁ ¦also¦ ¦known¦ ¦as¦ ▁ “ ¦ at y p ical¦ ¦pneumonia¦ ▁ ” ,▁ ¦was¦ ¦the¦ ¦first¦ ¦well¦ ¦d oc um ented¦ ¦hcov¦ - ¦caused¦ ¦pandemic¦ ¦in¦ ¦human¦ ¦h ist ory¦ ¦and¦ ¦the¦ ¦e ti ological¦ ¦ag ent¦ ¦is¦ ¦sars¦ - ¦cov¦ ,▁ ¦the¦ ¦thir d¦ ¦hcov¦ ¦dis covered¦ .
𐋇¦the¦ ¦first¦ ¦case¦ ¦of¦ ¦sars¦ ¦can¦ ¦be¦ ¦trac ed¦ ¦b ack¦ ¦to¦ ¦l ate¦ ¦20 0 2¦ ¦in¦ ¦gu a ng d o ng¦ ¦pro vi nce¦ ¦of¦ ¦china¦ .
𐋇¦the¦ ¦sars¦ ¦epidemic¦ ¦res ul ted¦ ¦in¦ ¦8¦ , ¦0 9 6¦ ¦reported¦ ¦cases¦ ¦with¦ ¦7 7 4¦ ¦deaths¦ ,▁ ¦sprea ding¦ ¦across¦ ¦many¦ ¦countries¦ ¦and¦ ¦contin ents¦ .
𐋇 ¦a par t¦ ¦from¦ ¦the¦ ¦su p er¦ - ¦sprea d ers¦ ,▁ ¦it¦ ¦was¦ ¦estim ated¦ ¦that¦ ¦each¦ ¦case¦ ¦could¦ ¦give¦ ¦r ise¦ ¦to¦ ¦appro xi ma tely¦ ¦two¦ ¦sec ond ary¦ ¦cases¦ ,▁ ¦with¦ ¦an¦ ¦inc ub ation¦ ¦period¦ ¦of¦ ¦4¦ ¦to¦ ¦7¦ ¦days¦ ¦and¦ ¦the¦ ¦p ea k¦ ¦of¦ ¦viral¦ ¦lo ad¦ ¦app earing¦ ¦on¦ ¦the¦ ¦1 0 th¦ ¦day¦ ¦of¦ ¦illness¦ .
𐋇 ¦patients¦ ¦infected¦ ¦with¦ ¦sars¦ - ¦cov¦ ¦in it ially¦ ¦pres ent¦ ¦with¦ ¦m y al g ia¦ ,▁ ¦h ea d a ch e¦ ,▁ ¦fever¦ ,▁ ¦ma la ise¦ ¦and¦ ¦c hi lls¦ ,▁ ¦fo ll owed¦ ¦by¦ ¦d ys p ne a¦ ,▁ ¦cough¦ ¦and¦ ¦respiratory¦ ¦di str ess¦ ¦as¦ ¦l ate¦ ¦symptoms¦ .
𐋇¦l y m ph op en ia¦ ,▁ ¦d er an ged¦ ¦li ver¦ ¦f un ction¦ ¦tests¦ ,▁ ¦and¦ ¦e le v ated¦ ¦cre at ine¦ ¦k in ase¦ ¦are¦ ¦common¦ ¦laboratory¦ ¦ab n orm al ities¦ ¦of¦ ¦sars¦ .
𐋇 ¦di ff use¦ ¦al ve o la r¦ ¦da m age¦ ,▁ ¦e p i th el ial¦ ¦c ell¦ ¦pr ol if er ation¦ ¦and¦ ¦an¦ ¦increase¦ ¦of¦ ¦m ac ro ph a ges¦ ¦are¦ ¦also¦ ¦ob s erv ed¦ ¦in¦ ¦sars¦ ¦patients¦ .
𐋇 ¦appro xi ma tely¦ ¦20¦ - ¦30¦ %▁ ¦of¦ ¦patients¦ ¦sub se qu e ntly¦ ¦requir e¦ ¦in tens ive¦ ¦care¦ ¦and¦ ¦me ch an ical¦ ¦ ventil ation¦ .
𐋇¦in¦ ¦add ition¦ ¦to¦ ¦lower¦ ¦respiratory¦ ¦trac t¦ ,▁ ¦mult ip le¦ ¦or g ans¦ ¦including¦ ¦ga st ro in te st in al¦ ¦trac t¦ ,▁ ¦li ver¦ ¦and¦ ¦k id ne y¦ ¦can¦ ¦also¦ ¦be¦ ¦infected¦ ¦in¦ ¦these¦ ¦severe¦ ¦cases¦ ,▁ ¦us ually¦ ¦acc o mp an ied¦ ¦with¦ ¦a¦ ¦c y t o k ine¦ ¦st or m¦ ,▁ ¦which¦ ¦might¦ ¦be¦ ¦le th al¦ ¦partic ul arly¦ ¦in¦ ¦immun oc o mp ro mi sed¦ ¦patients¦ .
𐋇¦the¦ ¦virus¦ ¦was¦ ¦first¦ ¦isol ated¦ ¦from¦ ¦the¦ ¦open¦ ¦lu ng¦ ¦bi op s y¦ ¦of¦ ¦a¦ ¦rel ative¦ ¦of¦ ¦the¦ ¦in de x¦ ¦pa ti ent¦ ¦who¦ ¦tra ve lled¦ ¦to¦ ¦ho ng¦ ¦ko ng¦ ¦from¦ ¦gu a ng z ho u¦ .
𐋇 ¦since¦ ¦then¦ ,▁ ¦tre m end o us¦ ¦eff orts¦ ¦have¦ ¦been¦ ¦d ed ic ated¦ ¦to¦ ¦hcov¦ ¦research¦ .
𐋇 ¦hcov¦ - ¦n l 6 3¦ ¦was¦ ¦isol ated¦ ¦from¦ ¦a¦ ¦7¦ - ¦mon th¦ - ¦o ld¦ ¦child¦ ¦from¦ ¦the¦ ¦ne ther l an ds¦ ¦during¦ ¦l ate¦ ¦20 0 4¦ .
𐋇¦it¦ ¦was¦ ¦in it ially¦ ¦found¦ ¦to¦ ¦be¦ ¦prev al ent¦ ¦in¦ ¦y ou ng¦ ¦children¦ ,▁ ¦the¦ ¦el d erly¦ ¦and¦ ¦immun oc o mp ro mi sed¦ ¦patients¦ ¦with¦ ¦respiratory¦ ¦i ll n es ses¦ .
𐋇 ¦pre se nt ation¦ ¦of¦ ¦cor y z a¦ ,▁ ¦con j un ct iv itis¦ ,▁ ¦fever¦ ,▁ ¦and¦ ¦b ro nc hi ol itis¦ ¦is¦ ¦common¦ ¦in¦ ¦the¦ ¦disease¦ ¦caused¦ ¦by¦ ¦hcov¦ - ¦n l 6 3¦ .
𐋇 ¦another¦ ¦in de p end ent¦ ¦study¦ ¦d esc rib ed¦ ¦the¦ ¦isolation¦ ¦of¦ ¦the¦ ¦same¦ ¦virus¦ ¦from¦ ¦a¦ ¦n as al¦ ¦spec im en¦ ¦from¦ ¦an¦ ¦8¦ - ¦mon th¦ - ¦o ld¦ ¦ bo y¦ ¦su ff ering¦ ¦from¦ ¦pneumonia¦ ¦in¦ ¦the¦ ¦ne ther l an ds¦ .
𐋇 ¦al th ough¦ ¦it¦ ¦was¦ ¦identified¦ ¦in¦ ¦ne ther l an ds¦ ,▁ ¦it¦ ¦is¦ ¦a ct ually¦ ¦d ist rib u ted¦ ¦gl ob ally¦ .
𐋇¦it¦ ¦has¦ ¦been¦ ¦estim ated¦ ¦that¦ ¦hcov¦ - ¦n l 6 3¦ ¦acc ou nts¦ ¦for¦ ¦appro xi ma tely¦ ¦4¦ . ¦7¦ %▁ ¦of¦ ¦common¦ ¦respiratory¦ ¦diseases¦ ,▁ ¦and¦ ¦its¦ ¦p ea k¦ ¦inc idence¦ ¦occur s¦ ¦during¦ ¦early¦ ¦su mm er¦ ,▁ ¦sp r ing¦ ¦and¦ ¦w in ter¦ .
𐋇 ¦hcov¦ - ¦n l 6 3¦ ¦is¦ ¦associated¦ ¦with¦ ¦ob str uc tive¦ ¦l ar y ng itis¦ ,▁ ¦also¦ ¦known¦ ¦as¦ ¦cr ou p¦ .
𐋇¦in¦ ¦the¦ ¦same¦ ¦year¦ ,▁ ¦hcov¦ - ¦h k u 1¦ ¦was¦ ¦isol ated¦ ¦from¦ ¦a¦ ¦7 1¦ - ¦year¦ - ¦o ld¦ ¦m an¦ ¦who¦ ¦had¦ ¦been¦ ¦hosp i tali zed¦ ¦with¦ ¦pneumonia¦ ¦and¦ ¦b ro nc hi ol itis¦ ¦in¦ ¦ho ng¦ ¦ko ng¦ .
𐋇 ¦be si des¦ ¦community¦ - ¦ac qu ir ed¦ ¦pneumonia¦ ¦and¦ ¦b ro nc hi ol itis¦ ,▁ ¦hcov¦ - ¦h k u 1¦ ¦was¦ ¦reported¦ ¦to¦ ¦be¦ ¦associated¦ ¦with¦ ¦acute¦ ¦as th m at ic¦ ¦ex ac er b ation¦ .
𐋇 ¦similar¦ ¦to¦ ¦hcov¦ - ¦n l 6 3¦ ,▁ ¦hcov¦ - ¦22 9 e¦ ¦and¦ ¦hcov¦ - ¦ oc 4 3¦ ,▁ ¦hcov¦ - ¦h k u 1¦ ¦was¦ ¦found¦ ¦worldwide¦ ,▁ ¦ca us ing¦ ¦mild¦ ¦respiratory¦ ¦diseases¦ .
𐋇 ¦all¦ ¦these¦ ¦four¦ ¦community¦ - ¦ac qu ir ed¦ ¦hcovs¦ ¦have¦ ¦been¦ ¦well¦ ¦ad ap ted¦ ¦to¦ ¦humans¦ ¦and¦ ¦are¦ ¦gener ally¦ ¦less¦ ¦likely¦ ¦to¦ ¦m ut ate¦ ¦to¦ ¦cause¦ ¦high ly¦ ¦path ogen ic¦ ¦diseases¦ ,▁ ¦th ough¦ ¦acc id ents¦ ¦d id¦ ¦occur ¦ ¦for¦ ¦un k n own¦ ¦re as ons¦ ¦as¦ ¦in¦ ¦the¦ ¦r are¦ ¦case¦ ¦of¦ ¦a¦ ¦more¦ ¦vir ul ent¦ ¦sub t y p e¦ ¦of¦ ¦hcov¦ - ¦n l 6 3¦ ,▁ ¦which¦ ¦has¦ ¦rece ntly¦ ¦been¦ ¦reported¦ ¦to¦ ¦cause¦ ¦severe¦ ¦lower¦ ¦respiratory¦ ¦trac t¦ ¦infection¦ ¦in¦ ¦china¦ .
𐋇 ¦gener ally¦ ,▁ ¦when¦ ¦these¦ ¦hcovs¦ ¦ac qu ir e¦ ¦the¦ ¦ab il ities¦ ¦to¦ ¦trans mi t¦ ¦eff ic ie ntly¦ ¦and¦ ¦to¦ ¦main tain¦ ¦the m s el ves¦ ¦contin u o us ly¦ ¦within¦ ¦humans¦ ,▁ ¦they¦ ¦also¦ ¦bec ome¦ ¦less¦ ¦vir ul ent¦ ¦or¦ ¦path ogen ic¦ .
𐋇 ¦mers¦ - ¦cov¦ ¦was¦ ¦first¦ ¦isol ated¦ ¦in¦ ¦20 1 2¦ ¦from¦ ¦the¦ ¦lu ng¦ ¦of¦ ¦a¦ ¦6 0¦ - ¦year¦ - ¦o ld¦ ¦pa ti ent¦ ¦who¦ ¦developed¦ ¦acute¦ ¦pneumonia¦ ¦and¦ ¦r en al¦ ¦fa il ure¦ ¦in¦ ¦sa ud i¦ ¦ar ab ia¦ .
𐋇¦w he rea s¦ ¦most¦ ¦of¦ ¦the¦ ¦laboratory¦ - ¦confirmed¦ ¦cases¦ ¦orig in ate¦ ¦from¦ ¦the¦ ¦m id d le¦ ¦e ast¦ ,▁ ¦imp or ted¦ ¦cases¦ ¦with¦ ¦occ a si on al¦ ¦sec ond ary¦ ¦sprea ds¦ ¦to¦ ¦close¦ ¦contac ts¦ ¦have¦ ¦been¦ ¦reported¦ ¦in¦ ¦v ar ious¦ ¦european¦ ¦countries¦ ¦and¦ ¦t un is ia¦ .
𐋇 ¦another¦ ¦sec ond ary¦ ¦outbreak¦ ¦occur r ed¦ ¦in¦ ¦south¦ ¦ko rea¦ ¦in¦ ¦20 1 5¦ ¦with¦ ¦1 8 6¦ ¦confirmed¦ ¦cases¦ .
𐋇 ¦clinical¦ ¦m an if e st ations¦ ¦of¦ ¦mers¦ ¦re se m ble¦ ¦those¦ ¦of¦ ¦sars¦ ,▁ ¦ch ara ct eri zed¦ ¦by¦ ¦pr og re ss ive¦ ¦acute¦ ¦pneumonia¦ .
𐋇 ¦un li ke¦ ¦sars¦ ,▁ ¦many¦ ¦patients¦ ¦with¦ ¦mers¦ ¦also¦ ¦developed¦ ¦acute¦ ¦r en al¦ ¦fa il ure¦ ,▁ ¦which¦ ¦is¦ ¦th us¦ ¦fa r¦ ¦uni q ue¦ ¦for¦ ¦mers¦ ¦among¦ ¦hcov¦ - ¦caused¦ ¦diseases¦ .
𐋇 ¦more¦ ¦than¦ ¦30¦ %▁ ¦of¦ ¦patients¦ ¦pres ent¦ ¦with¦ ¦ga st ro in te st in al¦ ¦symptoms¦ ,▁ ¦such¦ ¦as¦ ¦di arr he a¦ ¦and¦ ¦v o mi ting¦ .
𐋇¦as¦ ¦of¦ ¦february¦ ¦14¦ ,▁ ¦2020¦ ,▁ ¦over¦ ¦2 5 00¦ ¦laboratory¦ ¦confirmed¦ ¦cases¦ ¦were¦ ¦reported¦ ¦with¦ ¦a¦ ¦high¦ ¦case¦ ¦fat ality¦ ¦of¦ ¦3 4¦ . ¦4¦ % ,▁ ¦ma king¦ ¦mers¦ - ¦cov¦ ¦one¦ ¦of¦ ¦the¦ ¦most¦ ¦de v a st ating¦ ¦viruses¦ ¦known¦ ¦to¦ ¦humans¦ .
𐋇 ¦during¦ ¦m id d le¦ ¦to¦ ¦l ate¦ ¦december¦ ¦2019¦ ,▁ ¦c lu st ers¦ ¦of¦ ¦pneumonia¦ ¦patients¦ ¦r et r os p ect ively¦ ¦known¦ ¦to¦ ¦be¦ ¦associated¦ ¦with¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦infection¦ ¦were¦ ¦detected¦ ¦in¦ ¦wuhan¦ ,▁ ¦hub e i¦ ¦pro vi nce¦ ,▁ ¦china¦ .
𐋇 ¦world¦ ¦health¦ ¦organiz ation¦ ¦decl ared¦ ¦the¦ ¦o ng o ing¦ ¦outbreak¦ ¦of¦ ¦lower¦ ¦respiratory¦ ¦trac t¦ ¦infection¦ ¦caused¦ ¦by¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦a¦ ¦public¦ ¦health¦ ¦emergency¦ ¦of¦ ¦international¦ ¦concer n¦ ¦and¦ ¦also¦ ¦na med¦ ¦the¦ ¦disease¦ ¦covid¦ - ¦19¦ .
𐋇¦as¦ ¦of¦ ¦march¦ ¦3¦ ,▁ ¦2020¦ ,▁ ¦9 0¦ , ¦0 5 3¦ ¦cases¦ ¦have¦ ¦been¦ ¦confirmed¦ ¦worldwide¦ ,▁ ¦with¦ ¦a¦ ¦c ru de¦ ¦case¦ ¦fat ality¦ ¦of¦ ¦3¦ . ¦4¦ % .
𐋇¦n ot ab ly¦ ,▁ ¦the¦ ¦case¦ ¦fat ality¦ ¦in¦ ¦hub e i¦ ,▁ ¦china¦ ¦is¦ ¦4¦ . ¦2¦ % ,▁ ¦w he rea s¦ ¦the¦ ¦one¦ ¦outside¦ ¦of¦ ¦it¦ ¦is¦ ¦1¦ . ¦2¦ % .
𐋇 ¦sars¦ - ¦cov¦ - ¦2¦ ¦ca u ses¦ ¦severe¦ ¦respiratory¦ ¦infection¦ ¦like¦ ¦sars¦ - ¦cov¦ ¦and¦ ¦mers¦ - ¦cov¦ ,▁ ¦pres ented¦ ¦as¦ ¦fever¦ ,▁ ¦cough¦ ¦and¦ ¦d ys p ne a¦ .
𐋇 ¦di arr he a¦ ¦is¦ ¦also¦ ¦se en¦ ¦in¦ ¦some¦ ¦patients¦ .
𐋇 ¦pneumonia¦ ¦is¦ ¦one¦ ¦of¦ ¦the¦ ¦most¦ ¦severe¦ ¦symptoms¦ ¦and¦ ¦can¦ ¦pr og r ess¦ ¦rap id ly¦ ¦to¦ ¦acute¦ ¦respiratory¦ ¦di str ess¦ ¦syndrome¦ .
𐋇 ¦al th ough¦ ¦sars¦ - ¦cov¦ ¦and¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦are¦ ¦very¦ ¦similar¦ ¦due¦ ¦to¦ ¦high¦ ¦n uc le ot ide¦ ¦se qu ence¦ ¦h om ology¦ ¦of¦ ¦8 2¦ % ,▁ ¦they¦ ¦cl us ter¦ ¦into¦ ¦different¦ ¦br an ches¦ ¦in¦ ¦the¦ ¦ph y l ogen et ic¦ ¦tre e¦ .
𐋇 ¦sars¦ - ¦cov¦ - ¦2¦ ¦is¦ ¦app a re ntly¦ ¦less¦ ¦path ogen ic¦ ¦but¦ ¦more¦ ¦transm is si ble¦ ¦comp ared¦ ¦to¦ ¦sars¦ - ¦cov¦ ¦and¦ ¦mers¦ - ¦cov¦ .
𐋇 ¦as ymptomatic¦ ¦sub j ects¦ ¦infected¦ ¦with¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦have¦ ¦been¦ ¦reported¦ ¦and¦ ¦might¦ ¦cont rib ute¦ ¦to¦ ¦its¦ ¦rap id¦ ¦sprea ding¦ ¦around¦ ¦the¦ ¦world¦ .
𐋇¦c om par ing¦ ¦and¦ ¦contr as ting¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦with¦ ¦the¦ ¦other¦ ¦si x¦ ¦hcovs¦ ¦re ve al¦ ¦s im il ar ities¦ ¦and¦ ¦di ff er en ces¦ ¦of¦ ¦g re at¦ ¦inter est¦ .
𐋇 ¦first¦ ,▁ ¦the¦ ¦inc ub ation¦ ¦period¦ ¦and¦ ¦the¦ ¦d ur ation¦ ¦of¦ ¦the¦ ¦co ur se¦ ¦of¦ ¦hcov¦ ¦disease¦ ¦are¦ ¦very¦ ¦similar¦ .
𐋇¦in¦ ¦this¦ ¦reg ard¦ ,▁ ¦sars¦ - ¦cov¦ - ¦2¦ ¦fo ll ow s¦ ¦the¦ ¦general¦ ¦tr end¦ ¦of¦ ¦the¦ ¦other¦ ¦si x¦ ¦hcovs¦ .
𐋇 ¦second¦ ,▁ ¦the¦ ¦se ver ity¦ ¦of¦ ¦symptoms¦ ¦of¦ ¦covid¦ - ¦19¦ ¦l ies¦ ¦between¦ ¦sars¦ - ¦cov¦ ¦and¦ ¦the¦ ¦four¦ ¦community¦ - ¦ac qu ir ed¦ ¦hcovs¦ ▁( ¦i¦ . ¦ e¦ .▁ ¦hcov¦ - ¦22 9 e¦ ,▁ ¦hcov¦ - ¦ oc 4 3¦ ,▁ ¦hcov¦ - ¦h k u 1¦ ¦and¦ ¦hcov¦ - ¦n l 6 3¦ ).
𐋇¦on¦ ¦one¦ ¦hand¦ ,▁ ¦sars¦ - ¦cov¦ - ¦2¦ ¦infection¦ ¦ex hi b i ts¦ ¦fe at ures¦ ¦that¦ ¦are¦ ¦more¦ ¦comm on ly¦ ¦se en¦ ¦during¦ ¦infection¦ ¦with¦ ¦community¦ - ¦ac qu ir ed¦ ¦hcovs¦ ,▁ ¦including¦ ¦the¦ ¦pre se nt ation¦ ¦of¦ ¦non¦ - ¦specific¦ ,▁ ¦mild¦ ¦or¦ ¦even¦ ¦no¦ ¦symptoms¦ .
𐋇¦on¦ ¦the¦ ¦other¦ ¦hand¦ ,▁ ¦a¦ ¦sm all¦ ¦sub s et¦ ¦of¦ ¦severe¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦can¦ ¦also¦ ¦be¦ ¦se en¦ ¦as¦ ¦in¦ ¦the¦ ¦case¦ ¦of¦ ¦sars¦ - ¦cov¦ ¦infection¦ ,▁ ¦al th ough¦ ¦the¦ ¦ra ti o¦ ¦is¦ ¦a¦ ¦bi t¦ ¦lower¦ .
𐋇 ¦thir d¦ ,▁ ¦the¦ ¦transmission¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦also¦ ¦sh ow s¦ ¦inter es ting¦ ¦p at t er ns¦ ¦ch ara ct er ist ic¦ ¦of¦ ¦both¦ ¦community¦ - ¦ac qu ir ed¦ ¦hcovs¦ ¦and¦ ¦sars¦ - ¦cov¦ .
𐋇¦on¦ ¦one¦ ¦hand¦ ,▁ ¦the¦ ¦transm is si bility¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦is¦ ¦at¦ ¦least¦ ¦as¦ ¦high¦ ¦as¦ ¦that¦ ¦of¦ ¦community¦ - ¦ac qu ir ed¦ ¦hcovs¦ .
𐋇¦on¦ ¦the¦ ¦other¦ ¦hand¦ ,▁ ¦it¦ ¦rema ins¦ ¦to¦ ¦be¦ ¦ ver if ied¦ ¦wh ether¦ ¦the¦ ¦transm is si bility¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦dec rea ses¦ ¦after¦ ¦pa ss a ges¦ ¦in¦ ¦humans¦ ¦as¦ ¦in¦ ¦the¦ ¦cases¦ ¦of¦ ¦sars¦ - ¦cov¦ ¦and¦ ¦mers¦ - ¦cov¦ .
𐋇¦f in ally¦ ,▁ ¦same¦ ¦as¦ ¦the¦ ¦other¦ ¦hcovs¦ ,▁ ¦sars¦ - ¦cov¦ - ¦2¦ ¦can¦ ¦be¦ ¦detected¦ ¦in¦ ¦f ec al¦ ¦samples¦ .
𐋇 ¦wh ether¦ ¦f ec al¦ - ¦or al¦ ¦transmission¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦pl ays¦ ¦an¦ ¦important¦ ¦ro le¦ ¦as¦ ¦in¦ ¦the¦ ¦case¦ ¦of¦ ¦sars¦ - ¦cov¦ ¦at¦ ¦least¦ ¦under¦ ¦some¦ ¦c ir c um st ance¦ ¦rema ins¦ ¦to¦ ¦be¦ ¦cl ar if ied¦ ¦by¦ ¦f ut ure¦ ¦st u dies¦ .
𐋇¦it¦ ¦is¦ ¦also¦ ¦of¦ ¦partic ul arly¦ ¦g re at¦ ¦inter est¦ ¦to¦ ¦se e¦ ¦wh ether¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦might¦ ¦ex hi b i t¦ ¦se as on ality¦ ¦as¦ ¦in¦ ¦the¦ ¦cases¦ ¦of¦ ¦community¦ - ¦ac qu ir ed¦ ¦hcovs¦ .
𐋇 ¦ne ve rt he less¦ ,▁ ¦the¦ ¦fe at ures¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦including¦ ¦its¦ ¦transm is si bility¦ ,▁ ¦path ogen ic ity¦ ¦and¦ ¦s us ta in able¦ ¦sprea ding¦ ¦after¦ ¦pa ss a ges¦ ¦in¦ ¦humans¦ ¦will¦ ¦be¦ ¦influ e ntial¦ ¦on¦ ¦the¦ ¦ ult im ate¦ ¦f ate¦ ¦of¦ ¦the¦ ¦o ng o ing¦ ¦outbreak¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇 ¦all¦ ¦four¦ ¦community¦ - ¦ac qu ir ed¦ ¦hcovs¦ ¦ca us ing¦ ¦mild¦ ¦symptoms¦ ¦have¦ ¦been¦ ¦well¦ ¦ad ap ted¦ ¦to¦ ¦humans¦ .
𐋇 ¦from¦ ¦another¦ ¦pers p ective¦ ,▁ ¦it¦ ¦might¦ ¦also¦ ¦be¦ ¦tr ue¦ ¦that¦ ¦humans¦ ¦have¦ ¦been¦ ¦well¦ ¦ad ap ted¦ ¦to¦ ¦these¦ ¦four¦ ¦hcovs¦ .
𐋇¦in¦ ¦other¦ ¦wor ds¦ ,▁ ¦both¦ ¦could¦ ¦be¦ ¦the¦ ¦sur v iv ors¦ ¦of¦ ¦a nc i ent¦ ¦hcov¦ ¦p an de m ics¦ .
𐋇 ¦hcovs¦ ¦that¦ ¦cause¦ ¦severe¦ ¦diseases¦ ¦in¦ ¦humans¦ ¦and¦ ¦humans¦ ¦who¦ ¦developed¦ ¦severe¦ ¦hcov¦ ¦diseases¦ ¦have¦ ¦been¦ ¦e li min ated¦ .
𐋇¦for¦ ¦this¦ ¦to¦ ¦happ en¦ ,▁ ¦hcovs¦ ¦have¦ ¦to¦ ¦re pl ic ate¦ ¦in¦ ¦humans¦ ¦to¦ ¦su ff ici ent¦ ¦ext ent¦ ¦to¦ ¦all ow¦ ¦the¦ ¦acc um ul ation¦ ¦of¦ ¦ad ap tive¦ ¦m ut ations¦ ¦that¦ ¦cou nt er ac t¦ ¦host¦ ¦re st ri ction¦ ¦fa ctors¦ .
𐋇¦in¦ ¦this¦ ¦sen se¦ ,▁ ¦the¦ ¦lo nger¦ ¦the¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦outbreak¦ ¦per si sts¦ ¦and¦ ¦the¦ ¦more¦ ¦people¦ ¦that¦ ¦it¦ ¦inf ects¦ ,▁ ¦the¦ ¦g rea ter¦ ¦ch ance¦ ¦that¦ ¦it¦ ¦will¦ ¦f ul ly¦ ¦ad ap t¦ ¦to¦ ¦humans¦ .
𐋇¦if¦ ¦it¦ ¦ad ap ts¦ ¦well¦ ,▁ ¦its¦ ¦transmission¦ ¦in¦ ¦humans¦ ¦would¦ ¦be¦ ¦diffic ul t¦ ¦to¦ ¦sto p¦ ¦by¦ ¦quarantine¦ ¦or¦ ¦other¦ ¦infection¦ ¦control¦ ¦measures¦ .
𐋇¦for¦ ¦many¦ ¦years¦ ,▁ ¦the¦ ¦four¦ ¦community¦ - ¦ac qu ir ed¦ ¦covs¦ ¦c ir c ul ate¦ ¦in¦ ¦human¦ ¦p op ul ations¦ ,▁ ¦t ri gg ering¦ ¦common¦ ¦cold¦ ¦in¦ ¦immun oc o mp et ent¦ ¦sub j ects¦ .
𐋇¦these¦ ¦viruses¦ ¦do¦ ¦not¦ ¦need¦ ¦an¦ ¦anim al¦ ¦res erv oi r¦ .
𐋇¦in¦ ¦contr ast¦ ,▁ ¦high ly¦ ¦path ogen ic¦ ¦sars¦ - ¦cov¦ ¦and¦ ¦mers¦ - ¦cov¦ ¦have¦ ¦not¦ ¦ad ap ted¦ ¦to¦ ¦humans¦ ¦well¦ ¦and¦ ¦their¦ ¦transmission¦ ¦within¦ ¦humans¦ ¦cannot¦ ¦be¦ ¦s us ta ined¦ .
𐋇¦they¦ ¦need¦ ¦to¦ ¦main tain¦ ¦and¦ ¦pro pa g ate¦ ¦in¦ ¦their¦ ¦z o on ot ic¦ ¦res erv o ir s¦ ¦and¦ ¦s ee k¦ ¦the¦ ¦ch ance¦ ¦to¦ ¦sp il lo ver¦ ¦to¦ ¦s us cep ti ble¦ ¦human¦ ¦t arg ets¦ ,▁ ¦p os si b ly¦ ¦v ia¦ ¦one¦ ¦or¦ ¦more¦ ¦int erm ediate¦ ¦and¦ ¦a mpl if ying¦ ¦ho sts¦ .
𐋇 ¦sars¦ - ¦cov¦ - ¦2¦ ¦has¦ ¦fe at ures¦ ¦that¦ ¦are¦ ¦similar¦ ¦to¦ ¦both¦ ¦sars¦ - ¦cov¦ ▁/▁ ¦mers¦ - ¦cov¦ ¦and¦ ¦the¦ ¦four¦ ¦community¦ - ¦ac qu ir ed¦ ¦hcovs¦ .
𐋇¦it¦ ¦is¦ ¦high ly¦ ¦transm is si ble¦ ¦like¦ ¦community¦ - ¦ac qu ir ed¦ ¦hcovs¦ ,▁ ¦at¦ ¦least¦ ¦for¦ ¦the¦ ¦time¦ ¦being¦ .
𐋇¦however¦ ,▁ ¦it¦ ¦is¦ ¦more¦ ¦path ogen ic¦ ¦than¦ ¦community¦ - ¦ac qu ir ed¦ ¦hcovs¦ ¦and¦ ¦less¦ ¦path ogen ic¦ ¦than¦ ¦sars¦ - ¦cov¦ ¦or¦ ¦mers¦ - ¦cov¦ .
𐋇¦it¦ ¦rema ins¦ ¦to¦ ¦be¦ ¦se en¦ ¦wh ether¦ ¦it¦ ¦will¦ ¦ad ap t¦ ¦f ul ly¦ ¦to¦ ¦humans¦ ¦and¦ ¦c ir c ul ate¦ ¦within¦ ¦humans¦ ¦without¦ ¦a¦ ¦res erv oi r¦ ¦or¦ ¦int erm ediate¦ ¦anim al¦ ¦host¦ .
𐋇 ¦before¦ ¦disc u ss ing¦ ¦the¦ ¦anim al¦ ¦orig ins¦ ¦of¦ ¦hcovs¦ ,▁ ¦it¦ ¦will¦ ¦ser ve¦ ¦us¦ ¦well¦ ¦to¦ ¦disc us s¦ ¦the¦ ¦def in i tions¦ ¦and¦ ¦ch ara ct er ist ics¦ ¦of¦ ¦ev o lu tion ary¦ ,▁ ¦nat ural¦ ,▁ ¦res erv oi r¦ ,▁ ¦int erm ediate¦ ¦and¦ ¦a mpl if ying¦ ¦ho sts¦ ¦of¦ ¦hcovs¦ .
𐋇 ¦an¦ ¦anim al¦ ¦ser ves¦ ¦as¦ ¦the¦ ¦ev o lu tion ary¦ ¦host¦ ¦of¦ ¦an¦ ¦hcov¦ ¦if¦ ¦it¦ ¦h ar bo ur s¦ ¦a¦ ¦clos ely¦ ¦related¦ ¦an ce st or¦ ¦sh ar ing¦ ¦high¦ ¦h om ology¦ ¦at¦ ¦the¦ ¦level¦ ¦of¦ ¦n uc le ot ide¦ ¦se qu ence¦ .
𐋇¦the¦ ¦an ce str al¦ ¦virus¦ ¦is¦ ¦us ually¦ ¦well¦ ¦ad ap ted¦ ¦and¦ ¦non¦ - ¦path ogen ic¦ ¦in¦ ¦this¦ ¦host¦ .
𐋇 ¦li k e w ise¦ ,▁ ¦a¦ ¦res erv oi r¦ ¦host¦ ¦h ar bo ur s¦ ¦hcov¦ ¦contin u o us ly¦ ¦and¦ ¦for¦ ¦long¦ ¦ter m¦ .
𐋇¦in¦ ¦both¦ ¦cases¦ ,▁ ¦the¦ ¦ho sts¦ ¦are¦ ¦nat ur ally¦ ¦infected¦ ¦and¦ ¦are¦ ¦the¦ ¦nat ural¦ ¦ho sts¦ ¦of¦ ¦hcov¦ ¦or¦ ¦its¦ ¦pa re ntal¦ ¦virus¦ .
𐋇¦in¦ ¦contr ast¦ ,▁ ¦if¦ ¦the¦ ¦hcov¦ ¦is¦ ¦new ly¦ ¦int ro duc ed¦ ¦to¦ ¦an¦ ¦int erm ediate¦ ¦host¦ ¦r ight¦ ¦before¦ ¦or¦ ¦around¦ ¦its¦ ¦int ro d u ction¦ ¦to¦ ¦humans¦ ,▁ ¦it¦ ¦is¦ ¦not¦ ¦well¦ ¦ad ap ted¦ ¦to¦ ¦the¦ ¦new¦ ¦host¦ ¦and¦ ¦is¦ ¦often¦ ¦path ogen ic¦ .
𐋇¦this¦ ¦int erm ediate¦ ¦host¦ ¦can¦ ¦ser ve¦ ¦as¦ ¦the¦ ¦z o on ot ic¦ ¦sour ce¦ ¦of¦ ¦human¦ ¦infection¦ ¦and¦ ¦pl ay¦ ¦the¦ ¦ro le¦ ¦of¦ ¦an¦ ¦a mpl if ying¦ ¦host¦ ¦by¦ ¦all owing¦ ¦the¦ ¦virus¦ ¦to¦ ¦re pl ic ate¦ ¦trans ie ntly¦ ¦and¦ ¦then¦ ¦transm it ting¦ ¦it¦ ¦to¦ ¦humans¦ ¦to¦ ¦a mpl if y¦ ¦the¦ ¦sc a le¦ ¦of¦ ¦human¦ ¦infection¦ .
𐋇 ¦an¦ ¦hcov¦ ¦can¦ ¦under g o¦ ¦a¦ ¦d ead¦ - ¦end¦ ¦infection¦ ¦if¦ ¦it¦ ¦cannot¦ ¦s us tain¦ ¦its¦ ¦transmission¦ ¦within¦ ¦the¦ ¦int erm ediate¦ ¦host¦ .
𐋇¦on¦ ¦the¦ ¦contr ary¦ ,▁ ¦hcovs¦ ¦can¦ ¦also¦ ¦ad ap t¦ ¦to¦ ¦the¦ ¦int erm ediate¦ ¦host¦ ¦and¦ ¦even¦ ¦ es ta bl ish¦ ¦long¦ - ¦ter m¦ ¦en de m ic ity¦ .
𐋇¦in¦ ¦this¦ ¦case¦ ,▁ ¦the¦ ¦int erm ediate¦ ¦host¦ ¦bec omes¦ ¦a¦ ¦nat ural¦ ¦res erv oi r¦ ¦host¦ .
𐋇¦e p ide mi ological¦ ¦data¦ ¦re ve al ed¦ ¦r et r os p ect ively¦ ¦that¦ ¦the¦ ¦in de x¦ ¦case¦ ¦of¦ ¦sars¦ ¦had¦ ¦a¦ ¦contact¦ ¦h ist ory¦ ¦with¦ ¦ga me¦ ¦anim als¦ .
𐋇 ¦sub se qu ent¦ ¦ser op re v al ence¦ ¦in ve st ig ations¦ ¦indic ated¦ ¦that¦ ¦anim al¦ ¦t rad ers¦ ¦had¦ ¦a¦ ¦higher¦ ¦prev al ence¦ ¦of¦ ¦anti ¦ - ¦sars¦ - ¦cov¦ ¦ ig g¦ ¦comp ared¦ ¦with¦ ¦that¦ ¦of¦ ¦the¦ ¦general¦ ¦population¦ .
𐋇¦m as ked¦ ¦p al m¦ ¦c iv ets¦ ▁( ¦pa g um a¦ ¦l ar v at a¦ )▁ ¦and¦ ¦a¦ ¦r ac o on¦ ¦do g¦ ¦in¦ ¦live¦ ¦anim al¦ ¦mark ets¦ ¦were¦ ¦first¦ ¦identified¦ ¦to¦ ¦car ry¦ ¦sars¦ - ¦cov¦ - ¦like¦ ¦viruses¦ ¦that¦ ¦are¦ ¦al m ost¦ ¦ident ical¦ ¦to¦ ¦sars¦ - ¦cov¦ .
𐋇¦this¦ ¦was¦ ¦ind ir ect ly¦ ¦supp or ted¦ ¦by¦ ¦the¦ ¦f ac t¦ ¦that¦ ¦no¦ ¦further¦ ¦sars¦ ¦was¦ ¦reported¦ ¦after¦ ¦ki lling¦ ¦all¦ ¦c iv ets¦ ¦in¦ ¦the¦ ¦mark ets¦ .
𐋇¦however¦ ,▁ ¦it¦ ¦has¦ ¦been¦ ¦reported¦ ¦that¦ ¦m as ked¦ ¦p al m¦ ¦c iv ets¦ ¦from¦ ¦the¦ ¦w i ld¦ ¦or¦ ¦f ar ms¦ ¦without¦ ¦exp osure¦ ¦to¦ ¦the¦ ¦live¦ ¦anim al¦ ¦mark ets¦ ¦were¦ ¦l arg ely¦ ¦negative¦ ¦for¦ ¦sars¦ - ¦cov¦ ,▁ ¦su gg es ting¦ ¦that¦ ¦m as ked¦ ¦p al m¦ ¦c iv ets¦ ¦might¦ ¦only¦ ¦ser ve¦ ¦as¦ ¦the¦ ¦int erm ediate¦ ¦a mpl if ying¦ ¦host¦ ¦but¦ ¦not¦ ¦the¦ ¦nat ural¦ ¦res erv oi r¦ ¦of¦ ¦sars¦ - ¦cov¦ .
𐋇¦n ot ab ly¦ ,▁ ¦since¦ ¦8 0¦ %▁ ¦of¦ ¦the¦ ¦different¦ ¦anim als¦ ¦in¦ ¦the¦ ¦mark ets¦ ¦in¦ ¦gu a ng z ho u¦ ¦have¦ ¦anti ¦ - ¦sars¦ - ¦cov¦ ¦antibo dies¦ ,▁ ¦the¦ ¦p os si b il ities¦ ¦that¦ ¦mult ip le¦ ¦spec ies¦ ¦of¦ ¦sm all¦ ¦ma mm als¦ ¦might¦ ¦also¦ ¦ser ve¦ ¦as¦ ¦int erm ediate¦ ¦a mpl if ying¦ ¦ho sts¦ ¦of¦ ¦sars¦ - ¦cov¦ ¦cannot¦ ¦be¦ ¦ex c lu ded¦ .
𐋇 ¦all¦ ¦of¦ ¦these¦ ¦app ear¦ ¦to¦ ¦be¦ ¦d ead¦ - ¦end¦ ¦ho sts¦ ¦of¦ ¦sars¦ - ¦cov¦ .
𐋇 ¦sub se qu ent¦ ¦s ear ch¦ ¦for¦ ¦the¦ ¦nat ural¦ ¦anim al¦ ¦host¦ ¦of¦ ¦sars¦ - ¦cov¦ ¦un ve il ed¦ ¦a¦ ¦clos ely¦ ¦related¦ ¦bat¦ ¦cov¦ ,▁ ¦ter med¦ ¦sars¦ - ¦related¦ ¦r hi no lo ph us¦ ¦bat¦ ¦cov¦ ¦h k u 3¦ ▁( ¦sa rs r¦ - ¦r h ¦ - ¦b at cov ¦ ¦h k u 3¦ ),▁ ¦which¦ ¦e xi sts¦ ¦in¦ ¦chinese¦ ¦ho rs es ho e¦ ¦bats¦ .
𐋇¦these¦ ¦bats¦ ¦are¦ ¦positive¦ ¦for¦ ¦anti ¦ - ¦sars¦ - ¦cov¦ ¦antibo dies¦ ¦and¦ ¦gen ome¦ ¦se qu ence¦ ¦of¦ ¦sa rs r¦ - ¦r h ¦ - ¦b at cov ¦ ¦h k u 3¦ .
𐋇¦this¦ ¦and¦ ¦other¦ ¦bat¦ ¦covs¦ ¦share¦ ¦8 8¦ - ¦9 2¦ %▁ ¦n uc le ot ide¦ ¦se qu ence¦ ¦h om ology¦ ¦with¦ ¦sars¦ - ¦cov¦ .
𐋇¦these¦ ¦st u dies¦ ¦have¦ ¦la id¦ ¦the¦ ¦f ou nd ation¦ ¦for¦ ¦the¦ ¦new¦ ¦con cep t¦ ¦that¦ ¦bats¦ ¦host¦ ¦e mer ging¦ ¦human¦ ¦path og ens¦ .
𐋇 ¦several¦ ¦sars¦ - ¦like¦ ¦covs¦ ▁( ¦s l¦ - ¦covs¦ )▁ ¦have¦ ¦also¦ ¦been¦ ¦identified¦ ¦from¦ ¦bats¦ ,▁ ¦but¦ ¦n one¦ ¦ex cep t¦ ¦for¦ ¦one¦ ¦de si gn ated¦ ¦w iv 1¦ ¦can¦ ¦be¦ ¦isol ated¦ ¦as¦ ¦live¦ ¦virus¦ .
𐋇 ¦human¦ ¦a ng i o tens in¦ ¦con ver ting¦ ¦en z y me¦ ¦2¦ ▁( ¦a ce 2¦ )▁ ¦is¦ ¦known¦ ¦to¦ ¦be¦ ¦the¦ ¦rece pt or¦ ¦of¦ ¦sars¦ - ¦cov¦ .
𐋇¦w iv 1¦ ¦d er iv ed¦ ¦from¦ ¦f ec al¦ ¦sampl e¦ ¦of¦ ¦bats¦ ¦was¦ ¦dem on str ated¦ ¦to¦ ¦use¦ ¦bat¦ ,▁ ¦c iv et¦ ¦and¦ ¦human¦ ¦a ce 2¦ ¦as¦ ¦rece pt or¦ ¦for¦ ¦c ell¦ ¦ent ry¦ .
𐋇 ¦int r ig u i ng ly¦ ,▁ ¦ser a¦ ¦of¦ ¦con v al esc ent¦ ¦sars¦ ¦patients¦ ¦were¦ ¦c ap able¦ ¦of¦ ¦ne ut r al iz ing¦ ¦w iv 1¦ .
𐋇 ¦th us¦ ¦fa r¦ ,▁ ¦w iv 1¦ ¦rep r es ents¦ ¦the¦ ¦most¦ ¦clos ely¦ ¦related¦ ¦an ce st or¦ ¦of¦ ¦sars¦ - ¦cov¦ ¦in¦ ¦bats¦ ,▁ ¦sh ar ing¦ ¦9 5¦ %▁ ¦n uc le ot ide¦ ¦se qu ence¦ ¦h om ology¦ .
𐋇 ¦al b e i t¦ ¦the¦ ¦high¦ ¦h om ology¦ ¦between¦ ¦these¦ ¦two¦ ¦viruses¦ ,▁ ¦it¦ ¦is¦ ¦gener ally¦ ¦b el ie v ed¦ ¦that¦ ¦w iv 1¦ ¦is¦ ¦not¦ ¦the¦ ¦immediate¦ ¦pa re ntal¦ ¦virus¦ ¦of¦ ¦sars¦ - ¦cov¦ ¦and¦ ¦bats¦ ¦are¦ ¦not¦ ¦the¦ ¦immediate¦ ¦res erv oi r¦ ¦host¦ ¦of¦ ¦sars¦ - ¦cov¦ .
𐋇 ¦ph y l ogen et ic¦ ¦anal y sis¦ ¦c lu st ers¦ ¦mers¦ - ¦cov¦ ¦to¦ ¦the¦ ¦same¦ ¦group¦ ¦as¦ ¦bat¦ ¦cov¦ - ¦h k u 4¦ ¦and¦ ¦bat¦ ¦cov¦ - ¦h k u 5¦ .
𐋇 ¦bat¦ ¦cov¦ - ¦h k u 4¦ ¦and¦ ¦mers¦ - ¦cov¦ ¦ ut il iz e¦ ¦the¦ ¦same¦ ¦host¦ ¦rece pt or¦ ,▁ ¦d ip e pt id y l¦ ¦p e pt id ase¦ ¦4¦ ▁( ¦d pp 4¦ ),▁ ¦for¦ ¦virus¦ ¦ent ry¦ .
𐋇 ¦rna¦ - ¦dep end ent¦ ¦rna¦ ¦pol y mer ase¦ ¦se qu en ces¦ ¦of¦ ¦mers¦ - ¦cov¦ ¦are¦ ¦ph y l ogen et ically¦ ¦clos er¦ ¦to¦ ¦cou nt er par ts¦ ¦in¦ ¦bat¦ ¦bet a¦ - ¦covs¦ ¦identified¦ ¦from¦ ¦e ur ope¦ ¦and¦ ¦afr ica¦ .
𐋇 ¦up¦ ¦to¦ ¦n ow¦ ,▁ ¦no¦ ¦live¦ ¦mers¦ - ¦cov¦ ¦can¦ ¦be¦ ¦found¦ ¦in¦ ¦w i ld¦ ¦bats¦ .
𐋇 ¦mers¦ - ¦cov¦ ¦and¦ ¦its¦ ¦clos est¦ ¦rel ative¦ ¦bat¦ ¦cov¦ - ¦h k u 2 5¦ ¦share¦ ¦only¦ ¦8 7¦ %▁ ¦n uc le ot ide¦ ¦se qu ence¦ ¦h om ology¦ .
𐋇 ¦th us¦ ,▁ ¦bats¦ ¦might¦ ¦not¦ ¦be¦ ¦the¦ ¦immediate¦ ¦res erv oi r¦ ¦host¦ ¦of¦ ¦mers¦ - ¦cov¦ .
𐋇¦on¦ ¦the¦ ¦other¦ ¦hand¦ ,▁ ¦st u dies¦ ¦in¦ ¦m id d le¦ ¦e ast¦ ¦have¦ ¦sh own¦ ¦that¦ ¦dr om ed ary¦ ¦ca m els¦ ¦are¦ ¦ser op o si tive¦ ¦for¦ ¦mers¦ - ¦cov¦ - ¦specific¦ ¦ne ut r al iz ing¦ ¦antibo dies¦ ,▁ ¦same¦ ¦as¦ ¦ca m els¦ ¦of¦ ¦m id d le¦ ¦e ast¦ ¦orig in¦ ¦in¦ ¦mult ip le¦ ¦afr ic an¦ ¦countries¦ .
𐋇 ¦live¦ ¦mers¦ - ¦cov¦ ¦ident ical¦ ¦to¦ ¦the¦ ¦virus¦ ¦found¦ ¦in¦ ¦humans¦ ¦was¦ ¦isol ated¦ ¦from¦ ¦the¦ ¦n as al¦ ¦sw ab s¦ ¦of¦ ¦dr om ed ary¦ ¦ca m els¦ ,▁ ¦further¦ ¦indic ating¦ ¦that¦ ¦ca m els¦ ¦ser ve¦ ¦as¦ ¦the¦ ¦ bo na¦ ¦f ide¦ ¦res erv oi r¦ ¦host¦ ¦of¦ ¦mers¦ - ¦cov¦ .
𐋇¦it¦ ¦is¦ ¦also¦ ¦no te w or th y¦ ¦that¦ ¦gener ally¦ ¦mild¦ ¦symptoms¦ ¦but¦ ¦ma ss ive¦ ¦virus¦ ¦sh ed ding¦ ¦were¦ ¦ob s erv ed¦ ¦in¦ ¦ca m els¦ ¦exp eri me nt ally¦ ¦infected¦ ¦with¦ ¦mers¦ - ¦cov¦ .
𐋇¦n ot ab ly¦ ,▁ ¦infected¦ ¦ca m els¦ ¦sh ed¦ ¦viruses¦ ¦not¦ ¦only¦ ¦through¦ ¦respiratory¦ ¦ro ute¦ ¦but¦ ¦also¦ ¦through¦ ¦f ec al¦ - ¦or al¦ ¦ro ute¦ ,▁ ¦which¦ ¦is¦ ¦also¦ ¦the¦ ¦ma in¦ ¦ro ute¦ ¦for¦ ¦virus¦ ¦sh ed ding¦ ¦from¦ ¦bats¦ .
𐋇¦however¦ ,▁ ¦qu es tions¦ ¦still¦ ¦remain¦ ¦since¦ ¦many¦ ¦confirmed¦ ¦cases¦ ¦of¦ ¦mers¦ ¦have¦ ¦no¦ ¦contact¦ ¦h ist ory¦ ¦with¦ ¦ca m els¦ ¦pri or¦ ¦to¦ ¦s y m pt om¦ ¦o ns et¦ ,▁ ¦pla u si b ly¦ ¦as c rib ed¦ ¦to¦ ¦human¦ - ¦to¦ - ¦human¦ ¦transmission¦ ¦or¦ ¦un k n own¦ ¦transmission¦ ¦r ou tes¦ ¦invol ving¦ ¦un r ec o gn i zed¦ ¦anim al¦ ¦spec ies¦ ¦that¦ ¦h ar b ou r¦ ¦mers¦ - ¦cov¦ .
𐋇 ¦sars¦ - ¦cov¦ - ¦2¦ ¦sh ar es¦ ¦9 6¦ . ¦2¦ %▁ ¦n uc le ot ide¦ ¦h om ology¦ ¦with¦ ¦a¦ ¦bat¦ ¦cov¦ ¦r at g 1 3¦ ¦isol ated¦ ¦from¦ ¦r hi no lo ph us¦ ¦aff in i s¦ ¦bats¦ .
𐋇¦as¦ ¦in¦ ¦the¦ ¦cases¦ ¦of¦ ¦sars¦ - ¦cov¦ ¦and¦ ¦mers¦ - ¦cov¦ ,▁ ¦the¦ ¦se qu ence¦ ¦di ver g ence¦ ¦between¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦and¦ ¦r at g 1 3¦ ¦is¦ ¦to o¦ ¦g re at¦ ¦to¦ ¦ass ign¦ ¦pa re ntal¦ ¦re la tion s hi p¦ .
𐋇 ¦that¦ ¦is¦ ¦to¦ ¦s ay¦ ,▁ ¦bats¦ ¦might¦ ¦not¦ ¦be¦ ¦the¦ ¦immediate¦ ¦res erv oi r¦ ¦host¦ ▁( ¦s¦ )▁ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦un less¦ ¦al m ost¦ ¦ident ical¦ ¦bat¦ ¦covs¦ ¦are¦ ¦found¦ ¦in¦ ¦f ut ure¦ .
𐋇 ¦pres um ab ly¦ ,▁ ¦the¦ ¦int erm ediate¦ ¦anim al¦ ¦ho sts¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦should¦ ¦be¦ ¦among¦ ¦the¦ ¦w ild l ife¦ ¦spec ies¦ ¦so ld¦ ¦and¦ ¦ki lled¦ ¦at¦ ¦the¦ ¦h u an an¦ ¦s ea f ood¦ ¦wh ol es a le¦ ¦mark et¦ ,▁ ¦with¦ ¦which¦ ¦many¦ ¦of¦ ¦the¦ ¦in it ial¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦were¦ ¦associated¦ ,▁ ¦indic ative¦ ¦of¦ ¦a¦ ¦prob able¦ ¦anim al¦ - ¦to¦ - ¦human¦ ¦transmission¦ ¦ev ent¦ .
𐋇 ¦several¦ ¦rec ent¦ ¦st u dies¦ ¦based¦ ¦on¦ ¦me ta ge nomic¦ ¦se qu e ncing¦ ¦have¦ ¦su gg ested¦ ¦that¦ ¦a¦ ¦group¦ ¦of¦ ¦ end a ng ered¦ ¦sm all¦ ¦ma mm als¦ ¦known¦ ¦as¦ ¦pa ngol ins¦ ▁( ¦m an i s¦ ¦j a v an ica¦ )▁ ¦could¦ ¦also¦ ¦h ar b ou r¦ ¦an ce str al¦ ¦bet a¦ - ¦covs¦ ¦related¦ ¦to¦ ¦sars¦ - ¦cov¦ - ¦2¦ .
𐋇¦these¦ ¦novel¦ ¦pa ngol in¦ ¦cov¦ ¦gen omes¦ ¦share¦ ¦8 5¦ - ¦9 2¦ %▁ ¦n uc le ot ide¦ ¦se qu ence¦ ¦h om ology¦ ¦with¦ ¦sars¦ - ¦cov¦ - ¦2¦ .
𐋇¦however¦ ,▁ ¦they¦ ¦are¦ ¦e q ually¦ ¦clos ely¦ ¦related¦ ¦to¦ ¦r at g 1 3¦ ¦with¦ ¦about¦ ¦9 0¦ %▁ ¦ident ity¦ ¦at¦ ¦the¦ ¦level¦ ¦of¦ ¦n uc le ot ide¦ ¦se qu ence¦ .
𐋇¦they¦ ¦cl us ter¦ ¦into¦ ¦two¦ ¦sub ¦ - ¦l in ea ges¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ - ¦like¦ ¦viruses¦ ¦in¦ ¦the¦ ¦ph y l ogen et ic¦ ¦tre e¦ ,▁ ¦one¦ ¦of¦ ¦which¦ ¦share¦ ¦a¦ ¦more¦ ¦similar¦ ¦rece pt or¦ ¦b in ding¦ ¦do ma in¦ ▁( ¦r b d¦ )▁ ¦with¦ ¦sars¦ - ¦cov¦ - ¦2¦ ,▁ ¦with¦ ¦9 7¦ . ¦4¦ %▁ ¦a min o¦ ¦ac id¦ ¦se qu ence¦ ¦ident ity¦ .
𐋇¦in¦ ¦star k¦ ¦contr ast¦ ,▁ ¦the¦ ¦r b ds¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦and¦ ¦r at g 1 3¦ ¦are¦ ¦more¦ ¦di ver g ent¦ ,▁ ¦al b e i t¦ ¦a¦ ¦higher¦ ¦de g re e¦ ¦of¦ ¦se qu ence¦ ¦h om ology¦ ¦gen ome¦ - ¦w ide¦ .
𐋇 ¦an¦ ¦ ear li er¦ ¦study¦ ¦on¦ ¦dis ea sed¦ ¦pa ngol ins¦ ¦also¦ ¦reported¦ ¦the¦ ¦de te ction¦ ¦of¦ ¦viral¦ ¦cont ig s¦ ¦from¦ ¦lu ng¦ ¦samples¦ ,▁ ¦which¦ ¦t ur n¦ ¦out¦ ¦to¦ ¦be¦ ¦s im il arly¦ ¦related¦ ¦to¦ ¦sars¦ - ¦cov¦ - ¦2¦ .
𐋇¦this¦ ¦study¦ ¦ad op ted¦ ¦different¦ ¦as se mb ly¦ ¦met ho ds¦ ¦and¦ ¦m an ual¦ ¦cur ation¦ ¦to¦ ¦gener ate¦ ¦a¦ ¦part ial¦ ¦gen ome¦ ¦se qu ence¦ ¦comp r ising¦ ¦about¦ ¦8 6¦ . ¦3¦ %▁ ¦of¦ ¦the¦ ¦f ul l¦ - ¦le ng th¦ ¦viral¦ ¦gen ome¦ .
𐋇¦we¦ ¦cannot¦ ¦ex c lu de¦ ¦the¦ ¦p os si bility¦ ¦that¦ ¦pa ngol in¦ ¦is¦ ¦one¦ ¦of¦ ¦the¦ ¦int erm ediate¦ ¦anim al¦ ¦ho sts¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ .
𐋇¦however¦ ,▁ ¦cur re ntly¦ ¦there¦ ¦is¦ ¦no¦ ¦evidence¦ ¦in¦ ¦support¦ ¦of¦ ¦a¦ ¦direct¦ ¦pa ngol in¦ ¦orig in¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦due¦ ¦to¦ ¦the¦ ¦se qu ence¦ ¦di ver g ence¦ ¦between¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦and¦ ¦pa ngol in¦ ¦sars¦ - ¦cov¦ - ¦2¦ - ¦related¦ ¦bet a¦ - ¦covs¦ .
𐋇¦in¦ ¦add ition¦ ,▁ ¦the¦ ¦dista nce¦ ¦between¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦and¦ ¦r at g 1 3¦ ¦is¦ ¦even¦ ¦sh or ter¦ ¦than¦ ¦that¦ ¦between¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦and¦ ¦pa ngol in¦ ¦sars¦ - ¦cov¦ - ¦2¦ - ¦related¦ ¦bet a¦ - ¦covs¦ .
𐋇¦the¦ ¦ev o lu tion ary¦ ¦path w ay¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦in¦ ¦bats¦ ,▁ ¦pa ngol ins¦ ¦and¦ ¦other¦ ¦ma mm als¦ ¦rema ins¦ ¦to¦ ¦be¦ ¦ es ta bl ished¦ .
𐋇¦w he rea s¦ ¦the¦ ¦high est¦ ¦se qu ence¦ ¦h om ology¦ ¦has¦ ¦been¦ ¦found¦ ¦in¦ ¦the¦ ¦r b ds¦ ¦between¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦and¦ ¦pa ngol in¦ ,▁ ¦sars¦ - ¦cov¦ - ¦2¦ - ¦related¦ ¦bet a¦ - ¦covs¦ ,▁ ¦sars¦ - ¦cov¦ - ¦2¦ ¦and¦ ¦r at g 1 3¦ ¦share¦ ¦the¦ ¦high est¦ ¦gen ome¦ - ¦w ide¦ ¦se qu ence¦ ¦h om ology¦ .
𐋇¦it¦ ¦is¦ ¦high ly¦ ¦spec ul ative¦ ¦that¦ ¦the¦ ¦high¦ ¦de g re e¦ ¦of¦ ¦s im il ar ity¦ ¦between¦ ¦the¦ ¦r b ds¦ ¦of¦ ¦pa ngol in¦ ¦sars¦ - ¦cov¦ - ¦2¦ - ¦related¦ ¦bet a¦ - ¦covs¦ ¦and¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦is¦ ¦dr iv en¦ ¦by¦ ¦s el ect iv ity¦ - ¦me di ated¦ ¦con ver g ent¦ ¦ev ol ution¦ .
𐋇¦a¦ ¦co un ter¦ - ¦prop os al¦ ¦is¦ ¦in¦ ¦fa v ou r¦ ¦of¦ ¦a¦ ¦reco mb ination¦ ¦between¦ ¦a¦ ¦pa ngol in¦ ¦sars¦ - ¦cov¦ - ¦2¦ - ¦related¦ ¦bet a¦ - ¦cov¦ ¦and¦ ¦r at g 1 3¦ ¦in¦ ¦the¦ ¦thir d¦ ¦w i ld¦ ¦anim al¦ ¦spec ies¦ .
𐋇¦as¦ ¦a¦ ¦d ri ving¦ ¦for ce¦ ¦in¦ ¦ev ol ution¦ ,▁ ¦reco mb ination¦ ¦is¦ ¦wid esp r ead¦ ¦among¦ ¦bet a¦ - ¦covs¦ .
𐋇¦the¦ ¦j u ry¦ ¦is¦ ¦still¦ ¦out¦ ¦on¦ ¦the¦ ¦immediate¦ ¦z o on ot ic¦ ¦orig in¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ .
𐋇 ¦be si des¦ ¦the¦ ¦high ly¦ ¦path ogen ic¦ ¦hcovs¦ ,▁ ¦the¦ ¦z o on ot ic¦ ¦orig in¦ ¦of¦ ¦hcov¦ - ¦22 9 e¦ ,▁ ¦hcov¦ - ¦ oc 4 3¦ ,▁ ¦hcov¦ - ¦n l 6 3¦ ¦and¦ ¦hcov¦ - ¦h k u 1¦ ¦have¦ ¦also¦ ¦been¦ ¦st ud ied¦ .
𐋇 ¦ph y l ogen et ic¦ ¦evidence¦ ¦indic ated¦ ¦that¦ ¦both¦ ¦hcov¦ - ¦n l 6 3¦ ¦and¦ ¦hcov¦ - ¦22 9 e¦ ¦might¦ ¦have¦ ¦orig in ated¦ ¦from¦ ¦bat¦ ¦covs¦ ,▁ ¦while¦ ¦the¦ ¦pa re ntal¦ ¦viruses¦ ¦of¦ ¦hcov¦ - ¦ oc 4 3¦ ¦and¦ ¦hcov¦ - ¦h k u 1¦ ¦have¦ ¦been¦ ¦found¦ ¦in¦ ¦ro d ents¦ .
𐋇¦it¦ ¦has¦ ¦been¦ ¦reported¦ ¦that¦ ¦a¦ ¦bat¦ ¦cov¦ ¦ter med¦ ¦ar cov ¦ . ¦2¦ ▁( ¦app al ac hi an¦ ¦r id ge¦ ¦cov¦ )▁ ¦detected¦ ¦in¦ ¦n or th¦ ¦amer ic an¦ ¦tr ic ol or ed¦ ¦bat¦ ¦dis p la y ed¦ ¦close¦ ¦re la tion s hi p¦ ¦with¦ ¦hcov¦ - ¦n l 6 3¦ .
𐋇¦on¦ ¦the¦ ¦other¦ ¦hand¦ ,▁ ¦hcov¦ - ¦22 9 e¦ ¦was¦ ¦gen et ically¦ ¦related¦ ¦to¦ ¦another¦ ¦bat¦ ¦cov¦ ,▁ ¦ter med¦ ¦hi pp os ide ro s¦ ▁/▁ ¦ gh a na k w am¦ ▁/▁ ¦19¦ ▁/▁ ¦20 0 8¦ ,▁ ¦which¦ ¦was¦ ¦detected¦ ¦in¦ ¦ gh a na¦ ,▁ ¦while¦ ¦ca me li ds¦ ¦have¦ ¦also¦ ¦been¦ ¦suspected¦ ¦as¦ ¦its¦ ¦int erm ediate¦ ¦host¦ .
𐋇¦for¦ ¦cl ar ity¦ ,▁ ¦the¦ ¦current¦ ¦k n ow l ed ge¦ ¦on¦ ¦anim al¦ ¦orig ins¦ ¦of¦ ¦known¦ ¦hcovs¦ ¦is¦ ¦s um ma ri zed¦ ¦in¦ ¦f ig ure¦ ▁ ​ ▁ ¦1¦ ¦and¦ ¦t able¦ ¦2¦ .
𐋇 ¦ph y l ogen et ic¦ ¦anal y sis¦ ¦has¦ ¦provid ed¦ ¦evidence¦ ¦for¦ ¦inter s p ec ies¦ ¦transmission¦ ¦events¦ ¦of¦ ¦hcovs¦ ¦in¦ ¦the¦ ¦h ist ory¦ .
𐋇¦when¦ ¦hcov¦ - ¦ oc 4 3¦ ¦cr os sed¦ ¦spec ies¦ ¦to¦ ¦inf ect¦ ¦humans¦ ¦from¦ ¦do me st ic¦ ¦li ve st oc k¦ ¦around¦ ¦1 8 9 0¦ ,▁ ¦a¦ ¦pandemic¦ ¦of¦ ¦respiratory¦ ¦infection¦ ¦was¦ ¦recor ded¦ .
𐋇¦the¦ ¦inter s p ec ies¦ ¦transmission¦ ¦h ist ory¦ ¦of¦ ¦hcov¦ - ¦22 9 e¦ ¦is¦ ¦less¦ ¦cl ear¦ .
𐋇 ¦bat¦ ¦al ph a¦ - ¦covs¦ ¦clos ely¦ ¦related¦ ¦to¦ ¦hcov¦ - ¦22 9 e¦ ¦have¦ ¦been¦ ¦found¦ .
𐋇 ¦between¦ ¦them¦ ¦there¦ ¦is¦ ¦an¦ ¦al p ac a¦ ¦al ph a¦ - ¦cov¦ .
𐋇 ¦several¦ ¦l ines¦ ¦of¦ ¦evidence¦ ¦support¦ ¦the¦ ¦transmission¦ ¦of¦ ¦virus¦ ¦from¦ ¦bats¦ ¦to¦ ¦humans¦ ¦dir ect ly¦ .
𐋇 ¦first¦ ,▁ ¦humans¦ ¦but¦ ¦not¦ ¦al p ac a s¦ ¦might¦ ¦have¦ ¦contact¦ ¦with¦ ¦bats¦ ¦in¦ ¦a¦ ¦sh ared¦ ¦ec ological¦ ¦n i ch e¦ .
𐋇 ¦inst ead¦ ,▁ ¦humans¦ ¦have¦ ¦close¦ ¦contact¦ ¦with¦ ¦al p ac a s¦ .
𐋇 ¦second¦ ,▁ ¦hcov¦ - ¦22 9 e¦ - ¦related¦ ¦bat¦ ¦al ph a¦ - ¦covs¦ ¦are¦ ¦di ver se¦ ¦and¦ ¦non¦ - ¦path ogen ic¦ ¦in¦ ¦bats¦ ,▁ ¦w he rea s¦ ¦al p ac a¦ ¦al ph a¦ - ¦cov¦ ¦caused¦ ¦an¦ ¦outbreak¦ ¦of¦ ¦respiratory¦ ¦disease¦ ¦in¦ ¦infected¦ ¦anim als¦ .
𐋇¦f in ally¦ ,▁ ¦al p ac a¦ ¦al ph a¦ - ¦cov¦ ¦has¦ ¦not¦ ¦been¦ ¦found¦ ¦in¦ ¦f er al¦ ¦anim als¦ .
𐋇 ¦th us¦ ,▁ ¦the¦ ¦p os si bility¦ ¦cannot¦ ¦be¦ ¦ex c lu ded¦ ¦that¦ ¦al p ac a s¦ ¦ob tain¦ ¦the¦ ¦hcov¦ - ¦22 9 e¦ - ¦related¦ ¦al ph a¦ - ¦cov¦ ¦from¦ ¦humans¦ .
𐋇¦in¦ ¦f ac t¦ ,▁ ¦bats¦ ¦are¦ ¦the¦ ¦direct¦ ¦sour ce¦ ¦of¦ ¦human¦ ¦path ogen ic¦ ¦viruses¦ ¦including¦ ¦r ab ies¦ ¦virus¦ ,▁ ¦e b ol a¦ ¦virus¦ ,▁ ¦n i pa h ¦ ¦virus¦ ¦and¦ ¦h en dr a¦ ¦virus¦ .
𐋇¦it¦ ¦is¦ ¦the re f ore¦ ¦not¦ ¦to o¦ ¦sur p r ising¦ ¦that¦ ¦bats¦ ¦might¦ ¦trans mi t¦ ¦hcov¦ - ¦22 9 e¦ ¦to¦ ¦humans¦ ¦dir ect ly¦ .
𐋇 ¦al t er n at ively¦ ,▁ ¦w he rea s¦ ¦bat¦ ¦al ph a¦ - ¦covs¦ ¦ser ve¦ ¦as¦ ¦the¦ ¦gen e¦ ¦p oo l¦ ¦of¦ ¦hcov¦ - ¦22 9 e¦ ,▁ ¦al p ac a s¦ ¦and¦ ¦dr om ed ary¦ ¦ca m els¦ ¦might¦ ¦ser ve¦ ¦as¦ ¦int erm ediate¦ ¦ho sts¦ ¦that¦ ¦trans mi t¦ ¦viruses¦ ¦to¦ ¦humans¦ ,▁ ¦ex a ct ly¦ ¦as¦ ¦in¦ ¦the¦ ¦case¦ ¦of¦ ¦mers¦ - ¦cov¦ .
𐋇 ¦mers¦ - ¦cov¦ ¦ser ves¦ ¦as¦ ¦an¦ ¦ex ce ll ent¦ ¦example¦ ¦of¦ ¦inter s p ec ies¦ ¦transmission¦ ¦from¦ ¦bats¦ ¦to¦ ¦dr om ed ary¦ ¦ca m els¦ ¦and¦ ¦from¦ ¦dr om ed ary¦ ¦ca m els¦ ¦to¦ ¦humans¦ .
𐋇¦the¦ ¦ev o lu tion ary¦ ¦orig in¦ ¦of¦ ¦mers¦ - ¦cov¦ ¦from¦ ¦bats¦ ¦is¦ ¦known¦ ¦at¦ ¦its¦ ¦in it ial¦ ¦ident ific ation¦ ¦and¦ ¦has¦ ¦also¦ ¦been¦ ¦st re ng t he ned¦ ¦by¦ ¦sub se qu ent¦ ¦fi nd ings¦ .
𐋇¦it¦ ¦is¦ ¦ob v ious¦ ¦that¦ ¦bats¦ ¦provide¦ ¦a¦ ¦ ri ch¦ ¦p oo l¦ ¦of¦ ¦virus¦ ¦spec ies¦ ¦for¦ ¦inter s p ec ies¦ ¦ex ch ange¦ ¦of¦ ¦gen et ic¦ ¦fra g ments¦ ¦and¦ ¦inter s p ec ies¦ ¦transmission¦ .
𐋇¦l on ge v ity¦ ,▁ ¦de ns ely¦ ¦p ac ked¦ ¦c ol on ies¦ ,▁ ¦close¦ ¦social¦ ¦inter a ction¦ ¦and¦ ¦st ro ng¦ ¦a bility¦ ¦to¦ ¦f ly¦ ¦are¦ ¦all¦ ¦fa v o ur able¦ ¦conditions¦ ¦for¦ ¦bats¦ ¦to¦ ¦be¦ ¦an¦ ¦ ide al¦ ▁' ¦virus¦ ¦sprea der¦ ' .
𐋇¦on¦ ¦the¦ ¦other¦ ¦hand¦ ,▁ ¦mers¦ - ¦cov¦ ¦has¦ ¦been¦ ¦int ro duc ed¦ ¦to¦ ¦dr om ed ary¦ ¦ca m els¦ ¦for¦ ¦dec a des¦ .
𐋇¦it¦ ¦is¦ ¦well¦ ¦ad ap ted¦ ¦to¦ ¦these¦ ¦ca m els¦ ¦that¦ ¦have¦ ¦t ur ned¦ ¦from¦ ¦an¦ ¦int erm ediate¦ ¦host¦ ¦to¦ ¦a¦ ¦st able¦ ¦and¦ ¦nat ural¦ ¦res erv oi r¦ ¦host¦ .
𐋇 ¦mers¦ - ¦cov¦ ¦ca u ses¦ ¦very¦ ¦mild¦ ¦disease¦ ¦and¦ ¦main ta ins¦ ¦a¦ ¦rel at ively¦ ¦low¦ ¦m ut ation¦ ¦rate¦ ¦in¦ ¦these¦ ¦anim als¦ .
𐋇 ¦its¦ ¦sp o rad ic¦ ¦transmission¦ ¦to¦ ¦humans¦ ¦is¦ ¦an¦ ¦acc ident¦ ¦and¦ ¦humans¦ ¦remain¦ ¦a¦ ¦d ead¦ - ¦end¦ ¦host¦ ¦of¦ ¦mers¦ - ¦cov¦ ¦as¦ ¦its¦ ¦transmission¦ ¦cannot¦ ¦be¦ ¦s us ta ined¦ .
𐋇¦in¦ ¦contr ast¦ ¦to¦ ¦the¦ ¦ro le¦ ¦of¦ ¦ca m els¦ ¦in¦ ¦the¦ ¦transmission¦ ¦of¦ ¦mers¦ - ¦cov¦ ,▁ ¦the¦ ¦ro le¦ ¦of¦ ¦pa ngol ins¦ ,▁ ¦if¦ ¦there¦ ¦is¦ ¦any¦ ,▁ ¦in¦ ¦the¦ ¦transmission¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦is¦ ¦different¦ .
𐋇 ¦partic ul arly¦ ,▁ ¦pa ngol in¦ ¦bet a¦ - ¦covs¦ ¦are¦ ¦high ly¦ ¦path ogen ic¦ ¦in¦ ¦pa ngol ins¦ .
𐋇¦they¦ ¦might¦ ¦be¦ ¦a¦ ¦d ead¦ - ¦end¦ ¦host¦ ¦for¦ ¦sars¦ - ¦cov¦ - ¦2¦ - ¦related¦ ¦bet a¦ - ¦covs¦ ,▁ ¦similar¦ ¦to¦ ¦c iv ets¦ ¦in¦ ¦the¦ ¦case¦ ¦of¦ ¦sars¦ - ¦cov¦ .
𐋇 ¦several¦ ¦p os si b il ities¦ ¦for¦ ¦inter s p ec ies¦ ¦transmission¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦from¦ ¦anim als¦ ¦to¦ ¦humans¦ ¦have¦ ¦to¦ ¦be¦ ¦r ul ed¦ ¦in¦ ¦or¦ ¦r ul ed¦ ¦out¦ ¦in¦ ¦f ut ure¦ ¦st u dies¦ .
𐋇 ¦first¦ ,▁ ¦bats¦ ¦could¦ ¦be¦ ¦the¦ ¦res erv oi r¦ ¦host¦ ¦of¦ ¦a¦ ¦sars¦ - ¦cov¦ - ¦2¦ - ¦related¦ ¦virus¦ ¦al m ost¦ ¦ident ical¦ ¦to¦ ¦sars¦ - ¦cov¦ - ¦2¦ .
𐋇 ¦humans¦ ¦might¦ ¦share¦ ¦the¦ ¦ec ological¦ ¦n i ch e¦ ¦with¦ ¦bats¦ ¦through¦ ¦b ut ch ering¦ ¦or¦ ¦co al¦ ¦mi ning¦ .
𐋇 ¦second¦ ,▁ ¦pa ngol ins¦ ¦could¦ ¦be¦ ¦one¦ ¦of¦ ¦int erm ediate¦ ¦a mpl if ying¦ ¦host¦ ¦to¦ ¦which¦ ¦a¦ ¦sars¦ - ¦cov¦ - ¦2¦ - ¦related¦ ¦virus¦ ¦had¦ ¦been¦ ¦new ly¦ ¦int ro duc ed¦ .
𐋇 ¦humans¦ ¦contr ac t¦ ¦the¦ ¦virus¦ ¦through¦ ¦b ut ch ering¦ ¦and¦ ¦cons um ption¦ ¦of¦ ¦ga me¦ ¦me at¦ .
𐋇¦it¦ ¦is¦ ¦possible¦ ¦that¦ ¦many¦ ¦ma mm als¦ ¦including¦ ¦do me st ic¦ ¦anim als¦ ¦are¦ ¦s us cep ti ble¦ ¦to¦ ¦sars¦ - ¦cov¦ - ¦2¦ .
𐋇¦a¦ ¦sur ve y¦ ¦of¦ ¦do me st ic¦ ¦and¦ ¦w i ld¦ ¦anim als¦ ¦for¦ ¦antibo dies¦ ¦is¦ ¦w arr an ted¦ .
𐋇 ¦thir d¦ ,▁ ¦as¦ ¦m en tion ed¦ ¦a bo ve¦ ,▁ ¦reco mb ination¦ ¦and¦ ¦ad a pt ation¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦might¦ ¦have¦ ¦occur r ed¦ ¦in¦ ¦a¦ ¦thir d¦ ¦spec ies¦ ¦that¦ ¦has¦ ¦contact¦ ¦with¦ ¦both¦ ¦bats¦ ¦and¦ ¦pa ngol ins¦ .
𐋇¦the¦ ¦s ear ch¦ ¦for¦ ¦the¦ ¦anim al¦ ¦orig ins¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦is¦ ¦still¦ ¦on¦ .
𐋇 ¦a par t¦ ¦from¦ ¦different¦ ¦typ es¦ ¦of¦ ¦the¦ ¦anim al¦ ¦ho sts¦ ,▁ ¦three¦ ¦major¦ ¦fa ctors¦ ¦on¦ ¦the¦ ¦viral¦ ¦ side¦ ¦are¦ ¦also¦ ¦important¦ ¦in¦ ¦facil it ating¦ ¦covs¦ ¦to¦ ¦c ross¦ ¦spec ies¦ ¦b ar ri ers¦ .
𐋇 ¦first¦ ¦of¦ ¦all¦ ,▁ ¦their¦ ¦rel at ively¦ ¦high¦ ¦m ut ation¦ ¦r ates¦ ¦in¦ ¦rna¦ ¦re pl ic ation¦ .
𐋇¦in¦ ¦comp ar is on¦ ¦to¦ ¦other¦ ¦si ng le¦ - ¦stra nded¦ ¦rna¦ ¦viruses¦ ,▁ ¦the¦ ¦estim ated¦ ¦m ut ation¦ ¦r ates¦ ¦of¦ ¦covs¦ ¦could¦ ¦be¦ ¦reg ar ded¦ ¦as¦ ▁ “ ¦mod er ate¦ ▁ ” ▁ ¦to¦ “ ▁ ¦high¦ ▁ ” ▁ ¦with¦ ¦an¦ ¦a ver age¦ ¦sub st it ution¦ ¦rate¦ ¦being¦ ▁ ~ ▁ ¦10¦ - ¦4¦ ¦sub st it ution¦ ¦per¦ ¦year¦ ¦per¦ ¦s ite¦ ¦2¦ ,▁ ¦dep ending¦ ¦on¦ ¦the¦ ¦ph ase¦ ¦of¦ ¦cov¦ ¦ad a pt ation¦ ¦to¦ ¦novel¦ ¦ho sts¦ .
𐋇 ¦covs¦ ¦have¦ ¦a¦ ¦pr oo f¦ - ¦rea ding¦ ¦ex o rib on uc le ase¦ ,▁ ¦del et ion¦ ¦of¦ ¦which¦ ¦results¦ ¦in¦ ¦ex c ee di ng ly¦ ¦high¦ ¦m u ta bility¦ ¦and¦ ¦att en u ation¦ ¦or¦ ¦even¦ ¦inv ia bility¦ .
𐋇 ¦inter es ti ng ly¦ ,▁ ¦the¦ ¦n uc le ot ide¦ ¦anal og ue¦ ¦rem de si vi r¦ ¦is¦ ¦known¦ ¦to¦ ¦supp r ess¦ ¦cov¦ ¦re pl ic ation¦ ¦through¦ ¦in hi b ition¦ ¦of¦ ¦this¦ ¦ex o rib on uc le ase¦ ¦and¦ ¦the¦ ¦rna¦ - ¦dep end ent¦ ¦rna¦ ¦pol y mer ase¦ .
𐋇 ¦rem de si vi r¦ ¦is¦ ¦one¦ ¦of¦ ¦most¦ ¦pr om ising¦ ¦anti ¦ - ¦sars¦ - ¦cov¦ - ¦2¦ ¦ag ents¦ ¦to¦ ¦be¦ ¦tested¦ ¦in¦ ¦clinical¦ ¦trials¦ .
𐋇 ¦ne ve rt he less¦ ,▁ ¦m ut ation¦ ¦r ates¦ ¦of¦ ¦covs¦ ¦are¦ ¦about¦ ¦a¦ ¦million¦ ¦times¦ ¦higher¦ ¦than¦ ¦those¦ ¦of¦ ¦their¦ ¦ho sts¦ .
𐋇¦in¦ ¦add ition¦ ,▁ ¦m ut ation¦ ¦rate¦ ¦is¦ ¦often¦ ¦high¦ ¦when¦ ¦covs¦ ¦are¦ ¦not¦ ¦well¦ ¦ad ap ted¦ ¦to¦ ¦the¦ ¦host¦ .
𐋇 ¦comp ared¦ ¦to¦ ¦sars¦ - ¦cov¦ ¦with¦ ¦a¦ ¦high¦ ¦m ut ation¦ ¦rate¦ ,▁ ¦the¦ ¦m ut ation¦ ¦rate¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦is¦ ¦app a re ntly¦ ¦lower¦ ,▁ ¦su gg es tive¦ ¦of¦ ¦a¦ ¦higher¦ ¦level¦ ¦of¦ ¦ad a pt ation¦ ¦to¦ ¦humans¦ .
𐋇 ¦pres um ab ly¦ ,▁ ¦it¦ ¦has¦ ¦al rea dy¦ ¦been¦ ¦ad ap ted¦ ¦to¦ ¦another¦ ¦host¦ ¦close¦ ¦to¦ ¦humans¦ .
𐋇¦in¦ ¦add ition¦ ¦to¦ ¦sars¦ - ¦cov¦ - ¦2¦ ,▁ ¦this¦ ¦also¦ ¦app l ies¦ ¦to¦ ¦mers¦ - ¦cov¦ ,▁ ¦which¦ ¦is¦ ¦well¦ ¦ad ap ted¦ ¦to¦ ¦dr om ed ary¦ ¦ca m els¦ .
𐋇 ¦the or et ically¦ ,▁ ¦it¦ ¦is¦ ¦un li k ely¦ ¦that¦ ¦gen et ic¦ ¦dr if t¦ ¦would¦ ¦r en der¦ ¦vaccines¦ ¦and¦ ¦anti vir als¦ ¦against¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦i ne ff ective¦ ¦qu ick ly¦ .
𐋇 ¦second¦ ,▁ ¦the¦ ¦large¦ ¦rna¦ ¦gen ome¦ ¦in¦ ¦covs¦ ¦ex er ts¦ ¦ext r a¦ ¦pla st ic ity¦ ¦in¦ ¦gen ome¦ ¦mod ific ation¦ ¦for¦ ¦m ut ations¦ ¦and¦ ¦reco mb ination¦ ,▁ ¦the re b y¦ ¦incre as ing¦ ¦the¦ ¦prob a bility¦ ¦for¦ ¦inter s p ec ies¦ ¦c o¦ - ¦ev ol ution¦ ,▁ ¦which¦ ¦is¦ ¦ad v an ta ge o us¦ ¦for¦ ¦the¦ ¦e mer g ence¦ ¦of¦ ¦novel¦ ¦covs¦ ¦when¦ ¦the¦ ¦conditions¦ ¦bec ome¦ ¦appr op ri ate¦ .
𐋇¦this¦ ¦is¦ ¦supp or ted¦ ¦by¦ ¦the¦ ¦c op ious¦ ¦uni q ue¦ ¦open¦ ¦rea ding¦ ¦fra m es¦ ¦and¦ ¦protein¦ ¦f u nc tions¦ ¦e nc o ded¦ ¦t ow ards¦ ¦the¦ ¦3¦ ▁ ′ ▁ ¦end¦ ¦of¦ ¦the¦ ¦gen ome¦ .
𐋇 ¦thir d¦ ,▁ ¦covs¦ ¦ra nd om ly¦ ¦and¦ ¦fre qu e ntly¦ ¦sw it ch¦ ¦te mpl ates¦ ¦during¦ ¦rna¦ ¦re pl ic ation¦ ¦through¦ ¦a¦ ¦uni q ue¦ ▁ “ ¦c op y¦ - ¦c ho ice¦ ▁ ” ▁ ¦me ch an is m¦ .
𐋇¦in¦ ¦a¦ ¦host¦ ¦that¦ ¦ser ves¦ ¦as¦ ¦the¦ ¦mi x ing¦ ¦v es se l¦ ,▁ ¦ str and¦ ¦sw it c hing¦ ¦occur s¦ ¦fre qu e ntly¦ ¦during¦ ¦cov¦ ¦rna¦ ¦trans c ri ption¦ .
𐋇 ¦high ly¦ ¦h om ol og o us¦ ¦f ul l¦ - ¦le ng th¦ ¦and¦ ¦sub ge nomic¦ ¦r na s¦ ¦could¦ ¦reco mb ine¦ ¦to¦ ¦gener ate¦ ¦new¦ ¦covs¦ .
𐋇 ¦ph y l ogen et ic¦ ¦evidence¦ ¦of¦ ¦nat ural¦ ¦reco mb ination¦ ¦has¦ ¦been¦ ¦found¦ ¦in¦ ¦both¦ ¦hcov¦ - ¦h k u 1¦ ¦and¦ ¦hcov¦ - ¦ oc 4 3¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦anim al¦ ¦covs¦ ¦such¦ ¦as¦ ¦bat¦ ¦s l¦ - ¦cov¦ ¦and¦ ¦b at cov ¦ - ¦h k u 9¦ .
𐋇 ¦virus¦ - ¦host¦ ¦inter a ction¦ ¦in¦ ¦rel ation¦ ¦to¦ ¦transmission¦
𐋇 ¦be si des¦ ¦three¦ ¦viral¦ ¦fa ctors¦ ¦stated¦ ¦a bo ve¦ ,▁ ¦viral¦ ¦inter a ction¦ ¦with¦ ¦host¦ ¦rece pt or¦ ¦is¦ ¦another¦ ¦k e y¦ ¦fa ct or¦ ¦influ e ntial¦ ¦on¦ ¦inter s p ec ies¦ ¦transmission¦ .
𐋇 ¦he re in¦ ,▁ ¦reco mb ination¦ ¦of¦ ¦sars¦ - ¦cov¦ ¦is¦ ¦ta k en¦ ¦as¦ ¦a¦ ¦typ ical¦ ¦example¦ ,▁ ¦which¦ ¦also¦ ¦sh owed¦ ¦evidence¦ ¦of¦ ¦positive¦ ¦se le ction¦ ¦during¦ ¦inter s p ec ies¦ ¦transmission¦ ¦events¦ .
𐋇 ¦based¦ ¦on¦ ¦the¦ ¦comp ar ative¦ ¦anal y sis¦ ¦between¦ ¦isol ates¦ ¦of¦ ¦human¦ ¦and¦ ¦c iv et¦ ¦sars¦ - ¦covs¦ ,▁ ¦sars¦ - ¦cov¦ ¦is¦ ¦th ou gh t¦ ¦to¦ ¦under g o¦ ¦rap id¦ ¦ad a pt ation¦ ¦in¦ ¦different¦ ¦ho sts¦ ,▁ ¦partic ul arly¦ ¦with¦ ¦m ut ations¦ ¦at¦ ¦the¦ ¦r b d¦ ¦of¦ ¦the¦ ¦s¦ ¦protein¦ .
𐋇 ¦gener ally¦ ,▁ ¦the¦ ¦r b d¦ ¦in¦ ¦the¦ ¦s¦ ¦protein¦ ¦of¦ ¦a¦ ¦cov¦ ¦inter ac ts¦ ¦with¦ ¦the¦ ¦ce ll ular¦ ¦rece pt or¦ ¦and¦ ¦is¦ ¦in tens ely¦ ¦s el ected¦ ¦by¦ ¦the¦ ¦host¦ ¦antibo dy¦ ¦response¦ .
𐋇¦in¦ ¦sars¦ - ¦cov¦ ,▁ ¦the¦ ¦r b d¦ ¦is¦ ¦in¦ ¦the¦ ¦3 1 8 th¦ ¦to¦ ¦5 1 0 th¦ ¦a min o¦ ¦ac i ds¦ ¦on¦ ¦the¦ ¦s 1¦ ¦fra g ment¦ ,▁ ¦which¦ ¦b in ds¦ ¦to¦ ¦the¦ ¦human¦ ¦a ce 2¦ ¦as¦ ¦well¦ ¦as¦ ¦its¦ ¦co re ce pt ors¦ ¦for¦ ¦viral¦ ¦ent ry¦ .
𐋇¦the¦ ¦r b d¦ ¦of¦ ¦sars¦ - ¦cov¦ ¦is¦ ¦c ap able¦ ¦of¦ ¦reco gn iz ing¦ ¦the¦ ¦a ce 2¦ ¦rece pt ors¦ ¦of¦ ¦v ar ious¦ ¦anim als¦ ,▁ ¦including¦ ¦bat¦ ,▁ ¦c iv et¦ ,▁ ¦mo use¦ ¦and¦ ¦r ac c o on¦ ¦do g¦ ,▁ ¦all owing¦ ¦inter s p ec ies¦ ¦transmission¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦in¦ ¦f ac t¦ ,▁ ¦only¦ ¦6¦ ¦a min o¦ ¦ac id¦ ¦res id ues¦ ¦were¦ ¦ob s erv ed¦ ¦to¦ ¦be¦ ¦different¦ ¦from¦ ¦human¦ ¦and¦ ¦c iv et¦ ¦viral¦ ¦isol ates¦ ¦in¦ ¦the¦ ¦r b d¦ ¦and¦ ¦4¦ ¦of¦ ¦them¦ ¦loc ate¦ ¦in¦ ¦the¦ ¦rece pt or¦ - ¦b in ding¦ ¦mo ti f¦ ¦for¦ ¦inter a ction¦ ¦with¦ ¦the¦ ¦a ce 2¦ ¦rece pt or¦ .
𐋇¦c iv et¦ ¦sars¦ - ¦cov¦ ¦has¦ ¦k 4 7 9 n¦ ¦and¦ ¦s 4 8 7 t¦ ¦m ut ations¦ ¦in¦ ¦its¦ ¦r b d¦ ,▁ ¦which¦ ¦might¦ ¦increase¦ ¦the¦ ¦aff in ity¦ ¦of¦ ¦the¦ ¦inter a ction¦ ¦of¦ ¦sp i ke¦ ¦protein¦ ¦with¦ ¦human¦ ¦a ce 2¦ ¦rece pt or¦ .
𐋇¦in¦ ¦other¦ ¦wor ds¦ ,▁ ¦these¦ ¦two¦ ¦a min o¦ ¦ac id¦ ¦sub st itu tions¦ ¦might¦ ¦be¦ ¦crit ical¦ ¦to¦ ¦viral¦ ¦ad a ption¦ ¦to¦ ¦humans¦ .
𐋇¦it¦ ¦is¦ ¦no te w or th y¦ ¦that¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦sh ar es¦ ¦the¦ ¦same¦ ¦ce ll ular¦ ¦rece pt or¦ ¦with¦ ¦sars¦ - ¦cov¦ .
𐋇¦a¦ ¦30¦ %▁ ¦di ff er ence¦ ¦between¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦and¦ ¦sars¦ - ¦cov¦ ¦in¦ ¦the¦ ¦s 1¦ ¦uni t¦ ¦of¦ ¦the¦ ¦s¦ ¦protein¦ ¦i mpl ic ates¦ ¦that¦ ¦the¦ ¦b in ding¦ ¦aff in ity¦ ¦of¦ ¦its¦ ¦s¦ ¦protein¦ ¦with¦ ¦human¦ ¦a ce 2¦ ¦might¦ ¦have¦ ¦al t ered¦ .
𐋇 ¦in de ed¦ ,▁ ¦a¦ ¦cr y o¦ - ¦e m¦ ¦study¦ ¦indic ates¦ ¦a¦ ¦10¦ - ▁ ¦to¦ ¦20¦ - ¦fo ld¦ ¦higher¦ ¦aff in ity¦ ¦of¦ ¦this¦ ¦b in ding¦ ¦than¦ ¦that¦ ¦between¦ ¦human¦ ¦a ce 2¦ ¦and¦ ¦sars¦ - ¦cov¦ ¦s¦ ¦protein¦ .
𐋇¦it¦ ¦will¦ ¦also¦ ¦be¦ ¦of¦ ¦inter est¦ ¦to¦ ¦det erm ine¦ ¦wh ether¦ ¦any¦ ¦other¦ ¦co re ce pt or¦ ¦might¦ ¦be¦ ¦required¦ ¦for¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦transmission¦ .
𐋇 ¦int r ig u i ng ly¦ ,▁ ¦hcov¦ - ¦n l 6 3¦ ¦also¦ ¦b in ds¦ ¦to¦ ¦a ce 2¦ ¦but¦ ¦with¦ ¦a¦ ¦different¦ ¦par t¦ ¦of¦ ¦s¦ .
𐋇¦there¦ ¦ex ist¦ ¦many¦ ¦other¦ ¦hcov¦ ¦rece pt ors¦ ,▁ ¦such¦ ¦as¦ ¦a min op e pt id ase¦ ¦ n¦ ¦for¦ ¦hcov¦ - ¦22 9 e¦ ,▁ ¦and¦ ¦9¦ - ¦ o¦ - ¦ac et y l ated¦ ¦si al ic¦ ¦ac id¦ ¦for¦ ¦hcov¦ - ¦ oc 4 3¦ .
𐋇¦they¦ ¦might¦ ¦also¦ ¦acc o un t¦ ¦for¦ ¦s uc cess ful¦ ¦ad a pt ation¦ ¦of¦ ¦these¦ ¦covs¦ ¦in¦ ¦humans¦ ¦after¦ ¦inter s p ec ies¦ ¦transmission¦ ¦from¦ ¦their¦ ¦anim al¦ ¦ho sts¦ .
𐋇¦in¦ ¦add ition¦ ¦to¦ ¦ce ll ular¦ ¦rece pt ors¦ ,▁ ¦the¦ ¦out c ome¦ ¦of¦ ¦inter s p ec ies¦ ¦transmission¦ ¦of¦ ¦hcovs¦ ¦is¦ ¦also¦ ¦gover ned¦ ¦by¦ ¦other¦ ¦host¦ ¦dep en de ncy¦ ¦and¦ ¦re st ri ction¦ ¦fa ctors¦ .
𐋇¦the¦ ¦di ver g ence¦ ¦of¦ ¦these¦ ¦host¦ ¦prote ins¦ ¦between¦ ¦humans¦ ¦and¦ ¦nat ural¦ ¦res erv oi r¦ ¦ho sts¦ ¦of¦ ¦hcovs¦ ¦such¦ ¦as¦ ¦bats¦ ,▁ ¦dr om ed ary¦ ¦ca m els¦ ¦and¦ ¦ro d ents¦ ¦might¦ ¦con st it ute¦ ¦a¦ ¦b ar ri er¦ ¦to¦ ¦inter s p ec ies¦ ¦transmission¦ .
𐋇 ¦hcovs¦ ¦have¦ ¦to¦ ¦us ur p¦ ¦host¦ ¦dep en de ncy¦ ¦fa ctors¦ ¦and¦ ¦sub ver t¦ ¦host¦ ¦re st ri ction¦ ¦fa ctors¦ ¦for¦ ¦a¦ ¦s uc cess ful¦ ¦inter s p ec ies¦ ¦transmission¦ .
𐋇¦in¦ ¦this¦ ¦reg ard¦ ,▁ ¦m ol ec ular¦ ¦det er mi na nts¦ ¦in¦ ¦this¦ ¦important¦ ¦a rea¦ ¦of¦ ¦virus¦ - ¦host¦ ¦inter a ction¦ ¦remain¦ ¦to¦ ¦be¦ ¦identified¦ ¦and¦ ¦ch ara ct eri zed¦ .
𐋇 ¦an¦ ¦un b ia sed¦ ¦gen ome¦ - ¦w ide¦ ¦scre ening¦ ¦of¦ ¦host¦ ¦dep en de ncy¦ ¦and¦ ¦re st ri ction¦ ¦fa ctors¦ ¦for¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦using¦ ¦the¦ ¦state¦ - ¦of¦ - ¦the¦ - ¦ar t¦ ¦techn ology¦ ¦of¦ ¦cr is p r¦ ¦might¦ ¦be¦ ¦f ru it ful¦ .
𐋇¦e mer g ence¦ ¦of¦ ¦novel¦ ¦hcovs¦ :▁ 𐋇¦b ack¦ ¦to¦ ¦grou n d¦ ¦z er o¦
𐋇¦the¦ ¦di ve rs ity¦ ¦of¦ ¦bat¦ ¦covs¦ ¦provid es¦ ¦a mp le¦ ¦o pp ort un ities¦ ¦for¦ ¦the¦ ¦e mer g ence¦ ¦of¦ ¦novel¦ ¦hcovs¦ .
𐋇¦in¦ ¦this¦ ¦sen se¦ ,▁ ¦bat¦ ¦covs¦ ¦ser ve¦ ¦as¦ ¦the¦ ¦gen e¦ ¦p oo l¦ ¦of¦ ¦hcovs¦ .
𐋇¦in¦ ¦add ition¦ ,▁ ¦rap id¦ ¦m ut ation¦ ¦and¦ ¦gen et ic¦ ¦reco mb ination¦ ¦also¦ ¦dr ive¦ ¦hcov¦ ¦ev ol ution¦ ¦and¦ ¦ser ve¦ ¦as¦ ¦two¦ ¦important¦ ¦ste ps¦ ¦in¦ ¦this¦ ¦proc ess¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦the¦ ¦ac qu is ition¦ ¦or¦ ¦l os s¦ ¦of¦ ¦novel¦ ¦protein¦ - ¦co ding¦ ¦gen es¦ ¦has¦ ¦the¦ ¦pote ntial¦ ¦to¦ ¦d ra st ically¦ ¦mod if y¦ ¦viral¦ ¦ph en ot y p es¦ .
𐋇 ¦among¦ ¦sars¦ - ¦cov¦ ¦ac cess ory¦ ¦prote ins¦ ,▁ ¦or f 8¦ ¦has¦ ¦been¦ ¦th ou gh t¦ ¦to¦ ¦be¦ ¦important¦ ¦in¦ ¦ad a pt ation¦ ¦to¦ ¦humans¦ ,▁ ¦as¦ ¦sars¦ - ¦cov¦ - ¦related¦ ¦bat¦ ¦viruses¦ ¦were¦ ¦isol ated¦ ¦but¦ ¦found¦ ¦to¦ ¦e nc o de¦ ¦di ver g ent¦ ¦or f 8¦ ¦prote ins¦ .
𐋇¦a¦ ¦2 9¦ - ¦n uc le ot ide¦ ¦del et ion¦ ¦ch ara ct er ist ic¦ ¦of¦ ¦sars¦ - ¦covs¦ ¦has¦ ¦been¦ ¦found¦ ¦in¦ ¦stra ins¦ ¦isol ated¦ ¦at¦ ¦the¦ ¦beg in ning¦ ¦of¦ ¦the¦ ¦human¦ ¦epidemic¦ .
𐋇¦this¦ ¦del et ion¦ ¦sp li ts¦ ¦or f 8¦ ¦into¦ ¦or f 8 a¦ ¦and¦ ¦or f 8 b ¦ ¦and¦ ¦is¦ ¦th ou gh t¦ ¦to¦ ¦be¦ ¦an¦ ¦ad ap tive¦ ¦m ut ation¦ ¦that¦ ¦pro mo tes¦ ¦the¦ ¦sw it ch¦ ¦of¦ ¦ho sts¦ .
𐋇 ¦be si des¦ ,▁ ¦sars¦ - ¦cov¦ ¦has¦ ¦a¦ ¦possible¦ ¦reco mb ination¦ ¦h ist ory¦ ¦with¦ ¦l in ea ges¦ ¦of¦ ¦al ph a¦ - ▁ ¦and¦ ¦ga mm a¦ - ¦covs¦ ,▁ ¦where¦ ¦a¦ ¦large¦ ¦number¦ ¦of¦ ¦s ma ll er¦ ¦reco mb in ant¦ ¦regi ons¦ ¦were¦ ¦identified¦ ¦in¦ ¦the¦ ¦rna¦ - ¦dep end ent¦ ¦rna¦ ¦pol y mer ase¦ .
𐋇 ¦reco mb ination¦ ¦loc ations¦ ¦were¦ ¦also¦ ¦identified¦ ¦in¦ ¦the¦ ¦ ns p 9¦ ,▁ ¦most¦ ¦of¦ ¦ ns p 1 0¦ ,▁ ¦and¦ ¦par ts¦ ¦of¦ ¦ ns p 1 4¦ .
𐋇 ¦li k e w ise¦ ,▁ ¦it¦ ¦has¦ ¦been¦ ¦sh own¦ ¦that¦ ¦the¦ ¦epidemic¦ ¦mers¦ - ¦cov¦ ¦exp er ie nc ed¦ ¦reco mb ination¦ ¦events¦ ¦between¦ ¦different¦ ¦l in ea ges¦ ,▁ ¦which¦ ¦occur r ed¦ ¦in¦ ¦dr om ed ary¦ ¦ca m els¦ ¦in¦ ¦sa ud i¦ ¦ar ab ia¦ .
𐋇 ¦be si des¦ ¦sars¦ - ¦cov¦ ¦and¦ ¦mers¦ - ¦cov¦ ,▁ ¦reco mb ination¦ ¦events¦ ¦have¦ ¦also¦ ¦been¦ ¦ob s erv ed¦ ¦in¦ ¦other¦ ¦hcovs¦ ,▁ ¦in¦ ¦which¦ ¦the¦ ¦hcovs¦ ¦reco mb ine¦ ¦with¦ ¦other¦ ¦anim al¦ ¦covs¦ ¦in¦ ¦their¦ ¦non¦ - ¦st ru ct ural¦ ¦gen es¦ .
𐋇¦it¦ ¦should¦ ¦also¦ ¦be¦ ¦ca u tion ed¦ ¦that¦ ¦a rt ific ial¦ ¦se le ction¦ ¦can¦ ¦cont rib ute¦ ¦to¦ ¦un in te nded¦ ¦chan ges¦ ¦in¦ ¦viral¦ ¦gen omes¦ ,▁ ¦most¦ ¦likely¦ ¦res ul ting¦ ¦from¦ ¦rel ie ving¦ ¦viruses¦ ¦from¦ ¦se le ction¦ ¦pre ss ures¦ ¦ex er ted¦ ,▁ ¦such¦ ¦as¦ ¦by¦ ¦the¦ ¦host¦ ¦immune¦ ¦system¦ .
𐋇 ¦an¦ ¦example¦ ¦of¦ ¦these¦ ¦eff ects¦ ¦is¦ ¦the¦ ¦l os s¦ ¦of¦ ¦a¦ ¦f ul l¦ - ¦le ng th¦ ¦or f 4¦ ¦in¦ ¦the¦ ¦hcov¦ - ¦22 9 e¦ ¦prot ot y p e¦ ¦stra in¦ ,▁ ¦ owing¦ ¦to¦ ¦a¦ ¦two¦ - ¦n uc le ot ide¦ ¦del et ion¦ .
𐋇 ¦while¦ ¦int ac t¦ ¦or f 4¦ ¦could¦ ¦be¦ ¦ob s erv ed¦ ¦in¦ ¦bat¦ ¦and¦ ¦ca me l¦ ¦viruses¦ ¦related¦ ¦to¦ ¦hcov¦ - ¦22 9 e¦ ,▁ ¦the¦ ¦al p ac a¦ ¦al ph a¦ - ¦cov¦ ¦dis pl ays¦ ¦a¦ ¦si ng le¦ ¦n uc le ot ide¦ ¦in se rt ion¦ ,▁ ¦res ul ting¦ ¦in¦ ¦a¦ ¦fra m es h if t¦ .
𐋇 ¦last¦ ¦but¦ ¦not¦ ¦least¦ ,▁ ¦the¦ ¦ev ol ution¦ ¦of¦ ¦novel¦ ¦hcovs¦ ¦is¦ ¦also¦ ¦dr iv en¦ ¦by¦ ¦the¦ ¦se le ction¦ ¦pre ss ure¦ ¦in¦ ¦their¦ ¦res erv oi r¦ ¦ho sts¦ .
𐋇 ¦as ymptomatic¦ ¦or¦ ¦only¦ ¦mild¦ ¦symptoms¦ ¦were¦ ¦detected¦ ¦when¦ ¦bats¦ ¦were¦ ¦infected¦ ¦with¦ ¦covs¦ ,▁ ¦indic ating¦ ¦the¦ ¦m ut ual¦ ¦ad a pt ation¦ ¦between¦ ¦covs¦ ¦and¦ ¦bats¦ .
𐋇¦it¦ ¦app e ared¦ ¦that¦ ¦bats¦ ¦are¦ ¦well¦ ¦ad ap ted¦ ¦to¦ ¦covs¦ ¦an at om ically¦ ¦and¦ ¦ph y si ol og ically¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦def ects¦ ¦in¦ ¦the¦ ¦activ ation¦ ¦of¦ ¦pr o¦ - ¦inf la mm atory¦ ¦response¦ ¦in¦ ¦bats¦ ¦eff ic ie ntly¦ ¦reduce¦ ¦the¦ ¦path ology¦ ¦t ri gg ered¦ ¦by¦ ¦covs¦ .
𐋇 ¦be si des¦ ,▁ ¦the¦ ¦nat ural¦ ¦ki ll er¦ ¦c ell¦ ¦activ ity¦ ¦in¦ ¦bats¦ ¦is¦ ¦supp r es sed¦ ¦due¦ ¦to¦ ¦up re g ul ation¦ ¦of¦ ¦in hi b it ory¦ ¦nat ural¦ ¦ki ll er¦ ¦c ell¦ ¦rece pt or¦ ¦n k g 2¦ ▁/▁ ¦c d 9 4¦ ¦and¦ ¦low¦ ¦exp re ssion¦ ¦level¦ ¦of¦ ¦major¦ ¦h ist oc om pa ti bility¦ ¦comp le x¦ ¦cl ass¦ ¦i¦ ¦m ol ecu les¦ .
𐋇 ¦mo re o ver¦ ,▁ ¦the¦ ¦high¦ ¦level¦ ¦of¦ ¦re ac tive¦ ¦o x yg en¦ ¦spec ies¦ ▁( ¦ro s¦ )▁ ¦gener ated¦ ¦from¦ ¦high¦ ¦met ab ol ic¦ ¦activ ity¦ ¦of¦ ¦bats¦ ¦could¦ ¦both¦ ¦supp r ess¦ ¦cov¦ ¦re pl ic ation¦ ¦and¦ ¦aff ects¦ ¦pr oo f rea ding¦ ¦by¦ ¦ex o rib on uc le ase¦ ,▁ ¦th us¦ ¦provid ing¦ ¦the¦ ¦se le ction¦ ¦pre ss ure¦ ¦for¦ ¦the¦ ¦gener ation¦ ¦of¦ ¦virus¦ ¦stra ins¦ ¦high ly¦ ¦path ogen ic¦ ¦when¦ ¦int ro duc ed¦ ¦into¦ ¦a¦ ¦new¦ ¦host¦ .
𐋇 ¦more¦ ¦path ogen ic¦ ¦cov¦ ¦stra ins¦ ¦might¦ ¦also¦ ¦ev ol ve¦ ¦by¦ ¦reco mb ination¦ ,▁ ¦lea ding¦ ¦to¦ ¦the¦ ¦ac qu is ition¦ ¦of¦ ¦novel¦ ¦prote ins¦ ¦or¦ ¦protein¦ ¦fe at ures¦ ¦for¦ ¦host¦ ¦ad a pt ation¦ .
𐋇 ¦th us¦ ,▁ ¦it¦ ¦is¦ ¦not¦ ¦by¦ ¦ch ance¦ ¦that¦ ¦three¦ ¦novel¦ ¦hcovs¦ ¦have¦ ¦e mer ged¦ ¦in¦ ¦the¦ ¦p ast¦ ¦two¦ ¦dec a des¦ .
𐋇 ¦covs¦ ¦are¦ ¦non¦ - ¦path ogen ic¦ ¦or¦ ¦cause¦ ¦mild¦ ¦symptoms¦ ¦in¦ ¦their¦ ¦res erv oi r¦ ¦ho sts¦ ¦such¦ ¦as¦ ¦bats¦ ¦and¦ ¦ca m els¦ .
𐋇¦they¦ ¦re pl ic ate¦ ¦r ob u st ly¦ ¦without¦ ¦el ici ting¦ ¦a¦ ¦st ro ng¦ ¦host¦ ¦immune¦ ¦response¦ .
𐋇 ¦he re in¦ ¦li e¦ ¦the¦ ¦sec r ets¦ ¦of¦ ¦wh y¦ ¦as ymptomatic¦ ¦car ri ers¦ ¦are¦ ¦se en¦ ¦and¦ ¦what¦ ¦ca u ses¦ ¦the¦ ¦severe¦ ¦cases¦ ¦in¦ ¦human¦ ¦infection¦ .
𐋇¦the¦ ¦severe¦ ¦symptoms¦ ¦are¦ ¦main ly¦ ¦due¦ ¦to¦ ¦the¦ ¦h y p e ra ct iv ation¦ ¦of¦ ¦immune¦ ¦response¦ ¦and¦ ¦the¦ ¦c y t o k ine¦ ¦st or m¦ ¦w he re in¦ ¦the¦ ¦st ro nger¦ ¦the¦ ¦immune¦ ¦response¦ ,▁ ¦the¦ ¦more¦ ¦severe¦ ¦the¦ ¦lu ng¦ ¦da m age¦ .
𐋇¦in¦ ¦contr ast¦ ,▁ ¦in¦ ¦as ymptomatic¦ ¦car ri ers¦ ,▁ ¦the¦ ¦immune¦ ¦response¦ ¦has¦ ¦been¦ ¦de¦ - ¦cou pl ed¦ ¦from¦ ¦cov¦ ¦re pl ic ation¦ .
𐋇¦the¦ ¦same¦ ¦stra te g y¦ ¦of¦ ¦del in king¦ ¦the¦ ¦immune¦ ¦response¦ ¦might¦ ¦have¦ ¦be ne f ic ial¦ ¦eff ects¦ ¦in¦ ¦anti ¦ - ¦sars¦ - ¦cov¦ - ¦2¦ ¦ ther ap y¦ .
𐋇¦the¦ ¦inter f er on¦ ¦response¦ ¦is¦ ¦partic ul arly¦ ¦st ro ng¦ ¦in¦ ¦bats¦ .
𐋇 ¦th us¦ ,▁ ¦admin i str ation¦ ¦of¦ ¦typ e¦ ¦i¦ ¦inter f er on¦ ¦at¦ ¦least¦ ¦in¦ ¦the¦ ¦early¦ ¦ph ase¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦infection¦ ¦in¦ ¦humans¦ ¦should¦ ¦be¦ ¦be ne f ic ial¦ .
𐋇¦in¦ ¦add ition¦ ,▁ ¦n l r p 3¦ ¦inf la mm as ome¦ ¦activ ation¦ ¦in¦ ¦bats¦ ¦is¦ ¦def ective¦ .
𐋇¦by¦ ¦this¦ ¦re as o ning¦ ,▁ ¦in hi b ition¦ ¦of¦ ¦n l r p 3¦ ¦inf la mm as ome¦ ¦with¦ ¦m c c 9 5 0¦ ¦might¦ ¦be¦ ¦u se ful¦ ¦in¦ ¦the¦ ¦treatment¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇¦the¦ ¦e mer g ence¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦fo ll ow s¦ ¦the¦ ¦general¦ ¦the me¦ ¦by¦ ¦which¦ ¦sars¦ - ¦cov¦ ¦and¦ ¦mers¦ - ¦cov¦ ¦ar ose¦ .
𐋇¦w he rea s¦ ¦a¦ ¦bat¦ ¦bet a¦ - ¦cov¦ ¦sh ar ing¦ ¦9 5¦ %▁ ¦n uc le ot ide¦ ¦h om ology¦ ¦with¦ ¦sars¦ - ¦cov¦ ¦has¦ ¦been¦ ¦found¦ ,▁ ¦there¦ ¦also¦ ¦e xi sts¦ ¦a¦ ¦bat¦ - ¦cov¦ ¦sh ar ing¦ ¦9 6¦ %▁ ¦n uc le ot ide¦ ¦h om ology¦ ¦with¦ ¦sars¦ - ¦cov¦ - ¦2¦ .
𐋇¦w he rea s¦ ¦c iv ets¦ ¦and¦ ¦other¦ ¦anim als¦ ¦in¦ ¦the¦ ¦mark ets¦ ¦have¦ ¦been¦ ¦found¦ ¦to¦ ¦h ar b ou r¦ ¦viruses¦ ¦ident ical¦ ¦to¦ ¦sars¦ - ¦cov¦ ,▁ ¦immediate¦ ¦int erm ediate¦ ¦ho sts¦ ¦for¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦have¦ ¦not¦ ¦been¦ ¦identified¦ .
𐋇 ¦pa ngol in¦ ¦bet a¦ - ¦covs¦ ¦st ri k i ng ly¦ ¦h om ol og o us¦ ¦to¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦have¦ ¦been¦ ¦found¦ ,▁ ¦indic ating¦ ¦that¦ ¦pa ngol ins¦ ¦might¦ ¦ser ve¦ ¦as¦ ¦one¦ ¦of¦ ¦int erm ediate¦ ¦ho sts¦ ¦or¦ ¦pa ngol in¦ ¦bet a¦ - ¦covs¦ ¦could¦ ¦cont rib ute¦ ¦gen e¦ ¦fra g ments¦ ¦to¦ ¦the¦ ¦f in al¦ ¦ ve rs ion¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ .
𐋇 ¦al th ough¦ ¦qu es tions¦ ¦remain¦ ,▁ ¦there¦ ¦is¦ ¦no¦ ¦evidence¦ ¦that¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦is¦ ¦m an¦ - ¦made¦ ¦e it her¦ ¦de li b erat ely¦ ¦or¦ ¦acc ide nt ally¦ .
𐋇 ¦covs¦ ¦have¦ ¦retur ned¦ ¦to¦ ¦the¦ ¦l im el ight¦ ¦due¦ ¦to¦ ¦the¦ ¦rec ent¦ ¦outbreak¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ .
𐋇¦the¦ ¦study¦ ¦of¦ ¦covs¦ ¦in¦ ¦bats¦ ¦and¦ ¦other¦ ¦anim als¦ ¦has¦ ¦d ra st ically¦ ¦chan ged¦ ¦our¦ ¦per ce ption¦ ¦of¦ ¦the¦ ¦imp ort ance¦ ¦of¦ ¦z o on ot ic¦ ¦orig ins¦ ¦and¦ ¦anim al¦ ¦res erv o ir s¦ ¦of¦ ¦hcovs¦ ¦in¦ ¦human¦ ¦transmission¦ .
𐋇¦p erv as ive¦ ¦evidence¦ ¦has¦ ¦sh own¦ ¦that¦ ¦sars¦ - ¦cov¦ ,▁ ¦mers¦ - ¦cov¦ ¦and¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦have¦ ¦a¦ ¦bat¦ ¦orig in¦ ¦and¦ ¦are¦ ¦transm it ted¦ ¦to¦ ¦humans¦ ¦v ia¦ ¦int erm ediate¦ ¦ho sts¦ .
𐋇 ¦giv en¦ ¦that¦ ¦sars¦ - ¦cov¦ ¦infection¦ ¦orig in ates¦ ¦from¦ ¦the¦ ¦contact¦ ¦between¦ ¦humans¦ ¦and¦ ¦c iv ets¦ ¦in¦ ¦the¦ ¦mark ets¦ ,▁ ¦clos ing¦ ¦w et¦ ¦mark ets¦ ¦and¦ ¦ki lling¦ ¦c iv ets¦ ¦the re in¦ ¦could¦ ¦have¦ ¦eff ect ively¦ ¦e nded¦ ¦the¦ ¦sars¦ ¦epidemic¦ .
𐋇¦by¦ ¦the¦ ¦same¦ ¦re as o ning¦ ,▁ ¦pa ngol ins¦ ¦should¦ ¦be¦ ¦rem oved¦ ¦from¦ ¦w et¦ ¦mark ets¦ ¦to¦ ¦prevent¦ ¦z o on ot ic¦ ¦transmission¦ ,▁ ¦in¦ ¦v ie w¦ ¦of¦ ¦the¦ ¦disc o ve ry¦ ¦of¦ ¦mult ip le¦ ¦l in ea ges¦ ¦of¦ ¦pa ngol in¦ ¦bet a¦ - ¦covs¦ ¦clos ely¦ ¦related¦ ¦to¦ ¦sars¦ - ¦cov¦ - ¦2¦ .
𐋇¦however¦ ,▁ ¦wh ether¦ ¦and¦ ¦how¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦is¦ ¦transm it ted¦ ¦to¦ ¦humans¦ ¦through¦ ¦pa ngol ins¦ ¦and¦ ¦other¦ ¦ma mm als¦ ¦remain¦ ¦to¦ ¦be¦ ¦cl ar if ied¦ ¦in¦ ¦f ut ure¦ ¦in ve st ig ations¦ .
𐋇¦on¦ ¦the¦ ¦other¦ ¦hand¦ ,▁ ¦mers¦ - ¦cov¦ ¦has¦ ¦ex is ted¦ ¦in¦ ¦dr om ed ary¦ ¦ca m els¦ ¦for¦ ¦a¦ ¦long¦ ¦time¦ .
𐋇¦these¦ ¦ca m els¦ ¦ser ve¦ ¦as¦ ¦an¦ ¦important¦ ¦t oo l¦ ¦for¦ ¦trans p ort ation¦ ¦as¦ ¦well¦ ¦as¦ ¦a¦ ¦ma in¦ ¦sour ce¦ ¦of¦ ¦me at¦ ,▁ ¦m il k¦ ,▁ ¦le at her¦ ¦and¦ ¦w oo l¦ ¦produc ts¦ ¦for¦ ¦the¦ ¦local¦ ¦people¦ .
𐋇¦they¦ ¦are¦ ¦wid ely¦ ¦d ist rib u ted¦ ¦across¦ ¦the¦ ¦m id d le¦ ¦e ast¦ ¦and¦ ¦afr ica¦ .
𐋇¦it¦ ¦is¦ ¦the re f ore¦ ¦imp os si ble¦ ¦to¦ ¦s ac r if ice¦ ¦all¦ ¦ca m els¦ ¦for¦ ¦the¦ ¦control¦ ¦of¦ ¦mers¦ ,▁ ¦as¦ ¦what¦ ¦was¦ ¦d one¦ ¦in¦ ¦w i ld¦ ¦anim al¦ ¦mark ets¦ ¦in¦ ¦china¦ ¦to¦ ¦prevent¦ ¦the¦ ¦sprea ding¦ ¦of¦ ¦sars¦ - ¦cov¦ ¦and¦ ¦sars¦ - ¦cov¦ - ¦2¦ .
𐋇¦to¦ ¦sto p¦ ¦the¦ ¦rec ur r ent¦ ¦out b rea ks¦ ¦of¦ ¦mers¦ ,▁ ¦a¦ ¦comp re he ns ive¦ ¦appro a ch¦ ¦should¦ ¦be¦ ¦ta k en¦ ¦to¦ ¦develop ¦ ¦effective¦ ¦vaccines¦ ¦against¦ ¦mers¦ - ¦cov¦ ¦for¦ ¦ca m els¦ ,▁ ¦in¦ ¦co mb ination¦ ¦with¦ ¦other¦ ¦infection¦ ¦control¦ ¦measures¦ .
𐋇¦as¦ ¦we¦ ¦are¦ ¦not¦ ¦able¦ ¦to¦ ¦e li min ate¦ ¦these¦ ¦viruses¦ ,▁ ¦new¦ ¦gen ot y p es¦ ¦might¦ ¦e mer ge¦ ¦to¦ ¦cause¦ ¦out b rea ks¦ .
𐋇¦a¦ ¦vari et y¦ ¦of¦ ¦z o on ot ic¦ ¦covs¦ ¦are¦ ¦c ir c ul ating¦ ¦in¦ ¦the¦ ¦w i ld¦ .
𐋇 ¦partic ul arly¦ ,▁ ¦bat¦ ¦covs¦ ¦with¦ ¦z o on ot ic¦ ¦pote ntial¦ ¦are¦ ¦so¦ ¦di ver se¦ .
𐋇¦there¦ ¦are¦ ¦p le nt y¦ ¦of¦ ¦o pp ort un ities¦ ¦that¦ ¦these¦ ¦z o on ot ic¦ ¦covs¦ ¦ev ol ve¦ ¦and¦ ¦reco mb ine¦ ,▁ ¦res ul ting¦ ¦in¦ ¦the¦ ¦e mer g ence¦ ¦of¦ ¦new¦ ¦covs¦ ¦that¦ ¦are¦ ¦more¦ ¦transm is si ble¦ ¦and¦ ▁/▁ ¦or¦ ¦d ea d ly¦ ¦in¦ ¦humans¦ ¦in¦ ¦f ut ure¦ .
𐋇¦the¦ ¦c ult ure¦ ¦of¦ ¦e ating¦ ¦w i ld¦ ¦anim als¦ ¦in¦ ¦some¦ ¦places¦ ¦of¦ ¦china¦ ¦should¦ ¦be¦ ¦ab a nd o ned¦ ¦to¦ ¦reduce¦ ¦un ne cess ary¦ ¦contact¦ ¦between¦ ¦humans¦ ¦and¦ ¦anim als¦ .
𐋇 ¦with¦ ¦the¦ ¦or de als¦ ¦of¦ ¦sars¦ ,▁ ¦mers¦ ¦and¦ ¦covid¦ - ¦19¦ ,▁ ¦a¦ ¦bet ter¦ ¦pre par ed ness¦ ¦and¦ ¦response¦ ¦pl an¦ ¦should¦ ¦be¦ ¦in¦ ¦place¦ .
𐋇¦in¦ ¦f ac t¦ ,▁ ¦many¦ ¦viruses¦ ¦have¦ ¦ex is ted¦ ¦in¦ ¦the¦ ¦pl an et¦ ¦for¦ ¦a¦ ¦very¦ ¦long¦ ¦time¦ .
𐋇¦they¦ ¦stay¦ ¦in¦ ¦their¦ ¦ own¦ ¦nat ural¦ ¦res erv o ir s¦ ¦until¦ ¦there¦ ¦is¦ ¦a¦ ¦ch ance¦ ¦for¦ ¦sp il lo ver¦ .
𐋇 ¦al th ough¦ ¦bats¦ ¦have¦ ¦many¦ ¦fe at ures¦ ¦that¦ ¦fa v o ur s¦ ¦the¦ ¦sprea ding¦ ¦of¦ ¦viruses¦ ,▁ ¦the¦ ¦ch ance¦ ¦for¦ ¦humans¦ ¦to¦ ¦be¦ ¦in¦ ¦contact¦ ¦with¦ ¦bats¦ ¦and¦ ¦other¦ ¦w ild l ife¦ ¦spec ies¦ ¦can¦ ¦be¦ ¦min i mi zed¦ ¦if¦ ¦people¦ ¦are¦ ¦e duc ated¦ ¦to¦ ¦stay¦ ¦away¦ ¦from¦ ¦them¦ .
𐋇 ¦contin u o us¦ ¦surveillance¦ ¦in¦ ¦ma mm als¦ ¦is¦ ¦ne cess ary¦ ¦for¦ ¦bet ter¦ ¦under st an ding¦ ¦of¦ ¦the¦ ¦ec ology¦ ¦of¦ ¦covs¦ ¦and¦ ¦their¦ ¦nat ural¦ ¦ho sts¦ ,▁ ¦which¦ ¦will¦ ¦pro ve¦ ¦u se ful¦ ¦in¦ ¦prev en ting¦ ¦anim al¦ - ¦to¦ - ¦human¦ ¦transmission¦ ¦and¦ ¦f ut ure¦ ¦out b rea ks¦ .
𐋇¦to¦ ¦co nc lu de¦ ,▁ ¦the¦ ¦most¦ ¦effective¦ ¦way¦ ¦to¦ ¦prevent¦ ¦viral¦ ¦z oo no sis¦ ¦is¦ ¦for¦ ¦humans¦ ¦to¦ ¦stay¦ ¦away¦ ¦from¦ ¦the¦ ¦ec ological¦ ¦n i ches¦ ¦of¦ ¦the¦ ¦nat ural¦ ¦res erv o ir s¦ ¦of¦ ¦the¦ ¦z o on ot ic¦ ¦viruses¦ .
𐋇 ¦several¦ ¦p ie ces¦ ¦in¦ ¦the¦ ¦p u z z le¦ ¦of¦ ¦the¦ ¦z o on ot ic¦ ¦orig in¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦are¦ ¦still¦ ¦mi ss ing¦ .
𐋇 ¦first¦ ,▁ ¦if¦ ¦bats¦ ¦trans mi t¦ ¦an¦ ¦an ce str al¦ ¦virus¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦to¦ ¦pa ngol ins¦ ,▁ ¦it¦ ¦will¦ ¦be¦ ¦of¦ ¦inter est¦ ¦to¦ ¦se e¦ ¦under¦ ¦what¦ ¦c ir c um st an ces¦ ¦bats¦ ¦and¦ ¦pa ngol ins¦ ¦could¦ ¦share¦ ¦the¦ ¦same¦ ¦ec ological¦ ¦n i ch e¦ .
𐋇 ¦second¦ ,▁ ¦if¦ ¦bats¦ ¦pl ay¦ ¦a¦ ¦more¦ ¦direct¦ ¦ro le¦ ¦in¦ ¦human¦ ¦transmission¦ ,▁ ¦how¦ ¦humans¦ ¦get¦ ¦into¦ ¦contact¦ ¦with¦ ¦bats¦ ¦should¦ ¦be¦ ¦det erm ined¦ .
𐋇 ¦thir d¦ ,▁ ¦if¦ ¦a¦ ¦thir d¦ ¦ma mm al¦ ¦ac ts¦ ¦as¦ ¦the¦ ¦tr ue¦ ¦int erm ediate¦ ¦host¦ ,▁ ¦how¦ ¦it¦ ¦inter ac ts¦ ¦with¦ ¦the¦ ¦different¦ ¦spec ies¦ ¦including¦ ¦humans¦ ,▁ ¦bats¦ ¦and¦ ¦pa ngol ins¦ ¦has¦ ¦to¦ ¦be¦ ¦cl ar if ied¦ .
𐋇¦f in ally¦ ,▁ ¦since¦ ¦many¦ ¦ma mm als¦ ¦including¦ ¦do me st ic¦ ¦anim als¦ ¦might¦ ¦be¦ ¦s us cep ti ble¦ ¦to¦ ¦sars¦ - ¦cov¦ - ¦2¦ ,▁ ¦both¦ ¦surveillance¦ ¦and¦ ¦exp eri me ntal¦ ¦infection¦ ¦should¦ ¦be¦ ¦con duc ted¦ .
𐋇 ¦should¦ ¦it¦ ¦be¦ ¦a¦ ¦bat¦ ,▁ ¦a¦ ¦pa ngol in¦ ¦or¦ ¦another¦ ¦ma mm al¦ ,▁ ¦it¦ ¦is¦ ¦exp ected¦ ¦that¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦or¦ ¦its¦ ¦pa re ntal¦ ¦viruses¦ ¦that¦ ¦are¦ ¦al m ost¦ ¦ident ical¦ ¦will¦ ¦be¦ ¦identified¦ ¦in¦ ¦its¦ ¦nat ural¦ ¦ho sts¦ ¦in¦ ¦f ut ure¦ .
𐋇 ¦contin u ed¦ ¦in ve st ig ations¦ ¦in¦ ¦this¦ ¦a rea¦ ¦will¦ ¦el uc id ate¦ ¦the¦ ¦ev o lu tion ary¦ ¦path w ay¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦in¦ ¦anim als¦ ,▁ ¦with¦ ¦important¦ ¦i mpl ications¦ ¦in¦ ¦the¦ ¦pre vention¦ ¦and¦ ¦control¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦humans¦ .
𐋇 ¦up d ating¦ ¦the¦ ¦diagn o st ic¦ ¦crit er ia¦ ¦of¦ ¦covid¦ - ¦19¦ ▁ “ ¦suspected¦ ¦case¦ ▁ ” ▁ ¦and¦ “ ▁ ¦confirmed¦ ¦case¦ ▁ ” ▁ ¦is¦ ¦ne cess ary¦
𐋇¦on¦ ¦6¦ ¦february¦ ¦2020¦ ,▁ ¦our¦ ¦team¦ ¦had¦ ¦publ ished¦ ¦a¦ ¦rap id¦ ¦advice¦ ¦gu ide line¦ ¦for¦ ¦diagn o sis¦ ¦and¦ ¦treatment¦ ¦of¦ ¦2019¦ ¦novel¦ ¦coronavirus¦ ▁( ¦2019¦ - ¦n cov ¦ )▁ ¦infection¦ ,▁ ¦and¦ ¦this¦ ¦gu ide line¦ ¦provid ed¦ ¦our¦ ¦exp eri ence¦ ¦and¦ ¦make¦ ¦well¦ ¦ref er ence¦ ¦for¦ ¦fi gh ting¦ ¦against¦ ¦this¦ ¦pandemic¦ ¦worldwide¦ .
𐋇¦however¦ ,▁ ¦the¦ ¦coronavirus¦ ¦disease¦ ¦2019¦ ▁( ¦covid¦ - ¦19¦ )▁ ¦is¦ ¦a¦ ¦new¦ ¦disease¦ ,▁ ¦our¦ ¦a w a re ness¦ ¦and¦ ¦k n ow l ed ge¦ ¦are¦ ¦g rad ually¦ ¦incre as ing¦ ¦based¦ ¦on¦ ¦the¦ ¦o ng o ing¦ ¦research¦ ¦fi nd ings¦ ¦and¦ ¦clinical¦ ¦pract ice¦ ¦exp eri ence¦ ;▁ ¦h ence¦ ,▁ ¦the¦ ¦stra te g ies¦ ¦of¦ ¦diagn o sis¦ ¦and¦ ¦treatment¦ ¦are¦ ¦also¦ ¦contin ually¦ ¦up d ated¦ .
𐋇¦in¦ ¦this¦ ¦l et ter¦ ,▁ ¦we¦ ¦a ns w ered¦ ¦one¦ ¦comm ent¦ ¦on¦ ¦our¦ ¦gu ide line¦ ¦and¦ ¦provid ed¦ ¦the¦ ¦new est¦ ¦diagn o st ic¦ ¦crit er ia¦ ¦of¦ ▁ “ ¦suspected¦ ¦case¦ ▁ ” ▁ ¦and¦ “ ▁ ¦confirmed¦ ¦case¦ ▁ ” ▁ ¦according¦ ¦to¦ ¦the¦ ¦l at est¦ ¦diagn o sis¦ ¦and¦ ¦treatment¦ ¦gu id el ines¦ ¦for¦ ¦covid¦ - ¦19¦ ▁( ¦se v en th¦ ¦ ve rs ion¦ )▁ ¦that¦ ¦issued¦ ¦by¦ ¦the¦ ¦national¦ ¦health¦ ¦comm it te e¦ ¦of¦ ¦the¦ ¦people¦ ▁’▁ ¦s¦ ¦rep u bl ic¦ ¦of¦ ¦china¦ .
𐋇¦in¦ ¦december¦ ¦2019¦ ,▁ ¦the¦ ¦2019¦ ¦novel¦ ¦coronavirus¦ ▁( ¦2019¦ - ¦n cov ¦ )▁ ¦has¦ ¦caused¦ ¦an¦ ¦outbreak¦ ,▁ ¦which¦ ¦is¦ ¦n ow¦ ¦offic ially¦ ¦na med¦ ¦as¦ ¦the¦ ¦coronavirus¦ ¦disease¦ ¦2019¦ ▁( ¦covid¦ - ¦19¦ )▁ ¦and¦ ¦the¦ ¦virus¦ ¦has¦ ¦been¦ ¦na med¦ ¦severe¦ ¦acute¦ ¦respiratory¦ ¦syndrome¦ ¦coronavirus¦ ¦2¦ ▁( ¦sars¦ - ¦cov¦ - ¦2¦ ).
𐋇¦on¦ ¦11¦ ¦march¦ ¦2020¦ ,▁ ¦who¦ ¦ch ara ct eri zed¦ ¦covid¦ - ¦19¦ ¦as¦ ¦a¦ ¦pandemic¦ .
𐋇¦in¦ ¦order¦ ¦to¦ ¦f ight¦ ¦against¦ ¦the¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦infection¦ ,▁ ¦our¦ ¦team¦ ¦has¦ ¦developed¦ ¦a¦ ¦rap id¦ ¦advice¦ ¦gu ide line¦ ¦and¦ ¦that¦ ¦has¦ ¦been¦ ¦publ ished¦ ¦online¦ ¦in¦ ¦m il it ary¦ ¦medical¦ ¦research¦ ¦on¦ ¦0 6¦ ¦february¦ ¦2020¦ .
𐋇¦it¦ ¦has¦ ¦att r ac ted¦ ¦a¦ ¦g re at¦ ¦att e nt ion¦ ¦since¦ ¦publ ished¦ .
𐋇¦n ot e¦ ¦however¦ ¦that¦ ¦covid¦ - ¦19¦ ¦is¦ ¦a¦ ¦new¦ ¦disease¦ ,▁ ¦our¦ ¦a w a re ness¦ ¦and¦ ¦k n ow l ed ge¦ ¦is¦ ¦g rad ually¦ ¦incre as ing¦ ¦based¦ ¦on¦ ¦the¦ ¦o ng o ing¦ ¦research¦ ¦fi nd ings¦ ¦and¦ ¦clinical¦ ¦pract ice¦ ¦exp eri ence¦ ;▁ ¦h ence¦ ,▁ ¦the¦ ¦stra te g ies¦ ¦of¦ ¦diagn o sis¦ ¦and¦ ¦treatment¦ ¦are¦ ¦also¦ ¦contin ually¦ ¦up d ated¦ .
𐋇¦for¦ ¦inst ance¦ ¦the¦ ¦diagn o sis¦ ¦and¦ ¦treatment¦ ¦gu id el ines¦ ¦for¦ ¦covid¦ - ¦19¦ ¦issued¦ ¦by¦ ¦the¦ ¦national¦ ¦health¦ ¦comm it te e¦ ¦of¦ ¦the¦ ¦people¦ ▁’▁ ¦s¦ ¦rep u bl ic¦ ¦of¦ ¦china¦ ▁( ¦h t t p¦ :▁ / ▁/▁ ¦w w w¦ . ¦n h c¦ . ¦g ov ¦ . ¦c n¦ ▁ / ),▁ ¦among¦ ¦16¦ ¦january¦ ¦2020¦ ¦to¦ ¦3¦ ¦march¦ ¦2020¦ ,▁ ¦has¦ ¦issued¦ ¦a¦ ¦total¦ ¦of¦ ¦se v en¦ ¦e di tions¦ ¦with¦ ¦some¦ ¦con te x ts¦ ¦being¦ ¦sub s ta nt ively¦ ¦chan ged¦ .
𐋇¦n ow¦ ¦our¦ ¦gu ide line¦ ¦received¦ ¦a¦ ¦comm ent¦ ¦by¦ ¦z ho u¦ ¦ et¦ ¦ al¦ . ,▁ ¦they¦ ¦int ro duc ed¦ ¦a¦ ¦si mp le¦ ¦sc or ing¦ ¦prop os al¦ ¦based¦ ¦on¦ ¦their¦ ¦clinical¦ ¦exp eri ence¦ .
𐋇 ¦their¦ ¦work¦ ¦ad ded¦ ¦new¦ ¦evidence¦ ¦for¦ ¦our¦ ¦gu ide line¦ ¦and¦ ¦also¦ ¦make¦ ¦v a lu able¦ ¦ref er ence¦ ¦for¦ ¦this¦ ¦pandemic¦ ¦worldwide¦ .
𐋇¦we¦ ¦ end or se¦ ¦their¦ ¦sign ific ant¦ ¦work¦ ¦and¦ ¦exp r ess¦ ¦our¦ ¦th an ks¦ .
𐋇¦however¦ ,▁ ¦their¦ ¦work¦ ¦also¦ ¦needs¦ ¦up d ate¦ ¦according¦ ¦to¦ ¦the¦ ¦l at est¦ ¦diagn o sis¦ ¦and¦ ¦treatment¦ ¦gu id el ines¦ ¦for¦ ¦covid¦ - ¦19¦ ▁( ¦tr ial¦ ¦se v en th¦ ¦ ve rs ion¦ )▁ ¦and¦ ¦rece ntly¦ ¦st u dies¦ .
𐋇 ¦according¦ ¦to¦ ¦the¦ ¦se v en th¦ ¦ ed ition¦ ▁( ¦3¦ ¦march¦ ¦2020¦ ),▁ ¦to¦ ¦conf ir m¦ ¦the¦ ¦suspected¦ ¦case¦ ¦needs¦ ¦to¦ ¦co mb ine¦ ¦any¦ ¦one¦ ¦i te m¦ ¦of¦ ¦e p ide mi ological¦ ¦h ist ory¦ ¦fe at ures¦ ¦with¦ ¦two¦ ¦i tems¦ ¦of¦ ¦clinical¦ ¦m an if e st ations¦ ¦to¦ ¦make¦ ¦a¦ ¦comp re he ns ive¦ ¦anal y sis¦ ,▁ ¦or¦ ¦needs¦ ¦to¦ ¦me et¦ ¦three¦ ¦i tems¦ ¦of¦ ¦clinical¦ ¦m an if e st ations¦ ¦if¦ ¦without¦ ¦cl ear¦ ¦e p ide mi ological¦ ¦h ist ory¦ :
𐋇¦e p ide mi ological¦ ¦h ist ory¦ : ▁( ¦1¦ )▁ ¦a¦ ¦h ist ory¦ ¦of¦ ¦travel¦ ¦or¦ ¦res idence¦ ¦in¦ ¦wuhan¦ ¦city¦ ¦and¦ ¦sur ro un ding¦ ¦areas¦ ,▁ ¦or¦ ¦other¦ ¦comm un ities¦ ¦where¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦had¦ ¦been¦ ¦reported¦ ¦in¦ ¦the¦ ¦last¦ ¦14¦ ¦days¦ ¦before¦ ¦s y m pt om¦ ¦o ns et¦ ; ▁( ¦2¦ )▁ ¦a¦ ¦h ist ory¦ ¦of¦ ¦contact¦ ¦with¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦infectious¦ ¦cases¦ ▁( ¦with¦ ¦positive¦ ¦n uc le ic¦ ¦ac id¦ ¦test¦ ) ; ▁( ¦3¦ )▁ ¦a¦ ¦h ist ory¦ ¦of¦ ¦contac ting¦ ¦with¦ ¦patients¦ ¦with¦ ¦fever¦ ¦or¦ ¦respiratory¦ ¦symptoms¦ ¦from¦ ¦wuhan¦ ¦city¦ ¦and¦ ¦sur ro un ding¦ ¦areas¦ ,▁ ¦or¦ ¦other¦ ¦comm un ities¦ ¦where¦ ¦covid¦ - ¦19¦ ¦had¦ ¦been¦ ¦reported¦ ¦in¦ ¦the¦ ¦last¦ ¦14¦ ¦days¦ ¦before¦ ¦s y m pt om¦ ¦o ns et¦ ; ▁( ¦4¦ )▁ ¦a¦ ¦h ist ory¦ ¦of¦ ¦contac ting¦ ¦with¦ ¦cl us ter¦ ¦of¦ ¦confirmed¦ ¦cases¦ ▁( ≥ ▁ ¦2¦ ¦cases¦ ¦with¦ ¦fever¦ ¦and¦ ▁/▁ ¦or¦ ¦respiratory¦ ¦symptoms¦ ¦occur r ed¦ ¦within¦ ¦2¦ ¦weeks¦ ¦in¦ ¦sm all¦ ¦areas¦ ,▁ ¦such¦ ¦as¦ ¦home¦ ,▁ ¦off ice¦ ,▁ ¦cl ass¦ ¦of¦ ¦school¦ ,▁ ¦ et c¦ ).
𐋇 ¦clinical¦ ¦m an if e st ations¦ : ▁( ¦1¦ )▁ ¦fever¦ ¦and¦ ▁/▁ ¦or¦ ¦respiratory¦ ¦symptoms¦ ; ▁( ¦2¦ )▁ ¦with¦ ¦i ma ging¦ ¦fe at ures¦ ¦of¦ ¦covid¦ - ¦19¦ ¦infection¦ ; ▁( ¦3¦ )▁ ¦total¦ ¦wh ite¦ ¦blood¦ ¦c ell¦ ¦cou nts¦ ¦sh owing¦ ¦normal¦ ,▁ ¦dec rea sed¦ ,▁ ¦or¦ ¦reduc ed¦ ¦l y m ph oc y t e¦ ¦co un t¦ ¦in¦ ¦the¦ ¦early¦ ¦o ns et¦ ¦st age¦ .
𐋇 ¦diagn os ing¦ ¦the¦ ¦confirmed¦ ¦case¦ ¦should¦ ¦b ase¦ ¦on¦ ¦suspected¦ ¦case¦ ¦with¦ ¦any¦ ¦one¦ ¦i te m¦ ¦of¦ ¦path ogen ic¦ ¦or¦ ¦ser ological¦ ¦evidence¦ ¦as¦ ¦following¦ : ▁( ¦1¦ )▁ ¦re al¦ - ¦time¦ ¦p c r¦ ¦test¦ ¦positive¦ ¦for¦ ¦sars¦ - ¦cov¦ - ¦2¦ ; ▁( ¦2¦ )▁ ¦viral¦ ¦w ho le¦ ¦gen ome¦ ¦se qu e ncing¦ ¦sh owing¦ ¦high¦ ¦ho mo ge ne ity¦ ¦to¦ ¦the¦ ¦known¦ ¦novel¦ ¦coronaviruses¦ ; ▁( ¦3¦ )▁ ¦positive¦ ¦for¦ ¦the¦ ¦specific¦ ¦ ig m¦ ¦antibo dy¦ ¦and¦ ¦ ig g¦ ¦antibo dy¦ ¦to¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦in¦ ¦ser um¦ ¦test¦ ;▁ ¦or¦ ¦a¦ ¦ch ange¦ ¦of¦ ¦the¦ ¦sars¦ - ¦cov¦ - ¦2¦ - ¦specific¦ ¦ ig g¦ ¦antibo dy¦ ¦from¦ ¦negative¦ ¦to¦ ¦positive¦ ,▁ ¦or¦ ¦ti ter¦ ¦r ising¦ ▁ ≥ ▁ ¦4¦ ¦times¦ ¦in¦ ¦the¦ ¦reco ve ry¦ ¦ph ase¦ ¦a bo ve¦ ¦that¦ ¦in¦ ¦the¦ ¦acute¦ ¦ph ase¦ .
𐋇¦we¦ ¦can¦ ¦se e¦ ¦that¦ ¦the¦ ¦re al¦ - ¦time¦ ¦p c r¦ ¦test¦ ¦for¦ ¦n uc le ic¦ ¦ac id¦ ¦in¦ ¦respiratory¦ ¦trac t¦ ¦or¦ ¦blood¦ ¦samples¦ ¦was¦ ¦ad ded¦ ¦to¦ ¦the¦ ¦second¦ ▁( ¦18¦ ¦january¦ ¦2020¦ )▁ ¦and¦ ¦thir d¦ ▁( ¦2 2¦ ¦january¦ ¦2020¦ )▁ ¦e di tions¦ .
𐋇¦the¦ ¦path ogen ic¦ ¦de te ction¦ ¦of¦ ¦blood¦ ¦sampl e¦ ¦was¦ ¦ad ded¦ ¦to¦ ¦the¦ ¦fo ur th¦ ▁( ¦2 7¦ ¦january¦ ¦2020¦ )▁ ¦and¦ ¦f if th¦ ▁( ¦8¦ ¦february¦ ¦2020¦ )▁ ¦e di tions¦ ;▁ ¦and¦ ¦then¦ ¦the¦ ¦ser ological¦ ¦evidence¦ ¦was¦ ¦ad ded¦ ¦to¦ ¦the¦ ¦se v en th¦ ¦ ed ition¦ .
𐋇¦these¦ ¦mod if ications¦ ¦based¦ ¦on¦ ¦the¦ ¦res ear ch ers¦ ¦contin u ed¦ ¦work¦ ¦that¦ ¦to¦ ¦s ear ch¦ ¦for¦ ¦an¦ ¦o pt im al¦ ¦n uc le ic¦ ¦ac id¦ ¦de te ction¦ ¦ki t¦ ¦for¦ ¦rap id¦ ¦diagn o sis¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦the¦ ¦samples¦ ¦from¦ ¦respiratory¦ ¦trac t¦ ¦including¦ ¦blood¦ ¦sampl ing¦ ,▁ ¦which¦ ¦increased¦ ¦the¦ ¦a v ai la bility¦ ¦of¦ ¦different¦ ¦spec im ens¦ ,▁ ¦and¦ ¦supp or ted¦ ¦bringing¦ ¦the¦ ¦specific¦ ¦antibo dy¦ ¦positive¦ ¦result¦ ¦into¦ ¦the¦ ¦confirmed¦ ¦crit er ia¦ .
𐋇 ¦be si des¦ ,▁ ¦there¦ ¦are¦ ¦more¦ ¦and¦ ¦more¦ ¦evidence¦ ¦that¦ ¦rem ind¦ ¦us¦ ¦to¦ ¦ca ution¦ ¦with¦ ¦the¦ ¦ at y p ical¦ ¦s ymptomatic¦ ¦and¦ ¦as ymptomatic¦ ¦patients¦ .
𐋇¦h ence¦ ,▁ ¦the¦ ¦f l ow¦ ¦ch ar t¦ ¦of¦ ¦z ho u¦ ¦ et¦ ¦ al¦ .▁ ¦should¦ ¦be¦ ¦up d ated¦ ,▁ ¦as¦ ¦they¦ ¦c la ss if ied¦ ¦the¦ ¦person¦ ¦without¦ ¦clinical¦ ¦symptoms¦ ¦as¦ ▁ “ ¦low¦ ¦risk¦ ▁ ” .
𐋇¦the¦ ¦sc ore¦ ¦system¦ ¦also¦ ¦needs¦ ¦to¦ ¦be¦ ¦ ver if ied¦ ¦in¦ ¦further¦ ¦clinical¦ ¦pract ice¦ ¦and¦ ¦st u dies¦ .
𐋇¦to¦ ¦co nc lu de¦ ,▁ ¦we¦ ¦h ope¦ ¦more¦ ¦direct¦ ¦evidence¦ ¦c om ing¦ ¦up¦ ¦and¦ ¦call¦ ¦for¦ ¦rea d ers¦ ¦to¦ ¦provide¦ ¦their¦ ¦comm ents¦ .
𐋇¦for¦ ¦the¦ ¦diagn o sis¦ ¦of¦ ▁ “ ¦suspected¦ ¦case¦ ▁ ” ▁ ¦and¦ “ ▁ ¦confirmed¦ ¦case¦ ▁ ” ,▁ ¦we¦ ¦su gg est¦ ¦to¦ ¦tr ace¦ ¦and¦ ¦ob e y¦ ¦the¦ ¦new est¦ ¦gu id el ines¦ ¦of¦ ¦their¦ ¦home¦ ¦countries¦ .
𐋇 ¦our¦ ¦team¦ ¦will¦ ¦also¦ ¦t im ely¦ ¦up d ate¦ ¦our¦ ¦gu ide line¦ ¦to¦ ¦off er¦ ¦help¦ .
𐋇 ¦ba ng la d es h ¦ ¦rep orts¦ ¦five¦ ¦new¦ ¦deaths¦ ¦due¦ ¦to¦ ¦covid¦ - ¦19¦ ,▁ ¦a¦ ¦daily¦ ¦high est¦
𐋇 ¦y e st er day¦ ,▁ ¦ba ng la d es h ¦ ¦has¦ ¦confirmed¦ ¦five¦ ¦new¦ ¦deaths¦ ¦due¦ ¦to¦ ¦covid¦ - ¦19¦ ¦on¦ ¦the¦ ¦day¦ .
𐋇¦this¦ ¦is¦ ¦the¦ ¦high est¦ ¦number¦ ¦of¦ ¦fat al ities¦ ¦in¦ ¦a¦ ¦day¦ ¦due¦ ¦to¦ ¦the¦ ¦virus¦ .
𐋇¦as¦ ¦of¦ ¦y e st er day¦ ,▁ ¦ba ng la d es h ¦ ' ¦s¦ ¦inst it ute¦ ¦of¦ ¦e p ide mi ology¦ ,▁ ¦disease¦ ¦control¦ ¦and¦ ¦research¦ ▁( ¦i ed c r¦ )▁ ¦reported¦ ¦the¦ ¦number¦ ¦of¦ ¦recor ded¦ ¦infected¦ ¦cases¦ ¦inclu ded¦ ¦1 1 4¦ ¦ac tive¦ ¦cases¦ ¦and¦ ¦3 3¦ ¦re covered¦ ¦cases¦ ¦who¦ ¦were¦ ¦sta ying¦ ¦home¦ .
𐋇¦a¦ ¦total¦ ¦of¦ ¦1 7¦ ¦deaths¦ ¦have¦ ¦been¦ ¦recor ded¦ .
𐋇¦in¦ ¦an¦ ¦online¦ ¦new s¦ ¦br ie f ing¦ ,▁ ¦the¦ ¦dir ector¦ ¦of¦ ¦i ed c r¦ ,▁ ¦d r¦ ¦me er j a dy¦ ¦s ab ri na¦ ¦f l or a¦ ,▁ ¦said¦ ¦the¦ ¦fat al ities¦ ¦inclu ded¦ ¦four¦ ¦ma les¦ ¦and¦ ¦one¦ ¦fe ma le¦ .
𐋇 ¦according¦ ¦to¦ ¦d r¦ ¦me er j a dy¦ ,▁ ¦two¦ ¦cases¦ ¦were¦ ¦a ged¦ ¦a bo ve¦ ¦6 0¦ ,▁ ¦two¦ ¦between¦ ¦5 1¦ ¦and¦ ¦6 0¦ ,▁ ¦and¦ ¦one¦ ¦4 1¦ - ¦50¦ ¦years¦ ¦o ld¦ .
𐋇 ¦sh e¦ ¦also¦ ¦said¦ ¦two¦ ¦of¦ ¦the¦ ¦v ic ti ms¦ ¦were¦ ¦from¦ ¦d h a k a¦ .
𐋇¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ▁( ¦who¦ )▁ ¦decl ared¦ ¦covid¦ - ¦19¦ ¦a¦ ¦pandemic¦ ¦on¦ ¦march¦ ¦11¦ .
𐋇¦a¦ ¦hospital¦ ¦offic ial¦ ¦to ld¦ ¦a na d ol u¦ ¦a ge ncy¦ ,▁ ¦a¦ ¦local¦ ¦new s¦ ¦out l et¦ ,▁ ¦that¦ ¦one¦ ¦of¦ ¦the¦ ¦dec ea sed¦ ¦was¦ ¦j al al¦ ¦sa if u r¦ ¦ra h m an¦ ,▁ ¦a¦ ¦dir ector¦ ¦of¦ ¦be ng al i¦ ¦anti ¦ - ¦cor ru ption¦ ¦comm i ssion¦ ,▁ ¦who¦ ¦was¦ ¦c ared¦ ¦for¦ ¦at¦ ¦the¦ ¦k u w ai t¦ ¦ma it re e¦ ¦hospital¦ .
𐋇¦on¦ ¦s at ur day¦ ,▁ ¦in¦ ¦an¦ ¦online¦ ¦v ide o¦ ¦an no un ce ment¦ ,▁ ¦ba ng la d es h i¦ ¦ro ad¦ ¦transport¦ ¦and¦ ¦br id ges¦ ¦minister¦ ¦ob a id u l¦ ¦qu a der¦ ¦said¦ ¦public¦ ¦transport¦ ¦would¦ ¦be¦ ¦sh ut¦ ¦down¦ ¦for¦ ¦lo nger¦ ¦than¦ ¦in it ially¦ ¦pl an ned¦ ,▁ ¦until¦ ¦this¦ ¦c om ing¦ ¦s at ur day¦ .
𐋇¦this¦ ¦public¦ ¦transport¦ ¦sh ut d own¦ ¦had¦ ¦in it ially¦ ¦star ted¦ ¦on¦ ¦march¦ ¦26¦ ¦and¦ ¦was¦ ¦pl an ned¦ ¦to¦ ¦end¦ ¦on¦ ¦s at ur day¦ ,▁ ¦april¦ ¦4¦ .
𐋇 ¦transport¦ ¦of¦ ¦essential¦ ¦g oo ds¦ ▁ - - ▁ ¦medical¦ ,▁ ¦f u e l¦ ¦and¦ ¦food¦ ▁ - - ▁ ¦was¦ ¦still¦ ¦all owed¦ .
𐋇¦the¦ ¦first¦ ¦recor ded¦ ¦inc id ents¦ ¦of¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦in¦ ¦ba ng la d es h ¦ ¦were¦ ¦on¦ ¦march¦ ¦8¦ ,▁ ¦in¦ ¦two¦ ¦people¦ ¦who¦ ¦retur ned¦ ¦from¦ ¦italy¦ ¦and¦ ¦also¦ ¦the¦ ¦w ife¦ ¦of¦ ¦one¦ ¦of¦ ¦them¦ .
𐋇¦as¦ ¦of¦ ¦march¦ ¦19¦ ,▁ ¦these¦ ¦three¦ ¦had¦ ¦al rea dy¦ ¦re covered¦ .
𐋇 ¦sars¦ - ¦cov¦ - ¦2¦ ¦sur p as ses¦ ¦one¦ ¦million¦ ¦infections¦ ¦worldwide¦
𐋇¦on¦ ¦th u rs day¦ ,▁ ¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦of¦ ¦the¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦coronavirus¦ ¦infections¦ ¦sur p as sed¦ ¦one¦ ¦million¦ ¦worldwide¦ ,▁ ¦jo h ns¦ ¦h op k ins¦ ¦univers ity¦ ¦data¦ ¦indic ated¦ .
𐋇 ¦at¦ ¦least¦ ¦5 2¦ ¦t ho us and¦ ¦deaths¦ ¦were¦ ¦l in ked¦ ¦to¦ ¦covid¦ - ¦19¦ ,▁ ¦the¦ ¦disease¦ ¦caused¦ ¦by¦ ¦the¦ ¦coronavirus¦ .
𐋇¦the¦ ¦mi le st one¦ ¦ca me¦ ¦the¦ ¦same¦ ¦day¦ ¦ma la w i¦ ¦confirmed¦ ¦its¦ ¦first¦ ¦coronavirus¦ ¦infections¦ ¦and¦ ¦z a mb ia¦ ¦had¦ ¦its¦ ¦first¦ ¦coronavirus¦ - ¦related¦ ¦death¦ .
𐋇¦n or th¦ ¦ko rea¦ ¦cl ai med¦ ,▁ ¦as¦ ¦of¦ ¦th u rs day¦ ,▁ ¦it¦ ¦was¦ ¦one¦ ¦of¦ ¦the¦ ¦fe w¦ ¦countries¦ ¦rem aining¦ ¦fre e¦ ¦of¦ ¦coronavirus¦ ¦infections¦ .
𐋇¦by¦ ¦y e st er day¦ ,▁ ¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ¦reported¦ ¦1¦ , ¦0 5 1¦ , ¦6 3 5¦ ¦confirmed¦ ¦cases¦ ,▁ ¦including¦ ¦7 9¦ , ¦3 3 2¦ ¦cases¦ ¦in¦ ¦the¦ ¦t we nt y¦ ¦four¦ ¦hours¦ ¦pre ce ding¦ ¦10¦ ¦a¦ . ¦ m¦ .▁ ¦centr al¦ ¦european¦ ¦time¦ ▁( ¦0 8 00¦ ¦ ut c¦ )▁ ¦on¦ ¦april¦ ¦4¦ .
𐋇¦in¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦over¦ ¦2 4 4¦ ¦t ho us and¦ ¦coronavirus¦ ¦cases¦ ¦were¦ ¦recor ded¦ ,▁ ¦l in king¦ ¦to¦ ¦at¦ ¦least¦ ¦5¦ , ¦9 00¦ ¦deaths¦ .
𐋇¦c b s¦ ¦new s¦ ¦reported¦ ,▁ ¦c i ting¦ ¦jo h ns¦ ¦h op k ins¦ ¦univers ity¦ ¦data¦ ,▁ ¦there¦ ¦were¦ ¦over¦ ¦1¦ , ¦000¦ ¦us¦ ¦deaths¦ ¦on¦ ¦w ed n es day¦ ¦caused¦ ¦by¦ ¦coronavirus¦ ¦infections¦ .
𐋇 ¦around¦ ¦the¦ ¦world¦ ,▁ ¦countries¦ ¦announced¦ ¦ stric ter¦ ¦measures¦ ¦to¦ ¦in hi b i t¦ ¦the¦ ¦disease¦ ¦from¦ ¦sprea ding¦ .
𐋇¦on¦ ¦th u rs day¦ ,▁ ¦ser ge i¦ ¦s ob y an in¦ ,▁ ¦the¦ ¦ma y or¦ ¦of¦ ¦m os c ow¦ ,▁ ¦ex te nded¦ ¦the¦ ¦city¦ ¦lockdown¦ ¦to¦ ¦may¦ ¦1¦ .
𐋇 ¦na tion ally¦ ,▁ ¦pres ident¦ ¦v la di mi r¦ ¦p ut in¦ ¦decl ared¦ ¦r us si ans¦ ¦would¦ ¦continue¦ ¦to¦ ¦be¦ ¦pa id¦ ¦without¦ ¦go ing¦ ¦to¦ ¦work¦ ¦until¦ ¦april¦ ¦30¦ .
𐋇¦the¦ ¦par l ia ment¦ ¦of¦ ¦p ort u g al¦ ¦v o ted¦ ¦to¦ ¦ext end¦ ¦the¦ ¦national¦ ¦state¦ ¦of¦ ¦emergency¦ ¦by¦ ¦15¦ ¦days¦ ;▁ ¦the¦ ¦v ot e¦ ¦p as sed¦ ¦with¦ ¦2 1 5¦ ¦v o tes¦ ¦in¦ ¦fa v or¦ ,▁ ¦t en¦ ¦ab st en tions¦ ,▁ ¦and¦ ¦one¦ ¦v ot e¦ ¦against¦ .
𐋇 ¦sa ud i¦ ¦ar ab ia¦ ¦ex te nded¦ ¦cur f e w s¦ ¦in¦ ¦the¦ ¦ho ly¦ ¦c ities¦ ¦of¦ ¦m ec c a¦ ¦and¦ ¦me di na¦ ¦to¦ ¦last¦ ¦the¦ ¦ent ir e¦ ¦day¦ ;▁ ¦previously¦ ,▁ ¦the¦ ¦cur f e w¦ ¦was¦ ¦only¦ ¦in¦ ¦eff ect¦ ¦between¦ ¦3¦ ¦ p¦ . ¦ m¦ .▁ ¦and¦ ¦6¦ ¦a¦ . ¦ m¦ .
𐋇 ¦th ai land¦ ¦pl an ned¦ ¦to¦ ¦imp le ment¦ ¦a¦ ¦cur f e w¦ ¦between¦ ¦10¦ ¦ p¦ . ¦ m¦ .▁ ¦and¦ ¦4¦ ¦a¦ . ¦ m¦ .
𐋇¦the¦ ¦gover n or¦ ¦of¦ ¦o hi o¦ ,▁ ¦mi ke¦ ¦de w ine¦ ,▁ ¦announced¦ ¦the¦ ¦state¦ ¦had¦ ¦ex te nded¦ ¦its¦ ¦stay¦ - ¦at¦ - ¦home¦ ¦order¦ ¦until¦ ¦may¦ ¦1¦ .
𐋇 ¦st or es¦ ¦in¦ ¦a u str al ia¦ ¦lower¦ ¦to il et¦ ¦p ap er¦ ¦limi ts¦ ¦per¦ ¦trans a ction¦
𐋇¦on¦ ¦s un day¦ ¦and¦ ¦s at ur day¦ ¦ev ening¦ ,▁ ¦a u st ra li an¦ ¦st ore¦ ¦cha ins¦ ¦w o ol w or ths¦ ¦and¦ ¦co les¦ ¦l ow ered¦ ¦their¦ ¦p ur ch ase¦ ¦restrictions¦ ¦on¦ ¦to il et¦ ¦p ap er¦ ¦to¦ ¦two¦ ¦and¦ ¦one¦ ¦p ac k age¦ ¦per¦ ¦trans a ction¦ ¦in¦ ¦all¦ ¦st or es¦ ¦on¦ ¦national¦ ¦level¦ ,▁ ¦resp ect ively¦ .
𐋇 ¦al d i¦ ¦also¦ ¦int ro duc ed¦ ¦a¦ ¦one¦ - ¦p ack¦ ¦limi t¦ ,▁ ¦on¦ ¦mon day¦ .
𐋇¦these¦ ¦limi t ations¦ ¦were¦ ¦p os ted¦ ¦as¦ ¦me ss a ges¦ ¦on¦ ¦the¦ ¦chec k ou ts¦ ,▁ ¦and¦ ¦on¦ ¦the¦ ¦cha ins¦ ' ▁ ¦fa ce b ook¦ ¦pa ges¦ .
𐋇 ¦bu y ers¦ ¦were¦ ¦rep ort ed ly¦ ¦st oc king¦ ¦up¦ ¦due¦ ¦to¦ ¦f ear s¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦case¦ ¦people¦ ¦need¦ ¦to¦ ¦self¦ - ¦isol ate¦ .
𐋇¦on¦ ¦w ed n es day¦ ,▁ ¦w o ol w or ths¦ ¦also¦ ¦limi ted¦ ¦to il et¦ ¦p ap er¦ ¦p ur ch a ses¦ ¦for¦ ¦home¦ ¦de li ve ry¦ ¦to¦ ¦one¦ ¦p ack¦ ¦per¦ ¦order¦ .
𐋇¦these¦ ¦chan ges¦ ¦fo ll owed¦ ¦the¦ ¦prev ious¦ ¦four¦ - ¦p ack¦ ¦per¦ ¦trans a ction¦ ¦re st ri ction¦ ¦int ro duc ed¦ ¦by¦ ¦w o ol w or ths¦ ¦and¦ ¦co les¦ ¦on¦ ¦march¦ ¦4¦ ¦and¦ ¦5¦ ¦resp ect ively¦ .
𐋇 ¦co les¦ ,▁ ¦in¦ ¦its¦ ¦march¦ ¦8¦ ¦m ed ia¦ ¦re le ase¦ ,▁ ¦reported¦ ¦that¦ ¦with¦ ¦the¦ ¦four¦ - ¦p ack¦ ¦re st ri ction¦ ¦in¦ ¦place¦ , ▁" ¦many¦ ¦st or es¦ ¦are¦ ¦still¦ ¦se lling¦ ¦out¦ ¦within¦ ¦an¦ ¦hou r¦ ¦of¦ ¦de li ve ry¦ " ,▁ ¦and¦ ¦called¦ ¦the¦ ¦dem and¦ ▁" ¦un p r ec ed ented¦ " ,▁ ¦while¦ ¦al d i¦ ,▁ ¦in¦ ¦a¦ ¦fa ce b ook¦ ¦p ost¦ ¦on¦ ¦t u es day¦ ,▁ ¦called¦ ¦it¦ ▁" ¦u ne x p ected¦ " .
𐋇 ¦sa les¦ ¦w ent¦ ¦up¦ ¦in¦ ¦a¦ ▁" ¦sh ar p¦ ¦increase¦ "▁ ¦last¦ ¦week¦ ,▁ ¦according¦ ¦to¦ ¦a¦ ¦w o ol w or ths¦ ¦sp o k esp e rs on¦ .
𐋇 ¦co st c o¦ ' ¦s¦ ¦st ore¦ ¦in¦ ¦c an b er r a¦ ¦also¦ ¦limi ted¦ ¦the¦ ¦all owed¦ ¦a mo un t¦ ¦to¦ ¦two¦ ¦p ac ks¦ ¦last¦ ¦week¦ .
𐋇¦to¦ ¦further¦ ¦al le vi ate¦ ¦the¦ ¦sh ort age¦ ,▁ ¦co les¦ ¦or d ered¦ ¦bi gg er¦ ¦p ac k a ges¦ ¦from¦ ¦supp li ers¦ ¦and¦ ¦increased¦ ¦de li ve ry¦ ¦fre qu e ncy¦ ,▁ ¦w o ol w or ths¦ ¦or d ered¦ ¦ext r a¦ ¦st oc k¦ ,▁ ¦while¦ ¦al d i¦ ¦made¦ ¦st oc ks¦ ¦for¦ ¦a¦ ¦pl an ned¦ ¦w ed n es day¦ ¦spec ial¦ ¦available¦ ¦early¦ .
𐋇¦ ru ss ell¦ ¦z i mm erm an¦ ,▁ ¦ex ecu tive¦ ¦dir ector¦ ¦of¦ ¦the¦ ¦a u st ra li an¦ ¦re tail ers¦ ¦associ ation¦ ,▁ ¦said¦ ¦that¦ ¦re tail ers¦ ¦t ry¦ ¦to¦ ¦ra ise¦ ¦st oc k¦ ,▁ ¦but¦ ¦local¦ ¦cou nc il¦ ¦restrictions¦ ¦on¦ ¦the¦ ¦t im ing¦ ¦of¦ ¦tr uc k¦ - ¦de li ver ies¦ ¦make¦ ¦it¦ ¦h ard¦ .
𐋇¦h e¦ ¦exp ects¦ ¦r ising¦ ¦produc t ion¦ ¦co sts¦ ,▁ ¦as¦ ¦supp li ers¦ ¦t ry¦ ¦to¦ ¦me et¦ ¦dem and¦ ,▁ ¦and¦ ¦fe w er¦ ¦spec i als¦ .
𐋇¦on¦ ¦t u es day¦ ,▁ ¦al d i¦ ¦announced¦ ¦that¦ ¦following¦ ¦the¦ ¦early¦ ¦re le ase¦ ¦of¦ ¦st oc k¦ ,▁ ¦some¦ ¦st or es¦ ¦can¦ ' ¦t¦ ¦ ru n¦ ¦the¦ ¦w ed n es day¦ ¦spec ial¦ .
𐋇¦in¦ ¦a¦ ¦new s¦ . ¦c om¦ . ¦a u¦ ¦report¦ ,▁ ¦d r¦ ¦g ary¦ ¦m ort im er¦ ,▁ ¦re ta il¦ ¦exp er t¦ ¦from¦ ¦qu ee ns land¦ ¦univers ity¦ ¦of¦ ¦techn ology¦ ,▁ ¦said¦ ¦the¦ ¦st or es¦ ¦f ill¦ ¦the¦ ¦st oc k¦ ¦every¦ ¦n ight¦ .
𐋇¦h e¦ ¦rem ar ked¦ ¦to il et¦ ¦p ap er¦ ¦is¦ ¦a¦ ¦b ul k y¦ ¦i te m¦ ,▁ ¦lea ding¦ ¦to¦ ¦low¦ ¦qu a nt ity¦ ¦of¦ ¦st oc ks¦ ¦in¦ ¦nu mbers¦ ,▁ ¦and¦ ,▁ ¦when¦ ¦so ld¦ ¦out¦ ,▁ ¦lea ves¦ ¦v ast¦ ¦sh el f¦ ¦s pa ces¦ ¦e m pt y¦ ,▁ ¦h ar d ening¦ ¦the¦ ¦fe el ing¦ ¦of¦ ¦a¦ ¦sh ort age¦ .
𐋇 ¦co les¦ ¦and¦ ¦w o ol w or ths¦ ¦have¦ ¦a¦ ¦v ie w¦ ▁ [ ¦that¦ ] ▁ ¦if¦ ¦there¦ ¦was¦ ¦p le nt y¦ ¦of¦ ¦st u f f¦ ¦on¦ ¦the¦ ¦sh el f¦ ,▁ ¦if¦ ¦produc t¦ ¦like¦ ¦to il et¦ ¦ro lls¦ ¦and¦ ¦s an it is er¦ ¦could¦ ¦be¦ ▁ [ ¦b ou gh t¦ ] ▁ ¦and¦ ¦are¦ ¦there¦ ¦in¦ ¦qu a nt ities¦ ,▁ ¦you¦ ¦would¦ ¦prob ab ly¦ ¦min im ise¦ ¦the¦ ¦p an ic¦ ¦said¦ ¦ ru ss ell¦ ¦z i mm erm an¦ ¦per¦ ¦ab c¦ ¦new s¦ .
𐋇 ¦rec y c l ed¦ ¦to il et¦ ¦p ap er¦ ¦produc er¦ ¦who¦ ¦g ives¦ ¦a¦ ¦c ra p¦ ¦said¦ ¦on¦ ¦last¦ ¦w ed n es day¦ ¦they¦ ' ¦ d¦ ¦ ru n¦ ¦out¦ ¦of¦ ¦st oc k¦ .
𐋇 ¦ki mb erly¦ - ¦cl ar k¦ ,▁ ¦which¦ ¦ma k es¦ ¦k l ee ne x¦ ¦to il et¦ ¦ti ss ue¦ ,▁ ¦and¦ ¦so la ri s¦ ¦p ap er¦ ¦which¦ ¦ma k es¦ ¦s or b ent¦ ,▁ ¦e m ph a si zed¦ ¦they¦ ¦were¦ ¦wor king¦ ¦24¦ ▁/▁ ¦7¦ ¦to¦ ¦main tain¦ ¦the¦ ¦supp ly¦ ,▁ ¦according¦ ¦to¦ ¦the¦ ¦new s¦ . ¦c om¦ . ¦a u¦ ¦report¦ .
𐋇 ¦do ma in¦ . ¦c om¦ ,▁ ¦a¦ ¦re al¦ ¦e st ate¦ ¦s ite¦ ,▁ ¦reported¦ ¦some¦ ¦prop e rt y¦ ¦se ll ers¦ ¦off ering¦ ¦fre e¦ ¦to il et¦ ¦p ap er¦ ¦to¦ ¦the¦ ¦first¦ ¦b id der¦ ¦on¦ ¦a uc tions¦ ¦in¦ ¦m el bo ur n e¦ ,▁ ¦when¦ ¦fe w er¦ ¦a uc tions¦ ¦were¦ ¦he ld¦ ¦because¦ ¦of¦ ¦bu y ers¦ ¦having¦ ¦time¦ ¦off ¦ ¦on¦ ¦the¦ ¦long¦ ¦w ee k end¦ ¦of¦ ¦l ab ou r¦ ¦day¦ .
𐋇¦the¦ ¦th u rs day¦ ¦ ed ition¦ ¦of¦ ¦n t¦ ¦new s¦ ,▁ ¦a¦ ¦daily¦ ¦pr in ted¦ ¦in¦ ¦d ar w in¦ ,▁ ¦inclu ded¦ ¦an¦ ¦e ight¦ - ¦p age¦ ¦i ns er t¦ ¦me ant¦ ¦to¦ ¦be¦ ¦c ut¦ ¦up¦ ¦and¦ ¦used¦ ¦as¦ ¦to il et¦ ¦p ap er¦ .
𐋇¦the¦ ¦st or es¦ ¦were¦ ¦orig in ally¦ ¦re lu ct ant¦ ¦to¦ ¦imp ose¦ ¦restrictions¦ ,▁ ¦according¦ ¦to¦ ¦a¦ ¦report¦ ¦from¦ ¦ab c¦ ¦a u str al ia¦ ¦on¦ ¦march¦ ¦3¦ ¦in¦ ¦which¦ ¦they¦ ¦said¦ ¦they¦ ¦had¦ ¦no¦ ¦pl ans¦ ¦to¦ ¦int ro duc e¦ ¦restrictions¦ ¦on¦ ¦the¦ ¦p ur ch a ses¦ .
𐋇¦ ru ss ell¦ ¦z i mm erm an¦ ¦ad ded¦ ¦that¦ ¦other¦ ¦produc ts¦ ¦are¦ ¦also¦ ¦in¦ ¦high¦ ¦dem and¦ ,▁ ¦including¦ ¦masks¦ ,▁ ¦s an it is er¦ ,▁ ¦dr ied¦ ¦g oo ds¦ ,▁ ¦hand w as h ¦ ¦and¦ ¦f l ou r¦ .
𐋇¦s im il arly¦ ,▁ ¦outside¦ ¦of¦ ¦a u str al ia¦ ,▁ ¦on¦ ¦s un day¦ ¦ev ening¦ ¦online¦ ¦br it ish¦ ¦su p erm ar k et¦ ¦ oc a d o¦ ¦was¦ ¦ob s erv ed¦ ¦limi ting¦ ¦p ur ch a ses¦ ¦of¦ ¦an dr es¦ ¦to il et¦ ¦p ap er¦ ¦to¦ ¦two¦ ¦12¦ - ¦r ol l¦ ¦p ac ks¦ .
𐋇 ¦world¦ ¦health¦ ¦organiz ation¦ ¦decl ar es¦ ¦covid¦ - ¦19¦ ¦pandemic¦
𐋇¦on¦ ¦w ed n es day¦ ,▁ ¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ▁( ¦who¦ )▁ ¦decl ared¦ ¦the¦ ¦o ng o ing¦ ¦outbreak¦ ¦of¦ ¦covid¦ - ¦19¦ ▁ — ▁ ¦the¦ ¦disease¦ ¦caused¦ ¦by¦ ¦coronavirus¦ ¦sars¦ - ¦cov¦ - ¦2¦ ▁ — ▁ ¦to¦ ¦be¦ ¦a¦ ¦pandemic¦ .
𐋇 ¦al th ough¦ ¦the¦ ¦wor d¦ ▁" ¦pandemic¦ "▁ ¦only¦ ¦ref ers¦ ¦to¦ ¦how¦ ¦wid ely¦ ¦a¦ ¦disease¦ ¦has¦ ¦spread¦ ,▁ ¦not¦ ¦how¦ ¦d an ge ro us¦ ¦specific¦ ¦cases¦ ¦are¦ ,▁ ¦the¦ ¦who¦ ¦no ted¦ ¦the¦ ¦need¦ ¦to¦ ¦dr ive¦ ¦gover n ments¦ ¦to¦ ¦a ction¦ :
𐋇 ¦all¦ ¦countries¦ ¦can¦ ¦still¦ ¦ch ange¦ ¦the¦ ¦co ur se¦ ¦of¦ ¦this¦ ¦pandemic¦ .
𐋇¦if¦ ¦countries¦ ¦det ect¦ ,▁ ¦test¦ ,▁ ¦tre at¦ ,▁ ¦isol ate¦ ,▁ ¦tr ace¦ ¦and¦ ¦m ob il iz e¦ ¦their¦ ¦people¦ ¦in¦ ¦the¦ ¦response¦ ,▁ ¦said¦ ¦t ed ro s¦ ¦ad h an om¦ ¦g he b re y es us¦ ,▁ ¦the¦ ¦dir ector¦ - ¦general¦ ¦of¦ ¦the¦ ¦who¦ .
𐋇¦we¦ ¦are¦ ¦d ee p ly¦ ¦concer ned¦ ¦both¦ ¦by¦ ¦the¦ ¦al arm ing¦ ¦le v els¦ ¦of¦ ¦spread¦ ¦and¦ ¦se ver ity¦ ¦and¦ ¦by¦ ¦the¦ ¦al arm ing¦ ¦le v els¦ ¦of¦ ¦i na ction¦ .
𐋇 ¦according¦ ¦to¦ ¦d r¦ .▁ ¦t om¦ ¦f ri ed en¦ ,▁ ¦f orm erly¦ ¦the¦ ¦dir ector¦ ¦of¦ ¦the¦ ¦united¦ ¦states¦ ' ▁ ¦ce nt ers¦ ¦for¦ ¦disease¦ ¦control¦ ¦and¦ ¦pre vention¦ ,▁ ¦the¦ ¦pandemic¦ ¦is¦ ▁" ¦un p r ec ed ented¦ . "
𐋇¦h e¦ ¦said¦ ,▁ ¦in¦ ¦rem ar ks¦ ¦publ ished¦ ¦by¦ ¦c n n¦ ¦in¦ ¦february¦ , ▁" ¦other¦ ¦than¦ ¦influenza¦ ,▁ ¦no¦ ¦other¦ ¦respiratory¦ ¦virus¦ ¦has¦ ¦been¦ ¦trac ked¦ ¦from¦ ¦e mer g ence¦ ¦to¦ ¦contin u o us¦ ¦global¦ ¦spread¦ . "
𐋇 ¦g he b re y es us¦ ¦exp r es sed¦ ¦a¦ ¦similar¦ ¦v ie w¦ ,▁ ¦sa ying¦ ▁" ¦we¦ ¦have¦ ¦ne ver¦ ¦before¦ ¦se en¦ ¦a¦ ¦pandemic¦ ¦s par ked¦ ¦by¦ ¦a¦ ¦coronavirus¦ . "
𐋇¦h e¦ ¦contin u ed¦ , ▁" ¦and¦ ¦we¦ ¦have¦ ¦ne ver¦ ¦before¦ ¦se en¦ ¦a¦ ¦pandemic¦ ¦that¦ ¦can¦ ¦be¦ ¦cont ro lled¦ ¦at¦ ¦the¦ ¦same¦ ¦time¦ . "
𐋇¦the¦ ¦new¦ ¦st at us¦ ¦as¦ ¦a¦ ¦pandemic¦ ¦fo ll ow s¦ ¦the¦ ¦who¦ ' ¦s¦ ¦dec is ion¦ ¦in¦ ¦january¦ ¦to¦ ¦decl are¦ ¦the¦ ¦outbreak¦ ¦a¦ ¦public¦ ¦health¦ ¦emergency¦ ¦of¦ ¦international¦ ¦concer n¦ .
𐋇¦the¦ ¦united¦ ¦states¦ ' ▁ ¦national¦ ¦inst it ute¦ ¦of¦ ¦all er g y¦ ¦and¦ ¦infectious¦ ¦disease¦ ' ¦s¦ ¦dir ector¦ ,▁ ¦d r¦ .▁ ¦an th on y¦ ¦fa uc i¦ ,▁ ¦said¦ ¦of¦ ¦the¦ ¦outbreak¦ , ▁" ¦b ot t om¦ ¦ line¦ ,▁ ¦it¦ ' ¦s¦ ¦go ing¦ ¦to¦ ¦get¦ ¦wor se¦ . "
𐋇¦as¦ ¦of¦ ¦th u rs day¦ ,▁ ¦associated¦ ¦pr ess¦ ¦reported¦ ¦there¦ ¦were¦ ¦at¦ ¦least¦ ¦1 2 6¦ , ¦000¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦worldwide¦ ,▁ ¦res ul ting¦ ¦in¦ ¦over¦ ¦4¦ , ¦6 00¦ ¦deaths¦ .
𐋇¦the¦ ¦2019¦ ▁–▁ ¦20¦ ¦coronavirus¦ ¦pandemic¦ ¦is¦ ¦an¦ ¦o ng o ing¦ ¦pandemic¦ ¦of¦ ¦coronavirus¦ ¦disease¦ ¦2019¦ ▁( ¦covid¦ - ¦19¦ ),▁ ¦caused¦ ¦by¦ ¦severe¦ ¦acute¦ ¦respiratory¦ ¦syndrome¦ ¦coronavirus¦ ¦2¦ ▁( ¦sars¦ - ¦cov¦ - ¦2¦ ).
𐋇¦the¦ ¦outbreak¦ ¦was¦ ¦identified¦ ¦in¦ ¦wuhan¦ ,▁ ¦china¦ ,▁ ¦in¦ ¦december¦ ¦2019¦ ,▁ ¦decl ared¦ ¦to¦ ¦be¦ ¦a¦ ¦public¦ ¦health¦ ¦emergency¦ ¦of¦ ¦international¦ ¦concer n¦ ¦on¦ ¦30¦ ¦january¦ ¦2020¦ ,▁ ¦and¦ ¦reco gn i zed¦ ¦as¦ ¦a¦ ¦pandemic¦ ¦on¦ ¦11¦ ¦march¦ ¦2020¦ .
𐋇¦as¦ ¦of¦ ¦10¦ ¦april¦ ¦2020¦ ,▁ ¦appro xi ma tely¦ ¦1¦ . ¦6 1¦ ¦million¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦have¦ ¦been¦ ¦reported¦ ¦in¦ ¦2 1 0¦ ¦countries¦ ¦and¦ ¦ter r it or ies¦ ,▁ ¦res ul ting¦ ¦in¦ ¦appro xi ma tely¦ ¦9 7¦ , ¦000¦ ¦deaths¦ .
𐋇 ¦about¦ ¦3 6 4¦ , ¦000¦ ¦people¦ ¦have¦ ¦re covered¦ .
𐋇¦the¦ ¦case¦ ¦fat ality¦ ¦rate¦ ¦has¦ ¦been¦ ¦estim ated¦ ¦to¦ ¦be¦ ¦4¦ %▁ ¦in¦ ¦china¦ ,▁ ¦while¦ ¦gl ob ally¦ ¦r an ging¦ ¦from¦ ¦13¦ . ¦0 4¦ %▁ ¦in¦ ¦al g er ia¦ ¦to¦ ▁ . ¦0 8¦ %▁ ¦in¦ ¦new¦ ¦z ea land¦ .
𐋇 ¦common¦ ¦symptoms¦ ¦include¦ ¦fever¦ ,▁ ¦cough¦ ¦and¦ ¦sh ort ness¦ ¦of¦ ¦brea th¦ .
𐋇 ¦co mpl ications¦ ¦may¦ ¦include¦ ¦pneumonia¦ ¦and¦ ¦acute¦ ¦respiratory¦ ¦di str ess¦ ¦syndrome¦ .
𐋇¦the¦ ¦time¦ ¦from¦ ¦exp osure¦ ¦to¦ ¦o ns et¦ ¦of¦ ¦symptoms¦ ¦is¦ ¦typ ically¦ ¦around¦ ¦five¦ ¦days¦ ,▁ ¦but¦ ¦may¦ ¦r ange¦ ¦from¦ ¦two¦ ¦to¦ ¦fo ur te en¦ ¦days¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦known¦ ¦vaccine¦ ¦or¦ ¦specific¦ ¦anti vir al¦ ¦treatment¦ .
𐋇 ¦pr imary¦ ¦treatment¦ ¦is¦ ¦s ymptomatic¦ ¦and¦ ¦supp or tive¦ ¦ ther ap y¦ . ¦recommended¦ ¦prev en tive¦ ¦measures¦ ¦include¦ ¦hand¦ ¦washing¦ ,▁ ¦cov ering¦ ¦one¦ ' ¦s¦ ¦mouth¦ ¦when¦ ¦cou g hing¦ ,▁ ¦main t aining¦ ¦dista nce¦ ¦from¦ ¦other¦ ¦people¦ ,▁ ¦and¦ ¦monit or ing¦ ¦and¦ ¦self¦ - ¦isolation¦ ¦for¦ ¦people¦ ¦who¦ ¦susp ect¦ ¦they¦ ¦are¦ ¦infected¦ .
𐋇 ¦author ities¦ ¦worldwide¦ ¦have¦ ¦resp o nded¦ ¦by¦ ¦imp le m en ting¦ ¦travel¦ ¦restrictions¦ ,▁ ¦qu ara nt ines¦ ,▁ ¦cur f e w s¦ ,▁ ¦work pl ace¦ ¦ha z ard¦ ¦contr ols¦ ,▁ ¦and¦ ¦facil ity¦ ¦closures¦ .
𐋇¦the¦ ¦pandemic¦ ¦has¦ ¦l ed¦ ¦to¦ ¦severe¦ ¦global¦ ¦s oc i o ec onomic¦ ¦dis ru ption¦ ,▁ ¦the¦ ¦po st p o ne ment¦ ¦or¦ ¦cance ll ation¦ ¦of¦ ¦sp orting¦ ,▁ ¦rel ig ious¦ ,▁ ¦pol it ical¦ ¦and¦ ¦c ult ural¦ ¦events¦ ,▁ ¦and¦ ¦wid esp r ead¦ ¦sh or ta ges¦ ¦of¦ ¦supp l ies¦ ¦ex ac er b ated¦ ¦by¦ ¦p an ic¦ ¦bu ying¦ .
𐋇 ¦schools¦ ¦and¦ ¦univers ities¦ ¦have¦ ¦closed¦ ¦e it her¦ ¦on¦ ¦a¦ ¦na tion w ide¦ ¦or¦ ¦local¦ ¦ba sis¦ ¦in¦ ¦19 3¦ ¦countries¦ ,▁ ¦aff ecting¦ ¦appro xi ma tely¦ ¦9 9¦ . ¦4¦ ¦p erc ent¦ ¦of¦ ¦the¦ ¦world¦ ' ¦s¦ ¦st ud ent¦ ¦population¦ .
𐋇¦m is in f orm ation¦ ¦about¦ ¦the¦ ¦virus¦ ¦has¦ ¦spread¦ ¦online¦ ,▁ ¦and¦ ¦there¦ ¦have¦ ¦been¦ ¦inc id ents¦ ¦of¦ ¦ x e no ph ob ia¦ ¦and¦ ¦disc r im ination¦ ¦against¦ ¦chinese¦ ¦people¦ ,▁ ¦other¦ ¦people¦ ¦of¦ ¦e ast¦ ¦and¦ ¦so ut he ast¦ ¦a si an¦ ¦d esc ent¦ ¦and¦ ¦app ear ance¦ ,▁ ¦and¦ ¦others¦ ¦from¦ ¦areas¦ ¦with¦ ¦sign ific ant¦ ¦virus¦ ¦cases¦ .
𐋇 ¦due¦ ¦to¦ ¦reduc ed¦ ¦travel¦ ¦and¦ ¦closures¦ ¦of¦ ¦h ea v y¦ ¦ind u st ry¦ ,▁ ¦there¦ ¦has¦ ¦been¦ ¦a¦ ¦dec re ase¦ ¦in¦ ¦air ¦ ¦po ll ution¦ ¦and¦ ¦car b on¦ ¦e m is si ons¦ .
𐋇 ¦health¦ ¦author ities¦ ¦in¦ ¦wuhan¦ ,▁ ¦china¦ ▁( ¦the¦ ¦c ap it al¦ ¦of¦ ¦hub e i¦ ¦pro vi nce¦ )▁ ¦reported¦ ¦a¦ ¦cl us ter¦ ¦of¦ ¦pneumonia¦ ¦cases¦ ¦of¦ ¦un k n own¦ ¦cause¦ ¦on¦ ¦3 1¦ ¦december¦ ¦2019¦ ,▁ ¦and¦ ¦an¦ ¦in ve st ig ation¦ ¦was¦ ¦la un ched¦ ¦in¦ ¦early¦ ¦january¦ ¦2020¦ .
𐋇¦the¦ ¦cases¦ ¦mo st ly¦ ¦had¦ ¦l in ks¦ ¦to¦ ¦the¦ ¦h u an an¦ ¦s ea f ood¦ ¦wh ol es a le¦ ¦mark et¦ ¦and¦ ¦so¦ ¦the¦ ¦virus¦ ¦is¦ ¦th ou gh t¦ ¦to¦ ¦have¦ ¦a¦ ¦z o on ot ic¦ ¦orig in¦ .
𐋇¦the¦ ¦virus¦ ¦that¦ ¦caused¦ ¦the¦ ¦outbreak¦ ¦is¦ ¦known¦ ¦as¦ ¦sars¦ - ¦cov¦ - ¦2¦ ,▁ ¦a¦ ¦new ly¦ ¦dis covered¦ ¦virus¦ ¦clos ely¦ ¦related¦ ¦to¦ ¦bat¦ ¦coronaviruses¦ ,▁ ¦pa ngol in¦ ¦coronaviruses¦ ,▁ ¦and¦ ¦sars¦ - ¦cov¦ . ¦the¦ ¦ ear li est¦ ¦known¦ ¦person¦ ¦with¦ ¦symptoms¦ ¦was¦ ¦later¦ ¦dis covered¦ ¦to¦ ¦have¦ ¦fa ll en¦ ¦ ill¦ ¦on¦ ¦1¦ ¦december¦ ¦2019¦ ,▁ ¦and¦ ¦that¦ ¦person¦ ¦d id¦ ¦not¦ ¦have¦ ¦visi ble¦ ¦con n ec tions¦ ¦with¦ ¦the¦ ¦later¦ ¦w et¦ ¦mark et¦ ¦cl us ter¦ .
𐋇 ¦of¦ ¦the¦ ¦early¦ ¦cl us ter¦ ¦of¦ ¦cases¦ ¦reported¦ ¦in¦ ¦december¦ ¦2019¦ ,▁ ¦two¦ - ¦thir ds¦ ¦were¦ ¦found¦ ¦to¦ ¦have¦ ¦a¦ ¦l ink¦ ¦with¦ ¦the¦ ¦mark et¦ .
𐋇¦on¦ ¦13¦ ¦march¦ ¦2020¦ ,▁ ¦an¦ ¦un ver if ied¦ ¦report¦ ¦from¦ ¦the¦ ¦south¦ ¦china¦ ¦m or ning¦ ¦p ost¦ ¦su gg ested¦ ¦that¦ ¦a¦ ¦case¦ ¦trac ed¦ ¦b ack¦ ¦to¦ ¦1 7¦ ¦no ve mber¦ ¦2019¦ ,▁ ¦in¦ ¦a¦ ¦5 5¦ - ¦year¦ - ¦o ld¦ ¦from¦ ¦hub e i¦ ¦pro vi nce¦ ,▁ ¦may¦ ¦have¦ ¦been¦ ¦the¦ ¦first¦ . ¦on¦ ¦26¦ ¦february¦ ¦2020¦ ,▁ ¦the¦ ¦who¦ ¦reported¦ ¦that¦ ,▁ ¦as¦ ¦new¦ ¦cases¦ ¦rep ort ed ly¦ ¦decl ined¦ ¦in¦ ¦china¦ ¦but¦ ¦s ud d en ly¦ ¦increased¦ ¦in¦ ¦italy¦ ,▁ ¦iran¦ ,▁ ¦and¦ ¦south¦ ¦ko rea¦ ,▁ ¦the¦ ¦number¦ ¦of¦ ¦new¦ ¦cases¦ ¦outside¦ ¦china¦ ¦had¦ ¦ex c ee ded¦ ¦the¦ ¦number¦ ¦of¦ ¦new¦ ¦cases¦ ¦within¦ ¦china¦ ¦for¦ ¦the¦ ¦first¦ ¦time¦ .
𐋇¦there¦ ¦may¦ ¦be¦ ¦sub s ta ntial¦ ¦under re p orting¦ ¦of¦ ¦cases¦ ,▁ ¦partic ul arly¦ ¦among¦ ¦those¦ ¦with¦ ¦m il der¦ ¦symptoms¦ .
𐋇¦by¦ ¦26¦ ¦february¦ ,▁ ¦rel at ively¦ ¦fe w¦ ¦cases¦ ¦had¦ ¦been¦ ¦reported¦ ¦among¦ ¦y ou ths¦ ,▁ ¦with¦ ¦those¦ ¦19¦ ¦and¦ ¦under¦ ¦ma king¦ ¦up¦ ¦2¦ . ¦4¦ %▁ ¦of¦ ¦cases¦ ¦worldwide¦ . ¦the¦ ¦united¦ ¦ki ng d om¦ ' ¦s¦ ¦ch ief¦ ¦sc ie nt if ic¦ ¦ad v is er¦ ,▁ ¦p at r ick¦ ¦v a ll ance¦ ,▁ ¦estim ated¦ ¦that¦ ¦6 0¦ %▁ ¦of¦ ¦the¦ ¦br it ish¦ ¦population¦ ¦would¦ ¦need¦ ¦to¦ ¦bec ome¦ ¦infected¦ ¦before¦ ¦effective¦ ¦h er d¦ ¦immun ity¦ ¦could¦ ¦be¦ ¦a ch ie v ed¦ .
𐋇 ¦cases¦ ¦ref ers¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦people¦ ¦who¦ ¦have¦ ¦been¦ ¦tested¦ ¦for¦ ¦covid¦ - ¦19¦ ,▁ ¦and¦ ¦wh ose¦ ¦test¦ ¦has¦ ¦been¦ ¦confirmed¦ ¦positive¦ ¦according¦ ¦to¦ ¦offic ial¦ ¦prot oc ols¦ .
𐋇¦as¦ ¦of¦ ¦23¦ ¦march¦ ,▁ ¦no¦ ¦country¦ ¦had¦ ¦tested¦ ¦more¦ ¦than¦ ¦3¦ %▁ ¦of¦ ¦its¦ ¦population¦ ,▁ ¦and¦ ¦many¦ ¦countries¦ ¦have¦ ¦had¦ ¦offic ial¦ ¦pol ic ies¦ ¦not¦ ¦to¦ ¦test¦ ¦those¦ ¦with¦ ¦only¦ ¦mild¦ ¦symptoms¦ ,▁ ¦such¦ ¦as¦ ¦italy¦ ,▁ ¦the¦ ¦ne ther l an ds¦ ,▁ ¦s pa in¦ ,▁ ¦and¦ ¦sw it z er land¦ .
𐋇¦a¦ ¦study¦ ¦publ ished¦ ¦on¦ ¦16¦ ¦march¦ ¦found¦ ¦that¦ ¦in¦ ¦china¦ ,▁ ¦up¦ ¦to¦ ¦23¦ ¦january¦ ,▁ ¦an¦ ¦estim ated¦ ¦8 6¦ %▁ ¦of¦ ¦covid¦ - ¦19¦ ¦infections¦ ¦had¦ ¦not¦ ¦been¦ ¦detected¦ ,▁ ¦and¦ ¦that¦ ¦these¦ ¦u nd oc um ented¦ ¦infections¦ ¦were¦ ¦the¦ ¦infection¦ ¦sour ce¦ ¦for¦ ¦7 9¦ %▁ ¦of¦ ¦d oc um ented¦ ¦cases¦ .
𐋇¦a¦ ¦st at ist ical¦ ¦anal y sis¦ ¦publ ished¦ ¦30¦ ¦march¦ ¦estim ated¦ ¦that¦ ¦nu mbers¦ ¦of¦ ¦infections¦ ¦in¦ ¦italy¦ ¦were¦ ¦consid er ab ly¦ ¦g rea ter¦ ¦than¦ ¦the¦ ¦reported¦ ¦cases¦ .
𐋇¦the¦ ¦in it ial¦ ¦estim ates¦ ¦of¦ ¦the¦ ¦b as ic¦ ¦rep ro d u ction¦ ¦number¦ ▁( ¦r 0¦ )▁ ¦for¦ ¦covid¦ - ¦19¦ ¦were¦ ¦1¦ . ¦4¦ ¦to¦ ¦2¦ . ¦4¦ .
𐋇¦a¦ ¦study¦ ¦publ ished¦ ¦by¦ ¦the¦ ¦us¦ ¦center¦ ¦for¦ ¦disease¦ ¦control¦ ¦and¦ ¦pre vention¦ ¦has¦ ¦co nc lu ded¦ ¦that¦ ¦it¦ ¦may¦ ¦be¦ ¦5¦ . ¦7¦ .
𐋇 ¦most¦ ¦people¦ ¦with¦ ¦covid¦ - ¦19¦ ¦reco ver¦ .
𐋇¦for¦ ¦those¦ ¦who¦ ¦do¦ ¦not¦ ,▁ ¦the¦ ¦time¦ ¦from¦ ¦development¦ ¦of¦ ¦symptoms¦ ¦to¦ ¦death¦ ¦has¦ ¦been¦ ¦between¦ ¦6¦ ¦and¦ ¦4 1¦ ¦days¦ ,▁ ¦with¦ ¦the¦ ¦most¦ ¦common¦ ¦being¦ ¦14¦ ¦days¦ .
𐋇¦as¦ ¦of¦ ¦10¦ ¦april¦ ¦2020¦ ,▁ ¦appro xi ma tely¦ ¦9 7¦ , ¦000¦ ¦deaths¦ ¦had¦ ¦been¦ ¦att rib u ted¦ ¦to¦ ¦covid¦ - ¦19¦ .
𐋇¦in¦ ¦china¦ ,▁ ¦as¦ ¦of¦ ¦5¦ ¦february¦ ¦about¦ ¦8 0¦ %▁ ¦of¦ ¦deaths¦ ¦were¦ ¦in¦ ¦those¦ ¦over¦ ¦6 0¦ ,▁ ¦and¦ ¦7 5¦ %▁ ¦had¦ ¦pr e¦ - ¦ex is ting¦ ¦health¦ ¦conditions¦ ¦including¦ ¦car di ov as c ular¦ ¦diseases¦ ¦and¦ ¦di ab e tes¦ . ¦offic ial¦ ¦ta ll ies¦ ¦of¦ ¦deaths¦ ¦from¦ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ ¦gener ally¦ ¦ref er¦ ¦to¦ ¦d ead¦ ¦people¦ ¦who¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ ¦according¦ ¦to¦ ¦offic ial¦ ¦prot oc ols¦ .
𐋇¦the¦ ¦number¦ ¦of¦ ¦tr ue¦ ¦fat al ities¦ ¦from¦ ¦covid¦ - ¦19¦ ¦may¦ ¦be¦ ¦much¦ ¦higher¦ ,▁ ¦as¦ ¦it¦ ¦may¦ ¦not¦ ¦include¦ ¦people¦ ¦who¦ ¦di e¦ ¦without¦ ¦testing¦ ▁-▁ ¦ e¦ . ¦ g¦ .▁ ¦at¦ ¦home¦ ,▁ ¦in¦ ¦nu rs ing¦ ¦h omes¦ ,▁ ¦ et c¦ .
𐋇 ¦part ial¦ ¦data¦ ¦from¦ ¦italy¦ ¦found¦ ¦that¦ ¦the¦ ¦number¦ ¦of¦ ¦ex c ess¦ ¦deaths¦ ¦during¦ ¦the¦ ¦pandemic¦ ¦ex c ee ded¦ ¦the¦ ¦offic ial¦ ¦covid¦ ¦death¦ ¦t ally¦ ¦by¦ ¦a¦ ¦fa ct or¦ ¦of¦ ¦4¦ - ¦5 x¦ .
𐋇¦a¦ ¦sp o k es w om an¦ ¦for¦ ¦the¦ ¦u¦ . ¦s¦ .▁ ¦ce nt ers¦ ¦for¦ ¦disease¦ ¦control¦ ¦and¦ ¦pre vention¦ ▁( ¦c dc¦ )▁ ¦ac k n ow l ed ged¦ ▁" ¦we¦ ¦know¦ ¦that¦ ▁ [ ¦the¦ ¦stated¦ ¦death¦ ¦t ol l¦ ] ▁ ¦is¦ ¦an¦ ¦under e st im ation¦ " ,▁ ¦a¦ ¦sta te ment¦ ¦cor ro bor ated¦ ¦by¦ ¦an ec d ot al¦ ¦rep orts¦ ¦of¦ ¦under c o un ting¦ ¦in¦ ¦the¦ ¦u¦ . ¦s¦ .▁ ¦such¦ ¦under e st im ation¦ ¦often¦ ¦occur s¦ ¦in¦ ¦p an de m ics¦ ,▁ ¦such¦ ¦as¦ ¦the¦ ¦20 0 9¦ ¦h 1 n 1¦ ¦sw ine¦ ¦flu¦ ¦epidemic¦ . ¦the¦ ¦first¦ ¦confirmed¦ ¦death¦ ¦was¦ ¦in¦ ¦wuhan¦ ¦on¦ ¦9¦ ¦january¦ ¦2020¦ .
𐋇¦the¦ ¦first¦ ¦death¦ ¦outside¦ ¦main land¦ ¦china¦ ¦occur r ed¦ ¦on¦ ¦1¦ ¦february¦ ¦in¦ ¦the¦ ¦p hi li pp ines¦ ,▁ ¦and¦ ¦the¦ ¦first¦ ¦death¦ ¦outside¦ ¦as ia¦ ¦was¦ ¦in¦ ¦fra nce¦ ¦on¦ ¦14¦ ¦february¦ .
𐋇¦by¦ ¦2 8¦ ¦february¦ ,▁ ¦outside¦ ¦main land¦ ¦china¦ ,▁ ¦more¦ ¦than¦ ¦a¦ ¦do z en¦ ¦deaths¦ ¦each¦ ¦were¦ ¦recor ded¦ ¦in¦ ¦iran¦ ,▁ ¦south¦ ¦ko rea¦ ,▁ ¦and¦ ¦italy¦ .
𐋇¦by¦ ¦13¦ ¦march¦ ,▁ ¦more¦ ¦than¦ ¦f ort y¦ ¦countries¦ ¦and¦ ¦ter r it or ies¦ ¦had¦ ¦reported¦ ¦deaths¦ ,▁ ¦on¦ ¦every¦ ¦contin ent¦ ¦ex cep t¦ ¦a nt ar ct ica¦ . ¦several¦ ¦measures¦ ¦are¦ ¦comm on ly¦ ¦used¦ ¦to¦ ¦qu a nt if y¦ ¦m ort ality¦ .
𐋇¦these¦ ¦nu mbers¦ ¦v ary¦ ¦by¦ ¦reg ion¦ ¦and¦ ¦over¦ ¦time¦ ,▁ ¦and¦ ¦are¦ ¦influ e nc ed¦ ¦by¦ ¦the¦ ¦v o lu me¦ ¦of¦ ¦testing¦ ,▁ ¦healthcare¦ ¦system¦ ¦qu ality¦ ,▁ ¦treatment¦ ¦op tions¦ ,▁ ¦time¦ ¦since¦ ¦in it ial¦ ¦outbreak¦ ,▁ ¦and¦ ¦population¦ ¦ch ara ct er ist ics¦ ¦such¦ ¦as¦ ¦age¦ ,▁ ¦se x¦ ,▁ ¦and¦ ¦over all¦ ¦health¦ . ¦the¦ ¦death¦ - ¦to¦ - ¦case¦ ¦ra ti o¦ ¦ref l ects¦ ¦the¦ ¦number¦ ¦of¦ ¦deaths¦ ¦di vi ded¦ ¦by¦ ¦the¦ ¦number¦ ¦of¦ ¦diagn osed¦ ¦cases¦ ¦within¦ ¦a¦ ¦giv en¦ ¦time¦ ¦int erv al¦ .
𐋇 ¦based¦ ¦on¦ ¦jo h ns¦ ¦h op k ins¦ ¦univers ity¦ ¦st at ist ics¦ ,▁ ¦the¦ ¦global¦ ¦death¦ - ¦to¦ - ¦case¦ ¦ra ti o¦ ¦is¦ ¦6¦ . ¦ 0¦ % ▁( ¦9 7¦ , ¦0 3 9¦ ▁/▁ ¦1¦ , ¦6 1 7¦ , ¦20 4¦ )▁ ¦as¦ ¦of¦ ¦10¦ ¦april¦ ¦2020¦ .
𐋇¦the¦ ¦number¦ ¦vari es¦ ¦by¦ ¦reg ion¦ .
𐋇¦in¦ ¦china¦ ,▁ ¦estim ates¦ ¦for¦ ¦the¦ ¦death¦ - ¦to¦ - ¦case¦ ¦ra ti o¦ ¦dec rea sed¦ ¦from¦ ¦1 7¦ . ¦3¦ % ▁( ¦for¦ ¦those¦ ¦with¦ ¦s y m pt om¦ ¦o ns et¦ ¦1¦ ▁–▁ ¦10¦ ¦january¦ ¦2020¦ )▁ ¦to¦ ¦ 0¦ . ¦7¦ % ▁( ¦for¦ ¦those¦ ¦with¦ ¦s y m pt om¦ ¦o ns et¦ ¦after¦ ¦1¦ ¦february¦ ¦2020¦ )▁ . ¦other¦ ¦measures¦ ¦include¦ ¦the¦ ¦case¦ ¦fat ality¦ ¦rate¦ ▁( ¦c f r¦ ),▁ ¦which¦ ¦ref l ects¦ ¦the¦ ¦p erc ent¦ ¦of¦ ¦diagn osed¦ ¦people¦ ¦who¦ ¦di e¦ ¦from¦ ¦a¦ ¦disease¦ ,▁ ¦and¦ ¦the¦ ¦infection¦ ¦fat ality¦ ¦rate¦ ▁( ¦ if r¦ ),▁ ¦which¦ ¦ref l ects¦ ¦the¦ ¦p erc ent¦ ¦of¦ ¦infected¦ ▁( ¦diagn osed¦ ¦and¦ ¦u nd ia gn osed¦ )▁ ¦who¦ ¦di e¦ ¦from¦ ¦a¦ ¦disease¦ .
𐋇¦these¦ ¦st at ist ics¦ ¦are¦ ¦not¦ ¦ti me bo un d¦ ¦and¦ ¦follow¦ ¦a¦ ¦specific¦ ¦population¦ ¦from¦ ¦infection¦ ¦through¦ ¦case¦ ¦res ol ution¦ .
𐋇¦a¦ ¦number¦ ¦of¦ ¦ac a de m ics¦ ¦have¦ ¦att e mp ted¦ ¦to¦ ¦c al c ul ate¦ ¦these¦ ¦nu mbers¦ ¦for¦ ¦specific¦ ¦p op ul ations¦ .
𐋇¦the¦ ¦univers ity¦ ¦of¦ ¦o x for d¦ ' ¦s¦ ¦centre¦ ¦for¦ ¦evidence¦ - ¦based¦ ¦medic ine¦ ¦estim ates¦ ¦that¦ ¦the¦ ¦infection¦ ¦fat ality¦ ¦rate¦ ¦for¦ ¦the¦ ¦pandemic¦ ¦as¦ ¦a¦ ¦w ho le¦ ¦is¦ ¦between¦ ¦ 0¦ . ¦1¦ %▁ ¦and¦ ¦ 0¦ . ¦3 9¦ % .
𐋇¦the¦ ¦u pp er¦ ¦estim ate¦ ¦of¦ ¦this¦ ¦r ange¦ ¦is¦ ¦cons ist ent¦ ¦with¦ ¦the¦ ¦results¦ ¦from¦ ¦the¦ ¦first¦ ¦ra nd om¦ ¦testing¦ ¦for¦ ¦covid¦ - ¦19¦ ¦in¦ ¦g erm an y¦ ,▁ ¦and¦ ¦a¦ ¦st at ist ical¦ ¦study¦ ¦anal ys ing¦ ¦the¦ ¦impac t¦ ¦of¦ ¦testing¦ ¦on¦ ¦c f r¦ ¦estim ates¦ .
𐋇¦the¦ ¦who¦ ¦ass er ts¦ ¦that¦ ¦the¦ ¦pandemic¦ ¦can¦ ¦be¦ ¦cont ro lled¦ .
𐋇¦the¦ ¦p ea k¦ ¦and¦ ¦ ult im ate¦ ¦d ur ation¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦are¦ ¦u nc er tain¦ ¦and¦ ¦may¦ ¦di ff er¦ ¦by¦ ¦loc ation¦ .
𐋇¦m ac ie j ¦ ¦b on i¦ ¦of¦ ¦p en n¦ ¦state¦ ¦univers ity¦ ¦stated¦ , ▁" ¦le f t¦ ¦un ch ec ked¦ ,▁ ¦infectious¦ ¦out b rea ks¦ ¦typ ically¦ ¦pl at ea u¦ ¦and¦ ¦then¦ ¦star t¦ ¦to¦ ¦dec line¦ ¦when¦ ¦the¦ ¦disease¦ ¦ ru ns¦ ¦out¦ ¦of¦ ¦available¦ ¦ho sts¦ .
𐋇¦but¦ ¦it¦ ' ¦s¦ ¦al m ost¦ ¦imp os si ble¦ ¦to¦ ¦make¦ ¦any¦ ¦sen si ble¦ ¦pro j e ction¦ ¦r ight¦ ¦n ow¦ ¦about¦ ¦when¦ ¦that¦ ¦will¦ ¦be¦ ▁" .
𐋇¦the¦ ¦chinese¦ ¦government¦ ' ¦s¦ ¦sen i or¦ ¦medical¦ ¦ad v is er¦ ¦z ho ng¦ ¦na ns h an¦ ¦ arg u ed¦ ¦that¦ ▁" ¦it¦ ¦could¦ ¦be¦ ¦over¦ ¦by¦ ¦june¦ "▁ ¦if¦ ¦all¦ ¦countries¦ ¦can¦ ¦be¦ ¦m ob i li zed¦ ¦to¦ ¦follow¦ ¦the¦ ¦who¦ ' ¦s¦ ¦advice¦ ¦on¦ ¦measures¦ ¦to¦ ¦sto p¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦on¦ ¦1 7¦ ¦march¦ ,▁ ¦ad am¦ ¦k u ch a rs k i¦ ¦of¦ ¦the¦ ¦l ond on¦ ¦school¦ ¦of¦ ¦h yg ien e¦ ▁ & ▁ ¦a m p¦ ;▁ ¦tr op ical¦ ¦medic ine¦ ¦stated¦ ¦that¦ ¦sars¦ - ¦cov¦ - ¦2¦ ▁" ¦is¦ ¦go ing¦ ¦to¦ ¦be¦ ¦c ir c ul ating¦ ,▁ ¦pote nt ially¦ ¦for¦ ¦a¦ ¦year¦ ¦or¦ ¦two¦ " .
𐋇 ¦according¦ ¦to¦ ¦the¦ ¦imp er ial¦ ¦colle ge¦ ¦study¦ ¦l ed¦ ¦by¦ ¦ne il¦ ¦f er g us on¦ ,▁ ¦ph ys ical¦ ¦distancing¦ ¦and¦ ¦other¦ ¦measures¦ ¦will¦ ¦be¦ ¦required¦ ▁" ¦until¦ ¦a¦ ¦vaccine¦ ¦bec omes¦ ¦available¦ ▁( ¦pote nt ially¦ ¦18¦ ¦mon ths¦ ¦or¦ ¦more¦ ) " .
𐋇¦w il li am¦ ¦s ch a ff n er¦ ¦of¦ ¦v a nd er b il t¦ ¦univers ity¦ ¦stated¦ , ▁" ¦i¦ ¦th ink¦ ¦it¦ ' ¦s¦ ¦un li k ely¦ ¦that¦ ¦this¦ ¦coronavirus¦ ▁ — ▁ ¦because¦ ¦it¦ ' ¦s¦ ¦so¦ ¦rea di ly¦ ¦transm is si ble¦ ▁ — ▁ ¦will¦ ¦dis a pp ear¦ ¦comp le tely¦ "▁ ¦and¦ ¦it¦ ▁" ¦might¦ ¦t ur n¦ ¦into¦ ¦a¦ ¦se as on al¦ ¦disease¦ ,▁ ¦ma king¦ ¦a¦ ¦co me b ack¦ ¦every¦ ¦year¦ " .
𐋇¦the¦ ¦vir ul ence¦ ¦of¦ ¦the¦ ¦co me b ack¦ ¦would¦ ¦dep end¦ ¦on¦ ¦h er d¦ ¦immun ity¦ ¦and¦ ¦the¦ ¦ext ent¦ ¦of¦ ¦m ut ation¦ .
𐋇 ¦symptoms¦ ¦of¦ ¦covid¦ - ¦19¦ ¦can¦ ¦be¦ ¦rel at ively¦ ¦non¦ - ¦specific¦ ¦and¦ ¦infected¦ ¦people¦ ¦may¦ ¦be¦ ¦as ymptomatic¦ .
𐋇¦the¦ ¦two¦ ¦most¦ ¦common¦ ¦symptoms¦ ¦are¦ ¦fever¦ ▁( ¦8 8¦ % )▁ ¦and¦ ¦d ry¦ ¦cough¦ ▁( ¦6 8¦ % ).
𐋇 ¦less¦ ¦common¦ ¦symptoms¦ ¦include¦ ¦fat ig ue¦ ,▁ ¦respiratory¦ ¦sp ut um¦ ¦produc t ion¦ ▁( ¦ph le g m¦ ),▁ ¦l os s¦ ¦of¦ ¦the¦ ¦sen se¦ ¦of¦ ¦sm ell¦ ,▁ ¦sh ort ness¦ ¦of¦ ¦brea th¦ ,▁ ¦m us c le¦ ¦and¦ ¦jo in t¦ ¦pain¦ ,▁ ¦s ore¦ ¦th ro at¦ ,▁ ¦h ea d a ch e¦ ,▁ ¦c hi lls¦ ,▁ ¦v o mi ting¦ ,▁ ¦he mo pt y sis¦ ,▁ ¦di arr he a¦ ,▁ ¦or¦ ¦c y a no sis¦ . ¦the¦ ¦who¦ ¦states¦ ¦that¦ ¦appro xi ma tely¦ ¦one¦ ¦person¦ ¦in¦ ¦si x¦ ¦bec omes¦ ¦s eri o us ly¦ ¦ ill¦ ¦and¦ ¦has¦ ¦diffic ult y¦ ¦brea thing¦ .
𐋇¦the¦ ¦u¦ . ¦s¦ .▁ ¦ce nt ers¦ ¦for¦ ¦disease¦ ¦control¦ ¦and¦ ¦pre vention¦ ▁( ¦c dc¦ )▁ ¦li sts¦ ¦emergency¦ ¦symptoms¦ ¦as¦ ¦diffic ult y¦ ¦brea thing¦ ,▁ ¦pers ist ent¦ ¦chest¦ ¦pain¦ ¦or¦ ¦pre ss ure¦ ,▁ ¦s ud d en¦ ¦conf us ion¦ ,▁ ¦diffic ult y¦ ¦w a king¦ ,▁ ¦and¦ ¦b lu ish¦ ¦face¦ ¦or¦ ¦li ps¦ ;▁ ¦immediate¦ ¦medical¦ ¦att e nt ion¦ ¦is¦ ¦ad vi sed¦ ¦if¦ ¦these¦ ¦symptoms¦ ¦are¦ ¦pres ent¦ . ¦further¦ ¦development¦ ¦of¦ ¦the¦ ¦disease¦ ¦can¦ ¦l ead¦ ¦to¦ ¦severe¦ ¦pneumonia¦ ,▁ ¦acute¦ ¦respiratory¦ ¦di str ess¦ ¦syndrome¦ ,▁ ¦se p sis¦ ,▁ ¦se pt ic¦ ¦sh oc k¦ ¦and¦ ¦death¦ .
𐋇¦some¦ ¦of¦ ¦those¦ ¦infected¦ ¦may¦ ¦be¦ ¦as ymptomatic¦ ,▁ ¦with¦ ¦no¦ ¦clinical¦ ¦symptoms¦ ¦but¦ ¦with¦ ¦test¦ ¦results¦ ¦that¦ ¦conf ir m¦ ¦infection¦ ,▁ ¦so¦ ¦res ear ch ers¦ ¦have¦ ¦issued¦ ¦advice¦ ¦that¦ ¦those¦ ¦with¦ ¦close¦ ¦contact¦ ¦to¦ ¦confirmed¦ ¦infected¦ ¦people¦ ¦should¦ ¦be¦ ¦clos ely¦ ¦monit or ed¦ ¦and¦ ¦ex a m ined¦ ¦to¦ ¦ ru le¦ ¦out¦ ¦infection¦ .
𐋇 ¦chinese¦ ¦estim ates¦ ¦of¦ ¦the¦ ¦as ymptomatic¦ ¦ra ti o¦ ¦r ange¦ ¦from¦ ¦fe w¦ ¦to¦ ¦4 4¦ % .
𐋇¦the¦ ¦us ual¦ ¦inc ub ation¦ ¦period¦ ▁( ¦the¦ ¦time¦ ¦between¦ ¦infection¦ ¦and¦ ¦s y m pt om¦ ¦o ns et¦ )▁ ¦r an ges¦ ¦from¦ ¦one¦ ¦to¦ ¦14¦ ¦days¦ ;▁ ¦it¦ ¦is¦ ¦most¦ ¦comm on ly¦ ¦five¦ ¦days¦ . ¦as¦ ¦an¦ ¦example¦ ¦of¦ ¦un ce rt ai nt y¦ ,▁ ¦the¦ ¦estim ate¦ ¦of¦ ¦the¦ ¦fra ction¦ ¦of¦ ¦people¦ ¦with¦ ¦covid¦ - ¦19¦ ¦who¦ ¦l ost¦ ¦their¦ ¦sen se¦ ¦of¦ ¦sm ell¦ ¦was¦ ¦in it ially¦ ¦30¦ %▁ ¦and¦ ¦later¦ ¦f ell¦ ¦to¦ ¦15¦ % .
𐋇¦some¦ ¦detail s¦ ¦about¦ ¦how¦ ¦the¦ ¦disease¦ ¦is¦ ¦spread¦ ¦are¦ ¦still¦ ¦being¦ ¦det erm ined¦ .
𐋇¦the¦ ¦disease¦ ¦is¦ ¦b el ie v ed¦ ¦to¦ ¦be¦ ¦pri ma ri ly¦ ¦spread¦ ¦during¦ ¦close¦ ¦contact¦ ¦and¦ ¦by¦ ¦sm all¦ ¦dro pl ets¦ ¦produc ed¦ ¦during¦ ¦cou g hing¦ ,▁ ¦sneezing¦ ,▁ ¦or¦ ¦t al king¦ ;▁ ¦with¦ ¦close¦ ¦contact¦ ¦being¦ ¦within¦ ¦1¦ ¦to¦ ¦2¦ ¦met r es¦ ▁( ¦3¦ ¦to¦ ¦6¦ ¦fe et¦ ).
𐋇 ¦st u dies¦ ¦have¦ ¦found¦ ¦that¦ ¦an¦ ¦un covered¦ ¦cou g hing¦ ¦can¦ ¦l ead¦ ¦to¦ ¦dro pl ets¦ ¦tra ve lling¦ ¦up¦ ¦to¦ ¦4¦ . ¦5¦ ¦met r es¦ ▁( ¦15¦ ¦fe et¦ )▁ ¦to¦ ¦8¦ . ¦2¦ ¦met r es¦ ▁( ¦2 7¦ ¦fe et¦ ).
𐋇¦some¦ ¦have¦ ¦prop osed¦ ¦that¦ ¦the¦ ¦virus¦ ¦may¦ ¦also¦ ¦be¦ ¦transm it ted¦ ¦by¦ ¦sm all¦ ¦dro pl ets¦ ¦that¦ ¦stay¦ ¦for¦ ¦more¦ ¦pr ol on ged¦ ¦perio ds¦ ¦in¦ ¦the¦ ¦air ¦ ,▁ ¦that¦ ¦may¦ ¦be¦ ¦gener ated¦ ¦during¦ ¦sp ee ch¦ . ¦respiratory¦ ¦dro pl ets¦ ¦may¦ ¦also¦ ¦be¦ ¦produc ed¦ ¦during¦ ¦brea thing¦ ¦out¦ ,▁ ¦including¦ ¦when¦ ¦t al king¦ ,▁ ¦th ough¦ ¦the¦ ¦virus¦ ¦is¦ ¦not¦ ¦gener ally¦ ¦air bor n e¦ .
𐋇¦the¦ ¦dro pl ets¦ ¦can¦ ¦ land¦ ¦in¦ ¦the¦ ¦m ou ths¦ ¦or¦ ¦no ses¦ ¦of¦ ¦people¦ ¦who¦ ¦are¦ ¦n ear b y¦ ¦or¦ ¦p os si b ly¦ ¦be¦ ¦in h al ed¦ ¦into¦ ¦the¦ ¦lu ng s¦ .
𐋇¦some¦ ¦medical¦ ¦proc ed ures¦ ¦such¦ ¦as¦ ¦int ub ation¦ ¦and¦ ¦car di op ul m on ary¦ ¦res us c it ation¦ ▁( ¦c p r¦ )▁ ¦may¦ ¦cause¦ ¦respiratory¦ ¦sec re tions¦ ¦to¦ ¦be¦ ¦a er os o li zed¦ ¦and¦ ¦th us¦ ¦result¦ ¦in¦ ¦air bor n e¦ ¦spread¦ .
𐋇¦it¦ ¦may¦ ¦also¦ ¦spread¦ ¦when¦ ¦one¦ ¦tou ches¦ ¦a¦ ¦conta min ated¦ ¦sur f ace¦ ,▁ ¦including¦ ¦s k in¦ ,▁ ¦and¦ ¦then¦ ¦tou ches¦ ¦their¦ ¦ey es¦ ,▁ ¦nose¦ ,▁ ¦or¦ ¦mouth¦ .
𐋇 ¦while¦ ¦there¦ ¦are¦ ¦concer ns¦ ¦it¦ ¦may¦ ¦spread¦ ¦by¦ ¦fa e ces¦ ,▁ ¦this¦ ¦risk¦ ¦is¦ ¦b el ie v ed¦ ¦to¦ ¦be¦ ¦low¦ .
𐋇¦the¦ ¦government¦ ¦of¦ ¦china¦ ¦d en ied¦ ¦the¦ ¦p os si bility¦ ¦of¦ ¦fa ec al¦ - ¦or al¦ ¦transmission¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ . ¦the¦ ¦virus¦ ¦is¦ ¦most¦ ¦conta g ious¦ ¦during¦ ¦the¦ ¦first¦ ¦three¦ ¦days¦ ¦after¦ ¦o ns et¦ ¦of¦ ¦symptoms¦ ,▁ ¦al th ough¦ ¦spread¦ ¦may¦ ¦be¦ ¦possible¦ ¦before¦ ¦symptoms¦ ¦app ear¦ ¦and¦ ¦in¦ ¦later¦ ¦sta ges¦ ¦of¦ ¦the¦ ¦disease¦ .
𐋇 ¦people¦ ¦have¦ ¦tested¦ ¦positive¦ ¦for¦ ¦the¦ ¦disease¦ ¦up¦ ¦to¦ ¦three¦ ¦days¦ ¦before¦ ¦o ns et¦ ¦of¦ ¦symptoms¦ ¦su gg es ting¦ ¦transmission¦ ¦is¦ ¦possible¦ ¦before¦ ¦develop ing¦ ¦sign ific ant¦ ¦symptoms¦ .
𐋇 ¦only¦ ¦fe w¦ ¦rep orts¦ ¦of¦ ¦laboratory¦ - ¦confirmed¦ ¦as ymptomatic¦ ¦cases¦ ¦ex ist¦ ,▁ ¦but¦ ¦as ymptomatic¦ ¦transmission¦ ¦has¦ ¦been¦ ¦identified¦ ¦by¦ ¦some¦ ¦countries¦ ¦during¦ ¦contact¦ ¦trac ing¦ ¦in ve st ig ations¦ .
𐋇¦the¦ ¦european¦ ¦centre¦ ¦for¦ ¦disease¦ ¦pre vention¦ ¦and¦ ¦control¦ ▁( ¦ec dc¦ )▁ ¦states¦ ¦that¦ ¦while¦ ¦it¦ ¦is¦ ¦not¦ ¦ent ir ely¦ ¦cl ear¦ ¦how¦ ¦ ea si ly¦ ¦the¦ ¦disease¦ ¦sprea ds¦ ,▁ ¦one¦ ¦person¦ ¦gener ally¦ ¦inf ects¦ ¦two¦ ¦to¦ ¦three¦ ¦others¦ . ¦the¦ ¦virus¦ ¦sur v ives¦ ¦for¦ ¦hours¦ ¦to¦ ¦days¦ ¦on¦ ¦sur fa ces¦ .
𐋇 ¦spec if ically¦ ,▁ ¦the¦ ¦virus¦ ¦was¦ ¦found¦ ¦to¦ ¦be¦ ¦det ect able¦ ¦for¦ ¦up¦ ¦to¦ ¦three¦ ¦days¦ ¦on¦ ¦pla st ic¦ ▁( ¦pol y p r op y l en e¦ )▁ ¦and¦ ¦30 4¦ ¦sta in less¦ ¦st ee l¦ ,▁ ¦for¦ ¦one¦ ¦day¦ ¦on¦ ¦car d bo ard¦ ,▁ ¦and¦ ¦for¦ ¦up¦ ¦to¦ ¦four¦ ¦hours¦ ¦on¦ ¦co pp er¦ .
𐋇¦this¦ ,▁ ¦however¦ ,▁ ¦vari es¦ ¦based¦ ¦on¦ ¦the¦ ¦h um id ity¦ ¦and¦ ¦temp erat ure¦ . ¦p ets¦ ¦and¦ ¦other¦ ¦anim als¦ ¦have¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦evidence¦ ¦anim als¦ ¦can¦ ¦p ass¦ ¦the¦ ¦virus¦ ¦on¦ ¦to¦ ¦humans¦ ,▁ ¦th ough¦ ¦br it ish¦ ¦author ities¦ ¦ad v ise¦ ¦washing¦ ¦one¦ ' ¦s¦ ¦hands¦ ¦after¦ ¦contact¦ ¦with¦ ¦anim als¦ ,▁ ¦like¦ ¦after¦ ¦contact¦ ¦with¦ ¦other¦ ¦sur fa ces¦ ¦infected¦ ¦people¦ ¦could¦ ¦have¦ ¦tou ched¦ .
𐋇 ¦severe¦ ¦acute¦ ¦respiratory¦ ¦syndrome¦ ¦coronavirus¦ ¦2¦ ▁( ¦sars¦ - ¦cov¦ - ¦2¦ )▁ ¦is¦ ¦a¦ ¦novel¦ ¦virus¦ ,▁ ¦first¦ ¦isol ated¦ ¦from¦ ¦three¦ ¦people¦ ¦with¦ ¦pneumonia¦ ¦con n ected¦ ¦to¦ ¦the¦ ¦cl us ter¦ ¦of¦ ¦acute¦ ¦respiratory¦ ¦illness¦ ¦cases¦ ¦in¦ ¦wuhan¦ .
𐋇 ¦all¦ ¦fe at ures¦ ¦of¦ ¦the¦ ¦novel¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦virus¦ ¦occur ¦ ¦in¦ ¦related¦ ¦coronaviruses¦ ¦in¦ ¦nat ure¦ . ¦outside¦ ¦the¦ ¦human¦ ¦body¦ ,▁ ¦the¦ ¦virus¦ ¦is¦ ¦ki lled¦ ¦by¦ ¦hou se ho ld¦ ¦so a p¦ ,▁ ¦which¦ ¦di ss ol ves¦ ¦its¦ ¦prot ective¦ ¦en v el ope¦ . ¦sars¦ - ¦cov¦ - ¦2¦ ¦is¦ ¦clos ely¦ ¦related¦ ¦to¦ ¦the¦ ¦orig in al¦ ¦sars¦ - ¦cov¦ .
𐋇¦it¦ ¦is¦ ¦th ou gh t¦ ¦to¦ ¦have¦ ¦a¦ ¦z o on ot ic¦ ¦orig in¦ .
𐋇 ¦gen et ic¦ ¦anal y sis¦ ¦has¦ ¦re ve al ed¦ ¦that¦ ¦the¦ ¦coronavirus¦ ¦gen et ically¦ ¦c lu st ers¦ ¦with¦ ¦the¦ ¦gen us¦ ¦bet ac o ro na vir us¦ ,▁ ¦in¦ ¦sub g en us¦ ¦s ar b ec o vir us¦ ▁( ¦li ne age¦ ¦b ¦ )▁ ¦t og ether¦ ¦with¦ ¦two¦ ¦bat¦ - ¦d er iv ed¦ ¦stra ins¦ .
𐋇¦it¦ ¦is¦ ¦9 6¦ %▁ ¦ident ical¦ ¦at¦ ¦the¦ ¦w ho le¦ ¦gen ome¦ ¦level¦ ¦to¦ ¦other¦ ¦bat¦ ¦coronavirus¦ ¦samples¦ ▁( ¦b at cov ¦ ¦r at g 1 3¦ ).
𐋇¦in¦ ¦february¦ ¦2020¦ ,▁ ¦chinese¦ ¦res ear ch ers¦ ¦found¦ ¦that¦ ¦there¦ ¦is¦ ¦only¦ ¦one¦ ¦a min o¦ ¦ac id¦ ¦di ff er ence¦ ¦in¦ ¦c er tain¦ ¦par ts¦ ¦of¦ ¦the¦ ¦gen ome¦ ¦se qu en ces¦ ¦between¦ ¦the¦ ¦viruses¦ ¦from¦ ¦pa ngol ins¦ ¦and¦ ¦those¦ ¦from¦ ¦humans¦ .
𐋇¦w ho le¦ - ¦gen ome¦ ¦comp ar is on¦ ¦to¦ ¦date¦ ¦has¦ ¦found¦ ¦at¦ ¦most¦ ¦9 2¦ %▁ ¦of¦ ¦gen et ic¦ ¦m at er ial¦ ¦sh ared¦ ¦between¦ ¦pa ngol in¦ ¦coronavirus¦ ¦and¦ ¦sars¦ - ¦cov¦ - ¦2¦ ,▁ ¦which¦ ¦is¦ ¦i ns u ff ici ent¦ ¦to¦ ¦pro ve¦ ¦pa ngol ins¦ ¦to¦ ¦be¦ ¦the¦ ¦int erm ediate¦ ¦host¦ .
𐋇 ¦infection¦ ¦by¦ ¦the¦ ¦virus¦ ¦can¦ ¦be¦ ¦pro vi si on ally¦ ¦diagn osed¦ ¦on¦ ¦the¦ ¦ba sis¦ ¦of¦ ¦symptoms¦ ,▁ ¦th ough¦ ¦conf ir m ation¦ ¦is¦ ¦ ul ti ma tely¦ ¦by¦ ¦re ver se¦ ¦trans c ri ption¦ ¦pol y mer ase¦ ¦cha in¦ ¦rea ction¦ ▁( ¦r r t¦ - ¦p c r¦ )▁ ¦of¦ ¦infected¦ ¦sec re tions¦ ¦or¦ ¦c t¦ ¦i ma ging¦ .
𐋇¦a¦ ¦study¦ ¦comp ar ing¦ ¦p c r¦ ¦to¦ ¦c t¦ ¦in¦ ¦wuhan¦ ¦has¦ ¦su gg ested¦ ¦that¦ ¦c t¦ ¦is¦ ¦sign ific a ntly¦ ¦more¦ ¦sen si tive¦ ¦than¦ ¦p c r¦ ,▁ ¦th ough¦ ¦less¦ ¦specific¦ ,▁ ¦with¦ ¦many¦ ¦of¦ ¦its¦ ¦i ma ging¦ ¦fe at ures¦ ¦over la pping¦ ¦with¦ ¦other¦ ¦p ne um on ia s¦ ¦and¦ ¦disease¦ ¦proc es ses¦ .
𐋇¦as¦ ¦of¦ ¦march¦ ¦2020¦ ,▁ ¦the¦ ¦amer ic an¦ ¦colle ge¦ ¦of¦ ¦ra di ology¦ ¦recomm ends¦ ¦that¦ ▁" ¦c t¦ ¦should¦ ¦not¦ ¦be¦ ¦used¦ ¦to¦ ¦scre en¦ ¦for¦ ¦or¦ ¦as¦ ¦a¦ ¦first¦ - ¦ line¦ ¦test¦ ¦to¦ ¦diagn ose¦ ¦covid¦ - ¦19¦ " .
𐋇¦the¦ ¦who¦ ¦has¦ ¦publ ished¦ ¦several¦ ¦rna¦ ¦testing¦ ¦prot oc ols¦ ¦for¦ ¦sars¦ - ¦cov¦ - ¦2¦ ,▁ ¦with¦ ¦the¦ ¦first¦ ¦issued¦ ¦on¦ ¦1 7¦ ¦january¦ .
𐋇¦the¦ ¦test¦ ¦u ses¦ ¦re al¦ - ¦time¦ ¦re ver se¦ ¦trans c ri ption¦ ¦pol y mer ase¦ ¦cha in¦ ¦rea ction¦ ▁( ¦r r t¦ - ¦p c r¦ ).
𐋇¦the¦ ¦test¦ ¦can¦ ¦be¦ ¦d one¦ ¦on¦ ¦respiratory¦ ¦or¦ ¦blood¦ ¦samples¦ .
𐋇 ¦results¦ ¦are¦ ¦gener ally¦ ¦available¦ ¦within¦ ¦a¦ ¦fe w¦ ¦hours¦ ¦to¦ ¦days¦ .
𐋇 ¦gener ally¦ ¦this¦ ¦test¦ ¦is¦ ¦c arr ied¦ ¦out¦ ¦on¦ ¦a¦ ¦n as o ph ar y n ge al¦ ¦sw ab ¦ ¦th ough¦ ¦a¦ ¦th ro at¦ ¦sw ab ¦ ¦may¦ ¦also¦ ¦be¦ ¦used¦ . ¦a¦ ¦number¦ ¦of¦ ¦la bor at or ies¦ ¦and¦ ¦comp an ies¦ ¦are¦ ¦develop ing¦ ¦ser ological¦ ¦tests¦ ,▁ ¦which¦ ¦det ect¦ ¦antibo dies¦ .
𐋇¦as¦ ¦of¦ ¦6¦ ¦april¦ ¦2020¦ ,▁ ¦n one¦ ¦of¦ ¦these¦ ¦has¦ ¦been¦ ¦pr oved¦ ¦su ff ic ie ntly¦ ¦acc ur ate¦ ¦to¦ ¦be¦ ¦appr oved¦ ¦for¦ ¦wid esp r ead¦ ¦use¦ .
𐋇¦in¦ ¦the¦ ¦us¦ ¦a¦ ¦ser ological¦ ¦test¦ ¦developed¦ ¦by¦ ¦c el le x¦ ¦has¦ ¦been¦ ¦appr oved¦ ¦for¦ ¦emergency¦ ¦use¦ ¦by¦ ¦ce rt if ied¦ ¦la bor at or ies¦ ¦only¦ .
𐋇 ¦ch ara ct er ist ic¦ ¦i ma ging¦ ¦fe at ures¦ ¦on¦ ¦ra di ogra ph s¦ ¦and¦ ¦comp u ted¦ ¦t om ogra ph y¦ ▁( ¦c t¦ )▁ ¦of¦ ¦people¦ ¦who¦ ¦are¦ ¦s ymptomatic¦ ¦include¦ ¦as y mm et r ic¦ ¦p eri ph er al¦ ¦grou n d¦ ¦gl ass¦ ¦op ac ities¦ ¦and¦ ¦ab s ent¦ ¦p le ural¦ ¦eff u si ons¦ .
𐋇¦the¦ ¦i tali an¦ ¦ra di ological¦ ¦s oc i et y¦ ¦is¦ ¦comp il ing¦ ¦an¦ ¦international¦ ¦online¦ ¦d at ab ase¦ ¦of¦ ¦i ma ging¦ ¦fi nd ings¦ ¦for¦ ¦confirmed¦ ¦cases¦ .
𐋇 ¦due¦ ¦to¦ ¦over la p¦ ¦with¦ ¦other¦ ¦infections¦ ¦such¦ ¦as¦ ¦a de no vir us¦ ,▁ ¦i ma ging¦ ¦without¦ ¦conf ir m ation¦ ¦by¦ ¦p c r¦ ¦is¦ ¦of¦ ¦limi ted¦ ¦spec ific ity¦ ¦in¦ ¦ident if ying¦ ¦covid¦ - ¦19¦ .
𐋇¦a¦ ¦large¦ ¦study¦ ¦in¦ ¦china¦ ¦comp ared¦ ¦chest¦ ¦c t¦ ¦results¦ ¦to¦ ¦p c r¦ ¦and¦ ¦dem on str ated¦ ¦that¦ ¦th ough¦ ¦i ma ging¦ ¦is¦ ¦less¦ ¦specific¦ ¦for¦ ¦the¦ ¦infection¦ ,▁ ¦it¦ ¦is¦ ¦f as ter¦ ¦and¦ ¦more¦ ¦sen si tive¦ ,▁ ¦su gg es ting¦ ¦its¦ ¦consid er ation¦ ¦as¦ ¦a¦ ¦scre ening¦ ¦t oo l¦ ¦in¦ ¦epidemic¦ ¦areas¦ .
𐋇 ¦a rt ific ial¦ ¦in te ll ig ence¦ - ¦based¦ ¦con v o lu tional¦ ¦ne ural¦ ¦n et w or ks¦ ¦have¦ ¦been¦ ¦developed¦ ¦to¦ ¦det ect¦ ¦i ma ging¦ ¦fe at ures¦ ¦of¦ ¦the¦ ¦virus¦ ¦with¦ ¦both¦ ¦ra di ogra ph s¦ ¦and¦ ¦c t¦ .
𐋇 ¦stra te g ies¦ ¦for¦ ¦prev en ting¦ ¦transmission¦ ¦of¦ ¦the¦ ¦disease¦ ¦include¦ ¦main t aining¦ ¦over all¦ ¦g ood¦ ¦personal¦ ¦h yg ien e¦ ,▁ ¦washing¦ ¦hands¦ ,▁ ¦a v oi ding¦ ¦to uc hing¦ ¦the¦ ¦ey es¦ ,▁ ¦nose¦ ,▁ ¦or¦ ¦mouth¦ ¦with¦ ¦un w as h ed¦ ¦hands¦ ,▁ ¦and¦ ¦cou g hing¦ ¦or¦ ¦sneezing¦ ¦into¦ ¦a¦ ¦ti ss ue¦ ¦and¦ ¦p ut ting¦ ¦the¦ ¦ti ss ue¦ ¦dir ect ly¦ ¦into¦ ¦a¦ ¦w a st e¦ ¦conta in er¦ .
𐋇 ¦those¦ ¦who¦ ¦may¦ ¦al rea dy¦ ¦have¦ ¦the¦ ¦infection¦ ¦have¦ ¦been¦ ¦ad vi sed¦ ¦to¦ ¦wear¦ ¦a¦ ¦sur g ical¦ ¦mask¦ ¦in¦ ¦public¦ .
𐋇 ¦ph ys ical¦ ¦distancing¦ ¦measures¦ ¦are¦ ¦also¦ ¦recommended¦ ¦to¦ ¦prevent¦ ¦transmission¦ . ¦many¦ ¦gover n ments¦ ¦have¦ ¦re stric ted¦ ¦or¦ ¦ad vi sed¦ ¦against¦ ¦all¦ ¦non¦ - ¦essential¦ ¦travel¦ ¦to¦ ¦and¦ ¦from¦ ¦countries¦ ¦and¦ ¦areas¦ ¦affected¦ ¦by¦ ¦the¦ ¦outbreak¦ .
𐋇¦however¦ ,▁ ¦the¦ ¦virus¦ ¦has¦ ¦rea ched¦ ¦the¦ ¦st age¦ ¦of¦ ¦community¦ ¦spread¦ ¦in¦ ¦large¦ ¦par ts¦ ¦of¦ ¦the¦ ¦world¦ .
𐋇¦this¦ ¦me ans¦ ¦that¦ ¦the¦ ¦virus¦ ¦is¦ ¦sprea ding¦ ¦within¦ ¦comm un ities¦ ,▁ ¦and¦ ¦some¦ ¦community¦ ¦me mbers¦ ¦d on¦ ' ¦t¦ ¦know¦ ¦where¦ ¦or¦ ¦how¦ ¦they¦ ¦were¦ ¦infected¦ . ¦health¦ ¦care¦ ¦provid ers¦ ¦ta king¦ ¦care¦ ¦of¦ ¦someone¦ ¦who¦ ¦may¦ ¦be¦ ¦infected¦ ¦are¦ ¦recommended¦ ¦to¦ ¦use¦ ¦sta nd ard¦ ¦pr ec a u tions¦ ,▁ ¦contact¦ ¦pr ec a u tions¦ ,▁ ¦and¦ ¦ey e¦ ¦prote ction¦ . ¦contact¦ ¦trac ing¦ ¦is¦ ¦an¦ ¦important¦ ¦met ho d¦ ¦for¦ ¦health¦ ¦author ities¦ ¦to¦ ¦det erm ine¦ ¦the¦ ¦sour ce¦ ¦of¦ ¦an¦ ¦infection¦ ¦and¦ ¦to¦ ¦prevent¦ ¦further¦ ¦transmission¦ .
𐋇¦the¦ ¦use¦ ¦of¦ ¦loc ation¦ ¦data¦ ¦from¦ ¦m ob i le¦ ¦ph on es¦ ¦by¦ ¦gover n ments¦ ¦for¦ ¦this¦ ¦p ur p ose¦ ¦has¦ ¦pro mp ted¦ ¦priv acy¦ ¦concer ns¦ ,▁ ¦with¦ ¦a m ne st y¦ ¦international¦ ¦and¦ ¦over¦ ¦100¦ ¦other¦ ¦organiz ations¦ ¦i ss u ing¦ ¦a¦ ¦sta te ment¦ ¦ca lling¦ ¦for¦ ¦limi ts¦ ¦on¦ ¦this¦ ¦k ind¦ ¦of¦ ¦surveillance¦ .
𐋇 ¦v ar ious¦ ¦m ob i le¦ ¦app s¦ ¦have¦ ¦been¦ ¦imp le m ented¦ ¦or¦ ¦prop osed¦ ¦for¦ ¦v o lu nt ary¦ ¦use¦ ,▁ ¦and¦ ¦as¦ ¦of¦ ¦april¦ ¦7¦ ,▁ ¦2020¦ ,▁ ¦over¦ ¦a¦ ¦do z en¦ ¦exp er t¦ ¦grou ps¦ ¦were¦ ¦wor king¦ ¦on¦ ¦priv acy¦ - ¦f ri end ly¦ ¦so lu tions¦ ,▁ ¦such¦ ¦as¦ ¦using¦ ¦b lu et oo th¦ ¦to¦ ¦lo g¦ ¦a¦ ¦us er¦ ' ¦s¦ ¦pro x im ity¦ ¦to¦ ¦other¦ ¦ce ll ph on es¦ .
𐋇 ¦us ers¦ ¦then¦ ¦receive¦ ¦a¦ ¦me ss age¦ ¦if¦ ¦they¦ ' ¦ ve¦ ¦been¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ ¦someone¦ ¦who¦ ¦has¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ . ¦m is c on cep tions¦ ¦are¦ ¦c ir c ul ating¦ ¦about¦ ¦how¦ ¦to¦ ¦prevent¦ ¦infection¦ ;▁ ¦for¦ ¦example¦ ,▁ ¦ ri ns ing¦ ¦the¦ ¦nose¦ ¦and¦ ¦g arg l ing¦ ¦with¦ ¦m ou th w as h ¦ ¦are¦ ¦not¦ ¦effective¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ,▁ ¦th ough¦ ¦many¦ ¦organiz ations¦ ¦are¦ ¦wor king¦ ¦to¦ ¦develop ¦ ¦one¦ .
𐋇 ¦hand¦ ¦washing¦ ¦is¦ ¦recommended¦ ¦to¦ ¦prevent¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦disease¦ .
𐋇¦the¦ ¦c dc¦ ¦recomm ends¦ ¦that¦ ¦people¦ ¦wash¦ ¦hands¦ ¦often¦ ¦with¦ ¦so a p¦ ¦and¦ ¦water¦ ¦for¦ ¦at¦ ¦least¦ ¦t we nt y¦ ¦sec on ds¦ ,▁ ¦especially¦ ¦after¦ ¦go ing¦ ¦to¦ ¦the¦ ¦to il et¦ ¦or¦ ¦when¦ ¦hands¦ ¦are¦ ¦visi b ly¦ ¦di rt y¦ ;▁ ¦before¦ ¦e ating¦ ;▁ ¦and¦ ¦after¦ ¦ bl owing¦ ¦one¦ ' ¦s¦ ¦nose¦ ,▁ ¦cou g hing¦ ,▁ ¦or¦ ¦sneezing¦ .
𐋇¦this¦ ¦is¦ ¦because¦ ¦outside¦ ¦the¦ ¦human¦ ¦body¦ ,▁ ¦the¦ ¦virus¦ ¦is¦ ¦ki lled¦ ¦by¦ ¦hou se ho ld¦ ¦so a p¦ ,▁ ¦which¦ ¦b ur sts¦ ¦its¦ ¦prot ective¦ ¦b ub ble¦ .
𐋇¦c dc¦ ¦further¦ ¦recommended¦ ¦using¦ ¦an¦ ¦al c o ho l¦ - ¦based¦ ¦hand¦ ¦s an itiz er¦ ¦with¦ ¦at¦ ¦least¦ ¦6 0¦ %▁ ¦al c o ho l¦ ¦by¦ ¦v o lu me¦ ¦when¦ ¦so a p¦ ¦and¦ ¦water¦ ¦are¦ ¦not¦ ¦rea di ly¦ ¦available¦ .
𐋇¦the¦ ¦who¦ ¦ad vi ses¦ ¦people¦ ¦to¦ ¦avoid¦ ¦to uc hing¦ ¦the¦ ¦ey es¦ ,▁ ¦nose¦ ,▁ ¦or¦ ¦mouth¦ ¦with¦ ¦un w as h ed¦ ¦hands¦ .
𐋇 ¦sur fa ces¦ ¦may¦ ¦be¦ ¦dec on ta min ated¦ ¦with¦ ¦a¦ ¦number¦ ¦of¦ ¦so lu tions¦ ▁( ¦within¦ ¦one¦ ¦min ute¦ ¦of¦ ¦exp osure¦ ¦to¦ ¦the¦ ¦disinf ect ant¦ ¦for¦ ¦a¦ ¦sta in less¦ ¦st ee l¦ ¦sur f ace¦ ),▁ ¦including¦ ¦6 2¦ ▁–▁ ¦7 1¦ %▁ ¦e th a no l¦ ,▁ ¦50¦ ▁–▁ ¦100¦ %▁ ¦ is op ro pa no l¦ ,▁ ¦ 0¦ . ¦1¦ %▁ ¦so di um¦ ¦h y p o ch l or ite¦ ,▁ ¦ 0¦ . ¦5¦ %▁ ¦h y dr og en¦ ¦per o x ide¦ ,▁ ¦and¦ ¦ 0¦ . ¦2¦ ▁–▁ ¦7¦ . ¦5¦ %▁ ¦p ov id one¦ - ¦i o d ine¦ .
𐋇 ¦other¦ ¦so lu tions¦ ,▁ ¦such¦ ¦as¦ ¦b en z al k on i um¦ ¦ch l or ide¦ ¦and¦ ¦ch ro he x id ine¦ ¦gl uc on ate¦ ,▁ ¦are¦ ¦less¦ ¦effective¦ .
𐋇¦the¦ ¦c dc¦ ¦recomm ends¦ ¦that¦ ¦if¦ ¦a¦ ¦covid¦ ¦case¦ ¦is¦ ¦suspected¦ ¦or¦ ¦confirmed¦ ¦at¦ ¦a¦ ¦facil ity¦ ¦such¦ ¦as¦ ¦an¦ ¦off ice¦ ¦or¦ ¦day¦ ¦care¦ ,▁ ¦all¦ ¦areas¦ ¦such¦ ¦as¦ ¦offic es¦ ,▁ ¦ba th r oo ms¦ ,▁ ¦common¦ ¦areas¦ ,▁ ¦sh ared¦ ¦el ect r on ic¦ ¦equipment¦ ¦like¦ ¦ta bl ets¦ ,▁ ¦tou ch¦ ¦scre ens¦ ,▁ ¦k e y bo ards¦ ,▁ ¦rem ot e¦ ¦contr ols¦ ,▁ ¦and¦ ¦ at m¦ ¦ma ch ines¦ ¦used¦ ¦by¦ ¦the¦ ¦ ill¦ ¦pers ons¦ ,▁ ¦should¦ ¦be¦ ¦disinf ected¦ .
𐋇 ¦health¦ ¦organiz ations¦ ¦recommended¦ ¦that¦ ¦people¦ ¦cover¦ ¦their¦ ¦mouth¦ ¦and¦ ¦nose¦ ¦with¦ ¦a¦ ¦b ent¦ ¦el b ow¦ ¦or¦ ¦a¦ ¦ti ss ue¦ ¦when¦ ¦cou g hing¦ ¦or¦ ¦sneezing¦ ,▁ ¦and¦ ¦dis p os ing¦ ¦of¦ ¦any¦ ¦ti ss ue¦ ¦imm ed ia tely¦ .
𐋇 ¦sur g ical¦ ¦masks¦ ¦are¦ ¦recommended¦ ¦for¦ ¦those¦ ¦who¦ ¦may¦ ¦be¦ ¦infected¦ ,▁ ¦as¦ ¦w earing¦ ¦a¦ ¦mask¦ ¦can¦ ¦limi t¦ ¦the¦ ¦v o lu me¦ ¦and¦ ¦travel¦ ¦dista nce¦ ¦of¦ ¦exp ir atory¦ ¦dro pl ets¦ ¦dis p er sed¦ ¦when¦ ¦t al king¦ ,▁ ¦sneezing¦ ,▁ ¦and¦ ¦cou g hing¦ .
𐋇¦the¦ ¦who¦ ¦has¦ ¦issued¦ ¦in str uc tions¦ ¦on¦ ¦when¦ ¦and¦ ¦how¦ ¦to¦ ¦use¦ ¦masks¦ .
𐋇 ¦according¦ ¦to¦ ¦ste ph en¦ ¦g ri ff in¦ ,▁ ¦a¦ ¦vir ol og ist¦ ¦at¦ ¦the¦ ¦univers ity¦ ¦of¦ ¦l ee ds¦ , ▁" ¦w earing¦ ¦a¦ ¦mask¦ ¦can¦ ¦reduce¦ ¦the¦ ¦prop e ns ity¦ ▁ [ ¦of¦ ] ▁ ¦people¦ ¦to¦ ¦tou ch¦ ¦their¦ ¦fa ces¦ ,▁ ¦which¦ ¦is¦ ¦a¦ ¦major¦ ¦sour ce¦ ¦of¦ ¦infection¦ ¦without¦ ¦prop er¦ ¦hand¦ ¦h yg ien e¦ . "▁ 𐋇 ¦masks¦ ¦have¦ ¦also¦ ¦been¦ ¦recommended¦ ¦for¦ ¦use¦ ¦by¦ ¦those¦ ¦ta king¦ ¦care¦ ¦of¦ ¦someone¦ ¦who¦ ¦may¦ ¦have¦ ¦the¦ ¦disease¦ .
𐋇¦the¦ ¦who¦ ¦has¦ ¦recommended¦ ¦the¦ ¦w earing¦ ¦of¦ ¦masks¦ ¦by¦ ¦healthy¦ ¦people¦ ¦only¦ ¦if¦ ¦they¦ ¦are¦ ¦at¦ ¦high¦ ¦risk¦ ,▁ ¦such¦ ¦as¦ ¦those¦ ¦who¦ ¦are¦ ¦car ing¦ ¦for¦ ¦a¦ ¦person¦ ¦with¦ ¦covid¦ - ¦19¦ ,▁ ¦al th ough¦ ¦they¦ ¦also¦ ¦ac k n ow l ed ge¦ ¦that¦ ¦w earing¦ ¦masks¦ ¦may¦ ¦help¦ ¦people¦ ¦avoid¦ ¦to uc hing¦ ¦their¦ ¦face¦ .
𐋇 ¦several¦ ¦countries¦ ¦have¦ ¦star ted¦ ¦to¦ ¦e nc o ur age¦ ¦the¦ ¦use¦ ¦of¦ ¦face¦ ¦masks¦ ¦by¦ ¦me mbers¦ ¦of¦ ¦the¦ ¦public¦ .
𐋇¦in¦ ¦the¦ ¦u¦ . ¦s¦ . ,▁ ¦the¦ ¦c dc¦ ¦recomm ends¦ ¦w earing¦ ¦non¦ - ¦medical¦ ¦face¦ ¦mask¦ ¦made¦ ¦out¦ ¦of¦ ¦c lo th¦ . ¦china¦ ¦has¦ ¦spec if ically¦ ¦recommended¦ ¦the¦ ¦use¦ ¦of¦ ¦dis p os able¦ ¦medical¦ ¦masks¦ ¦by¦ ¦healthy¦ ¦me mbers¦ ¦of¦ ¦the¦ ¦public¦ ,▁ ¦partic ul arly¦ ¦when¦ ¦c om ing¦ ¦into¦ ¦close¦ ¦contact¦ ▁( ¦1¦ ¦met r e¦ ▁( ¦3¦ ¦f t¦ )▁ ¦or¦ ¦less¦ )▁ ¦with¦ ¦other¦ ¦people¦ .
𐋇 ¦ho ng¦ ¦ko ng¦ ¦recomm ends¦ ¦w earing¦ ¦a¦ ¦sur g ical¦ ¦mask¦ ¦when¦ ¦ta king¦ ¦public¦ ¦transport¦ ¦or¦ ¦sta ying¦ ¦in¦ ¦cr ow ded¦ ¦places¦ .
𐋇 ¦th ai land¦ ' ¦s¦ ¦health¦ ¦off ici als¦ ¦are¦ ¦e nc ou ra ging¦ ¦people¦ ¦to¦ ¦make¦ ¦c lo th¦ ¦fa ce m as ks¦ ¦at¦ ¦home¦ ¦and¦ ¦wash¦ ¦them¦ ¦daily¦ .
𐋇¦the¦ ¦c z e ch¦ ¦rep u bl ic¦ ¦and¦ ¦sl ov a k ia¦ ¦b an ned¦ ¦go ing¦ ¦out¦ ¦in¦ ¦public¦ ¦without¦ ¦w earing¦ ¦a¦ ¦mask¦ ¦or¦ ¦cov ering¦ ¦one¦ ' ¦s¦ ¦nose¦ ¦and¦ ¦mouth¦ .
𐋇¦on¦ ¦16¦ ¦march¦ ,▁ ¦ vi et n am¦ ¦re qu ested¦ ¦e veryone¦ ¦to¦ ¦wear¦ ¦a¦ ¦face¦ ¦mask¦ ¦when¦ ¦go ing¦ ¦to¦ ¦public¦ ¦areas¦ ¦in¦ ¦order¦ ¦to¦ ¦protect¦ ¦the m s el ves¦ ¦and¦ ¦others¦ .
𐋇¦the¦ ¦a u st ri an¦ ¦government¦ ¦mand ated¦ ¦that¦ ¦e veryone¦ ¦ent ering¦ ¦a¦ ¦g ro ce ry¦ ¦st ore¦ ¦must¦ ¦wear¦ ¦a¦ ¦face¦ ¦mask¦ .
𐋇¦ is ra e l¦ ¦has¦ ¦as ked¦ ¦all¦ ¦res id ents¦ ¦to¦ ¦wear¦ ¦face¦ ¦masks¦ ¦when¦ ¦in¦ ¦public¦ .
𐋇¦t ai w an¦ ,▁ ¦which¦ ¦has¦ ¦been¦ ¦produc ing¦ ¦t en¦ ¦million¦ ¦masks¦ ¦per¦ ¦day¦ ¦since¦ ¦m id¦ - ¦march¦ ,▁ ¦required¦ ¦p as se ng ers¦ ¦on¦ ¦tra ins¦ ¦and¦ ¦int erc ity¦ ¦bu ses¦ ¦to¦ ¦wear¦ ¦face¦ ¦masks¦ ¦on¦ ¦1¦ ¦april¦ .
𐋇 ¦pa na m a¦ ¦has¦ ¦made¦ ¦it¦ ¦o bl ig atory¦ ¦to¦ ¦wear¦ ¦a¦ ¦face¦ ¦mask¦ ¦w he ne ver¦ ¦go ing¦ ¦outside¦ ,▁ ¦while¦ ¦also¦ ¦recomm ending¦ ¦the¦ ¦m an u fa ct ure¦ ¦of¦ ¦a¦ ¦ho me ma de¦ ¦face¦ ¦mask¦ ¦for¦ ¦those¦ ¦who¦ ¦cannot¦ ¦p ur ch ase¦ ¦face¦ ¦masks¦ .
𐋇 ¦face¦ ¦masks¦ ¦have¦ ¦also¦ ¦been¦ ¦wid ely¦ ¦used¦ ¦in¦ ¦j ap an¦ ,▁ ¦south¦ ¦ko rea¦ ,▁ ¦ma la ys ia¦ ,▁ ¦and¦ ¦si ng ap ore¦ .
𐋇 ¦social¦ ¦distancing¦ ▁( ¦also¦ ¦known¦ ¦as¦ ¦ph ys ical¦ ¦distancing¦ )▁ ¦inclu des¦ ¦infection¦ ¦control¦ ¦ac tions¦ ¦in te nded¦ ¦to¦ ¦sl ow¦ ¦the¦ ¦spread¦ ¦of¦ ¦disease¦ ¦by¦ ¦min im iz ing¦ ¦close¦ ¦contact¦ ¦between¦ ¦individuals¦ .
𐋇 ¦met ho ds¦ ¦include¦ ¦qu ara nt ines¦ ;▁ ¦travel¦ ¦restrictions¦ ;▁ ¦and¦ ¦the¦ ¦clos ing¦ ¦of¦ ¦schools¦ ,▁ ¦work p la ces¦ ,▁ ¦sta di u ms¦ ,▁ ¦the at r es¦ ,▁ ¦or¦ ¦shopping¦ ¦centr es¦ .
𐋇 ¦individuals¦ ¦may¦ ¦app ly¦ ¦social¦ ¦distancing¦ ¦met ho ds¦ ¦by¦ ¦sta ying¦ ¦at¦ ¦home¦ ,▁ ¦limi ting¦ ¦travel¦ ,▁ ¦a v oi ding¦ ¦cr ow ded¦ ¦areas¦ ,▁ ¦using¦ ¦no¦ - ¦contact¦ ¦g re et ings¦ ,▁ ¦and¦ ¦ph ys ically¦ ¦distancing¦ ¦the m s el ves¦ ¦from¦ ¦others¦ .
𐋇 ¦many¦ ¦gover n ments¦ ¦are¦ ¦n ow¦ ¦mand ating¦ ¦or¦ ¦recomm ending¦ ¦social¦ ¦distancing¦ ¦in¦ ¦regi ons¦ ¦affected¦ ¦by¦ ¦the¦ ¦outbreak¦ .
𐋇¦the¦ ¦ma x im um¦ ¦ga th ering¦ ¦s iz e¦ ¦recommended¦ ¦by¦ ¦us¦ ¦government¦ ¦ bo dies¦ ¦and¦ ¦health¦ ¦organiz ations¦ ¦was¦ ¦sw if t ly¦ ¦reduc ed¦ ¦from¦ ¦2 5 0¦ ¦people¦ ▁( ¦if¦ ¦there¦ ¦was¦ ¦no¦ ¦known¦ ¦covid¦ - ¦19¦ ¦spread¦ ¦in¦ ¦a¦ ¦reg ion¦ )▁ ¦to¦ ¦50¦ ¦people¦ ,▁ ¦and¦ ¦later¦ ¦to¦ ¦10¦ ¦people¦ .
𐋇¦on¦ ¦2 2¦ ¦march¦ ¦2020¦ ,▁ ¦g erm an y¦ ¦b an ned¦ ¦public¦ ¦ga ther ings¦ ¦of¦ ¦more¦ ¦than¦ ¦two¦ ¦people¦ . ¦ ol der¦ ¦ad ul ts¦ ¦and¦ ¦those¦ ¦with¦ ¦underlying¦ ¦medical¦ ¦conditions¦ ¦such¦ ¦as¦ ¦di ab e tes¦ ,▁ ¦h ear t¦ ¦disease¦ ,▁ ¦respiratory¦ ¦disease¦ ,▁ ¦h y p er tens ion¦ ,▁ ¦and¦ ¦comp ro mi sed¦ ¦immune¦ ¦sys tems¦ ¦face¦ ¦increased¦ ¦risk¦ ¦of¦ ¦ser ious¦ ¦illness¦ ¦and¦ ¦co mpl ications¦ ¦and¦ ¦have¦ ¦been¦ ¦ad vi sed¦ ¦by¦ ¦the¦ ¦c dc¦ ¦to¦ ¦stay¦ ¦home¦ ¦as¦ ¦much¦ ¦as¦ ¦possible¦ ¦in¦ ¦areas¦ ¦of¦ ¦community¦ ¦outbreak¦ . ¦in¦ ¦l ate¦ ¦march¦ ¦2020¦ ,▁ ¦the¦ ¦who¦ ¦and¦ ¦other¦ ¦health¦ ¦ bo dies¦ ¦beg an¦ ¦to¦ ¦re pl ace¦ ¦the¦ ¦use¦ ¦of¦ ¦the¦ ¦ter m¦ ▁" ¦social¦ ¦distancing¦ "▁ ¦with¦ ▁" ¦ph ys ical¦ ¦distancing¦ " ,▁ ¦to¦ ¦cl ar if y¦ ¦that¦ ¦the¦ ¦ ai m¦ ¦is¦ ¦to¦ ¦reduce¦ ¦ph ys ical¦ ¦contact¦ ¦while¦ ¦main t aining¦ ¦social¦ ¦con n ec tions¦ ,▁ ¦e it her¦ ¦vir t ually¦ ¦or¦ ¦at¦ ¦a¦ ¦dista nce¦ .
𐋇¦the¦ ¦use¦ ¦of¦ ¦the¦ ¦ter m¦ ▁" ¦social¦ ¦distancing¦ "▁ ¦had¦ ¦l ed¦ ¦to¦ ¦i mpl ications¦ ¦that¦ ¦people¦ ¦should¦ ¦e ng age¦ ¦in¦ ¦co mpl et e¦ ¦social¦ ¦isolation¦ ,▁ ¦r at her¦ ¦than¦ ¦e nc ou ra ging¦ ¦them¦ ¦to¦ ¦stay¦ ¦in¦ ¦contact¦ ¦with¦ ¦others¦ ¦through¦ ¦al t er n ative¦ ¦me ans¦ . ¦some¦ ¦author ities¦ ¦have¦ ¦issued¦ ¦se x ual¦ ¦health¦ ¦gu id el ines¦ ¦for¦ ¦use¦ ¦during¦ ¦the¦ ¦pandemic¦ .
𐋇¦these¦ ¦include¦ ¦recomm end ations¦ ¦to¦ ¦only¦ ¦have¦ ¦se x¦ ¦with¦ ¦someone¦ ¦you¦ ¦live¦ ¦with¦ ,▁ ¦who¦ ¦does¦ ¦not¦ ¦have¦ ¦the¦ ¦virus¦ ¦or¦ ¦symptoms¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇 ¦self¦ - ¦isolation¦ ¦at¦ ¦home¦ ¦has¦ ¦been¦ ¦recommended¦ ¦for¦ ¦those¦ ¦diagn osed¦ ¦with¦ ¦covid¦ - ¦19¦ ¦and¦ ¦those¦ ¦who¦ ¦susp ect¦ ¦they¦ ¦have¦ ¦been¦ ¦infected¦ .
𐋇 ¦health¦ ¦a ge nc ies¦ ¦have¦ ¦issued¦ ¦detail ed¦ ¦in str uc tions¦ ¦for¦ ¦prop er¦ ¦self¦ - ¦isolation¦ . ¦many¦ ¦gover n ments¦ ¦have¦ ¦mand ated¦ ¦or¦ ¦recommended¦ ¦self¦ - ¦quarantine¦ ¦for¦ ¦ent ir e¦ ¦p op ul ations¦ ¦li ving¦ ¦in¦ ¦affected¦ ¦areas¦ .
𐋇¦the¦ ¦st ro ng est¦ ¦self¦ - ¦quarantine¦ ¦in str uc tions¦ ¦have¦ ¦been¦ ¦issued¦ ¦to¦ ¦those¦ ¦in¦ ¦high¦ ¦risk¦ ¦grou ps¦ .
𐋇 ¦those¦ ¦who¦ ¦may¦ ¦have¦ ¦been¦ ¦exp osed¦ ¦to¦ ¦someone¦ ¦with¦ ¦covid¦ - ¦19¦ ¦and¦ ¦those¦ ¦who¦ ¦have¦ ¦rece ntly¦ ¦tra ve lled¦ ¦to¦ ¦a¦ ¦country¦ ¦or¦ ¦reg ion¦ ¦with¦ ¦wid esp r ead¦ ¦transmission¦ ¦have¦ ¦been¦ ¦ad vi sed¦ ¦to¦ ¦self¦ - ¦quarantine¦ ¦for¦ ¦14¦ ¦days¦ ¦from¦ ¦the¦ ¦time¦ ¦of¦ ¦last¦ ¦possible¦ ¦exp osure¦ .
𐋇 ¦stra te g ies¦ ¦in¦ ¦the¦ ¦control¦ ¦of¦ ¦an¦ ¦outbreak¦ ¦are¦ ¦conta in ment¦ ¦or¦ ¦supp re ssion¦ ,▁ ¦and¦ ¦m it ig ation¦ .
𐋇 ¦conta in ment¦ ¦is¦ ¦under ta k en¦ ¦in¦ ¦the¦ ¦early¦ ¦sta ges¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦and¦ ¦ ai ms¦ ¦to¦ ¦tr ace¦ ¦and¦ ¦isol ate¦ ¦those¦ ¦infected¦ ¦as¦ ¦well¦ ¦as¦ ¦int ro duc e¦ ¦other¦ ¦measures¦ ¦of¦ ¦infection¦ ¦control¦ ¦and¦ ¦vacc in ations¦ ¦to¦ ¦sto p¦ ¦the¦ ¦disease¦ ¦from¦ ¦sprea ding¦ ¦to¦ ¦the¦ ¦r est¦ ¦of¦ ¦the¦ ¦population¦ .
𐋇¦when¦ ¦it¦ ¦is¦ ¦no¦ ¦lo nger¦ ¦possible¦ ¦to¦ ¦con tain¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦disease¦ ,▁ ¦eff orts¦ ¦then¦ ¦mo ve¦ ¦to¦ ¦the¦ ¦m it ig ation¦ ¦st age¦ :▁ 𐋇 ¦measures¦ ¦are¦ ¦ta k en¦ ¦to¦ ¦sl ow¦ ¦the¦ ¦spread¦ ¦and¦ ¦m it ig ate¦ ¦its¦ ¦eff ects¦ ¦on¦ ¦the¦ ¦healthcare¦ ¦system¦ ¦and¦ ¦s oc i et y¦ .
𐋇¦a¦ ¦co mb ination¦ ¦of¦ ¦both¦ ¦conta in ment¦ ¦and¦ ¦m it ig ation¦ ¦measures¦ ¦may¦ ¦be¦ ¦under ta k en¦ ¦at¦ ¦the¦ ¦same¦ ¦time¦ .
𐋇 ¦supp re ssion¦ ¦requir es¦ ¦more¦ ¦ext re me¦ ¦measures¦ ¦so¦ ¦as¦ ¦to¦ ¦re ver se¦ ¦the¦ ¦pandemic¦ ¦by¦ ¦reduc ing¦ ¦the¦ ¦b as ic¦ ¦rep ro d u ction¦ ¦number¦ ¦to¦ ¦less¦ ¦than¦ ¦1¦ . ¦par t¦ ¦of¦ ¦mana ging¦ ¦an¦ ¦infectious¦ ¦disease¦ ¦outbreak¦ ¦is¦ ¦tr ying¦ ¦to¦ ¦dec re ase¦ ¦the¦ ¦epidemic¦ ¦p ea k¦ ,▁ ¦known¦ ¦as¦ ¦f l at t ening¦ ¦the¦ ¦epidemic¦ ¦cur ve¦ .
𐋇¦this¦ ¦dec rea ses¦ ¦the¦ ¦risk¦ ¦of¦ ¦health¦ ¦services¦ ¦being¦ ¦over w h el med¦ ¦and¦ ¦provid es¦ ¦more¦ ¦time¦ ¦for¦ ¦vaccines¦ ¦and¦ ¦tre at ments¦ ¦to¦ ¦be¦ ¦developed¦ .
𐋇 ¦non¦ - ¦ph ar ma ce ut ical¦ ¦int erv en tions¦ ¦that¦ ¦may¦ ¦mana ge¦ ¦the¦ ¦outbreak¦ ¦include¦ ¦personal¦ ¦prev en tive¦ ¦measures¦ ,▁ ¦such¦ ¦as¦ ¦hand¦ ¦h yg ien e¦ ,▁ ¦w earing¦ ¦face¦ - ¦masks¦ ,▁ ¦and¦ ¦self¦ - ¦quarantine¦ ;▁ ¦community¦ ¦measures¦ ¦ ai med¦ ¦at¦ ¦ph ys ical¦ ¦distancing¦ ¦such¦ ¦as¦ ¦clos ing¦ ¦schools¦ ¦and¦ ¦cance lling¦ ¦m ass¦ ¦ga th ering¦ ¦events¦ ;▁ ¦community¦ ¦e ng a ge ment¦ ¦to¦ ¦e nc o ur age¦ ¦ac ce pt ance¦ ¦and¦ ¦partic ip ation¦ ¦in¦ ¦such¦ ¦int erv en tions¦ ;▁ ¦as¦ ¦well¦ ¦as¦ ¦en vir on me ntal¦ ¦measures¦ ¦such¦ ¦sur f ace¦ ¦cl ea ning¦ . ¦more¦ ¦d ra st ic¦ ¦ac tions¦ ¦ ai med¦ ¦at¦ ¦cont aining¦ ¦the¦ ¦outbreak¦ ¦were¦ ¦ta k en¦ ¦in¦ ¦china¦ ¦o nce¦ ¦the¦ ¦se ver ity¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦bec a me¦ ¦app ar ent¦ ,▁ ¦such¦ ¦as¦ ¦qu ar an ti ning¦ ¦ent ir e¦ ¦c ities¦ ¦and¦ ¦imp os ing¦ ¦ stric t¦ ¦travel¦ ¦b ans¦ .
𐋇 ¦other¦ ¦countries¦ ¦also¦ ¦ad op ted¦ ¦a¦ ¦vari et y¦ ¦of¦ ¦measures¦ ¦ ai med¦ ¦at¦ ¦limi ting¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇 ¦south¦ ¦ko rea¦ ¦int ro duc ed¦ ¦m ass¦ ¦scre ening¦ ¦and¦ ¦loc a li zed¦ ¦qu ara nt ines¦ ,▁ ¦and¦ ¦issued¦ ¦al er ts¦ ¦on¦ ¦the¦ ¦movements¦ ¦of¦ ¦infected¦ ¦individuals¦ .
𐋇 ¦si ng ap ore¦ ¦provid ed¦ ¦fi na nc ial¦ ¦support¦ ¦for¦ ¦those¦ ¦infected¦ ¦who¦ ¦qu ara nt ined¦ ¦the m s el ves¦ ¦and¦ ¦imp osed¦ ¦large¦ ¦fines¦ ¦for¦ ¦those¦ ¦who¦ ¦fa il ed¦ ¦to¦ ¦do¦ ¦so¦ .
𐋇¦t ai w an¦ ¦increased¦ ¦face¦ ¦mask¦ ¦produc t ion¦ ¦and¦ ¦p e na li zed¦ ¦ho ar ding¦ ¦of¦ ¦medical¦ ¦supp l ies¦ . ¦s im ul ations¦ ¦for¦ ¦g re at¦ ¦b ri tain¦ ¦and¦ ¦the¦ ¦united¦ ¦states¦ ¦sh ow¦ ¦that¦ ¦m it ig ation¦ ▁( ¦sl owing¦ ¦but¦ ¦not¦ ¦sto pping¦ ¦epidemic¦ ¦spread¦ )▁ ¦and¦ ¦supp re ssion¦ ▁( ¦re ve rs ing¦ ¦epidemic¦ ¦gr ow th¦ )▁ ¦have¦ ¦major¦ ¦cha ll en ges¦ .
𐋇 ¦o pt im al¦ ¦m it ig ation¦ ¦pol ic ies¦ ¦might¦ ¦reduce¦ ¦p ea k¦ ¦healthcare¦ ¦dem and¦ ¦by¦ ¦2¦ ▁/▁ ¦3¦ ¦and¦ ¦deaths¦ ¦by¦ ¦h al f¦ ,▁ ¦but¦ ¦still¦ ¦result¦ ¦in¦ ¦h u nd re ds¦ ¦of¦ ¦t ho us an ds¦ ¦of¦ ¦deaths¦ ¦and¦ ¦health¦ ¦sys tems¦ ¦being¦ ¦over w h el med¦ .
𐋇 ¦supp re ssion¦ ¦can¦ ¦be¦ ¦pre f er r ed¦ ¦but¦ ¦needs¦ ¦to¦ ¦be¦ ¦main ta ined¦ ¦for¦ ¦as¦ ¦long¦ ¦as¦ ¦the¦ ¦virus¦ ¦is¦ ¦c ir c ul ating¦ ¦in¦ ¦the¦ ¦human¦ ¦population¦ ▁( ¦or¦ ¦until¦ ¦a¦ ¦vaccine¦ ¦bec omes¦ ¦available¦ ,▁ ¦if¦ ¦that¦ ¦c omes¦ ¦first¦ ),▁ ¦as¦ ¦transmission¦ ¦o ther w ise¦ ¦qu ick ly¦ ¦re bo un ds¦ ¦when¦ ¦measures¦ ¦are¦ ¦re la x ed¦ .
𐋇 ¦long¦ - ¦ter m¦ ¦inter vention¦ ¦to¦ ¦supp r ess¦ ¦the¦ ¦pandemic¦ ¦ca u ses¦ ¦social¦ ¦and¦ ¦ec onomic¦ ¦co sts¦ .
𐋇¦there¦ ¦are¦ ¦no¦ ¦specific¦ ¦anti vir al¦ ¦medic ations¦ ¦appr oved¦ ¦for¦ ¦covid¦ - ¦19¦ ,▁ ¦but¦ ¦development¦ ¦eff orts¦ ¦are¦ ¦under w ay¦ ,▁ ¦including¦ ¦testing¦ ¦of¦ ¦ex is ting¦ ¦medic ations¦ .
𐋇 ¦ta king¦ ¦over¦ - ¦the¦ - ¦co un ter¦ ¦cold¦ ¦medic ations¦ ,▁ ¦dr in king¦ ¦f lu i ds¦ ,▁ ¦and¦ ¦res ting¦ ¦may¦ ¦help¦ ¦al le vi ate¦ ¦symptoms¦ .
𐋇 ¦dep ending¦ ¦on¦ ¦the¦ ¦se ver ity¦ ,▁ ¦o x yg en¦ ¦ ther ap y¦ ,▁ ¦int ra ve no us¦ ¦f lu i ds¦ ,▁ ¦and¦ ¦brea thing¦ ¦support¦ ¦may¦ ¦be¦ ¦required¦ .
𐋇¦the¦ ¦use¦ ¦of¦ ¦st er oi ds¦ ¦may¦ ¦wor s en¦ ¦out c omes¦ .
𐋇 ¦several¦ ¦comp o un ds¦ ¦that¦ ¦were¦ ¦previously¦ ¦appr oved¦ ¦for¦ ¦treatment¦ ¦of¦ ¦other¦ ¦viral¦ ¦diseases¦ ¦are¦ ¦being¦ ¦in ve st ig ated¦ ¦for¦ ¦use¦ ¦in¦ ¦tre ating¦ ¦covid¦ - ¦19¦ .
𐋇¦the¦ ¦who¦ ¦also¦ ¦stated¦ ¦that¦ ¦some¦ ▁" ¦tra di tional¦ ¦and¦ ¦home¦ ¦re me dies¦ "▁ ¦can¦ ¦provide¦ ¦rel ief¦ ¦of¦ ¦the¦ ¦symptoms¦ ¦caused¦ ¦by¦ ¦sars¦ - ¦cov¦ - ¦19¦ .
𐋇 ¦incre as ing¦ ¦c ap ac ity¦ ¦and¦ ¦ad ap ting¦ ¦healthcare¦ ¦for¦ ¦the¦ ¦needs¦ ¦of¦ ¦covid¦ - ¦19¦ ¦patients¦ ¦is¦ ¦d esc rib ed¦ ¦by¦ ¦the¦ ¦who¦ ¦as¦ ¦a¦ ¦f u nd a me ntal¦ ¦outbreak¦ ¦response¦ ¦me as ure¦ .
𐋇¦the¦ ¦ec dc¦ ¦and¦ ¦the¦ ¦european¦ ¦regi on al¦ ¦off ice¦ ¦of¦ ¦the¦ ¦who¦ ¦have¦ ¦issued¦ ¦gu id el ines¦ ¦for¦ ¦hosp it als¦ ¦and¦ ¦pr imary¦ ¦healthcare¦ ¦services¦ ¦for¦ ¦sh if ting¦ ¦of¦ ¦res o ur ces¦ ¦at¦ ¦mult ip le¦ ¦le v els¦ ,▁ ¦including¦ ¦f oc us ing¦ ¦laboratory¦ ¦services¦ ¦t ow ards¦ ¦covid¦ - ¦19¦ ¦testing¦ ,▁ ¦cance lling¦ ¦el ective¦ ¦proc ed ures¦ ¦w he ne ver¦ ¦possible¦ ,▁ ¦separ ating¦ ¦and¦ ¦isol ating¦ ¦covid¦ - ¦19¦ ¦positive¦ ¦patients¦ ,▁ ¦and¦ ¦incre as ing¦ ¦in tens ive¦ ¦care¦ ¦c ap ab il ities¦ ¦by¦ ¦tr aining¦ ¦pers on ne l¦ ¦and¦ ¦incre as ing¦ ¦the¦ ¦number¦ ¦of¦ ¦available¦ ¦ ventil at ors¦ ¦and¦ ¦be ds¦ .
𐋇¦there¦ ¦are¦ ¦v ar ious¦ ¦the or ies¦ ¦about¦ ¦where¦ ¦the¦ ¦very¦ ¦first¦ ¦case¦ ▁( ¦the¦ ¦so¦ - ¦called¦ ¦pa ti ent¦ ¦z er o¦ )▁ ¦may¦ ¦have¦ ¦orig in ated¦ .
𐋇¦the¦ ¦first¦ ¦known¦ ¦case¦ ¦of¦ ¦the¦ ¦novel¦ ¦coronavirus¦ ¦may¦ ¦tr ace¦ ¦b ack¦ ¦to¦ ¦1¦ ¦december¦ ¦2019¦ ¦in¦ ¦wuhan¦ ,▁ ¦hub e i¦ ,▁ ¦china¦ .
𐋇 ¦within¦ ¦a¦ ¦mon th¦ ,▁ ¦the¦ ¦number¦ ¦of¦ ¦coronavirus¦ ¦cases¦ ¦in¦ ¦hub e i¦ ¦g rad ually¦ ¦increased¦ .
𐋇¦these¦ ¦were¦ ¦mo st ly¦ ¦l in ked¦ ¦to¦ ¦the¦ ¦h u an an¦ ¦s ea f ood¦ ¦wh ol es a le¦ ¦mark et¦ ,▁ ¦which¦ ¦also¦ ¦so ld¦ ¦live¦ ¦anim als¦ ,▁ ¦and¦ ¦one¦ ¦the ory¦ ¦is¦ ¦that¦ ¦the¦ ¦virus¦ ¦ca me¦ ¦from¦ ¦one¦ ¦of¦ ¦these¦ ¦k in ds¦ ¦of¦ ¦anim als¦ ;▁ ¦or¦ ,▁ ¦in¦ ¦other¦ ¦wor ds¦ ,▁ ¦has¦ ¦a¦ ¦z o on ot ic¦ ¦orig in¦ . ¦a¦ ¦pneumonia¦ ¦cl us ter¦ ¦of¦ ¦un k n own¦ ¦cause¦ ¦was¦ ¦ob s erv ed¦ ¦on¦ ¦26¦ ¦december¦ ¦and¦ ¦tre ated¦ ¦by¦ ¦the¦ ¦doctor¦ ¦z h a ng¦ ¦j i xi an¦ ¦in¦ ¦hub e i¦ ¦pro vi nc ial¦ ¦hospital¦ ,▁ ¦who¦ ¦in for med¦ ¦the¦ ¦wuhan¦ ¦j i an gh an¦ ¦c dc¦ ¦on¦ ¦2 7¦ ¦december¦ .
𐋇¦on¦ ¦30¦ ¦december¦ ,▁ ¦a¦ ¦group¦ ¦of¦ ¦do ctors¦ ¦at¦ ¦wuhan¦ ¦centr al¦ ¦hospital¦ ¦al er ted¦ ¦their¦ ¦coll ea g ues¦ ¦of¦ ¦a¦ ▁" ¦sars¦ - ¦like¦ ¦coronavirus¦ " .
𐋇¦e ight¦ ¦of¦ ¦these¦ ¦do ctors¦ ,▁ ¦including¦ ¦l i¦ ¦w en l ia ng¦ ,▁ ¦were¦ ¦ad m on ished¦ ¦by¦ ¦the¦ ¦pol ice¦ ¦for¦ ¦sprea ding¦ ¦f al se¦ ¦ ru mo ur s¦ ,▁ ¦and¦ ¦another¦ ,▁ ¦a i¦ ¦ fen¦ ,▁ ¦was¦ ¦rep ri ma nded¦ ¦by¦ ¦ her¦ ¦su p eri ors¦ ¦for¦ ¦ra ising¦ ¦the¦ ¦al ar m¦ .
𐋇¦the¦ ¦wuhan¦ ¦m un ic ip al¦ ¦health¦ ¦comm i ssion¦ ¦later¦ ¦rel ea sed¦ ¦a¦ ¦public¦ ¦n ot ice¦ ¦on¦ ¦3 1¦ ¦december¦ ¦and¦ ¦in for med¦ ¦the¦ ¦who¦ .
𐋇 ¦en ough¦ ¦cases¦ ¦of¦ ¦un k n own¦ ¦pneumonia¦ ¦had¦ ¦been¦ ¦reported¦ ¦to¦ ¦health¦ ¦author ities¦ ¦in¦ ¦wuhan¦ ¦to¦ ¦t ri gg er¦ ¦an¦ ¦in ve st ig ation¦ ¦in¦ ¦early¦ ¦january¦ . ¦during¦ ¦the¦ ¦early¦ ¦sta ges¦ ¦of¦ ¦the¦ ¦outbreak¦ ,▁ ¦the¦ ¦number¦ ¦of¦ ¦cases¦ ¦d ou bl ed¦ ¦appro xi ma tely¦ ¦every¦ ¦se v en¦ ¦and¦ ¦a¦ ¦h al f¦ ¦days¦ .
𐋇¦in¦ ¦early¦ ¦and¦ ¦m id¦ - ¦january¦ ¦2020¦ ,▁ ¦the¦ ¦virus¦ ¦spread¦ ¦to¦ ¦other¦ ¦chinese¦ ¦pr ov in ces¦ ,▁ ¦h el p ed¦ ¦by¦ ¦the¦ ¦chinese¦ ¦new¦ ¦year¦ ¦m ig r ation¦ ¦and¦ ¦wuhan¦ ¦being¦ ¦a¦ ¦transport¦ ¦hub ¦ ¦and¦ ¦major¦ ¦ra il¦ ¦inter ch ange¦ .
𐋇¦on¦ ¦20¦ ¦january¦ ,▁ ¦china¦ ¦reported¦ ¦ne arly¦ ¦1 4 0¦ ¦new¦ ¦cases¦ ¦in¦ ¦one¦ ¦day¦ ,▁ ¦including¦ ¦two¦ ¦people¦ ¦in¦ ¦be i j ing¦ ¦and¦ ¦one¦ ¦in¦ ¦sh en z h en¦ .
𐋇 ¦later¦ ¦offic ial¦ ¦data¦ ¦sh ow s¦ ¦that¦ ¦6¦ , ¦1 7 4¦ ¦people¦ ¦had¦ ¦al rea dy¦ ¦developed¦ ¦symptoms¦ ¦by¦ ¦20¦ ¦january¦ ¦2020¦ . ¦as¦ ¦of¦ ¦26¦ ¦march¦ ,▁ ¦the¦ ¦united¦ ¦states¦ ¦has¦ ¦over ta k en¦ ¦china¦ ¦and¦ ¦italy¦ ¦with¦ ¦the¦ ¦high est¦ ¦number¦ ¦of¦ ¦confirmed¦ ¦cases¦ ¦in¦ ¦the¦ ¦world¦ . ¦as¦ ¦of¦ ¦9¦ ¦april¦ ¦2020¦ ,▁ ¦more¦ ¦than¦ ¦1¦ . ¦6 1¦ ¦million¦ ¦cases¦ ¦have¦ ¦been¦ ¦reported¦ ¦worldwide¦ ;▁ ¦more¦ ¦than¦ ¦9 7¦ , ¦000¦ ¦people¦ ¦have¦ ¦d ied¦ ¦and¦ ¦more¦ ¦than¦ ¦3 6 4¦ , ¦000¦ ¦have¦ ¦re covered¦ .
𐋇 ¦around¦ ¦2 00¦ ¦countries¦ ¦and¦ ¦ter r it or ies¦ ¦have¦ ¦had¦ ¦at¦ ¦least¦ ¦one¦ ¦case¦ .
𐋇 ¦due¦ ¦to¦ ¦the¦ ¦pandemic¦ ¦in¦ ¦e ur ope¦ ,▁ ¦many¦ ¦countries¦ ¦in¦ ¦the¦ ¦s che ng en¦ ¦a rea¦ ¦have¦ ¦re stric ted¦ ¦fre e¦ ¦mo ve ment¦ ¦and¦ ¦s et¦ ¦up¦ ¦ bor der¦ ¦contr ols¦ .
𐋇 ¦national¦ ¦re ac tions¦ ¦have¦ ¦inclu ded¦ ¦conta in ment¦ ¦measures¦ ¦such¦ ¦as¦ ¦qu ara nt ines¦ ▁( ¦known¦ ¦as¦ ¦stay¦ - ¦at¦ - ¦home¦ ¦or d ers¦ ,▁ ¦sh el ter¦ - ¦in¦ - ¦place¦ ¦or d ers¦ ,▁ ¦or¦ ¦lockdown¦ )▁ ¦and¦ ¦cur f e w s¦ . ¦as¦ ¦of¦ ¦2¦ ¦april¦ ,▁ ¦ne arly¦ ¦3 00¦ ¦million¦ ¦people¦ ,▁ ¦or¦ ¦about¦ ¦9 0¦ %▁ ¦of¦ ¦the¦ ¦population¦ ,▁ ¦are¦ ¦under¦ ¦some¦ ¦for m¦ ¦of¦ ¦lockdown¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦more¦ ¦than¦ ¦50¦ ¦million¦ ¦people¦ ¦are¦ ¦in¦ ¦lockdown¦ ¦in¦ ¦the¦ ¦p hi li pp ines¦ ,▁ ¦about¦ ¦5 9¦ ¦million¦ ¦people¦ ¦are¦ ¦in¦ ¦lockdown¦ ¦in¦ ¦south¦ ¦afr ica¦ ,▁ ¦and¦ ¦1¦ . ¦3¦ ¦bi ll ion¦ ¦people¦ ¦are¦ ¦in¦ ¦lockdown¦ ¦in¦ ¦ind ia¦ .
𐋇¦on¦ ¦26¦ ¦march¦ ,▁ ¦1¦ . ¦7¦ ¦bi ll ion¦ ¦people¦ ¦worldwide¦ ¦were¦ ¦under¦ ¦some¦ ¦for m¦ ¦of¦ ¦lockdown¦ ,▁ ¦which¦ ¦increased¦ ¦to¦ ¦2¦ . ¦6¦ ¦bi ll ion¦ ¦people¦ ¦two¦ ¦days¦ ¦later¦ ▁ — ▁ ¦around¦ ¦a¦ ¦thir d¦ ¦of¦ ¦the¦ ¦world¦ ' ¦s¦ ¦population¦ .
𐋇¦the¦ ¦first¦ ¦confirmed¦ ¦case¦ ¦of¦ ¦covid¦ - ¦19¦ ¦has¦ ¦been¦ ¦trac ed¦ ¦b ack¦ ¦to¦ ¦1¦ ¦december¦ ¦2019¦ ¦in¦ ¦wuhan¦ ;▁ ¦one¦ ¦u nc on f ir med¦ ¦report¦ ¦su g ge sts¦ ¦the¦ ¦ ear li est¦ ¦case¦ ¦was¦ ¦on¦ ¦1 7¦ ¦no ve mber¦ .
𐋇 ¦doctor¦ ¦z h a ng¦ ¦j i xi an¦ ¦ob s erv ed¦ ¦a¦ ¦cl us ter¦ ¦of¦ ¦pneumonia¦ ¦cases¦ ¦of¦ ¦un k n own¦ ¦cause¦ ¦on¦ ¦26¦ ¦december¦ ,▁ ¦up on¦ ¦which¦ ¦ her¦ ¦hospital¦ ¦in for med¦ ¦wuhan¦ ¦j i an gh an¦ ¦c dc¦ ¦on¦ ¦2 7¦ ¦december¦ .
𐋇 ¦in it ial¦ ¦gen et ic¦ ¦testing¦ ¦of¦ ¦pa ti ent¦ ¦samples¦ ¦on¦ ¦2 7¦ ¦december¦ ¦2019¦ ¦indic ated¦ ¦the¦ ¦pres ence¦ ¦of¦ ¦a¦ ¦sars¦ - ¦like¦ ¦coronavirus¦ .
𐋇¦a¦ ¦public¦ ¦n ot ice¦ ¦was¦ ¦rel ea sed¦ ¦by¦ ¦wuhan¦ ¦m un ic ip al¦ ¦health¦ ¦comm i ssion¦ ¦on¦ ¦3 1¦ ¦december¦ .
𐋇¦the¦ ¦who¦ ¦was¦ ¦in for med¦ ¦on¦ ¦the¦ ¦same¦ ¦day¦ .
𐋇¦as¦ ¦these¦ ¦n ot if ications¦ ¦occur r ed¦ ,▁ ¦do ctors¦ ¦in¦ ¦wuhan¦ ¦were¦ ¦w ar ned¦ ¦by¦ ¦pol ice¦ ¦for¦ ▁" ¦sprea ding¦ ¦ ru mo ur s¦ "▁ ¦about¦ ¦the¦ ¦outbreak¦ .
𐋇¦the¦ ¦chinese¦ ¦national¦ ¦health¦ ¦comm i ssion¦ ¦in it ially¦ ¦cl ai med¦ ¦that¦ ¦there¦ ¦was¦ ¦no¦ ▁" ¦cl ear¦ ¦evidence¦ "▁ ¦of¦ ¦human¦ - ¦to¦ - ¦human¦ ¦transmission¦ .
𐋇¦in¦ ¦l ate¦ ¦january¦ ,▁ ¦the¦ ¦chinese¦ ¦government¦ ¦la un ched¦ ¦a¦ ¦ rad ical¦ ¦ca m pa ign¦ ¦later¦ ¦d esc rib ed¦ ¦by¦ ¦the¦ ¦chinese¦ ¦comm un ist¦ ¦part y¦ ¦general¦ ¦sec r et ary¦ ¦ x i¦ ¦j in p ing¦ ¦as¦ ¦a¦ ▁" ¦people¦ ' ¦s¦ ¦w a r¦ "▁ ¦to¦ ¦con tain¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦in¦ ¦what¦ ¦has¦ ¦been¦ ¦d esc rib ed¦ ¦as¦ ▁" ¦the¦ ¦l arg est¦ ¦quarantine¦ ¦in¦ ¦human¦ ¦h ist ory¦ " ,▁ ¦a¦ ¦cor d on¦ ¦s an i ta ir e¦ ¦was¦ ¦announced¦ ¦on¦ ¦23¦ ¦january¦ ¦sto pping¦ ¦travel¦ ¦in¦ ¦and¦ ¦out¦ ¦of¦ ¦wuhan¦ ,▁ ¦which¦ ¦was¦ ¦ex te nded¦ ¦to¦ ¦a¦ ¦total¦ ¦of¦ ¦15¦ ¦c ities¦ ¦in¦ ¦hub e i¦ ,▁ ¦aff ecting¦ ¦a¦ ¦total¦ ¦of¦ ¦about¦ ¦5 7¦ ¦million¦ ¦people¦ .
𐋇 ¦priv ate¦ ¦ ve h ic le¦ ¦use¦ ¦was¦ ¦b an ned¦ ¦in¦ ¦the¦ ¦city¦ .
𐋇 ¦chinese¦ ¦new¦ ¦year¦ ▁( ¦2 5¦ ¦january¦ )▁ ¦ce le b r ations¦ ¦were¦ ¦cance lled¦ ¦in¦ ¦many¦ ¦places¦ .
𐋇¦the¦ ¦author ities¦ ¦also¦ ¦announced¦ ¦the¦ ¦con st ru ction¦ ¦of¦ ¦a¦ ¦temp or ary¦ ¦hospital¦ ,▁ ¦h u os he ns h an¦ ¦hospital¦ ,▁ ¦which¦ ¦was¦ ¦comp le ted¦ ¦in¦ ¦10¦ ¦days¦ .
𐋇 ¦another¦ ¦hospital¦ ¦was¦ ¦bu il t¦ ¦a f t er w ards¦ ,▁ ¦le is he ns h an¦ ¦hospital¦ ,▁ ¦to¦ ¦hand le¦ ¦ad di tional¦ ¦patients¦ .
𐋇¦in¦ ¦add ition¦ ¦to¦ ¦new ly¦ ¦con str uc ted¦ ¦hosp it als¦ ,▁ ¦china¦ ¦also¦ ¦con ver ted¦ ¦14¦ ¦other¦ ¦facil ities¦ ¦in¦ ¦wuhan¦ ,▁ ¦such¦ ¦as¦ ¦con vention¦ ¦ce nt ers¦ ¦and¦ ¦sta di u ms¦ ,▁ ¦into¦ ¦temp or ary¦ ¦hosp it als¦ . ¦on¦ ¦26¦ ¦january¦ ,▁ ¦the¦ ¦government¦ ¦inst itu ted¦ ¦further¦ ¦measures¦ ¦to¦ ¦con tain¦ ¦the¦ ¦covid¦ - ¦19¦ ¦outbreak¦ ,▁ ¦including¦ ¦i ss u ing¦ ¦health¦ ¦decl ar ations¦ ¦for¦ ¦tra ve ll ers¦ ¦and¦ ¦ext ending¦ ¦the¦ ¦sp r ing¦ ¦fe st iv al¦ ¦ho li day¦ .
𐋇 ¦univers ities¦ ¦and¦ ¦schools¦ ¦around¦ ¦the¦ ¦country¦ ¦were¦ ¦also¦ ¦closed¦ .
𐋇¦the¦ ¦regi ons¦ ¦of¦ ¦ho ng¦ ¦ko ng¦ ¦and¦ ¦m ac a u¦ ¦inst itu ted¦ ¦several¦ ¦measures¦ ,▁ ¦partic ul arly¦ ¦in¦ ¦reg ard¦ ¦to¦ ¦schools¦ ¦and¦ ¦univers ities¦ .
𐋇 ¦rem ot e¦ ¦wor king¦ ¦measures¦ ¦were¦ ¦inst itu ted¦ ¦in¦ ¦several¦ ¦chinese¦ ¦regi ons¦ .
𐋇 ¦travel¦ ¦restrictions¦ ¦were¦ ¦en ac ted¦ ¦in¦ ¦and¦ ¦outside¦ ¦of¦ ¦hub e i¦ .
𐋇 ¦public¦ ¦transport¦ ¦was¦ ¦mod if ied¦ ,▁ ¦and¦ ¦m u se u ms¦ ¦th r ou g ho ut¦ ¦china¦ ¦were¦ ¦temp o ra ri ly¦ ¦closed¦ .
𐋇 ¦control¦ ¦of¦ ¦public¦ ¦mo ve ment¦ ¦was¦ ¦app l ied¦ ¦in¦ ¦many¦ ¦c ities¦ ,▁ ¦and¦ ¦it¦ ¦has¦ ¦been¦ ¦estim ated¦ ¦that¦ ¦about¦ ¦7 6 0¦ ¦million¦ ¦people¦ ▁( ¦more¦ ¦than¦ ¦h al f¦ ¦the¦ ¦population¦ )▁ ¦f ac ed¦ ¦some¦ ¦for m¦ ¦of¦ ¦out door¦ ¦re st ri ction¦ . ¦after¦ ¦the¦ ¦outbreak¦ ¦ent ered¦ ¦its¦ ¦global¦ ¦ph ase¦ ¦in¦ ¦march¦ ,▁ ¦chinese¦ ¦author ities¦ ¦t ook¦ ¦ stric t¦ ¦measures¦ ¦to¦ ¦prevent¦ ¦the¦ ¦virus¦ ¦from¦ ▁" ¦imp orting¦ "▁ ¦from¦ ¦other¦ ¦countries¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦be i j ing¦ ¦has¦ ¦imp osed¦ ¦a¦ ¦14¦ - ¦day¦ ¦mand atory¦ ¦quarantine¦ ¦for¦ ¦all¦ ¦international¦ ¦tra ve ll ers¦ ¦ent ering¦ ¦the¦ ¦city¦ . ¦on¦ ¦23¦ ¦march¦ ,▁ ¦main land¦ ¦china¦ ¦only¦ ¦one¦ ¦case¦ ¦had¦ ¦transm it ted¦ ¦do me st ically¦ ¦in¦ ¦the¦ ¦five¦ ¦days¦ ¦pri or¦ ,▁ ¦in¦ ¦this¦ ¦inst ance¦ ¦v ia¦ ¦a¦ ¦tra ve ll er¦ ¦retur ning¦ ¦to¦ ¦gu a ng z ho u¦ ¦from¦ ¦ ist an b u l¦ .
𐋇¦on¦ ¦24¦ ¦march¦ ¦2020¦ ,▁ ¦chinese¦ ¦pre mi er¦ ¦l i¦ ¦k e q ia ng¦ ¦reported¦ ¦that¦ ¦the¦ ¦spread¦ ¦of¦ ¦do me st ically¦ ¦transm it ted¦ ¦cases¦ ¦has¦ ¦been¦ ¦b as ically¦ ¦ bl oc ked¦ ¦and¦ ¦the¦ ¦outbreak¦ ¦has¦ ¦been¦ ¦cont ro lled¦ ¦in¦ ¦china¦ .
𐋇¦the¦ ¦same¦ ¦day¦ ¦travel¦ ¦restrictions¦ ¦were¦ ¦ ea sed¦ ¦in¦ ¦hub e i¦ ,▁ ¦a par t¦ ¦from¦ ¦wuhan¦ ,▁ ¦two¦ ¦mon ths¦ ¦after¦ ¦the¦ ¦lockdown¦ ¦was¦ ¦imp osed¦ . ¦the¦ ¦chinese¦ ¦min ist ry¦ ¦of¦ ¦fo re ign¦ ¦aff a ir s¦ ¦announced¦ ¦on¦ ¦26¦ ¦march¦ ¦2020¦ ¦that¦ ¦ent ry¦ ¦for¦ ¦v is a¦ ¦or¦ ¦res idence¦ ¦per mi t¦ ¦h ol d ers¦ ¦would¦ ¦be¦ ¦susp e nded¦ ¦from¦ ¦2 8¦ ¦march¦ ¦ on w ards¦ ,▁ ¦with¦ ¦no¦ ¦specific¦ ¦detail s¦ ¦on¦ ¦when¦ ¦this¦ ¦pol ic y¦ ¦will¦ ¦end¦ .
𐋇 ¦those¦ ¦who¦ ¦w ish¦ ¦to¦ ¦en ter¦ ¦china¦ ¦will¦ ¦have¦ ¦to¦ ¦app ly¦ ¦for¦ ¦v is a s¦ ¦in¦ ¦chinese¦ ¦e mb a ss ies¦ ¦or¦ ¦cons ul ates¦ .
𐋇¦the¦ ¦chinese¦ ¦government¦ ¦e nc ou ra ged¦ ¦b us in es ses¦ ¦and¦ ¦fa ct or ies¦ ¦to¦ ¦r e¦ - ¦open¦ ¦on¦ ¦30¦ ¦march¦ ,▁ ¦and¦ ¦provid ed¦ ¦mon et ary¦ ¦st im ul us¦ ¦p ac k a ges¦ ¦for¦ ¦f ir ms¦ . ¦the¦ ¦state¦ ¦cou nc il¦ ¦decl ared¦ ¦a¦ ¦day¦ ¦of¦ ¦mo ur ning¦ ¦to¦ ¦beg in¦ ¦with¦ ¦a¦ ¦national¦ ¦three¦ - ¦min ute¦ ¦mo ment¦ ¦of¦ ¦s il ence¦ ¦on¦ ¦10¦ :▁ ¦ 00¦ ¦4¦ ¦april¦ ,▁ ¦c oi nc i ding¦ ¦with¦ ¦ q i ng m ing¦ ¦fe st iv al¦ ,▁ ¦al th ough¦ ¦the¦ ¦centr al¦ ¦government¦ ¦as ked¦ ¦fa m il ies¦ ¦to¦ ¦p ay¦ ¦their¦ ¦resp ects¦ ¦online¦ ¦in¦ ¦ob s erv ance¦ ¦of¦ ¦ph ys ical¦ ¦distancing¦ ¦as¦ ¦to¦ ¦avoid¦ ¦a¦ ¦re ne w ed¦ ¦covid¦ - ¦19¦ ¦outbreak¦ .
𐋇¦covid¦ - ¦19¦ ¦was¦ ¦confirmed¦ ¦to¦ ¦have¦ ¦spread¦ ¦to¦ ¦south¦ ¦ko rea¦ ¦on¦ ¦20¦ ¦january¦ ¦2020¦ ¦from¦ ¦china¦ .
𐋇¦the¦ ¦n ation¦ ' ¦s¦ ¦health¦ ¦a ge ncy¦ ¦reported¦ ¦a¦ ¦sign ific ant¦ ¦increase¦ ¦in¦ ¦confirmed¦ ¦cases¦ ¦on¦ ¦20¦ ¦february¦ ,▁ ¦l arg ely¦ ¦att rib u ted¦ ¦to¦ ¦a¦ ¦ga th ering¦ ¦in¦ ¦da e g u¦ ¦of¦ ¦a¦ ¦new¦ ¦rel ig ious¦ ¦mo ve ment¦ ¦known¦ ¦as¦ ¦the¦ ¦sh in che on j i¦ ¦ch ur ch¦ ¦of¦ ¦j es us¦ .
𐋇 ¦sh in che on j i¦ ¦de v o te es¦ ¦visi ting¦ ¦da e g u¦ ¦from¦ ¦wuhan¦ ¦were¦ ¦suspected¦ ¦to¦ ¦be¦ ¦the¦ ¦orig in¦ ¦of¦ ¦the¦ ¦outbreak¦ .
𐋇¦as¦ ¦of¦ ¦2 2¦ ¦february¦ ,▁ ¦among¦ ¦9¦ , ¦3 3 6¦ ¦fo ll ow ers¦ ¦of¦ ¦the¦ ¦ch ur ch¦ ,▁ ¦1¦ , ¦2 6 1¦ ¦or¦ ¦about¦ ¦13¦ %▁ ¦reported¦ ¦symptoms¦ . ¦south¦ ¦ko rea¦ ¦decl ared¦ ¦the¦ ¦high est¦ ¦level¦ ¦of¦ ¦alert¦ ¦on¦ ¦23¦ ¦february¦ ¦2020¦ .
𐋇¦on¦ ¦2 8¦ ¦february¦ ,▁ ¦more¦ ¦than¦ ¦2¦ , ¦000¦ ¦confirmed¦ ¦cases¦ ¦were¦ ¦reported¦ ¦in¦ ¦ko rea¦ ,▁ ¦r ising¦ ¦to¦ ¦3¦ , ¦1 5 0¦ ¦on¦ ¦2 9¦ ¦february¦ .
𐋇 ¦all¦ ¦south¦ ¦ko re an¦ ¦m il it ary¦ ¦ba ses¦ ¦were¦ ¦qu ara nt ined¦ ¦after¦ ¦tests¦ ¦confirmed¦ ¦that¦ ¦three¦ ¦s ol di ers¦ ¦were¦ ¦positive¦ ¦for¦ ¦the¦ ¦virus¦ .
𐋇 ¦air line¦ ¦s ch ed u les¦ ¦were¦ ¦also¦ ¦affected¦ ¦and¦ ¦the re f ore¦ ¦they¦ ¦were¦ ¦chan ged¦ . ¦south¦ ¦ko rea¦ ¦int ro duc ed¦ ¦what¦ ¦was¦ ¦consid ered¦ ¦the¦ ¦l arg est¦ ¦and¦ ¦b est¦ - ¦organiz ed¦ ¦pr ogra m me¦ ¦in¦ ¦the¦ ¦world¦ ¦to¦ ¦scre en¦ ¦the¦ ¦population¦ ¦for¦ ¦the¦ ¦virus¦ ,▁ ¦and¦ ¦isol ate¦ ¦any¦ ¦infected¦ ¦people¦ ¦as¦ ¦well¦ ¦as¦ ¦trac ing¦ ¦and¦ ¦qu ar an ti ning¦ ¦those¦ ¦who¦ ¦contac ted¦ ¦them¦ .
𐋇 ¦scre ening¦ ¦met ho ds¦ ¦inclu ded¦ ¦mand atory¦ ¦self¦ - ¦rep orting¦ ¦of¦ ¦symptoms¦ ¦by¦ ¦new¦ ¦international¦ ¦arr iv als¦ ¦through¦ ¦m ob i le¦ ¦app l ic ation¦ ,▁ ¦dr ive¦ - ¦th r u¦ ¦testing¦ ¦for¦ ¦the¦ ¦virus¦ ¦with¦ ¦the¦ ¦results¦ ¦available¦ ¦the¦ ¦ne xt¦ ¦day¦ ,▁ ¦and¦ ¦incre as ing¦ ¦testing¦ ¦ca pa bility¦ ¦to¦ ¦all ow¦ ¦up¦ ¦to¦ ¦20¦ , ¦000¦ ¦people¦ ¦to¦ ¦be¦ ¦tested¦ ¦every¦ ¦day¦ .
𐋇 ¦south¦ ¦ko rea¦ ' ¦s¦ ¦pr ogra m me¦ ¦is¦ ¦consid ered¦ ¦to¦ ¦be¦ ¦a¦ ¦s uc c ess¦ ¦in¦ ¦cont ro lling¦ ¦the¦ ¦outbreak¦ ¦d esp ite¦ ¦not¦ ¦qu ar an ti ning¦ ¦ent ir e¦ ¦c ities¦ . ¦the¦ ¦south¦ ¦ko re an¦ ¦s oc i et y¦ ¦was¦ ¦in it ially¦ ¦po la ri zed¦ ¦on¦ ¦pres ident¦ ¦mo on¦ ¦j a e¦ - ¦in¦ ' ¦s¦ ¦response¦ ¦to¦ ¦the¦ ¦c ri sis¦ .
𐋇 ¦many¦ ¦ko re ans¦ ¦sign ed¦ ¦p e ti tions¦ ¦e it her¦ ¦ca lling¦ ¦for¦ ¦the¦ ¦imp ea ch ment¦ ¦of¦ ¦mo on¦ ¦over¦ ¦what¦ ¦they¦ ¦cl ai med¦ ¦to¦ ¦be¦ ¦government¦ ¦m is h a nd l ing¦ ¦of¦ ¦the¦ ¦outbreak¦ ,▁ ¦or¦ ¦p ra ising¦ ¦hi s¦ ¦response¦ .
𐋇¦on¦ ¦23¦ ¦march¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦south¦ ¦ko rea¦ ¦had¦ ¦the¦ ¦l ow est¦ ¦one¦ - ¦day¦ ¦case¦ ¦total¦ ¦in¦ ¦four¦ ¦weeks¦ .
𐋇¦on¦ ¦2 9¦ ¦march¦ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦beg in ning¦ ¦1¦ ¦april¦ ¦all¦ ¦new¦ ¦over s ea s¦ ¦arr iv als¦ ¦will¦ ¦be¦ ¦qu ara nt ined¦ ¦for¦ ¦two¦ ¦weeks¦ .
𐋇 ¦per¦ ¦m ed ia¦ ¦rep orts¦ ¦on¦ ¦1¦ ¦april¦ ,▁ ¦south¦ ¦ko rea¦ ¦has¦ ¦received¦ ¦re qu e sts¦ ¦for¦ ¦virus¦ ¦testing¦ ¦ass ist ance¦ ¦from¦ ¦1 21¦ ¦different¦ ¦countries¦ .
𐋇 ¦iran¦ ¦reported¦ ¦its¦ ¦first¦ ¦confirmed¦ ¦cases¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦infections¦ ¦on¦ ¦19¦ ¦february¦ ¦in¦ ¦ q om¦ ,▁ ¦where¦ ,▁ ¦according¦ ¦to¦ ¦the¦ ¦min ist ry¦ ¦of¦ ¦health¦ ¦and¦ ¦medical¦ ¦education¦ ,▁ ¦two¦ ¦people¦ ¦d ied¦ ¦later¦ ¦that¦ ¦day¦ .
𐋇 ¦early¦ ¦measures¦ ¦announced¦ ¦by¦ ¦the¦ ¦government¦ ¦inclu ded¦ ¦the¦ ¦cance ll ation¦ ¦of¦ ¦concer ts¦ ¦and¦ ¦other¦ ¦c ult ural¦ ¦events¦ ,▁ ¦sp orting¦ ¦events¦ ,▁ ¦and¦ ¦f ri day¦ ¦p ra y ers¦ ,▁ ¦and¦ ¦closures¦ ¦of¦ ¦univers ities¦ ,▁ ¦higher¦ ¦education¦ ¦inst itu tions¦ ,▁ ¦and¦ ¦schools¦ .
𐋇 ¦iran¦ ¦all oc ated¦ ¦five¦ ¦t ri ll ion¦ ¦ ri als¦ ¦to¦ ¦co mb at¦ ¦the¦ ¦virus¦ .
𐋇 ¦pres ident¦ ¦ha ss an¦ ¦r ou h an i¦ ¦said¦ ¦on¦ ¦26¦ ¦february¦ ¦2020¦ ¦that¦ ¦there¦ ¦were¦ ¦no¦ ¦pl ans¦ ¦to¦ ¦quarantine¦ ¦areas¦ ¦affected¦ ¦by¦ ¦the¦ ¦outbreak¦ ,▁ ¦and¦ ¦only¦ ¦individuals¦ ¦would¦ ¦be¦ ¦qu ara nt ined¦ .
𐋇 ¦pl ans¦ ¦to¦ ¦limi t¦ ¦travel¦ ¦between¦ ¦c ities¦ ¦were¦ ¦announced¦ ¦in¦ ¦march¦ ,▁ ¦al th ough¦ ¦h ea v y¦ ¦tra ff ic¦ ¦between¦ ¦c ities¦ ¦a h ead¦ ¦of¦ ¦the¦ ¦per si an¦ ¦new¦ ¦year¦ ¦n ow ru z ¦ ¦contin u ed¦ .
𐋇 ¦sh ia¦ ¦sh r ines¦ ¦in¦ ¦ q om¦ ¦rema ined¦ ¦open¦ ¦to¦ ¦p il g ri ms¦ ¦until¦ ¦16¦ ¦march¦ ¦2020¦ . ¦iran¦ ¦bec a me¦ ¦a¦ ¦centre¦ ¦of¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ ¦after¦ ¦china¦ ¦during¦ ¦february¦ .
𐋇 ¦a m id s t¦ ¦cl ai ms¦ ¦of¦ ¦a¦ ¦cover¦ - ¦up¦ ¦of¦ ¦the¦ ¦ext ent¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦in¦ ¦iran¦ ,▁ ¦more¦ ¦than¦ ¦t en¦ ¦countries¦ ¦had¦ ¦trac ed¦ ¦their¦ ¦cases¦ ¦b ack¦ ¦to¦ ¦iran¦ ¦by¦ ¦2 8¦ ¦february¦ ,▁ ¦indic ating¦ ¦that¦ ¦the¦ ¦ext ent¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦may¦ ¦be¦ ¦more¦ ¦severe¦ ¦than¦ ¦the¦ ¦3 8 8¦ ¦cases¦ ¦reported¦ ¦by¦ ¦the¦ ¦ir an i an¦ ¦government¦ ¦by¦ ¦that¦ ¦date¦ .
𐋇¦the¦ ¦ir an i an¦ ¦par l ia ment¦ ¦was¦ ¦sh ut¦ ¦down¦ ,▁ ¦with¦ ¦23¦ ¦of¦ ¦its¦ ¦2 9 0¦ ¦me mbers¦ ¦reported¦ ¦to¦ ¦have¦ ¦had¦ ¦tested¦ ¦positive¦ ¦for¦ ¦the¦ ¦virus¦ ¦on¦ ¦3¦ ¦march¦ .
𐋇¦on¦ ¦12¦ ¦march¦ ,▁ ¦the¦ ¦human¦ ¦ ri gh ts¦ ¦w at ch¦ ¦ ur ged¦ ¦the¦ ¦ir an i an¦ ¦pr is on¦ ¦author ities¦ ¦to¦ ¦u nc on di tion ally¦ ¦re le ase¦ ¦the¦ ¦human¦ ¦ ri gh ts¦ ¦def end ers¦ ¦de ta ined¦ ¦for¦ ¦p ea ce ful¦ ¦di ss ent¦ ,▁ ¦and¦ ¦to¦ ¦also¦ ¦temp o ra ri ly¦ ¦re le ase¦ ¦all¦ ¦the¦ ¦el ig i ble¦ ¦pr is on ers¦ .
𐋇¦it¦ ¦stated¦ ¦that¦ ¦there¦ ¦is¦ ¦a¦ ¦g rea ter¦ ¦risk¦ ¦of¦ ¦the¦ ¦virus¦ ¦to¦ ¦spread¦ ¦in¦ ¦closed¦ ¦inst itu tions¦ ¦like¦ ¦de te nt ion¦ ¦centr es¦ ,▁ ¦which¦ ¦also¦ ¦l ack¦ ¦a de qu ate¦ ¦medical¦ ¦care¦ .
𐋇¦on¦ ¦15¦ ¦march¦ ,▁ ¦the¦ ¦ir an i an¦ ¦government¦ ¦reported¦ ¦100¦ ¦deaths¦ ¦in¦ ¦a¦ ¦si ng le¦ ¦day¦ ,▁ ¦the¦ ¦most¦ ¦recor ded¦ ¦in¦ ¦the¦ ¦country¦ ¦since¦ ¦the¦ ¦outbreak¦ ¦beg an¦ .
𐋇 ¦at¦ ¦least¦ ¦12¦ ¦s it ting¦ ¦or¦ ¦f orm er¦ ¦ir an i an¦ ¦pol it ici ans¦ ¦and¦ ¦government¦ ¦off ici als¦ ¦had¦ ¦d ied¦ ¦from¦ ¦the¦ ¦disease¦ ¦by¦ ¦1 7¦ ¦march¦ .
𐋇¦by¦ ¦23¦ ¦march¦ ,▁ ¦iran¦ ¦was¦ ¦exp er ie ncing¦ ¦50¦ ¦new¦ ¦cases¦ ¦every¦ ¦hou r¦ ¦and¦ ¦one¦ ¦new¦ ¦death¦ ¦every¦ ¦t en¦ ¦min u tes¦ ¦due¦ ¦to¦ ¦coronavirus¦ .
𐋇 ¦according¦ ¦to¦ ¦a¦ ¦who¦ ¦offic ial¦ ,▁ ¦there¦ ¦may¦ ¦be¦ ¦five¦ ¦times¦ ¦more¦ ¦cases¦ ¦in¦ ¦iran¦ ¦than¦ ¦what¦ ¦is¦ ¦being¦ ¦reported¦ .
𐋇¦it¦ ¦is¦ ¦also¦ ¦su gg ested¦ ¦that¦ ¦u¦ . ¦s¦ .▁ ¦sa nc tions¦ ¦on¦ ¦iran¦ ¦may¦ ¦be¦ ¦aff ecting¦ ¦the¦ ¦country¦ ' ¦s¦ ¦fi na nc ial¦ ¦a bility¦ ¦to¦ ¦resp on d¦ ¦to¦ ¦the¦ ¦viral¦ ¦outbreak¦ .
𐋇¦the¦ ¦u n¦ ¦high¦ ¦comm is si on er¦ ¦for¦ ¦human¦ ¦ ri gh ts¦ ¦has¦ ¦de ma nded¦ ¦ec onomic¦ ¦sa nc tions¦ ¦to¦ ¦be¦ ¦ ea sed¦ ¦for¦ ¦n ations¦ ¦most¦ ¦affected¦ ¦by¦ ¦the¦ ¦pandemic¦ ,▁ ¦including¦ ¦iran¦ .
𐋇¦the¦ ¦outbreak¦ ¦was¦ ¦confirmed¦ ¦to¦ ¦have¦ ¦spread¦ ¦to¦ ¦italy¦ ¦on¦ ¦3 1¦ ¦january¦ ,▁ ¦when¦ ¦two¦ ¦chinese¦ ¦tou ri sts¦ ¦tested¦ ¦positive¦ ¦for¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦in¦ ¦r ome¦ .
𐋇 ¦cases¦ ¦beg an¦ ¦to¦ ¦r ise¦ ¦sh ar p ly¦ ,▁ ¦which¦ ¦pro mp ted¦ ¦the¦ ¦i tali an¦ ¦government¦ ¦to¦ ¦susp end¦ ¦all¦ ¦f li gh ts¦ ¦to¦ ¦and¦ ¦from¦ ¦china¦ ¦and¦ ¦decl are¦ ¦a¦ ¦state¦ ¦of¦ ¦emergency¦ .
𐋇 ¦an¦ ¦u na ss oc i ated¦ ¦cl us ter¦ ¦of¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦was¦ ¦later¦ ¦detected¦ ,▁ ¦star ting¦ ¦with¦ ¦16¦ ¦confirmed¦ ¦cases¦ ¦in¦ ¦lo mb ar dy¦ ¦on¦ ¦ 21¦ ¦february¦ . ¦on¦ ¦2 2¦ ¦february¦ ,▁ ¦the¦ ¦cou nc il¦ ¦of¦ ¦min ist ers¦ ¦announced¦ ¦a¦ ¦new¦ ¦dec re e¦ - ¦la w¦ ¦to¦ ¦con tain¦ ¦the¦ ¦outbreak¦ ,▁ ¦including¦ ¦qu ar an ti ning¦ ¦more¦ ¦than¦ ¦50¦ , ¦000¦ ¦people¦ ¦from¦ ¦11¦ ¦different¦ ¦m un ic ip al ities¦ ¦in¦ ¦n or ther n¦ ¦italy¦ .
𐋇 ¦pri me¦ ¦minister¦ ¦g i u se pp e¦ ¦cont e¦ ¦said¦ , ▁" ¦in¦ ¦the¦ ¦outbreak¦ ¦areas¦ ,▁ ¦ent ry¦ ¦and¦ ¦e xi t¦ ¦will¦ ¦not¦ ¦be¦ ¦provid ed¦ .
𐋇 ¦susp e ns ion¦ ¦of¦ ¦work¦ ¦activ ities¦ ¦and¦ ¦sp orts¦ ¦events¦ ¦has¦ ¦al rea dy¦ ¦been¦ ¦or d ered¦ ¦in¦ ¦those¦ ¦areas¦ . ▁" 𐋇¦on¦ ¦4¦ ¦march¦ ,▁ ¦the¦ ¦i tali an¦ ¦government¦ ¦or d ered¦ ¦the¦ ¦f ul l¦ ¦cl osure¦ ¦of¦ ¦all¦ ¦schools¦ ¦and¦ ¦univers ities¦ ¦na tion w ide¦ ¦as¦ ¦italy¦ ¦rea ched¦ ¦100¦ ¦deaths¦ .
𐋇 ¦all¦ ¦major¦ ¦sp orting¦ ¦events¦ ,▁ ¦including¦ ¦s eri e¦ ¦a¦ ¦fo ot b all¦ ¦m at ches¦ ,▁ ¦were¦ ¦to¦ ¦be¦ ¦he ld¦ ¦be h ind¦ ¦closed¦ ¦do ors¦ ¦until¦ ¦april¦ ,▁ ¦but¦ ¦on¦ ¦9¦ ¦march¦ ,▁ ¦all¦ ¦sp ort¦ ¦was¦ ¦susp e nded¦ ¦comp le tely¦ ¦for¦ ¦at¦ ¦least¦ ¦one¦ ¦mon th¦ .
𐋇¦on¦ ¦11¦ ¦march¦ ,▁ ¦pri me¦ ¦minister¦ ¦cont e¦ ¦or d ered¦ ¦sto pp age¦ ¦of¦ ¦ne arly¦ ¦all¦ ¦comm erc ial¦ ¦activ ity¦ ¦ex cep t¦ ¦su p erm ar k ets¦ ¦and¦ ¦ph arm ac ies¦ . ¦on¦ ¦6¦ ¦march¦ ,▁ ¦the¦ ¦i tali an¦ ¦colle ge¦ ¦of¦ ¦a na es th es ia¦ ,▁ ¦anal g es ia¦ ,▁ ¦res us c it ation¦ ¦and¦ ¦in tens ive¦ ¦care¦ ▁( ¦s ia a rt i¦ )▁ ¦publ ished¦ ¦medical¦ ¦e th ics¦ ¦recomm end ations¦ ¦reg ar ding¦ ¦t ri age¦ ¦prot oc ols¦ ¦that¦ ¦might¦ ¦be¦ ¦e mploy ed¦ .
𐋇¦on¦ ¦19¦ ¦march¦ ,▁ ¦italy¦ ¦over t ook¦ ¦china¦ ¦as¦ ¦the¦ ¦country¦ ¦with¦ ¦the¦ ¦most¦ ¦coronavirus¦ - ¦related¦ ¦deaths¦ ¦in¦ ¦the¦ ¦world¦ ¦after¦ ¦rep orting¦ ¦3¦ , ¦4 0 5¦ ¦fat al ities¦ ¦from¦ ¦the¦ ¦pandemic¦ .
𐋇¦on¦ ¦2 2¦ ¦march¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦ ru ss ia¦ ¦had¦ ¦s ent¦ ¦n ine¦ ¦m il it ary¦ ¦pl an es¦ ¦with¦ ¦medical¦ ¦equipment¦ ¦to¦ ¦italy¦ .
𐋇¦as¦ ¦of¦ ¦5¦ ¦april¦ ,▁ ¦there¦ ¦were¦ ¦1 2 8¦ , ¦9 4 8¦ ¦confirmed¦ ¦cases¦ ,▁ ¦15¦ , ¦8 8 7¦ ¦deaths¦ ,▁ ¦and¦ ¦ 21¦ , ¦8 1 5¦ ¦reco ver ies¦ ¦in¦ ¦italy¦ ,▁ ¦with¦ ¦the¦ ¦ma j or ity¦ ¦of¦ ¦those¦ ¦cases¦ ¦occur r ing¦ ¦in¦ ¦the¦ ¦lo mb ar dy¦ ¦reg ion¦ .
𐋇¦a¦ ¦c n n¦ ¦report¦ ¦indic ated¦ ¦that¦ ¦the¦ ¦co mb ination¦ ¦of¦ ¦italy¦ ' ¦s¦ ¦large¦ ¦el d erly¦ ¦population¦ ¦and¦ ¦i na bility¦ ¦to¦ ¦test¦ ¦all¦ ¦who¦ ¦have¦ ¦the¦ ¦virus¦ ¦to¦ ¦date¦ ¦may¦ ¦be¦ ¦cont rib u ting¦ ¦to¦ ¦the¦ ¦high¦ ¦fat ality¦ ¦rate¦ .
𐋇¦the¦ ¦united¦ ¦ki ng d om¦ ' ¦s¦ ¦response¦ ¦to¦ ¦the¦ ¦virus¦ ¦first¦ ¦e mer ged¦ ¦as¦ ¦one¦ ¦of¦ ¦the¦ ¦most¦ ¦re la x ed¦ ¦of¦ ¦the¦ ¦affected¦ ¦countries¦ ,▁ ¦and¦ ¦until¦ ¦18¦ ¦march¦ ¦2020¦ ,▁ ¦the¦ ¦br it ish¦ ¦government¦ ¦d id¦ ¦not¦ ¦imp ose¦ ¦any¦ ¦for m¦ ¦of¦ ¦social¦ ¦distancing¦ ¦or¦ ¦m ass¦ ¦quarantine¦ ¦measures¦ ¦on¦ ¦its¦ ¦c itiz ens¦ .
𐋇¦as¦ ¦a¦ ¦result¦ ,▁ ¦the¦ ¦government¦ ¦received¦ ¦crit ic is m¦ ¦for¦ ¦the¦ ¦per ce iv ed¦ ¦l ack¦ ¦of¦ ¦p ace¦ ¦and¦ ¦in tens ity¦ ¦in¦ ¦its¦ ¦response¦ ¦to¦ ¦concer ns¦ ¦f ac ed¦ ¦by¦ ¦the¦ ¦public¦ . ¦on¦ ¦16¦ ¦march¦ ,▁ ¦pri me¦ ¦minister¦ ¦ bo ri s¦ ¦jo h ns on¦ ¦made¦ ¦an¦ ¦an no un ce ment¦ ¦ad v ising¦ ¦against¦ ¦all¦ ¦non¦ - ¦essential¦ ¦travel¦ ¦and¦ ¦social¦ ¦contact¦ ,▁ ¦su gg es ting¦ ¦people¦ ¦work¦ ¦from¦ ¦home¦ ¦where¦ ¦possible¦ ¦and¦ ¦avoid¦ ¦v en ues¦ ¦such¦ ¦as¦ ¦p ub s¦ ,▁ ¦res ta u ra nts¦ ,▁ ¦and¦ ¦the at r es¦ .
𐋇¦on¦ ¦20¦ ¦march¦ ,▁ ¦the¦ ¦government¦ ¦announced¦ ¦that¦ ¦all¦ ¦le is ure¦ ¦ es ta bl is h ments¦ ¦such¦ ¦as¦ ¦p ub s¦ ¦and¦ ¦g y ms¦ ¦were¦ ¦to¦ ¦close¦ ¦as¦ ¦so on¦ ¦as¦ ¦possible¦ ,▁ ¦and¦ ¦pro mi sed¦ ¦to¦ ¦p ay¦ ¦up¦ ¦to¦ ¦8 0¦ %▁ ¦of¦ ¦workers¦ ' ▁ ¦w a ges¦ ¦to¦ ¦a¦ ¦limi t¦ ¦of¦ ▁ £ ¦2¦ , ¦5 00¦ ¦per¦ ¦mon th¦ ¦to¦ ¦prevent¦ ¦u ne mploy ment¦ ¦in¦ ¦the¦ ¦c ri sis¦ . ¦on¦ ¦23¦ ¦march¦ ,▁ ¦the¦ ¦pri me¦ ¦minister¦ ¦announced¦ ¦tou g her¦ ¦social¦ ¦distancing¦ ¦measures¦ ,▁ ¦b an ning¦ ¦ga ther ings¦ ¦of¦ ¦more¦ ¦than¦ ¦two¦ ¦people¦ ¦and¦ ¦re stric ting¦ ¦travel¦ ¦and¦ ¦out door¦ ¦activ ity¦ ¦to¦ ¦that¦ ¦d ee med¦ ¦st ri ct ly¦ ¦ne cess ary¦ .
𐋇 ¦un li ke¦ ¦prev ious¦ ¦measures¦ ,▁ ¦these¦ ¦restrictions¦ ¦were¦ ¦en for ce able¦ ¦by¦ ¦pol ice¦ ¦through¦ ¦the¦ ¦i ss u ing¦ ¦of¦ ¦fines¦ ¦and¦ ¦the¦ ¦dis p e rs al¦ ¦of¦ ¦ga ther ings¦ .
𐋇 ¦most¦ ¦b us in es ses¦ ¦were¦ ¦or d ered¦ ¦to¦ ¦close¦ ,▁ ¦with¦ ¦ex cep tions¦ ¦for¦ ¦b us in es ses¦ ¦d ee med¦ ▁" ¦essential¦ " ,▁ ¦including¦ ¦su p erm ar k ets¦ ,▁ ¦ph arm ac ies¦ ,▁ ¦b an ks¦ ,▁ ¦h ar d w are¦ ¦sho ps¦ ,▁ ¦p et ro l¦ ¦st ations¦ ,▁ ¦and¦ ¦g ara ges¦ .
𐋇¦on¦ ¦20¦ ¦january¦ ,▁ ¦the¦ ¦first¦ ¦known¦ ¦case¦ ¦of¦ ¦covid¦ - ¦19¦ ¦was¦ ¦confirmed¦ ¦in¦ ¦the¦ ¦p ac if ic¦ ¦n or th w est¦ ¦state¦ ¦of¦ ¦w as hi ng t on¦ ¦in¦ ¦a¦ ¦m an¦ ¦who¦ ¦had¦ ¦retur ned¦ ¦from¦ ¦wuhan¦ ¦on¦ ¦15¦ ¦january¦ .
𐋇¦the¦ ¦wh ite¦ ¦house¦ ¦coronavirus¦ ¦t as k¦ ¦for ce¦ ¦was¦ ¦ es ta bl ished¦ ¦on¦ ¦2 9¦ ¦january¦ .
𐋇¦on¦ ¦3 1¦ ¦january¦ ,▁ ¦the¦ ¦tr um p¦ ¦admin i str ation¦ ¦decl ared¦ ¦a¦ ¦public¦ ¦health¦ ¦emergency¦ ,▁ ¦and¦ ¦pl ac ed¦ ¦restrictions¦ ¦on¦ ¦ent ry¦ ¦for¦ ¦tra ve ll ers¦ ¦from¦ ¦china¦ .
𐋇¦on¦ ¦2 8¦ ¦january¦ ¦2020¦ ,▁ ¦the¦ ¦center¦ ¦for¦ ¦disease¦ ¦control¦ ▁ — ▁ ¦the¦ ¦lea ding¦ ¦public¦ ¦health¦ ¦inst it ute¦ ¦of¦ ¦the¦ ¦u¦ . ¦s¦ .▁ ¦government¦ ▁ — ▁ ¦announced¦ ¦they¦ ¦had¦ ¦developed¦ ¦their¦ ¦ own¦ ¦testing¦ ¦ki t¦ .
𐋇¦d esp ite¦ ¦do ing¦ ¦so¦ ,▁ ¦the¦ ¦united¦ ¦states¦ ¦had¦ ¦a¦ ¦sl ow¦ ¦star t¦ ¦in¦ ¦testing¦ ,▁ ¦which¦ ¦ob s c ur ed¦ ¦the¦ ¦tr ue¦ ¦ext ent¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦at¦ ¦the¦ ¦time¦ .
𐋇 ¦testing¦ ¦was¦ ¦m arr ed¦ ¦by¦ ¦def ective¦ ¦test¦ ¦ki ts¦ ¦produc ed¦ ¦by¦ ¦the¦ ¦f ed er al¦ ¦government¦ ¦in¦ ¦february¦ ,▁ ¦a¦ ¦l ack¦ ¦of¦ ¦f ed er al¦ ¦government¦ ¦appr ov al¦ ¦for¦ ¦non¦ - ¦government¦ ¦test¦ ¦ki ts¦ ▁( ¦by¦ ¦ac a de m ia¦ ,▁ ¦comp an ies¦ ¦and¦ ¦hosp it als¦ )▁ ¦until¦ ¦the¦ ¦end¦ ¦of¦ ¦february¦ ,▁ ¦and¦ ¦re stric tive¦ ¦crit er ia¦ ¦for¦ ¦people¦ ¦to¦ ¦qu al if y¦ ¦for¦ ¦a¦ ¦test¦ ¦until¦ ¦early¦ ¦march¦ ▁( ¦a¦ ¦doctor¦ ' ¦s¦ ¦order¦ ¦was¦ ¦required¦ ¦the rea f ter¦ ).
𐋇¦by¦ ¦2 7¦ ¦february¦ ,▁ ¦the¦ ¦w as hi ng t on¦ ¦p ost¦ ¦reported¦ ¦fe w er¦ ¦than¦ ¦4¦ , ¦000¦ ¦tests¦ ¦had¦ ¦been¦ ¦con duc ted¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ .
𐋇¦by¦ ¦13¦ ¦march¦ ,▁ ¦the¦ ¦ at la nt ic¦ ¦reported¦ ¦that¦ ¦less¦ ¦than¦ ¦14¦ , ¦000¦ ¦tests¦ ¦had¦ ¦been¦ ¦con duc ted¦ .
𐋇¦on¦ ¦2 2¦ ¦march¦ ,▁ ¦the¦ ¦associated¦ ¦pr ess¦ ¦reported¦ : ▁" 𐋇 ¦many¦ ¦people¦ ¦who¦ ¦have¦ ¦symptoms¦ ¦and¦ ¦a¦ ¦doctor¦ ' ¦s¦ ¦order¦ ¦have¦ ¦wai ted¦ ¦hours¦ ¦or¦ ¦days¦ ¦for¦ ¦a¦ ¦test¦ . "▁ 𐋇 ¦after¦ ¦the¦ ¦first¦ ¦death¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ¦was¦ ¦reported¦ ¦in¦ ¦w as hi ng t on¦ ¦state¦ ¦on¦ ¦2 9¦ ¦february¦ ,▁ ¦gover n or¦ ¦j ay¦ ¦i ns le e¦ ¦decl ared¦ ¦a¦ ¦state¦ ¦of¦ ¦emergency¦ ,▁ ¦an¦ ¦a ction¦ ¦that¦ ¦was¦ ¦so on¦ ¦fo ll owed¦ ¦by¦ ¦other¦ ¦states¦ .
𐋇 ¦schools¦ ¦in¦ ¦the¦ ¦se at t le¦ ¦a rea¦ ¦cance lled¦ ¦cl as ses¦ ¦on¦ ¦3¦ ¦march¦ ,▁ ¦and¦ ¦by¦ ¦m id¦ - ¦march¦ ,▁ ¦schools¦ ¦across¦ ¦the¦ ¦country¦ ¦were¦ ¦sh ut ting¦ ¦down¦ . ¦on¦ ¦6¦ ¦march¦ ¦2020¦ ,▁ ¦the¦ ¦united¦ ¦states¦ ¦was¦ ¦ad vi sed¦ ¦of¦ ¦pro j ec tions¦ ¦for¦ ¦the¦ ¦impac t¦ ¦of¦ ¦the¦ ¦new¦ ¦coronavirus¦ ¦on¦ ¦the¦ ¦country¦ ¦by¦ ¦a¦ ¦group¦ ¦of¦ ¦e p ide mi ol og i sts¦ ¦at¦ ¦imp er ial¦ ¦colle ge¦ ¦l ond on¦ .
𐋇¦on¦ ¦the¦ ¦same¦ ¦day¦ ¦pres ident¦ ¦tr um p¦ ¦sign ed¦ ¦the¦ ¦coronavirus¦ ¦pre par ed ness¦ ¦and¦ ¦response¦ ¦supp le me ntal¦ ¦appr op ri ations¦ ¦ac t¦ ,▁ ¦which¦ ¦provid ed¦ ▁ $ ¦8¦ . ¦3¦ ¦bi ll ion¦ ¦in¦ ¦emergency¦ ¦f un ding¦ ¦for¦ ¦f ed er al¦ ¦a ge nc ies¦ ¦to¦ ¦resp on d¦ ¦to¦ ¦the¦ ¦outbreak¦ .
𐋇 ¦cor p or ations¦ ¦imp osed¦ ¦e mploy e e¦ ¦travel¦ ¦restrictions¦ ,▁ ¦cance lled¦ ¦conf er en ces¦ ,▁ ¦and¦ ¦e nc ou ra ged¦ ¦e mploy e es¦ ¦to¦ ¦work¦ ¦from¦ ¦home¦ .
𐋇 ¦sp orts¦ ¦events¦ ¦and¦ ¦se as ons¦ ¦were¦ ¦cance lled¦ . ¦on¦ ¦11¦ ¦march¦ ,▁ ¦tr um p¦ ¦announced¦ ¦travel¦ ¦restrictions¦ ¦for¦ ¦most¦ ¦of¦ ¦e ur ope¦ ,▁ ¦ex c lu ding¦ ¦the¦ ¦united¦ ¦ki ng d om¦ ,▁ ¦for¦ ¦30¦ ¦days¦ ,▁ ¦effective¦ ¦13¦ ¦march¦ .
𐋇¦the¦ ¦following¦ ¦day¦ ,▁ ¦h e¦ ¦ex pa nded¦ ¦the¦ ¦restrictions¦ ¦to¦ ¦include¦ ¦the¦ ¦united¦ ¦ki ng d om¦ ¦and¦ ¦ireland¦ .
𐋇¦on¦ ¦13¦ ¦march¦ ,▁ ¦h e¦ ¦decl ared¦ ¦a¦ ¦national¦ ¦emergency¦ ,▁ ¦which¦ ¦made¦ ¦f ed er al¦ ¦f un ds¦ ¦available¦ ¦to¦ ¦resp on d¦ ¦to¦ ¦the¦ ¦c ri sis¦ .
𐋇 ¦beg in ning¦ ¦on¦ ¦15¦ ¦march¦ ,▁ ¦many¦ ¦b us in es ses¦ ¦closed¦ ¦or¦ ¦reduc ed¦ ¦hours¦ ¦th r ou g ho ut¦ ¦the¦ ¦u¦ . ¦s¦ .▁ ¦to¦ ¦t ry¦ ¦to¦ ¦reduce¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦by¦ ¦1 7¦ ¦march¦ ,▁ ¦the¦ ¦epidemic¦ ¦had¦ ¦been¦ ¦confirmed¦ ¦in¦ ¦all¦ ¦50¦ ¦states¦ ¦and¦ ¦in¦ ¦the¦ ¦di stric t¦ ¦of¦ ¦co lu mb ia¦ . ¦on¦ ¦23¦ ¦march¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦new¦ ¦y or k¦ ¦city¦ ¦had¦ ¦10¦ , ¦7 00¦ ¦cases¦ ¦of¦ ¦the¦ ¦coronavirus¦ ,▁ ¦more¦ ¦than¦ ¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦in¦ ¦south¦ ¦ko rea¦ .
𐋇¦on¦ ¦2 5¦ ¦march¦ ,▁ ¦the¦ ¦gover n or¦ ¦said¦ ¦that¦ ¦social¦ ¦distancing¦ ¦s ee med¦ ¦to¦ ¦be¦ ¦wor king¦ ,▁ ¦as¦ ¦estim ates¦ ¦of¦ ¦case¦ ¦d ou bl ing¦ ¦sl owed¦ ¦from¦ ¦2¦ . ¦ 0¦ ¦days¦ ¦to¦ ¦4¦ . ¦7¦ ¦days¦ .
𐋇¦as¦ ¦of¦ ¦2 8¦ ¦march¦ ,▁ ¦there¦ ¦were¦ ¦3 2¦ , ¦30 8¦ ¦confirmed¦ ¦cases¦ ¦in¦ ¦new¦ ¦y or k¦ ¦city¦ ,▁ ¦and¦ ¦6 7 2¦ ¦people¦ ¦had¦ ¦d ied¦ ¦from¦ ¦the¦ ¦virus¦ . ¦on¦ ¦26¦ ¦march¦ ,▁ ¦the¦ ¦united¦ ¦states¦ ¦was¦ ¦reported¦ ¦to¦ ¦have¦ ¦more¦ ¦confirmed¦ ¦coronavirus¦ ¦infection¦ ¦cases¦ ¦than¦ ¦any¦ ¦other¦ ¦country¦ ¦in¦ ¦the¦ ¦world¦ ,▁ ¦including¦ ¦china¦ ¦and¦ ¦italy¦ . ¦as¦ ¦of¦ ¦8¦ ¦april¦ ,▁ ¦4 00¦ , ¦3 3 5¦ ¦cases¦ ¦have¦ ¦been¦ ¦confirmed¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦and¦ ¦12¦ , ¦8 4 1¦ ¦people¦ ¦have¦ ¦d ied¦ .
𐋇 ¦per¦ ¦m ed ia¦ ¦rep orts¦ ¦on¦ ¦30¦ ¦march¦ ,▁ ¦u¦ . ¦s¦ .▁ ¦pres ident¦ ¦tr um p¦ ¦has¦ ¦dec i ded¦ ¦to¦ ¦ext end¦ ¦social¦ ¦distancing¦ ¦gu id el ines¦ ¦until¦ ¦30¦ ¦april¦ .
𐋇¦on¦ ¦the¦ ¦same¦ ¦day¦ ,▁ ¦the¦ ¦us ns¦ ¦c om f ort¦ ,▁ ¦a¦ ¦hospital¦ ¦s hi p¦ ¦with¦ ¦about¦ ¦1 0 00¦ ¦be ds¦ ,▁ ¦made¦ ¦an ch or¦ ¦in¦ ¦new¦ ¦y or k¦ .
𐋇¦on¦ ¦3¦ ¦april¦ ,▁ ¦the¦ ¦u¦ . ¦s¦ .▁ ¦had¦ ¦a¦ ¦recor d¦ ¦8 8 4¦ ¦deaths¦ ¦due¦ ¦to¦ ¦the¦ ¦coronavirus¦ ¦in¦ ¦a¦ ¦24¦ - ¦hou r¦ ¦period¦ .
𐋇¦in¦ ¦the¦ ¦state¦ ¦of¦ ¦new¦ ¦y or k¦ ¦the¦ ¦cases¦ ¦have¦ ¦ex c ee ded¦ ¦100¦ , ¦000¦ ¦people¦ ¦on¦ ¦3¦ ¦april¦ . ¦the¦ ¦wh ite¦ ¦house¦ ¦has¦ ¦been¦ ¦crit ici zed¦ ¦for¦ ¦d ow n p la ying¦ ¦the¦ ¦th re at¦ ¦and¦ ¦cont ro lling¦ ¦the¦ ¦me ss a ging¦ ¦by¦ ¦dir ecting¦ ¦health¦ ¦off ici als¦ ¦and¦ ¦sc ien ti sts¦ ¦to¦ ¦co or d in ate¦ ¦public¦ ¦sta te ments¦ ¦and¦ ¦publ ications¦ ¦related¦ ¦to¦ ¦the¦ ¦virus¦ ¦with¦ ¦the¦ ¦off ice¦ ¦of¦ ¦v ice¦ - ¦pres ident¦ ¦mi ke¦ ¦p ence¦ .
𐋇 ¦over all¦ ¦appr ov al¦ ¦of¦ ¦tr um p¦ ' ¦s¦ ¦mana ge ment¦ ¦of¦ ¦the¦ ¦c ri sis¦ ¦has¦ ¦been¦ ¦po la ri zed¦ ¦a lo ng¦ ¦part is an¦ ¦l ines¦ .
𐋇¦some¦ ¦u¦ . ¦s¦ .▁ ¦off ici als¦ ¦and¦ ¦comm e nt at ors¦ ¦crit ici zed¦ ¦the¦ ¦u¦ . ¦s¦ .▁ ¦re li ance¦ ¦on¦ ¦imp ort ation¦ ¦of¦ ¦crit ical¦ ¦m at eri als¦ ,▁ ¦including¦ ¦essential¦ ¦medical¦ ¦supp l ies¦ ,▁ ¦from¦ ¦china¦ .
𐋇 ¦an¦ ¦anal y sis¦ ¦of¦ ¦air ¦ ¦travel¦ ¦p at t er ns¦ ¦was¦ ¦used¦ ¦to¦ ¦ma p¦ ¦and¦ ¦pr ed ic t¦ ¦p at t er ns¦ ¦of¦ ¦spread¦ ¦and¦ ¦was¦ ¦publ ished¦ ¦in¦ ¦the¦ ¦jo ur n al¦ ¦of¦ ¦travel¦ ¦medic ine¦ ¦in¦ ¦m id¦ - ¦january¦ ¦2020¦ .
𐋇 ¦based¦ ¦on¦ ¦20 1 8¦ ¦information¦ ¦from¦ ¦the¦ ¦international¦ ¦air ¦ ¦transport¦ ¦associ ation¦ ,▁ ¦ba ng k o k¦ ,▁ ¦ho ng¦ ¦ko ng¦ ,▁ ¦to k y o¦ ,▁ ¦and¦ ¦ta ip e i¦ ¦had¦ ¦the¦ ¦l arg est¦ ¦v o lu me¦ ¦of¦ ¦tra ve ll ers¦ ¦from¦ ¦wuhan¦ .
𐋇¦d ub a i¦ ,▁ ¦s y d ne y¦ ,▁ ¦and¦ ¦m el bo ur n e¦ ¦were¦ ¦also¦ ¦reported¦ ¦as¦ ¦p op ular¦ ¦de st in ations¦ ¦for¦ ¦people¦ ¦tra ve lling¦ ¦from¦ ¦wuhan¦ .
𐋇¦b al i¦ ¦was¦ ¦reported¦ ¦as¦ ¦least¦ ¦able¦ ¦among¦ ¦the¦ ¦20¦ ¦most¦ ¦p op ular¦ ¦de st ination¦ ¦c ities¦ ¦in¦ ¦ter ms¦ ¦of¦ ¦pre par ed ness¦ ,▁ ¦while¦ ¦c ities¦ ¦in¦ ¦a u str al ia¦ ¦were¦ ¦consid ered¦ ¦most¦ ¦able¦ . ¦a u str al ia¦ ¦rel ea sed¦ ¦its¦ ¦emergency¦ ¦response¦ ¦pl an¦ ¦for¦ ¦novel¦ ¦coronavirus¦ ▁( ¦covid¦ - ¦19¦ )▁ ¦on¦ ¦7¦ ¦february¦ .
𐋇¦it¦ ¦stated¦ ¦that¦ ¦much¦ ¦was¦ ¦y et¦ ¦to¦ ¦be¦ ¦dis covered¦ ¦about¦ ¦covid¦ - ¦19¦ ,▁ ¦and¦ ¦that¦ ¦a u str al ia¦ ¦would¦ ¦e m ph as iz e¦ ¦ bor der¦ ¦control¦ ¦and¦ ¦comm un ic ation¦ ¦in¦ ¦its¦ ¦response¦ ¦to¦ ¦the¦ ¦pandemic¦ .
𐋇¦on¦ ¦ 21¦ ¦march¦ ,▁ ¦a¦ ¦human¦ ¦bi os ec ur ity¦ ¦emergency¦ ¦was¦ ¦decl ared¦ ¦in¦ ¦a u str al ia¦ .
𐋇¦ owing¦ ¦to¦ ¦the¦ ¦effective¦ ¦quarantine¦ ¦of¦ ¦public¦ ¦transport¦ ¦in¦ ¦wuhan¦ ¦and¦ ¦hub e i¦ ,▁ ¦several¦ ¦countries¦ ¦have¦ ¦pl an ned¦ ¦to¦ ¦ev ac u ate¦ ¦their¦ ¦c itiz ens¦ ¦and¦ ¦di pl om at ic¦ ¦staff¦ ¦from¦ ¦the¦ ¦a rea¦ ,▁ ¦pri ma ri ly¦ ¦through¦ ¦cha rt ered¦ ¦f li gh ts¦ ¦of¦ ¦the¦ ¦home¦ ¦n ation¦ ,▁ ¦with¦ ¦chinese¦ ¦author ities¦ ¦provid ing¦ ¦cl ear ance¦ .
𐋇 ¦ca na d a¦ ,▁ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦j ap an¦ ,▁ ¦ind ia¦ ,▁ ¦s r i¦ ¦l an k a¦ ,▁ ¦a u str al ia¦ ,▁ ¦fra nce¦ ,▁ ¦ arg en ti na¦ ,▁ ¦g erm an y¦ ,▁ ¦and¦ ¦th ai land¦ ¦were¦ ¦among¦ ¦the¦ ¦first¦ ¦to¦ ¦pl an¦ ¦the¦ ¦ev ac u ation¦ ¦of¦ ¦their¦ ¦c itiz ens¦ .
𐋇 ¦pa k ist an¦ ¦has¦ ¦said¦ ¦that¦ ¦it¦ ¦will¦ ¦not¦ ¦be¦ ¦ev ac u ating¦ ¦any¦ ¦c itiz ens¦ ¦from¦ ¦china¦ .
𐋇¦on¦ ¦7¦ ¦february¦ ,▁ ¦b ra z il¦ ¦ev ac u ated¦ ¦3 4¦ ¦b ra z i li ans¦ ¦or¦ ¦family¦ ¦me mbers¦ ¦in¦ ¦add ition¦ ¦to¦ ¦four¦ ¦po les¦ ,▁ ¦a¦ ¦chinese¦ ¦person¦ ,▁ ¦and¦ ¦an¦ ¦in di an¦ ¦c itiz en¦ .
𐋇¦the¦ ¦c itiz ens¦ ¦of¦ ¦po land¦ ,▁ ¦china¦ ,▁ ¦and¦ ¦ind ia¦ ¦dep la ned¦ ¦in¦ ¦po land¦ ,▁ ¦where¦ ¦the¦ ¦b ra z i li an¦ ¦pl an e¦ ¦made¦ ¦a¦ ¦st op o ver¦ ¦before¦ ¦following¦ ¦its¦ ¦ro ute¦ ¦to¦ ¦b ra z il¦ .
𐋇¦b ra z i li an¦ ¦c itiz ens¦ ¦who¦ ¦w ent¦ ¦to¦ ¦wuhan¦ ¦were¦ ¦qu ara nt ined¦ ¦at¦ ¦a¦ ¦m il it ary¦ ¦b ase¦ ¦n ear¦ ¦br as í l ia¦ .
𐋇¦on¦ ¦the¦ ¦same¦ ¦day¦ ,▁ ¦2 1 5¦ ¦ca na di ans¦ ▁( ¦1 7 6¦ ¦from¦ ¦the¦ ¦first¦ ¦pl an e¦ ,▁ ¦and¦ ¦3 9¦ ¦from¦ ¦a¦ ¦second¦ ¦pl an e¦ ¦cha rt ered¦ ¦by¦ ¦the¦ ¦u¦ . ¦s¦ .▁ ¦government¦ )▁ ¦were¦ ¦ev ac u ated¦ ¦from¦ ¦wuhan¦ ¦to¦ ¦c f b ¦ ¦tre nt on¦ ¦to¦ ¦be¦ ¦qu ara nt ined¦ ¦for¦ ¦two¦ ¦weeks¦ .
𐋇¦on¦ ¦11¦ ¦february¦ ,▁ ¦another¦ ¦pl an e¦ ¦of¦ ¦1 8 5¦ ¦ca na di ans¦ ¦from¦ ¦wuhan¦ ¦la nded¦ ¦at¦ ¦c f b ¦ ¦tre nt on¦ .
𐋇 ¦a u st ra li an¦ ¦author ities¦ ¦ev ac u ated¦ ¦2 7 7¦ ¦c itiz ens¦ ¦on¦ ¦3¦ ¦and¦ ¦4¦ ¦february¦ ¦to¦ ¦the¦ ¦ch r ist ma s¦ ¦ is land¦ ¦de te nt ion¦ ¦centre¦ ,▁ ¦which¦ ¦had¦ ¦been¦ ¦rep ur p osed¦ ¦as¦ ¦a¦ ¦quarantine¦ ¦facil ity¦ ,▁ ¦where¦ ¦they¦ ¦rema ined¦ ¦for¦ ¦14¦ ¦days¦ .
𐋇¦a¦ ¦new¦ ¦z ea land¦ ¦ev ac u ation¦ ¦f l ight¦ ¦arr iv ed¦ ¦in¦ ¦a uc k land¦ ¦on¦ ¦5¦ ¦february¦ ;▁ ¦its¦ ¦p as se ng ers¦ ▁( ¦including¦ ¦some¦ ¦from¦ ¦a u str al ia¦ ¦and¦ ¦the¦ ¦p ac if ic¦ )▁ ¦were¦ ¦qu ara nt ined¦ ¦at¦ ¦a¦ ¦na v al¦ ¦b ase¦ ¦in¦ ¦wh a ng a pa ro a¦ ,▁ ¦n or th¦ ¦of¦ ¦a uc k land¦ .
𐋇¦on¦ ¦15¦ ¦february¦ ,▁ ¦the¦ ¦united¦ ¦states¦ ¦announced¦ ¦that¦ ¦it¦ ¦would¦ ¦ev ac u ate¦ ¦amer ic ans¦ ¦a bo ard¦ ¦the¦ ¦c ru ise¦ ¦s hi p¦ ¦d ia m on d¦ ¦pri nc ess¦ .
𐋇¦on¦ ¦ 21¦ ¦february¦ ,▁ ¦a¦ ¦pl an e¦ ¦c arr ying¦ ¦1 2 9¦ ¦ca na di an¦ ¦p as se ng ers¦ ¦who¦ ¦had¦ ¦been¦ ¦ev ac u ated¦ ¦from¦ ¦d ia m on d¦ ¦pri nc ess¦ ¦la nded¦ ¦in¦ ¦tre nt on¦ ,▁ ¦ on ta ri o¦ .
𐋇¦in¦ ¦early¦ ¦march¦ ,▁ ¦the¦ ¦in di an¦ ¦government¦ ¦beg an¦ ¦ev ac u ating¦ ¦its¦ ¦c itiz ens¦ ¦from¦ ¦iran¦ . ¦on¦ ¦14¦ ¦march¦ ¦a¦ ¦south¦ ¦afr ic an¦ ¦air w ays¦ ¦air c ra f t¦ ¦cha rt ered¦ ¦by¦ ¦the¦ ¦south¦ ¦afr ic an¦ ¦government¦ ¦rep at ri ated¦ ¦1 1 2¦ ¦south¦ ¦afr ic an¦ ¦c itiz ens¦ .
𐋇 ¦medical¦ ¦scre ening¦ ¦was¦ ¦per for med¦ ¦pri or¦ ¦to¦ ¦de pa rt ure¦ ,▁ ¦and¦ ¦four¦ ¦south¦ ¦afr ic ans¦ ¦who¦ ¦were¦ ¦sh owing¦ ¦signs¦ ¦of¦ ¦coronavirus¦ ¦were¦ ¦le f t¦ ¦be h ind¦ ¦to¦ ¦m it ig ate¦ ¦risk¦ .
𐋇 ¦only¦ ¦south¦ ¦afr ic ans¦ ¦who¦ ¦tested¦ ¦negative¦ ¦were¦ ¦rep at ri ated¦ .
𐋇 ¦test¦ ¦results¦ ¦c le ared¦ ¦all¦ ¦the¦ ¦south¦ ¦afr ic ans¦ ,▁ ¦including¦ ¦the¦ ¦f l ight¦ ¦cre w¦ ,▁ ¦p i lo ts¦ ,▁ ¦ho te l¦ ¦staff¦ ,▁ ¦pol ice¦ ¦and¦ ¦s ol di ers¦ ¦invol v ed¦ ¦in¦ ¦the¦ ¦h um an i ta ri an¦ ¦mi ssion¦ ¦who¦ ,▁ ¦as¦ ¦a¦ ¦pr ec a u tion ary¦ ¦me as ure¦ ,▁ ¦all¦ ¦rema ined¦ ¦under¦ ¦ob s erv ation¦ ¦and¦ ¦in¦ ¦quarantine¦ ¦for¦ ¦a¦ ¦14¦ - ¦day¦ ¦period¦ ¦at¦ ¦the¦ ¦r an ch¦ ¦res ort¦ .
𐋇¦on¦ ¦20¦ ¦march¦ ,▁ ¦the¦ ¦united¦ ¦states¦ ¦beg an¦ ¦to¦ ¦part ially¦ ¦w i th d ra w al¦ ¦its¦ ¦tr oo ps¦ ¦from¦ ¦i ra q ¦ ¦due¦ ¦to¦ ¦the¦ ¦pandemic¦ .
𐋇¦on¦ ¦5¦ ¦february¦ ,▁ ¦the¦ ¦chinese¦ ¦fo re ign¦ ¦min ist ry¦ ¦stated¦ ¦that¦ ¦ 21¦ ¦countries¦ ▁( ¦including¦ ¦b el ar us¦ ,▁ ¦pa k ist an¦ ,▁ ¦tr in id ad¦ ¦and¦ ¦t ob a g o¦ ,▁ ¦e g y p t¦ ,▁ ¦and¦ ¦iran¦ )▁ ¦had¦ ¦s ent¦ ¦a id¦ ¦to¦ ¦china¦ .
𐋇¦some¦ ¦chinese¦ ¦students¦ ¦at¦ ¦amer ic an¦ ¦univers ities¦ ¦jo ined¦ ¦t og ether¦ ¦to¦ ¦help¦ ¦s end¦ ¦a id¦ ¦to¦ ¦virus¦ - ¦ str ick en¦ ¦par ts¦ ¦of¦ ¦china¦ ,▁ ¦with¦ ¦a¦ ¦jo in t¦ ¦group¦ ¦in¦ ¦the¦ ¦g rea ter¦ ¦ch ic a g o¦ ¦a rea¦ ¦rep ort ed ly¦ ¦mana ging¦ ¦to¦ ¦s end¦ ¦50¦ , ¦000¦ ¦n 9 5¦ ¦masks¦ ¦to¦ ¦hosp it als¦ ¦in¦ ¦the¦ ¦hub e i¦ ¦pro vi nce¦ ¦on¦ ¦30¦ ¦january¦ . ¦the¦ ¦h um an i ta ri an¦ ¦a id¦ ¦organiz ation¦ ¦direct¦ ¦rel ief¦ ,▁ ¦in¦ ¦co or d ination¦ ¦with¦ ¦fe de x¦ ,▁ ¦s ent¦ ¦2 00¦ , ¦000¦ ¦face¦ ¦masks¦ ¦a lo ng¦ ¦with¦ ¦other¦ ¦personal¦ ¦prot ective¦ ¦equipment¦ ,▁ ¦including¦ ¦g lo ves¦ ¦and¦ ¦g ow ns¦ ,▁ ¦by¦ ¦emergency¦ ¦air l if t¦ ¦to¦ ¦the¦ ¦wuhan¦ ¦un ion¦ ¦hospital¦ ¦by¦ ¦30¦ ¦january¦ .
𐋇¦on¦ ¦5¦ ¦february¦ ,▁ ¦b ill¦ ¦and¦ ¦me li nd a¦ ¦g ates¦ ¦announced¦ ¦a¦ ▁ $ ¦100¦ ¦million¦ ¦d on ation¦ ¦to¦ ¦the¦ ¦who¦ ¦to¦ ¦f un d¦ ¦vaccine¦ ¦research¦ ¦and¦ ¦treatment¦ ¦eff orts¦ ¦a lo ng¦ ¦with¦ ¦prot ecting¦ ▁" ¦at¦ - ¦risk¦ ¦p op ul ations¦ ¦in¦ ¦afr ica¦ ¦and¦ ¦south¦ ¦as ia¦ " .
𐋇 ¦inter a k s y on¦ ¦reported¦ ¦that¦ ¦the¦ ¦chinese¦ ¦government¦ ¦d on ated¦ ¦2 00¦ , ¦000¦ ¦masks¦ ¦to¦ ¦the¦ ¦p hi li pp ines¦ ¦on¦ ¦6¦ ¦february¦ ,▁ ¦after¦ ¦sen at or¦ ¦ ri ch ard¦ ¦g or d on¦ ¦s hi pp ed¦ ¦3¦ . ¦16¦ ¦million¦ ¦masks¦ ¦to¦ ¦wuhan¦ .
𐋇¦on¦ ¦19¦ ¦february¦ ,▁ ¦the¦ ¦si ng ap ore¦ ¦r ed¦ ¦c ross¦ ¦announced¦ ¦that¦ ¦it¦ ¦would¦ ¦s end¦ ▁ $ ¦2¦ . ¦26¦ ¦million¦ ¦wor th¦ ¦of¦ ¦a id¦ ¦to¦ ¦china¦ .
𐋇 ¦j ap an¦ ¦d on ated¦ ¦one¦ ¦million¦ ¦face¦ ¦masks¦ ¦to¦ ¦wuhan¦ ,▁ ¦t ur k e y¦ ¦dis p at ched¦ ¦medical¦ ¦equipment¦ ,▁ ¦ ru ss ia¦ ¦s ent¦ ¦more¦ ¦than¦ ¦13¦ ¦t on n es¦ ¦of¦ ¦medical¦ ¦supp l ies¦ ¦to¦ ¦wuhan¦ ,▁ ¦ma la ys ia¦ ¦announced¦ ¦a¦ ¦d on ation¦ ¦of¦ ¦18¦ ¦million¦ ¦medical¦ ¦g lo ves¦ ¦to¦ ¦china¦ ,▁ ¦g erm an y¦ ¦del iv ered¦ ¦v ar ious¦ ¦medical¦ ¦supp l ies¦ ¦including¦ ¦10¦ , ¦000¦ ¦ha z m at¦ ¦su i ts¦ ,▁ ¦and¦ ¦the¦ ¦united¦ ¦states¦ ¦d on ated¦ ¦1 7¦ . ¦8¦ ¦t ons¦ ¦of¦ ¦medical¦ ¦supp l ies¦ ¦to¦ ¦china¦ ¦and¦ ¦pro mi sed¦ ¦an¦ ¦ad di tional¦ ▁ $ ¦100¦ ¦million¦ ¦in¦ ¦fi na nc ial¦ ¦support¦ ¦to¦ ¦affected¦ ¦countries¦ . ¦after¦ ¦cases¦ ¦in¦ ¦china¦ ¦s ee med¦ ¦to¦ ¦st ab il iz e¦ ,▁ ¦the¦ ¦country¦ ¦has¦ ¦been¦ ¦s ending¦ ¦a id¦ ¦to¦ ¦v ar ious¦ ¦n ations¦ ¦hi t¦ ¦by¦ ¦the¦ ¦pandemic¦ .
𐋇¦in¦ ¦march¦ ,▁ ¦china¦ ,▁ ¦c ub a¦ ¦and¦ ¦ ru ss ia¦ ¦s ent¦ ¦medical¦ ¦supp l ies¦ ¦and¦ ¦exp er ts¦ ¦to¦ ¦help¦ ¦italy¦ ¦de al¦ ¦with¦ ¦its¦ ¦coronavirus¦ ¦outbreak¦ .
𐋇 ¦bu si ne ss m an¦ ¦j ack¦ ¦m a¦ ¦s ent¦ ¦1¦ . ¦1¦ ¦million¦ ¦testing¦ ¦ki ts¦ ,▁ ¦6¦ ¦million¦ ¦face¦ ¦masks¦ ,▁ ¦and¦ ¦6 0¦ , ¦000¦ ¦prot ective¦ ¦su i ts¦ ¦to¦ ¦ad di s¦ ¦ab ab a¦ ,▁ ¦ et hi op ia¦ ¦for¦ ¦d ist rib ution¦ ¦by¦ ¦the¦ ¦afr ic an¦ ¦un ion¦ .
𐋇¦h e¦ ¦later¦ ¦s ent¦ ¦5¦ , ¦000¦ ¦testing¦ ¦ki ts¦ ,▁ ¦100¦ , ¦000¦ ¦face¦ ¦masks¦ ¦and¦ ¦5¦ ¦ ventil at ors¦ ¦to¦ ¦pa na m a¦ .
𐋇¦m a¦ ¦also¦ ¦d on ated¦ ¦medical¦ ¦supp l ies¦ ¦to¦ ¦ca na d a¦ . ¦the¦ ¦ne ther l an ds¦ ,▁ ¦s pa in¦ ,▁ ¦t ur k e y¦ ,▁ ¦ ge or g ia¦ ,▁ ¦and¦ ¦the¦ ¦c z e ch¦ ¦rep u bl ic¦ ¦exp r es sed¦ ¦their¦ ¦concer ns¦ ¦over¦ ¦chinese¦ - ¦made¦ ¦masks¦ ¦and¦ ¦test¦ ¦ki ts¦ .
𐋇¦for¦ ¦inst ance¦ ,▁ ¦s pa in¦ ¦w i th d re w¦ ¦5 8¦ , ¦000¦ ¦chinese¦ - ¦made¦ ¦coronavirus¦ ¦testing¦ ¦ki ts¦ ¦with¦ ¦an¦ ¦acc ur acy¦ ¦rate¦ ¦of¦ ¦j ust¦ ¦30¦ % ,▁ ¦me an w hi le¦ ,▁ ¦the¦ ¦ne ther l an ds¦ ¦rec a lled¦ ¦6 00¦ , ¦000¦ ¦chinese¦ ¦face¦ ¦masks¦ ¦which¦ ¦were¦ ¦def ective¦ .
𐋇¦b el g i um¦ ¦rec a lled¦ ¦100¦ , ¦000¦ ¦un us able¦ ¦masks¦ ,▁ ¦th ou gh t¦ ¦to¦ ¦be¦ ¦from¦ ¦china¦ ,▁ ¦but¦ ¦were¦ ¦in¦ ¦f ac t¦ ¦from¦ ¦co lo mb ia¦ .
𐋇¦on¦ ¦the¦ ¦other¦ ¦hand¦ ,▁ ¦chinese¦ ¦a id¦ ¦has¦ ¦been¦ ¦well¦ - ¦received¦ ¦in¦ ¦par ts¦ ¦of¦ ¦l at in¦ ¦amer ica¦ ¦and¦ ¦afr ica¦ . ¦on¦ ¦2¦ ¦april¦ ,▁ ¦the¦ ¦world¦ ¦b an k¦ ¦la un ched¦ ¦emergency¦ ¦support¦ ¦op er ations¦ ¦for¦ ¦develop ing¦ ¦countries¦ .
𐋇¦the¦ ¦who¦ ¦has¦ ¦comm e nded¦ ¦the¦ ¦eff orts¦ ¦of¦ ¦chinese¦ ¦author ities¦ ¦in¦ ¦mana ging¦ ¦and¦ ¦cont aining¦ ¦the¦ ¦epidemic¦ .
𐋇¦the¦ ¦who¦ ¦no ted¦ ¦the¦ ¦contr ast¦ ¦between¦ ¦the¦ ¦20 0 2¦ ▁–▁ ¦20 0 4¦ ¦sars¦ ¦outbreak¦ ,▁ ¦where¦ ¦chinese¦ ¦author ities¦ ¦were¦ ¦acc u sed¦ ¦of¦ ¦sec r ec y¦ ¦that¦ ¦imp e ded¦ ¦pre vention¦ ¦and¦ ¦conta in ment¦ ¦eff orts¦ ,▁ ¦and¦ ¦the¦ ¦current¦ ¦c ri sis¦ ¦where¦ ¦the¦ ¦centr al¦ ¦government¦ ▁" ¦has¦ ¦provid ed¦ ¦reg ular¦ ¦up d ates¦ ¦to¦ ¦avoid¦ ¦p an ic¦ ¦a h ead¦ ¦of¦ ¦lu na r¦ ¦new¦ ¦year¦ ¦h ol id ays¦ " .
𐋇¦on¦ ¦23¦ ¦january¦ ,▁ ¦in¦ ¦rea ction¦ ¦to¦ ¦the¦ ¦centr al¦ ¦author ities¦ ' ▁ ¦dec is ion¦ ¦to¦ ¦imp le ment¦ ¦a¦ ¦trans p ort ation¦ ¦b an¦ ¦in¦ ¦wuhan¦ ,▁ ¦who¦ ¦rep re se nt ative¦ ¦ga ud en¦ ¦ga le a¦ ¦rem ar ked¦ ¦that¦ ¦while¦ ¦it¦ ¦was¦ ▁" ¦c er ta in ly¦ ¦not¦ ¦a¦ ¦recomm end ation¦ ¦the¦ ¦who¦ ¦has¦ ¦made¦ " ,▁ ¦it¦ ¦was¦ ¦also¦ ▁" ¦a¦ ¦very¦ ¦important¦ ¦indic ation¦ ¦of¦ ¦the¦ ¦comm it ment¦ ¦to¦ ¦con tain¦ ¦the¦ ¦epidemic¦ ¦in¦ ¦the¦ ¦place¦ ¦where¦ ¦it¦ ¦is¦ ¦most¦ ¦con ce nt r ated¦ "▁ ¦and¦ ¦called¦ ¦it¦ ▁" ¦un p r ec ed ented¦ ¦in¦ ¦public¦ ¦health¦ ¦h ist ory¦ "▁ . ¦on¦ ¦30¦ ¦january¦ ,▁ ¦following¦ ¦conf ir m ation¦ ¦of¦ ¦human¦ - ¦to¦ - ¦human¦ ¦transmission¦ ¦outside¦ ¦china¦ ¦and¦ ¦the¦ ¦increase¦ ¦in¦ ¦the¦ ¦number¦ ¦of¦ ¦cases¦ ¦in¦ ¦other¦ ¦countries¦ ,▁ ¦the¦ ¦who¦ ¦decl ared¦ ¦the¦ ¦outbreak¦ ¦a¦ ¦public¦ ¦health¦ ¦emergency¦ ¦of¦ ¦international¦ ¦concer n¦ ▁( ¦p he ic¦ ),▁ ¦the¦ ¦si x th¦ ¦p he ic¦ ¦since¦ ¦the¦ ¦me as ure¦ ¦was¦ ¦first¦ ¦inv o ked¦ ¦during¦ ¦the¦ ¦20 0 9¦ ¦sw ine¦ ¦flu¦ ¦pandemic¦ .
𐋇 ¦who¦ ¦dir ector¦ - ¦general¦ ¦t ed ro s¦ ¦ad h an om¦ ¦said¦ ¦that¦ ¦the¦ ¦p he ic¦ ¦was¦ ¦due¦ ¦to¦ ▁" ¦the¦ ¦risk¦ ¦of¦ ¦global¦ ¦spread¦ ,▁ ¦especially¦ ¦to¦ ¦low¦ - ▁ ¦and¦ ¦m id d le¦ - ¦inc ome¦ ¦countries¦ ¦without¦ ¦r ob ust¦ ¦health¦ ¦sys tems¦ .
𐋇¦in¦ ¦response¦ ¦to¦ ¦the¦ ¦imp le me nt ations¦ ¦of¦ ¦travel¦ ¦restrictions¦ ,▁ ¦t ed ro s¦ ¦stated¦ ¦that¦ ▁" ¦there¦ ¦is¦ ¦no¦ ¦re as on¦ ¦for¦ ¦measures¦ ¦that¦ ¦un ne cess a ri ly¦ ¦inter f er e¦ ¦with¦ ¦international¦ ¦travel¦ ¦and¦ ¦tra de¦ "▁ ¦and¦ ¦that¦ ¦the¦ ▁" ¦who¦ ¦do es n¦ ' ¦t¦ ¦recomm end¦ ¦limi ting¦ ¦tra de¦ ¦and¦ ¦mo ve ment¦ . "
𐋇¦on¦ ¦5¦ ¦february¦ ,▁ ¦the¦ ¦who¦ ¦app e al ed¦ ¦to¦ ¦the¦ ¦global¦ ¦community¦ ¦for¦ ¦a¦ ▁ $ ¦6 7 5¦ ¦million¦ ¦cont rib ution¦ ¦to¦ ¦f un d¦ ¦stra te g ic¦ ¦pre par ed ness¦ ¦in¦ ¦low¦ - ¦inc ome¦ ¦countries¦ ,▁ ¦c i ting¦ ¦the¦ ¦ ur ge ncy¦ ¦to¦ ¦support¦ ¦those¦ ¦countries¦ ¦which¦ ▁" ¦do¦ ¦not¦ ¦have¦ ¦the¦ ¦sys tems¦ ¦in¦ ¦place¦ ¦to¦ ¦det ect¦ ¦people¦ ¦who¦ ¦have¦ ¦contr ac ted¦ ¦the¦ ¦virus¦ ,▁ ¦even¦ ¦if¦ ¦it¦ ¦were¦ ¦to¦ ¦e mer ge¦ " .
𐋇¦t ed ro s¦ ¦further¦ ¦made¦ ¦sta te ments¦ ¦decl ar ing¦ ¦that¦ ▁" ¦we¦ ¦are¦ ¦only¦ ¦as¦ ¦st ro ng¦ ¦as¦ ¦our¦ ¦w ea k est¦ ¦l ink¦ "▁ ¦and¦ ¦ ur ged¦ ¦the¦ ¦international¦ ¦community¦ ¦to¦ ▁" ¦inv est¦ ¦to day¦ ¦or¦ ¦p ay¦ ¦more¦ ¦later¦ "▁ . ¦on¦ ¦11¦ ¦february¦ ,▁ ¦the¦ ¦who¦ ¦in¦ ¦a¦ ¦pr ess¦ ¦conf er ence¦ ¦ es ta bl ished¦ ¦covid¦ - ¦19¦ ¦as¦ ¦the¦ ¦na me¦ ¦of¦ ¦the¦ ¦disease¦ .
𐋇¦on¦ ¦the¦ ¦same¦ ¦day¦ ,▁ ¦t ed ro s¦ ¦stated¦ ¦that¦ ¦u n¦ ¦sec r et ary¦ - ¦general¦ ¦a nt ó n i o¦ ¦g ut er r es¦ ¦had¦ ¦ag re ed¦ ¦to¦ ¦provide¦ ¦the¦ ▁" ¦p ower¦ ¦of¦ ¦the¦ ¦ent ir e¦ ¦u n¦ ¦system¦ ¦in¦ ¦the¦ ¦response¦ " .
𐋇¦a¦ ¦u n¦ ¦c ri sis¦ ¦mana ge ment¦ ¦team¦ ¦was¦ ¦activ ated¦ ¦as¦ ¦a¦ ¦result¦ ,▁ ¦all owing¦ ¦co or d ination¦ ¦of¦ ¦the¦ ¦ent ir e¦ ¦united¦ ¦n ations¦ ¦response¦ ,▁ ¦which¦ ¦the¦ ¦who¦ ¦states¦ ¦will¦ ¦all ow¦ ¦them¦ ¦to¦ ▁" ¦f oc us¦ ¦on¦ ¦the¦ ¦health¦ ¦response¦ ¦while¦ ¦the¦ ¦other¦ ¦a ge nc ies¦ ¦can¦ ¦br ing¦ ¦their¦ ¦exp e rt ise¦ ¦to¦ ¦b ear¦ ¦on¦ ¦the¦ ¦wid er¦ ¦social¦ ,▁ ¦ec onomic¦ ¦and¦ ¦develop me ntal¦ ¦i mpl ications¦ ¦of¦ ¦the¦ ¦outbreak¦ " .
𐋇¦on¦ ¦14¦ ¦february¦ ,▁ ¦a¦ ¦who¦ - ¦l ed¦ ¦jo in t¦ ¦mi ssion¦ ¦team¦ ¦with¦ ¦china¦ ¦was¦ ¦activ ated¦ ¦to¦ ¦provide¦ ¦international¦ ¦and¦ ¦who¦ ¦exp er ts¦ ¦on¦ ¦the¦ ¦grou n d¦ ¦in¦ ¦china¦ ¦to¦ ¦ass ist¦ ¦in¦ ¦the¦ ¦do me st ic¦ ¦mana ge ment¦ ¦and¦ ¦ev a lu ate¦ ▁" ¦the¦ ¦se ver ity¦ ¦and¦ ¦the¦ ¦transm is si bility¦ ¦of¦ ¦the¦ ¦disease¦ "▁ ¦by¦ ¦h os ting¦ ¦work s ho ps¦ ¦and¦ ¦me et ings¦ ¦with¦ ¦k e y¦ ¦national¦ - ¦level¦ ¦inst itu tions¦ ¦and¦ ¦to¦ ¦con duc t¦ ¦f ie ld¦ ¦visi ts¦ ¦to¦ ¦ass ess¦ ¦the¦ ▁" ¦impac t¦ ¦of¦ ¦response¦ ¦activ ities¦ ¦at¦ ¦pro vi nc ial¦ ¦and¦ ¦county¦ ¦le v els¦ ,▁ ¦including¦ ¦ ur b an¦ ¦and¦ ¦r ural¦ ¦s et t ings¦ "▁ . ¦on¦ ¦2 5¦ ¦february¦ ,▁ ¦the¦ ¦who¦ ¦decl ared¦ ¦that¦ ▁" ¦the¦ ¦world¦ ¦should¦ ¦do¦ ¦more¦ ¦to¦ ¦pre p are¦ ¦for¦ ¦a¦ ¦possible¦ ¦coronavirus¦ ¦pandemic¦ , "▁ ¦st ating¦ ¦that¦ ¦while¦ ¦it¦ ¦was¦ ¦still¦ ¦to o¦ ¦early¦ ¦to¦ ¦call¦ ¦it¦ ¦a¦ ¦pandemic¦ ,▁ ¦countries¦ ¦should¦ ¦n on et he less¦ ¦be¦ ▁" ¦in¦ ¦a¦ ¦ph ase¦ ¦of¦ ¦pre par ed ness¦ " .
𐋇¦in¦ ¦response¦ ¦to¦ ¦a¦ ¦develop ing¦ ¦outbreak¦ ¦in¦ ¦iran¦ ,▁ ¦the¦ ¦who¦ ¦s ent¦ ¦a¦ ¦jo in t¦ ¦mi ssion¦ ¦team¦ ¦there¦ ¦to¦ ¦ass ess¦ ¦the¦ ¦s itu ation¦ . ¦on¦ ¦2 8¦ ¦february¦ ,▁ ¦who¦ ¦off ici als¦ ¦said¦ ¦that¦ ¦the¦ ¦coronavirus¦ ¦th re at¦ ¦as se ss ment¦ ¦at¦ ¦the¦ ¦global¦ ¦level¦ ¦would¦ ¦be¦ ¦r ai sed¦ ¦from¦ ▁" ¦high¦ "▁ ¦to¦ ▁" ¦very¦ ¦high¦ " ,▁ ¦its¦ ¦high est¦ ¦level¦ ¦of¦ ¦alert¦ ¦and¦ ¦risk¦ ¦as se ss ment¦ .
𐋇 ¦mi ke¦ ¦r y an¦ ,▁ ¦ex ecu tive¦ ¦dir ector¦ ¦of¦ ¦the¦ ¦who¦ ' ¦s¦ ¦health¦ ¦e mer ge nc ies¦ ¦pr ogra m¦ ,▁ ¦w ar ned¦ ¦in¦ ¦a¦ ¦sta te ment¦ ¦that¦ ▁" ¦this¦ ¦is¦ ¦a¦ ¦re ality¦ ¦ch eck¦ ¦for¦ ¦every¦ ¦government¦ ¦on¦ ¦the¦ ¦pl an et¦ :▁ 𐋇¦w a ke¦ ¦up¦ .
𐋇¦this¦ ¦virus¦ ¦may¦ ¦be¦ ¦on¦ ¦its¦ ¦way¦ ¦and¦ ¦you¦ ¦need¦ ¦to¦ ¦be¦ ¦rea dy¦ , ▁" ¦ ur ging¦ ¦that¦ ¦the¦ ¦r ight¦ ¦response¦ ¦measures¦ ¦could¦ ¦help¦ ¦the¦ ¦world¦ ¦avoid¦ "▁ ¦the¦ ¦wor s t¦ ¦of¦ ¦it¦ ▁" .
𐋇 ¦r y an¦ ¦further¦ ¦stated¦ ¦that¦ ¦the¦ ¦current¦ ¦data¦ ¦d id¦ ¦not¦ ¦w arr ant¦ ¦public¦ ¦health¦ ¦off ici als¦ ¦to¦ ¦decl are¦ ¦a¦ ¦global¦ ¦pandemic¦ ,▁ ¦sa ying¦ ¦that¦ ¦such¦ ¦a¦ ¦decl ar ation¦ ¦would¦ ¦me an¦ ▁" ¦we¦ ' ¦r e¦ ¦ es se nt ially¦ ¦ac cep ting¦ ¦that¦ ¦every¦ ¦human¦ ¦on¦ ¦the¦ ¦pl an et¦ ¦will¦ ¦be¦ ¦exp osed¦ ¦to¦ ¦that¦ ¦virus¦ . "
𐋇¦on¦ ¦11¦ ¦march¦ ,▁ ¦the¦ ¦who¦ ¦decl ared¦ ¦the¦ ¦coronavirus¦ ¦outbreak¦ ¦a¦ ¦pandemic¦ .
𐋇¦the¦ ¦dir ector¦ - ¦general¦ ¦said¦ ¦that¦ ¦the¦ ¦who¦ ¦was¦ ▁" ¦d ee p ly¦ ¦concer ned¦ ¦both¦ ¦by¦ ¦the¦ ¦al arm ing¦ ¦le v els¦ ¦of¦ ¦spread¦ ¦and¦ ¦se ver ity¦ ,▁ ¦and¦ ¦by¦ ¦the¦ ¦al arm ing¦ ¦le v els¦ ¦of¦ ¦i na ction¦ "▁ . ¦the¦ ¦who¦ ¦has¦ ¦f ac ed¦ ¦sign ific ant¦ ¦crit ic is m¦ ¦for¦ ¦what¦ ¦is¦ ¦se en¦ ¦as¦ ¦i na de qu ate¦ ¦hand l ing¦ ¦of¦ ¦the¦ ¦pandemic¦ ,▁ ¦including¦ ¦the¦ ¦l ate¦ ¦decl ar ation¦ ¦of¦ ¦a¦ ¦public¦ ¦health¦ ¦emergency¦ ¦and¦ ¦the¦ ¦c la ss ific ation¦ ¦of¦ ¦the¦ ¦virus¦ ¦as¦ ¦a¦ ¦pandemic¦ .
𐋇¦the¦ ¦b ac k l as h ¦ ¦inclu ded¦ ¦a¦ ¦p et ition¦ ¦for¦ ¦the¦ ¦who¦ ¦dir ector¦ - ¦general¦ ¦t ed ro s¦ ¦ad h an om¦ ¦to¦ ¦t en der¦ ¦hi s¦ ¦re si gn ation¦ ,▁ ¦sign ed¦ ¦by¦ ¦7 3 3¦ , ¦000¦ ¦people¦ ¦as¦ ¦of¦ ¦6¦ ¦april¦ .
𐋇¦on¦ ¦26¦ ¦march¦ ¦2020¦ ,▁ ¦do z ens¦ ¦of¦ ¦u n¦ ¦human¦ ¦ ri gh ts¦ ¦exp er ts¦ ¦e m ph a si zed¦ ¦resp ecting¦ ¦the¦ ¦ ri gh ts¦ ¦of¦ ¦every¦ ¦ind iv id ual¦ ¦during¦ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ .
𐋇¦the¦ ¦exp er t¦ ¦group¦ ¦stated¦ ¦that¦ ¦e veryone¦ ¦is¦ ¦ent it l ed¦ ¦to¦ ¦l ife¦ - ¦sa ving¦ ¦int erv en tions¦ ¦and¦ ¦the¦ ¦government¦ ¦h ol ds¦ ¦this¦ ¦resp on si bility¦ .
𐋇¦the¦ ¦group¦ ¦ str es sed¦ ¦that¦ ¦the¦ ¦l ack¦ ¦of¦ ¦res o ur ces¦ ¦or¦ ¦health¦ ¦i ns ur ance¦ ¦should¦ ¦ne ver¦ ¦ser ve¦ ¦as¦ ¦a¦ ¦j u st ific ation¦ ¦for¦ ¦disc r im ination¦ ¦against¦ ¦a¦ ¦specific¦ ¦group¦ .
𐋇¦the¦ ¦exp er ts¦ ¦under s c or ed¦ ¦that¦ ¦every¦ ¦ind iv id ual¦ ¦has¦ ¦the¦ ¦r ight¦ ¦to¦ ¦health¦ ,▁ ¦including¦ ¦people¦ ¦with¦ ¦dis ab il ities¦ ,▁ ¦b el on ging¦ ¦to¦ ¦min or ity¦ ¦grou ps¦ ,▁ ¦ ol der¦ ¦people¦ ,▁ ¦inter n ally¦ ¦dis pl ac ed¦ ¦people¦ ,▁ ¦the¦ ¦ho me less¦ ,▁ ¦those¦ ¦li ving¦ ¦in¦ ¦ext re m ely¦ ¦po or¦ ¦conditions¦ ,▁ ¦people¦ ¦in¦ ¦de te nt ion¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦ref u ge es¦ ¦and¦ ¦other¦ ¦u ns p ec if ied¦ ¦grou ps¦ ¦in¦ ¦need¦ ¦of¦ ¦government¦ ¦support¦ .
𐋇 ¦international¦ ¦gover n me ntal¦ ¦organiz ations¦ ¦are¦ ¦add re ss ing¦ ¦the¦ ¦ec onomic¦ ¦and¦ ¦social¦ ¦impac ts¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦c ri sis¦ .
𐋇¦the¦ ¦or g an is ation¦ ¦for¦ ¦ec onomic¦ ¦c o¦ - ¦op er ation¦ ¦and¦ ¦development¦ ¦has¦ ¦la un ched¦ ¦a¦ ¦pl at for m¦ ¦to¦ ¦provide¦ ¦t im ely¦ ¦and¦ ¦comp re he ns ive¦ ¦information¦ ¦on¦ ¦pol ic y¦ ¦resp on ses¦ ¦in¦ ¦countries¦ ¦around¦ ¦the¦ ¦world¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦v ie w p oi nts¦ ¦and¦ ¦advice¦ .
𐋇 ¦from¦ ¦pol ic ies¦ ¦to¦ ¦st re ng th en¦ ¦health¦ ¦sys tems¦ ¦and¦ ¦the¦ ¦world¦ ¦ec on om y¦ ¦to¦ ¦add re ss ing¦ ¦the¦ ¦eff ects¦ ¦of¦ ¦lockdown¦ ¦and¦ ¦restrictions¦ ¦on¦ ¦travel¦ ,▁ ¦the¦ ¦d ig it al¦ ¦hub ¦ ¦inclu des¦ ¦a¦ ¦country¦ ¦pol ic y¦ ¦tracker¦ ,▁ ¦and¦ ¦ ai ms¦ ¦to¦ ¦help¦ ¦countries¦ ¦lear n¦ ¦from¦ ¦each¦ ¦other¦ ¦and¦ ¦to¦ ¦facil it ate¦ ¦a¦ ¦c o¦ - ¦or d in ated¦ ¦global¦ ¦response¦ ¦to¦ ¦the¦ ¦coronavirus¦ ¦cha ll en ge¦ .
𐋇¦the¦ ¦chinese¦ ¦government¦ ¦has¦ ¦been¦ ¦crit ici zed¦ ¦by¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦uk¦ ¦minister¦ ¦for¦ ¦the¦ ¦c ab in et¦ ¦off ice¦ ¦mi ch a e l¦ ¦go ve¦ ,▁ ¦and¦ ¦b ra z il¦ ¦pres ident¦ ¦j ai r¦ ¦b ol s on ar o¦ ' ¦s¦ ¦s on¦ ¦ ed u ar d o¦ ¦b ol s on ar o¦ ¦for¦ ¦its¦ ¦hand l ing¦ ¦of¦ ¦the¦ ¦pandemic¦ ,▁ ¦which¦ ¦beg an¦ ¦in¦ ¦the¦ ¦chinese¦ ¦pro vi nce¦ ¦of¦ ¦hub e i¦ .
𐋇¦a¦ ¦number¦ ¦of¦ ¦pro vi nc ial¦ - ¦level¦ ¦admin i str at ors¦ ¦of¦ ¦the¦ ¦comm un ist¦ ¦part y¦ ¦of¦ ¦china¦ ▁( ¦c p c¦ )▁ ¦were¦ ¦dis m is sed¦ ¦over¦ ¦their¦ ¦hand l ing¦ ¦of¦ ¦the¦ ¦quarantine¦ ¦eff orts¦ ¦in¦ ¦centr al¦ ¦china¦ ,▁ ¦a¦ ¦s ign¦ ¦of¦ ¦disc o nt ent¦ ¦with¦ ¦the¦ ¦pol it ical¦ ¦ es ta bl is h ment¦ ' ¦s¦ ¦response¦ ¦to¦ ¦the¦ ¦outbreak¦ ¦in¦ ¦those¦ ¦regi ons¦ .
𐋇¦some¦ ¦comm e nt at ors¦ ¦b el ie ve¦ ¦that¦ ¦this¦ ¦mo ve¦ ¦was¦ ¦in te nded¦ ¦to¦ ¦protect¦ ¦chinese¦ ¦comm un ist¦ ¦part y¦ ¦general¦ ¦sec r et ary¦ ¦ x i¦ ¦j in p ing¦ ¦from¦ ¦the¦ ¦public¦ ' ¦s¦ ¦a nger¦ ¦over¦ ¦the¦ ¦coronavirus¦ ¦outbreak¦ .
𐋇¦some¦ ¦chinese¦ ¦off ici als¦ ,▁ ¦ e¦ . ¦ g¦ .▁ ¦z h a o¦ ¦li j i an¦ ¦re j ected¦ ¦an¦ ¦ ear li er¦ ¦ac k n ow l ed ge ment¦ ¦of¦ ¦the¦ ¦coronavirus¦ ¦outbreak¦ ¦star ting¦ ¦in¦ ¦wuhan¦ ,▁ ¦in¦ ¦fa v ou r¦ ¦of¦ ¦cons p ir acy¦ ¦the or ies¦ ¦about¦ ¦the¦ ¦covid¦ - ¦19¦ ¦orig in ating¦ ¦from¦ ¦the¦ ¦u¦ . ¦s¦ .▁ ¦or¦ ¦italy¦ .
𐋇¦the¦ ¦u¦ . ¦s¦ .▁ ¦admin i str ation¦ ¦of¦ ¦do na ld¦ ¦tr um p¦ ¦has¦ ¦ref er r ed¦ ¦to¦ ¦the¦ ¦coronavirus¦ ¦as¦ ▁" ¦chinese¦ ¦virus¦ "▁ ¦or¦ ▁" ¦wuhan¦ ¦virus¦ "▁ ¦sa ying¦ ¦that¦ ¦china¦ ' ¦s¦ ▁" ¦ce ns o rs hi p¦ ¦su p er ch ar ged¦ ¦a¦ ¦virus¦ ¦that¦ ¦has¦ ¦n ow¦ ¦t ur ned¦ ¦into¦ ¦a¦ ¦global¦ ¦pandemic¦ " ,▁ ¦which¦ ¦has¦ ¦in¦ ¦t ur n¦ ¦been¦ ¦crit ici zed¦ ¦by¦ ¦some¦ ¦crit ics¦ ¦as¦ ¦r ac is m¦ ¦and¦ ▁" ¦di str ac t¦ ▁ [ ¦ ing¦ ] ▁ ¦from¦ ¦hi s¦ ¦admin i str ation¦ ' ¦s¦ ¦fa il ure¦ ¦to¦ ¦con tain¦ ¦the¦ ¦disease¦ " .
𐋇¦the¦ ¦daily¦ ¦be ast¦ ¦ob ta ined¦ ¦a¦ ¦u¦ . ¦s¦ .▁ ¦government¦ ¦c able¦ ¦out li ning¦ ¦a¦ ¦comm un ications¦ ¦stra ta ge m¦ ¦with¦ ¦app ar ent¦ ¦orig ins¦ ¦in¦ ¦the¦ ¦national¦ ¦sec ur ity¦ ¦cou nc il¦ ,▁ ¦with¦ ¦the¦ ¦stra te g y¦ ¦being¦ ¦qu o ted¦ ¦as¦ ▁" ¦e ver y thing¦ ¦is¦ ¦about¦ ¦china¦ .
𐋇¦we¦ ' ¦r e¦ ¦being¦ ¦to ld¦ ¦to¦ ¦t ry¦ ¦and¦ ¦get¦ ¦this¦ ¦me ss a ging¦ ¦out¦ ¦in¦ ¦any¦ ¦way¦ ¦possible¦ ,▁ ¦including¦ ¦pr ess¦ ¦conf er en ces¦ ¦and¦ ¦te le v is ion¦ ¦app ear an ces¦ . ▁" 𐋇 ¦out l ets¦ ¦such¦ ¦as¦ ¦pol it ic o¦ ,▁ ¦fo re ign¦ ¦pol ic y¦ ,▁ ¦and¦ ¦ bl oo mb er g¦ ¦have¦ ¦cl ai med¦ ¦that¦ ¦china¦ ' ¦s¦ ¦eff orts¦ ¦to¦ ¦s end¦ ¦a id¦ ¦to¦ ¦virus¦ - ¦ str ick en¦ ¦countries¦ ¦is¦ ¦par t¦ ¦of¦ ¦a¦ ¦pro pa g a nd a¦ ¦p us h ¦ ¦for¦ ¦global¦ ¦influ ence¦ .
𐋇 ¦eu¦ ¦fo re ign¦ ¦pol ic y¦ ¦ch ief¦ ¦jo se p¦ ¦ bor r ell¦ ¦w ar ned¦ ¦that¦ ¦there¦ ¦is¦ ▁" ¦a¦ ¦ ge o¦ - ¦pol it ical¦ ¦comp on ent¦ ¦including¦ ¦a¦ ¦st ru gg le¦ ¦for¦ ¦influ ence¦ ¦through¦ ¦sp in ning¦ ¦and¦ ¦the¦ ▁' ¦pol it ics¦ ¦of¦ ¦gener os ity¦ ' " .
𐋇¦ bor r ell¦ ¦also¦ ¦said¦ ¦that¦ ▁" ¦china¦ ¦is¦ ¦a gg re ss ively¦ ¦p us hing¦ ¦the¦ ¦me ss age¦ ¦that¦ ,▁ ¦un li ke¦ ¦the¦ ¦us¦ ,▁ ¦it¦ ¦is¦ ¦a¦ ¦resp on si ble¦ ¦and¦ ¦re li able¦ ¦part n er¦ . "
𐋇 ¦china¦ ¦has¦ ¦also¦ ¦called¦ ¦for¦ ¦the¦ ¦us¦ ¦to¦ ¦l if t¦ ¦its¦ ¦sa nc tions¦ ¦off ¦ ¦of¦ ¦s y r ia¦ ,▁ ¦ ve ne z u el a¦ ¦and¦ ¦iran¦ ,▁ ¦while¦ ¦rep ort ed ly¦ ¦s ending¦ ¦a id¦ ¦to¦ ¦the¦ ¦l at ter¦ ¦two¦ ¦countries¦ .
𐋇 ¦j ack¦ ¦m a¦ ' ¦s¦ ¦d on ation¦ ¦of¦ ¦100¦ , ¦000¦ ¦masks¦ ¦to¦ ¦c ub a¦ ¦was¦ ¦ bl oc ked¦ ¦by¦ ¦us¦ ¦sa nc tions¦ ¦on¦ ¦3¦ ¦april¦ .
𐋇 ¦us¦ ¦author ities¦ ¦have¦ ¦also¦ ¦been¦ ¦acc u sed¦ ¦of¦ ¦di ver ting¦ ¦a id¦ ¦me ant¦ ¦for¦ ¦other¦ ¦n ations¦ ¦to¦ ¦their¦ ¦ own¦ ¦country¦ .
𐋇 ¦and¦ ¦there¦ ¦have¦ ¦been¦ ¦mask¦ - ¦related¦ ¦dis p u tes¦ ¦reported¦ ¦between¦ ¦other¦ ¦countries¦ ,▁ ¦such¦ ¦as¦ ¦g erm an y¦ ,▁ ¦a u str ia¦ ¦and¦ ¦sw it z er land¦ ;▁ ¦and¦ ¦the¦ ¦c z e ch¦ ¦rep u bl ic¦ ¦and¦ ¦italy¦ .
𐋇¦in¦ ¦add ition¦ ,▁ ¦t ur k e y¦ ¦se i zed¦ ¦h u nd re ds¦ ¦of¦ ¦ ventil at ors¦ ¦de st ined¦ ¦for¦ ¦s pa in¦ .
𐋇¦in¦ ¦early¦ ¦march¦ ,▁ ¦the¦ ¦i tali an¦ ¦government¦ ¦crit ici zed¦ ¦the¦ ¦european¦ ¦un ion¦ ' ¦s¦ ¦l ack¦ ¦of¦ ¦s ol id ar ity¦ ¦with¦ ¦coronavirus¦ - ¦affected¦ ¦italy¦ .
𐋇 ¦ma ur iz i o¦ ¦ma ss ar i¦ ,▁ ¦italy¦ ' ¦s¦ ¦a mb a ss a d or¦ ¦to¦ ¦the¦ ¦eu¦ ,▁ ¦said¦ ¦that¦ ▁" ¦only¦ ¦china¦ ¦resp o nded¦ ¦b il at er ally¦ .
𐋇¦c er ta in ly¦ ,▁ ¦this¦ ¦is¦ ¦not¦ ¦a¦ ¦g ood¦ ¦s ign¦ ¦of¦ ¦european¦ ¦s ol id ar ity¦ . ▁"
𐋇¦on¦ ¦2 2¦ ¦march¦ ,▁ ¦after¦ ¦a¦ ¦phone¦ ¦call¦ ¦with¦ ¦i tali an¦ ¦pri me¦ ¦minister¦ ¦g i u se pp e¦ ¦cont e¦ ,▁ ¦r us si an¦ ¦pres ident¦ ¦v la di mi r¦ ¦p ut in¦ ¦arr an ged¦ ¦the¦ ¦r us si an¦ ¦ arm y¦ ¦to¦ ¦s end¦ ¦m il it ary¦ ¦medic s¦ ,▁ ¦spec ial¦ ¦disinf e ction¦ ¦ ve h ic les¦ ,▁ ¦and¦ ¦other¦ ¦medical¦ ¦equipment¦ ¦to¦ ¦italy¦ .
𐋇 ¦italy¦ ' ¦s¦ ¦l a¦ ¦sta mp a¦ ¦new s p ap er¦ ¦c i ted¦ ¦an¦ ¦an on y mo us¦ ▁" ¦high¦ - ¦level¦ ¦pol it ical¦ ¦sour ce¦ "▁ ¦that¦ ¦8 0¦ ¦p erc ent¦ ¦of¦ ¦ ru ss ia¦ ' ¦s¦ ¦a id¦ ¦was¦ ▁" ¦u se less¦ ¦or¦ ¦of¦ ¦l it t le¦ ¦use¦ ¦to¦ ¦italy¦ " .
𐋇¦the¦ ¦sour ce¦ ¦acc u sed¦ ¦ ru ss ia¦ ¦of¦ ¦e mb ar king¦ ¦on¦ ¦a¦ ▁" ¦ ge op ol it ical¦ ¦and¦ ¦di pl om at ic¦ "▁ ¦ch ar m¦ ¦off e ns ive¦ .
𐋇¦the¦ ¦pres ident¦ ¦of¦ ¦lo mb ar dy¦ ,▁ ¦att i li o¦ ¦f on ta na¦ ,▁ ¦and¦ ¦i tali an¦ ¦fo re ign¦ ¦minister¦ ¦lu ig i¦ ¦d i¦ ¦m ai o¦ ¦dis m is sed¦ ¦the¦ ¦m ed ia¦ ¦rep orts¦ ¦and¦ ¦exp r es sed¦ ¦their¦ ¦gr at itu de¦ .
𐋇¦ ru ss ia¦ ¦also¦ ¦s ent¦ ¦a¦ ¦c arg o¦ ¦pl an e¦ ¦with¦ ¦medical¦ ¦a id¦ ¦to¦ ¦the¦ ¦united¦ ¦states¦ .
𐋇 ¦k re m l in¦ ¦sp o k es m an¦ ¦d m it ry¦ ¦p es k ov ¦ ¦said¦ ¦that¦ ▁" ¦when¦ ¦off ering¦ ¦ass ist ance¦ ¦to¦ ¦us¦ ¦coll ea g ues¦ ,▁ [ ¦p ut in¦ ] ▁ ¦ass um es¦ ¦that¦ ¦when¦ ¦us¦ ¦m an u fa ct ur ers¦ ¦of¦ ¦medical¦ ¦equipment¦ ¦and¦ ¦m at eri als¦ ¦ga in¦ ¦mo me nt um¦ ,▁ ¦they¦ ¦will¦ ¦also¦ ¦be¦ ¦able¦ ¦to¦ ¦rec ip r oc ate¦ ¦if¦ ¦ne cess ary¦ . "
𐋇¦the¦ ¦pl an ned¦ ¦nat o¦ ▁" ¦def en der¦ ¦2020¦ "▁ ¦m il it ary¦ ¦exerc ise¦ ¦in¦ ¦g erm an y¦ ,▁ ¦po land¦ ,▁ ¦and¦ ¦the¦ ¦b al t ic¦ ¦states¦ ,▁ ¦the¦ ¦l arg est¦ ¦nat o¦ ¦w a r¦ ¦exerc ise¦ ¦since¦ ¦the¦ ¦end¦ ¦of¦ ¦the¦ ¦cold¦ ¦w a r¦ ,▁ ¦will¦ ¦be¦ ¦he ld¦ ¦on¦ ¦a¦ ¦reduc ed¦ ¦sc a le¦ .
𐋇¦the¦ ¦ca m pa ign¦ ¦for¦ ¦n uc l ear¦ ¦dis ar ma ment¦ ' ¦s¦ ¦general¦ ¦sec r et ary¦ ¦k ate¦ ¦h ud s on¦ ¦crit ici zed¦ ¦the¦ ¦def en der¦ ¦2020¦ ¦exerc ise¦ : ▁" 𐋇¦in¦ ¦the¦ ¦current¦ ¦public¦ - ¦health¦ ¦c ri sis¦ ,▁ ¦it¦ ¦j e o par d iz es¦ ¦the¦ ¦l ives¦ ¦not¦ ¦only¦ ¦of¦ ¦the¦ ¦tr oo ps¦ ¦from¦ ¦the¦ ¦us¦ ¦and¦ ¦the¦ ¦many¦ ¦european¦ ¦countries¦ ¦partic ip ating¦ ¦but¦ ¦the¦ ¦in h ab i ta nts¦ ¦of¦ ¦the¦ ¦countries¦ ¦in¦ ¦which¦ ¦they¦ ¦are¦ ¦op er ating¦ . "▁ 𐋇¦the¦ ¦ir an i an¦ ¦government¦ ¦has¦ ¦been¦ ¦h ea vi ly¦ ¦affected¦ ¦by¦ ¦the¦ ¦virus¦ ,▁ ¦with¦ ¦around¦ ¦two¦ ¦do z en¦ ¦par l ia ment¦ ¦me mbers¦ ¦infected¦ ¦as¦ ¦well¦ ¦as¦ ¦f if te en¦ ¦other¦ ¦current¦ ¦or¦ ¦f orm er¦ ¦pol it ical¦ ¦f ig ures¦ .
𐋇 ¦iran¦ ' ¦s¦ ¦pres ident¦ ¦ha ss an¦ ¦r ou h an i¦ ¦w r ot e¦ ¦a¦ ¦public¦ ¦l et ter¦ ¦to¦ ¦world¦ ¦lea d ers¦ ¦as king¦ ¦for¦ ¦help¦ ¦on¦ ¦14¦ ¦march¦ ¦2020¦ ,▁ ¦sa ying¦ ¦that¦ ¦hi s¦ ¦country¦ ¦is¦ ¦st ru gg l ing¦ ¦to¦ ¦f ight¦ ¦the¦ ¦outbreak¦ ¦due¦ ¦to¦ ¦l ack¦ ¦of¦ ¦acc ess¦ ¦to¦ ¦international¦ ¦mark ets¦ ¦as¦ ¦a¦ ¦result¦ ¦of¦ ¦the¦ ¦united¦ ¦states¦ ¦sa nc tions¦ ¦against¦ ¦iran¦ . ¦the¦ ¦outbreak¦ ¦has¦ ¦pro mp ted¦ ¦ca lls¦ ¦for¦ ¦the¦ ¦united¦ ¦states¦ ¦to¦ ¦ad op t¦ ¦social¦ ¦pol ic ies¦ ¦common¦ ¦in¦ ¦other¦ ¦we al th y¦ ¦countries¦ ,▁ ¦including¦ ¦univers al¦ ¦health¦ ¦care¦ ,▁ ¦univers al¦ ¦child¦ ¦care¦ ,▁ ¦pa id¦ ¦family¦ ¦lea ve¦ ,▁ ¦and¦ ¦higher¦ ¦le v els¦ ¦of¦ ¦f un ding¦ ¦for¦ ¦public¦ ¦health¦ .
𐋇 ¦pol it ical¦ ¦anal y sts¦ ¦anti c ip ated¦ ¦it¦ ¦may¦ ¦ne g at ively¦ ¦aff ect¦ ¦do na ld¦ ¦tr um p¦ ' ¦s¦ ¦chan ces¦ ¦of¦ ¦r e¦ - ¦e le ction¦ ¦in¦ ¦the¦ ¦2020¦ ¦pres ide ntial¦ ¦e le ction¦ . ¦di pl om at ic¦ ¦rel ations¦ ¦between¦ ¦j ap an¦ ¦and¦ ¦south¦ ¦ko rea¦ ¦wor se ned¦ ¦due¦ ¦to¦ ¦the¦ ¦pandemic¦ .
𐋇 ¦south¦ ¦ko rea¦ ¦crit ici zed¦ ¦j ap an¦ ' ¦s¦ ▁" ¦a mb ig u o us¦ ¦and¦ ¦pa ss ive¦ ¦quarantine¦ ¦eff orts¦ "▁ ¦after¦ ¦j ap an¦ ¦announced¦ ¦an y bo dy¦ ¦c om ing¦ ¦from¦ ¦south¦ ¦ko rea¦ ¦will¦ ¦be¦ ¦pl ac ed¦ ¦in¦ ¦two¦ ¦weeks¦ ' ▁ ¦quarantine¦ ¦at¦ ¦government¦ - ¦de si gn ated¦ ¦si tes¦ .
𐋇¦the¦ ¦south¦ ¦ko re an¦ ¦s oc i et y¦ ¦was¦ ¦in it ially¦ ¦po la ri zed¦ ¦on¦ ¦pres ident¦ ¦mo on¦ ¦j a e¦ - ¦in¦ ' ¦s¦ ¦response¦ ¦to¦ ¦the¦ ¦c ri sis¦ .
𐋇 ¦many¦ ¦ko re ans¦ ¦sign ed¦ ¦p e ti tions¦ ¦e it her¦ ¦ca lling¦ ¦for¦ ¦the¦ ¦imp ea ch ment¦ ¦of¦ ¦mo on¦ ¦over¦ ¦what¦ ¦they¦ ¦cl ai med¦ ¦to¦ ¦be¦ ¦government¦ ¦m is h a nd l ing¦ ¦of¦ ¦the¦ ¦outbreak¦ ,▁ ¦or¦ ¦p ra ising¦ ¦hi s¦ ¦response¦ . ¦the¦ ¦pandemic¦ ¦has¦ ¦all owed¦ ¦countries¦ ¦to¦ ¦p ass¦ ¦emergency¦ ¦le g is l ation¦ ¦in¦ ¦response¦ .
𐋇¦some¦ ¦comm e nt at ors¦ ¦have¦ ¦exp r es sed¦ ¦concer ns¦ ¦that¦ ¦it¦ ¦could¦ ¦all ow¦ ¦gover n ments¦ ¦to¦ ¦st re ng th en¦ ¦their¦ ¦g ri p¦ ¦on¦ ¦p ower¦ .
𐋇¦in¦ ¦h u ng ary¦ ,▁ ¦its¦ ¦par l ia ment¦ ¦v o ted¦ ¦to¦ ¦all ow¦ ¦the¦ ¦pri me¦ ¦minister¦ ,▁ ¦ vi k t or¦ ¦or b á n¦ ,▁ ¦to¦ ¦ ru le¦ ¦by¦ ¦dec re e¦ ¦in de f in i tely¦ ,▁ ¦susp end¦ ¦par l ia ment¦ ¦as¦ ¦well¦ ¦as¦ ¦el ec tions¦ ¦and¦ ¦p un ish¦ ¦those¦ ¦d ee med¦ ¦to¦ ¦have¦ ¦spread¦ ¦f al se¦ ¦information¦ ¦about¦ ¦the¦ ¦virus¦ ¦and¦ ¦the¦ ¦government¦ ' ¦s¦ ¦hand l ing¦ ¦of¦ ¦the¦ ¦c ri sis¦ .
𐋇¦the¦ ¦coronavirus¦ ¦outbreak¦ ¦has¦ ¦been¦ ¦b la med¦ ¦for¦ ¦several¦ ¦inst an ces¦ ¦of¦ ¦supp ly¦ ¦sh or ta ges¦ ,▁ ¦ste mm ing¦ ¦from¦ ¦gl ob ally¦ ¦increased¦ ¦us age¦ ¦of¦ ¦equipment¦ ¦to¦ ¦f ight¦ ¦the¦ ¦out b rea ks¦ ,▁ ¦p an ic¦ ¦bu ying¦ ,▁ ¦and¦ ¦dis ru ption¦ ¦to¦ ¦fa ct ory¦ ¦and¦ ¦l og ist ic¦ ¦op er ations¦ .
𐋇¦the¦ ¦united¦ ¦states¦ ¦food¦ ¦and¦ ¦drug¦ ¦admin i str ation¦ ¦has¦ ¦issued¦ ¦w ar n ings¦ ¦about¦ ¦sh or ta ges¦ ¦of¦ ¦d ru g s¦ ¦and¦ ¦medical¦ ¦equipment¦ ¦due¦ ¦to¦ ¦increased¦ ¦cons um er¦ ¦dem and¦ ¦and¦ ¦supp li er¦ ¦dis ru ption¦ .
𐋇 ¦several¦ ¦loc al ities¦ ¦also¦ ¦w it n es sed¦ ¦p an ic¦ ¦bu ying¦ ¦that¦ ¦l ed¦ ¦to¦ ¦sh el ves¦ ¦being¦ ¦c le ared¦ ¦of¦ ¦g ro ce ry¦ ¦e ss en ti als¦ ¦such¦ ¦as¦ ¦food¦ ,▁ ¦to il et¦ ¦p ap er¦ ,▁ ¦and¦ ¦b ot t l ed¦ ¦water¦ ,▁ ¦in duc ing¦ ¦supp ly¦ ¦sh or ta ges¦ .
𐋇¦the¦ ¦techn ology¦ ¦ind u st ry¦ ¦in¦ ¦partic ular¦ ¦has¦ ¦been¦ ¦w ar ning¦ ¦about¦ ¦del ays¦ ¦to¦ ¦sh ip ments¦ ¦of¦ ¦el ect r on ic¦ ¦g oo ds¦ .
𐋇 ¦according¦ ¦to¦ ¦who¦ ¦dir ector¦ - ¦general¦ ¦t ed ro s¦ ¦ad h an om¦ ,▁ ¦the¦ ¦dem and¦ ¦for¦ ¦personal¦ ¦prote ction¦ ¦equipment¦ ¦has¦ ¦r is en¦ ¦100¦ - ¦fo ld¦ .
𐋇¦this¦ ¦dem and¦ ¦has¦ ¦l ed¦ ¦to¦ ¦the¦ ¦increase¦ ¦in¦ ¦pri ces¦ ¦of¦ ¦up¦ ¦to¦ ¦t we nt y¦ ¦times¦ ¦the¦ ¦normal¦ ¦pr ice¦ ¦and¦ ¦also¦ ¦in duc ed¦ ¦del ays¦ ¦on¦ ¦the¦ ¦supp ly¦ ¦of¦ ¦medical¦ ¦i tems¦ ¦for¦ ¦four¦ ¦to¦ ¦si x¦ ¦mon ths¦ .
𐋇¦it¦ ¦has¦ ¦also¦ ¦caused¦ ¦a¦ ¦sh ort age¦ ¦of¦ ¦personal¦ ¦prot ective¦ ¦equipment¦ ¦worldwide¦ ,▁ ¦with¦ ¦the¦ ¦who¦ ¦w ar ning¦ ¦that¦ ¦this¦ ¦will¦ ¦ end a nger¦ ¦health¦ ¦workers¦ .
𐋇¦in¦ ¦a u str al ia¦ ,▁ ¦the¦ ¦pandemic¦ ¦provid ed¦ ¦a¦ ¦new¦ ¦o pp ort un ity¦ ¦for¦ ¦da ig o u¦ ¦sho pp ers¦ ¦to¦ ¦s ell¦ ¦a u st ra li an¦ ¦produc ts¦ ¦into¦ ¦china¦ .
𐋇¦the¦ ¦activ ity¦ ¦has¦ ¦cre ated¦ ¦a¦ ¦sh ort age¦ ¦of¦ ¦baby¦ ¦f orm ul a¦ ¦in¦ ¦some¦ ¦su p erm ar k ets¦ ¦and¦ ¦was¦ ¦sub se qu e ntly¦ ¦b an ned¦ ¦by¦ ¦the¦ ¦a u st ra li an¦ ¦government¦ . ¦d esp ite¦ ¦the¦ ¦high¦ ¦prev al ence¦ ¦of¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦in¦ ¦n or ther n¦ ¦italy¦ ¦and¦ ¦the¦ ¦wuhan¦ ¦reg ion¦ ,▁ ¦and¦ ¦the¦ ¦e ns u ing¦ ¦high¦ ¦dem and¦ ¦for¦ ¦food¦ ¦produc ts¦ ,▁ ¦both¦ ¦areas¦ ¦have¦ ¦been¦ ¦sp ared¦ ¦from¦ ¦acute¦ ¦food¦ ¦sh or ta ges¦ .
𐋇 ¦measures¦ ¦by¦ ¦china¦ ¦and¦ ¦italy¦ ¦against¦ ¦the¦ ¦ho ar ding¦ ¦and¦ ¦i ll ici t¦ ¦tra de¦ ¦of¦ ¦crit ical¦ ¦produc ts¦ ¦have¦ ¦been¦ ¦s uc cess ful¦ ,▁ ¦a v oi ding¦ ¦acute¦ ¦food¦ ¦sh or ta ges¦ ¦that¦ ¦were¦ ¦anti c ip ated¦ ¦in¦ ¦e ur ope¦ ¦as¦ ¦well¦ ¦as¦ ¦in¦ ¦n or th¦ ¦amer ica¦ .
𐋇¦n or ther n¦ ¦italy¦ ¦with¦ ¦its¦ ¦sign ific ant¦ ¦ag r ic ult ural¦ ¦produc t ion¦ ¦has¦ ¦not¦ ¦se en¦ ¦a¦ ¦large¦ ¦reduc t ion¦ ,▁ ¦but¦ ¦pri ces¦ ¦may¦ ¦increase¦ ¦according¦ ¦to¦ ¦ind u st ry¦ ¦rep re se nt at ives¦ .
𐋇¦e m pt y¦ ¦food¦ ¦sh el ves¦ ¦were¦ ¦only¦ ¦e nc ou nt ered¦ ¦temp o ra ri ly¦ ,▁ ¦even¦ ¦in¦ ¦wuhan¦ ¦city¦ ,▁ ¦while¦ ¦chinese¦ ¦government¦ ¦off ici als¦ ¦rel ea sed¦ ¦p or k¦ ¦res er ves¦ ¦to¦ ¦ass ure¦ ¦su ff ici ent¦ ¦no ur is h ment¦ ¦of¦ ¦the¦ ¦population¦ .
𐋇 ¦similar¦ ¦la w s¦ ¦ex ist¦ ¦in¦ ¦italy¦ ¦requir ing¦ ¦food¦ ¦produc ers¦ ¦to¦ ¦keep¦ ¦res er ves¦ ¦for¦ ¦such¦ ¦e mer ge nc ies¦ .
𐋇 ¦da m age¦ ¦to¦ ¦the¦ ¦global¦ ¦ec on om y¦ ¦has¦ ¦been¦ ¦f el t¦ ¦in¦ ¦china¦ :▁ 𐋇 ¦according¦ ¦to¦ ¦a¦ ¦m ed ia¦ ¦report¦ ¦on¦ ¦16¦ ¦march¦ ,▁ ¦the¦ ¦ec on om y¦ ¦in¦ ¦china¦ ¦was¦ ¦very¦ ¦h ard¦ ¦hi t¦ ¦in¦ ¦the¦ ¦first¦ ¦two¦ ¦mon ths¦ ¦of¦ ¦2020¦ ¦due¦ ¦to¦ ¦the¦ ¦measures¦ ¦ta k en¦ ¦by¦ ¦the¦ ¦government¦ ¦to¦ ¦cur ta il¦ ¦virus¦ ¦spread¦ ,▁ ¦and¦ ¦re ta il¦ ¦sa les¦ ¦pl un ged¦ ¦20¦ . ¦5¦ % .
𐋇¦as¦ ¦main land¦ ¦china¦ ¦is¦ ¦a¦ ¦major¦ ¦ec on om y¦ ¦and¦ ¦m an u fa ct ur ing¦ ¦hub ¦ ,▁ ¦the¦ ¦viral¦ ¦outbreak¦ ¦has¦ ¦been¦ ¦se en¦ ¦to¦ ¦p ose¦ ¦a¦ ¦major¦ ¦de st ab il iz ing¦ ¦th re at¦ ¦to¦ ¦the¦ ¦global¦ ¦ec on om y¦ .
𐋇 ¦ag a th e¦ ¦dem ar ai s¦ ¦of¦ ¦the¦ ¦ec on om ist¦ ¦in te ll ig ence¦ ¦uni t¦ ¦has¦ ¦for ec ast¦ ¦that¦ ¦mark ets¦ ¦will¦ ¦remain¦ ¦v o la ti le¦ ¦until¦ ¦a¦ ¦cl ear er¦ ¦ im age¦ ¦e mer ges¦ ¦on¦ ¦pote ntial¦ ¦out c omes¦ .
𐋇¦in¦ ¦january¦ ¦2020¦ ,▁ ¦some¦ ¦anal y sts¦ ¦estim ated¦ ¦that¦ ¦the¦ ¦ec onomic¦ ¦f al lo ut¦ ¦of¦ ¦the¦ ¦epidemic¦ ¦on¦ ¦global¦ ¦gr ow th¦ ¦could¦ ¦sur p ass¦ ¦that¦ ¦of¦ ¦the¦ ¦20 0 2¦ ▁–▁ ¦20 0 4¦ ¦sars¦ ¦outbreak¦ .
𐋇 ¦one¦ ¦estim ate¦ ¦from¦ ¦an¦ ¦exp er t¦ ¦at¦ ¦w as hi ng t on¦ ¦univers ity¦ ¦in¦ ¦s t¦ .▁ ¦l ou i s¦ ¦ga ve¦ ¦a¦ ▁ $ ¦3 00¦ ▁ + ▁ ¦bi ll ion¦ ¦impac t¦ ¦on¦ ¦the¦ ¦world¦ ' ¦s¦ ¦supp ly¦ ¦cha in¦ ¦that¦ ¦could¦ ¦last¦ ¦up¦ ¦to¦ ¦two¦ ¦years¦ .
𐋇¦the¦ ¦organiz ation¦ ¦of¦ ¦the¦ ¦p et ro le um¦ ¦exp orting¦ ¦countries¦ ▁( ¦op e c¦ )▁ ¦rep ort ed ly¦ ▁" ¦sc ra m bl ed¦ "▁ ¦after¦ ¦a¦ ¦st ee p¦ ¦dec line¦ ¦in¦ ¦o il¦ ¦pri ces¦ ¦due¦ ¦to¦ ¦lower¦ ¦dem and¦ ¦from¦ ¦china¦ .
𐋇 ¦global¦ ¦st oc k¦ ¦mark ets¦ ¦f ell¦ ¦on¦ ¦24¦ ¦february¦ ¦due¦ ¦to¦ ¦a¦ ¦sign ific ant¦ ¦r ise¦ ¦in¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦outside¦ ¦main land¦ ¦china¦ .
𐋇¦on¦ ¦2 7¦ ¦february¦ ,▁ ¦due¦ ¦to¦ ¦mo un ting¦ ¦wor r ies¦ ¦about¦ ¦the¦ ¦coronavirus¦ ¦outbreak¦ ,▁ ¦v ar ious¦ ¦u¦ . ¦s¦ .▁ ¦st oc k¦ ¦in de x es¦ ¦including¦ ¦the¦ ¦n as d a q ¦ - ¦100¦ ,▁ ¦the¦ ¦s¦ ▁ & ▁ ¦a m p¦ ;▁ ¦ p¦ ¦5 00¦ ¦in de x¦ ,▁ ¦and¦ ¦the¦ ¦d ow¦ ¦j on es¦ ¦ind u str ial¦ ¦a ver age¦ ¦p os ted¦ ¦their¦ ¦sh ar p est¦ ¦fa lls¦ ¦since¦ ¦20 0 8¦ ,▁ ¦with¦ ¦the¦ ¦d ow¦ ¦fa lling¦ ¦1¦ , ¦19 1¦ ¦p oi nts¦ ,▁ ¦the¦ ¦l arg est¦ ¦one¦ - ¦day¦ ¦dro p¦ ¦since¦ ¦the¦ ¦fi na nc ial¦ ¦c ri sis¦ ¦of¦ ¦20 0 7¦ ▁–▁ ¦0 8¦ .
𐋇 ¦all¦ ¦three¦ ¦in de x es¦ ¦e nded¦ ¦the¦ ¦week¦ ¦down¦ ¦more¦ ¦than¦ ¦10¦ % .
𐋇¦on¦ ¦2 8¦ ¦february¦ ,▁ ¦sc ope¦ ¦r at ings¦ ¦g mb h ¦ ¦aff ir med¦ ¦china¦ ' ¦s¦ ¦so ve re ign¦ ¦cre di t¦ ¦r ating¦ ,▁ ¦but¦ ¦main ta ined¦ ¦a¦ ¦negative¦ ¦out l ook¦ .
𐋇 ¦st oc ks¦ ¦pl un ged¦ ¦ag a in¦ ¦based¦ ¦on¦ ¦coronavirus¦ ¦f ear s¦ ,▁ ¦the¦ ¦l arg est¦ ¦f all¦ ¦being¦ ¦on¦ ¦16¦ ¦march¦ .
𐋇 ¦many¦ ¦consid er¦ ¦an¦ ¦ec onomic¦ ¦rece ssion¦ ¦to¦ ¦be¦ ¦likely¦ .
𐋇 ¦ec on om ist¦ ¦mo h a med¦ ¦e l¦ - ¦ eri an¦ ¦pr ai sed¦ ¦centr al¦ ¦b an ks¦ ' ▁ ¦and¦ ¦states¦ ' ▁ ¦t im ely¦ ¦emergency¦ ¦measures¦ .
𐋇 ¦centr al¦ ¦b an ks¦ ¦are¦ ¦re ac ting¦ ¦more¦ ¦qu ick ly¦ ¦than¦ ¦they¦ ¦d id¦ ¦to¦ ¦the¦ ¦20 0 8¦ ¦fi na nc ial¦ ¦cr as h ¦ .
𐋇 ¦to ur is m¦ ¦is¦ ¦one¦ ¦of¦ ¦the¦ ¦wor s t¦ ¦affected¦ ¦se ctors¦ ¦due¦ ¦to¦ ¦travel¦ ¦b ans¦ ,▁ ¦clos ing¦ ¦of¦ ¦public¦ ¦places¦ ¦including¦ ¦travel¦ ¦att r ac tions¦ ,▁ ¦and¦ ¦advice¦ ¦of¦ ¦gover n ments¦ ¦against¦ ¦any¦ ¦travel¦ ¦all¦ ¦over¦ ¦the¦ ¦world¦ .
𐋇¦as¦ ¦a¦ ¦con se qu ence¦ ,▁ ¦nu me ro us¦ ¦air l ines¦ ¦have¦ ¦cance lled¦ ¦f li gh ts¦ ¦due¦ ¦to¦ ¦lower¦ ¦dem and¦ ,▁ ¦including¦ ¦br it ish¦ ¦air w ays¦ ,▁ ¦china¦ ¦ ea st er n¦ ¦air l ines¦ ,▁ ¦and¦ ¦ q an ta s¦ ,▁ ¦while¦ ¦br it ish¦ ¦regi on al¦ ¦air line¦ ¦f l y b e¦ ¦coll ap sed¦ .
𐋇¦the¦ ¦impac t¦ ¦on¦ ¦the¦ ¦c ru ise¦ ¦ line¦ ¦ind u st ry¦ ¦was¦ ¦at¦ ¦a¦ ¦level¦ ¦ne ver¦ ¦se en¦ ¦before¦ .
𐋇 ¦several¦ ¦tra in¦ ¦st ations¦ ¦and¦ ¦f er ry¦ ¦p orts¦ ¦have¦ ¦also¦ ¦been¦ ¦closed¦ .
𐋇¦the¦ ¦epidemic¦ ¦c oi nc i ded¦ ¦with¦ ¦the¦ ¦ch un y u n¦ ,▁ ¦a¦ ¦major¦ ¦travel¦ ¦se as on¦ ¦associated¦ ¦with¦ ¦the¦ ¦chinese¦ ¦new¦ ¦year¦ ¦ho li day¦ .
𐋇¦a¦ ¦number¦ ¦of¦ ¦events¦ ¦invol ving¦ ¦large¦ ¦cr ow ds¦ ¦were¦ ¦cance lled¦ ¦by¦ ¦national¦ ¦and¦ ¦regi on al¦ ¦gover n ments¦ ,▁ ¦including¦ ¦an n ual¦ ¦new¦ ¦year¦ ¦fe st iv als¦ ,▁ ¦with¦ ¦priv ate¦ ¦comp an ies¦ ¦also¦ ¦in de p en de ntly¦ ¦clos ing¦ ¦their¦ ¦sho ps¦ ¦and¦ ¦to ur ist¦ ¦att r ac tions¦ ¦such¦ ¦as¦ ¦ho ng¦ ¦ko ng¦ ¦dis ne y land¦ ¦and¦ ¦sh an gh a i¦ ¦dis ne y land¦ .
𐋇 ¦many¦ ¦lu na r¦ ¦new¦ ¦year¦ ¦events¦ ¦and¦ ¦to ur ist¦ ¦att r ac tions¦ ¦have¦ ¦been¦ ¦closed¦ ¦to¦ ¦prevent¦ ¦m ass¦ ¦ga ther ings¦ ,▁ ¦including¦ ¦the¦ ¦for b id d en¦ ¦city¦ ¦in¦ ¦be i j ing¦ ¦and¦ ¦tra di tional¦ ¦temp le¦ ¦fa ir s¦ .
𐋇¦in¦ ¦24¦ ¦of¦ ¦china¦ ' ¦s¦ ¦3 1¦ ¦pr ov in ces¦ ,▁ ¦m un ic ip al ities¦ ¦and¦ ¦regi ons¦ ,▁ ¦author ities¦ ¦ex te nded¦ ¦the¦ ¦new¦ ¦year¦ ' ¦s¦ ¦ho li day¦ ¦to¦ ¦10¦ ¦february¦ ,▁ ¦in str uc ting¦ ¦most¦ ¦work p la ces¦ ¦not¦ ¦to¦ ¦r e¦ - ¦open¦ ¦until¦ ¦that¦ ¦date¦ .
𐋇¦these¦ ¦regi ons¦ ¦rep r es ented¦ ¦8 0¦ %▁ ¦of¦ ¦the¦ ¦country¦ ' ¦s¦ ¦g d p¦ ¦and¦ ¦9 0¦ %▁ ¦of¦ ¦exp orts¦ .
𐋇 ¦ho ng¦ ¦ko ng¦ ¦r ai sed¦ ¦its¦ ¦infectious¦ ¦disease¦ ¦response¦ ¦level¦ ¦to¦ ¦the¦ ¦high est¦ ¦and¦ ¦decl ared¦ ¦an¦ ¦emergency¦ ,▁ ¦clos ing¦ ¦schools¦ ¦until¦ ¦march¦ ¦and¦ ¦cance lling¦ ¦its¦ ¦new¦ ¦year¦ ¦ce le b r ations¦ . ¦the¦ ¦re ta il¦ ¦s ector¦ ¦has¦ ¦been¦ ¦impac ted¦ ¦gl ob ally¦ ,▁ ¦with¦ ¦reduc tions¦ ¦in¦ ¦st ore¦ ¦hours¦ ¦or¦ ¦temp or ary¦ ¦closures¦ .
𐋇 ¦visi ts¦ ¦to¦ ¦re tail ers¦ ¦in¦ ¦e ur ope¦ ¦and¦ ¦l at in¦ ¦amer ica¦ ¦decl ined¦ ¦by¦ ¦4 0¦ % .
𐋇¦n or th¦ ¦amer ica¦ ¦and¦ ¦m id d le¦ ¦e ast¦ ¦re tail ers¦ ¦sa w¦ ¦a¦ ¦50¦ ▁–▁ ¦6 0¦ %▁ ¦dro p¦ .
𐋇¦this¦ ¦also¦ ¦res ul ted¦ ¦in¦ ¦a¦ ¦3 3¦ ▁–▁ ¦4 3¦ %▁ ¦dro p¦ ¦in¦ ¦fo ot¦ ¦tra ff ic¦ ¦to¦ ¦shopping¦ ¦centr es¦ ¦in¦ ¦march¦ ¦comp ared¦ ¦to¦ ¦february¦ .
𐋇 ¦shopping¦ ¦m all¦ ¦op erat ors¦ ¦around¦ ¦the¦ ¦world¦ ¦imp osed¦ ¦ad di tional¦ ¦measures¦ ,▁ ¦such¦ ¦increased¦ ¦s an it ation¦ ,▁ ¦inst a ll ation¦ ¦of¦ ¦th erm al¦ ¦sc an n ers¦ ¦to¦ ¦ch eck¦ ¦the¦ ¦temp erat ure¦ ¦of¦ ¦sho pp ers¦ ,▁ ¦and¦ ¦cance ll ation¦ ¦of¦ ¦events¦ . ¦according¦ ¦to¦ ¦a¦ ¦united¦ ¦n ations¦ ¦ec onomic¦ ¦comm i ssion¦ ¦for¦ ¦l at in¦ ¦amer ica¦ ¦estim ate¦ ,▁ ¦the¦ ¦pandemic¦ - ¦in duc ed¦ ¦rece ssion¦ ¦could¦ ¦lea ve¦ ¦between¦ ¦14¦ ¦and¦ ¦2 2¦ ¦million¦ ¦more¦ ¦people¦ ¦in¦ ¦ext re me¦ ¦po ve rt y¦ ¦in¦ ¦l at in¦ ¦amer ica¦ ¦than¦ ¦would¦ ¦have¦ ¦been¦ ¦in¦ ¦that¦ ¦s itu ation¦ ¦without¦ ¦the¦ ¦pandemic¦ .
𐋇¦in¦ ¦january¦ ¦and¦ ¦february¦ ¦2020¦ ,▁ ¦during¦ ¦the¦ ¦he ight¦ ¦of¦ ¦the¦ ¦epidemic¦ ¦in¦ ¦wuhan¦ ,▁ ¦about¦ ¦5¦ ¦million¦ ¦people¦ ¦in¦ ¦china¦ ¦l ost¦ ¦their¦ ¦j ob s¦ .
𐋇 ¦many¦ ¦of¦ ¦china¦ ' ¦s¦ ¦ne arly¦ ¦3 00¦ ¦million¦ ¦r ural¦ ¦m ig r ant¦ ¦workers¦ ¦have¦ ¦been¦ ¦stra nded¦ ¦at¦ ¦home¦ ¦in¦ ¦in land¦ ¦pr ov in ces¦ ¦or¦ ¦tra pp ed¦ ¦in¦ ¦hub e i¦ ¦pro vi nce¦ . ¦in¦ ¦march¦ ¦2020¦ ,▁ ¦more¦ ¦than¦ ¦10¦ ¦million¦ ¦amer ic ans¦ ¦l ost¦ ¦their¦ ¦j ob s¦ ¦and¦ ¦app l ied¦ ¦for¦ ¦government¦ ¦a id¦ .
𐋇¦the¦ ¦coronavirus¦ ¦outbreak¦ ¦could¦ ¦c ost¦ ¦4 7¦ ¦million¦ ¦j ob s¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ¦and¦ ¦u ne mploy ment¦ ¦rate¦ ¦may¦ ¦hi t¦ ¦3 2¦ % ,▁ ¦according¦ ¦to¦ ¦estim ates¦ ¦by¦ ¦the¦ ¦f ed er al¦ ¦res er ve¦ ¦b an k¦ ¦of¦ ¦s t¦ .▁ ¦l ou i s¦ . ¦the¦ ¦lockdown¦ ¦in¦ ¦ind ia¦ ¦has¦ ¦le f t¦ ¦t ens¦ ¦of¦ ¦m il li ons¦ ¦of¦ ¦in di an¦ ¦m ig r ant¦ ¦workers¦ ▁( ¦who¦ ¦are¦ ¦pa id¦ ¦through¦ ¦daily¦ ¦w a ges¦ )▁ ¦u ne mploy ed¦ . ¦the¦ ¦sur ve y¦ ¦from¦ ¦the¦ ¦a ng us¦ ¦re id¦ ¦inst it ute¦ ¦found¦ ¦that¦ ¦4 4¦ %▁ ¦of¦ ¦ca na di an¦ ¦hou se h ol ds¦ ¦have¦ ¦exp er ie nc ed¦ ¦some¦ ¦typ e¦ ¦of¦ ¦u ne mploy ment¦ . ¦ne arly¦ ¦9 00¦ , ¦000¦ ¦workers¦ ¦l ost¦ ¦their¦ ¦j ob s¦ ¦in¦ ¦s pa in¦ ¦since¦ ¦it¦ ¦w ent¦ ¦into¦ ¦lockdown¦ ¦in¦ ¦m id¦ - ¦march¦ ¦2020¦ .
𐋇 ¦during¦ ¦the¦ ¦second¦ ¦h al f¦ ¦of¦ ¦march¦ ,▁ ¦4¦ ¦million¦ ¦fre n ch¦ ¦workers¦ ¦app l ied¦ ¦for¦ ¦temp or ary¦ ¦u ne mploy ment¦ ¦be ne f i ts¦ ¦and¦ ¦1¦ ¦million¦ ¦br it ish¦ ¦workers¦ ¦app l ied¦ ¦for¦ ¦a¦ ¦univers al¦ ¦cre di t¦ ¦s che me¦ . ¦al m ost¦ ¦h al f¦ ¦a¦ ¦million¦ ¦comp an ies¦ ¦in¦ ¦g erm an y¦ ¦have¦ ¦s ent¦ ¦their¦ ¦workers¦ ¦on¦ ¦a¦ ¦government¦ - ¦sub si di zed¦ ¦sh ort¦ - ¦time¦ ¦wor king¦ ¦s che m es¦ ¦known¦ ¦as¦ ¦k ur z ar b e i t¦ .
𐋇¦the¦ ¦g erm an¦ ¦sh ort¦ - ¦time¦ ¦work¦ ¦comp e ns ation¦ ¦s che me¦ ¦has¦ ¦been¦ ¦ad op ted¦ ¦by¦ ¦fra nce¦ ¦and¦ ¦b ri tain¦ .
𐋇¦the¦ ¦per f orm ing¦ ¦ar ts¦ ¦and¦ ¦c ult ural¦ ¦h er it age¦ ¦se ctors¦ ¦have¦ ¦been¦ ¦pro f ou nd ly¦ ¦affected¦ ¦by¦ ¦the¦ ¦pandemic¦ ,▁ ¦impac ting¦ ¦organiz ations¦ ' ▁ ¦op er ations¦ ¦as¦ ¦well¦ ¦as¦ ¦individuals¦ ▁ — ▁ ¦both¦ ¦e mploy ed¦ ¦and¦ ¦in de p end ent¦ ▁ — ▁ ¦gl ob ally¦ .
𐋇 ¦ar ts¦ ¦and¦ ¦c ult ure¦ ¦s ector¦ ¦organiz ations¦ ¦att e mp ted¦ ¦to¦ ¦up ho ld¦ ¦their¦ ▁( ¦often¦ ¦publ ic ly¦ ¦f u nded¦ )▁ ¦mi ssion¦ ¦to¦ ¦provide¦ ¦acc ess¦ ¦to¦ ¦c ult ural¦ ¦h er it age¦ ¦to¦ ¦the¦ ¦community¦ ,▁ ¦main tain¦ ¦the¦ ¦safety¦ ¦of¦ ¦their¦ ¦e mploy e es¦ ¦and¦ ¦the¦ ¦public¦ ,▁ ¦and¦ ¦support¦ ¦ar ti sts¦ ¦where¦ ¦possible¦ .
𐋇¦by¦ ¦march¦ ¦2020¦ ,▁ ¦across¦ ¦the¦ ¦world¦ ¦and¦ ¦to¦ ¦v ar ying¦ ¦de g re es¦ ,▁ ¦m u se u ms¦ ,▁ ¦li b r ar ies¦ ,▁ ¦per f orm ance¦ ¦v en ues¦ ,▁ ¦and¦ ¦other¦ ¦c ult ural¦ ¦inst itu tions¦ ¦had¦ ¦been¦ ¦in de f in i tely¦ ¦closed¦ ¦with¦ ¦their¦ ¦ex hi b i tions¦ ,▁ ¦events¦ ¦and¦ ¦per f orm an ces¦ ¦cance lled¦ ¦or¦ ¦po st p o ned¦ .
𐋇¦in¦ ¦response¦ ¦there¦ ¦were¦ ¦in tens ive¦ ¦eff orts¦ ¦to¦ ¦provide¦ ¦al t er n ative¦ ¦services¦ ¦through¦ ¦d ig it al¦ ¦pl at for ms¦ . ¦another¦ ¦rec ent¦ ¦and¦ ¦rap id ly¦ ¦acc el er ating¦ ¦f al lo ut¦ ¦of¦ ¦the¦ ¦disease¦ ¦is¦ ¦the¦ ¦cance ll ation¦ ¦of¦ ¦rel ig ious¦ ¦services¦ ,▁ ¦major¦ ¦events¦ ¦in¦ ¦sp orts¦ ,▁ ¦and¦ ¦other¦ ¦social¦ ¦events¦ ,▁ ¦such¦ ¦as¦ ¦m us ic¦ ¦fe st iv als¦ ¦and¦ ¦concer ts¦ ,▁ ¦techn ology¦ ¦conf er en ces¦ ,▁ ¦and¦ ¦f as h ion¦ ¦sh ow s¦ .
𐋇¦the¦ ¦f il m¦ ¦ind u st ry¦ ¦has¦ ¦also¦ ¦exp er ie nc ed¦ ¦dis ru ption¦ . ¦the¦ ¦v at ic an¦ ¦announced¦ ¦that¦ ¦ho ly¦ ¦week¦ ¦ob s erv an ces¦ ¦in¦ ¦r ome¦ ,▁ ¦which¦ ¦occur ¦ ¦during¦ ¦the¦ ¦last¦ ¦week¦ ¦of¦ ¦the¦ ¦ch r is ti an¦ ¦p en i te ntial¦ ¦se as on¦ ¦of¦ ¦l ent¦ ,▁ ¦have¦ ¦been¦ ¦cance lled¦ .
𐋇 ¦many¦ ¦di o ce ses¦ ¦have¦ ¦recommended¦ ¦ ol der¦ ¦ch r is ti ans¦ ¦to¦ ¦stay¦ ¦at¦ ¦home¦ ¦r at her¦ ¦than¦ ¦att ending¦ ¦m ass¦ ¦on¦ ¦su nd ays¦ ;▁ ¦some¦ ¦ch ur ches¦ ¦have¦ ¦made¦ ¦ch ur ch¦ ¦services¦ ¦available¦ ¦v ia¦ ¦ra di o¦ ,▁ ¦online¦ ¦live¦ ¦st rea m ing¦ ¦or¦ ¦te le v is ion¦ ¦while¦ ¦others¦ ¦are¦ ¦off ering¦ ¦dr ive¦ - ¦in¦ ¦wor s hi p¦ .
𐋇 ¦with¦ ¦the¦ ¦r om an¦ ¦ca th ol ic¦ ¦di o ce se¦ ¦of¦ ¦r ome¦ ¦clos ing¦ ¦its¦ ¦ch ur ches¦ ¦and¦ ¦ch ap els¦ ¦and¦ ¦s t¦ .▁ ¦p e ter¦ ' ¦s¦ ¦s qu are¦ ¦e m pt ied¦ ¦of¦ ¦ch r is ti an¦ ¦p il g ri ms¦ ,▁ ¦other¦ ¦rel ig ious¦ ¦ bo dies¦ ¦also¦ ¦cance lled¦ ¦services¦ ¦and¦ ¦limi ted¦ ¦public¦ ¦ga ther ings¦ ¦in¦ ¦ch ur ches¦ ,▁ ¦m os q ues¦ ,▁ ¦s y na g og ues¦ ,▁ ¦temp les¦ ¦and¦ ¦g ur d w ara s¦ .
𐋇 ¦iran¦ ' ¦s¦ ¦health¦ ¦min ist ry¦ ¦announced¦ ¦the¦ ¦cance ll ation¦ ¦of¦ ¦f ri day¦ ¦p ra y ers¦ ¦in¦ ¦areas¦ ¦affected¦ ¦by¦ ¦the¦ ¦outbreak¦ ¦and¦ ¦sh r ines¦ ¦were¦ ¦later¦ ¦closed¦ ,▁ ¦while¦ ¦sa ud i¦ ¦ar ab ia¦ ¦b an ned¦ ¦the¦ ¦ent ry¦ ¦of¦ ¦fo re ign¦ ¦p il g ri ms¦ ¦as¦ ¦well¦ ¦as¦ ¦its¦ ¦res id ents¦ ¦to¦ ¦ho ly¦ ¦si tes¦ ¦in¦ ¦m ec c a¦ ¦and¦ ¦me di na¦ .
𐋇¦the¦ ¦pandemic¦ ¦has¦ ¦caused¦ ¦the¦ ¦most¦ ¦sign ific ant¦ ¦dis ru ption¦ ¦to¦ ¦the¦ ¦worldwide¦ ¦sp orting¦ ¦c al end a r¦ ¦since¦ ¦the¦ ¦second¦ ¦world¦ ¦w a r¦ .
𐋇 ¦most¦ ¦major¦ ¦sp orting¦ ¦events¦ ¦have¦ ¦been¦ ¦e it her¦ ¦cance lled¦ ¦or¦ ¦po st p o ned¦ ,▁ ¦including¦ ¦the¦ ¦2019¦ ▁–▁ ¦20¦ ¦u e f a¦ ¦cha mp i ons¦ ¦lea g ue¦ ,▁ ¦2019¦ ▁–▁ ¦20¦ ¦pre mi er¦ ¦lea g ue¦ ,▁ ¦u e f a¦ ¦e ur o¦ ¦2020¦ ,▁ ¦2019¦ ▁–▁ ¦20¦ ¦n b a¦ ¦se as on¦ ,▁ ¦and¦ ¦2019¦ ▁–▁ ¦20¦ ¦n h l¦ ¦se as on¦ .
𐋇¦the¦ ¦outbreak¦ ¦dis ru p ted¦ ¦pl ans¦ ¦for¦ ¦the¦ ¦2020¦ ¦su mm er¦ ¦ ol y mp ics¦ ,▁ ¦which¦ ¦were¦ ¦orig in ally¦ ¦s ch ed ul ed¦ ¦to¦ ¦star t¦ ¦at¦ ¦the¦ ¦end¦ ¦of¦ ¦j u ly¦ ;▁ ¦the¦ ¦international¦ ¦ ol y mp ic¦ ¦comm it te e¦ ¦announced¦ ¦on¦ ¦24¦ ¦march¦ ¦that¦ ¦the¦ ¦ev ent¦ ¦will¦ ¦be¦ ▁" ¦res ch ed ul ed¦ ¦to¦ ¦a¦ ¦date¦ ¦be y on d¦ ¦2020¦ ¦but¦ ¦not¦ ¦later¦ ¦than¦ ¦su mm er¦ ¦2021¦ "▁ . ¦ca si no s¦ ¦and¦ ¦other¦ ¦ga m ing¦ ¦v en ues¦ ¦worldwide¦ ¦have¦ ¦closed¦ ¦and¦ ¦live¦ ¦po k er¦ ¦to ur na ments¦ ¦have¦ ¦been¦ ¦e it her¦ ¦po st p o ned¦ ¦or¦ ¦cance lled¦ .
𐋇¦this¦ ¦has¦ ¦l ed¦ ¦many¦ ¦ga m bl ers¦ ¦to¦ ¦mo ve¦ ¦online¦ ,▁ ¦with¦ ¦many¦ ¦online¦ ¦ga m bl ing¦ ¦si tes¦ ¦rep orting¦ ¦sign ific ant¦ ¦inc rea ses¦ ¦in¦ ¦their¦ ¦r ates¦ ¦of¦ ¦new¦ ¦s ign¦ - ¦u ps¦ . ¦the¦ ¦ent er ta in ment¦ ¦ind u st ry¦ ¦has¦ ¦also¦ ¦been¦ ¦affected¦ ,▁ ¦with¦ ¦v ar ious¦ ¦m us ic¦ ¦grou ps¦ ¦susp ending¦ ¦or¦ ¦cance lling¦ ¦concer t¦ ¦to ur s¦ .
𐋇 ¦many¦ ¦large¦ ¦the at r es¦ ¦such¦ ¦as¦ ¦those¦ ¦on¦ ¦b ro a d w ay¦ ¦also¦ ¦susp e nded¦ ¦all¦ ¦per f orm an ces¦ .
𐋇¦some¦ ¦ar ti sts¦ ¦have¦ ¦ex pl or ed¦ ¦w ays¦ ¦to¦ ¦continue¦ ¦to¦ ¦produc e¦ ¦and¦ ¦share¦ ¦work¦ ¦over¦ ¦the¦ ¦inter n et¦ ¦as¦ ¦an¦ ¦al t er n ative¦ ¦to¦ ¦tra di tional¦ ¦live¦ ¦per f orm ance¦ ,▁ ¦such¦ ¦as¦ ¦live¦ ¦st rea m ing¦ ¦concer ts¦ ¦or¦ ¦cre ating¦ ¦we b ¦ - ¦based¦ ▁" ¦fe st iv als¦ "▁ ¦for¦ ¦ar ti sts¦ ¦to¦ ¦per for m¦ ,▁ ¦d ist rib ute¦ ,▁ ¦and¦ ¦publ ic iz e¦ ¦their¦ ¦work¦ .
𐋇 ¦online¦ ,▁ ¦nu me ro us¦ ¦coronavirus¦ - ¦the med¦ ¦inter n et¦ ¦me m es¦ ¦have¦ ¦spread¦ ¦as¦ ¦many¦ ¦t ur n¦ ¦to¦ ¦h um ou r¦ ¦and¦ ¦d ist ra ction¦ ¦a m id¦ ¦un ce rt ai nt y¦ .
𐋇 ¦since¦ ¦the¦ ¦outbreak¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦he i gh te ned¦ ¦pre j ud ice¦ ,▁ ¦ x e no ph ob ia¦ ,▁ ¦and¦ ¦r ac is m¦ ¦have¦ ¦been¦ ¦no ted¦ ¦t ow ard¦ ¦people¦ ¦of¦ ¦chinese¦ ¦and¦ ¦e ast¦ ¦a si an¦ ¦d esc ent¦ ,▁ ¦and¦ ¦against¦ ¦people¦ ¦from¦ ¦h ot s p o ts¦ ¦in¦ ¦e ur ope¦ ,▁ ¦the¦ ¦united¦ ¦states¦ ¦and¦ ¦other¦ ¦countries¦ .
𐋇 ¦inc id ents¦ ¦of¦ ¦f ear¦ ,▁ ¦susp ic ion¦ ,▁ ¦and¦ ¦ho st il ity¦ ¦have¦ ¦been¦ ¦ob s erv ed¦ ¦in¦ ¦many¦ ¦countries¦ ,▁ ¦partic ul arly¦ ¦in¦ ¦e ur ope¦ ,▁ ¦e ast¦ ¦as ia¦ ,▁ ¦n or th¦ ¦amer ica¦ ,▁ ¦and¦ ¦the¦ ¦as ia¦ - ¦p ac if ic¦ ¦reg ion¦ .
𐋇 ¦rep orts¦ ¦from¦ ¦february¦ ▁( ¦when¦ ¦the¦ ¦ma j or ity¦ ¦of¦ ¦the¦ ¦cases¦ ¦had¦ ¦still¦ ¦been¦ ¦conf ined¦ ¦to¦ ¦china¦ )▁ ¦have¦ ¦d oc um ented¦ ¦r ac ist¦ ¦sen ti ments¦ ¦exp r es sed¦ ¦in¦ ¦v ar ious¦ ¦grou ps¦ ¦worldwide¦ ¦of¦ ¦chinese¦ ¦people¦ ¦d es er ving¦ ¦the¦ ¦virus¦ ¦or¦ ¦rece i ving¦ ¦what¦ ¦has¦ ¦been¦ ¦cl ai med¦ ¦as¦ ¦j u st if ied¦ ¦r et rib ution¦ .
𐋇¦some¦ ¦countries¦ ¦in¦ ¦afr ica¦ ¦have¦ ¦also¦ ¦se en¦ ¦a¦ ¦r ise¦ ¦in¦ ¦anti ¦ - ¦chinese¦ ¦sen ti ment¦ .
𐋇 ¦many¦ ¦res id ents¦ ¦of¦ ¦wuhan¦ ¦and¦ ¦hub e i¦ ¦have¦ ¦reported¦ ¦disc r im ination¦ ¦based¦ ¦on¦ ¦their¦ ¦regi on al¦ ¦orig in¦ .
𐋇¦there¦ ¦has¦ ¦been¦ ¦support¦ ¦for¦ ¦the¦ ¦chinese¦ ,▁ ¦both¦ ¦on¦ ¦and¦ ¦off line¦ ,▁ ¦and¦ ¦t ow ards¦ ¦those¦ ¦in¦ ¦virus¦ - ¦ str ick en¦ ¦areas¦ .
𐋇 ¦following¦ ¦the¦ ¦pr og re ssion¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦to¦ ¦new¦ ¦h ot s p ot¦ ¦countries¦ ,▁ ¦people¦ ¦from¦ ¦italy¦ ,▁ ¦the¦ ¦first¦ ¦country¦ ¦in¦ ¦e ur ope¦ ¦to¦ ¦exp eri ence¦ ¦a¦ ¦ser ious¦ ¦outbreak¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦could¦ ¦also¦ ¦be¦ ¦sub j ected¦ ¦to¦ ¦susp ic ion¦ ¦and¦ ¦ x e no ph ob ia¦ . ¦c itiz ens¦ ¦in¦ ¦countries¦ ¦including¦ ¦ma la ys ia¦ ,▁ ¦new¦ ¦z ea land¦ ,▁ ¦si ng ap ore¦ ,▁ ¦and¦ ¦south¦ ¦ko rea¦ ¦in it ially¦ ¦sign ed¦ ¦p e ti tions¦ ¦l ob b ying¦ ¦to¦ ¦b an¦ ¦chinese¦ ¦people¦ ¦from¦ ¦ent ering¦ ¦their¦ ¦countries¦ ¦in¦ ¦an¦ ¦eff ort¦ ¦to¦ ¦sto p¦ ¦the¦ ¦disease¦ .
𐋇¦in¦ ¦j ap an¦ ,▁ ¦the¦ ¦h as h ta g¦ ▁ # ▁ ¦ch in es ed o nt c om et o j ap an¦ ¦tre nded¦ ¦on¦ ¦t w it ter¦ .
𐋇 ¦chinese¦ ¦people¦ ¦as¦ ¦well¦ ¦as¦ ¦other¦ ¦a si ans¦ ¦in¦ ¦the¦ ¦united¦ ¦ki ng d om¦ ¦and¦ ¦the¦ ¦united¦ ¦states¦ ¦have¦ ¦reported¦ ¦incre as ing¦ ¦le v els¦ ¦of¦ ¦r ac ist¦ ¦ab use¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦ass a ul ts¦ .
𐋇 ¦u¦ . ¦s¦ .▁ ¦pres ident¦ ¦do na ld¦ ¦tr um p¦ ¦has¦ ¦f ac ed¦ ¦crit ic is m¦ ¦for¦ ¦ref er r ing¦ ¦to¦ ¦the¦ ¦coronavirus¦ ¦as¦ ¦the¦ ▁" ¦chinese¦ ¦virus¦ " ,▁ ¦a¦ ¦ter m¦ ¦consid ered¦ ¦by¦ ¦crit ics¦ ¦to¦ ¦be¦ ¦r ac ist¦ ¦and¦ ¦anti ¦ - ¦chinese¦ .
𐋇 ¦prote st ers¦ ¦in¦ ¦u k ra ine¦ ¦att ac ked¦ ¦bu ses¦ ¦c arr ying¦ ¦u k ra in i an¦ ¦and¦ ¦fo re ign¦ ¦ev ac u e es¦ ¦from¦ ¦wuhan¦ ¦to¦ ¦n ov i¦ ¦s an z h ary¦ .
𐋇 ¦students¦ ¦who¦ ¦come¦ ¦from¦ ¦n ort he ast¦ ¦ind ia¦ ,▁ ¦which¦ ¦sh ar es¦ ¦a¦ ¦ bor der¦ ¦with¦ ¦china¦ ,▁ ¦and¦ ¦study¦ ¦in¦ ¦major¦ ¦in di an¦ ¦c ities¦ ¦have¦ ¦rep ort ed ly¦ ¦exp er ie nc ed¦ ¦h ara ss ment¦ ¦related¦ ¦to¦ ¦the¦ ¦coronavirus¦ ¦outbreak¦ .
𐋇¦the¦ ¦b h ara ti y a¦ ¦j an at a¦ ¦part y¦ ' ¦s¦ ¦state¦ ¦uni t¦ ¦pres ident¦ ¦in¦ ¦w est¦ ¦be ng al¦ ¦di li p¦ ¦ gh os h ¦ ¦stated¦ ¦that¦ ¦the¦ ¦chinese¦ ¦had¦ ¦de st ro y ed¦ ¦nat ure¦ ¦and¦ ▁" ¦that¦ ' ¦s¦ ¦wh y¦ ¦the¦ ¦go d¦ ¦t ook¦ ¦re v en ge¦ ¦against¦ ¦them¦ . "
𐋇¦the¦ ¦rem ar ks¦ ¦were¦ ¦later¦ ¦con de m ned¦ ¦by¦ ¦the¦ ¦chinese¦ ¦cons ul ate¦ ¦in¦ ¦k ol k at a¦ ,▁ ¦ca lling¦ ¦it¦ ▁" ¦ er ro ne o us¦ "▁ . ¦in¦ ¦china¦ ,▁ ¦ x e no ph ob ia¦ ¦and¦ ¦r ac is m¦ ¦ag a ins¦ ¦non¦ - ¦chinese¦ ¦res id ents¦ ¦has¦ ¦been¦ ¦inf la med¦ ¦by¦ ¦the¦ ¦pandemic¦ ,▁ ¦with¦ ¦fo re i gn ers¦ ¦d esc rib ed¦ ¦as¦ ▁" ¦fo re ign¦ ¦g ar b age¦ "▁ ¦and¦ ¦t ar ge ted¦ ¦for¦ ▁" ¦dis p os al¦ " .
𐋇 ¦many¦ ¦new s p ap ers¦ ¦with¦ ¦pa y w a lls¦ ¦have¦ ¦rem oved¦ ¦them¦ ¦for¦ ¦some¦ ¦or¦ ¦all¦ ¦of¦ ¦their¦ ¦coronavirus¦ ¦co ver age¦ .
𐋇 ¦many¦ ¦sc ie nt if ic¦ ¦publ is h ers¦ ¦made¦ ¦sc ie nt if ic¦ ¦p ap ers¦ ¦related¦ ¦to¦ ¦the¦ ¦outbreak¦ ¦available¦ ¦with¦ ¦open¦ ¦acc ess¦ .
𐋇¦some¦ ¦sc ien ti sts¦ ¦ch ose¦ ¦to¦ ¦share¦ ¦their¦ ¦results¦ ¦qu ick ly¦ ¦on¦ ¦pre p r in t¦ ¦s erv ers¦ ¦such¦ ¦as¦ ¦bi or x iv ¦ .
𐋇¦e mer ging¦ ¦infectious¦ ¦disease¦ ▁–▁ ¦infectious¦ ¦disease¦ ¦of¦ ¦e mer ging¦ ¦path og en¦ ,▁ ¦often¦ ¦novel¦ ¦in¦ ¦its¦ ¦outbreak¦ ¦r ange¦ ¦or¦ ¦transmission¦ ¦mo de¦
𐋇 ¦gl ob al iz ation¦ ¦and¦ ¦disease¦ ▁–▁ ¦over v ie w¦ ¦of¦ ¦gl ob al iz ation¦ ¦and¦ ¦disease¦ ¦transmission¦
𐋇¦l ist¦ ¦of¦ ¦e p ide m ics¦ ¦and¦ ¦p an de m ics¦ ▁–▁ ¦a¦ ¦l ist¦ ¦of¦ ¦death¦ ¦to lls¦ ¦due¦ ¦to¦ ¦infectious¦ ¦disease¦
𐋇¦w ild l ife¦ ¦sm u gg l ing¦ ¦and¦ ¦z oo no ses¦ ▁–▁ ¦health¦ ¦r is ks¦ ¦associated¦ ¦with¦ ¦the¦ ¦tra de¦ ¦in¦ ¦ex ot ic¦ ¦w ild l ife¦
𐋇 ¦laboratory¦ ¦testing¦ ¦for¦ ¦the¦ ¦respiratory¦ ¦coronavirus¦ ¦disease¦ ¦2019¦ ▁( ¦covid¦ - ¦19¦ )▁ ¦and¦ ¦the¦ ¦associated¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦virus¦ ¦inclu des¦ ¦met ho ds¦ ¦that¦ ¦det ect¦ ¦the¦ ¦pres ence¦ ¦of¦ ¦virus¦ ¦and¦ ¦those¦ ¦that¦ ¦det ect¦ ¦antibo dies¦ ¦produc ed¦ ¦in¦ ¦response¦ ¦to¦ ¦infection¦ .
𐋇¦the¦ ¦pres ence¦ ¦of¦ ¦viruses¦ ¦in¦ ¦samples¦ ¦is¦ ¦confirmed¦ ¦by¦ ¦r t¦ - ¦p c r¦ ,▁ ¦which¦ ¦det ects¦ ¦the¦ ¦coronavirus¦ ' ▁ ¦rna¦ .
𐋇¦this¦ ¦test¦ ¦is¦ ¦specific¦ ¦and¦ ¦is¦ ¦d es ig ned¦ ¦to¦ ¦only¦ ¦det ect¦ ¦the¦ ¦rna¦ ¦of¦ ¦the¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦virus¦ .
𐋇¦it¦ ¦is¦ ¦used¦ ¦to¦ ¦conf ir m¦ ¦very¦ ¦rec ent¦ ¦or¦ ¦ac tive¦ ¦infections¦ .
𐋇 ¦de te ction¦ ¦of¦ ¦antibo dies¦ ▁( ¦ser ology¦ )▁ ¦can¦ ¦be¦ ¦used¦ ¦both¦ ¦for¦ ¦diagn o sis¦ ¦and¦ ¦population¦ ¦surveillance¦ .
𐋇 ¦antibo dy¦ ¦tests¦ ¦sh ow¦ ¦how¦ ¦many¦ ¦people¦ ¦have¦ ¦had¦ ¦the¦ ¦disease¦ ,▁ ¦including¦ ¦those¦ ¦wh ose¦ ¦symptoms¦ ¦were¦ ¦to o¦ ¦min or¦ ¦to¦ ¦report¦ ¦or¦ ¦who¦ ¦were¦ ¦as ymptomatic¦ .
𐋇 ¦an¦ ¦acc ur ate¦ ¦m ort ality¦ ¦rate¦ ¦of¦ ¦the¦ ¦disease¦ ¦and¦ ¦the¦ ¦level¦ ¦of¦ ¦h er d¦ ¦immun ity¦ ¦in¦ ¦the¦ ¦population¦ ¦can¦ ¦be¦ ¦det erm ined¦ ¦from¦ ¦the¦ ¦results¦ ¦of¦ ¦this¦ ¦test¦ .
𐋇 ¦due¦ ¦to¦ ¦limi ted¦ ¦testing¦ ,▁ ¦as¦ ¦of¦ ¦march¦ ¦2020¦ ¦no¦ ¦countries¦ ¦had¦ ¦re li able¦ ¦data¦ ¦on¦ ¦the¦ ¦prev al ence¦ ¦of¦ ¦the¦ ¦virus¦ ¦in¦ ¦their¦ ¦population¦ .
𐋇¦by¦ ¦23¦ ¦march¦ ,▁ ¦no¦ ¦country¦ ¦had¦ ¦tested¦ ¦more¦ ¦than¦ ¦3¦ %▁ ¦of¦ ¦their¦ ¦population¦ ,▁ ¦and¦ ¦there¦ ¦are¦ ¦ma ss ive¦ ¦vari ations¦ ¦in¦ ¦how¦ ¦much¦ ¦testing¦ ¦has¦ ¦been¦ ¦d one¦ ¦across¦ ¦countries¦ .
𐋇¦this¦ ¦vari a bility¦ ¦is¦ ¦also¦ ¦likely¦ ¦to¦ ¦be¦ ¦sign ific a ntly¦ ¦aff ecting¦ ¦reported¦ ¦case¦ ¦fat ality¦ ¦r ates¦ ,▁ ¦which¦ ¦are¦ ¦likely¦ ¦to¦ ¦be¦ ¦sign ific a ntly¦ ¦over¦ - ¦estim ated¦ ¦in¦ ¦some¦ ¦countries¦ .
𐋇 ¦using¦ ¦re al¦ - ¦time¦ ¦re ver se¦ ¦trans c ri ption¦ ¦pol y mer ase¦ ¦cha in¦ ¦rea ction¦ ▁( ¦r r t¦ - ¦p c r¦ )▁ ¦the¦ ¦test¦ ¦can¦ ¦be¦ ¦d one¦ ¦on¦ ¦respiratory¦ ¦samples¦ ¦ob ta ined¦ ¦by¦ ¦v ar ious¦ ¦met ho ds¦ ,▁ ¦including¦ ¦n as o ph ar y n ge al¦ ¦sw ab ¦ ¦or¦ ¦sp ut um¦ ¦sampl e¦ .
𐋇 ¦results¦ ¦are¦ ¦gener ally¦ ¦available¦ ¦within¦ ¦a¦ ¦fe w¦ ¦hours¦ ¦to¦ ¦2¦ ¦days¦ .
𐋇¦the¦ ¦r t¦ - ¦p c r¦ ¦test¦ ¦per for med¦ ¦with¦ ¦th ro at¦ ¦sw ab s¦ ¦is¦ ¦only¦ ¦re li able¦ ¦in¦ ¦the¦ ¦first¦ ¦week¦ ¦of¦ ¦the¦ ¦disease¦ .
𐋇 ¦later¦ ¦on¦ ¦the¦ ¦virus¦ ¦can¦ ¦dis a pp ear¦ ¦in¦ ¦the¦ ¦th ro at¦ ¦while¦ ¦it¦ ¦contin ues¦ ¦to¦ ¦mult ip ly¦ ¦in¦ ¦the¦ ¦lu ng s¦ .
𐋇¦for¦ ¦infected¦ ¦people¦ ¦tested¦ ¦in¦ ¦the¦ ¦second¦ ¦week¦ ,▁ ¦al t er n at ively¦ ¦sampl e¦ ¦m at er ial¦ ¦can¦ ¦then¦ ¦be¦ ¦ta k en¦ ¦from¦ ¦the¦ ¦d ee p¦ ¦air w ays¦ ¦by¦ ¦su ction¦ ¦c at he ter¦ ¦or¦ ¦cou g hing¦ ¦up¦ ¦m at er ial¦ ▁( ¦sp ut um¦ )▁ ¦can¦ ¦be¦ ¦used¦ .
𐋇 ¦one¦ ¦of¦ ¦the¦ ¦early¦ ¦p c r¦ ¦tests¦ ¦was¦ ¦developed¦ ¦at¦ ¦ch ar it é ¦ ¦in¦ ¦b er l in¦ ¦in¦ ¦january¦ ¦2020¦ ¦using¦ ¦re al¦ - ¦time¦ ¦re ver se¦ ¦trans c ri ption¦ ¦pol y mer ase¦ ¦cha in¦ ¦rea ction¦ ▁( ¦r r t¦ - ¦p c r¦ ),▁ ¦and¦ ¦for med¦ ¦the¦ ¦ba sis¦ ¦of¦ ¦2 5 0¦ , ¦000¦ ¦ki ts¦ ¦for¦ ¦d ist rib ution¦ ¦by¦ ¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ▁( ¦who¦ ).
𐋇¦the¦ ¦united¦ ¦ki ng d om¦ ¦had¦ ¦also¦ ¦developed¦ ¦a¦ ¦test¦ ¦by¦ ¦23¦ ¦january¦ ¦2020¦ . ¦the¦ ¦south¦ ¦ko re an¦ ¦comp an y¦ ¦ko ge ne b i o te ch¦ ¦developed¦ ¦a¦ ¦clinical¦ ¦g ra de¦ ,▁ ¦p c r¦ - ¦based¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦de te ction¦ ¦ki t¦ ▁( ¦p ow er che k¦ ¦coronavirus¦ )▁ ¦on¦ ¦2 8¦ ¦january¦ ¦2020¦ .
𐋇¦it¦ ¦l oo ks¦ ¦for¦ ¦the¦ ▁" ¦ e¦ "▁ ¦gen e¦ ¦sh ared¦ ¦by¦ ¦all¦ ¦bet a¦ ¦coronaviruses¦ ,▁ ¦and¦ ¦the¦ ¦r dr p¦ ¦gen e¦ ¦specific¦ ¦to¦ ¦sars¦ - ¦cov¦ - ¦2¦ . ¦in¦ ¦china¦ ,▁ ¦b g i¦ ¦group¦ ¦was¦ ¦one¦ ¦of¦ ¦the¦ ¦first¦ ¦comp an ies¦ ¦to¦ ¦receive¦ ¦emergency¦ ¦use¦ ¦appr ov al¦ ¦from¦ ¦china¦ ' ¦s¦ ¦national¦ ¦medical¦ ¦produc ts¦ ¦admin i str ation¦ ¦for¦ ¦a¦ ¦p c r¦ - ¦based¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦de te ction¦ ¦ki t¦ . ¦in¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦the¦ ¦ce nt ers¦ ¦for¦ ¦disease¦ ¦control¦ ¦and¦ ¦pre vention¦ ▁( ¦c dc¦ )▁ ¦is¦ ¦d ist rib u ting¦ ¦its¦ ¦2019¦ - ¦novel¦ ¦coronavirus¦ ▁( ¦2019¦ - ¦n cov ¦ )▁ ¦re al¦ - ¦time¦ ¦r t¦ - ¦p c r¦ ¦diagn o st ic¦ ¦pa ne l¦ ¦to¦ ¦public¦ ¦health¦ ¦l ab s¦ ¦through¦ ¦the¦ ¦international¦ ¦rea g ent¦ ¦res o ur ce¦ .
𐋇 ¦one¦ ¦of¦ ¦three¦ ¦gen et ic¦ ¦tests¦ ¦in¦ ¦ ol der¦ ¦ ver si ons¦ ¦of¦ ¦the¦ ¦test¦ ¦ki ts¦ ¦caused¦ ¦inc o nc l us ive¦ ¦results¦ ¦due¦ ¦to¦ ¦fa ult y¦ ¦rea g ents¦ ,▁ ¦and¦ ¦a¦ ¦b ot t l en eck¦ ¦of¦ ¦testing¦ ¦at¦ ¦the¦ ¦c dc¦ ¦in¦ ¦ at la nt a¦ ;▁ ¦this¦ ¦res ul ted¦ ¦in¦ ¦an¦ ¦a ver age¦ ¦of¦ ¦fe w er¦ ¦than¦ ¦100¦ ¦samples¦ ¦a¦ ¦day¦ ¦being¦ ¦s uc cess f ul ly¦ ¦proc es sed¦ ¦th r ou g ho ut¦ ¦the¦ ¦w ho le¦ ¦of¦ ¦february¦ ¦2020¦ .
𐋇 ¦tests¦ ¦using¦ ¦two¦ ¦comp on ents¦ ¦were¦ ¦not¦ ¦det erm ined¦ ¦to¦ ¦be¦ ¦re li able¦ ¦until¦ ¦2 8¦ ¦february¦ ¦2020¦ ,▁ ¦and¦ ¦it¦ ¦was¦ ¦not¦ ¦until¦ ¦then¦ ¦that¦ ¦state¦ ¦and¦ ¦local¦ ¦la bor at or ies¦ ¦were¦ ¦p erm it ted¦ ¦to¦ ¦beg in¦ ¦testing¦ .
𐋇¦the¦ ¦test¦ ¦was¦ ¦appr oved¦ ¦by¦ ¦the¦ ¦food¦ ¦and¦ ¦drug¦ ¦admin i str ation¦ ¦under¦ ¦an¦ ¦emergency¦ ¦use¦ ¦author iz ation¦ . ¦us¦ ¦comm erc ial¦ ¦l ab s¦ ¦beg an¦ ¦testing¦ ¦in¦ ¦early¦ ¦march¦ ¦2020¦ .
𐋇¦as¦ ¦of¦ ¦5¦ ¦march¦ ¦2020¦ ¦l ab c or p¦ ¦announced¦ ¦na tion w ide¦ ¦a v ai la bility¦ ¦of¦ ¦covid¦ - ¦19¦ ¦testing¦ ¦based¦ ¦on¦ ¦r t¦ - ¦p c r¦ .
𐋇 ¦qu est¦ ¦diagn o st ics¦ ¦s im il arly¦ ¦made¦ ¦na tion w ide¦ ¦covid¦ - ¦19¦ ¦testing¦ ¦available¦ ¦as¦ ¦of¦ ¦9¦ ¦march¦ ¦2020¦ .
𐋇 ¦no¦ ¦qu a nt ity¦ ¦limi t ations¦ ¦were¦ ¦announced¦ ;▁ ¦spec im en¦ ¦colle ction¦ ¦and¦ ¦pro cess ing¦ ¦must¦ ¦be¦ ¦per for med¦ ¦according¦ ¦to¦ ¦c dc¦ ¦requir e ments¦ .
𐋇¦in¦ ¦ ru ss ia¦ ,▁ ¦the¦ ¦covid¦ - ¦19¦ ¦test¦ ¦was¦ ¦developed¦ ¦and¦ ¦produc ed¦ ¦by¦ ¦the¦ ¦state¦ ¦research¦ ¦center¦ ¦of¦ ¦vir ology¦ ¦and¦ ¦bi o te ch n ology¦ ¦v ector¦ .
𐋇¦on¦ ¦11¦ ¦february¦ ¦2020¦ ¦the¦ ¦test¦ ¦was¦ ¦reg ist ered¦ ¦by¦ ¦the¦ ¦f ed er al¦ ¦service¦ ¦for¦ ¦surveillance¦ ¦in¦ ¦healthcare¦ . ¦on¦ ¦12¦ ¦march¦ ¦2020¦ ,▁ ¦ma y o¦ ¦cl in ic¦ ¦was¦ ¦reported¦ ¦to¦ ¦have¦ ¦developed¦ ¦a¦ ¦test¦ ¦to¦ ¦det ect¦ ¦covid¦ - ¦19¦ ¦infection¦ . ¦on¦ ¦13¦ ¦march¦ ¦2020¦ ,▁ ¦ro ch e¦ ¦diagn o st ics¦ ¦received¦ ¦f d a¦ ¦appr ov al¦ ¦for¦ ¦a¦ ¦test¦ ¦which¦ ¦could¦ ¦be¦ ¦per for med¦ ¦within¦ ¦3¦ . ¦5¦ ¦hours¦ ¦in¦ ¦high¦ ¦v o lu me¦ ,▁ ¦th us¦ ¦all owing¦ ¦one¦ ¦ma ch ine¦ ¦to¦ ¦do¦ ¦appro xi ma tely¦ ¦4¦ , ¦1 2 8¦ ¦tests¦ ¦in¦ ¦a¦ ¦24¦ - ¦hou r¦ ¦period¦ .
𐋇¦on¦ ¦19¦ ¦march¦ ¦2020¦ ,▁ ¦the¦ ¦f d a¦ ¦issued¦ ¦emergency¦ ¦use¦ ¦author iz ation¦ ▁( ¦e u a¦ )▁ ¦to¦ ¦ab b ot t¦ ¦la bor at or ies¦ ¦for¦ ¦a¦ ¦test¦ ¦on¦ ¦ab b ot t¦ ' ¦s¦ ¦m 2 0 00¦ ¦system¦ ;▁ ¦the¦ ¦f d a¦ ¦had¦ ¦previously¦ ¦issued¦ ¦similar¦ ¦author iz ation¦ ¦to¦ ¦h ol og ic¦ ,▁ ¦l ab c or p¦ ,▁ ¦and¦ ¦th erm o¦ ¦f is her¦ ¦sc ie nt if ic¦ .
𐋇¦on¦ ¦ 21¦ ¦march¦ ¦2020¦ ,▁ ¦ cep he id¦ ¦s im il arly¦ ¦received¦ ¦e u a¦ ¦from¦ ¦the¦ ¦f d a¦ ¦for¦ ¦a¦ ¦test¦ ¦that¦ ¦ta k es¦ ¦about¦ ¦4 5¦ ¦min u tes¦ .
𐋇¦the¦ ¦f d a¦ ¦has¦ ¦appr oved¦ ¦a¦ ¦test¦ ¦that¦ ¦u ses¦ ¦ is o th erm al¦ ¦n uc le ic¦ ¦ac id¦ ¦a mpl ific ation¦ ¦techn ology¦ ¦inst ead¦ ¦of¦ ¦p c r¦ .
𐋇 ¦since¦ ¦this¦ ¦does¦ ¦not¦ ¦requir e¦ ¦a¦ ¦ser ies¦ ¦of¦ ¦al t er n ating¦ ¦temp erat ure¦ ¦c y c les¦ ¦this¦ ¦met ho d¦ ¦can¦ ¦de li ver¦ ¦positive¦ ¦results¦ ¦in¦ ¦as¦ ¦l it t le¦ ¦as¦ ¦five¦ ¦min u tes¦ ¦and¦ ¦negative¦ ¦results¦ ¦in¦ ¦13¦ ¦min u tes¦ .
𐋇¦there¦ ¦are¦ ¦cur re ntly¦ ¦about¦ ¦18¦ , ¦000¦ ¦of¦ ¦these¦ ¦ma ch ines¦ ¦in¦ ¦the¦ ¦u¦ . ¦s¦ .▁ ¦and¦ ¦ab b ot t¦ ¦exp ects¦ ¦to¦ ¦ra m p¦ ¦up¦ ¦m an u fa ct ur ing¦ ¦to¦ ¦de li ver¦ ¦50¦ , ¦000¦ ¦tests¦ ¦per¦ ¦day¦ . ¦a¦ ¦test¦ ¦which¦ ¦u ses¦ ¦a¦ ¦mon oc l on al¦ ¦antibo dy¦ ¦which¦ ¦spec if ically¦ ¦b in ds¦ ¦to¦ ¦the¦ ¦n uc le oc ap s id¦ ¦protein¦ ▁( ¦ n¦ ¦protein¦ )▁ ¦of¦ ¦the¦ ¦novel¦ ¦coronavirus¦ ¦is¦ ¦being¦ ¦developed¦ ¦in¦ ¦t ai w an¦ ,▁ ¦with¦ ¦the¦ ¦h ope¦ ¦that¦ ¦it¦ ¦can¦ ¦provide¦ ¦results¦ ¦in¦ ¦15¦ ¦to¦ ¦20¦ ¦min u tes¦ ¦j ust¦ ¦like¦ ¦a¦ ¦rap id¦ ¦influenza¦ ¦test¦ .
𐋇¦a¦ ¦march¦ ¦2020¦ ¦l it erat ure¦ ¦re v ie w¦ ¦co nc lu ded¦ ¦that¦ ▁" ¦chest¦ ¦ra di ogra ph s¦ ¦are¦ ¦of¦ ¦l it t le¦ ¦diagn o st ic¦ ¦v al ue¦ ¦in¦ ¦early¦ ¦sta ges¦ ,▁ ¦w he rea s¦ ¦c t¦ ▁ [ ¦comp u ted¦ ¦t om ogra ph y¦ ] ▁ ¦fi nd ings¦ ¦may¦ ¦be¦ ¦pres ent¦ ¦even¦ ¦before¦ ¦s y m pt om¦ ¦o ns et¦ . "
𐋇¦for¦ ¦example¦ ,▁ ¦po st ers¦ ¦with¦ ▁" ¦cor r ect¦ ¦hand¦ ¦washing¦ ¦techn i q ues¦ "▁ ¦were¦ ¦h u ng¦ ¦up¦ ¦ne xt¦ ¦to¦ ¦hand¦ ¦washing¦ ¦s in ks¦ ¦in¦ ¦public¦ ¦to il ets¦ ¦and¦ ¦in¦ ¦the¦ ¦to il ets¦ ¦of¦ ¦off ice¦ ¦bu ild ings¦ ¦and¦ ¦air p orts¦ ¦in¦ ¦g erm an y¦ .
𐋇¦the¦ ¦ph r ase¦ ▁" ¦washing¦ ¦one¦ ' ¦s¦ ¦hands¦ ¦of¦ "▁ ¦so me thing¦ ,▁ ¦me ans¦ ¦decl ar ing¦ ¦one¦ ' ¦s¦ ¦un w il li ng ness¦ ¦to¦ ¦take¦ ¦resp on si bility¦ ¦for¦ ¦the¦ ¦ thing¦ ¦or¦ ¦share¦ ¦co mpl ic ity¦ ¦in¦ ¦it¦ .
𐋇¦it¦ ¦orig in ates¦ ¦from¦ ¦the¦ ¦bi ble¦ ¦pa ss age¦ ¦in¦ ¦m at t he w¦ ¦where¦ ¦p on ti us¦ ¦p il ate¦ ¦w as h ed¦ ¦hi s¦ ¦hands¦ ¦of¦ ¦the¦ ¦dec is ion¦ ¦to¦ ¦cr uc if y¦ ¦j es us¦ ¦ch r ist¦ ,▁ ¦but¦ ¦has¦ ¦bec ome¦ ¦a¦ ¦ph r ase¦ ¦with¦ ¦a¦ ¦much¦ ¦wid er¦ ¦us age¦ ¦in¦ ¦some¦ ¦e ng l ish¦ ¦comm un ities¦ .
𐋇¦in¦ ¦sh a k esp e are¦ ' ¦s¦ ¦m ac b e th¦ ,▁ ¦la dy¦ ¦m ac b e th¦ ¦beg ins¦ ¦to¦ ¦comp ul s ively¦ ¦wash¦ ¦ her¦ ¦hands¦ ¦in¦ ¦an¦ ¦att e mp t¦ ¦to¦ ¦c le an se¦ ¦an¦ ¦i ma g ined¦ ¦s tain¦ ,▁ ¦rep r es en ting¦ ¦ her¦ ¦gu il t y¦ ¦cons c i ence¦ ¦reg ar ding¦ ¦cr im es¦ ¦sh e¦ ¦had¦ ¦comm it ted¦ ¦and¦ ¦in duc ed¦ ¦ her¦ ¦h us b and¦ ¦to¦ ¦comm i t¦ .
𐋇¦it¦ ¦has¦ ¦also¦ ¦been¦ ¦found¦ ¦that¦ ¦people¦ ,▁ ¦after¦ ¦having¦ ¦rec a lled¦ ¦or¦ ¦con te mpl ated¦ ¦u ne th ical¦ ¦ac ts¦ ,▁ ¦t end¦ ¦to¦ ¦wash¦ ¦hands¦ ¦more¦ ¦often¦ ¦than¦ ¦others¦ ,▁ ¦and¦ ¦t end¦ ¦to¦ ¦v al ue¦ ¦hand¦ ¦washing¦ ¦equipment¦ ¦more¦ .
𐋇¦f ur th erm ore¦ ,▁ ¦those¦ ¦who¦ ¦are¦ ¦all owed¦ ¦to¦ ¦wash¦ ¦their¦ ¦hands¦ ¦after¦ ¦such¦ ¦a¦ ¦con te mpl ation¦ ¦are¦ ¦less¦ ¦likely¦ ¦to¦ ¦e ng age¦ ¦in¦ ¦other¦ ▁" ¦cl ea ns ing¦ "▁ ¦comp e ns atory¦ ¦ac tions¦ ,▁ ¦such¦ ¦as¦ ¦v ol un te ering¦ .
𐋇 ¦rel ig i ons¦ ¦pr esc rib e¦ ¦hand¦ ¦washing¦ ¦for¦ ¦both¦ ¦h yg ien ic¦ ¦and¦ ¦s y mb ol ic¦ ¦p ur p o ses¦ . ¦s y mb ol ic¦ ¦hand¦ ¦washing¦ ,▁ ¦using¦ ¦water¦ ¦but¦ ¦no¦ ¦so a p¦ ¦to¦ ¦wash¦ ¦hands¦ ,▁ ¦is¦ ¦a¦ ¦par t¦ ¦of¦ ¦r it ual¦ ¦hand¦ ¦washing¦ ¦fe at ur ed¦ ¦in¦ ¦many¦ ¦rel ig i ons¦ ,▁ ¦including¦ ¦ba h á ¦ ' ¦ í ¦ ¦f ai th¦ ,▁ ¦hi nd u is m¦ ,▁ ¦te vi la h ¦ ¦and¦ ¦n et il at¦ ¦y a d a y i m¦ ¦in¦ ¦j ud a is m¦ ,▁ ¦la v ab o¦ ¦in¦ ¦ch r is ti an ity¦ ,▁ ¦and¦ ¦w ud h u¦ ¦in¦ ¦ is l am¦ . ¦rel ig i ons¦ ¦also¦ ¦pr esc rib e¦ ¦h yg ien ic¦ ¦hand¦ ¦washing¦ ,▁ ¦especially¦ ¦after¦ ¦c er tain¦ ¦ac tions¦ .
𐋇 ¦hi nd u is m¦ ,▁ ¦j ud a is m¦ ¦and¦ ¦ is l am¦ ¦mand ate¦ ¦washing¦ ¦of¦ ¦hands¦ ¦after¦ ¦using¦ ¦the¦ ¦to il et¦ .
𐋇 ¦and¦ ,▁ ¦hi nd u is m¦ ,▁ ¦b ud d h is m¦ ,▁ ¦si k h is m¦ ,▁ ¦j ud a is m¦ ¦and¦ ¦ is l am¦ ¦mand ate¦ ¦washing¦ ¦of¦ ¦hands¦ ¦before¦ ¦and¦ ¦after¦ ¦every¦ ¦me al¦ .
𐋇 ¦work pl ace¦ ¦ha z ard¦ ¦contr ols¦ ¦for¦ ¦covid¦ - ¦19¦
𐋇 ¦work pl ace¦ ¦ha z ard¦ ¦contr ols¦ ¦for¦ ¦covid¦ - ¦19¦ ¦are¦ ¦the¦ ¦app l ic ation¦ ¦of¦ ¦occ u pa tional¦ ¦safety¦ ¦and¦ ¦health¦ ¦met ho d ol og ies¦ ¦for¦ ¦ha z ard¦ ¦contr ols¦ ¦to¦ ¦the¦ ¦pre vention¦ ¦of¦ ¦coronavirus¦ ¦disease¦ ¦2019¦ ▁( ¦covid¦ - ¦19¦ ).
𐋇¦the¦ ¦prop er¦ ¦ha z ard¦ ¦contr ols¦ ¦in¦ ¦the¦ ¦work pl ace¦ ¦dep end¦ ¦on¦ ¦the¦ ¦work s ite¦ ¦and¦ ¦j ob ¦ ¦t as k¦ ,▁ ¦based¦ ¦on¦ ¦a¦ ¦risk¦ ¦as se ss ment¦ ¦of¦ ¦sour ces¦ ¦of¦ ¦exp osure¦ ,▁ ¦disease¦ ¦se ver ity¦ ¦in¦ ¦the¦ ¦community¦ ,▁ ¦and¦ ¦risk¦ ¦fa ctors¦ ¦of¦ ¦ind iv id ual¦ ¦workers¦ ¦who¦ ¦may¦ ¦be¦ ¦v ul n er able¦ ¦to¦ ¦contr ac ting¦ ¦covid¦ - ¦19¦ .
𐋇 ¦according¦ ¦to¦ ¦the¦ ¦u¦ . ¦s¦ .▁ ¦occ u pa tional¦ ¦safety¦ ¦and¦ ¦health¦ ¦admin i str ation¦ ▁( ¦ os h a¦ ),▁ ¦lower¦ ¦exp osure¦ ¦risk¦ ¦j ob s¦ ¦have¦ ¦min im al¦ ¦occ u pa tional¦ ¦contact¦ ¦with¦ ¦the¦ ¦public¦ ¦and¦ ¦other¦ ¦c ow or k ers¦ ,▁ ¦for¦ ¦which¦ ¦b as ic¦ ¦infection¦ ¦pre vention¦ ¦measures¦ ¦are¦ ¦recommended¦ ,▁ ¦including¦ ¦hand¦ ¦washing¦ ,▁ ¦e nc ou ra ging¦ ¦workers¦ ¦to¦ ¦stay¦ ¦home¦ ¦if¦ ¦they¦ ¦are¦ ¦sick¦ ,▁ ¦respiratory¦ ¦e ti qu et t e¦ ,▁ ¦and¦ ¦main t aining¦ ¦ro ut ine¦ ¦cl ea ning¦ ¦and¦ ¦disinf ecting¦ ¦of¦ ¦the¦ ¦work¦ ¦en vir on ment¦ .
𐋇 ¦me di um¦ ¦exp osure¦ ¦risk¦ ¦j ob s¦ ¦include¦ ¦those¦ ¦that¦ ¦requir e¦ ¦fre qu ent¦ ¦or¦ ¦close¦ ¦contact¦ ¦with¦ ¦people¦ ¦who¦ ¦are¦ ¦not¦ ¦known¦ ¦or¦ ¦suspected¦ ¦with¦ ¦covid¦ - ¦19¦ ,▁ ¦but¦ ¦may¦ ¦be¦ ¦infected¦ ¦due¦ ¦to¦ ¦o ng o ing¦ ¦community¦ ¦transmission¦ ¦or¦ ¦international¦ ¦travel¦ .
𐋇¦this¦ ¦inclu des¦ ¦workers¦ ¦who¦ ¦have¦ ¦contact¦ ¦with¦ ¦the¦ ¦general¦ ¦public¦ ¦such¦ ¦as¦ ¦in¦ ¦schools¦ ,▁ ¦high¦ - ¦population¦ - ¦de ns ity¦ ¦work¦ ¦en vir on ments¦ ,▁ ¦and¦ ¦some¦ ¦high¦ - ¦v o lu me¦ ¦re ta il¦ ¦s et t ings¦ .
𐋇 ¦ha z ard¦ ¦contr ols¦ ¦for¦ ¦this¦ ¦group¦ ,▁ ¦in¦ ¦add ition¦ ¦to¦ ¦b as ic¦ ¦infection¦ ¦pre vention¦ ¦measures¦ ,▁ ¦include¦ ¦ ventil ation¦ ¦using¦ ¦high¦ - ¦eff ic ie ncy¦ ¦air ¦ ¦f il t ers¦ ,▁ ¦s n ee z e¦ ¦gu ards¦ ,▁ ¦and¦ ¦having¦ ¦personal¦ ¦prot ective¦ ¦equipment¦ ¦available¦ ¦in¦ ¦case¦ ¦a¦ ¦person¦ ¦with¦ ¦covid¦ - ¦19¦ ¦is¦ ¦e nc ou nt ered¦ .
𐋇¦ os h a¦ ¦consid ers¦ ¦healthcare¦ ¦and¦ ¦m ort u ary¦ ¦workers¦ ¦exp osed¦ ¦to¦ ¦known¦ ¦or¦ ¦suspected¦ ¦person¦ ¦with¦ ¦covid¦ - ¦19¦ ¦to¦ ¦be¦ ¦at¦ ¦high¦ ¦exp osure¦ ¦risk¦ ,▁ ¦which¦ ¦inc rea ses¦ ¦to¦ ¦very¦ ¦high¦ ¦exp osure¦ ¦risk¦ ¦if¦ ¦workers¦ ¦per for m¦ ¦a er os o l¦ - ¦gener ating¦ ¦proc ed ures¦ ¦on¦ ,▁ ¦or¦ ¦coll ect¦ ¦or¦ ¦hand le¦ ¦spec im ens¦ ¦from¦ ,▁ ¦known¦ ¦or¦ ¦suspected¦ ¦person¦ ¦with¦ ¦covid¦ - ¦19¦ .
𐋇 ¦ha z ard¦ ¦contr ols¦ ¦appr op ri ate¦ ¦for¦ ¦these¦ ¦workers¦ ¦include¦ ¦e ng i ne ering¦ ¦contr ols¦ ¦such¦ ¦as¦ ¦negative¦ ¦pre ss ure¦ ¦ ventil ation¦ ¦r oo ms¦ ,▁ ¦and¦ ¦personal¦ ¦prot ective¦ ¦equipment¦ ¦appr op ri ate¦ ¦to¦ ¦the¦ ¦j ob ¦ ¦t as k¦ .
𐋇¦covid¦ - ¦19¦ ¦out b rea ks¦ ¦can¦ ¦have¦ ¦several¦ ¦eff ects¦ ¦within¦ ¦the¦ ¦work pl ace¦ .
𐋇 ¦workers¦ ¦may¦ ¦be¦ ¦ab s ent¦ ¦from¦ ¦work¦ ¦due¦ ¦to¦ ¦bec om ing¦ ¦sick¦ ,▁ ¦nee ding¦ ¦to¦ ¦care¦ ¦for¦ ¦others¦ ,▁ ¦or¦ ¦from¦ ¦f ear¦ ¦of¦ ¦possible¦ ¦exp osure¦ .
𐋇¦p at t er ns¦ ¦of¦ ¦comm er ce¦ ¦may¦ ¦ch ange¦ ,▁ ¦both¦ ¦in¦ ¦ter ms¦ ¦of¦ ¦what¦ ¦g oo ds¦ ¦are¦ ¦de ma nded¦ ,▁ ¦and¦ ¦the¦ ¦me ans¦ ¦of¦ ¦ac qu ir ing¦ ¦these¦ ¦g oo ds¦ ▁( ¦such¦ ¦as¦ ¦shopping¦ ¦at¦ ¦off ¦ - ¦p ea k¦ ¦hours¦ ¦or¦ ¦through¦ ¦de li ve ry¦ ¦or¦ ¦dr ive¦ - ¦through¦ ¦services¦ ).
𐋇 ¦la st ly¦ ,▁ ¦sh ip ments¦ ¦of¦ ¦i tems¦ ¦from¦ ¦ ge ogra ph ic¦ ¦areas¦ ¦se ver ely¦ ¦affected¦ ¦by¦ ¦covid¦ - ¦19¦ ¦may¦ ¦be¦ ¦inter ru p ted¦ . ¦an¦ ¦infectious¦ ¦disease¦ ¦pre par ed ness¦ ¦and¦ ¦response¦ ¦pl an¦ ¦can¦ ¦be¦ ¦used¦ ¦to¦ ¦gu ide¦ ¦prot ective¦ ¦ac tions¦ .
𐋇 ¦pl ans¦ ¦ad dr ess¦ ¦the¦ ¦le v els¦ ¦of¦ ¦risk¦ ¦associated¦ ¦with¦ ¦v ar ious¦ ¦work si tes¦ ¦and¦ ¦j ob ¦ ¦t as ks¦ ,▁ ¦including¦ ¦sour ces¦ ¦of¦ ¦exp osure¦ ,▁ ¦risk¦ ¦fa ctors¦ ¦ar ising¦ ¦from¦ ¦home¦ ¦and¦ ¦community¦ ¦s et t ings¦ ,▁ ¦and¦ ¦risk¦ ¦fa ctors¦ ¦of¦ ¦ind iv id ual¦ ¦workers¦ ¦such¦ ¦as¦ ¦o ld¦ ¦age¦ ¦or¦ ¦ch r on ic¦ ¦medical¦ ¦conditions¦ .
𐋇¦they¦ ¦also¦ ¦out line¦ ¦contr ols¦ ¦ne cess ary¦ ¦to¦ ¦ad dr ess¦ ¦those¦ ¦r is ks¦ ,▁ ¦and¦ ¦contin ge ncy¦ ¦pl ans¦ ¦for¦ ¦s itu ations¦ ¦that¦ ¦may¦ ¦ar ise¦ ¦as¦ ¦a¦ ¦result¦ ¦of¦ ¦out b rea ks¦ .
𐋇 ¦infectious¦ ¦disease¦ ¦pre par ed ness¦ ¦and¦ ¦response¦ ¦pl ans¦ ¦may¦ ¦be¦ ¦sub j ect¦ ¦to¦ ¦national¦ ¦or¦ ¦sub na tional¦ ¦recomm end ations¦ .
𐋇 ¦ob j ect ives¦ ¦for¦ ¦response¦ ¦to¦ ¦an¦ ¦outbreak¦ ¦include¦ ¦reduc ing¦ ¦transmission¦ ¦among¦ ¦staff¦ ,▁ ¦prot ecting¦ ¦people¦ ¦who¦ ¦are¦ ¦at¦ ¦higher¦ ¦risk¦ ¦for¦ ¦ad ver se¦ ¦health¦ ¦co mpl ications¦ ,▁ ¦main t aining¦ ¦bu si ness¦ ¦op er ations¦ ,▁ ¦and¦ ¦min im iz ing¦ ¦ad ver se¦ ¦eff ects¦ ¦on¦ ¦other¦ ¦ent ities¦ ¦in¦ ¦their¦ ¦supp ly¦ ¦cha ins¦ .
𐋇¦the¦ ¦disease¦ ¦se ver ity¦ ¦in¦ ¦the¦ ¦community¦ ¦where¦ ¦the¦ ¦bu si ness¦ ¦is¦ ¦loc ated¦ ¦aff ects¦ ¦the¦ ¦resp on ses¦ ¦ta k en¦ .
𐋇¦the¦ ¦hi er ar ch y¦ ¦of¦ ¦ha z ard¦ ¦contr ols¦ ¦is¦ ¦a¦ ¦fra me w or k¦ ¦wid ely¦ ¦used¦ ¦in¦ ¦occ u pa tional¦ ¦safety¦ ¦and¦ ¦health¦ ¦to¦ ¦group¦ ¦ha z ard¦ ¦contr ols¦ ¦by¦ ¦eff ec ti ve ness¦ .
𐋇 ¦where¦ ¦covid¦ - ¦19¦ ¦ha z ards¦ ¦cannot¦ ¦be¦ ¦e li min ated¦ ,▁ ¦the¦ ¦most¦ ¦effective¦ ¦contr ols¦ ¦are¦ ¦e ng i ne ering¦ ¦contr ols¦ ,▁ ¦fo ll owed¦ ¦by¦ ¦admin i str ative¦ ¦contr ols¦ ,▁ ¦and¦ ¦la st ly¦ ¦personal¦ ¦prot ective¦ ¦equipment¦ .
𐋇¦e ng i ne ering¦ ¦contr ols¦ ¦invol ve¦ ¦isol ating¦ ¦e mploy e es¦ ¦from¦ ¦work¦ - ¦related¦ ¦ha z ards¦ ¦without¦ ¦rel ying¦ ¦on¦ ¦work er¦ ¦be h a vi or¦ ,▁ ¦and¦ ¦can¦ ¦be¦ ¦the¦ ¦most¦ ¦c ost¦ - ¦effective¦ ¦s ol ution¦ ¦to¦ ¦imp le ment¦ .
𐋇 ¦admin i str ative¦ ¦contr ols¦ ¦are¦ ¦chan ges¦ ¦in¦ ¦work¦ ¦pol ic y¦ ¦or¦ ¦proc ed ures¦ ¦that¦ ¦requir e¦ ¦a ction¦ ¦by¦ ¦the¦ ¦work er¦ ¦or¦ ¦e mploy er¦ .
𐋇 ¦personal¦ ¦prot ective¦ ¦equipment¦ ▁( ¦ pp e¦ )▁ ¦is¦ ¦consid ered¦ ¦less¦ ¦effective¦ ¦than¦ ¦e ng i ne ering¦ ¦and¦ ¦admin i str ative¦ ¦contr ols¦ ,▁ ¦but¦ ¦can¦ ¦help¦ ¦prevent¦ ¦some¦ ¦exp os ures¦ .
𐋇 ¦all¦ ¦typ es¦ ¦of¦ ¦ pp e¦ ¦must¦ ¦be¦ ¦s el ected¦ ¦based¦ ¦up on¦ ¦the¦ ¦ha z ard¦ ¦to¦ ¦the¦ ¦work er¦ ,▁ ¦properly¦ ¦f it ted¦ ¦as¦ ¦app l ic able¦ ▁( ¦ e¦ . ¦ g¦ . ,▁ ¦resp ir at ors¦ ),▁ ¦cons is te ntly¦ ¦and¦ ¦properly¦ ¦wor n¦ ,▁ ¦regul arly¦ ¦i ns p ected¦ ,▁ ¦main ta ined¦ ,▁ ¦and¦ ¦re pl ac ed¦ ,▁ ¦as¦ ¦ne cess ary¦ ,▁ ¦and¦ ¦properly¦ ¦rem oved¦ ,▁ ¦cl ea ned¦ ,▁ ¦and¦ ¦st or ed¦ ¦or¦ ¦dis p osed¦ ¦of¦ ¦to¦ ¦avoid¦ ¦conta m ination¦ .
𐋇 ¦according¦ ¦to¦ ¦the¦ ¦u¦ . ¦s¦ .▁ ¦occ u pa tional¦ ¦safety¦ ¦and¦ ¦health¦ ¦admin i str ation¦ ▁( ¦ os h a¦ ),▁ ¦lower¦ ¦exp osure¦ ¦risk¦ ¦j ob s¦ ¦have¦ ¦min im al¦ ¦occ u pa tional¦ ¦contact¦ ¦with¦ ¦the¦ ¦public¦ ¦and¦ ¦other¦ ¦c ow or k ers¦ .
𐋇¦b as ic¦ ¦infection¦ ¦pre vention¦ ¦measures¦ ¦recommended¦ ¦for¦ ¦all¦ ¦work p la ces¦ ¦include¦ ¦fre qu ent¦ ¦and¦ ¦th or ough¦ ¦hand¦ ¦washing¦ ,▁ ¦e nc ou ra ging¦ ¦workers¦ ¦to¦ ¦stay¦ ¦home¦ ¦if¦ ¦they¦ ¦are¦ ¦sick¦ ,▁ ¦respiratory¦ ¦e ti qu et t e¦ ¦including¦ ¦cov ering¦ ¦cou gh s¦ ¦and¦ ¦s n ee z es¦ ,▁ ¦provid ing¦ ¦ti ss ues¦ ¦and¦ ¦tr as h ¦ ¦rece pt ac les¦ ,▁ ¦pre par ing¦ ¦for¦ ¦t el ec o mm u ting¦ ¦or¦ ¦sta gg ered¦ ¦sh if ts¦ ¦if¦ ¦nee ded¦ ,▁ ¦disc ou ra ging¦ ¦workers¦ ¦from¦ ¦using¦ ¦others¦ ' ▁ ¦to ols¦ ¦and¦ ¦equipment¦ ,▁ ¦and¦ ¦main t aining¦ ¦ro ut ine¦ ¦cl ea ning¦ ¦and¦ ¦disinf ecting¦ ¦of¦ ¦the¦ ¦work¦ ¦en vir on ment¦ .
𐋇 ¦pro mp t¦ ¦ident ific ation¦ ¦and¦ ¦isolation¦ ¦of¦ ¦pote nt ially¦ ¦infectious¦ ¦individuals¦ ¦is¦ ¦a¦ ¦crit ical¦ ¦ste p¦ ¦in¦ ¦prot ecting¦ ¦workers¦ ,▁ ¦c u st om ers¦ ,▁ ¦visi t ors¦ ,▁ ¦and¦ ¦others¦ ¦at¦ ¦a¦ ¦work s ite¦ .
𐋇¦the¦ ¦u¦ . ¦s¦ .▁ ¦ce nt ers¦ ¦for¦ ¦disease¦ ¦control¦ ¦and¦ ¦pre vention¦ ▁( ¦c dc¦ )▁ ¦recomm ends¦ ¦that¦ ¦e mploy e es¦ ¦who¦ ¦have¦ ¦symptoms¦ ¦of¦ ¦acute¦ ¦respiratory¦ ¦illness¦ ¦are¦ ¦to¦ ¦stay¦ ¦home¦ ¦until¦ ¦they¦ ¦are¦ ¦fre e¦ ¦of¦ ¦fever¦ ,▁ ¦signs¦ ¦of¦ ¦a¦ ¦fever¦ ,▁ ¦and¦ ¦any¦ ¦other¦ ¦symptoms¦ ¦for¦ ¦at¦ ¦least¦ ¦24¦ ¦hours¦ ¦without¦ ¦the¦ ¦use¦ ¦of¦ ¦fever¦ - ¦reduc ing¦ ¦or¦ ¦other¦ ¦s y m pt om¦ - ¦al t ering¦ ¦medic ines¦ ,▁ ¦and¦ ¦that¦ ¦sick¦ ¦lea ve¦ ¦pol ic ies¦ ¦are¦ ¦f le xi ble¦ ,▁ ¦per mi t¦ ¦e mploy e es¦ ¦to¦ ¦stay¦ ¦home¦ ¦to¦ ¦care¦ ¦for¦ ¦a¦ ¦sick¦ ¦family¦ ¦me mber¦ ,▁ ¦and¦ ¦that¦ ¦e mploy e es¦ ¦are¦ ¦a w are¦ ¦of¦ ¦these¦ ¦pol ic ies¦ .
𐋇 ¦according¦ ¦to¦ ¦ os h a¦ ,▁ ¦me di um¦ ¦exp osure¦ ¦risk¦ ¦j ob s¦ ¦include¦ ¦those¦ ¦that¦ ¦requir e¦ ¦fre qu ent¦ ¦or¦ ¦close¦ ¦contact¦ ¦within¦ ¦si x¦ ¦fe et¦ ▁( ¦1¦ . ¦8¦ ¦ m¦ )▁ ¦of¦ ¦people¦ ¦who¦ ¦are¦ ¦not¦ ¦known¦ ¦or¦ ¦suspected¦ ¦covid¦ - ¦19¦ ¦patients¦ ,▁ ¦but¦ ¦may¦ ¦be¦ ¦infected¦ ¦with¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦due¦ ¦to¦ ¦o ng o ing¦ ¦community¦ ¦transmission¦ ¦around¦ ¦the¦ ¦bu si ness¦ ¦loc ation¦ ,▁ ¦or¦ ¦because¦ ¦the¦ ¦ind iv id ual¦ ¦has¦ ¦rec ent¦ ¦international¦ ¦travel¦ ¦to¦ ¦a¦ ¦loc ation¦ ¦with¦ ¦wid esp r ead¦ ¦covid¦ - ¦19¦ ¦transmission¦ .
𐋇¦these¦ ¦include¦ ¦workers¦ ¦who¦ ¦have¦ ¦contact¦ ¦with¦ ¦the¦ ¦general¦ ¦public¦ ¦such¦ ¦as¦ ¦in¦ ¦schools¦ ,▁ ¦high¦ - ¦population¦ - ¦de ns ity¦ ¦work¦ ¦en vir on ments¦ ,▁ ¦and¦ ¦some¦ ¦high¦ - ¦v o lu me¦ ¦re ta il¦ ¦s et t ings¦ . ¦e ng i ne ering¦ ¦contr ols¦ ¦for¦ ¦this¦ ¦and¦ ¦higher¦ ¦risk¦ ¦grou ps¦ ¦include¦ ¦inst a lling¦ ¦high¦ - ¦eff ic ie ncy¦ ¦air ¦ ¦f il t ers¦ ,▁ ¦incre as ing¦ ¦ ventil ation¦ ¦r ates¦ ,▁ ¦inst a lling¦ ¦ph ys ical¦ ¦b ar ri ers¦ ¦such¦ ¦as¦ ¦cl ear¦ ¦pla st ic¦ ¦s n ee z e¦ ¦gu ards¦ ,▁ ¦and¦ ¦inst a lling¦ ¦a¦ ¦dr ive¦ - ¦through¦ ¦w i nd ow¦ ¦for¦ ¦c u st om er¦ ¦service¦ . ¦admin i str ative¦ ¦contr ols¦ ¦for¦ ¦this¦ ¦and¦ ¦higher¦ ¦risk¦ ¦grou ps¦ ¦include¦ ¦e nc ou ra ging¦ ¦sick¦ ¦workers¦ ¦to¦ ¦stay¦ ¦at¦ ¦home¦ ,▁ ¦re pl ac ing¦ ¦face¦ - ¦to¦ - ¦face¦ ¦me et ings¦ ¦with¦ ¦vir t ual¦ ¦comm un ications¦ ,▁ ¦ es ta bl is hing¦ ¦sta gg ered¦ ¦sh if ts¦ ,▁ ¦disc o nt in u ing¦ ¦n on es se ntial¦ ¦travel¦ ¦to¦ ¦loc ations¦ ¦with¦ ¦o ng o ing¦ ¦covid¦ - ¦19¦ ¦out b rea ks¦ ,▁ ¦develop ing¦ ¦emergency¦ ¦comm un ications¦ ¦pl ans¦ ¦including¦ ¦a¦ ¦for um¦ ¦for¦ ¦a ns w ering¦ ¦workers¦ ▁’▁ ¦concer ns¦ ,▁ ¦provid ing¦ ¦workers¦ ¦with¦ ¦up¦ - ¦to¦ - ¦date¦ ¦education¦ ¦and¦ ¦tr aining¦ ¦on¦ ¦covid¦ - ¦19¦ ¦risk¦ ¦fa ctors¦ ¦and¦ ¦prot ective¦ ¦be h a vi ors¦ ,▁ ¦tr aining¦ ¦workers¦ ¦who¦ ¦need¦ ¦to¦ ¦use¦ ¦prot ecting¦ ¦c lo thing¦ ¦and¦ ¦equipment¦ ¦how¦ ¦to¦ ¦use¦ ¦it¦ ,▁ ¦provid ing¦ ¦res o ur ces¦ ¦and¦ ¦a¦ ¦work¦ ¦en vir on ment¦ ¦that¦ ¦pro mo tes¦ ¦personal¦ ¦h yg ien e¦ ,▁ ¦requir ing¦ ¦reg ular¦ ¦hand¦ ¦washing¦ ,▁ ¦limi ting¦ ¦c u st om ers¦ ' ▁ ¦and¦ ¦the¦ ¦public¦ ' ¦s¦ ¦acc ess¦ ¦to¦ ¦the¦ ¦work s ite¦ ,▁ ¦and¦ ¦p os ting¦ ¦sign age¦ ¦about¦ ¦hand¦ ¦washing¦ ¦and¦ ¦other¦ ¦covid¦ - ¦19¦ ¦prot ective¦ ¦measures¦ . ¦dep ending¦ ¦on¦ ¦the¦ ¦work¦ ¦t as k¦ ,▁ ¦workers¦ ¦with¦ ¦at¦ ¦least¦ ¦me di um¦ ¦exp osure¦ ¦risk¦ ¦may¦ ¦need¦ ¦to¦ ¦wear¦ ¦personal¦ ¦prot ective¦ ¦equipment¦ ¦including¦ ¦some¦ ¦co mb ination¦ ¦of¦ ¦g lo ves¦ ,▁ ¦a¦ ¦g own¦ ,▁ ¦a¦ ¦face¦ ¦sh ie ld¦ ¦or¦ ¦face¦ ¦mask¦ ,▁ ¦or¦ ¦go gg les¦ .
𐋇 ¦workers¦ ¦in¦ ¦this¦ ¦risk¦ ¦group¦ ¦r ar ely¦ ¦requir e¦ ¦use¦ ¦of¦ ¦resp ir at ors¦ .
𐋇¦if¦ ¦a¦ ¦person¦ ¦bec omes¦ ¦sick¦ ¦on¦ ¦an¦ ¦air pl an e¦ ,▁ ¦prop er¦ ¦contr ols¦ ¦to¦ ¦protect¦ ¦workers¦ ¦and¦ ¦other¦ ¦p as se ng ers¦ ¦include¦ ¦separ ating¦ ¦the¦ ¦sick¦ ¦person¦ ¦from¦ ¦others¦ ¦by¦ ¦a¦ ¦dista nce¦ ¦of¦ ¦6¦ ¦fe et¦ ,▁ ¦de si gn ating¦ ¦one¦ ¦cre w¦ ¦me mber¦ ¦to¦ ¦ser ve¦ ¦the¦ ¦sick¦ ¦person¦ ,▁ ¦and¦ ¦off ering¦ ¦a¦ ¦face¦ ¦mask¦ ¦to¦ ¦the¦ ¦sick¦ ¦person¦ ¦or¦ ¦as king¦ ¦the¦ ¦sick¦ ¦person¦ ¦to¦ ¦cover¦ ¦their¦ ¦mouth¦ ¦and¦ ¦nose¦ ¦with¦ ¦ti ss ues¦ ¦when¦ ¦cou g hing¦ ¦or¦ ¦sneezing¦ .
𐋇¦c ab in¦ ¦cre w¦ ¦should¦ ¦wear¦ ¦dis p os able¦ ¦medical¦ ¦g lo ves¦ ¦when¦ ¦t ending¦ ¦to¦ ¦a¦ ¦sick¦ ¦tra v el er¦ ¦or¦ ¦to uc hing¦ ¦body¦ ¦f lu i ds¦ ¦or¦ ¦pote nt ially¦ ¦conta min ated¦ ¦sur fa ces¦ ,▁ ¦and¦ ¦p os si b ly¦ ¦ad di tional¦ ¦personal¦ ¦prot ective¦ ¦equipment¦ ¦if¦ ¦the¦ ¦sick¦ ¦tra v el er¦ ¦has¦ ¦fever¦ ,▁ ¦pers ist ent¦ ¦cough¦ ,▁ ¦or¦ ¦diffic ult y¦ ¦brea thing¦ .
𐋇 ¦g lo ves¦ ¦and¦ ¦other¦ ¦dis p os able¦ ¦i tems¦ ¦should¦ ¦be¦ ¦dis p osed¦ ¦of¦ ¦in¦ ¦a¦ ¦bi o h a z ard¦ ¦ba g¦ ,▁ ¦and¦ ¦conta min ated¦ ¦sur fa ces¦ ¦should¦ ¦be¦ ¦cl ea ned¦ ¦and¦ ¦disinf ected¦ ¦a f t er w ards¦ . ¦for¦ ¦comm erc ial¦ ¦s hi pping¦ ,▁ ¦including¦ ¦c ru ise¦ ¦s hi ps¦ ¦and¦ ¦other¦ ¦p as se nger¦ ¦ ve ss els¦ ,▁ ¦ha z ard¦ ¦contr ols¦ ¦include¦ ¦po st p o ning¦ ¦travel¦ ¦when¦ ¦sick¦ ,▁ ¦and¦ ¦self¦ - ¦isol ating¦ ¦and¦ ¦inf orm ing¦ ¦the¦ ¦ on bo ard¦ ¦medical¦ ¦center¦ ¦imm ed ia tely¦ ¦if¦ ¦one¦ ¦develop s¦ ¦a¦ ¦fever¦ ¦or¦ ¦other¦ ¦symptoms¦ ¦while¦ ¦on¦ ¦ bo ard¦ .
𐋇¦ ide ally¦ ,▁ ¦medical¦ ¦follow¦ - ¦up¦ ¦should¦ ¦occur ¦ ¦in¦ ¦the¦ ¦isol ated¦ ¦person¦ ' ¦s¦ ¦c ab in¦ . ¦for¦ ¦schools¦ ¦and¦ ¦ch ild c are¦ ¦facil ities¦ ,▁ ¦c dc¦ ¦recomm ends¦ ¦sh ort¦ - ¦ter m¦ ¦cl osure¦ ¦to¦ ¦clean¦ ¦or¦ ¦disinf ect¦ ¦if¦ ¦an¦ ¦infected¦ ¦person¦ ¦has¦ ¦been¦ ¦in¦ ¦a¦ ¦school¦ ¦bu il ding¦ ¦reg ar d less¦ ¦of¦ ¦community¦ ¦spread¦ .
𐋇¦when¦ ¦there¦ ¦is¦ ¦min im al¦ ¦to¦ ¦mod er ate¦ ¦community¦ ¦transmission¦ ,▁ ¦social¦ ¦distancing¦ ¦stra te g ies¦ ¦can¦ ¦be¦ ¦imp le m ented¦ ¦such¦ ¦as¦ ¦cance l ing¦ ¦f ie ld¦ ¦t ri ps¦ ,▁ ¦as se m bl ies¦ ,▁ ¦and¦ ¦other¦ ¦large¦ ¦ga ther ings¦ ¦such¦ ¦as¦ ¦ph ys ical¦ ¦education¦ ¦or¦ ¦ch oi r¦ ¦cl as ses¦ ¦or¦ ¦me als¦ ¦in¦ ¦a¦ ¦ca f et er ia¦ ,▁ ¦incre as ing¦ ¦the¦ ¦sp ace¦ ¦between¦ ¦d es ks¦ ,▁ ¦sta gg ering¦ ¦arr iv al¦ ¦and¦ ¦dis mi ss al¦ ¦times¦ ,▁ ¦limi ting¦ ¦n on es se ntial¦ ¦visi t ors¦ ,▁ ¦and¦ ¦using¦ ¦a¦ ¦separ ate¦ ¦health¦ ¦off ice¦ ¦loc ation¦ ¦for¦ ¦children¦ ¦with¦ ¦flu¦ - ¦like¦ ¦symptoms¦ .
𐋇¦when¦ ¦there¦ ¦is¦ ¦sub s ta ntial¦ ¦transmission¦ ¦in¦ ¦the¦ ¦local¦ ¦community¦ ,▁ ¦in¦ ¦add ition¦ ¦to¦ ¦social¦ ¦distancing¦ ¦stra te g ies¦ ,▁ ¦ex te nded¦ ¦school¦ ¦dis mi ss als¦ ¦may¦ ¦be¦ ¦consid ered¦ . ¦for¦ ¦la w¦ ¦en for ce ment¦ ¦pers on ne l¦ ¦per f orm ing¦ ¦daily¦ ¦ro ut ine¦ ¦activ ities¦ ,▁ ¦the¦ ¦immediate¦ ¦health¦ ¦risk¦ ¦is¦ ¦consid ered¦ ¦low¦ ¦by¦ ¦c dc¦ .
𐋇 ¦la w¦ ¦en for ce ment¦ ¦off ici als¦ ¦who¦ ¦must¦ ¦make¦ ¦contact¦ ¦with¦ ¦individuals¦ ¦confirmed¦ ¦or¦ ¦suspected¦ ¦to¦ ¦have¦ ¦covid¦ - ¦19¦ ¦are¦ ¦recommended¦ ¦to¦ ¦follow¦ ¦the¦ ¦same¦ ¦gu id el ines¦ ¦as¦ ¦emergency¦ ¦medical¦ ¦techn ici ans¦ ,▁ ¦including¦ ¦prop er¦ ¦personal¦ ¦prot ective¦ ¦equipment¦ .
𐋇¦if¦ ¦close¦ ¦contact¦ ¦occur s¦ ¦during¦ ¦app re he ns ion¦ ,▁ ¦workers¦ ¦should¦ ¦clean¦ ¦and¦ ¦disinf ect¦ ¦their¦ ¦d ut y¦ ¦b el t¦ ¦and¦ ¦g ear¦ ¦pri or¦ ¦to¦ ¦re use¦ ¦using¦ ¦a¦ ¦hou se ho ld¦ ¦cl ea ning¦ ¦sp r ay¦ ¦or¦ ¦w ip e¦ ,▁ ¦and¦ ¦follow¦ ¦sta nd ard¦ ¦op er ating¦ ¦proc ed ures¦ ¦for¦ ¦the¦ ¦conta in ment¦ ¦and¦ ¦dis p os al¦ ¦of¦ ¦used¦ ¦ pp e¦ ¦and¦ ¦for¦ ¦cont aining¦ ¦and¦ ¦la u nd ering¦ ¦c lo th es¦ .
𐋇¦ os h a¦ ¦consid ers¦ ¦c er tain¦ ¦healthcare¦ ¦and¦ ¦m ort u ary¦ ¦workers¦ ¦to¦ ¦be¦ ¦at¦ ¦high¦ ¦or¦ ¦very¦ ¦high¦ ¦ca te g or ies¦ ¦of¦ ¦exp osure¦ ¦risk¦ .
𐋇 ¦high¦ ¦exp osure¦ ¦risk¦ ¦j ob s¦ ¦include¦ ¦healthcare¦ ¦de li ve ry¦ ,▁ ¦support¦ ,▁ ¦laboratory¦ ,▁ ¦and¦ ¦medical¦ ¦transport¦ ¦workers¦ ¦who¦ ¦are¦ ¦exp osed¦ ¦to¦ ¦known¦ ¦or¦ ¦suspected¦ ¦covid¦ - ¦19¦ ¦patients¦ .
𐋇¦these¦ ¦bec ome¦ ¦very¦ ¦high¦ ¦exp osure¦ ¦risk¦ ¦if¦ ¦workers¦ ¦per for m¦ ¦a er os o l¦ - ¦gener ating¦ ¦proc ed ures¦ ¦on¦ ,▁ ¦or¦ ¦coll ect¦ ¦or¦ ¦hand le¦ ¦spec im ens¦ ¦from¦ ,▁ ¦known¦ ¦or¦ ¦suspected¦ ¦covid¦ - ¦19¦ ¦patients¦ .
𐋇 ¦a er os o l¦ - ¦gener ating¦ ¦proc ed ures¦ ¦include¦ ¦int ub ation¦ ,▁ ¦cough¦ ¦ind u ction¦ ¦proc ed ures¦ ,▁ ¦br on ch os c op ies¦ ,▁ ¦some¦ ¦de ntal¦ ¦proc ed ures¦ ¦and¦ ¦ex a ms¦ ,▁ ¦or¦ ¦inv as ive¦ ¦spec im en¦ ¦colle ction¦ .
𐋇 ¦high¦ ¦exp osure¦ ¦risk¦ ¦m ort u ary¦ ¦j ob s¦ ¦include¦ ¦workers¦ ¦invol v ed¦ ¦in¦ ¦pre par ing¦ ¦the¦ ¦ bo dies¦ ¦of¦ ¦people¦ ¦who¦ ¦had¦ ¦known¦ ¦or¦ ¦suspected¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦at¦ ¦the¦ ¦time¦ ¦of¦ ¦their¦ ¦death¦ ;▁ ¦these¦ ¦bec ome¦ ¦very¦ ¦high¦ ¦exp osure¦ ¦risk¦ ¦if¦ ¦they¦ ¦per for m¦ ¦an¦ ¦a ut op s y¦ . ¦ad di tional¦ ¦e ng i ne ering¦ ¦contr ols¦ ¦for¦ ¦these¦ ¦risk¦ ¦grou ps¦ ¦include¦ ¦isolation¦ ¦r oo ms¦ ¦for¦ ¦patients¦ ¦with¦ ¦known¦ ¦or¦ ¦suspected¦ ¦covid¦ - ¦19¦ ,▁ ¦including¦ ¦when¦ ¦a er os o l¦ - ¦gener ating¦ ¦proc ed ures¦ ¦are¦ ¦per for med¦ .
𐋇 ¦spec ia li zed¦ ¦negative¦ ¦pre ss ure¦ ¦ ventil ation¦ ¦may¦ ¦be¦ ¦appr op ri ate¦ ¦in¦ ¦some¦ ¦healthcare¦ ¦and¦ ¦m ort u ary¦ ¦s et t ings¦ .
𐋇 ¦spec im ens¦ ¦should¦ ¦be¦ ¦hand l ed¦ ¦with¦ ¦bi os a f et y¦ ¦level¦ ¦3¦ ¦pr ec a u tions¦ .
𐋇¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ▁( ¦who¦ )▁ ¦recomm ends¦ ¦that¦ ¦inc om ing¦ ¦patients¦ ¦be¦ ¦separ ated¦ ¦into¦ ¦dis ti nc t¦ ¦wai ting¦ ¦areas¦ ¦dep ending¦ ¦on¦ ¦wh ether¦ ¦they¦ ¦are¦ ¦a¦ ¦suspected¦ ¦covid¦ - ¦19¦ ¦case¦ . ¦in¦ ¦add ition¦ ¦to¦ ¦other¦ ¦ pp e¦ ,▁ ¦ os h a¦ ¦recomm ends¦ ¦resp ir at ors¦ ¦for¦ ¦those¦ ¦who¦ ¦work¦ ¦within¦ ¦6¦ ¦fe et¦ ¦of¦ ¦patients¦ ¦known¦ ¦to¦ ¦be¦ ,▁ ¦or¦ ¦suspected¦ ¦of¦ ¦being¦ ,▁ ¦infected¦ ¦with¦ ¦sars¦ - ¦cov¦ - ¦2¦ ,▁ ¦and¦ ¦those¦ ¦per f orm ing¦ ¦a er os o l¦ - ¦gener ating¦ ¦proc ed ures¦ .
𐋇¦in¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦n i os h ¦ - ¦appr oved¦ ¦n 9 5¦ ¦f il t ering¦ ¦fa cep ie ce¦ ¦resp ir at ors¦ ¦or¦ ¦bet ter¦ ¦must¦ ¦be¦ ¦used¦ ¦in¦ ¦the¦ ¦con te xt¦ ¦of¦ ¦a¦ ¦comp re he ns ive¦ ,▁ ¦w r it t en¦ ¦respiratory¦ ¦prote ction¦ ¦pr ogra m¦ ¦that¦ ¦inclu des¦ ¦fi t¦ - ¦testing¦ ,▁ ¦tr aining¦ ,▁ ¦and¦ ¦medical¦ ¦ex a ms¦ .
𐋇 ¦other¦ ¦typ es¦ ¦of¦ ¦resp ir at ors¦ ¦can¦ ¦provide¦ ¦g rea ter¦ ¦prote ction¦ ¦and¦ ¦imp ro ve¦ ¦work er¦ ¦c om f ort¦ . ¦the¦ ¦who¦ ¦does¦ ¦not¦ ¦recomm end¦ ¦co ve ra lls¦ ,▁ ¦as¦ ¦covid¦ - ¦19¦ ¦is¦ ¦a¦ ¦respiratory¦ ¦disease¦ ¦r at her¦ ¦than¦ ¦being¦ ¦transm it ted¦ ¦through¦ ¦ bo di ly¦ ¦f lu i ds¦ .
𐋇 ¦who¦ ¦recomm ends¦ ¦only¦ ¦a¦ ¦sur g ical¦ ¦mask¦ ¦for¦ ¦po in t¦ - ¦of¦ - ¦ent ry¦ ¦scre ening¦ ¦pers on ne l¦ .
𐋇¦for¦ ¦those¦ ¦who¦ ¦are¦ ¦coll ecting¦ ¦respiratory¦ ¦spec im ens¦ ¦from¦ ,▁ ¦car ing¦ ¦for¦ ,▁ ¦or¦ ¦trans p orting¦ ¦covid¦ - ¦19¦ ¦patients¦ ¦without¦ ¦any¦ ¦a er os o l¦ - ¦gener ating¦ ¦proc ed ures¦ ,▁ ¦who¦ ¦recomm ends¦ ¦a¦ ¦sur g ical¦ ¦mask¦ ,▁ ¦go gg les¦ ,▁ ¦or¦ ¦face¦ ¦sh ie ld¦ ,▁ ¦g own¦ ,▁ ¦and¦ ¦g lo ves¦ .
𐋇¦if¦ ¦an¦ ¦a er os o l¦ - ¦gener ating¦ ¦proc ed ure¦ ¦is¦ ¦per for med¦ ,▁ ¦the¦ ¦sur g ical¦ ¦mask¦ ¦is¦ ¦re pl ac ed¦ ¦with¦ ¦an¦ ¦n 9 5¦ ¦or¦ ¦ ff p 2¦ ¦resp ir at or¦ .
𐋇 ¦giv en¦ ¦that¦ ¦the¦ ¦global¦ ¦supp ly¦ ¦of¦ ¦ pp e¦ ¦is¦ ¦i ns u ff ici ent¦ ,▁ ¦who¦ ¦recomm ends¦ ¦min im iz ing¦ ¦the¦ ¦need¦ ¦for¦ ¦ pp e¦ ¦through¦ ¦te le m ed ic ine¦ ,▁ ¦ph ys ical¦ ¦b ar ri ers¦ ¦such¦ ¦as¦ ¦cl ear¦ ¦w i nd ow s¦ ,▁ ¦all owing¦ ¦only¦ ¦those¦ ¦invol v ed¦ ¦in¦ ¦direct¦ ¦care¦ ¦to¦ ¦en ter¦ ¦a¦ ¦ro om¦ ¦with¦ ¦a¦ ¦covid¦ - ¦19¦ ¦pa ti ent¦ ,▁ ¦using¦ ¦only¦ ¦the¦ ¦ pp e¦ ¦ne cess ary¦ ¦for¦ ¦the¦ ¦specific¦ ¦t as k¦ ,▁ ¦contin u ing¦ ¦use¦ ¦of¦ ¦the¦ ¦same¦ ¦resp ir at or¦ ¦without¦ ¦re mo ving¦ ¦it¦ ¦while¦ ¦car ing¦ ¦for¦ ¦mult ip le¦ ¦patients¦ ¦with¦ ¦the¦ ¦same¦ ¦diagn o sis¦ ,▁ ¦monit or ing¦ ¦and¦ ¦co or d in ating¦ ¦the¦ ¦ pp e¦ ¦supp ly¦ ¦cha in¦ ,▁ ¦and¦ ¦disc ou ra ging¦ ¦the¦ ¦use¦ ¦of¦ ¦masks¦ ¦for¦ ¦as ymptomatic¦ ¦individuals¦ .
𐋇 ¦from¦ :▁ 𐋇 ¦k a ther ine¦ ¦ma her¦ ,▁ ¦w i k im ed ia¦ ¦f ou nd ation¦ ¦ce o¦
𐋇¦to¦ :▁ 𐋇 ¦all¦ ¦w i k im ed ia¦ ¦f ou nd ation¦ ¦staff¦
𐋇 ¦sub j ect¦ ¦ line¦ :▁ [ 𐋇¦covid¦ - ¦19¦ ] ▁ ¦li gh t ening¦ ¦the¦ ¦lo ad¦ ¦and¦ ¦pre par ing¦ ¦for¦ ¦the¦ ¦f ut ure¦
𐋇¦s end¦ ¦date¦ ▁/▁ ¦time¦ :▁ ¦14¦ ¦march¦ ,▁ ¦2020¦ ,▁ ¦ 00¦ :▁ ¦24¦ ¦ ut c¦
𐋇 ¦li ce ns ing¦ :▁ 𐋇¦c c 0¦ :▁ 𐋇 ¦no¦ ¦ ri gh ts¦ ¦res erv ed¦
𐋇¦we¦ ¦f ind¦ ¦ ou rs el ves¦ ¦in¦ ¦rem ar k able¦ ¦c ir c um st an ces¦ ¦this¦ ¦mon th¦ .
𐋇¦the¦ ¦covid¦ - ¦19¦ ¦epidemic¦ ¦is¦ ¦so me thing¦ ¦that¦ ¦ma k es¦ ¦cl ear¦ ¦our¦ ¦global¦ ¦human¦ ¦int erc on n ect ed ness¦ ¦and¦ ¦the¦ ¦resp on si b il ities¦ ¦we¦ ¦have¦ ¦to¦ ¦one¦ ¦another¦ .
𐋇¦we¦ ¦d on¦ ▁’▁ ¦t¦ ¦have¦ ¦pr ec ed ent¦ ¦for¦ ¦its¦ ¦cha ll en ges¦ ,▁ ¦but¦ ¦we¦ ¦do¦ ¦know¦ ¦that¦ ¦our¦ ¦b est¦ ¦response¦ ¦rel ies¦ ¦on¦ ¦the¦ ¦s ort¦ ¦of¦ ¦global¦ ¦e m pa th y¦ ,▁ ¦co op er ation¦ ,▁ ¦and¦ ¦community¦ ¦bu il ding¦ ¦that¦ ¦si ts¦ ¦at¦ ¦the¦ ¦h ear t¦ ¦of¦ ¦this¦ ¦organiz ation¦ .
𐋇¦the¦ ¦ca ma rad eri e¦ ¦and¦ ¦care¦ ¦we¦ ¦have¦ ¦se en¦ ¦among¦ ¦all¦ ¦of¦ ¦our¦ ¦coll ea g ues¦ ¦over¦ ¦e ma il¦ ,▁ ¦ca lls¦ ,▁ ¦and¦ ¦cha ts¦ ¦is¦ ¦a¦ ¦rem ar k able¦ ¦v al id ation¦ ¦of¦ ¦the¦ ¦incre di ble¦ ¦humans¦ ¦we¦ ¦are¦ ¦f ort un ate¦ ¦en ough¦ ¦to¦ ¦work¦ ¦with¦ .
𐋇 ¦i¦ ¦co ul d n¦ ▁’▁ ¦t¦ ¦be¦ ¦more¦ ¦g ra te ful¦ ¦and¦ ¦pr ou d¦ ¦to¦ ¦co un t¦ ¦you¦ ¦all¦ ¦as¦ ¦coll ea g ues¦ .
𐋇 ¦last¦ ¦week¦ ,▁ ¦someone¦ ¦sh ared¦ ¦with¦ ¦ me¦ ¦their¦ ¦appr ec i ation¦ ¦for¦ ¦our¦ ¦work¦ .
𐋇¦they¦ ¦re mi nded¦ ¦ me¦ ¦how¦ ¦me an i ng ful¦ ¦it¦ ¦is¦ ¦for¦ ¦the¦ ¦world¦ ¦to¦ ¦be¦ ¦able¦ ¦to¦ ¦t ur n¦ ¦to¦ ¦w i k ip ed ia¦ ¦r ight¦ ¦n ow¦ ,▁ ¦and¦ ¦what¦ ¦a¦ ¦p ow er ful¦ ¦s y m bo l¦ ¦it¦ ¦is¦ ¦for¦ ¦this¦ ¦crit ical¦ ¦res o ur ce¦ ¦to¦ ¦remain¦ ¦online¦ ¦and¦ ¦available¦ ¦to¦ ¦all¦ .
𐋇¦your¦ ¦work¦ ¦ma k es¦ ¦this¦ ¦possible¦ ,▁ ¦wh ether¦ ¦you¦ ¦keep¦ ¦the¦ ¦si tes¦ ¦stay¦ ¦up¦ ¦or¦ ¦our¦ ¦coll ea g ues¦ ¦pa id¦ ¦or¦ ¦our¦ ¦comm un ities¦ ¦safe¦ .
𐋇¦the¦ ¦world¦ ¦needs¦ ¦the¦ ¦information¦ ¦that¦ ¦w i k ip ed ia¦ ¦provid es¦ ,▁ ¦n ow¦ ¦more¦ ¦than¦ ¦e ver¦ .
𐋇¦this¦ ¦is¦ ¦a¦ ¦mo ment¦ ¦in¦ ¦which¦ ¦not¦ ¦only¦ ¦what¦ ¦we¦ ¦do¦ ,▁ ¦but¦ ¦how¦ ¦we¦ ¦do¦ ¦it¦ ,▁ ¦will¦ ¦make¦ ¦a¦ ¦me an i ng ful¦ ¦impac t¦ ¦on¦ ¦the¦ ¦world¦ .
𐋇 ¦because¦ ¦of¦ ¦the¦ ¦imp ort ance¦ ¦of¦ ¦this¦ ¦mi ssion¦ ¦and¦ ¦your¦ ¦ro le¦ ¦in¦ ¦it¦ ,▁ ¦we¦ ¦will¦ ¦be¦ ¦ma king¦ ¦some¦ ¦sign ific ant¦ ¦ad j u st ments¦ ¦to¦ ¦how¦ ¦we¦ ¦work¦ ¦t og ether¦ ,▁ ¦star ting¦ ¦this¦ ¦c om ing¦ ¦week¦ .
𐋇 ¦ad j u st ments¦ ¦to¦ ¦our¦ ¦work¦ ¦and¦ ¦s ch ed u les¦
𐋇¦as¦ ¦r ob y n¦ ¦m en tion ed¦ ¦previously¦ ,▁ ¦the¦ ¦ c¦ - ¦team¦ ¦m et¦ ¦last¦ ¦n ight¦ ¦to¦ ¦disc us s¦ ¦our¦ ¦appro a ch¦ ¦and¦ ¦s ch ed u le¦ ¦for¦ ¦the¦ ¦c om ing¦ ¦days¦ ¦and¦ ¦mon ths¦ .
𐋇¦in¦ ¦that¦ ¦con ve rs ation¦ ,▁ ¦we¦ ¦consid ered¦ ¦what¦ ¦we¦ ¦th ou gh t¦ ¦would¦ ¦be¦ ¦an¦ ¦appr op ri ate¦ ¦response¦ ¦to¦ ¦what¦ ¦we¦ ▁’▁ ¦r e¦ ¦f ac ing¦ ¦and¦ ¦the¦ ¦b est¦ ¦way¦ ¦to¦ ¦keep¦ ¦the¦ ¦organiz ation¦ ¦s us ta in able¦ ¦during¦ ¦this¦ ¦time¦ .
𐋇 ¦over w h el mi ng ly¦ ¦we¦ ¦w an ted¦ ¦to¦ ¦re mo ve¦ ¦ str ess¦ ¦and¦ ¦support¦ ¦our¦ ¦mi ssion¦ ¦for¦ ¦the¦ ¦long¦ ¦ter m¦ .
𐋇¦if¦ ¦you¦ ¦need¦ ¦to¦ ¦d ial¦ ¦b ack¦ ,▁ ¦that¦ ▁’▁ ¦s¦ ¦o k ay¦ .
𐋇¦for¦ ¦all¦ ¦staff¦ ,▁ ¦cont ra ctors¦ ,▁ ¦and¦ ¦contr ac t¦ ¦workers¦ :
𐋇 ¦our¦ ¦daily¦ ¦wor king¦ ¦exp ect ations¦ ¦will¦ ¦be¦ ¦about¦ ¦4¦ ¦hours¦ ¦a¦ ¦day¦ ,▁ ¦or¦ ¦20¦ ¦hours¦ ¦a¦ ¦week¦ ¦until¦ ¦further¦ ¦n ot ice¦ .
𐋇¦we¦ ▁’▁ ¦r e¦ ¦not¦ ¦decl ar ing¦ ¦a¦ ¦ho li day¦ ▁-▁ ¦if¦ ¦you¦ ¦are¦ ¦able¦ ¦to¦ ¦work¦ ¦more¦ ¦normal¦ ¦hours¦ ,▁ ¦the¦ ¦mi ssion¦ ¦can¦ ¦use¦ ¦you¦ .
𐋇¦however¦ ,▁ ¦the¦ ¦world¦ ¦is¦ ¦un p re di ct able¦ ¦r ight¦ ¦n ow¦ ,▁ ¦and¦ ¦wh ether¦ ¦you¦ ¦need¦ ¦to¦ ¦care¦ ¦for¦ ¦l oved¦ ¦ on es¦ ,▁ ¦get¦ ¦gr oc er ies¦ ,▁ ¦or¦ ¦go¦ ¦to¦ ¦the¦ ¦doctor¦ ,▁ ¦your¦ ¦well¦ - ¦being¦ ¦is¦ ¦our¦ ¦pri or ity¦ .
𐋇¦we¦ ¦are¦ ¦not¦ ¦tracking¦ ¦your¦ ¦time¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦sick¦ ,▁ ¦do¦ ¦not¦ ¦work¦ .
𐋇¦this¦ ¦should¦ ¦go¦ ¦without¦ ¦sa ying¦ ,▁ ¦but¦ ¦we¦ ▁’▁ ¦r e¦ ¦sa ying¦ ¦it¦ .
𐋇 ¦no¦ ¦sick¦ ¦days¦ ¦or¦ ¦ pt o¦ ¦required¦ ▁-▁ ¦j ust¦ ¦t ell¦ ¦your¦ ¦mana g er¦ ¦and¦ ¦help¦ ¦your¦ ¦team¦ ¦re v ise¦ ¦c al end ar s¦ ¦and¦ ¦s ch ed u les¦ ¦to¦ ¦make¦ ¦sure¦ ¦k e y¦ ¦areas¦ ¦of¦ ¦work¦ ¦are¦ ¦ covered¦ .
( 𐋇¦if¦ ¦you¦ ¦are¦ ¦diagn osed¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ ,▁ ¦p le ase¦ ¦l et¦ ¦br y an¦ ¦within¦ ¦t¦ ▁ & ▁ ¦a m p¦ ;▁ ¦ c¦ ¦o ps¦ ¦know¦ ¦so¦ ¦t¦ ▁ & ▁ ¦a m p¦ ;▁ ¦ c¦ ¦can¦ ¦help¦ ¦with¦ ¦support¦ ¦and¦ ¦make¦ ¦sure¦ ¦your¦ ¦s itu ation¦ ¦g ets¦ ¦appr op ri ate¦ ¦att e nt ion¦ ¦from¦ ¦mana ge ment¦ ).
𐋇 ¦ho ur ly¦ ¦f ol ks¦ ¦will¦ ¦be¦ ¦f ul ly¦ ¦pa id¦ .
𐋇¦we¦ ¦have¦ ¦al rea dy¦ ¦said¦ ,▁ ¦and¦ ¦are¦ ¦recomm it ting¦ ¦to¦ ¦h on or¦ ¦our¦ ¦comm it ments¦ ¦to¦ ¦our¦ ¦cont ra ctors¦ ¦and¦ ¦ho ur ly¦ ¦staff¦ ¦coll ea g ues¦ .
𐋇¦e veryone¦ ¦will¦ ¦be¦ ¦pa id¦ ¦on¦ ¦the¦ ¦ba sis¦ ¦of¦ ¦their¦ ¦us ual¦ ¦hours¦ ¦wor ked¦ ¦during¦ ¦normal¦ ¦c ir c um st an ces¦ .
𐋇¦this¦ ¦inclu des¦ ¦if¦ ¦you¦ ¦are¦ ¦sick¦ ¦and¦ ¦un able¦ ¦to¦ ¦work¦ .
𐋇¦if¦ ¦you¦ ¦w ant¦ ¦to¦ ¦work¦ ,▁ ¦we¦ ¦support¦ ¦you¦ .
𐋇 ¦many¦ ¦people¦ ¦use¦ ¦work¦ ¦as¦ ¦a¦ ¦way¦ ¦of¦ ¦chan n el ing¦ ¦their¦ ¦ str ess¦ ¦with¦ ¦the¦ ¦world¦ ¦around¦ ¦us¦ .
𐋇 ¦what¦ ¦we¦ ¦do¦ ¦can¦ ¦be¦ ¦incre di b ly¦ ¦re w ar ding¦ ,▁ ¦especially¦ ¦during¦ ¦times¦ ¦like¦ ¦this¦ .
𐋇 ¦ag a in¦ ,▁ ¦this¦ ¦is¦ ¦about¦ ¦your¦ ¦self¦ - ¦care¦ .
𐋇¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ ,▁ ¦also¦ ¦known¦ ¦as¦ ¦the¦ ¦coronavirus¦ ¦pandemic¦ ,▁ ¦is¦ ¦an¦ ¦o ng o ing¦ ¦global¦ ¦pandemic¦ ¦of¦ ¦coronavirus¦ ¦disease¦ ¦2019¦ ▁( ¦covid¦ - ¦19¦ ),▁ ¦which¦ ¦is¦ ¦caused¦ ¦by¦ ¦severe¦ ¦acute¦ ¦respiratory¦ ¦syndrome¦ ¦coronavirus¦ ¦2¦ ▁( ¦sars¦ - ¦cov¦ - ¦2¦ ).
𐋇¦the¦ ¦virus¦ ¦was¦ ¦first¦ ¦identified¦ ¦in¦ ¦december¦ ¦2019¦ ¦in¦ ¦wuhan¦ ,▁ ¦china¦ .
𐋇¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ¦decl ared¦ ¦a¦ ¦public¦ ¦health¦ ¦emergency¦ ¦of¦ ¦international¦ ¦concer n¦ ¦on¦ ¦30¦ ¦january¦ ¦2020¦ ,▁ ¦and¦ ¦later¦ ¦decl ared¦ ¦a¦ ¦pandemic¦ ¦on¦ ¦11¦ ¦march¦ ¦2020¦ .
𐋇¦as¦ ¦of¦ ¦24¦ ¦june¦ ¦2021¦ ,▁ ¦more¦ ¦than¦ ¦1 7 9¦ ¦million¦ ¦cases¦ ¦have¦ ¦been¦ ¦confirmed¦ ,▁ ¦with¦ ¦more¦ ¦than¦ ¦3¦ . ¦8 9¦ ¦million¦ ¦confirmed¦ ¦deaths¦ ¦att rib u ted¦ ¦to¦ ¦covid¦ - ¦19¦ ,▁ ¦ma king¦ ¦it¦ ¦one¦ ¦of¦ ¦the¦ ¦d ea d li est¦ ¦p an de m ics¦ ¦in¦ ¦h ist ory¦ .
𐋇¦the¦ ¦se ver ity¦ ¦of¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ¦is¦ ¦high ly¦ ¦vari able¦ ,▁ ¦r an ging¦ ¦from¦ ¦un no ti ce able¦ ¦to¦ ¦l ife¦ - ¦th re at ening¦ .
𐋇 ¦severe¦ ¦illness¦ ¦is¦ ¦more¦ ¦likely¦ ¦in¦ ¦el d erly¦ ¦covid¦ - ¦19¦ ¦patients¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦those¦ ¦who¦ ¦have¦ ¦underlying¦ ¦medical¦ ¦conditions¦ .
𐋇¦covid¦ - ¦19¦ ¦trans mi ts¦ ¦when¦ ¦people¦ ¦brea th e¦ ¦in¦ ¦air ¦ ¦conta min ated¦ ¦by¦ ¦dro pl ets¦ ¦and¦ ¦sm all¦ ¦air bor n e¦ ¦partic les¦ .
𐋇¦the¦ ¦risk¦ ¦of¦ ¦brea thing¦ ¦these¦ ¦in¦ ¦is¦ ¦high est¦ ¦when¦ ¦people¦ ¦are¦ ¦in¦ ¦close¦ ¦pro x im ity¦ ,▁ ¦but¦ ¦they¦ ¦can¦ ¦be¦ ¦in h al ed¦ ¦over¦ ¦lo nger¦ ¦dista n ces¦ ,▁ ¦partic ul arly¦ ¦ind o ors¦ .
𐋇 ¦transmission¦ ¦can¦ ¦also¦ ¦occur ¦ ¦if¦ ¦s pl as h ed¦ ¦or¦ ¦sp ra y ed¦ ¦with¦ ¦conta min ated¦ ¦f lu i ds¦ ,▁ ¦in¦ ¦the¦ ¦ey es¦ ,▁ ¦nose¦ ¦or¦ ¦mouth¦ ,▁ ¦and¦ ,▁ ¦r ar ely¦ ,▁ ¦v ia¦ ¦conta min ated¦ ¦sur fa ces¦ .
𐋇 ¦people¦ ¦remain¦ ¦conta g ious¦ ¦for¦ ¦up¦ ¦to¦ ¦20¦ ¦days¦ ,▁ ¦and¦ ¦can¦ ¦spread¦ ¦the¦ ¦virus¦ ¦even¦ ¦if¦ ¦they¦ ¦do¦ ¦not¦ ¦develop ¦ ¦any¦ ¦symptoms¦ .
𐋇 ¦recommended¦ ¦prev en tive¦ ¦measures¦ ¦include¦ ¦social¦ ¦distancing¦ ,▁ ¦w earing¦ ¦face¦ ¦masks¦ ¦in¦ ¦public¦ ,▁ ¦ ventil ation¦ ¦and¦ ¦air ¦ - ¦f il t ering¦ ,▁ ¦hand¦ ¦washing¦ ,▁ ¦cov ering¦ ¦one¦ ' ¦s¦ ¦mouth¦ ¦when¦ ¦sneezing¦ ¦or¦ ¦cou g hing¦ ,▁ ¦disinf ecting¦ ¦sur fa ces¦ ,▁ ¦and¦ ¦monit or ing¦ ¦and¦ ¦self¦ - ¦isolation¦ ¦for¦ ¦people¦ ¦exp osed¦ ¦or¦ ¦s ymptomatic¦ .
𐋇 ¦several¦ ¦vaccines¦ ¦have¦ ¦been¦ ¦developed¦ ¦and¦ ¦wid ely¦ ¦d ist rib u ted¦ ¦in¦ ¦most¦ ¦developed¦ ¦countries¦ ¦since¦ ¦december¦ ¦2020¦ .
𐋇 ¦current¦ ¦tre at ments¦ ¦f oc us¦ ¦on¦ ¦add re ss ing¦ ¦symptoms¦ ,▁ ¦but¦ ¦work¦ ¦is¦ ¦under w ay¦ ¦to¦ ¦develop ¦ ¦medic ations¦ ¦that¦ ¦in hi b i t¦ ¦the¦ ¦virus¦ .
𐋇 ¦author ities¦ ¦worldwide¦ ¦have¦ ¦resp o nded¦ ¦by¦ ¦imp le m en ting¦ ¦travel¦ ¦restrictions¦ ,▁ ¦loc k d ow ns¦ ¦and¦ ¦qu ara nt ines¦ ,▁ ¦work pl ace¦ ¦ha z ard¦ ¦contr ols¦ ,▁ ¦and¦ ¦bu si ness¦ ¦closures¦ .
𐋇 ¦nu me ro us¦ ¦j ur is d ic tions¦ ¦have¦ ¦also¦ ¦wor ked¦ ¦to¦ ¦increase¦ ¦testing¦ ¦c ap ac ity¦ ¦and¦ ¦tr ace¦ ¦contac ts¦ ¦of¦ ¦the¦ ¦infected¦ .
𐋇¦the¦ ¦pandemic¦ ¦has¦ ¦res ul ted¦ ¦in¦ ¦sign ific ant¦ ¦global¦ ¦social¦ ¦and¦ ¦ec onomic¦ ¦dis ru ption¦ ,▁ ¦including¦ ¦the¦ ¦l arg est¦ ¦global¦ ¦rece ssion¦ ¦since¦ ¦the¦ ¦g re at¦ ¦dep re ssion¦ ¦of¦ ¦the¦ ¦19 3 0 s¦ .
𐋇¦it¦ ¦has¦ ¦l ed¦ ¦to¦ ¦wid esp r ead¦ ¦supp ly¦ ¦sh or ta ges¦ ¦ex ac er b ated¦ ¦by¦ ¦p an ic¦ ¦bu ying¦ ,▁ ¦ag r ic ult ural¦ ¦dis ru ption¦ ,▁ ¦and¦ ¦food¦ ¦sh or ta ges¦ .
𐋇¦however¦ ,▁ ¦there¦ ¦have¦ ¦also¦ ¦been¦ ¦dec rea sed¦ ¦e m is si ons¦ ¦of¦ ¦pol lu ta nts¦ ¦and¦ ¦g re en ho use¦ ¦ga ses¦ .
𐋇 ¦nu me ro us¦ ¦e duc a tional¦ ¦inst itu tions¦ ¦and¦ ¦public¦ ¦areas¦ ¦have¦ ¦been¦ ¦part ially¦ ¦or¦ ¦f ul ly¦ ¦closed¦ ,▁ ¦and¦ ¦many¦ ¦events¦ ¦have¦ ¦been¦ ¦cance lled¦ ¦or¦ ¦po st p o ned¦ .
𐋇¦m is in f orm ation¦ ¦has¦ ¦c ir c ul ated¦ ¦through¦ ¦social¦ ¦m ed ia¦ ¦and¦ ¦m ass¦ ¦m ed ia¦ ,▁ ¦and¦ ¦pol it ical¦ ¦t en si ons¦ ¦have¦ ¦been¦ ¦ex ac er b ated¦ .
𐋇¦the¦ ¦pandemic¦ ¦has¦ ¦r ai sed¦ ¦i ss ues¦ ¦of¦ ¦r ac ial¦ ¦and¦ ¦ ge ogra ph ic¦ ¦disc r im ination¦ ,▁ ¦health¦ ¦e qu ity¦ ,▁ ¦and¦ ¦the¦ ¦b al ance¦ ¦between¦ ¦public¦ ¦health¦ ¦imp erat ives¦ ¦and¦ ¦ind iv id ual¦ ¦ ri gh ts¦ .
𐋇 ¦al th ough¦ ¦the¦ ¦ex ac t¦ ¦orig in¦ ¦of¦ ¦the¦ ¦virus¦ ¦is¦ ¦still¦ ¦un k n own¦ ,▁ ¦the¦ ¦first¦ ¦outbreak¦ ¦star ted¦ ¦in¦ ¦wuhan¦ ,▁ ¦hub e i¦ ,▁ ¦china¦ ¦in¦ ¦l ate¦ ¦2019¦ .
𐋇 ¦many¦ ¦early¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦were¦ ¦l in ked¦ ¦to¦ ¦people¦ ¦who¦ ¦had¦ ¦visi ted¦ ¦the¦ ¦h u an an¦ ¦s ea f ood¦ ¦wh ol es a le¦ ¦mark et¦ ¦in¦ ¦wuhan¦ ,▁ ¦but¦ ¦it¦ ¦is¦ ¦possible¦ ¦that¦ ¦human¦ - ¦to¦ - ¦human¦ ¦transmission¦ ¦was¦ ¦al rea dy¦ ¦happ ening¦ ¦before¦ ¦this¦ .
𐋇¦on¦ ¦11¦ ¦february¦ ¦2020¦ ,▁ ¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ▁( ¦who¦ )▁ ¦na med¦ ¦the¦ ¦disease¦ ▁" ¦covid¦ - ¦19¦ " ,▁ ¦which¦ ¦is¦ ¦sh ort¦ ¦for¦ ¦coronavirus¦ ¦disease¦ ¦2019¦ .
𐋇¦the¦ ¦virus¦ ¦that¦ ¦caused¦ ¦the¦ ¦outbreak¦ ¦is¦ ¦known¦ ¦as¦ ¦severe¦ ¦acute¦ ¦respiratory¦ ¦syndrome¦ ¦coronavirus¦ ¦2¦ ▁( ¦sars¦ - ¦cov¦ - ¦2¦ ),▁ ¦a¦ ¦new ly¦ ¦dis covered¦ ¦virus¦ ¦clos ely¦ ¦related¦ ¦to¦ ¦bat¦ ¦coronaviruses¦ ,▁ ¦pa ngol in¦ ¦coronaviruses¦ ,▁ ¦and¦ ¦sars¦ - ¦cov¦ .
𐋇¦the¦ ¦current¦ ¦sc ie nt if ic¦ ¦con se ns us¦ ¦is¦ ¦that¦ ¦the¦ ¦virus¦ ¦is¦ ¦most¦ ¦likely¦ ¦of¦ ¦z o on ot ic¦ ¦orig in¦ ,▁ ¦from¦ ¦bats¦ ¦or¦ ¦another¦ ¦clos ely¦ - ¦related¦ ¦ma mm al¦ .
𐋇¦d esp ite¦ ¦this¦ ,▁ ¦the¦ ¦sub j ect¦ ¦has¦ ¦gener ated¦ ¦a¦ ¦sign ific ant¦ ¦a mo un t¦ ¦of¦ ¦spec ul ation¦ ¦and¦ ¦cons p ir acy¦ ¦the or ies¦ ,▁ ¦which¦ ¦were¦ ¦a mpl if ied¦ ¦by¦ ¦rap id ly¦ ¦gr owing¦ ¦online¦ ¦e ch o¦ ¦cha mbers¦ .
𐋇 ¦global¦ ¦ ge op ol it ical¦ ¦di vi si ons¦ ,▁ ¦n ot ab ly¦ ¦between¦ ¦the¦ ¦united¦ ¦states¦ ¦and¦ ¦china¦ ,▁ ¦have¦ ¦been¦ ¦he i gh te ned¦ ¦because¦ ¦of¦ ¦this¦ ¦i ss ue¦ .
𐋇¦the¦ ¦ ear li est¦ ¦known¦ ¦person¦ ¦with¦ ¦symptoms¦ ¦was¦ ¦later¦ ¦dis covered¦ ¦to¦ ¦have¦ ¦fa ll en¦ ¦ ill¦ ¦on¦ ¦1¦ ¦december¦ ¦2019¦ ,▁ ¦and¦ ¦that¦ ¦person¦ ¦d id¦ ¦not¦ ¦have¦ ¦visi ble¦ ¦con n ec tions¦ ¦with¦ ¦the¦ ¦later¦ ¦w et¦ ¦mark et¦ ¦cl us ter¦ .
𐋇¦however¦ ,▁ ¦an¦ ¦ ear li er¦ ¦case¦ ¦of¦ ¦infection¦ ¦could¦ ¦have¦ ¦occur r ed¦ ¦on¦ ¦1 7¦ ¦no ve mber¦ .
𐋇 ¦of¦ ¦the¦ ¦early¦ ¦cl us ter¦ ¦of¦ ¦cases¦ ¦reported¦ ¦that¦ ¦mon th¦ ,▁ ¦two¦ - ¦thir ds¦ ¦were¦ ¦found¦ ¦to¦ ¦have¦ ¦a¦ ¦l ink¦ ¦with¦ ¦the¦ ¦mark et¦ .
𐋇¦m ol ec ular¦ ¦cl oc k¦ ¦anal y sis¦ ¦su g ge sts¦ ¦that¦ ¦the¦ ¦in de x¦ ¦case¦ ¦is¦ ¦likely¦ ¦to¦ ¦have¦ ¦been¦ ¦infected¦ ¦with¦ ¦the¦ ¦virus¦ ¦between¦ ¦m id¦ - ¦o ct ob er¦ ¦and¦ ¦m id¦ - ¦no ve mber¦ ¦2019¦ .
𐋇 ¦offic ial¦ ¦case¦ ¦cou nts¦ ¦ref er¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦people¦ ¦who¦ ¦have¦ ¦been¦ ¦tested¦ ¦for¦ ¦covid¦ - ¦19¦ ¦and¦ ¦wh ose¦ ¦test¦ ¦has¦ ¦been¦ ¦confirmed¦ ¦positive¦ ¦according¦ ¦to¦ ¦offic ial¦ ¦prot oc ols¦ .
𐋇 ¦many¦ ¦countries¦ ,▁ ¦early¦ ¦on¦ ,▁ ¦had¦ ¦offic ial¦ ¦pol ic ies¦ ¦to¦ ¦not¦ ¦test¦ ¦those¦ ¦with¦ ¦only¦ ¦mild¦ ¦symptoms¦ .
𐋇 ¦an¦ ¦anal y sis¦ ¦of¦ ¦the¦ ¦early¦ ¦ph ase¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦up¦ ¦to¦ ¦23¦ ¦january¦ ¦estim ated¦ ¦8 6¦ ¦per¦ ¦c ent¦ ¦of¦ ¦covid¦ - ¦19¦ ¦infections¦ ¦had¦ ¦not¦ ¦been¦ ¦detected¦ ,▁ ¦and¦ ¦that¦ ¦these¦ ¦u nd oc um ented¦ ¦infections¦ ¦were¦ ¦the¦ ¦sour ce¦ ¦for¦ ¦7 9¦ ¦per¦ ¦c ent¦ ¦of¦ ¦d oc um ented¦ ¦cases¦ .
𐋇 ¦several¦ ¦other¦ ¦st u dies¦ ,▁ ¦using¦ ¦a¦ ¦vari et y¦ ¦of¦ ¦met ho ds¦ ,▁ ¦have¦ ¦estim ated¦ ¦that¦ ¦nu mbers¦ ¦of¦ ¦infections¦ ¦in¦ ¦many¦ ¦countries¦ ¦are¦ ¦likely¦ ¦to¦ ¦be¦ ¦consid er ab ly¦ ¦g rea ter¦ ¦than¦ ¦the¦ ¦reported¦ ¦cases¦ .
𐋇¦on¦ ¦9¦ ¦april¦ ¦2020¦ ,▁ ¦pre li min ary¦ ¦results¦ ¦found¦ ¦that¦ ¦15¦ ¦per¦ ¦c ent¦ ¦of¦ ¦people¦ ¦tested¦ ¦in¦ ¦ga ng el t¦ ,▁ ¦the¦ ¦centre¦ ¦of¦ ¦a¦ ¦major¦ ¦infection¦ ¦cl us ter¦ ¦in¦ ¦g erm an y¦ ,▁ ¦tested¦ ¦positive¦ ¦for¦ ¦antibo dies¦ .
𐋇 ¦scre ening¦ ¦for¦ ¦covid¦ - ¦19¦ ¦in¦ ¦pre gnant¦ ¦women¦ ¦in¦ ¦new¦ ¦y or k¦ ¦city¦ ,▁ ¦and¦ ¦blood¦ ¦d on ors¦ ¦in¦ ¦the¦ ¦ne ther l an ds¦ ,▁ ¦has¦ ¦also¦ ¦found¦ ¦r ates¦ ¦of¦ ¦positive¦ ¦antibo dy¦ ¦tests¦ ¦that¦ ¦may¦ ¦indic ate¦ ¦more¦ ¦infections¦ ¦than¦ ¦reported¦ .
𐋇 ¦ser op re v al ence¦ ¦based¦ ¦estim ates¦ ¦are¦ ¦cons erv ative¦ ¦as¦ ¦some¦ ¦st u dies¦ ¦sh ow¦ ¦that¦ ¦pers ons¦ ¦with¦ ¦mild¦ ¦symptoms¦ ¦do¦ ¦not¦ ¦have¦ ¦det ect able¦ ¦antibo dies¦ .
𐋇¦some¦ ¦results¦ ▁( ¦such¦ ¦as¦ ¦the¦ ¦ga ng el t¦ ¦study¦ )▁ ¦have¦ ¦received¦ ¦sub s ta ntial¦ ¦pr ess¦ ¦co ver age¦ ¦without¦ ¦first¦ ¦pa ss ing¦ ¦through¦ ¦p e er¦ ¦re v ie w¦ .
𐋇 ¦an¦ ¦anal y sis¦ ¦in¦ ¦early¦ ¦2020¦ ¦of¦ ¦cases¦ ¦by¦ ¦age¦ ¦in¦ ¦china¦ ¦indic ated¦ ¦that¦ ¦a¦ ¦rel at ively¦ ¦low¦ ¦prop ort ion¦ ¦of¦ ¦cases¦ ¦occur r ed¦ ¦in¦ ¦individuals¦ ¦under¦ ¦20¦ .
𐋇¦it¦ ¦was¦ ¦not¦ ¦cl ear¦ ¦wh ether¦ ¦this¦ ¦was¦ ¦because¦ ¦y ou ng¦ ¦people¦ ¦were¦ ¦less¦ ¦likely¦ ¦to¦ ¦be¦ ¦infected¦ ,▁ ¦or¦ ¦less¦ ¦likely¦ ¦to¦ ¦develop ¦ ¦ser ious¦ ¦symptoms¦ ¦and¦ ¦s ee k¦ ¦medical¦ ¦att e nt ion¦ ¦and¦ ¦be¦ ¦tested¦ .
𐋇¦a¦ ¦r et r os p ective¦ ¦co h ort¦ ¦study¦ ¦in¦ ¦china¦ ¦found¦ ¦that¦ ¦children¦ ¦and¦ ¦ad ul ts¦ ¦were¦ ¦j ust¦ ¦as¦ ¦likely¦ ¦to¦ ¦be¦ ¦infected¦ .
𐋇 ¦in it ial¦ ¦estim ates¦ ¦of¦ ¦the¦ ¦b as ic¦ ¦rep ro d u ction¦ ¦number¦ ▁( ¦r 0¦ )▁ ¦for¦ ¦covid¦ - ¦19¦ ¦in¦ ¦january¦ ¦were¦ ¦between¦ ¦1¦ . ¦4¦ ¦and¦ ¦2¦ . ¦5¦ ,▁ ¦but¦ ¦a¦ ¦sub se qu ent¦ ¦anal y sis¦ ¦co nc lu ded¦ ¦that¦ ¦it¦ ¦may¦ ¦be¦ ¦about¦ ¦5¦ . ¦7¦ ▁( ¦with¦ ¦a¦ ¦9 5¦ ¦per¦ ¦c ent¦ ¦conf idence¦ ¦int erv al¦ ¦of¦ ¦3¦ . ¦8¦ ¦to¦ ¦8¦ . ¦9¦ ).
𐋇 ¦r 0¦ ¦can¦ ¦v ary¦ ¦across¦ ¦p op ul ations¦ ¦and¦ ¦is¦ ¦not¦ ¦to¦ ¦be¦ ¦conf u sed¦ ¦with¦ ¦the¦ ¦effective¦ ¦rep ro d u ction¦ ¦number¦ ▁( ¦comm on ly¦ ¦j ust¦ ¦called¦ ¦ r¦ ),▁ ¦which¦ ¦ta k es¦ ¦into¦ ¦acc o un t¦ ¦eff ects¦ ¦such¦ ¦as¦ ¦social¦ ¦distancing¦ ¦and¦ ¦h er d¦ ¦immun ity¦ .
𐋇¦by¦ ¦m id¦ - ¦may¦ ¦2020¦ ,▁ ¦the¦ ¦effective¦ ¦ r¦ ¦was¦ ¦close¦ ¦to¦ ¦or¦ ¦b el ow¦ ¦1¦ . ¦ 0¦ ¦in¦ ¦many¦ ¦countries¦ ,▁ ¦m ea ning¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦disease¦ ¦in¦ ¦these¦ ¦areas¦ ¦at¦ ¦that¦ ¦time¦ ¦was¦ ¦st able¦ ¦or¦ ¦dec re as ing¦ .
𐋇 ¦offic ial¦ ¦deaths¦ ¦from¦ ¦covid¦ - ¦19¦ ¦gener ally¦ ¦ref er¦ ¦to¦ ¦people¦ ¦who¦ ¦d ied¦ ¦after¦ ¦testing¦ ¦positive¦ ¦according¦ ¦to¦ ¦prot oc ols¦ .
𐋇¦these¦ ¦cou nts¦ ¦may¦ ¦i gn ore¦ ¦deaths¦ ¦of¦ ¦people¦ ¦who¦ ¦di e¦ ¦without¦ ¦having¦ ¦been¦ ¦tested¦ .
𐋇 ¦con ve rs ely¦ ,▁ ¦deaths¦ ¦of¦ ¦people¦ ¦who¦ ¦had¦ ¦underlying¦ ¦conditions¦ ¦may¦ ¦l ead¦ ¦to¦ ¦over¦ - ¦co un ting¦ .
𐋇¦c om par is ons¦ ¦of¦ ¦st at ist ics¦ ¦for¦ ¦deaths¦ ¦for¦ ¦all¦ ¦ca u ses¦ ¦ ve rs us¦ ¦the¦ ¦se as on al¦ ¦a ver age¦ ¦indic ate¦ ¦ex c ess¦ ¦m ort ality¦ ¦in¦ ¦many¦ ¦countries¦ .
𐋇¦this¦ ¦may¦ ¦include¦ ¦deaths¦ ¦due¦ ¦to¦ ¦stra ined¦ ¦healthcare¦ ¦sys tems¦ ¦and¦ ¦b ans¦ ¦on¦ ¦el ective¦ ¦sur ge ry¦ .
𐋇¦the¦ ¦first¦ ¦confirmed¦ ¦death¦ ¦was¦ ¦in¦ ¦wuhan¦ ¦on¦ ¦9¦ ¦january¦ ¦2020¦ .
𐋇¦the¦ ¦first¦ ¦reported¦ ¦death¦ ¦outside¦ ¦of¦ ¦china¦ ¦occur r ed¦ ¦on¦ ¦1¦ ¦february¦ ¦in¦ ¦the¦ ¦p hi li pp ines¦ ,▁ ¦and¦ ¦the¦ ¦first¦ ¦reported¦ ¦death¦ ¦outside¦ ¦as ia¦ ¦was¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ¦on¦ ¦6¦ ¦february¦ .
𐋇 ¦more¦ ¦than¦ ¦9 5¦ ¦per¦ ¦c ent¦ ¦of¦ ¦the¦ ¦people¦ ¦who¦ ¦contr ac t¦ ¦covid¦ - ¦19¦ ¦reco ver¦ .
𐋇 ¦o ther w ise¦ ,▁ ¦the¦ ¦time¦ ¦between¦ ¦symptoms¦ ¦o ns et¦ ¦and¦ ¦death¦ ¦us ually¦ ¦r an ges¦ ¦from¦ ¦6¦ ¦to¦ ¦4 1¦ ¦days¦ ,▁ ¦typ ically¦ ¦about¦ ¦14¦ ¦days¦ .
𐋇¦as¦ ¦of¦ ¦24¦ ¦june¦ ¦2021¦ ,▁ ¦more¦ ¦than¦ ¦3¦ . ¦8 9¦ ¦million¦ ¦deaths¦ ¦have¦ ¦been¦ ¦att rib u ted¦ ¦to¦ ¦covid¦ - ¦19¦ .
𐋇 ¦people¦ ¦at¦ ¦the¦ ¦g re at est¦ ¦risk¦ ¦of¦ ¦m ort ality¦ ¦from¦ ¦covid¦ - ¦19¦ ¦t end¦ ¦to¦ ¦be¦ ¦those¦ ¦with¦ ¦underlying¦ ¦conditions¦ ,▁ ¦such¦ ¦as¦ ¦those¦ ¦with¦ ¦a¦ ¦w ea k e ned¦ ¦immune¦ ¦system¦ ,▁ ¦ser ious¦ ¦h ear t¦ ¦or¦ ¦lu ng¦ ¦prob le ms¦ ,▁ ¦severe¦ ¦ob es ity¦ ,▁ ¦or¦ ¦the¦ ¦el d erly¦ ▁( ¦including¦ ¦individuals¦ ¦age¦ ¦6 5¦ ¦years¦ ¦or¦ ¦ ol der¦ ).
𐋇 ¦mult ip le¦ ¦measures¦ ¦are¦ ¦used¦ ¦to¦ ¦qu a nt if y¦ ¦m ort ality¦ .
𐋇¦these¦ ¦nu mbers¦ ¦v ary¦ ¦by¦ ¦reg ion¦ ¦and¦ ¦over¦ ¦time¦ ,▁ ¦influ e nc ed¦ ¦by¦ ¦testing¦ ¦v o lu me¦ ,▁ ¦healthcare¦ ¦system¦ ¦qu ality¦ ,▁ ¦treatment¦ ¦op tions¦ ,▁ ¦government¦ ¦response¦ ,▁ ¦time¦ ¦since¦ ¦the¦ ¦in it ial¦ ¦outbreak¦ ,▁ ¦and¦ ¦population¦ ¦ch ara ct er ist ics¦ ,▁ ¦such¦ ¦as¦ ¦age¦ ,▁ ¦se x¦ ,▁ ¦and¦ ¦over all¦ ¦health¦ .
𐋇 ¦countries¦ ¦like¦ ¦b el g i um¦ ¦include¦ ¦deaths¦ ¦from¦ ¦suspected¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦reg ar d less¦ ¦of¦ ¦wh ether¦ ¦the¦ ¦person¦ ¦was¦ ¦tested¦ ,▁ ¦res ul ting¦ ¦in¦ ¦higher¦ ¦nu mbers¦ ¦comp ared¦ ¦to¦ ¦countries¦ ¦that¦ ¦include¦ ¦only¦ ¦test¦ - ¦confirmed¦ ¦cases¦ .
𐋇¦the¦ ¦death¦ - ¦to¦ - ¦case¦ ¦ra ti o¦ ¦ref l ects¦ ¦the¦ ¦number¦ ¦of¦ ¦deaths¦ ¦att rib u ted¦ ¦to¦ ¦covid¦ - ¦19¦ ¦di vi ded¦ ¦by¦ ¦the¦ ¦number¦ ¦of¦ ¦diagn osed¦ ¦cases¦ ¦within¦ ¦a¦ ¦giv en¦ ¦time¦ ¦int erv al¦ .
𐋇 ¦based¦ ¦on¦ ¦jo h ns¦ ¦h op k ins¦ ¦univers ity¦ ¦st at ist ics¦ ,▁ ¦the¦ ¦global¦ ¦death¦ - ¦to¦ - ¦case¦ ¦ra ti o¦ ¦is¦ ¦2¦ . ¦2¦ ¦p erc ent¦ ▁( ¦3¦ , ¦8 9 0¦ , ¦4 3 7¦ ¦deaths¦ ¦for¦ ¦1 7 9¦ , ¦5 4 1¦ , ¦4 8 1¦ ¦cases¦ )▁ ¦as¦ ¦of¦ ¦24¦ ¦june¦ ¦2021¦ .
𐋇¦the¦ ¦number¦ ¦vari es¦ ¦by¦ ¦reg ion¦
𐋇¦the¦ ¦offic ial¦ ¦death¦ ¦cou nts¦ ¦have¦ ¦been¦ ¦crit ici sed¦ ¦for¦ ¦under re p orting¦ ¦the¦ ¦a ct ual¦ ¦death¦ ¦t ol l¦ ,▁ ¦because¦ ¦comp ar is ons¦ ¦of¦ ¦death¦ ¦r ates¦ ¦before¦ ¦and¦ ¦during¦ ¦the¦ ¦pandemic¦ ¦sh ow¦ ¦an¦ ¦increase¦ ¦in¦ ¦deaths¦ ¦that¦ ¦is¦ ¦not¦ ¦exp la ined¦ ¦by¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦al one¦ .
𐋇 ¦using¦ ¦such¦ ¦data¦ ,▁ ¦estim ates¦ ¦of¦ ¦the¦ ¦tr ue¦ ¦number¦ ¦of¦ ¦deaths¦ ¦from¦ ¦covid¦ - ¦19¦ ¦worldwide¦ ¦have¦ ¦inclu ded¦ ¦a¦ ¦r ange¦ ¦from¦ ¦7¦ ¦to¦ ¦13¦ ¦million¦ ¦by¦ ¦the¦ ¦ec on om ist¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦over¦ ¦9¦ ¦million¦ ¦by¦ ¦the¦ ¦inst it ute¦ ¦for¦ ¦health¦ ¦met r ics¦ ¦and¦ ¦ev a lu ation¦ .
𐋇¦on¦ ¦24¦ ¦march¦ ¦2020¦ ,▁ ¦the¦ ¦ce nt ers¦ ¦for¦ ¦disease¦ ¦control¦ ¦and¦ ¦pre vention¦ ▁( ¦c dc¦ )▁ ¦of¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦indic ated¦ ¦the¦ ¦who¦ ¦had¦ ¦provid ed¦ ¦two¦ ¦co des¦ ¦for¦ ¦covid¦ - ¦19¦ :▁ 𐋇 ¦u 0 7¦ . ¦1¦ ¦when¦ ¦confirmed¦ ¦by¦ ¦laboratory¦ ¦testing¦ ¦and¦ ¦u 0 7¦ . ¦2¦ ¦for¦ ¦cl in ically¦ ¦or¦ ¦e p ide mi ological¦ ¦diagn o sis¦ ¦where¦ ¦laboratory¦ ¦conf ir m ation¦ ¦is¦ ¦inc o nc l us ive¦ ¦or¦ ¦not¦ ¦available¦ .
𐋇¦the¦ ¦c dc¦ ¦no ted¦ ¦that¦ ▁" ¦because¦ ¦laboratory¦ ¦test¦ ¦results¦ ¦are¦ ¦not¦ ¦typ ically¦ ¦reported¦ ¦on¦ ¦death¦ ¦ce rt ific ates¦ ¦in¦ ¦the¦ ¦u¦ . ¦s¦ . ,▁ [ ¦the¦ ¦national¦ ¦center¦ ¦for¦ ¦health¦ ¦st at ist ics¦ ▁( ¦n ch s¦ ) ] ▁ ¦is¦ ¦not¦ ¦pl an ning¦ ¦to¦ ¦imp le ment¦ ¦u 0 7¦ . ¦2¦ ¦for¦ ¦m ort ality¦ ¦st at ist ics¦ "▁ ¦and¦ ¦that¦ ¦u 0 7¦ . ¦1¦ ¦would¦ ¦be¦ ¦used¦ ▁" ¦if¦ ¦the¦ ¦death¦ ¦ce rt ific ate¦ ¦rep orts¦ ¦ter ms¦ ¦such¦ ¦as¦ ' ▁ ¦prob able¦ ¦covid¦ - ¦19¦ ▁' ¦or¦ ' ▁ ¦likely¦ ¦covid¦ - ¦19¦ ▁' . "
𐋇¦the¦ ¦c dc¦ ¦also¦ ¦no ted¦ ▁" ¦it¦ ¦is¦ ¦not¦ ¦likely¦ ¦that¦ ¦n ch s¦ ¦will¦ ¦follow¦ ¦up¦ ¦on¦ ¦these¦ ¦cases¦ "▁ ¦and¦ ¦while¦ ¦the¦ ▁" ¦underlying¦ ¦cause¦ ¦dep ends¦ ¦up on¦ ¦what¦ ¦and¦ ¦where¦ ¦conditions¦ ¦are¦ ¦reported¦ ¦on¦ ¦the¦ ¦death¦ ¦ce rt ific ate¦ , . . .
𐋇¦the¦ ¦ ru les¦ ¦for¦ ¦co ding¦ ¦and¦ ¦se le ction¦ ¦of¦ ¦the¦ . . .▁ ¦cause¦ ¦of¦ ¦death¦ ¦are¦ ¦exp ected¦ ¦to¦ ¦result¦ ¦in¦ ¦covid¦ ▁–▁ ¦19¦ ¦being¦ ¦the¦ ¦underlying¦ ¦cause¦ ¦more¦ ¦often¦ ¦than¦ ¦not¦ . ▁"
𐋇¦on¦ ¦16¦ ¦april¦ ¦2020¦ ,▁ ¦the¦ ¦who¦ ,▁ ¦in¦ ¦its¦ ¦f ormal¦ ¦publ ic ation¦ ¦of¦ ¦the¦ ¦two¦ ¦co des¦ ,▁ ¦u 0 7¦ . ¦1¦ ¦and¦ ¦u 0 7¦ . ¦2¦ , ▁" ¦reco gn i zed¦ ¦that¦ ¦in¦ ¦many¦ ¦countries¦ ¦detail ¦ ¦as¦ ¦to¦ ¦the¦ ¦laboratory¦ ¦conf ir m ation¦ . . .▁ ¦will¦ ¦not¦ ¦be¦ ¦reported¦ ▁ [ ¦and¦ ] ▁ ¦recommended¦ ,▁ ¦for¦ ¦m ort ality¦ ¦p ur p o ses¦ ¦only¦ ,▁ ¦to¦ ¦co de¦ ¦covid¦ - ¦19¦ ¦pro vi si on ally¦ ¦to¦ ¦co de¦ ¦u 0 7¦ . ¦1¦ ¦un less¦ ¦it¦ ¦is¦ ¦stated¦ ¦as¦ ' ▁ ¦prob able¦ ▁' ¦or¦ ' ▁ ¦suspected¦ ▁' . "
𐋇¦it¦ ¦was¦ ¦also¦ ¦no ted¦ ¦that¦ ¦the¦ ¦who¦ ▁" ¦does¦ ¦not¦ ¦dis ti ng u ish¦ "▁ ¦between¦ ¦infection¦ ¦by¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦and¦ ¦covid¦ - ¦19¦ .
𐋇¦a¦ ¦cr uc ial¦ ¦met r ic¦ ¦in¦ ¦as se ss ing¦ ¦the¦ ¦se ver ity¦ ¦of¦ ¦a¦ ¦disease¦ ¦is¦ ¦the¦ ¦infection¦ ¦fat ality¦ ¦ra ti o¦ ▁( ¦ if r¦ ),▁ ¦which¦ ¦is¦ ¦the¦ ¦c um ul ative¦ ¦number¦ ¦of¦ ¦deaths¦ ¦att rib u ted¦ ¦to¦ ¦the¦ ¦disease¦ ¦di vi ded¦ ¦by¦ ¦the¦ ¦c um ul ative¦ ¦number¦ ¦of¦ ¦infected¦ ¦individuals¦ ▁( ¦including¦ ¦as ymptomatic¦ ¦and¦ ¦u nd ia gn osed¦ ¦infections¦ )▁ ¦as¦ ¦me as ur ed¦ ¦or¦ ¦estim ated¦ ¦as¦ ¦of¦ ¦a¦ ¦specific¦ ¦date¦ .
𐋇¦e p ide mi ol og i sts¦ ¦fre qu e ntly¦ ¦ref er¦ ¦to¦ ¦this¦ ¦met r ic¦ ¦as¦ ¦the¦ ▁' ¦infection¦ ¦fat ality¦ ¦rate¦ ' ▁ ¦to¦ ¦cl ar if y¦ ¦that¦ ¦it¦ ¦is¦ ¦exp r es sed¦ ¦in¦ ¦per ce nt age¦ ¦p oi nts¦ ▁( ¦not¦ ¦as¦ ¦a¦ ¦dec im al¦ ).
𐋇 ¦other¦ ¦publ ished¦ ¦st u dies¦ ¦ref er¦ ¦to¦ ¦this¦ ¦met r ic¦ ¦as¦ ¦the¦ ▁' ¦infection¦ ¦fat ality¦ ¦risk¦ ' .
𐋇¦in¦ ¦no ve mber¦ ¦2020¦ ,▁ ¦a¦ ¦re v ie w¦ ¦a rt ic le¦ ¦in¦ ¦nat ure¦ ¦reported¦ ¦estim ates¦ ¦of¦ ¦population¦ - ¦we i gh ted¦ ¦ if r s¦ ¦for¦ ¦a¦ ¦number¦ ¦of¦ ¦countries¦ ,▁ ¦ex c lu ding¦ ¦deaths¦ ¦in¦ ¦el d erly¦ ¦care¦ ¦facil ities¦ ,▁ ¦and¦ ¦found¦ ¦a¦ ¦me di an¦ ¦r ange¦ ¦of¦ ¦ 0¦ . ¦24¦ %▁ ¦to¦ ¦1¦ . ¦4 9¦ % .
𐋇¦in¦ ¦december¦ ¦2020¦ ,▁ ¦a¦ ¦sys te m at ic¦ ¦re v ie w¦ ¦and¦ ¦met a¦ - ¦anal y sis¦ ¦publ ished¦ ¦in¦ ¦the¦ ¦european¦ ¦jo ur n al¦ ¦of¦ ¦e p ide mi ology¦ ¦estim ated¦ ¦that¦ ¦population¦ - ¦we i gh ted¦ ¦ if r¦ ¦was¦ ¦ 0¦ . ¦5¦ %▁ ¦to¦ ¦1¦ %▁ ¦in¦ ¦some¦ ¦countries¦ ▁( ¦fra nce¦ ,▁ ¦ne ther l an ds¦ ,▁ ¦new¦ ¦z ea land¦ ,▁ ¦and¦ ¦p ort u g al¦ ),▁ ¦1¦ %▁ ¦to¦ ¦2¦ %▁ ¦in¦ ¦several¦ ¦other¦ ¦countries¦ ▁( ¦a u str al ia¦ ,▁ ¦e ng land¦ ,▁ ¦li th u an ia¦ ,▁ ¦and¦ ¦s pa in¦ ),▁ ¦and¦ ¦about¦ ¦2¦ . ¦5¦ %▁ ¦in¦ ¦italy¦ ;▁ ¦these¦ ¦estim ates¦ ¦inclu ded¦ ¦fat al ities¦ ¦in¦ ¦el d erly¦ ¦care¦ ¦facil ities¦ .
𐋇¦this¦ ¦study¦ ¦also¦ ¦found¦ ¦that¦ ¦most¦ ¦of¦ ¦the¦ ¦di ff er en ces¦ ¦in¦ ¦ if r¦ ¦across¦ ¦loc ations¦ ¦ref l ected¦ ¦cor r esp on ding¦ ¦di ff er en ces¦ ¦in¦ ¦the¦ ¦age¦ ¦comp os ition¦ ¦of¦ ¦the¦ ¦population¦ ¦and¦ ¦the¦ ¦age¦ - ¦specific¦ ¦p at t er n¦ ¦of¦ ¦infection¦ ¦r ates¦ ,▁ ¦due¦ ¦to¦ ¦very¦ ¦low¦ ¦ if r s¦ ¦for¦ ¦children¦ ¦and¦ ¦y ou nger¦ ¦ad ul ts¦ ▁( ¦ e¦ . ¦ g¦ . ,▁ ¦ 0¦ . ¦0 0 2¦ %▁ ¦at¦ ¦age¦ ¦10¦ ¦and¦ ¦ 0¦ . ¦0 1¦ %▁ ¦at¦ ¦age¦ ¦2 5¦ )▁ ¦and¦ ¦pr og re ss ively¦ ¦higher¦ ¦ if r s¦ ¦for¦ ¦ ol der¦ ¦ad ul ts¦ ▁( ¦ 0¦ . ¦4¦ %▁ ¦at¦ ¦age¦ ¦5 5¦ ,▁ ¦1¦ . ¦4¦ %▁ ¦at¦ ¦age¦ ¦6 5¦ ,▁ ¦4¦ . ¦6¦ %▁ ¦at¦ ¦age¦ ¦7 5¦ ,▁ ¦and¦ ¦15¦ %▁ ¦at¦ ¦age¦ ¦8 5¦ ).
𐋇¦these¦ ¦results¦ ¦were¦ ¦also¦ ¦high li gh ted¦ ¦in¦ ¦a¦ ¦december¦ ¦2020¦ ¦report¦ ¦issued¦ ¦by¦ ¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ .
𐋇 ¦an¦ ¦anal y sis¦ ¦of¦ ¦those¦ ¦ if r¦ ¦r ates¦ ¦indic ates¦ ¦that¦ ¦covid¦ - ¦19¦ ¦is¦ ¦ha z ar d o us¦ ¦not¦ ¦only¦ ¦for¦ ¦the¦ ¦el d erly¦ ¦but¦ ¦also¦ ¦for¦ ¦m id d le¦ - ¦a ged¦ ¦ad ul ts¦ ,▁ ¦for¦ ¦wh om¦ ¦a¦ ¦fat al¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦is¦ ¦two¦ ¦or d ers¦ ¦of¦ ¦ma gn itu de¦ ¦more¦ ¦likely¦ ¦than¦ ¦the¦ ¦an n u a li sed¦ ¦risk¦ ¦of¦ ¦a¦ ¦fat al¦ ¦a ut om ob i le¦ ¦acc ident¦ ¦and¦ ¦fa r¦ ¦more¦ ¦d an ge ro us¦ ¦than¦ ¦se as on al¦ ¦influenza¦
𐋇 ¦another¦ ¦met r ic¦ ¦in¦ ¦as se ss ing¦ ¦death¦ ¦rate¦ ¦is¦ ¦the¦ ¦case¦ ¦fat ality¦ ¦ra ti o¦ ▁( ¦c f r¦ ),▁ [ ¦a¦ ] ▁ ¦which¦ ¦is¦ ¦deaths¦ ¦att rib u ted¦ ¦to¦ ¦disease¦ ¦di vi ded¦ ¦by¦ ¦individuals¦ ¦diagn osed¦ ¦to¦ - ¦date¦ .
𐋇¦this¦ ¦met r ic¦ ¦can¦ ¦be¦ ¦m is l ea ding¦ ¦because¦ ¦of¦ ¦the¦ ¦del ay¦ ¦between¦ ¦s y m pt om¦ ¦o ns et¦ ¦and¦ ¦death¦ ¦and¦ ¦because¦ ¦testing¦ ¦f oc u ses¦ ¦on¦ ¦individuals¦ ¦with¦ ¦symptoms¦ ▁( ¦and¦ ¦partic ul arly¦ ¦on¦ ¦those¦ ¦m an if es ting¦ ¦more¦ ¦severe¦ ¦symptoms¦ ).
𐋇¦on¦ ¦4¦ ¦a u g ust¦ ¦2020¦ ,▁ ¦who¦ ¦indic ated¦ ▁" ¦at¦ ¦this¦ ¦early¦ ¦st age¦ ¦of¦ ¦the¦ ¦pandemic¦ ,▁ ¦most¦ ¦estim ates¦ ¦of¦ ¦fat ality¦ ¦ra ti o s¦ ¦have¦ ¦been¦ ¦based¦ ¦on¦ ¦cases¦ ¦detected¦ ¦through¦ ¦surveillance¦ ¦and¦ ¦c al c ul ated¦ ¦using¦ ¦c ru de¦ ¦met ho ds¦ ,▁ ¦giv ing¦ ¦r ise¦ ¦to¦ ¦wid ely¦ ¦vari able¦ ¦estim ates¦ ¦of¦ ¦c f r¦ ¦by¦ ¦country¦ ▁–▁ ¦from¦ ¦less¦ ¦than¦ ¦ 0¦ . ¦1¦ %▁ ¦to¦ ¦over¦ ¦2 5¦ % . "
𐋇 ¦symptoms¦ ¦of¦ ¦covid¦ - ¦19¦ ¦are¦ ¦vari able¦ ,▁ ¦r an ging¦ ¦from¦ ¦mild¦ ¦symptoms¦ ¦to¦ ¦severe¦ ¦illness¦ .
𐋇 ¦common¦ ¦symptoms¦ ¦include¦ ¦h ea d a ch e¦ ,▁ ¦l os s¦ ¦of¦ ¦sm ell¦ ¦and¦ ¦ta st e¦ ,▁ ¦n as al¦ ¦con ge st ion¦ ¦and¦ ¦r un n y¦ ¦nose¦ ,▁ ¦cough¦ ,▁ ¦m us c le¦ ¦pain¦ ,▁ ¦s ore¦ ¦th ro at¦ ,▁ ¦fever¦ ,▁ ¦di arr he a¦ ,▁ ¦and¦ ¦brea thing¦ ¦diffic ult ies¦ .
𐋇 ¦people¦ ¦with¦ ¦the¦ ¦same¦ ¦infection¦ ¦may¦ ¦have¦ ¦different¦ ¦symptoms¦ ,▁ ¦and¦ ¦their¦ ¦symptoms¦ ¦may¦ ¦ch ange¦ ¦over¦ ¦time¦ .
𐋇 ¦three¦ ¦common¦ ¦c lu st ers¦ ¦of¦ ¦symptoms¦ ¦have¦ ¦been¦ ¦identified¦ :▁ 𐋇 ¦one¦ ¦respiratory¦ ¦s y m pt om¦ ¦cl us ter¦ ¦with¦ ¦cough¦ ,▁ ¦sp ut um¦ ,▁ ¦sh ort ness¦ ¦of¦ ¦brea th¦ ,▁ ¦and¦ ¦fever¦ ;▁ ¦a¦ ¦m us c ul os k el et al¦ ¦s y m pt om¦ ¦cl us ter¦ ¦with¦ ¦m us c le¦ ¦and¦ ¦jo in t¦ ¦pain¦ ,▁ ¦h ea d a ch e¦ ,▁ ¦and¦ ¦fat ig ue¦ ;▁ ¦a¦ ¦cl us ter¦ ¦of¦ ¦d ig es tive¦ ¦symptoms¦ ¦with¦ ¦ab d o min al¦ ¦pain¦ ,▁ ¦v o mi ting¦ ,▁ ¦and¦ ¦di arr he a¦ .
𐋇¦in¦ ¦people¦ ¦without¦ ¦pri or¦ ¦ ear¦ ,▁ ¦nose¦ ,▁ ¦and¦ ¦th ro at¦ ¦dis or d ers¦ ,▁ ¦l os s¦ ¦of¦ ¦ta st e¦ ¦co mb ined¦ ¦with¦ ¦l os s¦ ¦of¦ ¦sm ell¦ ¦is¦ ¦associated¦ ¦with¦ ¦covid¦ - ¦19¦ .
𐋇 ¦of¦ ¦people¦ ¦who¦ ¦sh ow¦ ¦symptoms¦ ,▁ ¦8 1¦ %▁ ¦develop ¦ ¦only¦ ¦mild¦ ¦to¦ ¦mod er ate¦ ¦symptoms¦ ¦and¦ ¦can¦ ¦get¦ ¦a m n es ia¦ ¦after¦ ¦reco ve ry¦ ▁( ¦up¦ ¦to¦ ¦mild¦ ¦pneumonia¦ ),▁ ¦while¦ ¦14¦ %▁ ¦develop ¦ ¦severe¦ ¦symptoms¦ ▁( ¦d ys p ne a¦ ,▁ ¦h y p o x ia¦ ,▁ ¦or¦ ¦more¦ ¦than¦ ¦50¦ %▁ ¦lu ng¦ ¦invol ve ment¦ ¦on¦ ¦i ma ging¦ )▁ ¦and¦ ¦5¦ %▁ ¦of¦ ¦patients¦ ¦su ff er¦ ¦crit ical¦ ¦symptoms¦ ▁( ¦respiratory¦ ¦fa il ure¦ ,▁ ¦sh oc k¦ ,▁ ¦or¦ ¦mult i or g an¦ ¦d ys f un ction¦ ).
𐋇 ¦at¦ ¦least¦ ¦a¦ ¦thir d¦ ¦of¦ ¦the¦ ¦people¦ ¦who¦ ¦are¦ ¦infected¦ ¦with¦ ¦the¦ ¦virus¦ ¦do¦ ¦not¦ ¦develop ¦ ¦no ti ce able¦ ¦symptoms¦ ¦at¦ ¦any¦ ¦po in t¦ ¦in¦ ¦time¦ .
𐋇¦these¦ ¦as ymptomatic¦ ¦car ri ers¦ ¦t end¦ ¦not¦ ¦to¦ ¦get¦ ¦tested¦ ¦and¦ ¦can¦ ¦spread¦ ¦the¦ ¦disease¦ .
𐋇 ¦other¦ ¦infected¦ ¦people¦ ¦will¦ ¦develop ¦ ¦symptoms¦ ¦later¦ ,▁ ¦called¦ ▁" ¦pr e¦ - ¦s ymptomatic¦ " ,▁ ¦or¦ ¦have¦ ¦very¦ ¦mild¦ ¦symptoms¦ ¦and¦ ¦can¦ ¦also¦ ¦spread¦ ¦the¦ ¦virus¦ .
𐋇¦as¦ ¦is¦ ¦common¦ ¦with¦ ¦infections¦ ,▁ ¦there¦ ¦is¦ ¦a¦ ¦del ay¦ ¦between¦ ¦the¦ ¦mo ment¦ ¦a¦ ¦person¦ ¦first¦ ¦bec omes¦ ¦infected¦ ¦and¦ ¦the¦ ¦app ear ance¦ ¦of¦ ¦the¦ ¦first¦ ¦symptoms¦ .
𐋇¦the¦ ¦me di an¦ ¦del ay¦ ¦for¦ ¦covid¦ - ¦19¦ ¦is¦ ¦four¦ ¦to¦ ¦five¦ ¦days¦ .
𐋇 ¦most¦ ¦s ymptomatic¦ ¦people¦ ¦exp eri ence¦ ¦symptoms¦ ¦within¦ ¦two¦ ¦to¦ ¦se v en¦ ¦days¦ ¦after¦ ¦exp osure¦ ,▁ ¦and¦ ¦al m ost¦ ¦all¦ ¦will¦ ¦exp eri ence¦ ¦at¦ ¦least¦ ¦one¦ ¦s y m pt om¦ ¦within¦ ¦12¦ ¦days¦ .
𐋇 ¦most¦ ¦people¦ ¦reco ver¦ ¦from¦ ¦the¦ ¦acute¦ ¦ph ase¦ ¦of¦ ¦the¦ ¦disease¦ .
𐋇¦however¦ ,▁ ¦some¦ ¦people¦ ¦continue¦ ¦to¦ ¦exp eri ence¦ ¦a¦ ¦r ange¦ ¦of¦ ¦eff ects¦ ¦for¦ ¦mon ths¦ ¦after¦ ¦reco ve ry¦ ▁ — ▁ ¦na med¦ ¦long¦ ¦covid¦ ▁ — ▁ ¦and¦ ¦da m age¦ ¦to¦ ¦or g ans¦ ¦has¦ ¦been¦ ¦ob s erv ed¦ .
𐋇 ¦mult i¦ - ¦year¦ ¦st u dies¦ ¦are¦ ¦under w ay¦ ¦to¦ ¦further¦ ¦in ve st ig ate¦ ¦the¦ ¦long¦ - ¦ter m¦ ¦eff ects¦ ¦of¦ ¦the¦ ¦disease¦ .
𐋇¦the¦ ¦disease¦ ¦is¦ ¦main ly¦ ¦transm it ted¦ ¦v ia¦ ¦the¦ ¦respiratory¦ ¦ro ute¦ ¦when¦ ¦people¦ ¦in h a le¦ ¦dro pl ets¦ ¦and¦ ¦partic les¦ ¦that¦ ¦infected¦ ¦people¦ ¦re le ase¦ ¦as¦ ¦they¦ ¦brea th e¦ ,▁ ¦t alk¦ ,▁ ¦cough¦ ,▁ ¦s n ee z e¦ ,▁ ¦or¦ ¦s ing¦ .
𐋇 ¦infected¦ ¦people¦ ¦are¦ ¦more¦ ¦likely¦ ¦to¦ ¦trans mi t¦ ¦covid¦ - ¦19¦ ¦the¦ ¦when¦ ¦they¦ ¦are¦ ¦ph ys ically¦ ¦close¦ .
𐋇¦however¦ ,▁ ¦infection¦ ¦can¦ ¦occur ¦ ¦over¦ ¦lo nger¦ ¦dista n ces¦ ,▁ ¦partic ul arly¦ ¦ind o ors¦ .
𐋇 ¦inf ect iv ity¦ ¦beg ins¦ ¦as¦ ¦early¦ ¦as¦ ¦three¦ ¦days¦ ¦before¦ ¦symptoms¦ ¦app ear¦ ,▁ ¦and¦ ¦people¦ ¦are¦ ¦most¦ ¦infectious¦ ¦j ust¦ ¦pri or¦ ¦to¦ ¦and¦ ¦during¦ ¦the¦ ¦o ns et¦ ¦of¦ ¦symptoms¦ .
𐋇¦it¦ ¦decl ines¦ ¦after¦ ¦the¦ ¦first¦ ¦week¦ ,▁ ¦but¦ ¦infected¦ ¦people¦ ¦remain¦ ¦conta g ious¦ ¦for¦ ¦up¦ ¦to¦ ¦20¦ ¦days¦ .
𐋇 ¦people¦ ¦can¦ ¦spread¦ ¦the¦ ¦disease¦ ¦even¦ ¦if¦ ¦they¦ ¦are¦ ¦as ymptomatic¦ .
𐋇 ¦infectious¦ ¦partic les¦ ¦r ange¦ ¦in¦ ¦s iz e¦ ¦from¦ ¦a er os ols¦ ¦that¦ ¦remain¦ ¦susp e nded¦ ¦in¦ ¦the¦ ¦air ¦ ¦for¦ ¦long¦ ¦perio ds¦ ¦of¦ ¦time¦ ¦to¦ ¦l arg er¦ ¦dro pl ets¦ ¦that¦ ¦remain¦ ¦air bor n e¦ ¦or¦ ¦f all¦ ¦to¦ ¦the¦ ¦grou n d¦ .
𐋇 ¦v ar ious¦ ¦grou ps¦ ¦ ut il ise¦ ¦ter ms¦ ¦such¦ ¦as¦ ▁" ¦air bor n e¦ "▁ ¦and¦ ▁" ¦dro pl et¦ "▁ ¦both¦ ¦in¦ ¦techn ical¦ ¦and¦ ¦general¦ ¦w ays¦ ,▁ ¦lea ding¦ ¦to¦ ¦conf us ion¦ ¦around¦ ¦ter min ology¦ .
𐋇 ¦ad di tion ally¦ ,▁ ¦covid¦ - ¦19¦ ¦research¦ ¦has¦ ¦re de f ined¦ ¦the¦ ¦tra di tional¦ ¦under st an ding¦ ¦of¦ ¦how¦ ¦respiratory¦ ¦viruses¦ ¦trans mi t¦ .
𐋇¦the¦ ¦l arg est¦ ¦dro pl ets¦ ¦of¦ ¦respiratory¦ ¦f lu id¦ ¦do¦ ¦not¦ ¦travel¦ ¦fa r¦ ,▁ ¦and¦ ¦can¦ ¦be¦ ¦in h al ed¦ ¦or¦ ¦ land¦ ¦on¦ ¦m uc o us¦ ¦me mb r an es¦ ¦on¦ ¦the¦ ¦ey es¦ ,▁ ¦nose¦ ,▁ ¦or¦ ¦mouth¦ ¦to¦ ¦inf ect¦ .
𐋇 ¦a er os ols¦ ¦are¦ ¦high est¦ ¦in¦ ¦con ce nt r ation¦ ¦when¦ ¦people¦ ¦are¦ ¦in¦ ¦close¦ ¦pro x im ity¦ ,▁ ¦which¦ ¦lea ds¦ ¦to¦ ¦ ea si er¦ ¦viral¦ ¦transmission¦ ¦when¦ ¦people¦ ¦are¦ ¦ph ys ically¦ ¦close¦ ,▁ ¦but¦ ¦air bor n e¦ ¦transmission¦ ¦can¦ ¦occur ¦ ¦at¦ ¦lo nger¦ ¦dista n ces¦ ,▁ ¦main ly¦ ¦in¦ ¦loc ations¦ ¦that¦ ¦are¦ ¦po or ly¦ ¦ ventil ated¦ ;▁ ¦in¦ ¦those¦ ¦conditions¦ ¦sm all¦ ¦partic les¦ ¦can¦ ¦remain¦ ¦susp e nded¦ ¦in¦ ¦the¦ ¦air ¦ ¦for¦ ¦min u tes¦ ¦to¦ ¦hours¦ .
𐋇¦the¦ ¦number¦ ¦of¦ ¦people¦ ¦gener ally¦ ¦infected¦ ¦by¦ ¦one¦ ¦infected¦ ¦person¦ ¦vari es¦ ;▁ ¦with¦ ¦only¦ ¦10¦ ¦to¦ ¦20¦ %▁ ¦of¦ ¦people¦ ¦resp on si ble¦ ¦for¦ ¦the¦ ¦diseases¦ ¦spread¦ .
𐋇¦it¦ ¦often¦ ¦sprea ds¦ ¦in¦ ¦c lu st ers¦ ,▁ ¦where¦ ¦infections¦ ¦can¦ ¦be¦ ¦trac ed¦ ¦b ack¦ ¦to¦ ¦an¦ ¦in de x¦ ¦case¦ ¦or¦ ¦ ge ogra ph ical¦ ¦loc ation¦ .
𐋇 ¦often¦ ¦in¦ ¦these¦ ¦cases¦ ,▁ ¦su p e rs p rea ding¦ ¦events¦ ¦occur ¦ ,▁ ¦where¦ ¦many¦ ¦people¦ ¦are¦ ¦infected¦ ¦by¦ ¦one¦ ¦person¦ .
𐋇 ¦sars¦ ▁ ‑ ▁ ¦cov¦ ▁ ‑ ▁ ¦2¦ ¦be lo ng s¦ ¦to¦ ¦the¦ ¦b ro ad¦ ¦family¦ ¦of¦ ¦viruses¦ ¦known¦ ¦as¦ ¦coronaviruses¦ .
𐋇¦it¦ ¦is¦ ¦a¦ ¦positive¦ - ¦sen se¦ ¦si ng le¦ - ¦stra nded¦ ¦rna¦ ▁( + ▁ ¦ ss r na¦ )▁ ¦virus¦ ,▁ ¦with¦ ¦a¦ ¦si ng le¦ ¦l in ear¦ ¦rna¦ ¦se g ment¦ .
𐋇 ¦coronaviruses¦ ¦inf ect¦ ¦humans¦ ,▁ ¦other¦ ¦ma mm als¦ ,▁ ¦and¦ ¦a vi an¦ ¦spec ies¦ ,▁ ¦including¦ ¦li ve st oc k¦ ¦and¦ ¦comp an ion¦ ¦anim als¦ .
𐋇 ¦human¦ ¦coronaviruses¦ ¦are¦ ¦c ap able¦ ¦of¦ ¦ca us ing¦ ¦i ll n es ses¦ ¦r an ging¦ ¦from¦ ¦the¦ ¦common¦ ¦cold¦ ¦to¦ ¦more¦ ¦severe¦ ¦diseases¦ ¦such¦ ¦as¦ ¦m id d le¦ ¦e ast¦ ¦respiratory¦ ¦syndrome¦ ▁( ¦mers¦ ,▁ ¦fat ality¦ ¦rate¦ ▁ ~ ▁ ¦3 4¦ % ).
𐋇 ¦sars¦ - ¦cov¦ - ¦2¦ ¦is¦ ¦the¦ ¦se v en th¦ ¦known¦ ¦coronavirus¦ ¦to¦ ¦inf ect¦ ¦people¦ ,▁ ¦after¦ ¦22 9 e¦ ,▁ ¦n l 6 3¦ ,▁ ¦ oc 4 3¦ ,▁ ¦h k u 1¦ ,▁ ¦mers¦ - ¦cov¦ ,▁ ¦and¦ ¦the¦ ¦orig in al¦ ¦sars¦ - ¦cov¦ .
𐋇 ¦viral¦ ¦gen et ic¦ ¦se qu ence¦ ¦data¦ ¦can¦ ¦provide¦ ¦crit ical¦ ¦information¦ ¦about¦ ¦wh ether¦ ¦viruses¦ ¦separ ated¦ ¦by¦ ¦time¦ ¦and¦ ¦sp ace¦ ¦are¦ ¦likely¦ ¦to¦ ¦be¦ ¦e p ide mi ol og ically¦ ¦l in ked¦ .
𐋇 ¦with¦ ¦a¦ ¦su ff ici ent¦ ¦number¦ ¦of¦ ¦se qu e nc ed¦ ¦gen omes¦ ,▁ ¦it¦ ¦is¦ ¦possible¦ ¦to¦ ¦rec on str uc t¦ ¦a¦ ¦ph y l ogen et ic¦ ¦tre e¦ ¦of¦ ¦the¦ ¦m ut ation¦ ¦h ist ory¦ ¦of¦ ¦a¦ ¦family¦ ¦of¦ ¦viruses¦ .
𐋇¦by¦ ¦12¦ ¦january¦ ¦2020¦ ,▁ ¦five¦ ¦gen omes¦ ¦of¦ ¦sars¦ ▁ ‑ ▁ ¦cov¦ ▁ ‑ ▁ ¦2¦ ¦had¦ ¦been¦ ¦isol ated¦ ¦from¦ ¦wuhan¦ ¦and¦ ¦reported¦ ¦by¦ ¦the¦ ¦chinese¦ ¦center¦ ¦for¦ ¦disease¦ ¦control¦ ¦and¦ ¦pre vention¦ ▁( ¦c c dc¦ )▁ ¦and¦ ¦other¦ ¦inst itu tions¦ ;▁ ¦the¦ ¦number¦ ¦of¦ ¦gen omes¦ ¦increased¦ ¦to¦ ¦4 2¦ ¦by¦ ¦30¦ ¦january¦ ¦2020¦ .
𐋇¦a¦ ¦ph y l ogen et ic¦ ¦anal y sis¦ ¦of¦ ¦those¦ ¦samples¦ ¦sh owed¦ ¦they¦ ¦were¦ ▁" ¦high ly¦ ¦related¦ ¦with¦ ¦at¦ ¦most¦ ¦se v en¦ ¦m ut ations¦ ¦rel ative¦ ¦to¦ ¦a¦ ¦common¦ ¦an ce st or¦ " ,▁ ¦i mpl ying¦ ¦that¦ ¦the¦ ¦first¦ ¦human¦ ¦infection¦ ¦occur r ed¦ ¦in¦ ¦no ve mber¦ ¦or¦ ¦december¦ ¦2019¦ .
𐋇 ¦ex a m ination¦ ¦of¦ ¦the¦ ¦t op ology¦ ¦of¦ ¦the¦ ¦ph y l ogen et ic¦ ¦tre e¦ ¦at¦ ¦the¦ ¦star t¦ ¦of¦ ¦the¦ ¦pandemic¦ ¦also¦ ¦found¦ ¦high¦ ¦s im il ar ities¦ ¦between¦ ¦human¦ ¦isol ates¦ .
𐋇¦as¦ ¦of¦ ¦7¦ ¦may¦ ¦2020¦ ,▁ ¦4¦ , ¦6 9 0¦ ¦sars¦ ▁ ‑ ▁ ¦cov¦ ▁ ‑ ▁ ¦2¦ ¦gen omes¦ ¦sampl ed¦ ¦on¦ ¦si x¦ ¦contin ents¦ ¦were¦ ¦publ ic ly¦ ¦available¦ .
𐋇¦the¦ ¦sta nd ard¦ ¦met ho ds¦ ¦of¦ ¦testing¦ ¦for¦ ¦pres ence¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦are¦ ¦n uc le ic¦ ¦ac id¦ ¦tests¦ ,▁ ¦which¦ ¦det ects¦ ¦the¦ ¦pres ence¦ ¦of¦ ¦viral¦ ¦rna¦ ¦fra g ments¦ .
𐋇¦as¦ ¦these¦ ¦tests¦ ¦det ect¦ ¦rna¦ ¦but¦ ¦not¦ ¦infectious¦ ¦virus¦ ,▁ ¦its¦ ▁" ¦a bility¦ ¦to¦ ¦det erm ine¦ ¦d ur ation¦ ¦of¦ ¦inf ect iv ity¦ ¦of¦ ¦patients¦ ¦is¦ ¦limi ted¦ . "▁ 𐋇¦the¦ ¦test¦ ¦is¦ ¦typ ically¦ ¦d one¦ ¦on¦ ¦respiratory¦ ¦samples¦ ¦ob ta ined¦ ¦by¦ ¦a¦ ¦n as o ph ar y n ge al¦ ¦sw ab ¦ ;▁ ¦however¦ ,▁ ¦a¦ ¦n as al¦ ¦sw ab ¦ ¦or¦ ¦sp ut um¦ ¦sampl e¦ ¦may¦ ¦also¦ ¦be¦ ¦used¦ .
𐋇 ¦results¦ ¦are¦ ¦gener ally¦ ¦available¦ ¦within¦ ¦hours¦ .
𐋇¦the¦ ¦who¦ ¦has¦ ¦publ ished¦ ¦several¦ ¦testing¦ ¦prot oc ols¦ ¦for¦ ¦the¦ ¦disease¦ .
𐋇 ¦chest¦ ¦c t¦ ¦sc ans¦ ¦may¦ ¦be¦ ¦h el p ful¦ ¦to¦ ¦diagn ose¦ ¦covid¦ - ¦19¦ ¦in¦ ¦individuals¦ ¦with¦ ¦a¦ ¦high¦ ¦clinical¦ ¦susp ic ion¦ ¦of¦ ¦infection¦ ¦but¦ ¦are¦ ¦not¦ ¦recommended¦ ¦for¦ ¦ro ut ine¦ ¦scre ening¦ .
𐋇¦b il at er al¦ ¦mult il ob a r¦ ¦grou n d¦ - ¦gl ass¦ ¦op ac ities¦ ¦with¦ ¦a¦ ¦p eri ph er al¦ ,▁ ¦as y mm et r ic¦ ,▁ ¦and¦ ¦po st eri or¦ ¦d ist rib ution¦ ¦are¦ ¦common¦ ¦in¦ ¦early¦ ¦infection¦ .
𐋇 ¦sub p le ural¦ ¦do min ance¦ ,▁ ¦c ra z y¦ ¦pa ving¦ ▁( ¦l ob ular¦ ¦se pt al¦ ¦th ick ening¦ ¦with¦ ¦vari able¦ ¦al ve o la r¦ ¦fi lling¦ ),▁ ¦and¦ ¦cons ol id ation¦ ¦may¦ ¦app ear¦ ¦as¦ ¦the¦ ¦disease¦ ¦pr og r es ses¦ .
𐋇 ¦ch ara ct er ist ic¦ ¦i ma ging¦ ¦fe at ures¦ ¦on¦ ¦chest¦ ¦ra di ogra ph s¦ ¦and¦ ¦comp u ted¦ ¦t om ogra ph y¦ ▁( ¦c t¦ )▁ ¦of¦ ¦people¦ ¦who¦ ¦are¦ ¦s ymptomatic¦ ¦include¦ ¦as y mm et r ic¦ ¦p eri ph er al¦ ¦grou n d¦ - ¦gl ass¦ ¦op ac ities¦ ¦without¦ ¦p le ural¦ ¦eff u si ons¦ .
𐋇 ¦prev en tive¦ ¦measures¦ ¦to¦ ¦reduce¦ ¦the¦ ¦chan ces¦ ¦of¦ ¦infection¦ ¦include¦ ¦getting¦ ¦vaccinated¦ ,▁ ¦sta ying¦ ¦at¦ ¦home¦ ,▁ ¦w earing¦ ¦a¦ ¦mask¦ ¦in¦ ¦public¦ ,▁ ¦a v oi ding¦ ¦cr ow ded¦ ¦places¦ ,▁ ¦k ee p ing¦ ¦dista nce¦ ¦from¦ ¦others¦ ,▁ ¦ ventil ating¦ ¦in door¦ ¦s pa ces¦ ,▁ ¦mana ging¦ ¦pote ntial¦ ¦exp osure¦ ¦d ur ations¦ ,▁ ¦washing¦ ¦hands¦ ¦with¦ ¦so a p¦ ¦and¦ ¦water¦ ¦often¦ ¦and¦ ¦for¦ ¦at¦ ¦least¦ ¦t we nt y¦ ¦sec on ds¦ ,▁ ¦pract ising¦ ¦g ood¦ ¦respiratory¦ ¦h yg ien e¦ ,▁ ¦and¦ ¦a v oi ding¦ ¦to uc hing¦ ¦the¦ ¦ey es¦ ,▁ ¦nose¦ ,▁ ¦or¦ ¦mouth¦ ¦with¦ ¦un w as h ed¦ ¦hands¦ .
𐋇 ¦those¦ ¦diagn osed¦ ¦with¦ ¦covid¦ - ¦19¦ ¦or¦ ¦who¦ ¦b el ie ve¦ ¦they¦ ¦may¦ ¦be¦ ¦infected¦ ¦are¦ ¦ad vi sed¦ ¦by¦ ¦the¦ ¦c dc¦ ¦to¦ ¦stay¦ ¦home¦ ¦ex cep t¦ ¦to¦ ¦get¦ ¦medical¦ ¦care¦ ,▁ ¦call¦ ¦a h ead¦ ¦before¦ ¦visi ting¦ ¦a¦ ¦healthcare¦ ¦provid er¦ ,▁ ¦wear¦ ¦a¦ ¦face¦ ¦mask¦ ¦before¦ ¦ent ering¦ ¦the¦ ¦healthcare¦ ¦provid er¦ ' ¦s¦ ¦off ice¦ ¦and¦ ¦when¦ ¦in¦ ¦any¦ ¦ro om¦ ¦or¦ ¦ ve h ic le¦ ¦with¦ ¦another¦ ¦person¦ ,▁ ¦cover¦ ¦cou gh s¦ ¦and¦ ¦s n ee z es¦ ¦with¦ ¦a¦ ¦ti ss ue¦ ,▁ ¦regul arly¦ ¦wash¦ ¦hands¦ ¦with¦ ¦so a p¦ ¦and¦ ¦water¦ ¦and¦ ¦avoid¦ ¦sh ar ing¦ ¦personal¦ ¦hou se ho ld¦ ¦i tems¦ .
𐋇¦in¦ ¦ph ase¦ ¦i i i¦ ¦trials¦ ,▁ ¦several¦ ¦covid¦ ▁ ‑ ▁ ¦19¦ ¦vaccines¦ ¦have¦ ¦dem on str ated¦ ¦eff ic acy¦ ¦as¦ ¦high¦ ¦as¦ ¦9 5¦ %▁ ¦in¦ ¦prev en ting¦ ¦s ymptomatic¦ ¦covid¦ ▁ ‑ ▁ ¦19¦ ¦infections¦ .
𐋇¦as¦ ¦of¦ ¦june¦ ¦2021¦ ,▁ ¦18¦ ¦vaccines¦ ¦are¦ ¦author i zed¦ ¦by¦ ¦at¦ ¦least¦ ¦one¦ ¦national¦ ¦regul atory¦ ¦author ity¦ ¦for¦ ¦public¦ ¦use¦ :▁ 𐋇 ¦two¦ ¦rna¦ ¦vaccines¦ ▁( ¦p f iz er¦ ▁–▁ ¦bi on te ch¦ ¦and¦ ¦mod er na¦ ),▁ ¦n ine¦ ¦con v en tional¦ ¦i na ct iv ated¦ ¦vaccines¦ ▁( ¦b b i b p¦ - ¦cor v ¦ ,▁ ¦chinese¦ ¦ac a de m y¦ ¦of¦ ¦medical¦ ¦sc ien ces¦ ,▁ ¦corona v a c¦ ,▁ ¦cov a x in¦ ,▁ ¦cov iv a c¦ ,▁ ¦co vir an¦ ¦b ara k at¦ ,▁ ¦min h a i¦ - ¦k a ng ta i¦ ,▁ ¦ q a z v a c¦ ,▁ ¦and¦ ¦w i b p¦ - ¦cor v ¦ ),▁ ¦five¦ ¦viral¦ ¦v ector¦ ¦vaccines¦ ▁( ¦sp ut n i k¦ ¦l ight¦ ,▁ ¦sp ut n i k¦ ¦v ¦ ,▁ ¦o x for d¦ ▁–▁ ¦astrazeneca¦ ,▁ ¦con v id ec ia¦ ,▁ ¦and¦ ¦jo h ns on¦ ▁ & ▁ ¦jo h ns on¦ ),▁ ¦and¦ ¦two¦ ¦protein¦ ¦sub un i t¦ ¦vaccines¦ ▁( ¦e p iv ac c o ro na¦ ¦and¦ ¦r b d¦ - ¦d im er¦ ).
𐋇¦in¦ ¦total¦ ,▁ ¦as¦ ¦of¦ ¦march¦ ¦2021¦ ,▁ ¦30 8¦ ¦vaccine¦ ¦ca nd id ates¦ ¦are¦ ¦in¦ ¦v ar ious¦ ¦sta ges¦ ¦of¦ ¦development¦ ,▁ ¦with¦ ¦7 3¦ ¦in¦ ¦clinical¦ ¦research¦ ,▁ ¦including¦ ¦24¦ ¦in¦ ¦ph ase¦ ¦i¦ ¦trials¦ ,▁ ¦3 3¦ ¦in¦ ¦ph ase¦ ¦i¦ ▁–▁ ¦i i¦ ¦trials¦ ,▁ ¦and¦ ¦16¦ ¦in¦ ¦ph ase¦ ¦i i i¦ ¦development¦ .
𐋇 ¦many¦ ¦countries¦ ¦have¦ ¦imp le m ented¦ ¦ph a sed¦ ¦d ist rib ution¦ ¦pl ans¦ ¦that¦ ¦pri or itiz e¦ ¦those¦ ¦at¦ ¦high est¦ ¦risk¦ ¦of¦ ¦co mpl ications¦ ,▁ ¦such¦ ¦as¦ ¦the¦ ¦el d erly¦ ,▁ ¦and¦ ¦those¦ ¦at¦ ¦high¦ ¦risk¦ ¦of¦ ¦exp osure¦ ¦and¦ ¦transmission¦ ,▁ ¦such¦ ¦as¦ ¦healthcare¦ ¦workers¦ .
𐋇 ¦si ng le¦ ¦d ose¦ ¦int eri m¦ ¦use¦ ¦is¦ ¦under¦ ¦consid er ation¦ ¦to¦ ¦ext end¦ ¦vacc ination¦ ¦to¦ ¦as¦ ¦many¦ ¦people¦ ¦as¦ ¦possible¦ ¦until¦ ¦vaccine¦ ¦a v ai la bility¦ ¦imp ro ves¦ .
𐋇¦on¦ ¦ 21¦ ¦december¦ ¦2020¦ ,▁ ¦the¦ ¦european¦ ¦un ion¦ ¦appr oved¦ ¦the¦ ¦p f iz er¦ ¦bi on te ch¦ ¦vaccine¦ .
𐋇 ¦vacc in ations¦ ¦beg an¦ ¦to¦ ¦be¦ ¦admin ist ered¦ ¦on¦ ¦2 7¦ ¦december¦ ¦2020¦ .
𐋇¦the¦ ¦mod er na¦ ¦vaccine¦ ¦was¦ ¦author i sed¦ ¦on¦ ¦6¦ ¦january¦ ¦2021¦ ¦and¦ ¦the¦ ¦astrazeneca¦ ¦vaccine¦ ¦was¦ ¦author i sed¦ ¦on¦ ¦2 9¦ ¦january¦ ¦2021¦ .
𐋇¦on¦ ¦4¦ ¦february¦ ¦2020¦ ,▁ ¦us¦ ¦sec r et ary¦ ¦of¦ ¦health¦ ¦and¦ ¦human¦ ¦services¦ ¦a le x¦ ¦a z a r¦ ¦publ ished¦ ¦a¦ ¦n ot ice¦ ¦of¦ ¦decl ar ation¦ ¦under¦ ¦the¦ ¦public¦ ¦rea di ness¦ ¦and¦ ¦emergency¦ ¦pre par ed ness¦ ¦ac t¦ ¦for¦ ¦medical¦ ¦cou nt er me as ures¦ ¦against¦ ¦covid¦ - ¦19¦ ,▁ ¦cov ering¦ ▁" ¦any¦ ¦vaccine¦ ,▁ ¦used¦ ¦to¦ ¦tre at¦ ,▁ ¦diagn ose¦ ,▁ ¦c ure¦ ,▁ ¦prevent¦ ,▁ ¦or¦ ¦m it ig ate¦ ¦covid¦ - ¦19¦ ,▁ ¦or¦ ¦the¦ ¦transmission¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦or¦ ¦a¦ ¦virus¦ ¦m ut ating¦ ¦the re f r om¦ " ,▁ ¦and¦ ¦st ating¦ ¦that¦ ¦the¦ ¦decl ar ation¦ ¦pr ec lu des¦ ▁" ¦l ia bility¦ ¦cl ai ms¦ ¦al le ging¦ ¦ne g l ig ence¦ ¦by¦ ¦a¦ ¦m an u fa ct ur er¦ ¦in¦ ¦cre ating¦ ¦a¦ ¦vaccine¦ ,▁ ¦or¦ ¦ne g l ig ence¦ ¦by¦ ¦a¦ ¦health¦ ¦care¦ ¦provid er¦ ¦in¦ ¦pr esc rib ing¦ ¦the¦ ¦w ro ng¦ ¦d ose¦ ,▁ ¦ab s ent¦ ¦w i ll ful¦ ¦m is c on duc t¦ " .
𐋇¦the¦ ¦decl ar ation¦ ¦is¦ ¦effective¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ¦through¦ ¦1¦ ¦o ct ob er¦ ¦20 2 4¦ .
𐋇¦on¦ ¦8¦ ¦december¦ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦the¦ ¦astrazeneca¦ ¦vaccine¦ ¦is¦ ¦about¦ ¦7 0¦ %▁ ¦effective¦ ,▁ ¦according¦ ¦to¦ ¦a¦ ¦study¦ .
𐋇¦by¦ ¦m id¦ - ¦june¦ ¦2021¦ ,▁ ¦8 5¦ ¦p erc ent¦ ¦of¦ ¦vacc in ations¦ ¦have¦ ¦been¦ ¦admin ist ered¦ ¦in¦ ¦high¦ - ▁ ¦and¦ ¦u pp er¦ - ¦m id d le¦ - ¦inc ome¦ ¦countries¦ .
𐋇 ¦only¦ ¦ 0¦ . ¦3¦ ¦p erc ent¦ ¦of¦ ¦doses¦ ¦have¦ ¦been¦ ¦admin ist ered¦ ¦in¦ ¦low¦ - ¦inc ome¦ ¦countries¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦specific¦ ,▁ ¦effective¦ ¦treatment¦ ¦or¦ ¦c ure¦ ¦for¦ ¦coronavirus¦ ¦disease¦ ¦2019¦ ▁( ¦covid¦ - ¦19¦ ),▁ ¦the¦ ¦disease¦ ¦caused¦ ¦by¦ ¦the¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦virus¦ .
𐋇 ¦th us¦ ,▁ ¦the¦ ¦cor n er st one¦ ¦of¦ ¦mana ge ment¦ ¦of¦ ¦covid¦ - ¦19¦ ¦is¦ ¦supp or tive¦ ¦care¦ ,▁ ¦which¦ ¦inclu des¦ ¦treatment¦ ¦to¦ ¦rel ie ve¦ ¦symptoms¦ ,▁ ¦f lu id¦ ¦ ther ap y¦ ,▁ ¦o x yg en¦ ¦support¦ ¦and¦ ¦pr one¦ ¦po si tion ing¦ ¦as¦ ¦nee ded¦ ,▁ ¦and¦ ¦medic ations¦ ¦or¦ ¦de vi ces¦ ¦to¦ ¦support¦ ¦other¦ ¦affected¦ ¦v it al¦ ¦or g ans¦ .
𐋇¦a¦ ¦crit ically¦ ¦ ill¦ ¦pa ti ent¦ ¦rece i ving¦ ¦inv as ive¦ ¦ ventil ation¦ ¦in¦ ¦the¦ ¦in tens ive¦ ¦care¦ ¦uni t¦ ¦of¦ ¦the¦ ¦h ear t¦ ¦inst it ute¦ ,▁ ¦univers ity¦ ¦of¦ ¦s ã o¦ ¦pa ul o¦ .
𐋇 ¦due¦ ¦to¦ ¦a¦ ¦sh ort age¦ ¦of¦ ¦me ch an ical¦ ¦ ventil at ors¦ ,▁ ¦a¦ ¦br id ge¦ ¦ ventil at or¦ ¦is¦ ¦being¦ ¦used¦ ¦to¦ ¦a ut om at ically¦ ¦a ct u ate¦ ¦a¦ ¦ba g¦ ¦v al ve¦ ¦mask¦ .
𐋇 ¦most¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦are¦ ¦mild¦ .
𐋇¦in¦ ¦these¦ ,▁ ¦supp or tive¦ ¦care¦ ¦inclu des¦ ¦medic ation¦ ¦such¦ ¦as¦ ¦p ara ce ta mo l¦ ¦or¦ ¦ ns ai ds¦ ¦to¦ ¦rel ie ve¦ ¦symptoms¦ ▁( ¦fever¦ ,▁ ¦body¦ ¦a ches¦ ,▁ ¦cough¦ ),▁ ¦prop er¦ ¦in ta ke¦ ¦of¦ ¦f lu i ds¦ ,▁ ¦r est¦ ,▁ ¦and¦ ¦n as al¦ ¦brea thing¦ .
𐋇 ¦g ood¦ ¦personal¦ ¦h yg ien e¦ ¦and¦ ¦a¦ ¦healthy¦ ¦di et¦ ¦are¦ ¦also¦ ¦recommended¦ .
𐋇¦the¦ ¦u¦ . ¦s¦ .▁ ¦ce nt ers¦ ¦for¦ ¦disease¦ ¦control¦ ¦and¦ ¦pre vention¦ ▁( ¦c dc¦ )▁ ¦recomm end¦ ¦that¦ ¦those¦ ¦who¦ ¦susp ect¦ ¦they¦ ¦are¦ ¦c arr ying¦ ¦the¦ ¦virus¦ ¦isol ate¦ ¦the m s el ves¦ ¦at¦ ¦home¦ ¦and¦ ¦wear¦ ¦a¦ ¦face¦ ¦mask¦ .
𐋇 ¦people¦ ¦with¦ ¦more¦ ¦severe¦ ¦cases¦ ¦may¦ ¦need¦ ¦treatment¦ ¦in¦ ¦hospital¦ .
𐋇¦in¦ ¦those¦ ¦with¦ ¦low¦ ¦o x yg en¦ ¦le v els¦ ,▁ ¦use¦ ¦of¦ ¦the¦ ¦gl uc oc ort ic o id¦ ¦de x a me th as one¦ ¦is¦ ¦st ro ng ly¦ ¦recommended¦ ,▁ ¦as¦ ¦it¦ ¦can¦ ¦reduce¦ ¦the¦ ¦risk¦ ¦of¦ ¦death¦ .
𐋇¦n on in v as ive¦ ¦ ventil ation¦ ¦and¦ ,▁ ¦ ul ti ma tely¦ ,▁ ¦ad mi ssion¦ ¦to¦ ¦an¦ ¦in tens ive¦ ¦care¦ ¦uni t¦ ¦for¦ ¦me ch an ical¦ ¦ ventil ation¦ ¦may¦ ¦be¦ ¦required¦ ¦to¦ ¦support¦ ¦brea thing¦ .
𐋇 ¦ext r ac or p o re al¦ ¦me mb r an e¦ ¦o x yg en ation¦ ▁( ¦ec m o¦ )▁ ¦has¦ ¦been¦ ¦used¦ ¦to¦ ¦ad dr ess¦ ¦the¦ ¦i ss ue¦ ¦of¦ ¦respiratory¦ ¦fa il ure¦ ,▁ ¦but¦ ¦its¦ ¦be ne f i ts¦ ¦are¦ ¦still¦ ¦under¦ ¦consid er ation¦ .
𐋇 ¦several¦ ¦exp eri me ntal¦ ¦tre at ments¦ ¦are¦ ¦being¦ ¦activ ely¦ ¦st ud ied¦ ¦in¦ ¦clinical¦ ¦trials¦ .
𐋇 ¦others¦ ¦were¦ ¦th ou gh t¦ ¦to¦ ¦be¦ ¦pr om ising¦ ¦early¦ ¦in¦ ¦the¦ ¦pandemic¦ ,▁ ¦such¦ ¦as¦ ¦h y d ro x y ch lo ro qu ine¦ ¦and¦ ¦l op i na vi r¦ ▁/▁ ¦r it o na vi r¦ ,▁ ¦but¦ ¦later¦ ¦research¦ ¦found¦ ¦them¦ ¦to¦ ¦be¦ ¦i ne ff ective¦ ¦or¦ ¦even¦ ¦h arm ful¦ .
𐋇¦d esp ite¦ ¦o ng o ing¦ ¦research¦ ,▁ ¦there¦ ¦is¦ ¦still¦ ¦not¦ ¦en ough¦ ¦high¦ - ¦qu ality¦ ¦evidence¦ ¦to¦ ¦recomm end¦ ¦so¦ - ¦called¦ ¦early¦ ¦treatment¦ .
𐋇 ¦ne ve rt he less¦ ,▁ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦two¦ ¦mon oc l on al¦ ¦antibo dy¦ - ¦based¦ ¦ ther ap ies¦ ¦are¦ ¦available¦ ¦for¦ ¦early¦ ¦use¦ ¦in¦ ¦cases¦ ¦th ou gh t¦ ¦to¦ ¦be¦ ¦at¦ ¦high¦ ¦risk¦ ¦of¦ ¦pr og re ssion¦ ¦to¦ ¦severe¦ ¦disease¦ .
𐋇¦the¦ ¦anti vir al¦ ¦rem de si vi r¦ ¦is¦ ¦available¦ ¦in¦ ¦the¦ ¦u¦ . ¦s¦ . ,▁ ¦ca na d a¦ ,▁ ¦a u str al ia¦ ,▁ ¦and¦ ¦several¦ ¦other¦ ¦countries¦ ,▁ ¦with¦ ¦v ar ying¦ ¦restrictions¦ ;▁ ¦however¦ ,▁ ¦it¦ ¦is¦ ¦not¦ ¦recommended¦ ¦for¦ ¦people¦ ¦nee ding¦ ¦me ch an ical¦ ¦ ventil ation¦ ,▁ ¦and¦ ¦is¦ ¦disc ou ra ged¦ ¦al t og ether¦ ¦by¦ ¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ▁( ¦who¦ ),▁ ¦due¦ ¦to¦ ¦limi ted¦ ¦evidence¦ ¦of¦ ¦its¦ ¦eff ic acy¦ .
𐋇 ¦several¦ ¦vari a nts¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦have¦ ¦e mer ged¦ ¦that¦ ¦are¦ ¦sprea ding¦ ¦gl ob ally¦ .
𐋇¦the¦ ¦most¦ ¦cur re ntly¦ ¦prev al ent¦ ,▁ ¦all¦ ¦of¦ ¦which¦ ¦share¦ ¦the¦ ¦more¦ ¦infectious¦ ¦d 6 1 4 g¦ ¦m ut ation¦ ,▁ ¦are¦ :
𐋇¦b ¦ . ¦1¦ . ¦1¦ . ¦7¦ ,▁ ¦first¦ ¦detected¦ ¦in¦ ¦the¦ ¦uk¦ ,▁ ¦which¦ ¦has¦ ¦spread¦ ¦to¦ ¦over¦ ¦1 2 0¦ ¦countries¦
𐋇¦ p¦ . ¦1¦ ,▁ ¦first¦ ¦detected¦ ¦in¦ ¦b ra z il¦ ,▁ ¦which¦ ¦has¦ ¦spread¦ ¦to¦ ¦more¦ ¦than¦ ¦50¦ ¦countries¦
𐋇¦b ¦ . ¦1¦ . ¦3 5 1¦ ,▁ ¦first¦ ¦detected¦ ¦in¦ ¦south¦ ¦afr ica¦ ,▁ ¦which¦ ¦has¦ ¦spread¦ ¦to¦ ¦over¦ ¦8 0¦ ¦countries¦
𐋇¦the¦ ¦se ver ity¦ ¦of¦ ¦covid¦ - ¦19¦ ¦vari es¦ .
𐋇¦the¦ ¦disease¦ ¦may¦ ¦take¦ ¦a¦ ¦mild¦ ¦co ur se¦ ¦with¦ ¦fe w¦ ¦or¦ ¦no¦ ¦symptoms¦ ,▁ ¦re se m bl ing¦ ¦other¦ ¦common¦ ¦u pp er¦ ¦respiratory¦ ¦diseases¦ ¦such¦ ¦as¦ ¦the¦ ¦common¦ ¦cold¦ .
𐋇¦in¦ ¦3¦ ▁–▁ ¦4¦ %▁ ¦of¦ ¦cases¦ ▁( ¦7¦ . ¦4¦ %▁ ¦for¦ ¦those¦ ¦over¦ ¦age¦ ¦6 5¦ )▁ ¦symptoms¦ ¦are¦ ¦severe¦ ¦en ough¦ ¦to¦ ¦cause¦ ¦hosp it al iz ation¦ .
𐋇 ¦mild¦ ¦cases¦ ¦typ ically¦ ¦reco ver¦ ¦within¦ ¦two¦ ¦weeks¦ ,▁ ¦while¦ ¦those¦ ¦with¦ ¦severe¦ ¦or¦ ¦crit ical¦ ¦diseases¦ ¦may¦ ¦take¦ ¦three¦ ¦to¦ ¦si x¦ ¦weeks¦ ¦to¦ ¦reco ver¦ .
𐋇 ¦among¦ ¦those¦ ¦who¦ ¦have¦ ¦d ied¦ ,▁ ¦the¦ ¦time¦ ¦from¦ ¦s y m pt om¦ ¦o ns et¦ ¦to¦ ¦death¦ ¦has¦ ¦r an ged¦ ¦from¦ ¦two¦ ¦to¦ ¦e ight¦ ¦weeks¦ .
𐋇¦the¦ ¦i tali an¦ ¦ ist it ut o¦ ¦su p eri ore¦ ¦d i¦ ¦s an it à ¦ ¦reported¦ ¦that¦ ¦the¦ ¦me di an¦ ¦time¦ ¦between¦ ¦the¦ ¦o ns et¦ ¦of¦ ¦symptoms¦ ¦and¦ ¦death¦ ¦was¦ ¦t w el ve¦ ¦days¦ ,▁ ¦with¦ ¦se v en¦ ¦being¦ ¦hosp i tali sed¦ .
𐋇¦however¦ ,▁ ¦people¦ ¦trans f er r ed¦ ¦to¦ ¦an¦ ¦ ic u¦ ¦had¦ ¦a¦ ¦me di an¦ ¦time¦ ¦of¦ ¦t en¦ ¦days¦ ¦between¦ ¦hosp it al is ation¦ ¦and¦ ¦death¦ .
𐋇 ¦pr ol on ged¦ ¦pro th ro mb in¦ ¦time¦ ¦and¦ ¦e le v ated¦ ¦ c¦ - ¦re ac tive¦ ¦protein¦ ¦le v els¦ ¦on¦ ¦ad mi ssion¦ ¦to¦ ¦the¦ ¦hospital¦ ¦are¦ ¦associated¦ ¦with¦ ¦severe¦ ¦co ur se¦ ¦of¦ ¦covid¦ - ¦19¦ ¦and¦ ¦with¦ ¦a¦ ¦trans f er¦ ¦to¦ ¦ ic u¦ .
𐋇 ¦sp e ed¦ ¦and¦ ¦sc a le¦ ¦are¦ ¦k e y¦ ¦to¦ ¦m it ig ation¦ ,▁ ¦due¦ ¦to¦ ¦the¦ ¦f at¦ - ¦ tail ed¦ ¦nat ure¦ ¦of¦ ¦pandemic¦ ¦risk¦ ¦and¦ ¦the¦ ¦exp o ne ntial¦ ¦gr ow th¦ ¦of¦ ¦covid¦ - ¦19¦ ¦infections¦ .
𐋇¦for¦ ¦m it ig ation¦ ¦to¦ ¦be¦ ¦effective¦ , ▁( ¦a¦ )▁ ¦cha ins¦ ¦of¦ ¦transmission¦ ¦must¦ ¦be¦ ¦b ro k en¦ ¦as¦ ¦qu ick ly¦ ¦as¦ ¦possible¦ ¦through¦ ¦scre ening¦ ¦and¦ ¦conta in ment¦ , ▁( ¦b ¦ )▁ ¦health¦ ¦care¦ ¦must¦ ¦be¦ ¦available¦ ¦to¦ ¦provide¦ ¦for¦ ¦the¦ ¦needs¦ ¦of¦ ¦those¦ ¦infected¦ ,▁ ¦and¦ ▁( ¦ c¦ )▁ ¦contin ge nc ies¦ ¦must¦ ¦be¦ ¦in¦ ¦place¦ ¦to¦ ¦all ow¦ ¦for¦ ¦effective¦ ¦r ol lo ut¦ ¦of¦ ▁( ¦a¦ )▁ ¦and¦ ▁( ¦b ¦ ).
𐋇 ¦stra te g ies¦ ¦in¦ ¦the¦ ¦control¦ ¦of¦ ¦an¦ ¦outbreak¦ ¦are¦ ¦scre ening¦ ,▁ ¦conta in ment¦ ▁( ¦or¦ ¦supp re ssion¦ ),▁ ¦and¦ ¦m it ig ation¦ .
𐋇 ¦scre ening¦ ¦is¦ ¦d one¦ ¦with¦ ¦a¦ ¦de v ice¦ ¦such¦ ¦as¦ ¦a¦ ¦ ther mo me ter¦ ¦to¦ ¦det ect¦ ¦the¦ ¦e le v ated¦ ¦body¦ ¦temp erat ure¦ ¦associated¦ ¦with¦ ¦fe v ers¦ ¦caused¦ ¦by¦ ¦the¦ ¦infection¦ .
𐋇 ¦conta in ment¦ ¦is¦ ¦under ta k en¦ ¦in¦ ¦the¦ ¦early¦ ¦sta ges¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦and¦ ¦ ai ms¦ ¦to¦ ¦tr ace¦ ¦and¦ ¦isol ate¦ ¦those¦ ¦infected¦ ¦as¦ ¦well¦ ¦as¦ ¦int ro duc e¦ ¦other¦ ¦measures¦ ¦to¦ ¦sto p¦ ¦the¦ ¦disease¦ ¦from¦ ¦sprea ding¦ .
𐋇¦when¦ ¦it¦ ¦is¦ ¦no¦ ¦lo nger¦ ¦possible¦ ¦to¦ ¦con tain¦ ¦the¦ ¦disease¦ ,▁ ¦eff orts¦ ¦then¦ ¦mo ve¦ ¦to¦ ¦the¦ ¦m it ig ation¦ ¦st age¦ :▁ 𐋇 ¦measures¦ ¦are¦ ¦ta k en¦ ¦to¦ ¦sl ow¦ ¦the¦ ¦spread¦ ¦and¦ ¦m it ig ate¦ ¦its¦ ¦eff ects¦ ¦on¦ ¦the¦ ¦healthcare¦ ¦system¦ ¦and¦ ¦s oc i et y¦ .
𐋇¦a¦ ¦co mb ination¦ ¦of¦ ¦both¦ ¦conta in ment¦ ¦and¦ ¦m it ig ation¦ ¦measures¦ ¦may¦ ¦be¦ ¦under ta k en¦ ¦at¦ ¦the¦ ¦same¦ ¦time¦ .
𐋇 ¦supp re ssion¦ ¦requir es¦ ¦more¦ ¦ext re me¦ ¦measures¦ ¦so¦ ¦as¦ ¦to¦ ¦re ver se¦ ¦the¦ ¦pandemic¦ ¦by¦ ¦reduc ing¦ ¦the¦ ¦b as ic¦ ¦rep ro d u ction¦ ¦number¦ ¦to¦ ¦less¦ ¦than¦ ¦1¦ .
𐋇 ¦par t¦ ¦of¦ ¦mana ging¦ ¦an¦ ¦infectious¦ ¦disease¦ ¦outbreak¦ ¦is¦ ¦tr ying¦ ¦to¦ ¦del ay¦ ¦and¦ ¦dec re ase¦ ¦the¦ ¦epidemic¦ ¦p ea k¦ ,▁ ¦known¦ ¦as¦ ¦f l at t ening¦ ¦the¦ ¦epidemic¦ ¦cur ve¦ .
𐋇¦this¦ ¦dec rea ses¦ ¦the¦ ¦risk¦ ¦of¦ ¦health¦ ¦services¦ ¦being¦ ¦over w h el med¦ ¦and¦ ¦provid es¦ ¦more¦ ¦time¦ ¦for¦ ¦vaccines¦ ¦and¦ ¦tre at ments¦ ¦to¦ ¦be¦ ¦developed¦ .
𐋇 ¦non¦ - ¦ph ar ma ce ut ical¦ ¦int erv en tions¦ ¦that¦ ¦may¦ ¦mana ge¦ ¦the¦ ¦outbreak¦ ¦include¦ ¦personal¦ ¦prev en tive¦ ¦measures¦ ¦such¦ ¦as¦ ¦hand¦ ¦h yg ien e¦ ,▁ ¦w earing¦ ¦face¦ ¦masks¦ ,▁ ¦and¦ ¦self¦ - ¦quarantine¦ ;▁ ¦community¦ ¦measures¦ ¦ ai med¦ ¦at¦ ¦ph ys ical¦ ¦distancing¦ ¦such¦ ¦as¦ ¦clos ing¦ ¦schools¦ ¦and¦ ¦cance lling¦ ¦m ass¦ ¦ga th ering¦ ¦events¦ ;▁ ¦community¦ ¦e ng a ge ment¦ ¦to¦ ¦e nc o ur age¦ ¦ac ce pt ance¦ ¦and¦ ¦partic ip ation¦ ¦in¦ ¦such¦ ¦int erv en tions¦ ;▁ ¦as¦ ¦well¦ ¦as¦ ¦en vir on me ntal¦ ¦measures¦ ¦such¦ ¦sur f ace¦ ¦cl ea ning¦ .
𐋇¦some¦ ¦measures¦ ,▁ ¦partic ul arly¦ ¦those¦ ¦that¦ ¦f oc us¦ ¦on¦ ¦cl ea ning¦ ¦sur fa ces¦ ¦r at her¦ ¦than¦ ¦prev en ting¦ ¦air bor n e¦ ¦transmission¦ ,▁ ¦have¦ ¦been¦ ¦crit ici sed¦ ¦as¦ ¦h yg ien e¦ ¦the at r e¦ .
𐋇 ¦more¦ ¦d ra st ic¦ ¦ac tions¦ ¦ ai med¦ ¦at¦ ¦cont aining¦ ¦the¦ ¦outbreak¦ ¦were¦ ¦ta k en¦ ¦in¦ ¦china¦ ¦o nce¦ ¦the¦ ¦se ver ity¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦bec a me¦ ¦app ar ent¦ ,▁ ¦such¦ ¦as¦ ¦qu ar an ti ning¦ ¦ent ir e¦ ¦c ities¦ ¦and¦ ¦imp os ing¦ ¦ stric t¦ ¦travel¦ ¦b ans¦ .
𐋇 ¦other¦ ¦countries¦ ¦also¦ ¦ad op ted¦ ¦a¦ ¦vari et y¦ ¦of¦ ¦measures¦ ¦ ai med¦ ¦at¦ ¦limi ting¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇 ¦south¦ ¦ko rea¦ ¦int ro duc ed¦ ¦m ass¦ ¦scre ening¦ ¦and¦ ¦loc a li sed¦ ¦qu ara nt ines¦ ¦and¦ ¦issued¦ ¦al er ts¦ ¦on¦ ¦the¦ ¦movements¦ ¦of¦ ¦infected¦ ¦individuals¦ .
𐋇 ¦si ng ap ore¦ ¦provid ed¦ ¦fi na nc ial¦ ¦support¦ ¦for¦ ¦those¦ ¦infected¦ ¦who¦ ¦qu ara nt ined¦ ¦the m s el ves¦ ¦and¦ ¦imp osed¦ ¦large¦ ¦fines¦ ¦for¦ ¦those¦ ¦who¦ ¦fa il ed¦ ¦to¦ ¦do¦ ¦so¦ .
𐋇¦t ai w an¦ ¦increased¦ ¦face¦ ¦mask¦ ¦produc t ion¦ ¦and¦ ¦p e na li sed¦ ¦the¦ ¦ho ar ding¦ ¦of¦ ¦medical¦ ¦supp l ies¦ .
𐋇¦s im ul ations¦ ¦for¦ ¦g re at¦ ¦b ri tain¦ ¦and¦ ¦the¦ ¦united¦ ¦states¦ ¦sh ow¦ ¦that¦ ¦m it ig ation¦ ▁( ¦sl owing¦ ¦but¦ ¦not¦ ¦sto pping¦ ¦epidemic¦ ¦spread¦ )▁ ¦and¦ ¦supp re ssion¦ ▁( ¦re ve rs ing¦ ¦epidemic¦ ¦gr ow th¦ )▁ ¦have¦ ¦major¦ ¦cha ll en ges¦ .
𐋇 ¦o pt im al¦ ¦m it ig ation¦ ¦pol ic ies¦ ¦might¦ ¦reduce¦ ¦p ea k¦ ¦healthcare¦ ¦dem and¦ ¦by¦ ¦two¦ - ¦thir ds¦ ¦and¦ ¦deaths¦ ¦by¦ ¦h al f¦ ,▁ ¦but¦ ¦still¦ ¦result¦ ¦in¦ ¦h u nd re ds¦ ¦of¦ ¦t ho us an ds¦ ¦of¦ ¦deaths¦ ¦and¦ ¦over w h el med¦ ¦health¦ ¦sys tems¦ .
𐋇 ¦supp re ssion¦ ¦can¦ ¦be¦ ¦pre f er r ed¦ ¦but¦ ¦needs¦ ¦to¦ ¦be¦ ¦main ta ined¦ ¦for¦ ¦as¦ ¦long¦ ¦as¦ ¦the¦ ¦virus¦ ¦is¦ ¦c ir c ul ating¦ ¦in¦ ¦the¦ ¦human¦ ¦population¦ ▁( ¦or¦ ¦until¦ ¦a¦ ¦vaccine¦ ¦bec omes¦ ¦available¦ ),▁ ¦as¦ ¦transmission¦ ¦o ther w ise¦ ¦qu ick ly¦ ¦re bo un ds¦ ¦when¦ ¦measures¦ ¦are¦ ¦re la x ed¦ .
𐋇 ¦long¦ - ¦ter m¦ ¦inter vention¦ ¦to¦ ¦supp r ess¦ ¦the¦ ¦pandemic¦ ¦has¦ ¦consid er able¦ ¦social¦ ¦and¦ ¦ec onomic¦ ¦co sts¦ .
𐋇 ¦contact¦ ¦trac ing¦ ¦is¦ ¦an¦ ¦important¦ ¦met ho d¦ ¦for¦ ¦health¦ ¦author ities¦ ¦to¦ ¦det erm ine¦ ¦the¦ ¦sour ce¦ ¦of¦ ¦infection¦ ¦and¦ ¦to¦ ¦prevent¦ ¦further¦ ¦transmission¦ .
𐋇¦the¦ ¦use¦ ¦of¦ ¦loc ation¦ ¦data¦ ¦from¦ ¦m ob i le¦ ¦ph on es¦ ¦by¦ ¦gover n ments¦ ¦for¦ ¦this¦ ¦p ur p ose¦ ¦has¦ ¦pro mp ted¦ ¦priv acy¦ ¦concer ns¦ ,▁ ¦with¦ ¦a m ne st y¦ ¦international¦ ¦and¦ ¦more¦ ¦than¦ ¦a¦ ¦h un dr ed¦ ¦other¦ ¦or g an is ations¦ ¦i ss u ing¦ ¦a¦ ¦sta te ment¦ ¦ca lling¦ ¦for¦ ¦limi ts¦ ¦on¦ ¦this¦ ¦k ind¦ ¦of¦ ¦surveillance¦ .
𐋇 ¦several¦ ¦m ob i le¦ ¦app s¦ ¦have¦ ¦been¦ ¦imp le m ented¦ ¦or¦ ¦prop osed¦ ¦for¦ ¦v o lu nt ary¦ ¦use¦ ,▁ ¦and¦ ¦as¦ ¦of¦ ¦7¦ ¦april¦ ¦2020¦ ¦more¦ ¦than¦ ¦a¦ ¦do z en¦ ¦exp er t¦ ¦grou ps¦ ¦were¦ ¦wor king¦ ¦on¦ ¦priv acy¦ - ¦f ri end ly¦ ¦so lu tions¦ ¦such¦ ¦as¦ ¦using¦ ¦b lu et oo th¦ ¦to¦ ¦lo g¦ ¦a¦ ¦us er¦ ' ¦s¦ ¦pro x im ity¦ ¦to¦ ¦other¦ ¦ce ll ph on es¦ .
( 𐋇 ¦us ers¦ ¦are¦ ¦al er ted¦ ¦if¦ ¦they¦ ¦have¦ ¦been¦ ¦n ear¦ ¦someone¦ ¦who¦ ¦sub se qu e ntly¦ ¦tests¦ ¦positive¦ . )
𐋇¦on¦ ¦10¦ ¦april¦ ¦2020¦ ,▁ ¦go og le¦ ¦and¦ ¦app le¦ ¦j oi ntly¦ ¦announced¦ ¦an¦ ¦in i ti ative¦ ¦for¦ ¦priv acy¦ - ¦pres er ving¦ ¦contact¦ ¦trac ing¦ ¦based¦ ¦on¦ ¦b lu et oo th¦ ¦techn ology¦ ¦and¦ ¦cr y pt ogra ph y¦ .
𐋇¦the¦ ¦system¦ ¦is¦ ¦in te nded¦ ¦to¦ ¦all ow¦ ¦gover n ments¦ ¦to¦ ¦cre ate¦ ¦offic ial¦ ¦priv acy¦ - ¦pres er ving¦ ¦coronavirus¦ ¦tracking¦ ¦app s¦ ,▁ ¦with¦ ¦the¦ ¦e vent ual¦ ¦go al¦ ¦of¦ ¦in te g r ation¦ ¦of¦ ¦this¦ ¦f u nc tion ality¦ ¦dir ect ly¦ ¦into¦ ¦the¦ ¦i o s¦ ¦and¦ ¦a nd ro id¦ ¦m ob i le¦ ¦pl at for ms¦ .
𐋇¦in¦ ¦e ur ope¦ ¦and¦ ¦in¦ ¦the¦ ¦u¦ . ¦s¦ . ,▁ ¦p al an ti r¦ ¦techn ol og ies¦ ¦is¦ ¦also¦ ¦provid ing¦ ¦covid¦ - ¦19¦ ¦tracking¦ ¦services¦ .
𐋇 ¦incre as ing¦ ¦c ap ac ity¦ ¦and¦ ¦ad ap ting¦ ¦healthcare¦ ¦for¦ ¦the¦ ¦needs¦ ¦of¦ ¦covid¦ - ¦19¦ ¦patients¦ ¦is¦ ¦d esc rib ed¦ ¦by¦ ¦the¦ ¦who¦ ¦as¦ ¦a¦ ¦f u nd a me ntal¦ ¦outbreak¦ ¦response¦ ¦me as ure¦ .
𐋇¦the¦ ¦ec dc¦ ¦and¦ ¦the¦ ¦european¦ ¦regi on al¦ ¦off ice¦ ¦of¦ ¦the¦ ¦who¦ ¦have¦ ¦issued¦ ¦gu id el ines¦ ¦for¦ ¦hosp it als¦ ¦and¦ ¦pr imary¦ ¦healthcare¦ ¦services¦ ¦for¦ ¦sh if ting¦ ¦of¦ ¦res o ur ces¦ ¦at¦ ¦mult ip le¦ ¦le v els¦ ,▁ ¦including¦ ¦f oc us ing¦ ¦laboratory¦ ¦services¦ ¦t ow ards¦ ¦covid¦ - ¦19¦ ¦testing¦ ,▁ ¦cance lling¦ ¦el ective¦ ¦proc ed ures¦ ¦w he ne ver¦ ¦possible¦ ,▁ ¦separ ating¦ ¦and¦ ¦isol ating¦ ¦covid¦ - ¦19¦ ¦positive¦ ¦patients¦ ,▁ ¦and¦ ¦incre as ing¦ ¦in tens ive¦ ¦care¦ ¦c ap ab il ities¦ ¦by¦ ¦tr aining¦ ¦pers on ne l¦ ¦and¦ ¦incre as ing¦ ¦the¦ ¦number¦ ¦of¦ ¦available¦ ¦ ventil at ors¦ ¦and¦ ¦be ds¦ .
𐋇¦in¦ ¦add ition¦ ,▁ ¦in¦ ¦an¦ ¦att e mp t¦ ¦to¦ ¦main tain¦ ¦ph ys ical¦ ¦distancing¦ ,▁ ¦and¦ ¦to¦ ¦protect¦ ¦both¦ ¦patients¦ ¦and¦ ¦cl in ici ans¦ ,▁ ¦in¦ ¦some¦ ¦areas¦ ¦non¦ - ¦emergency¦ ¦healthcare¦ ¦services¦ ¦are¦ ¦being¦ ¦provid ed¦ ¦vir t ually¦ .
𐋇 ¦due¦ ¦to¦ ¦c ap ac ity¦ ¦limi t ations¦ ¦in¦ ¦the¦ ¦sta nd ard¦ ¦supp ly¦ ¦cha ins¦ ,▁ ¦some¦ ¦m an u fa ct ur ers¦ ¦are¦ ¦3 d¦ ¦pr in ting¦ ¦healthcare¦ ¦m at er ial¦ ¦such¦ ¦as¦ ¦n as al¦ ¦sw ab s¦ ¦and¦ ¦ ventil at or¦ ¦par ts¦ .
𐋇¦in¦ ¦one¦ ¦example¦ ,▁ ¦when¦ ¦an¦ ¦i tali an¦ ¦hospital¦ ¦ ur ge ntly¦ ¦required¦ ¦a¦ ¦ ventil at or¦ ¦v al ve¦ ,▁ ¦and¦ ¦the¦ ¦supp li er¦ ¦was¦ ¦un able¦ ¦to¦ ¦de li ver¦ ¦in¦ ¦the¦ ¦t im esc a le¦ ¦required¦ ,▁ ¦a¦ ¦local¦ ¦sta rt u p¦ ¦received¦ ¦le g al¦ ¦th rea ts¦ ¦due¦ ¦to¦ ¦al le ged¦ ¦p at ent¦ ¦inf r in ge ment¦ ¦after¦ ¦re ver se¦ - ¦e ng i ne ering¦ ¦and¦ ¦pr in ting¦ ¦the¦ ¦required¦ ¦h un dr ed¦ ¦v al ves¦ ¦over n ight¦ .
𐋇¦on¦ ¦23¦ ¦april¦ ¦2020¦ ,▁ ¦n as a¦ ¦reported¦ ¦bu il ding¦ ,▁ ¦in¦ ¦3 7¦ ¦days¦ ,▁ ¦a¦ ¦ ventil at or¦ ¦which¦ ¦is¦ ¦cur re ntly¦ ¦under g o ing¦ ¦further¦ ¦testing¦ .
𐋇¦n as a¦ ¦is¦ ¦s ee king¦ ¦f ast¦ - ¦tr ack¦ ¦appr ov al¦ .
𐋇 ¦individuals¦ ¦and¦ ¦grou ps¦ ¦of¦ ¦ma k ers¦ ¦around¦ ¦the¦ ¦world¦ ¦also¦ ¦ass is ted¦ ¦in¦ ¦the¦ ¦eff orts¦ ¦by¦ ¦cre ating¦ ¦and¦ ¦sh ar ing¦ ¦open¦ ¦sour ce¦ ¦d es ig ns¦ ,▁ ¦and¦ ¦m an u fa ct ur ing¦ ¦de vi ces¦ ¦using¦ ¦loc ally¦ ¦sour c ed¦ ¦m at eri als¦ ,▁ ¦se w ing¦ ,▁ ¦and¦ ¦3 d¦ ¦pr in ting¦ .
𐋇¦m il li ons¦ ¦of¦ ¦face¦ ¦s hi el ds¦ ,▁ ¦prot ective¦ ¦g ow ns¦ ,▁ ¦and¦ ¦masks¦ ¦were¦ ¦made¦ .
𐋇 ¦other¦ ¦medical¦ ¦supp l ies¦ ¦were¦ ¦made¦ ¦such¦ ¦as¦ ¦sho es¦ ¦cov ers¦ ,▁ ¦sur g ical¦ ¦ca ps¦ ,▁ ¦p ow ered¦ ¦air ¦ - ¦p ur if ying¦ ¦resp ir at ors¦ ,▁ ¦and¦ ¦hand¦ ¦s an itiz er¦ .
𐋇 ¦novel¦ ¦de vi ces¦ ¦were¦ ¦cre ated¦ ¦such¦ ¦as¦ ¦ ear¦ ¦sa v ers¦ ,▁ ¦non¦ - ¦inv as ive¦ ¦ ventil ation¦ ¦h el m ets¦ ,▁ ¦and¦ ¦ ventil at or¦ ¦s pl it t ers¦ .
𐋇 ¦based¦ ¦on¦ ¦the¦ ¦r et r os p ective¦ ¦anal y sis¦ ,▁ ¦star ting¦ ¦from¦ ¦december¦ ¦2019¦ ,▁ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦in¦ ¦hub e i¦ ¦g rad ually¦ ¦increased¦ ,▁ ¦re ac hing¦ ¦6 0¦ ¦by¦ ¦20¦ ¦december¦ ¦and¦ ¦at¦ ¦least¦ ¦2 6 6¦ ¦by¦ ¦3 1¦ ¦december¦ .
𐋇¦on¦ ¦24¦ ¦december¦ ¦2019¦ ,▁ ¦wuhan¦ ¦centr al¦ ¦hospital¦ ¦s ent¦ ¦a¦ ¦b ro nc ho al ve o la r¦ ¦la v age¦ ¦f lu id¦ ▁( ¦b al¦ )▁ ¦sampl e¦ ¦from¦ ¦an¦ ¦un r es ol v ed¦ ¦clinical¦ ¦case¦ ¦to¦ ¦se qu e ncing¦ ¦comp an y¦ ¦visi on¦ ¦medic als¦ .
𐋇¦on¦ ¦2 7¦ ¦and¦ ¦2 8¦ ¦december¦ ,▁ ¦visi on¦ ¦medic als¦ ¦in for med¦ ¦the¦ ¦wuhan¦ ¦centr al¦ ¦hospital¦ ¦and¦ ¦the¦ ¦chinese¦ ¦c dc¦ ¦of¦ ¦the¦ ¦results¦ ¦of¦ ¦the¦ ¦test¦ ,▁ ¦sh owing¦ ¦a¦ ¦new¦ ¦coronavirus¦ .
𐋇¦a¦ ¦pneumonia¦ ¦cl us ter¦ ¦of¦ ¦un k n own¦ ¦cause¦ ¦was¦ ¦ob s erv ed¦ ¦on¦ ¦26¦ ¦december¦ ¦and¦ ¦tre ated¦ ¦by¦ ¦the¦ ¦doctor¦ ¦z h a ng¦ ¦j i xi an¦ ¦in¦ ¦hub e i¦ ¦pro vi nc ial¦ ¦hospital¦ ,▁ ¦who¦ ¦in for med¦ ¦the¦ ¦wuhan¦ ¦j i an gh an¦ ¦c dc¦ ¦on¦ ¦2 7¦ ¦december¦ .
𐋇¦on¦ ¦30¦ ¦december¦ ¦2019¦ ,▁ ¦a¦ ¦test¦ ¦report¦ ¦ad dr es sed¦ ¦to¦ ¦wuhan¦ ¦centr al¦ ¦hospital¦ ,▁ ¦from¦ ¦comp an y¦ ¦c ap it al b i o¦ ¦m ed l ab ¦ ,▁ ¦stated¦ ¦that¦ ¦there¦ ¦was¦ ¦an¦ ¦ er ro ne o us¦ ¦positive¦ ¦result¦ ¦for¦ ¦sars¦ ,▁ ¦ca us ing¦ ¦a¦ ¦group¦ ¦of¦ ¦do ctors¦ ¦at¦ ¦wuhan¦ ¦centr al¦ ¦hospital¦ ¦to¦ ¦alert¦ ¦their¦ ¦coll ea g ues¦ ¦and¦ ¦re le v ant¦ ¦hospital¦ ¦author ities¦ ¦of¦ ¦the¦ ¦result¦ .
𐋇¦e ight¦ ¦of¦ ¦those¦ ¦do ctors¦ ,▁ ¦including¦ ¦l i¦ ¦w en l ia ng¦ ▁( ¦who¦ ¦was¦ ¦also¦ ¦p un ished¦ ¦on¦ ¦3¦ ¦january¦ ),▁ ¦were¦ ¦later¦ ¦ad m on ished¦ ¦by¦ ¦the¦ ¦pol ice¦ ¦for¦ ¦sprea ding¦ ¦f al se¦ ¦ ru mo ur s¦ ;▁ ¦and¦ ¦another¦ ¦doctor¦ ,▁ ¦a i¦ ¦ fen¦ ,▁ ¦was¦ ¦rep ri ma nded¦ ¦by¦ ¦ her¦ ¦su p eri ors¦ ¦for¦ ¦ra ising¦ ¦the¦ ¦al ar m¦ .
𐋇 ¦that¦ ¦ev ening¦ ,▁ ¦the¦ ¦wuhan¦ ¦m un ic ip al¦ ¦health¦ ¦comm i ssion¦ ¦issued¦ ¦a¦ ¦n ot ice¦ ¦to¦ ¦v ar ious¦ ¦medical¦ ¦inst itu tions¦ ¦about¦ ▁" ¦the¦ ¦treatment¦ ¦of¦ ¦pneumonia¦ ¦of¦ ¦un k n own¦ ¦cause¦ " .
𐋇¦the¦ ¦ne xt¦ ¦day¦ ,▁ ¦the¦ ¦wuhan¦ ¦m un ic ip al¦ ¦health¦ ¦comm i ssion¦ ¦made¦ ¦the¦ ¦first¦ ¦public¦ ¦an no un ce ment¦ ¦of¦ ¦a¦ ¦pneumonia¦ ¦outbreak¦ ¦of¦ ¦un k n own¦ ¦cause¦ ,▁ ¦conf ir m ing¦ ¦2 7¦ ¦cases¦ ▁ — ▁ ¦en ough¦ ¦to¦ ¦t ri gg er¦ ¦an¦ ¦in ve st ig ation¦ .
𐋇¦the¦ ¦following¦ ¦day¦ ,▁ ¦on¦ ¦3 1¦ ¦december¦ ,▁ ¦the¦ ¦who¦ ¦off ice¦ ¦in¦ ¦china¦ ¦was¦ ¦in for med¦ ¦of¦ ¦cases¦ ¦of¦ ¦pneumonia¦ ¦of¦ ¦un k n own¦ ¦cause¦ ¦in¦ ¦wuhan¦ .
𐋇 ¦an¦ ¦in ve st ig ation¦ ¦was¦ ¦la un ched¦ ¦at¦ ¦the¦ ¦star t¦ ¦of¦ ¦january¦ ¦2020¦ .
𐋇 ¦according¦ ¦to¦ ¦offic ial¦ ¦chinese¦ ¦sour ces¦ ,▁ ¦the¦ ¦early¦ ¦cases¦ ¦were¦ ¦mo st ly¦ ¦l in ked¦ ¦to¦ ¦the¦ ¦h u an an¦ ¦s ea f ood¦ ¦wh ol es a le¦ ¦mark et¦ ,▁ ¦which¦ ¦also¦ ¦so ld¦ ¦live¦ ¦anim als¦ .
𐋇¦however¦ ,▁ ¦in¦ ¦may¦ ¦2020¦ ,▁ ¦ ge or ge¦ ¦ga o¦ ,▁ ¦the¦ ¦dir ector¦ ¦of¦ ¦the¦ ¦chinese¦ ¦center¦ ¦for¦ ¦disease¦ ¦control¦ ¦and¦ ¦pre vention¦ ,▁ ¦said¦ ¦anim al¦ ¦samples¦ ¦coll ected¦ ¦from¦ ¦the¦ ¦s ea f ood¦ ¦mark et¦ ¦had¦ ¦tested¦ ¦negative¦ ¦for¦ ¦the¦ ¦virus¦ ,▁ ¦indic ating¦ ¦the¦ ¦mark et¦ ¦was¦ ¦not¦ ¦the¦ ¦sour ce¦ ¦of¦ ¦the¦ ¦in it ial¦ ¦outbreak¦ .
𐋇¦in¦ ¦march¦ ¦2021¦ ,▁ ¦the¦ ¦who¦ ¦publ ished¦ ¦their¦ ¦report¦ ¦on¦ ¦the¦ ¦pote ntial¦ ¦z o on ot ic¦ ¦sour ce¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦the¦ ¦who¦ ¦co nc lu ded¦ ¦that¦ ¦human¦ ¦sp il lo ver¦ ¦v ia¦ ¦an¦ ¦int erm ediate¦ ¦anim al¦ ¦host¦ ¦was¦ ¦the¦ ¦most¦ ¦likely¦ ¦ex pl an ation¦ ,▁ ¦with¦ ¦direct¦ ¦sp il lo ver¦ ¦from¦ ¦bats¦ ¦ne xt¦ ¦most¦ ¦likely¦ ¦and¦ ¦int ro d u ction¦ ¦through¦ ¦the¦ ¦food¦ ¦supp ly¦ ¦cha in¦ ¦as¦ ¦another¦ ¦possible¦ ¦ex pl an ation¦ .
𐋇¦on¦ ¦11¦ ¦january¦ ,▁ ¦who¦ ¦received¦ ¦further¦ ¦information¦ ¦from¦ ¦the¦ ¦chinese¦ ¦national¦ ¦health¦ ¦comm i ssion¦ ¦that¦ ¦the¦ ¦outbreak¦ ¦is¦ ¦associated¦ ¦with¦ ¦exp os ures¦ ¦in¦ ¦one¦ ¦s ea f ood¦ ¦mark et¦ ¦in¦ ¦wuhan¦ ,▁ ¦and¦ ¦that¦ ¦the¦ ¦chinese¦ ¦author ities¦ ¦had¦ ¦identified¦ ¦a¦ ¦new¦ ¦typ e¦ ¦of¦ ¦coronavirus¦ ,▁ ¦which¦ ¦was¦ ¦isol ated¦ ¦on¦ ¦7¦ ¦january¦ .
𐋇 ¦during¦ ¦the¦ ¦early¦ ¦sta ges¦ ¦of¦ ¦the¦ ¦outbreak¦ ,▁ ¦the¦ ¦number¦ ¦of¦ ¦cases¦ ¦d ou bl ed¦ ¦appro xi ma tely¦ ¦every¦ ¦se v en¦ ¦and¦ ¦a¦ ¦h al f¦ ¦days¦ .
𐋇¦in¦ ¦early¦ ¦and¦ ¦m id¦ - ¦january¦ ,▁ ¦the¦ ¦virus¦ ¦spread¦ ¦to¦ ¦other¦ ¦chinese¦ ¦pr ov in ces¦ ,▁ ¦h el p ed¦ ¦by¦ ¦the¦ ¦chinese¦ ¦new¦ ¦year¦ ¦m ig r ation¦ ¦and¦ ¦wuhan¦ ¦being¦ ¦a¦ ¦transport¦ ¦hub ¦ ¦and¦ ¦major¦ ¦ra il¦ ¦inter ch ange¦ .
𐋇¦on¦ ¦10¦ ¦january¦ ,▁ ¦the¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦gen et ic¦ ¦se qu ence¦ ¦data¦ ¦was¦ ¦sh ared¦ ¦through¦ ¦g is a id¦ .
𐋇¦on¦ ¦20¦ ¦january¦ ,▁ ¦china¦ ¦reported¦ ¦ne arly¦ ¦1 4 0¦ ¦new¦ ¦cases¦ ¦in¦ ¦one¦ ¦day¦ ,▁ ¦including¦ ¦two¦ ¦people¦ ¦in¦ ¦be i j ing¦ ¦and¦ ¦one¦ ¦in¦ ¦sh en z h en¦ .
𐋇¦a¦ ¦r et r os p ective¦ ¦offic ial¦ ¦study¦ ¦publ ished¦ ¦in¦ ¦march¦ ¦found¦ ¦that¦ ¦6¦ , ¦1 7 4¦ ¦people¦ ¦had¦ ¦al rea dy¦ ¦developed¦ ¦symptoms¦ ¦by¦ ¦20¦ ¦january¦ ▁( ¦most¦ ¦of¦ ¦them¦ ¦would¦ ¦be¦ ¦diagn osed¦ ¦later¦ )▁ ¦and¦ ¦more¦ ¦may¦ ¦have¦ ¦been¦ ¦infected¦ .
𐋇¦a¦ ¦report¦ ¦in¦ ¦the¦ ¦la nc et¦ ¦on¦ ¦24¦ ¦january¦ ¦indic ated¦ ¦human¦ ¦transmission¦ ,▁ ¦st ro ng ly¦ ¦recommended¦ ¦personal¦ ¦prot ective¦ ¦equipment¦ ¦for¦ ¦health¦ ¦workers¦ ,▁ ¦and¦ ¦said¦ ¦testing¦ ¦for¦ ¦the¦ ¦virus¦ ¦was¦ ¦essential¦ ¦due¦ ¦to¦ ¦its¦ ▁" ¦pandemic¦ ¦pote ntial¦ " .
𐋇¦on¦ ¦3 1¦ ¦january¦ ¦the¦ ¦la nc et¦ ¦would¦ ¦publ ish¦ ¦the¦ ¦first¦ ¦mo de lling¦ ¦study¦ ¦ex pl ic it ly¦ ¦w ar ning¦ ¦of¦ ¦i ne v it able¦ ▁" ¦in de p end ent¦ ¦self¦ - ¦su st aining¦ ¦out b rea ks¦ ¦in¦ ¦major¦ ¦c ities¦ ¦gl ob ally¦ "▁ ¦and¦ ¦ca lling¦ ¦for¦ ▁" ¦large¦ - ¦sc a le¦ ¦public¦ ¦health¦ ¦int erv en tions¦ . "
𐋇¦on¦ ¦30¦ ¦january¦ ,▁ ¦with¦ ¦7¦ , ¦8 1 8¦ ¦confirmed¦ ¦cases¦ ¦across¦ ¦19¦ ¦countries¦ ,▁ ¦the¦ ¦who¦ ¦decl ared¦ ¦the¦ ¦covid¦ - ¦19¦ ¦outbreak¦ ¦a¦ ¦public¦ ¦health¦ ¦emergency¦ ¦of¦ ¦international¦ ¦concer n¦ ▁( ¦p he ic¦ ),▁ ¦and¦ ¦then¦ ¦a¦ ¦pandemic¦ ¦on¦ ¦11¦ ¦march¦ ¦2020¦ ¦as¦ ¦italy¦ ,▁ ¦iran¦ ,▁ ¦south¦ ¦ko rea¦ ,▁ ¦and¦ ¦j ap an¦ ¦reported¦ ¦incre as ing¦ ¦nu mbers¦ ¦of¦ ¦cases¦ .
𐋇¦on¦ ¦3 1¦ ¦january¦ ,▁ ¦italy¦ ¦had¦ ¦its¦ ¦first¦ ¦confirmed¦ ¦cases¦ ,▁ ¦two¦ ¦tou ri sts¦ ¦from¦ ¦china¦ .
𐋇¦on¦ ¦19¦ ¦march¦ ,▁ ¦italy¦ ¦over t ook¦ ¦china¦ ¦as¦ ¦the¦ ¦country¦ ¦with¦ ¦the¦ ¦most¦ ¦reported¦ ¦deaths¦ .
𐋇¦by¦ ¦26¦ ¦march¦ ,▁ ¦the¦ ¦united¦ ¦states¦ ¦had¦ ¦over ta k en¦ ¦china¦ ¦and¦ ¦italy¦ ¦with¦ ¦the¦ ¦high est¦ ¦number¦ ¦of¦ ¦confirmed¦ ¦cases¦ ¦in¦ ¦the¦ ¦world¦ .
𐋇 ¦research¦ ¦on¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦gen omes¦ ¦indic ates¦ ¦the¦ ¦ma j or ity¦ ¦of¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦in¦ ¦new¦ ¦y or k¦ ¦ca me¦ ¦from¦ ¦european¦ ¦tra ve ll ers¦ ,▁ ¦r at her¦ ¦than¦ ¦dir ect ly¦ ¦from¦ ¦china¦ ¦or¦ ¦any¦ ¦other¦ ¦a si an¦ ¦country¦ .
𐋇 ¦r et es ting¦ ¦of¦ ¦pri or¦ ¦samples¦ ¦found¦ ¦a¦ ¦person¦ ¦in¦ ¦fra nce¦ ¦who¦ ¦had¦ ¦the¦ ¦virus¦ ¦on¦ ¦2 7¦ ¦december¦ ¦2019¦ ¦and¦ ¦a¦ ¦person¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ¦who¦ ¦d ied¦ ¦from¦ ¦the¦ ¦disease¦ ¦on¦ ¦6¦ ¦february¦ ¦2020¦ .
𐋇¦on¦ ¦11¦ ¦june¦ ,▁ ¦after¦ ¦5 5¦ ¦days¦ ¦without¦ ¦a¦ ¦loc ally¦ ¦transm it ted¦ ¦case¦ ¦being¦ ¦offic ially¦ ¦reported¦ ,▁ ¦the¦ ¦city¦ ¦of¦ ¦be i j ing¦ ¦reported¦ ¦a¦ ¦si ng le¦ ¦covid¦ - ¦19¦ ¦case¦ ,▁ ¦fo ll owed¦ ¦by¦ ¦two¦ ¦more¦ ¦cases¦ ¦on¦ ¦12¦ ¦june¦ .
𐋇¦as¦ ¦of¦ ¦15¦ ¦june¦ ¦2020¦ ,▁ ¦7 9¦ ¦cases¦ ¦were¦ ¦offic ially¦ ¦confirmed¦ .
𐋇 ¦most¦ ¦of¦ ¦these¦ ¦patients¦ ¦w ent¦ ¦to¦ ¦ x in fa d i¦ ¦wh ol es a le¦ ¦mark et¦ .
𐋇¦on¦ ¦2 9¦ ¦june¦ ,▁ ¦who¦ ¦w ar ned¦ ¦that¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ ¦was¦ ¦still¦ ¦acc el er ating¦ ¦as¦ ¦countries¦ ¦reop e ned¦ ¦their¦ ¦ec on om ies¦ ,▁ ¦d esp ite¦ ¦many¦ ¦countries¦ ¦having¦ ¦made¦ ¦pr og r ess¦ ¦in¦ ¦sl owing¦ ¦down¦ ¦the¦ ¦spread¦ .
𐋇¦on¦ ¦15¦ ¦j u ly¦ ,▁ ¦one¦ ¦covid¦ - ¦19¦ ¦case¦ ¦was¦ ¦offic ially¦ ¦reported¦ ¦in¦ ¦da li an¦ ¦in¦ ¦more¦ ¦than¦ ¦three¦ ¦mon ths¦ .
𐋇¦the¦ ¦pa ti ent¦ ¦d id¦ ¦not¦ ¦travel¦ ¦outside¦ ¦the¦ ¦city¦ ¦in¦ ¦the¦ ¦14¦ ¦days¦ ¦before¦ ¦develop ing¦ ¦symptoms¦ ,▁ ¦n or¦ ¦d id¦ ¦h e¦ ¦have¦ ¦contact¦ ¦with¦ ¦people¦ ¦from¦ ▁" ¦areas¦ ¦of¦ ¦att e nt ion¦ . "
𐋇¦in¦ ¦o ct ob er¦ ,▁ ¦the¦ ¦who¦ ¦stated¦ ,▁ ¦at¦ ¦a¦ ¦spec ial¦ ¦m ee ting¦ ¦of¦ ¦who¦ ¦lea d ers¦ ,▁ ¦that¦ ¦one¦ ¦in¦ ¦t en¦ ¦people¦ ¦around¦ ¦the¦ ¦world¦ ¦may¦ ¦have¦ ¦been¦ ¦infected¦ ¦with¦ ¦covid¦ - ¦19¦ .
𐋇 ¦at¦ ¦the¦ ¦time¦ ,▁ ¦that¦ ¦trans l ated¦ ¦to¦ ¦7 8 0¦ ¦million¦ ¦people¦ ¦being¦ ¦infected¦ ,▁ ¦while¦ ¦only¦ ¦3 5¦ ¦million¦ ¦infections¦ ¦had¦ ¦been¦ ¦confirmed¦ .
𐋇¦in¦ ¦early¦ ¦no ve mber¦ ,▁ ¦d en m ar k¦ ¦reported¦ ¦on¦ ¦an¦ ¦outbreak¦ ¦of¦ ¦a¦ ¦uni q ue¦ ¦m ut ated¦ ¦vari ant¦ ¦being¦ ¦transm it ted¦ ¦to¦ ¦humans¦ ¦from¦ ¦min ks¦ ¦in¦ ¦its¦ ¦n or th¦ ¦j ut land¦ ¦reg ion¦ .
𐋇 ¦all¦ ¦t w el ve¦ ¦human¦ ¦cases¦ ¦of¦ ¦the¦ ¦m ut ated¦ ¦vari ant¦ ¦were¦ ¦identified¦ ¦in¦ ¦se p te mber¦ ¦2020¦ .
𐋇¦the¦ ¦who¦ ¦rel ea sed¦ ¦a¦ ¦report¦ ¦sa ying¦ ¦the¦ ¦vari ant¦ ▁" ¦had¦ ¦a¦ ¦co mb ination¦ ¦of¦ ¦m ut ations¦ ¦or¦ ¦chan ges¦ ¦that¦ ¦have¦ ¦not¦ ¦been¦ ¦previously¦ ¦ob s erv ed¦ . "▁ 𐋇¦in¦ ¦response¦ ,▁ ¦pri me¦ ¦minister¦ ¦met t e¦ ¦fre d eri k s en¦ ¦or d ered¦ ¦for¦ ¦the¦ ¦country¦ ▁–▁ ¦the¦ ¦world¦ ' ¦s¦ ¦l arg est¦ ¦produc er¦ ¦of¦ ¦m ink¦ ¦f u r¦ ▁–▁ ¦to¦ ¦c ul l¦ ¦its¦ ¦m ink¦ ¦population¦ ¦by¦ ¦as¦ ¦many¦ ¦as¦ ¦1 7¦ ¦million¦ .
𐋇¦on¦ ¦9¦ ¦no ve mber¦ ,▁ ¦p f iz er¦ ¦rel ea sed¦ ¦their¦ ¦tr ial¦ ¦results¦ ¦for¦ ¦a¦ ¦ca nd id ate¦ ¦vaccine¦ ,▁ ¦sh owing¦ ¦that¦ ¦it¦ ¦is¦ ¦9 0¦ %▁ ¦effective¦ ¦against¦ ¦the¦ ¦virus¦ .
𐋇 ¦later¦ ¦that¦ ¦day¦ ,▁ ¦n ov a v a x¦ ¦ent ered¦ ¦an¦ ¦f d a¦ ¦f ast¦ ¦tr ack¦ ¦app l ic ation¦ ¦for¦ ¦their¦ ¦vaccine¦ .
𐋇 ¦vir ol og ist¦ ¦and¦ ¦u¦ . ¦s¦ .▁ ¦national¦ ¦inst it ute¦ ¦of¦ ¦all er g y¦ ¦and¦ ¦infectious¦ ¦diseases¦ ¦dir ector¦ ¦an th on y¦ ¦fa uc i¦ ¦indic ated¦ ¦that¦ ¦the¦ ¦p f iz er¦ ¦vaccine¦ ¦t arg ets¦ ¦the¦ ¦sp i ke¦ ¦protein¦ ¦used¦ ¦to¦ ¦inf ect¦ ¦ce lls¦ ¦by¦ ¦the¦ ¦virus¦ .
𐋇¦some¦ ¦i ss ues¦ ¦le f t¦ ¦to¦ ¦be¦ ¦a ns w ered¦ ¦are¦ ¦how¦ ¦long¦ ¦the¦ ¦vaccine¦ ¦off ers¦ ¦prote ction¦ ,▁ ¦and¦ ¦if¦ ¦it¦ ¦off ers¦ ¦the¦ ¦same¦ ¦level¦ ¦of¦ ¦prote ction¦ ¦to¦ ¦all¦ ¦a ges¦ .
𐋇 ¦in it ial¦ ¦doses¦ ¦will¦ ¦likely¦ ¦go¦ ¦to¦ ¦healthcare¦ ¦workers¦ ¦on¦ ¦the¦ ¦f r on t¦ ¦l ines¦ .
𐋇¦on¦ ¦9¦ ¦no ve mber¦ ¦2020¦ ,▁ ¦the¦ ¦united¦ ¦states¦ ¦sur p as sed¦ ¦10¦ ¦million¦ ¦confirmed¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦ma king¦ ¦it¦ ¦the¦ ¦country¦ ¦with¦ ¦the¦ ¦most¦ ¦cases¦ ¦worldwide¦ ¦by¦ ¦a¦ ¦large¦ ¦m arg in¦ .
𐋇¦it¦ ¦was¦ ¦reported¦ ¦on¦ ¦2 7¦ ¦no ve mber¦ ,▁ ¦that¦ ¦a¦ ¦publ ic ation¦ ¦rel ea sed¦ ¦by¦ ¦the¦ ¦ce nt ers¦ ¦for¦ ¦disease¦ ¦control¦ ¦and¦ ¦pre vention¦ ¦indic ated¦ ¦that¦ ¦the¦ ¦current¦ ¦nu mbers¦ ¦of¦ ¦viral¦ ¦infection¦ ¦are¦ ¦v ia¦ ¦confirmed¦ ¦laboratory¦ ¦test¦ ¦only¦ .
𐋇¦however¦ ,▁ ¦the¦ ¦tr ue¦ ¦number¦ ¦could¦ ¦be¦ ¦about¦ ¦e ight¦ ¦times¦ ¦the¦ ¦reported¦ ¦number¦ ;▁ ¦the¦ ¦report¦ ¦further¦ ¦indic ated¦ ¦that¦ ¦the¦ ¦tr ue¦ ¦number¦ ¦of¦ ¦virus¦ ¦infected¦ ¦cases¦ ¦could¦ ¦be¦ ¦around¦ ¦100¦ ¦million¦ ¦in¦ ¦the¦ ¦u¦ . ¦s¦ .
𐋇¦on¦ ¦14¦ ¦december¦ ,▁ ¦public¦ ¦health¦ ¦e ng land¦ ¦reported¦ ¦a¦ ¦new¦ ¦vari ant¦ ¦had¦ ¦been¦ ¦dis covered¦ ¦in¦ ¦the¦ ¦south¦ ¦e ast¦ ¦of¦ ¦e ng land¦ ,▁ ¦pr ed o mi na ntly¦ ¦in¦ ¦k ent¦ .
𐋇¦the¦ ¦vari ant¦ ,▁ ¦na med¦ ¦vari ant¦ ¦of¦ ¦concer n¦ ¦20 2 0 1 2¦ ▁/▁ ¦0 1¦ ,▁ ¦sh owed¦ ¦chan ges¦ ¦to¦ ¦the¦ ¦sp i ke¦ ¦protein¦ ¦which¦ ¦could¦ ¦make¦ ¦the¦ ¦virus¦ ¦more¦ ¦infectious¦ .
𐋇¦as¦ ¦of¦ ¦13¦ ¦december¦ ,▁ ¦there¦ ¦were¦ ¦1¦ , ¦1 0 8¦ ¦cases¦ ¦identified¦ .
𐋇 ¦many¦ ¦countries¦ ¦h al ted¦ ¦all¦ ¦f li gh ts¦ ¦from¦ ¦the¦ ¦uk¦ ;▁ ¦fra nce¦ - ¦ bo un d¦ ¦e ur ot un ne l¦ ¦service¦ ¦was¦ ¦susp e nded¦ ¦and¦ ¦f er r ies¦ ¦c arr ying¦ ¦p as se ng ers¦ ¦and¦ ¦acc o mp an ied¦ ¦fre ight¦ ¦were¦ ¦cance lled¦ ¦as¦ ¦the¦ ¦fre n ch¦ ¦ bor der¦ ¦closed¦ ¦to¦ ¦people¦ ¦on¦ ¦20¦ ¦december¦ .
𐋇¦on¦ ¦2¦ ¦january¦ ,▁ ¦v o c¦ - ¦20 2 0 1 2¦ ▁/▁ ¦0 1¦ ,▁ ¦a¦ ¦vari ant¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦first¦ ¦dis covered¦ ¦in¦ ¦the¦ ¦uk¦ ,▁ ¦had¦ ¦been¦ ¦identified¦ ¦in¦ ¦3 3¦ ¦countries¦ ¦around¦ ¦the¦ ¦world¦ ,▁ ¦including¦ ¦pa k ist an¦ ,▁ ¦south¦ ¦ko rea¦ ,▁ ¦sw it z er land¦ ,▁ ¦t ai w an¦ ,▁ ¦n or w ay¦ ,▁ ¦italy¦ ,▁ ¦j ap an¦ ,▁ ¦le b an on¦ ,▁ ¦ind ia¦ ,▁ ¦ca na d a¦ ,▁ ¦d en m ar k¦ ,▁ ¦fra nce¦ ,▁ ¦g erm an y¦ ,▁ ¦i ce land¦ ,▁ ¦and¦ ¦china¦ .
𐋇¦on¦ ¦6¦ ¦january¦ ,▁ ¦the¦ ¦ p¦ . ¦1¦ ¦vari ant¦ ¦was¦ ¦first¦ ¦identified¦ ¦in¦ ¦j a pa ne se¦ ¦tra ve ll ers¦ ¦who¦ ¦had¦ ¦j ust¦ ¦retur ned¦ ¦from¦ ¦b ra z il¦ .
𐋇¦on¦ ¦12¦ ¦january¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦a¦ ¦team¦ ¦of¦ ¦sc ien ti sts¦ ¦from¦ ¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ¦would¦ ¦arr ive¦ ¦in¦ ¦wuhan¦ ¦on¦ ¦the¦ ¦1 4 th¦ ¦of¦ ¦the¦ ¦mon th¦ ;▁ ¦this¦ ¦is¦ ¦to¦ ¦as c er tain¦ ¦the¦ ¦orig in¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦and¦ ¦det erm ine¦ ¦what¦ ¦were¦ ¦the¦ ¦int erm ediate¦ ¦ho sts¦ ¦between¦ ¦the¦ ¦orig in al¦ ¦res erv oi r¦ ¦and¦ ¦humans¦ .
𐋇¦on¦ ¦the¦ ¦following¦ ¦day¦ ,▁ ¦two¦ ¦of¦ ¦the¦ ¦who¦ ¦me mbers¦ ¦were¦ ¦b arr ed¦ ¦from¦ ¦ent ering¦ ¦china¦ ¦because¦ ,▁ ¦according¦ ¦to¦ ¦the¦ ¦country¦ ,▁ ¦antibo dies¦ ¦for¦ ¦the¦ ¦virus¦ ¦were¦ ¦detected¦ ¦in¦ ¦both¦ .
𐋇¦on¦ ¦2 9¦ ¦january¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦the¦ ¦n ov a v a x¦ ¦vaccine¦ ¦was¦ ¦only¦ ¦4 9¦ %▁ ¦effective¦ ¦against¦ ¦the¦ ¦5 0 1¦ . ¦v 2¦ ¦vari ant¦ ¦in¦ ¦a¦ ¦clinical¦ ¦tr ial¦ ¦in¦ ¦south¦ ¦afr ica¦ .
𐋇¦the¦ ¦china¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦corona v a c¦ ¦indic ated¦ ¦50¦ . ¦4¦ %▁ ¦eff ect iv ity¦ ¦in¦ ¦a¦ ¦b ra z il¦ ¦clinical¦ ¦tr ial¦ .
𐋇¦on¦ ¦12¦ ¦march¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦several¦ ¦countries¦ ¦including¦ ¦th ai land¦ ,▁ ¦d en m ar k¦ ,▁ ¦b ul g ar ia¦ ,▁ ¦n or w ay¦ ,▁ ¦and¦ ¦i ce land¦ ¦had¦ ¦sto pp ed¦ ¦using¦ ¦the¦ ¦o x for d¦ - ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦due¦ ¦to¦ ¦what¦ ¦was¦ ¦being¦ ¦called¦ ¦severe¦ ¦blood¦ ¦cl ot ting¦ ¦prob le ms¦ ,▁ ¦a¦ ¦ce re b r al¦ ¦ ve no us¦ ¦s in us¦ ¦th r om bo sis¦ ▁( ¦c v s t¦ ).
𐋇 ¦ad di tion ally¦ ,▁ ¦a u str ia¦ ¦h al ted¦ ¦the¦ ¦use¦ ¦of¦ ¦one¦ ¦b at ch¦ ¦of¦ ¦the¦ ¦a for e m en tion ed¦ ¦vaccine¦ ¦as¦ ¦well¦ .
𐋇¦on¦ ¦20¦ ¦march¦ ,▁ ¦the¦ ¦who¦ ¦and¦ ¦european¦ ¦medic ines¦ ¦a ge ncy¦ ¦found¦ ¦no¦ ¦l ink¦ ¦between¦ ¦th ro mb us¦ ▁( ¦a¦ ¦blood¦ ¦cl ot¦ ¦of¦ ¦clinical¦ ¦imp ort ance¦ ),▁ ¦lea ding¦ ¦several¦ ¦european¦ ¦countries¦ ¦to¦ ¦res u me¦ ¦admin ist ering¦ ¦the¦ ¦astrazeneca¦ ¦vaccine¦ .
𐋇¦on¦ ¦2 9¦ ¦march¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦the¦ ¦u¦ . ¦s¦ .▁ ¦government¦ ¦was¦ ¦pl an ning¦ ¦to¦ ¦int ro duc e¦ ¦covid¦ - ¦19¦ ¦vacc ination¦ ▁' ¦pa ss p orts¦ ' ▁ ¦to¦ ¦all ow¦ ¦those¦ ¦who¦ ¦have¦ ¦been¦ ¦vaccinated¦ ¦the¦ ¦a bility¦ ¦to¦ ¦ bo ard¦ ¦a e ro pl an es¦ ,▁ ¦c ru ise¦ ¦s hi ps¦ ¦as¦ ¦well¦ ¦as¦ ¦other¦ ¦activ ities¦ .
𐋇¦as¦ ¦of¦ ¦24¦ ¦june¦ ¦2021¦ ,▁ ¦more¦ ¦than¦ ¦1 7 9¦ ¦million¦ ¦cases¦ ¦have¦ ¦been¦ ¦reported¦ ¦worldwide¦ ¦due¦ ¦to¦ ¦covid¦ - ¦19¦ ;▁ ¦more¦ ¦than¦ ¦3¦ . ¦8 9¦ ¦million¦ ¦have¦ ¦d ied¦ .
𐋇 ¦due¦ ¦to¦ ¦the¦ ¦pandemic¦ ¦in¦ ¦e ur ope¦ ,▁ ¦many¦ ¦countries¦ ¦in¦ ¦the¦ ¦s che ng en¦ ¦a rea¦ ¦have¦ ¦re stric ted¦ ¦fre e¦ ¦mo ve ment¦ ¦and¦ ¦s et¦ ¦up¦ ¦ bor der¦ ¦contr ols¦ .
𐋇 ¦national¦ ¦re ac tions¦ ¦have¦ ¦inclu ded¦ ¦conta in ment¦ ¦measures¦ ¦such¦ ¦as¦ ¦qu ara nt ines¦ ¦and¦ ¦cur f e w s¦ ▁( ¦known¦ ¦as¦ ¦stay¦ - ¦at¦ - ¦home¦ ¦or d ers¦ ,▁ ¦sh el ter¦ - ¦in¦ - ¦place¦ ¦or d ers¦ ,▁ ¦or¦ ¦loc k d ow ns¦ ).
𐋇¦the¦ ¦who¦ ' ¦s¦ ¦recomm end ation¦ ¦on¦ ¦cur f e w s¦ ¦and¦ ¦loc k d ow ns¦ ¦is¦ ¦that¦ ¦they¦ ¦should¦ ¦be¦ ¦sh ort¦ - ¦ter m¦ ¦measures¦ ¦to¦ ¦re or g an ise¦ ,▁ ¦reg r ou p¦ ,▁ ¦re b al ance¦ ¦res o ur ces¦ ,▁ ¦and¦ ¦protect¦ ¦health¦ ¦workers¦ ¦who¦ ¦are¦ ¦ex h a us ted¦ .
𐋇¦to¦ ¦a ch ie ve¦ ¦a¦ ¦b al ance¦ ¦between¦ ¦restrictions¦ ¦and¦ ¦normal¦ ¦l ife¦ ,▁ ¦the¦ ¦long¦ - ¦ter m¦ ¦resp on ses¦ ¦to¦ ¦the¦ ¦pandemic¦ ¦should¦ ¦cons ist¦ ¦of¦ ¦ stric t¦ ¦personal¦ ¦h yg ien e¦ ,▁ ¦effective¦ ¦contact¦ ¦trac ing¦ ,▁ ¦and¦ ¦isol ating¦ ¦when¦ ¦ ill¦ .
𐋇¦by¦ ¦26¦ ¦march¦ ¦2020¦ ,▁ ¦1¦ . ¦7¦ ¦bi ll ion¦ ¦people¦ ¦worldwide¦ ¦were¦ ¦under¦ ¦some¦ ¦for m¦ ¦of¦ ¦lockdown¦ ,▁ ¦which¦ ¦increased¦ ¦to¦ ¦3¦ . ¦9¦ ¦bi ll ion¦ ¦people¦ ¦by¦ ¦the¦ ¦first¦ ¦week¦ ¦of¦ ¦april¦ ▁ — ▁ ¦more¦ ¦than¦ ¦h al f¦ ¦the¦ ¦world¦ ' ¦s¦ ¦population¦ .
𐋇¦by¦ ¦l ate¦ ¦april¦ ¦2020¦ ,▁ ¦around¦ ¦3 00¦ ¦million¦ ¦people¦ ¦were¦ ¦under¦ ¦lockdown¦ ¦in¦ ¦n ations¦ ¦of¦ ¦e ur ope¦ ,▁ ¦including¦ ¦but¦ ¦not¦ ¦limi ted¦ ¦to¦ ¦italy¦ ,▁ ¦s pa in¦ ,▁ ¦fra nce¦ ,▁ ¦and¦ ¦the¦ ¦united¦ ¦ki ng d om¦ ,▁ ¦while¦ ¦around¦ ¦2 00¦ ¦million¦ ¦people¦ ¦were¦ ¦under¦ ¦lockdown¦ ¦in¦ ¦l at in¦ ¦amer ica¦ .
𐋇 ¦ne arly¦ ¦3 00¦ ¦million¦ ¦people¦ ,▁ ¦or¦ ¦about¦ ¦9 0¦ ¦per¦ ¦c ent¦ ¦of¦ ¦the¦ ¦population¦ ,▁ ¦were¦ ¦under¦ ¦some¦ ¦for m¦ ¦of¦ ¦lockdown¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦around¦ ¦100¦ ¦million¦ ¦people¦ ¦in¦ ¦the¦ ¦p hi li pp ines¦ ,▁ ¦about¦ ¦5 9¦ ¦million¦ ¦people¦ ¦in¦ ¦south¦ ¦afr ica¦ ,▁ ¦and¦ ¦1¦ . ¦3¦ ¦bi ll ion¦ ¦people¦ ¦have¦ ¦been¦ ¦under¦ ¦lockdown¦ ¦in¦ ¦ind ia¦ .
𐋇¦as¦ ¦of¦ ¦30¦ ¦april¦ ¦2020¦ ,▁ ¦cases¦ ¦have¦ ¦been¦ ¦reported¦ ¦in¦ ¦all¦ ¦a si an¦ ¦countries¦ ¦ex cep t¦ ¦for¦ ¦t ur k m en ist an¦ ¦and¦ ¦n or th¦ ¦ko rea¦ ,▁ ¦al th ough¦ ¦these¦ ¦countries¦ ¦likely¦ ¦also¦ ¦have¦ ¦cases¦ .
𐋇¦d esp ite¦ ¦being¦ ¦the¦ ¦first¦ ¦a rea¦ ¦of¦ ¦the¦ ¦world¦ ¦hi t¦ ¦by¦ ¦the¦ ¦outbreak¦ ,▁ ¦the¦ ¦early¦ ¦w ide¦ - ¦sc a le¦ ¦response¦ ¦of¦ ¦some¦ ¦a si an¦ ¦states¦ ,▁ ¦partic ul arly¦ ¦b h ut an¦ ,▁ ¦si ng ap ore¦ ,▁ ¦t ai w an¦ ¦and¦ ¦ vi et n am¦ ¦has¦ ¦all owed¦ ¦them¦ ¦to¦ ¦f are¦ ¦comp ar at ively¦ ¦well¦ .
𐋇 ¦china¦ ¦is¦ ¦crit ici sed¦ ¦for¦ ¦in it ially¦ ¦min im ising¦ ¦the¦ ¦se ver ity¦ ¦of¦ ¦the¦ ¦outbreak¦ ,▁ ¦but¦ ¦the¦ ¦de la y ed¦ ¦w ide¦ - ¦sc a le¦ ¦response¦ ¦has¦ ¦l arg ely¦ ¦conta ined¦ ¦the¦ ¦disease¦ ¦since¦ ¦march¦ ¦2020¦ .
𐋇¦in¦ ¦j ap an¦ ,▁ ¦the¦ ¦pandemic¦ ¦has¦ ¦been¦ ¦b el ie v ed¦ ¦to¦ ¦have¦ ¦caused¦ ¦direct¦ ¦ side¦ ¦eff ects¦ ¦in¦ ¦reg ards¦ ¦to¦ ¦me ntal¦ ¦health¦ .
𐋇 ¦according¦ ¦to¦ ¦the¦ ¦report¦ ¦by¦ ¦the¦ ¦country¦ ' ¦s¦ ¦national¦ ¦pol ice¦ ¦a ge ncy¦ ,▁ ¦su ici des¦ ¦had¦ ¦increased¦ ¦to¦ ¦2¦ , ¦1 5 3¦ ¦in¦ ¦o ct ob er¦ .
𐋇 ¦exp er ts¦ ¦also¦ ¦state¦ ¦that¦ ¦the¦ ¦pandemic¦ ¦has¦ ¦wor se ned¦ ¦me ntal¦ ¦health¦ ¦i ss ues¦ ¦due¦ ¦to¦ ¦loc k d ow ns¦ ¦and¦ ¦isolation¦ ¦from¦ ¦family¦ ¦me mbers¦ ,▁ ¦among¦ ¦other¦ ¦i ss ues¦ .
𐋇¦as¦ ¦of¦ ¦14¦ ¦j u ly¦ ¦2020¦ ,▁ ¦there¦ ¦are¦ ¦8 3¦ , ¦5 4 5¦ ¦cases¦ ¦confirmed¦ ¦in¦ ¦china¦ ▁ — ▁ ¦ex c lu ding¦ ¦1 1 4¦ ¦as ymptomatic¦ ¦cases¦ ,▁ ¦6 2¦ ¦of¦ ¦which¦ ¦were¦ ¦imp or ted¦ ,▁ ¦under¦ ¦medical¦ ¦ob s erv ation¦ ;▁ ¦as ymptomatic¦ ¦cases¦ ¦have¦ ¦not¦ ¦been¦ ¦reported¦ ¦pri or¦ ¦to¦ ¦3 1¦ ¦march¦ ¦2020¦ ▁ — ▁ ¦with¦ ¦4¦ , ¦6 3 4¦ ¦deaths¦ ¦and¦ ¦7 8¦ , ¦5 0 9¦ ¦reco ver ies¦ ,▁ ¦m ea ning¦ ¦there¦ ¦are¦ ¦only¦ ¦4 0 2¦ ¦cases¦ .
𐋇 ¦hub e i¦ ¦has¦ ¦the¦ ¦most¦ ¦cases¦ ,▁ ¦fo ll owed¦ ¦by¦ ¦ x in j ia ng¦ .
𐋇¦by¦ ¦march¦ ¦2020¦ ,▁ ¦covid¦ - ¦19¦ ¦infections¦ ¦have¦ ¦l arg ely¦ ¦been¦ ¦p ut¦ ¦under¦ ¦control¦ ¦in¦ ¦china¦ ,▁ ¦with¦ ¦min or¦ ¦out b rea ks¦ ¦since¦ .
𐋇¦it¦ ¦was¦ ¦reported¦ ¦on¦ ¦2 5¦ ¦no ve mber¦ ,▁ ¦that¦ ¦some¦ ¦1¦ ¦million¦ ¦people¦ ¦in¦ ¦the¦ ¦country¦ ¦of¦ ¦china¦ ¦have¦ ¦been¦ ¦vaccinated¦ ¦according¦ ¦to¦ ¦china¦ ' ¦s¦ ¦state¦ ¦cou nc il¦ ;▁ ¦the¦ ¦vaccines¦ ¦against¦ ¦covid¦ - ¦19¦ ¦come¦ ¦from¦ ¦si no ph ar m¦ ¦which¦ ¦ma k es¦ ¦two¦ ¦and¦ ¦one¦ ¦produc ed¦ ¦by¦ ¦s in ov a c¦ .
𐋇¦the¦ ¦first¦ ¦case¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦ind ia¦ ¦was¦ ¦reported¦ ¦on¦ ¦30¦ ¦january¦ ¦2020¦ .
𐋇 ¦ind ia¦ ¦or d ered¦ ¦a¦ ¦na tion w ide¦ ¦lockdown¦ ¦for¦ ¦the¦ ¦ent ir e¦ ¦population¦ ¦star ting¦ ¦24¦ ¦march¦ ¦2020¦ ,▁ ¦with¦ ¦a¦ ¦ph a sed¦ ¦un l oc k¦ ¦beg in ning¦ ¦1¦ ¦june¦ ¦2020¦ .
𐋇 ¦si x¦ ¦c ities¦ ¦acc o un t¦ ¦for¦ ¦around¦ ¦h al f¦ ¦of¦ ¦all¦ ¦reported¦ ¦cases¦ ¦in¦ ¦the¦ ¦country¦ ▁ — ▁ ¦m u mb a i¦ ,▁ ¦del h i¦ ,▁ ¦a h m ed ab ad¦ ,▁ ¦ch en na i¦ ,▁ ¦p un e¦ ¦and¦ ¦k ol k at a¦ .
𐋇¦on¦ ¦10¦ ¦june¦ ¦2020¦ ,▁ ¦ind ia¦ ' ¦s¦ ¦reco ver ies¦ ¦ex c ee ded¦ ¦ac tive¦ ¦cases¦ ¦for¦ ¦the¦ ¦first¦ ¦time¦ .
𐋇¦on¦ ¦30¦ ¦a u g ust¦ ¦2020¦ ,▁ ¦ind ia¦ ¦sur p as sed¦ ¦the¦ ¦us¦ ¦recor d¦ ¦for¦ ¦the¦ ¦most¦ ¦cases¦ ¦in¦ ¦a¦ ¦si ng le¦ ¦day¦ ,▁ ¦with¦ ¦more¦ ¦than¦ ¦7 8¦ , ¦000¦ ¦cases¦ ,▁ ¦and¦ ¦s et¦ ¦a¦ ¦new¦ ¦recor d¦ ¦on¦ ¦16¦ ¦se p te mber¦ ¦2020¦ ,▁ ¦with¦ ¦al m ost¦ ¦9 8¦ , ¦000¦ ¦cases¦ ¦reported¦ ¦that¦ ¦day¦ .
𐋇¦as¦ ¦of¦ ¦30¦ ¦a u g ust¦ ¦2020¦ ,▁ ¦ind ia¦ ' ¦s¦ ¦case¦ ¦fat ality¦ ¦rate¦ ¦is¦ ¦rel at ively¦ ¦low¦ ¦at¦ ¦2¦ . ¦3¦ % ,▁ ¦against¦ ¦the¦ ¦global¦ ¦4¦ . ¦7¦ % .
𐋇¦as¦ ¦of¦ ¦se p te mber¦ ¦2020¦ ,▁ ¦ind ia¦ ¦had¦ ¦the¦ ¦l arg est¦ ¦number¦ ¦of¦ ¦confirmed¦ ¦cases¦ ¦in¦ ¦as ia¦ ;▁ ¦and¦ ¦the¦ ¦second¦ - ¦high est¦ ¦number¦ ¦of¦ ¦confirmed¦ ¦cases¦ ¦in¦ ¦the¦ ¦world¦ ,▁ ¦be h ind¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦with¦ ¦the¦ ¦number¦ ¦of¦ ¦total¦ ¦confirmed¦ ¦cases¦ ¦brea c hing¦ ¦the¦ ¦100¦ , ¦000¦ ¦mark ¦ ¦on¦ ¦19¦ ¦may¦ ¦2020¦ ,▁ ¦1¦ , ¦000¦ , ¦000¦ ¦on¦ ¦16¦ ¦j u ly¦ ¦2020¦ ,▁ ¦and¦ ¦5¦ , ¦000¦ , ¦000¦ ¦confirmed¦ ¦cases¦ ¦on¦ ¦16¦ ¦se p te mber¦ ¦2020¦ .
𐋇¦on¦ ¦19¦ ¦december¦ ¦2020¦ ,▁ ¦ind ia¦ ¦cr os sed¦ ¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦10¦ , ¦000¦ , ¦000¦ ¦confirmed¦ ¦cases¦ ¦but¦ ¦with¦ ¦a¦ ¦sl ow¦ ¦p ace¦ .
𐋇¦the¦ ¦in di an¦ ¦min ist ry¦ ¦of¦ ¦sc i ence¦ ¦in i ti ated¦ ¦a¦ ¦m at he m at ical¦ ¦s im ul ation¦ ¦of¦ ¦the¦ ¦pandemic¦ ,▁ ¦the¦ ¦so¦ - ¦called¦ ▁" ¦in di an¦ ¦su p er mo de l¦ " ,▁ ¦which¦ ¦cor r ect ly¦ ¦pr ed ic ted¦ ¦the¦ ¦dec re ase¦ ¦of¦ ¦ac tive¦ ¦cases¦ ¦star ting¦ ¦in¦ ¦se p te mber¦ ¦2020¦ .
𐋇¦a¦ ¦second¦ ¦w a ve¦ ¦hi t¦ ¦ind ia¦ ¦in¦ ¦april¦ ¦2021¦ ,▁ ¦pl ac ing¦ ¦healthcare¦ ¦services¦ ¦under¦ ¦severe¦ ¦stra in¦ .
𐋇¦by¦ ¦l ate¦ ¦april¦ ,▁ ¦the¦ ¦government¦ ¦was¦ ¦rep orting¦ ¦over¦ ¦3 00¦ , ¦000¦ ¦new¦ ¦infections¦ ¦and¦ ¦2¦ , ¦000¦ ¦deaths¦ ¦per¦ ¦day¦ ,▁ ¦with¦ ¦concer ns¦ ¦of¦ ¦under c o un ting¦ .
𐋇 ¦iran¦ ¦reported¦ ¦its¦ ¦first¦ ¦confirmed¦ ¦cases¦ ¦of¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦infections¦ ¦on¦ ¦19¦ ¦february¦ ¦2020¦ ¦in¦ ¦ q om¦ ,▁ ¦where¦ ,▁ ¦according¦ ¦to¦ ¦the¦ ¦min ist ry¦ ¦of¦ ¦health¦ ¦and¦ ¦medical¦ ¦education¦ ,▁ ¦two¦ ¦people¦ ¦had¦ ¦d ied¦ ¦that¦ ¦day¦ .
𐋇 ¦early¦ ¦measures¦ ¦announced¦ ¦by¦ ¦the¦ ¦government¦ ¦inclu ded¦ ¦the¦ ¦cance ll ation¦ ¦of¦ ¦concer ts¦ ¦and¦ ¦other¦ ¦c ult ural¦ ¦events¦ ,▁ ¦sp orting¦ ¦events¦ ,▁ ¦f ri day¦ ¦p ra y ers¦ ,▁ ¦and¦ ¦closures¦ ¦of¦ ¦univers ities¦ ,▁ ¦higher¦ ¦education¦ ¦inst itu tions¦ ,▁ ¦and¦ ¦schools¦ .
𐋇 ¦iran¦ ¦all oc ated¦ ¦5¦ ¦t ri ll ion¦ ¦ ri als¦ ▁( ¦e qu iv al ent¦ ¦to¦ ¦us¦ ▁ $ ¦1 2 0¦ , ¦000¦ , ¦000¦ )▁ ¦to¦ ¦co mb at¦ ¦the¦ ¦virus¦ .
𐋇 ¦pres ident¦ ¦ha ss an¦ ¦r ou h an i¦ ¦said¦ ¦on¦ ¦26¦ ¦february¦ ¦2020¦ ¦there¦ ¦were¦ ¦no¦ ¦pl ans¦ ¦to¦ ¦quarantine¦ ¦areas¦ ¦affected¦ ¦by¦ ¦the¦ ¦outbreak¦ ,▁ ¦and¦ ¦only¦ ¦individuals¦ ¦would¦ ¦be¦ ¦qu ara nt ined¦ .
𐋇 ¦pl ans¦ ¦to¦ ¦limi t¦ ¦travel¦ ¦between¦ ¦c ities¦ ¦were¦ ¦announced¦ ¦in¦ ¦march¦ ¦2020¦ ,▁ ¦al th ough¦ ¦h ea v y¦ ¦tra ff ic¦ ¦between¦ ¦c ities¦ ¦a h ead¦ ¦of¦ ¦the¦ ¦per si an¦ ¦new¦ ¦year¦ ¦n ow ru z ¦ ¦contin u ed¦ .
𐋇 ¦sh ia¦ ¦sh r ines¦ ¦in¦ ¦ q om¦ ¦rema ined¦ ¦open¦ ¦to¦ ¦p il g ri ms¦ ¦until¦ ¦16¦ ¦march¦ .
𐋇 ¦iran¦ ¦bec a me¦ ¦a¦ ¦centre¦ ¦of¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ ¦after¦ ¦china¦ ¦in¦ ¦february¦ ¦2020¦ .
𐋇 ¦more¦ ¦than¦ ¦t en¦ ¦countries¦ ¦had¦ ¦trac ed¦ ¦their¦ ¦cases¦ ¦b ack¦ ¦to¦ ¦iran¦ ¦by¦ ¦2 8¦ ¦february¦ ,▁ ¦indic ating¦ ¦the¦ ¦outbreak¦ ¦may¦ ¦have¦ ¦been¦ ¦more¦ ¦severe¦ ¦than¦ ¦the¦ ¦3 8 8¦ ¦cases¦ ¦reported¦ ¦by¦ ¦the¦ ¦ir an i an¦ ¦government¦ ¦by¦ ¦that¦ ¦date¦ .
𐋇¦the¦ ¦ir an i an¦ ¦par l ia ment¦ ¦was¦ ¦sh ut¦ ¦down¦ ,▁ ¦with¦ ¦23¦ ¦of¦ ¦its¦ ¦2 9 0¦ ¦me mbers¦ ¦reported¦ ¦to¦ ¦have¦ ¦had¦ ¦tested¦ ¦positive¦ ¦for¦ ¦the¦ ¦virus¦ ¦on¦ ¦3¦ ¦march¦ ¦2020¦ .
𐋇¦on¦ ¦15¦ ¦march¦ ¦2020¦ ,▁ ¦the¦ ¦ir an i an¦ ¦government¦ ¦reported¦ ¦a¦ ¦h un dr ed¦ ¦deaths¦ ¦in¦ ¦a¦ ¦si ng le¦ ¦day¦ ,▁ ¦the¦ ¦most¦ ¦recor ded¦ ¦in¦ ¦the¦ ¦country¦ ¦since¦ ¦the¦ ¦outbreak¦ ¦beg an¦ .
𐋇 ¦at¦ ¦least¦ ¦t w el ve¦ ¦s it ting¦ ¦or¦ ¦f orm er¦ ¦ir an i an¦ ¦pol it ici ans¦ ¦and¦ ¦government¦ ¦off ici als¦ ¦had¦ ¦d ied¦ ¦from¦ ¦the¦ ¦disease¦ ¦by¦ ¦1 7¦ ¦march¦ ¦2020¦ .
𐋇¦by¦ ¦23¦ ¦march¦ ¦2020¦ ,▁ ¦iran¦ ¦was¦ ¦exp er ie ncing¦ ¦f if t y¦ ¦new¦ ¦cases¦ ¦every¦ ¦hou r¦ ¦and¦ ¦one¦ ¦new¦ ¦death¦ ¦every¦ ¦t en¦ ¦min u tes¦ ¦due¦ ¦to¦ ¦covid¦ - ¦19¦ .
𐋇 ¦according¦ ¦to¦ ¦a¦ ¦who¦ ¦offic ial¦ ,▁ ¦there¦ ¦may¦ ¦be¦ ¦five¦ ¦times¦ ¦more¦ ¦cases¦ ¦in¦ ¦iran¦ ¦than¦ ¦what¦ ¦is¦ ¦being¦ ¦reported¦ .
𐋇¦it¦ ¦is¦ ¦also¦ ¦su gg ested¦ ¦that¦ ¦u¦ . ¦s¦ .▁ ¦sa nc tions¦ ¦on¦ ¦iran¦ ¦may¦ ¦be¦ ¦aff ecting¦ ¦the¦ ¦country¦ ' ¦s¦ ¦fi na nc ial¦ ¦a bility¦ ¦to¦ ¦resp on d¦ ¦to¦ ¦the¦ ¦viral¦ ¦outbreak¦ .
𐋇¦on¦ ¦20¦ ¦april¦ ¦2020¦ ,▁ ¦iran¦ ¦reop e ned¦ ¦shopping¦ ¦ma lls¦ ¦and¦ ¦other¦ ¦shopping¦ ¦areas¦ ¦across¦ ¦the¦ ¦country¦ .
𐋇 ¦after¦ ¦re ac hing¦ ¦a¦ ¦low¦ ¦in¦ ¦new¦ ¦cases¦ ¦in¦ ¦early¦ ¦may¦ ,▁ ¦a¦ ¦new¦ ¦p ea k¦ ¦was¦ ¦reported¦ ¦on¦ ¦4¦ ¦june¦ ¦2020¦ ,▁ ¦ra ising¦ ¦f ear¦ ¦of¦ ¦a¦ ¦second¦ ¦w a ve¦ .
𐋇¦on¦ ¦18¦ ¦j u ly¦ ¦2020¦ ,▁ ¦pres ident¦ ¦r ou h an i¦ ¦estim ated¦ ¦that¦ ¦2 5¦ ¦million¦ ¦ir an i ans¦ ¦had¦ ¦al rea dy¦ ¦bec ome¦ ¦infected¦ ,▁ ¦which¦ ¦is¦ ¦consid er ab ly¦ ¦higher¦ ¦than¦ ¦the¦ ¦offic ial¦ ¦co un t¦ .
𐋇 ¦lea ked¦ ¦data¦ ¦su gg est¦ ¦that¦ ¦4 2¦ , ¦000¦ ¦people¦ ¦had¦ ¦d ied¦ ¦with¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ¦by¦ ¦20¦ ¦j u ly¦ ¦2020¦ ,▁ ¦ne arly¦ ¦t ri pl ing¦ ¦the¦ ¦14¦ , ¦4 0 5¦ ¦offic ially¦ ¦reported¦ ¦by¦ ¦that¦ ¦date¦ .
𐋇¦covid¦ - ¦19¦ ¦was¦ ¦confirmed¦ ¦to¦ ¦have¦ ¦spread¦ ¦to¦ ¦south¦ ¦ko rea¦ ¦on¦ ¦20¦ ¦january¦ ¦2020¦ ¦from¦ ¦china¦ .
𐋇¦the¦ ¦n ation¦ ' ¦s¦ ¦health¦ ¦a ge ncy¦ ¦reported¦ ¦a¦ ¦sign ific ant¦ ¦increase¦ ¦in¦ ¦confirmed¦ ¦cases¦ ¦on¦ ¦20¦ ¦february¦ ,▁ ¦l arg ely¦ ¦att rib u ted¦ ¦to¦ ¦a¦ ¦ga th ering¦ ¦in¦ ¦da e g u¦ ¦of¦ ¦the¦ ¦sh in che on j i¦ ¦ch ur ch¦ ¦of¦ ¦j es us¦ .
𐋇 ¦sh in che on j i¦ ¦de v o te es¦ ¦visi ting¦ ¦da e g u¦ ¦from¦ ¦wuhan¦ ¦were¦ ¦suspected¦ ¦to¦ ¦be¦ ¦the¦ ¦orig in¦ ¦of¦ ¦the¦ ¦outbreak¦ .
𐋇¦by¦ ¦2 2¦ ¦february¦ ,▁ ¦among¦ ¦9¦ , ¦3 3 6¦ ¦fo ll ow ers¦ ¦of¦ ¦the¦ ¦ch ur ch¦ ,▁ ¦1¦ , ¦2 6 1¦ ¦or¦ ¦about¦ ¦13¦ ¦per¦ ¦c ent¦ ¦reported¦ ¦symptoms¦ .
𐋇 ¦south¦ ¦ko rea¦ ¦decl ared¦ ¦the¦ ¦high est¦ ¦level¦ ¦of¦ ¦alert¦ ¦on¦ ¦23¦ ¦february¦ ¦2020¦ .
𐋇¦on¦ ¦2 9¦ ¦february¦ ,▁ ¦more¦ ¦than¦ ¦3¦ , ¦1 5 0¦ ¦confirmed¦ ¦cases¦ ¦were¦ ¦reported¦ .
𐋇 ¦all¦ ¦south¦ ¦ko re an¦ ¦m il it ary¦ ¦ba ses¦ ¦were¦ ¦qu ara nt ined¦ ¦after¦ ¦tests¦ ¦sh owed¦ ¦three¦ ¦s ol di ers¦ ¦had¦ ¦the¦ ¦virus¦ .
𐋇 ¦air line¦ ¦s ch ed u les¦ ¦were¦ ¦also¦ ¦chan ged¦ .
𐋇 ¦south¦ ¦ko rea¦ ¦int ro duc ed¦ ¦what¦ ¦was¦ ¦consid ered¦ ¦the¦ ¦l arg est¦ ¦and¦ ¦b est¦ - ¦or g an i sed¦ ¦pr ogra m me¦ ¦in¦ ¦the¦ ¦world¦ ¦to¦ ¦scre en¦ ¦the¦ ¦population¦ ¦for¦ ¦the¦ ¦virus¦ ,▁ ¦isol ate¦ ¦any¦ ¦infected¦ ¦people¦ ,▁ ¦and¦ ¦tr ace¦ ¦and¦ ¦quarantine¦ ¦those¦ ¦who¦ ¦contac ted¦ ¦them¦ .
𐋇 ¦scre ening¦ ¦met ho ds¦ ¦inclu ded¦ ¦mand atory¦ ¦self¦ - ¦rep orting¦ ¦of¦ ¦symptoms¦ ¦by¦ ¦new¦ ¦international¦ ¦arr iv als¦ ¦through¦ ¦m ob i le¦ ¦app l ic ation¦ ,▁ ¦dr ive¦ - ¦through¦ ¦testing¦ ¦for¦ ¦the¦ ¦virus¦ ¦with¦ ¦the¦ ¦results¦ ¦available¦ ¦the¦ ¦ne xt¦ ¦day¦ ,▁ ¦and¦ ¦incre as ing¦ ¦testing¦ ¦ca pa bility¦ ¦to¦ ¦all ow¦ ¦up¦ ¦to¦ ¦20¦ , ¦000¦ ¦people¦ ¦to¦ ¦be¦ ¦tested¦ ¦every¦ ¦day¦ .
𐋇¦d esp ite¦ ¦some¦ ¦early¦ ¦crit ic is ms¦ ¦of¦ ¦pres ident¦ ¦mo on¦ ¦j a e¦ - ¦in¦ ' ¦s¦ ¦response¦ ¦to¦ ¦the¦ ¦c ri sis¦ ,▁ ¦south¦ ¦ko rea¦ ' ¦s¦ ¦pr ogra m me¦ ¦is¦ ¦consid ered¦ ¦a¦ ¦s uc c ess¦ ¦in¦ ¦cont ro lling¦ ¦the¦ ¦outbreak¦ ¦without¦ ¦qu ar an ti ning¦ ¦ent ir e¦ ¦c ities¦ .
𐋇¦on¦ ¦23¦ ¦march¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦south¦ ¦ko rea¦ ¦had¦ ¦the¦ ¦l ow est¦ ¦one¦ - ¦day¦ ¦case¦ ¦total¦ ¦in¦ ¦four¦ ¦weeks¦ .
𐋇¦on¦ ¦2 9¦ ¦march¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦beg in ning¦ ¦1¦ ¦april¦ ¦all¦ ¦new¦ ¦over s ea s¦ ¦arr iv als¦ ¦will¦ ¦be¦ ¦qu ara nt ined¦ ¦for¦ ¦two¦ ¦weeks¦ .
𐋇 ¦per¦ ¦m ed ia¦ ¦rep orts¦ ¦on¦ ¦1¦ ¦april¦ ,▁ ¦south¦ ¦ko rea¦ ¦has¦ ¦received¦ ¦re qu e sts¦ ¦for¦ ¦virus¦ ¦testing¦ ¦ass ist ance¦ ¦from¦ ¦1 21¦ ¦different¦ ¦countries¦ .
𐋇 ¦pers ist ent¦ ¦local¦ ¦grou ps¦ ¦of¦ ¦infections¦ ¦in¦ ¦the¦ ¦g rea ter¦ ¦se ou l¦ ¦a rea¦ ¦contin u ed¦ ¦to¦ ¦be¦ ¦found¦ ,▁ ¦which¦ ¦l ed¦ ¦to¦ ¦ko rea¦ ' ¦s¦ ¦c dc¦ ¦dir ector¦ ¦sa ying¦ ¦in¦ ¦june¦ ¦that¦ ¦the¦ ¦country¦ ¦had¦ ¦ent ered¦ ¦the¦ ¦second¦ ¦w a ve¦ ¦of¦ ¦infections¦ ,▁ ¦al th ough¦ ¦a¦ ¦who¦ ¦offic ial¦ ¦dis a g re ed¦ ¦with¦ ¦that¦ ¦as se ss ment¦ .
𐋇¦by¦ ¦13¦ ¦march¦ ¦2020¦ ,▁ ¦when¦ ¦the¦ ¦number¦ ¦of¦ ¦reported¦ ¦new¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦bec a me¦ ¦g rea ter¦ ¦than¦ ¦those¦ ¦in¦ ¦china¦ ,▁ ¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ▁( ¦who¦ )▁ ¦beg an¦ ¦to¦ ¦consid er¦ ¦e ur ope¦ ¦the¦ ¦ac tive¦ ¦centre¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ .
𐋇¦by¦ ¦2 2¦ ¦may¦ ¦2020¦ ,▁ ¦the¦ ¦who¦ ¦said¦ ¦that¦ ¦south¦ ¦amer ica¦ ¦was¦ ¦n ow¦ ¦exp er ie ncing¦ ¦a¦ ¦wor se¦ ¦outbreak¦ .
𐋇¦by¦ ¦1 7¦ ¦march¦ ¦2020¦ ,▁ ¦all¦ ¦countries¦ ¦within¦ ¦e ur ope¦ ¦had¦ ¦a¦ ¦confirmed¦ ¦case¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦with¦ ¦mon te ne g r o¦ ¦being¦ ¦the¦ ¦last¦ ¦european¦ ¦country¦ ¦to¦ ¦report¦ ¦at¦ ¦least¦ ¦one¦ ¦case¦ .
𐋇 ¦at¦ ¦least¦ ¦one¦ ¦death¦ ¦has¦ ¦been¦ ¦reported¦ ¦in¦ ¦all¦ ¦european¦ ¦countries¦ ,▁ ¦a par t¦ ¦from¦ ¦the¦ ¦v at ic an¦ ¦city¦ .
𐋇¦by¦ ¦18¦ ¦march¦ ¦2020¦ ,▁ ¦more¦ ¦than¦ ¦2 5 0¦ ¦million¦ ¦people¦ ¦were¦ ¦in¦ ¦lockdown¦ ¦in¦ ¦e ur ope¦ .
𐋇¦on¦ ¦24¦ ¦may¦ ¦2020¦ ,▁ ¦6 8¦ ¦days¦ ¦since¦ ¦its¦ ¦first¦ ¦recor ded¦ ¦case¦ ,▁ ¦mon te ne g r o¦ ¦bec a me¦ ¦the¦ ¦first¦ ¦covid¦ - ¦fre e¦ ¦country¦ ¦in¦ ¦e ur ope¦ ,▁ ¦but¦ ¦this¦ ¦s itu ation¦ ¦l as ted¦ ¦only¦ ¦4 4¦ ¦days¦ ¦before¦ ¦a¦ ¦new ly¦ ¦imp or ted¦ ¦case¦ ¦was¦ ¦identified¦ ¦there¦ .
𐋇 ¦european¦ ¦countries¦ ¦with¦ ¦the¦ ¦high est¦ ¦number¦ ¦of¦ ¦confirmed¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦are¦ ¦ ru ss ia¦ ,▁ ¦the¦ ¦united¦ ¦ki ng d om¦ ,▁ ¦fra nce¦ ,▁ ¦s pa in¦ ,▁ ¦and¦ ¦italy¦ .
𐋇¦on¦ ¦ 21¦ ¦a u g ust¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦the¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦were¦ ¦c li mb ing¦ ¦among¦ ¦y ou nger¦ ¦individuals¦ ¦across¦ ¦e ur ope¦ .
𐋇¦on¦ ¦ 21¦ ¦no ve mber¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦by¦ ¦the¦ ¦v o ice¦ ¦of¦ ¦amer ica¦ ¦that¦ ¦e ur ope¦ ¦is¦ ¦the¦ ¦wor s t¦ ¦hi t¦ ¦a rea¦ ¦by¦ ¦the¦ ¦covid¦ - ¦19¦ ¦virus¦ ,▁ ¦with¦ ¦nu mbers¦ ¦ex c ee ding¦ ¦15¦ ¦million¦ ¦cases¦ .
𐋇 ¦al th ough¦ ¦it¦ ¦was¦ ¦orig in ally¦ ¦th ou gh t¦ ¦the¦ ¦pandemic¦ ¦rea ched¦ ¦fra nce¦ ¦on¦ ¦24¦ ¦january¦ ¦2020¦ ,▁ ¦when¦ ¦the¦ ¦first¦ ¦covid¦ - ¦19¦ ¦case¦ ¦in¦ ¦e ur ope¦ ¦was¦ ¦confirmed¦ ¦in¦ ¦ bor d ea u x¦ ,▁ ¦it¦ ¦was¦ ¦later¦ ¦dis covered¦ ¦that¦ ¦a¦ ¦person¦ ¦n ear¦ ¦pa ri s¦ ¦had¦ ¦tested¦ ¦positive¦ ¦for¦ ¦the¦ ¦virus¦ ¦on¦ ¦2 7¦ ¦december¦ ¦2019¦ ¦after¦ ¦r et es ting¦ ¦o ld¦ ¦samples¦ .
𐋇¦a¦ ¦k e y¦ ¦ev ent¦ ¦in¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦disease¦ ¦in¦ ¦the¦ ¦country¦ ¦was¦ ¦the¦ ¦an n ual¦ ¦as se mb ly¦ ¦of¦ ¦the¦ ¦ch r is ti an¦ ¦open¦ ¦ door¦ ¦ch ur ch¦ ¦between¦ ¦1 7¦ ¦and¦ ¦24¦ ¦february¦ ¦in¦ ¦m ul ho use¦ ,▁ ¦which¦ ¦was¦ ¦att e nded¦ ¦by¦ ¦about¦ ¦2¦ , ¦5 00¦ ¦people¦ ,▁ ¦at¦ ¦least¦ ¦h al f¦ ¦of¦ ¦wh om¦ ¦are¦ ¦b el ie v ed¦ ¦to¦ ¦have¦ ¦contr ac ted¦ ¦the¦ ¦virus¦ .
𐋇¦on¦ ¦13¦ ¦march¦ ,▁ ¦pri me¦ ¦minister¦ ¦ é d ou ard¦ ¦p hi li pp e¦ ¦or d ered¦ ¦the¦ ¦cl osure¦ ¦of¦ ¦all¦ ¦non¦ - ¦essential¦ ¦public¦ ¦places¦ ,▁ ¦and¦ ¦on¦ ¦16¦ ¦march¦ ,▁ ¦fre n ch¦ ¦pres ident¦ ¦e mm an u e l¦ ¦m ac r on¦ ¦announced¦ ¦mand atory¦ ¦home¦ ¦conf i ne ment¦ ,▁ ¦a¦ ¦pol ic y¦ ¦which¦ ¦was¦ ¦ex te nded¦ ¦at¦ ¦least¦ ¦until¦ ¦11¦ ¦may¦ .
𐋇¦as¦ ¦of¦ ¦14¦ ¦se p te mber¦ ,▁ ¦fra nce¦ ¦has¦ ¦reported¦ ¦more¦ ¦than¦ ¦4 0 2¦ , ¦000¦ ¦confirmed¦ ¦cases¦ ,▁ ¦30¦ , ¦000¦ ¦deaths¦ ,▁ ¦and¦ ¦9 0¦ , ¦000¦ ¦reco ver ies¦ ,▁ ¦r an king¦ ¦fo ur th¦ ¦in¦ ¦number¦ ¦of¦ ¦confirmed¦ ¦cases¦ .
𐋇¦in¦ ¦april¦ ,▁ ¦there¦ ¦were¦ ¦ ri o ts¦ ¦in¦ ¦some¦ ¦pa ri s¦ ¦sub ur b s¦ .
𐋇¦on¦ ¦18¦ ¦may¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦schools¦ ¦in¦ ¦fra nce¦ ¦had¦ ¦to¦ ¦close¦ ¦ag a in¦ ¦after¦ ¦reop ening¦ ,▁ ¦due¦ ¦to¦ ¦covid¦ - ¦19¦ ¦case¦ ¦f l are¦ - ¦u ps¦ .
𐋇¦on¦ ¦12¦ ¦no ve mber¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦fra nce¦ ¦had¦ ¦bec ome¦ ¦the¦ ¦wor s t¦ - ¦hi t¦ ¦country¦ ¦by¦ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ ,▁ ¦in¦ ¦all¦ ¦of¦ ¦e ur ope¦ ,▁ ¦in¦ ¦the¦ ¦proc ess¦ ¦sur pa ss ing¦ ¦ ru ss ia¦ .
𐋇¦the¦ ¦new¦ ¦total¦ ¦of¦ ¦confirmed¦ ¦cases¦ ¦was¦ ¦more¦ ¦than¦ ¦1¦ . ¦8¦ ¦million¦ ¦and¦ ¦co un ting¦ ;▁ ¦ad di tion ally¦ ¦it¦ ¦was¦ ¦indic ated¦ ¦by¦ ¦the¦ ¦fre n ch¦ ¦government¦ ¦that¦ ¦the¦ ¦current¦ ¦national¦ ¦lockdown¦ ¦would¦ ¦remain¦ ¦in¦ ¦place¦ .
𐋇¦the¦ ¦outbreak¦ ¦was¦ ¦confirmed¦ ¦to¦ ¦have¦ ¦spread¦ ¦to¦ ¦italy¦ ¦on¦ ¦3 1¦ ¦january¦ ¦2020¦ ,▁ ¦when¦ ¦two¦ ¦chinese¦ ¦tou ri sts¦ ¦tested¦ ¦positive¦ ¦for¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦in¦ ¦r ome¦ .
𐋇 ¦cases¦ ¦beg an¦ ¦to¦ ¦r ise¦ ¦sh ar p ly¦ ,▁ ¦which¦ ¦pro mp ted¦ ¦the¦ ¦i tali an¦ ¦government¦ ¦to¦ ¦susp end¦ ¦all¦ ¦f li gh ts¦ ¦to¦ ¦and¦ ¦from¦ ¦china¦ ¦and¦ ¦decl are¦ ¦a¦ ¦state¦ ¦of¦ ¦emergency¦ .
𐋇 ¦an¦ ¦u na ss oc i ated¦ ¦cl us ter¦ ¦of¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦was¦ ¦later¦ ¦detected¦ ,▁ ¦star ting¦ ¦with¦ ¦16¦ ¦confirmed¦ ¦cases¦ ¦in¦ ¦lo mb ar dy¦ ¦on¦ ¦ 21¦ ¦february¦ ¦2020¦ .
𐋇¦on¦ ¦2 2¦ ¦february¦ ¦2020¦ ,▁ ¦the¦ ¦cou nc il¦ ¦of¦ ¦min ist ers¦ ¦announced¦ ¦a¦ ¦new¦ ¦dec re e¦ - ¦la w¦ ¦to¦ ¦con tain¦ ¦the¦ ¦outbreak¦ ,▁ ¦including¦ ¦qu ar an ti ning¦ ¦more¦ ¦than¦ ¦50¦ , ¦000¦ ¦people¦ ¦from¦ ¦e le v en¦ ¦different¦ ¦m un ic ip al ities¦ ¦in¦ ¦n or ther n¦ ¦italy¦ .
𐋇 ¦pri me¦ ¦minister¦ ¦g i u se pp e¦ ¦cont e¦ ¦said¦ , ▁" ¦in¦ ¦the¦ ¦outbreak¦ ¦areas¦ ,▁ ¦ent ry¦ ¦and¦ ¦e xi t¦ ¦will¦ ¦not¦ ¦be¦ ¦provid ed¦ .
𐋇 ¦susp e ns ion¦ ¦of¦ ¦work¦ ¦activ ities¦ ¦and¦ ¦sp orts¦ ¦events¦ ¦has¦ ¦al rea dy¦ ¦been¦ ¦or d ered¦ ¦in¦ ¦those¦ ¦areas¦ . ▁"
𐋇¦on¦ ¦4¦ ¦march¦ ¦2020¦ ,▁ ¦the¦ ¦i tali an¦ ¦government¦ ¦or d ered¦ ¦the¦ ¦f ul l¦ ¦cl osure¦ ¦of¦ ¦all¦ ¦schools¦ ¦and¦ ¦univers ities¦ ¦na tion w ide¦ ¦as¦ ¦italy¦ ¦rea ched¦ ¦a¦ ¦h un dr ed¦ ¦deaths¦ .
𐋇 ¦all¦ ¦major¦ ¦sp orting¦ ¦events¦ ¦were¦ ¦to¦ ¦be¦ ¦he ld¦ ¦be h ind¦ ¦closed¦ ¦do ors¦ ¦until¦ ¦april¦ ,▁ ¦but¦ ¦on¦ ¦9¦ ¦march¦ ,▁ ¦all¦ ¦sp ort¦ ¦was¦ ¦susp e nded¦ ¦comp le tely¦ ¦for¦ ¦at¦ ¦least¦ ¦one¦ ¦mon th¦ .
𐋇¦on¦ ¦11¦ ¦march¦ ¦2020¦ ,▁ ¦pri me¦ ¦minister¦ ¦cont e¦ ¦or d ered¦ ¦sto pp age¦ ¦of¦ ¦ne arly¦ ¦all¦ ¦comm erc ial¦ ¦activ ity¦ ¦ex cep t¦ ¦su p erm ar k ets¦ ¦and¦ ¦ph arm ac ies¦ .
𐋇¦on¦ ¦6¦ ¦march¦ ¦2020¦ ,▁ ¦the¦ ¦i tali an¦ ¦colle ge¦ ¦of¦ ¦a na es th es ia¦ ,▁ ¦anal g es ia¦ ,▁ ¦res us c it ation¦ ¦and¦ ¦in tens ive¦ ¦care¦ ▁( ¦s ia a rt i¦ )▁ ¦publ ished¦ ¦medical¦ ¦e th ics¦ ¦recomm end ations¦ ¦reg ar ding¦ ¦t ri age¦ ¦prot oc ols¦ .
𐋇¦on¦ ¦19¦ ¦march¦ ¦2020¦ ,▁ ¦italy¦ ¦over t ook¦ ¦china¦ ¦as¦ ¦the¦ ¦country¦ ¦with¦ ¦the¦ ¦most¦ ¦covid¦ - ¦19¦ - ¦related¦ ¦deaths¦ ¦in¦ ¦the¦ ¦world¦ ¦after¦ ¦rep orting¦ ¦3¦ , ¦4 0 5¦ ¦fat al ities¦ ¦from¦ ¦the¦ ¦pandemic¦ .
𐋇¦on¦ ¦2 2¦ ¦march¦ ¦2020¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦ ru ss ia¦ ¦had¦ ¦s ent¦ ¦n ine¦ ¦m il it ary¦ ¦pl an es¦ ¦with¦ ¦medical¦ ¦equipment¦ ¦to¦ ¦italy¦ .
𐋇¦as¦ ¦of¦ ¦2 8¦ ¦march¦ ,▁ ¦there¦ ¦were¦ ¦3¦ , ¦5 3 2¦ , ¦0 5 7¦ ¦confirmed¦ ¦cases¦ ,▁ ¦1 0 7¦ , ¦9 3 3¦ ¦deaths¦ ,▁ ¦and¦ ¦2¦ , ¦8 5 0¦ , ¦8 8 9¦ ¦reco ver ies¦ ¦in¦ ¦italy¦ ,▁ ¦with¦ ¦a¦ ¦large¦ ¦number¦ ¦of¦ ¦those¦ ¦cases¦ ¦occur r ing¦ ¦in¦ ¦the¦ ¦lo mb ar dy¦ ¦reg ion¦ .
𐋇¦a¦ ¦c n n¦ ¦report¦ ¦indic ated¦ ¦that¦ ¦the¦ ¦co mb ination¦ ¦of¦ ¦italy¦ ' ¦s¦ ¦large¦ ¦el d erly¦ ¦population¦ ¦and¦ ¦i na bility¦ ¦to¦ ¦test¦ ¦all¦ ¦who¦ ¦have¦ ¦the¦ ¦virus¦ ¦to¦ ¦date¦ ¦may¦ ¦be¦ ¦cont rib u ting¦ ¦to¦ ¦the¦ ¦high¦ ¦fat ality¦ ¦rate¦ .
𐋇¦on¦ ¦19¦ ¦april¦ ¦2020¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦the¦ ¦country¦ ¦had¦ ¦its¦ ¦l ow est¦ ¦deaths¦ ¦at¦ ¦4 3 3¦ ¦in¦ ¦se v en¦ ¦days¦ ¦and¦ ¦some¦ ¦b us in es ses¦ ¦were¦ ¦as king¦ ¦for¦ ¦a¦ ¦lo os ening¦ ¦of¦ ¦restrictions¦ ¦after¦ ¦si x¦ ¦weeks¦ ¦of¦ ¦lockdown¦ .
𐋇¦on¦ ¦13¦ ¦o ct ob er¦ ¦2020¦ ,▁ ¦the¦ ¦i tali an¦ ¦government¦ ¦ag a in¦ ¦issued¦ ¦re stric tive¦ ¦ ru les¦ ¦to¦ ¦con tain¦ ¦a¦ ¦r ise¦ ¦in¦ ¦infections¦ .
𐋇¦on¦ ¦11¦ ¦no ve mber¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦s il ve str o¦ ¦sc ot t i¦ ,▁ ¦pres ident¦ ¦of¦ ¦the¦ ¦i tali an¦ ¦f ed er ation¦ ¦of¦ ¦general¦ ¦practi tion ers¦ ¦indic ated¦ ¦that¦ ¦all¦ ¦of¦ ¦italy¦ ¦should¦ ¦come¦ ¦under¦ ¦restrictions¦ ¦due¦ ¦to¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇¦a¦ ¦cou p le¦ ¦of¦ ¦days¦ ¦pri or¦ ¦fi li pp o¦ ¦a ne ll i¦ ,▁ ¦pres ident¦ ¦of¦ ¦the¦ ¦national¦ ¦f ed er ation¦ ¦of¦ ¦doctor¦ ' ¦s¦ ¦gu il ds¦ ▁( ¦f n om ce o¦ )▁ ¦as ked¦ ¦for¦ ¦a¦ ¦co mpl et e¦ ¦lockdown¦ ¦of¦ ¦the¦ ¦p en i ns ular¦ ¦n ation¦ ¦due¦ ¦to¦ ¦the¦ ¦pandemic¦ .
𐋇¦on¦ ¦the¦ ¦1 0 th¦ ,▁ ¦a¦ ¦day¦ ¦before¦ ,▁ ¦italy¦ ¦sur p as sed¦ ¦1¦ ¦million¦ ¦confirmed¦ ¦covid¦ - ¦19¦ ¦cases¦ .
𐋇¦on¦ ¦23¦ ¦no ve mber¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦the¦ ¦second¦ ¦w a ve¦ ¦of¦ ¦the¦ ¦virus¦ ¦has¦ ¦caused¦ ¦some¦ ¦hosp it als¦ ¦in¦ ¦italy¦ ¦to¦ ¦sto p¦ ¦ac cep ting¦ ¦patients¦ .
𐋇¦the¦ ¦virus¦ ¦was¦ ¦first¦ ¦confirmed¦ ¦to¦ ¦have¦ ¦spread¦ ¦to¦ ¦s pa in¦ ¦on¦ ¦3 1¦ ¦january¦ ¦2020¦ ,▁ ¦when¦ ¦a¦ ¦g erm an¦ ¦to ur ist¦ ¦tested¦ ¦positive¦ ¦for¦ ¦sars¦ - ¦cov¦ - ¦2¦ ¦in¦ ¦l a¦ ¦go mer a¦ ,▁ ¦c an ary¦ ¦ is l an ds¦ .
𐋇¦p ost¦ - ¦ho c¦ ¦gen et ic¦ ¦anal y sis¦ ¦has¦ ¦sh own¦ ¦that¦ ¦at¦ ¦least¦ ¦15¦ ¦stra ins¦ ¦of¦ ¦the¦ ¦virus¦ ¦had¦ ¦been¦ ¦imp or ted¦ ,▁ ¦and¦ ¦community¦ ¦transmission¦ ¦beg an¦ ¦by¦ ¦m id¦ - ¦february¦ .
𐋇¦by¦ ¦13¦ ¦march¦ ,▁ ¦cases¦ ¦had¦ ¦been¦ ¦confirmed¦ ¦in¦ ¦all¦ ¦50¦ ¦pr ov in ces¦ ¦of¦ ¦the¦ ¦country¦ .
𐋇¦a¦ ¦lockdown¦ ¦was¦ ¦imp osed¦ ¦on¦ ¦14¦ ¦march¦ ¦2020¦ .
𐋇¦on¦ ¦2 9¦ ¦march¦ ,▁ ¦it¦ ¦was¦ ¦announced¦ ¦that¦ ,▁ ¦beg in ning¦ ¦the¦ ¦following¦ ¦day¦ ,▁ ¦all¦ ¦non¦ - ¦essential¦ ¦workers¦ ¦were¦ ¦or d ered¦ ¦to¦ ¦remain¦ ¦at¦ ¦home¦ ¦for¦ ¦the¦ ¦ne xt¦ ¦14¦ ¦days¦ .
𐋇¦by¦ ¦l ate¦ ¦march¦ ,▁ ¦the¦ ¦community¦ ¦of¦ ¦ma dr id¦ ¦has¦ ¦recor ded¦ ¦the¦ ¦most¦ ¦cases¦ ¦and¦ ¦deaths¦ ¦in¦ ¦the¦ ¦country¦ .
𐋇 ¦medical¦ ¦pro f es si on als¦ ¦and¦ ¦those¦ ¦who¦ ¦live¦ ¦in¦ ¦re ti re ment¦ ¦h omes¦ ¦have¦ ¦exp er ie nc ed¦ ¦especially¦ ¦high¦ ¦infection¦ ¦r ates¦ .
𐋇¦on¦ ¦2 5¦ ¦march¦ ,▁ ¦the¦ ¦offic ial¦ ¦death¦ ¦t ol l¦ ¦in¦ ¦s pa in¦ ¦sur p as sed¦ ¦that¦ ¦of¦ ¦main land¦ ¦china¦ .
𐋇¦on¦ ¦2¦ ¦april¦ ,▁ ¦9 5 0¦ ¦people¦ ¦d ied¦ ¦of¦ ¦the¦ ¦virus¦ ¦in¦ ¦a¦ ¦24¦ - ¦hou r¦ ¦period¦ ▁ — ▁ ¦at¦ ¦the¦ ¦time¦ ,▁ ¦the¦ ¦most¦ ¦by¦ ¦any¦ ¦country¦ ¦in¦ ¦a¦ ¦si ng le¦ ¦day¦ .
𐋇¦on¦ ¦1 7¦ ¦may¦ ,▁ ¦the¦ ¦daily¦ ¦death¦ ¦t ol l¦ ¦announced¦ ¦by¦ ¦the¦ ¦sp an ish¦ ¦government¦ ¦f ell¦ ¦b el ow¦ ¦100¦ ¦for¦ ¦the¦ ¦first¦ ¦time¦ ,▁ ¦and¦ ¦1¦ ¦june¦ ¦was¦ ¦the¦ ¦first¦ ¦day¦ ¦without¦ ¦deaths¦ ¦by¦ ¦covid¦ - ¦19¦ .
𐋇¦the¦ ¦state¦ ¦of¦ ¦al ar m¦ ¦e nded¦ ¦on¦ ¦ 21¦ ¦june¦ .
𐋇¦however¦ ,▁ ¦the¦ ¦number¦ ¦of¦ ¦cases¦ ¦increased¦ ¦ag a in¦ ¦in¦ ¦j u ly¦ ¦in¦ ¦a¦ ¦number¦ ¦of¦ ¦c ities¦ ¦including¦ ¦b ar ce lo na¦ ,▁ ¦z ara g o z a¦ ¦and¦ ¦ma dr id¦ ,▁ ¦which¦ ¦l ed¦ ¦to¦ ¦re i mp os ition¦ ¦of¦ ¦some¦ ¦restrictions¦ ¦but¦ ¦no¦ ¦national¦ ¦lockdown¦ .
𐋇 ¦st u dies¦ ¦have¦ ¦su gg ested¦ ¦that¦ ¦the¦ ¦number¦ ¦of¦ ¦infections¦ ¦and¦ ¦deaths¦ ¦may¦ ¦have¦ ¦been¦ ¦under e st im ated¦ ¦due¦ ¦to¦ ¦l ack¦ ¦of¦ ¦testing¦ ¦and¦ ¦rep orting¦ ,▁ ¦and¦ ¦many¦ ¦people¦ ¦with¦ ¦only¦ ¦mild¦ ¦or¦ ¦no¦ ¦symptoms¦ ¦were¦ ¦not¦ ¦tested¦ .
𐋇 ¦rep orts¦ ¦in¦ ¦may¦ ¦su gg ested¦ ¦that¦ ,▁ ¦based¦ ¦on¦ ¦a¦ ¦sampl e¦ ¦of¦ ¦more¦ ¦than¦ ¦6 3¦ , ¦000¦ ¦people¦ ,▁ ¦the¦ ¦number¦ ¦of¦ ¦infections¦ ¦may¦ ¦be¦ ¦t en¦ ¦times¦ ¦higher¦ ¦than¦ ¦the¦ ¦number¦ ¦of¦ ¦confirmed¦ ¦cases¦ ¦by¦ ¦that¦ ¦date¦ ,▁ ¦and¦ ¦ma dr id¦ ¦and¦ ¦several¦ ¦pr ov in ces¦ ¦of¦ ¦c as ti ll a¦ ▁–▁ ¦l a¦ ¦m an ch a¦ ¦and¦ ¦c as ti le¦ ¦and¦ ¦le ó n¦ ¦were¦ ¦the¦ ¦most¦ ¦affected¦ ¦areas¦ ¦with¦ ¦a¦ ¦per ce nt age¦ ¦of¦ ¦infection¦ ¦g rea ter¦ ¦than¦ ¦10¦ % .
𐋇¦there¦ ¦may¦ ¦also¦ ¦be¦ ¦as¦ ¦many¦ ¦as¦ ¦15¦ , ¦8 1 5¦ ¦more¦ ¦deaths¦ ¦according¦ ¦to¦ ¦the¦ ¦sp an ish¦ ¦min ist ry¦ ¦of¦ ¦health¦ ¦monit or ing¦ ¦system¦ ¦on¦ ¦daily¦ ¦ex c ess¦ ¦m ort ality¦ ▁( ¦s is te m a¦ ¦de¦ ¦monit or iz ac i ó n¦ ¦de¦ ¦l a¦ ¦m ort al id ad¦ ¦di ar ia¦ ▁–▁ ¦m om o¦ ).
𐋇¦on¦ ¦6¦ ¦j u ly¦ ¦2020¦ ,▁ ¦the¦ ¦results¦ ¦of¦ ¦a¦ ¦government¦ ¦of¦ ¦s pa in¦ ¦na tion w ide¦ ¦ser op re v al ence¦ ¦study¦ ¦sh owed¦ ¦that¦ ¦about¦ ¦two¦ ¦million¦ ¦people¦ ,▁ ¦or¦ ¦5¦ . ¦2¦ %▁ ¦of¦ ¦the¦ ¦population¦ ,▁ ¦could¦ ¦have¦ ¦been¦ ¦infected¦ ¦during¦ ¦the¦ ¦pandemic¦ .
𐋇¦s pa in¦ ¦was¦ ¦the¦ ¦second¦ ¦country¦ ¦in¦ ¦e ur ope¦ ▁( ¦be h ind¦ ¦ ru ss ia¦ )▁ ¦to¦ ¦recor d¦ ¦h al f¦ ¦a¦ ¦million¦ ¦cases¦ .
𐋇¦on¦ ¦ 21¦ ¦o ct ob er¦ ,▁ ¦s pa in¦ ¦p as sed¦ ¦1¦ ¦million¦ ¦covid¦ - ¦19¦ ¦cases¦ ,▁ ¦with¦ ¦1¦ , ¦0 0 5¦ , ¦2 9 5¦ ¦infections¦ ¦and¦ ¦3 4¦ , ¦3 6 6¦ ¦deaths¦ ¦reported¦ ,▁ ¦a¦ ¦thir d¦ ¦of¦ ¦which¦ ¦occur r ed¦ ¦in¦ ¦ma dr id¦ .
𐋇 ¦sw ed en¦ ¦di ff ered¦ ¦from¦ ¦most¦ ¦other¦ ¦european¦ ¦countries¦ ¦in¦ ¦that¦ ¦it¦ ¦mo st ly¦ ¦rema ined¦ ¦open¦ .
𐋇 ¦per¦ ¦the¦ ¦sw ed ish¦ ¦con st it ution¦ ,▁ ¦the¦ ¦public¦ ¦health¦ ¦a ge ncy¦ ¦of¦ ¦sw ed en¦ ¦has¦ ¦a ut on om y¦ ¦which¦ ¦prev ents¦ ¦pol it ical¦ ¦inter f er ence¦ ¦and¦ ¦the¦ ¦a ge ncy¦ ' ¦s¦ ¦pol ic y¦ ¦fa v o ur ed¦ ¦for g o ing¦ ¦a¦ ¦lockdown¦ .
𐋇¦the¦ ¦sw ed ish¦ ¦stra te g y¦ ¦f oc u sed¦ ¦on¦ ¦measures¦ ¦that¦ ¦could¦ ¦be¦ ¦p ut¦ ¦in¦ ¦place¦ ¦over¦ ¦a¦ ¦lo nger¦ ¦period¦ ¦of¦ ¦time¦ ,▁ ¦based¦ ¦on¦ ¦the¦ ¦ass um ption¦ ¦that¦ ¦the¦ ¦virus¦ ¦would¦ ¦star t¦ ¦sprea ding¦ ¦ag a in¦ ¦after¦ ¦a¦ ¦sh or ter¦ ¦lockdown¦ .
𐋇¦the¦ ¦new¦ ¦y or k¦ ¦times¦ ¦said¦ ¦that¦ ,▁ ¦as¦ ¦of¦ ¦may¦ ¦2020¦ ,▁ ¦the¦ ¦outbreak¦ ¦had¦ ¦been¦ ¦fa r¦ ¦d ea d li er¦ ¦there¦ ¦but¦ ¦the¦ ¦ec onomic¦ ¦impac t¦ ¦had¦ ¦been¦ ¦reduc ed¦ ¦as¦ ¦s we des¦ ¦have¦ ¦contin u ed¦ ¦to¦ ¦go¦ ¦to¦ ¦work¦ ,▁ ¦res ta u ra nts¦ ,▁ ¦and¦ ¦shopping¦ .
𐋇¦on¦ ¦19¦ ¦may¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦the¦ ¦country¦ ¦had¦ ¦in¦ ¦the¦ ¦week¦ ¦of¦ ¦12¦ ▁–▁ ¦19¦ ¦may¦ ¦the¦ ¦high est¦ ¦per¦ ¦c ap it a¦ ¦deaths¦ ¦in¦ ¦e ur ope¦ ,▁ ¦6¦ . ¦2 5¦ ¦deaths¦ ¦per¦ ¦million¦ ¦per¦ ¦day¦ .
𐋇¦in¦ ¦the¦ ¦end¦ ¦of¦ ¦june¦ ,▁ ¦sw ed en¦ ¦no¦ ¦lo nger¦ ¦had¦ ¦ex c ess¦ ¦m ort ality¦ .
𐋇 ¦de v ol ution¦ ¦in¦ ¦the¦ ¦united¦ ¦ki ng d om¦ ¦me ant¦ ¦that¦ ¦each¦ ¦of¦ ¦the¦ ¦four¦ ¦countries¦ ¦of¦ ¦the¦ ¦uk¦ ¦had¦ ¦its¦ ¦ own¦ ¦different¦ ¦response¦ ¦to¦ ¦covid¦ - ¦19¦ ,▁ ¦and¦ ¦the¦ ¦uk¦ ¦government¦ ,▁ ¦on¦ ¦be h al f¦ ¦of¦ ¦e ng land¦ ,▁ ¦m oved¦ ¦qu ick er¦ ¦to¦ ¦l if t¦ ¦restrictions¦ .
𐋇¦the¦ ¦uk¦ ¦government¦ ¦star ted¦ ¦en for c ing¦ ¦social¦ ¦distancing¦ ¦and¦ ¦quarantine¦ ¦measures¦ ¦on¦ ¦18¦ ¦march¦ ¦2020¦ ¦and¦ ¦was¦ ¦crit ici sed¦ ¦for¦ ¦a¦ ¦per ce iv ed¦ ¦l ack¦ ¦of¦ ¦in tens ity¦ ¦in¦ ¦its¦ ¦response¦ ¦to¦ ¦concer ns¦ ¦f ac ed¦ ¦by¦ ¦the¦ ¦public¦ .
𐋇¦on¦ ¦16¦ ¦march¦ ,▁ ¦pri me¦ ¦minister¦ ¦ bo ri s¦ ¦jo h ns on¦ ¦ad vi sed¦ ¦against¦ ¦non¦ - ¦essential¦ ¦travel¦ ¦and¦ ¦social¦ ¦contact¦ ,▁ ¦su gg es ting¦ ¦people¦ ¦work¦ ¦from¦ ¦home¦ ¦and¦ ¦avoid¦ ¦v en ues¦ ¦such¦ ¦as¦ ¦p ub s¦ ,▁ ¦res ta u ra nts¦ ,▁ ¦and¦ ¦the at r es¦ .
𐋇¦on¦ ¦20¦ ¦march¦ ,▁ ¦the¦ ¦government¦ ¦or d ered¦ ¦all¦ ¦le is ure¦ ¦ es ta bl is h ments¦ ¦to¦ ¦close¦ ¦as¦ ¦so on¦ ¦as¦ ¦possible¦ ,▁ ¦and¦ ¦pro mi sed¦ ¦to¦ ¦prevent¦ ¦u ne mploy ment¦ .
𐋇¦on¦ ¦23¦ ¦march¦ ,▁ ¦jo h ns on¦ ¦b an ned¦ ¦ga ther ings¦ ¦of¦ ¦mult ip le¦ ¦people¦ ¦and¦ ¦re stric ting¦ ¦non¦ - ¦essential¦ ¦travel¦ ¦and¦ ¦out door¦ ¦activ ity¦ .
𐋇 ¦un li ke¦ ¦prev ious¦ ¦measures¦ ,▁ ¦these¦ ¦restrictions¦ ¦were¦ ¦en for ce able¦ ¦by¦ ¦pol ice¦ ¦through¦ ¦fines¦ ¦and¦ ¦dis p e rs al¦ ¦of¦ ¦ga ther ings¦ .
𐋇 ¦most¦ ¦non¦ - ¦essential¦ ¦b us in es ses¦ ¦were¦ ¦or d ered¦ ¦to¦ ¦close¦ .
𐋇¦on¦ ¦24¦ ¦april¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦a¦ ¦pr om ising¦ ¦vaccine¦ ¦tr ial¦ ¦had¦ ¦beg u n¦ ¦in¦ ¦e ng land¦ ;▁ ¦the¦ ¦government¦ ¦pl ed ged¦ ¦more¦ ¦than¦ ▁ £ ¦50¦ ¦million¦ ¦t ow ards¦ ¦research¦ .
𐋇¦a¦ ¦number¦ ¦of¦ ¦temp or ary¦ ¦crit ical¦ ¦care¦ ¦hosp it als¦ ¦were¦ ¦bu il t¦ .
𐋇¦the¦ ¦first¦ ¦op er ating¦ ¦was¦ ¦the¦ ¦4¦ , ¦000¦ - ¦b ed¦ ¦n h s¦ ¦n i gh ti ng a le¦ ¦hospital¦ ¦l ond on¦ ,▁ ¦con str uc ted¦ ¦for¦ ¦over¦ ¦n ine¦ ¦days¦ .
𐋇¦on¦ ¦4¦ ¦may¦ ,▁ ¦it¦ ¦was¦ ¦announced¦ ¦that¦ ¦it¦ ¦would¦ ¦be¦ ¦pl ac ed¦ ¦on¦ ¦sta nd b y¦ ¦and¦ ¦rem aining¦ ¦patients¦ ¦trans f er r ed¦ ¦to¦ ¦other¦ ¦facil ities¦ ;▁ ¦5 1¦ ¦patients¦ ¦had¦ ¦been¦ ¦tre ated¦ ¦in¦ ¦the¦ ¦first¦ ¦three¦ ¦weeks¦ .
𐋇¦on¦ ¦16¦ ¦april¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦the¦ ¦uk¦ ¦would¦ ¦have¦ ¦first¦ ¦acc ess¦ ¦to¦ ¦the¦ ¦o x for d¦ ¦vaccine¦ ,▁ ¦due¦ ¦to¦ ¦a¦ ¦pri or¦ ¦contr ac t¦ ;▁ ¦should¦ ¦the¦ ¦tr ial¦ ¦be¦ ¦s uc cess ful¦ ,▁ ¦some¦ ¦30¦ ¦million¦ ¦doses¦ ¦in¦ ¦the¦ ¦uk¦ ¦would¦ ¦be¦ ¦available¦ .
𐋇¦on¦ ¦2¦ ¦december¦ ,▁ ¦the¦ ¦uk¦ ¦bec a me¦ ¦the¦ ¦first¦ ¦we st er n¦ ¦country¦ ¦to¦ ¦appro ve¦ ¦the¦ ¦p f iz er¦ ¦vaccine¦ ¦against¦ ¦the¦ ¦covid¦ - ¦19¦ ¦virus¦ ;▁ ¦8 00¦ , ¦000¦ ¦doses¦ ¦would¦ ¦be¦ ¦imm ed ia tely¦ ¦available¦ ¦for¦ ¦use¦ .
𐋇¦it¦ ¦was¦ ¦reported¦ ¦on¦ ¦5¦ ¦december¦ ,▁ ¦that¦ ¦the¦ ¦united¦ ¦ki ng d om¦ ¦would¦ ¦beg in¦ ¦vacc ination¦ ¦against¦ ¦the¦ ¦virus¦ ¦on¦ ¦8¦ ¦december¦ ,▁ ¦less¦ ¦than¦ ¦a¦ ¦week¦ ¦after¦ ¦having¦ ¦been¦ ¦appr oved¦ .
𐋇¦on¦ ¦9¦ ¦december¦ ,▁ ¦m h r a¦ ¦stated¦ ¦that¦ ¦any¦ ¦ind iv id ual¦ ¦with¦ ¦a¦ ¦sign ific ant¦ ¦all er g ic¦ ¦rea ction¦ ¦to¦ ¦a¦ ¦vaccine¦ ,▁ ¦such¦ ¦as¦ ¦an¦ ¦a na ph y la ct o id¦ ¦rea ction¦ ,▁ ¦should¦ ¦not¦ ¦take¦ ¦the¦ ¦p f iz er¦ ¦vaccine¦ ¦for¦ ¦covid¦ - ¦19¦ ¦prote ction¦ .
𐋇¦the¦ ¦first¦ ¦cases¦ ¦in¦ ¦n or th¦ ¦amer ica¦ ¦were¦ ¦reported¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ¦on¦ ¦the¦ ¦23¦ ¦january¦ ¦2020¦ .
𐋇 ¦cases¦ ¦were¦ ¦reported¦ ¦in¦ ¦all¦ ¦n or th¦ ¦amer ic an¦ ¦countries¦ ¦after¦ ¦sa in t¦ ¦k it ts¦ ¦and¦ ¦ne vi s¦ ¦confirmed¦ ¦a¦ ¦case¦ ¦on¦ ¦2 5¦ ¦march¦ ,▁ ¦and¦ ¦in¦ ¦all¦ ¦n or th¦ ¦amer ic an¦ ¦ter r it or ies¦ ¦after¦ ¦ bo na ir e¦ ¦confirmed¦ ¦a¦ ¦case¦ ¦on¦ ¦16¦ ¦april¦ .
𐋇¦as¦ ¦of¦ ¦24¦ ¦may¦ ¦2021¦ ,▁ ¦ca na d a¦ ¦has¦ ¦reported¦ ¦1¦ , ¦3 6 1¦ , ¦5 6 4¦ ¦cases¦ ¦and¦ ¦2 5¦ , ¦2 6 5¦ ¦deaths¦ ,▁ ¦while¦ ¦me x ic o¦ ¦has¦ ¦reported¦ ¦2¦ , ¦3 9 6¦ , ¦6 0 4¦ ¦cases¦ ¦and¦ ¦2 21¦ , ¦6 4 7¦ ¦deaths¦ .
𐋇¦the¦ ¦most¦ ¦cases¦ ¦by¦ ¦state¦ ¦is¦ ¦ca li for n ia¦ ¦with¦ ¦3¦ , ¦7 7 8¦ , ¦7 1 1¦ ¦cases¦ ¦and¦ ¦6 2¦ , ¦9 4 5¦ ¦deaths¦ ¦as¦ ¦of¦ ¦24¦ ¦may¦ ¦2021¦ .
𐋇 ¦more¦ ¦than¦ ¦3 3¦ . ¦5¦ ¦million¦ ¦confirmed¦ ¦cases¦ ¦have¦ ¦been¦ ¦reported¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ¦since¦ ¦january¦ ¦2020¦ ,▁ ¦res ul ting¦ ¦in¦ ¦more¦ ¦than¦ ¦6 0 2¦ , ¦000¦ ¦deaths¦ ,▁ ¦the¦ ¦most¦ ¦of¦ ¦any¦ ¦country¦ ,▁ ¦and¦ ¦the¦ ¦t we nt ie th¦ - ¦high est¦ ¦per¦ ¦c ap it a¦ ¦worldwide¦ .
𐋇¦as¦ ¦many¦ ¦infections¦ ¦have¦ ¦g one¦ ¦u nd et ected¦ ,▁ ¦the¦ ¦ce nt ers¦ ¦for¦ ¦disease¦ ¦control¦ ¦estim ated¦ ¦that¦ ,▁ ¦as¦ ¦of¦ ¦march¦ ¦2021¦ ,▁ ¦there¦ ¦are¦ ¦a¦ ¦total¦ ¦1 1 4¦ . ¦6¦ ¦million¦ ¦infections¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦or¦ ¦more¦ ¦than¦ ¦a¦ ¦thir d¦ ¦of¦ ¦the¦ ¦total¦ ¦population¦ .
𐋇¦the¦ ¦u¦ . ¦s¦ .▁ ¦has¦ ¦about¦ ¦one¦ - ¦f if th¦ ¦of¦ ¦the¦ ¦world¦ ' ¦s¦ ¦confirmed¦ ¦cases¦ ¦and¦ ¦deaths¦ .
𐋇¦covid¦ - ¦19¦ ¦bec a me¦ ¦the¦ ¦thir d¦ - ¦lea ding¦ ¦cause¦ ¦of¦ ¦death¦ ¦in¦ ¦the¦ ¦u¦ . ¦s¦ .▁ ¦in¦ ¦2020¦ ,▁ ¦be h ind¦ ¦h ear t¦ ¦disease¦ ¦and¦ ¦cance r¦ .
𐋇 ¦u¦ . ¦s¦ . ¦l ife¦ ¦exp ec ta ncy¦ ¦dro pp ed¦ ¦from¦ ¦7 8¦ . ¦8¦ ¦years¦ ¦in¦ ¦2019¦ ¦to¦ ¦7 7¦ . ¦8¦ ¦years¦ ¦in¦ ¦the¦ ¦first¦ ¦h al f¦ ¦of¦ ¦2020¦ .
𐋇¦the¦ ¦first¦ ¦amer ic an¦ ¦case¦ ¦was¦ ¦reported¦ ¦on¦ ¦january¦ ¦20¦ ,▁ ¦and¦ ¦pres ident¦ ¦do na ld¦ ¦tr um p¦ ¦decl ared¦ ¦the¦ ¦u¦ . ¦s¦ .▁ ¦outbreak¦ ¦a¦ ¦public¦ ¦health¦ ¦emergency¦ ¦on¦ ¦january¦ ¦3 1¦ .
𐋇 ¦restrictions¦ ¦were¦ ¦pl ac ed¦ ¦on¦ ¦f li gh ts¦ ¦ar ri ving¦ ¦from¦ ¦china¦ ,▁ ¦but¦ ¦the¦ ¦in it ial¦ ¦u¦ . ¦s¦ .▁ ¦response¦ ¦to¦ ¦the¦ ¦pandemic¦ ¦was¦ ¦o ther w ise¦ ¦sl ow¦ ,▁ ¦in¦ ¦ter ms¦ ¦of¦ ¦pre par ing¦ ¦the¦ ¦healthcare¦ ¦system¦ ,▁ ¦sto pping¦ ¦other¦ ¦travel¦ ,▁ ¦and¦ ¦testing¦ .
𐋇 ¦me an w hi le¦ ,▁ ¦tr um p¦ ¦rema ined¦ ¦o pt im ist ic¦ ¦and¦ ¦was¦ ¦acc u sed¦ ¦by¦ ¦hi s¦ ¦crit ics¦ ¦of¦ ¦under e st im ating¦ ¦the¦ ¦se ver ity¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦the¦ ¦first¦ ¦known¦ ¦amer ic an¦ ¦deaths¦ ¦occur r ed¦ ¦in¦ ¦february¦ .
𐋇¦on¦ ¦march¦ ¦6¦ ,▁ ¦2020¦ ,▁ ¦tr um p¦ ¦sign ed¦ ¦the¦ ¦coronavirus¦ ¦pre par ed ness¦ ¦and¦ ¦response¦ ¦supp le me ntal¦ ¦appr op ri ations¦ ¦ac t¦ ,▁ ¦which¦ ¦provid ed¦ ▁ $ ¦8¦ . ¦3¦ ¦bi ll ion¦ ¦in¦ ¦emergency¦ ¦f un ding¦ ¦for¦ ¦f ed er al¦ ¦a ge nc ies¦ ¦to¦ ¦resp on d¦ ¦to¦ ¦the¦ ¦outbreak¦ .
𐋇¦on¦ ¦march¦ ¦13¦ ,▁ ¦pres ident¦ ¦tr um p¦ ¦decl ared¦ ¦a¦ ¦national¦ ¦emergency¦ .
𐋇¦in¦ ¦m id¦ - ¦march¦ ,▁ ¦the¦ ¦tr um p¦ ¦admin i str ation¦ ¦star ted¦ ¦to¦ ¦p ur ch ase¦ ¦large¦ ¦qu a nt ities¦ ¦of¦ ¦medical¦ ¦equipment¦ ,▁ ¦and¦ ¦in¦ ¦l ate¦ ¦march¦ ,▁ ¦it¦ ¦inv o ked¦ ¦the¦ ¦def en se¦ ¦produc t ion¦ ¦ac t¦ ¦of¦ ¦19 5 0¦ ¦to¦ ¦direct¦ ¦ind u str ies¦ ¦to¦ ¦produc e¦ ¦medical¦ ¦equipment¦ .
𐋇¦by¦ ¦april¦ ¦1 7¦ ,▁ ¦the¦ ¦f ed er al¦ ¦government¦ ¦appr oved¦ ¦dis as ter¦ ¦decl ar ations¦ ¦for¦ ¦all¦ ¦states¦ ¦and¦ ¦ter r it or ies¦ .
𐋇¦by¦ ¦m id¦ - ¦april¦ ,▁ ¦cases¦ ¦had¦ ¦been¦ ¦confirmed¦ ¦in¦ ¦all¦ ¦f if t y¦ ¦u¦ . ¦s¦ . ¦states¦ ,▁ ¦and¦ ¦by¦ ¦no ve mber¦ ¦in¦ ¦all¦ ¦in h ab i ted¦ ¦u¦ . ¦s¦ . ¦ter r it or ies¦ .
𐋇¦the¦ ¦pandemic¦ ¦was¦ ¦confirmed¦ ¦to¦ ¦have¦ ¦rea ched¦ ¦south¦ ¦amer ica¦ ¦on¦ ¦26¦ ¦february¦ ¦2020¦ ¦when¦ ¦b ra z il¦ ¦confirmed¦ ¦a¦ ¦case¦ ¦in¦ ¦s ã o¦ ¦pa ul o¦ .
𐋇¦by¦ ¦3¦ ¦april¦ ,▁ ¦all¦ ¦countries¦ ¦and¦ ¦ter r it or ies¦ ¦in¦ ¦south¦ ¦amer ica¦ ¦had¦ ¦recor ded¦ ¦at¦ ¦least¦ ¦one¦ ¦case¦ .
𐋇¦on¦ ¦13¦ ¦may¦ ¦2020¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦l at in¦ ¦amer ica¦ ¦and¦ ¦the¦ ¦ca rib b e an¦ ¦had¦ ¦reported¦ ¦over¦ ¦4 00¦ , ¦000¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦with¦ ,▁ ¦23¦ , ¦0 9 1¦ ¦deaths¦ .
𐋇¦on¦ ¦2 2¦ ¦may¦ ¦2020¦ ,▁ ¦c i ting¦ ¦the¦ ¦rap id¦ ¦increase¦ ¦of¦ ¦infections¦ ¦in¦ ¦b ra z il¦ ,▁ ¦the¦ ¦who¦ ¦decl ared¦ ¦south¦ ¦amer ica¦ ¦the¦ ¦e p i ce nt r e¦ ¦of¦ ¦the¦ ¦pandemic¦ .
𐋇¦as¦ ¦of¦ ¦2 2¦ ¦june¦ ¦2021¦ ,▁ ¦south¦ ¦amer ica¦ ¦had¦ ¦recor ded¦ ¦3 1¦ , ¦8 7 6¦ , ¦0 7 8¦ ¦confirmed¦ ¦cases¦ ¦and¦ ¦9 7 7¦ , ¦4 5 2¦ ¦deaths¦ ¦from¦ ¦covid¦ - ¦19¦ .
𐋇 ¦due¦ ¦to¦ ¦a¦ ¦sh ort age¦ ¦of¦ ¦testing¦ ¦and¦ ¦medical¦ ¦facil ities¦ ,▁ ¦it¦ ¦is¦ ¦b el ie v ed¦ ¦that¦ ¦the¦ ¦outbreak¦ ¦is¦ ¦fa r¦ ¦l arg er¦ ¦than¦ ¦the¦ ¦offic ial¦ ¦nu mbers¦ ¦sh ow¦ .
𐋇¦on¦ ¦20¦ ¦may¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦b ra z il¦ ¦had¦ ¦a¦ ¦recor d¦ ¦1¦ , ¦1 7 9¦ ¦deaths¦ ¦in¦ ¦a¦ ¦si ng le¦ ¦day¦ ,▁ ¦for¦ ¦a¦ ¦total¦ ¦of¦ ¦al m ost¦ ¦18¦ , ¦000¦ ¦fat al ities¦ .
𐋇 ¦with¦ ¦a¦ ¦total¦ ¦number¦ ¦of¦ ¦al m ost¦ ¦2 7 2¦ , ¦000¦ ¦cases¦ ,▁ ¦b ra z il¦ ¦bec a me¦ ¦the¦ ¦country¦ ¦with¦ ¦the¦ ¦thir d¦ - ¦high est¦ ¦number¦ ¦of¦ ¦cases¦ ,▁ ¦following¦ ¦ ru ss ia¦ ¦and¦ ¦the¦ ¦united¦ ¦states¦ .
𐋇¦on¦ ¦2 5¦ ¦may¦ ,▁ ¦b ra z il¦ ¦ex c ee ded¦ ¦the¦ ¦number¦ ¦of¦ ¦reported¦ ¦cases¦ ¦in¦ ¦ ru ss ia¦ ¦when¦ ¦they¦ ¦reported¦ ¦that¦ ¦11¦ , ¦6 8 7¦ ¦new¦ ¦cases¦ ¦had¦ ¦been¦ ¦confirmed¦ ¦over¦ ¦the¦ ¦prev ious¦ ¦24¦ ¦hours¦ ,▁ ¦bringing¦ ¦the¦ ¦total¦ ¦number¦ ¦to¦ ¦over¦ ¦3 7 4¦ , ¦8 00¦ ,▁ ¦with¦ ¦more¦ ¦than¦ ¦23¦ , ¦4 00¦ ¦deaths¦ .
𐋇 ¦pres ident¦ ¦j ai r¦ ¦b ol s on ar o¦ ¦has¦ ¦cre ated¦ ¦cont ro ve rs y¦ ¦by¦ ¦ref er r ing¦ ¦to¦ ¦the¦ ¦virus¦ ¦as¦ ¦a¦ ▁" ¦l it t le¦ ¦flu¦ "▁ ¦and¦ ¦fre qu e ntly¦ ¦sp ea king¦ ¦out¦ ¦against¦ ¦prev en tive¦ ¦measures¦ ¦such¦ ¦as¦ ¦loc k d ow ns¦ ¦and¦ ¦qu ara nt ines¦ .
𐋇 ¦hi s¦ ¦att itu de¦ ¦t ow ards¦ ¦the¦ ¦outbreak¦ ¦has¦ ¦been¦ ¦li k e ned¦ ¦to¦ ¦that¦ ¦of¦ ¦f orm er¦ ¦u¦ . ¦s¦ .
𐋇 ¦pres ident¦ ¦tr um p¦ ,▁ ¦with¦ ¦b ol s on ar o¦ ¦being¦ ¦called¦ ¦the¦ ▁" ¦tr um p¦ ¦of¦ ¦the¦ ¦tr op ics¦ " .
𐋇¦b ol s on ar o¦ ¦later¦ ¦tested¦ ¦positive¦ ¦for¦ ¦the¦ ¦virus¦ .
𐋇¦in¦ ¦june¦ ¦2020¦ ,▁ ¦the¦ ¦government¦ ¦of¦ ¦b ra z il¦ ¦att e mp ted¦ ¦to¦ ¦con ce al¦ ¦the¦ ¦a ct ual¦ ¦f ig ures¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦ac tive¦ ¦cases¦ ¦and¦ ¦deaths¦ ,▁ ¦as¦ ¦it¦ ¦sto pp ed¦ ¦publ is hing¦ ¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦infections¦ ¦and¦ ¦deaths¦ .
𐋇¦on¦ ¦5¦ ¦june¦ ,▁ ¦b ra z il¦ ' ¦s¦ ¦health¦ ¦min ist ry¦ ¦t ook¦ ¦down¦ ¦the¦ ¦offic ial¦ ¦we b s ite¦ ¦ref l ecting¦ ¦the¦ ¦total¦ ¦nu mbers¦ ¦of¦ ¦infections¦ ¦and¦ ¦deaths¦ .
𐋇¦the¦ ¦we b s ite¦ ¦was¦ ¦live¦ ¦on¦ ¦6¦ ¦june¦ ,▁ ¦with¦ ¦only¦ ¦the¦ ¦number¦ ¦of¦ ¦infections¦ ¦of¦ ¦the¦ ¦prev ious¦ ¦24¦ ¦hours¦ .
𐋇¦the¦ ¦last¦ ¦offic ial¦ ¦nu mbers¦ ¦reported¦ ¦about¦ ¦6 1 5¦ , ¦000¦ ¦infections¦ ¦and¦ ¦over¦ ¦3 4¦ , ¦000¦ ¦deaths¦ .
𐋇¦on¦ ¦15¦ ¦june¦ ,▁ ¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦the¦ ¦worldwide¦ ¦cases¦ ¦had¦ ¦j u mp ed¦ ¦from¦ ¦se v en¦ ¦to¦ ¦e ight¦ ¦million¦ ¦in¦ ¦one¦ ¦week¦ ,▁ ¦c i ting¦ ¦l at in¦ ¦amer ica¦ ,▁ ¦spec if ically¦ ¦b ra z il¦ ¦as¦ ¦one¦ ¦of¦ ¦the¦ ¦countries¦ ¦where¦ ¦cases¦ ¦are¦ ¦sur ging¦ ,▁ ¦in¦ ¦this¦ ¦case¦ ,▁ ¦t ow ards¦ ¦1¦ ¦million¦ ¦cases¦ .
𐋇¦b ra z il¦ ¦br ie f ly¦ ¦pa u sed¦ ¦ph ase¦ ¦i i i¦ ¦trials¦ ¦for¦ ¦the¦ ¦corona v a c¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦on¦ ¦10¦ ¦no ve mber¦ ¦after¦ ¦the¦ ¦su ic ide¦ ¦of¦ ¦a¦ ¦v ol un te er¦ ¦before¦ ¦res um ing¦ ¦on¦ ¦11¦ ¦no ve mber¦ .
𐋇¦by¦ ¦early¦ ¦2021¦ ,▁ ¦the¦ ¦death¦ ¦t ol l¦ ¦had¦ ¦c li mb ed¦ ¦to¦ ¦2 3 1¦ , ¦5 3 4¦ .
𐋇¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦on¦ ¦7¦ ¦february¦ ¦ex c ee ded¦ ¦9¦ . ¦5¦ ¦million¦ .
𐋇¦the¦ ¦only¦ ¦countries¦ ¦with¦ ¦wor se¦ ¦out b rea ks¦ ¦were¦ ¦ind ia¦ ¦and¦ ¦the¦ ¦united¦ ¦states¦ .
𐋇¦the¦ ¦pandemic¦ ¦was¦ ¦confirmed¦ ¦to¦ ¦have¦ ¦spread¦ ¦to¦ ¦afr ica¦ ¦on¦ ¦14¦ ¦february¦ ¦2020¦ ,▁ ¦with¦ ¦the¦ ¦first¦ ¦confirmed¦ ¦case¦ ¦announced¦ ¦in¦ ¦e g y p t¦ .
𐋇¦the¦ ¦first¦ ¦confirmed¦ ¦case¦ ¦in¦ ¦sub ¦ - ¦sa h ar an¦ ¦afr ica¦ ¦was¦ ¦announced¦ ¦in¦ ¦n ig er ia¦ ¦at¦ ¦the¦ ¦end¦ ¦of¦ ¦february¦ ¦2020¦ .
𐋇 ¦within¦ ¦three¦ ¦mon ths¦ ,▁ ¦the¦ ¦virus¦ ¦had¦ ¦spread¦ ¦th r ou g ho ut¦ ¦the¦ ¦contin ent¦ ,▁ ¦as¦ ¦l es o th o¦ ,▁ ¦the¦ ¦last¦ ¦afr ic an¦ ¦so ve re ign¦ ¦state¦ ¦to¦ ¦have¦ ¦rema ined¦ ¦fre e¦ ¦of¦ ¦the¦ ¦virus¦ ,▁ ¦reported¦ ¦a¦ ¦case¦ ¦on¦ ¦13¦ ¦may¦ ¦2020¦ .
𐋇¦by¦ ¦26¦ ¦may¦ ,▁ ¦it¦ ¦app e ared¦ ¦that¦ ¦most¦ ¦afr ic an¦ ¦countries¦ ¦were¦ ¦exp er ie ncing¦ ¦community¦ ¦transmission¦ ,▁ ¦al th ough¦ ¦testing¦ ¦c ap ac ity¦ ¦was¦ ¦limi ted¦ .
𐋇 ¦most¦ ¦of¦ ¦the¦ ¦identified¦ ¦imp or ted¦ ¦cases¦ ¦arr iv ed¦ ¦from¦ ¦e ur ope¦ ¦and¦ ¦the¦ ¦united¦ ¦states¦ ¦r at her¦ ¦than¦ ¦from¦ ¦china¦ ¦where¦ ¦the¦ ¦virus¦ ¦orig in ated¦ .
𐋇¦in¦ ¦early¦ ¦june¦ ¦2021¦ ,▁ ¦afr ica¦ ¦f ac ed¦ ¦a¦ ¦thir d¦ ¦w a ve¦ ¦of¦ ¦covid¦ ¦infections¦ ¦with¦ ¦cases¦ ¦r ising¦ ¦in¦ ¦14¦ ¦countries¦ .
𐋇¦it¦ ¦is¦ ¦b el ie v ed¦ ¦that¦ ¦there¦ ¦is¦ ¦wid esp r ead¦ ¦under¦ - ¦rep orting¦ ¦in¦ ¦many¦ ¦afr ic an¦ ¦countries¦ ¦with¦ ¦less¦ ¦developed¦ ¦healthcare¦ ¦sys tems¦ .
𐋇 ¦according¦ ¦to¦ ¦the¦ ¦a ut um n¦ ¦2020¦ ¦ser op re v al ence¦ ¦study¦ ¦in¦ ¦j ub a¦ ¦in¦ ¦south¦ ¦s ud an¦ ,▁ ¦less¦ ¦than¦ ¦1¦ %▁ ¦of¦ ¦infected¦ ¦were¦ ¦a ct ually¦ ¦reported¦ .
𐋇¦the¦ ¦pandemic¦ ¦was¦ ¦confirmed¦ ¦to¦ ¦have¦ ¦rea ched¦ ¦o ce an ia¦ ¦on¦ ¦2 5¦ ¦january¦ ¦2020¦ ¦with¦ ¦the¦ ¦first¦ ¦confirmed¦ ¦case¦ ¦reported¦ ¦in¦ ¦m el bo ur n e¦ ,▁ ¦a u str al ia¦ .
𐋇¦it¦ ¦has¦ ¦since¦ ¦spread¦ ¦el se w h er e¦ ¦in¦ ¦the¦ ¦reg ion¦ ,▁ ¦al th ough¦ ¦many¦ ¦sm all¦ ¦p ac if ic¦ ¦ is land¦ ¦n ations¦ ¦have¦ ¦th us¦ ¦fa r¦ ¦a v oi ded¦ ¦the¦ ¦outbreak¦ ¦by¦ ¦clos ing¦ ¦their¦ ¦international¦ ¦ bor d ers¦ .
𐋇 ¦three¦ ¦o ce an ia¦ ¦so ve re ign¦ ¦states¦ ¦have¦ ¦y et¦ ¦to¦ ¦report¦ ¦a¦ ¦case¦ :▁ 𐋇 ¦na ur u¦ ,▁ ¦to ng a¦ ,▁ ¦and¦ ¦t u v al u¦ .
𐋇 ¦a u str al ia¦ ¦and¦ ¦new¦ ¦z ea land¦ ¦have¦ ¦been¦ ¦pr ai sed¦ ¦for¦ ¦their¦ ¦hand l ing¦ ¦of¦ ¦the¦ ¦pandemic¦ ¦comp ared¦ ¦to¦ ¦other¦ ¦we st er n¦ ¦n ations¦ ,▁ ¦with¦ ¦both¦ ¦new¦ ¦z ea land¦ ¦and¦ ¦each¦ ¦of¦ ¦a u str al ia¦ ' ¦s¦ ¦states¦ ¦w ip ing¦ ¦out¦ ¦all¦ ¦community¦ ¦transmission¦ ¦of¦ ¦the¦ ¦virus¦ ¦several¦ ¦times¦ ¦even¦ ¦after¦ ¦being¦ ¦r e¦ - ¦int ro duc ed¦ ¦into¦ ¦the¦ ¦community¦ .
𐋇 ¦due¦ ¦to¦ ¦its¦ ¦re mo te ness¦ ¦and¦ ¦s par se¦ ¦population¦ ,▁ ¦a nt ar ct ica¦ ¦was¦ ¦the¦ ¦last¦ ¦contin ent¦ ¦to¦ ¦have¦ ¦confirmed¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦and¦ ¦was¦ ¦one¦ ¦of¦ ¦the¦ ¦last¦ ¦regi ons¦ ¦of¦ ¦the¦ ¦world¦ ¦affected¦ ¦dir ect ly¦ ¦by¦ ¦the¦ ¦pandemic¦ .
𐋇¦the¦ ¦first¦ ¦cases¦ ¦were¦ ¦reported¦ ¦in¦ ¦december¦ ¦2020¦ ,▁ ¦al m ost¦ ¦a¦ ¦year¦ ¦after¦ ¦the¦ ¦first¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦were¦ ¦detected¦ ¦in¦ ¦china¦ .
𐋇 ¦at¦ ¦least¦ ¦3 6¦ ¦people¦ ¦are¦ ¦confirmed¦ ¦to¦ ¦have¦ ¦been¦ ¦infected¦ .
𐋇 ¦even¦ ¦before¦ ¦the¦ ¦first¦ ¦cases¦ ¦on¦ ¦the¦ ¦contin ent¦ ¦were¦ ¦reported¦ ,▁ ¦human¦ ¦activ ity¦ ¦in¦ ¦a nt ar ct ica¦ ¦was¦ ¦ind ir ect ly¦ ¦impac ted¦ .
𐋇¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ ¦sh ook¦ ¦the¦ ¦world¦ ' ¦s¦ ¦ec on om y¦ ,▁ ¦with¦ ¦especially¦ ¦severe¦ ¦ec onomic¦ ¦da m age¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦e ur ope¦ ,▁ ¦and¦ ¦l at in¦ ¦amer ica¦ .
𐋇¦a¦ ¦con se ns us¦ ¦report¦ ¦by¦ ¦amer ic an¦ ¦in te ll ig ence¦ ¦a ge nc ies¦ ¦in¦ ¦april¦ ¦2021¦ ¦co nc lu ded¦ , ▁" ¦eff orts¦ ¦to¦ ¦con tain¦ ¦and¦ ¦mana ge¦ ¦the¦ ¦virus¦ ¦have¦ ¦re in for c ed¦ ¦na tion al ist¦ ¦tr ends¦ ¦gl ob ally¦ ,▁ ¦as¦ ¦some¦ ¦states¦ ¦t ur ned¦ ¦in w ard¦ ¦to¦ ¦protect¦ ¦their¦ ¦c itiz ens¦ ¦and¦ ¦s om et im es¦ ¦c ast¦ ¦b la me¦ ¦on¦ ¦m arg i na li zed¦ ¦grou ps¦ . "▁ 𐋇¦f ur th erm ore¦ ,▁ ¦covid¦ - ¦19¦ ¦has¦ ¦inf la med¦ ¦part is a ns hi p¦ ¦and¦ ¦pol ar is ation¦ ¦around¦ ¦the¦ ¦world¦ ¦as¦ ¦b it ter¦ ¦ arg u ments¦ ¦exp lo de¦ ¦over¦ ¦wh om¦ ¦to¦ ¦sc ap e g o at¦ ¦and¦ ¦wh om¦ ¦to¦ ¦help¦ ¦first¦ .
𐋇¦the¦ ¦r is ks¦ ¦include¦ ¦further¦ ¦dis ru ption¦ ¦of¦ ¦international¦ ¦tra de¦ ¦and¦ ¦the¦ ¦f orm ation¦ ¦of¦ ¦no¦ - ¦ent ry¦ ¦e nc la ves¦ .
𐋇¦as¦ ¦a¦ ¦result¦ ¦of¦ ¦the¦ ¦pandemic¦ ,▁ ¦many¦ ¦countries¦ ¦and¦ ¦regi ons¦ ¦imp osed¦ ¦qu ara nt ines¦ ,▁ ¦ent ry¦ ¦b ans¦ ,▁ ¦or¦ ¦other¦ ¦restrictions¦ ,▁ ¦e it her¦ ¦for¦ ¦c itiz ens¦ ,▁ ¦rec ent¦ ¦tra ve ll ers¦ ¦to¦ ¦affected¦ ¦areas¦ ,▁ ¦or¦ ¦for¦ ¦all¦ ¦tra ve ll ers¦ .
𐋇¦t og ether¦ ¦with¦ ¦a¦ ¦dec rea sed¦ ¦w il li ng ness¦ ¦to¦ ¦travel¦ ,▁ ¦this¦ ¦had¦ ¦a¦ ¦negative¦ ¦ec onomic¦ ¦and¦ ¦social¦ ¦impac t¦ ¦on¦ ¦the¦ ¦travel¦ ¦s ector¦ .
𐋇 ¦concer ns¦ ¦have¦ ¦been¦ ¦r ai sed¦ ¦over¦ ¦the¦ ¦eff ec ti ve ness¦ ¦of¦ ¦travel¦ ¦restrictions¦ ¦to¦ ¦con tain¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇¦a¦ ¦study¦ ¦in¦ ¦sc i ence¦ ¦found¦ ¦that¦ ¦travel¦ ¦restrictions¦ ¦had¦ ¦only¦ ¦mo de st ly¦ ¦affected¦ ¦the¦ ¦in it ial¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦un less¦ ¦co mb ined¦ ¦with¦ ¦infection¦ ¦pre vention¦ ¦and¦ ¦control¦ ¦measures¦ ¦to¦ ¦consid er ab ly¦ ¦reduce¦ ¦transm is si ons¦ .
𐋇 ¦res ear ch ers¦ ¦co nc lu ded¦ ¦that¦ ▁" ¦travel¦ ¦restrictions¦ ¦are¦ ¦most¦ ¦u se ful¦ ¦in¦ ¦the¦ ¦early¦ ¦and¦ ¦l ate¦ ¦ph ase¦ ¦of¦ ¦an¦ ¦epidemic¦ "▁ ¦and¦ ▁" ¦restrictions¦ ¦of¦ ¦travel¦ ¦from¦ ¦wuhan¦ ¦un f ort u na tely¦ ¦ca me¦ ¦to o¦ ¦l ate¦ " .
𐋇¦the¦ ¦european¦ ¦un ion¦ ¦re j ected¦ ¦the¦ ¦ ide a¦ ¦of¦ ¦susp ending¦ ¦the¦ ¦s che ng en¦ ¦fre e¦ ¦travel¦ ¦z one¦ .
𐋇¦ owing¦ ¦to¦ ¦the¦ ¦effective¦ ¦lockdown¦ ¦of¦ ¦wuhan¦ ¦and¦ ¦hub e i¦ ,▁ ¦several¦ ¦countries¦ ¦ev ac u ated¦ ¦their¦ ¦c itiz ens¦ ¦and¦ ¦di pl om at ic¦ ¦staff¦ ¦from¦ ¦the¦ ¦a rea¦ ,▁ ¦pri ma ri ly¦ ¦through¦ ¦cha rt ered¦ ¦f li gh ts¦ ¦of¦ ¦the¦ ¦home¦ ¦n ation¦ ,▁ ¦with¦ ¦chinese¦ ¦author ities¦ ¦provid ing¦ ¦cl ear ance¦ .
𐋇 ¦ca na d a¦ ,▁ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦j ap an¦ ,▁ ¦ind ia¦ ,▁ ¦s r i¦ ¦l an k a¦ ,▁ ¦a u str al ia¦ ,▁ ¦fra nce¦ ,▁ ¦ arg en ti na¦ ,▁ ¦g erm an y¦ ,▁ ¦and¦ ¦th ai land¦ ¦were¦ ¦among¦ ¦the¦ ¦first¦ ¦to¦ ¦pl an¦ ¦the¦ ¦ev ac u ation¦ ¦of¦ ¦their¦ ¦c itiz ens¦ .
𐋇¦b ra z il¦ ¦and¦ ¦new¦ ¦z ea land¦ ¦also¦ ¦ev ac u ated¦ ¦their¦ ¦ own¦ ¦na tion als¦ ¦and¦ ¦some¦ ¦other¦ ¦people¦ .
𐋇¦on¦ ¦14¦ ¦march¦ ¦2020¦ ,▁ ¦south¦ ¦afr ica¦ ¦rep at ri ated¦ ¦1 1 2¦ ¦south¦ ¦afr ic ans¦ ¦who¦ ¦tested¦ ¦negative¦ ¦for¦ ¦the¦ ¦virus¦ ¦from¦ ¦wuhan¦ ,▁ ¦while¦ ¦four¦ ¦who¦ ¦sh owed¦ ¦symptoms¦ ¦were¦ ¦le f t¦ ¦be h ind¦ ¦to¦ ¦m it ig ate¦ ¦risk¦ .
𐋇 ¦pa k ist an¦ ¦said¦ ¦it¦ ¦would¦ ¦not¦ ¦ev ac u ate¦ ¦c itiz ens¦ ¦from¦ ¦china¦ .
𐋇¦on¦ ¦15¦ ¦february¦ ¦2020¦ ,▁ ¦the¦ ¦u¦ . ¦s¦ .▁ ¦announced¦ ¦it¦ ¦would¦ ¦ev ac u ate¦ ¦amer ic ans¦ ¦a bo ard¦ ¦the¦ ¦c ru ise¦ ¦s hi p¦ ¦d ia m on d¦ ¦pri nc ess¦ ,▁ ¦and¦ ¦on¦ ¦ 21¦ ¦february¦ ,▁ ¦ca na d a¦ ¦ev ac u ated¦ ¦1 2 9¦ ¦ca na di an¦ ¦p as se ng ers¦ ¦from¦ ¦the¦ ¦s hi p¦ .
𐋇¦in¦ ¦early¦ ¦march¦ ,▁ ¦the¦ ¦in di an¦ ¦government¦ ¦beg an¦ ¦ev ac u ating¦ ¦its¦ ¦c itiz ens¦ ¦from¦ ¦iran¦ .
𐋇¦on¦ ¦20¦ ¦march¦ ,▁ ¦the¦ ¦united¦ ¦states¦ ¦beg an¦ ¦to¦ ¦part ially¦ ¦w i th d ra w¦ ¦its¦ ¦tr oo ps¦ ¦from¦ ¦i ra q ¦ ¦due¦ ¦to¦ ¦the¦ ¦pandemic¦ .
𐋇¦in¦ ¦june¦ ¦2020¦ ,▁ ¦the¦ ¦sec r et ary¦ - ¦general¦ ¦of¦ ¦the¦ ¦united¦ ¦n ations¦ ¦la un ched¦ ¦the¦ ▁" ¦u n¦ ¦comp re he ns ive¦ ¦response¦ ¦to¦ ¦covid¦ - ¦19¦ " .
𐋇¦the¦ ¦united¦ ¦n ations¦ ¦conf er ence¦ ¦on¦ ¦tra de¦ ¦and¦ ¦development¦ ▁( ¦u ns c¦ )▁ ¦has¦ ¦been¦ ¦crit ici sed¦ ¦for¦ ¦a¦ ¦sl ow¦ ¦co or d in ated¦ ¦response¦ ,▁ ¦especially¦ ¦reg ar ding¦ ¦the¦ ¦u n¦ ' ¦s¦ ¦global¦ ¦c ea se f ir e¦ ,▁ ¦which¦ ¦ ai ms¦ ¦to¦ ¦open¦ ¦up¦ ¦h um an i ta ri an¦ ¦acc ess¦ ¦to¦ ¦the¦ ¦world¦ ' ¦s¦ ¦most¦ ¦v ul n er able¦ ¦in¦ ¦conf l ic t¦ ¦z on es¦ .
𐋇¦the¦ ¦who¦ ¦is¦ ¦a¦ ¦lea ding¦ ¦or g an is ation¦ ¦invol v ed¦ ¦in¦ ¦the¦ ¦global¦ ¦co or d ination¦ ¦for¦ ¦m it ig ating¦ ¦the¦ ¦pandemic¦ .
𐋇¦the¦ ¦who¦ ¦has¦ ¦sp ear h ea ded¦ ¦several¦ ¦in i ti at ives¦ ¦like¦ ¦the¦ ¦covid¦ - ¦19¦ ¦s ol id ar ity¦ ¦response¦ ¦f un d¦ ¦to¦ ¦ra ise¦ ¦mo ne y¦ ¦for¦ ¦the¦ ¦pandemic¦ ¦response¦ ,▁ ¦the¦ ¦u n¦ ¦covid¦ - ¦19¦ ¦supp ly¦ ¦cha in¦ ¦t as k¦ ¦for ce¦ ,▁ ¦and¦ ¦the¦ ¦s ol id ar ity¦ ¦tr ial¦ ¦for¦ ¦in ve st ig ating¦ ¦pote ntial¦ ¦treatment¦ ¦op tions¦ ¦for¦ ¦the¦ ¦disease¦ .
𐋇¦the¦ ¦who¦ ' ¦s¦ ¦cov a x¦ ¦vaccine¦ - ¦sh ar ing¦ ¦pr ogra m¦ ¦ ai ms¦ ¦to¦ ¦d ist rib ute¦ ¦2¦ ¦bi ll ion¦ ¦doses¦ ¦of¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦for¦ ¦fre e¦ ¦or¦ ¦at¦ ¦a¦ ¦reduc ed¦ ¦c ost¦ ¦by¦ ¦the¦ ¦end¦ ¦of¦ ¦2021¦ ,▁ ¦and¦ ¦has¦ ¦beg u n¦ ¦d ist rib u ting¦ ¦them¦ .
𐋇¦the¦ ¦who¦ ' ¦s¦ ¦hand l ing¦ ¦of¦ ¦the¦ ¦in it ial¦ ¦outbreak¦ ¦of¦ ¦the¦ ¦pandemic¦ ¦has¦ ¦required¦ ¦a¦ ▁" ¦di pl om at ic¦ ¦ba la ncing¦ ¦ac t¦ "▁ ¦between¦ ¦me mber¦ ¦states¦ ,▁ ¦in¦ ¦partic ular¦ ¦between¦ ¦the¦ ¦united¦ ¦states¦ ¦and¦ ¦china¦ .
𐋇¦on¦ ¦a u g ust¦ ¦2 7¦ ,▁ ¦the¦ ¦who¦ ¦announced¦ ¦the¦ ¦s etting¦ ¦up¦ ¦of¦ ¦an¦ ¦in de p end ent¦ ¦exp er t¦ ¦re v ie w¦ ¦comm it te e¦ ¦to¦ ¦ex a m ine¦ ¦as p ects¦ ¦of¦ ¦the¦ ¦international¦ ¦tre at y¦ ¦that¦ ¦gover ns¦ ¦pre par ed ness¦ ¦and¦ ¦response¦ ¦to¦ ¦health¦ ¦e mer ge nc ies¦ .
𐋇¦a¦ ¦who¦ - ¦l ed¦ ¦international¦ ¦mi ssion¦ ¦arr iv ed¦ ¦in¦ ¦china¦ ¦in¦ ¦january¦ ¦2021¦ ¦to¦ ¦in ve st ig ate¦ ¦the¦ ¦orig ins¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ ¦and¦ ¦rel ea sed¦ ¦pre li min ary¦ ¦fi nd ings¦ ¦in¦ ¦february¦ ¦2021¦ .
𐋇¦in¦ ¦several¦ ¦countries¦ ,▁ ¦prote sts¦ ¦have¦ ¦r is en¦ ¦against¦ ¦gover n me ntal¦ ¦re stric tive¦ ¦resp on ses¦ ¦to¦ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ ,▁ ¦such¦ ¦as¦ ¦loc k d ow ns¦ .
𐋇¦a¦ ¦february¦ ¦2021¦ ¦study¦ ¦found¦ ¦that¦ ¦large¦ ¦prot est¦ ¦ra ll ies¦ ¦against¦ ¦covid¦ - ¦19¦ ¦measures¦ ¦are¦ ¦likely¦ ¦to¦ ¦dir ect ly¦ ¦increase¦ ¦the¦ ¦spread¦ ¦of¦ ¦viruses¦ ,▁ ¦including¦ ¦covid¦ - ¦19¦ .
𐋇¦the¦ ¦outbreak¦ ¦is¦ ¦a¦ ¦major¦ ¦de st ab il ising¦ ¦th re at¦ ¦to¦ ¦the¦ ¦global¦ ¦ec on om y¦ .
𐋇 ¦one¦ ¦estim ate¦ ¦from¦ ¦an¦ ¦exp er t¦ ¦at¦ ¦w as hi ng t on¦ ¦univers ity¦ ¦in¦ ¦s t¦ .
𐋇¦l ou i s¦ ¦ga ve¦ ¦a¦ ▁ $ ¦3 00¦ ▁ + ▁ ¦bi ll ion¦ ¦impac t¦ ¦on¦ ¦the¦ ¦world¦ ' ¦s¦ ¦supp ly¦ ¦cha in¦ ¦that¦ ¦could¦ ¦last¦ ¦up¦ ¦to¦ ¦two¦ ¦years¦ .
𐋇 ¦global¦ ¦st oc k¦ ¦mark ets¦ ¦f ell¦ ¦on¦ ¦24¦ ¦february¦ ¦due¦ ¦to¦ ¦a¦ ¦sign ific ant¦ ¦r ise¦ ¦in¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦outside¦ ¦china¦ .
𐋇¦on¦ ¦2 7¦ ¦february¦ ,▁ ¦due¦ ¦to¦ ¦mo un ting¦ ¦wor r ies¦ ¦about¦ ¦the¦ ¦covid¦ - ¦19¦ ¦outbreak¦ ,▁ ¦u¦ . ¦s¦ . ¦st oc k¦ ¦in de x es¦ ¦p os ted¦ ¦their¦ ¦sh ar p est¦ ¦fa lls¦ ¦since¦ ¦20 0 8¦ ,▁ ¦with¦ ¦the¦ ¦d ow¦ ¦fa lling¦ ¦1¦ , ¦19 1¦ ¦p oi nts¦ ▁( ¦the¦ ¦l arg est¦ ¦one¦ - ¦day¦ ¦dro p¦ ¦since¦ ¦the¦ ¦fi na nc ial¦ ¦c ri sis¦ ¦of¦ ¦20 0 7¦ ▁–▁ ¦0 8¦ )▁ ¦and¦ ¦all¦ ¦three¦ ¦major¦ ¦in de x es¦ ¦ ending¦ ¦the¦ ¦week¦ ¦down¦ ¦more¦ ¦than¦ ¦10¦ ¦per¦ ¦c ent¦ .
𐋇¦on¦ ¦2 8¦ ¦february¦ ,▁ ¦sc ope¦ ¦r at ings¦ ¦g mb h ¦ ¦aff ir med¦ ¦china¦ ' ¦s¦ ¦so ve re ign¦ ¦cre di t¦ ¦r ating¦ ¦but¦ ¦main ta ined¦ ¦a¦ ¦negative¦ ¦out l ook¦ .
𐋇 ¦st oc ks¦ ¦pl un ged¦ ¦ag a in¦ ¦due¦ ¦to¦ ¦coronavirus¦ ¦f ear s¦ ,▁ ¦the¦ ¦l arg est¦ ¦f all¦ ¦being¦ ¦on¦ ¦16¦ ¦march¦ .
𐋇¦l lo y d¦ ' ¦s¦ ¦of¦ ¦l ond on¦ ¦estim ated¦ ¦that¦ ¦the¦ ¦global¦ ¦i ns ur ance¦ ¦ind u st ry¦ ¦will¦ ¦ab s or b ¦ ¦l os ses¦ ¦of¦ ¦us¦ ▁ $ ¦20 4¦ ¦bi ll ion¦ ,▁ ¦ex c ee ding¦ ¦the¦ ¦l os ses¦ ¦from¦ ¦the¦ ¦20 1 7¦ ¦ at la nt ic¦ ¦h ur r ic an e¦ ¦se as on¦ ¦and¦ ¦11¦ ¦se p te mber¦ ¦att ac ks¦ ,▁ ¦su gg es ting¦ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ ¦will¦ ¦likely¦ ¦go¦ ¦down¦ ¦in¦ ¦h ist ory¦ ¦as¦ ¦the¦ ¦co st li est¦ ¦dis as ter¦ ¦e ver¦ ¦in¦ ¦human¦ ¦h ist ory¦ .
𐋇 ¦to ur is m¦ ¦is¦ ¦one¦ ¦of¦ ¦the¦ ¦wor s t¦ ¦affected¦ ¦se ctors¦ ¦due¦ ¦to¦ ¦travel¦ ¦b ans¦ ,▁ ¦clos ing¦ ¦of¦ ¦public¦ ¦places¦ ¦including¦ ¦travel¦ ¦att r ac tions¦ ,▁ ¦and¦ ¦advice¦ ¦of¦ ¦gover n ments¦ ¦against¦ ¦travel¦ .
𐋇 ¦nu me ro us¦ ¦air l ines¦ ¦have¦ ¦cance lled¦ ¦f li gh ts¦ ¦due¦ ¦to¦ ¦lower¦ ¦dem and¦ ,▁ ¦and¦ ¦br it ish¦ ¦regi on al¦ ¦air line¦ ¦f l y b e¦ ¦coll ap sed¦ .
𐋇¦the¦ ¦c ru ise¦ ¦ line¦ ¦ind u st ry¦ ¦was¦ ¦h ard¦ ¦hi t¦ ,▁ ¦and¦ ¦several¦ ¦tra in¦ ¦st ations¦ ¦and¦ ¦f er ry¦ ¦p orts¦ ¦have¦ ¦also¦ ¦been¦ ¦closed¦ .
𐋇 ¦international¦ ¦ma il¦ ¦between¦ ¦some¦ ¦countries¦ ¦sto pp ed¦ ¦or¦ ¦was¦ ¦de la y ed¦ ¦due¦ ¦to¦ ¦reduc ed¦ ¦trans p ort ation¦ ¦between¦ ¦them¦ ¦or¦ ¦susp e ns ion¦ ¦of¦ ¦do me st ic¦ ¦service¦ .
𐋇¦the¦ ¦re ta il¦ ¦s ector¦ ¦has¦ ¦been¦ ¦impac ted¦ ¦gl ob ally¦ ,▁ ¦with¦ ¦reduc tions¦ ¦in¦ ¦st ore¦ ¦hours¦ ¦or¦ ¦temp or ary¦ ¦closures¦ .
𐋇 ¦visi ts¦ ¦to¦ ¦re tail ers¦ ¦in¦ ¦e ur ope¦ ¦and¦ ¦l at in¦ ¦amer ica¦ ¦decl ined¦ ¦by¦ ¦4 0¦ ¦per¦ ¦c ent¦ .
𐋇¦n or th¦ ¦amer ica¦ ¦and¦ ¦m id d le¦ ¦e ast¦ ¦re tail ers¦ ¦sa w¦ ¦a¦ ¦50¦ ▁–▁ ¦6 0¦ ¦per¦ ¦c ent¦ ¦dro p¦ .
𐋇¦this¦ ¦also¦ ¦res ul ted¦ ¦in¦ ¦a¦ ¦3 3¦ ▁–▁ ¦4 3¦ ¦per¦ ¦c ent¦ ¦dro p¦ ¦in¦ ¦fo ot¦ ¦tra ff ic¦ ¦to¦ ¦shopping¦ ¦centr es¦ ¦in¦ ¦march¦ ¦comp ared¦ ¦to¦ ¦february¦ .
𐋇 ¦shopping¦ ¦m all¦ ¦op erat ors¦ ¦around¦ ¦the¦ ¦world¦ ¦imp osed¦ ¦ad di tional¦ ¦measures¦ ,▁ ¦such¦ ¦as¦ ¦increased¦ ¦s an it ation¦ ,▁ ¦inst a ll ation¦ ¦of¦ ¦th erm al¦ ¦sc an n ers¦ ¦to¦ ¦ch eck¦ ¦the¦ ¦temp erat ure¦ ¦of¦ ¦sho pp ers¦ ,▁ ¦and¦ ¦cance ll ation¦ ¦of¦ ¦events¦ .
𐋇¦h u nd re ds¦ ¦of¦ ¦m il li ons¦ ¦of¦ ¦j ob s¦ ¦could¦ ¦be¦ ¦l ost¦ ¦gl ob ally¦ .
𐋇 ¦more¦ ¦than¦ ¦4 0¦ ¦million¦ ¦amer ic ans¦ ¦l ost¦ ¦their¦ ¦j ob s¦ ¦and¦ ¦f il ed¦ ¦u ne mploy ment¦ ¦i ns ur ance¦ ¦cl ai ms¦ .
𐋇¦the¦ ¦ec onomic¦ ¦impac t¦ ¦and¦ ¦m ass¦ ¦u ne mploy ment¦ ¦caused¦ ¦by¦ ¦the¦ ¦pandemic¦ ¦has¦ ¦r ai sed¦ ¦f ear s¦ ¦of¦ ¦a¦ ¦m ass¦ ¦e vi ction¦ ¦c ri sis¦ ,▁ ¦with¦ ¦an¦ ¦anal y sis¦ ¦by¦ ¦the¦ ¦as p en¦ ¦inst it ute¦ ¦indic ating¦ ¦between¦ ¦30¦ ¦and¦ ¦4 0¦ ¦million¦ ¦amer ic ans¦ ¦are¦ ¦at¦ ¦risk¦ ¦for¦ ¦e vi ction¦ ¦by¦ ¦the¦ ¦end¦ ¦of¦ ¦2020¦ .
𐋇 ¦according¦ ¦to¦ ¦a¦ ¦report¦ ¦by¦ ¦y el p¦ ,▁ ¦about¦ ¦6 0¦ %▁ ¦of¦ ¦u¦ . ¦s¦ .▁ ¦b us in es ses¦ ¦that¦ ¦have¦ ¦closed¦ ¦since¦ ¦the¦ ¦star t¦ ¦of¦ ¦the¦ ¦pandemic¦ ¦will¦ ¦stay¦ ¦sh ut¦ ¦per ma ne ntly¦ .
𐋇 ¦according¦ ¦to¦ ¦a¦ ¦united¦ ¦n ations¦ ¦ec onomic¦ ¦comm i ssion¦ ¦for¦ ¦l at in¦ ¦amer ica¦ ¦estim ate¦ ,▁ ¦the¦ ¦pandemic¦ - ¦in duc ed¦ ¦rece ssion¦ ¦could¦ ¦lea ve¦ ¦14¦ ▁–▁ ¦2 2¦ ¦million¦ ¦more¦ ¦people¦ ¦in¦ ¦ext re me¦ ¦po ve rt y¦ ¦in¦ ¦l at in¦ ¦amer ica¦ ¦than¦ ¦would¦ ¦have¦ ¦been¦ ¦in¦ ¦that¦ ¦s itu ation¦ ¦without¦ ¦the¦ ¦pandemic¦ .
𐋇 ¦according¦ ¦to¦ ¦the¦ ¦world¦ ¦b an k¦ ,▁ ¦up¦ ¦to¦ ¦100¦ ¦million¦ ¦more¦ ¦people¦ ¦gl ob ally¦ ¦could¦ ¦f all¦ ¦into¦ ¦ext re me¦ ¦po ve rt y¦ ¦due¦ ¦to¦ ¦the¦ ¦sh ut d ow ns¦ .
𐋇¦the¦ ¦international¦ ¦l ab ou r¦ ¦organiz ation¦ ▁( ¦ il o¦ )▁ ¦in for med¦ ¦that¦ ¦the¦ ¦inc ome¦ ¦gener ated¦ ¦in¦ ¦the¦ ¦first¦ ¦n ine¦ ¦mon ths¦ ¦of¦ ¦2020¦ ¦from¦ ¦work¦ ¦across¦ ¦the¦ ¦world¦ ¦dro pp ed¦ ¦by¦ ¦10¦ . ¦7¦ ¦per¦ ¦c ent¦ ,▁ ¦or¦ ▁ $ ¦3¦ . ¦5¦ ¦t ri ll ion¦ ,▁ ¦a m id s t¦ ¦the¦ ¦covid¦ - ¦19¦ ¦outbreak¦ .
𐋇¦the¦ ¦spread¦ ¦of¦ ¦p an ic¦ ¦bu ying¦ ¦has¦ ¦been¦ ¦found¦ ¦to¦ ¦ste m¦ ¦from¦ ¦per ce iv ed¦ ¦th re at¦ ,▁ ¦per ce iv ed¦ ¦sc ar c ity¦ ,▁ ¦f ear¦ ¦of¦ ¦the¦ ¦un k n own¦ ,▁ ¦c op ing¦ ¦be h a vi ou r¦ ¦and¦ ¦social¦ ¦p s y ch ological¦ ¦fa ctors¦ ▁( ¦ e¦ . ¦ g¦ .
𐋇 ¦social¦ ¦influ ence¦ ¦and¦ ¦tr ust¦ ).
𐋇¦the¦ ¦techn ology¦ ¦ind u st ry¦ ,▁ ¦in¦ ¦partic ular¦ ,▁ ¦has¦ ¦w ar ned¦ ¦of¦ ¦del ays¦ ¦to¦ ¦sh ip ments¦ ¦of¦ ¦el ect r on ic¦ ¦g oo ds¦ .
𐋇 ¦according¦ ¦to¦ ¦the¦ ¦who¦ ¦dir ector¦ - ¦general¦ ¦t ed ro s¦ ¦ad h an om¦ ,▁ ¦dem and¦ ¦for¦ ¦personal¦ ¦prote ction¦ ¦equipment¦ ¦has¦ ¦r is en¦ ¦a¦ ¦h un dr ed f o ld¦ ,▁ ¦lea ding¦ ¦to¦ ¦pri ces¦ ¦up¦ ¦to¦ ¦t we nt y¦ ¦times¦ ¦the¦ ¦normal¦ ¦pr ice¦ ¦and¦ ¦also¦ ¦del ays¦ ¦in¦ ¦the¦ ¦supp ly¦ ¦of¦ ¦medical¦ ¦i tems¦ ¦of¦ ¦four¦ ¦to¦ ¦si x¦ ¦mon ths¦ .
𐋇¦it¦ ¦has¦ ¦also¦ ¦caused¦ ¦a¦ ¦sh ort age¦ ¦of¦ ¦personal¦ ¦prot ective¦ ¦equipment¦ ¦worldwide¦ ,▁ ¦with¦ ¦the¦ ¦who¦ ¦w ar ning¦ ¦that¦ ¦this¦ ¦will¦ ¦ end a nger¦ ¦health¦ ¦workers¦ .
𐋇¦the¦ ¦impac t¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦outbreak¦ ¦was¦ ¦worldwide¦ .
𐋇¦the¦ ¦virus¦ ¦cre ated¦ ¦a¦ ¦sh ort age¦ ¦of¦ ¦pr ecu rs ors¦ ▁( ¦ra w¦ ¦m at er ial¦ )▁ ¦used¦ ¦in¦ ¦the¦ ¦m an u fa ct ur ing¦ ¦of¦ ¦fe nt an y l¦ ¦and¦ ¦me th a mp he ta m ine¦ .
𐋇 ¦pr ice¦ ¦inc rea ses¦ ¦and¦ ¦sh or ta ges¦ ¦in¦ ¦these¦ ¦ il le g al¦ ¦d ru g s¦ ¦have¦ ¦been¦ ¦n ot ic ed¦ ¦on¦ ¦the¦ ¦st re ets¦ ¦of¦ ¦the¦ ¦uk¦ .
𐋇¦the¦ ¦pandemic¦ ¦has¦ ¦dis ru p ted¦ ¦global¦ ¦food¦ ¦supp l ies¦ ¦and¦ ¦th re at ens¦ ¦to¦ ¦t ri gg er¦ ¦a¦ ¦new¦ ¦food¦ ¦c ri sis¦ .
𐋇 ¦da v id¦ ¦be as le y¦ ,▁ ¦h ead¦ ¦of¦ ¦the¦ ¦world¦ ¦food¦ ¦pr ogra m me¦ ▁( ¦w f p¦ ),▁ ¦said¦ ▁" ¦we¦ ¦could¦ ¦be¦ ¦f ac ing¦ ¦mult ip le¦ ¦fa m ines¦ ¦of¦ ¦bi bl ical¦ ¦prop or tions¦ ¦within¦ ¦a¦ ¦sh ort¦ ¦fe w¦ ¦mon ths¦ . "▁ 𐋇 ¦sen i or¦ ¦off ici als¦ ¦at¦ ¦the¦ ¦united¦ ¦n ations¦ ¦estim ated¦ ¦in¦ ¦april¦ ¦2020¦ ¦that¦ ¦an¦ ¦ad di tional¦ ¦1 3 0¦ ¦million¦ ¦people¦ ¦could¦ ¦star ve¦ ,▁ ¦for¦ ¦a¦ ¦total¦ ¦of¦ ¦2 6 5¦ ¦million¦ ¦by¦ ¦the¦ ¦end¦ ¦of¦ ¦2020¦ .
𐋇¦in¦ ¦early¦ ¦february¦ ¦2020¦ ,▁ ¦organiz ation¦ ¦of¦ ¦the¦ ¦p et ro le um¦ ¦exp orting¦ ¦countries¦ ▁( ¦op e c¦ ) ▁" ¦sc ra m bl ed¦ "▁ ¦after¦ ¦a¦ ¦st ee p¦ ¦dec line¦ ¦in¦ ¦o il¦ ¦pri ces¦ ¦due¦ ¦to¦ ¦lower¦ ¦dem and¦ ¦from¦ ¦china¦ .
𐋇¦on¦ ¦mon day¦ ,▁ ¦20¦ ¦april¦ ,▁ ¦the¦ ¦pr ice¦ ¦of¦ ¦w est¦ ¦te x a s¦ ¦int erm ediate¦ ▁( ¦w t i¦ )▁ ¦w ent¦ ¦negative¦ ¦and¦ ¦f ell¦ ¦to¦ ¦a¦ ¦recor d¦ ¦low¦ ▁( ¦min us¦ ▁ $ ¦3 7¦ . ¦6 3¦ ¦a¦ ¦b ar re l¦ )▁ ¦due¦ ¦to¦ ¦t rad ers¦ ' ▁ ¦off lo a ding¦ ¦h ol d ings¦ ¦so¦ ¦as¦ ¦not¦ ¦to¦ ¦take¦ ¦de li ve ry¦ ¦and¦ ¦inc u r¦ ¦st or age¦ ¦co sts¦ .
𐋇 ¦june¦ ¦pri ces¦ ¦were¦ ¦down¦ ¦but¦ ¦in¦ ¦the¦ ¦positive¦ ¦r ange¦ ,▁ ¦with¦ ¦a¦ ¦b ar re l¦ ¦of¦ ¦w est¦ ¦te x a s¦ ¦tra ding¦ ¦a bo ve¦ ▁ $ ¦20¦ .
𐋇¦the¦ ¦per f orm ing¦ ¦ar ts¦ ¦and¦ ¦c ult ural¦ ¦h er it age¦ ¦se ctors¦ ¦have¦ ¦been¦ ¦pro f ou nd ly¦ ¦affected¦ ¦by¦ ¦the¦ ¦pandemic¦ ,▁ ¦impac ting¦ ¦or g an is ations¦ ' ▁ ¦op er ations¦ ¦as¦ ¦well¦ ¦as¦ ¦individuals¦ ▁ — ▁ ¦both¦ ¦e mploy ed¦ ¦and¦ ¦in de p end ent¦ ▁ — ▁ ¦gl ob ally¦ .
𐋇¦by¦ ¦march¦ ¦2020¦ ,▁ ¦across¦ ¦the¦ ¦world¦ ¦and¦ ¦to¦ ¦v ar ying¦ ¦de g re es¦ ,▁ ¦m u se u ms¦ ,▁ ¦li b r ar ies¦ ,▁ ¦per f orm ance¦ ¦v en ues¦ ,▁ ¦and¦ ¦other¦ ¦c ult ural¦ ¦inst itu tions¦ ¦had¦ ¦been¦ ¦in de f in i tely¦ ¦closed¦ ¦with¦ ¦their¦ ¦ex hi b i tions¦ ,▁ ¦events¦ ¦and¦ ¦per f orm an ces¦ ¦cance lled¦ ¦or¦ ¦po st p o ned¦ .
𐋇¦some¦ ¦services¦ ¦contin u ed¦ ¦through¦ ¦d ig it al¦ ¦pl at for ms¦ ,▁ ¦such¦ ¦as¦ ¦live¦ ¦st rea m ing¦ ¦concer ts¦ ¦or¦ ¦we b ¦ - ¦based¦ ¦ar ts¦ ¦fe st iv als¦ .
𐋇 ¦ho ly¦ ¦week¦ ¦ob s erv an ces¦ ¦in¦ ¦r ome¦ ,▁ ¦which¦ ¦occur ¦ ¦during¦ ¦the¦ ¦last¦ ¦week¦ ¦of¦ ¦the¦ ¦ch r is ti an¦ ¦p en i te ntial¦ ¦se as on¦ ¦of¦ ¦l ent¦ ,▁ ¦were¦ ¦cance lled¦ .
𐋇 ¦many¦ ¦di o ce ses¦ ¦have¦ ¦recommended¦ ¦ ol der¦ ¦ch r is ti ans¦ ¦stay¦ ¦home¦ ¦r at her¦ ¦than¦ ¦att end¦ ¦m ass¦ ¦on¦ ¦su nd ays¦ ;▁ ¦services¦ ¦have¦ ¦been¦ ¦made¦ ¦available¦ ¦v ia¦ ¦ra di o¦ ,▁ ¦online¦ ¦live¦ ¦st rea m ing¦ ¦and¦ ¦te le v is ion¦ ,▁ ¦th ough¦ ¦some¦ ¦co ng re g ations¦ ¦have¦ ¦made¦ ¦pro vi si ons¦ ¦for¦ ¦dr ive¦ - ¦in¦ ¦wor s hi p¦ .
𐋇 ¦with¦ ¦the¦ ¦r om an¦ ¦ca th ol ic¦ ¦di o ce se¦ ¦of¦ ¦r ome¦ ¦clos ing¦ ¦its¦ ¦ch ur ches¦ ¦and¦ ¦ch ap els¦ ¦and¦ ¦s t¦ .
𐋇¦p e ter¦ ' ¦s¦ ¦s qu are¦ ¦e m pt ied¦ ¦of¦ ¦ch r is ti an¦ ¦p il g ri ms¦ ,▁ ¦other¦ ¦rel ig ious¦ ¦ bo dies¦ ¦also¦ ¦cance lled¦ ¦in¦ - ¦person¦ ¦services¦ ¦and¦ ¦limi ted¦ ¦public¦ ¦ga ther ings¦ ¦in¦ ¦ch ur ches¦ ,▁ ¦m os q ues¦ ,▁ ¦s y na g og ues¦ ,▁ ¦temp les¦ ¦and¦ ¦g ur d w ara s¦ .
𐋇 ¦iran¦ ' ¦s¦ ¦health¦ ¦min ist ry¦ ¦announced¦ ¦the¦ ¦cance ll ation¦ ¦of¦ ¦f ri day¦ ¦p ra y ers¦ ¦in¦ ¦areas¦ ¦affected¦ ¦by¦ ¦the¦ ¦outbreak¦ ¦and¦ ¦sh r ines¦ ¦were¦ ¦later¦ ¦closed¦ ,▁ ¦while¦ ¦sa ud i¦ ¦ar ab ia¦ ¦b an ned¦ ¦the¦ ¦ent ry¦ ¦of¦ ¦fo re ign¦ ¦p il g ri ms¦ ¦as¦ ¦well¦ ¦as¦ ¦its¦ ¦res id ents¦ ¦to¦ ¦ho ly¦ ¦si tes¦ ¦in¦ ¦m ec c a¦ ¦and¦ ¦me di na¦ .
𐋇¦the¦ ¦2020¦ ¦ha j j ¦ ¦was¦ ¦limi ted¦ ¦to¦ ¦around¦ ¦1¦ , ¦000¦ ¦s el ected¦ ¦p il g ri ms¦ ,▁ ¦in¦ ¦contr ast¦ ¦to¦ ¦the¦ ¦us ual¦ ¦number¦ ¦of¦ ¦over¦ ¦2¦ ¦million¦ .
𐋇¦the¦ ¦pandemic¦ ¦has¦ ¦caused¦ ¦the¦ ¦most¦ ¦sign ific ant¦ ¦dis ru ption¦ ¦to¦ ¦the¦ ¦worldwide¦ ¦sp orting¦ ¦c al end a r¦ ¦since¦ ¦the¦ ¦second¦ ¦world¦ ¦w a r¦ .
𐋇 ¦most¦ ¦major¦ ¦sp orting¦ ¦events¦ ¦have¦ ¦been¦ ¦cance lled¦ ¦or¦ ¦po st p o ned¦ ,▁ ¦including¦ ¦the¦ ¦2019¦ ▁–▁ ¦20¦ ¦u e f a¦ ¦cha mp i ons¦ ¦lea g ue¦ ,▁ ¦2019¦ ▁–▁ ¦20¦ ¦pre mi er¦ ¦lea g ue¦ ,▁ ¦u e f a¦ ¦e ur o¦ ¦2020¦ ,▁ ¦2020¦ ¦major¦ ¦lea g ue¦ ¦ba se b all¦ ¦se as on¦ ,▁ ¦2019¦ ▁–▁ ¦20¦ ¦n b a¦ ¦se as on¦ ,▁ ¦2019¦ ▁–▁ ¦20¦ ¦n h l¦ ¦se as on¦ ,▁ ¦and¦ ¦2020¦ ¦ar ct ic¦ ¦w in ter¦ ¦ga m es¦ .
𐋇¦the¦ ¦outbreak¦ ¦dis ru p ted¦ ¦pl ans¦ ¦for¦ ¦the¦ ¦2020¦ ¦su mm er¦ ¦ ol y mp ics¦ ¦in¦ ¦to k y o¦ ,▁ ¦j ap an¦ ,▁ ¦which¦ ¦were¦ ¦orig in ally¦ ¦s ch ed ul ed¦ ¦to¦ ¦star t¦ ¦at¦ ¦24¦ ¦j u ly¦ ¦2020¦ ,▁ ¦and¦ ¦were¦ ¦po st p o ned¦ ¦by¦ ¦the¦ ¦international¦ ¦ ol y mp ic¦ ¦comm it te e¦ ¦to¦ ¦23¦ ¦j u ly¦ ¦2021¦ .
𐋇¦the¦ ¦ent er ta in ment¦ ¦ind u st ry¦ ¦has¦ ¦also¦ ¦been¦ ¦affected¦ ,▁ ¦with¦ ¦many¦ ¦m us ic¦ ¦grou ps¦ ¦susp ending¦ ¦or¦ ¦cance lling¦ ¦concer t¦ ¦to ur s¦ .
𐋇¦the¦ ¦e ur ov is ion¦ ¦so ng¦ ¦cont est¦ ,▁ ¦which¦ ¦was¦ ¦due¦ ¦to¦ ¦be¦ ¦he ld¦ ¦in¦ ¦r ot t er d am¦ ,▁ ¦the¦ ¦ne ther l an ds¦ ¦in¦ ¦may¦ ,▁ ¦was¦ ¦cance lled¦ ;▁ ¦however¦ ,▁ ¦the¦ ¦ne ther l an ds¦ ¦was¦ ¦re ta ined¦ ¦as¦ ¦host¦ ¦for¦ ¦2021¦ .
𐋇 ¦many¦ ¦large¦ ¦the at r es¦ ¦such¦ ¦as¦ ¦those¦ ¦on¦ ¦b ro a d w ay¦ ¦also¦ ¦susp e nded¦ ¦all¦ ¦per f orm an ces¦ .
𐋇¦the¦ ¦large¦ ¦number¦ ¦of¦ ¦people¦ ¦wor king¦ ¦or¦ ¦learning¦ ¦from¦ ¦home¦ ¦v ia¦ ¦v ide oc on f e re ncing¦ ¦so f t w are¦ ¦l ed¦ ¦to¦ ¦several¦ ¦new¦ ¦ter ms¦ ¦and¦ ¦tr ends¦ ,▁ ¦including¦ ▁" ¦z o om¦ ¦fat ig ue¦ " ,▁ ¦a¦ ¦dec line¦ ¦in¦ ¦dem and¦ ¦for¦ ¦f ormal¦ ¦c lo thing¦ ,▁ ¦and¦ ¦increased¦ ¦f as h ion¦ ¦f oc us¦ ¦on¦ ¦masks¦ ¦and¦ ¦c lo th es¦ ¦for¦ ¦the¦ ¦u pp er¦ ¦body¦ ▁( ¦the¦ ¦lower¦ ¦body¦ ¦gener ally¦ ¦not¦ ¦being¦ ¦visi ble¦ ¦on¦ ¦a¦ ¦v ide oc on f er ence¦ ).
𐋇¦the¦ ¦ter m¦ ▁" ¦do om s c ro lling¦ "▁ ¦bec a me¦ ¦more¦ ¦wid ely¦ ¦used¦ .
𐋇 ¦online¦ ,▁ ¦nu me ro us¦ ¦covid¦ - ¦19¦ - ¦the med¦ ¦inter n et¦ ¦me m es¦ ¦have¦ ¦spread¦ ¦as¦ ¦many¦ ¦t ur n¦ ¦to¦ ¦h um ou r¦ ¦and¦ ¦d ist ra ction¦ ¦a m id¦ ¦the¦ ¦un ce rt ai nt y¦ .
𐋇¦the¦ ¦pandemic¦ ¦has¦ ¦affected¦ ¦the¦ ¦pol it ical¦ ¦sys tems¦ ¦of¦ ¦mult ip le¦ ¦countries¦ ,▁ ¦ca us ing¦ ¦susp en si ons¦ ¦of¦ ¦le g is l ative¦ ¦activ ities¦ ,▁ ¦isol ations¦ ¦or¦ ¦deaths¦ ¦of¦ ¦mult ip le¦ ¦pol it ici ans¦ ,▁ ¦and¦ ¦res ch ed ul ing¦ ¦of¦ ¦el ec tions¦ ¦due¦ ¦to¦ ¦f ear s¦ ¦of¦ ¦sprea ding¦ ¦the¦ ¦virus¦ .
𐋇 ¦al th ough¦ ¦they¦ ¦have¦ ¦b ro ad¦ ¦support¦ ¦among¦ ¦e p ide mi ol og i sts¦ ,▁ ¦social¦ ¦distancing¦ ¦measures¦ ¦have¦ ¦been¦ ¦pol it ically¦ ¦cont ro ve rs ial¦ ¦in¦ ¦many¦ ¦countries¦ .
𐋇 ¦in te ll ect ual¦ ¦o pp os ition¦ ¦to¦ ¦social¦ ¦distancing¦ ¦has¦ ¦come¦ ¦pri ma ri ly¦ ¦from¦ ¦w r it ers¦ ¦of¦ ¦other¦ ¦fi el ds¦ ,▁ ¦al th ough¦ ¦there¦ ¦are¦ ¦a¦ ¦fe w¦ ¦he te ro d o x¦ ¦e p ide mi ol og i sts¦ .
𐋇¦on¦ ¦23¦ ¦march¦ ¦2020¦ ,▁ ¦united¦ ¦n ations¦ ¦sec r et ary¦ - ¦general¦ ¦a nt ó n i o¦ ¦m an u e l¦ ¦de¦ ¦o li ve ir a¦ ¦g ut er r es¦ ¦issued¦ ¦an¦ ¦app e al¦ ¦for¦ ¦a¦ ¦global¦ ¦c ea se f ir e¦ ¦in¦ ¦response¦ ¦to¦ ¦the¦ ¦pandemic¦ ;▁ ¦1 7 2¦ ¦u n¦ ¦me mber¦ ¦states¦ ¦and¦ ¦ob s erv ers¦ ¦sign ed¦ ¦a¦ ¦non¦ - ¦b in ding¦ ¦sta te ment¦ ¦in¦ ¦support¦ ¦of¦ ¦the¦ ¦app e al¦ ¦in¦ ¦june¦ ,▁ ¦and¦ ¦the¦ ¦u n¦ ¦sec ur ity¦ ¦cou nc il¦ ¦p as sed¦ ¦a¦ ¦res ol ution¦ ¦supp orting¦ ¦it¦ ¦in¦ ¦j u ly¦ .
𐋇¦the¦ ¦government¦ ¦of¦ ¦china¦ ¦has¦ ¦been¦ ¦crit ici sed¦ ¦by¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦the¦ ¦uk¦ ¦minister¦ ¦for¦ ¦the¦ ¦c ab in et¦ ¦off ice¦ ¦mi ch a e l¦ ¦go ve¦ ,▁ ¦and¦ ¦others¦ ¦for¦ ¦its¦ ¦hand l ing¦ ¦of¦ ¦the¦ ¦pandemic¦ .
𐋇¦a¦ ¦number¦ ¦of¦ ¦pro vi nc ial¦ - ¦level¦ ¦admin i str at ors¦ ¦of¦ ¦the¦ ¦comm un ist¦ ¦part y¦ ¦of¦ ¦china¦ ¦were¦ ¦dis m is sed¦ ¦over¦ ¦their¦ ¦hand l ing¦ ¦of¦ ¦the¦ ¦quarantine¦ ¦measures¦ ¦in¦ ¦china¦ ,▁ ¦a¦ ¦s ign¦ ¦of¦ ¦disc o nt ent¦ ¦with¦ ¦their¦ ¦response¦ ¦to¦ ¦the¦ ¦outbreak¦ .
𐋇¦some¦ ¦comm e nt at ors¦ ¦b el ie v ed¦ ¦this¦ ¦mo ve¦ ¦was¦ ¦in te nded¦ ¦to¦ ¦protect¦ ¦c c p¦ ¦general¦ ¦sec r et ary¦ ¦ x i¦ ¦j in p ing¦ ¦from¦ ¦the¦ ¦cont ro ve rs y¦ .
𐋇¦the¦ ¦u¦ . ¦s¦ .▁ ¦in te ll ig ence¦ ¦community¦ ¦cl ai ms¦ ¦china¦ ¦int en tion ally¦ ¦under¦ - ¦reported¦ ¦its¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦cases¦ .
𐋇¦the¦ ¦chinese¦ ¦government¦ ¦main ta ins¦ ¦it¦ ¦has¦ ¦ac ted¦ ¦sw if t ly¦ ¦and¦ ¦trans pa re ntly¦ .
𐋇¦however¦ ,▁ ¦jo ur na li sts¦ ¦and¦ ¦activ i sts¦ ¦who¦ ¦have¦ ¦reported¦ ¦on¦ ¦the¦ ¦pandemic¦ ¦have¦ ¦been¦ ¦de ta ined¦ ¦by¦ ¦author ities¦ ,▁ ¦such¦ ¦as¦ ¦z h a ng¦ ¦z h an¦ ,▁ ¦who¦ ¦was¦ ¦arr ested¦ ¦and¦ ¦t ort ur ed¦ ¦for¦ ¦rep orting¦ ¦on¦ ¦the¦ ¦pandemic¦ ¦and¦ ¦the¦ ¦de ta in ment¦ ¦of¦ ¦other¦ ¦in de p end ent¦ ¦jo ur na li sts¦ .
𐋇¦in¦ ¦early¦ ¦march¦ ,▁ ¦the¦ ¦i tali an¦ ¦government¦ ¦crit ici sed¦ ¦the¦ ¦eu¦ ' ¦s¦ ¦l ack¦ ¦of¦ ¦s ol id ar ity¦ ¦with¦ ¦coronavirus¦ - ¦affected¦ ¦italy¦ ▁ — ▁ ¦ma ur iz i o¦ ¦ma ss ar i¦ ,▁ ¦italy¦ ' ¦s¦ ¦a mb a ss a d or¦ ¦to¦ ¦the¦ ¦eu¦ ,▁ ¦said¦ ▁" ¦only¦ ¦china¦ ¦resp o nded¦ ¦b il at er ally¦ " ,▁ ¦not¦ ¦the¦ ¦eu¦ .
𐋇¦on¦ ¦2 2¦ ¦march¦ ,▁ ¦after¦ ¦a¦ ¦phone¦ ¦call¦ ¦with¦ ¦i tali an¦ ¦pri me¦ ¦minister¦ ¦g i u se pp e¦ ¦cont e¦ ,▁ ¦r us si an¦ ¦pres ident¦ ¦v la di mi r¦ ¦p ut in¦ ¦had¦ ¦the¦ ¦r us si an¦ ¦ arm y¦ ¦s end¦ ¦m il it ary¦ ¦medic s¦ ,▁ ¦disinf e ction¦ ¦ ve h ic les¦ ,▁ ¦and¦ ¦other¦ ¦medical¦ ¦equipment¦ ¦to¦ ¦italy¦ .
𐋇 ¦pres ident¦ ¦of¦ ¦lo mb ar dy¦ ¦att i li o¦ ¦f on ta na¦ ¦and¦ ¦i tali an¦ ¦fo re ign¦ ¦minister¦ ¦lu ig i¦ ¦d i¦ ¦m ai o¦ ¦exp r es sed¦ ¦their¦ ¦gr at itu de¦ ¦for¦ ¦the¦ ¦a id¦ .
𐋇¦ ru ss ia¦ ¦also¦ ¦s ent¦ ¦a¦ ¦c arg o¦ ¦pl an e¦ ¦with¦ ¦medical¦ ¦a id¦ ¦to¦ ¦the¦ ¦united¦ ¦states¦ .
𐋇 ¦k re m l in¦ ¦sp o k es m an¦ ¦d m it ry¦ ¦p es k ov ¦ ¦said¦ ▁" ¦when¦ ¦off ering¦ ¦ass ist ance¦ ¦to¦ ¦u¦ . ¦s¦ .▁ ¦coll ea g ues¦ ,▁ [ ¦p ut in¦ ] ▁ ¦ass um es¦ ¦that¦ ¦when¦ ¦u¦ . ¦s¦ .▁ ¦m an u fa ct ur ers¦ ¦of¦ ¦medical¦ ¦equipment¦ ¦and¦ ¦m at eri als¦ ¦ga in¦ ¦mo me nt um¦ ,▁ ¦they¦ ¦will¦ ¦also¦ ¦be¦ ¦able¦ ¦to¦ ¦rec ip r oc ate¦ ¦if¦ ¦ne cess ary¦ . "▁ 𐋇¦in¦ ¦early¦ ¦april¦ ,▁ ¦n or w ay¦ ¦and¦ ¦eu¦ ¦states¦ ¦like¦ ¦r om an ia¦ ¦and¦ ¦a u str ia¦ ¦star ted¦ ¦to¦ ¦off er¦ ¦help¦ ¦by¦ ¦s ending¦ ¦medical¦ ¦pers on ne l¦ ¦and¦ ¦disinf ect ant¦ ,▁ ¦and¦ ¦u rs ul a¦ ¦v on¦ ¦ der¦ ¦le y en¦ ¦off ered¦ ¦an¦ ¦offic ial¦ ¦ ap ology¦ ¦to¦ ¦the¦ ¦country¦ .
𐋇¦the¦ ¦outbreak¦ ¦pro mp ted¦ ¦ca lls¦ ¦for¦ ¦the¦ ¦united¦ ¦states¦ ¦to¦ ¦ad op t¦ ¦social¦ ¦pol ic ies¦ ¦common¦ ¦in¦ ¦other¦ ¦we al th y¦ ¦countries¦ ,▁ ¦including¦ ¦univers al¦ ¦health¦ ¦care¦ ,▁ ¦univers al¦ ¦child¦ ¦care¦ ,▁ ¦pa id¦ ¦sick¦ ¦lea ve¦ ,▁ ¦and¦ ¦higher¦ ¦le v els¦ ¦of¦ ¦f un ding¦ ¦for¦ ¦public¦ ¦health¦ .
𐋇 ¦pol it ical¦ ¦anal y sts¦ ¦b el ie ve¦ ¦it¦ ¦may¦ ¦have¦ ¦cont rib u ted¦ ¦to¦ ¦do na ld¦ ¦tr um p¦ ' ¦s¦ ¦l os s¦ ¦in¦ ¦the¦ ¦2020¦ ¦pres ide ntial¦ ¦e le ction¦ .
𐋇 ¦beg in ning¦ ¦in¦ ¦m id¦ - ¦april¦ ¦2020¦ ,▁ ¦there¦ ¦were¦ ¦prote sts¦ ¦in¦ ¦several¦ ¦u¦ . ¦s¦ .▁ ¦states¦ ¦against¦ ¦government¦ - ¦imp osed¦ ¦bu si ness¦ ¦closures¦ ¦and¦ ¦re stric ted¦ ¦personal¦ ¦mo ve ment¦ ¦and¦ ¦associ ation¦ .
𐋇¦s im ul ta ne o us ly¦ ,▁ ¦prote sts¦ ¦e ns u ed¦ ¦by¦ ¦essential¦ ¦workers¦ ¦in¦ ¦the¦ ¦for m¦ ¦of¦ ¦a¦ ¦general¦ ¦st ri ke¦ .
𐋇¦in¦ ¦early¦ ¦o ct ob er¦ ¦2020¦ ,▁ ¦do na ld¦ ¦tr um p¦ ,▁ ¦hi s¦ ¦family¦ ¦me mbers¦ ,▁ ¦and¦ ¦many¦ ¦other¦ ¦government¦ ¦off ici als¦ ¦were¦ ¦diagn osed¦ ¦with¦ ¦covid¦ - ¦19¦ ,▁ ¦further¦ ¦dis ru p ting¦ ¦the¦ ¦country¦ ' ¦s¦ ¦pol it ics¦ .
𐋇¦the¦ ¦pl an ned¦ ¦nat o¦ ▁" ¦def en der¦ ¦2020¦ "▁ ¦m il it ary¦ ¦exerc ise¦ ¦in¦ ¦g erm an y¦ ,▁ ¦po land¦ ,▁ ¦and¦ ¦the¦ ¦b al t ic¦ ¦states¦ ,▁ ¦the¦ ¦l arg est¦ ¦nat o¦ ¦w a r¦ ¦exerc ise¦ ¦since¦ ¦the¦ ¦end¦ ¦of¦ ¦the¦ ¦cold¦ ¦w a r¦ ,▁ ¦was¦ ¦he ld¦ ¦on¦ ¦a¦ ¦reduc ed¦ ¦sc a le¦ .
𐋇¦the¦ ¦ca m pa ign¦ ¦for¦ ¦n uc l ear¦ ¦dis ar ma ment¦ ' ¦s¦ ¦general¦ ¦sec r et ary¦ ¦k ate¦ ¦h ud s on¦ ¦crit ici sed¦ ¦the¦ ¦exerc ise¦ ,▁ ¦sa ying¦ ▁" ¦it¦ ¦j e o par di ses¦ ¦the¦ ¦l ives¦ ¦not¦ ¦only¦ ¦of¦ ¦the¦ ¦tr oo ps¦ ¦from¦ ¦the¦ ¦u¦ . ¦s¦ .▁ ¦and¦ ¦the¦ ¦many¦ ¦european¦ ¦countries¦ ¦partic ip ating¦ ¦but¦ ¦the¦ ¦in h ab i ta nts¦ ¦of¦ ¦the¦ ¦countries¦ ¦in¦ ¦which¦ ¦they¦ ¦are¦ ¦op er ating¦ . "
𐋇¦the¦ ¦ir an i an¦ ¦government¦ ¦has¦ ¦been¦ ¦h ea vi ly¦ ¦affected¦ ¦by¦ ¦the¦ ¦virus¦ ,▁ ¦with¦ ¦about¦ ¦two¦ ¦do z en¦ ¦par l ia ment¦ ¦me mbers¦ ¦and¦ ¦f if te en¦ ¦current¦ ¦or¦ ¦f orm er¦ ¦pol it ical¦ ¦f ig ures¦ ¦infected¦ .
𐋇 ¦iran¦ ' ¦s¦ ¦pres ident¦ ¦ha ss an¦ ¦r ou h an i¦ ¦w r ot e¦ ¦a¦ ¦public¦ ¦l et ter¦ ¦to¦ ¦world¦ ¦lea d ers¦ ¦as king¦ ¦for¦ ¦help¦ ¦on¦ ¦14¦ ¦march¦ ¦2020¦ ,▁ ¦sa ying¦ ¦they¦ ¦were¦ ¦st ru gg l ing¦ ¦to¦ ¦f ight¦ ¦the¦ ¦outbreak¦ ¦due¦ ¦to¦ ¦a¦ ¦l ack¦ ¦of¦ ¦acc ess¦ ¦to¦ ¦international¦ ¦mark ets¦ ¦from¦ ¦the¦ ¦united¦ ¦states¦ ¦sa nc tions¦ ¦against¦ ¦iran¦ .
𐋇 ¦sa ud i¦ ¦ar ab ia¦ ,▁ ¦which¦ ¦la un ched¦ ¦a¦ ¦m il it ary¦ ¦inter vention¦ ¦in¦ ¦y e m en¦ ¦in¦ ¦march¦ ¦20 1 5¦ ,▁ ¦decl ared¦ ¦a¦ ¦c ea se f ir e¦ .
𐋇 ¦di pl om at ic¦ ¦rel ations¦ ¦between¦ ¦j ap an¦ ¦and¦ ¦south¦ ¦ko rea¦ ¦wor se ned¦ ¦due¦ ¦to¦ ¦the¦ ¦pandemic¦ .
𐋇 ¦south¦ ¦ko rea¦ ¦crit ici sed¦ ¦j ap an¦ ' ¦s¦ ▁" ¦a mb ig u o us¦ ¦and¦ ¦pa ss ive¦ ¦quarantine¦ ¦eff orts¦ "▁ ¦after¦ ¦j ap an¦ ¦announced¦ ¦an yone¦ ¦c om ing¦ ¦from¦ ¦south¦ ¦ko rea¦ ¦would¦ ¦be¦ ¦pl ac ed¦ ¦in¦ ¦quarantine¦ ¦for¦ ¦two¦ ¦weeks¦ ¦at¦ ¦government¦ - ¦de si gn ated¦ ¦si tes¦ .
𐋇 ¦south¦ ¦ko re an¦ ¦s oc i et y¦ ¦was¦ ¦in it ially¦ ¦po la ri sed¦ ¦on¦ ¦pres ident¦ ¦mo on¦ ¦j a e¦ - ¦in¦ ' ¦s¦ ¦response¦ ¦to¦ ¦the¦ ¦c ri sis¦ ;▁ ¦many¦ ¦ko re ans¦ ¦sign ed¦ ¦p e ti tions¦ ¦e it her¦ ¦ca lling¦ ¦for¦ ¦mo on¦ ' ¦s¦ ¦imp ea ch ment¦ ¦or¦ ¦p ra ising¦ ¦hi s¦ ¦response¦ .
𐋇¦some¦ ¦countries¦ ¦have¦ ¦p as sed¦ ¦emergency¦ ¦le g is l ation¦ ¦in¦ ¦response¦ ¦to¦ ¦the¦ ¦pandemic¦ .
𐋇¦some¦ ¦comm e nt at ors¦ ¦have¦ ¦exp r es sed¦ ¦concer n¦ ¦that¦ ¦it¦ ¦could¦ ¦all ow¦ ¦gover n ments¦ ¦to¦ ¦st re ng th en¦ ¦their¦ ¦g ri p¦ ¦on¦ ¦p ower¦ .
𐋇¦in¦ ¦the¦ ¦p hi li pp ines¦ ,▁ ¦la w ma k ers¦ ¦gr an ted¦ ¦pres ident¦ ¦ro dr ig o¦ ¦d u te rt e¦ ¦temp or ary¦ ¦emergency¦ ¦p ow ers¦ ¦during¦ ¦the¦ ¦pandemic¦ .
𐋇¦in¦ ¦h u ng ary¦ ,▁ ¦the¦ ¦par l ia ment¦ ¦v o ted¦ ¦to¦ ¦all ow¦ ¦the¦ ¦pri me¦ ¦minister¦ ,▁ ¦ vi k t or¦ ¦or b á n¦ ,▁ ¦to¦ ¦ ru le¦ ¦by¦ ¦dec re e¦ ¦in de f in i tely¦ ,▁ ¦susp end¦ ¦par l ia ment¦ ¦as¦ ¦well¦ ¦as¦ ¦el ec tions¦ ,▁ ¦and¦ ¦p un ish¦ ¦those¦ ¦d ee med¦ ¦to¦ ¦have¦ ¦spread¦ ¦f al se¦ ¦information¦ ¦about¦ ¦the¦ ¦virus¦ ¦and¦ ¦the¦ ¦government¦ ' ¦s¦ ¦hand l ing¦ ¦of¦ ¦the¦ ¦c ri sis¦ .
𐋇¦in¦ ¦some¦ ¦countries¦ ,▁ ¦including¦ ¦e g y p t¦ ,▁ ¦t ur k e y¦ ,▁ ¦and¦ ¦th ai land¦ ,▁ ¦o pp os ition¦ ¦activ i sts¦ ¦and¦ ¦government¦ ¦crit ics¦ ¦have¦ ¦been¦ ¦arr ested¦ ¦for¦ ¦al le g ed ly¦ ¦sprea ding¦ ¦fa ke¦ ¦new s¦ ¦about¦ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ .
𐋇¦in¦ ¦ind ia¦ ,▁ ¦jo ur na li sts¦ ¦crit ic ising¦ ¦the¦ ¦government¦ ' ¦s¦ ¦response¦ ¦were¦ ¦arr ested¦ ¦or¦ ¦issued¦ ¦w ar n ings¦ ¦by¦ ¦pol ice¦ ¦and¦ ¦author ities¦ .
𐋇 ¦r ates¦ ¦of¦ ¦imp r is o ned¦ ¦or¦ ¦de ta ined¦ ¦jo ur na li sts¦ ¦increased¦ ¦worldwide¦ ,▁ ¦with¦ ¦some¦ ¦being¦ ¦related¦ ¦to¦ ¦the¦ ¦pandemic¦ .
𐋇¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ ¦has¦ ¦dis ru p ted¦ ¦ag r ic ult ural¦ ¦and¦ ¦food¦ ¦sys tems¦ ¦worldwide¦ .
𐋇¦covid¦ - ¦19¦ ¦hi t¦ ¦at¦ ¦a¦ ¦time¦ ¦when¦ ¦h u nger¦ ¦or¦ ¦under no ur is h ment¦ ¦was¦ ¦o nce¦ ¦ag a in¦ ¦on¦ ¦the¦ ¦r ise¦ ¦in¦ ¦the¦ ¦world¦ ,▁ ¦with¦ ¦an¦ ¦estim ated¦ ¦6 9 0¦ ¦million¦ ¦people¦ ¦al rea dy¦ ¦go ing¦ ¦h u ng ry¦ ¦in¦ ¦2019¦ .
𐋇 ¦based¦ ¦on¦ ¦the¦ ¦l at est¦ ¦u n¦ ¦estim ates¦ ,▁ ¦the¦ ¦ec onomic¦ ¦rece ssion¦ ¦t ri gg ered¦ ¦by¦ ¦the¦ ¦pandemic¦ ¦may¦ ¦l ead¦ ¦to¦ ¦another¦ ¦8 3¦ ¦million¦ ¦people¦ ,▁ ¦and¦ ¦p os si b ly¦ ¦as¦ ¦many¦ ¦as¦ ¦1 3 2¦ ¦million¦ ,▁ ¦go ing¦ ¦h u ng ry¦ ¦in¦ ¦2020¦ .
𐋇¦this¦ ¦is¦ ¦main ly¦ ¦due¦ ¦to¦ ¦a¦ ¦l ack¦ ¦of¦ ¦acc ess¦ ¦to¦ ¦food¦ ▁–▁ ¦l in ked¦ ¦to¦ ¦fa lling¦ ¦inc omes¦ ,▁ ¦l ost¦ ¦rem it t an ces¦ ¦and¦ ,▁ ¦in¦ ¦some¦ ¦cases¦ ,▁ ¦a¦ ¦r ise¦ ¦in¦ ¦food¦ ¦pri ces¦ .
𐋇¦in¦ ¦countries¦ ¦that¦ ¦al rea dy¦ ¦su ff er¦ ¦from¦ ¦high¦ ¦le v els¦ ¦of¦ ¦acute¦ ¦food¦ ¦i ns ec ur ity¦ ,▁ ¦it¦ ¦is¦ ¦no¦ ¦lo nger¦ ¦an¦ ¦i ss ue¦ ¦of¦ ¦acc ess¦ ¦to¦ ¦food¦ ¦al one¦ ,▁ ¦but¦ ¦inc rea si ng ly¦ ¦also¦ ¦one¦ ¦of¦ ¦food¦ ¦produc t ion¦ .
𐋇¦the¦ ¦pandemic¦ ,▁ ¦a lo ng side¦ ¦loc k d ow ns¦ ¦and¦ ¦travel¦ ¦restrictions¦ ,▁ ¦has¦ ¦prev ented¦ ¦mo ve ment¦ ¦of¦ ¦a id¦ ¦and¦ ¦g re at ly¦ ¦impac ted¦ ¦food¦ ¦produc t ion¦ .
𐋇¦as¦ ¦a¦ ¦result¦ ,▁ ¦several¦ ¦fa m ines¦ ¦are¦ ¦for ec ast¦ ,▁ ¦which¦ ¦the¦ ¦u n¦ ¦called¦ ¦a¦ ¦c ri sis¦ ▁" ¦of¦ ¦bi bl ical¦ ¦prop or tions¦ , "▁ ¦or¦ ▁" ¦h u nger¦ ¦pandemic¦ . "▁ 𐋇¦it¦ ¦is¦ ¦estim ated¦ ¦that¦ ¦without¦ ¦inter vention¦ ¦30¦ ¦million¦ ¦people¦ ¦may¦ ¦di e¦ ¦of¦ ¦h u nger¦ ,▁ ¦with¦ ¦o x f am¦ ¦rep orting¦ ¦that¦ ▁" ¦12¦ , ¦000¦ ¦people¦ ¦per¦ ¦day¦ ¦could¦ ¦di e¦ ¦from¦ ¦covid¦ - ¦19¦ ¦l in ked¦ ¦h u nger¦ "▁ ¦by¦ ¦the¦ ¦end¦ ¦of¦ ¦2020¦ .
𐋇¦this¦ ¦pandemic¦ ,▁ ¦in¦ ¦con j un ction¦ ¦with¦ ¦the¦ ¦2019¦ ▁–▁ ¦2021¦ ¦loc ust¦ ¦inf e st ations¦ ¦and¦ ¦several¦ ¦o ng o ing¦ ¦ar med¦ ¦conf l ic ts¦ ,▁ ¦is¦ ¦pr ed ic ted¦ ¦to¦ ¦for m¦ ¦the¦ ¦wor s t¦ ¦ser ies¦ ¦of¦ ¦fa m ines¦ ¦since¦ ¦the¦ ¦g re at¦ ¦chinese¦ ¦fa m ine¦ ,▁ ¦aff ecting¦ ¦between¦ ¦10¦ ¦and¦ ¦20¦ ¦per¦ ¦c ent¦ ¦of¦ ¦the¦ ¦global¦ ¦population¦ ¦in¦ ¦some¦ ¦way¦ .
¦5 5¦ ¦countries¦ ¦are¦ ¦reported¦ ¦to¦ ¦be¦ ¦at¦ ¦risk¦ ,▁ ¦with¦ ¦three¦ ¦do z en¦ ¦s uc c u mb ing¦ ¦to¦ ¦c ri sis¦ - ¦level¦ ¦fa m ines¦ ¦or¦ ¦a bo ve¦ ¦in¦ ¦the¦ ¦wor s t¦ - ¦case¦ ¦s ce na ri o¦ .
¦2 6 5¦ ¦million¦ ¦people¦ ¦are¦ ¦for ec ast¦ ¦to¦ ¦be¦ ¦in¦ ¦fa m ine¦ ¦conditions¦ ,▁ ¦an¦ ¦increase¦ ¦of¦ ¦1 2 5¦ ¦million¦ ¦due¦ ¦to¦ ¦the¦ ¦pandemic¦ .
𐋇¦the¦ ¦pandemic¦ ¦has¦ ¦se ver ely¦ ¦impac ted¦ ¦e duc a tional¦ ¦sys tems¦ ¦gl ob ally¦ .
𐋇 ¦most¦ ¦gover n ments¦ ¦have¦ ¦temp o ra ri ly¦ ¦closed¦ ¦e duc a tional¦ ¦inst itu tions¦ ,▁ ¦with¦ ¦many¦ ¦sw it c hing¦ ¦to¦ ¦online¦ ¦education¦ .
𐋇¦as¦ ¦of¦ ¦se p te mber¦ ¦2020¦ ,▁ ¦appro xi ma tely¦ ¦1¦ . ¦0 7 7¦ ¦bi ll ion¦ ¦lear n ers¦ ¦were¦ ¦affected¦ ¦due¦ ¦to¦ ¦school¦ ¦closures¦ ¦in¦ ¦response¦ ¦to¦ ¦the¦ ¦pandemic¦ .
𐋇 ¦according¦ ¦to¦ ¦uni ce f¦ ¦monit or ing¦ ,▁ ¦as¦ ¦of¦ ¦march¦ ¦2020¦ ,▁ ¦5 3¦ ¦countries¦ ¦had¦ ¦closed¦ ¦all¦ ¦schools¦ ¦and¦ ¦2 7¦ ¦some¦ ,▁ ¦impac ting¦ ¦about¦ ¦6 1¦ . ¦6¦ ¦per¦ ¦c ent¦ ¦of¦ ¦the¦ ¦world¦ ' ¦s¦ ¦st ud ent¦ ¦population¦ .
𐋇 ¦school¦ ¦closures¦ ¦impac t¦ ¦not¦ ¦only¦ ¦students¦ ,▁ ¦t ea ch ers¦ ,▁ ¦and¦ ¦fa m il ies¦ ¦but¦ ¦have¦ ¦fa r¦ - ¦re ac hing¦ ¦ec onomic¦ ¦and¦ ¦s oc i et al¦ ¦con se qu en ces¦ .
𐋇¦they¦ ¦sh ed¦ ¦l ight¦ ¦on¦ ¦social¦ ¦and¦ ¦ec onomic¦ ¦i ss ues¦ ,▁ ¦including¦ ¦st ud ent¦ ¦de b t¦ ,▁ ¦d ig it al¦ ¦learning¦ ,▁ ¦food¦ ¦i ns ec ur ity¦ ,▁ ¦and¦ ¦ho me le ss ness¦ ,▁ ¦as¦ ¦well¦ ¦as¦ ¦acc ess¦ ¦to¦ ¦ch ild c are¦ ,▁ ¦health¦ ¦care¦ ,▁ ¦ho us ing¦ ,▁ ¦inter n et¦ ,▁ ¦and¦ ¦dis a bility¦ ¦services¦ .
𐋇¦the¦ ¦impac t¦ ¦has¦ ¦been¦ ¦more¦ ¦severe¦ ¦for¦ ¦dis a d v an ta ged¦ ¦children¦ ¦and¦ ¦their¦ ¦fa m il ies¦ .▁ [ 𐋇¦c it ation¦ ¦nee ded¦ ]
𐋇¦the¦ ¦higher¦ ¦education¦ ¦pol ic y¦ ¦inst it ute¦ ¦con duc ted¦ ¦a¦ ¦report¦ ¦which¦ ¦dis covered¦ ¦that¦ ¦around¦ ¦6 3¦ %▁ ¦of¦ ¦students¦ ¦cl ai med¦ ¦that¦ ¦their¦ ¦me ntal¦ ¦health¦ ¦had¦ ¦been¦ ¦wor se ned¦ ¦as¦ ¦a¦ ¦result¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ ,▁ ¦and¦ ¦a lo ng side¦ ¦this¦ ¦3 8¦ %▁ ¦dem on str ated¦ ¦s at is fa ction¦ ¦with¦ ¦the¦ ¦acc es si bility¦ ¦of¦ ¦me ntal¦ ¦health¦ ¦services¦ .
𐋇¦d esp ite¦ ¦this¦ ,▁ ¦the¦ ¦dir ector¦ ¦for¦ ¦pol ic y¦ ¦and¦ ¦ad v oc acy¦ ¦at¦ ¦the¦ ¦inst it ute¦ ¦has¦ ¦exp la ined¦ ¦that¦ ¦it¦ ¦is¦ ¦still¦ ¦u nc l ear¦ ¦as¦ ¦to¦ ¦how¦ ¦and¦ ¦when¦ ¦n orm ality¦ ¦will¦ ¦res u me¦ ¦for¦ ¦students¦ ¦reg ar ding¦ ¦their¦ ¦education¦ ¦and¦ ¦li ving¦ ¦s itu ation¦ .
𐋇¦the¦ ¦pandemic¦ ¦has¦ ¦had¦ ¦many¦ ¦impac ts¦ ¦on¦ ¦global¦ ¦health¦ ¦be y on d¦ ¦those¦ ¦caused¦ ¦by¦ ¦the¦ ¦covid¦ - ¦19¦ ¦disease¦ ¦ it s el f¦ .
𐋇¦it¦ ¦has¦ ¦l ed¦ ¦to¦ ¦a¦ ¦reduc t ion¦ ¦in¦ ¦hospital¦ ¦visi ts¦ ¦for¦ ¦other¦ ¦re as ons¦ .
𐋇¦there¦ ¦have¦ ¦been¦ ¦3 8¦ ¦per¦ ¦c ent¦ ¦fe w er¦ ¦hospital¦ ¦visi ts¦ ¦for¦ ¦h ear t¦ ¦att ack¦ ¦symptoms¦ ¦in¦ ¦the¦ ¦united¦ ¦states¦ ¦and¦ ¦4 0¦ ¦per¦ ¦c ent¦ ¦fe w er¦ ¦in¦ ¦s pa in¦ .
𐋇¦the¦ ¦h ead¦ ¦of¦ ¦car di ology¦ ¦at¦ ¦the¦ ¦univers ity¦ ¦of¦ ¦ar iz o na¦ ¦said¦ , ▁" ¦m y¦ ¦wor ry¦ ¦is¦ ¦some¦ ¦of¦ ¦these¦ ¦people¦ ¦are¦ ¦d ying¦ ¦at¦ ¦home¦ ¦because¦ ¦they¦ ' ¦r e¦ ¦to o¦ ¦sc ared¦ ¦to¦ ¦go¦ ¦to¦ ¦the¦ ¦hospital¦ . "▁ 𐋇¦there¦ ¦is¦ ¦also¦ ¦concer n¦ ¦that¦ ¦people¦ ¦with¦ ¦st ro k es¦ ¦and¦ ¦app end ic itis¦ ¦are¦ ¦not¦ ¦s ee king¦ ¦t im ely¦ ¦treatment¦ .
𐋇 ¦sh or ta ges¦ ¦of¦ ¦medical¦ ¦supp l ies¦ ¦have¦ ¦impac ted¦ ¦people¦ ¦with¦ ¦v ar ious¦ ¦conditions¦ .
𐋇¦in¦ ¦several¦ ¦countries¦ ¦there¦ ¦has¦ ¦been¦ ¦a¦ ¦mark ed¦ ¦reduc t ion¦ ¦of¦ ¦spread¦ ¦of¦ ¦se x ually¦ ¦transm it ted¦ ¦infections¦ ,▁ ¦including¦ ¦h iv ¦ ▁/▁ ¦ ai ds¦ ,▁ ¦att rib ut able¦ ¦to¦ ¦covid¦ - ¦19¦ ¦qu ara nt ines¦ ,▁ ¦social¦ ¦distancing¦ ¦measures¦ ,▁ ¦and¦ ¦recomm end ations¦ ¦to¦ ¦not¦ ¦e ng age¦ ¦in¦ ¦c as ual¦ ¦se x¦ .
𐋇¦s im il arly¦ ,▁ ¦in¦ ¦some¦ ¦places¦ ,▁ ¦r ates¦ ¦of¦ ¦transmission¦ ¦of¦ ¦influenza¦ ¦and¦ ¦other¦ ¦respiratory¦ ¦viruses¦ ¦sign ific a ntly¦ ¦dec rea sed¦ ¦during¦ ¦the¦ ¦pandemic¦ .
𐋇¦the¦ ¦pandemic¦ ¦has¦ ¦also¦ ¦ne g at ively¦ ¦impac ted¦ ¦me ntal¦ ¦health¦ ¦gl ob ally¦ ,▁ ¦including¦ ¦increased¦ ¦lo ne li ness¦ ¦res ul ting¦ ¦from¦ ¦social¦ ¦distancing¦ ¦and¦ ¦dep re ssion¦ ¦and¦ ¦do me st ic¦ ¦ vi ol ence¦ ¦from¦ ¦loc k d ow ns¦ .
𐋇¦as¦ ¦of¦ ¦june¦ ¦2020¦ ,▁ ¦4 0¦ %▁ ¦of¦ ¦u¦ . ¦s¦ .▁ ¦ad ul ts¦ ¦were¦ ¦exp er ie ncing¦ ¦ad ver se¦ ¦me ntal¦ ¦health¦ ¦symptoms¦ ,▁ ¦with¦ ¦11¦ %▁ ¦having¦ ¦s eri o us ly¦ ¦consid ered¦ ¦tr ying¦ ¦to¦ ¦k ill¦ ¦the m s el ves¦ ¦in¦ ¦the¦ ¦p ast¦ ¦mon th¦ .
𐋇 ¦pa ying¦ ¦att e nt ion¦ ¦and¦ ¦ta king¦ ¦measures¦ ¦to¦ ¦prevent¦ ¦me ntal¦ ¦health¦ ¦prob le ms¦ ¦and¦ ¦p ost¦ - ¦tra um at ic¦ ¦ str ess¦ ¦syndrome¦ ,▁ ¦partic ul arly¦ ¦in¦ ¦women¦ ,▁ ¦is¦ ¦al rea dy¦ ¦a¦ ¦need¦ .
𐋇¦the¦ ¦worldwide¦ ¦dis ru ption¦ ¦caused¦ ¦by¦ ¦the¦ ¦pandemic¦ ¦has¦ ¦res ul ted¦ ¦in¦ ¦nu me ro us¦ ¦positive¦ ¦eff ects¦ ¦to¦ ¦the¦ ¦en vir on ment¦ ¦and¦ ¦cl im ate¦ .
𐋇¦the¦ ¦global¦ ¦reduc t ion¦ ¦in¦ ¦mod er n¦ ¦human¦ ¦activ ity¦ ¦such¦ ¦as¦ ¦the¦ ¦consid er able¦ ¦dec line¦ ¦in¦ ¦pl an ned¦ ¦travel¦ ¦was¦ ¦co ined¦ ¦an th ro pa use¦ ¦and¦ ¦has¦ ¦caused¦ ¦a¦ ¦large¦ ¦dro p¦ ¦in¦ ¦air ¦ ¦po ll ution¦ ¦and¦ ¦water¦ ¦po ll ution¦ ¦in¦ ¦many¦ ¦regi ons¦ .
𐋇¦in¦ ¦china¦ ,▁ ¦loc k d ow ns¦ ¦and¦ ¦other¦ ¦measures¦ ¦res ul ted¦ ¦in¦ ¦a¦ ¦2 5¦ ¦p erc ent¦ ¦reduc t ion¦ ¦in¦ ¦car b on¦ ¦e m is si ons¦ ¦and¦ ¦50¦ ¦p erc ent¦ ¦reduc t ion¦ ¦in¦ ¦n it r og en¦ ¦o xi des¦ ¦e m is si ons¦ ,▁ ¦which¦ ¦one¦ ¦ ear th¦ ¦sys tems¦ ¦sc ie nt ist¦ ¦estim ated¦ ¦may¦ ¦have¦ ¦sa v ed¦ ¦at¦ ¦least¦ ¦7 7¦ , ¦000¦ ¦l ives¦ ¦over¦ ¦two¦ ¦mon ths¦ .
𐋇 ¦other¦ ¦positive¦ ¦eff ects¦ ¦on¦ ¦the¦ ¦en vir on ment¦ ¦include¦ ¦gover n ance¦ - ¦system¦ - ¦cont ro lled¦ ¦in ve st ments¦ ¦t ow ards¦ ¦a¦ ¦s us ta in able¦ ¦en er g y¦ ¦trans ition¦ ¦and¦ ¦other¦ ¦go als¦ ¦related¦ ¦to¦ ¦en vir on me ntal¦ ¦prote ction¦ ¦such¦ ¦as¦ ¦the¦ ¦european¦ ¦un ion¦ ' ¦s¦ ¦se v en¦ - ¦year¦ ▁ € ¦1¦ ¦t ri ll ion¦ ¦b ud g et¦ ¦prop os al¦ ¦and¦ ▁ € ¦7 5 0¦ ¦bi ll ion¦ ¦reco ve ry¦ ¦pl an¦ ▁" ¦ne xt¦ ¦gener ation¦ ¦eu¦ "▁ ¦which¦ ¦s ee ks¦ ¦to¦ ¦res er ve¦ ¦2 5¦ %▁ ¦of¦ ¦eu¦ ¦sp ending¦ ¦for¦ ¦cl im ate¦ - ¦f ri end ly¦ ¦exp end it ure¦ .
𐋇¦however¦ ,▁ ¦the¦ ¦pandemic¦ ¦has¦ ¦also¦ ¦provid ed¦ ¦cover¦ ¦for¦ ¦ il le g al¦ ¦activ ities¦ ¦such¦ ¦as¦ ¦def o re st ation¦ ¦of¦ ¦the¦ ¦a ma z on¦ ¦ra in for est¦ ¦and¦ ¦increased¦ ¦po ac hing¦ ¦in¦ ¦afr ica¦ .
𐋇¦the¦ ¦hi nd ering¦ ¦of¦ ¦en vir on me ntal¦ ¦di pl om acy¦ ¦eff orts¦ ¦in¦ ¦co mb ination¦ ¦of¦ ¦l ate¦ ¦c ap it al is m¦ ¦also¦ ¦cre ated¦ ¦ec onomic¦ ¦f al lo ut¦ ¦that¦ ¦some¦ ¦pr ed ic t¦ ¦will¦ ¦sl ow¦ ¦in ve st ment¦ ¦in¦ ¦g re en¦ ¦en er g y¦ ¦techn ol og ies¦ .
𐋇 ¦he i gh te ned¦ ¦pre j ud ice¦ ,▁ ¦ x e no ph ob ia¦ ,▁ ¦and¦ ¦r ac is m¦ ¦have¦ ¦been¦ ¦d oc um ented¦ ¦around¦ ¦the¦ ¦world¦ ¦t ow ard¦ ¦people¦ ¦of¦ ¦chinese¦ ¦and¦ ¦e ast¦ ¦a si an¦ ¦d esc ent¦ .
𐋇 ¦rep orts¦ ¦from¦ ¦february¦ ¦2020¦ ▁( ¦when¦ ¦most¦ ¦confirmed¦ ¦cases¦ ¦were¦ ¦conf ined¦ ¦to¦ ¦china¦ )▁ ¦d oc um ented¦ ¦r ac ist¦ ¦sen ti ments¦ ¦exp r es sed¦ ¦in¦ ¦grou ps¦ ¦worldwide¦ ¦about¦ ¦chinese¦ ¦people¦ ▁' ¦d es er ving¦ ' ▁ ¦the¦ ¦virus¦ .
𐋇 ¦chinese¦ ¦people¦ ¦and¦ ¦other¦ ¦a si an¦ ¦p e op les¦ ¦in¦ ¦the¦ ¦united¦ ¦ki ng d om¦ ¦and¦ ¦united¦ ¦states¦ ¦have¦ ¦reported¦ ¦incre as ing¦ ¦le v els¦ ¦of¦ ¦r ac ist¦ ¦ab use¦ ¦and¦ ¦ass a ul ts¦ .
𐋇¦f orm er¦ ¦u¦ . ¦s¦ .▁ ¦pres ident¦ ¦do na ld¦ ¦tr um p¦ ¦was¦ ¦crit ici sed¦ ¦for¦ ¦ref er r ing¦ ¦to¦ ¦the¦ ¦covid¦ - ¦19¦ ¦as¦ ¦the¦ ▁" ¦chinese¦ ¦virus¦ "▁ ¦and¦ ▁" ¦k u ng¦ ¦flu¦ " ,▁ ¦which¦ ¦has¦ ¦been¦ ¦con de m ned¦ ¦as¦ ¦r ac ist¦ ¦and¦ ¦ x e no ph ob ic¦ .
𐋇¦on¦ ¦14¦ ¦march¦ ,▁ ¦an¦ ¦a si an¦ ¦family¦ ,▁ ¦including¦ ¦a¦ ¦two¦ - ¦year¦ - ¦o ld¦ ¦g ir l¦ ,▁ ¦was¦ ¦att ac ked¦ ¦at¦ ¦k n if e p o in t¦ ¦in¦ ¦te x a s¦ ¦in¦ ¦what¦ ¦the¦ ¦f b i¦ ¦has¦ ¦called¦ ¦a¦ ¦covid¦ - ¦19¦ ¦related¦ ¦h ate¦ ¦c ri me¦ .
𐋇 ¦following¦ ¦the¦ ¦pr og re ssion¦ ¦of¦ ¦the¦ ¦outbreak¦ ¦to¦ ¦new¦ ¦h ot s p ot¦ ¦countries¦ ,▁ ¦people¦ ¦from¦ ¦italy¦ ▁( ¦the¦ ¦first¦ ¦country¦ ¦in¦ ¦e ur ope¦ ¦to¦ ¦exp eri ence¦ ¦a¦ ¦ser ious¦ ¦outbreak¦ ¦of¦ ¦covid¦ - ¦19¦ )▁ ¦were¦ ¦also¦ ¦sub j ected¦ ¦to¦ ¦susp ic ion¦ ¦and¦ ¦ x e no ph ob ia¦ ,▁ ¦as¦ ¦were¦ ¦people¦ ¦from¦ ¦h ot s p o ts¦ ¦in¦ ¦other¦ ¦countries¦ .
𐋇 ¦disc r im ination¦ ¦against¦ ¦m us li ms¦ ¦in¦ ¦ind ia¦ ¦ esc al ated¦ ¦after¦ ¦public¦ ¦health¦ ¦author ities¦ ¦identified¦ ¦an¦ ¦ is la m ic¦ ¦m is si on ary¦ ▁( ¦t ab li gh i¦ ¦j a ma at¦ )▁ ¦group¦ ' ¦s¦ ¦ga th ering¦ ¦in¦ ¦new¦ ¦del h i¦ ¦in¦ ¦early¦ ¦march¦ ¦2020¦ ¦as¦ ¦a¦ ¦sour ce¦ ¦of¦ ¦spread¦ .
𐋇¦as¦ ¦of¦ ¦l ate¦ ¦april¦ ¦2020¦ ,▁ ¦pa ri s¦ ¦had¦ ¦se en¦ ¦ ri o ts¦ ¦brea k¦ ¦out¦ ¦over¦ ¦pol ice¦ ¦treatment¦ ¦of¦ ¦m arg i na li sed¦ ¦e th n ic¦ ¦grou ps¦ ¦during¦ ¦the¦ ¦then¦ ¦in¦ - ¦place¦ ¦lockdown¦ .
𐋇 ¦r ac is m¦ ¦and¦ ¦ x e no ph ob ia¦ ¦t ow ards¦ ¦s ou ther n¦ ¦and¦ ¦south¦ ¦e ast¦ ¦a si ans¦ ¦increased¦ ¦in¦ ¦the¦ ¦ar ab ¦ ¦states¦ ¦of¦ ¦the¦ ¦per si an¦ ¦g ul f¦ .
𐋇 ¦south¦ ¦ko rea¦ ' ¦s¦ ¦l g b t q ¦ ¦community¦ ¦was¦ ¦b la med¦ ¦by¦ ¦some¦ ¦for¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦se ou l¦ .
𐋇¦in¦ ¦china¦ ,▁ ¦some¦ ¦people¦ ¦of¦ ¦afr ic an¦ ¦d esc ent¦ ¦were¦ ¦ev ic ted¦ ¦from¦ ¦their¦ ¦h omes¦ ¦and¦ ¦to ld¦ ¦to¦ ¦lea ve¦ ¦china¦ ¦within¦ ¦24¦ ¦hours¦ ,▁ ¦due¦ ¦to¦ ¦disinf orm ation¦ ¦that¦ ¦they¦ ¦and¦ ¦other¦ ¦fo re i gn ers¦ ¦were¦ ¦sprea ding¦ ¦the¦ ¦virus¦ .
𐋇¦this¦ ¦r ac is m¦ ¦and¦ ¦ x e no ph ob ia¦ ¦was¦ ¦crit ici sed¦ ¦by¦ ¦some¦ ¦fo re ign¦ ¦gover n ments¦ ,▁ ¦di pl om at ic¦ ¦cor ps¦ ,▁ ¦and¦ ¦the¦ ¦chinese¦ ¦a mb a ss a d or¦ ¦to¦ ¦z i mb ab w e¦ .
𐋇 ¦age¦ - ¦based¦ ¦disc r im ination¦ ¦against¦ ¦ ol der¦ ¦ad ul ts¦ ,▁ ¦while¦ ¦al rea dy¦ ¦pres ent¦ ¦before¦ ¦the¦ ¦pandemic¦ ,▁ ¦was¦ ¦more¦ ¦prev al ent¦ ¦during¦ ¦the¦ ¦pandemic¦ .
𐋇¦this¦ ¦has¦ ¦been¦ ¦att rib u ted¦ ¦to¦ ¦their¦ ¦per ce iv ed¦ ¦v ul ne ra bility¦ ¦to¦ ¦the¦ ¦virus¦ ¦and¦ ¦sub se qu ent¦ ¦ph ys ical¦ ¦and¦ ¦social¦ ¦isolation¦ ¦measures¦ ,▁ ¦which¦ ,▁ ¦cou pl ed¦ ¦with¦ ¦their¦ ¦al rea dy¦ ¦reduc ed¦ ¦social¦ ¦activ ity¦ ,▁ ¦has¦ ¦increased¦ ¦dep en de ncy¦ ¦on¦ ¦others¦ .
𐋇¦s im il arly¦ ,▁ ¦limi ted¦ ¦d ig it al¦ ¦l it er acy¦ ¦has¦ ¦le f t¦ ¦the¦ ¦el d erly¦ ¦more¦ ¦v ul n er able¦ ¦to¦ ¦the¦ ¦eff ects¦ ¦of¦ ¦isolation¦ ,▁ ¦dep re ssion¦ ,▁ ¦and¦ ¦lo ne li ness¦ .
𐋇¦the¦ ¦pandemic¦ ¦has¦ ¦res ul ted¦ ¦in¦ ¦many¦ ¦people¦ ¦ad ap ting¦ ¦to¦ ¦ma ss ive¦ ¦chan ges¦ ¦in¦ ¦l ife¦ ,▁ ¦from¦ ¦increased¦ ¦inter n et¦ ¦comm er ce¦ ¦activ ity¦ ¦to¦ ¦the¦ ¦j ob ¦ ¦mark et¦ .
𐋇 ¦social¦ ¦distancing¦ ¦has¦ ¦caused¦ ¦increased¦ ¦sa les¦ ¦from¦ ¦large¦ ¦ e¦ - ¦comm er ce¦ ¦comp an ies¦ ¦such¦ ¦as¦ ¦a ma z on¦ ,▁ ¦a li b ab a¦ ,▁ ¦and¦ ¦cou pa ng¦ .
𐋇 ¦online¦ ¦re tail ers¦ ¦in¦ ¦the¦ ¦us¦ ¦p os ted¦ ¦7 9 1¦ . ¦7 0¦ ¦bi ll ion¦ ¦do ll ar s¦ ¦in¦ ¦sa les¦ ¦in¦ ¦2020¦ ,▁ ¦an¦ ¦increase¦ ¦of¦ ¦3 2¦ . ¦4¦ %▁ ¦from¦ ¦5 9 8¦ . ¦0 2¦ ¦bi ll ion¦ ¦do ll ar s¦ ¦from¦ ¦the¦ ¦year¦ ¦before¦ .
𐋇¦the¦ ¦tr end¦ ¦of¦ ¦home¦ ¦de li ve ry¦ ¦or d ers¦ ¦have¦ ¦increased¦ ¦due¦ ¦to¦ ¦the¦ ¦pandemic¦ ,▁ ¦with¦ ¦in door¦ ¦di ning¦ ¦res ta u ra nts¦ ¦sh ut ting¦ ¦down¦ ¦due¦ ¦to¦ ¦lockdown¦ ¦or d ers¦ ¦or¦ ¦low¦ ¦sa les¦ .
𐋇¦h ac k ers¦ ¦and¦ ¦cyb erc ri min als¦ ▁/▁ ¦sc a mm ers¦ ¦have¦ ¦star ted¦ ¦t ar ge ting¦ ¦people¦ ¦due¦ ¦to¦ ¦the¦ ¦ma ss ive¦ ¦chan ges¦ ,▁ ¦with¦ ¦some¦ ¦pr et ending¦ ¦to¦ ¦be¦ ¦par t¦ ¦of¦ ¦the¦ ¦c dc¦ ,▁ ¦and¦ ¦others¦ ¦using¦ ¦different¦ ¦ph is hing¦ ¦s che m es¦ .
𐋇 ¦education¦ ¦worldwide¦ ¦has¦ ¦inc rea si ng ly¦ ¦sh if ted¦ ¦from¦ ¦ph ys ical¦ ¦att end ance¦ ¦to¦ ¦v ide o¦ ¦conf e re ncing¦ ¦app s¦ ¦such¦ ¦as¦ ¦z o om¦ ¦as¦ ¦lockdown¦ ¦measures¦ ¦have¦ ¦res ul ted¦ ¦in¦ ¦schools¦ ¦being¦ ¦for c ed¦ ¦to¦ ¦sh ut¦ ¦down¦ .
𐋇 ¦due¦ ¦to¦ ¦the¦ ¦pandemic¦ ,▁ ¦m ass¦ ¦la y o ff s¦ ¦have¦ ¦occur r ed¦ ¦in¦ ¦the¦ ¦air line¦ ,▁ ¦travel¦ ,▁ ¦hosp it ality¦ ,▁ ¦and¦ ¦some¦ ¦other¦ ¦ind u str ies¦ .
( 𐋇¦there¦ ¦were¦ ¦no¦ ¦signs¦ ¦of¦ ¦p erm an ent¦ ¦reco ve ry¦ ¦as¦ ¦of¦ ¦may¦ ¦2021¦ . )
𐋇 ¦o ng o ing¦ ¦covid¦ - ¦19¦ ¦research¦ ¦is¦ ¦in de x ed¦ ¦and¦ ¦s ear ch able¦ ¦in¦ ¦the¦ ¦n i h ¦ ¦covid¦ - ¦19¦ ¦p ort f o li o¦ .
𐋇¦some¦ ¦new s p ap er¦ ¦a ge nc ies¦ ¦rem oved¦ ¦their¦ ¦online¦ ¦pa y w a lls¦ ¦for¦ ¦some¦ ¦or¦ ¦all¦ ¦of¦ ¦their¦ ¦covid¦ - ¦19¦ - ¦related¦ ¦a rt ic les¦ ¦and¦ ¦po sts¦ ,▁ ¦while¦ ¦sc ie nt if ic¦ ¦publ is h ers¦ ¦made¦ ¦sc ie nt if ic¦ ¦p ap ers¦ ¦related¦ ¦to¦ ¦the¦ ¦outbreak¦ ¦available¦ ¦with¦ ¦open¦ ¦acc ess¦ .
𐋇¦some¦ ¦sc ien ti sts¦ ¦ch ose¦ ¦to¦ ¦share¦ ¦their¦ ¦results¦ ¦qu ick ly¦ ¦on¦ ¦pre p r in t¦ ¦s erv ers¦ ¦such¦ ¦as¦ ¦bi or x iv ¦ .
𐋇 ¦ma ps¦ ¦have¦ ¦pla y ed¦ ¦a¦ ¦k e y¦ ¦ro le¦ ¦in¦ ¦dis se min ating¦ ¦information¦ ¦concer ning¦ ¦the¦ ¦sp at ial¦ ¦d ist rib ution¦ ¦of¦ ¦the¦ ¦disease¦ ,▁ ¦especially¦ ¦with¦ ¦the¦ ¦development¦ ¦of¦ ¦d as h bo ards¦ ¦to¦ ¦pres ent¦ ¦data¦ ¦in¦ ¦n ear¦ ¦re al¦ - ¦time¦ .
𐋇 ¦met ho ds¦ ¦of¦ ¦data¦ ¦v is u al is ation¦ ¦have¦ ¦d ra w n¦ ¦some¦ ¦crit ic is m¦ ,▁ ¦however¦ ,▁ ¦in¦ ¦the¦ ¦over¦ - ¦si mpl ific ation¦ ¦of¦ ¦ ge ogra ph ical¦ ¦p at t er ns¦ ¦indic ated¦ ¦by¦ ¦ch or op le th¦ ¦ma ps¦ ¦that¦ ¦ad op t¦ ¦national¦ ,▁ ¦r at her¦ ¦than¦ ¦local¦ ,▁ ¦ma p¦ ¦sc a les¦ .
𐋇¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ ¦has¦ ¦res ul ted¦ ¦in¦ ¦m is in f orm ation¦ ¦and¦ ¦cons p ir acy¦ ¦the or ies¦ ¦about¦ ¦the¦ ¦sc a le¦ ¦of¦ ¦the¦ ¦pandemic¦ ¦and¦ ¦the¦ ¦orig in¦ ,▁ ¦pre vention¦ ,▁ ¦diagn o sis¦ ,▁ ¦and¦ ¦treatment¦ ¦of¦ ¦the¦ ¦disease¦ .
𐋇¦f al se¦ ¦information¦ ,▁ ¦including¦ ¦int en tional¦ ¦disinf orm ation¦ ,▁ ¦has¦ ¦been¦ ¦spread¦ ¦through¦ ¦social¦ ¦m ed ia¦ ,▁ ¦te xt¦ ¦me ss a ging¦ ,▁ ¦and¦ ¦m ass¦ ¦m ed ia¦ .
𐋇 ¦jo ur na li sts¦ ¦have¦ ¦been¦ ¦arr ested¦ ¦for¦ ¦al le g ed ly¦ ¦sprea ding¦ ¦fa ke¦ ¦new s¦ ¦about¦ ¦the¦ ¦pandemic¦ .
𐋇¦f al se¦ ¦information¦ ¦has¦ ¦also¦ ¦been¦ ¦pro pa g ated¦ ¦by¦ ¦ce le b r ities¦ ,▁ ¦pol it ici ans¦ ,▁ ¦and¦ ¦other¦ ¦pro min ent¦ ¦public¦ ¦f ig ures¦ .
𐋇¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ ¦m is in f orm ation¦ ¦by¦ ¦gover n ments¦ ¦has¦ ¦also¦ ¦been¦ ¦sign ific ant¦ .
𐋇 ¦comm erc ial¦ ¦sc a ms¦ ¦have¦ ¦cl ai med¦ ¦to¦ ¦off er¦ ¦at¦ - ¦home¦ ¦tests¦ ,▁ ¦supp osed¦ ¦pre vent ives¦ ,▁ ¦and¦ ▁" ¦m ir ac le¦ "▁ ¦c ures¦ .
𐋇 ¦several¦ ¦rel ig ious¦ ¦grou ps¦ ¦have¦ ¦cl ai med¦ ¦their¦ ¦f ai th¦ ¦will¦ ¦protect¦ ¦them¦ ¦from¦ ¦the¦ ¦virus¦ .
𐋇 ¦without¦ ¦evidence¦ ,▁ ¦some¦ ¦people¦ ¦have¦ ¦cl ai med¦ ¦the¦ ¦virus¦ ¦is¦ ¦a¦ ¦bi o we ap on¦ ¦acc ide nt ally¦ ¦or¦ ¦de li b erat ely¦ ¦lea ked¦ ¦from¦ ¦a¦ ¦laboratory¦ ,▁ ¦a¦ ¦population¦ ¦control¦ ¦s che me¦ ,▁ ¦the¦ ¦result¦ ¦of¦ ¦a¦ ¦sp y¦ ¦op er ation¦ ,▁ ¦or¦ ¦the¦ ¦ side¦ ¦eff ect¦ ¦of¦ ¦5 g¦ ¦up g ra des¦ ¦to¦ ¦ce ll ular¦ ¦n et w or ks¦ .
𐋇¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ▁( ¦who¦ )▁ ¦decl ared¦ ¦an¦ ▁" ¦inf o de m ic¦ "▁ ¦of¦ ¦inc or r ect¦ ¦information¦ ¦about¦ ¦the¦ ¦virus¦ ¦that¦ ¦po ses¦ ¦r is ks¦ ¦to¦ ¦global¦ ¦health¦ .
𐋇 ¦while¦ ¦b el ief¦ ¦in¦ ¦cons p ir acy¦ ¦the or ies¦ ¦is¦ ¦not¦ ¦a¦ ¦new¦ ¦ph en om en on¦ ,▁ ¦in¦ ¦the¦ ¦con te xt¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ ,▁ ¦this¦ ¦can¦ ¦l ead¦ ¦to¦ ¦ad ver se¦ ¦health¦ ¦eff ects¦ .
𐋇 ¦co gn i tive¦ ¦b ia ses¦ ,▁ ¦such¦ ¦as¦ ¦j u mp ing¦ ¦to¦ ¦co nc lu si ons¦ ¦and¦ ¦conf ir m ation¦ ¦b ia s¦ ,▁ ¦may¦ ¦be¦ ¦l in ked¦ ¦to¦ ¦the¦ ¦occur r ence¦ ¦of¦ ¦cons p ir acy¦ ¦b el ie f s¦ .
¦1¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦1¦ , ¦7 5 4¦ ¦cases¦ ¦and¦ ¦11¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦9 3¦ , ¦5 3 2¦ ¦cases¦ ¦and¦ ¦2¦ , ¦2 4 8¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦case¦ ¦was¦ ¦de¦ - ¦notified¦ .
𐋇 ¦minister¦ ¦for¦ ¦children¦ ,▁ ¦e qu ality¦ ,▁ ¦dis a bility¦ ,▁ ¦in te g r ation¦ ¦and¦ ¦y ou th¦ ¦ro d er ic¦ ¦ o¦ ' ¦g orm an¦ ¦announced¦ ¦that¦ ¦the¦ ¦res um ption¦ ¦of¦ ¦pr e¦ - ¦school¦ ¦pr ogra mm es¦ ¦would¦ ¦be¦ ¦de la y ed¦ ¦until¦ ¦11¦ ¦january¦ ,▁ ¦in¦ ¦ line¦ ¦with¦ ¦the¦ ¦reop ening¦ ¦of¦ ¦pr imary¦ ¦and¦ ¦sec ond ary¦ ¦schools¦ .
¦2¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦3¦ , ¦3 9 4¦ ¦cases¦ ¦and¦ ¦4¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦9 6¦ , ¦9 2 6¦ ¦cases¦ ¦and¦ ¦2¦ , ¦2 5 2¦ ¦deaths¦ .
𐋇¦it¦ ¦was¦ ¦re ve al ed¦ ¦that¦ ¦there¦ ¦were¦ ¦appro xi ma tely¦ ¦9¦ , ¦000¦ ¦positive¦ ¦covid¦ - ¦19¦ ¦tests¦ ¦not¦ ¦y et¦ ¦l og ged¦ ¦on¦ ¦the¦ ¦hse¦ ' ¦s¦ ¦it¦ ¦sys tems¦ ,▁ ¦due¦ ¦to¦ ¦both¦ ¦limi t ations¦ ¦in¦ ¦the¦ ¦so f t w are¦ ;▁ ¦and¦ ¦l ack¦ ¦of¦ ¦staff¦ ¦to¦ ¦ch eck¦ ¦and¦ ¦in p ut¦ ¦detail s¦ ,▁ ¦m ea ning¦ ¦there¦ ¦is¦ ¦an¦ ¦effective¦ ¦ce il ing¦ ¦of¦ ¦appro xi ma tely¦ ¦1¦ , ¦7 00¦ ¦to¦ ¦2¦ , ¦000¦ ¦cases¦ ¦that¦ ¦can¦ ¦be¦ ¦l og ged¦ ¦each¦ ¦day¦ .
𐋇¦the¦ ¦dir ector¦ ¦of¦ ¦the¦ ¦national¦ ¦virus¦ ¦ref er ence¦ ¦laboratory¦ ¦c il li an¦ ¦de¦ ¦g as c u n¦ ¦announced¦ ¦that¦ ¦a¦ ¦further¦ ¦9¦ ¦cases¦ ¦of¦ ¦the¦ ¦uk¦ ¦vari ant¦ ¦of¦ ¦covid¦ - ¦19¦ ¦had¦ ¦been¦ ¦detected¦ ¦in¦ ¦the¦ ¦rep u bl ic¦ ¦of¦ ¦ireland¦ ¦from¦ ¦23¦ ¦december¦ ¦to¦ ¦2 9¦ ¦december¦ ,▁ ¦bringing¦ ¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦identified¦ ¦to¦ ¦16¦ .
¦3¦ ¦january¦ ▁–▁ ¦a¦ ¦further¦ ¦4¦ , ¦9 6 2¦ ¦cases¦ ¦and¦ ¦7¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 0 1¦ , ¦8 8 7¦ ¦cases¦ ¦and¦ ¦2¦ , ¦2 5 9¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦case¦ ¦was¦ ¦de¦ - ¦notified¦ .
¦4¦ ¦january¦ ▁–▁ ¦a¦ ¦further¦ ¦6¦ , ¦1 1 0¦ ¦cases¦ ¦and¦ ¦6¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 0 7¦ , ¦9 9 7¦ ¦cases¦ ¦and¦ ¦2¦ , ¦2 6 5¦ ¦deaths¦ .
¦5¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦5¦ , ¦3 2 5¦ ¦cases¦ ¦and¦ ¦1 7¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 1 3¦ , ¦3 2 2¦ ¦cases¦ ¦and¦ ¦2¦ , ¦2 8 2¦ ¦deaths¦ .
𐋇¦a¦ ¦9 5¦ - ¦year¦ - ¦o ld¦ ¦wom an¦ ¦bec a me¦ ¦the¦ ¦first¦ ¦nu rs ing¦ ¦home¦ ¦res ident¦ ¦in¦ ¦the¦ ¦rep u bl ic¦ ¦of¦ ¦ireland¦ ¦to¦ ¦receive¦ ¦the¦ ¦p f iz er¦ ▁/▁ ¦bi on te ch¦ ¦covid¦ - ¦19¦ ¦vaccine¦ .
𐋇 ¦an¦ ¦infectious¦ ¦diseases¦ ¦cons ult ant¦ ¦bec a me¦ ¦the¦ ¦first¦ ¦healthcare¦ ¦work er¦ ¦in¦ ¦the¦ ¦ma ter¦ ¦univers ity¦ ¦hospital¦ ¦to¦ ¦receive¦ ¦the¦ ¦covid¦ - ¦19¦ ¦vaccine¦ .
𐋇 ¦ta o is ea ch¦ ¦mi che á l¦ ¦ma rt in¦ ¦announced¦ ¦that¦ ¦up¦ ¦to¦ ¦1 3 5¦ , ¦000¦ ¦people¦ ¦would¦ ¦be¦ ¦vaccinated¦ ¦na tion w ide¦ ¦by¦ ¦the¦ ¦end¦ ¦of¦ ¦february¦ ¦2021¦ .
𐋇¦the¦ ¦ir ish¦ ¦pr is on¦ ¦service¦ ¦announced¦ ¦that¦ ¦five¦ ¦pr is on ers¦ ¦in¦ ¦l ou gh an¦ ¦house¦ ¦open¦ ¦centre¦ ¦in¦ ¦county¦ ¦ca v an¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ .
¦6¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦7¦ , ¦8 3 6¦ ¦cases¦ ¦and¦ ¦1 7¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 21¦ , ¦1 5 4¦ ¦cases¦ ¦and¦ ¦2¦ , ¦2 9 9¦ ¦deaths¦ .
¦4¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦government¦ ¦of¦ ¦ireland¦ ¦ag re ed¦ ¦a¦ ¦number¦ ¦of¦ ¦new¦ ¦lockdown¦ ¦measures¦ ¦including¦ ¦the¦ ¦cl osure¦ ¦of¦ ¦all¦ ¦schools¦ ¦until¦ ¦february¦ ¦with¦ ¦lea ving¦ ¦ce rt ific ate¦ ¦students¦ ¦all owed¦ ¦to¦ ¦att end¦ ¦school¦ ¦for¦ ¦three¦ ¦days¦ ¦a¦ ¦week¦ ,▁ ¦the¦ ¦cl osure¦ ¦of¦ ¦all¦ ¦non¦ - ¦essential¦ ¦con st ru ction¦ ¦si tes¦ ¦with¦ ¦c er tain¦ ¦ex cep tions¦ ¦at¦ ¦6 p m¦ ¦on¦ ¦8¦ ¦january¦ ,▁ ¦the¦ ¦requir e ment¦ ¦from¦ ¦9¦ ¦january¦ ¦for¦ ¦all¦ ¦p as se ng ers¦ ¦from¦ ¦the¦ ¦uk¦ ¦and¦ ¦south¦ ¦afr ica¦ ¦to¦ ¦have¦ ¦a¦ ¦negative¦ ¦p c r¦ ¦test¦ ¦that¦ ¦they¦ ¦ac qu ir ed¦ ¦within¦ ¦7 2¦ ¦hours¦ ¦of¦ ¦tra ve lling¦ ¦and¦ ¦the¦ ¦pro hi b ition¦ ¦of¦ ¦cl ick¦ - ¦and¦ - ¦coll ect¦ ¦services¦ ¦for¦ ¦non¦ - ¦essential¦ ¦re ta il¦ .
𐋇 ¦following¦ ¦the¦ ¦appr ov al¦ ¦of¦ ¦the¦ ¦mod er na¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦by¦ ¦the¦ ¦european¦ ¦medic ines¦ ¦a ge ncy¦ ¦on¦ ¦6¦ ¦january¦ ¦2021¦ ,▁ ¦t á na ist e¦ ¦le o¦ ¦v a rad k a r¦ ¦announced¦ ¦that¦ ¦the¦ ¦vaccine¦ ¦would¦ ¦all ow¦ ¦10¦ , ¦000¦ ¦more¦ ¦people¦ ¦in¦ ¦ireland¦ ¦to¦ ¦be¦ ¦vaccinated¦ ¦per¦ ¦week¦ .
𐋇¦it¦ ¦was¦ ¦announced¦ ¦that¦ ¦minister¦ ¦for¦ ¦j u st ice¦ ¦h el en¦ ¦m c en te e¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ .
¦7¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦6¦ , ¦5 21¦ ¦cases¦ ¦and¦ ¦10¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 2 7¦ , ¦6 5 7¦ ¦cases¦ ¦and¦ ¦2¦ , ¦30 7¦ ¦deaths¦ .
¦2¦ ¦previously¦ ¦notified¦ ¦deaths¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦national¦ ¦public¦ ¦health¦ ¦emergency¦ ¦team¦ ¦confirmed¦ ¦that¦ ¦the¦ ¦b ac k lo g¦ ¦of¦ ¦cases¦ ¦due¦ ¦to¦ ¦a¦ ¦del ay¦ ¦in¦ ¦rep orting¦ ¦positive¦ ¦laboratory¦ ¦results¦ ¦have¦ ¦been¦ ¦c le ared¦ .
𐋇¦the¦ ¦government¦ ¦of¦ ¦ireland¦ ¦was¦ ¦for c ed¦ ¦to¦ ¦ab a nd on¦ ¦pl ans¦ ¦for¦ ¦lea ving¦ ¦ce rt ific ate¦ ¦students¦ ¦to¦ ¦att end¦ ¦school¦ ¦on¦ ¦three¦ ¦days¦ ¦a¦ ¦week¦ ,▁ ¦and¦ ¦inst ead¦ ¦students¦ ¦would¦ ¦retur n¦ ¦to¦ ¦h om esc ho ol ing¦ ¦a lo ng¦ ¦with¦ ¦other¦ ¦students¦ ¦until¦ ¦february¦ ,▁ ¦after¦ ¦the¦ ¦associ ation¦ ¦of¦ ¦sec ond ary¦ ¦t ea ch ers¦ ,▁ ¦ireland¦ ▁( ¦a st i¦ )▁ ¦dir ected¦ ¦its¦ ¦me mbers¦ ¦not¦ ¦to¦ ¦retur n¦ ¦to¦ ¦in¦ - ¦school¦ ¦te ac hing¦ .
𐋇¦the¦ ¦r ol lo ut¦ ¦of¦ ¦the¦ ¦p f iz er¦ ▁/▁ ¦bi on te ch¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦in¦ ¦priv ate¦ ¦and¦ ¦v o lu nt ary¦ ¦nu rs ing¦ ¦h omes¦ ¦beg an¦ ¦na tion w ide¦ ,▁ ¦with¦ ¦2 2¦ ¦nu rs ing¦ ¦h omes¦ ¦of¦ ¦3¦ , ¦000¦ ¦res id ents¦ ¦and¦ ¦staff¦ ¦to¦ ¦be¦ ¦vaccinated¦ .
𐋇¦t á na ist e¦ ¦le o¦ ¦v a rad k a r¦ ¦announced¦ ¦that¦ ¦the¦ ¦government¦ ¦would¦ ¦consid er¦ ¦b an ning¦ ¦the¦ ¦sa le¦ ¦of¦ ¦al c o ho l¦ ¦after¦ ¦a¦ ¦c er tain¦ ¦time¦ ¦in¦ ¦a¦ ¦day¦ ,▁ ¦while¦ ¦all¦ ¦p ub s¦ ,▁ ¦res ta u ra nts¦ ¦and¦ ¦other¦ ¦b us in es ses¦ ¦were¦ ¦s et¦ ¦to¦ ¦remain¦ ¦closed¦ ¦until¦ ¦april¦ .
¦8¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦8¦ , ¦2 4 8¦ ¦cases¦ ▁( ¦the¦ ¦high est¦ ¦number¦ ¦of¦ ¦confirmed¦ ¦cases¦ ¦recor ded¦ ¦in¦ ¦a¦ ¦si ng le¦ ¦day¦ ¦since¦ ¦the¦ ¦pandemic¦ ¦beg an¦ )▁ ¦and¦ ¦20¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 3 5¦ , ¦8 8 4¦ ¦cases¦ ¦and¦ ¦2¦ , ¦3 2 7¦ ¦deaths¦ .
¦ 21¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦in¦ ¦a¦ ¦sta te ment¦ ¦from¦ ¦the¦ ¦national¦ ¦public¦ ¦health¦ ¦emergency¦ ¦team¦ ,▁ ¦ch ief¦ ¦medical¦ ¦offic er¦ ¦t on y¦ ¦ho lo h an¦ ¦confirmed¦ ¦that¦ ¦three¦ ¦cases¦ ¦of¦ ¦the¦ ¦south¦ ¦afr ic an¦ ¦vari ant¦ ¦of¦ ¦covid¦ - ¦19¦ ¦had¦ ¦been¦ ¦detected¦ ¦in¦ ¦the¦ ¦rep u bl ic¦ ¦of¦ ¦ireland¦ ¦by¦ ¦w ho le¦ ¦gen ome¦ ¦se qu e ncing¦ ¦associated¦ ¦with¦ ¦travel¦ ¦from¦ ¦south¦ ¦afr ica¦ .
¦9¦ ¦january¦ ▁–▁ ¦a¦ ¦further¦ ¦4¦ , ¦8 2 4¦ ¦cases¦ ▁( ¦including¦ ¦1¦ ¦prob able¦ ¦case¦ )▁ ¦and¦ ¦9¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 4 0¦ , ¦7 2 7¦ ¦cases¦ ¦and¦ ¦2¦ , ¦3 3 6¦ ¦deaths¦ .
¦10¦ ¦january¦ ▁–▁ ¦a¦ ¦further¦ ¦6¦ , ¦8 8 8¦ ¦cases¦ ¦and¦ ¦8¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 4 7¦ , ¦6 1 3¦ ¦cases¦ ¦and¦ ¦2¦ , ¦3 4 4¦ ¦deaths¦ .
¦2¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦11¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦4¦ , ¦9 2 9¦ ¦cases¦ ¦and¦ ¦8¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 5 2¦ , ¦5 3 9¦ ¦cases¦ ¦and¦ ¦2¦ , ¦3 5 2¦ ¦deaths¦ .
¦3¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦p ur ch ase¦ ¦of¦ ¦al c o ho l¦ ¦with¦ ¦su p erm ar k et¦ ¦v ou ch ers¦ ¦as¦ ¦well¦ ¦as¦ ¦a¦ ¦number¦ ¦of¦ ¦mult i¦ - ¦bu y¦ ¦s che m es¦ ¦were¦ ¦b an ned¦ ¦under¦ ¦new¦ ¦le g is l ation¦ ¦that¦ ¦ca me¦ ¦into¦ ¦eff ect¦ .
𐋇¦f ig ures¦ ¦re ve al ed¦ ¦by¦ ¦the¦ ¦our¦ ¦world¦ ¦in¦ ¦data¦ ¦or g an is ation¦ ¦sh owed¦ ¦that¦ ¦ireland¦ ¦had¦ ¦the¦ ¦high est¦ ¦daily¦ ¦number¦ ¦of¦ ¦new¦ ¦confirmed¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦in¦ ¦the¦ ¦world¦ ¦for¦ ¦every¦ ¦million¦ ¦people¦ .
𐋇 ¦gardaí¦ ¦received¦ ¦new¦ ¦covid¦ - ¦19¦ ¦en for ce ment¦ ¦p ow ers¦ ,▁ ¦including¦ ¦the¦ ¦p ower¦ ¦to¦ ¦f ine¦ ¦people¦ ▁ € ¦100¦ ¦in¦ ¦brea ch¦ ¦in¦ ¦the¦ ¦5¦ ¦k m¦ ¦travel¦ ¦limi t¦ .
¦12¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦3¦ , ¦0 8 6¦ ¦cases¦ ¦and¦ ¦4 6¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 5 5¦ , ¦5 9 1¦ ¦cases¦ ¦and¦ ¦2¦ , ¦3 9 7¦ ¦deaths¦ .
¦3 4¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦government¦ ¦of¦ ¦ireland¦ ¦ag re ed¦ ¦that¦ ¦all¦ ¦p as se ng ers¦ ¦ar ri ving¦ ¦into¦ ¦ireland¦ ¦would¦ ¦need¦ ¦a¦ ¦negative¦ ¦p c r¦ ¦covid¦ - ¦19¦ ¦test¦ ¦ta k en¦ ¦7 2¦ ¦hours¦ ¦before¦ ¦de pa rt ure¦ ¦from¦ ¦s at ur day¦ ¦16¦ ¦january¦ .
𐋇¦the¦ ¦first¦ ¦sh ip ment¦ ¦of¦ ¦the¦ ¦mod er na¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦arr iv ed¦ ¦in¦ ¦the¦ ¦rep u bl ic¦ ¦of¦ ¦ireland¦ .
𐋇¦the¦ ¦ir ish¦ ¦pr is on¦ ¦service¦ ¦announced¦ ¦that¦ ¦three¦ ¦pr is on ers¦ ¦in¦ ¦p ort la o ise¦ ¦and¦ ¦m ou nt j o y¦ ¦pr is ons¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ .
¦13¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦3¦ , ¦5 6 9¦ ¦cases¦ ¦and¦ ¦6 3¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 5 9¦ , ¦1 4 4¦ ¦cases¦ ¦and¦ ¦2¦ , ¦4 6 0¦ ¦deaths¦ .
¦16¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦ir ish¦ ¦n ur ses¦ ¦and¦ ¦m id w ives¦ ¦or g an is ation¦ ▁( ¦in m o¦ )▁ ¦called¦ ¦for¦ ¦the¦ ¦government¦ ¦to¦ ¦decl are¦ ¦a¦ ¦national¦ ¦emergency¦ ¦and¦ ¦for¦ ¦all¦ ¦priv ate¦ ¦hospital¦ ¦c ap ac ity¦ ¦to¦ ¦be¦ ¦f ul ly¦ ¦na tion a li sed¦ ¦into¦ ¦the¦ ¦public¦ ¦healthcare¦ ¦system¦ ¦as¦ ¦the¦ ¦number¦ ¦of¦ ¦hosp it al is ations¦ ¦d ou bl ed¦ ¦the¦ ¦p ea k¦ ¦of¦ ¦april¦ ¦2020¦ .
¦14¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦3¦ , ¦9 5 5¦ ¦cases¦ ¦and¦ ¦2 8¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 6 3¦ , ¦0 5 7¦ ¦cases¦ ¦and¦ ¦2¦ , ¦4 8 8¦ ¦deaths¦ .
¦4 2¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦gardaí¦ ¦issued¦ ¦2 9¦ ¦fines¦ ¦to¦ ¦people¦ ¦brea c hing¦ ¦the¦ ¦5¦ ¦k m¦ ¦travel¦ ¦limi t¦ ¦over¦ ¦the¦ ¦prev ious¦ ¦7¦ ¦days¦ ¦including¦ ¦three¦ ¦people¦ ¦who¦ ¦tra ve lled¦ ¦8 0¦ ¦k m¦ ¦to¦ ▁" ¦coll ect¦ ¦b ur g ers¦ ¦from¦ ¦a¦ ¦ta k ea w ay¦ "▁ ¦in¦ ¦ ri ng s end¦ ,▁ ¦dublin¦ .
𐋇¦the¦ ¦national¦ ¦transport¦ ¦author ity¦ ¦announced¦ ¦that¦ ¦reduc ed¦ ¦t im et ab les¦ ¦for¦ ¦b us¦ ¦op erat ors¦ ¦in¦ ¦dublin¦ ▁( ¦including¦ ¦dublin¦ ¦b us¦ ¦and¦ ¦go¦ - ¦a h ead¦ ¦ireland¦ )▁ ¦would¦ ¦recomm ence¦ ¦from¦ ¦mon day¦ ¦18¦ ¦january¦ ¦and¦ ¦would¦ ¦ ru n¦ ¦at¦ ¦8 0¦ %▁ ¦c ap ac ity¦ .
¦15¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦3¦ , ¦4 9 8¦ ¦cases¦ ¦and¦ ¦50¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 6 6¦ , ¦5 4 8¦ ¦cases¦ ¦and¦ ¦2¦ , ¦5 3 6¦ ¦deaths¦ .
¦7¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦ch ief¦ ¦medical¦ ¦offic ers¦ ¦of¦ ¦ireland¦ ¦and¦ ¦n or ther n¦ ¦ireland¦ ¦t on y¦ ¦ho lo h an¦ ¦and¦ ¦mi ch a e l¦ ¦m c b r ide¦ ¦issued¦ ¦a¦ ¦jo in t¦ ¦sta te ment¦ ¦ ur ging¦ ¦e veryone¦ ¦to¦ ¦stay¦ ¦at¦ ¦home¦ .
¦16¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦3¦ , ¦2 3 1¦ ¦cases¦ ¦and¦ ¦6 0¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 6 9¦ , ¦7 8 0¦ ¦cases¦ ¦and¦ ¦2¦ , ¦5 9 5¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦death¦ ¦and¦ ¦7¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦around¦ ¦1¦ , ¦8 00¦ ¦healthcare¦ ¦workers¦ ¦received¦ ¦the¦ ¦mod er na¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦at¦ ¦three¦ ¦m ass¦ ¦vacc ination¦ ¦centr es¦ ¦that¦ ¦op e ned¦ ¦in¦ ¦dublin¦ ,▁ ¦g al w ay¦ ¦and¦ ¦p ort la o ise¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦announced¦ ¦the¦ ¦susp e ns ion¦ ¦of¦ ¦all¦ ¦nu rs ing¦ ¦and¦ ¦m id w if e ry¦ ¦st ud ent¦ ¦pla ce ments¦ ¦for¦ ¦two¦ ¦weeks¦ ¦due¦ ¦to¦ ¦the¦ ¦impac t¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ ¦on¦ ¦sta ff ing¦ ¦le v els¦ .
¦1 7¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦2¦ , ¦9 4 4¦ ¦cases¦ ¦and¦ ¦13¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 7 2¦ , ¦7 2 6¦ ¦cases¦ ¦and¦ ¦2¦ , ¦6 0 8¦ ¦deaths¦ .
𐋇¦the¦ ¦government¦ ¦of¦ ¦ireland¦ ¦re qu ested¦ ¦early¦ ¦de li ver ies¦ ¦of¦ ¦the¦ ¦o x for d¦ ▁–▁ ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦as¦ ¦disc us si ons¦ ¦to¦ ¦sec ure¦ ¦early¦ ¦de li ve ry¦ ¦of¦ ¦the¦ ¦vaccine¦ ¦g ot¦ ¦under w ay¦ .
𐋇¦the¦ ¦ir ish¦ ¦n ur ses¦ ¦and¦ ¦m id w ives¦ ¦or g an is ation¦ ▁( ¦in m o¦ )▁ ¦called¦ ¦for¦ ¦further¦ ¦cl ar ity¦ ¦on¦ ¦the¦ ¦dec is ion¦ ¦to¦ ¦susp end¦ ¦n ur se ry¦ ¦and¦ ¦m id w if e ry¦ ¦st ud ent¦ ¦pla ce ments¦ ¦for¦ ¦two¦ ¦weeks¦ .
¦18¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦2¦ , ¦1 21¦ ¦cases¦ ¦and¦ ¦8¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 7 4¦ , ¦8 4 3¦ ¦cases¦ ¦and¦ ¦2¦ , ¦6 1 6¦ ¦deaths¦ .
¦4¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦number¦ ¦of¦ ¦patients¦ ¦with¦ ¦covid¦ - ¦19¦ ¦being¦ ¦tre ated¦ ¦in¦ ¦hosp it als¦ ¦around¦ ¦the¦ ¦country¦ ¦rea ched¦ ¦a¦ ¦recor d¦ ¦2¦ , ¦0 2 3¦ ,▁ ¦with¦ ¦2 00¦ ¦in¦ ¦ ic us¦ ¦and¦ ¦over¦ ¦4 00¦ ¦people¦ ¦rece i ving¦ ¦high¦ - ¦g ra de¦ ¦ ventil ation¦ ¦and¦ ¦respiratory¦ ¦support¦ .
¦19¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦2¦ , ¦0 0 1¦ ¦cases¦ ¦and¦ ¦9 3¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 7 6¦ , ¦8 3 9¦ ¦cases¦ ¦and¦ ¦2¦ , ¦7 0 8¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦death¦ ¦and¦ ¦5¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦government¦ ¦of¦ ¦ireland¦ ¦was¦ ¦for c ed¦ ¦to¦ ¦ab a nd on¦ ¦pl ans¦ ¦to¦ ¦reop en¦ ¦spec ial¦ ¦schools¦ ¦on¦ ¦th u rs day¦ ¦ 21¦ ¦january¦ ¦for¦ ¦t ho us an ds¦ ¦of¦ ¦children¦ ¦with¦ ¦spec ial¦ ¦e duc a tional¦ ¦needs¦ ¦following¦ ¦safety¦ ¦concer ns¦ ¦among¦ ¦staff¦ ¦uni ons¦ .
¦20¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦2¦ , ¦4 8 8¦ ¦cases¦ ¦and¦ ¦6 1¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 7 9¦ , ¦3 2 4¦ ¦cases¦ ¦and¦ ¦2¦ , ¦7 6 8¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦deaths¦ ¦and¦ ¦3¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦s t¦ ¦p at r ick¦ ' ¦s¦ ¦day¦ ¦p ara de¦ ¦in¦ ¦dublin¦ ¦was¦ ¦cance lled¦ ¦for¦ ¦a¦ ¦second¦ ¦year¦ .
¦ 21¦ ¦january¦ ▁–▁ ¦a¦ ¦further¦ ¦2¦ , ¦6 0 8¦ ¦cases¦ ¦and¦ ¦5 1¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 8 1¦ , ¦9 2 2¦ ¦cases¦ ¦and¦ ¦2¦ , ¦8 1 8¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦death¦ ¦was¦ ¦de¦ - ¦notified¦ .
¦2 2¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦2¦ , ¦3 7 1¦ ¦cases¦ ¦and¦ ¦5 2¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 8 4¦ , ¦2 7 9¦ ¦cases¦ ¦and¦ ¦2¦ , ¦8 7 0¦ ¦deaths¦ .
¦14¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦ta o is ea ch¦ ¦mi che á l¦ ¦ma rt in¦ ¦confirmed¦ ¦that¦ ¦there¦ ¦would¦ ¦be¦ ¦no¦ ¦e as ing¦ ¦of¦ ¦level¦ ¦5¦ ¦lockdown¦ ¦restrictions¦ ¦at¦ ¦the¦ ¦end¦ ¦of¦ ¦january¦ ¦and¦ ¦su gg ested¦ ¦the¦ ¦current¦ ¦restrictions¦ ¦would¦ ¦be¦ ¦in¦ ¦place¦ ¦for¦ ¦at¦ ¦least¦ ¦another¦ ¦four¦ ¦weeks¦ .
𐋇 ¦gardaí¦ ¦issued¦ ¦7 7 1¦ ¦fines¦ ¦to¦ ¦people¦ ¦brea c hing¦ ¦the¦ ¦5¦ ¦k m¦ ¦travel¦ ¦limi t¦ ¦since¦ ¦11¦ ¦january¦ ¦with¦ ¦the¦ ¦ma j or ity¦ ¦issued¦ ¦in¦ ¦w ick l ow¦ ,▁ ¦cor k¦ ,▁ ¦la oi s¦ ¦and¦ ¦lo ng for d¦ ,▁ ¦while¦ ¦30¦ ¦fines¦ ¦were¦ ¦issued¦ ¦for¦ ¦the¦ ¦non¦ - ¦w earing¦ ¦of¦ ¦face¦ ¦co ver ings¦ ¦in¦ ¦c er tain¦ ¦loc ations¦ .
𐋇 ¦sp ea king¦ ¦on¦ ¦ rt é ¦ ' ¦s¦ ¦m or ning¦ ¦ireland¦ ,▁ ¦ch ief¦ ¦clinical¦ ¦offic er¦ ¦of¦ ¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦c ol m¦ ¦h en ry¦ ¦stated¦ ¦that¦ ¦covid¦ - ¦19¦ ¦transmission¦ ¦le v els¦ ¦remain¦ ¦to o¦ ¦high¦ ¦for¦ ¦schools¦ ¦to¦ ¦reop en¦ ¦in¦ ¦february¦ .
𐋇¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦confirmed¦ ¦that¦ ¦11¦ ¦res id ents¦ ¦of¦ ¦a¦ ¦nu rs ing¦ ¦home¦ ¦in¦ ¦n or th¦ ¦county¦ ¦dublin¦ ¦d ied¦ ¦after¦ ¦testing¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ .
¦23¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦1¦ , ¦9 1 0¦ ¦cases¦ ¦and¦ ¦7 7¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 8 6¦ , ¦1 8 4¦ ¦cases¦ ¦and¦ ¦2¦ , ¦9 4 7¦ ¦deaths¦ .
¦5¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦sp ea king¦ ¦on¦ ¦ rt é ¦ ' ¦s¦ ¦br end an¦ ¦ o¦ ' ¦con n or¦ ¦pr ogra m me¦ ,▁ ¦ta o is ea ch¦ ¦mi che á l¦ ¦ma rt in¦ ¦stated¦ ¦that¦ ¦covid¦ - ¦19¦ ¦vacc in ations¦ ¦for¦ ¦people¦ ¦over¦ ¦the¦ ¦age¦ ¦of¦ ¦7 0¦ ¦may¦ ¦be¦ ¦de la y ed¦ ¦due¦ ¦to¦ ¦i ss ues¦ ¦with¦ ¦the¦ ¦supp ly¦ ¦of¦ ¦the¦ ¦o x for d¦ ▁–▁ ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ,▁ ¦and¦ ¦also¦ ¦stated¦ ¦that¦ ¦covid¦ - ¦19¦ ¦restrictions¦ ¦would¦ ¦be¦ ¦in¦ ¦place¦ ¦for¦ ¦at¦ ¦least¦ ¦the¦ ¦first¦ ¦si x¦ ¦mon ths¦ ¦of¦ ¦the¦ ¦year¦ ¦and¦ ¦that¦ ¦not¦ ¦all¦ ¦of¦ ¦the¦ ¦1¦ ¦million¦ ¦students¦ ¦na tion w ide¦ ¦would¦ ¦be¦ ¦b ack¦ ¦in¦ ¦school¦ ¦before¦ ¦s t¦ ¦p at r ick¦ ' ¦s¦ ¦day¦ .
¦24¦ ¦january¦ ▁–▁ ¦a¦ ¦further¦ ¦1¦ , ¦3 7 8¦ ¦cases¦ ¦and¦ ¦23¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 8 7¦ , ¦5 5 4¦ ¦cases¦ ¦and¦ ¦2¦ , ¦9 7 0¦ ¦deaths¦ .
¦8¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦2 5¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦1¦ , ¦3 7 2¦ ¦cases¦ ¦and¦ ¦7¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 8 8¦ , ¦9 2 3¦ ¦cases¦ ¦and¦ ¦2¦ , ¦9 7 7¦ ¦deaths¦ .
¦3¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦gardaí¦ ¦w ar ned¦ ¦that¦ ¦fo re ign¦ ¦h ol id ays¦ ¦were¦ ¦not¦ ¦d ee med¦ ¦essential¦ ¦as¦ ¦1¦ , ¦5 00¦ ¦fines¦ ¦were¦ ¦issued¦ ¦to¦ ¦people¦ ¦brea c hing¦ ¦the¦ ¦5¦ ¦k m¦ ¦travel¦ ¦limi t¦ ¦in¦ ¦the¦ ¦prev ious¦ ¦two¦ ¦weeks¦ .
𐋇 ¦minister¦ ¦for¦ ¦health¦ ¦ste ph en¦ ¦d on n el ly¦ ¦announced¦ ¦that¦ ¦community¦ ¦vacc ination¦ ¦of¦ ¦people¦ ¦a ged¦ ¦7 0¦ ¦and¦ ¦over¦ ¦would¦ ¦beg in¦ ¦in¦ ¦m id¦ - ¦february¦ .
𐋇¦a¦ ¦me at¦ ¦pro cess ing¦ ¦pl ant¦ ¦in¦ ¦bu nc lo dy¦ ,▁ ¦county¦ ¦we x for d¦ ¦confirmed¦ ¦4 2¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦following¦ ¦scre ening¦ ¦of¦ ¦all¦ ¦staff¦ ¦on¦ ¦15¦ ¦january¦ .
𐋇¦the¦ ¦gard a¦ ¦s í o ch á na¦ ,▁ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦and¦ ¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦w ar ned¦ ¦the¦ ¦public¦ ¦to¦ ¦be¦ ¦a w are¦ ¦of¦ ¦possible¦ ¦sc am¦ ¦te xt¦ ¦me ss a ges¦ ¦and¦ ¦phone¦ ¦ca lls¦ ¦relating¦ ¦to¦ ¦the¦ ¦covid¦ - ¦19¦ ¦vaccine¦ .
¦26¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦9 2 8¦ ¦cases¦ ¦and¦ ¦9 0¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦1 8 9¦ , ¦8 5 1¦ ¦cases¦ ¦and¦ ¦3¦ , ¦0 6 6¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦death¦ ¦was¦ ¦de¦ - ¦notified¦ .
𐋇¦in¦ ¦a¦ ¦sta te ment¦ ¦from¦ ¦the¦ ¦national¦ ¦public¦ ¦health¦ ¦emergency¦ ¦team¦ ,▁ ¦ch ief¦ ¦medical¦ ¦offic er¦ ¦t on y¦ ¦ho lo h an¦ ¦confirmed¦ ¦that¦ ¦a¦ ¦further¦ ¦6¦ ¦cases¦ ¦of¦ ¦the¦ ¦south¦ ¦afr ic an¦ ¦vari ant¦ ¦of¦ ¦covid¦ - ¦19¦ ¦had¦ ¦been¦ ¦detected¦ ¦in¦ ¦the¦ ¦rep u bl ic¦ ¦of¦ ¦ireland¦ .
𐋇¦the¦ ¦government¦ ¦of¦ ¦ireland¦ ¦announced¦ ¦the¦ ¦ex tens ion¦ ¦of¦ ¦the¦ ¦level¦ ¦5¦ ¦lockdown¦ ¦restrictions¦ ¦until¦ ¦5¦ ¦march¦ ,▁ ¦a lo ng¦ ¦with¦ ¦a¦ ¦number¦ ¦of¦ ¦new¦ ¦measures¦ ¦including¦ ¦a¦ ¦mand atory¦ ¦14¦ - ¦day¦ ¦quarantine¦ ¦period¦ ¦for¦ ¦all¦ ¦people¦ ¦tra ve lling¦ ¦into¦ ¦the¦ ¦country¦ ¦without¦ ¦a¦ ¦negative¦ ¦covid¦ - ¦19¦ ¦test¦ ,▁ ¦including¦ ¦all¦ ¦arr iv als¦ ¦from¦ ¦b ra z il¦ ¦and¦ ¦south¦ ¦afr ica¦ .
𐋇¦the¦ ¦government¦ ¦made¦ ¦the¦ ¦w earing¦ ¦of¦ ¦face¦ ¦co ver ings¦ ¦in¦ ¦all¦ ¦b an ks¦ ,▁ ¦cre di t¦ ¦uni ons¦ ¦and¦ ¦p ost¦ ¦offic es¦ ¦mand atory¦ .
𐋇¦t al ks¦ ¦between¦ ¦the¦ ¦department¦ ¦of¦ ¦education¦ ¦and¦ ¦uni ons¦ ¦contin u ed¦ ¦with¦ ¦h op es¦ ¦that¦ ¦schools¦ ¦would¦ ¦be¦ ¦able¦ ¦to¦ ¦reop en¦ ¦on¦ ¦a¦ ¦ph a sed¦ ¦ba sis¦ ¦between¦ ¦february¦ ¦and¦ ¦march¦ .
¦2 7¦ ¦january¦ ▁–▁ ¦a¦ ¦further¦ ¦1¦ , ¦3 3 5¦ ¦cases¦ ¦and¦ ¦5 4¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦19 1¦ , ¦1 8 2¦ ¦cases¦ ¦and¦ ¦3¦ , ¦1 2 0¦ ¦deaths¦ .
¦4¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦2 8¦ ¦january¦ ▁–▁ ¦a¦ ¦further¦ ¦1¦ , ¦4 6 6¦ ¦cases¦ ¦and¦ ¦4 7¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦19 2¦ , ¦6 4 5¦ ¦cases¦ ¦and¦ ¦3¦ , ¦1 6 7¦ ¦deaths¦ .
¦3¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦2 9¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦1¦ , ¦2 5 4¦ ¦cases¦ ¦and¦ ¦4 8¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦19 3¦ , ¦8 9 2¦ ¦cases¦ ¦and¦ ¦3¦ , ¦2 1 4¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦death¦ ¦and¦ ¦7¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦ireland¦ ¦was¦ ¦exp ected¦ ¦to¦ ¦receive¦ ¦3 00¦ , ¦000¦ ¦fe w er¦ ¦doses¦ ¦of¦ ¦the¦ ¦o x for d¦ ▁–▁ ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦by¦ ¦the¦ ¦end¦ ¦of¦ ¦march¦ ¦as¦ ¦a¦ ¦result¦ ¦of¦ ¦a¦ ¦sh ort f all¦ ¦in¦ ¦de li ver ies¦ ¦to¦ ¦the¦ ¦eu¦ .
𐋇 ¦gardaí¦ ¦issued¦ ¦more¦ ¦than¦ ¦2¦ , ¦4 00¦ ¦fines¦ ¦to¦ ¦people¦ ¦brea c hing¦ ¦the¦ ¦5¦ ¦k m¦ ¦travel¦ ¦limi t¦ ¦in¦ ¦the¦ ¦prev ious¦ ¦two¦ ¦weeks¦ ,▁ ¦including¦ ¦a¦ ¦m an¦ ¦who¦ ¦tra ve lled¦ ¦2 00¦ ¦k m¦ ¦to¦ ▁" ¦coll ect¦ ¦a¦ ¦p u pp y¦ ¦as¦ ¦a¦ ¦g if t¦ "▁ ¦in¦ ¦cor k¦ .
¦30¦ ¦january¦
𐋇¦a¦ ¦further¦ ¦1¦ , ¦4 1 4¦ ¦cases¦ ¦and¦ ¦7 9¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦19 5¦ , ¦30 3¦ ¦cases¦ ¦and¦ ¦3¦ , ¦2 9 2¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦death¦ ¦and¦ ¦3¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦ch ief¦ ¦medical¦ ¦offic er¦ ¦t on y¦ ¦ho lo h an¦ ¦announced¦ ¦that¦ ¦more¦ ¦cases¦ ¦had¦ ¦been¦ ¦confirmed¦ ¦in¦ ¦one¦ ¦mon th¦ ¦than¦ ¦th r ou g ho ut¦ ¦2020¦ ¦with¦ ¦over¦ ¦1¦ , ¦000¦ ¦deaths¦ ¦and¦ ¦more¦ ¦than¦ ¦100¦ , ¦000¦ ¦cases¦ ¦confirmed¦ ¦in¦ ¦january¦ .
𐋇 ¦sp ea king¦ ¦on¦ ¦ rt é ¦ ¦ra di o¦ ¦1¦ ' ¦s¦ ¦s at ur day¦ ¦with¦ ¦k a ti e¦ ¦h an n on¦ ,▁ ¦the¦ ¦dir ector¦ ¦of¦ ¦the¦ ¦national¦ ¦virus¦ ¦ref er ence¦ ¦laboratory¦ ¦c il li an¦ ¦de¦ ¦g as c u n¦ ¦stated¦ ¦that¦ ¦there¦ ¦was¦ ¦no¦ ¦sign ific ant¦ ¦transmission¦ ¦of¦ ¦the¦ ¦south¦ ¦afr ic an¦ ¦covid¦ - ¦19¦ ¦vari ant¦ ¦in¦ ¦ireland¦ ¦as¦ ¦cases¦ ¦of¦ ¦the¦ ¦vari ant¦ ¦identified¦ ¦had¦ ¦been¦ ¦conta ined¦ .
¦3 1¦ ¦january¦ ▁–▁ ¦a¦ ¦further¦ ¦1¦ , ¦2 4 7¦ ¦cases¦ ¦and¦ ¦15¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦19 6¦ , ¦5 4 7¦ ¦cases¦ ¦and¦ ¦3¦ , ¦30 7¦ ¦deaths¦ .
¦3¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦february¦ ¦2021¦
¦1¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦1¦ , ¦0 6 2¦ ¦cases¦ ¦and¦ ¦10¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦19 7¦ , ¦5 5 3¦ ¦cases¦ ¦and¦ ¦3¦ , ¦3 1 7¦ ¦deaths¦ .
¦5 7¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦education¦ ¦ag re ed¦ ¦to¦ ¦reop en¦ ¦spec ial¦ ¦schools¦ ¦with¦ ¦50¦ %▁ ¦c ap ac ity¦ ¦on¦ ¦th u rs day¦ ¦11¦ ¦february¦ ¦and¦ ¦spec ial¦ ¦cl as ses¦ ¦in¦ ¦main st re am¦ ¦schools¦ ¦on¦ ¦mon day¦ ¦2 2¦ ¦february¦ .
𐋇¦e ur op o l¦ ¦w ar ned¦ ¦tra ve ll ers¦ ¦to¦ ¦w at ch¦ ¦for¦ ¦or g an i sed¦ ¦c ri me¦ ¦ga ng s¦ ¦se lling¦ ¦fa ke¦ ¦negative¦ ¦covid¦ - ¦19¦ ¦ce rt ific ates¦ ¦at¦ ¦air p orts¦ .
𐋇¦l at est¦ ¦f ig ures¦ ¦sh owed¦ ¦that¦ ¦in¦ ¦the¦ ¦last¦ ¦4¦ ¦days¦ ¦of¦ ¦january¦ ,▁ ¦gardaí¦ ¦f ined¦ ¦2 8 0¦ ¦people¦ ¦at¦ ¦dublin¦ ¦air p ort¦ ¦for¦ ¦lea ving¦ ¦the¦ ¦country¦ ¦for¦ ¦non¦ - ¦essential¦ ¦travel¦ ,▁ ¦while¦ ¦more¦ ¦than¦ ¦3¦ , ¦5 00¦ ¦fines¦ ¦had¦ ¦been¦ ¦issued¦ ¦in¦ ¦total¦ ¦for¦ ¦brea ches¦ ¦of¦ ¦covid¦ - ¦19¦ ¦regul ations¦ ,▁ ¦with¦ ¦2¦ , ¦100¦ ¦fines¦ ¦for¦ ¦tra ve lling¦ ¦without¦ ¦a¦ ¦re as on able¦ ¦ex c use¦ .
𐋇¦a¦ ¦nu rs ing¦ ¦home¦ ¦in¦ ¦t u am¦ ,▁ ¦county¦ ¦g al w ay¦ ¦app e al ed¦ ¦for¦ ¦help¦ ¦from¦ ¦qu al if ied¦ ¦n ur ses¦ ¦following¦ ¦the¦ ¦deaths¦ ¦of¦ ¦12¦ ¦res id ents¦ ¦due¦ ¦to¦ ¦covid¦ - ¦19¦ .
𐋇¦it¦ ¦was¦ ¦announced¦ ¦that¦ ¦more¦ ¦than¦ ¦30¦ ¦res id ents¦ ¦of¦ ¦4¦ ¦cor k¦ ¦nu rs ing¦ ¦h omes¦ ¦and¦ ¦a¦ ¦community¦ ¦hospital¦ ¦in¦ ¦k er ry¦ ¦d ied¦ ¦in¦ ¦the¦ ¦prev ious¦ ¦two¦ ¦weeks¦ ¦following¦ ¦covid¦ - ¦19¦ ¦out b rea ks¦ .
¦2¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦8 7 9¦ ¦cases¦ ¦and¦ ¦1 0 1¦ ¦deaths¦ ▁( ¦the¦ ¦high est¦ ¦number¦ ¦of¦ ¦confirmed¦ ¦deaths¦ ¦recor ded¦ ¦in¦ ¦a¦ ¦si ng le¦ ¦day¦ ¦since¦ ¦the¦ ¦pandemic¦ ¦beg an¦ )▁ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦19 8¦ , ¦4 2 4¦ ¦cases¦ ¦and¦ ¦3¦ , ¦4 1 8¦ ¦deaths¦ .
¦8¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦l at est¦ ¦f ig ures¦ ¦sh owed¦ ¦a¦ ¦total¦ ¦of¦ ¦1¦ , ¦5 4 3¦ ¦staff¦ ¦and¦ ¦res id ents¦ ¦in¦ ¦nu rs ing¦ ¦h omes¦ ¦d ied¦ ¦during¦ ¦the¦ ¦pandemic¦ ¦with¦ ¦3 6 9¦ ¦in¦ ¦january¦ ¦al one¦ .
𐋇 ¦over¦ ¦2¦ , ¦000¦ ¦students¦ ¦who¦ ¦s at¦ ¦the¦ ¦po st p o ned¦ ¦w r it t en¦ ¦lea ving¦ ¦ce rt ific ate¦ ¦ex a ms¦ ¦in¦ ¦no ve mber¦ ¦2020¦ ¦received¦ ¦their¦ ¦results¦ ,▁ ¦with¦ ¦over¦ ¦4 0¦ %▁ ¦of¦ ¦the¦ ¦g ra des¦ ¦higher¦ ¦than¦ ¦the¦ ¦c al c ul ated¦ ¦g ra des¦ ¦students¦ ¦had¦ ¦received¦ .
¦3¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦1¦ , ¦0 1 3¦ ¦cases¦ ¦and¦ ¦9 4¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦19 9¦ , ¦4 3 0¦ ¦cases¦ ¦and¦ ¦3¦ , ¦5 1 2¦ ¦deaths¦ .
¦7¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦another¦ ¦outbreak¦ ¦of¦ ¦covid¦ - ¦19¦ ¦at¦ ¦a¦ ¦direct¦ ¦pr ov is ion¦ ¦centre¦ ¦in¦ ¦new b r id ge¦ ,▁ ¦county¦ ¦k ild are¦ ¦was¦ ¦confirmed¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦public¦ ¦health¦ ¦exp r es sed¦ ¦concer n¦ ¦over¦ ¦inc rea ses¦ ¦in¦ ¦covid¦ - ¦19¦ ¦transmission¦ ¦l in ked¦ ¦to¦ ¦social¦ ¦ga ther ings¦ ¦invol ving¦ ¦the¦ ¦st ud ent¦ ¦population¦ ¦in¦ ¦the¦ ¦m id¦ - ¦w est¦ ¦reg ion¦ .
¦4¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦1¦ , ¦3 1 8¦ ¦cases¦ ¦and¦ ¦7 5¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 00¦ , ¦7 4 4¦ ¦cases¦ ¦and¦ ¦3¦ , ¦5 8 6¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦death¦ ¦and¦ ¦4¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦in¦ ¦ireland¦ ¦sur p as sed¦ ¦2 00¦ , ¦000¦ ¦cases¦ ,▁ ¦with¦ ¦over¦ ¦h al f¦ ¦confirmed¦ ¦in¦ ¦2021¦ .
𐋇 ¦minister¦ ¦for¦ ¦health¦ ¦ste ph en¦ ¦d on n el ly¦ ¦sign ed¦ ¦new¦ ¦regul ations¦ ¦that¦ ¦e mp ower¦ ¦gardaí¦ ¦to¦ ¦call¦ ¦to¦ ¦the¦ ¦h omes¦ ¦of¦ ¦people¦ ¦who¦ ¦arr ive¦ ¦from¦ ¦international¦ ¦travel¦ ¦and¦ ¦e ns ure¦ ¦that¦ ¦they¦ ¦are¦ ¦ab i ding¦ ¦by¦ ¦mand atory¦ ¦quarantine¦ ¦ ru les¦ ,▁ ¦with¦ ¦a¦ ▁ € ¦2¦ , ¦5 00¦ ¦f ine¦ ¦or¦ ¦an¦ ¦imp r is on ment¦ ¦se nt ence¦ ¦of¦ ¦6¦ ¦mon ths¦ ¦for¦ ¦non¦ - ¦comp li ance¦ .
¦5¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦1¦ , ¦0 4 7¦ ¦cases¦ ¦and¦ ¦3 5¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦20 1¦ , ¦7 6 3¦ ¦cases¦ ¦and¦ ¦3¦ , ¦6 21¦ ¦deaths¦ .
¦2 8¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦minister¦ ¦for¦ ¦education¦ ¦n orm a¦ ¦fo le y¦ ¦announced¦ ¦a¦ ¦new¦ ¦ph ase¦ ¦of¦ ¦pl an ning¦ ¦for¦ ¦the¦ ¦lea ving¦ ¦ce rt ific ate¦ ¦ex a min ations¦ .
𐋇 ¦gardaí¦ ¦issued¦ ¦more¦ ¦than¦ ¦3 7 5¦ ¦fines¦ ¦to¦ ¦people¦ ¦brea c hing¦ ¦the¦ ¦5¦ ¦k m¦ ¦travel¦ ¦limi t¦ ¦over¦ ¦the¦ ¦prev ious¦ ¦7¦ ¦days¦ ,▁ ¦bringing¦ ¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦brea ches¦ ¦to¦ ¦over¦ ¦4¦ , ¦6 00¦ .
𐋇 ¦minister¦ ¦for¦ ¦health¦ ¦ste ph en¦ ¦d on n el ly¦ ¦announced¦ ¦that¦ ¦the¦ ¦first¦ ¦b at ches¦ ¦of¦ ¦ 21¦ , ¦6 00¦ ¦doses¦ ¦of¦ ¦the¦ ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦would¦ ¦arr ive¦ ¦in¦ ¦the¦ ¦w ee k end¦ ,▁ ¦with¦ ¦19 0¦ , ¦000¦ ¦doses¦ ¦exp ected¦ ¦to¦ ¦arr ive¦ ¦by¦ ¦the¦ ¦end¦ ¦of¦ ¦february¦ .
¦6¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦8 2 7¦ ¦cases¦ ¦and¦ ¦5 5¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦20 2¦ , ¦5 4 8¦ ¦cases¦ ¦and¦ ¦3¦ , ¦6 7 4¦ ¦deaths¦ .
¦4 2¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦first¦ ¦sh ip ment¦ ¦of¦ ¦ 21¦ , ¦6 00¦ ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦arr iv ed¦ ¦in¦ ¦the¦ ¦rep u bl ic¦ ¦of¦ ¦ireland¦ .
¦7¦ ¦february¦ ▁–▁ ¦a¦ ¦further¦ ¦1¦ , ¦0 2 4¦ ¦cases¦ ¦and¦ ¦12¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦20 3¦ , ¦5 6 8¦ ¦cases¦ ¦and¦ ¦3¦ , ¦6 8 6¦ ¦deaths¦ .
¦4¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦8¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦8 2 9¦ ¦cases¦ ¦and¦ ¦6¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦20 4¦ , ¦3 9 7¦ ¦cases¦ ¦and¦ ¦3¦ , ¦6 8 7¦ ¦deaths¦ .
¦5¦ ¦previously¦ ¦notified¦ ¦deaths¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦minister¦ ¦for¦ ¦ho us ing¦ ,▁ ¦local¦ ¦government¦ ¦and¦ ¦h er it age¦ ¦d ar ra gh ¦ ¦ o¦ ' ¦b ri en¦ ¦confirmed¦ ¦that¦ ¦the¦ ¦government¦ ¦is¦ ¦wor king¦ ¦to¦ ¦reop en¦ ¦the¦ ¦con st ru ction¦ ¦s ector¦ ¦on¦ ¦5¦ ¦march¦ .
𐋇 ¦people¦ ¦li ving¦ ¦in¦ ¦n or ther n¦ ¦ireland¦ ¦who¦ ¦c ross¦ ¦the¦ ¦ bor der¦ ¦without¦ ¦a¦ ¦re as on able¦ ¦ex c use¦ ¦face¦ ¦a¦ ▁ € ¦100¦ ¦f ine¦ ¦from¦ ¦to day¦ .
¦9¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦5 5 6¦ ¦cases¦ ¦and¦ ¦6 8¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦20 4¦ , ¦9 4 0¦ ¦cases¦ ¦and¦ ¦3¦ , ¦7 5 2¦ ¦deaths¦ .
¦3¦ ¦previously¦ ¦notified¦ ¦deaths¦ ¦and¦ ¦13¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦government¦ ¦of¦ ¦ireland¦ ¦announced¦ ¦f un ding¦ ¦of¦ ▁ € ¦1 6 0¦ ¦million¦ ¦in¦ ¦ad di tional¦ ¦supp orts¦ ¦for¦ ¦b us in es ses¦ ¦affected¦ ¦by¦ ¦covid¦ - ¦19¦ .
𐋇¦t á na ist e¦ ¦le o¦ ¦v a rad k a r¦ ¦announced¦ ¦that¦ ¦the¦ ¦government¦ ¦is¦ ¦wor king¦ ¦on¦ ¦a¦ ¦re vi sed¦ ¦ ve rs ion¦ ¦of¦ ¦the¦ ▁" ¦li ving¦ ¦with¦ ¦covid¦ - ¦19¦ "▁ ¦pl an¦ ¦which¦ ¦h e¦ ¦h op ed¦ ¦would¦ ¦be¦ ¦announced¦ ¦in¦ ¦the¦ ¦week¦ ¦of¦ ¦2 2¦ ¦february¦ .
𐋇¦l at est¦ ¦f ig ures¦ ¦rel ea sed¦ ¦by¦ ¦the¦ ¦national¦ ¦public¦ ¦health¦ ¦emergency¦ ¦team¦ ¦sh owed¦ ¦that¦ ¦more¦ ¦than¦ ¦one¦ ¦in¦ ¦three¦ ¦deaths¦ ¦from¦ ¦covid¦ - ¦19¦ ¦in¦ ¦february¦ ¦reported¦ ¦were¦ ¦associated¦ ¦with¦ ¦out b rea ks¦ ¦in¦ ¦nu rs ing¦ ¦h omes¦ .
¦10¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦1¦ , ¦0 0 6¦ ¦cases¦ ¦and¦ ¦5 4¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦20 5¦ , ¦9 3 9¦ ¦cases¦ ¦and¦ ¦3¦ , ¦7 9 4¦ ¦deaths¦ .
¦12¦ ¦previously¦ ¦notified¦ ¦deaths¦ ¦and¦ ¦7¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦ta o is ea ch¦ ¦mi che á l¦ ¦ma rt in¦ ¦announced¦ ¦that¦ ¦fines¦ ¦for¦ ¦non¦ - ¦essential¦ ¦travel¦ ¦ab ro ad¦ ¦would¦ ¦be¦ ¦increased¦ ¦from¦ ▁ € ¦5 00¦ ¦to¦ ▁ € ¦2¦ , ¦000¦ ,▁ ¦after¦ ¦a¦ ¦re qu est¦ ¦was¦ ¦made¦ ¦to¦ ¦minister¦ ¦for¦ ¦health¦ ¦ste ph en¦ ¦d on n el ly¦ ¦to¦ ¦s ign¦ ¦off ¦ ¦on¦ ¦the¦ ¦increase¦ .
𐋇 ¦minister¦ ¦for¦ ¦education¦ ¦n orm a¦ ¦fo le y¦ ¦and¦ ¦minister¦ ¦of¦ ¦state¦ ¦for¦ ¦spec ial¦ ¦education¦ ¦and¦ ¦inclu s ion¦ ¦jo se ph a¦ ¦ma d ig an¦ ¦announced¦ ¦detail s¦ ¦of¦ ¦a¦ ¦retur n¦ ¦to¦ ¦in¦ - ¦school¦ ¦te ac hing¦ ¦and¦ ¦learning¦ ¦for¦ ¦students¦ ¦att ending¦ ¦spec ial¦ ¦cl as ses¦ ¦in¦ ¦sec ond ary¦ ¦schools¦ ¦from¦ ¦mon day¦ ¦2 2¦ ¦february¦ ,▁ ¦after¦ ¦a¦ ¦de al¦ ¦was¦ ¦ag re ed¦ ¦between¦ ¦te ac her¦ ¦and¦ ¦s na¦ ¦tra de¦ ¦uni ons¦ ¦and¦ ¦the¦ ¦department¦ ¦of¦ ¦education¦ .
𐋇 ¦sp ea king¦ ¦on¦ ¦ rt é ¦ ' ¦s¦ ¦to day¦ ¦with¦ ¦c la ir e¦ ¦b y r n e¦ ,▁ ¦dir ector¦ ¦of¦ ¦the¦ ¦national¦ ¦virus¦ ¦ref er ence¦ ¦laboratory¦ ¦c il li an¦ ¦de¦ ¦g as c u n¦ ¦stated¦ ¦that¦ ¦the¦ ¦government¦ ¦should¦ ¦be¦ ¦vaccinated¦ ¦as¦ ¦so on¦ ¦as¦ ¦possible¦ ¦and¦ ¦that¦ ¦ta o is ea ch¦ ¦mi che á l¦ ¦ma rt in¦ ¦should¦ ¦receive¦ ¦hi s¦ ¦vaccine¦ ¦a h ead¦ ¦of¦ ¦travel¦ ¦if¦ ¦h e¦ ¦is¦ ¦to¦ ¦visit¦ ¦the¦ ¦united¦ ¦states¦ ¦for¦ ¦s t¦ ¦p at r ick¦ ' ¦s¦ ¦day¦ .
𐋇¦the¦ ¦world¦ ¦health¦ ¦organiz ation¦ ¦pr ai sed¦ ¦ireland¦ ' ¦s¦ ¦reco ve ry¦ ¦from¦ ¦the¦ ¦thir d¦ ¦w a ve¦ ¦of¦ ¦covid¦ - ¦19¦ ¦but¦ ¦w ar ned¦ ¦of¦ ¦the¦ ¦da nger¦ ¦of¦ ¦a¦ ¦fo ur th¦ ¦w a ve¦ .
¦11¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦8 6 6¦ ¦cases¦ ¦and¦ ¦5 2¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦20 6¦ , ¦8 0 1¦ ¦deaths¦ ¦3¦ , ¦8 4 6¦ ¦cases¦ .
¦4¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦up¦ ¦to¦ ¦4¦ , ¦000¦ ¦children¦ ¦with¦ ¦ad di tional¦ ¦e duc a tional¦ ¦needs¦ ¦retur ned¦ ¦to¦ ¦in¦ - ¦person¦ ¦education¦ ¦as¦ ¦spec ial¦ ¦schools¦ ¦na tion w ide¦ ¦reop e ned¦ ¦their¦ ¦do ors¦ ,▁ ¦under¦ ¦pl ans¦ ¦ag re ed¦ ¦between¦ ¦the¦ ¦department¦ ¦of¦ ¦education¦ ¦and¦ ¦te ac her¦ ¦and¦ ¦s na¦ ¦tra de¦ ¦uni ons¦ .
𐋇¦the¦ ¦associ ation¦ ¦of¦ ¦sec ond ary¦ ¦t ea ch ers¦ ,▁ ¦ireland¦ ▁( ¦a st i¦ )▁ ¦w i th d re w¦ ¦from¦ ¦disc us si ons¦ ¦with¦ ¦the¦ ¦department¦ ¦of¦ ¦education¦ ¦on¦ ¦the¦ ¦lea ving¦ ¦ce rt ific ate¦ ¦2021¦ ¦after¦ ¦it¦ ¦said¦ ¦that¦ ¦the¦ ¦pl an¦ ¦being¦ ¦developed¦ ¦would¦ ¦not¦ ¦provide¦ ¦a¦ ▁" ¦me an i ng ful¦ ¦lea ving¦ ¦ce rt ific ate¦ "▁ ¦for¦ ¦students¦ .
𐋇 ¦sp ea king¦ ¦on¦ ¦ rt é ¦ ' ¦s¦ ¦m or ning¦ ¦ireland¦ ,▁ ¦ta o is ea ch¦ ¦mi che á l¦ ¦ma rt in¦ ¦stated¦ ¦that¦ ¦the¦ ¦ma j or ity¦ ¦of¦ ¦the¦ ¦current¦ ¦level¦ ¦5¦ ¦lockdown¦ ¦restrictions¦ ¦were¦ ¦s et¦ ¦to¦ ¦be¦ ¦ex te nded¦ ¦until¦ ¦the¦ ¦e as ter¦ ¦period¦ ,▁ ¦with¦ ¦only¦ ¦schools¦ ¦and¦ ¦the¦ ¦con st ru ction¦ ¦s ector¦ ¦likely¦ ¦to¦ ¦be¦ ¦all owed¦ ¦to¦ ¦reop en¦ ¦before¦ ¦e as ter¦ .
𐋇 ¦dir ector¦ - ¦general¦ ¦of¦ ¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦pa u l¦ ¦re id¦ ¦su gg ested¦ ¦that¦ ¦healthcare¦ ¦workers¦ ¦who¦ ¦ref use¦ ¦to¦ ¦take¦ ¦the¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦may¦ ¦be¦ ¦rem oved¦ ¦from¦ ¦their¦ ¦f ro nt line¦ ¦d ut ies¦ .
¦12¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦9 21¦ ¦cases¦ ¦and¦ ¦23¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦20 7¦ , ¦7 2 0¦ ¦cases¦ ¦and¦ ¦3¦ , ¦8 6 5¦ ¦deaths¦ .
¦4¦ ¦previously¦ ¦notified¦ ¦deaths¦ ¦and¦ ¦2¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦ad ded¦ ¦a¦ ¦further¦ ¦18¦ ¦countries¦ ¦to¦ ¦the¦ ¦government¦ ' ¦s¦ ¦covid¦ - ¦19¦ ▁" ¦high¦ - ¦risk¦ "▁ ¦l ist¦ ¦for¦ ¦international¦ ¦travel¦ .
𐋇¦the¦ ¦countries¦ ¦ad ded¦ ¦were¦ :▁ 𐋇 ¦a ngol a¦ ,▁ ¦a u str ia¦ ,▁ ¦b ot s w a na¦ ,▁ ¦bu ru nd i¦ ,▁ ¦c ap e¦ ¦ ver de¦ ,▁ ¦dem oc r at ic¦ ¦rep u bl ic¦ ¦of¦ ¦the¦ ¦co ng o¦ ,▁ ¦l es o th o¦ ,▁ ¦ma la w i¦ ,▁ ¦ es w at in i¦ ,▁ ¦ma u ri ti us¦ ,▁ ¦mo z a mb i q ue¦ ,▁ ¦na mi b ia¦ ,▁ ¦r w a nd a¦ ,▁ ¦se y ch el les¦ ,▁ ¦t an z an ia¦ ,▁ ¦united¦ ¦ar ab ¦ ¦e m ir ates¦ ,▁ ¦z a mb ia¦ ¦and¦ ¦z i mb ab w e¦ .
𐋇 ¦sp ea king¦ ¦on¦ ¦ rt é ¦ ' ¦s¦ ¦m or ning¦ ¦ireland¦ ,▁ ¦ch ai r¦ ¦of¦ ¦the¦ ¦n ph et¦ ¦ir ish¦ ¦e p ide mi ological¦ ¦mo de lling¦ ¦ad v is ory¦ ¦group¦ ¦p hi li p¦ ¦n ol an¦ ¦stated¦ ¦that¦ ¦it¦ ¦would¦ ¦be¦ ¦at¦ ¦least¦ ¦si x¦ ¦weeks¦ ¦before¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦dro p¦ ¦to¦ ¦around¦ ¦100¦ ¦a¦ ¦day¦ ¦and¦ ¦that¦ ¦the¦ ¦country¦ ¦should¦ ¦be¦ ¦at¦ ¦around¦ ¦2 00¦ ▁–▁ ¦4 00¦ ¦cases¦ ¦a¦ ¦day¦ ¦h ea ding¦ ¦into¦ ¦march¦ ¦and¦ ¦appro ac hing¦ ¦100¦ ▁–▁ ¦2 00¦ ¦cases¦ ¦a¦ ¦day¦ ¦by¦ ¦the¦ ¦end¦ ¦of¦ ¦march¦ .
𐋇 ¦gardaí¦ ¦issued¦ ¦more¦ ¦than¦ ¦6¦ , ¦5 00¦ ¦fines¦ ¦to¦ ¦people¦ ¦brea c hing¦ ¦covid¦ - ¦19¦ ¦regul ations¦ ¦over¦ ¦the¦ ¦p ast¦ ¦mon th¦ ,▁ ¦with¦ ¦over¦ ¦4¦ , ¦9 00¦ ¦fines¦ ¦issued¦ ¦for¦ ¦non¦ - ¦essential¦ ¦travel¦ .
𐋇¦it¦ ¦was¦ ¦confirmed¦ ¦that¦ ¦the¦ ¦tra di tional¦ ¦s t¦ ¦p at r ick¦ ' ¦s¦ ¦day¦ ¦m ee ting¦ ¦between¦ ¦us¦ ¦pres ident¦ ¦jo e¦ ¦b id en¦ ¦and¦ ¦ta o is ea ch¦ ¦mi che á l¦ ¦ma rt in¦ ¦at¦ ¦the¦ ¦wh ite¦ ¦house¦ ¦would¦ ¦take¦ ¦place¦ ¦vir t ually¦ ¦due¦ ¦to¦ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ .
¦13¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦1¦ , ¦0 7 8¦ ¦cases¦ ¦and¦ ¦6 6¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦20 8¦ , ¦7 9 6¦ ¦cases¦ ¦and¦ ¦3¦ , ¦9 3 1¦ ¦deaths¦ .
¦2¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦associ ation¦ ¦of¦ ¦sec ond ary¦ ¦t ea ch ers¦ ,▁ ¦ireland¦ ▁( ¦a st i¦ )▁ ¦r e¦ - ¦jo ined¦ ¦disc us si ons¦ ¦with¦ ¦the¦ ¦department¦ ¦of¦ ¦education¦ ¦on¦ ¦the¦ ¦lea ving¦ ¦ce rt ific ate¦ ¦2021¦ ¦after¦ ¦p u lling¦ ¦out¦ ¦on¦ ¦11¦ ¦february¦ .
𐋇¦the¦ ¦p ace¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦r ol lo ut¦ ¦in¦ ¦ireland¦ ¦was¦ ¦s et¦ ¦to¦ ¦increase¦ ¦from¦ ¦mon day¦ ¦15¦ ¦february¦ ¦with¦ ¦the¦ ¦first¦ ¦doses¦ ¦admin ist ered¦ ¦to¦ ¦over¦ - ¦8 5 s¦ ¦in¦ ¦the¦ ¦community¦ ¦and¦ ¦the¦ ¦first¦ ¦wid esp r ead¦ ¦use¦ ¦of¦ ¦the¦ ¦astrazeneca¦ ¦vaccine¦ .
¦14¦ ¦february¦ ▁–▁ ¦a¦ ¦further¦ ¦7 8 8¦ ¦cases¦ ¦and¦ ¦1 7¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦20 9¦ , ¦5 8 2¦ ¦cases¦ ¦and¦ ¦3¦ , ¦9 4 8¦ ¦deaths¦ .
¦2¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦15¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦8 21¦ ¦cases¦ ¦and¦ ¦no¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 1 0¦ , ¦4 0 2¦ ¦cases¦ ¦and¦ ¦3¦ , ¦9 4 8¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦case¦ ¦was¦ ¦de¦ - ¦notified¦ .
𐋇 ¦minister¦ ¦for¦ ¦health¦ ¦ste ph en¦ ¦d on n el ly¦ ¦confirmed¦ ¦loc ations¦ ¦for¦ ¦3 7¦ ¦vacc ination¦ ¦centr es¦ ¦across¦ ¦all¦ ¦cou nt ies¦ ¦as¦ ¦par t¦ ¦of¦ ¦the¦ ¦country¦ ' ¦s¦ ¦covid¦ - ¦19¦ ¦vacc ination¦ ¦pr ogra m me¦ .
𐋇 ¦vaccines¦ ¦offic ially¦ ¦beg an¦ ¦for¦ ¦the¦ ¦thir d¦ ¦co h ort¦ ¦in¦ ¦ireland¦ ' ¦s¦ ¦pri or it is ation¦ ¦l ist¦ ,▁ ¦with¦ ¦over¦ ¦8 0¦ , ¦000¦ ¦people¦ ¦exp ected¦ ¦to¦ ¦receive¦ ¦covid¦ - ¦19¦ ¦vaccines¦ .
𐋇¦it¦ ¦was¦ ¦announced¦ ¦that¦ ¦two¦ ¦univers ities¦ ¦in¦ ¦g al w ay¦ ¦and¦ ¦li mer ick¦ ¦had¦ ¦been¦ ¦hi t¦ ¦by¦ ¦major¦ ¦covid¦ - ¦19¦ ¦out b rea ks¦ ¦of¦ ¦up¦ ¦to¦ ¦ne arly¦ ¦2 5 0¦ ¦confirmed¦ ¦cases¦ ¦due¦ ¦to¦ ¦students¦ ¦brea c hing¦ ¦level¦ ¦5¦ ¦lockdown¦ ¦regul ations¦ ,▁ ¦which¦ ¦caused¦ ¦c lu st ers¦ ¦of¦ ¦infection¦ ¦invol ving¦ ¦up¦ ¦to¦ ¦4 0¦ ¦people¦ .
¦16¦ ¦february¦ ▁–▁ ¦a¦ ¦further¦ ¦7 4 4¦ ¦cases¦ ¦and¦ ¦3 3¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 1 1¦ , ¦1 1 3¦ ¦cases¦ ¦and¦ ¦3¦ , ¦9 8 0¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦death¦ ¦and¦ ¦3 3¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦1 7¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦6 5 0¦ ¦cases¦ ¦and¦ ¦5 7¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 1 1¦ , ¦7 5 1¦ ¦cases¦ ¦and¦ ¦4¦ , ¦0 3 6¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦death¦ ¦and¦ ¦12¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦ireland¦ ' ¦s¦ ¦covid¦ - ¦19¦ ¦death¦ ¦t ol l¦ ¦sur p as sed¦ ¦4¦ , ¦000¦ ¦as¦ ¦dep ut y¦ ¦ch ief¦ ¦medical¦ ¦offic er¦ ¦r on an¦ ¦gl y n n¦ ¦announced¦ ¦that¦ ¦9 0¦ %▁ ¦of¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦in¦ ¦ireland¦ ¦were¦ ¦the¦ ¦uk¦ ¦vari ant¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇 ¦minister¦ ¦for¦ ¦education¦ ¦n orm a¦ ¦fo le y¦ ¦confirmed¦ ¦that¦ ¦lea ving¦ ¦ce rt ific ate¦ ¦ex a min ations¦ ¦would¦ ¦pro ce ed¦ ¦with¦ ¦students¦ ¦giv en¦ ¦the¦ ¦o ption¦ ¦between¦ ¦a¦ ¦mod if ied¦ ¦ ve rs ion¦ ¦of¦ ¦c al c ul ated¦ ¦g ra des¦ ¦or¦ ¦w r it t en¦ ¦ex a ms¦ ,▁ ¦while¦ ¦j un i or¦ ¦ce rt ific ate¦ ¦ex a min ations¦ ¦were¦ ¦cance lled¦ ¦for¦ ¦a¦ ¦second¦ ¦year¦ ¦in¦ ¦a¦ ¦r ow¦ .
𐋇 ¦four¦ ¦people¦ ,▁ ¦including¦ ¦two¦ ¦pol it ici ans¦ ,▁ ¦were¦ ¦exp ected¦ ¦to¦ ¦face¦ ¦ch ar ges¦ ¦over¦ ¦al le ged¦ ¦brea ches¦ ¦of¦ ¦covid¦ - ¦19¦ ¦regul ations¦ ¦during¦ ¦an¦ ¦ oi rea ch ta s¦ ¦g ol f¦ ¦s oc i et y¦ ¦ev ent¦ ¦in¦ ¦cl if d en¦ ,▁ ¦g al w ay¦ ¦in¦ ¦a u g ust¦ ¦2020¦ .
¦18¦ ¦february¦ ▁–▁ ¦a¦ ¦further¦ ¦9 0 1¦ ¦cases¦ ¦and¦ ¦4 7¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 1 2¦ , ¦6 4 7¦ ¦cases¦ ¦and¦ ¦4¦ , ¦0 8 2¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦death¦ ¦and¦ ¦5¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦19¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦7 6 3¦ ¦cases¦ ¦and¦ ¦2 8¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 1 3¦ , ¦4 00¦ ¦cases¦ ¦and¦ ¦4¦ , ¦1 0 9¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦death¦ ¦and¦ ¦10¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦in¦ ¦a¦ ¦sta te ment¦ ¦from¦ ¦the¦ ¦national¦ ¦public¦ ¦health¦ ¦emergency¦ ¦team¦ ,▁ ¦dep ut y¦ ¦ch ief¦ ¦medical¦ ¦offic er¦ ¦r on an¦ ¦gl y n n¦ ¦confirmed¦ ¦that¦ ¦three¦ ¦cases¦ ¦of¦ ¦the¦ ¦b ra z i li an¦ ¦vari ant¦ ¦of¦ ¦covid¦ - ¦19¦ ¦had¦ ¦been¦ ¦detected¦ ¦in¦ ¦the¦ ¦rep u bl ic¦ ¦of¦ ¦ireland¦ ¦all¦ ¦associated¦ ¦with¦ ¦travel¦ ¦from¦ ¦b ra z il¦ .
𐋇¦ stric t¦ ¦level¦ ¦5¦ ¦restrictions¦ ¦were¦ ¦exp ected¦ ¦to¦ ¦remain¦ ¦in¦ ¦place¦ ¦until¦ ¦may¦ ¦as¦ ¦all¦ ¦pr imary¦ ¦school¦ ¦students¦ ¦were¦ ¦to¦ ¦retur n¦ ¦by¦ ¦15¦ ¦march¦ ,▁ ¦with¦ ¦the¦ ¦first¦ ¦four¦ ¦cl as ses¦ ¦in¦ ¦pr imary¦ ¦schools¦ ¦and¦ ¦lea ving¦ ¦ce rt ific ate¦ ¦students¦ ¦the¦ ¦first¦ ¦to¦ ¦retur n¦ ¦on¦ ¦1¦ ¦march¦ .
𐋇¦l at est¦ ¦f ig ures¦ ¦sh owed¦ ¦that¦ ¦as¦ ¦of¦ ¦18¦ ¦february¦ ,▁ ¦gardaí¦ ¦had¦ ¦issued¦ ¦over¦ ¦8¦ , ¦000¦ ¦fines¦ ¦to¦ ¦people¦ ¦brea c hing¦ ¦covid¦ - ¦19¦ ¦regul ations¦ ,▁ ¦with¦ ¦over¦ ¦6¦ , ¦5 00¦ ¦fines¦ ¦issued¦ ¦for¦ ¦non¦ - ¦essential¦ ¦travel¦ ¦and¦ ¦9 4 4¦ ¦fines¦ ¦issued¦ ¦for¦ ¦att ending¦ ¦or¦ ¦h os ting¦ ¦house¦ ¦part ies¦ .
𐋇 ¦ta o is ea ch¦ ¦mi che á l¦ ¦ma rt in¦ ¦exp r es sed¦ ¦hi s¦ ¦c ond ol en ces¦ ¦to¦ ¦ch ief¦ ¦medical¦ ¦offic er¦ ¦t on y¦ ¦ho lo h an¦ ¦and¦ ¦hi s¦ ¦family¦ ¦after¦ ¦hi s¦ ¦w ife¦ ,▁ ¦e m er¦ ,▁ ¦d ied¦ ¦following¦ ¦a¦ ¦long¦ ¦illness¦ ¦with¦ ¦mult ip le¦ ¦m y el om a¦ .
¦20¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦9 8 8¦ ¦cases¦ ¦and¦ ¦26¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 1 4¦ , ¦3 7 8¦ ¦cases¦ ¦and¦ ¦4¦ , ¦1 3 5¦ ¦deaths¦ .
¦10¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦sp ea king¦ ¦on¦ ¦ rt é ¦ ' ¦s¦ ¦r ai di ó ¦ ¦ na¦ ¦ga el ta ch t a¦ ,▁ ¦ta o is ea ch¦ ¦mi che á l¦ ¦ma rt in¦ ¦stated¦ ¦that¦ ¦p ub s¦ ¦and¦ ¦res ta u ra nts¦ ¦would¦ ¦likely¦ ¦not¦ ¦reop en¦ ¦until¦ ¦the¦ ¦m id d le¦ ¦of¦ ¦the¦ ¦su mm er¦ .
𐋇 ¦ne arly¦ ¦1¦ , ¦000¦ ¦patients¦ ¦over¦ ¦the¦ ¦age¦ ¦of¦ ¦8 5¦ ¦received¦ ¦their¦ ¦first¦ ¦d ose¦ ¦of¦ ¦a¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦at¦ ¦the¦ ¦country¦ ' ¦s¦ ¦first¦ ¦m ass¦ ¦vacc ination¦ ¦centre¦ ¦at¦ ¦the¦ ¦he li x¦ ¦in¦ ¦dublin¦ ¦city¦ ¦univers ity¦ .
𐋇 ¦following¦ ¦a¦ ¦re qu est¦ ¦from¦ ¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ ),▁ ¦the¦ ¦ir ish¦ ¦air ¦ ¦cor ps¦ ¦del iv ered¦ ¦the¦ ¦first¦ ¦con si gn ment¦ ¦of¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦to¦ ¦the¦ ¦ar an¦ ¦ is l an ds¦ ¦in¦ ¦county¦ ¦g al w ay¦ ¦and¦ ¦to¦ ¦ á ra in n¦ ¦m h ó r¦ ¦in¦ ¦county¦ ¦do ne g al¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦fo re ign¦ ¦aff a ir s¦ ¦announced¦ ¦that¦ ¦the¦ ¦pa ss p ort¦ ¦service¦ ¦had¦ ¦susp e nded¦ ¦most¦ ¦of¦ ¦its¦ ¦op er ations¦ ¦due¦ ¦to¦ ¦level¦ ¦5¦ ¦restrictions¦ ,▁ ¦with¦ ¦h ol id a y ma k ers¦ ¦f ac ing¦ ¦del ays¦ ¦of¦ ¦up¦ ¦to¦ ¦two¦ ¦mon ths¦ ¦in¦ ¦sec ur ing¦ ¦a¦ ¦pa ss p ort¦ .
¦ 21¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦6 7 9¦ ¦cases¦ ¦and¦ ¦1¦ ¦death¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 1 5¦ , ¦0 5 7¦ ¦cases¦ ¦and¦ ¦4¦ , ¦1 3 6¦ ¦deaths¦ .
𐋇 ¦fa ce b ook¦ ¦sh ut¦ ¦down¦ ¦and¦ ¦re stric ted¦ ¦acc ess¦ ¦to¦ ¦a¦ ¦number¦ ¦of¦ ¦inst a g r am¦ ¦acc ou nts¦ ¦that¦ ¦were¦ ¦ad ve rt ising¦ ¦an¦ ¦ il le g al¦ ▁" ¦lockdown¦ ¦ra ve¦ "▁ ¦on¦ ¦s t¦ ¦p at r ick¦ ' ¦s¦ ¦day¦ .
¦2 2¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦6 8 6¦ ¦cases¦ ¦and¦ ¦1¦ ¦death¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 1 5¦ , ¦7 4 3¦ ¦cases¦ ¦and¦ ¦4¦ , ¦1 3 7¦ ¦deaths¦ .
𐋇¦the¦ ¦c ab in et¦ ¦covid¦ - ¦19¦ ¦sub ¦ - ¦comm it te e¦ ¦ag re ed¦ ¦that¦ ¦level¦ ¦5¦ ¦restrictions¦ ¦would¦ ¦remain¦ ¦in¦ ¦place¦ ¦until¦ ¦5¦ ¦april¦ ¦at¦ ¦the¦ ¦ ear li est¦ ¦under¦ ¦the¦ ¦government¦ ' ¦s¦ ¦re vi sed¦ ¦li ving¦ ¦with¦ ¦covid¦ - ¦19¦ ¦pl an¦ ,▁ ¦due¦ ¦to¦ ¦be¦ ¦publ ished¦ ¦on¦ ¦23¦ ¦february¦ .
𐋇 ¦spec ial¦ ¦cl as ses¦ ¦in¦ ¦main st re am¦ ¦pr imary¦ ¦and¦ ¦sec ond ary¦ ¦schools¦ ¦reop e ned¦ ¦as¦ ¦the¦ ¦ph a sed¦ ¦reop ening¦ ¦of¦ ¦schools¦ ¦contin u ed¦ .
¦23¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦5 7 5¦ ¦cases¦ ¦and¦ ¦4 5¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 1 6¦ , ¦3 00¦ ¦cases¦ ¦and¦ ¦4¦ , ¦1 8 1¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦death¦ ¦and¦ ¦8¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦ta o is ea ch¦ ¦mi che á l¦ ¦ma rt in¦ ¦announced¦ ¦the¦ ¦ex tens ion¦ ¦of¦ ¦level¦ ¦5¦ ¦lockdown¦ ¦restrictions¦ ¦for¦ ¦another¦ ¦si x¦ ¦weeks¦ ¦until¦ ¦5¦ ¦april¦ ▁( ¦e as ter¦ ¦mon day¦ )▁ ¦at¦ ¦the¦ ¦ ear li est¦ ¦as¦ ¦the¦ ¦government¦ ¦of¦ ¦ireland¦ ¦publ ished¦ ¦its¦ ¦new¦ ¦re vi sed¦ ¦li ving¦ ¦with¦ ¦covid¦ - ¦19¦ ¦pl an¦ ¦called¦ ▁" ¦the¦ ¦pa th¦ ¦a h ead¦ " ,▁ ¦which¦ ¦inclu des¦ ¦the¦ ¦ph a sed¦ ¦reop ening¦ ¦of¦ ¦schools¦ ¦and¦ ¦ch ild c are¦ ¦and¦ ¦the¦ ¦ex tens ion¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ ¦u ne mploy ment¦ ¦pa y ment¦ ¦and¦ ¦the¦ ¦e mploy ment¦ ¦w age¦ ¦sub si dy¦ ¦s che me¦ .
𐋇 ¦minister¦ ¦for¦ ¦health¦ ¦ste ph en¦ ¦d on n el ly¦ ¦announced¦ ¦an¦ ¦up d ate¦ ¦to¦ ¦the¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦all oc ation¦ ¦stra te g y¦ ¦with¦ ¦people¦ ¦a ged¦ ¦between¦ ¦16¦ ¦and¦ ¦6 9¦ ¦who¦ ¦are¦ ¦at¦ ¦very¦ ¦high¦ ¦risk¦ ¦of¦ ¦develop ing¦ ¦severe¦ ¦covid¦ - ¦19¦ ¦m oved¦ ¦up¦ ¦the¦ ¦pri or ity¦ ¦l ist¦ ,▁ ¦after¦ ¦the¦ ¦national¦ ¦public¦ ¦health¦ ¦emergency¦ ¦team¦ ¦ end or sed¦ ¦recomm end ations¦ ¦by¦ ¦the¦ ¦national¦ ¦immun is ation¦ ¦ad v is ory¦ ¦comm it te e¦ .
¦24¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦5 7 4¦ ¦cases¦ ¦and¦ ¦5 6¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 1 6¦ , ¦8 7 0¦ ¦cases¦ ¦and¦ ¦4¦ , ¦2 3 7¦ ¦deaths¦ .
𐋇 ¦among¦ ¦the¦ ¦deaths¦ ¦confirmed¦ ¦was¦ ¦a¦ ¦16¦ - ¦year¦ - ¦o ld¦ ¦t ee na g er¦ .
¦4¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦minister¦ ¦for¦ ¦health¦ ¦ste ph en¦ ¦d on n el ly¦ ¦announced¦ ¦that¦ ¦ireland¦ ¦had¦ ¦or d ered¦ ¦en ough¦ ¦vaccines¦ ¦to¦ ¦vacc in ate¦ ¦10¦ . ¦3¦ ¦million¦ ¦people¦ ¦with¦ ¦18¦ . ¦5¦ ¦million¦ ¦doses¦ ¦of¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦or d ered¦ .
𐋇¦t á na ist e¦ ¦le o¦ ¦v a rad k a r¦ ¦ad dr es sed¦ ¦a¦ ¦m ee ting¦ ¦of¦ ¦f ine¦ ¦ga e l¦ ¦t ds¦ ,▁ ¦sen at ors¦ ¦and¦ ¦me ps¦ ¦and¦ ¦stated¦ ¦that¦ ¦crit ic is m¦ ¦of¦ ¦how¦ ¦the¦ ¦government¦ ¦had¦ ¦been¦ ¦comm un ic ating¦ ¦was¦ ¦re as on able¦ ,▁ ¦had¦ ¦been¦ ¦he ard¦ ¦l ou d¦ ¦and¦ ¦cl ear¦ ,▁ ¦and¦ ¦would¦ ¦be¦ ¦ta k en¦ ¦ on bo ard¦ ,▁ ¦after¦ ¦a¦ ¦number¦ ¦of¦ ¦f ine¦ ¦ga e l¦ ¦pol it ici ans¦ ¦la un ched¦ ¦an¦ ¦att ack¦ ¦on¦ ¦ta o is ea ch¦ ¦mi che á l¦ ¦ma rt in¦ ¦over¦ ¦hi s¦ ¦hand l ing¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ .
𐋇 ¦minister¦ ¦of¦ ¦state¦ ¦for¦ ¦international¦ ¦and¦ ¦ro ad¦ ¦transport¦ ¦and¦ ¦l og ist ics¦ ¦h il de g ar de¦ ¦na u gh t on¦ ¦announced¦ ¦a¦ ¦further¦ ¦ex tens ion¦ ¦to¦ ¦the¦ ¦exp i ry¦ ¦d ates¦ ¦of¦ ¦d ri ving¦ ¦l ic en ces¦ ¦in¦ ¦l ight¦ ¦of¦ ¦the¦ ¦dis ru ption¦ ¦to¦ ¦li ce ncing¦ ¦services¦ ¦caused¦ ¦by¦ ¦covid¦ - ¦19¦ ¦across¦ ¦the¦ ¦european¦ ¦un ion¦ ,▁ ¦as¦ ¦national¦ ¦d ri ver¦ ¦l ic ence¦ ¦service¦ ▁( ¦ nd l s¦ )▁ ¦centr es¦ ¦remain¦ ¦open¦ ¦to¦ ¦essential¦ ¦workers¦ ¦during¦ ¦the¦ ¦ex te nded¦ ¦level¦ ¦5¦ ¦restrictions¦ .
¦2 5¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦6 1 3¦ ¦cases¦ ¦and¦ ¦3 5¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 1 7¦ , ¦4 7 8¦ ¦cases¦ ¦and¦ ¦4¦ , ¦2 7 1¦ ¦deaths¦ .
¦5¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦dir ector¦ ¦of¦ ¦the¦ ¦national¦ ¦virus¦ ¦ref er ence¦ ¦laboratory¦ ¦c il li an¦ ¦de¦ ¦g as c u n¦ ¦confirmed¦ ¦that¦ ¦the¦ ¦first¦ ¦case¦ ¦of¦ ¦the¦ ¦b ¦ . ¦1¦ . ¦5 2 5¦ ¦vari ant¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦first¦ ¦identified¦ ¦in¦ ¦the¦ ¦united¦ ¦ki ng d om¦ ¦and¦ ¦n ig er ia¦ ,▁ ¦had¦ ¦been¦ ¦detected¦ ¦in¦ ¦the¦ ¦rep u bl ic¦ ¦of¦ ¦ireland¦ ,▁ ¦while¦ ¦a¦ ¦further¦ ¦four¦ ¦cases¦ ¦of¦ ¦the¦ ¦south¦ ¦afr ic an¦ ¦vari ant¦ ¦had¦ ¦been¦ ¦detected¦ ,▁ ¦bringing¦ ¦the¦ ¦total¦ ¦to¦ ¦15¦ .
¦26¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦7 7 6¦ ¦cases¦ ¦and¦ ¦2 9¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 1 8¦ , ¦2 5 1¦ ¦cases¦ ¦and¦ ¦4¦ , ¦3 00¦ ¦deaths¦ .
¦3¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦ad ded¦ ¦a¦ ¦further¦ ¦13¦ ¦countries¦ ¦to¦ ¦the¦ ¦government¦ ' ¦s¦ ¦covid¦ - ¦19¦ ▁" ¦high¦ - ¦risk¦ "▁ ¦l ist¦ ¦for¦ ¦international¦ ¦travel¦ ,▁ ¦which¦ ¦br ou gh t¦ ¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦countries¦ ¦ad ded¦ ¦to¦ ¦3 3¦ .
𐋇¦the¦ ¦countries¦ ¦ad ded¦ ¦were¦ :▁ 𐋇¦ arg en ti na¦ ,▁ ¦b ol iv ia¦ ,▁ ¦c hi le¦ ,▁ ¦co lo mb ia¦ ,▁ ¦ ecu a d or¦ ,▁ ¦fre n ch¦ ¦gu ia na¦ ,▁ ¦gu y a na¦ ,▁ ¦pa na m a¦ ,▁ ¦p ara g u ay¦ ,▁ ¦per u¦ ,▁ ¦su ri na me¦ ,▁ ¦u ru g u ay¦ ¦and¦ ¦ ve ne z u el a¦ .
𐋇 ¦dep ut y¦ ¦ch ief¦ ¦medical¦ ¦offic er¦ ¦r on an¦ ¦gl y n n¦ ¦issued¦ ¦a¦ ¦l et ter¦ ¦app e al ing¦ ¦to¦ ¦par ents¦ ¦to¦ ¦ad h er e¦ ¦to¦ ¦public¦ ¦health¦ ¦gu id el ines¦ ¦and¦ ¦not¦ ¦to¦ ¦co ng re g ate¦ ¦at¦ ¦school¦ ¦g ates¦ ¦or¦ ¦to¦ ¦or g an ise¦ ¦pl ay¦ ¦d ates¦ ,▁ ¦a h ead¦ ¦of¦ ¦schools¦ ¦reop ening¦ ¦and¦ ¦the¦ ¦retur n¦ ¦of¦ ¦3 2 0¦ , ¦000¦ ¦students¦ ¦from¦ ¦mon day¦ ¦1¦ ¦march¦ .
𐋇¦l at est¦ ¦f ig ures¦ ¦rel ea sed¦ ¦by¦ ¦the¦ ¦centr al¦ ¦st at ist ics¦ ¦off ice¦ ¦sh owed¦ ¦that¦ ¦dublin¦ ,▁ ¦do ne g al¦ ,▁ ¦li mer ick¦ ,▁ ¦l ou th¦ ¦and¦ ¦mo na gh an¦ ¦were¦ ¦the¦ ¦h ar d est¦ ¦hi t¦ ¦cou nt ies¦ ¦in¦ ¦ter ms¦ ¦of¦ ¦cases¦ ,▁ ¦while¦ ¦ca v an¦ ,▁ ¦dublin¦ ,▁ ¦k ild are¦ ,▁ ¦ma y o¦ ¦and¦ ¦mo na gh an¦ ¦were¦ ¦the¦ ¦cou nt ies¦ ¦with¦ ¦the¦ ¦most¦ ¦deaths¦ .
𐋇¦l at est¦ ¦f ig ures¦ ¦sh owed¦ ¦that¦ ¦as¦ ¦of¦ ¦2 5¦ ¦february¦ ,▁ ¦gardaí¦ ¦had¦ ¦issued¦ ¦over¦ ¦9¦ , ¦8 00¦ ¦fines¦ ¦to¦ ¦people¦ ¦brea c hing¦ ¦covid¦ - ¦19¦ ¦regul ations¦ ,▁ ¦with¦ ¦over¦ ¦7¦ , ¦5 6 6¦ ¦fines¦ ¦issued¦ ¦for¦ ¦non¦ - ¦essential¦ ¦travel¦ ¦and¦ ¦1¦ , ¦3 8 6¦ ¦fines¦ ¦issued¦ ¦for¦ ¦att ending¦ ¦or¦ ¦h os ting¦ ¦house¦ ¦part ies¦ .
¦2 7¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦7 3 8¦ ¦cases¦ ¦and¦ ¦13¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 1 8¦ , ¦9 8 0¦ ¦cases¦ ¦and¦ ¦4¦ , ¦3 1 3¦ ¦deaths¦ .
¦9¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦23¦ ¦people¦ ¦were¦ ¦arr ested¦ ¦and¦ ¦3¦ ¦gardaí¦ ¦were¦ ¦in j ur ed¦ ▁( ¦including¦ ¦one¦ ¦hosp i tali sed¦ ),▁ ¦as¦ ¦around¦ ¦5 00¦ ¦prote st ers¦ ¦t ook¦ ¦par t¦ ¦in¦ ¦an¦ ¦anti ¦ - ¦lockdown¦ ¦prot est¦ ¦in¦ ¦dublin¦ ¦city¦ ¦centre¦ ,▁ ¦with¦ ¦fi re w or ks¦ ¦being¦ ¦f ir ed¦ ¦at¦ ¦gardaí¦ ,▁ ¦while¦ ¦s t¦ ¦ste ph en¦ ' ¦s¦ ¦g re en¦ ¦and¦ ¦the¦ ¦ iv ea gh ¦ ¦gard ens¦ ¦closed¦ ¦in¦ ¦ad v ance¦ ¦of¦ ¦the¦ ¦prot est¦ .
𐋇¦the¦ ¦prot est¦ ¦was¦ ¦wid ely¦ ¦con de m ned¦ ¦by¦ ¦the¦ ¦gardaí¦ ¦and¦ ¦pol it ici ans¦ ,▁ ¦including¦ ¦the¦ ¦ta o is ea ch¦ ,▁ ¦t á na ist e¦ ¦and¦ ¦minister¦ ¦for¦ ¦j u st ice¦ .
¦2 8¦ ¦february¦
𐋇¦a¦ ¦further¦ ¦6 1 2¦ ¦cases¦ ¦and¦ ¦6¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 1 9¦ , ¦5 9 2¦ ¦cases¦ ¦and¦ ¦4¦ , ¦3 1 9¦ ¦deaths¦ .
𐋇 ¦ireland¦ ¦offic ially¦ ¦mark ed¦ ¦one¦ ¦year¦ ¦since¦ ¦the¦ ¦first¦ ¦case¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦the¦ ¦country¦ ¦was¦ ¦confirmed¦ ¦on¦ ¦2 9¦ ¦february¦ ¦2020¦ .
¦13¦ ¦people¦ ,▁ ¦including¦ ¦12¦ ¦m en¦ ¦and¦ ¦1¦ ¦wom an¦ ,▁ ¦were¦ ¦ch ar ged¦ ¦and¦ ¦rema nded¦ ¦in¦ ¦c u st o dy¦ ¦for¦ ¦public¦ ¦order¦ ¦off en ces¦ ¦after¦ ¦anti ¦ - ¦lockdown¦ ¦prote sts¦ ¦in¦ ¦dublin¦ ¦city¦ ¦centre¦ ¦t ur ned¦ ¦ vi ol ent¦ ¦on¦ ¦2 7¦ ¦february¦ ,▁ ¦while¦ ¦t á na ist e¦ ¦le o¦ ¦v a rad k a r¦ ¦stated¦ ¦that¦ ¦the¦ ¦ vi ol ence¦ ¦on¦ ¦the¦ ¦st re ets¦ ¦of¦ ¦dublin¦ ¦was¦ ▁" ¦not¦ ¦a¦ ¦prot est¦ ¦and¦ ¦was¦ ¦a¦ ¦ ri ot¦ " .
𐋇 ¦march¦ ¦2021¦
¦1¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦6 8 7¦ ¦cases¦ ¦and¦ ¦1¦ ¦death¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦22 0¦ , ¦2 7 3¦ ¦cases¦ ¦and¦ ¦4¦ , ¦3 1 9¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦death¦ ¦and¦ ¦6¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦over¦ ¦3 2 0¦ , ¦000¦ ¦j un i or¦ ¦pr imary¦ ¦school¦ ¦p u p il s¦ ¦and¦ ¦lea ving¦ ¦ce rt ific ate¦ ¦students¦ ¦na tion w ide¦ ¦retur ned¦ ¦to¦ ¦school¦ ¦for¦ ¦the¦ ¦first¦ ¦time¦ ¦since¦ ¦ch r ist ma s¦ .
𐋇¦a¦ ¦school¦ ¦in¦ ¦n or th¦ ¦dublin¦ ¦confirmed¦ ¦a¦ ¦case¦ ¦of¦ ¦covid¦ - ¦19¦ ¦on¦ ¦the¦ ¦first¦ ¦day¦ ¦of¦ ¦reop ening¦ ¦schools¦ ¦na tion w ide¦ ¦as¦ ¦par ents¦ ¦received¦ ¦an¦ ¦ ur g ent¦ ¦l et ter¦ ¦from¦ ¦the¦ ¦school¦ .
¦2¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦3 5 9¦ ¦cases¦ ¦and¦ ¦14¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦22 0¦ , ¦6 3 0¦ ¦cases¦ ¦and¦ ¦4¦ , ¦3 3 3¦ ¦deaths¦ .
¦2¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦a¦ ¦m an¦ ¦in¦ ¦hi s¦ ¦30 s¦ ¦was¦ ¦arr ested¦ ¦in¦ ¦con ne ction¦ ¦with¦ ¦a¦ ¦fi re w or k¦ ¦att ack¦ ¦on¦ ¦gardaí¦ ¦at¦ ¦a¦ ¦ vi ol ent¦ ¦anti ¦ - ¦lockdown¦ ¦prot est¦ ¦in¦ ¦dublin¦ ¦city¦ ¦centre¦ ¦on¦ ¦2 7¦ ¦february¦ .
𐋇 ¦three¦ ¦m en¦ ¦in¦ ¦their¦ ¦20 s¦ ¦were¦ ¦arr ested¦ ¦and¦ ¦more¦ ¦than¦ ¦50¦ ¦fi x ed¦ ¦pa y ment¦ ¦no ti ces¦ ¦were¦ ¦issued¦ ¦in¦ ¦li mer ick¦ ¦after¦ ¦gardaí¦ ¦b ro ke¦ ¦up¦ ¦a¦ ¦st re et¦ ¦part y¦ ¦invol ving¦ ¦large¦ ¦grou ps¦ ¦of¦ ¦students¦ ¦dr in king¦ ,▁ ¦da ncing¦ ,▁ ¦s in ging¦ ¦and¦ ¦s etting¦ ¦of¦ ¦fi re w or ks¦ ,▁ ¦n ear¦ ¦the¦ ¦univers ity¦ ¦of¦ ¦li mer ick¦ .
𐋇¦a¦ ¦sec ond ary¦ ¦school¦ ¦in¦ ¦cor k¦ ¦confirmed¦ ¦a¦ ¦case¦ ¦of¦ ¦covid¦ - ¦19¦ ¦while¦ ¦a¦ ¦south¦ ¦dublin¦ ¦school¦ ¦announced¦ ¦its¦ ¦cl osure¦ ¦due¦ ¦to¦ ¦a¦ ¦confirmed¦ ¦case¦ ¦of¦ ¦covid¦ - ¦19¦ ¦j ust¦ ¦one¦ ¦day¦ ¦after¦ ¦schools¦ ¦reop e ned¦ .
¦3¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦5 6 6¦ ¦cases¦ ¦and¦ ¦2 5¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 21¦ , ¦1 8 9¦ ¦cases¦ ¦and¦ ¦4¦ , ¦3 5 7¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦death¦ ¦and¦ ¦7¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦one¦ ¦of¦ ¦the¦ ¦three¦ ¦m en¦ ¦arr ested¦ ¦following¦ ¦a¦ ¦st re et¦ ¦part y¦ ¦in¦ ¦ca st l et ro y¦ ,▁ ¦li mer ick¦ ¦on¦ ¦the¦ ¦n ight¦ ¦of¦ ¦2¦ ¦march¦ ¦was¦ ¦ch ar ged¦ ¦with¦ ¦public¦ ¦order¦ ¦off en ces¦ ,▁ ¦as¦ ¦the¦ ¦univers ity¦ ¦of¦ ¦li mer ick¦ ¦w ar ned¦ ¦that¦ ¦any¦ ¦st ud ent¦ ¦who¦ ¦were¦ ¦found¦ ¦brea king¦ ¦the¦ ¦univers ity¦ ' ¦s¦ ¦co de¦ ¦of¦ ¦con duc t¦ ¦could¦ ¦face¦ ¦temp or ary¦ ¦susp e ns ion¦ ¦or¦ ¦exp ul s ion¦ ,▁ ¦while¦ ¦minister¦ ¦for¦ ¦j u st ice¦ ¦h el en¦ ¦m c en te e¦ ¦ ur ged¦ ¦y ou ng¦ ¦people¦ ¦to¦ ¦comp ly¦ ¦with¦ ¦covid¦ - ¦19¦ ¦restrictions¦ .
𐋇 ¦j a ke¦ ¦ mer r im an¦ ,▁ ¦a¦ ¦30¦ - ¦year¦ - ¦o ld¦ ¦m an¦ ,▁ ¦app e ared¦ ¦in¦ ¦co ur t¦ ¦ch ar ged¦ ¦in¦ ¦con ne ction¦ ¦with¦ ¦a¦ ¦fi re w or k¦ ¦att ack¦ ¦on¦ ¦gardaí¦ ¦at¦ ¦an¦ ¦anti ¦ - ¦lockdown¦ ¦prot est¦ ¦in¦ ¦dublin¦ ¦city¦ ¦centre¦ ¦on¦ ¦2 7¦ ¦february¦ .
¦4¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦4 6 2¦ ¦cases¦ ¦and¦ ¦3 9¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 21¦ , ¦6 4 9¦ ¦cases¦ ¦and¦ ¦4¦ , ¦3 9 6¦ ¦deaths¦ .
¦2¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦dep ut y¦ ¦ch ief¦ ¦medical¦ ¦offic er¦ ¦r on an¦ ¦gl y n n¦ ¦announced¦ ¦that¦ ¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦was¦ ¦made¦ ¦a w are¦ ¦of¦ ¦four¦ ¦pre li min ary¦ ¦rep orts¦ ¦of¦ ¦s ti ll b ir ths¦ ¦in¦ ¦ireland¦ ¦that¦ ¦could¦ ¦pote nt ially¦ ¦be¦ ¦associated¦ ¦with¦ ¦a¦ ¦c ond ition¦ ¦called¦ ¦covid¦ ¦pla ce nt itis¦ .
𐋇¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦confirmed¦ ¦that¦ ¦a¦ ¦si ng le¦ ¦outbreak¦ ¦of¦ ¦covid¦ - ¦19¦ ¦among¦ ¦students¦ ¦in¦ ¦the¦ ¦w est¦ ¦of¦ ¦the¦ ¦country¦ ¦had¦ ¦l ed¦ ¦to¦ ¦more¦ ¦than¦ ¦4 4 2¦ ¦further¦ ¦cases¦ ¦in¦ ¦more¦ ¦than¦ ¦2 00¦ ¦separ ate¦ ¦hou se ho ld¦ ¦out b rea ks¦ ,▁ ¦invol ving¦ ¦y ou ng¦ ¦ad ul ts¦ ¦a ged¦ ¦18¦ ¦to¦ ¦24¦ .
¦5¦ ¦march¦ ▁–▁ ¦a¦ ¦further¦ ¦5 2 2¦ ¦cases¦ ¦and¦ ¦9¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦22 2¦ , ¦1 6 0¦ ¦cases¦ ¦and¦ ¦4¦ , ¦4 0 5¦ ¦deaths¦ .
¦2¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦6¦ ¦march¦
¦9¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦ta o is ea ch¦ ¦mi che á l¦ ¦ma rt in¦ ¦announced¦ ¦that¦ ¦ireland¦ ¦had¦ ¦rea ched¦ ¦the¦ ¦mi le st one¦ ¦of¦ ¦h al f¦ ¦a¦ ¦million¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦admin ist ered¦ .
𐋇 ¦gardaí¦ ¦arr ested¦ ¦6¦ ¦people¦ ▁( ¦5¦ ¦m en¦ ¦and¦ ¦1¦ ¦wom an¦ )▁ ¦as¦ ¦around¦ ¦4 5 0¦ ¦people¦ ¦att e nded¦ ¦an¦ ¦anti ¦ - ¦lockdown¦ ¦prot est¦ ¦in¦ ¦cor k¦ ¦city¦ ¦centre¦ ¦that¦ ¦e nded¦ ¦without¦ ¦inc ident¦ .
¦5¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦pres ident¦ ¦mi ch a e l¦ ¦ d¦ .
𐋇 ¦hi gg ins¦ ¦sign ed¦ ¦into¦ ¦la w¦ ¦the¦ ¦le g is l ation¦ ¦to¦ ¦br ing¦ ¦in¦ ¦mand atory¦ ¦ho te l¦ ¦quarantine¦ ¦for¦ ¦c er tain¦ ¦p as se ng ers¦ ¦ent ering¦ ¦the¦ ¦country¦ ¦from¦ ¦high¦ - ¦risk¦ ¦countries¦ .
¦8¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦4 3 7¦ ¦cases¦ ¦and¦ ¦no¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦22 3¦ , ¦6 5 1¦ ¦cases¦ ¦and¦ ¦4¦ , ¦4 2 2¦ ¦deaths¦ .
¦5¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦health¦ ¦information¦ ¦and¦ ¦qu ality¦ ¦author ity¦ ▁( ¦hi q a¦ )▁ ¦ad vi sed¦ ¦the¦ ¦national¦ ¦public¦ ¦health¦ ¦emergency¦ ¦team¦ ¦that¦ ¦the¦ ¦d ur ation¦ ¦of¦ ¦immun ity¦ ¦following¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦should¦ ¦be¦ ¦consid ered¦ ¦to¦ ¦be¦ ¦si x¦ ¦mon ths¦ .
𐋇 ¦around¦ ¦100¦ , ¦000¦ ¦children¦ ¦retur ned¦ ¦to¦ ¦pr e¦ - ¦school¦ ¦under¦ ¦the¦ ¦early¦ ¦ch ild h ood¦ ¦care¦ ¦and¦ ¦education¦ ¦s che me¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦education¦ ¦and¦ ¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦confirmed¦ ¦that¦ ¦the¦ ¦g rad ual¦ ¦ph a sed¦ ¦reop ening¦ ¦of¦ ¦schools¦ ¦would¦ ¦pro ce ed¦ ¦as¦ ¦pl an ned¦ ¦with¦ ¦all¦ ¦pr imary¦ ¦p u p il s¦ ¦and¦ ¦f if th¦ ¦year¦ ¦students¦ ¦retur ning¦ ¦to¦ ¦school¦ ¦on¦ ¦15¦ ¦march¦ .
¦9¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦3 1 1¦ ¦cases¦ ¦and¦ ¦30¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦22 3¦ , ¦9 5 7¦ ¦cases¦ ¦and¦ ¦4¦ , ¦4 5 2¦ ¦deaths¦ .
¦5¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦a¦ ¦further¦ ¦three¦ ¦cases¦ ¦of¦ ¦the¦ ¦b ra z i li an¦ ¦vari ant¦ ¦were¦ ¦detected¦ ¦in¦ ¦the¦ ¦country¦ ,▁ ¦bringing¦ ¦the¦ ¦total¦ ¦to¦ ¦6¦ .
𐋇 ¦minister¦ ¦for¦ ¦education¦ ¦n orm a¦ ¦fo le y¦ ¦l ost¦ ¦ her¦ ¦app e als¦ ¦against¦ ¦fi nd ings¦ ¦that¦ ¦two¦ ¦home¦ - ¦sc ho ol ed¦ ¦students¦ ¦were¦ ¦un fa ir ly¦ ¦ex c lu ded¦ ¦from¦ ¦the¦ ¦lea ving¦ ¦ce rt ific ate¦ ¦c al c ul ated¦ ¦g ra des¦ ¦proc ess¦ .
¦10¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦6 3 1¦ ¦cases¦ ¦and¦ ¦4 7¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦22 4¦ , ¦5 8 8¦ ¦cases¦ ¦and¦ ¦4¦ , ¦4 9 9¦ ¦deaths¦ .
𐋇 ¦ta o is ea ch¦ ¦mi che á l¦ ¦ma rt in¦ ¦confirmed¦ ¦that¦ ¦ireland¦ ¦was¦ ¦to¦ ¦receive¦ ¦a¦ ¦further¦ ¦4 6¦ , ¦5 00¦ ¦doses¦ ¦of¦ ¦the¦ ¦p f iz er¦ ▁–▁ ¦bi on te ch¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦before¦ ¦the¦ ¦end¦ ¦of¦ ¦march¦ .
¦11¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦5 9 2¦ ¦cases¦ ¦and¦ ¦10¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦22 5¦ , ¦1 7 9¦ ¦cases¦ ¦and¦ ¦4¦ , ¦5 0 9¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦case¦ ¦was¦ ¦de¦ - ¦notified¦ .
𐋇 ¦ireland¦ ¦offic ially¦ ¦mark ed¦ ¦one¦ ¦year¦ ¦since¦ ¦the¦ ¦first¦ ¦death¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦the¦ ¦country¦ ¦was¦ ¦confirmed¦ ¦on¦ ¦11¦ ¦march¦ ¦2020¦ ,▁ ¦the¦ ¦same¦ ¦day¦ ¦when¦ ¦covid¦ - ¦19¦ ¦was¦ ¦decl ared¦ ¦a¦ ¦pandemic¦ .
𐋇 ¦under¦ ¦new¦ ¦nu rs ing¦ ¦home¦ ¦visi t ation¦ ¦gu id ance¦ ¦appr oved¦ ¦by¦ ¦the¦ ¦national¦ ¦public¦ ¦health¦ ¦emergency¦ ¦team¦ ,▁ ¦res id ents¦ ¦in¦ ¦nu rs ing¦ ¦h omes¦ ¦would¦ ¦be¦ ¦p erm it ted¦ ¦two¦ ¦visi ts¦ ¦per¦ ¦week¦ ¦on¦ ¦general¦ ¦comp as si on ate¦ ¦grou n ds¦ ¦from¦ ¦2 2¦ ¦march¦ .
¦12¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦6 4 6¦ ¦cases¦ ¦and¦ ¦10¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦22 5¦ , ¦8 2 0¦ ¦cases¦ ¦and¦ ¦4¦ , ¦5 1 8¦ ¦deaths¦ .
¦5¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦l at est¦ ¦f ig ures¦ ¦sh owed¦ ¦that¦ ¦as¦ ¦of¦ ¦11¦ ¦march¦ ,▁ ¦gardaí¦ ¦had¦ ¦issued¦ ¦over¦ ¦13¦ , ¦6 00¦ ¦fines¦ ¦to¦ ¦people¦ ¦brea c hing¦ ¦covid¦ - ¦19¦ ¦regul ations¦ ,▁ ¦with¦ ¦over¦ ¦10¦ , ¦0 1 3¦ ¦fines¦ ¦issued¦ ¦for¦ ¦non¦ - ¦essential¦ ¦travel¦ ¦and¦ ¦2¦ , ¦0 4 0¦ ¦fines¦ ¦issued¦ ¦for¦ ¦att ending¦ ¦or¦ ¦h os ting¦ ¦house¦ ¦part ies¦ .
𐋇 ¦gardaí¦ ¦confirmed¦ ¦that¦ ¦two¦ ¦people¦ ¦were¦ ¦arr ested¦ ¦and¦ ¦more¦ ¦than¦ ¦8 0¦ ¦fines¦ ¦were¦ ¦issued¦ ¦after¦ ¦around¦ ¦3 00¦ ¦people¦ ¦ga th ered¦ ¦for¦ ¦the¦ ¦f un er al¦ ¦of¦ ¦a¦ ¦y ou ng¦ ¦tra ve ll er¦ ¦m an¦ ¦in¦ ¦c arr ick¦ - ¦on¦ - ¦sh an n on¦ ¦on¦ ¦11¦ ¦march¦ ,▁ ¦d esp ite¦ ¦level¦ ¦5¦ ¦restrictions¦ ¦limi ting¦ ¦mo ur n ers¦ ¦to¦ ¦10¦ ¦people¦ .
𐋇¦n ine¦ ¦res id ents¦ ¦at¦ ¦a¦ ¦nu rs ing¦ ¦home¦ ¦with¦ ¦an¦ ¦outbreak¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦t ri m¦ ,▁ ¦county¦ ¦m ea th¦ ¦d ied¦ ¦after¦ ¦the¦ ¦first¦ ¦doses¦ ¦of¦ ¦a¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦were¦ ¦admin ist ered¦ ¦there¦ .
¦13¦ ¦march¦ ▁–▁ ¦a¦ ¦further¦ ¦5 4 3¦ ¦cases¦ ¦and¦ ¦16¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦22 6¦ , ¦3 5 8¦ ¦cases¦ ¦and¦ ¦4¦ , ¦5 3 4¦ ¦deaths¦ .
¦5¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦14¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦3 8 4¦ ¦cases¦ ¦and¦ ¦no¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦22 6¦ , ¦7 4 1¦ ¦cases¦ ¦and¦ ¦4¦ , ¦5 3 4¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦case¦ ¦was¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦admin i str ation¦ ¦of¦ ¦the¦ ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦was¦ ¦susp e nded¦ ¦in¦ ¦ireland¦ ¦by¦ ¦the¦ ¦national¦ ¦immun is ation¦ ¦ad v is ory¦ ¦comm it te e¦ ▁( ¦n ia c¦ )▁ ¦as¦ ¦a¦ ¦pr ec a u tion ary¦ ¦me as ure¦ ¦following¦ ¦concer ns¦ ¦over¦ ¦ser ious¦ ¦blood¦ ¦c lo ts¦ ¦in¦ ¦n or w ay¦ .
𐋇 ¦two¦ ¦m en¦ ¦in¦ ¦their¦ ¦20 s¦ ¦were¦ ¦ch ar ged¦ ¦after¦ ¦three¦ ¦gardaí¦ ¦were¦ ¦ass a ul ted¦ ¦following¦ ¦a¦ ¦house¦ ¦part y¦ ¦in¦ ¦m il for d¦ ,▁ ¦county¦ ¦do ne g al¦ ¦on¦ ¦13¦ ¦march¦ .
¦15¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦5 7 5¦ ¦cases¦ ¦and¦ ¦no¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦22 7¦ , ¦3 1 6¦ ¦cases¦ ¦and¦ ¦4¦ , ¦5 3 4¦ ¦deaths¦ .
𐋇 ¦over¦ ¦3 5 0¦ , ¦000¦ ¦rem aining¦ ¦pr imary¦ ¦school¦ ¦p u p il s¦ ¦and¦ ¦f if th¦ ¦year¦ ¦students¦ ¦na tion w ide¦ ¦retur ned¦ ¦to¦ ¦school¦ ¦for¦ ¦the¦ ¦first¦ ¦time¦ ¦since¦ ¦ch r ist ma s¦ .
¦30¦ , ¦000¦ ¦fe w er¦ ¦people¦ ¦received¦ ¦a¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦from¦ ¦15¦ ¦march¦ ¦due¦ ¦to¦ ¦the¦ ¦temp or ary¦ ¦susp e ns ion¦ ¦of¦ ¦the¦ ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦in¦ ¦ireland¦ .
¦16¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦3 4 9¦ ¦cases¦ ¦and¦ ¦18¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦22 7¦ , ¦6 6 3¦ ¦cases¦ ¦and¦ ¦4¦ , ¦5 5 2¦ ¦deaths¦ .
¦2¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦gard a¦ ¦s í o ch á na¦ ¦ ur ged¦ ¦people¦ ¦to¦ ¦stay¦ ¦at¦ ¦home¦ ¦for¦ ¦s t¦ ¦p at r ick¦ ' ¦s¦ ¦day¦ ¦as¦ ¦a¦ ¦sign ific ant¦ ¦pol ic ing¦ ¦op er ation¦ ¦was¦ ¦p ut¦ ¦in¦ ¦place¦ ¦to¦ ¦de al¦ ¦with¦ ¦pl an ned¦ ¦prote sts¦ ¦in¦ ¦dublin¦ ¦city¦ ¦with¦ ¦2¦ , ¦5 00¦ ¦gardaí¦ ¦being¦ ¦dep lo y ed¦ ¦across¦ ¦the¦ ¦country¦ .
𐋇¦l at est¦ ¦f ig ures¦ ¦rel ea sed¦ ¦by¦ ¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦sh owed¦ ¦that¦ ¦1¦ , ¦8 4 2¦ ¦tests¦ ¦for¦ ¦covid¦ - ¦19¦ ¦were¦ ¦c arr ied¦ ¦out¦ ¦in¦ ¦1 0 8¦ ¦schools¦ ¦in¦ ¦the¦ ¦p ast¦ ¦7¦ ¦days¦ ,▁ ¦with¦ ¦4 4¦ ¦positive¦ ¦cases¦ ¦confirmed¦ ¦in¦ ¦pr imary¦ ,▁ ¦sec ond ary¦ ¦and¦ ¦spec ial¦ ¦schools¦ ¦across¦ ¦the¦ ¦country¦ .
¦1 7¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦5 5 7¦ ¦cases¦ ¦and¦ ¦1 7¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦22 8¦ , ¦2 1 5¦ ¦cases¦ ¦and¦ ¦4¦ , ¦5 6 6¦ ¦deaths¦ .
¦2¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦gardaí¦ ¦arr ested¦ ¦ 21¦ ¦people¦ ¦after¦ ¦around¦ ¦7 00¦ ¦prote st ors¦ ¦t ook¦ ¦par t¦ ¦in¦ ¦a¦ ¦number¦ ¦of¦ ¦anti ¦ - ¦lockdown¦ ¦prote sts¦ ¦in¦ ¦dublin¦ ¦city¦ ¦centre¦ ,▁ ¦h er b er t¦ ¦par k¦ ¦and¦ ¦at¦ ¦the¦ ¦ rt é ¦ ¦ca mp us¦ ¦in¦ ¦d on n y b r ook¦ .
¦18¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦5 8 2¦ ¦cases¦ ¦and¦ ¦no¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦22 8¦ , ¦7 9 6¦ ¦cases¦ ¦and¦ ¦4¦ , ¦5 6 6¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦case¦ ¦was¦ ¦de¦ - ¦notified¦ .
𐋇¦it¦ ¦was¦ ¦confirmed¦ ¦that¦ ¦7¦ ¦gardaí¦ ¦were¦ ¦in j ur ed¦ ▁( ¦including¦ ¦five¦ ¦hosp i tali sed¦ )▁ ¦after¦ ¦being¦ ¦k ic ked¦ ,▁ ¦p un ched¦ ¦and¦ ¦sp at¦ ¦at¦ ¦in¦ ¦separ ate¦ ¦ vi ol ent¦ ¦anti ¦ - ¦lockdown¦ ¦prote sts¦ ¦which¦ ¦t ook¦ ¦place¦ ¦in¦ ¦dublin¦ ¦on¦ ¦s t¦ ¦p at r ick¦ ' ¦s¦ ¦day¦ .
¦19¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦5 0 7¦ ¦cases¦ ▁( ¦including¦ ¦3¦ ¦prob able¦ ¦cases¦ )▁ ¦and¦ ¦10¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦22 9¦ , ¦3 6 0¦ ¦cases¦ ¦and¦ ¦4¦ , ¦5 7 6¦ ¦deaths¦ .
¦5 7¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦national¦ ¦immun is ation¦ ¦ad v is ory¦ ¦comm it te e¦ ▁( ¦n ia c¦ )▁ ¦recommended¦ ¦that¦ ¦the¦ ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦could¦ ¦continue¦ ¦to¦ ¦be¦ ¦used¦ ¦in¦ ¦ireland¦ ¦following¦ ¦appr ov al¦ ¦from¦ ¦the¦ ¦european¦ ¦medic ines¦ ¦a ge ncy¦ ▁( ¦e m a¦ )▁ ¦on¦ ¦18¦ ¦march¦ .
𐋇¦l at est¦ ¦f ig ures¦ ¦sh owed¦ ¦that¦ ¦as¦ ¦of¦ ¦18¦ ¦march¦ ,▁ ¦gardaí¦ ¦had¦ ¦issued¦ ¦over¦ ¦15¦ , ¦3 5 8¦ ¦fines¦ ¦to¦ ¦people¦ ¦brea c hing¦ ¦covid¦ - ¦19¦ ¦regul ations¦ ,▁ ¦with¦ ¦over¦ ¦11¦ , ¦0 7 2¦ ¦fines¦ ¦issued¦ ¦for¦ ¦non¦ - ¦essential¦ ¦travel¦ ¦and¦ ¦over¦ ¦2¦ , ¦3 00¦ ¦fines¦ ¦issued¦ ¦for¦ ¦att ending¦ ¦or¦ ¦h os ting¦ ¦house¦ ¦part ies¦ .
¦20¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦5 2 5¦ ¦cases¦ ¦and¦ ¦9¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦22 9¦ , ¦8 3 1¦ ¦cases¦ ¦and¦ ¦4¦ , ¦5 8 5¦ ¦deaths¦ .
𐋇¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦res u med¦ ¦admin ist ering¦ ¦the¦ ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦at¦ ¦a¦ ¦number¦ ¦of¦ ¦hosp it als¦ ¦across¦ ¦the¦ ¦country¦ ¦after¦ ¦a¦ ¦pr ec a u tion ary¦ ¦pa use¦ .
𐋇 ¦gardaí¦ ¦arr ested¦ ¦11¦ ¦people¦ ¦and¦ ¦issued¦ ¦a¦ ¦number¦ ¦of¦ ¦fines¦ ¦after¦ ¦around¦ ¦2 00¦ ¦prote st ors¦ ¦t ook¦ ¦par t¦ ¦in¦ ¦an¦ ¦anti ¦ - ¦lockdown¦ ¦prot est¦ ¦in¦ ¦the¦ ¦p ho en i x¦ ¦par k¦ ¦in¦ ¦dublin¦ ¦city¦ ¦centre¦ .
¦ 21¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦7 6 9¦ ¦cases¦ ¦and¦ ¦2¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 3 0¦ , ¦5 9 9¦ ¦cases¦ ¦and¦ ¦4¦ , ¦5 8 7¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦case¦ ¦was¦ ¦de¦ - ¦notified¦ .
𐋇 ¦minister¦ ¦for¦ ¦public¦ ¦exp end it ure¦ ¦and¦ ¦re for m¦ ¦mi ch a e l¦ ¦m c g ra th¦ ¦stated¦ ¦that¦ ¦mand atory¦ ¦ho te l¦ ¦quarantine¦ ¦for¦ ¦tra ve ll ers¦ ¦ar ri ving¦ ¦into¦ ¦ireland¦ ¦from¦ ¦de si gn ated¦ ¦countries¦ ¦would¦ ¦come¦ ¦into¦ ¦eff ect¦ ¦by¦ ¦the¦ ¦end¦ ¦of¦ ¦the¦ ¦week¦ .
¦2 2¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦5 2 0¦ ¦cases¦ ¦and¦ ¦1¦ ¦death¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 3 1¦ , ¦1 1 9¦ ¦cases¦ ¦and¦ ¦4¦ , ¦5 8 8¦ ¦deaths¦ .
𐋇 ¦sp ea king¦ ¦on¦ ¦ rt é ¦ ' ¦s¦ ¦m or ning¦ ¦ireland¦ ,▁ ¦pro f e ss or¦ ¦ma rt in¦ ¦c orm ic an¦ ¦w ar ned¦ ¦that¦ ¦ireland¦ ¦could¦ ¦be¦ ¦f ac ing¦ ¦another¦ ¦w a ve¦ ¦of¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦and¦ ¦d esc rib ed¦ ¦case¦ ¦nu mbers¦ ¦as¦ ▁" ¦st uc k¦ "▁ ¦and¦ ¦p os si b ly¦ ¦r ising¦ ,▁ ¦while¦ ¦ch ief¦ ¦clinical¦ ¦offic er¦ ¦c ol m¦ ¦h en ry¦ ¦d esc rib ed¦ ¦the¦ ¦s itu ation¦ ¦as¦ ▁" ¦dis h ea rt ening¦ " .
𐋇¦it¦ ¦was¦ ¦announced¦ ¦that¦ ¦pres ident¦ ¦mi ch a e l¦ ¦ d¦ .
𐋇 ¦hi gg ins¦ ¦and¦ ¦hi s¦ ¦w ife¦ ¦s ab i na¦ ¦hi gg ins¦ ¦received¦ ¦their¦ ¦first¦ ¦doses¦ ¦of¦ ¦a¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦on¦ ¦19¦ ¦march¦ .
𐋇¦a¦ ¦pr imary¦ ¦school¦ ¦in¦ ¦c arr ick¦ - ¦on¦ - ¦su i r¦ ,▁ ¦county¦ ¦ti pp er ary¦ ¦closed¦ ¦after¦ ¦two¦ ¦positive¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦were¦ ¦confirmed¦ .
¦23¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦3 7 1¦ ¦cases¦ ¦and¦ ¦24¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 3 1¦ , ¦4 8 4¦ ¦cases¦ ¦and¦ ¦4¦ , ¦6 1 0¦ ¦deaths¦ .
¦2¦ ¦previously¦ ¦notified¦ ¦deaths¦ ¦and¦ ¦6¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦b oo king¦ ¦p ort al¦ ¦for¦ ¦mand atory¦ ¦ho te l¦ ¦quarantine¦ ¦in¦ ¦ireland¦ ¦op e ned¦ ¦for¦ ¦those¦ ¦ar ri ving¦ ¦into¦ ¦the¦ ¦country¦ ¦from¦ ¦f ri day¦ ¦26¦ ¦march¦ ,▁ ¦with¦ ¦a¦ ¦12¦ - ¦n ight¦ ¦stay¦ ¦for¦ ¦p as se ng ers¦ ¦ar ri ving¦ ¦from¦ ¦high¦ ¦risk¦ ¦countries¦ ¦c os ting¦ ▁ € ¦1¦ , ¦8 7 5¦ ¦each¦ .
𐋇 ¦si x¦ ¦cl as ses¦ ¦were¦ ¦s ent¦ ¦home¦ ¦from¦ ¦a¦ ¦pr imary¦ ¦school¦ ¦in¦ ¦county¦ ¦lo ng for d¦ ¦after¦ ¦five¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦were¦ ¦confirmed¦ .
𐋇¦a¦ ¦cl ass¦ ¦was¦ ¦s ent¦ ¦home¦ ¦following¦ ¦an¦ ¦outbreak¦ ¦of¦ ¦covid¦ - ¦19¦ ¦at¦ ¦a¦ ¦pr imary¦ ¦school¦ ¦in¦ ¦dublin¦ .
¦24¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦6 8 3¦ ¦cases¦ ¦and¦ ¦18¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 3 2¦ , ¦1 6 4¦ ¦cases¦ ¦and¦ ¦4¦ , ¦6 2 8¦ ¦deaths¦ .
¦4¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦government¦ ¦of¦ ¦ireland¦ ¦announced¦ ¦that¦ ¦five¦ ¦new¦ ¦w alk¦ - ¦in¦ ¦covid¦ - ¦19¦ ¦test¦ ¦centr es¦ ¦would¦ ¦open¦ ¦in¦ ¦dublin¦ ¦and¦ ¦off a ly¦ ¦on¦ ¦2 5¦ ¦march¦ ¦in¦ ¦an¦ ¦eff ort¦ ¦to¦ ¦br ing¦ ¦down¦ ¦cases¦ ¦that¦ ¦are¦ ¦high¦ ¦in¦ ¦c er tain¦ ¦areas¦ .
𐋇¦the¦ ¦national¦ ¦public¦ ¦health¦ ¦emergency¦ ¦team¦ ▁( ¦n ph et¦ )▁ ¦po st p o ned¦ ¦a¦ ¦k e y¦ ¦m ee ting¦ ¦on¦ ¦dec i ding¦ ¦wh ether¦ ¦any¦ ¦level¦ ¦5¦ ¦restrictions¦ ¦could¦ ¦be¦ ¦ ea sed¦ ¦from¦ ¦5¦ ¦april¦ ¦so¦ ¦that¦ ¦l at est¦ ¦tr ends¦ ¦in¦ ¦covid¦ - ¦19¦ ¦data¦ ¦could¦ ¦be¦ ¦ta k en¦ ¦into¦ ¦acc o un t¦ ¦in¦ ¦its¦ ¦f in al¦ ¦anal y sis¦ ¦for¦ ¦the¦ ¦government¦ .
𐋇¦the¦ ¦state¦ ¦ex a min ations¦ ¦comm i ssion¦ ¦and¦ ¦minister¦ ¦for¦ ¦education¦ ¦n orm a¦ ¦fo le y¦ ¦issued¦ ¦new¦ ¦gu id el ines¦ ¦to¦ ¦schools¦ ¦ad v ising¦ ¦that¦ ¦face¦ ¦co ver ings¦ ¦would¦ ¦be¦ ¦required¦ ¦during¦ ¦the¦ ¦lea ving¦ ¦ce rt ific ate¦ ¦or al¦ ¦ex a ms¦ ,▁ ¦which¦ ¦beg in¦ ¦on¦ ¦f ri day¦ ¦26¦ ¦march¦ .
𐋇¦a¦ ¦m an¦ ¦was¦ ¦arr ested¦ ¦after¦ ▁ € ¦1 4 0¦ , ¦000¦ ¦wor th¦ ¦of¦ ¦suspected¦ ¦c an n ab i s¦ ¦h er b ¦ ¦was¦ ¦se i zed¦ ¦during¦ ¦a¦ ¦chec k p o in t¦ ¦op er ation¦ ¦in¦ ¦county¦ ¦cor k¦ .
¦2 5¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦6 0 6¦ ¦cases¦ ¦and¦ ¦3¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 3 2¦ , ¦7 5 8¦ ¦cases¦ ¦and¦ ¦4¦ , ¦6 3 1¦ ¦deaths¦ .
𐋇 ¦ne arly¦ ¦1¦ , ¦7 00¦ ¦people¦ ¦att e nded¦ ¦the¦ ¦five¦ ¦new¦ ¦temp or ary¦ ¦w alk¦ - ¦in¦ ¦covid¦ - ¦19¦ ¦testing¦ ¦centr es¦ ¦for¦ ¦people¦ ¦with¦ ¦no¦ ¦symptoms¦ ¦op er ated¦ ¦by¦ ¦the¦ ¦national¦ ¦a mb ul ance¦ ¦service¦ ¦that¦ ¦op e ned¦ ¦in¦ ¦dublin¦ ¦and¦ ¦off a ly¦ .
𐋇¦t á na ist e¦ ¦le o¦ ¦v a rad k a r¦ ¦to ld¦ ¦the¦ ¦d á il¦ ¦that¦ ¦getting¦ ¦daily¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦to¦ ¦the¦ ¦low¦ ¦nu mbers¦ ¦a ch ie v ed¦ ¦last¦ ¦year¦ ¦was¦ ▁" ¦not¦ ¦a¦ ¦pr os p ect¦ "▁ ¦due¦ ¦to¦ ¦the¦ ¦b ¦ . ¦1¦ . ¦1¦ . ¦7¦ ¦vari ant¦ ¦and¦ ¦that¦ ¦it¦ ¦was¦ ▁" ¦very¦ ¦h ard¦ ¦to¦ ¦se e¦ "▁ ¦how¦ ¦it¦ ¦was¦ ¦possible¦ ¦to¦ ¦sec ure¦ ¦a¦ ¦rate¦ ¦lower¦ ¦than¦ ¦5 00¦ ¦cases¦ ¦per¦ ¦day¦ ,▁ ¦d esp ite¦ ▁" ¦the¦ ¦en or mo us¦ ¦eff orts¦ ¦of¦ ¦the¦ ¦ir ish¦ ¦people¦ " .
¦26¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦5 8 4¦ ¦cases¦ ¦and¦ ¦20¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 3 3¦ , ¦3 2 7¦ ¦cases¦ ¦and¦ ¦4¦ , ¦6 5 1¦ ¦deaths¦ .
¦15¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦ireland¦ ' ¦s¦ ¦mand atory¦ ¦ho te l¦ ¦quarantine¦ ¦system¦ ¦for¦ ¦all¦ ¦p as se ng ers¦ ¦ar ri ving¦ ¦into¦ ¦the¦ ¦country¦ ¦from¦ ¦high¦ - ¦risk¦ ¦countries¦ ¦ca me¦ ¦into¦ ¦for ce¦ ¦at¦ ¦4¦ ¦ am¦ .
𐋇¦the¦ ¦lea der¦ ¦of¦ ¦the¦ ¦l ab ou r¦ ¦part y¦ ¦al an¦ ¦k el ly¦ ¦called¦ ¦for¦ ¦the¦ ¦ch ief¦ ¦ex ecu tive¦ ¦of¦ ¦the¦ ¦be ac on¦ ¦hospital¦ ¦to¦ ¦res ign¦ ¦after¦ ¦it¦ ¦ga ve¦ ¦20¦ ¦le f t o ver¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦to¦ ¦a¦ ¦number¦ ¦of¦ ¦t ea ch ers¦ ¦and¦ ¦staff¦ ¦at¦ ¦a¦ ¦priv ate¦ ¦sec ond ary¦ ¦school¦ ¦in¦ ¦br ay¦ ,▁ ¦county¦ ¦w ick l ow¦ ¦on¦ ¦23¦ ¦march¦ .
𐋇¦l at est¦ ¦f ig ures¦ ¦sh owed¦ ¦that¦ ¦as¦ ¦of¦ ¦2 5¦ ¦march¦ ,▁ ¦gardaí¦ ¦had¦ ¦issued¦ ¦over¦ ¦16¦ , ¦8 3 4¦ ¦fines¦ ¦to¦ ¦people¦ ¦brea c hing¦ ¦covid¦ - ¦19¦ ¦regul ations¦ ,▁ ¦with¦ ¦over¦ ¦12¦ , ¦3 3 6¦ ¦fines¦ ¦issued¦ ¦for¦ ¦non¦ - ¦essential¦ ¦travel¦ ¦and¦ ¦over¦ ¦2¦ , ¦7 00¦ ¦fines¦ ¦issued¦ ¦for¦ ¦att ending¦ ¦or¦ ¦h os ting¦ ¦house¦ ¦part ies¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦education¦ ¦confirmed¦ ¦that¦ ¦the¦ ¦f in al¦ ¦ph ase¦ ¦of¦ ¦the¦ ¦g rad ual¦ ¦reop ening¦ ¦of¦ ¦schools¦ ¦would¦ ¦pro ce ed¦ ¦as¦ ¦pl an ned¦ ¦with¦ ¦all¦ ¦rem aining¦ ¦sec ond ary¦ ¦school¦ ¦students¦ ¦retur ning¦ ¦to¦ ¦school¦ ¦after¦ ¦the¦ ¦e as ter¦ ¦h ol id ays¦ ¦on¦ ¦12¦ ¦april¦ .
𐋇¦a¦ ¦number¦ ¦of¦ ¦students¦ ¦were¦ ¦as ked¦ ¦to¦ ¦stay¦ ¦at¦ ¦home¦ ¦after¦ ¦mult ip le¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦were¦ ¦confirmed¦ ¦at¦ ¦a¦ ¦sec ond ary¦ ¦school¦ ¦in¦ ¦li mer ick¦ .
¦2 7¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦6 2 4¦ ¦cases¦ ¦and¦ ¦2¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 3 3¦ , ¦9 3 7¦ ¦cases¦ ¦and¦ ¦4¦ , ¦6 5 3¦ ¦deaths¦ .
¦14¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦minister¦ ¦for¦ ¦health¦ ¦ste ph en¦ ¦d on n el ly¦ ¦re qu ested¦ ¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦to¦ ¦susp end¦ ¦vaccine¦ ¦op er ations¦ ¦at¦ ¦the¦ ¦be ac on¦ ¦hospital¦ ¦following¦ ¦cont ro ve rs y¦ ¦after¦ ¦20¦ ¦t ea ch ers¦ ¦received¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦at¦ ¦the¦ ¦priv ate¦ ¦hospital¦ .
𐋇 ¦gardaí¦ ¦beg an¦ ¦an¦ ¦in ve st ig ation¦ ¦after¦ ¦three¦ ¦people¦ ¦ab s c o nded¦ ¦from¦ ¦a¦ ¦mand atory¦ ¦ho te l¦ ¦quarantine¦ ¦facil ity¦ ¦n ear¦ ¦dublin¦ ¦air p ort¦ ¦while¦ ¦on¦ ¦a¦ ¦s mo king¦ ¦brea k¦ ¦outside¦ ¦under¦ ¦su p erv is ion¦ ,▁ ¦with¦ ¦one¦ ¦person¦ ¦loc ated¦ .
𐋇¦a¦ ¦family¦ ¦of¦ ¦five¦ ¦re ne w ed¦ ¦their¦ ¦app e al¦ ¦against¦ ¦their¦ ¦mand atory¦ ¦ho te l¦ ¦quarantine¦ ¦after¦ ¦they¦ ¦cl ai med¦ ¦the¦ ¦facil ities¦ ¦were¦ ¦not¦ ¦fi t¦ ¦for¦ ¦p ur p ose¦ ,▁ ¦following¦ ¦the¦ ¦re j e ction¦ ¦of¦ ¦their¦ ¦app e al¦ ¦by¦ ¦the¦ ¦department¦ ¦of¦ ¦j u st ice¦ .
¦2 8¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦6 0 4¦ ¦cases¦ ¦and¦ ¦13¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 3 4¦ , ¦5 4 1¦ ¦cases¦ ¦and¦ ¦4¦ , ¦6 6 6¦ ¦deaths¦ .
𐋇¦a¦ ¦second¦ ¦person¦ ¦who¦ ¦ab s c o nded¦ ¦from¦ ¦a¦ ¦mand atory¦ ¦ho te l¦ ¦quarantine¦ ¦facil ity¦ ¦on¦ ¦2 7¦ ¦march¦ ¦was¦ ¦loc ated¦ ,▁ ¦while¦ ¦a¦ ¦s ear ch¦ ¦for¦ ¦the¦ ¦thir d¦ ¦ma le¦ ¦contin u ed¦ .
¦2 9¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦5 3 9¦ ¦cases¦ ¦and¦ ¦1¦ ¦death¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 3 5¦ , ¦0 7 8¦ ¦cases¦ ¦and¦ ¦4¦ , ¦6 6 7¦ ¦deaths¦ .
¦2¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦l at est¦ ¦f ig ures¦ ¦rel ea sed¦ ¦by¦ ¦the¦ ¦centr al¦ ¦st at ist ics¦ ¦off ice¦ ¦sh owed¦ ¦that¦ ¦ser ious¦ ¦c ri me¦ ¦dro pp ed¦ ¦by¦ ¦over¦ ¦a¦ ¦thir d¦ ¦in¦ ¦2020¦ ¦during¦ ¦the¦ ¦pandemic¦ ,▁ ¦while¦ ¦over¦ ¦1¦ , ¦000¦ ¦brea ches¦ ¦of¦ ¦covid¦ - ¦19¦ ¦regul ations¦ ¦were¦ ¦c la ss if ied¦ ¦as¦ ¦cr im es¦ ¦by¦ ¦gardaí¦ ¦including¦ ¦the¦ ¦non¦ - ¦w earing¦ ¦of¦ ¦face¦ ¦co ver ings¦ ¦and¦ ¦international¦ ¦travel¦ .
¦30¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦3 6 8¦ ¦cases¦ ¦and¦ ¦14¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 3 5¦ , ¦4 4 4¦ ¦cases¦ ¦and¦ ¦4¦ , ¦6 8 1¦ ¦deaths¦ .
¦2¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦government¦ ¦of¦ ¦ireland¦ ¦announced¦ ¦a¦ ¦ph a sed¦ ¦e as ing¦ ¦of¦ ¦level¦ ¦5¦ ¦restrictions¦ ¦from¦ ¦mon day¦ ¦12¦ ¦april¦ ,▁ ¦with¦ ¦people¦ ¦all owed¦ ¦to¦ ¦travel¦ ¦within¦ ¦their¦ ¦county¦ ,▁ ¦two¦ ¦hou se h ol ds¦ ¦all owed¦ ¦to¦ ¦me et¦ ¦s oc ially¦ ¦out d o ors¦ ,▁ ¦people¦ ¦who¦ ¦are¦ ¦f ul ly¦ ¦vaccinated¦ ¦against¦ ¦covid¦ - ¦19¦ ¦all owed¦ ¦to¦ ¦me et¦ ¦other¦ ¦f ul ly¦ ¦vaccinated¦ ¦people¦ ¦ind o ors¦ ,▁ ¦and¦ ¦the¦ ¦res um ption¦ ¦of¦ ¦all¦ ¦res ide ntial¦ ¦con st ru ction¦ ¦pro j ects¦ ¦from¦ ¦that¦ ¦date¦ .
𐋇 ¦from¦ ¦19¦ ¦april¦ :
𐋇 ¦el ite¦ - ¦level¦ ¦sen i or¦ ¦ga a¦ ¦m at ches¦ ¦and¦ ¦tr aining¦ ¦could¦ ¦res u me¦
𐋇 ¦from¦ ¦26¦ ¦april¦ :
𐋇 ¦out door¦ ¦sp orts¦ ¦facil ities¦ ▁( ¦such¦ ¦as¦ ¦p it ches¦ ,▁ ¦g ol f¦ ¦co ur ses¦ ¦and¦ ¦t en n i s¦ ¦co ur ts¦ )▁ ¦could¦ ¦reop en¦
𐋇 ¦out door¦ ¦visi t or¦ ¦att r ac tions¦ ▁( ¦such¦ ¦as¦ ¦z oo s¦ ,▁ ¦open¦ ¦p et¦ ¦f ar ms¦ ,▁ ¦h er it age¦ ¦si tes¦ )▁ ¦could¦ ¦reop en¦
𐋇 ¦ma x im um¦ ¦att end ance¦ ¦at¦ ¦f un er als¦ ¦would¦ ¦increase¦ ¦from¦ ¦10¦ ¦to¦ ¦2 5¦ ¦on¦ ¦comp as si on ate¦ ¦grou n ds¦
𐋇 ¦from¦ ¦4¦ ¦may¦ :
𐋇¦f ul l¦ ¦reop ening¦ ¦of¦ ¦con st ru ction¦ ¦activ ity¦
𐋇 ¦ph a sed¦ ¦reop ening¦ ¦of¦ ¦non¦ - ¦essential¦ ¦re ta il¦ ¦and¦ ¦personal¦ ¦services¦
𐋇 ¦rel ig ious¦ ¦services¦ ,▁ ¦m u se u ms¦ ¦and¦ ¦ga ll er ies¦ ¦could¦ ¦reop en¦ ¦and¦ ¦res u me¦
𐋇¦the¦ ¦united¦ ¦states¦ ¦and¦ ¦a¦ ¦number¦ ¦of¦ ¦eu¦ ¦countries¦ ,▁ ¦including¦ ¦fra nce¦ ,▁ ¦g erm an y¦ ¦and¦ ¦italy¦ ,▁ ¦were¦ ¦recommended¦ ¦for¦ ¦inclu s ion¦ ¦in¦ ¦ireland¦ ' ¦s¦ ¦mand atory¦ ¦ho te l¦ ¦quarantine¦ ¦l ist¦ ¦in¦ ¦advice¦ ¦giv en¦ ¦to¦ ¦minister¦ ¦for¦ ¦health¦ ¦ste ph en¦ ¦d on n el ly¦ ¦by¦ ¦the¦ ¦national¦ ¦public¦ ¦health¦ ¦emergency¦ ¦team¦ .
𐋇 ¦minister¦ ¦for¦ ¦health¦ ¦ste ph en¦ ¦d on n el ly¦ ¦announced¦ ¦an¦ ¦up d ate¦ ¦to¦ ¦the¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦all oc ation¦ ¦stra te g y¦ ¦with¦ ¦pri or ity¦ ¦grou ps¦ ¦being¦ ¦chan ged¦ ¦to¦ ¦an¦ ¦age¦ - ¦based¦ ¦system¦ ¦after¦ ¦v ul n er able¦ ¦people¦ ¦with¦ ¦underlying¦ ¦conditions¦ ¦were¦ ¦vaccinated¦ .
𐋇¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦confirmed¦ ¦that¦ ¦three¦ ¦p as se ng ers¦ ¦sta ying¦ ¦in¦ ¦mand atory¦ ¦ho te l¦ ¦quarantine¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ .
¦3 1¦ ¦march¦
𐋇¦a¦ ¦further¦ ¦4 1 1¦ ¦cases¦ ¦and¦ ¦6¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 3 5¦ , ¦8 5 4¦ ¦cases¦ ¦and¦ ¦4¦ , ¦6 8 7¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦case¦ ¦was¦ ¦de¦ - ¦notified¦ .
𐋇 ¦ta o is ea ch¦ ¦mi che á l¦ ¦ma rt in¦ ¦confirmed¦ ¦that¦ ¦sho e¦ ¦sho ps¦ ¦would¦ ¦be¦ ¦all owed¦ ¦to¦ ¦s ell¦ ¦children¦ ' ¦s¦ ¦fo ot w ear¦ ¦by¦ ¦appointment¦ ¦only¦ .
𐋇¦the¦ ¦ta o is ea ch¦ ¦to ld¦ ¦the¦ ¦d á il¦ ¦that¦ ¦a¦ ¦national¦ ¦p ort al¦ ¦all owing¦ ¦for¦ ¦e veryone¦ ¦to¦ ¦reg is ter¦ ¦for¦ ¦a¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦would¦ ¦be¦ ¦available¦ ¦by¦ ¦the¦ ¦thir d¦ ¦week¦ ¦in¦ ¦april¦ .
𐋇¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦announced¦ ¦that¦ ¦se v en¦ ¦new¦ ¦w alk¦ - ¦in¦ ¦covid¦ - ¦19¦ ¦testing¦ ¦centr es¦ ¦for¦ ¦as ymptomatic¦ ¦people¦ ¦would¦ ¦open¦ ¦from¦ ¦april¦ ¦in¦ ¦dublin¦ ,▁ ¦m ea th¦ ,▁ ¦we st m ea th¦ ,▁ ¦k ild are¦ ¦and¦ ¦g al w ay¦ ¦in¦ ¦an¦ ¦eff ort¦ ¦to¦ ¦br ing¦ ¦down¦ ¦cases¦ ¦that¦ ¦are¦ ¦high¦ ¦in¦ ¦c er tain¦ ¦areas¦ .
𐋇 ¦april¦ ¦2021¦
¦1¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦7 6 1¦ ¦cases¦ ¦and¦ ¦18¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 3 6¦ , ¦6 00¦ ¦cases¦ ¦and¦ ¦4¦ , ¦7 0 5¦ ¦deaths¦ .
¦15¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦dep ut y¦ ¦ch ief¦ ¦medical¦ ¦offic er¦ ¦r on an¦ ¦gl y n n¦ ¦and¦ ¦n or ther n¦ ¦ireland¦ ¦ch ief¦ ¦medical¦ ¦offic er¦ ¦mi ch a e l¦ ¦m c b r ide¦ ¦issued¦ ¦a¦ ¦jo in t¦ ¦sta te ment¦ ¦ ur ging¦ ¦the¦ ¦public¦ ¦across¦ ¦ireland¦ ¦to¦ ¦continue¦ ¦to¦ ¦follow¦ ¦public¦ ¦health¦ ¦advice¦ ¦to¦ ¦e ns ure¦ ¦e veryone¦ ¦can¦ ¦have¦ ¦a¦ ¦safe¦ ¦e as ter¦ .
𐋇 ¦an¦ ¦in de p end ent¦ ¦re v ie w¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦vacc ination¦ ¦pr ogra m me¦ ¦at¦ ¦the¦ ¦c oo mb e¦ ¦hospital¦ ¦found¦ ¦that¦ ¦a¦ ¦cons ult ant¦ ¦br ou gh t¦ ¦two¦ ¦le f t o ver¦ ¦vaccine¦ ¦doses¦ ¦home¦ ¦to¦ ¦admin is ter¦ ¦them¦ ¦to¦ ¦two¦ ¦family¦ ¦me mbers¦ .
𐋇 ¦dublin¦ ¦ga a¦ ¦susp e nded¦ ¦sen i or¦ ¦fo ot b all¦ ¦mana g er¦ ¦d es si e¦ ¦f arr ell¦ ¦for¦ ¦12¦ ¦weeks¦ ¦after¦ ¦a¦ ¦number¦ ¦of¦ ¦dublin¦ ¦fo ot b a ll ers¦ ¦were¦ ¦ph ot ogra ph ed¦ ¦att ending¦ ¦a¦ ¦tr aining¦ ¦se ssion¦ ¦on¦ ¦the¦ ¦m or ning¦ ¦of¦ ¦3 1¦ ¦march¦ ¦in¦ ¦brea ch¦ ¦of¦ ¦covid¦ - ¦19¦ ¦regul ations¦ .
𐋇 ¦pl ans¦ ¦by¦ ¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦to¦ ¦exp and¦ ¦mand atory¦ ¦ho te l¦ ¦quarantine¦ ¦to¦ ¦4 3¦ ¦ad di tional¦ ¦countries¦ ,▁ ¦including¦ ¦the¦ ¦united¦ ¦states¦ ,▁ ¦g erm an y¦ ¦and¦ ¦fra nce¦ ,▁ ¦s par ked¦ ¦a¦ ¦major¦ ¦r ow¦ ¦within¦ ¦government¦ ,▁ ¦after¦ ¦the¦ ¦att or ne y¦ ¦general¦ ,▁ ¦the¦ ¦european¦ ¦un ion¦ ¦and¦ ¦a¦ ¦number¦ ¦of¦ ¦min ist ers¦ ¦exp r es sed¦ ¦concer ns¦ ¦about¦ ¦the¦ ¦pl ans¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦ad ded¦ ¦a¦ ¦further¦ ¦26¦ ¦countries¦ ¦to¦ ¦the¦ ¦government¦ ' ¦s¦ ¦covid¦ - ¦19¦ ▁" ¦high¦ - ¦risk¦ "▁ ¦l ist¦ ¦for¦ ¦international¦ ¦travel¦ ¦and¦ ¦rem oved¦ ¦one¦ ¦country¦ ,▁ ¦which¦ ¦br ou gh t¦ ¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦countries¦ ¦ad ded¦ ¦to¦ ¦5 9¦ .
𐋇¦the¦ ¦countries¦ ¦ad ded¦ ¦were¦ :▁ 𐋇 ¦al b an ia¦ ,▁ ¦a nd or r a¦ ,▁ ¦ar ub a¦ ,▁ ¦ba h ra in¦ ,▁ ¦ bo na ir e¦ ,▁ ¦s in t¦ ¦e us ta ti us¦ ,▁ ¦ et hi op ia¦ ,▁ ¦ is ra e l¦ ,▁ ¦j or d an¦ ,▁ ¦k os ov o¦ ,▁ ¦k u w ai t¦ ,▁ ¦le b an on¦ ,▁ ¦m ol d ov a¦ ,▁ ¦mon ac o¦ ,▁ ¦mon te ne g r o¦ ,▁ ¦n ig er ia¦ ,▁ ¦n or th¦ ¦m ac ed on ia¦ ,▁ ¦ om an¦ ,▁ ¦pa le st ine¦ ,▁ ¦p hi li pp ines¦ ,▁ ¦p u e rt o¦ ¦r ic o¦ ,▁ ¦ q a ta r¦ ,▁ ¦sa in t¦ ¦l uc ia¦ ,▁ ¦s an¦ ¦m ar in o¦ ,▁ ¦ser b ia¦ ,▁ ¦s om al ia¦ ¦and¦ ¦w al li s¦ ¦and¦ ¦f ut u na¦ ¦ is l an ds¦ .
𐋇 ¦ma u ri ti us¦ ¦was¦ ¦rem oved¦ ¦from¦ ¦the¦ ¦l ist¦ .
¦2¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦5 9 1¦ ¦cases¦ ¦and¦ ¦8¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 3 7¦ , ¦1 8 7¦ ¦cases¦ ¦and¦ ¦4¦ , ¦7 1 3¦ ¦deaths¦ .
¦4¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦two¦ ¦women¦ ¦in¦ ¦their¦ ¦30 s¦ ¦were¦ ¦arr ested¦ ¦and¦ ¦ch ar ged¦ ¦after¦ ¦ref us ing¦ ¦to¦ ¦en ter¦ ¦mand atory¦ ¦ho te l¦ ¦quarantine¦ ¦up on¦ ¦arr iv al¦ ¦in¦ ¦dublin¦ ¦air p ort¦ ¦from¦ ¦d ub a i¦ .
𐋇¦a¦ ¦covid¦ - ¦19¦ ¦outbreak¦ ¦of¦ ¦15¦ ¦cases¦ ¦was¦ ¦confirmed¦ ¦in¦ ¦a¦ ¦spec ial¦ ¦school¦ ¦in¦ ¦c lo nt ar f¦ ,▁ ¦dublin¦ .
¦3¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦5 1 1¦ ¦cases¦ ¦and¦ ¦2¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 3 7¦ , ¦6 9 5¦ ¦cases¦ ¦and¦ ¦4¦ , ¦7 1 5¦ ¦deaths¦ .
¦3¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦around¦ ¦3 00¦ ¦prote st ors¦ ¦t ook¦ ¦par t¦ ¦in¦ ¦an¦ ¦anti ¦ - ¦lockdown¦ ¦prot est¦ ¦at¦ ¦the¦ ¦national¦ ¦mon u ment¦ ¦on¦ ¦the¦ ¦gr and¦ ¦p ara de¦ ¦in¦ ¦cor k¦ ¦city¦ ¦centre¦ .
¦4¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦4 5 7¦ ¦cases¦ ¦and¦ ¦3¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 3 8¦ , ¦1 4 8¦ ¦cases¦ ¦and¦ ¦4¦ , ¦7 1 8¦ ¦deaths¦ .
¦4¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦high¦ ¦co ur t¦ ¦made¦ ¦or d ers¦ ¦all owing¦ ¦two¦ ¦women¦ ¦who¦ ¦ref u sed¦ ¦to¦ ¦en ter¦ ¦mand atory¦ ¦ho te l¦ ¦quarantine¦ ¦after¦ ¦ar ri ving¦ ¦into¦ ¦dublin¦ ¦air p ort¦ ¦following¦ ¦their¦ ¦retur n¦ ¦from¦ ¦a¦ ¦t ri p¦ ¦to¦ ¦d ub a i¦ ¦for¦ ¦c os m et ic¦ ¦proc ed ures¦ ¦to¦ ¦lea ve¦ ¦m ou nt j o y¦ ¦women¦ ' ¦s¦ ¦pr is on¦ ¦and¦ ¦continue¦ ¦to¦ ¦quarantine¦ ¦at¦ ¦a¦ ¦de si gn ated¦ ¦ho te l¦ .
𐋇 ¦gardaí¦ ¦arr ested¦ ¦8¦ ¦people¦ ¦as¦ ¦par t¦ ¦of¦ ¦a¦ ¦pol ic ing¦ ¦pl an¦ ¦around¦ ¦an¦ ¦anti ¦ - ¦lockdown¦ ¦prot est¦ ¦pl an ned¦ ¦in¦ ¦dublin¦ ¦city¦ ¦centre¦ .
¦5¦ ¦april¦ ▁–▁ ¦a¦ ¦further¦ ¦3 2 0¦ ¦cases¦ ¦and¦ ¦no¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 3 8¦ , ¦4 6 6¦ ¦cases¦ ¦and¦ ¦4¦ , ¦7 1 8¦ ¦deaths¦ .
¦2¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦6¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦4 4 3¦ ¦cases¦ ¦and¦ ¦9¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 3 8¦ , ¦9 0 7¦ ¦cases¦ ¦and¦ ¦4¦ , ¦7 2 7¦ ¦deaths¦ .
¦2¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦a¦ ¦number¦ ¦of¦ ¦gardaí¦ ¦were¦ ¦for c ed¦ ¦to¦ ¦self¦ - ¦isol ate¦ ¦after¦ ¦a¦ ¦gu est¦ ¦sta ying¦ ¦at¦ ¦a¦ ¦quarantine¦ ¦ho te l¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇 ¦minister¦ ¦for¦ ¦education¦ ¦n orm a¦ ¦fo le y¦ ¦def e nded¦ ¦the¦ ¦government¦ ¦dec is ion¦ ¦to¦ ¦ch ange¦ ¦the¦ ¦vaccine¦ ¦r ol l¦ - ¦out¦ ¦s ch ed u le¦ ¦to¦ ¦an¦ ¦a ged¦ - ¦based¦ ¦system¦ ¦st ating¦ ¦it¦ ¦was¦ ▁" ¦not¦ ¦a¦ ¦v al ue¦ ¦j ud ge ment¦ ¦on¦ ¦any¦ ¦giv en¦ ¦pro f e ssion¦ " ,▁ ¦as¦ ¦t ea ch ers¦ ' ▁ ¦uni ons¦ ¦contin u ed¦ ¦to¦ ¦call¦ ¦for¦ ¦their¦ ¦me mbers¦ ¦to¦ ¦be¦ ¦pri o ri ti sed¦ .
𐋇 ¦three¦ ¦women¦ ¦who¦ ¦ab s c o nded¦ ¦from¦ ¦a¦ ¦mand atory¦ ¦ho te l¦ ¦quarantine¦ ¦facil ity¦ ¦in¦ ¦dublin¦ ¦were¦ ¦found¦ ¦by¦ ¦gardaí¦ ¦al m ost¦ ¦2 00¦ ¦k m¦ ¦away¦ ¦n ear¦ ¦l ou gh rea¦ ,▁ ¦county¦ ¦g al w ay¦ .
¦7¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦4 2 3¦ ¦cases¦ ¦and¦ ¦5¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 3 9¦ , ¦3 2 5¦ ¦cases¦ ¦and¦ ¦4¦ , ¦7 3 2¦ ¦deaths¦ .
¦5¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦three¦ ¦te ac her¦ ¦uni ons¦ ¦v o ted¦ ¦for¦ ¦an¦ ¦emergency¦ ¦m ot ion¦ ¦b ac king¦ ¦ind u str ial¦ ¦a ction¦ ,▁ ¦up¦ ¦to¦ ¦and¦ ¦including¦ ¦st ri ke¦ ¦a ction¦ ,▁ ¦if¦ ¦they¦ ¦were¦ ¦not¦ ¦pri o ri ti sed¦ ¦for¦ ¦vacc ination¦ .
𐋇 ¦minister¦ ¦for¦ ¦health¦ ¦ste ph en¦ ¦d on n el ly¦ ¦confirmed¦ ¦that¦ ¦a¦ ¦fa il ure¦ ¦to¦ ¦follow¦ ¦vacc ination¦ ¦res er ve¦ ¦l ist¦ ¦prot oc ols¦ ¦l ed¦ ¦to¦ ¦t ea ch ers¦ ¦and¦ ¦spec ial¦ ¦needs¦ ¦ass is ta nts¦ ▁( ¦s na s¦ )▁ ¦in¦ ¦a¦ ¦number¦ ¦of¦ ¦spec ial¦ ¦needs¦ ¦schools¦ ¦in¦ ¦dublin¦ ¦and¦ ¦w ick l ow¦ ¦to¦ ¦receive¦ ¦covid¦ - ¦19¦ ¦vacc in ations¦ ¦from¦ ¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦on¦ ¦6¦ ¦april¦ .
¦8¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦4 00¦ ¦cases¦ ¦and¦ ¦7¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 3 9¦ , ¦7 2 3¦ ¦cases¦ ¦and¦ ¦4¦ , ¦7 3 7¦ ¦deaths¦ .
𐋇 ¦mo na gh an¦ ¦ga a¦ ¦susp e nded¦ ¦sen i or¦ ¦fo ot b all¦ ¦mana g er¦ ¦s é a m us¦ ¦m ce na ne y¦ ¦for¦ ¦12¦ ¦weeks¦ ¦after¦ ¦a¦ ¦d os si er¦ ¦s ent¦ ¦to¦ ¦the¦ ¦department¦ ¦of¦ ¦j u st ice¦ ¦sh owed¦ ¦v ide o¦ ¦and¦ ¦ph ot ogra ph ic¦ ¦evidence¦ ¦of¦ ¦a¦ ¦tr aining¦ ¦se ssion¦ ¦ta king¦ ¦place¦ ¦in¦ ¦brea ch¦ ¦of¦ ¦covid¦ - ¦19¦ ¦regul ations¦ .
𐋇¦the¦ ¦ce o¦ ¦of¦ ¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦pa u l¦ ¦re id¦ ¦announced¦ ¦that¦ ¦ireland¦ ¦had¦ ¦rea ched¦ ¦the¦ ¦mi le st one¦ ¦of¦ ¦one¦ ¦million¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦admin ist ered¦ .
𐋇¦the¦ ¦health¦ ¦produc ts¦ ¦regul atory¦ ¦author ity¦ ▁( ¦h p r a¦ )▁ ¦beg an¦ ¦an¦ ¦in ve st ig ation¦ ¦after¦ ¦the¦ ¦first¦ ¦case¦ ¦of¦ ¦a¦ ¦very¦ ¦r are¦ ¦blood¦ ¦cl ot¦ ¦in¦ ¦the¦ ¦b ra in¦ ¦of¦ ¦a¦ ¦person¦ ¦after¦ ¦vacc ination¦ ¦with¦ ¦the¦ ¦astrazeneca¦ ¦vaccine¦ ¦was¦ ¦confirmed¦ ¦in¦ ¦a¦ ¦4 0¦ - ¦year¦ - ¦o ld¦ ¦dublin¦ ¦wom an¦ .
𐋇¦l at est¦ ¦f ig ures¦ ¦from¦ ¦the¦ ¦hse¦ ¦sh owed¦ ¦that¦ ¦10¦ ¦confirmed¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦had¦ ¦been¦ ¦detected¦ ¦among¦ ¦arr iv als¦ ¦into¦ ¦ireland¦ ¦who¦ ¦were¦ ¦in¦ ¦mand atory¦ ¦ho te l¦ ¦quarantine¦ .
¦9¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦4 7 3¦ ¦cases¦ ¦and¦ ¦3 4¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 0¦ , ¦19 2¦ ¦cases¦ ¦and¦ ¦4¦ , ¦7 6 9¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦death¦ ¦and¦ ¦4¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦announced¦ ¦that¦ ¦five¦ ¦new¦ ¦w alk¦ - ¦in¦ ¦covid¦ - ¦19¦ ¦testing¦ ¦centr es¦ ¦for¦ ¦as ymptomatic¦ ¦people¦ ¦would¦ ¦open¦ ¦from¦ ¦10¦ ¦april¦ ¦in¦ ¦dublin¦ ,▁ ¦li mer ick¦ ¦and¦ ¦w at er for d¦ ¦in¦ ¦an¦ ¦eff ort¦ ¦to¦ ¦br ing¦ ¦down¦ ¦cases¦ ¦that¦ ¦are¦ ¦high¦ ¦in¦ ¦c er tain¦ ¦areas¦ .
𐋇 ¦following¦ ¦an¦ ¦inc or p o re al¦ ¦c ab in et¦ ¦m ee ting¦ ,▁ ¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦ad ded¦ ¦a¦ ¦further¦ ¦16¦ ¦countries¦ ¦to¦ ¦the¦ ¦government¦ ' ¦s¦ ¦covid¦ - ¦19¦ ▁" ¦high¦ - ¦risk¦ "▁ ¦l ist¦ ¦for¦ ¦international¦ ¦travel¦ ¦and¦ ¦rem oved¦ ¦three¦ ¦countries¦ ,▁ ¦which¦ ¦would¦ ¦come¦ ¦into¦ ¦eff ect¦ ¦from¦ ¦4¦ ¦ am¦ ¦on¦ ¦th u rs day¦ ¦15¦ ¦april¦ .
𐋇¦the¦ ¦countries¦ ¦ad ded¦ ¦were¦ :▁ 𐋇 ¦ba ng la d es h ¦ ,▁ ¦b el g i um¦ ,▁ ¦fra nce¦ ,▁ ¦italy¦ ,▁ ¦k en y a¦ ,▁ ¦lu x e m bo ur g¦ ,▁ ¦pa k ist an¦ ,▁ ¦t ur k e y¦ ,▁ ¦the¦ ¦us a¦ ,▁ ¦ca na d a¦ ,▁ ¦ arm en ia¦ ,▁ ¦b erm ud a¦ ,▁ ¦b os n ia¦ ¦and¦ ¦h er z e g o vi na¦ ,▁ ¦cur a ç a o¦ ,▁ ¦m al d ives¦ ¦and¦ ¦u k ra ine¦ .
𐋇 ¦al b an ia¦ ,▁ ¦ is ra e l¦ ¦and¦ ¦sa in t¦ ¦l uc ia¦ ¦were¦ ¦rem oved¦ ¦from¦ ¦the¦ ¦l ist¦ .
𐋇¦a¦ ¦f ul ly¦ ¦vaccinated¦ ¦wom an¦ ¦qu ar an ti ning¦ ¦in¦ ¦a¦ ¦dublin¦ ¦ho te l¦ ¦after¦ ¦ her¦ ¦arr iv al¦ ¦into¦ ¦the¦ ¦country¦ ¦from¦ ¦ is ra e l¦ ¦as ked¦ ¦the¦ ¦high¦ ¦co ur t¦ ¦for¦ ¦an¦ ¦in qu i ry¦ ¦into¦ ¦what¦ ¦sh e¦ ¦cl ai med¦ ¦a mo un ted¦ ¦to¦ ¦un la w ful¦ ¦de te nt ion¦ .
𐋇¦l at est¦ ¦f ig ures¦ ¦sh owed¦ ¦that¦ ¦as¦ ¦of¦ ¦8¦ ¦april¦ ,▁ ¦gardaí¦ ¦had¦ ¦issued¦ ¦over¦ ¦19¦ , ¦8 6 5¦ ¦fines¦ ¦to¦ ¦people¦ ¦brea c hing¦ ¦covid¦ - ¦19¦ ¦regul ations¦ ,▁ ¦with¦ ¦over¦ ¦13¦ , ¦9 7 2¦ ¦fines¦ ¦issued¦ ¦for¦ ¦non¦ - ¦essential¦ ¦travel¦ ¦and¦ ¦over¦ ¦3¦ , ¦3 00¦ ¦fines¦ ¦issued¦ ¦for¦ ¦att ending¦ ¦or¦ ¦h os ting¦ ¦house¦ ¦part ies¦ .
¦10¦ ¦april¦ ▁–▁ ¦a¦ ¦further¦ ¦4 5 5¦ ¦cases¦ ¦and¦ ¦14¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 0¦ , ¦6 4 3¦ ¦cases¦ ¦and¦ ¦4¦ , ¦7 8 3¦ ¦deaths¦ .
¦4¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦11¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦30 3¦ ¦cases¦ ▁( ¦the¦ ¦l ow est¦ ¦number¦ ¦of¦ ¦daily¦ ¦cases¦ ¦recor ded¦ ¦since¦ ¦m id¦ - ¦december¦ ¦2020¦ )▁ ¦and¦ ¦2¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 0¦ , ¦9 4 5¦ ¦cases¦ ¦and¦ ¦4¦ , ¦7 8 5¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦case¦ ¦was¦ ¦de¦ - ¦notified¦ .
𐋇 ¦an¦ ¦ir ish¦ ¦m an¦ ¦and¦ ¦an¦ ¦ is ra el i¦ ¦wom an¦ ¦who¦ ¦cha ll en ged¦ ¦their¦ ¦de te nt ion¦ ¦in¦ ¦mand atory¦ ¦ho te l¦ ¦quarantine¦ ¦and¦ ¦cl ai med¦ ¦they¦ ¦had¦ ¦been¦ ¦f ul ly¦ ¦vaccinated¦ ¦against¦ ¦covid¦ - ¦19¦ ¦were¦ ¦rel ea sed¦ ¦p ending¦ ¦co ur t¦ ¦h ear ings¦ .
¦12¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦3 9 4¦ ¦cases¦ ¦and¦ ¦no¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 1¦ , ¦3 3 0¦ ¦cases¦ ¦and¦ ¦4¦ , ¦7 8 5¦ ¦deaths¦ .
¦9¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦ph a sed¦ ¦e as ing¦ ¦of¦ ¦level¦ ¦5¦ ¦restrictions¦ ¦beg an¦ ¦with¦ ¦the¦ ¦5¦ ¦k m¦ ¦travel¦ ¦limi t¦ ¦l if ted¦ ,▁ ¦the¦ ¦res um ption¦ ¦of¦ ¦all¦ ¦res ide ntial¦ ¦con st ru ction¦ ¦work¦ ,▁ ¦two¦ ¦hou se h ol ds¦ ¦could¦ ¦me et¦ ¦up¦ ¦out d o ors¦ ¦and¦ ¦the¦ ¦f ul l¦ ¦reop ening¦ ¦of¦ ¦all¦ ¦schools¦ .
𐋇 ¦following¦ ¦a¦ ¦le ng th y¦ ¦m ee ting¦ ,▁ ¦the¦ ¦national¦ ¦immun is ation¦ ¦ad v is ory¦ ¦comm it te e¦ ▁( ¦n ia c¦ )▁ ¦recomm end¦ ¦that¦ ¦only¦ ¦people¦ ¦over¦ ¦6 0¦ ¦years¦ ¦of¦ ¦age¦ ¦should¦ ¦get¦ ¦the¦ ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦and¦ ¦that¦ ¦a¦ ¦second¦ ¦d ose¦ ¦of¦ ¦the¦ ¦vaccine¦ ¦should¦ ¦not¦ ¦be¦ ¦giv en¦ ¦to¦ ¦an yone¦ ¦who¦ ¦developed¦ ¦un us ual¦ ¦blood¦ ¦c lo ts¦ ¦with¦ ¦low¦ ¦pl at el ets¦ ¦after¦ ¦the¦ ¦first¦ ¦d ose¦ .
𐋇 ¦minister¦ ¦for¦ ¦health¦ ¦ste ph en¦ ¦d on n el ly¦ ¦announced¦ ¦that¦ ¦arr iv als¦ ¦from¦ ¦ is ra e l¦ ,▁ ¦al b an ia¦ ¦and¦ ¦s t¦ ¦l uc ia¦ ¦were¦ ¦no¦ ¦lo nger¦ ¦required¦ ¦to¦ ¦co mpl et e¦ ¦their¦ ¦quarantine¦ ¦period¦ ¦in¦ ¦a¦ ¦ho te l¦ ¦and¦ ¦could¦ ¦quarantine¦ ¦at¦ ¦home¦ ¦inst ead¦ .
𐋇 ¦according¦ ¦to¦ ¦the¦ ¦ir ish¦ ¦times¦ ,▁ ¦si x¦ ¦s ti ll b ir ths¦ ¦in¦ ¦ireland¦ ¦had¦ ¦been¦ ¦l in ked¦ ¦to¦ ¦covid¦ - ¦19¦ - ¦related¦ ¦infection¦ ¦of¦ ¦the¦ ¦pla ce nt a¦ .
¦13¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦3 5 8¦ ¦cases¦ ¦and¦ ¦18¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 1¦ , ¦6 8 4¦ ¦cases¦ ¦and¦ ¦4¦ , ¦8 0 3¦ ¦deaths¦ .
¦4¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦announced¦ ¦that¦ ¦all¦ ¦astrazeneca¦ ¦cl in ics¦ ¦were¦ ¦cance lled¦ ¦for¦ ¦the¦ ¦r est¦ ¦of¦ ¦the¦ ¦week¦ ,▁ ¦ex cep t¦ ¦for¦ ¦those¦ ¦arr an ged¦ ¦for¦ ¦c er tain¦ ¦people¦ ¦a ged¦ ¦over¦ ¦6 0¦ .
𐋇 ¦minister¦ ¦for¦ ¦health¦ ¦ste ph en¦ ¦d on n el ly¦ ¦announced¦ ¦that¦ ¦mand atory¦ ¦ho te l¦ ¦quarantine¦ ¦b oo k ings¦ ¦were¦ ¦pa u sed¦ ¦on¦ ¦a¦ ¦pr ec a u tion ary¦ ¦ba sis¦ ,▁ ¦in¦ ¦order¦ ¦to¦ ¦ra m p¦ ¦up¦ ¦c ap ac ity¦ ¦in¦ ¦the¦ ¦system¦ .
¦14¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦4 3 1¦ ¦cases¦ ¦and¦ ¦12¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 2¦ , ¦1 0 5¦ ¦cases¦ ¦and¦ ¦4¦ , ¦8 1 2¦ ¦deaths¦ .
¦10¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦ireland¦ ¦was¦ ¦s et¦ ¦to¦ ¦receive¦ ¦5 4 5¦ , ¦000¦ ¦ad di tional¦ ¦doses¦ ¦of¦ ¦the¦ ¦p f iz er¦ ▁–▁ ¦bi on te ch¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦from¦ ¦april¦ ¦to¦ ¦june¦ ¦as¦ ¦par t¦ ¦of¦ ¦a¦ ¦wid er¦ ¦eu¦ ¦ag r ee ment¦ .
¦15¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦30 9¦ ¦cases¦ ¦and¦ ¦8¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 2¦ , ¦4 0 2¦ ¦cases¦ ¦and¦ ¦4¦ , ¦8 2 0¦ ¦deaths¦ .
¦12¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦over¦ ¦26¦ , ¦000¦ ¦people¦ ¦reg ist ered¦ ¦for¦ ¦a¦ ¦covid¦ - ¦19¦ ¦vacc ination¦ ¦after¦ ¦the¦ ¦online¦ ¦p ort al¦ ¦for¦ ¦6 9¦ - ¦year¦ - ¦ ol ds¦ ¦w ent¦ ¦live¦ .
𐋇¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦announced¦ ¦that¦ ¦four¦ ¦new¦ ¦w alk¦ - ¦in¦ ¦covid¦ - ¦19¦ ¦testing¦ ¦centr es¦ ¦for¦ ¦as ymptomatic¦ ¦people¦ ¦would¦ ¦open¦ ¦from¦ ¦2 2¦ ¦april¦ ¦in¦ ¦dublin¦ ¦and¦ ¦ti pp er ary¦ ¦in¦ ¦an¦ ¦eff ort¦ ¦to¦ ¦br ing¦ ¦down¦ ¦cases¦ ¦that¦ ¦are¦ ¦high¦ ¦in¦ ¦c er tain¦ ¦areas¦ .
¦16¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦4 2 0¦ ¦cases¦ ¦and¦ ¦11¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 2¦ , ¦8 1 9¦ ¦cases¦ ¦and¦ ¦4¦ , ¦8 3 1¦ ¦deaths¦ .
¦3¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦european¦ ¦comm i ssion¦ ¦ ur ged¦ ¦the¦ ¦government¦ ¦of¦ ¦ireland¦ ¦to¦ ¦a m end¦ ¦or¦ ¦p os si b ly¦ ¦sc ra p¦ ¦mand atory¦ ¦ho te l¦ ¦quarantine¦ ¦for¦ ¦eu¦ ¦c itiz ens¦ ¦and¦ ¦s ou gh t¦ ¦cl ar if ications¦ ¦as¦ ¦to¦ ¦wh y¦ ¦a¦ ¦number¦ ¦of¦ ¦eu¦ ¦me mber¦ ¦states¦ ¦were¦ ¦sub j ect¦ ¦to¦ ¦the¦ ¦ ru les¦ .
𐋇¦l at est¦ ¦f ig ures¦ ¦sh owed¦ ¦that¦ ¦as¦ ¦of¦ ¦15¦ ¦april¦ ,▁ ¦gardaí¦ ¦had¦ ¦issued¦ ¦over¦ ¦20¦ , ¦2 8 0¦ ¦fines¦ ¦to¦ ¦people¦ ¦brea c hing¦ ¦covid¦ - ¦19¦ ¦regul ations¦ ,▁ ¦with¦ ¦over¦ ¦14¦ , ¦6 5 0¦ ¦fines¦ ¦issued¦ ¦for¦ ¦non¦ - ¦essential¦ ¦travel¦ ¦and¦ ¦over¦ ¦3¦ , ¦5 00¦ ¦fines¦ ¦issued¦ ¦for¦ ¦att ending¦ ¦or¦ ¦h os ting¦ ¦house¦ ¦part ies¦ .
¦1 7¦ ¦april¦ ▁–▁ ¦a¦ ¦further¦ ¦4 2 0¦ ¦cases¦ ¦and¦ ¦4¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 3¦ , ¦2 3 8¦ ¦cases¦ ¦and¦ ¦4¦ , ¦8 3 5¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦case¦ ¦was¦ ¦de¦ - ¦notified¦ .
¦18¦ ¦april¦ ▁–▁ ¦a¦ ¦further¦ ¦2 6 9¦ ¦cases¦ ¦and¦ ¦1¦ ¦death¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 3¦ , ¦5 0 8¦ ¦cases¦ ¦and¦ ¦4¦ , ¦8 3 6¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦case¦ ¦was¦ ¦de¦ - ¦notified¦ .
¦19¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦4 0 3¦ ¦cases¦ ¦and¦ ¦no¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 3¦ , ¦9 1 1¦ ¦cases¦ ¦and¦ ¦4¦ , ¦8 3 6¦ ¦deaths¦ .
𐋇¦the¦ ¦dir ector¦ ¦of¦ ¦the¦ ¦national¦ ¦virus¦ ¦ref er ence¦ ¦laboratory¦ ¦c il li an¦ ¦de¦ ¦g as c u n¦ ¦confirmed¦ ¦that¦ ¦three¦ ¦cases¦ ¦of¦ ¦the¦ ¦b ¦ . ¦1¦ . ¦6 1 7¦ ¦vari ant¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦first¦ ¦identified¦ ¦in¦ ¦ind ia¦ ,▁ ¦had¦ ¦been¦ ¦detected¦ ¦in¦ ¦the¦ ¦rep u bl ic¦ ¦of¦ ¦ireland¦ .
¦20¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦3 9 0¦ ¦cases¦ ¦and¦ ¦11¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 4¦ , ¦2 9 7¦ ¦cases¦ ¦and¦ ¦4¦ , ¦8 4 7¦ ¦deaths¦ .
¦4¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦a¦ ¦nu rs ing¦ ¦home¦ ¦in¦ ¦county¦ ¦l ou th¦ ¦susp e nded¦ ¦all¦ ¦in door¦ ¦visi ts¦ ¦after¦ ¦two¦ ¦staff¦ ¦me mbers¦ ¦who¦ ¦had¦ ¦been¦ ¦f ul ly¦ ¦vaccinated¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦confirmed¦ ¦that¦ ¦ch ief¦ ¦medical¦ ¦offic er¦ ¦t on y¦ ¦ho lo h an¦ ¦had¦ ¦retur ned¦ ¦to¦ ¦work¦ ¦after¦ ¦ta king¦ ¦lea ve¦ ¦following¦ ¦the¦ ¦death¦ ¦of¦ ¦hi s¦ ¦w ife¦ .
¦ 21¦ ¦april¦ ▁–▁ ¦a¦ ¦further¦ ¦4 0 1¦ ¦cases¦ ¦and¦ ¦15¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 4¦ , ¦6 9 5¦ ¦cases¦ ¦and¦ ¦4¦ , ¦8 5 6¦ ¦deaths¦ .
¦6¦ ¦previously¦ ¦notified¦ ¦deaths¦ ¦and¦ ¦3¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦2 2¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦6 1 7¦ ¦cases¦ ¦and¦ ¦10¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 5¦ , ¦3 1 0¦ ¦cases¦ ¦and¦ ¦4¦ , ¦8 6 6¦ ¦deaths¦ .
¦2¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦an¦ ¦outbreak¦ ¦of¦ ¦at¦ ¦least¦ ¦7 0¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦was¦ ¦confirmed¦ ¦at¦ ¦in te l¦ ' ¦s¦ ¦con st ru ction¦ ¦s ite¦ ¦in¦ ¦le i x li p¦ ,▁ ¦county¦ ¦k ild are¦ .
¦23¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦4 3 4¦ ¦cases¦ ¦and¦ ¦1¦ ¦death¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 5¦ , ¦7 4 3¦ ¦cases¦ ¦and¦ ¦4¦ , ¦8 6 7¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦case¦ ¦was¦ ¦de¦ - ¦notified¦ .
𐋇¦l at est¦ ¦f ig ures¦ ¦sh owed¦ ¦that¦ ¦as¦ ¦of¦ ¦2 2¦ ¦april¦ ,▁ ¦gardaí¦ ¦had¦ ¦issued¦ ¦over¦ ¦20¦ , ¦5 6 6¦ ¦fines¦ ¦to¦ ¦people¦ ¦brea c hing¦ ¦covid¦ - ¦19¦ ¦regul ations¦ ,▁ ¦with¦ ¦over¦ ¦14¦ , ¦7 3 0¦ ¦fines¦ ¦issued¦ ¦for¦ ¦non¦ - ¦essential¦ ¦travel¦ ¦and¦ ¦over¦ ¦3¦ , ¦6 00¦ ¦fines¦ ¦issued¦ ¦for¦ ¦att ending¦ ¦or¦ ¦h os ting¦ ¦house¦ ¦part ies¦ .
𐋇¦the¦ ¦health¦ ¦produc ts¦ ¦regul atory¦ ¦author ity¦ ¦reported¦ ¦a¦ ¦number¦ ¦of¦ ¦ser ious¦ ¦blood¦ ¦cl ot ting¦ ¦events¦ ¦associated¦ ¦with¦ ¦the¦ ¦astrazeneca¦ ¦vaccine¦ ¦in¦ ¦people¦ ¦who¦ ¦received¦ ¦the¦ ¦vaccine¦ .
𐋇¦a¦ ¦covid¦ - ¦19¦ ¦outbreak¦ ¦res ul ted¦ ¦in¦ ¦all¦ ¦lea ving¦ ¦ce rt ific ate¦ ¦students¦ ¦being¦ ¦s ent¦ ¦home¦ ¦from¦ ¦a¦ ¦sec ond ary¦ ¦school¦ ¦in¦ ¦l et t er k en n y¦ ,▁ ¦county¦ ¦do ne g al¦ .
¦24¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦4 6 1¦ ¦cases¦ ¦and¦ ¦5¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 6¦ , ¦20 4¦ ¦cases¦ ¦and¦ ¦4¦ , ¦8 7 2¦ ¦deaths¦ .
𐋇 ¦according¦ ¦to¦ ¦the¦ ¦ch ai r¦ ¦of¦ ¦the¦ ¦high¦ - ¦level¦ ¦t as k¦ ¦for ce¦ ¦on¦ ¦covid¦ - ¦19¦ ¦vacc ination¦ ¦b ri an¦ ¦m ac c r ai th¦ ,▁ ¦one¦ ¦in¦ ¦four¦ ¦ad ul ts¦ ▁( ¦2 5¦ % )▁ ¦in¦ ¦ireland¦ ¦had¦ ¦received¦ ¦at¦ ¦least¦ ¦their¦ ¦first¦ ¦d ose¦ ¦of¦ ¦a¦ ¦covid¦ - ¦19¦ ¦vaccine¦ .
¦2 5¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦4 2 9¦ ¦cases¦ ¦and¦ ¦1¦ ¦death¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 6¦ , ¦6 3 3¦ ¦cases¦ ¦and¦ ¦4¦ , ¦8 7 3¦ ¦deaths¦ .
𐋇 ¦sp ea king¦ ¦on¦ ¦ rt é ¦ ' ¦s¦ ¦the¦ ¦week¦ ¦in¦ ¦pol it ics¦ ,▁ ¦ta o is ea ch¦ ¦mi che á l¦ ¦ma rt in¦ ¦stated¦ ¦that¦ ¦the¦ ¦government¦ ¦was¦ ¦mo ving¦ ¦ca u ti o us ly¦ ¦on¦ ¦the¦ ¦reop ening¦ ¦of¦ ¦s oc i et y¦ ¦and¦ ¦that¦ ¦out door¦ ¦activ ities¦ ¦would¦ ¦be¦ ¦the¦ ▁" ¦the me¦ ¦for¦ ¦the¦ ¦su mm er¦ " .
𐋇 ¦ta o is ea ch¦ ¦mi che á l¦ ¦ma rt in¦ ¦announced¦ ¦that¦ ¦ireland¦ ¦had¦ ¦rea ched¦ ¦the¦ ¦mi le st one¦ ¦of¦ ¦one¦ ¦million¦ ¦first¦ ¦doses¦ ¦of¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦admin ist ered¦ .
¦26¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦4 3 7¦ ¦cases¦ ¦and¦ ¦1¦ ¦death¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 7¦ , ¦0 6 9¦ ¦cases¦ ¦and¦ ¦4¦ , ¦8 7 4¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦case¦ ¦was¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦further¦ ¦e as ing¦ ¦of¦ ¦level¦ ¦5¦ ¦restrictions¦ ¦ca me¦ ¦into¦ ¦eff ect¦ ¦with¦ ¦all¦ ¦sp orts¦ ¦p it ches¦ ,▁ ¦g ol f¦ ¦co ur ses¦ ,▁ ¦t en n i s¦ ¦co ur ts¦ ,▁ ¦z oo s¦ ,▁ ¦p et¦ ¦f ar ms¦ ¦and¦ ¦h er it age¦ ¦si tes¦ ¦reop ening¦ .
𐋇 ¦minister¦ ¦for¦ ¦health¦ ¦ste ph en¦ ¦d on n el ly¦ ¦announced¦ ¦that¦ ¦ireland¦ ¦was¦ ¦to¦ ¦d on ate¦ ¦7 00¦ ¦o x yg en¦ ¦con ce nt r at ors¦ ¦to¦ ¦ind ia¦ ¦as¦ ¦par t¦ ¦of¦ ¦eff orts¦ ¦to¦ ¦ass ist¦ ¦with¦ ¦the¦ ¦covid¦ - ¦19¦ ¦outbreak¦ ¦in¦ ¦the¦ ¦country¦ .
𐋇¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦announced¦ ¦that¦ ¦two¦ ¦new¦ ¦w alk¦ - ¦in¦ ¦covid¦ - ¦19¦ ¦testing¦ ¦centr es¦ ¦for¦ ¦as ymptomatic¦ ¦people¦ ¦would¦ ¦open¦ ¦in¦ ¦k ild are¦ ¦and¦ ¦off a ly¦ ¦in¦ ¦an¦ ¦eff ort¦ ¦to¦ ¦br ing¦ ¦down¦ ¦cases¦ ¦that¦ ¦are¦ ¦high¦ ¦in¦ ¦c er tain¦ ¦areas¦ .
¦2 7¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦4 2 6¦ ¦cases¦ ¦and¦ ¦10¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 7¦ , ¦4 8 9¦ ¦cases¦ ¦and¦ ¦4¦ , ¦8 8 4¦ ¦deaths¦ .
¦6¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦new¦ ¦recomm end ations¦ ¦by¦ ¦n ia c¦ ¦were¦ ¦appr oved¦ ¦by¦ ¦the¦ ¦government¦ ¦of¦ ¦ireland¦ ¦with¦ ¦the¦ ¦jo h ns on¦ ▁ & ▁ ¦jo h ns on¦ ¦and¦ ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦recommended¦ ¦for¦ ¦people¦ ¦a ged¦ ¦50¦ ¦and¦ ¦ ol der¦ ,▁ ¦pre gnant¦ ¦women¦ ¦off ered¦ ¦an¦ ¦m r na¦ ¦vaccine¦ ¦between¦ ¦14¦ ¦and¦ ¦3 6¦ ¦weeks¦ ¦ ge st ation¦ ,▁ ¦and¦ ¦people¦ ¦a ged¦ ¦under¦ ¦50¦ ¦years¦ ¦who¦ ¦had¦ ¦a¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦rece i ving¦ ¦j ust¦ ¦one¦ ¦vaccine¦ ¦d ose¦ ¦and¦ ¦be¦ ¦consid ered¦ ¦f ul ly¦ - ¦vaccinated¦ .
𐋇¦a¦ ¦pr imary¦ ¦school¦ ¦in¦ ¦county¦ ¦off a ly¦ ¦closed¦ ¦following¦ ¦conf ir m ation¦ ¦of¦ ¦23¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ .
¦2 8¦ ¦april¦ ▁–▁ ¦a¦ ¦further¦ ¦3 7 1¦ ¦cases¦ ¦and¦ ¦13¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 7¦ , ¦8 5 7¦ ¦cases¦ ¦and¦ ¦4¦ , ¦8 9 6¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦death¦ ¦and¦ ¦3¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦2 9¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦4 7 4¦ ¦cases¦ ¦and¦ ¦3¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 8¦ , ¦3 2 6¦ ¦cases¦ ¦and¦ ¦4¦ , ¦8 9 9¦ ¦deaths¦ .
¦5¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦government¦ ¦of¦ ¦ireland¦ ¦announced¦ ¦a¦ ¦reop ening¦ ¦pl an¦ ¦for¦ ¦the¦ ¦country¦ ¦th r ou g ho ut¦ ¦may¦ ¦and¦ ¦june¦ ¦from¦ ¦10¦ ¦may¦ ,▁ ¦with¦ ¦in ter¦ - ¦county¦ ¦travel¦ ¦all owed¦ ,▁ ¦the¦ ¦reop ening¦ ¦of¦ ¦all¦ ¦ha ir d re ss ers¦ ,▁ ¦li b r ar ies¦ ,▁ ¦m u se u ms¦ ¦and¦ ¦ga ll er ies¦ ,▁ ¦up¦ ¦to¦ ¦50¦ ¦people¦ ¦all owed¦ ¦to¦ ¦att end¦ ¦rel ig ious¦ ¦services¦ ,▁ ¦the¦ ¦res um ption¦ ¦of¦ ¦cl ick¦ - ¦and¦ - ¦coll ect¦ ¦services¦ ¦and¦ ¦the¦ ¦all ow an ces¦ ¦of¦ ¦three¦ ¦hou se h ol ds¦ ¦to¦ ¦me et¦ ¦out d o ors¦ ▁( ¦including¦ ¦in¦ ¦priv ate¦ ¦gard ens¦ )▁ ¦and¦ ¦a¦ ¦vaccinated¦ ¦hou se ho ld¦ ¦to¦ ¦me et¦ ¦an¦ ¦un v ac c in ated¦ ¦hou se ho ld¦ ¦ind o ors¦ ¦from¦ ¦that¦ ¦date¦ .
𐋇 ¦from¦ ¦1 7¦ ¦may¦
𐋇 ¦all¦ ¦re ta il¦ ¦could¦ ¦reop en¦
𐋇 ¦from¦ ¦2¦ ¦june¦
𐋇¦h ot els¦ ,▁ ¦b ¦ ▁ & ▁ ¦b s¦ ,▁ ¦self¦ - ¦c at ering¦ ¦and¦ ¦ho st els¦ ¦could¦ ¦reop en¦ ¦but¦ ¦services¦ ¦must¦ ¦be¦ ¦re stric ted¦ ¦to¦ ¦over n ight¦ ¦gu e sts¦ ¦and¦ ¦res id ents¦
𐋇 ¦from¦ ¦7¦ ¦june¦
𐋇 ¦out door¦ ¦sp orts¦ ¦m at ches¦ ¦could¦ ¦recomm ence¦ ¦with¦ ¦no¦ ¦sp ect at ors¦ ¦p erm it ted¦
𐋇 ¦g y ms¦ ,▁ ¦sw i mm ing¦ ¦po ols¦ ¦and¦ ¦le is ure¦ ¦centr es¦ ¦could¦ ¦reop en¦ ¦for¦ ¦ind iv id ual¦ ¦tr aining¦ ¦only¦
𐋇 ¦out door¦ ¦services¦ ¦in¦ ¦res ta u ra nts¦ ¦and¦ ¦b ar s¦ ¦could¦ ¦recomm ence¦ ,▁ ¦with¦ ¦grou ps¦ ¦limi ted¦ ¦to¦ ¦a¦ ¦ma x im um¦ ¦of¦ ¦6¦ ¦people¦
𐋇¦the¦ ¦nu mbers¦ ¦of¦ ¦gu e sts¦ ¦att ending¦ ¦w ed ding¦ ¦ce le b r ations¦ ▁/▁ ¦re cep tions¦ ¦could¦ ¦increase¦ ¦to¦ ¦2 5¦
𐋇 ¦visi t ors¦ ¦from¦ ¦one¦ ¦other¦ ¦hou se ho ld¦ ¦could¦ ¦be¦ ¦p erm it ted¦ ¦in¦ ¦priv ate¦ ¦h omes¦
¦30¦ ¦april¦
𐋇¦a¦ ¦further¦ ¦5 4 5¦ ¦cases¦ ¦and¦ ¦4¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 8¦ , ¦8 7 0¦ ¦cases¦ ¦and¦ ¦4¦ , ¦9 0 3¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦case¦ ¦was¦ ¦de¦ - ¦notified¦ .
𐋇 ¦minister¦ ¦for¦ ¦health¦ ¦ste ph en¦ ¦d on n el ly¦ ¦announced¦ ¦that¦ ¦ne arly¦ ¦1 5 0¦ ¦cases¦ ¦of¦ ¦vari a nts¦ ¦of¦ ¦concer n¦ ¦had¦ ¦been¦ ¦identified¦ ¦in¦ ¦ireland¦ ,▁ ¦including¦ :▁ ¦7 1¦ ¦cases¦ ¦of¦ ¦the¦ ¦south¦ ¦afr ic an¦ ¦vari ant¦ ,▁ ¦2 7¦ ¦cases¦ ¦of¦ ¦the¦ ¦b ra z i li an¦ ¦vari ant¦ ,▁ ¦8¦ ¦cases¦ ¦of¦ ¦the¦ ¦in di an¦ ¦vari ant¦ ,▁ ¦6¦ ¦cases¦ ¦of¦ ¦the¦ ¦new¦ ¦y or k¦ ¦vari ant¦ ¦and¦ ¦20¦ ¦cases¦ ¦of¦ ¦the¦ ¦n ig eri an¦ ¦vari ant¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦ad ded¦ ¦a¦ ¦further¦ ¦5¦ ¦countries¦ ¦to¦ ¦the¦ ¦government¦ ' ¦s¦ ¦covid¦ - ¦19¦ ▁" ¦high¦ - ¦risk¦ "▁ ¦l ist¦ ¦for¦ ¦international¦ ¦travel¦ ¦and¦ ¦rem oved¦ ¦6¦ ¦countries¦ ,▁ ¦which¦ ¦would¦ ¦come¦ ¦into¦ ¦eff ect¦ ¦from¦ ¦4¦ ¦ am¦ ¦on¦ ¦t u es day¦ ¦4¦ ¦may¦ .
𐋇¦the¦ ¦countries¦ ¦ad ded¦ ¦were¦ :▁ 𐋇 ¦co st a¦ ¦r ica¦ ,▁ ¦ ge or g ia¦ ,▁ ¦ind ia¦ ,▁ ¦iran¦ ¦and¦ ¦mo ngol ia¦ .
𐋇¦ bo na ir e¦ ,▁ ¦s in t¦ ¦e us ta ti us¦ ¦and¦ ¦s ab a¦ ,▁ ¦s an¦ ¦m ar in o¦ ,▁ ¦mon ac o¦ ,▁ ¦w al li s¦ ¦and¦ ¦f ut u na¦ ¦ is l an ds¦ ,▁ ¦and¦ ¦m ol d ov a¦ ¦were¦ ¦rem oved¦ ¦with¦ ¦immediate¦ ¦eff ect¦ .
𐋇 ¦ch ief¦ ¦medical¦ ¦offic er¦ ¦t on y¦ ¦ho lo h an¦ ¦stated¦ ¦that¦ ¦there¦ ¦were¦ ¦concer ns¦ ¦around¦ ¦the¦ ¦level¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦do ne g al¦ ¦and¦ ¦that¦ ¦there¦ ¦were¦ ¦out b rea ks¦ ¦occur r ing¦ ¦in¦ ¦lo ts¦ ¦of¦ ¦different¦ ¦s et t ings¦ ¦in¦ ¦the¦ ¦county¦ .
𐋇¦l at est¦ ¦f ig ures¦ ¦sh owed¦ ¦that¦ ¦as¦ ¦of¦ ¦2 9¦ ¦april¦ ,▁ ¦gardaí¦ ¦had¦ ¦issued¦ ¦over¦ ¦20¦ , ¦9 7 4¦ ¦fines¦ ¦to¦ ¦people¦ ¦brea c hing¦ ¦covid¦ - ¦19¦ ¦regul ations¦ ,▁ ¦with¦ ¦over¦ ¦14¦ , ¦7 4 9¦ ¦fines¦ ¦issued¦ ¦for¦ ¦non¦ - ¦essential¦ ¦travel¦ ¦and¦ ¦over¦ ¦3¦ , ¦9 00¦ ¦fines¦ ¦issued¦ ¦for¦ ¦att ending¦ ¦or¦ ¦h os ting¦ ¦house¦ ¦part ies¦ .
¦1¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦5 6 9¦ ¦cases¦ ¦and¦ ¦3¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 9¦ , ¦4 3 7¦ ¦cases¦ ¦and¦ ¦4¦ , ¦9 0 6¦ ¦deaths¦ .
¦2¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦around¦ ¦3 7 0¦ ¦prote st ors¦ ¦t ook¦ ¦par t¦ ¦in¦ ¦an¦ ¦anti ¦ - ¦lockdown¦ ¦prot est¦ ¦at¦ ¦the¦ ¦national¦ ¦mon u ment¦ ¦on¦ ¦the¦ ¦gr and¦ ¦p ara de¦ ¦in¦ ¦cor k¦ ¦city¦ ¦centre¦ .
𐋇¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦announced¦ ¦that¦ ¦se v en¦ ¦new¦ ¦w alk¦ - ¦in¦ ¦covid¦ - ¦19¦ ¦testing¦ ¦centr es¦ ¦for¦ ¦as ymptomatic¦ ¦people¦ ¦would¦ ¦open¦ ¦in¦ ¦dublin¦ ,▁ ¦cor k¦ ,▁ ¦k ild are¦ ¦and¦ ¦ma y o¦ ¦in¦ ¦an¦ ¦eff ort¦ ¦to¦ ¦br ing¦ ¦down¦ ¦cases¦ ¦that¦ ¦are¦ ¦high¦ ¦in¦ ¦c er tain¦ ¦areas¦ .
¦2¦ ¦may¦ ▁–▁ ¦a¦ ¦further¦ ¦4 0 2¦ ¦cases¦ ¦and¦ ¦1¦ ¦death¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 4 9¦ , ¦8 3 8¦ ¦cases¦ ¦and¦ ¦4¦ , ¦9 0 6¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦death¦ ¦and¦ ¦1¦ ¦previously¦ ¦notified¦ ¦case¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦3¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦4 5 3¦ ¦cases¦ ¦and¦ ¦no¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 5 0¦ , ¦2 9 0¦ ¦cases¦ ¦and¦ ¦4¦ , ¦9 0 6¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦case¦ ¦was¦ ¦de¦ - ¦notified¦ .
𐋇¦in¦ ¦an¦ ¦open¦ ¦l et ter¦ ¦to¦ ¦those¦ ¦who¦ ¦had¦ ¦been¦ ¦f ul ly¦ ¦vaccinated¦ ,▁ ¦ch ief¦ ¦medical¦ ¦offic er¦ ¦t on y¦ ¦ho lo h an¦ ¦pr ai sed¦ ¦the¦ ¦s ac r ific es¦ ¦people¦ ¦had¦ ¦made¦ ¦over¦ ¦the¦ ¦p ast¦ ¦year¦ ¦and¦ ¦ad vi sed¦ ¦those¦ ¦who¦ ¦were¦ ¦vaccinated¦ ¦to¦ ¦make¦ ¦the¦ ¦most¦ ¦of¦ ¦s oc i al ising¦ ¦out d o ors¦ .
¦4¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦3 8 3¦ ¦cases¦ ¦and¦ ¦2¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 5 0¦ , ¦6 7 2¦ ¦cases¦ ¦and¦ ¦4¦ , ¦9 0 8¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦case¦ ¦was¦ ¦de¦ - ¦notified¦ .
𐋇¦a¦ ¦spec ial¦ ¦h ot line¦ ¦to¦ ¦all ow¦ ¦the¦ ¦public¦ ¦to¦ ¦in for m¦ ¦the¦ ¦gardaí¦ ¦about¦ ¦ il le g al¦ ¦part ies¦ ¦or¦ ¦ga ther ings¦ ¦in¦ ¦county¦ ¦do ne g al¦ ¦was¦ ¦s et¦ ¦up¦ ¦in¦ ¦response¦ ¦to¦ ¦a¦ ¦sp i ke¦ ¦in¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦cases¦ ¦in¦ ¦the¦ ¦county¦ ¦in¦ ¦rec ent¦ ¦days¦ .
𐋇¦the¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦regi str ation¦ ¦p ort al¦ ¦op e ned¦ ¦to¦ ¦people¦ ¦a ged¦ ¦between¦ ¦50¦ ¦and¦ ¦5 9¦ ¦on¦ ¦a¦ ¦ph a sed¦ ¦ba sis¦ ,▁ ¦star ting¦ ¦with¦ ¦people¦ ¦a ged¦ ¦5 9¦ .
¦5¦ ¦may¦ ▁–▁ ¦a¦ ¦further¦ ¦4 1 8¦ ¦cases¦ ¦and¦ ¦7¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 5 1¦ , ¦0 8 7¦ ¦cases¦ ¦and¦ ¦4¦ , ¦9 1 5¦ ¦deaths¦ .
¦3¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦6¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦3 9 3¦ ¦cases¦ ¦and¦ ¦8¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 5 1¦ , ¦4 7 4¦ ¦cases¦ ¦and¦ ¦4¦ , ¦9 21¦ ¦deaths¦ .
¦2¦ ¦previously¦ ¦notified¦ ¦deaths¦ ¦and¦ ¦6¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦first¦ ¦doses¦ ¦of¦ ¦the¦ ¦jo h ns on¦ ▁ & ▁ ¦jo h ns on¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦were¦ ¦admin ist ered¦ ¦through¦ ¦ho me less¦ ¦services¦ ¦at¦ ¦a¦ ¦temp or ary¦ ¦vacc ination¦ ¦cl in ic¦ ¦s et¦ ¦up¦ ¦in¦ ¦dublin¦ .
𐋇 ¦around¦ ¦1 2 0¦ ¦re ve ll ers¦ ¦def ied¦ ¦an¦ ¦emergency¦ ¦co ur t¦ ¦order¦ ¦after¦ ¦att ending¦ ¦a¦ ¦p ost¦ - ¦w ed ding¦ ¦ce le b r ation¦ ¦invol ving¦ ¦me mbers¦ ¦of¦ ¦the¦ ¦tra ve ll er¦ ¦community¦ ¦in¦ ¦a¦ ¦m ar qu e e¦ ¦in¦ ¦county¦ ¦lo ng for d¦ ¦on¦ ¦5¦ ¦may¦ .
¦7¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦4 3 4¦ ¦cases¦ ¦and¦ ¦4¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 5 1¦ , ¦9 0 4¦ ¦cases¦ ¦and¦ ¦4¦ , ¦9 1 8¦ ¦deaths¦ .
¦4¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦to ur is m¦ ,▁ ¦c ult ure¦ ,▁ ¦ar ts¦ ,▁ ¦ga el ta ch t¦ ,▁ ¦sp ort¦ ¦and¦ ¦m ed ia¦ ¦announced¦ ¦that¦ ¦all¦ ¦su mm er¦ ¦ir ish¦ ¦la ng u age¦ ¦colle ge¦ ¦co ur ses¦ ¦in¦ ¦the¦ ¦ga el ta ch t¦ ¦were¦ ¦cance lled¦ ¦for¦ ¦a¦ ¦second¦ ¦year¦ ¦r un ning¦ .
¦8¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦4 0 8¦ ¦cases¦ ¦and¦ ¦1¦ ¦death¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 5 2¦ , ¦30 3¦ ¦cases¦ ¦and¦ ¦4¦ , ¦9 1 9¦ ¦deaths¦ .
¦9¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦ad ded¦ ¦a¦ ¦further¦ ¦2¦ ¦countries¦ ¦to¦ ¦the¦ ¦government¦ ' ¦s¦ ¦covid¦ - ¦19¦ ▁" ¦high¦ - ¦risk¦ "▁ ¦l ist¦ ¦for¦ ¦international¦ ¦travel¦ ¦and¦ ¦rem oved¦ ¦11¦ ¦countries¦ ,▁ ¦which¦ ¦would¦ ¦come¦ ¦into¦ ¦eff ect¦ ¦from¦ ¦4¦ ¦ am¦ ¦on¦ ¦w ed n es day¦ ¦12¦ ¦may¦ .
𐋇¦the¦ ¦countries¦ ¦ad ded¦ ¦were¦ :▁ 𐋇 ¦ne p al¦ ¦and¦ ¦a ng u i ll a¦ .
𐋇¦ arm en ia¦ ,▁ ¦ar ub a¦ ,▁ ¦a u str ia¦ ,▁ ¦b os n ia¦ ¦and¦ ¦h er z e g o vi na¦ ,▁ ¦cur a ç a o¦ ,▁ ¦italy¦ ,▁ ¦j or d an¦ ,▁ ¦k os ov o¦ ,▁ ¦le b an on¦ ,▁ ¦n or th¦ ¦m ac ed on ia¦ ¦and¦ ¦u k ra ine¦ ¦were¦ ¦rem oved¦ ¦with¦ ¦immediate¦ ¦eff ect¦ .
¦9¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦5 1 4¦ ¦cases¦ ¦and¦ ¦2¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 5 2¦ , ¦8 0 9¦ ¦cases¦ ¦and¦ ¦4¦ , ¦9 21¦ ¦deaths¦ .
¦8¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇 ¦ta o is ea ch¦ ¦mi che á l¦ ¦ma rt in¦ ¦received¦ ¦hi s¦ ¦first¦ ¦d ose¦ ¦of¦ ¦a¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦in¦ ¦cor k¦ ¦city¦ ¦h all¦ ¦and¦ ¦ ur ged¦ ¦people¦ ¦to¦ ¦get¦ ¦vaccinated¦ ¦to¦ ¦protect¦ ¦the m s el ves¦ ,▁ ¦while¦ ¦a¦ ¦recor d¦ ¦5 2¦ , ¦2 7 8¦ ¦doses¦ ¦were¦ ¦admin ist ered¦ ¦on¦ ¦f ri day¦ ¦7¦ ¦may¦ .
¦10¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦3 8 1¦ ¦cases¦ ¦and¦ ¦no¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 5 3¦ , ¦1 8 9¦ ¦cases¦ ¦and¦ ¦4¦ , ¦9 21¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦case¦ ¦was¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦further¦ ¦e as ing¦ ¦of¦ ¦level¦ ¦5¦ ¦restrictions¦ ¦ca me¦ ¦into¦ ¦eff ect¦ ¦with¦ ¦all¦ ¦ha ir d re ss ers¦ ,▁ ¦b ar b ers¦ ,▁ ¦b ea ut ici ans¦ ,▁ ¦ga ll er ies¦ ,▁ ¦m u se u ms¦ ,▁ ¦li b r ar ies¦ ¦and¦ ¦other¦ ¦c ult ural¦ ¦att r ac tions¦ ¦reop ening¦ ,▁ ¦the¦ ¦res um ption¦ ¦of¦ ¦non¦ - ¦essential¦ ¦re ta il¦ ¦on¦ ¦a¦ ¦ph a sed¦ ¦ba sis¦ ,▁ ¦in ter¦ - ¦county¦ ¦travel¦ ¦and¦ ¦in¦ - ¦person¦ ¦rel ig ious¦ ¦services¦ ,▁ ¦and¦ ¦the¦ ¦all ow ance¦ ¦of¦ ¦three¦ ¦hou se h ol ds¦ ▁( ¦or¦ ¦si x¦ ¦people¦ )▁ ¦from¦ ¦ind iv id ual¦ ¦hou se h ol ds¦ ¦to¦ ¦me et¦ ¦out d o ors¦ .
𐋇¦the¦ ¦ir ish¦ ¦pr is on¦ ¦service¦ ¦confirmed¦ ¦that¦ ¦an¦ ¦outbreak¦ ¦of¦ ¦19¦ ¦cases¦ ¦of¦ ¦covid¦ - ¦19¦ ¦had¦ ¦been¦ ¦identified¦ ¦at¦ ¦m ou nt j o y¦ ¦pr is on¦ .
¦11¦ ¦may¦ ▁–▁ ¦a¦ ¦further¦ ¦3 7 9¦ ¦cases¦ ¦and¦ ¦9¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 5 3¦ , ¦5 6 7¦ ¦cases¦ ¦and¦ ¦4¦ , ¦9 2 9¦ ¦deaths¦ .
¦1¦ ¦previously¦ ¦notified¦ ¦death¦ ¦and¦ ¦1¦ ¦case¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦12¦ ¦may¦ ▁–▁ ¦a¦ ¦further¦ ¦4 4 8¦ ¦cases¦ ¦and¦ ¦8¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 5 4¦ , ¦0 1 3¦ ¦cases¦ ¦and¦ ¦4¦ , ¦9 3 7¦ ¦deaths¦ .
¦2¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦13¦ ¦may¦ ▁–▁ ¦a¦ ¦further¦ ¦4 5 6¦ ¦cases¦ ¦and¦ ¦no¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 5 4¦ , ¦4 5 0¦ ¦cases¦ ¦and¦ ¦4¦ , ¦9 3 7¦ ¦deaths¦ .
¦19¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
¦14¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦4 2 5¦ ¦cases¦ ¦and¦ ¦4¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 5 4¦ , ¦8 7 0¦ ¦cases¦ ¦and¦ ¦4¦ , ¦9 4 0¦ ¦deaths¦ .
¦5¦ ¦previously¦ ¦notified¦ ¦cases¦ ¦were¦ ¦de¦ - ¦notified¦ .
𐋇¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦sh ut¦ ¦down¦ ¦all¦ ¦of¦ ¦its¦ ¦it¦ ¦sys tems¦ ¦after¦ ¦a¦ ¦major¦ ¦ra ns om w are¦ ¦att ack¦ ,▁ ¦with¦ ¦ireland¦ ' ¦s¦ ¦gp¦ ¦and¦ ¦close¦ ¦contact¦ ¦ref er r al¦ ¦system¦ ¦and¦ ¦the¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦regi str ation¦ ¦p ort al¦ ¦down¦ ,▁ ¦while¦ ¦the¦ ¦covid¦ - ¦19¦ ¦vacc ination¦ ¦pr ogra m me¦ ¦had¦ ¦not¦ ¦been¦ ¦affected¦ ¦by¦ ¦the¦ ¦att ack¦ .
𐋇¦the¦ ¦2021¦ ¦national¦ ¦pl ou g hing¦ ¦cha mp i o ns hi ps¦ ,▁ ¦due¦ ¦to¦ ¦have¦ ¦ta k en¦ ¦place¦ ¦in¦ ¦county¦ ¦la oi s¦ ¦in¦ ¦se p te mber¦ ,▁ ¦was¦ ¦cance lled¦ ¦for¦ ¦a¦ ¦second¦ ¦year¦ ¦due¦ ¦to¦ ¦un ce rt ai nt y¦ ¦over¦ ¦covid¦ - ¦19¦ ¦restrictions¦ .
¦15¦ ¦may¦
𐋇¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦announced¦ ¦that¦ ¦there¦ ¦would¦ ¦be¦ ¦no¦ ¦daily¦ ¦covid¦ - ¦19¦ ¦f ig ures¦ ¦up d ate¦ ¦provid ed¦ ¦due¦ ¦to¦ ¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ¦cyberat tack¦ ,▁ ¦with¦ ¦b ac k d ated¦ ¦f ig ures¦ ¦being¦ ¦publ ished¦ ▁" ¦when¦ ¦possible¦ " .
𐋇¦the¦ ¦hse¦ ¦stated¦ ¦that¦ ¦there¦ ¦was¦ ▁" ¦sub s ta ntial¦ ¦cance ll ations¦ ¦across¦ ¦all¦ ¦out pa ti ent¦ ¦services¦ ¦with¦ ¦wid esp r ead¦ ¦cance ll ation¦ ¦of¦ ¦ra di ology¦ ¦services¦ "▁ ¦following¦ ¦a¦ ¦ra ns om w are¦ ¦att ack¦ ¦on¦ ¦its¦ ¦it¦ ¦sys tems¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦rem oved¦ ¦5¦ ¦countries¦ ¦from¦ ¦the¦ ¦government¦ ' ¦s¦ ¦covid¦ - ¦19¦ ▁" ¦high¦ - ¦risk¦ "▁ ¦l ist¦ ¦for¦ ¦international¦ ¦travel¦ ¦with¦ ¦immediate¦ ¦eff ect¦ .
𐋇¦the¦ ¦countries¦ ¦rem oved¦ ¦were¦ :▁ 𐋇¦b erm ud a¦ ,▁ ¦iran¦ ,▁ ¦mon te ne g r o¦ ,▁ ¦pa le st ine¦ ¦and¦ ¦ser b ia¦ .
¦16¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦8 0 2¦ ¦cases¦ ¦were¦ ¦reported¦ ¦in¦ ¦the¦ ¦p ast¦ ¦4 8¦ ¦hours¦ ,▁ ¦with¦ ¦4 4 7¦ ¦cases¦ ¦reported¦ ¦on¦ ¦15¦ ¦may¦ ¦and¦ ¦3 5 5¦ ¦cases¦ ¦reported¦ ¦on¦ ¦16¦ ¦may¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦confirmed¦ ¦that¦ ¦it¦ ¦had¦ ¦been¦ ¦the¦ ¦v ic ti m¦ ¦of¦ ¦a¦ ¦separ ate¦ ¦cyb er¦ ¦att ack¦ ¦similar¦ ¦to¦ ¦the¦ ¦ra ns om w are¦ ¦att ack¦ ¦on¦ ¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ,▁ ¦pro mp ting¦ ¦the¦ ¦sh ut ting¦ ¦down¦ ¦of¦ ¦much¦ ¦of¦ ¦its¦ ¦it¦ ¦inf ra st ru ct ure¦ .
¦1 7¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦3 6 0¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇¦the¦ ¦further¦ ¦e as ing¦ ¦of¦ ¦level¦ ¦5¦ ¦restrictions¦ ¦ca me¦ ¦into¦ ¦eff ect¦ ¦with¦ ¦the¦ ¦reop ening¦ ¦of¦ ¦all¦ ¦non¦ - ¦essential¦ ¦re ta il¦ ¦for¦ ¦the¦ ¦first¦ ¦time¦ ¦in¦ ¦over¦ ¦four¦ ¦mon ths¦ .
𐋇¦the¦ ¦national¦ ¦immun is ation¦ ¦ad v is ory¦ ¦comm it te e¦ ▁( ¦n ia c¦ )▁ ¦confirmed¦ ¦that¦ ¦people¦ ¦in¦ ¦their¦ ¦4 0 s¦ ¦would¦ ¦be¦ ¦giv en¦ ¦a¦ ¦c ho ice¦ ¦to¦ ¦ac cep t¦ ¦the¦ ¦jo h ns on¦ ▁ & ▁ ¦jo h ns on¦ ¦or¦ ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦or¦ ¦op t¦ ¦to¦ ¦wai t¦ ¦for¦ ¦another¦ ¦vaccine¦ .
¦18¦ ¦may¦ ▁–▁ ¦a¦ ¦further¦ ¦3 5 8¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
¦19¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦5 0 3¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇¦the¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦regi str ation¦ ¦p ort al¦ ¦op e ned¦ ¦to¦ ¦people¦ ¦a ged¦ ¦between¦ ¦4 5¦ ¦and¦ ¦4 9¦ ¦on¦ ¦a¦ ¦ph a sed¦ ¦ba sis¦ ,▁ ¦star ting¦ ¦with¦ ¦people¦ ¦a ged¦ ¦4 9¦ .
𐋇¦p f iz er¦ ¦announced¦ ¦that¦ ¦it¦ ¦would¦ ¦beg in¦ ¦using¦ ¦its¦ ¦w est¦ ¦dublin¦ ¦facil ity¦ ¦as¦ ¦par t¦ ¦of¦ ¦its¦ ¦supp ly¦ ¦cha in¦ ¦for¦ ¦its¦ ¦covid¦ - ¦19¦ ¦vaccine¦ .
¦20¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦4 6 9¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇¦it¦ ¦was¦ ¦reported¦ ¦that¦ ¦the¦ ¦or g an i sed¦ ¦cyb er¦ ¦c ri me¦ ¦group¦ ¦that¦ ¦att ac ked¦ ¦the¦ ¦hse¦ ¦and¦ ¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦it¦ ¦sys tems¦ ¦provid ed¦ ¦a¦ ¦dec r y ption¦ ¦k e y¦ ,▁ ¦while¦ ¦the¦ ¦public¦ ¦was¦ ¦ad vi sed¦ ¦to¦ ¦be¦ ¦a w are¦ ¦of¦ ¦a¦ ¦number¦ ¦of¦ ¦call¦ ¦and¦ ¦te xt¦ ¦sc a ms¦ ¦in¦ ¦the¦ ¦w a ke¦ ¦of¦ ¦the¦ ¦cyb er¦ ¦att ack¦ .
¦ 21¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦5 2 4¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇 ¦minister¦ ¦for¦ ¦r ural¦ ¦and¦ ¦community¦ ¦development¦ ¦he at her¦ ¦h um ph re y s¦ ¦announced¦ ¦the¦ ¦retur n¦ ¦of¦ ¦the¦ ¦ti dy¦ ¦t ow ns¦ ¦comp et ition¦ ¦after¦ ¦it¦ ¦was¦ ¦cance lled¦ ¦in¦ ¦2020¦ ¦due¦ ¦to¦ ¦the¦ ¦pandemic¦ .
¦2 2¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦3 8 1¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦rem oved¦ ¦6¦ ¦countries¦ ¦from¦ ¦the¦ ¦government¦ ' ¦s¦ ¦covid¦ - ¦19¦ ▁" ¦high¦ - ¦risk¦ "▁ ¦l ist¦ ¦for¦ ¦international¦ ¦travel¦ ¦with¦ ¦immediate¦ ¦eff ect¦ .
𐋇¦the¦ ¦countries¦ ¦rem oved¦ ¦were¦ :▁ 𐋇 ¦a nd or r a¦ ,▁ ¦ ge or g ia¦ ,▁ ¦k u w ai t¦ ,▁ ¦mo ngol ia¦ ,▁ ¦n ig er ia¦ ¦and¦ ¦p u e rt o¦ ¦r ic o¦ .
¦23¦ ¦may¦ ▁–▁ ¦a¦ ¦further¦ ¦4 3 8¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
¦24¦ ¦may¦ ▁–▁ ¦a¦ ¦further¦ ¦3 4 5¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
¦2 5¦ ¦may¦ ▁–▁ ¦a¦ ¦further¦ ¦3 6 5¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
¦26¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦4 4 8¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇 ¦under¦ ¦new¦ ¦covid¦ - ¦19¦ ¦safety¦ ¦gu id el ines¦ ¦issued¦ ¦by¦ ¦f á il t e¦ ¦ireland¦ ,▁ ¦a¦ ¦ma x im um¦ ¦of¦ ¦si x¦ ¦people¦ ¦a ged¦ ¦13¦ ¦years¦ ¦and¦ ¦over¦ ¦would¦ ¦be¦ ¦all owed¦ ¦per¦ ¦t able¦ ¦when¦ ¦res ta u ra nts¦ ,▁ ¦p ub s¦ ¦and¦ ¦ca f é s¦ ¦open¦ ¦in¦ ¦june¦ ,▁ ¦with¦ ¦up¦ ¦to¦ ¦15¦ ¦people¦ ¦all owed¦ ¦when¦ ¦acc o mp an ying¦ ¦children¦ ¦under¦ ¦the¦ ¦age¦ ¦of¦ ¦12¦ .
¦2 7¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦4 3 6¦ ¦cases¦ ¦and¦ ¦8¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦and¦ ¦deaths¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇¦the¦ ¦ch ief¦ ¦ex ecu tive¦ ¦of¦ ¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ▁( ¦hse¦ )▁ ¦pa u l¦ ¦re id¦ ¦stated¦ ¦that¦ ¦the¦ ¦c ost¦ ¦of¦ ¦the¦ ¦cyb er¦ ¦att ack¦ ¦on¦ ¦its¦ ¦it¦ ¦sys tems¦ ¦could¦ ¦ex ce ed¦ ▁ € ¦100¦ ¦million¦ .
¦2 8¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦4 6 7¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇¦the¦ ¦hse¦ ¦confirmed¦ ¦that¦ ¦data¦ ¦relating¦ ¦to¦ ¦5 2 0¦ ¦patients¦ ,▁ ¦including¦ ¦sen si tive¦ ¦information¦ ,▁ ¦was¦ ¦publ ished¦ ¦online¦ ¦following¦ ¦the¦ ¦ra ns om w are¦ ¦att ack¦ ¦on¦ ¦14¦ ¦may¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦rem oved¦ ¦4¦ ¦countries¦ ¦from¦ ¦the¦ ¦government¦ ' ¦s¦ ¦covid¦ - ¦19¦ ▁" ¦high¦ - ¦risk¦ "▁ ¦l ist¦ ¦for¦ ¦international¦ ¦travel¦ ¦with¦ ¦immediate¦ ¦eff ect¦ .
𐋇¦the¦ ¦countries¦ ¦rem oved¦ ¦were¦ :▁ 𐋇¦b el g i um¦ ,▁ ¦fra nce¦ ,▁ ¦lu x e m bo ur g¦ ¦and¦ ¦the¦ ¦united¦ ¦states¦ .
𐋇¦the¦ ¦government¦ ¦of¦ ¦ireland¦ ¦announced¦ ¦a¦ ¦further¦ ¦reop ening¦ ¦pl an¦ ¦for¦ ¦the¦ ¦country¦ ¦th r ou g ho ut¦ ¦june¦ ,▁ ¦j u ly¦ ¦and¦ ¦a u g ust¦ ,▁ ¦with¦ ¦the¦ ¦reop ening¦ ¦of¦ ¦all¦ ¦h ot els¦ ¦from¦ ¦2¦ ¦june¦ ,▁ ¦out door¦ ¦hosp it ality¦ ,▁ ¦c i ne ma s¦ ,▁ ¦sw i mm ing¦ ¦po ols¦ ,▁ ¦g y ms¦ ¦from¦ ¦7¦ ¦june¦ ,▁ ¦and¦ ¦in door¦ ¦hosp it ality¦ ¦from¦ ¦5¦ ¦j u ly¦ .
𐋇 ¦from¦ ¦2¦ ¦june¦ :
𐋇 ¦reop ening¦ ¦of¦ ¦acc om mo d ation¦ ¦services¦ ¦including¦ ¦h ot els¦ ,▁ ¦b ¦ ▁ & ▁ ¦b s¦ ,▁ ¦self¦ - ¦c at ering¦ ¦and¦ ¦ho st els¦
𐋇 ¦from¦ ¦7¦ ¦june¦ :
𐋇¦the¦ ¦nu mbers¦ ¦p erm it ted¦ ¦at¦ ¦or g an i sed¦ ¦out door¦ ¦events¦ ¦could¦ ¦increase¦ ¦to¦ ¦a¦ ¦ma x im um¦ ¦of¦ ¦100¦ ¦for¦ ¦the¦ ¦ma j or ity¦ ¦of¦ ¦v en ues¦ ,▁ ¦with¦ ¦a¦ ¦ma x im um¦ ¦of¦ ¦2 00¦ ¦for¦ ¦out door¦ ¦v en ues¦ ¦with¦ ¦a¦ ¦min im um¦ ¦acc re di ted¦ ¦c ap ac ity¦ ¦of¦ ¦5¦ , ¦000¦
𐋇 ¦reop ening¦ ¦of¦ ¦all¦ ¦c i ne ma s¦ ,▁ ¦the at r es¦ ,▁ ¦g y ms¦ ,▁ ¦sw i mm ing¦ ¦po ols¦ ¦and¦ ¦le is ure¦ ¦centr es¦
𐋇 ¦reop ening¦ ¦of¦ ¦out door¦ ¦a m u se ment¦ ¦par ks¦ ,▁ ¦the me¦ ¦par ks¦ ¦and¦ ¦f un fa ir s¦
𐋇 ¦res um ption¦ ¦of¦ ¦out door¦ ¦services¦ ¦in¦ ¦res ta u ra nts¦ ¦and¦ ¦p ub s¦
𐋇 ¦visi ting¦ ¦ind o ors¦ ¦in¦ ¦priv ate¦ ¦h omes¦
𐋇 ¦part ial¦ ¦reop ening¦ ¦of¦ ¦d ri ver¦ ¦the ory¦ ¦test¦ ¦services¦
𐋇 ¦res um ption¦ ¦of¦ ¦out door¦ ¦sp orts¦ ¦m at ches¦
𐋇 ¦from¦ ¦5¦ ¦j u ly¦ :
𐋇 ¦up¦ ¦to¦ ¦three¦ ¦hou se h ol ds¦ ¦p erm it ted¦ ¦to¦ ¦me et¦ ¦ind o ors¦ ¦in¦ ¦priv ate¦ ¦h omes¦ ¦in¦ ¦ line¦ ¦with¦ ¦level¦ ¦2¦
𐋇 ¦res um ption¦ ¦of¦ ¦or g an i sed¦ ¦in door¦ ¦events¦
𐋇¦the¦ ¦nu mbers¦ ¦p erm it ted¦ ¦at¦ ¦out door¦ ¦or g an i sed¦ ¦events¦ ¦could¦ ¦further¦ ¦increase¦ ¦to¦ ¦a¦ ¦ma x im um¦ ¦of¦ ¦2 00¦ ¦for¦ ¦the¦ ¦ma j or ity¦ ¦of¦ ¦v en ues¦ ,▁ ¦with¦ ¦a¦ ¦ma x im um¦ ¦of¦ ¦5 00¦ ¦for¦ ¦out door¦ ¦sta d ia¦ ▁/▁ ¦v en ues¦ ¦with¦ ¦a¦ ¦min im um¦ ¦acc re di ted¦ ¦c ap ac ity¦ ¦of¦ ¦5¦ , ¦000¦
𐋇 ¦res um ption¦ ¦of¦ ¦in door¦ ¦services¦ ¦in¦ ¦res ta u ra nts¦ ¦and¦ ¦p ub s¦
𐋇 ¦reop ening¦ ¦of¦ ¦b ow l ing¦ ¦al le y s¦ ,▁ ¦s n oo k er¦ ¦ha lls¦ ,▁ ¦a m u se ment¦ ¦ar c a des¦ ,▁ ¦ ice¦ - ¦s k ating¦ ▁/▁ ¦ro ll er¦ ¦s k ating¦ ¦r in ks¦ ¦and¦ ¦in door¦ ¦w at er par ks¦
𐋇 ¦from¦ ¦19¦ ¦j u ly¦ :
𐋇 ¦international¦ ¦non¦ - ¦essential¦ ¦travel¦ ¦would¦ ¦be¦ ¦all owed¦ ¦with¦ ¦the¦ ¦eu¦ ¦d ig it al¦ ¦covid¦ - ¦19¦ ¦ce rt ific ate¦ ¦for¦ ¦travel¦ ¦c om ing¦ ¦into¦ ¦for ce¦ ¦in¦ ¦ireland¦
¦2 9¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦4 6 4¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇 ¦four¦ ¦people¦ ¦were¦ ¦arr ested¦ ¦for¦ ¦public¦ ¦order¦ ¦off en ces¦ ¦after¦ ¦large¦ ¦cr ow ds¦ ¦ga th ered¦ ¦in¦ ¦par ts¦ ¦of¦ ¦dublin¦ ¦city¦ ¦centre¦ ,▁ ¦while¦ ¦ch ief¦ ¦medical¦ ¦offic er¦ ¦t on y¦ ¦ho lo h an¦ ¦stated¦ ¦that¦ ¦h e¦ ¦was¦ ▁" ¦ab s o lu tely¦ ¦sh oc ked¦ "▁ ¦by¦ ¦the¦ ¦cr ow ds¦ ¦that¦ ¦ga th ered¦ .
¦30¦ ¦may¦ ▁–▁ ¦a¦ ¦further¦ ¦3 7 4¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
¦3 1¦ ¦may¦
𐋇¦a¦ ¦further¦ ¦3 7 8¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇¦it¦ ¦was¦ ¦announced¦ ¦that¦ ¦the¦ ¦2021¦ ¦ ed ition¦ ¦of¦ ¦the¦ ¦r ose¦ ¦of¦ ¦tra le e¦ ¦would¦ ¦be¦ ¦cance lled¦ ¦for¦ ¦the¦ ¦second¦ ¦year¦ ¦in¦ ¦a¦ ¦r ow¦ .
¦1¦ ¦june¦
𐋇¦a¦ ¦further¦ ¦3 3 7¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇 ¦according¦ ¦to¦ ¦a¦ ¦new¦ ¦study¦ ¦publ ished¦ ¦by¦ ¦the¦ ¦ir ish¦ ¦medical¦ ¦jo ur n al¦ ,▁ ¦medic s¦ ¦reported¦ ¦what¦ ¦they¦ ¦b el ie v ed¦ ¦to¦ ¦be¦ ¦the¦ ¦first¦ ¦case¦ ¦of¦ ¦covid¦ - ¦19¦ ¦re in f e ction¦ ¦in¦ ¦ireland¦ ¦in¦ ¦a¦ ¦4 0¦ - ¦year¦ - ¦o ld¦ ¦fe ma le¦ ¦healthcare¦ ¦work er¦ .
𐋇¦the¦ ¦government¦ ¦of¦ ¦ireland¦ ¦la un ched¦ ¦a¦ ▁ € ¦3¦ . ¦5¦ ¦bi ll ion¦ ¦ec onomic¦ ¦reco ve ry¦ ¦pl an¦ ¦to¦ ¦a ch ie ve¦ ¦rap id¦ ¦j ob ¦ ¦cre ation¦ ¦and¦ ¦ec onomic¦ ¦gr ow th¦ ¦after¦ ¦the¦ ¦pandemic¦ ,▁ ¦with¦ ¦the¦ ¦covid¦ - ¦19¦ ¦pandemic¦ ¦u ne mploy ment¦ ¦pa y ment¦ ¦and¦ ¦the¦ ¦e mploy ment¦ ¦w age¦ ¦sub si dy¦ ¦s che me¦ ¦ex te nded¦ ¦until¦ ¦se p te mber¦ ¦2021¦ ,▁ ¦when¦ ¦g rad ual¦ ¦reduc tions¦ ¦would¦ ¦beg in¦ .
¦2¦ ¦june¦
𐋇¦a¦ ¦further¦ ¦4 0 7¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇¦the¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦regi str ation¦ ¦p ort al¦ ¦op e ned¦ ¦to¦ ¦people¦ ¦a ged¦ ¦between¦ ¦4 0¦ ¦and¦ ¦4 4¦ ¦on¦ ¦a¦ ¦ph a sed¦ ¦ba sis¦ ,▁ ¦star ting¦ ¦with¦ ¦people¦ ¦a ged¦ ¦4 4¦ .
𐋇¦the¦ ¦g rad ual¦ ¦e as ing¦ ¦of¦ ¦covid¦ - ¦19¦ ¦restrictions¦ ¦on¦ ¦the¦ ¦to ur is m¦ ¦and¦ ¦hosp it ality¦ ¦s ector¦ ¦ca me¦ ¦into¦ ¦eff ect¦ ¦with¦ ¦the¦ ¦reop ening¦ ¦of¦ ¦all¦ ¦h ot els¦ ,▁ ¦b ¦ ▁ & ▁ ¦b s¦ ,▁ ¦self¦ - ¦c at ering¦ ¦acc om mo d ation¦ ¦and¦ ¦ho st els¦ .
𐋇¦a¦ ¦prob a tion ary¦ ¦gard a¦ ¦a v oi ded¦ ¦a¦ ¦j a il¦ ¦se nt ence¦ ¦for¦ ¦brea c hing¦ ¦covid¦ - ¦19¦ ¦restrictions¦ ,▁ ¦and¦ ¦inst ead¦ ¦received¦ ¦a¦ ▁ € ¦1¦ , ¦000¦ ¦f ine¦ ¦for¦ ¦the¦ ¦brea ch¦ ¦a lo ng¦ ¦with¦ ¦a¦ ¦ch ar ge¦ ¦for¦ ¦being¦ ¦int o x ic ated¦ ¦in¦ ¦public¦ .
𐋇¦the¦ ¦dir ector¦ ¦of¦ ¦the¦ ¦national¦ ¦virus¦ ¦ref er ence¦ ¦laboratory¦ ¦c il li an¦ ¦de¦ ¦g as c u n¦ ¦confirmed¦ ¦that¦ ¦there¦ ¦had¦ ¦been¦ ¦1 1 5¦ ¦cases¦ ¦of¦ ¦the¦ ¦in di an¦ ¦vari ant¦ ¦of¦ ¦covid¦ - ¦19¦ ¦detected¦ ¦in¦ ¦ireland¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦education¦ ¦announced¦ ¦that¦ ¦lea ving¦ ¦ce rt ific ate¦ ¦results¦ ¦would¦ ¦be¦ ¦de la y ed¦ ¦for¦ ¦a¦ ¦second¦ ¦year¦ ¦in¦ ¦a¦ ¦r ow¦ ,▁ ¦with¦ ¦students¦ ¦to¦ ¦receive¦ ¦their¦ ¦results¦ ¦on¦ ¦3¦ ¦se p te mber¦ .
¦3¦ ¦june¦
𐋇¦a¦ ¦further¦ ¦4 6 5¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇¦the¦ ¦health¦ ¦information¦ ¦and¦ ¦qu ality¦ ¦author ity¦ ▁( ¦hi q a¦ )▁ ¦ad vi sed¦ ¦the¦ ¦national¦ ¦public¦ ¦health¦ ¦emergency¦ ¦team¦ ¦that¦ ¦the¦ ¦d ur ation¦ ¦of¦ ¦immun ity¦ ¦following¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦should¦ ¦be¦ ¦ex te nded¦ ¦from¦ ¦si x¦ ¦to¦ ¦n ine¦ ¦mon ths¦ .
𐋇¦the¦ ¦government¦ ' ¦s¦ ¦emergency¦ ¦covid¦ - ¦19¦ ¦p ow ers¦ ¦including¦ ¦ad di tional¦ ¦gard a¦ ¦p ow ers¦ ¦int ro duc ed¦ ¦to¦ ¦de al¦ ¦with¦ ¦covid¦ - ¦19¦ ¦was¦ ¦ex te nded¦ ¦until¦ ¦no ve mber¦ ¦2021¦ .
𐋇 ¦sp ea king¦ ¦on¦ ¦ rt é ¦ ' ¦s¦ ¦m or ning¦ ¦ireland¦ ,▁ ¦minister¦ ¦for¦ ¦further¦ ¦and¦ ¦higher¦ ¦education¦ ¦s im on¦ ¦h ar ri s¦ ¦stated¦ ¦that¦ ¦h e¦ ¦exp ected¦ ¦students¦ ¦and¦ ¦staff¦ ¦to¦ ¦be¦ ¦b ack¦ ¦on¦ ¦ca mp us¦ ¦for¦ ¦the¦ ¦new¦ ¦ac a de m ic¦ ¦year¦ ¦of¦ ¦2021¦ ▁/▁ ¦2 2¦ .
𐋇¦the¦ ¦national¦ ¦immun is ation¦ ¦ad v is ory¦ ¦comm it te e¦ ▁( ¦n ia c¦ )▁ ¦ad vi sed¦ ¦that¦ ¦the¦ ¦ga p¦ ¦between¦ ¦two¦ ¦doses¦ ¦of¦ ¦the¦ ¦astrazeneca¦ ¦vaccine¦ ¦could¦ ¦be¦ ¦reduc ed¦ ¦from¦ ¦12¦ ¦weeks¦ ¦to¦ ¦8¦ ¦weeks¦ .
¦4¦ ¦june¦
𐋇¦a¦ ¦further¦ ¦5 2 9¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇 ¦minister¦ ¦of¦ ¦state¦ ¦with¦ ¦resp on si bility¦ ¦for¦ ¦the¦ ¦off ice¦ ¦of¦ ¦public¦ ¦wor ks¦ ¦p at r ick¦ ¦ o¦ ' ¦d on ov an¦ ¦app e al ed¦ ¦to¦ ¦people¦ ¦visi ting¦ ¦s t¦ ¦ste ph en¦ ' ¦s¦ ¦g re en¦ ¦in¦ ¦dublin¦ ¦to¦ ¦resp ect¦ ¦the¦ ¦s ite¦ ¦after¦ ¦rec k less¦ ¦be h a vi ou r¦ ¦was¦ ¦w it n es sed¦ ¦on¦ ¦3¦ ¦june¦ ¦when¦ ¦a¦ ¦group¦ ¦of¦ ¦people¦ ¦ga ined¦ ¦acc ess¦ ¦to¦ ¦the¦ ¦ba nd st and¦ ¦which¦ ¦had¦ ¦been¦ ¦fe nc ed¦ ¦off ¦ ¦for¦ ¦health¦ ¦and¦ ¦safety¦ ¦re as ons¦ .
¦5¦ ¦june¦
𐋇¦a¦ ¦further¦ ¦4 1 6¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
¦14¦ ¦people¦ ▁( ¦including¦ ¦5¦ ¦j u v en i les¦ )▁ ¦were¦ ¦arr ested¦ ¦for¦ ¦public¦ ¦order¦ ¦off en ces¦ ¦and¦ ¦a¦ ¦gard a¦ ¦received¦ ¦hospital¦ ¦treatment¦ ¦on¦ ¦the¦ ¦n ight¦ ¦of¦ ¦4¦ ¦june¦ ,▁ ¦after¦ ¦ vi ol ence¦ ¦b ro ke¦ ¦out¦ ¦in¦ ¦dublin¦ ¦city¦ ¦centre¦ ¦in¦ ¦which¦ ¦gl ass¦ ¦b ot t les¦ ¦were¦ ¦th r own¦ ¦at¦ ¦gardaí¦ ,▁ ¦which¦ ¦res ul ted¦ ¦in¦ ¦a¦ ¦p at ro l¦ ¦ca r¦ ¦being¦ ¦da ma ged¦ .
𐋇 ¦minister¦ ¦for¦ ¦health¦ ¦ste ph en¦ ¦d on n el ly¦ ¦d esc rib ed¦ ¦the¦ ¦inc id ents¦ ¦as¦ ▁" ¦th u gg ish¦ ¦be h a vi ou r¦ ¦and¦ ¦comp le tely¦ ¦un ac ce pt able¦ " .
𐋇 ¦minister¦ ¦for¦ ¦health¦ ¦ste ph en¦ ¦d on n el ly¦ ¦received¦ ¦hi s¦ ¦first¦ ¦d ose¦ ¦of¦ ¦a¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦in¦ ¦g re y st on es¦ ,▁ ¦county¦ ¦w ick l ow¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦ad ded¦ ¦a¦ ¦further¦ ¦5¦ ¦countries¦ ¦to¦ ¦the¦ ¦government¦ ' ¦s¦ ¦covid¦ - ¦19¦ ▁" ¦high¦ - ¦risk¦ "▁ ¦l ist¦ ¦for¦ ¦international¦ ¦travel¦ ,▁ ¦which¦ ¦would¦ ¦come¦ ¦into¦ ¦eff ect¦ ¦from¦ ¦4¦ ¦ am¦ ¦on¦ ¦t u es day¦ ¦8¦ ¦june¦ .
𐋇¦the¦ ¦countries¦ ¦ad ded¦ ¦were¦ :▁ 𐋇 ¦a f gh an ist an¦ ,▁ ¦e g y p t¦ ,▁ ¦s r i¦ ¦l an k a¦ ,▁ ¦s ud an¦ ¦and¦ ¦tr in id ad¦ ¦and¦ ¦t ob a g o¦ .
¦6¦ ¦june¦
𐋇¦a¦ ¦further¦ ¦3 1 3¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
¦19¦ ¦people¦ ▁( ¦including¦ ¦2¦ ¦j u v en i les¦ )▁ ¦were¦ ¦arr ested¦ ¦for¦ ¦public¦ ¦order¦ ¦off en ces¦ ¦and¦ ¦two¦ ¦gardaí¦ ¦received¦ ¦hospital¦ ¦treatment¦ ¦on¦ ¦the¦ ¦n ight¦ ¦of¦ ¦5¦ ¦june¦ ,▁ ¦after¦ ¦ vi ol ence¦ ¦b ro ke¦ ¦out¦ ¦in¦ ¦dublin¦ ' ¦s¦ ¦south¦ ¦city¦ ¦centre¦ ¦for¦ ¦a¦ ¦second¦ ¦cons ecu tive¦ ¦n ight¦ ¦in¦ ¦which¦ ¦a¦ ¦person¦ ¦was¦ ¦ass a ul ted¦ ,▁ ¦a¦ ¦b in¦ ¦was¦ ¦s et¦ ¦on¦ ¦f ir e¦ ¦and¦ ¦gl ass¦ ¦b ot t les¦ ¦were¦ ¦th r own¦ ,▁ ¦which¦ ¦res ul ted¦ ¦in¦ ¦a¦ ¦p at ro l¦ ¦ca r¦ ¦being¦ ¦da ma ged¦ .
¦7¦ ¦june¦
𐋇¦a¦ ¦further¦ ¦3 7 7¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇¦the¦ ¦g rad ual¦ ¦e as ing¦ ¦of¦ ¦covid¦ - ¦19¦ ¦restrictions¦ ¦contin u ed¦ ¦with¦ ¦the¦ ¦reop ening¦ ¦of¦ ¦all¦ ¦b ar s¦ ,▁ ¦res ta u ra nts¦ ¦and¦ ¦ca f é s¦ ¦for¦ ¦out door¦ ¦service¦ ,▁ ¦g y ms¦ ,▁ ¦sw i mm ing¦ ¦po ols¦ ,▁ ¦le is ure¦ ¦centr es¦ ,▁ ¦c i ne ma s¦ ¦and¦ ¦the at r es¦ ,▁ ¦the¦ ¦part ial¦ ¦res um ption¦ ¦of¦ ¦d ri ver¦ ¦the ory¦ ¦test¦ ¦services¦ ,▁ ¦and¦ ¦the¦ ¦all ow ance¦ ¦of¦ ¦an¦ ¦un v ac c in ated¦ ¦hou se ho ld¦ ¦to¦ ¦visit¦ ¦another¦ ¦un v ac c in ated¦ ¦hou se ho ld¦ ¦ind o ors¦ .
¦14¦ ¦people¦ ▁( ¦including¦ ¦3¦ ¦j u v en i les¦ )▁ ¦were¦ ¦arr ested¦ ¦for¦ ¦public¦ ¦order¦ ¦off en ces¦ ¦on¦ ¦the¦ ¦n ight¦ ¦of¦ ¦6¦ ¦june¦ ,▁ ¦after¦ ¦ vi ol ence¦ ¦b ro ke¦ ¦out¦ ¦in¦ ¦dublin¦ ' ¦s¦ ¦south¦ ¦city¦ ¦centre¦ ¦for¦ ¦a¦ ¦thir d¦ ¦cons ecu tive¦ ¦n ight¦ ,▁ ¦while¦ ¦gardaí¦ ¦arr ested¦ ¦8¦ ¦people¦ ¦in¦ ¦cor k¦ .
¦8¦ ¦june¦ ▁–▁ ¦a¦ ¦further¦ ¦2 7 1¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
¦9¦ ¦june¦ ▁–▁ ¦a¦ ¦further¦ ¦2 5 9¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
¦10¦ ¦june¦
𐋇¦a¦ ¦further¦ ¦3 9 8¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇¦the¦ ¦first¦ ¦in¦ ¦a¦ ¦ser ies¦ ¦of¦ ¦live¦ ¦p il ot¦ ¦concer ts¦ ¦t ook¦ ¦place¦ ¦at¦ ¦the¦ ¦ iv ea gh ¦ ¦gard ens¦ ,▁ ¦dublin¦ ,▁ ¦with¦ ¦j a m es¦ ¦ vi nc ent¦ ¦m c m or r ow¦ ¦and¦ ¦spec ial¦ ¦gu est¦ ¦s or ch a¦ ¦ ri ch ar d s on¦ ¦pla ying¦ ¦to¦ ¦5 00¦ ¦people¦ ¦at¦ ¦the¦ ¦sh ow¦ .
¦11¦ ¦june¦ ▁–▁ ¦a¦ ¦further¦ ¦3 1 9¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
¦12¦ ¦june¦ ▁–▁ ¦a¦ ¦further¦ ¦4 3 1¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
¦13¦ ¦june¦
𐋇¦a¦ ¦further¦ ¦3 1 5¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦ad ded¦ ¦one¦ ¦ad di tional¦ ¦country¦ ¦to¦ ¦the¦ ¦government¦ ' ¦s¦ ¦covid¦ - ¦19¦ ▁" ¦high¦ - ¦risk¦ "▁ ¦l ist¦ ¦for¦ ¦international¦ ¦travel¦ ,▁ ¦which¦ ¦would¦ ¦come¦ ¦into¦ ¦eff ect¦ ¦from¦ ¦4¦ ¦ am¦ ¦on¦ ¦w ed n es day¦ ¦16¦ ¦june¦ .
𐋇¦the¦ ¦country¦ ¦ad ded¦ ¦was¦ :▁ 𐋇 ¦u g a nd a¦ .
¦14¦ ¦june¦ ▁–▁ ¦a¦ ¦further¦ ¦2 4 2¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
¦15¦ ¦june¦
𐋇¦a¦ ¦further¦ ¦2 8 3¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦however¦ ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦and¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇¦the¦ ¦government¦ ¦of¦ ¦ireland¦ ¦ag re ed¦ ¦to¦ ¦increase¦ ¦the¦ ¦self¦ - ¦isolation¦ ¦period¦ ¦for¦ ¦tra ve ll ers¦ ¦ar ri ving¦ ¦in¦ ¦ireland¦ ¦from¦ ¦b ri tain¦ ¦from¦ ¦5¦ ¦to¦ ¦10¦ ¦days¦ ¦for¦ ¦those¦ ¦who¦ ¦are¦ ¦not¦ ¦f ul ly¦ ¦vaccinated¦ ¦a m id¦ ¦del t a¦ ¦vari ant¦ ¦concer ns¦ .
¦16¦ ¦june¦ ▁–▁ ¦a¦ ¦further¦ ¦3 2 9¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦to¦ ¦2 6 7¦ , ¦5 7 6¦ .
𐋇 ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
¦1 7¦ ¦june¦
𐋇¦a¦ ¦further¦ ¦3 7 3¦ ¦cases¦ ¦and¦ ¦26¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 6 7¦ , ¦9 4 9¦ ¦cases¦ ¦and¦ ¦4¦ , ¦9 7 9¦ ¦deaths¦ .
𐋇 ¦hse¦ ¦ch ief¦ ¦clinical¦ ¦offic er¦ ¦c ol m¦ ¦h en ry¦ ¦confirmed¦ ¦that¦ ¦there¦ ¦had¦ ¦been¦ ¦1 8 0¦ ¦cases¦ ¦of¦ ¦the¦ ¦del t a¦ ¦vari ant¦ ¦detected¦ ¦in¦ ¦ireland¦ .
¦18¦ ¦june¦
𐋇¦a¦ ¦further¦ ¦3 1 3¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦to¦ ¦2 6 8¦ , ¦2 5 1¦ .
𐋇 ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇¦the¦ ¦department¦ ¦of¦ ¦health¦ ¦ad ded¦ ¦one¦ ¦country¦ ¦and¦ ¦rem oved¦ ¦one¦ ¦country¦ ¦to¦ ¦the¦ ¦government¦ ' ¦s¦ ¦covid¦ - ¦19¦ ▁" ¦high¦ - ¦risk¦ "▁ ¦l ist¦ ¦for¦ ¦international¦ ¦travel¦ ,▁ ¦which¦ ¦would¦ ¦come¦ ¦into¦ ¦eff ect¦ ¦from¦ ¦4¦ ¦ am¦ ¦on¦ ¦t u es day¦ ¦2 2¦ ¦june¦ .
𐋇¦the¦ ¦country¦ ¦ad ded¦ ¦was¦ :▁ 𐋇 ¦mo ngol ia¦ .
𐋇 ¦ca na d a¦ ¦was¦ ¦rem oved¦ ¦from¦ ¦the¦ ¦l ist¦ .
¦19¦ ¦june¦
𐋇¦a¦ ¦further¦ ¦3 9 3¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦to¦ ¦2 6 8¦ , ¦6 4 4¦ .
𐋇 ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇¦a¦ ¦pr imary¦ ¦school¦ ¦in¦ ¦county¦ ¦off a ly¦ ¦confirmed¦ ¦a¦ ¦suspected¦ ¦case¦ ¦of¦ ¦the¦ ¦del t a¦ ¦vari ant¦ ¦with¦ ¦the¦ ¦children¦ ¦to ld¦ ¦to¦ ¦self¦ ¦isol ate¦ ¦at¦ ¦home¦ .
𐋇 ¦after¦ ¦disc u ss ing¦ ¦the¦ ¦ev ol ving¦ ¦pro f i le¦ ¦of¦ ¦covid¦ - ¦19¦ ¦across¦ ¦the¦ ¦ is land¦ ,▁ ¦the¦ ¦ch ief¦ ¦medical¦ ¦offic ers¦ ¦of¦ ¦ireland¦ ¦and¦ ¦n or ther n¦ ¦ireland¦ ¦t on y¦ ¦ho lo h an¦ ¦and¦ ¦mi ch a e l¦ ¦m c b r ide¦ ¦issued¦ ¦a¦ ¦jo in t¦ ¦sta te ment¦ ¦re min ding¦ ¦people¦ ¦who¦ ¦in te nded¦ ¦to¦ ¦travel¦ ¦across¦ ¦the¦ ¦ bor der¦ ¦to¦ ¦be¦ ¦alert¦ ¦to¦ ¦the¦ ¦e p ide mi ological¦ ¦s itu ation¦ ¦in¦ ¦the¦ ¦re le v ant¦ ¦local¦ ¦areas¦ ¦and¦ ¦to¦ ¦e ns ure¦ ¦that¦ ¦they¦ ¦avoid¦ ¦activ ities¦ ¦which¦ ¦could¦ ¦place¦ ¦them¦ ¦or¦ ¦their¦ ¦fa m il ies¦ ¦at¦ ¦risk¦ ¦of¦ ¦covid¦ - ¦19¦ ¦infection¦ .
¦20¦ ¦june¦
𐋇¦a¦ ¦further¦ ¦2 8 8¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦to¦ ¦2 6 9¦ , ¦0 3 7¦ .
𐋇 ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇¦the¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦regi str ation¦ ¦p ort al¦ ¦op e ned¦ ¦to¦ ¦people¦ ¦a ged¦ ¦between¦ ¦3 5¦ ¦and¦ ¦3 9¦ ¦on¦ ¦a¦ ¦ph a sed¦ ¦ba sis¦ ,▁ ¦star ting¦ ¦with¦ ¦people¦ ¦a ged¦ ¦3 9¦ .
¦ 21¦ ¦june¦
𐋇¦a¦ ¦further¦ ¦2 8 4¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦cases¦ ¦to¦ ¦2 6 9¦ , ¦3 21¦ .
𐋇 ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇 ¦ch ief¦ ¦medical¦ ¦offic er¦ ¦t on y¦ ¦ho lo h an¦ ¦stated¦ ¦that¦ ¦the¦ ¦l at est¦ ¦data¦ ¦sh owed¦ ¦a¦ ▁" ¦concer ning¦ ¦increase¦ ¦in¦ ¦transmission¦ "▁ ¦of¦ ¦the¦ ¦del t a¦ ¦vari ant¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦ireland¦ .
𐋇 ¦minister¦ ¦for¦ ¦j u st ice¦ ¦he at her¦ ¦h um ph re y s¦ ¦sp o ke¦ ¦to¦ ¦gard a¦ ¦comm is si on er¦ ¦d re w¦ ¦h ar ri s¦ ¦about¦ ¦the¦ ¦le g al¦ ¦i ss ues¦ ¦around¦ ¦out door¦ ¦dr in king¦ ¦and¦ ¦pl ed ged¦ ¦to¦ ¦take¦ ¦le g is l ative¦ ¦a ction¦ ¦to¦ ¦facil it ate¦ ¦out door¦ ¦hosp it ality¦ ¦if¦ ¦it¦ ¦was¦ ¦required¦ ,▁ ¦after¦ ¦gardaí¦ ¦w ar ned¦ ¦that¦ ¦al c o ho l¦ ¦l ic en ces¦ ¦were¦ ¦not¦ ¦v al id¦ ¦for¦ ¦areas¦ ¦outside¦ ¦p ub s¦ ¦and¦ ¦res ta u ra nts¦ .
¦2 2¦ ¦june¦
𐋇¦a¦ ¦further¦ ¦2 9 4¦ ¦cases¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦total¦ ¦number¦ ¦of¦ ¦confirmed¦ ¦cases¦ ¦to¦ ¦2 6 9¦ , ¦4 9 5¦ .
𐋇 ¦data¦ ¦relating¦ ¦to¦ ¦the¦ ¦number¦ ¦of¦ ¦covid¦ - ¦19¦ ¦deaths¦ ¦were¦ ¦not¦ ¦available¦ ¦due¦ ¦to¦ ¦the¦ ¦hse¦ ¦cyberat tack¦ .
𐋇¦the¦ ¦hse¦ ' ¦s¦ ¦dir ector¦ ¦of¦ ¦public¦ ¦health¦ ¦for¦ ¦the¦ ¦m id l an ds¦ ¦u na¦ ¦fa ll on¦ ¦announced¦ ¦that¦ ¦a¦ ¦covid¦ - ¦19¦ ¦outbreak¦ ¦in¦ ¦a th l one¦ ¦had¦ ¦been¦ ¦identified¦ ¦as¦ ▁" ¦prob ab ly¦ "▁ ¦the¦ ¦del t a¦ ¦vari ant¦ ¦after¦ ¦a¦ ¦cl us ter¦ ¦of¦ ¦14¦ ¦pr imary¦ ¦cases¦ ¦associated¦ ¦with¦ ¦s oc i al ising¦ ¦by¦ ¦the¦ ¦ ri ver¦ ¦sh an n on¦ ¦were¦ ¦confirmed¦ ¦on¦ ¦f ri day¦ ¦11¦ ¦june¦ .
𐋇 ¦an¦ ¦online¦ ¦b oo king¦ ¦system¦ ¦for¦ ¦covid¦ - ¦19¦ ¦test¦ ¦ref er r al¦ ¦op e ned¦ ¦for¦ ¦people¦ ¦in¦ ¦all¦ ¦cou nt ies¦ .
¦23¦ ¦june¦
𐋇¦a¦ ¦further¦ ¦3 4 8¦ ¦cases¦ ¦and¦ ¦10¦ ¦deaths¦ ¦were¦ ¦reported¦ ,▁ ¦bringing¦ ¦the¦ ¦totals¦ ¦to¦ ¦2 6 9¦ , ¦7 9 3¦ ¦cases¦ ¦and¦ ¦4¦ , ¦9 8 9¦ ¦deaths¦ .
𐋇¦it¦ ¦was¦ ¦confirmed¦ ¦that¦ ¦at¦ ¦least¦ ¦three¦ ¦qu a rt ers¦ ¦of¦ ¦the¦ ¦hse¦ ' ¦s¦ ¦it¦ ¦s erv ers¦ ¦had¦ ¦been¦ ¦dec r y p ted¦ ¦and¦ ¦7 0¦ %▁ ¦of¦ ¦comp u ter¦ ¦de vi ces¦ ¦were¦ ¦b ack¦ ¦in¦ ¦use¦ ,▁ ¦following¦ ¦the¦ ¦cyb er¦ ¦att ack¦ ¦in¦ ¦may¦ .
𐋇 ¦vaccines¦ ¦are¦ ¦the¦ ¦most¦ ¦effective¦ ¦way¦ ¦to¦ ¦prevent¦ ¦infectious¦ ¦diseases¦ .
𐋇¦they¦ ¦pre p are¦ ¦your¦ ¦immune¦ ¦system¦ ▁( ¦the¦ ¦body¦ ' ¦s¦ ¦nat ural¦ ¦def ence¦ )▁ ¦to¦ ¦reco gn iz e¦ ¦a¦ ¦partic ular¦ ¦virus¦ ¦and¦ ¦protect¦ ¦against¦ ¦that¦ ¦virus¦ .
𐋇¦the¦ ¦j an ss en¦ ¦vaccine¦ ¦is¦ ¦also¦ ¦known¦ ¦as¦ ¦the¦ ▁' ¦jo h ns on¦ ▁ & ▁ ¦jo h ns on¦ ¦vaccine¦ ' .
𐋇¦this¦ ¦vaccine¦ ¦is¦ ¦produc ed¦ ¦by¦ ¦jo h ns on¦ ▁ & ▁ ¦jo h ns on¦ .
𐋇¦this¦ ¦vaccine¦ ¦is¦ ¦giv en¦ ¦as¦ ¦an¦ ¦in j e ction¦ ¦into¦ ¦the¦ ¦u pp er¦ ¦ar m¦ .
𐋇¦it¦ ¦only¦ ¦ta k es¦ ¦a¦ ¦fe w¦ ¦min u tes¦ .
𐋇 ¦doses¦
𐋇 ¦only¦ ¦one¦ ¦d ose¦ ¦of¦ ¦the¦ ¦j an ss en¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦is¦ ¦required¦ ¦for¦ ¦long¦ - ¦ter m¦ ¦prote ction¦ .
𐋇¦the¦ ¦vaccine¦ ¦ta k es¦ ¦f ul l¦ ¦eff ect¦ ¦after¦ ¦14¦ ¦days¦ .
𐋇¦you¦ ¦will¦ ¦then¦ ¦be¦ ¦f ul ly¦ ¦vaccinated¦ .
𐋇 ¦immun ity¦
𐋇 ¦vaccines¦ ¦en able¦ ¦your¦ ¦immune¦ ¦system¦ ¦to¦ ¦protect¦ ¦you¦ ¦from¦ ¦disease¦ .
𐋇¦it¦ ¦would¦ ¦be¦ ¦b est¦ ¦if¦ ¦your¦ ¦immune¦ ¦system¦ ¦could¦ ¦protect¦ ¦you¦ ¦with¦ ¦the¦ ¦vaccine¦ ¦inst ead¦ ¦of¦ ¦getting¦ ¦covid¦ - ¦19¦ .
𐋇 ¦safety¦
𐋇¦the¦ ¦j an ss en¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦was¦ ¦developed¦ ¦according¦ ¦to¦ ¦international¦ ¦safety¦ ¦sta nd ards¦ .
𐋇¦the¦ ¦vaccine¦ ¦has¦ ¦been¦ ¦tested¦ ¦on¦ ¦t ho us an ds¦ ¦of¦ ¦people¦ ¦during¦ ¦clinical¦ ¦trials¦
𐋇¦ side¦ ¦eff ects¦
𐋇 ¦vaccines¦ ,▁ ¦like¦ ¦all¦ ¦other¦ ¦medic ines¦ ,▁ ¦can¦ ¦have¦ ¦ side¦ ¦eff ects¦ .
𐋇 ¦most¦ ¦of¦ ¦these¦ ¦are¦ ¦mild¦ ¦or¦ ¦mod er ate¦ ¦and¦ ¦do¦ ¦not¦ ¦last¦ ¦long¦ .
𐋇 ¦not¦ ¦e veryone¦ ¦g ets¦ ¦ side¦ ¦eff ects¦ .
𐋇 ¦getting¦ ¦your¦ ¦vaccine¦
𐋇 ¦most¦ ¦people¦ ¦will¦ ¦be¦ ¦giv en¦ ¦the¦ ¦vaccine¦ ¦at¦ ¦a¦ ¦gp¦ ¦sur ge ry¦ ¦or¦ ¦vacc ination¦ ¦center¦ .
𐋇¦you¦ ¦are¦ ¦getting¦ ¦your¦ ¦vaccine¦ ▁-▁ ¦more¦ ¦information¦ ¦h er e¦ .
𐋇¦the¦ ¦b est¦ ¦vaccine¦
𐋇 ¦all¦ ¦vaccines¦ ¦are¦ ¦tested¦ ¦for¦ ¦safety¦ ¦and¦ ¦eff ic acy¦ ¦before¦ ¦use¦ .
𐋇¦the¦ ¦hse¦ ¦only¦ ¦u ses¦ ¦a¦ ¦vaccine¦ ¦if¦ ¦it¦ ¦me ets¦ ¦the¦ ¦required¦ ¦safety¦ ¦and¦ ¦eff ic acy¦ ¦sta nd ards¦ .
𐋇¦you¦ ¦should¦ ¦take¦ ¦wh a te ver¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦is¦ ¦off ered¦ ¦to¦ ¦you¦ .
𐋇¦f ind¦ ¦out¦ ¦more¦ ¦about¦ ¦the¦ ¦development¦ ¦of¦ ¦covid¦ - ¦19¦ ¦vaccines¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦pre gnant¦
𐋇¦the¦ ¦co ss id¦ - ¦19¦ ¦j an ss en¦ ¦vaccine¦ ¦is¦ ¦not¦ ¦recommended¦ ¦for¦ ¦pre gnant¦ ¦women¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦off ered¦ ¦another¦ ¦vaccine¦ .
𐋇¦t alk¦ ¦to¦ ¦your¦ ¦gp¦ ¦or¦ ¦ob st et r ici an¦ ¦about¦ ¦getting¦ ¦your¦ ¦covid¦ - ¦19¦ ¦vaccine¦ .
𐋇¦f ind¦ ¦out¦ ¦more¦ ¦about¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦during¦ ¦pregn a ncy¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦f ee ding¦ ¦your¦ ¦child¦ ¦yourself¦
𐋇¦you¦ ¦can¦ ¦get¦ ¦the¦ ¦covid¦ - ¦10¦ ¦vaccine¦ ¦if¦ ¦you¦ ¦are¦ ¦f ee ding¦ ¦your¦ ¦baby¦ ¦yourself¦ .
𐋇¦the¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦will¦ ¦not¦ ¦be¦ ¦giv en¦ ¦to¦ ¦your¦ ¦baby¦ .
𐋇¦f ind¦ ¦out¦ ¦more¦ ¦about¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦if¦ ¦you¦ ¦are¦ ¦brea st f ee ding¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦a ged¦ ¦between¦ ¦5 6¦ ¦and¦ ¦6 9¦ ,▁ ¦you¦ ¦can¦ ¦reg is ter¦ ¦n ow¦ ¦to¦ ¦receive¦ ¦your¦ ¦covid¦ - ¦19¦ ¦vaccine¦ .
𐋇 ¦vaccines¦ ¦are¦ ¦the¦ ¦most¦ ¦effective¦ ¦way¦ ¦to¦ ¦prevent¦ ¦infectious¦ ¦diseases¦ .
𐋇¦they¦ ¦pre p are¦ ¦your¦ ¦immune¦ ¦system¦ ▁( ¦the¦ ¦body¦ ' ¦s¦ ¦nat ural¦ ¦def ence¦ )▁ ¦to¦ ¦reco gn iz e¦ ¦a¦ ¦partic ular¦ ¦virus¦ ¦and¦ ¦protect¦ ¦against¦ ¦that¦ ¦virus¦ .
𐋇¦the¦ ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦is¦ ¦effective¦ ¦for¦ ¦any¦ ¦age¦ ¦group¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦been¦ ¦vaccinated¦ ,▁ ¦you¦ ¦will¦ ¦be¦ ¦prot ected¦ ¦against¦ ¦covid¦ - ¦19¦ .
𐋇¦the¦ ¦risk¦ ¦of¦ ¦illness¦ ¦if¦ ¦you¦ ¦get¦ ¦covid¦ - ¦19¦ ¦fa r¦ ¦out we i gh s¦ ¦any¦ ¦risk¦ ¦associated¦ ¦with¦ ¦the¦ ¦vaccine¦ .
𐋇 ¦astrazeneca¦ ¦is¦ ¦not¦ ¦recommended¦ ¦for¦ ¦people¦ ¦under¦ ¦6 0¦ ¦years¦ ¦of¦ ¦age¦ ¦due¦ ¦to¦ ¦an¦ ¦ab n ormal¦ ¦risk¦ ¦of¦ ¦low¦ ¦pl at el et¦ ¦blood¦ ¦c lo ts¦ ¦after¦ ¦rece i ving¦ ¦the¦ ¦vaccine¦ .
𐋇¦it¦ ¦is¦ ¦a¦ ¦pr ec a ution¦ ¦because¦ ¦people¦ ¦under¦ ¦6 0¦ ¦are¦ ¦less¦ ¦likely¦ ¦to¦ ¦get¦ ¦a¦ ¦severe¦ ¦covid¦ - ¦19¦ ¦illness¦ ¦and¦ ¦other¦ ¦vaccines¦ ¦are¦ ¦available¦ .
𐋇 ¦lear n¦ ¦more¦ ¦about¦ ¦u nc o mm on¦ ¦ side¦ ¦eff ects¦ ¦and¦ ¦the¦ ¦new¦ ¦gu ide¦
𐋇 ¦doses¦
𐋇¦you¦ ¦will¦ ¦need¦ ¦two¦ ¦doses¦ ¦of¦ ¦the¦ ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccine¦ .
𐋇¦you¦ ¦will¦ ¦receive¦ ¦the¦ ¦second¦ ¦d ose¦ ¦12¦ ¦weeks¦ ¦after¦ ¦the¦ ¦first¦ ¦d ose¦ ¦if¦
𐋇¦you¦ ¦are¦ ¦6 0¦ ¦years¦ ¦of¦ ¦age¦ ¦or¦ ¦ ol der¦
𐋇¦you¦ ¦have¦ ¦a¦ ¦health¦ ¦c ond ition¦ ¦that¦ ¦p u ts¦ ¦you¦ ¦at¦ ¦high¦ ¦or¦ ¦very¦ ¦high¦ ¦risk¦ ¦from¦ ¦covid¦ - ¦19¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦under¦ ¦6 0¦ ¦and¦ ¦do¦ ¦not¦ ¦have¦ ¦a¦ ¦health¦ ¦c ond ition¦ ¦that¦ ¦p u ts¦ ¦you¦ ¦at¦ ¦high¦ ¦or¦ ¦very¦ ¦high¦ ¦risk¦ ¦from¦ ¦covid¦ - ¦19¦ ,▁ ¦you¦ ¦should¦ ¦wai t¦ ¦16¦ ¦weeks¦ ¦to¦ ¦receive¦ ¦a¦ ¦second¦ ¦d ose¦ .
𐋇¦this¦ ¦has¦ ¦increased¦ ¦from¦ ¦12¦ ¦weeks¦ .
𐋇¦this¦ ¦ext r a¦ ¦time¦ ¦all ow s¦ ¦us¦ ¦to¦ ¦do¦ ¦more¦ ¦research¦ ¦as¦ ¦more¦ ¦evidence¦ ¦bec omes¦ ¦available¦ .
𐋇 ¦vaccine¦ ▁' ¦b on us¦ '
¦2 8¦ ¦days¦ ¦after¦ ¦your¦ ¦first¦ ¦d ose¦ ¦of¦ ¦the¦ ¦astrazeneca¦ ¦vaccine¦ ,▁ ¦you¦ ¦can¦ ¦follow¦ ¦the¦ ¦same¦ ▁' ¦vaccine¦ ¦b on us¦ ' ▁ ¦public¦ ¦health¦ ¦advice¦ ¦as¦ ¦people¦ ¦who¦ ¦have¦ ¦been¦ ¦f ul ly¦ ¦vaccinated¦ .
𐋇¦this¦ ¦does¦ ¦not¦ ¦include¦ ¦travel¦ ¦ab ro ad¦ .
𐋇¦you¦ ¦still¦ ¦need¦ ¦to¦ ¦get¦ ¦your¦ ¦second¦ ¦d ose¦ ¦to¦ ¦make¦ ¦sure¦ ¦your¦ ¦vaccine¦ ¦prote ction¦ ¦la sts¦ .
𐋇¦read¦ ¦government¦ ¦advice¦ ¦on¦ ¦the¦ ¦vaccine¦ ¦b on us¦
𐋇 ¦safety¦
𐋇 ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦was¦ ¦developed¦ ¦according¦ ¦to¦ ¦international¦ ¦safety¦ ¦sta nd ards¦ .
𐋇¦the¦ ¦vaccine¦ ¦has¦ ¦been¦ ¦tested¦ ¦on¦ ¦t ho us an ds¦ ¦of¦ ¦people¦ ¦during¦ ¦clinical¦ ¦trials¦
𐋇 ¦lear n¦ ¦more¦ ¦about¦ ¦the¦ ¦safety¦ ¦of¦ ¦the¦ ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccine¦
𐋇¦ side¦ ¦eff ects¦
𐋇 ¦vaccines¦ ,▁ ¦like¦ ¦all¦ ¦other¦ ¦medic ines¦ ,▁ ¦can¦ ¦have¦ ¦ side¦ ¦eff ects¦ .
𐋇 ¦most¦ ¦of¦ ¦these¦ ¦are¦ ¦mild¦ ¦or¦ ¦mod er ate¦ ¦and¦ ¦do¦ ¦not¦ ¦last¦ ¦long¦
𐋇 ¦not¦ ¦e veryone¦ ¦g ets¦ ¦ side¦ ¦eff ects¦ .
𐋇 ¦more¦ ¦e o a li s¦ ¦about¦ ¦ side¦ ¦eff ects¦ ¦after¦ ¦vacc ination¦ ¦covid¦ - ¦19¦ ¦astrazeneca¦ ¦to¦ ¦f ind¦
𐋇¦the¦ ¦b est¦ ¦vaccine¦
𐋇 ¦all¦ ¦vaccines¦ ¦are¦ ¦tested¦ ¦for¦ ¦safety¦ ¦and¦ ¦eff ic acy¦ ¦before¦ ¦use¦ .
𐋇¦the¦ ¦hse¦ ¦only¦ ¦u ses¦ ¦a¦ ¦vaccine¦ ¦if¦ ¦it¦ ¦me ets¦ ¦the¦ ¦required¦ ¦safety¦ ¦and¦ ¦eff ic acy¦ ¦sta nd ards¦ .
𐋇¦you¦ ¦should¦ ¦take¦ ¦wh a te ver¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦is¦ ¦off ered¦ ¦to¦ ¦you¦ .
𐋇¦f ind¦ ¦out¦ ¦more¦ ¦about¦ ¦the¦ ¦development¦ ¦of¦ ¦covid¦ - ¦19¦ ¦vaccines¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦pre gnant¦ ¦or¦ ¦nu rs ing¦ ¦your¦ ¦child¦ ¦yourself¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦not¦ ¦y et¦ ¦been¦ ¦vaccinated¦ ,▁ ¦you¦ ¦will¦ ¦be¦ ¦off ered¦ ¦a¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦other¦ ¦than¦ ¦astrazeneca¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦pre gnant¦ ¦or¦ ¦brea st f ee ding¦ ¦and¦ ¦have¦ ¦received¦ ¦your¦ ¦first¦ ¦d ose¦ ¦of¦ ¦the¦ ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ,▁ ¦wai t¦ ¦at¦ ¦least¦ ¦12¦ ¦weeks¦ ¦before¦ ¦rece i ving¦ ¦the¦ ¦second¦ ¦d ose¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦at¦ ¦g rea ter¦ ¦risk¦ ¦of¦ ¦ser ious¦ ¦illness¦ ¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦receive¦ ¦your¦ ¦second¦ ¦d ose¦ .
𐋇¦the¦ ¦be ne f i ts¦ ¦out we i gh ¦ ¦the¦ ¦h ar ms¦ ¦of¦ ¦getting¦ ¦a¦ ¦vaccine¦ .
𐋇 ¦getting¦ ¦two¦ ¦vaccines¦ ¦will¦ ¦reduce¦ ¦your¦ ¦chan ces¦ ¦of¦ ¦bec om ing¦ ¦very¦ ¦ ill¦ ¦because¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇¦for¦ ¦ad ul ts¦ ,▁ ¦self¦ - ¦isolation¦ ¦me ans¦ ¦sta ying¦ ¦in side¦ ¦and¦ ¦sta ying¦ ¦away¦ ¦from¦ ¦others¦ ¦al t og ether¦ .
𐋇¦but¦ ¦there¦ ¦is¦ ¦other¦ ¦advice¦ ¦for¦ ¦children¦ .
𐋇 ¦children¦ ¦cannot¦ ¦be¦ ¦as ked¦ ¦to¦ ¦self¦ - ¦isol ate¦ ¦on¦ ¦their¦ ¦ own¦ ,▁ ¦especially¦ ¦if¦ ¦they¦ ¦are¦ ¦very¦ ¦y ou ng¦ .
𐋇 ¦an¦ ¦ad ul t¦ ¦will¦ ¦need¦ ¦to¦ ¦care¦ ¦for¦ ¦a¦ ¦child¦ ¦and¦ ¦help¦ ¦the¦ ¦child¦ ¦reduce¦ ¦the¦ ¦risk¦ ¦of¦ ¦the¦ ¦virus¦ ¦sprea ding¦ .
𐋇¦the¦ ¦child¦ ¦and¦ ¦ad ul t¦ ¦should¦ ¦stay¦ ¦away¦ ¦from¦ ¦others¦ ,▁ ¦especially¦ ¦those¦ ¦who¦ ¦live¦ ¦with¦ ¦them¦ .
𐋇¦c ho ose¦ ¦one¦ ¦car er¦ ¦to¦ ¦care¦ ¦for¦ ¦the¦ ¦child¦ .
𐋇 ¦one¦ ¦person¦ ¦should¦ ¦take¦ ¦care¦ ¦of¦ ¦the¦ ¦child¦ ¦when¦ ¦self¦ - ¦isol ating¦ .
𐋇 ¦that¦ ¦person¦ ¦must¦ ¦be¦ ¦in¦ ¦g ood¦ ¦health¦ .
𐋇 ¦one¦ ¦should¦ ¦not¦ ¦c ho ose¦ ¦to¦ :
𐋇¦they¦ ¦have¦ ¦a¦ ¦long¦ - ¦ter m¦ ¦illness¦
𐋇¦they¦ ¦have¦ ¦a¦ ¦w ea k¦ ¦immune¦ ¦system¦
𐋇 ¦over¦ ¦7 0¦ ¦years¦ ¦o ld¦
𐋇 ¦people¦ ¦in¦ ¦these¦ ¦grou ps¦ ¦are¦ ¦at¦ ¦high¦ ¦risk¦ ¦from¦ ¦covid¦ - ¦19¦
𐋇¦when¦ ¦should¦ ¦your¦ ¦child¦ ¦stay¦ ¦away¦ ¦from¦ ¦others¦
𐋇¦your¦ ¦child¦ ¦must¦ ¦be¦ ¦k e p t¦ ¦out¦ ¦of¦ ¦others¦ ¦if¦ :
𐋇¦they¦ ¦have¦ ¦a¦ ¦temp erat ure¦ ¦of¦ ¦3 8¦ ¦de g re es¦ ¦c el si us¦ ¦or¦ ¦higher¦
𐋇¦they¦ ¦get¦ ¦a¦ ¦new¦ ¦cough¦
𐋇¦there¦ ¦is¦ ¦a¦ ¦ch ange¦ ¦in¦ ¦ta st e¦ ¦or¦ ¦sm ell¦
𐋇 ¦are¦ ¦brea th le ss ness¦ ¦them¦
𐋇¦they¦ ¦al rea dy¦ ¦have¦ ¦a¦ ¦wor s ening¦ ¦brea thing¦ ¦c ond ition¦ ▁-▁ ¦as th m a¦ ,▁ ¦for¦ ¦example¦
𐋇 ¦call¦ ¦your¦ ¦gp¦ .
𐋇¦your¦ ¦child¦ ¦may¦ ¦need¦ ¦a¦ ¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ )▁ ¦test¦ .
𐋇¦read¦ ¦advice¦ ¦for¦ ¦self¦ - ¦isol ated¦ ¦people¦
𐋇¦your¦ ¦child¦ ¦does¦ ¦not¦ ¦have¦ ¦to¦ ¦isol ate¦ :
𐋇¦if¦ ¦they¦ ¦have¦ ¦had¦ ¦direct¦ ¦contact¦ ¦with¦ ¦a¦ ¦covid¦ - ¦19¦ ¦case¦ ¦that¦ ¦is¦ ¦confirmed¦ ¦but¦ ¦has¦ ¦no¦ ¦symptoms¦ ¦on¦ ¦the¦ ¦pl ate¦
𐋇¦if¦ ¦the¦ ¦child¦ ¦is¦ ¦li ving¦ ¦with¦ ¦someone¦ ¦who¦ ¦is¦ ¦ ill¦ ¦and¦ ¦may¦ ¦be¦ ¦infected¦ ¦with¦ ¦the¦ ¦virus¦ .
𐋇¦but¦ ¦in¦ ¦these¦ ¦s itu ations¦ ,▁ ¦they¦ ¦will¦ ¦have¦ ¦to¦ ¦restrict¦ ¦their¦ ¦movements¦ .
𐋇¦the¦ ¦di ff er ence¦ ¦between¦ ¦isolation¦ ¦and¦ ¦re st ri ction¦ ¦of¦ ¦movements¦
𐋇 ¦self¦ - ¦isolation¦ ¦and¦ ¦re stric ting¦ ¦movements¦ ¦are¦ ¦two¦ ¦different¦ ¦th ings¦ .
𐋇¦in¦ ¦both¦ ¦cases¦ ,▁ ¦the¦ ¦child¦ ¦should¦ ¦not¦ ¦go¦ ¦to¦ ¦school¦ ¦or¦ ¦ch ild c are¦ .
𐋇¦e veryone¦ ¦who¦ ¦l ives¦ ¦with¦ ¦the¦ ¦child¦ ¦should¦ ¦stay¦ ¦home¦ .
𐋇¦your¦ ¦child¦ ¦or¦ ¦the¦ ¦people¦ ¦li ving¦ ¦with¦ ¦them¦ ¦may¦ ¦have¦ ¦been¦ ¦as ked¦ ¦to¦ ¦restrict¦ ¦their¦ ¦movements¦ .
𐋇¦it¦ ¦me ans¦ ¦that¦ ¦they¦ ¦should¦ ¦stay¦ ¦at¦ ¦home¦ ¦and¦ ¦stay¦ ¦away¦ ¦from¦ ¦the¦ ¦others¦ ¦in¦ ¦the¦ ¦hou se ho ld¦ .
𐋇¦read¦ ¦more¦ ¦about¦ ¦the¦ ¦d if r í o ct aí¦ ¦between¦ ¦self¦ - ¦isolation¦ ¦and¦ ¦restrict¦ ¦your¦ ¦mo ve ment¦ ¦is¦
𐋇¦e veryone¦ ¦in¦ ¦the¦ ¦hou se ho ld¦ ¦should¦ ¦restrict¦ ¦their¦ ¦movements¦
𐋇¦your¦ ¦child¦ ¦may¦ ¦need¦ ¦help¦ ¦with¦ ¦daily¦ ¦activ ities¦ ¦such¦ ¦as¦ ¦washing¦ ,▁ ¦e ating¦ ¦or¦ ¦go ing¦ ¦to¦ ¦the¦ ¦to il et¦ .
𐋇¦as¦ ¦a¦ ¦result¦ ,▁ ¦e veryone¦ ¦should¦ ¦take¦ ¦ext r a¦ ¦care¦ ¦to¦ ¦reduce¦ ¦the¦ ¦risk¦ ¦of¦ ¦the¦ ¦virus¦ ¦sprea ding¦ .
𐋇¦you¦ ¦and¦ ¦e veryone¦ ¦in¦ ¦the¦ ¦hou se ho ld¦ ¦must¦ ¦restrict¦ ¦your¦ ¦movements¦ ¦for¦ ¦1 7¦ ¦days¦ .
𐋇¦this¦ ¦inclu des¦ ¦the¦ ¦t en¦ ¦days¦ ¦your¦ ¦child¦ ¦will¦ ¦be¦ ¦isol ated¦ ¦and¦ ¦se v en¦ ¦days¦ ¦later¦ .
𐋇¦as¦ ¦e veryone¦ ¦in¦ ¦the¦ ¦hou se ho ld¦ ¦is¦ ¦close¦ ¦contact¦ ,▁ ¦e veryone¦ ¦must¦ ¦be¦ ¦tested¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇¦how¦ ¦long¦ ¦your¦ ¦child¦ ¦should¦ ¦stay¦ ¦away¦ ¦from¦ ¦others¦
𐋇¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦to¦ ¦isol ate¦ ,▁ ¦they¦ ¦will¦ ¦have¦ ¦to¦ ¦stay¦ ¦isol ated¦ ¦until¦ ¦they¦ ¦receive¦ ¦test¦ ¦results¦ .
𐋇¦if¦ ¦the¦ ¦test¦ ¦is¦ ¦positive¦ ,▁ ¦your¦ ¦child¦ ¦will¦ ¦need¦ ¦to¦ ¦continue¦ ¦to¦ ¦isol ate¦ ¦until¦ ¦both¦ ¦of¦ ¦the¦ ¦following¦ ¦conditions¦ ¦app ly¦ :
𐋇 ¦has¦ ¦not¦ ¦had¦ ¦a¦ ¦high¦ ¦temp erat ure¦ ▁( ¦3 8¦ ¦de g re es¦ ¦c el si us¦ ¦or¦ ¦more¦ )▁ ¦for¦ ¦5¦ ¦days¦
𐋇 ¦that¦ ¦10¦ ¦days¦ ¦have¦ ¦el ap sed¦ ¦since¦ ¦the¦ ¦symptoms¦ ¦occur r ed¦
𐋇¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦no¦ ¦signs¦ ¦of¦ ¦illness¦ ¦but¦ ¦has¦ ¦been¦ ¦tested¦ ¦because¦ ¦they¦ ¦were¦ ¦a¦ ¦close¦ ¦contact¦ ,▁ ¦isolation¦ ¦can¦ ¦be¦ ¦sto pp ed¦ ¦t en¦ ¦days¦ ¦from¦ ¦the¦ ¦day¦ ¦they¦ ¦were¦ ¦tested¦ .
𐋇¦read¦ ¦h er e¦ ¦about¦ ¦what¦ ¦to¦ ¦do¦ ¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦a¦ ¦negative¦ ¦test¦ ¦result¦ .
𐋇¦if¦ ¦an yone¦ ¦el se¦ ¦in¦ ¦the¦ ¦house¦ ¦g ets¦ ¦symptoms¦ ¦or¦ ¦bec omes¦ ¦ ill¦
𐋇¦if¦ ¦an yone¦ ¦el se¦ ¦in¦ ¦the¦ ¦hou se ho ld¦ ¦bec omes¦ ¦sick¦ ,▁ ¦self¦ - ¦isol ated¦ ¦and¦ ¦call¦ ¦the¦ ¦gp¦ .
𐋇¦there¦ ¦is¦ ¦specific¦ ¦advice¦ ¦for¦ ¦ad ul ts¦ ¦and¦ ¦children¦ ¦over¦ ¦the¦ ¦age¦ ¦of¦ ¦13¦ ¦on¦ ¦self¦ - ¦isolation¦ .
𐋇¦you¦ ¦may¦ ¦need¦ ¦a¦ ¦covid¦ - ¦19¦ ¦test¦ ¦and¦ ¦tre at¦ ¦your¦ ¦symptoms¦ ¦at¦ ¦home¦
𐋇¦you¦ ¦can¦ ¦get¦ ¦a¦ ¦fre e¦ ¦covid¦ - ¦19¦ ¦tr ial¦ ¦at¦ ¦a¦ ¦w alk¦ - ¦in¦ ¦test¦ ¦centre¦ ¦if¦ ¦you¦ ¦have¦ ¦no¦ ¦symptoms¦ .
𐋇¦you¦ ¦do¦ ¦not¦ ¦need¦ ¦a¦ ¦gp¦ ¦appointment¦ ¦or¦ ¦ref er r al¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ,▁ ¦do¦ ¦not¦ ¦go¦ ¦to¦ ¦a¦ ¦w alk¦ - ¦in¦ ¦centre¦ .
𐋇¦stay¦ ¦al one¦ ▁( ¦stay¦ ¦in¦ ¦your¦ ¦ro om¦ )▁ ¦and¦ ¦call¦ ¦a¦ ¦gp¦ ¦imm ed ia tely¦ .
𐋇 ¦who¦ ¦can¦ ¦use¦ ¦the¦ ¦w alk¦ - ¦in¦ ¦service¦
𐋇¦you¦ ¦can¦ ¦use¦ ¦the¦ ¦covid¦ - ¦19¦ ¦w alk¦ - ¦in¦ ¦test¦ ¦service¦ ¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦have¦ ¦covid¦ - ¦19¦ ¦signs¦ ¦and¦ :
𐋇¦if¦ ¦you¦ ¦are¦ ¦a ged¦ ¦16¦ ¦or¦ ¦over¦
𐋇¦if¦ ¦you¦ ¦live¦ ¦in¦ ¦an¦ ¦a rea¦ ¦where¦ ¦there¦ ¦is¦ ¦a¦ ¦w alk¦ - ¦in¦ ¦test¦ ¦centre¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦not¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ ¦in¦ ¦the¦ ¦last¦ ¦si x¦ ¦mon ths¦
𐋇 ¦each¦ ¦test¦ ¦will¦ ¦be¦ ¦one¦ ¦test¦ .
𐋇¦t alk¦ ¦to¦ ¦your¦ ¦gp¦ ¦if¦ ¦you¦ ¦th ink¦ ¦you¦ ¦need¦ ¦another¦ ¦test¦ .
𐋇 ¦what¦ ¦you¦ ¦need¦ ¦to¦ ¦br ing¦ ¦with¦ ¦you¦
𐋇¦you¦ ¦must¦ ¦br ing¦ ¦a¦ ¦ph ot o¦ ¦ id¦ ¦and¦ ¦a¦ ¦m ob i le¦ ¦phone¦ ¦number¦ .
𐋇 ¦v en ues¦ ,▁ ¦d ates¦ ¦and¦ ¦times¦
𐋇¦do¦ ¦not¦ ¦come¦ ¦to¦ ¦a¦ ¦test¦ ¦centre¦ ¦before¦ ¦op ening¦ ¦time¦ .
𐋇 ¦test¦ ¦centr es¦ ¦are¦ ¦bu st l ing¦ ,▁ ¦and¦ ¦you¦ ¦may¦ ¦have¦ ¦to¦ ¦wai t¦ .
𐋇¦if¦ ¦you¦ ¦come¦ ¦close¦ ¦to¦ ¦clos ing¦ ¦time¦ ¦and¦ ¦there¦ ¦is¦ ¦a¦ ¦qu e ue¦ ,▁ ¦chan ces¦ ¦are¦ ¦you¦ ¦will¦ ¦not¦ ¦be¦ ¦tested¦ ¦that¦ ¦day¦ .
𐋇 ¦car l ow¦
𐋇 ¦car l ow¦ ¦test¦ ¦center¦
𐋇¦s t¦ .▁ ¦da mi an¦ ' ¦s¦ ¦hospital¦
𐋇 ¦a th y¦ ¦ro ad¦
𐋇¦c o¦ .▁ 𐋇 ¦car l ow¦ .
𐋇 ¦r 9 3¦ ¦y 2 v 0¦
𐋇¦open¦ ¦daily¦ ,▁ ¦8¦ . ¦30¦ ¦ am¦ ¦to¦ ¦6¦ . ¦30¦ ¦p m¦
𐋇 ¦ca v an¦
𐋇¦covid¦ - ¦19¦ ¦community¦ ¦testing¦ ¦center¦ ,
𐋇 ¦sh a nd a rs an¦ ¦ca st le¦ ,
𐋇¦b el t ur b et¦ ,
𐋇¦c o¦ .▁ 𐋇 ¦ca v an¦ ¦t ow n land¦
𐋇¦h 1 4¦ ¦f p 8 3¦
𐋇¦open¦ ¦daily¦ ¦from¦ ¦10¦ . ¦ 00¦ ¦ am¦ ¦to¦ ¦6¦ . ¦ 00¦ ¦p m¦
𐋇 ¦cl are¦
𐋇¦ bl oc k¦ ¦1¦ ,▁ ¦ba ll y mo y le¦ ¦bu si ness¦ ¦par k¦ ,
𐋇 ¦in i s¦ ,
𐋇¦c o¦ .▁ ¦of¦ ¦cl are¦ .
𐋇 ¦v 9 5¦ ¦y 9 8 1¦
𐋇¦open¦ ¦mon day¦ ¦to¦ ¦f ri day¦ ¦11¦ . ¦3 5 p m¦ ¦to¦ ¦6¦ . ¦30 p m¦
𐋇 ¦cor c ai gh ¦
𐋇 ¦ga a¦ ¦cl ub ¦ ,▁ ¦ra nd al¦ ¦ ó g¦ ,
𐋇¦d un m an w ay¦ ,
𐋇¦c o¦ .▁ 𐋇 ¦cor k¦ .
𐋇¦p 4 7¦ ¦c k 7 0¦
𐋇¦open¦ ¦mon day¦ ¦to¦ ¦s at ur day¦ ¦9 am¦ .▁ ¦to¦ ¦5¦ ¦ p¦ . ¦ m¦ .
𐋇 ¦closed¦ ¦on¦ ¦su nd ays¦ .
𐋇 ¦le e¦ ' ¦s¦ ¦covid¦ ¦scre ening¦ ¦center¦ ,
𐋇 ¦uni ts¦ ¦7¦ ¦to¦ ¦10¦ ,▁ ¦n or th¦ ¦l ink¦ ¦bu si ness¦ ¦par k¦ ,
𐋇 ¦o ld¦ ¦ma ll ow¦ ¦ro ad¦ ,
𐋇 ¦cor c ai gh ¦
𐋇¦t 2 3¦ ¦k r 9 6¦
𐋇¦open¦ ¦from¦ ¦9 am¦ .▁ ¦to¦ ¦1 1 r¦ . ¦ n¦ .▁ ¦every¦ ¦day¦ .▁ 𐋇 ¦an¦ ¦u ne x p ected¦ ¦person¦ ¦will¦ ¦not¦ ¦be¦ ¦ac cep ted¦ ¦after¦ ¦1 1 am¦ .
𐋇 ¦do ne g al¦
𐋇¦s t¦ .▁ ¦con n ell¦ ' ¦s¦ ¦hospital¦ ¦ca mp us¦
𐋇¦l et t er k en n y¦ ,
𐋇¦c o¦ .▁ 𐋇 ¦do ne g al¦ .
𐋇¦f 9 2¦ ¦t d 9 2¦
𐋇¦open¦ ¦mon day¦ ¦to¦ ¦f ri day¦ ,▁ ¦9¦ . ¦30 am¦ ¦to¦ ¦7 p m¦ ,▁ ¦1 1 am¦ .▁ ¦to¦ ¦5 i¦ . ¦ n¦ .▁ ¦on¦ ¦s at ur d ays¦ ¦and¦ ¦su nd ays¦
𐋇 ¦cl ar ke¦ ¦center¦
𐋇¦b ot her¦ ¦ba ll y bo f e y¦
𐋇 ¦dr um lo na g her¦ ,
𐋇¦c o¦ .▁ 𐋇 ¦do ne g al¦ .
𐋇¦f 9 4¦ ¦e h 3 0¦
𐋇¦open¦ ¦mon day¦ ¦to¦ ¦f ri day¦ ,▁ ¦9¦ . ¦30 am¦ ¦to¦ ¦5 p m¦ ,▁ ¦closed¦ ¦on¦ ¦s at ur d ays¦ ¦and¦ ¦su nd ays¦
𐋇 ¦dublin¦
𐋇¦ ot¦ ¦dublin¦ ,▁ ¦c ore¦ ▁( ¦ bl oc k¦ ¦ c¦ ) ,
𐋇¦ bl an ch ar d st own¦ ¦ca mp us¦ ,
𐋇¦ bl an ch ar d st own¦ ¦n or th¦ ¦ro ad¦ ,
𐋇¦open¦ ¦from¦ ¦10¦ ¦a¦ . ¦ m¦ .▁ ¦to¦ ¦6¦ ¦ p¦ . ¦ m¦ .▁ ¦every¦ ¦day¦ .
𐋇 ¦sh re w s b u ry¦ ¦ro ad¦ ¦community¦ ¦test¦ ¦center¦ ,
𐋇¦h all¦ ¦8 a¦ ,▁ ¦s im on¦ ' ¦s¦ ¦co ur t¦ ¦pa v il ion¦ ,
𐋇 ¦sh re w s b u ry¦ ¦ro ad¦ ,
𐋇¦open¦ ¦mon day¦ ¦to¦ ¦f ri day¦ ¦9¦ . ¦30 am¦ ¦to¦ ¦6 p m¦ .▁ 𐋇¦open¦ ¦10¦ . ¦1 5 am¦ ¦to¦ ¦5 p¦ . ¦ m¦ .▁ ¦on¦ ¦s at ur d ays¦ ¦and¦ ¦su nd ays¦ .
𐋇¦covid¦ - ¦19¦ ¦community¦ ¦test¦ ¦center¦ ¦city¦ ¦w est¦ ¦ho te l¦ ,
𐋇¦open¦ ¦1 1 am¦ .▁ ¦to¦ ¦6¦ . ¦30 p m¦ ¦every¦ ¦day¦ .
𐋇¦c ro ke¦ ¦par k¦ ¦hand b all¦ ¦co ur t¦ ,▁ ¦covid¦ - ¦19¦ ¦community¦ ¦test¦
𐋇¦s ac k v il le¦ ¦a v en ue¦ ,
𐋇¦open¦ ¦mon day¦ ¦to¦ ¦s at ur day¦ ¦11¦ ¦a¦ . ¦ m¦ .▁ ¦to¦ ¦7¦ ¦ p¦ . ¦ m¦ .▁ ¦closed¦ ¦on¦ ¦su nd ays¦ .
𐋇 ¦national¦ ¦ex hi b ition¦ ¦center¦ ,▁ ¦covid¦ - ¦19¦ ¦community¦ ¦testing¦ ,
𐋇 ¦in n er¦ ¦l an e¦ ,
𐋇¦c lo ch r á n¦ ,
𐋇¦c o¦ .▁ 𐋇 ¦dublin¦ .
𐋇 ¦k 6 7¦ ¦v f 4 3¦
𐋇¦open¦ ¦mon day¦ ¦to¦ ¦s at ur day¦ ,▁ ¦8¦ . ¦30 am¦ ¦to¦ ¦7 p m¦ ,▁ ¦s un day¦ ¦from¦ ¦1 0 am¦ .▁ ¦to¦ ¦6 i¦ . ¦ n¦ .
𐋇¦the¦ ¦o ld¦ ¦hse¦ ¦health¦ ¦center¦
¦1 2 4 e¦ ¦b ó th a r¦ ¦e mm et¦ ,
𐋇 ¦in se¦ ¦ch oi r¦ ,
𐋇 ¦dublin¦ ¦8¦
𐋇¦d 0 8¦ ¦r 2 w 2¦
𐋇¦open¦ ¦from¦ ¦1 1 am¦ .▁ ¦to¦ ¦7¦ ¦p m¦ ,▁ ¦w ed n es day¦ ¦16¦ ¦june¦ ¦to¦ ¦f ri day¦ ¦18¦ ¦june¦ .
𐋇 ¦g ai ll im h ¦
𐋇 ¦g al w ay¦ ¦air p ort¦ ,
𐋇 ¦car n m ore¦ ¦t ow n land¦
𐋇¦c o¦ .▁ 𐋇 ¦g al w ay¦ .
𐋇¦open¦ ¦mon day¦ ¦to¦ ¦f ri day¦ ,▁ ¦1 0 am¦ .▁ ¦to¦ ¦7¦ . ¦30 p m¦ ,▁ ¦s at ur day¦ ¦and¦ ¦s un day¦ ¦1 0 am¦ .▁ ¦at¦ ¦5¦ . ¦30 p m¦
𐋇 ¦nu i g¦ ¦ca mp us¦ ,▁ ¦covid¦ - ¦19¦ ¦community¦ ¦testing¦ ¦center¦ ,
¦9¦ ¦d ist il le ry¦ ¦ro ad¦ ,
𐋇 ¦g ai ll im h ¦ .
𐋇¦open¦ ¦mon day¦ ¦to¦ ¦f ri day¦ ¦10¦ . ¦30 am¦ ¦to¦ ¦5 p m¦ ,▁ ¦s at ur day¦ ¦1 0 p¦ . ¦ m¦ .▁ ¦to¦ ¦5¦ ¦ p¦ . ¦ m¦ .
𐋇 ¦closed¦ ¦on¦ ¦su nd ays¦
𐋇 ¦no¦ ¦par king¦ ¦sp ace¦ ¦available¦ .
𐋇 ¦k er ry¦
𐋇 ¦mi ll t own¦ ¦b arr ac ks¦ ,
𐋇 ¦tr a¦ ¦ ly¦ ,
𐋇¦open¦ ¦mon day¦ ¦to¦ ¦s at ur day¦ ¦9¦ . ¦30 am¦ ¦to¦ ¦1 2 p m¦ ¦and¦ ¦2 p¦ . ¦ m¦ .▁ ¦to¦ ¦5¦ ¦ p¦ . ¦ m¦ .▁ ¦open¦ ¦on¦ ¦su nd ays¦ ¦from¦ ¦2 p m¦ ¦to¦ ¦5 p m¦
𐋇¦c ill¦ ¦d ar a¦
𐋇¦p un che st own¦ ¦r ac ec o ur se¦ ,
𐋇 ¦ph ú in se¦ ¦b all¦ ,
𐋇 ¦na a s¦ ,
𐋇¦c o¦ .▁ 𐋇 ¦ch ill¦ ¦d ar a¦ .
𐋇¦w 9 1¦ ¦v c x 4¦
𐋇¦open¦ ¦from¦ ¦1 1 am¦ .▁ ¦to¦ ¦3 i¦ . ¦ n¦ .▁ ¦every¦ ¦day¦ .
𐋇 ¦k il k en n y¦
𐋇¦covid¦ - ¦19¦ ¦community¦ ¦testing¦ ¦center¦
𐋇 ¦uni t¦ ¦24¦ ¦he b r on¦ ¦ind u str ial¦ ¦e st ates¦
𐋇 ¦k il k en n y¦
𐋇 ¦r 9 5¦ ¦ x 8 9 5¦
𐋇¦open¦ ¦daily¦ ,▁ ¦8¦ . ¦30 am¦ ¦to¦ ¦7 p¦ . ¦ m¦ .
𐋇 ¦la oi s¦
𐋇¦s t¦ .▁ ¦fi nt an¦ ' ¦s¦ ¦hospital¦ ,
𐋇 ¦dublin¦ ¦ro ad¦ ,
𐋇¦p ort¦ ¦la o ise¦ ,
𐋇¦c o¦ .▁ 𐋇 ¦la o ise¦ .
𐋇¦n 4 1¦ ¦d 7 p 3¦
𐋇¦open¦ ¦mon day¦ ¦to¦ ¦s at ur day¦ ¦9¦ . ¦30 am¦ ¦to¦ ¦4¦ . ¦30 p m¦ .▁ ¦closed¦ ¦on¦ ¦su nd ays¦ .
𐋇 ¦le it ri m¦
𐋇¦n or th w est¦ ¦bu si ness¦ ¦and¦ ¦techn ology¦ ¦par k¦ ,
𐋇¦c arr ick¦ - ¦on¦ - ¦sh an n on¦
𐋇¦c o¦ .▁ 𐋇 ¦li at r om a¦ .
𐋇¦n 4 1¦ ¦d 7 p 3¦
𐋇¦open¦ ¦mon day¦ ¦to¦ ¦f ri day¦ ¦2 p¦ . ¦ m¦ .▁ ¦to¦ ¦4¦ . ¦30 p m¦ ¦closed¦ ¦on¦ ¦s at ur d ays¦ ¦and¦ ¦su nd ays¦ .
𐋇 ¦li mer ick¦
𐋇¦ ea st p o in t¦ ¦bu si ness¦ ¦par k¦ ¦uni t¦ ¦6 d¦ ,
𐋇¦s im on st own¦ ¦ro ad¦ ,
𐋇 ¦li mer ick¦ .
𐋇 ¦v 9 4¦ ¦k n 7 3¦
𐋇¦open¦ ¦daily¦ ¦from¦ ¦8 am¦ .▁ ¦to¦ ¦4¦ ¦ p¦ . ¦ m¦ .
𐋇 ¦li mer ick¦ ¦city¦ ¦w alk¦ ▁-▁ ¦in¦ ¦test¦ ¦center¦
𐋇¦s t¦ .▁ ¦jo se ph ¦ ' ¦s¦ ¦hospital¦ ¦grou n ds¦ ,
¦3¦ ¦m ul g ra ve¦ ¦st re et¦ ,
𐋇¦c o¦ .▁ 𐋇 ¦li mer ick¦ .
𐋇 ¦v 9 4¦ ¦a x 2 3¦
𐋇¦open¦ ¦1 1 am¦ .▁ ¦to¦ ¦6¦ . ¦15¦ ¦every¦ ¦day¦ ¦until¦ ¦mon day¦ ,▁ ¦june¦ ¦2 8 th¦ .
𐋇 ¦lo ng f ort¦
𐋇 ¦uni t¦ ¦1 0 a¦ ,▁ ¦ma st er te ch¦ ¦bu si ness¦ ¦par k¦
𐋇 ¦lo ng f ort¦
𐋇¦n 3 9¦ ¦k 5 3 5¦
𐋇¦open¦ ¦mon day¦ ¦to¦ ¦s at ur day¦ ¦9¦ . ¦30 am¦ ¦to¦ ¦4¦ . ¦30 p m¦ ¦closed¦ ¦on¦ ¦su nd ays¦ .
𐋇¦l ou th¦
𐋇¦s t¦ .▁ ¦br ig id¦ ' ¦s¦ ¦ca mp us¦ ,
𐋇 ¦k e lls¦ ¦ro ad¦
𐋇 ¦ar de e¦ ,
𐋇 ¦what¦ .▁ 𐋇¦l ú ¦ .
𐋇 ¦a 9 2¦ ¦dr n 0¦
𐋇 ¦available¦ ¦9¦ . ¦30 am¦ ¦to¦ ¦4¦ . ¦30 p m¦ ¦daily¦ .
𐋇 ¦ma y o¦
𐋇¦m ch a le¦ ▁' ¦s¦ ¦par k¦
𐋇 ¦ca st le b a r¦ ,
𐋇¦c o¦ .▁ 𐋇 ¦ma y o¦ .
𐋇¦f 2 3¦ ¦f x 3 4¦
𐋇¦open¦ ¦mon day¦ ¦to¦ ¦f ri day¦ ,▁ ¦1 0 am¦ .▁ ¦to¦ ¦5 p m¦ ,▁ ¦s at ur day¦ ¦9¦ . ¦30 am¦ ¦to¦ ¦11¦ . ¦30 am¦ ¦and¦ ¦s un day¦ ¦1 0 am¦ .▁ ¦to¦ ¦4 i¦ . ¦ n¦ .
𐋇¦the¦ ¦mon th¦
𐋇 ¦o ld¦ ¦health¦ ¦center¦ ,▁ ¦covid¦ - ¦19¦ ¦test¦ ¦center¦ ,
𐋇 ¦as h bo ur n e¦ ,
𐋇 ¦what¦ .▁ ¦to¦ ¦ me¦ .
𐋇 ¦a 8 4¦ ¦c 2 h 0¦
𐋇¦open¦ ¦9¦ . ¦30 am¦ ¦to¦ ¦4¦ . ¦30 p m¦ ¦daily¦ .
𐋇 ¦mo na gh an¦
𐋇 ¦mo na gh an¦ ¦ga a¦ ¦center¦ ,▁ ¦covid¦ - ¦19¦ ¦test¦ ¦center¦
𐋇 ¦cl if d en¦ ,
𐋇 ¦mo na gh an¦ .
𐋇 ¦a 7 5¦ ¦ ve 8 4¦
𐋇¦open¦ ¦10¦ . ¦30 am¦ ¦to¦ ¦5¦ . ¦30 p m¦ ¦daily¦ .
𐋇 ¦off a ly¦
𐋇¦c lu a in¦ ¦min se¦ ,
𐋇¦t ul la m ore¦ ,
𐋇¦c o¦ .▁ 𐋇 ¦off a ly¦ .
𐋇 ¦r 3 5¦ ¦w 5 y 8¦
𐋇 ¦available¦ ¦9¦ . ¦30 am¦ ¦to¦ ¦4¦ . ¦30 p m¦ ¦daily¦ .
𐋇 ¦r os c o mm on¦
𐋇 ¦ca st le rea¦ ¦f ir e¦ ¦st ation¦
𐋇 ¦ca st le rea¦ ,
𐋇 ¦what¦ .▁ 𐋇 ¦ro s¦ ¦c om á in¦ .
𐋇¦f 4 5¦ ¦p x 8 4¦
𐋇¦open¦ ¦mon day¦ ¦to¦ ¦f ri day¦ ,▁ ¦1 0 am¦ .▁ ¦to¦ ¦5¦ ¦ p¦ . ¦ m¦ . ,▁ ¦s at ur day¦ ¦and¦ ¦s un day¦ ¦1 0 am¦ .▁ ¦to¦ ¦4 i¦ . ¦ n¦ .
𐋇 ¦sl ig ea ch¦
𐋇 ¦hse¦ ¦bu il ding¦ ,▁ ¦covid¦ - ¦19¦ ¦community¦ ¦testing¦ ¦center¦ ,
𐋇 ¦fi ng al¦ ,
𐋇¦f 9 1¦ ¦y p 7 6¦
𐋇 ¦mon day¦ ¦to¦ ¦f ri day¦ ,▁ ¦1 0 am¦ .▁ ¦to¦ ¦5¦ ¦ p¦ . ¦ m¦ . ,▁ ¦s at ur day¦ ¦and¦ ¦s un day¦ ¦1 2 p¦ . ¦ m¦ .▁ ¦to¦ ¦4 i¦ . ¦ n¦ .
𐋇 ¦ti pp er ary¦
𐋇¦n or th¦ ¦ti pp er ary¦
𐋇 ¦o ld¦ ¦ca st le b r and¦ ¦fa ct ory¦ ,
𐋇¦s t¦ .▁ ¦jo h n¦ ' ¦s¦ ,
𐋇 ¦ne na gh ¦ ,
𐋇¦c o¦ .▁ 𐋇 ¦ti pp er ary¦ .
𐋇¦e 4 5¦ ¦t y 0 4¦
𐋇¦open¦ ¦mon day¦ ¦to¦ ¦s un day¦ ,▁ ¦9 am¦ .▁ ¦to¦ ¦7¦ . ¦4 5¦ ¦p m¦
𐋇 ¦south¦ ¦ti pp er ary¦
𐋇 ¦mo y le¦ ¦r ov ers¦ ¦ga a¦ ,▁ ¦covid¦ - ¦19¦ ¦community¦ ¦testing¦ ¦center¦
𐋇¦m ick¦ ¦m c c ar th y¦ ¦mi ll en n i um¦ ¦center¦ ,
𐋇 ¦fe th ard¦ ¦ro ad¦
𐋇 ¦cl on me l¦ ,
𐋇¦c o¦ .▁ 𐋇 ¦ti pp er ary¦
𐋇¦e 9 1¦ ¦ey 7 3¦
𐋇¦open¦ ¦daily¦ ,▁ ¦8¦ . ¦30 am¦ ¦to¦ ¦7 p m¦
𐋇¦w at er for d¦
𐋇 ¦k il c o og an¦ ¦test¦ ¦center¦ ,
𐋇¦w at er for d¦ .
𐋇¦n 9 1¦ ¦ x 3 6 e¦
𐋇¦open¦ ¦daily¦ ¦from¦ ¦8¦ . ¦30 am¦ ¦to¦ ¦7 p m¦
𐋇 ¦we st m ea th¦
𐋇¦s t¦ .▁ ¦l om an¦ ' ¦s¦ ¦hospital¦ ¦ca mp us¦
𐋇¦m ul li ng a r¦
𐋇¦c o¦ .▁ 𐋇 ¦we st m ea th¦ .
𐋇¦n 9 1¦ ¦ x 3 6 e¦
𐋇¦open¦ ¦9¦ . ¦30 am¦ ¦to¦ ¦4¦ . ¦30 p m¦ ¦daily¦ .
𐋇 ¦lo ch¦ ¦g arm an¦
𐋇 ¦we x for d¦ ¦covid¦ - ¦19¦ ¦test¦ ¦center¦
𐋇¦w hi te m ill¦ ¦ind u str ial¦ ¦e st ates¦
𐋇 ¦lo ch¦ ¦g arm an¦
𐋇 ¦y 3 5¦ ¦v k 5 9¦
𐋇¦open¦ ¦daily¦ ,▁ ¦1 0 am¦ .▁ ¦to¦ ¦6 i¦ . ¦ n¦ .
𐋇¦w ick l ow¦
𐋇 ¦k il la gh ra in an¦ ¦community¦ ¦testing¦ ¦center¦
𐋇¦c o¦ .▁ 𐋇¦w ick l ow¦ .
𐋇¦n ear¦ ¦new c a st le¦ ¦hospital¦ ,▁ ¦k en n ed y st own¦
𐋇¦open¦ ¦mon day¦ ¦to¦ ¦s un day¦ ¦1 0 am¦ .▁ ¦to¦ ¦5¦ ¦ p¦ . ¦ m¦ .
𐋇 ¦sour ces¦ ¦are¦ ¦ex pl or ed¦ ¦when¦ ¦tr ying¦ ¦to¦ ¦f ind¦ ¦out¦ ¦how¦ ¦or¦ ¦when¦ ¦someone¦ ¦first¦ ¦contr ac ted¦ ¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ ).
𐋇¦a¦ ¦person¦ ,▁ ¦place¦ ¦or¦ ¦ev ent¦ ¦can¦ ¦be¦ ¦a¦ ¦sour ce¦ ¦of¦ ¦infection¦ .
𐋇 ¦an¦ ¦in ve st ig ation¦ ¦of¦ ¦the¦ ¦sour ce¦ ¦g ives¦ ¦us¦ ¦information¦ ¦about¦ ¦si tes¦ ¦and¦ ¦cases¦ ¦where¦ ¦covid¦ - ¦19¦ ¦is¦ ¦dis se min ated¦ .
𐋇¦it¦ ¦h el ps¦ ¦us¦ ¦ident if y¦ ¦and¦ ¦prevent¦ ¦the¦ ¦develop ing¦ ¦covid¦ - ¦19¦ ¦c lu st ers¦ ¦in¦ ¦the¦ ¦community¦ .
𐋇¦the¦ ¦di ff er ence¦ ¦between¦ ¦sour ce¦ ¦ex pl or ation¦ ¦and¦ ¦contact¦ ¦tracking¦
𐋇 ¦contact¦ ¦tracking¦
𐋇 ¦people¦ ¦who¦ ¦have¦ ¦been¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ ¦a¦ ¦person¦ ¦with¦ ¦covid¦ - ¦19¦ ¦are¦ ¦identified¦ .
𐋇 ¦during¦ ¦contact¦ ¦trac ing¦ ,▁ ¦the¦ ¦ti me line¦ ,▁ ¦in¦ ¦that¦ ¦case¦ ,▁ ¦will¦ ¦dep end¦ ¦on¦ ¦wh ether¦ ¦they¦ ¦had¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦when¦ ¦tested¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇¦read¦ ¦about¦ ¦contact¦ ¦tracking¦
𐋇 ¦ex pl or ation¦ ¦of¦ ¦sour ces¦
𐋇¦the¦ ¦in ve st ig ation¦ ¦will¦ ¦f ind¦ ¦a¦ ¦c it ation¦ :
𐋇¦a¦ ¦case¦ ¦in¦ ¦which¦ ¦a¦ ¦person¦ ¦may¦ ¦bec ome¦ ¦infected¦
𐋇 ¦who¦ ¦may¦ ¦inf ect¦ ¦them¦
𐋇¦we¦ ¦will¦ ¦as k¦ ¦people¦ ¦with¦ ¦covid¦ - ¦19¦ ¦if¦ ¦they¦ ¦have¦ ¦been¦ ¦in¦ ¦contact¦ ¦with¦ ¦someone¦ ¦who¦ ¦has¦ ¦covid¦ - ¦19¦ .
𐋇¦if¦ ¦not¦ ,▁ ¦we¦ ¦will¦ ¦as k¦ ¦them¦ ¦about¦ ¦events¦ ¦or¦ ¦places¦ ¦they¦ ¦were¦ ¦in¦ ¦the¦ ¦week¦ ¦before¦ ¦they¦ ¦bec a me¦ ¦ ill¦ .
𐋇¦if¦ ¦they¦ ¦d id¦ ¦not¦ ¦sh ow¦ ¦signs¦ ¦of¦ ¦illness¦ ,▁ ¦we¦ ¦would¦ ¦as k¦ ¦them¦ ¦about¦ ¦events¦ ¦they¦ ¦att e nded¦ ¦or¦ ¦where¦ ¦they¦ ¦were¦ ¦tested¦ ¦the¦ ¦week¦ ¦before¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇¦the¦ ¦sour ce¦ ¦of¦ ¦infection¦ ¦can¦ ¦be¦ ¦trac ed¦ ¦that¦ ¦way¦ .
𐋇 ¦other¦ ¦infections¦ ¦from¦ ¦the¦ ¦same¦ ¦sour ce¦ ¦may¦ ¦sto p¦ .
𐋇 ¦people¦ ¦in¦ ¦the¦ ¦same¦ ¦place¦ ¦or¦ ¦at¦ ¦the¦ ¦same¦ ¦ev ent¦ ¦that¦ ¦the¦ ¦person¦ ¦with¦ ¦covid¦ - ¦19¦ ¦att e nded¦ ¦could¦ ¦be¦ ¦contac ted¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦received¦ ¦a¦ ¦te xt¦ ¦me ss age¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦received¦ ¦a¦ ¦te xt¦ ¦me ss age¦ ¦from¦ ¦the¦ ¦sour ce¦ ¦a u di t¦ ¦team¦ ,▁ ¦a¦ ¦fre e¦ ¦covid¦ - ¦19¦ ¦test¦ ¦will¦ ¦be¦ ¦arr an ged¦ ¦for¦ ¦you¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦s ent¦ ¦a¦ ¦te xt¦ ¦me ss age¦ ¦with¦ ¦detail s¦ ¦of¦ ¦your¦ ¦test¦ ¦appointment¦ .
𐋇¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦have¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ,▁ ¦you¦ ¦do¦ ¦not¦ ¦need¦ ¦to¦ ¦restrict¦ ¦your¦ ¦movements¦ ▁( ¦stay¦ ¦at¦ ¦home¦ ).
𐋇¦if¦ ¦you¦ ¦have¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ,▁ ¦you¦ ¦must¦ ¦self¦ - ¦isol ate¦ ▁( ¦stay¦ ¦in¦ ¦your¦ ¦ro om¦ )▁ ¦and¦ ¦call¦ ¦your¦ ¦gp¦ ¦imm ed ia tely¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦pre gnant¦ ,▁ ¦you¦ ¦should¦ ¦get¦ ¦your¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦when¦ ¦it¦ ¦is¦ ¦off ered¦ ¦to¦ ¦you¦ .
𐋇¦it¦ ¦reduc es¦ ¦the¦ ¦chan ces¦ ¦of¦ ¦you¦ ¦getting¦ ¦sick¦ .
𐋇¦it¦ ¦may¦ ¦also¦ ¦reduce¦ ¦the¦ ¦chan ces¦ ¦of¦ ¦you¦ ¦having¦ ¦co mpl ications¦ ¦during¦ ¦pregn a ncy¦ ,▁ ¦such¦ ¦as¦ ¦giv ing¦ ¦b ir th¦ ¦pre m at ur ely¦ .
𐋇 ¦that¦ ¦could¦ ¦happ en¦ ¦if¦ ¦you¦ ¦are¦ ¦very¦ ¦ ill¦ ¦with¦ ¦covid¦ - ¦19¦ . ▁( 𐋇 ¦coronavirus¦ ).
𐋇¦covid¦ - ¦19¦ ¦vaccines¦ ¦are¦ ¦new¦ ¦vaccines¦ .
𐋇¦we¦ ¦are¦ ¦still¦ ¦learning¦ ¦about¦ ¦the¦ ¦safety¦ ¦of¦ ¦the¦ ¦vaccine¦ ¦during¦ ¦pregn a ncy¦ ¦and¦ ¦when¦ ¦a¦ ¦m ot her¦ ¦is¦ ¦brea st f ee ding¦ .
𐋇¦the¦ ¦vaccines¦ ¦have¦ ¦not¦ ¦been¦ ¦tested¦ ¦on¦ ¦pre gnant¦ ¦or¦ ¦brea st f ee ding¦ ¦women¦ .
𐋇 ¦our¦ ¦k n ow l ed ge¦ ¦to¦ ¦date¦ ¦sh ow s¦ ¦that¦ ¦the¦ ¦astrazeneca¦ ,▁ ¦mod er na¦ ¦and¦ ¦p f iz er¦ ▁/▁ ¦bi on te ch¦ ¦vaccines¦ ¦have¦ ¦no¦ ¦ad ver se¦ ¦eff ects¦ ¦on¦ ¦un bor n¦ ¦bab ies¦ .
𐋇¦they¦ ¦are¦ ¦not¦ ¦live¦ ¦vaccines¦ ,▁ ¦so¦ ¦ne it her¦ ¦the¦ ¦m ot her¦ ¦n or¦ ¦the¦ ¦baby¦ ¦can¦ ¦be¦ ¦infected¦ ¦with¦ ¦covid¦ - ¦19¦ .
𐋇 ¦vaccines¦ ¦brea k¦ ¦down¦ ¦qu ick ly¦ ¦in¦ ¦the¦ ¦body¦ ¦and¦ ¦cannot¦ ¦be¦ ¦par t¦ ¦of¦ ¦the¦ ¦d na¦ ¦of¦ ¦the¦ ¦m ot her¦ ¦or¦ ¦baby¦ .
𐋇 ¦all¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦can¦ ¦be¦ ¦giv en¦ ¦to¦ ¦women¦ ¦who¦ ¦are¦ ¦brea st f ee ding¦ .
𐋇¦they¦ ¦have¦ ¦no¦ ¦eff ect¦ ¦on¦ ¦children¦ ¦on¦ ¦the¦ ¦b re ast¦ .
𐋇¦read¦ ¦about¦ ¦the¦ ¦first¦ ¦grou ps¦ ¦to¦ ¦get¦ ¦the¦ ¦covid¦ - ¦19¦ ¦vaccine¦
𐋇¦covid¦ - ¦19¦ ¦vaccine¦ ¦doses¦
𐋇¦when¦ ¦you¦ ¦receive¦ ¦your¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ,▁ ¦you¦ ¦will¦ ¦need¦ ¦two¦ ¦doses¦ .
𐋇¦you¦ ¦should¦ ¦receive¦ ¦the¦ ¦first¦ ¦d ose¦ ¦at¦ ¦or¦ ¦after¦ ¦14¦ ¦weeks¦ ¦of¦ ¦pregn a ncy¦ .
𐋇¦you¦ ¦should¦ ¦receive¦ ¦a¦ ¦second¦ ¦d ose¦ ¦before¦ ¦the¦ ¦end¦ ¦of¦ ¦3 6¦ ¦weeks¦ ¦of¦ ¦pregn a ncy¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦not¦ ¦giv en¦ ¦a¦ ¦second¦ ¦d ose¦ ¦by¦ ¦the¦ ¦end¦ ¦of¦ ¦3 6¦ ¦weeks¦ ,▁ ¦it¦ ¦should¦ ¦be¦ ¦po st p o ned¦ ¦until¦ ¦you¦ ¦have¦ ¦your¦ ¦baby¦ .
𐋇¦this¦ ¦is¦ ¦recommended¦ ¦because¦ ¦you¦ ¦may¦ ¦get¦ ¦a¦ ¦fever¦ ¦after¦ ¦the¦ ¦second¦ ¦d ose¦ .
𐋇¦f ind¦ ¦out¦ ¦more¦ ¦about¦ ¦your¦ ¦covid¦ - ¦19¦ ¦vaccine¦
𐋇¦ side¦ ¦eff ects¦
𐋇 ¦like¦ ¦all¦ ¦medic ines¦ ,▁ ¦vaccines¦ ¦can¦ ¦cause¦ ¦ side¦ ¦eff ects¦ .
𐋇 ¦most¦ ¦are¦ ¦mild¦ ¦or¦ ¦mod er ate¦ ¦and¦ ¦sh ort¦ - ¦ter m¦ .
𐋇 ¦not¦ ¦e veryone¦ ¦g ets¦ ¦ side¦ ¦eff ects¦ .
𐋇¦read¦ ¦about¦ ¦ side¦ ¦eff ects¦ ¦after¦ ¦covid¦ - ¦19¦ ¦vaccines¦
𐋇 ¦pre gnant¦ ¦women¦ ¦are¦ ¦at¦ ¦high¦ ¦risk¦
𐋇¦you¦ ¦should¦ ¦t alk¦ ¦to¦ ¦your¦ ¦ob st et r ici an¦ ¦or¦ ¦gp¦ ¦about¦ ¦getting¦ ¦your¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦if¦ :
𐋇¦you¦ ¦are¦ ¦a¦ ¦pre gnant¦ ¦healthcare¦ ¦work er¦
𐋇¦you¦ ¦are¦ ¦at¦ ¦g rea ter¦ ¦risk¦ ¦from¦ ¦covid¦ - ¦19¦
𐋇 ¦pre gnant¦ ¦after¦ ¦your¦ ¦covid¦ - ¦19¦ ¦vaccine¦
𐋇¦you¦ ¦do¦ ¦not¦ ¦need¦ ¦to¦ ¦lea ve¦ ¦any¦ ¦ga p¦ ¦between¦ ¦having¦ ¦your¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦and¦ ¦getting¦ ¦pre gnant¦ .
𐋇¦if¦ ¦you¦ ¦bec ome¦ ¦pre gnant¦ ¦after¦ ¦rece i ving¦ ¦the¦ ¦first¦ ¦d ose¦
𐋇¦if¦ ¦you¦ ¦bec ome¦ ¦pre gnant¦ ¦after¦ ¦rece i ving¦ ¦the¦ ¦first¦ ¦d ose¦ ¦of¦ ¦your¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ,▁ ¦you¦ ¦should¦ ¦wai t¦ ¦14¦ ¦weeks¦ ¦or¦ ¦later¦ ¦to¦ ¦receive¦ ¦the¦ ¦second¦ ¦d ose¦ .
𐋇¦d on¦ ' ¦t¦ ¦wor ry¦ ¦if¦ ¦you¦ ¦get¦ ¦your¦ ¦vaccine¦ ¦before¦ ¦you¦ ¦know¦ ¦you¦ ¦are¦ ¦pre gnant¦ .
𐋇¦to¦ ¦be¦ ¦ca re ful¦ ,▁ ¦you¦ ¦should¦ ¦wai t¦ ¦14¦ ¦weeks¦ ¦or¦ ¦later¦ ¦to¦ ¦get¦ ¦your¦ ¦vaccine¦ .
𐋇¦this¦ ¦is¦ ¦recommended¦ ¦to¦ ¦avoid¦ ¦any¦ ¦possible¦ ¦l ink¦ ¦between¦ ¦the¦ ¦vaccine¦ ¦and¦ ¦m is c ar ri age¦ .
𐋇 ¦other¦ ¦vaccines¦ ¦during¦ ¦pregn a ncy¦
𐋇¦you¦ ¦will¦ ¦need¦ ¦other¦ ¦vaccines¦ ¦during¦ ¦pregn a ncy¦ .
𐋇¦these¦ ¦are¦ :
𐋇¦p e rt us sis¦ ¦vaccine¦
𐋇 ¦flu¦ ¦vaccine¦ ▁-▁ ¦if¦ ¦you¦ ¦are¦ ¦pre gnant¦ ¦during¦ ¦the¦ ¦flu¦ ¦se as on¦ ¦from¦ ¦o ct ob er¦ ¦to¦ ¦the¦ ¦end¦ ¦of¦ ¦april¦
𐋇 ¦lea ve¦ ¦a¦ ¦14¦ - ¦day¦ ¦ga p¦ ¦between¦ ¦your¦ ¦covid¦ - ¦19¦ ¦vacc ination¦ ¦and¦ ¦any¦ ¦other¦ ¦vaccine¦ .
𐋇¦read¦ ¦more¦ ¦about¦ ¦vaccines¦ ¦nee ded¦ ¦during¦ ¦pregn a ncy¦
𐋇 ¦fe rt il ity¦ ¦treatment¦
𐋇¦there¦ ¦is¦ ¦no¦ ¦evidence¦ ¦that¦ ¦covid¦ - ¦19¦ ¦vacc ination¦ ¦aff ects¦ ¦fe rt il ity¦ .
𐋇¦you¦ ¦do¦ ¦not¦ ¦have¦ ¦to¦ ¦lea ve¦ ¦any¦ ¦ga p¦ ¦after¦ ¦rece i ving¦ ¦your¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦and¦ ¦your¦ ¦fe rt il ity¦ ¦treatment¦ ¦such¦ ¦as¦ ¦ iv f¦ .
𐋇¦but¦ ¦you¦ ¦may¦ ¦w ant¦ ¦to¦ ¦wai t¦ ¦until¦ ¦you¦ ¦are¦ ¦f ul ly¦ ¦vaccinated¦ ¦before¦ ¦att e mp ting¦ ¦to¦ ¦con ce ive¦ ¦or¦ ¦under g o¦ ¦fe rt il ity¦ ¦treatment¦ .
𐋇¦this¦ ¦is¦ ¦recommended¦ ¦because¦ ¦you¦ ¦may¦ ¦get¦ ¦a¦ ¦fever¦ ¦in¦ ¦the¦ ¦4 8¦ ¦hours¦ ¦after¦ ¦rece i ving¦ ¦your¦ ¦vaccine¦ ,▁ ¦especially¦ ¦the¦ ¦second¦ ¦d ose¦ .
𐋇 ¦brea st f ee ding¦ ¦after¦ ¦your¦ ¦covid¦ - ¦19¦ ¦vaccine¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦brea st f ee ding¦ ,▁ ¦you¦ ¦should¦ ¦get¦ ¦your¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦when¦ ¦it¦ ¦is¦ ¦off ered¦ ¦to¦ ¦you¦ .
𐋇¦you¦ ¦can¦ ¦brea st f e ed¦ ¦your¦ ¦baby¦ ¦after¦ ¦your¦ ¦vacc ination¦ .
𐋇¦the¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦have¦ ¦not¦ ¦been¦ ¦tested¦ ¦on¦ ¦brea st f ee ding¦ ¦women¦ .
𐋇¦but¦ ¦there¦ ¦is¦ ¦no¦ ¦known¦ ¦re as on¦ ¦to¦ ¦avoid¦ ¦brea st f ee ding¦ ¦if¦ ¦you¦ ¦have¦ ¦been¦ ¦vaccinated¦ .
𐋇¦if¦ ¦very¦ ¦sm all¦ ¦p or tions¦ ¦of¦ ¦vaccine¦ ¦en ter¦ ¦your¦ ¦b re ast¦ ¦m il k¦ ,▁ ¦they¦ ¦will¦ ¦be¦ ¦d ig ested¦ ¦in¦ ¦your¦ ¦baby¦ ' ¦s¦ ¦sto ma ch¦ .
𐋇¦your¦ ¦vaccine¦ ¦brea ks¦ ¦down¦ ¦qu ick ly¦ ¦in¦ ¦your¦ ¦body¦ ¦and¦ ¦cannot¦ ¦be¦ ¦par t¦ ¦of¦ ¦your¦ ¦child¦ ' ¦s¦ ¦d na¦ .
𐋇¦your¦ ¦baby¦ ¦cannot¦ ¦be¦ ¦infected¦ ¦with¦ ¦covid¦ - ¦19¦ ¦in¦ ¦this¦ ¦way¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦been¦ ¦vaccinated¦ ¦while¦ ¦pre gnant¦ ,▁ ¦your¦ ¦b re ast¦ ¦m il k¦ ¦may¦ ¦con tain¦ ¦antibo dies¦ ¦against¦ ¦covid¦ - ¦19¦ ¦and¦ ¦may¦ ¦give¦ ¦the¦ ¦baby¦ ¦some¦ ¦prote ction¦ .
𐋇¦this¦ ¦advice¦ ¦is¦ ¦for¦ ¦in fa nts¦ ¦and¦ ¦children¦ ¦of¦ ¦pr imary¦ ¦and¦ ¦sec ond ary¦ ¦school¦ ¦age¦ ▁-▁ ¦us ually¦ ¦18¦ ¦years¦ ¦o ld¦ .
𐋇¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦symptoms¦ ¦of¦ ¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ )▁ ¦or¦ ¦has¦ ¦had¦ ¦close¦ ¦contact¦ ¦with¦ ¦someone¦ ¦with¦ ¦covid¦ - ¦19¦ ,▁ ¦do¦ ¦not¦ ¦l et¦ ¦them¦ ¦go¦ ¦to¦ ¦school¦ ¦or¦ ¦att end¦ ¦ch ild c are¦ .
𐋇¦covid¦ - ¦19¦ ¦testing¦ ¦may¦ ¦be¦ ¦required¦
𐋇¦read¦ ¦more¦ ¦about¦ ¦when¦ ¦your¦ ¦child¦ ¦should¦ ¦be¦ ¦k e p t¦ ¦home¦ ¦from¦ ¦school¦ .
𐋇¦when¦ ¦is¦ ¦it¦ ¦o k¦ ¦to¦ ¦l et¦ ¦your¦ ¦child¦ ¦att end¦ ¦school¦ ¦or¦ ¦ch ild c are¦ ?
𐋇¦if¦ ¦h e¦ ▁/▁ ¦sh e¦ ¦is¦ ¦not¦ ¦a¦ ¦close¦ ¦contact¦ ,▁ ¦it¦ ¦is¦ ¦us ually¦ ¦o k¦ ¦to¦ ¦l et¦ ¦a¦ ¦child¦ ¦go¦ ¦to¦ ¦school¦ :
𐋇¦if¦ ¦they¦ ¦have¦ ¦only¦ ¦one¦ ¦n as al¦ ¦s y m pt om¦ ,▁ ¦such¦ ¦as¦ ¦a¦ ¦r un n y¦ ¦or¦ ¦sneezing¦ ¦nose¦
𐋇¦if¦ ¦they¦ ¦do¦ ¦not¦ ¦have¦ ¦a¦ ¦high¦ ¦temp erat ure¦ ,▁ ¦as¦ ¦long¦ ¦as¦ ¦their¦ ¦temp erat ure¦ ¦has¦ ¦not¦ ¦been¦ ¦l ow ered¦ ¦by¦ ¦ta king¦ ¦any¦ ¦for m¦ ¦of¦ ¦p ara ce ta mo l¦ ¦or¦ ¦i b u p ro fen¦ ▁-▁ ¦this¦ ¦can¦ ¦h ide¦ ¦a¦ ¦high¦ ¦temp erat ure¦
𐋇 ¦un less¦ ¦they¦ ¦have¦ ¦a¦ ¦new¦ ¦cough¦
𐋇¦if¦ ¦they¦ ¦do¦ ¦not¦ ¦live¦ ¦with¦ ¦an yone¦ ¦who¦ ¦is¦ ¦ ill¦ ¦and¦ ¦may¦ ¦have¦ ¦covid¦ - ¦19¦
𐋇¦if¦ ¦a¦ ¦gp¦ ¦has¦ ¦said¦ ¦that¦ ¦their¦ ¦illness¦ ¦is¦ ¦caused¦ ¦by¦ ¦so me thing¦ ¦el se¦ ,▁ ¦it¦ ¦is¦ ¦not¦ ¦covid¦ - ¦19¦ .
𐋇¦your¦ ¦gp¦ ¦will¦ ¦t ell¦ ¦you¦ ¦when¦ ¦they¦ ¦can¦ ¦retur n¦ ¦to¦ ¦school¦ ¦or¦ ¦att end¦ ¦ch ild c are¦ ¦after¦ ¦an¦ ¦illness¦ .
𐋇¦the¦ ¦child¦ ¦tested¦ ¦negative¦ ¦for¦ ¦the¦ ¦covid¦ - ¦19¦ ¦test¦ ,▁ ¦and¦ ¦the¦ ¦child¦ ¦had¦ ¦no¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦for¦ ¦4 8¦ ¦hours¦ .
𐋇¦if¦ ¦the¦ ¦child¦ ¦has¦ ¦not¦ ¦had¦ ¦di arr ho e a¦ ¦for¦ ¦4 8¦ ¦hours¦
𐋇¦if¦ ¦they¦ ¦are¦ ¦being¦ ¦tested¦ ¦as¦ ¦par t¦ ¦of¦ ¦a¦ ¦ser ies¦ ¦testing¦ ¦pr ogra m¦ ¦and¦ ¦are¦ ¦not¦ ¦sh owing¦ ¦signs¦ ¦of¦ ¦illness¦ ¦and¦ ¦are¦ ¦not¦ ¦a¦ ¦close¦ ¦contact¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦some¦ ¦children¦ ¦live¦ ¦ind ir ect¦ ¦supp ly¦ ¦centr es¦
𐋇¦if¦ ¦the¦ ¦child¦ ¦is¦ ¦regul arly¦ ¦tested¦ ¦as¦ ¦a¦ ¦me mber¦ ¦of¦ ¦a¦ ¦v ul n er able¦ ¦group¦ .
𐋇¦a¦ ¦gp¦ ¦ce rt ific ate¦ ¦is¦ ¦not¦ ¦required¦ .
𐋇¦you¦ ¦do¦ ¦not¦ ¦need¦ ¦a¦ ¦gp¦ ¦ce rt ific ate¦ ¦or¦ ¦gp¦ ¦n ot e¦ ¦to¦ ¦retur n¦ ¦to¦ ¦school¦ .
𐋇¦the¦ ¦school¦ ¦may¦ ¦as k¦ ¦you¦ ¦to¦ ¦s ign¦ ¦a¦ ¦for m¦ ¦conf ir m ing¦ ¦that¦ ¦your¦ ¦child¦ ¦is¦ ¦fi t¦ ¦to¦ ¦att end¦ .
𐋇 ¦th or n y¦ ¦or¦ ¦sneezing¦ ¦nose¦
𐋇¦it¦ ' ¦s¦ ¦o k ay¦ ¦to¦ ¦take¦ ¦your¦ ¦child¦ ¦to¦ ¦school¦ ¦or¦ ¦ch ild c are¦ ¦if¦ ¦they¦ ¦have¦ ¦symptoms¦ ¦of¦ ¦a¦ ¦r un n y¦ ¦nose¦ ¦or¦ ¦sneezing¦ .
𐋇¦a¦ ¦r un n y¦ ¦nose¦ ¦or¦ ¦sneezing¦ ¦al one¦ ¦is¦ ¦more¦ ¦likely¦ ¦to¦ ¦be¦ ¦a¦ ¦s ign¦ ¦of¦ ¦a¦ ¦cold¦ ¦or¦ ¦other¦ ¦viral¦ ¦infection¦ .
𐋇¦but¦ ¦if¦ ¦they¦ ¦have¦ ¦a¦ ¦high¦ ¦temp erat ure¦ ▁( ¦3 8¦ ¦de g re es¦ ¦c el si us¦ ¦or¦ ¦higher¦ ) ;▁ ¦l ost¦ ¦sm ell¦ ¦or¦ ¦ta st e¦ ;▁ ¦cough¦ ;▁ ¦or¦ ¦sh ort ness¦ ¦of¦ ¦brea th¦ :
𐋇 ¦separ ate¦ ¦your¦ ¦child¦ ¦from¦ ¦others¦
𐋇 ¦call¦ ¦your¦ ¦gp¦
𐋇 ¦restrict¦ ¦your¦ ¦movements¦
𐋇 ¦most¦ ¦of¦ ¦the¦ ¦time¦ ,▁ ¦you¦ ¦do¦ ¦not¦ ¦need¦ ¦to¦ ¦call¦ ¦your¦ ¦gp¦ ¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦symptoms¦ ¦of¦ ¦a¦ ¦r un n y¦ ¦nose¦ ¦or¦ ¦sneezing¦ .
𐋇¦it¦ ¦is¦ ¦b est¦ ¦to¦ ¦t alk¦ ¦to¦ ¦your¦ ¦ph arm ac ist¦ .
𐋇¦t ea ch¦ ¦the¦ ¦child¦ ¦to¦ ¦s n ee z e¦ ¦and¦ ¦cough¦ ¦in¦ ¦their¦ ¦el b ow¦ .
𐋇 ¦have¦ ¦them¦ ¦also¦ ¦use¦ ¦a¦ ¦p ap er¦ ¦to we l¦ ¦to¦ ¦clean¦ ¦their¦ ¦nose¦ ¦and¦ ¦th r ow¦ ¦it¦ ¦in¦ ¦the¦ ¦b in¦ ¦after¦ ¦use¦ .
𐋇¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ )▁ ¦is¦ ¦spread¦ ¦by¦ ¦sneezing¦ ¦or¦ ¦cou g hing¦ .
𐋇¦it¦ ¦must¦ ¦p ass¦ ¦from¦ ¦the¦ ¦nose¦ ¦or¦ ¦mouth¦ ¦of¦ ¦an¦ ¦infected¦ ¦person¦ ¦into¦ ¦your¦ ¦ey es¦ ,▁ ¦nose¦ ¦or¦ ¦mouth¦ ¦to¦ ¦get¦ ¦the¦ ¦virus¦ .
𐋇¦this¦ ¦can¦ ¦happ en¦ ¦if¦ ¦someone¦ ¦with¦ ¦the¦ ¦virus¦ ¦cou gh s¦ ¦or¦ ¦s n ee z es¦ ¦n ear¦ ¦you¦ ¦or¦ ¦tou ches¦ ¦an¦ ¦ob j ect¦ ¦or¦ ¦sur f ace¦ ¦they¦ ¦have¦ ¦come¦ ¦in¦ ¦contact¦ ¦with¦ ¦them¦ .
𐋇¦it¦ ¦is¦ ¦essential¦ ¦to¦ :
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦often¦ ¦and¦ ¦a de qu a tely¦
𐋇 ¦pract ice¦ ¦social¦ ¦separ ation¦
𐋇 ¦cov ers¦ ¦cou gh s¦ ¦and¦ ¦s n ee z es¦
𐋇 ¦follow¦ ¦government¦ ¦gu id ance¦ ¦on¦ ¦restrictions¦
𐋇 ¦follow¦ ¦the¦ ¦advice¦ ¦on¦ ¦this¦ ¦p age¦ ¦as¦ ¦much¦ ¦as¦ ¦possible¦ ¦and¦ ¦e nc o ur age¦ ¦others¦ ¦to¦ ¦do¦ ¦the¦ ¦same¦ .
𐋇 ¦people¦ ¦at¦ ¦g rea ter¦ ¦risk¦ ¦from¦ ¦covid¦ - ¦19¦
𐋇¦covid¦ - ¦19¦ ¦can¦ ¦cause¦ ¦ser ious¦ ¦illness¦ ¦to¦ ¦an yone¦ .
𐋇¦for¦ ¦some¦ ¦people¦ ,▁ ¦the¦ ¦risk¦ ¦is¦ ¦more¦ ¦sign ific ant¦ .
𐋇 ¦people¦ ¦who¦ ¦are¦ ¦at¦ ¦g rea ter¦ ¦risk¦ ¦from¦ ¦covid¦ - ¦19¦ ¦should¦ ¦be¦ ¦more¦ ¦ca re ful¦ .
𐋇¦read¦ ¦advice¦ ¦for¦ ¦people¦ ¦who¦ ¦are¦ ¦more¦ ¦at¦ ¦risk¦ ¦from¦ ¦the¦ ¦virus¦
𐋇 ¦wash¦ ¦your¦ ¦hands¦
𐋇 ¦prop er¦ ¦and¦ ¦fre qu ent¦ ¦hand w as hing¦ ¦will¦ ¦help¦ ¦prevent¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇 ¦use¦ ¦so a p¦ ¦and¦ ¦water¦ ¦or¦ ¦a¦ ¦hand¦ ¦s an it is er¦ ¦with¦ ¦al c o ho l¦ ¦to¦ ¦clean¦ ¦your¦ ¦hands¦ :
𐋇 ¦after¦ ¦cou g hing¦ ¦or¦ ¦sneezing¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦been¦ ¦in¦ ¦contact¦ ¦with¦ ¦someone¦ ¦who¦ ¦has¦ ¦a¦ ¦fever¦ ¦or¦ ¦respiratory¦ ¦symptoms¦ ▁( ¦cough¦ ,▁ ¦sh ort ness¦ ¦of¦ ¦brea th¦ ,▁ ¦diffic ult y¦ ¦brea thing¦ )
𐋇 ¦before¦ ¦and¦ ¦after¦ ¦you¦ ¦are¦ ¦on¦ ¦public¦ ¦transport¦ ,▁ ¦if¦ ¦you¦ ¦have¦ ¦to¦ ¦use¦ ¦it¦
𐋇 ¦before¦ ¦and¦ ¦after¦ ¦being¦ ¦in¦ ¦a¦ ¦cr ow d¦ ▁( ¦especially¦ ¦an¦ ¦in door¦ ¦cr ow d¦ )
𐋇¦when¦ ¦you¦ ¦en ter¦ ¦and¦ ¦lea ve¦ ¦bu ild ings¦ ,▁ ¦your¦ ¦ own¦ ¦home¦ ¦or¦ ¦an yone¦ ¦el se¦ ▁’▁ ¦s¦ ¦house¦
𐋇 ¦before¦ ¦you¦ ¦s mo ke¦ ¦a¦ ¦c ig ar et t e¦ ¦or¦ ¦a¦ ¦c ig ar et t e¦
𐋇 ¦even¦ ¦if¦ ¦you¦ ¦d on¦ ▁’▁ ¦t¦ ¦se e¦ ¦dir t¦ ¦on¦ ¦your¦ ¦hands¦
𐋇 ¦after¦ ¦using¦ ¦the¦ ¦to il et¦
𐋇 ¦take¦ ¦care¦ ¦of¦ ¦your¦ ¦hands¦ .
𐋇 ¦app ly¦ ¦mo ist ur iz er¦ ¦often¦ .
𐋇 ¦any¦ ¦produc t¦ ¦will¦ ¦make¦ ¦a¦ ¦re as on¦ ,▁ ¦a¦ ¦b as ic¦ ¦one¦ ¦without¦ ¦per f u me¦ ¦or¦ ¦c ol ou r¦ .
𐋇¦read¦ ¦about¦ ¦how¦ ¦to¦ ¦clean¦ ¦your¦ ¦hands¦ ¦properly¦
𐋇¦f ac ial¦ ¦cov ers¦
𐋇 ¦wear¦ ¦face¦ ¦cover¦ ¦on¦ ¦public¦ ¦transport¦ ,▁ ¦in¦ ¦sho ps¦ ¦and¦ ¦all¦ ¦in door¦ ¦loc ations¦ .
𐋇 ¦that¦ ' ¦s¦ ¦the¦ ¦la w¦ .
𐋇¦you¦ ¦could¦ ¦be¦ ¦f ined¦ ¦or¦ ¦ref u sed¦ ¦ent ry¦ ¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦wear¦ ¦one¦ .
𐋇¦you¦ ¦should¦ ¦also¦ ¦wear¦ ¦face¦ ¦cover¦ ¦in¦ ¦cr ow ded¦ ¦work p la ces¦ ,▁ ¦places¦ ¦of¦ ¦wor s hi p¦ ¦and¦ ¦out door¦ ¦s pa ces¦ ¦where¦ ¦many¦ ¦people¦ ¦g at her¦ .
𐋇¦read¦ ¦more¦ ¦about¦ ¦face¦ ¦masks¦ ,▁ ¦medical¦ ¦masks¦ ¦and¦ ¦dis p os able¦ ¦g lo ves¦
𐋇¦s n ee z es¦ ¦and¦ ¦cou gh s¦
𐋇¦when¦ ¦you¦ ¦cough¦ ¦or¦ ¦s n ee z e¦ ,▁ ¦cover¦ ¦your¦ ¦mouth¦ ¦and¦ ¦nose¦ ¦with¦ ¦a¦ ¦p ap er¦ ¦to we l¦ ¦or¦ ¦sl ee ve¦ .
𐋇¦p ut¦ ¦the¦ ¦hand k er ch ief¦ ¦in¦ ¦the¦ ¦b in¦ ¦and¦ ¦wash¦ ¦your¦ ¦hands¦ .
𐋇¦do¦ ¦not¦ ¦tou ch¦ ¦your¦ ¦ey es¦ ,▁ ¦nose¦ ¦or¦ ¦mouth¦ ¦un less¦ ¦they¦ ¦are¦ ¦clean¦ .
𐋇¦by¦ ¦some¦ ¦th ings¦
𐋇¦do¦ ¦not¦ ¦share¦ ¦i tems¦ ¦that¦ ¦come¦ ¦in¦ ¦contact¦ ¦with¦ ¦your¦ ¦mouth¦ ,▁ ¦for¦ ¦example¦ ,▁ ¦b ot t les¦ ¦or¦ ¦c u ps¦ .
𐋇 ¦clean¦ ¦and¦ ¦disinf ect¦ ¦all¦ ¦sur fa ces¦ ¦and¦ ¦hand les¦ ¦fre qu e ntly¦ .
𐋇 ¦social¦ ¦separ ation¦
𐋇 ¦social¦ ¦separ ation¦ ¦is¦ ¦important¦ ¦to¦ ¦del ay¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ ¦by¦ ¦k ee p ing¦ ¦infected¦ ¦people¦ ¦and¦ ¦healthy¦ ¦people¦ ¦a par t¦ .
𐋇¦this¦ ¦will¦ ¦reduce¦ ¦the¦ ¦contact¦ ¦between¦ ¦infected¦ ¦and¦ ¦healthy¦ ¦people¦ .
𐋇¦you¦ ¦should¦ :
𐋇¦stay¦ ¦2¦ ¦meters¦ ▁( ¦6¦ ¦fe et¦ )▁ ¦away¦ ¦from¦ ¦others¦ ,
𐋇 ¦avoid¦ ¦sh ared¦ ¦sl ee p ing¦ ¦areas¦ ,
𐋇 ¦avoid¦ ¦cr ow ded¦ ¦places¦ ,
𐋇¦do¦ ¦not¦ ¦sh a ke¦ ¦hands¦ ¦or¦ ¦make¦ ¦close¦ ¦contact¦ ¦with¦ ¦others¦ ,▁ ¦if¦ ¦possible¦
𐋇¦there¦ ¦is¦ ¦l it t le¦ ¦da nger¦ ¦if¦ ¦you¦ ¦are¦ ¦pa ss ing¦ ¦someone¦ .
𐋇¦but¦ ¦t ry¦ ¦to¦ ¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ¦as¦ ¦much¦ ¦as¦ ¦possible¦ .
𐋇¦when¦ ¦you¦ ¦can¦ ' ¦t¦ ¦wai t¦ ¦for¦ ¦2¦ ¦meters¦ ¦from¦ ¦others¦
𐋇¦t ry¦ ¦to¦ ¦stay¦ ¦cl ear¦ ¦of¦ ¦places¦ ¦that¦ ¦do¦ ¦not¦ ¦all ow¦ ¦you¦ ¦to¦ ¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦others¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦in¦ ¦a¦ ¦public¦ ¦place¦ ¦where¦ ¦it¦ ¦is¦ ¦to o¦ ¦diffic ul t¦ ¦to¦ ¦wai t¦ ¦for¦ ¦2¦ ¦meters¦ ¦from¦ ¦others¦ ,▁ ¦you¦ ¦should¦ ¦wear¦ ¦a¦ ¦face¦ ¦cover¦ .
𐋇¦m ee ting¦ ¦others¦
𐋇 ¦at¦ ¦level¦ ¦5¦ ,▁ ¦no¦ ¦visi t or¦ ¦to¦ ¦your¦ ¦home¦ ¦is¦ ¦all owed¦ ¦ex cep t¦ :
𐋇¦if¦ ¦there¦ ¦is¦ ¦an¦ ¦essential¦ ¦family¦ ¦cause¦
𐋇 ¦people¦ ¦in¦ ¦your¦ ¦support¦ ¦b ul b s¦
𐋇 ¦support¦ ¦b ul b s¦
𐋇 ¦people¦ ¦li ving¦ ¦al one¦ ¦or¦ ¦with¦ ¦one¦ ¦par ent¦ ¦can¦ ¦p ai r¦ ¦with¦ ¦one¦ ¦other¦ ¦family¦ ¦for¦ ¦support¦ .
𐋇¦these¦ ¦are¦ ¦called¦ ▁' ¦support¦ ¦b ul b s¦ ' .
𐋇¦the¦ ¦people¦ ¦in¦ ¦your¦ ▁' ¦support¦ ¦b ul b ¦ ' ▁ ¦can¦ ¦be¦ ¦visi ted¦ ,▁ ¦and¦ ¦they¦ ¦can¦ ¦visit¦ ¦you¦ .
𐋇¦you¦ ¦can¦ ¦me et¦ ¦outside¦ ¦and¦ ¦el se w h er e¦ .
𐋇¦read¦ ¦more¦ ¦about¦ ¦the¦ ¦support¦ ¦b ul b s¦ ¦on¦ ¦g ov ¦ . ¦i e¦
𐋇¦if¦ ¦visi t ors¦ ¦can¦ ¦come¦ ¦to¦ ¦your¦ ¦home¦
𐋇¦if¦ ¦the¦ ¦current¦ ¦restrictions¦ ¦all ow¦ ¦you¦ ,▁ ¦visi t ors¦ ,▁ ¦t ell¦ ¦them¦ ¦to¦ ¦wash¦ ¦their¦ ¦hands¦ ¦when¦ ¦they¦ ¦en ter¦ .
𐋇¦when¦ ¦they¦ ¦dis a pp ear¦ ,▁ ¦clean¦ ¦all¦ ¦sur fa ces¦ ¦they¦ ¦have¦ ¦been¦ ¦in¦ ¦contact¦ ¦with¦ ¦them¦ .
𐋇 ¦use¦ ¦for¦ ¦ro ut ine¦ ¦hou se ho ld¦ ¦cl ea ning¦ ¦and¦ ¦disinf ec ta nts¦ .
𐋇¦do¦ ¦not¦ ¦wear¦ ¦dis p os able¦ ¦g lo ves¦ ¦inst ead¦ ¦of¦ ¦cl ea ning¦ ¦your¦ ¦hands¦ .
𐋇¦the¦ ¦virus¦ ¦aff ects¦ ¦them¦ ¦the¦ ¦same¦ ¦way¦ ¦it¦ ¦g ets¦ ¦on¦ ¦your¦ ¦hands¦ .
𐋇 ¦cor ru ption¦ ¦can¦ ¦get¦ ¦on¦ ¦the¦ ¦hands¦ ¦when¦ ¦you¦ ¦re mo ve¦ ¦them¦ .
𐋇 ¦wear¦ ¦face¦ ¦co ver age¦ ¦when¦ ¦visi ting¦ ¦people¦ ¦who¦ ¦are¦ ¦7 0¦ ¦years¦ ¦of¦ ¦age¦ ¦or¦ ¦ ol der¦ ¦or¦ ¦people¦ ¦who¦ ¦are¦ ¦at¦ ¦g rea ter¦ ¦risk¦ ¦from¦ ¦covid¦ - ¦19¦ .
𐋇¦when¦ ¦to¦ ¦me et¦ ¦others¦
𐋇¦do¦ ¦not¦ ¦visit¦ ¦others¦ ¦if¦ :
𐋇¦you¦ ¦have¦ ¦any¦ ¦s ign¦ ¦of¦ ¦covid¦ - ¦19¦
𐋇¦if¦ ¦the¦ ¦contact¦ ¦trac k ers¦ ¦have¦ ¦to ld¦ ¦you¦ ¦that¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦
𐋇 ¦ch eck¦ ¦with¦ ¦people¦ ¦in¦ ¦ad v ance¦ ¦before¦ ¦you¦ ¦visit¦ ¦that¦ ¦they¦ ¦have¦ ¦no¦ ¦symptoms¦ ¦and¦ ¦are¦ ¦fe el ing¦ ¦well¦ .
𐋇¦read¦ ¦advice¦ ¦on¦ ¦those¦ ¦at¦ ¦g rea ter¦ ¦risk¦
𐋇 ¦travel¦
𐋇 ¦avoid¦ ¦public¦ ¦transport¦ .
𐋇¦w alk¦ ¦or¦ ¦c y c le¦ ¦inst ead¦ ¦of¦ ¦using¦ ¦public¦ ¦transport¦ ,▁ ¦if¦ ¦possible¦ .
𐋇¦read¦ ¦about¦ ¦the¦ ¦current¦ ¦restrictions¦ ¦on¦ ¦public¦ ¦transport¦ ¦or¦ ¦in land¦ ¦travel¦
𐋇¦do¦ ¦not¦ ¦share¦ ¦ ve h ic les¦ ¦with¦ ¦people¦ ¦who¦ ¦are¦ ¦not¦ ¦me mbers¦ ¦of¦ ¦your¦ ¦hou se ho ld¦ .
𐋇¦if¦ ¦you¦ ¦do¦ ,▁ ¦wear¦ ¦a¦ ¦face¦ ¦cover¦
𐋇 ¦work¦
𐋇¦do¦ ¦your¦ ¦work¦ ¦from¦ ¦home¦ ¦if¦ ¦possible¦ .
𐋇 ¦only¦ ¦essential¦ ¦workers¦ ¦should¦ ¦be¦ ¦go ing¦ ¦to¦ ¦work p la ces¦ .
𐋇 ¦face¦ ¦cov ers¦ ¦are¦ ¦recommended¦ ¦in¦ ¦cr ow ded¦ ¦work p la ces¦ .
𐋇¦read¦ ¦more¦ ¦about¦ ¦the¦ ¦current¦ ¦restrictions¦ ¦on¦ ¦work¦ ¦on¦ ¦g ov ¦ . ¦i e¦
𐋇 ¦social¦ ¦separ ation¦ ¦at¦ ¦work¦
𐋇 ¦follow¦ ¦the¦ ¦advice¦ ¦on¦ ¦social¦ ¦se g re g ation¦ ¦e ver y w h er e¦ ¦outside¦ ¦your¦ ¦home¦ ,▁ ¦including¦ ¦your¦ ¦work pl ace¦ .
𐋇 ¦get¦ ¦advice¦
𐋇 ¦contact¦ ¦the¦ ¦health¦ ¦and¦ ¦safety¦ ¦author ity¦ ▁( ¦h s a¦ )▁ ¦by¦ ¦e ma il¦ ¦w c u¦ ▁ @ ▁ ¦h s a¦ . ¦i e¦ :
𐋇¦you¦ ¦are¦ ¦concer ned¦ ¦about¦ ¦the¦ ¦imp le me nt ation¦ ¦of¦ ¦social¦ ¦se g re g ation¦ ¦measures¦ ¦in¦ ¦the¦ ¦work pl ace¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦the¦ ¦e mploy er¦ ¦and¦ ¦need¦ ¦advice¦ ¦on¦ ¦prev en ting¦ ¦covid¦ - ¦19¦ ¦in¦ ¦the¦ ¦work pl ace¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦retur ning¦ ¦to¦ ¦work¦ ,▁ ¦r ead¦ ¦information¦ ¦about¦ ¦retur ning¦ ¦to¦ ¦work¦ ¦sa f ely¦ .
𐋇 ¦use¦ ¦the¦ ¦covid¦ ¦tracker¦
𐋇¦the¦ ¦covid¦ ¦tracker¦ ¦is¦ ¦a¦ ¦fre e¦ ¦and¦ ¦e as y¦ ¦to¦ ¦use¦ ¦app¦ ¦and¦ :
𐋇 ¦will¦ ¦s end¦ ¦you¦ ¦an¦ ¦immediate¦ ¦contact¦ ¦alert¦ ¦if¦ ¦someone¦ ¦you¦ ¦have¦ ¦had¦ ¦close¦ ¦contact¦ ¦with¦ ¦g ets¦ ¦a¦ ¦positive¦ ¦result¦ ¦for¦ ¦covid¦ ▁ - ¦19¦
𐋇¦it¦ ¦will¦ ¦give¦ ¦you¦ ¦advice¦ ¦on¦ ¦how¦ ¦to¦ ¦protect¦ ¦yourself¦ ¦and¦ ¦others¦
𐋇¦it¦ ¦will¦ ¦alert¦ ¦other¦ ¦us ers¦ ¦of¦ ¦the¦ ¦app¦ ¦you¦ ¦contac ted¦ ¦dir ect ly¦ ¦if¦ ¦you¦ ¦get¦ ¦a¦ ¦positive¦ ¦result¦ ¦for¦ ¦covid¦ - ¦19¦
𐋇¦the¦ ¦app¦ ¦is¦ ¦par t¦ ¦of¦ ¦our¦ ¦contact¦ ¦tracking¦ .
𐋇 ¦contact¦ ¦tracking¦ ¦is¦ ¦very¦ ¦important¦ ¦to¦ ¦prevent¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇¦the¦ ¦more¦ ¦people¦ ¦who¦ ¦f ind¦ ¦and¦ ¦use¦ ¦the¦ ¦app¦ ,▁ ¦the¦ ¦bet ter¦ ¦the¦ ¦contact¦ ¦tracking¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦a ged¦ ¦between¦ ¦6 5¦ ¦and¦ ¦6 9¦ ,▁ ¦you¦ ¦can¦ ¦reg is ter¦ ¦n ow¦ ¦to¦ ¦receive¦ ¦your¦ ¦covid¦ - ¦19¦ ¦vaccine¦ .
𐋇¦a¦ ¦vaccine¦ ¦is¦ ¦the¦ ¦most¦ ¦effective¦ ¦way¦ ¦to¦ ¦prevent¦ ¦infectious¦ ¦diseases¦ .
𐋇¦they¦ ¦pre p are¦ ¦your¦ ¦immune¦ ¦system¦ ▁( ¦your¦ ¦body¦ ' ¦s¦ ¦nat ural¦ ¦def ence¦ )▁ ¦to¦ ¦reco gn iz e¦ ¦and¦ ¦f ight¦ ¦a¦ ¦partic ular¦ ¦virus¦ .
𐋇 ¦all¦ ¦vaccines¦ ¦do¦ ¦this¦ .
𐋇 ¦different¦ ¦vaccines¦ ¦work¦ ¦in¦ ¦different¦ ¦w ays¦ .
𐋇¦some¦ ¦vaccines¦ ¦con tain¦ ¦a¦ ¦live¦ ¦virus¦ .
𐋇¦some¦ ¦typ es¦ ¦of¦ ¦the¦ ¦vaccine¦ ¦con tain¦ ¦live¦ ¦virus¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦the¦ ¦flu¦ ¦vaccine¦ ¦conta ins¦ ¦a¦ ¦sm all¦ ¦a mo un t¦ ¦of¦ ¦the¦ ¦flu¦ ¦virus¦ .
𐋇¦but¦ ¦n one¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦in¦ ¦use¦ ¦conta ins¦ ¦the¦ ¦covid¦ - ¦19¦ ¦virus¦ .
𐋇¦they¦ ¦work¦ ¦di ff e re ntly¦ .
𐋇¦there¦ ¦are¦ ¦two¦ ¦typ es¦ ¦of¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦in¦ ¦use¦ :
𐋇¦m r na¦
𐋇 ¦viral¦ ¦v ector¦
𐋇¦m r na¦ ¦vaccines¦
𐋇¦the¦ ¦p f iz er¦ ▁/▁ ¦bi on te ch¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦and¦ ¦the¦ ¦mod er na¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦are¦ ¦m r na¦ ¦vaccines¦ .
𐋇¦m r na¦ ¦vaccines¦ ¦en able¦ ¦your¦ ¦body¦ ¦to¦ ¦make¦ ¦the¦ ¦protein¦ ¦that¦ ¦st im ul ates¦ ¦an¦ ¦immune¦ ¦response¦ ¦without¦ ¦using¦ ¦a¦ ¦live¦ ¦virus¦ .
𐋇 ¦after¦ ¦rece i ving¦ ¦an¦ ¦m r na¦ ¦vaccine¦ ,▁ ¦your¦ ¦body¦ ¦produc es¦ ¦antibo dies¦ ¦that¦ ¦help¦ ¦you¦ ¦f ight¦ ¦infection¦ ¦if¦ ¦a¦ ¦virus¦ ¦ent ers¦ ¦your¦ ¦body¦ ¦in¦ ¦the¦ ¦f ut ure¦ .
𐋇 ¦res ear ch ers¦ ¦have¦ ¦been¦ ¦st ud ying¦ ¦and¦ ¦wor king¦ ¦with¦ ¦m r na¦ ¦vaccines¦ ¦for¦ ¦years¦
𐋇¦how¦ ¦covid¦ - ¦19¦ ¦m r na¦ ¦vaccines¦ ¦work¦
𐋇¦the¦ ¦sur f ace¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦virus¦ ¦is¦ ¦inter t w ined¦ ¦with¦ ¦prote ins¦ ¦known¦ ¦as¦ ▁ “ ¦sp i ke¦ ¦prote ins¦ ▁ ” .
𐋇¦the¦ ¦virus¦ ¦u ses¦ ¦these¦ ¦sp i k es¦ ¦to¦ ¦en ter¦ ¦human¦ ¦ce lls¦ ,▁ ¦giv ing¦ ¦you¦ ¦a¦ ¦covid¦ - ¦19¦ ¦infection¦ .
𐋇¦the¦ ¦in str uc tions¦ ¦for¦ ¦ma king¦ ¦this¦ ¦sp ice¦ ¦protein¦ ¦are¦ ¦conta ined¦ ¦in¦ ¦the¦ ¦covid¦ - ¦19¦ ¦m r na¦ ¦vaccines¦ .
𐋇¦when¦ ¦you¦ ¦get¦ ¦the¦ ¦vaccine¦ ,▁ ¦your¦ ¦immune¦ ¦system¦ ¦reco gn iz es¦ ¦that¦ ¦the¦ ¦protein¦ ¦is¦ ¦not¦ ¦invol v ed¦ .
𐋇 ¦then¦ ¦your¦ ¦body¦ ¦star ts¦ ¦the¦ ¦immune¦ ¦response¦ ¦to¦ ¦f ight¦ ¦against¦ ¦what¦ ¦it¦ ¦th in ks¦ ¦is¦ ¦an¦ ¦infection¦ .
𐋇¦this¦ ¦immune¦ ¦response¦ ¦ma k es¦ ¦antibo dies¦ .
𐋇¦the¦ ¦antibo dies¦ ¦protect¦ ¦you¦ ¦against¦ ¦covid¦ - ¦19¦ .
𐋇¦it¦ ¦is¦ ¦much¦ ¦sa f er¦ ¦for¦ ¦the¦ ¦immune¦ ¦system¦ ¦to¦ ¦lear n¦ ¦how¦ ¦to¦ ¦protect¦ ¦you¦ ¦from¦ ¦covid¦ - ¦19¦ ¦by¦ ¦getting¦ ¦vaccinated¦ ¦inst ead¦ ¦of¦ ¦getting¦ ¦the¦ ¦virus¦ .
𐋇¦your¦ ¦ce lls¦ ¦then¦ ¦brea k¦ ¦down¦ ¦the¦ ¦in str uc tions¦ ¦on¦ ¦ma king¦ ¦the¦ ¦sp ice¦ ¦protein¦ ¦and¦ ¦exp e l¦ ¦them¦ ¦from¦ ¦your¦ ¦body¦ .
𐋇 ¦viral¦ ¦v ector¦ ¦vaccines¦
𐋇¦the¦ ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦is¦ ¦a¦ ¦viral¦ ¦v ector¦ ¦vaccine¦ .
𐋇 ¦virus¦ ¦viral¦ ¦vaccines¦ ¦use¦ ¦another¦ ¦h arm less¦ ¦virus¦ ¦as¦ ¦a¦ ¦de li ve ry¦ ¦system¦ .
𐋇¦this¦ ¦vaccine¦ ¦all ow s¦ ¦your¦ ¦body¦ ¦to¦ ¦make¦ ¦the¦ ¦protein¦ ¦that¦ ¦st im ul ates¦ ¦an¦ ¦immune¦ ¦response¦ .
𐋇¦h u nd re ds¦ ¦of¦ ¦sc ie nt if ic¦ ¦st u dies¦ ¦on¦ ¦viral¦ ¦v ector¦ ¦vaccines¦ ¦have¦ ¦been¦ ¦con duc ted¦ ¦and¦ ¦publ ished¦ ¦worldwide¦ .
𐋇 ¦several¦ ¦rece ntly¦ ¦used¦ ¦vaccines¦ ¦for¦ ¦e b ol a¦ ¦out b rea ks¦ ¦have¦ ¦used¦ ¦the¦ ¦viral¦ ¦v ector¦ ¦techn ology¦ .
𐋇 ¦other¦ ¦st u dies¦ ¦have¦ ¦f oc u sed¦ ¦on¦ ¦a¦ ¦viral¦ ¦v ector¦ ¦vaccine¦ ¦against¦ ¦z i k a¦ ,▁ ¦influenza¦ ¦and¦ ¦h iv ¦ .
𐋇¦how¦ ¦covid¦ - ¦19¦ ¦viral¦ ¦v ector¦ ¦vaccines¦ ¦work¦
𐋇 ¦viral¦ ¦v ector¦ ¦vaccines¦ ¦are¦ ¦like¦ ¦m es se ng ers¦ .
𐋇¦they¦ ¦use¦ ¦a¦ ¦w ea k e ned¦ ¦ ve rs ion¦ ¦of¦ ¦another¦ ¦virus¦ ▁( ¦the¦ ¦v ector¦ )▁ ¦to¦ ¦gu ide¦ ¦the¦ ¦ce lls¦ ¦in¦ ¦your¦ ¦body¦ ,
𐋇¦covid¦ - ¦19¦ ¦vaccines¦ ¦use¦ ¦the¦ ¦a de no vir us¦ ¦as¦ ¦a¦ ¦v ector¦ .
𐋇 ¦a de no vir us¦ ¦is¦ ¦the¦ ¦virus¦ ¦that¦ ¦ca u ses¦ ¦the¦ ¦common¦ ¦cold¦ .
𐋇¦the¦ ¦sur f ace¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦virus¦ ¦is¦ ¦inter t w ined¦ ¦with¦ ¦prote ins¦ ¦known¦ ¦as¦ ▁ “ ¦sp i ke¦ ¦prote ins¦ ▁ ” .
𐋇¦the¦ ¦virus¦ ¦u ses¦ ¦these¦ ¦sp i k es¦ ¦to¦ ¦en ter¦ ¦human¦ ¦ce lls¦ ,▁ ¦giv ing¦ ¦you¦ ¦a¦ ¦covid¦ - ¦19¦ ¦infection¦ .
𐋇¦when¦ ¦you¦ ¦receive¦ ¦a¦ ¦viral¦ ¦v ector¦ ¦vaccine¦ ,▁ ¦the¦ ¦v ector¦ ▁( ¦a de no vir us¦ )▁ ¦ent ers¦ ¦a¦ ¦c ell¦ ¦in¦ ¦your¦ ¦body¦ .
𐋇¦it¦ ¦t ea ches¦ ¦the¦ ¦c ell¦ ¦how¦ ¦to¦ ¦produc e¦ ¦covid¦ - ¦19¦ ¦sp ice¦ ¦protein¦ .
𐋇 ¦after¦ ¦rece i ving¦ ¦the¦ ¦vaccine¦ ,▁ ¦your¦ ¦immune¦ ¦system¦ ¦reco gn iz es¦ ¦that¦ ¦the¦ ¦protein¦ ¦is¦ ¦not¦ ¦invol v ed¦ .
𐋇 ¦then¦ ¦your¦ ¦body¦ ¦star ts¦ ¦the¦ ¦immune¦ ¦response¦ ¦to¦ ¦f ight¦ ¦against¦ ¦what¦ ¦it¦ ¦th in ks¦ ¦is¦ ¦an¦ ¦infection¦ .
𐋇¦this¦ ¦immune¦ ¦response¦ ¦ma k es¦ ¦antibo dies¦ .
𐋇¦the¦ ¦antibo dies¦ ¦protect¦ ¦you¦ ¦against¦ ¦covid¦ - ¦19¦ .
𐋇¦it¦ ¦is¦ ¦much¦ ¦sa f er¦ ¦for¦ ¦the¦ ¦immune¦ ¦system¦ ¦to¦ ¦lear n¦ ¦how¦ ¦to¦ ¦protect¦ ¦you¦ ¦from¦ ¦covid¦ - ¦19¦ ¦by¦ ¦getting¦ ¦vaccinated¦ ¦inst ead¦ ¦of¦ ¦getting¦ ¦the¦ ¦virus¦ .
𐋇¦this¦ ¦t op ic¦ ¦has¦ ¦been¦ ¦ex a m ined¦ ¦by¦ ¦vaccine¦ ¦exp er ts¦ ¦wor king¦ ¦in¦ ¦ireland¦ .
𐋇¦covid¦ ¦tracker¦ ¦app¦
𐋇 ¦wh y¦ ¦use¦ ¦the¦ ¦covid¦ ¦tracker¦ ¦app¦ ?
𐋇¦if¦ ¦you¦ ¦receive¦ ¦a¦ ¦call¦ ¦alert¦
𐋇 ¦using¦ ¦the¦ ¦covid¦ ¦tracking¦ ¦app¦ ¦if¦ ¦you¦ ¦get¦ ¦a¦ ¦positive¦ ¦result¦ ¦on¦ ¦your¦ ¦test¦
𐋇 ¦tracking¦ ¦your¦ ¦sign als¦
𐋇¦the¦ ¦techn ology¦ ¦used¦ ¦by¦ ¦the¦ ¦covid¦ ¦tracker¦ ¦app¦
𐋇 ¦priv acy¦ ¦and¦ ¦how¦ ¦we¦ ¦use¦ ¦your¦ ¦data¦
𐋇¦the¦ ¦covid¦ ¦tracker¦ ¦app¦ ¦is¦ ¦par t¦ ¦of¦ ¦our¦ ¦contact¦ ¦tracking¦ ¦ca m pa ign¦ .
𐋇¦it¦ ¦u ses¦ ¦a¦ ¦techn ology¦ ¦developed¦ ¦by¦ ¦app le¦ ¦and¦ ¦go og le¦ ¦called¦ ¦the¦ ¦disc l osure¦ ¦n ot ific ation¦ ¦system¦ ▁( ¦ ens¦ ).
𐋇¦ ens¦ ¦is¦ ¦fre e¦ ¦and¦ ¦is¦ ¦available¦ ¦on¦ ¦al m ost¦ ¦all¦ ¦m ob i le¦ ¦ph on es¦ ¦under¦ ¦5¦ ¦years¦ ¦of¦ ¦age¦ .
𐋇¦you¦ ¦need¦ ¦to¦ ¦up d ate¦ ¦your¦ ¦phone¦ ' ¦s¦ ¦op er ating¦ ¦system¦ ¦to¦ ¦make¦ ¦sure¦ ¦it¦ ¦has¦ ¦ ens¦ .
𐋇¦ ens¦ ¦u ses¦ ¦b lu et oo th¦ ¦and¦ ¦ra nd om ly¦ ¦gener ated¦ ¦i ds¦ ¦to¦ ¦lo g¦ ¦an on y mo us ly¦ ¦on¦ :
𐋇 ¦any¦ ¦m ob i le¦ ¦phone¦ ¦with¦ ¦which¦ ¦you¦ ¦have¦ ¦direct¦ ¦contact¦ ¦and¦ ¦which¦ ¦has¦ ¦the¦ ¦app¦ .
𐋇¦the¦ ¦dista nce¦ ¦between¦ ¦your¦ ¦m ob i le¦ ¦phone¦ ¦and¦ ¦another¦ ¦app¦ ¦us er¦ ' ¦s¦ ¦m ob i le¦ ¦phone¦
𐋇¦the¦ ¦le ng th¦ ¦of¦ ¦time¦ ¦your¦ ¦c ell¦ ¦phone¦ ¦st ays¦ ¦ne xt¦ ¦to¦ ¦another¦ ¦app¦ ¦us er¦ ' ¦s¦ ¦c ell¦ ¦phone¦
𐋇¦it¦ ¦does¦ ¦not¦ ¦tr ack¦ ¦where¦ ¦you¦ ¦are¦ ¦or¦ ¦use¦ ¦that¦ ¦information¦ .
𐋇¦the¦ ¦app¦ ¦will¦ ¦ne ver¦ ¦know¦ ¦where¦ ¦you¦ ¦were¦ ¦or¦ ¦who¦ ¦was¦ ¦with¦ ¦you¦ .
𐋇¦the¦ ¦app¦ ¦wor ks¦ ¦with¦ ¦other¦ ¦similar¦ ¦app s¦ ¦used¦ ¦by¦ ¦other¦ ¦health¦ ¦services¦ ¦such¦ ¦as¦ ¦n or ther n¦ ¦ireland¦ ,▁ ¦g erm an y¦ ,▁ ¦italy¦ ,▁ ¦d en m ar k¦ ,▁ ¦s pa in¦ ,▁ ¦h u ng ary¦ ¦and¦ ¦l at v ia¦ .
𐋇¦how¦ ¦the¦ ¦app¦ ¦wor ks¦
𐋇¦the¦ ¦app¦ ¦d ow n lo a ds¦ ¦a¦ ¦l ist¦ ¦of¦ ¦ra nd om¦ ¦i ds¦ ¦every¦ ¦2¦ ¦hours¦ .
𐋇¦these¦ ¦i ds¦ ¦are¦ ¦sh ared¦ ¦an on y mo us ly¦ ¦with¦ ¦app¦ ¦us ers¦ ¦who¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ ).
𐋇¦if¦ ¦you¦ ¦have¦ ¦been¦ ¦within¦ ¦2¦ ¦meters¦ ¦of¦ ¦an yone¦ ¦for¦ ¦more¦ ¦than¦ ¦15¦ ¦min u tes¦ ,▁ ¦you¦ ¦will¦ ¦receive¦ ¦an¦ ¦alert¦ ¦that¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦ .
𐋇¦the¦ ¦app¦ ¦does¦ ¦this¦ ¦work¦ ¦in¦ ¦the¦ ¦b ac k g ro un d¦ .
𐋇¦this¦ ¦me ans¦ ¦you¦ ¦can¦ ¦use¦ ¦your¦ ¦m ob i le¦ ¦phone¦ ¦as¦ ¦us ual¦ .
𐋇¦b lu et oo th¦
𐋇¦the¦ ¦b lu et oo th¦ ¦on¦ ¦your¦ ¦m ob i le¦ ¦phone¦ ¦must¦ ¦be¦ ¦t ur ned¦ ¦on¦ ¦in¦ ¦order¦ ¦for¦ ¦the¦ ¦contact¦ ¦tracking¦ ¦system¦ ¦to¦ ¦f un ction¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦as ked¦ ¦to¦ ¦give¦ ¦the¦ ¦app¦ ¦your¦ ¦per mi ssion¦ ¦to¦ ¦use¦ ¦the¦ ¦ ens¦ ¦o nce¦ ¦you¦ ¦star t¦ ¦using¦ ¦the¦ ¦app¦ .
𐋇¦this¦ ¦will¦ ¦also¦ ¦t ur n¦ ¦on¦ ¦b lu et oo th¦ .
𐋇¦the¦ ¦app¦ ¦u ses¦ ¦low¦ ¦en er g y¦ ¦b lu et oo th¦ ▁( ¦ le¦ )▁ ¦to¦ ¦estim ate¦ ¦the¦ ¦dista nce¦ ¦and¦ ¦time¦ ¦between¦ ¦app¦ ¦us ers¦ .
𐋇¦it¦ ¦would¦ ¦be¦ ¦able¦ ¦to¦ ¦t ell¦ ¦you¦ ¦pr ec is ely¦ ¦if¦ ¦you¦ ¦sp ent¦ ¦15¦ ¦min u tes¦ ¦or¦ ¦more¦ ¦n ear¦ ¦someone¦ ¦who¦ ¦tested¦ ¦positive¦ ¦for¦ ¦the¦ ¦virus¦ .
𐋇¦it¦ ¦will¦ ¦t ell¦ ¦ex a ct ly¦ ¦how¦ ¦fa r¦ ¦you¦ ¦were¦ ¦from¦ ¦the¦ ¦other¦ ¦app¦ ¦us er¦ ¦most¦ ¦of¦ ¦the¦ ¦time¦ .
𐋇¦but¦ ¦this¦ ¦or¦ ¦any¦ ¦other¦ ¦tracking¦ ¦met ho d¦ ¦is¦ ¦not¦ ¦ent ir ely¦ ¦acc ur ate¦ .
𐋇 ¦that¦ ' ¦s¦ ¦wh y¦ ¦we¦ ¦use¦ ¦2¦ ¦contact¦ ¦tracking¦ ¦met ho ds¦ ▁-▁ ¦the¦ ¦contact¦ ¦tracking¦ ¦team¦ ¦and¦ ¦the¦ ¦covid¦ ¦tracker¦ ¦app¦ .
𐋇 ¦ra nd om¦ ¦ident ities¦
𐋇¦ ens¦ ¦en ab les¦ ¦m ob i le¦ ¦ph on es¦ ¦to¦ ¦share¦ ¦ra nd om¦ ¦i ds¦ ¦using¦ ¦b lu et oo th¦ .
𐋇¦these¦ ¦i ds¦ ¦con tain¦ ¦information¦ ¦about¦ ¦how¦ ¦fa r¦ ¦you¦ ¦have¦ ¦been¦ ¦from¦ ¦another¦ ¦app¦ ¦us er¦ ¦and¦ ¦how¦ ¦much¦ ¦time¦ ¦you¦ ¦have¦ ¦sp ent¦ ¦n ear¦ ¦it¦ .
𐋇¦these¦ ¦co des¦ ¦are¦ ¦l et t ers¦ ¦and¦ ¦nu mbers¦ .
𐋇¦you¦ ¦ne ver¦ ¦se e¦ ¦them¦ .
𐋇¦they¦ ¦cannot¦ ¦be¦ ¦used¦ ¦to¦ ¦ident if y¦ ¦us ers¦ ¦or¦ ¦their¦ ¦c ell¦ ¦ph on es¦ .
𐋇¦by¦ ¦using¦ ¦ra nd om¦ ¦ident if ications¦ ,▁ ¦all¦ ¦information¦ ¦is¦ ¦coll ected¦ ¦an on y mo us ly¦ .
𐋇 ¦no¦ ¦one¦ ,▁ ¦even¦ ¦the¦ ¦hse¦ ,▁ ¦will¦ ¦know¦ ¦your¦ ¦detail s¦ ¦un less¦ ¦you¦ ¦c ho ose¦ ¦to¦ ¦share¦ ¦them¦ .
𐋇 ¦use¦ ¦of¦ ¦m ob i le¦ ¦data¦
𐋇¦the¦ ¦app¦ ¦u ses¦ ¦around¦ ¦1 mb ¦ ¦of¦ ¦data¦ ¦per¦ ¦day¦ .
𐋇¦this¦ ¦is¦ ¦the¦ ¦same¦ ¦a mo un t¦ ¦of¦ ¦data¦ ¦you¦ ¦would¦ ¦use¦ ¦if¦ ¦you¦ ¦were¦ ¦br ow s ing¦ ¦the¦ ¦inter n et¦ ¦for¦ ¦6¦ ¦min u tes¦ .
𐋇¦b at te ry¦ ¦l ife¦
𐋇 ¦using¦ ¦the¦ ¦app¦ ¦should¦ ¦not¦ ¦make¦ ¦any¦ ¦di ff er ence¦ ¦to¦ ¦the¦ ¦b at te ry¦ ¦l ife¦ ¦of¦ ¦your¦ ¦m ob i le¦ ¦phone¦ .
𐋇¦the¦ ¦app¦ ¦u ses¦ ¦low¦ ¦en er g y¦ ¦b lu et oo th¦ .
𐋇¦this¦ ¦is¦ ¦the¦ ¦same¦ ¦techn ology¦ ¦used¦ ¦in¦ ¦sm ar t¦ ¦w at ches¦ ¦or¦ ¦w i re less¦ ¦h ea d ph on es¦ .
𐋇¦it¦ ¦is¦ ¦d es ig ned¦ ¦to¦ ¦be¦ ¦en er g y¦ ¦eff ici ent¦ .
𐋇 ¦wh y¦ ¦use¦ ¦the¦ ¦covid¦ ¦tracker¦ ¦app¦ ?
𐋇¦if¦ ¦you¦ ¦receive¦ ¦a¦ ¦call¦ ¦alert¦
𐋇 ¦using¦ ¦the¦ ¦covid¦ ¦tracking¦ ¦app¦ ¦if¦ ¦you¦ ¦get¦ ¦a¦ ¦positive¦ ¦result¦ ¦on¦ ¦your¦ ¦test¦
𐋇 ¦tracking¦ ¦your¦ ¦sign als¦
𐋇¦the¦ ¦techn ology¦ ¦used¦ ¦by¦ ¦the¦ ¦covid¦ ¦tracker¦ ¦app¦
𐋇 ¦priv acy¦ ¦and¦ ¦how¦ ¦we¦ ¦use¦ ¦your¦ ¦data¦
𐋇¦covid¦ ¦tracking¦ ¦app¦
𐋇¦if¦ ¦you¦ ¦test¦ ¦positive¦ ¦for¦ ¦your¦ ¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ ¦detected¦ )▁ ¦test¦ ,▁ ¦you¦ ¦can¦ ¦use¦ ¦the¦ ¦app¦ ¦to¦ ¦share¦ ¦your¦ ¦close¦ ¦contac ts¦ ¦with¦ ¦the¦ ¦contact¦ ¦tracking¦ ¦team¦ .
𐋇¦this¦ ¦is¦ ¦d one¦ ¦an on y mo us ly¦ ¦using¦ ¦ra nd om¦ ¦i ds¦ .
𐋇¦you¦ ¦will¦ ¦not¦ ¦know¦ ¦any¦ ¦detail s¦ ¦relating¦ ¦to¦ ¦your¦ ¦immediate¦ ¦contac ts¦ ¦and¦ ¦will¦ ¦not¦ ¦know¦ ¦your¦ ¦ own¦ ¦detail s¦ .
𐋇 ¦sh ar ing¦ ¦your¦ ¦direct¦ ¦contac ts¦ ¦v ia¦ ¦the¦ ¦app¦ ¦e ns ures¦ ¦that¦ ¦those¦ ¦you¦ ¦have¦ ¦been¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ ¦are¦ ¦al er ted¦ .
𐋇¦this¦ ¦sp ee ds¦ ¦up¦ ¦contact¦ ¦tracking¦ .
𐋇¦it¦ ▁’▁ ¦s¦ ¦up¦ ¦to¦ ¦you¦ ¦if¦ ¦you¦ ¦w ant¦ ¦to¦ ¦do¦ ¦this¦ .
𐋇 ¦get¦ ¦an¦ ¦up lo ad¦ ¦co de¦
𐋇¦the¦ ¦contact¦ ¦tracking¦ ¦team¦ ¦will¦ ¦call¦ ¦you¦ ¦and¦ ¦as k¦ ¦for¦ ¦your¦ ¦contact¦ ¦detail s¦ .
𐋇¦you¦ ¦will¦ ¦also¦ ¦be¦ ¦as ked¦ ¦if¦ ¦you¦ ¦are¦ ¦using¦ ¦the¦ ¦app¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦the¦ ¦app¦ ,▁ ¦you¦ ¦will¦ ¦be¦ ¦s ent¦ ¦a¦ ¦uni q ue¦ ¦te xt¦ ¦up lo ad¦ ¦co de¦ .
𐋇¦this¦ ¦co de¦ ¦all ow s¦ ¦you¦ ¦to¦ ¦up lo ad¦ ¦your¦ ¦direct¦ ¦contac ts¦ ¦an on y mo us ly¦ .
𐋇 ¦up lo ad¦ ¦co des¦ ¦are¦ ¦issued¦ ¦only¦ ¦by¦ ¦me mbers¦ ¦of¦ ¦the¦ ¦contact¦ ¦tracking¦ ¦team¦ .
𐋇 ¦up lo a ding¦ ¦your¦ ¦contac ts¦
𐋇¦when¦ ¦you¦ ¦receive¦ ¦the¦ ¦up lo ad¦ ¦co de¦ :
𐋇¦open¦ ¦the¦ ¦app¦
𐋇 ¦cl ick¦ ¦on¦ ¦the¦ ▁' ¦contact¦ ¦tracker¦ ' ▁ ¦ ic on¦ ¦at¦ ¦the¦ ¦b ot t om¦ ¦of¦ ¦the¦ ¦app¦
𐋇 ¦sc r ol l¦ ¦down¦ ¦and¦ ¦cl ick¦ ¦on¦ ▁' ¦up lo ad¦ ¦your¦ ¦ra nd om¦ ¦i ds¦
𐋇 ¦en ter¦ ¦your¦ ¦uni q ue¦ ¦co de¦ ▁( ¦you¦ ¦can¦ ¦c op y¦ ¦and¦ ¦pa st e¦ ¦this¦ ¦from¦ ¦te xt¦ )
𐋇¦the¦ ¦ra nd om¦ ¦i ds¦ ¦coll ected¦ ¦by¦ ¦your¦ ¦phone¦ ¦in¦ ¦the¦ ¦last¦ ¦14¦ ¦days¦ ¦will¦ ¦be¦ ¦up lo a ded¦ .
𐋇¦these¦ ¦i ds¦ ¦t ell¦ ¦how¦ ¦close¦ ¦you¦ ¦were¦ ¦to¦ ¦other¦ ¦us ers¦ ¦of¦ ¦the¦ ¦app¦ ¦and¦ ¦how¦ ¦close¦ ¦you¦ ¦were¦ ¦to¦ ¦them¦ .
𐋇¦your¦ ¦priv acy¦ ¦is¦ ¦prot ected¦
𐋇¦your¦ ¦ra nd om¦ ¦i ds¦ ¦are¦ ¦an on y mo us¦ ¦and¦ ¦protect¦ ¦your¦ ¦priv acy¦ ¦when¦ ¦you¦ ¦up lo ad¦ ¦them¦ .
𐋇 ¦no¦ ¦one¦ ¦will¦ ¦know¦ ¦your¦ ¦personal¦ ¦detail s¦ ¦un less¦ ¦they¦ ¦share¦ ¦them¦ ¦with¦ ¦you¦ ,▁ ¦including¦ ¦the¦ ¦hse¦ .
𐋇 ¦no¦ ¦one¦ ¦will¦ ¦know¦ :
𐋇¦your¦ ¦na me¦
𐋇 ¦who¦ ¦m et¦ ¦you¦ ¦or¦ ¦was¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ ¦you¦ .
𐋇¦the¦ ¦places¦ ¦you¦ ¦were¦
𐋇 ¦who¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ ▁( ¦virus¦ ¦detected¦ )
𐋇 ¦priv acy¦ ¦and¦ ¦how¦ ¦we¦ ¦use¦ ¦your¦ ¦data¦
𐋇 ¦priv acy¦ ¦and¦ ¦data¦ ¦sec ur ity¦ ¦are¦ ¦v it al¦ ¦to¦ ¦the¦ ¦hse¦ .
𐋇¦the¦ ¦covid¦ ¦tracking¦ ¦app¦ ¦prot ects¦ ¦the¦ ¦priv acy¦ ¦of¦ ¦e veryone¦ ¦who¦ ¦u ses¦ ¦the¦ ¦app¦ .
𐋇 ¦prot ecting¦ ¦your¦ ¦priv acy¦
𐋇 ¦an¦ ¦ ai p¦ :
𐋇¦the¦ ¦app¦ ¦does¦ ¦not¦ ¦coll ect¦ ¦your¦ ¦na me¦ ,▁ ¦age¦ ¦or¦ ¦ad dr ess¦
𐋇¦it¦ ¦only¦ ¦k ee ps¦ ¦your¦ ¦phone¦ ¦number¦ ¦if¦ ¦you¦ ¦c ho ose¦ ¦to¦ ¦share¦ ¦it¦
𐋇¦it¦ ¦cannot¦ ¦be¦ ¦used¦ ¦to¦ ¦tr ack¦ ¦where¦ ¦you¦ ¦are¦
𐋇¦it¦ ¦cannot¦ ¦be¦ ¦used¦ ¦to¦ ¦ch eck¦ ¦wh ether¦ ¦you¦ ¦should¦ ¦be¦ ¦self¦ - ¦isol ating¦
𐋇¦it¦ ¦can¦ ¦only¦ ¦acc ess¦ ¦information¦ ¦on¦ ¦the¦ ¦phone¦ ¦of¦ ¦your¦ ¦c ho ice¦
𐋇¦it¦ ¦cannot¦ ¦be¦ ¦used¦ ¦to¦ ¦ident if y¦ ¦your¦ ¦immediate¦ ¦contac ts¦
𐋇¦it¦ ¦cannot¦ ¦be¦ ¦used¦ ¦to¦ ¦ident if y¦ ¦people¦ ¦who¦ ¦have¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ )
𐋇¦you¦ ¦c ho ose¦ ¦the¦ ¦data¦ ¦you¦ ¦share¦
𐋇¦it¦ ' ¦s¦ ¦al w ays¦ ¦your¦ ¦c ho ice¦ :
𐋇 ¦using¦ ¦or¦ ¦not¦ ¦using¦ ¦the¦ ¦app¦
𐋇 ¦sh ar ing¦ ¦data¦ ¦and¦ ¦information¦ ¦with¦ ¦or¦ ¦without¦ ¦us¦
𐋇¦you¦ ¦can¦ :
𐋇 ¦ch ange¦ ¦your¦ ¦pre f er ence¦ ¦at¦ ¦any¦ ¦time¦ ¦in¦ ¦the¦ ¦app¦ ¦s et t ings¦
𐋇 ¦use¦ ¦par t¦ ¦of¦ ¦the¦ ¦app¦ ¦without¦ ¦sh ar ing¦ ¦data¦ ¦at¦ ¦all¦
𐋇 ¦use¦ ¦or¦ ¦not¦ ¦use¦ ¦fe at ures¦ ¦of¦ ¦the¦ ¦app¦ ¦in de p en de ntly¦
𐋇 ¦del et e¦ ¦or¦ ¦up d ate¦ ¦the¦ ¦information¦ ¦you¦ ¦provide¦ ¦to¦ ¦the¦ ¦app¦ ¦at¦ ¦any¦ ¦time¦
𐋇¦the¦ ¦data¦ ¦coll ected¦ ¦by¦ ¦the¦ ¦app¦ ¦is¦ ¦st or ed¦ ¦on¦ ¦your¦ ¦phone¦ ¦only¦ .
𐋇 ¦no¦ ¦one¦ ¦el se¦ ¦can¦ ¦acc ess¦ ¦them¦ ¦un less¦ ¦you¦ ¦c ho ose¦ ¦to¦ ¦share¦ ¦them¦ .
𐋇¦the¦ ¦data¦ ¦you¦ ¦share¦ ¦g ives¦ ¦health¦ ¦pro f es si on als¦ ¦more¦ ¦information¦ ¦about¦ ¦the¦ ¦virus¦ ¦and¦ ¦h el ps¦ ¦prevent¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦the¦ ¦data¦ ¦coll ected¦
𐋇¦the¦ ¦app¦ ¦coll ects¦ ¦and¦ ¦u ses¦ ¦a¦ ¦co mb ination¦ ¦of¦ ¦personal¦ ¦and¦ ¦an on y mo us¦ ¦data¦ .
𐋇 ¦personal¦ ¦detail s¦
𐋇¦you¦ ¦can¦ ¦c ho ose¦ ¦to¦ ¦share¦ ¦your¦ ¦phone¦ ¦number¦ ,▁ ¦dem ogra ph ics¦ ¦and¦ ¦data¦ ¦related¦ ¦to¦ ¦your¦ ¦health¦ .
𐋇¦you¦ ¦do¦ ¦not¦ ¦have¦ ¦to¦ ¦provide¦ ¦these¦ ¦detail s¦ ¦un less¦ ¦you¦ ¦w ish¦ .
𐋇¦your¦ ¦phone¦ ¦a ut om at ically¦ ¦sh ar es¦ ¦your¦ ¦i p¦ ¦ad dr ess¦ .
𐋇¦we¦ ¦do¦ ¦not¦ ¦need¦ ¦your¦ ¦i p¦ ¦ad dr ess¦ .
𐋇¦we¦ ¦del et e¦ ¦this¦ ¦data¦ ¦as¦ ¦so on¦ ¦as¦ ¦your¦ ¦phone¦ ¦s ends¦ ¦it¦ ¦to¦ ¦us¦ .
𐋇¦your¦ ¦phone¦ ¦number¦
𐋇¦we¦ ¦will¦ ¦only¦ ¦know¦ ¦your¦ ¦phone¦ ¦number¦ ¦if¦ ¦you¦ ¦c ho ose¦ ¦to¦ ¦share¦ ¦it¦ ¦with¦ ¦us¦ .
𐋇¦you¦ ¦may¦ ¦c ho ose¦ ¦to¦ ¦share¦ ¦it¦ ¦if¦ ¦you¦ ¦need¦ ¦to¦ ¦receive¦ ¦a¦ ¦call¦ ¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦ ¦for¦ ¦someone¦ ¦who¦ ¦has¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇¦this¦ ¦pla ce ment¦ ¦can¦ ¦be¦ ¦chan ged¦ ¦at¦ ¦any¦ ¦time¦ .
𐋇¦the¦ ¦app¦ ¦will¦ ¦only¦ ¦share¦ ¦your¦ ¦phone¦ ¦number¦ ¦with¦ ¦the¦ ¦hse¦ ¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦ .
𐋇¦a¦ ¦contact¦ ¦tracking¦ ¦team¦ ¦will¦ ¦then¦ ¦call¦ ¦you¦ ¦to¦ ¦arr ange¦ ¦a¦ ¦covid¦ - ¦19¦ ¦test¦ .
𐋇¦the¦ ¦app¦ ¦will¦ ¦share¦ ¦the¦ ¦l at est¦ ¦date¦ ¦you¦ ¦were¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ ¦someone¦ ¦who¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇¦this¦ ¦is¦ ¦d one¦ ¦so¦ ¦that¦ ¦we¦ ¦can¦ ¦give¦ ¦you¦ ¦the¦ ¦appr op ri ate¦ ¦health¦ ¦advice¦ ¦based¦ ¦on¦ ¦how¦ ¦long¦ ¦ag o¦ ¦you¦ ¦were¦ ¦un p r ot ected¦ ¦by¦ ¦the¦ ¦virus¦ .
𐋇¦the¦ ¦contact¦ ¦tracking¦ ¦team¦ ¦is¦ ¦giv en¦ ¦immediate¦ ¦contact¦ ¦phone¦ ¦nu mbers¦ ¦when¦ ¦t al king¦ ¦to¦ ¦people¦ ¦who¦ ¦have¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇¦this¦ ¦me ans¦ ¦you¦ ¦can¦ ¦get¦ ¦a¦ ¦call¦ ¦from¦ ¦them¦ ¦even¦ ¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦share¦ ¦your¦ ¦phone¦ ¦number¦ ¦in¦ ¦the¦ ¦app¦ .
𐋇 ¦health¦ ¦and¦ ¦dem ogra ph ic¦ ¦information¦
𐋇¦if¦ ¦you¦ ¦use¦ ¦the¦ ¦covid¦ - ¦19¦ ¦app¦ ¦to¦ ¦ch eck¦ ¦your¦ ¦sign als¦ ,▁ ¦p le ase¦ ¦share¦ ¦the¦ ¦following¦ ¦with¦ ¦us¦ :
𐋇¦the¦ ¦county¦ ¦or¦ ¦t own¦ ¦in¦ ¦which¦ ¦you¦ ¦live¦
𐋇 ¦o ld¦ ¦group¦
𐋇¦ d¦ ' ¦i ns c n e¦
𐋇¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦
𐋇¦if¦ ¦you¦ ¦share¦ ¦the¦ ¦information¦ ¦with¦ ¦us¦ ,▁ ¦it¦ ¦will¦ ¦be¦ ¦up lo a ded¦ ¦to¦ ¦the¦ ¦hse¦ ¦and¦ ¦sh ared¦ ¦an on y mo us ly¦ ¦with¦ ¦the¦ ¦centr al¦ ¦st at ist ics¦ ¦off ice¦ ▁( ¦c s o¦ ).
𐋇¦this¦ ¦information¦ ¦h el ps¦ ¦us¦ ¦to¦ ¦under st and¦ ¦more¦ ¦about¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇 ¦wh ether¦ ¦or¦ ¦not¦ ¦you¦ ¦w ant¦ ¦to¦ ¦share¦ ¦this¦ ¦data¦ ¦with¦ ¦us¦ ¦is¦ ¦al w ays¦ ¦your¦ ¦c ho ice¦ .
𐋇¦you¦ ¦can¦ ¦ch ange¦ ¦the¦ ¦information¦ ¦you¦ ¦need¦ ¦to¦ ¦share¦ ¦with¦ ¦us¦ ¦at¦ ¦any¦ ¦time¦ .
𐋇¦read¦ ¦more¦ ¦about¦ ¦the¦ ¦data¦ ¦coll ected¦ ¦and¦ ¦proc es sed¦ .
𐋇 ¦i p¦ ¦ad dr ess¦
𐋇¦your¦ ¦i p¦ ¦ad dr ess¦ ¦is¦ ¦a¦ ¦uni q ue¦ ¦colle ction¦ ¦of¦ ¦nu mbers¦ ¦that¦ ¦ident if ies¦ ¦your¦ ¦phone¦ ¦or¦ ¦comp u ter¦ ¦when¦ ¦you¦ ¦use¦ ¦the¦ ¦inter n et¦ .
𐋇 ¦i p¦ ¦ad dr es ses¦ ¦are¦ ¦used¦ ¦so¦ ¦that¦ ¦you¦ ¦can¦ ¦s end¦ ¦and¦ ¦receive¦ ¦information¦ ¦online¦ .
𐋇¦your¦ ¦i p¦ ¦ad dr ess¦ ¦is¦ ¦a ut om at ically¦ ¦sh ared¦ ¦each¦ ¦time¦ ¦you¦ ¦use¦ ¦an¦ ¦app¦ ¦or¦ ¦visit¦ ¦a¦ ¦we b s ite¦ .
𐋇¦we¦ ¦do¦ ¦not¦ ¦need¦ ¦your¦ ¦i p¦ ¦ad dr ess¦ .
𐋇¦we¦ ¦del et e¦ ¦it¦ ¦from¦ ¦the¦ ¦ser ver¦ ¦as¦ ¦so on¦ ¦as¦ ¦we¦ ¦receive¦ ¦the¦ ¦data¦ ¦you¦ ¦share¦ ¦with¦ ¦us¦ ¦from¦ ¦the¦ ¦app¦ .
𐋇 ¦un k n own¦ ¦data¦
𐋇 ¦an on y mo us¦ ¦data¦ ¦we¦ ¦coll ect¦ ¦inclu des¦ :
𐋇 ¦detail s¦ ¦of¦ ¦how¦ ¦you¦ ¦use¦ ¦the¦ ¦app¦
𐋇 ¦data¦ ¦we¦ ¦use¦ ¦for¦ ¦contact¦ ¦tracking¦
𐋇 ¦detail s¦ ¦on¦ ¦how¦ ¦you¦ ¦use¦ ¦the¦ ¦app¦
𐋇¦we¦ ¦coll ect¦ ¦data¦ ¦about¦ ¦how¦ ¦you¦ ¦use¦ ¦the¦ ¦app¦ .
𐋇¦this¦ ¦is¦ ¦called¦ ▁' ¦app¦ ¦met r ic¦ ¦data¦ ' .
𐋇¦we¦ ¦coll ect¦ ¦this¦ ¦data¦ ¦in¦ ¦order¦ ¦to¦ ¦imp ro ve¦ ¦the¦ ¦app¦ ¦and¦ ¦to¦ ¦under st and¦ :
𐋇¦how¦ ¦the¦ ¦app¦ ¦is¦ ¦used¦
𐋇 ¦its¦ ¦eff ect¦ ¦on¦ ¦sl owing¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦
𐋇 ¦met r ic¦ ¦data¦ ¦of¦ ¦this¦ ¦app¦ ¦does¦ ¦not¦ ¦re ve al¦ ¦your¦ ¦na me¦ .
𐋇¦but¦ ¦it¦ ¦is¦ ¦your¦ ¦c ho ice¦ ¦wh ether¦ ¦or¦ ¦not¦ ¦you¦ ¦w ant¦ ¦to¦ ¦share¦ ¦this¦ ¦data¦ .
𐋇 ¦contact¦ ¦tracking¦ ¦detail s¦
𐋇¦to¦ ¦en able¦ ¦contact¦ ¦tracking¦ ,▁ ¦the¦ ¦covid¦ ¦tracker¦ ¦u ses¦ ¦a¦ ¦techn ology¦ ¦developed¦ ¦by¦ ¦app le¦ ¦and¦ ¦go og le¦ ¦called¦ ¦disc l osure¦ ¦n ot ific ation¦ .
𐋇¦the¦ ¦disc l osure¦ ¦n ot ific ation¦ ¦en ab les¦ ¦your¦ ¦phone¦ ¦to¦ ¦cre ate¦ ¦and¦ ¦share¦ ¦ra nd om¦ ¦i ds¦ .
𐋇¦these¦ ¦ra nd om¦ ¦i ds¦ ¦are¦ ¦sh ared¦ ¦when¦ ¦you¦ ¦are¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ ¦other¦ ¦us ers¦ ¦of¦ ¦the¦ ¦app¦ .
𐋇¦you¦ ¦can¦ ¦r ead¦ ¦more¦ ¦about¦ ¦the¦ ¦disc l osure¦ ¦n ot ific ation¦ ¦system¦ ¦on¦ ¦the¦ ¦app le¦ ¦or¦ ¦go og le¦ ¦we b s ite¦ .
𐋇¦the¦ ¦app¦ ¦u ses¦ ¦this¦ ¦an on y mo us¦ ¦data¦ ¦to¦ ¦n ot if y¦ ¦you¦ ¦of¦ :
𐋇¦the¦ ¦time¦ ¦you¦ ¦sp ent¦ ¦with¦ ¦another¦ ¦un k n own¦ ¦us er¦ ¦of¦ ¦the¦ ¦app¦
𐋇¦the¦ ¦st re ng th¦ ¦of¦ ¦the¦ ¦b lu et oo th¦ ¦sign al¦ ¦of¦ ¦the¦ ¦other¦ ¦us er¦ ¦of¦ ¦the¦ ¦other¦ ¦app¦ ¦and¦ ¦how¦ ¦to¦ ¦work¦ ¦out¦ ¦how¦ ¦close¦ ¦you¦ ¦were¦ ¦to¦ ¦them¦
𐋇 ¦that¦ ¦data¦ ¦st ays¦ ¦on¦ ¦your¦ ¦phone¦ .
𐋇 ¦no¦ ¦one¦ ¦can¦ ¦acc ess¦ ¦them¦ ¦un less¦ ¦you¦ ¦c ho ose¦ ¦to¦ ¦share¦ ¦them¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦as ked¦ ¦if¦ ¦you¦ ¦w ish¦ ¦to¦ ¦share¦ ¦the¦ ¦data¦ ¦with¦ ¦the¦ ¦hse¦ ¦if¦ ¦you¦ ¦test¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇 ¦ra nd om¦ ¦i ds¦ ¦sh ared¦ ¦with¦ ¦the¦ ¦hse¦ ¦are¦ ¦de le ted¦ ¦every¦ ¦14¦ ¦days¦ .
𐋇¦you¦ ¦can¦ ¦del et e¦ ¦the¦ ¦app¦ ¦as¦ ¦well¦ ¦as¦ ¦the¦ ¦data¦ ¦coll ected¦ ¦on¦ ¦it¦ ¦w he ne ver¦ ¦you¦ ¦w ant¦ .
𐋇¦we¦ ¦have¦ ¦wor ked¦ ¦with¦ ¦app le¦ ¦and¦ ¦go og le¦ ¦to¦ ¦e ns ure¦ ¦that¦ ¦contact¦ ¦tracking¦ ¦f u nc tion ality¦ ¦wor ks¦ ¦eff ect ively¦ ¦for¦ ¦as¦ ¦many¦ ¦ph on es¦ ¦as¦ ¦possible¦ .
𐋇 ¦thir d¦ ¦part y¦ ¦ bo dies¦
𐋇¦for¦ ¦the¦ ¦f u nc tion ality¦ ¦of¦ ¦the¦ ¦app¦ ,▁ ¦we¦ ¦use¦ ¦services¦ ¦from¦ ¦a¦ ¦number¦ ¦of¦ ¦comp an ies¦ .
𐋇¦these¦ ¦thir d¦ - ¦part y¦ ¦comp an ies¦ ¦proc ess¦ ¦some¦ ¦data¦ ¦from¦ ¦the¦ ¦app¦ ,▁ ¦including¦ ¦your¦ ¦an on y mo us¦ ¦information¦ .
𐋇 ¦safe¦ ,▁ ¦sec ure¦ ¦and¦ ¦comp li ant¦
𐋇¦we¦ ¦cre ated¦ ¦the¦ ¦app¦ ¦based¦ ¦on¦ ¦eu¦ ¦gu id el ines¦ ,▁ ¦eu¦ ¦recomm end ations¦ ¦on¦ ¦priv acy¦ ,▁ ¦hse¦ ¦sta nd ards¦ ¦and¦ ¦data¦ ¦prote ction¦ ¦la w¦ .
𐋇¦this¦ ¦me ans¦ ¦that¦ ¦the¦ ¦app¦ :
𐋇 ¦safe¦ ¦and¦ ¦sec ure¦ ¦to¦ ¦use¦
𐋇 ¦la w¦ - ¦ab i ding¦
𐋇 ¦me ets¦ ¦the¦ ¦sta nd ards¦ ¦exp ected¦ ¦to¦ ¦keep¦ ¦data¦ ¦sec ure¦ ¦and¦ ¦conf ide ntial¦
𐋇 ¦contact¦ ¦tracking¦ ¦on¦ ¦the¦ ¦ent ir e¦ ¦app¦ ¦is¦ ¦de ce nt ra li zed¦ .
𐋇¦the¦ ¦ra nd om¦ ¦i ds¦ ¦on¦ ¦your¦ ¦phone¦ ¦are¦ ¦m at ched¦ .
𐋇¦this¦ ¦me ans¦ ¦that¦ ¦no¦ ¦one¦ ¦can¦ ¦tr ack¦ ¦your¦ ¦loc ation¦ ,▁ ¦your¦ ¦movements¦ ¦or¦ ¦the¦ ¦people¦ ¦you¦ ¦have¦ ¦contac ted¦ .
𐋇¦read¦ ¦more¦ ¦about¦ ¦comp li ance¦ ¦and¦ ¦sec ur ity¦ .
𐋇 ¦de le ting¦ ¦your¦ ¦data¦
𐋇¦you¦ ¦can¦ ¦c ho ose¦ ¦to¦ ¦del et e¦ ¦the¦ ¦app¦ ¦and¦ ¦del et e¦ ¦your¦ ¦data¦ ¦at¦ ¦any¦ ¦time¦ .
𐋇¦to¦ ¦do¦ ¦this¦ :
𐋇 ¦go¦ ¦to¦ ▁' ¦s et t ings¦ ' ▁ ¦in¦ ¦the¦ ¦app¦ .
𐋇¦s el ect¦ ▁' ¦lea ve¦ ' .
𐋇 ¦cl ick¦ ¦on¦ ▁' ¦i¦ ¦w ant¦ ¦to¦ ¦lea ve¦ ' .
𐋇¦this¦ ¦will¦ ¦del et e¦ ¦the¦ ¦app¦ ¦and¦ ¦your¦ ¦data¦ .
𐋇¦when¦ ¦the¦ ¦government¦ ¦an no un ces¦ ¦the¦ ¦outbreak¦ ¦is¦ ¦over¦ ,▁ ¦the¦ ¦app¦ ¦will¦ ¦no¦ ¦lo nger¦ ¦work¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦pro mp ted¦ ¦to¦ ¦del et e¦ ¦the¦ ¦app¦ ¦and¦ ¦all¦ ¦data¦ .
𐋇¦it¦ ¦will¦ ¦no¦ ¦lo nger¦ ¦be¦ ¦available¦ ¦on¦ ¦the¦ ¦app¦ ¦st or es¦ ¦e it her¦ .
𐋇 ¦contact¦ ¦the¦ ¦data¦ ¦prote ction¦ ¦offic er¦
𐋇¦the¦ ¦hse¦ ¦data¦ ¦prote ction¦ ¦offic er¦ ¦can¦ ¦be¦ ¦contac ted¦ ¦at¦ ¦d p o¦ ▁ @ ▁ ¦hse¦ . ¦i e¦ .
𐋇 ¦trans pa re ncy¦
𐋇¦as¦ ¦par t¦ ¦of¦ ¦our¦ ¦comm it ment¦ ¦to¦ ¦trans pa re ncy¦ ,▁ ¦the¦ ¦following¦ ¦l in ks¦ ¦can¦ ¦be¦ ¦consid ered¦ :
𐋇 ¦data¦ ¦prote ction¦ ¦impac t¦ ¦as se ss ment¦
𐋇 ¦data¦ ¦prote ction¦ ¦information¦ ¦n ot ice¦
𐋇 ¦priv acy¦ ¦d es ig ns¦
𐋇 ¦sour ce¦ ¦co de¦
𐋇 ¦g i th ub ¦ ¦the¦ ¦covid¦ ¦tracker¦
𐋇¦read¦ ¦more¦ ¦about¦ ¦how¦ ¦we¦ ¦keep¦ ¦your¦ ¦data¦ ¦sec ure¦ .
𐋇 ¦part n er¦ ¦organiz ations¦
𐋇 ¦organiz ations¦ ¦from¦ ¦ireland¦ ¦and¦ ¦around¦ ¦the¦ ¦world¦ ¦wor ked¦ ¦t og ether¦ ¦to¦ ¦develop ¦ ¦the¦ ¦covid¦ ¦tracker¦ ¦app¦ .
𐋇¦this¦ ¦inclu des¦ ¦part ne rs hi ps¦ ¦for¦ :
𐋇 ¦pro j ect¦ ¦gover n ance¦ ¦and¦ ¦de li ve ry¦
𐋇 ¦research¦
𐋇 ¦techn ology¦
𐋇¦c om mer ce¦
𐋇 ¦pro j ect¦ ¦gover n ance¦ ¦and¦ ¦de li ve ry¦
𐋇 ¦department¦ ¦of¦ ¦health¦
𐋇¦f s s¦
𐋇 ¦off ice¦ ¦of¦ ¦the¦ ¦ch ief¦ ¦government¦ ¦information¦ ¦offic er¦ ,▁ ¦department¦ ¦of¦ ¦public¦ ¦exp end it ure¦ ¦and¦ ¦re for m¦ ▁( ¦op o f r¦ ,▁ ¦d p er¦ )
𐋇¦the¦ ¦pol ice¦
𐋇 ¦research¦
𐋇 ¦sc i ence¦ ¦f ou nd ation¦ ¦ireland¦ ▁( ¦s f i¦ )
𐋇 ¦be h a vi or al¦ ¦research¦ ¦uni t¦ ¦of¦ ¦the¦ ¦ec onomic¦ ¦and¦ ¦social¦ ¦research¦ ¦inst it ute¦ ¦t¦ ▁( ¦ at i¦ ¦i tes¦ )
𐋇 ¦ir ish¦ ¦government¦ ¦ec onomic¦ ¦and¦ ¦as se ss ment¦ ¦services¦ ▁( ¦se m r é ¦ )
𐋇 ¦priv acy¦ - ¦pro x im ity¦ ¦de ce nt r al iz ation¦ ¦tracking¦ ▁( ¦d p 3 t¦ ,▁ ¦sw it z er land¦ )
𐋇 ¦ma ss a ch us et ts¦ ¦inst it ute¦ ¦of¦ ¦techn ology¦ ▁-▁ ¦a ut om ated¦ ¦priv ate¦ ¦contact¦ ¦tracking¦ ▁( ¦mi t¦ - ¦p ac t¦ )
𐋇 ¦tracking¦ ¦your¦ ¦sign als¦
𐋇 ¦wh y¦ ¦use¦ ¦the¦ ¦covid¦ ¦tracker¦ ¦app¦ ?
𐋇¦if¦ ¦you¦ ¦receive¦ ¦a¦ ¦call¦ ¦alert¦
𐋇 ¦using¦ ¦the¦ ¦covid¦ ¦tracking¦ ¦app¦ ¦if¦ ¦you¦ ¦get¦ ¦a¦ ¦positive¦ ¦result¦ ¦on¦ ¦your¦ ¦test¦
𐋇 ¦tracking¦ ¦your¦ ¦sign als¦
𐋇¦the¦ ¦techn ology¦ ¦used¦ ¦by¦ ¦the¦ ¦covid¦ ¦tracker¦ ¦app¦
𐋇 ¦priv acy¦ ¦and¦ ¦how¦ ¦we¦ ¦use¦ ¦your¦ ¦data¦
𐋇¦you¦ ¦can¦ ¦use¦ ¦the¦ ¦covid¦ ¦tracker¦ ¦app¦ ¦to¦ ¦f ind¦ ¦out¦ :
𐋇¦how¦ ¦you¦ ¦feel¦ ¦every¦ ¦day¦
𐋇 ¦are¦ ¦you¦ ¦sh owing¦ ¦signs¦ ¦of¦ ¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ )
𐋇 ¦what¦ ¦you¦ ¦should¦ ¦do¦
𐋇 ¦wh y¦ ¦you¦ ¦should¦ ¦tr ack¦ ¦your¦ ¦signs¦
𐋇¦when¦ ¦you¦ ¦keep¦ ¦a¦ ¦recor d¦ ¦of¦ ¦your¦ ¦symptoms¦ ¦every¦ ¦day¦ :
𐋇¦you¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦re me mber¦ ¦when¦ ¦you¦ ¦bec a me¦ ¦ ill¦
𐋇¦it¦ ¦will¦ ¦be¦ ¦u se ful¦ ¦if¦ ¦you¦ ¦have¦ ¦to¦ ¦t alk¦ ¦to¦ ¦your¦ ¦gp¦
𐋇¦it¦ ¦will¦ ¦help¦ ¦you¦ ¦get¦ ¦re li able¦ ¦advice¦ ¦qu ick ly¦
𐋇¦it¦ ¦will¦ ¦help¦ ¦us¦ ¦ma p¦ ¦the¦ ¦virus¦ ¦and¦ ¦pr ed ic t¦ ¦how¦ ¦it¦ ¦will¦ ¦spread¦ .
𐋇¦the¦ ¦app¦ ¦will¦ ¦keep¦ ¦a¦ ¦recor d¦ ¦of¦ ¦your¦ ¦daily¦ ¦ch eck¦ - ¦in¦ ¦for¦ ¦2 8¦ ¦days¦ ¦so¦ ¦you¦ ¦can¦ ¦re v ie w¦ ¦them¦ .
𐋇 ¦any¦ ¦health¦ ¦information¦ ¦you¦ ¦share¦ ¦will¦ ¦be¦ ¦an on y mo us¦ .
𐋇¦you¦ ¦do¦ ¦not¦ ¦need¦ ¦to¦ ¦tr ack¦ ¦your¦ ¦sign als¦ ¦for¦ ¦other¦ ¦app¦ ¦f u nc tions¦ ¦to¦ ¦work¦ .
𐋇¦how¦ ¦covid¦ ¦ch eck¦ - ¦in¦ ¦wor ks¦
𐋇 ¦pr ess¦ ¦the¦ ▁' ¦ch eck¦ - ¦in¦ ¦covid¦ ' ▁ ¦b ut t on¦ ¦at¦ ¦the¦ ¦b ot t om¦ ¦of¦ ¦the¦ ¦app¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦giv en¦ ¦2¦ ¦op tions¦ :
' ¦i¦ ' ¦ m¦ ¦f ine¦ ,▁ ¦i¦ ¦have¦ ¦no¦ ¦s ign¦ ▁' .
' ¦i¦ ¦d on¦ ' ¦t¦ ¦feel¦ ¦well¦ ¦to day¦ ▁' .
𐋇¦if¦ ¦you¦ ¦have¦ ¦no¦ ¦symptoms¦
𐋇¦when¦ ¦you¦ ¦s el ect¦ ▁' ¦i¦ ' ¦ m¦ ¦f ine¦ ,▁ ¦i¦ ¦have¦ ¦no¦ ¦s ign¦ ' ,▁ ¦your¦ ¦ch eck¦ - ¦in¦ ¦will¦ ¦end¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦symptoms¦
𐋇¦if¦ ¦you¦ ¦c ho ose¦ ▁' ¦i¦ ¦d on¦ ' ¦t¦ ¦feel¦ ¦well¦ ¦to day¦ ' ,▁ ¦you¦ ¦will¦ ¦be¦ ¦as ked¦ ¦4¦ ¦qu es tions¦ ¦about¦ ¦normal¦ ¦covid¦ - ¦19¦ ¦sign als¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦giv en¦ ¦the¦ ¦l at est¦ ¦advice¦ ¦based¦ ¦on¦ ¦your¦ ¦symptoms¦ .
𐋇¦but¦ ¦if¦ ¦you¦ ¦have¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ,▁ ¦stay¦ ¦away¦ ¦from¦ ¦yourself¦ ¦and¦ ¦call¦ ¦your¦ ¦gp¦ .
𐋇 ¦op tional¦ ¦sh ar ing¦ ¦of¦ ¦information¦
𐋇¦when¦ ¦you¦ ¦first¦ ¦use¦ ¦the¦ ¦app¦ ,▁ ¦you¦ ¦will¦ ¦have¦ ¦the¦ ¦o ption¦ ¦to¦ ¦share¦ ¦information¦ ¦about¦ :
𐋇¦the¦ ¦county¦ ¦and¦ ¦t own¦ ¦in¦ ¦which¦ ¦you¦ ¦live¦
𐋇¦for¦ ¦age¦ ¦group¦
𐋇¦ d¦ ' ¦i ns c n e¦
𐋇¦covid¦ ¦tracker¦ ¦app¦
𐋇 ¦wh y¦ ¦use¦ ¦the¦ ¦covid¦ ¦tracker¦ ¦app¦ ?
𐋇¦if¦ ¦you¦ ¦receive¦ ¦a¦ ¦call¦ ¦alert¦
𐋇 ¦using¦ ¦the¦ ¦covid¦ ¦tracking¦ ¦app¦ ¦if¦ ¦you¦ ¦get¦ ¦a¦ ¦positive¦ ¦result¦ ¦on¦ ¦your¦ ¦test¦
𐋇 ¦tracking¦ ¦your¦ ¦sign als¦
𐋇¦the¦ ¦techn ology¦ ¦used¦ ¦by¦ ¦the¦ ¦covid¦ ¦tracker¦ ¦app¦
𐋇 ¦priv acy¦ ¦and¦ ¦how¦ ¦we¦ ¦use¦ ¦your¦ ¦data¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦been¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ ¦another¦ ¦app¦ ¦us er¦ ¦who¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ ¦you¦ ¦will¦ ¦receive¦ ¦an¦ ¦alert¦ ¦on¦ ¦your¦ ¦m ob i le¦ ¦phone¦ .
𐋇 ¦what¦ ¦is¦ ¦the¦ ¦m ea ning¦ ¦of¦ ¦an¦ ¦immediate¦ ¦contact¦ ¦alert¦ ?
𐋇 ¦an¦ ¦immediate¦ ¦contact¦ ¦alert¦ ¦me ans¦ ¦that¦ ¦you¦ ¦have¦ ¦been¦ ¦within¦ ¦2¦ ¦meters¦ ¦of¦ ¦a¦ ¦person¦ ¦with¦ ¦the¦ ¦virus¦ ¦for¦ ¦a¦ ¦rel at ively¦ ¦long¦ ¦time¦ ▁( ¦more¦ ¦than¦ ¦15¦ ¦min u tes¦ )▁ ¦and¦ ¦that¦ ¦you¦ ¦could¦ ¦get¦ ¦the¦ ¦virus¦ .
𐋇¦you¦ ¦will¦ ¦ne ver¦ ¦know¦ ¦who¦ ¦is¦ ¦infected¦ ¦or¦ ¦where¦ ¦the¦ ¦first¦ ¦contact¦ ¦occur r ed¦ .
𐋇¦you¦ ¦will¦ ¦need¦ ¦to¦ ¦ac t¦ ¦as¦ ¦you¦ ¦could¦ ¦spread¦ ¦the¦ ¦virus¦ ¦to¦ ¦others¦ .
𐋇 ¦what¦ ¦you¦ ¦should¦ ¦do¦
𐋇¦the¦ ¦alert¦ ¦will¦ ¦ad v ise¦ ¦you¦ ¦to¦ :
𐋇 ¦restrict¦ ¦your¦ ¦movements¦ ¦if¦ ¦you¦ ¦have¦ ¦no¦ ¦symptoms¦ .
𐋇 ¦self¦ - ¦isolation¦ ¦if¦ ¦you¦ ¦have¦ ¦symptoms¦ .
𐋇 ¦get¦ ¦a¦ ¦covid¦ - ¦19¦ ¦test¦ .
𐋇¦it¦ ¦is¦ ¦important¦ ¦to¦ ¦follow¦ ¦this¦ ¦advice¦ ¦to¦ ¦protect¦ ¦yourself¦ ¦and¦ ¦others¦ .
𐋇 ¦arr ange¦ ¦a¦ ¦test¦ ¦appointment¦
𐋇¦you¦ ¦will¦ ¦be¦ ¦as ked¦ ¦if¦ ¦you¦ ¦w ant¦ ¦to¦ ¦share¦ ¦your¦ ¦phone¦ ¦number¦ ¦when¦ ¦you¦ ¦first¦ ¦la un ch¦ ¦the¦ ¦app¦ ¦on¦ ¦your¦ ¦m ob i le¦ ¦phone¦ ¦and¦ ¦when¦ ¦you¦ ¦receive¦ ¦an¦ ¦alert¦ .
𐋇¦if¦ ¦you¦ ¦give¦ ¦us¦ ¦your¦ ¦phone¦ ¦number¦ ,▁ ¦the¦ ¦contact¦ ¦tracking¦ ¦team¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦call¦ ¦you¦ .
𐋇¦they¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦arr ange¦ ¦a¦ ¦fre e¦ ¦covid¦ - ¦19¦ ¦test¦ ¦for¦ ¦you¦ .
𐋇¦if¦ ¦you¦ ¦dec ide¦ ¦not¦ ¦to¦ ¦give¦ ¦us¦ ¦your¦ ¦phone¦ ¦number¦ ¦on¦ ¦the¦ ¦app¦ ,▁ ¦call¦ ¦the¦ ¦covid¦ ¦h el p line¦ .
𐋇¦they¦ ¦will¦ ¦take¦ ¦your¦ ¦data¦ ¦so¦ ¦that¦ ¦someone¦ ¦can¦ ¦call¦ ¦you¦ ¦and¦ ¦arr ange¦ ¦a¦ ¦test¦ ¦for¦ ¦you¦ .
𐋇¦you¦ ¦may¦ ¦receive¦ ¦a¦ ¦call¦ ¦from¦ ¦the¦ ¦contact¦ ¦tracking¦ ¦team¦ ¦even¦ ¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦provide¦ ¦your¦ ¦phone¦ ¦number¦ .
𐋇¦s om et im es¦ ¦this¦ ¦happ ens¦ ¦if¦ ¦someone¦ ¦el se¦ ¦who¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ ¦g ives¦ ¦your¦ ¦staff¦ ¦phone¦ ¦number¦ ¦because¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦ .
𐋇¦how¦ ¦to¦ ¦v ie w¦ ¦the¦ ¦immediate¦ ¦contact¦ ¦alert¦
𐋇¦you¦ ¦will¦ ¦se e¦ ¦an¦ ¦inst ant¦ ¦contact¦ ¦alert¦ ¦in¦ ¦2¦ ¦places¦ ¦on¦ ¦your¦ ¦m ob i le¦ ¦phone¦ .
𐋇¦you¦ ¦will¦ ¦se e¦ ¦it¦ :
𐋇¦as¦ ¦a¦ ¦scre en¦ ¦n ot ific ation¦ ¦for¦ ¦a¦ ¦m ob i le¦ ¦phone¦
𐋇¦when¦ ¦you¦ ¦open¦ ¦the¦ ¦covid¦ ¦tracker¦ ¦app¦
𐋇¦n ot ice¦ ¦on¦ ¦the¦ ¦home¦ ¦scre en¦
𐋇¦this¦ ¦is¦ ¦how¦ ¦you¦ ¦will¦ ¦se e¦ ¦the¦ ¦alert¦ ¦n ot ific ation¦ ¦on¦ ¦the¦ ¦home¦ ¦scre en¦ ¦of¦ ¦your¦ ¦m ob i le¦ ¦phone¦ .
𐋇¦the¦ ¦me ss age¦ ¦in¦ ¦the¦ ¦n ot ific ation¦ ¦will¦ ¦be¦ : ▁' 𐋇 ¦close¦ ¦contact¦ ¦alert¦ :▁ 𐋇¦p le ase¦ ¦se e¦ ¦the¦ ¦covid¦ ¦tracker¦ ¦app¦ ¦n ow¦ ' .
𐋇 ¦ma y b e¦ ¦it¦ ¦will¦ ¦go¦ ¦away¦ ¦after¦ ¦a¦ ¦while¦ .
𐋇 ¦alert¦ ¦within¦ ¦the¦ ¦covid¦ ¦admin i str at or¦ ¦app¦
𐋇¦this¦ ¦is¦ ¦how¦ ¦you¦ ¦will¦ ¦se e¦ ¦the¦ ¦alert¦ ¦n ot ific ation¦ ¦when¦ ¦you¦ ¦open¦ ¦the¦ ¦covid¦ ¦tracker¦ ¦app¦ .
𐋇¦this¦ ¦alert¦ ¦will¦ ¦be¦ ¦in¦ ¦a¦ ¦r ed¦ ¦ bo x¦ : ▁' 𐋇 ¦close¦ ¦contact¦ ¦alert¦ :▁ 𐋇¦the¦ ¦app¦ ¦det ects¦ ¦that¦ ¦you¦ ¦were¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ ¦someone¦ ¦who¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ ' .
𐋇¦this¦ ¦alert¦ ¦will¦ ¦remain¦ ¦on¦ ¦your¦ ¦phone¦ ¦for¦ ¦14¦ ¦days¦ .
𐋇¦it¦ ¦will¦ ¦be¦ ¦on¦ ¦the¦ ¦scre en¦ ¦for¦ ¦this¦ ¦period¦ ¦w he ne ver¦ ¦you¦ ¦open¦ ¦the¦ ¦app¦ .
𐋇¦the¦ ¦alert¦ ¦can¦ ¦be¦ ¦c le ared¦ ¦in¦ ¦the¦ ¦app¦ ' ¦s¦ ¦contact¦ ¦tracking¦ ¦s et t ings¦ .
𐋇 ¦pote ntial¦ ¦disc l osure¦ ¦alert¦
𐋇¦you¦ ¦will¦ ¦only¦ ¦se e¦ ¦this¦ ¦alert¦ ¦if¦ ¦you¦ ¦are¦ ¦using¦ ¦an¦ ¦ ol der¦ ¦ ve rs ion¦ ¦of¦ ¦the¦ ¦m ob i le¦ ¦phone¦ ¦op er ating¦ ¦system¦ .
𐋇¦you¦ ¦should¦ ¦up d ate¦ ¦your¦ ¦so f t w are¦ ¦and¦ ¦get¦ ¦the¦ ¦l at est¦ ¦ ve rs ion¦ ¦of¦ ¦i o s¦ ¦or¦ ¦a nd ro id¦ ¦for¦ ¦fre e¦ .
𐋇¦a¦ ¦pote ntial¦ ¦exp osure¦ ¦alert¦ ¦is¦ ¦not¦ ¦the¦ ¦same¦ ¦as¦ ¦an¦ ¦immediate¦ ¦contact¦ ¦alert¦ .
𐋇¦you¦ ¦d on¦ ▁’▁ ¦t¦ ¦have¦ ¦to¦ ¦do¦ ¦an y thing¦ .
𐋇 ¦pote ntial¦ ¦exp osure¦ ¦me ans¦ ¦that¦ ¦you¦ ¦may¦ ¦have¦ ¦been¦ ¦close¦ ¦to¦ ¦someone¦ ¦who¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ ¦but¦ ¦were¦ ¦not¦ ¦close¦ ¦en ough¦ ¦for¦ ¦a¦ ¦long¦ ¦time¦ ¦to¦ ¦be¦ ¦a¦ ¦close¦ ¦contact¦ .
𐋇 ¦the re f ore¦ ¦there¦ ¦is¦ ¦l it t le¦ ¦risk¦ ¦of¦ ¦you¦ ¦getting¦ ¦the¦ ¦virus¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦it¦ ¦could¦ ¦be¦ ¦someone¦ ¦who¦ ¦p as sed¦ ¦by¦ ¦on¦ ¦the¦ ¦st re et¦ ¦or¦ ¦qu e u ed¦ ¦them¦ ¦for¦ ¦less¦ ¦than¦ ¦15¦ ¦min u tes¦ .
𐋇¦if¦ ¦you¦ ¦work¦ ¦in¦ ¦a¦ ¦healthcare¦ ¦s etting¦ ¦or¦ ¦school¦
𐋇¦there¦ ¦is¦ ¦l it t le¦ ¦risk¦ ¦of¦ ¦you¦ ¦getting¦ ¦the¦ ¦virus¦ ¦if¦ ¦the¦ ¦people¦ ¦around¦ ¦you¦ ¦are¦ ¦w earing¦ ¦personal¦ ¦prot ective¦ ¦equipment¦ ,▁ ¦such¦ ¦as¦ ¦in¦ ¦a¦ ¦hospital¦ ¦or¦ ¦school¦ .
𐋇¦however¦ ,▁ ¦you¦ ¦may¦ ¦receive¦ ¦an¦ ¦immediate¦ ¦contact¦ ¦alert¦ ¦an y w ay¦ .
𐋇 ¦healthcare¦ ¦workers¦
𐋇¦read¦ ¦advice¦ ¦for¦ ¦healthcare¦ ¦workers¦ ¦who¦ ¦use¦ ¦the¦ ¦app¦ ¦and¦ ¦wear¦ ¦personal¦ ¦prot ective¦ ¦equipment¦ .
𐋇 ¦schools¦
𐋇¦if¦ ¦a¦ ¦covid¦ - ¦19¦ ¦case¦ ¦has¦ ¦been¦ ¦confirmed¦ ¦in¦ ¦your¦ ¦school¦ ,▁ ¦you¦ ¦will¦ ¦be¦ ¦contac ted¦ ¦by¦ ¦your¦ ¦local¦ ¦public¦ ¦health¦ ¦team¦ .
𐋇¦they¦ ¦will¦ ¦t ell¦ ¦you¦ ¦if¦ ¦you¦ ¦need¦ ¦to¦ ¦do¦ ¦an y thing¦ .
𐋇¦if¦ ¦you¦ ¦receive¦ ¦an¦ ¦immediate¦ ¦contact¦ ¦alert¦ ¦and¦ ¦you¦ ¦receive¦ ¦a¦ ¦call¦ ¦from¦ ¦a¦ ¦contact¦ ¦tracker¦ ,▁ ¦t ell¦ ¦them¦ ¦where¦ ¦you¦ ¦work¦ .
𐋇¦if¦ ¦there¦ ¦has¦ ¦been¦ ¦a¦ ¦case¦ ¦rece ntly¦ ,▁ ¦t ell¦ ¦them¦ .
𐋇¦they¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦t ell¦ ¦you¦ ¦what¦ ¦you¦ ¦should¦ ¦do¦ .
𐋇 ¦wh y¦ ¦use¦ ¦the¦ ¦covid¦ ¦tracker¦ ¦app¦ ?
𐋇¦if¦ ¦you¦ ¦receive¦ ¦a¦ ¦call¦ ¦alert¦
𐋇 ¦using¦ ¦the¦ ¦covid¦ ¦tracking¦ ¦app¦ ¦if¦ ¦you¦ ¦get¦ ¦a¦ ¦positive¦ ¦result¦ ¦on¦ ¦your¦ ¦test¦
𐋇 ¦tracking¦ ¦your¦ ¦sign als¦
𐋇¦the¦ ¦techn ology¦ ¦used¦ ¦by¦ ¦the¦ ¦covid¦ ¦tracker¦ ¦app¦
𐋇 ¦priv acy¦ ¦and¦ ¦how¦ ¦we¦ ¦use¦ ¦your¦ ¦data¦
𐋇¦the¦ ¦covid¦ ¦tracking¦ ¦app¦ ¦is¦ ¦a¦ ¦fre e¦ ¦and¦ ¦e as y¦ - ¦to¦ - ¦use¦ ¦phone¦ ¦app l ic ation¦ ¦that¦ :
𐋇¦it¦ ¦al er ts¦ ¦you¦ ¦if¦ ¦you¦ ¦have¦ ¦been¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ ¦someone¦ ¦who¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ )
𐋇¦it¦ ¦will¦ ¦keep¦ ¦other¦ ¦app¦ ¦us ers¦ ¦safe¦ ¦as¦ ¦it¦ ¦al er ts¦ ¦them¦ ¦if¦ ¦you¦ ¦test¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦
𐋇¦h e¦ ¦will¦ ¦ad v ise¦ ¦you¦ ¦on¦ ¦what¦ ¦to¦ ¦do¦ ¦if¦ ¦you¦ ¦have¦ ¦symptoms¦
𐋇 ¦where¦ ¦the¦ ¦app¦ ¦is¦ ¦available¦
𐋇¦d ow n lo ad¦ ¦the¦ ¦fre e¦ ¦app¦ ¦from¦ ¦app le¦ ' ¦s¦ ¦app st ore¦ ¦or¦ ¦go og le pl ay¦ ¦st ore¦ .
𐋇¦you¦ ¦should¦ ¦be¦ ¦able¦ ¦to¦ ¦use¦ ¦the¦ ¦app¦ ¦if¦ ¦your¦ ¦phone¦ :
𐋇 ¦under¦ ¦5¦ ¦years¦ ¦o ld¦
𐋇 ¦using¦ ¦i o s¦ ¦13¦ . ¦5¦ ¦or¦ ¦higher¦ ¦if¦ ¦it¦ ' ¦s¦ ¦app le¦ ¦or¦ ¦from¦ ¦a nd ro id¦ ¦6¦ . ¦ 0¦ ¦up w ards¦ ¦in¦ ¦the¦ ¦case¦ ¦of¦ ¦go og le¦
𐋇¦you¦ ¦will¦ ¦need¦ ¦to¦ ¦decl are¦ ¦that¦ ¦you¦ ¦are¦ ¦16¦ ¦years¦ ¦of¦ ¦age¦ ¦or¦ ¦ ol der¦ .
𐋇¦this¦ ¦is¦ ¦the¦ ¦age¦ ¦of¦ ¦d ig it al¦ ¦cons ent¦ .
𐋇¦b lu et oo th¦ ¦must¦ ¦be¦ ¦t ur ned¦ ¦on¦ ¦for¦ ¦the¦ ¦app¦ ¦to¦ ¦work¦ .
𐋇¦w ar ning¦ ¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦
𐋇¦your¦ ¦phone¦ ¦will¦ ¦be¦ ¦al er ted¦ ¦if¦ ¦you¦ ¦have¦ ¦been¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ ¦another¦ ¦us er¦ ¦of¦ ¦the¦ ¦app¦ ¦who¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦ad vi sed¦ ¦to¦ :
𐋇 ¦restrict¦ ¦your¦ ¦movements¦ ¦if¦ ¦you¦ ¦have¦ ¦no¦ ¦symptoms¦ .
𐋇 ¦self¦ - ¦isolation¦ ¦if¦ ¦you¦ ¦have¦ ¦symptoms¦
𐋇 ¦get¦ ¦a¦ ¦covid¦ - ¦19¦ ¦test¦ .
𐋇¦read¦ ¦about¦ ¦an¦ ¦immediate¦ ¦contact¦ ¦alert¦ ¦and¦ ¦what¦ ¦you¦ ¦should¦ ¦do¦ ¦if¦ ¦you¦ ¦get¦ ¦one¦ .
𐋇 ¦protect¦ ¦others¦ ¦if¦ ¦you¦ ¦get¦ ¦a¦ ¦positive¦ ¦test¦ ¦result¦
𐋇¦if¦ ¦you¦ ¦test¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ ,▁ ¦you¦ ¦can¦ ¦use¦ ¦the¦ ¦app¦ ¦to¦ ¦alert¦ ¦others¦ ¦you¦ ¦have¦ ¦been¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ .
𐋇¦this¦ ¦is¦ ¦d one¦ ¦an on y mo us ly¦ .
𐋇 ¦no¦ ¦one¦ ¦will¦ ¦know¦ ¦that¦ ¦you¦ ¦tested¦ ¦your¦ ¦test¦ ¦p os it ively¦ .
𐋇¦but¦ ¦your¦ ¦contac ts¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦take¦ ¦a ction¦ ¦to¦ ¦prevent¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇 ¦tr ack¦ ¦your¦ ¦signs¦
𐋇¦you¦ ¦can¦ ¦ch eck¦ ¦into¦ ¦the¦ ¦covid¦ ¦app¦ ¦to¦ ¦tr ack¦ ¦your¦ ¦sign als¦ ¦and¦ ¦get¦ ¦advice¦ ¦on¦ ¦them¦ .
𐋇¦it¦ ' ¦s¦ ¦up¦ ¦to¦ ¦you¦ ¦if¦ ¦you¦ ¦w ant¦ ¦to¦ ¦tr ack¦ ¦your¦ ¦sign als¦ .
𐋇¦you¦ ¦do¦ ¦not¦ ¦need¦ ¦to¦ ¦tr ack¦ ¦your¦ ¦sign als¦ ¦for¦ ¦the¦ ¦other¦ ¦f u nc tions¦ ¦of¦ ¦the¦ ¦app¦ ¦to¦ ¦work¦ .
𐋇¦your¦ ¦priv acy¦ ¦is¦ ¦prot ected¦
𐋇¦the¦ ¦app¦ ¦is¦ ¦d es ig ned¦ ¦to¦ ¦protect¦ ¦your¦ ¦priv acy¦ ¦at¦ ¦all¦ ¦times¦ .
𐋇¦it¦ ' ¦s¦ ¦up¦ ¦to¦ ¦you¦
𐋇 ¦using¦ ¦or¦ ¦not¦ ¦using¦ ¦the¦ ¦app¦
𐋇 ¦dec ide¦ ¦wh ether¦ ¦or¦ ¦not¦ ¦you¦ ¦w ant¦ ¦to¦ ¦share¦ ¦the¦ ¦information¦ ¦you¦ ¦w ant¦ ¦to¦ ¦share¦
𐋇¦your¦ ¦na me¦ ¦and¦ ¦ad dr ess¦ ¦are¦ ¦ne ver¦ ¦as ked¦ .
𐋇¦the¦ ¦app¦ ¦does¦ ¦not¦ ¦tr ack¦ ¦where¦ ¦you¦ ¦are¦ .
𐋇¦you¦ ¦will¦ ¦remain¦ ¦an on y mo us¦ ▁-▁ ¦other¦ ¦us ers¦ ¦of¦ ¦the¦ ¦app¦ ¦will¦ ¦not¦ ¦know¦ ¦who¦ ¦you¦ ¦are¦ .
𐋇¦the¦ ¦l at est¦ ¦new s¦ ¦and¦ ¦information¦
𐋇¦you¦ ¦can¦ ¦use¦ ¦the¦ ¦app¦ ¦to¦ ¦get¦ ¦the¦ ¦l at est¦ ¦f ac ts¦ ¦and¦ ¦f ig ures¦ ¦about¦ ¦covid¦ - ¦19¦ ¦in¦ ¦ireland¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦f ind¦ ¦information¦ ¦that¦ ¦will¦ ¦help¦ ¦you¦ ¦take¦ ¦care¦ ¦of¦ ¦yourself¦ ¦if¦ ¦you¦ ¦are¦ ¦ ill¦ .
𐋇 ¦pri or itiz e¦ ¦public¦ ¦health¦ ¦advice¦
𐋇¦the¦ ¦covid¦ ¦tracking¦ ¦app¦ ¦is¦ ¦d es ig ned¦ ¦to¦ ¦make¦ ¦the¦ ¦b est¦ ¦use¦ ¦of¦ ¦the¦ ¦b est¦ ¦available¦ ¦health¦ ¦advice¦ ¦and¦ ¦techn ology¦ .
𐋇¦but¦ ¦it¦ ▁’▁ ¦s¦ ¦not¦ ¦per f ect¦ .
𐋇¦it¦ ¦is¦ ¦j ust¦ ¦one¦ ¦of¦ ¦our¦ ¦w ays¦ ¦to¦ ¦del ay¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦and¦ ¦current¦ ¦public¦ ¦health¦ ¦gu id el ines¦ ¦should¦ ¦not¦ ¦be¦ ¦i gn or ed¦ .
𐋇¦it¦ ¦is¦ ¦still¦ ¦important¦ ¦to¦ :
𐋇 ¦follow¦ ¦social¦ ¦separ ation¦ ¦advice¦ ▁-▁ ¦keep¦ ¦2¦ ¦meters¦ ▁( ¦6¦ . ¦5¦ ¦fe et¦ )▁ ¦away¦ ¦from¦ ¦others¦
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦often¦ ¦and¦ ¦a de qu a tely¦
𐋇 ¦cover¦ ¦your¦ ¦mouth¦ ¦with¦ ¦a¦ ¦hand k er ch ief¦ ¦or¦ ¦sl ee ve¦ ¦when¦ ¦you¦ ¦cough¦ ¦or¦ ¦s n ee z e¦
𐋇 ¦wear¦ ¦a¦ ¦face¦ ¦cover¦
𐋇 ¦get¦ ¦tested¦ ¦if¦ ¦you¦ ¦have¦ ¦symptoms¦ ¦or¦ ¦have¦ ¦been¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ ¦someone¦ ¦who¦ ¦has¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦un able¦ ¦to¦ ¦use¦ ¦the¦ ¦app¦
𐋇¦the¦ ¦app¦ ¦is¦ ¦j ust¦ ¦one¦ ¦as p ect¦ ¦of¦ ¦our¦ ¦contact¦ ¦tracking¦ ¦op er ation¦ .
𐋇¦the¦ ¦contact¦ ¦tracking¦ ¦centre¦ ¦is¦ ¦al w ays¦ ¦open¦ .
𐋇¦e veryone¦ ¦is¦ ¦inclu ded¦ ¦in¦ ¦that¦ ¦proc ess¦ ,▁ ¦wh ether¦ ¦you¦ ¦use¦ ¦the¦ ¦app¦ ¦or¦ ¦not¦ .
𐋇¦we¦ ¦h ope¦ ¦that¦ ¦more¦ ¦people¦ ¦will¦ ¦have¦ ¦acc ess¦ ¦to¦ ¦the¦ ¦up d ated¦ ¦ ver si ons¦ ¦of¦ ¦the¦ ¦app¦ ¦in¦ ¦the¦ ¦f ut ure¦ .
𐋇¦we¦ ¦continue¦ ¦to¦ ¦l ook¦ ¦at¦ ¦so lu tions¦ ¦to¦ ¦include¦ ¦e veryone¦ ¦over¦ ¦the¦ ¦age¦ ¦of¦ ¦16¦ .
𐋇 ¦keep¦ ¦your¦ ¦child¦ ¦at¦ ¦home¦
𐋇¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦had¦ ¦close¦ ¦contact¦ ¦with¦ ¦someone¦ ¦with¦ ¦covid¦ - ¦19¦ ,▁ ¦if¦ ¦your¦ ¦child¦ ¦l ives¦ ¦with¦ ¦someone¦ ¦with¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ¦or¦ ¦has¦ ¦been¦ ¦ab ro ad¦ ,▁ ¦do¦ ¦not¦ ¦all ow¦ ¦them¦ ¦to¦ ¦go¦ ¦to¦ ¦school¦ ¦or¦ ¦att end¦ ¦ch ild c are¦
𐋇¦they¦ ¦will¦ ¦have¦ ¦to¦ ¦restrict¦ ¦their¦ ¦movements¦ ¦for¦ ¦14¦ ¦days¦ ¦even¦ ¦if¦ ¦they¦ ¦have¦ ¦no¦ ¦signs¦ ¦of¦ ¦illness¦ .
𐋇¦they¦ ¦may¦ ¦sto p¦ ¦re stric ting¦ ¦their¦ ¦movements¦ ¦when¦ ¦both¦ ¦of¦ ¦the¦ ¦following¦ ¦conditions¦ ¦app ly¦ :
𐋇¦when¦ ¦they¦ ¦tested¦ ¦negative¦ ▁( ¦covid¦ - ¦19¦ ¦was¦ ¦not¦ ¦detected¦ )▁ ¦10¦ ¦days¦ ¦after¦ ¦contact¦ ¦with¦ ¦the¦ ¦person¦ ¦who¦ ¦tested¦ ¦positive¦ .
𐋇¦when¦ ¦they¦ ¦do¦ ¦not¦ ¦have¦ ¦covid¦ - ¦19¦ ¦symptoms¦ .
𐋇¦if¦ ¦your¦ ¦child¦ ¦is¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ ¦covid¦ - ¦19¦
𐋇¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ¦and¦ ¦is¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ ¦someone¦ ¦who¦ ¦has¦ ¦tested¦ ¦positive¦ ,▁ ¦h e¦ ▁/▁ ¦sh e¦ ¦should¦ :
𐋇¦stay¦ ¦away¦ ¦from¦ ¦others¦ ¦imm ed ia tely¦
𐋇 ¦call¦ ¦your¦ ¦gp¦
𐋇 ¦follow¦ ¦the¦ ¦advice¦ ¦for¦ ¦children¦ ¦with¦ ¦covid¦ - ¦19¦ ¦symptoms¦ .
𐋇¦if¦ ¦your¦ ¦child¦ ¦is¦ ¦a¦ ¦close¦ ¦contact¦ ¦but¦ ¦does¦ ¦not¦ ¦have¦ ¦covid¦ - ¦19¦ ¦symptoms¦ :
𐋇 ¦restrict¦ ¦your¦ ¦movements¦ ¦for¦ ¦14¦ ¦days¦ ▁-▁ ¦d on¦ ' ¦t¦ ¦go¦ ¦to¦ ¦school¦ ¦e it her¦
𐋇 ¦get¦ ¦a¦ ¦covid¦ - ¦19¦ ¦test¦ ▁-▁ ¦this¦ ¦will¦ ¦be¦ ¦arr an ged¦ ¦by¦ ¦a¦ ¦contact¦ ¦admin i str at or¦ ¦when¦ ¦h e¦ ▁/▁ ¦sh e¦ ¦ca lls¦ ¦you¦
𐋇¦the¦ ¦child¦ ¦can¦ ¦sto p¦ ¦re stric ting¦ ¦their¦ ¦movements¦ ¦if¦ :
𐋇¦if¦ ¦they¦ ¦test¦ ¦negative¦ ▁( ¦covid¦ - ¦19¦ ¦was¦ ¦not¦ ¦detected¦ )▁ ¦10¦ ¦days¦ ¦after¦ ¦contact¦ ¦with¦ ¦the¦ ¦person¦ ¦who¦ ¦tested¦ ¦positive¦
𐋇¦if¦ ¦they¦ ¦do¦ ¦not¦ ¦have¦ ¦covid¦ - ¦19¦ ¦symptoms¦
𐋇 ¦people¦ ¦li ving¦ ¦with¦ ¦the¦ ¦child¦ ,▁ ¦including¦ ¦si bl ings¦ ,▁ ¦do¦ ¦not¦ ¦need¦ ¦to¦ ¦restrict¦ ¦their¦ ¦movements¦ .
𐋇¦if¦ ¦your¦ ¦child¦ ¦l ives¦ ¦with¦ ¦someone¦ ¦suspected¦ ¦of¦ ¦having¦ ¦covid¦ - ¦19¦
𐋇¦your¦ ¦child¦ ¦will¦ ¦need¦ ¦to¦ ¦restrict¦ ¦their¦ ¦movements¦ .
𐋇¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦symptoms¦ ,▁ ¦keep¦ ¦them¦ ¦away¦ ¦from¦ ¦others¦ ¦and¦ ¦call¦ ¦your¦ ¦doctor¦ .
𐋇¦if¦ ¦your¦ ¦child¦ ¦was¦ ¦ab ro ad¦
𐋇¦your¦ ¦child¦ ¦will¦ ¦have¦ ¦to¦ ¦restrict¦ ¦their¦ ¦movements¦ ¦for¦ ¦14¦ ¦days¦ ¦if¦ ¦they¦ ¦have¦ ¦retur ned¦ ¦from¦ ¦a¦ ¦fo re ign¦ ¦country¦ .
𐋇¦h e¦ ¦will¦ ¦have¦ ¦to¦ ¦stay¦ ¦home¦ ¦and¦ ¦not¦ ¦att end¦ ¦school¦ ,▁ ¦even¦ ¦if¦ ¦h e¦ ¦does¦ ¦not¦ ¦feel¦ ¦ ill¦ .
𐋇¦they¦ ¦only¦ ¦need¦ ¦to¦ ¦go¦ ¦to¦ ¦the¦ ¦gp¦ ¦if¦ ¦they¦ ¦have¦ ¦symptoms¦ ¦of¦ ¦illness¦ .
𐋇¦a¦ ¦sw ab ¦ ¦is¦ ¦ta k en¦ ¦from¦ ¦your¦ ¦nose¦ ¦during¦ ¦the¦ ¦covid¦ - ¦19¦ ¦anti g en¦ ¦test¦ .▁ 𐋇¦the¦ ¦sampl e¦ ¦does¦ ¦not¦ ¦need¦ ¦to¦ ¦be¦ ¦ta k en¦ ¦to¦ ¦the¦ ¦laboratory¦ .
𐋇¦the¦ ¦test¦ ¦results¦ ¦are¦ ¦f as ter¦ ¦than¦ ¦the¦ ¦covid¦ - ¦19¦ ¦p c r¦ ¦test¦ ,▁ ¦but¦ ¦it¦ ¦is¦ ¦limi ted¦ .
𐋇 ¦anti g en¦ ¦testing¦ ¦is¦ ¦also¦ ¦known¦ ¦as¦ ¦rap id¦ ¦anti g en¦ ¦diagn o st ic¦ ¦testing¦ ▁( ¦ rad t¦ ).
𐋇 ¦where¦ ¦the¦ ¦covid¦ - ¦19¦ ¦anti g en¦ ¦tests¦ ¦are¦ ¦used¦
𐋇 ¦anti g en¦ ¦tests¦ ¦are¦ ¦provid ed¦ ¦for¦ :
𐋇¦some¦ ¦hospital¦ ¦patients¦ ¦with¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ,▁ ¦including¦ ¦those¦ ¦att ending¦ ¦the¦ ¦emergency¦ ¦department¦ ▁( ¦ ed¦ )
𐋇 ¦people¦ ¦in¦ ¦loc ations¦ ¦where¦ ¦there¦ ¦is¦ ¦an¦ ¦outbreak¦ ¦of¦ ¦covid¦ - ¦19¦
𐋇 ¦what¦ ¦happ ens¦ ¦during¦ ¦the¦ ¦test¦
𐋇¦the¦ ¦t es ter¦ ¦will¦ ¦give¦ ¦you¦ ¦a¦ ¦mask¦ ¦to¦ ¦exp la in¦ ¦what¦ ¦will¦ ¦happ en¦ ¦and¦ ¦as k¦ ¦you¦ ¦some¦ ¦qu es tions¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦as ked¦ ¦to¦ ¦clean¦ ¦your¦ ¦hands¦ ¦properly¦ ¦with¦ ¦a¦ ¦hand¦ ¦disinf ect ant¦ .
𐋇¦the¦ ¦t es ter¦ ¦will¦ ¦take¦ ¦some¦ ¦personal¦ ¦data¦ ¦from¦ ¦you¦ ,▁ ¦including¦ ¦your¦ ¦te le ph one¦ ¦number¦ .
𐋇 ¦make¦ ¦sure¦ ¦they¦ ¦have¦ ¦the¦ ¦cor r ect¦ ¦number¦ .
𐋇¦the¦ ¦t es ter¦ ¦will¦ ¦use¦ ¦a¦ ¦sw ab ¦ ¦to¦ ¦take¦ ¦a¦ ¦sampl e¦ ¦from¦ ¦your¦ ¦nose¦ .
𐋇¦this¦ ¦may¦ ¦be¦ ¦u nc om f ort able¦ ,▁ ¦but¦ ¦it¦ ¦will¦ ¦not¦ ¦be¦ ¦pa in ful¦ .
𐋇¦the¦ ¦t es ter¦ ¦will¦ ¦test¦ ¦the¦ ¦sampl e¦ ¦on¦ - ¦s ite¦ .
𐋇¦if¦ ¦you¦ ¦get¦ ¦a¦ ¦positive¦ ¦result¦ ¦on¦ ¦your¦ ¦anti g en¦ ¦test¦
𐋇 ¦within¦ ¦1¦ ¦hou r¦ ¦of¦ ¦your¦ ¦tr ial¦ ,▁ ¦you¦ ¦will¦ ¦be¦ ¦notified¦ ¦if¦ ¦a¦ ¦positive¦ ¦impac t¦ ▁( ¦covid¦ - ¦19¦ ¦is¦ ¦found¦ )▁ ¦on¦ ¦your¦ ¦test¦ .
𐋇¦this¦ ¦me ans¦ ¦that¦ ¦the¦ ¦virus¦ ¦was¦ ¦detected¦ ¦in¦ ¦your¦ ¦sampl e¦ .
𐋇¦you¦ ¦will¦ ¦have¦ ¦to¦ ¦stay¦ ¦on¦ ¦your¦ ¦ own¦ ¦because¦ ¦there¦ ¦is¦ ¦a¦ ¦re al¦ ¦risk¦ ¦that¦ ¦you¦ ¦will¦ ¦p ass¦ ¦on¦ ¦the¦ ¦virus¦ ¦to¦ ¦others¦ .
𐋇 ¦what¦ ¦you¦ ¦need¦ ¦to¦ ¦do¦ ¦if¦ ¦you¦ ¦have¦ ¦a¦ ¦positive¦ ¦covid¦ - ¦19¦ ¦test¦ ¦result¦
𐋇¦if¦ ¦you¦ ¦get¦ ¦a¦ ¦negative¦ ¦or¦ ¦inv al id¦ ¦result¦ ¦on¦ ¦your¦ ¦anti g en¦ ¦test¦
𐋇¦a¦ ¦negative¦ ¦result¦ ¦indic ates¦ ¦that¦ ¦the¦ ¦virus¦ ¦was¦ ¦not¦ ¦detected¦ ¦in¦ ¦your¦ ¦sampl e¦ .
𐋇¦s om et im es¦ ¦a¦ ¦positive¦ ¦or¦ ¦negative¦ ¦result¦ ¦is¦ ¦not¦ ¦detected¦ ¦on¦ ¦the¦ ¦anti g en¦ ¦test¦ .
𐋇¦this¦ ¦is¦ ¦called¦ ¦an¦ ▁' ¦inv al id¦ ¦result¦ ' .
𐋇¦if¦ ¦the¦ ¦first¦ ¦sampl e¦ ¦is¦ ¦negative¦ ¦or¦ ¦inv al id¦ ,▁ ¦we¦ ¦will¦ ¦s end¦ ¦the¦ ¦second¦ ¦sampl e¦ ¦to¦ ¦a¦ ¦laboratory¦ ¦for¦ ¦covid¦ - ¦19¦ ¦p c r¦ ¦testing¦ .
𐋇¦if¦ ¦the¦ ¦second¦ ¦test¦ ¦is¦ ¦positive¦
𐋇¦you¦ ¦will¦ ¦receive¦ ¦a¦ ¦te xt¦ ¦me ss age¦ ¦with¦ ¦the¦ ¦result¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦p c r¦ ¦test¦ .
𐋇¦if¦ ¦the¦ ¦result¦ ¦is¦ ¦positive¦ ,▁ ¦you¦ ¦will¦ ¦receive¦ ¦a¦ ¦phone¦ ¦call¦ ¦from¦ ¦a¦ ¦contact¦ ¦tracker¦ .
𐋇 ¦contact¦ ¦trac ing¦
𐋇¦how¦ ¦to¦ ¦self¦ - ¦isol ate¦ ▁( ¦stay¦ ¦in¦ ¦your¦ ¦ro om¦ )
𐋇¦there¦ ¦is¦ ¦a¦ ¦limi t¦ ¦to¦ ¦what¦ ¦the¦ ¦anti g en¦ ¦test¦ ¦for¦ ¦covid¦ - ¦19¦ ¦can¦ ¦do¦
𐋇 ¦no¦ ¦co mpl et e¦ ¦test¦ ¦is¦ ¦acc ur ate¦ .
𐋇¦there¦ ¦is¦ ¦a¦ ¦limi t¦ ¦to¦ ¦what¦ ¦any¦ ¦test¦ ¦can¦ ¦do¦ ,
𐋇 ¦anti g en¦ ¦testing¦ ¦is¦ ¦less¦ ¦acc ur ate¦ ¦than¦ ¦p c r¦ ¦testing¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇¦the¦ ¦test¦ ¦will¦ ¦det ect¦ ¦the¦ ¦virus¦ ¦in¦ ¦most¦ ¦people¦ ¦with¦ ¦symptoms¦ ¦of¦ ¦illness¦
𐋇¦but¦ ¦in¦ ¦some¦ ¦cases¦ ,▁ ¦the¦ ¦test¦ ¦will¦ ¦not¦ ¦det ect¦ ¦the¦ ¦virus¦ .
𐋇¦t ell¦ ¦the¦ ¦healthcare¦ ¦work er¦ ¦imm ed ia tely¦ ¦if¦ ¦you¦ ¦have¦ ¦covid¦ - ¦19¦ ¦symptoms¦ .
𐋇¦the¦ ¦hse¦ ¦only¦ ¦ac cep ts¦ ¦pol y mer ase¦ ¦cha in¦ ¦rea ction¦ ▁( ¦p c r¦ )▁ ¦tests¦ ¦to¦ ¦diagn ose¦ ¦covid¦ - ¦19¦ .
𐋇¦this¦ ¦is¦ ¦the¦ ¦most¦ ¦re li able¦ ¦way¦ ¦to¦ ¦test¦ .
𐋇 ¦priv ate¦ ¦comp an ies¦ ¦can¦ ¦off er¦ ¦other¦ ¦typ es¦ ¦of¦ ¦tests¦ .
𐋇¦we¦ ¦do¦ ¦not¦ ¦recomm end¦ ¦any¦ ¦partic ular¦ ¦test¦ ¦provid er¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ,▁ ¦you¦ ¦should¦ ¦isol ate¦ ¦yourself¦ ¦imm ed ia tely¦ .
𐋇 ¦call¦ ¦your¦ ¦doctor¦ ,▁ ¦and¦ ¦they¦ ¦will¦ ¦arr ange¦ ¦a¦ ¦fre e¦ ¦hse¦ ¦test¦ ¦for¦ ¦you¦ .
𐋇¦read¦ ¦about¦ ¦how¦ ¦to¦ ¦test¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇¦read¦ ¦about¦ ¦what¦ ¦to¦ ¦do¦ ¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦
𐋇 ¦pol y mer ase¦ ¦cha in¦ ¦rea ction¦ ¦test¦
𐋇¦this¦ ¦is¦ ¦the¦ ¦most¦ ¦re li able¦ ¦covid¦ - ¦19¦ ¦test¦ ¦available¦ ¦because¦ ¦it¦ ¦l oo ks¦ ¦at¦ ¦the¦ ¦gen et ic¦ ¦m at er ial¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦the¦ ¦test¦ ¦is¦ ¦d one¦ ¦in¦ ¦a¦ ¦laboratory¦ ¦and¦ ¦can¦ ¦be¦ ¦rel ied¦ ¦up on¦ ¦if¦ ¦you¦ ¦need¦ ¦to¦ ¦know¦ ¦if¦ ¦you¦ ¦have¦ ¦covid¦ - ¦19¦ .
𐋇¦if¦ ¦you¦ ¦receive¦ ¦an¦ ¦ is p¦ ¦test¦ ¦from¦ ¦a¦ ¦priv ate¦ ¦comp an y¦ ¦and¦ ¦test¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ ,▁ ¦the¦ ¦laboratory¦ ¦must¦ ¦report¦ ¦this¦ ¦to¦ ¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ .
𐋇¦this¦ ¦information¦ ¦is¦ ¦required¦ ¦so¦ ¦that¦ ¦the¦ ¦contact¦ ¦tracking¦ ¦team¦ ¦can¦ ¦acc ess¦ ¦your¦ ¦immediate¦ ¦contac ts¦ .
𐋇¦read¦ ¦more¦ ¦about¦ ¦contact¦ ¦tracking¦ .
𐋇 ¦anti g en¦ ¦testing¦
𐋇 ¦anti g en¦ ¦testing¦ ¦is¦ ¦f as ter¦ ¦than¦ ¦ is p¦ ¦testing¦ ¦but¦ ¦not¦ ¦as¦ ¦re li able¦ .
𐋇¦this¦ ¦typ e¦ ¦of¦ ¦test¦ ¦does¦ ¦not¦ ¦requir e¦ ¦a¦ ¦laboratory¦ .
𐋇¦the¦ ¦hse¦ ¦does¦ ¦not¦ ¦cur re ntly¦ ¦ac cep t¦ ¦anti g en¦ ¦testing¦ .
𐋇¦if¦ ¦your¦ ¦anti g en¦ ¦test¦ ¦is¦ ¦positive¦
𐋇¦if¦ ¦you¦ ¦receive¦ ¦an¦ ¦anti g en¦ ¦test¦ ¦from¦ ¦a¦ ¦priv ate¦ ¦comp an y¦ ¦and¦ ¦test¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ ,▁ ¦the¦ ¦laboratory¦ ¦will¦ ¦not¦ ¦report¦ ¦this¦ ¦to¦ ¦the¦ ¦hse¦ .
𐋇¦this¦ ¦me ans¦ ¦that¦ ¦your¦ ¦immediate¦ ¦contac ts¦ ¦will¦ ¦not¦ ¦be¦ ¦notified¦ ¦and¦ ¦may¦ ¦spread¦ ¦covid¦ - ¦19¦ ¦to¦ ¦others¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦tested¦ ¦positive¦ ,▁ ¦you¦ ¦should¦ ¦self¦ - ¦isol ate¦ ¦and¦ ¦call¦ ¦your¦ ¦gp¦ .
𐋇¦h e¦ ▁/▁ ¦sh e¦ ¦will¦ ¦arr ange¦ ¦for¦ ¦you¦ ¦a¦ ¦fre e¦ ¦ is p¦ ¦test¦ .
𐋇¦f ind¦ ¦a¦ ¦doctor¦ ¦in¦ ¦your¦ ¦a rea¦ .
𐋇¦you¦ ¦will¦ ¦need¦ ¦to¦ ¦sh ow¦ ¦pr oo f¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦test¦ ¦result¦ ¦to¦ ¦the¦ ¦doctor¦ .
𐋇¦you¦ ¦will¦ ¦need¦ ¦one¦ ¦of¦ ¦the¦ ¦following¦ :
𐋇 ¦te xt¦ ¦me ss age¦
𐋇¦e ma il¦
𐋇 ¦pr in ted¦ ¦report¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦but¦ ¦your¦ ¦test¦ ¦for¦ ¦covid¦ - ¦19¦ ¦was¦ ¦negative¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ,▁ ¦you¦ ¦should¦ ¦self¦ - ¦isol ate¦ ¦even¦ ¦if¦ ¦your¦ ¦anti g en¦ ¦test¦ ¦result¦ ¦is¦ ¦negative¦ .
𐋇 ¦call¦ ¦your¦ ¦doctor¦ ,▁ ¦and¦ ¦they¦ ¦will¦ ¦arr ange¦ ¦a¦ ¦fre e¦ ¦ is p¦ ¦test¦ ¦for¦ ¦you¦ .
𐋇 ¦ma s¦ ¦g ar th ea g m h á l aí¦ ¦anim al¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦ ,▁ ¦you¦ ¦should¦ ¦continue¦ ¦to¦ ¦restrict¦ ¦your¦ ¦movements¦ ¦even¦ ¦if¦ ¦your¦ ¦test¦ ¦was¦ ¦negative¦ .
𐋇 ¦continue¦ ¦to¦ ¦restrict¦ ¦your¦ ¦movements¦ ¦for¦ ¦14¦ ¦days¦ ¦from¦ ¦the¦ ¦last¦ ¦time¦ ¦you¦ ¦were¦ ¦in¦ ¦contact¦ ¦with¦ ¦the¦ ¦person¦ ¦who¦ ¦tested¦ ¦positive¦ ¦for¦ ¦the¦ ¦covid¦ - ¦19¦ ¦test¦ .
𐋇 ¦antibo dy¦ ¦tests¦
𐋇 ¦antibo dy¦ ¦tests¦ ¦ch eck¦ ¦for¦ ¦antibo dies¦ ¦if¦ ¦a¦ ¦person¦ ¦has¦ ¦had¦ ¦the¦ ¦virus¦ ¦in¦ ¦the¦ ¦p ast¦ .
𐋇¦a¦ ¦blood¦ ¦sampl e¦ ¦is¦ ¦required¦ ¦to¦ ¦per for m¦ ¦this¦ ¦test¦ .
𐋇¦the¦ ¦hse¦ ¦does¦ ¦not¦ ¦cur re ntly¦ ¦off er¦ ¦these¦ ¦tests¦ .
𐋇¦if¦ ¦you¦ ¦ca me¦ ¦to¦ ¦ireland¦ ¦from¦ ¦b ra z il¦ ¦or¦ ¦south¦ ¦afr ica¦ :
𐋇¦you¦ ¦should¦ ¦isol ate¦ ¦yourself¦ ▁( ¦stay¦ ¦in¦ ¦your¦ ¦ro om¦ )▁ ¦for¦ ¦14¦ ¦days¦ ¦from¦ ¦the¦ ¦date¦ ¦you¦ ¦arr iv ed¦ ¦in¦ ¦ireland¦
𐋇 ¦call¦ ¦your¦ ¦gp¦ ¦to¦ ¦arr ange¦ ¦a¦ ¦covid¦ - ¦19¦ ¦test¦ ▁-▁ ¦the¦ ¦test¦ ¦should¦ ¦be¦ ¦d one¦ ¦five¦ ¦days¦ ¦after¦ ¦you¦ ¦arr ive¦ ¦in¦ ¦ireland¦ ¦or¦ ¦as¦ ¦so on¦ ¦as¦ ¦you¦ ¦can¦ ¦after¦ ¦that¦ ¦five¦ ¦days¦ .
𐋇¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦have¦ ¦a¦ ¦gp¦ ,▁ ¦any¦ ¦doctor¦ ,▁ ¦or¦ ¦an¦ ¦out¦ - ¦of¦ - ¦hours¦ ¦doctor¦ ¦service¦ ,▁ ¦we¦ ¦can¦ ¦arr ange¦ ¦a¦ ¦fre e¦ ¦covid¦ - ¦19¦ ¦test¦ ¦for¦ ¦you¦ .
𐋇¦this¦ ¦advice¦ ¦is¦ ¦being¦ ¦giv en¦ ¦because¦ ¦there¦ ¦are¦ ¦new¦ ¦stra ins¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦these¦ ¦countries¦ .
𐋇¦these¦ ¦new¦ ¦stra ins¦ ¦of¦ ¦covid¦ - ¦19¦ ¦are¦ ¦sprea ding¦ ¦f as ter¦ ¦than¦ ¦the¦ ¦other¦ ¦stra ins¦ ¦and¦ ¦are¦ ¦the re f ore¦ ¦more¦ ¦d an ge ro us¦ .
𐋇 ¦positive¦ ¦test¦ ¦result¦
𐋇¦the¦ ¦following¦ ¦information¦ ¦is¦ ¦for¦ ¦people¦ ¦who¦ ¦have¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ :
𐋇 ¦people¦ ¦who¦ ¦rece ntly¦ ¦arr iv ed¦ ¦from¦ ¦south¦ ¦afr ica¦ ¦and¦ ¦b ra z il¦ ¦or¦
𐋇 ¦people¦ ¦li ving¦ ¦or¦ ¦wor king¦ ¦with¦ ¦a¦ ¦person¦ ¦who¦ ¦has¦ ¦come¦ ¦from¦ ¦south¦ ¦afr ica¦ ¦or¦ ¦b ra z il¦ ¦in¦ ¦the¦ ¦last¦ ¦14¦ ¦days¦
𐋇 ¦what¦ ¦you¦ ¦should¦ ¦do¦
𐋇¦stay¦ ¦al one¦ ▁( ¦stay¦ ¦in¦ ¦your¦ ¦ro om¦ )▁ ¦for¦ ¦14¦ ¦days¦ .
𐋇 ¦what¦ ¦your¦ ¦close¦ ¦contac ts¦ ¦should¦ ¦do¦
𐋇 ¦all¦ ¦your¦ ¦contac ts¦ ¦will¦ ¦need¦ ¦to¦ ¦be¦ ¦tested¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇¦they¦ ¦will¦ ¦have¦ ¦to¦ ¦wai t¦ ¦on¦ ¦their¦ ¦ own¦ ¦for¦ ¦14¦ ¦days¦ .
𐋇¦t ell¦ ¦your¦ ¦close¦ ¦contac ts¦ ¦to¦ ¦call¦ ¦their¦ ¦doctor¦ ¦and¦ ¦exp la in¦ ¦that¦ ¦they¦ ¦are¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ ¦someone¦ ¦who¦ ¦has¦ ¦tra ve lled¦ ¦from¦ ¦b ra z il¦ ¦or¦ ¦south¦ ¦afr ica¦ .
𐋇¦the¦ ¦doctor¦ ¦will¦ ¦pri or itiz e¦ ¦them¦ ¦for¦ ¦a¦ ¦covid¦ - ¦19¦ ¦test¦ .
𐋇¦when¦ ¦a¦ ¦face¦ ¦cover¦ ¦should¦ ¦be¦ ¦wor n¦
𐋇¦if¦ ¦they¦ ¦develop ¦ ¦symptoms¦ ,▁ ¦they¦ ¦will¦ ¦have¦ ¦to¦ ¦stay¦ ¦al one¦ ▁( ¦stay¦ ¦in¦ ¦their¦ ¦r oo ms¦ )▁ ¦and¦ ¦call¦ ¦their¦ ¦g ps¦ ¦imm ed ia tely¦ .
𐋇 ¦close¦ ¦contac ts¦ ¦of¦ ¦close¦ ¦contac ts¦
𐋇¦if¦ ¦you¦ ¦live¦ ¦with¦ ¦someone¦ ¦who¦ ¦has¦ ¦had¦ ¦close¦ ¦contact¦ ¦with¦ ¦someone¦ ¦who¦ ¦has¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ ¦and¦ ¦rece ntly¦ ¦ca me¦ ¦from¦ ¦south¦ ¦afr ica¦ ¦or¦ ¦b ra z il¦ :
𐋇¦p le ase¦ ¦restrict¦ ¦your¦ ¦ gh la u is ea ch t aí¦ ▁( ¦stay¦ ¦at¦ ¦home¦ )▁ ¦for¦ ¦14¦ ¦days¦
𐋇¦you¦ ¦do¦ ¦not¦ ¦need¦ ¦to¦ ¦take¦ ¦the¦ ¦covid¦ - ¦19¦ ¦test¦
𐋇¦if¦ ¦they¦ ¦develop ¦ ¦symptoms¦ ,▁ ¦they¦ ¦will¦ ¦have¦ ¦to¦ ¦stay¦ ¦al one¦ ▁( ¦stay¦ ¦in¦ ¦their¦ ¦r oo ms¦ )▁ ¦and¦ ¦call¦ ¦their¦ ¦g ps¦ ¦imm ed ia tely¦
𐋇 ¦negative¦ ¦test¦ ¦result¦
𐋇¦if¦ ¦your¦ ¦test¦ ¦is¦ ¦negative¦ ▁( ¦covid¦ - ¦19¦ ¦not¦ ¦detected¦ ),▁ ¦there¦ ¦will¦ ¦be¦ ¦no¦ ¦need¦ ¦to¦ ¦test¦ ¦your¦ ¦immediate¦ ¦contac ts¦ .
𐋇¦you¦ ¦need¦ ¦to¦ ¦do¦ ¦a¦ ¦f ul l¦ ¦14¦ ¦days¦ ¦of¦ ¦self¦ - ¦isolation¦ ,▁ ¦even¦ ¦if¦ ¦your¦ ¦test¦ ¦result¦ ¦is¦ ¦negative¦ .
𐋇 ¦people¦ ¦li ving¦ ¦with¦ ¦you¦ ¦will¦ ¦have¦ ¦to¦ ¦restrict¦ ¦their¦ ¦movements¦ ▁( ¦stay¦ ¦at¦ ¦home¦ )▁ ¦for¦ ¦four¦ ¦days¦ .
𐋇¦they¦ ¦should¦ ¦do¦ ¦this¦ ¦from¦ ¦the¦ ¦date¦ ¦they¦ ¦last¦ ¦contac ted¦ ¦you¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦received¦ ¦a¦ ¦priv ate¦ ¦test¦ ¦for¦ ¦covid¦ - ¦19¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦al rea dy¦ ¦had¦ ¦a¦ ¦priv ate¦ ¦test¦ ¦for¦ ¦covid¦ - ¦19¦ ,▁ ¦you¦ ¦will¦ ¦have¦ ¦to¦ ¦wai t¦ ¦on¦ ¦your¦ ¦ own¦ ¦for¦ ¦14¦ ¦days¦ ¦reg ar d less¦ ¦of¦ ¦the¦ ¦result¦ .
𐋇¦you¦ ¦should¦ ¦arr ange¦ ¦another¦ ¦test¦ ¦for¦ ¦covid¦ - ¦19¦ ¦through¦ ¦the¦ ¦out¦ - ¦of¦ - ¦hours¦ ¦doctor¦ ¦service¦ ¦or¦ ¦your¦ ¦gp¦ .
𐋇¦if¦ ¦you¦ ¦develop ¦ ¦symptoms¦ ¦of¦ ¦covid¦ - ¦19¦
𐋇 ¦call¦ ¦your¦ ¦doctor¦ ¦to¦ ¦b ook¦ ¦a¦ ¦test¦ ¦for¦ ¦covid¦ - ¦19¦ ¦and¦ ¦t ell¦ ¦them¦ ¦that¦ ¦you¦ ¦have¦ ¦rece ntly¦ ¦been¦ ¦to¦ ¦b ra z il¦ ¦or¦ ¦south¦ ¦afr ica¦ ¦and¦ ¦are¦ ¦sh owing¦ ¦signs¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇¦do¦ ¦this¦ ¦even¦ ¦if¦ ¦your¦ ¦test¦ ¦was¦ ¦negative¦ ▁( ¦covid¦ - ¦19¦ ¦not¦ ¦detected¦ ).
𐋇¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦have¦ ¦a¦ ¦doctor¦ ,▁ ¦you¦ ¦can¦ ¦call¦ ¦any¦ ¦doctor¦ ¦or¦ ¦the¦ ¦out¦ - ¦of¦ - ¦hours¦ ¦doctor¦ ¦service¦ .
𐋇¦you¦ ¦can¦ ¦also¦ ¦s ee k¦ ¦advice¦ ¦through¦ ¦the¦ ¦ ff s¦ ¦h el p line¦ .
𐋇¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦have¦ ¦a¦ ¦p ps¦ ¦number¦
𐋇¦when¦ ¦you¦ ¦call¦ ¦a¦ ¦gp¦ ¦to¦ ¦arr ange¦ ¦a¦ ¦test¦ ,▁ ¦the¦ ¦doctor¦ ¦will¦ ¦as k¦ ¦you¦ ¦for¦ ¦your¦ ¦p ps¦ ¦number¦ .
𐋇¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦have¦ ¦a¦ ¦p ps¦ ¦number¦ ,▁ ¦you¦ ¦can¦ ¦give¦ ¦the¦ ¦number¦ ¦from¦ ¦any¦ ¦of¦ ¦the¦ ¦following¦ :
𐋇 ¦european¦ ¦health¦ ¦i ns ur ance¦ ¦c ard¦ ▁( ¦e h ic¦ )
𐋇¦d ri ving¦ ¦l ic en se¦
𐋇 ¦not¦
𐋇 ¦national¦ ¦i ns ur ance¦
𐋇 ¦national¦ ¦health¦ ¦service¦
𐋇 ¦medical¦ ¦c ard¦
𐋇 ¦gp¦ ¦visit¦ ¦c ard¦
𐋇 ¦vaccines¦ ¦under g o¦ ¦safety¦ ¦and¦ ¦eff ic acy¦ ¦tests¦ ¦before¦ ¦use¦ .
𐋇¦the¦ ¦hse¦ ¦only¦ ¦u ses¦ ¦a¦ ¦vaccine¦ ¦if¦ ¦it¦ ¦me ets¦ ¦the¦ ¦appr op ri ate¦ ¦safety¦ ¦and¦ ¦eff ic acy¦ ¦sta nd ards¦ .
𐋇 ¦development¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦vaccines¦
𐋇¦this¦ ¦vaccine¦ ¦was¦ ¦developed¦ ¦in¦ ¦a¦ ¦sh or ter¦ ¦time¦ ¦fra me¦ ¦than¦ ¦us ual¦ .
𐋇¦they¦ ¦w ent¦ ¦through¦ ¦all¦ ¦sta ges¦ ¦of¦ ¦development¦ ¦at¦ ¦the¦ ¦same¦ ¦time¦ ¦and¦ ¦not¦ ¦in¦ ¦s uc ce ssion¦ ¦in¦ ¦order¦ ¦to¦ ¦be¦ ¦available¦ ¦as¦ ¦so on¦ ¦as¦ ¦possible¦ .
𐋇¦how¦ ¦the¦ ¦vaccines¦ ¦were¦ ¦made¦ ¦so¦ ¦f ast¦ .
𐋇 ¦work¦ ¦on¦ ¦the¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦was¦ ¦c arr ied¦ ¦out¦ ¦more¦ ¦qu ick ly¦ ¦than¦ ¦us ual¦ ¦to¦ ¦make¦ ¦them¦ ¦available¦ ¦as¦ ¦so on¦ ¦as¦ ¦possible¦ .
𐋇¦the¦ ¦us ual¦ ¦ste ps¦ ¦required¦ ¦to¦ ¦provide¦ ¦a¦ ¦safe¦ ¦and¦ ¦effective¦ ¦vaccine¦ ¦were¦ ¦fo ll owed¦ .
𐋇 ¦no¦ ¦sh ort c ut¦ ¦was¦ ¦ta k en¦ .
𐋇¦the¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦are¦ ¦appr oved¦
𐋇¦there¦ ¦are¦ ¦two¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦appr oved¦ ¦in¦ ¦the¦ ¦state¦ :
𐋇 ¦astrazeneca¦ ¦vaccine¦
𐋇¦p f iz er¦ ▁/▁ ¦bi on te ch¦ ¦vaccine¦
𐋇 ¦mod er na¦ ¦vaccine¦
𐋇 ¦all¦ ¦clinical¦ ¦trials¦ ¦and¦ ¦safety¦ ¦chec ks¦ ¦have¦ ¦been¦ ¦c arr ied¦ ¦out¦ ¦in¦ ¦acc or d ance¦ ¦with¦ ¦international¦ ¦safety¦ ¦sta nd ards¦ .
𐋇¦the¦ ¦following¦ ¦was¦ ¦d one¦ :
𐋇¦they¦ ¦have¦ ¦been¦ ¦tested¦ ¦on¦ ¦t ho us an ds¦ ¦of¦ ¦people¦ ¦during¦ ¦clinical¦ ¦trials¦
𐋇¦they¦ ¦m et¦ ¦ stric t¦ ¦sta nd ards¦ ¦of¦ ¦safety¦ ,▁ ¦qu ality¦ ¦and¦ ¦eff ic ie ncy¦
𐋇¦they¦ ¦have¦ ¦been¦ ¦appr oved¦ ¦and¦ ¦l ic en sed¦ ¦by¦ ¦the¦ ¦european¦ ¦medic ines¦ ¦a ge ncy¦ ▁( ¦e m a¦ )
𐋇¦covid¦ - ¦19¦ ¦astrazeneca¦ ¦vaccine¦
𐋇 ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦is¦ ¦the¦ ¦thir d¦ ¦vaccine¦ ¦appr oved¦ ¦by¦ ¦the¦ ¦e m a¦ ¦in¦ ¦this¦ ¦state¦ .
𐋇¦it¦ ¦is¦ ¦a¦ ¦viral¦ ¦v ector¦ ¦vaccine¦ .
𐋇¦the¦ ¦viral¦ ¦v ector¦ ¦vaccine¦ ¦conta ins¦ ¦an¦ ¦imp a ir ed¦ ¦ ve rs ion¦ ¦of¦ ¦a¦ ¦different¦ ¦virus¦ ▁( ¦the¦ ¦v ector¦ ).
𐋇¦this¦ ¦m r na¦ ¦vaccine¦ ¦en ab les¦ ¦your¦ ¦body¦ ¦to¦ ¦make¦ ¦protein¦ ¦that¦ ¦st im ul ates¦ ¦an¦ ¦immune¦ ¦response¦ .
𐋇¦your¦ ¦body¦ ¦will¦ ¦then¦ ¦make¦ ¦antibo dies¦ ¦to¦ ¦help¦ ¦you¦ ¦f ight¦ ¦an¦ ¦infection¦ ¦if¦ ¦the¦ ¦virus¦ ¦ent ers¦ ¦your¦ ¦body¦ ¦in¦ ¦the¦ ¦f ut ure¦ .
¦6 0¦ %▁ ¦of¦ ¦those¦ ¦who¦ ¦received¦ ¦the¦ ¦astrazeneca¦ ¦vaccine¦ ¦during¦ ¦trials¦ ¦were¦ ¦prot ected¦ ¦against¦ ¦covid¦ - ¦19¦ .
𐋇¦the¦ ¦vaccine¦ ¦has¦ ¦been¦ ¦tested¦ ¦in¦ ¦people¦ ¦18¦ ¦years¦ ¦of¦ ¦age¦ ¦and¦ ¦ ol der¦ .
𐋇 ¦i ng re di ent¦ ¦of¦ ¦the¦ ¦vaccine¦ ¦astrazeneca¦ ¦covid¦ - ¦19¦
𐋇¦the¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦from¦ ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦conta ins¦ ¦no¦ ¦e gg s¦ ,▁ ¦n ut ri ents¦ ¦or¦ ¦la te x¦ .
𐋇¦the¦ ¦co mpl et e¦ ¦l ist¦ ¦of¦ ¦i ng re di ents¦ ¦is¦ ¦available¦ ¦in¦ ¦the¦ ¦astrazeneca¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦fa ct s he et¦ .
𐋇¦covid¦ - ¦19¦ ¦mod er na¦ ¦vaccine¦
𐋇¦the¦ ¦covid¦ - ¦19¦ ¦mod er na¦ ¦vaccine¦ ¦is¦ ¦the¦ ¦second¦ ¦vaccine¦ ¦appr oved¦ ¦by¦ ¦the¦ ¦e m a¦ ¦in¦ ¦this¦ ¦state¦ .
𐋇¦it¦ ¦is¦ ¦an¦ ¦m r na¦ ¦vaccine¦ .
𐋇¦this¦ ¦m r na¦ ¦vaccine¦ ¦en ab les¦ ¦your¦ ¦body¦ ¦to¦ ¦make¦ ¦a¦ ¦protein¦ ¦that¦ ¦st im ul ates¦ ¦an¦ ¦immune¦ ¦response¦ ¦but¦ ¦does¦ ¦not¦ ¦use¦ ¦the¦ ¦live¦ ¦virus¦ ¦that¦ ¦ca u ses¦ ¦covid¦ - ¦19¦ .
𐋇¦your¦ ¦body¦ ¦will¦ ¦then¦ ¦make¦ ¦antibo dies¦ ¦to¦ ¦help¦ ¦you¦ ¦f ight¦ ¦an¦ ¦infection¦ ¦if¦ ¦the¦ ¦virus¦ ¦ent ers¦ ¦your¦ ¦body¦ ¦in¦ ¦the¦ ¦f ut ure¦ .
¦9 4¦ . ¦5¦ %▁ ¦of¦ ¦those¦ ¦who¦ ¦received¦ ¦the¦ ¦mod er na¦ ¦vaccine¦ ¦during¦ ¦trials¦ ¦were¦ ¦prot ected¦ ¦against¦ ¦covid¦ - ¦19¦ .
¦9 4¦ . ¦5¦ %▁ ¦eff ic acy¦ ¦rate¦
𐋇¦the¦ ¦vaccine¦ ¦has¦ ¦been¦ ¦tested¦ ¦in¦ ¦people¦ ¦18¦ ¦years¦ ¦of¦ ¦age¦ ¦and¦ ¦ ol der¦ .
𐋇 ¦i ng re di ent¦ ¦of¦ ¦the¦ ¦mod er na¦ ¦vaccine¦
𐋇¦the¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦from¦ ¦mod er na¦ ¦conta ins¦ ¦no¦ ¦e gg s¦ ,▁ ¦n ut ri ents¦ ¦or¦ ¦la te x¦ .
𐋇¦the¦ ¦f ul l¦ ¦l ist¦ ¦of¦ ¦i ng re di ents¦ ¦is¦ ¦available¦ ¦in¦ ¦the¦ ¦covid¦ - ¦19¦ ¦mod er na¦ ¦vaccine¦ ¦information¦ ¦lea f l et¦ .
𐋇¦covid¦ - ¦19¦ ¦p f iz er¦ ▁/▁ ¦bi on te ch¦ ¦vaccine¦
𐋇¦the¦ ¦covid¦ - ¦19¦ ¦p f iz er¦ ▁/▁ ¦bi on te ch¦ ¦vaccine¦ ¦was¦ ¦the¦ ¦first¦ ¦vaccine¦ ¦appr oved¦ ¦by¦ ¦the¦ ¦e m a¦ ¦for¦ ¦use¦ ¦in¦ ¦the¦ ¦state¦ .
𐋇¦it¦ ¦is¦ ▁" ¦c om ir n at y¦ " .
𐋇 ¦its¦ ¦offic ial¦ ¦na me¦ .
𐋇¦it¦ ¦is¦ ¦an¦ ¦m r na¦ ¦vaccine¦ .
𐋇¦this¦ ¦m r na¦ ¦vaccine¦ ¦en ab les¦ ¦your¦ ¦body¦ ¦to¦ ¦make¦ ¦a¦ ¦protein¦ ¦that¦ ¦st im ul ates¦ ¦an¦ ¦immune¦ ¦response¦ ¦but¦ ¦does¦ ¦not¦ ¦use¦ ¦the¦ ¦live¦ ¦virus¦ ¦that¦ ¦ca u ses¦ ¦covid¦ - ¦19¦ .
𐋇¦your¦ ¦body¦ ¦will¦ ¦then¦ ¦make¦ ¦antibo dies¦ ¦to¦ ¦help¦ ¦you¦ ¦f ight¦ ¦an¦ ¦infection¦ ¦if¦ ¦the¦ ¦virus¦ ¦ent ers¦ ¦your¦ ¦body¦ ¦in¦ ¦the¦ ¦f ut ure¦ .
𐋇¦m il li ons¦ ¦of¦ ¦people¦ ¦have¦ ¦received¦ ¦the¦ ¦co f id¦ - ¦19¦ ¦p f iz er¦ ▁/▁ ¦bi on te ch¦ ¦vaccine¦ ¦in¦ ¦b ri tain¦ ¦and¦ ¦the¦ ¦us¦ .
¦9 5¦ %▁ ¦of¦ ¦those¦ ¦who¦ ¦received¦ ¦the¦ ¦p f iz er¦ ▁/▁ ¦bi on te ch¦ ¦vaccine¦ ¦during¦ ¦trials¦ ¦were¦ ¦prot ected¦ ¦against¦ ¦covid¦ - ¦19¦ .
¦9 5¦ %▁ ¦eff ic acy¦ ¦rate¦
𐋇¦the¦ ¦vaccine¦ ¦has¦ ¦been¦ ¦tested¦ ¦in¦ ¦people¦ ¦a ged¦ ¦16¦ ¦and¦ ¦over¦ .
𐋇 ¦i ng re di ent¦ ¦of¦ ¦the¦ ¦covid¦ - ¦19¦ ¦p f iz er¦ ▁/▁ ¦bi on te ch¦ ¦vaccine¦
𐋇¦the¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦from¦ ¦p f iz er¦ ▁/▁ ¦bi on te ch¦ ¦conta ins¦ ¦no¦ ¦e gg s¦ ,▁ ¦n ut ri ents¦ ¦or¦ ¦la te x¦
𐋇¦the¦ ¦co mpl et e¦ ¦l ist¦ ¦of¦ ¦i ng re di ents¦ ¦is¦ ¦available¦ ¦in¦ ¦the¦ ¦vaccine¦ ¦information¦ ¦lea f l et¦ ¦for¦ ¦the¦ ¦p f iz er¦ ▁/▁ ¦bi on te ch¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ▁( ¦c om ir n at y¦ ).
𐋇 ¦other¦ ¦vaccines¦
𐋇¦the¦ ¦f in al¦ ¦sta ges¦ ¦of¦ ¦li ce ns ing¦ ¦and¦ ¦appro ving¦ ¦other¦ ¦covid¦ - ¦19¦ ¦vaccines¦ ¦are¦ ¦cur re ntly¦ ¦under w ay¦ .
𐋇¦we¦ ¦will¦ ¦publ ish¦ ¦more¦ ¦information¦ ¦about¦ ¦the¦ ¦mod er na¦ ¦covid¦ - ¦19¦ ¦vaccine¦ ¦when¦ ¦it¦ ¦bec omes¦ ¦available¦ .
𐋇¦this¦ ¦t op ic¦ ¦has¦ ¦been¦ ¦ex a m ined¦ ¦by¦ ¦vaccine¦ ¦exp er ts¦ ¦wor king¦ ¦in¦ ¦ireland¦ .
𐋇¦by¦ ¦la w¦ ,▁ ¦you¦ ¦must¦ ¦wear¦ ¦a¦ ¦face¦ ¦mask¦ :
𐋇¦on¦ ¦public¦ ¦transport¦
𐋇¦in¦ ¦sho ps¦ ,▁ ¦shopping¦ ¦ma lls¦ ¦and¦ ¦a¦ ¦number¦ ¦of¦ ¦other¦ ¦in door¦ ¦loc ations¦
𐋇¦in¦ ¦b an ks¦ ,▁ ¦p ost¦ ¦offic es¦ ¦and¦ ¦cre di t¦ ¦uni ons¦
𐋇 ¦face¦ ¦cover¦ ¦should¦ ¦also¦ ¦be¦ ¦wor n¦ :
𐋇¦when¦ ¦it¦ ¦is¦ ¦not¦ ¦possible¦ ¦to¦ ¦stay¦ ¦away¦ ¦2¦ ¦meters¦ ¦from¦ ¦others¦
𐋇¦in¦ ¦hosp it als¦ ,▁ ¦doctor¦ ' ¦s¦ ¦dis p e ns ary¦ ,▁ ¦nu rs ing¦ ¦h omes¦ ¦and¦ ¦at¦ ¦the¦ ¦de nt ist¦ ¦and¦ ¦other¦ ¦health¦ ¦centr es¦
𐋇¦when¦ ¦people¦ ¦are¦ ¦visi ting¦ ¦people¦ ¦who¦ ¦are¦ ¦at¦ ¦g rea ter¦ ¦risk¦ ¦from¦ ¦covid¦ - ¦19¦ ▁-▁ ¦ e¦ . ¦ g¦ .▁ ¦people¦ ¦over¦ ¦the¦ ¦age¦ ¦of¦ ¦7 0¦ ¦or¦ ¦people¦ ¦who¦ ¦are¦ ¦v ul n er able¦ ¦to¦ ¦health¦
𐋇¦in¦ ¦cr ow ded¦ ¦work p la ces¦ ,▁ ¦places¦ ¦of¦ ¦wor s hi p¦ ¦and¦ ¦b us y¦ ¦out door¦ ¦places¦ ¦where¦ ¦many¦ ¦people¦ ¦g at her¦
𐋇¦there¦ ¦are¦ ¦people¦ ¦who¦ ¦should¦ ¦not¦ ▁/▁ ¦cannot¦ ¦wear¦ ¦face¦ ¦cover¦ .
𐋇¦read¦ ¦about¦ ¦those¦ ¦who¦ ¦should¦ ¦not¦ ¦wear¦ ¦one¦ .
𐋇¦when¦ ¦a¦ ¦dis p os able¦ ¦mask¦ ¦should¦ ¦be¦ ¦wor n¦
𐋇¦a¦ ¦si ng le¦ - ¦use¦ ¦mask¦ ¦is¦ ¦also¦ ¦called¦ ¦a¦ ¦sur g ical¦ ¦mask¦ .
𐋇¦this¦ ¦is¦ ¦the¦ ¦us ual¦ ¦typ e¦ ¦of¦ ¦face¦ ¦mask¦ ¦that¦ ¦is¦ ¦typ ically¦ ¦so ld¦ ¦in¦ ¦ph arm ac ies¦ ¦and¦ ¦other¦ ¦st or es¦ .
𐋇 ¦wear¦ ¦a¦ ¦si ng le¦ - ¦use¦ ¦mask¦ ¦inst ead¦ ¦of¦ ¦a¦ ¦face¦ ¦mask¦ ¦if¦ ¦you¦ ¦are¦ ¦at¦ ¦increased¦ ¦risk¦ ¦of¦ ¦contr ac ting¦ ¦a¦ ¦ser ious¦ ¦illness¦ ¦caused¦ ¦by¦ ¦covid¦ - ¦19¦ .
𐋇¦it¦ ¦is¦ ¦not¦ ¦the¦ ¦same¦ ¦as¦ ¦a¦ ¦face¦ ¦cover¦ ¦and¦ ¦g ives¦ ¦you¦ ¦bet ter¦ ¦prote ction¦ .
𐋇¦you¦ ¦should¦ ¦wear¦ ¦a¦ ¦dis p os able¦ ¦mask¦ ¦at¦ ¦home¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦self¦ - ¦isol ated¦
𐋇¦if¦ ¦you¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ ▁-▁ ¦you¦ ¦must¦ ¦stay¦ ¦in¦ ¦your¦ ¦ro om¦
𐋇¦if¦ ¦you¦ ¦live¦ ¦with¦ ¦someone¦ ¦with¦ ¦covid¦ - ¦19¦
𐋇¦read¦ ¦about¦ ¦face¦ ¦masks¦ ,▁ ¦masks¦ ¦and¦ ¦ce ll ul ite¦ ¦h er e¦
𐋇 ¦wh y¦ ¦a¦ ¦face¦ ¦cover¦ ¦should¦ ¦be¦ ¦wor n¦
𐋇¦covid¦ - ¦19¦ ¦is¦ ¦main ly¦ ¦spread¦ ¦by¦ ¦direct¦ ¦contact¦ ¦and¦ ¦dro pl ets¦ ¦c om ing¦ ¦from¦ ¦your¦ ¦nose¦ ¦and¦ ¦mouth¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦when¦ ¦you¦ ¦are¦ ¦cou g hing¦ ,▁ ¦sneezing¦ ¦or¦ ¦t al king¦ ¦lo ud ly¦ .
𐋇¦w earing¦ ¦a¦ ¦f ac ial¦ ¦cover¦ ¦reduc es¦ ¦the¦ ¦spread¦ ¦of¦ ¦these¦ ¦dro pl ets¦ .
𐋇¦it¦ ¦also¦ ¦h el ps¦ ¦prevent¦ ¦people¦ ¦who¦ ¦do¦ ¦not¦ ¦know¦ ¦they¦ ¦have¦ ¦the¦ ¦virus¦ ¦from¦ ¦sprea ding¦ ¦it¦ .
𐋇¦if¦ ¦you¦ ¦wear¦ ¦a¦ ¦face¦ ¦mask¦ ,▁ ¦you¦ ¦should¦ ¦do¦ ¦the¦ ¦other¦ ¦important¦ ¦th ings¦ ¦to¦ ¦prevent¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦these¦ ¦include¦ :
𐋇 ¦social¦ ¦separ ation¦
𐋇 ¦cov ering¦ ¦your¦ ¦mouth¦ ¦and¦ ¦nose¦ ¦with¦ ¦a¦ ¦hand k er ch ief¦ ¦or¦ ¦sl ee ve¦ ¦while¦ ¦cou g hing¦ ¦and¦ ¦sneezing¦
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦properly¦ ,▁ ¦and¦ ¦often¦
𐋇 ¦not¦ ¦to¦ ¦tou ch¦ ¦your¦ ¦ey es¦ ,▁ ¦nose¦ ¦or¦ ¦mouth¦ ¦un less¦ ¦your¦ ¦hands¦ ¦are¦ ¦clean¦
𐋇¦read¦ ¦the¦ ¦advice¦ ¦on¦ ¦how¦ ¦to¦ ¦protect¦ ¦yourself¦ ¦and¦ ¦others¦ .
𐋇¦when¦ ¦a¦ ¦face¦ ¦cover¦ ¦should¦ ¦be¦ ¦wor n¦ .
𐋇¦by¦ ¦la w¦ ,▁ ¦you¦ ¦must¦ ¦wear¦ ¦face¦ ¦cover¦ ¦on¦ ¦public¦ ¦transport¦ ,▁ ¦and¦ :
𐋇 ¦sho ps¦ ¦and¦ ¦ph arm ac ies¦ ¦and¦ ¦i¦
𐋇 ¦shopping¦ ¦centr es¦
𐋇 ¦li b r ar ies¦
𐋇¦c i ne ma s¦
𐋇 ¦the at ers¦
𐋇 ¦concer t¦ ¦ha lls¦
𐋇 ¦bi ng o¦ ¦ha lls¦
𐋇¦m u se u ms¦
𐋇 ¦na il¦ ¦s al on¦
𐋇¦h ai r¦ ¦s al on¦ ¦and¦ ¦b ar b ers¦
𐋇¦t at t o o¦ ¦and¦ ¦p i erc ing¦ ¦sho ps¦
𐋇 ¦travel¦ ¦ag ents¦ ¦and¦ ¦tou r¦ ¦op erat ors¦
𐋇 ¦la u nd ry¦ ¦and¦ ¦d ry¦ ¦c le an ers¦
𐋇¦b oo k ma k ers¦
𐋇¦when¦ ¦you¦ ¦can¦ ¦re mo ve¦ ¦the¦ ¦face¦ ¦cover¦
𐋇¦you¦ ¦can¦ ¦re mo ve¦ ¦the¦ ¦face¦ ¦cover¦ ¦to¦ :
𐋇¦t alk¦ ¦to¦ ¦someone¦ ¦who¦ ¦has¦ ¦comm un ic ation¦ ¦diffic ult ies¦
𐋇 ¦provid ing¦ ¦emergency¦ ¦ass ist ance¦ ¦or¦ ¦care¦ ¦to¦ ¦a¦ ¦v ul n er able¦ ¦person¦
𐋇 ¦ta king¦ ¦medic ation¦
𐋇¦you¦ ¦may¦ ¦be¦ ¦as ked¦ ¦to¦ ¦re mo ve¦ ¦your¦ ¦face¦ ¦cover¦ ¦to¦ ¦conf ir m¦ ¦your¦ ¦age¦ ¦or¦ ¦ident ity¦ .
𐋇¦you¦ ¦can¦ ¦also¦ ¦re mo ve¦ ¦your¦ ¦face¦ ¦cover¦ ¦when¦ ¦you¦ ¦are¦ :
𐋇¦e ating¦ ¦and¦ ¦dr in king¦ ¦in¦ ¦a¦ ¦res ta ur ant¦ ¦or¦ ¦ca f é ¦ ▁-▁ ¦th r ow¦ ¦one¦ ¦when¦ ¦you¦ ' ¦r e¦ ¦not¦ ¦at¦ ¦your¦ ¦t able¦
𐋇¦when¦ ¦you¦ ¦are¦ ¦rece i ving¦ ¦medical¦ ¦or¦ ¦de ntal¦ ¦treatment¦
𐋇¦you¦ ¦do¦ ¦not¦ ¦need¦ ¦to¦ ¦wear¦ ¦a¦ ¦face¦ ¦cover¦ ¦if¦ ¦you¦ ¦have¦ ¦an¦ ¦illness¦ ¦or¦ ¦w ea k ness¦ ¦that¦ ¦would¦ ¦make¦ ¦it¦ ¦diffic ul t¦ ¦for¦ ¦you¦ ¦to¦ ¦wear¦ ¦a¦ ¦face¦ ¦cover¦ .
𐋇 ¦people¦ ¦who¦ ¦should¦ ¦not¦ ¦wear¦ ¦a¦ ¦face¦ ¦cover¦
𐋇 ¦face¦ ¦masks¦ ¦are¦ ¦not¦ ¦recommended¦ ¦for¦ ¦the¦ ¦following¦ :
𐋇 ¦someone¦ ¦who¦ ¦has¦ ¦tr ou ble¦ ¦brea thing¦
𐋇 ¦u nc o ns c ious¦ ¦person¦ ¦or¦ ¦sp ee ch¦
𐋇¦a¦ ¦person¦ ¦who¦ ¦is¦ ¦un able¦ ¦to¦ ¦re mo ve¦ ¦it¦ ¦without¦ ¦help¦
𐋇¦a¦ ¦person¦ ¦with¦ ¦spec ial¦ ¦needs¦ ¦or¦ ¦h earing¦ ¦diffic ult ies¦ ¦or¦ ¦who¦ ¦is¦ ¦d ea f¦
𐋇¦a¦ ¦person¦ ¦who¦ ¦comm un ic ates¦ ¦with¦ ¦a¦ ¦person¦ ¦with¦ ¦learning¦ ¦diffic ult ies¦ ¦or¦ ¦who¦ ¦is¦ ¦h ard¦ ¦of¦ ¦h earing¦ ¦or¦ ¦d ea f¦
𐋇¦in¦ ¦cases¦ ¦like¦ ¦this¦ ,▁ ¦the¦ ¦person¦ ¦will¦ ¦get¦ ¦some¦ ¦prote ction¦ ¦from¦ ¦the¦ ¦c el la r¦ ¦if¦ ¦they¦ ¦are¦ ¦able¦ ¦to¦ ¦wear¦ ¦it¦ .
𐋇¦but¦ ¦it¦ ¦is¦ ¦only¦ ¦in¦ ¦these¦ ¦cases¦ ¦that¦ ¦ce lls¦ ¦should¦ ¦be¦ ¦cons u med¦ .
𐋇¦it¦ ¦is¦ ¦b est¦ ¦to¦ ¦wear¦ ¦a¦ ¦face¦ ¦cover¦ ¦made¦ ¦of¦ ¦c lo th¦ ¦to¦ ¦protect¦ ¦yourself¦ ¦from¦ ¦covid¦ - ¦19¦ .
𐋇¦l et t ers¦ ¦of¦ ¦ex e m ption¦
𐋇¦some¦ ¦work p la ces¦ ¦or¦ ¦schools¦ ¦may¦ ¦re qu est¦ ¦a¦ ¦medical¦ ¦ce rt ific ate¦ .
𐋇¦but¦ ¦gener ally¦ ,▁ ¦you¦ ¦do¦ ¦not¦ ¦need¦ ¦to¦ ¦as k¦ ¦for¦ ¦a¦ ¦l et ter¦ ¦from¦ ¦a¦ ¦gp¦ ¦about¦ ¦your¦ ¦re as on¦ ¦for¦ ¦not¦ ¦w earing¦ ¦a¦ ¦face¦ ¦cover¦ .
𐋇 ¦children¦ ¦and¦ ¦face¦ ¦cov ers¦
𐋇 ¦children¦ ¦under¦ ¦the¦ ¦age¦ ¦of¦ ¦13¦ ¦are¦ ¦not¦ ¦ad vi sed¦ ¦to¦ ¦wear¦ ¦face¦ ¦masks¦ ,▁ ¦but¦ ¦some¦ ¦children¦ ¦may¦ ¦c ho ose¦ ¦to¦ ¦wear¦ ¦one¦ .
𐋇¦there¦ ¦is¦ ¦a¦ ¦g ood¦ ¦ch ance¦ ¦that¦ ¦y ou ng¦ ¦children¦ ¦will¦ ¦not¦ ¦follow¦ ¦the¦ ¦advice¦ ¦on¦ ¦how¦ ¦to¦ ¦wear¦ ¦face¦ ¦masks¦ ¦properly¦ .
𐋇¦but¦ ¦children¦ ¦under¦ ¦13¦ ¦should¦ ¦wear¦ ¦face¦ ¦cover¦ ¦if¦ ¦their¦ ¦doctor¦ ¦or¦ ¦healthcare¦ ¦work er¦ ¦recomm ends¦ ¦they¦ ¦do¦ ¦so¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦some¦ ¦children¦ ¦may¦ ¦be¦ ¦e nc ou ra ged¦ ¦to¦ ¦do¦ ¦this¦ ¦while¦ ¦att ending¦ ¦a¦ ¦hospital¦ ¦cl in ic¦ ¦for¦ ¦example¦ .
𐋇 ¦children¦ ¦who¦ ¦may¦ ¦be¦ ¦under¦ ¦13¦ ¦in¦ ¦their¦ ¦first¦ ¦year¦ ¦of¦ ¦sec ond ary¦ ¦school¦ ¦should¦ ¦wear¦ ¦face¦ ¦cover¦ ¦while¦ ¦att ending¦ ¦school¦ .
𐋇¦this¦ ¦is¦ ¦because¦ ¦they¦ ¦are¦ ¦at¦ ¦the¦ ¦same¦ ¦st age¦ ¦of¦ ¦development¦ ¦as¦ ¦their¦ ¦p e ers¦ ¦and¦ ¦can¦ ¦follow¦ ¦the¦ ¦advice¦ ¦on¦ ¦using¦ ¦face¦ ¦masks¦ ¦properly¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦evidence¦ ¦that¦ ¦a¦ ¦coronavirus¦ ¦can¦ ¦be¦ ¦se x ually¦ ¦transm it ted¦ .
𐋇¦however¦ ,▁ ¦it¦ ¦can¦ ¦be¦ ¦spread¦ ¦through¦ ¦close¦ ¦contact¦ ¦with¦ ¦someone¦ ¦who¦ ¦has¦ ¦the¦ ¦virus¦ .
𐋇 ¦reduc ing¦ ¦your¦ ¦risk¦ ¦of¦ ¦contr ac ting¦ ¦the¦ ¦corona ry¦ ¦virus¦
𐋇¦you¦ ¦may¦ ¦not¦ ¦know¦ ¦if¦ ¦someone¦ ¦has¦ ¦a¦ ¦coronavirus¦ .
𐋇¦there¦ ¦is¦ ¦some¦ ¦risk¦ ¦of¦ ¦getting¦ ¦the¦ ¦virus¦ ¦if¦ ¦you¦ ¦are¦ ¦se x ually¦ ¦ac tive¦ ¦with¦ ¦another¦ ¦person¦ .
𐋇¦you¦ ¦can¦ ¦reduce¦ ¦this¦ ¦risk¦ ¦by¦ :
𐋇 ¦have¦ ¦se x ual¦ ¦int erc o ur se¦ ¦with¦ ¦a¦ ¦part n er¦ ¦you¦ ¦live¦ ¦with¦ ¦and¦ ¦who¦ ¦does¦ ¦not¦ ¦have¦ ¦the¦ ¦virus¦ ¦or¦ ¦symptoms¦ ¦of¦ ¦the¦ ¦virus¦
𐋇¦d on¦ ' ¦t¦ ¦k is s¦ ¦an yone¦ ¦outside¦ ¦your¦ ¦family¦ ¦and¦ ¦an yone¦ ¦with¦ ¦symptoms¦ ▁-▁ ¦it¦ ' ¦s¦ ¦e as y¦ ¦to¦ ¦spread¦ ¦the¦ ¦cr own¦ ¦virus¦ ¦by¦ ¦ki ss ing¦
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦properly¦ ¦before¦ ¦and¦ ¦after¦ ¦se x¦
𐋇¦if¦ ¦you¦ ¦dec ide¦ ¦to¦ ¦have¦ ¦se x¦ ¦with¦ ¦someone¦ ¦who¦ ¦does¦ ¦not¦ ¦live¦ ¦with¦ ¦you¦ ,▁ ¦limi t¦ ¦it¦ ¦to¦ ¦a¦ ¦fe w¦ ¦part n ers¦ ¦as¦ ¦possible¦ ,▁ ¦one¦ ¦reg ular¦ ¦part n er¦ ¦if¦ ¦possible¦ .
𐋇¦read¦ ¦more¦ ¦about¦ ¦se x¦ ¦and¦ ¦the¦ ¦cr own¦ ¦virus¦ ¦on¦ ¦se x ual¦ ¦we ll b e ing¦ .▁ ¦i e¦
𐋇¦read¦ ¦more¦ ¦about¦ ¦how¦ ¦the¦ ¦coronavirus¦ ¦is¦ ¦spread¦ .
𐋇 ¦re st ri ction¦ ¦on¦ ¦se x ually¦ ¦transm it ted¦ ¦infection¦ ▁( ¦st i¦ )▁ ¦services¦
𐋇 ¦many¦ ¦st i¦ ¦services¦ ¦are¦ ¦cur re ntly¦ ¦re stric ted¦ ¦due¦ ¦to¦ ¦the¦ ¦coronavirus¦ .
𐋇 ¦te le ph one¦ ¦support¦ ¦is¦ ¦available¦ ¦in¦ ¦some¦ ¦services¦ .
𐋇 ¦further¦ ¦information¦ ¦is¦ ¦available¦ ¦on¦ ¦the¦ ¦h iv ¦ ¦ireland¦ ¦we b s ite¦ .
𐋇 ¦cont ra ce ption¦
𐋇 ¦ph arm ac ies¦ ¦are¦ ¦open¦ ¦as¦ ¦us ual¦ ¦and¦ ¦can¦ ¦give¦ ¦you¦ ¦your¦ ¦us ual¦ ¦cont ra cep tive¦ ¦pr esc ri ption¦ .
𐋇¦if¦ ¦your¦ ¦h orm on al¦ ¦cont ra cep tive¦ ¦pr esc ri ption¦ ¦is¦ ¦to¦ ¦be¦ ¦re ne w ed¦ ,▁ ¦your¦ ¦ph arm ac ist¦ ¦may¦ ¦be¦ ¦able¦ ¦to¦ ¦provide¦ ¦you¦ ¦with¦ ¦ext r a¦ ¦supp l ies¦ ¦if¦ ¦it¦ ¦is¦ ¦safe¦ ¦and¦ ¦appr op ri ate¦ ¦to¦ ¦do¦ ¦so¦ .
𐋇 ¦emergency¦ ¦cont ra ce ption¦
𐋇¦you¦ ¦can¦ ¦get¦ ¦emergency¦ ▁( ¦h orm on al¦ )▁ ¦cont ra ce ption¦ ¦without¦ ¦a¦ ¦pr esc ri ption¦ ¦from¦ ¦your¦ ¦local¦ ¦ph arm acy¦ .
𐋇 ¦call¦ ¦your¦ ¦ph arm ac ist¦ ¦to¦ ¦se e¦ ¦if¦ ¦they¦ ¦can¦ ¦do¦ ¦the¦ ¦cons ult ation¦ ¦over¦ ¦the¦ ¦phone¦ .
𐋇¦this¦ ¦reduc es¦ ¦the¦ ¦a mo un t¦ ¦of¦ ¦time¦ ¦you¦ ¦have¦ ¦to¦ ¦sp end¦ ¦in¦ ¦the¦ ¦ph arm acy¦ .
𐋇 ¦emergency¦ ¦h orm on al¦ ¦cont ra ce ption¦ ¦can¦ ¦be¦ ¦ta k en¦ ¦up¦ ¦to¦ ¦5¦ ¦days¦ ¦after¦ ¦un p r ot ected¦ ¦se x¦ .
𐋇¦the¦ ¦so on er¦ ¦you¦ ¦take¦ ¦it¦ ,▁ ¦the¦ ¦more¦ ¦effective¦ ¦it¦ ¦bec omes¦ .
𐋇¦read¦ ¦more¦ ¦about¦ ¦emergency¦ ¦cont ra ce ption¦ ¦on¦ ¦se x ual¦ ¦we ll b e ing¦ .▁ ¦i e¦ .
𐋇 ¦support¦ ¦for¦ ¦un pl an ned¦ ¦pregn a ncy¦
𐋇¦m y¦ ¦op tions¦ ¦provid es¦ ¦information¦ ¦and¦ ¦support¦ ¦for¦ ¦un pl an ned¦ ¦pregn a nc ies¦ .
𐋇¦this¦ ¦service¦ ¦is¦ ¦op er ating¦ ¦as¦ ¦normal¦ .
𐋇¦f r ee ph one¦ :
𐋇¦the¦ ¦hse¦ - ¦f u nded¦ ¦one¦ - ¦to¦ - ¦one¦ ¦un pl an ned¦ ¦pregn a ncy¦ ¦cou ns el ing¦ ¦services¦ ¦have¦ ¦m oved¦ ¦their¦ ¦services¦ ¦to¦ ¦te le ph one¦ ¦or¦ ¦rem ot e¦ ¦support¦ .
𐋇¦f ind¦ ¦contact¦ ¦detail s¦ ¦for¦ ¦one¦ - ¦to¦ - ¦one¦ ¦un pl an ned¦ ¦pregn a ncy¦ ¦cou ns el ing¦ ¦services¦ :
𐋇¦f ind¦ ¦contact¦ ¦detail s¦ ¦for¦ ¦face¦ - ¦to¦ - ¦face¦ ¦un pl an ned¦ ¦pregn a ncy¦ ¦co un se lling¦ ¦services¦
𐋇 ¦ab ort ion¦ ¦services¦ ¦are¦ ¦still¦ ¦available¦ ¦ab ort ion¦ ¦services¦ .
𐋇 ¦during¦ ¦the¦ ¦coronavirus¦ ¦pandemic¦ ¦it¦ ¦is¦ ¦possible¦ ¦to¦ ¦have¦ ¦pr e¦ - ¦ab ort ion¦ ¦cons ult ations¦ ¦by¦ ¦phone¦ ¦or¦ ¦v ide o¦ ¦l ink¦ ¦with¦ ¦a¦ ¦doctor¦ .
𐋇¦when¦ ¦to¦ ¦call¦ ¦your¦ ¦gp¦ ¦imm ed ia tely¦
𐋇 ¦call¦ ¦your¦ ¦gp¦ ¦imm ed ia tely¦ ¦if¦ ¦you¦ ¦have¦ :
𐋇¦your¦ ¦child¦ ¦is¦ ¦between¦ ¦3¦ ¦and¦ ¦6¦ ¦mon ths¦ ¦o ld¦ ¦with¦ ¦a¦ ¦temp erat ure¦ ¦of¦ ¦3 8¦ ¦de g re es¦ ¦c el si us¦ ¦or¦ ¦higher¦ ,▁ ¦or¦ ¦if¦ ¦you¦ ¦th ink¦ ¦they¦ ¦have¦ ¦a¦ ¦fever¦
𐋇¦h e¦ ¦has¦ ¦diffic ult y¦ ¦brea thing¦ ¦while¦ ¦p u lling¦ ¦hi s¦ ¦ab d om en¦ ¦under¦ ¦the¦ ¦ rib s¦ ¦if¦ ¦h e¦ ¦ob s er ves¦ ¦that¦ ¦the¦ ¦m us c les¦ ¦of¦ ¦hi s¦ ¦n eck¦ ¦are¦ ¦mo ving¦ ¦when¦ ¦h e¦ ¦brea th es¦ ¦or¦ ¦that¦ ¦hi s¦ ¦h ead¦ ¦is¦ ¦mo ving¦ ¦up¦ ¦and¦ ¦down¦ ¦while¦ ¦brea thing¦
𐋇¦your¦ ¦child¦ ¦de h y dr ated¦ ▁ - ▁-▁ ¦a¦ ¦na pp y¦ ¦that¦ ¦is¦ ¦not¦ ¦to o¦ ¦w et¦ ,▁ ¦ey es¦ ¦w at ering¦ ¦in¦ ¦hi s¦ ¦h ead¦ ,▁ ¦mouth¦ ¦d ry¦ ¦or¦ ¦no¦ ¦t ear s¦ ¦in¦ ¦hi s¦ ¦ey es¦ ¦while¦ ¦cr ying¦
𐋇¦your¦ ¦child¦ ¦is¦ ¦t ir ed¦ ▁( ¦very¦ ¦t ir ed¦ )▁ ¦or¦ ¦ir r it able¦ ¦and¦ ¦can¦ ' ¦t¦ ¦c al m¦ ¦down¦ ¦with¦ ¦to y s¦ ,▁ ¦food¦ ,▁ ¦t v ¦ ¦or¦ ¦if¦ ¦you¦ ¦p ick¦ ¦it¦ ¦up¦ ▁-▁ ¦and¦ ¦especially¦ ¦if¦ ¦this¦ ¦happ ens¦ ¦after¦ ¦their¦ ¦temp erat ure¦ ¦has¦ ¦dro pp ed¦
𐋇¦your¦ ¦child¦ ¦sh a king¦ ¦ba d ly¦ ¦or¦ ¦co mpl aining¦ ¦of¦ ¦m us c le¦ ¦a ches¦
𐋇¦your¦ ¦child¦ ¦cons ta ntly¦ ¦having¦ ¦con st ant¦ ¦na u se a¦ ¦or¦ ¦pain¦ ¦in¦ ¦hi s¦ ¦sto ma ch¦
𐋇¦the¦ ¦test¦ ¦for¦ ¦covid¦ - ¦19¦ ¦may¦ ¦be¦ ¦d one¦ ¦on¦ ¦your¦ ¦child¦
𐋇¦there¦ ¦are¦ ¦many¦ ¦possible¦ ¦ca u ses¦ ¦for¦ ¦your¦ ¦child¦ ¦to¦ ¦bec ome¦ ¦ ill¦ ¦s ud d en ly¦ .
𐋇¦covid¦ - ¦19¦ ¦does¦ ¦not¦ ¦us ually¦ ¦cause¦ ¦ser ious¦ ¦illness¦ ¦in¦ ¦children¦ ,▁ ¦but¦ ¦it¦ ¦s om et im es¦ ¦does¦ .
𐋇 ¦that¦ ' ¦s¦ ¦wh y¦ ¦your¦ ¦doctor¦ ¦would¦ ¦have¦ ¦to¦ ¦ ru le¦ ¦out¦ ¦covid¦ - ¦19¦ .
𐋇¦your¦ ¦gp¦ ¦will¦ ¦as k¦ ¦your¦ ¦child¦ ¦to¦ ¦test¦ ¦for¦ ¦covid¦ - ¦19¦ ¦if¦ ¦they¦ ¦have¦ ¦been¦ ¦in¦ ¦contact¦ ¦with¦ ¦someone¦ ¦who¦ ¦has¦ ¦had¦ ¦a¦ ¦negative¦ ¦result¦ .
𐋇¦your¦ ¦child¦ ¦may¦ ¦also¦ ¦need¦ ¦to¦ ¦be¦ ¦tested¦ ¦for¦ ¦covid¦ - ¦19¦ ¦in¦ ¦the¦ ¦following¦ ¦s itu ations¦ :
𐋇 ¦un less¦ ¦your¦ ¦gp¦ ¦is¦ ¦u ns ure¦ ¦of¦ ¦your¦ ¦child¦ ▁' ¦s¦ ¦illness¦
𐋇 ¦someone¦ ¦el se¦ ¦in¦ ¦the¦ ¦house¦ ¦is¦ ¦sick¦ ¦but¦ ¦does¦ ¦not¦ ¦know¦ ¦wh y¦
𐋇 ¦what¦ ¦will¦ ¦happ en¦ ¦ne xt¦ ?
𐋇¦your¦ ¦gp¦ ¦will¦ ¦ass ess¦ ¦your¦ ¦child¦ ¦and¦ ¦recomm end¦ ¦treatment¦ ¦for¦ ¦their¦ ¦symptoms¦ ¦of¦ ¦illness¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦as ked¦ ¦to¦ ¦keep¦ ¦an¦ ¦ey e¦ ¦on¦ ¦your¦ ¦child¦ ¦in¦ ¦case¦ ¦it¦ ¦g ets¦ ¦wor se¦ .
𐋇¦your¦ ¦child¦ ¦will¦ ¦need¦ ¦to¦ ¦stay¦ ¦away¦ ¦from¦ ¦others¦ ¦until¦ ¦they¦ ¦know¦ ¦for¦ ¦sure¦ ¦that¦ ¦they¦ ¦do¦ ¦not¦ ¦have¦ ¦covid¦ - ¦19¦ ¦by¦ :
𐋇 ¦different¦ ¦diagn o sis¦ ¦or¦
𐋇 ¦negative¦ ¦test¦ ¦result¦
𐋇 ¦sta ying¦ ¦away¦ ¦from¦ ¦others¦ ¦is¦ ¦like¦ ¦k ee p ing¦ ¦your¦ ¦child¦ ¦at¦ ¦home¦ ¦and¦ ¦separ ated¦ ¦from¦ ¦others¦ .
𐋇¦do¦ ¦not¦ ¦all ow¦ ¦any¦ ¦visi t ors¦ .
𐋇¦read¦ ¦advice¦ ¦on¦ ¦how¦ ¦to¦ ¦care¦ ¦for¦ ¦a¦ ¦child¦ ¦who¦ ¦has¦ ¦to¦ ¦self¦ - ¦isol ate¦ .
𐋇 ¦make¦ ¦sure¦ ¦your¦ ¦child¦ ¦contin ues¦ ¦to¦ ¦wash¦ ¦their¦ ¦hands¦ ¦properly¦ ¦and¦ ¦regul arly¦ ¦and¦ ¦follow¦ ¦the¦ ¦cough¦ ¦and¦ ¦sneezing¦ ¦advice¦ ;▁ ¦wash¦ ¦their¦ ¦hands¦ ¦properly¦ ¦and¦ ¦regul arly¦ ¦and¦ ¦follow¦ ¦h yg ien e¦ ¦advice¦ ¦around¦ ¦cou g hing¦ ¦and¦ ¦sneezing¦ .
𐋇¦if¦ ¦your¦ ¦child¦ ¦is¦ ¦not¦ ¦tested¦ ¦and¦ ¦your¦ ¦doctor¦ ¦does¦ ¦not¦ ¦know¦ ¦what¦ ¦their¦ ¦illness¦ ¦is¦ ,▁ ¦they¦ ¦will¦ ¦be¦ ¦tre ated¦ ¦as¦ ¦if¦ ¦they¦ ¦had¦ ¦covid¦ - ¦19¦ .
𐋇¦e veryone¦ ¦who¦ ¦has¦ ¦been¦ ¦in¦ ¦contact¦ ¦with¦ ¦your¦ ¦child¦ ¦should¦ ¦be¦ ¦a w are¦ ¦of¦ ¦the¦ ¦symptoms¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦case¦ ¦the¦ ¦symptoms¦ ¦occur ¦ .
𐋇¦p e di at r ic¦ ¦mult ip le¦ ¦inf la mm atory¦ ¦syndrome¦ ▁( ¦p i ms¦ )
𐋇¦a¦ ¦sm all¦ ¦number¦ ¦of¦ ¦children¦ ¦with¦ ¦coronavirus¦ ¦had¦ ¦to¦ ¦under g o¦ ¦hospital¦ ¦treatment¦ ¦for¦ ¦an¦ ¦inf la mm atory¦ ¦syndrome¦ ¦known¦ ¦as¦ ¦p e di at r ic¦ ¦mult ip le¦ ¦sys te m ic¦ ¦inf la mm atory¦ ¦syndrome¦ ▁( ¦p i ms¦ ).
𐋇¦p i ms¦ ¦is¦ ¦a¦ ¦l ife¦ - ¦th re at ening¦ ¦dis or der¦ .
𐋇¦it¦ ¦is¦ ¦caused¦ ¦by¦ ¦an¦ ¦ab n ormal¦ ¦response¦ ¦of¦ ¦the¦ ¦body¦ ' ¦s¦ ¦immune¦ ¦system¦ ¦to¦ ¦infection¦ .
𐋇¦it¦ ¦is¦ ¦similar¦ ¦to¦ ¦k a w as a k i¦ ¦disease¦ ¦or¦ ¦to x ic¦ ¦d ist ur b ance¦ ¦syndrome¦ ¦and¦ ¦is¦ ¦u nc o mm on¦ .
𐋇¦we¦ ¦do¦ ¦not¦ ¦know¦ ¦if¦ ¦these¦ ¦children¦ ¦received¦ ¦p i ms¦ ¦because¦ ¦they¦ ¦had¦ ¦covid¦ - ¦19¦ .
𐋇¦it¦ ¦is¦ ¦to o¦ ¦early¦ ¦to¦ ¦se e¦ ¦if¦ ¦there¦ ¦is¦ ¦any¦ ¦con ne ction¦ .
𐋇 ¦children¦ ¦who¦ ¦requir e¦ ¦hospital¦ ¦treatment¦ ¦for¦ ¦p i ms¦ ¦are¦ ¦n ow¦ ¦being¦ ¦tested¦ ¦for¦ ¦the¦ ¦virus¦ .
𐋇¦this¦ ¦is¦ ¦a¦ ¦pr ec a ution¦ .
𐋇¦it¦ ¦is¦ ¦important¦ ¦that¦ ¦your¦ ¦children¦ ¦are¦ ¦invol v ed¦ ¦in¦ ¦your¦ ¦pl ans¦ ¦to¦ ¦de al¦ ¦with¦ ¦the¦ ¦coronavirus¦ .
𐋇 ¦th ink¦ ¦about¦ ¦how¦ ¦they¦ ¦feel¦ .
𐋇 ¦give¦ ¦children¦ ¦and¦ ¦y ou ng¦ ¦people¦ ¦time¦ ¦and¦ ¦sp ace¦ ¦to¦ ¦t alk¦ ¦about¦ ¦the¦ ¦outbreak¦ .
𐋇 ¦share¦ ¦the¦ ¦f ac ts¦ ¦with¦ ¦them¦ ¦in¦ ¦a¦ ¦way¦ ¦that¦ ¦su i ts¦ ¦their¦ ¦age¦ ¦and¦ ¦att itu de¦ ,▁ ¦and¦ ¦do¦ ¦not¦ ¦be¦ ¦afr a id¦ .
𐋇¦t alk¦ ¦to¦ ¦your¦ ¦children¦ ¦about¦ ¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ ).
𐋇 ¦restrict¦ ¦what¦ ¦new s¦ ¦and¦ ¦social¦ ¦m ed ia¦ ¦they¦ ¦se e¦ .
𐋇¦this¦ ¦is¦ ¦especially¦ ¦important¦ ¦for¦ ¦ ol der¦ ¦children¦ ¦as¦ ¦they¦ ¦sp end¦ ¦more¦ ¦time¦ ¦online¦ .
𐋇¦it¦ ¦could¦ ¦be¦ ¦a¦ ¦cause¦ ¦for¦ ¦concer n¦ ¦for¦ ¦them¦ .
𐋇¦if¦ ¦they¦ ¦are¦ ¦online¦ ,▁ ¦t ell¦ ¦them¦ ¦where¦ ¦to¦ ¦f ind¦ ¦acc ur ate¦ ¦information¦ .
𐋇 ¦children¦ ¦with¦ ¦a ut is m¦ ¦and¦ ¦in te ll ect ual¦ ¦dis ab il ities¦
𐋇 ¦use¦ ¦st or ies¦ ¦to¦ ¦help¦ ¦children¦ ¦with¦ ¦a ut is m¦ ¦under st and¦ ¦coronavirus¦ ▁-▁ ¦from¦ ¦the¦ ¦a ut is m¦ ¦ch ar ity¦ ▁' ¦as¦ ¦i¦ ¦ am¦ ' .
𐋇 ¦g ps¦ ,▁ ¦hosp it als¦ ¦and¦ ¦other¦ ¦health¦ ¦services¦ ¦are¦ ¦open¦ ¦and¦ ¦provid ing¦ ¦care¦ ¦to¦ ¦patients¦ .
𐋇¦you¦ ¦can¦ ¦get¦ ¦medical¦ ¦help¦ ¦and¦ ¦pr esc r ip tions¦ ¦online¦ ¦or¦ ¦over¦ ¦the¦ ¦phone¦ .
𐋇 ¦all¦ ¦health¦ ¦services¦ ¦have¦ ¦pr ec a u tions¦ ¦in¦ ¦place¦ ¦to¦ ¦restrict¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ ).
𐋇¦the¦ ¦ste ps¦ ¦we¦ ¦are¦ ¦ta king¦ ¦to¦ ¦keep¦ ¦e veryone¦ ¦safe¦ ¦may¦ ¦l ead¦ ¦to¦ ¦chan ges¦ ¦in¦ ¦app oi nt ments¦ ¦and¦ ¦services¦ .
𐋇¦but¦ ¦you¦ ¦should¦ ¦get¦ ¦medical¦ ¦treatment¦ ¦if¦ ¦you¦ ¦need¦ ¦it¦ .
𐋇¦if¦ ¦you¦ ¦d on¦ ' ¦t¦ ¦feel¦ ¦well¦
𐋇 ¦disc us s¦ ¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦with¦ ¦your¦ ¦gp¦ ¦over¦ ¦the¦ ¦phone¦ .
𐋇¦you¦ ¦may¦ ¦be¦ ¦able¦ ¦to¦ ¦get¦ ¦advice¦ ¦over¦ ¦the¦ ¦phone¦ ¦or¦ ¦arr ange¦ ¦an¦ ¦appointment¦ .
𐋇¦ ur g ent¦ ¦medical¦ ¦ass ist ance¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦not¦ ¦fe el ing¦ ¦well¦ ¦and¦ ¦need¦ ¦help¦ ¦ ur ge ntly¦ ,▁ ¦call¦ ¦1 1 2¦ ¦or¦ ¦9 9 9¦ ¦to¦ ¦get¦ ¦an¦ ¦a mb ul ance¦ .
𐋇¦you¦ ¦can¦ ¦also¦ ¦go¦ ¦to¦ ¦your¦ ¦local¦ ¦emergency¦ ¦department¦ .
𐋇 ¦symptoms¦ ¦of¦ ¦a¦ ¦h ear t¦ ¦att ack¦
𐋇¦your¦ ¦chest¦ ¦is¦ ¦t ight¦ ¦or¦ ¦h ea v y¦ .
𐋇¦you¦ ¦have¦ ¦pain¦ ¦that¦ ¦sprea ds¦ ¦to¦ ¦your¦ ¦hands¦ ,▁ ¦b ack¦ ,▁ ¦n eck¦ ¦and¦ ¦j a w s¦
𐋇¦you¦ ¦are¦ ¦fe el ing¦ ¦sick¦ ¦or¦ ¦out¦ ¦of¦ ¦brea th¦ .
𐋇¦a¦ ¦h ear t¦ ¦att ack¦ ¦is¦ ¦an¦ ¦ ur g ent¦ ¦medical¦ ¦c ond ition¦ .
𐋇¦d on¦ ' ¦t¦ ¦wor ry¦ ¦if¦ ¦you¦ ' ¦r e¦ ¦not¦ ¦sure¦ .
𐋇 ¦a mb ul ance¦ ¦staff¦ ¦al w ays¦ ¦pre f er¦ ¦to¦ ¦sa ve¦ ¦l ives¦ .
𐋇 ¦st ro ke¦ ¦symptoms¦ ▁-▁ ¦f ast¦
𐋇 ¦st ro ke¦ ¦is¦ ¦an¦ ¦ ur g ent¦ ¦medical¦ ¦c ond ition¦ .
𐋇 ¦getting¦ ¦treatment¦ ¦for¦ ¦a¦ ¦st ro ke¦ ¦on¦ ¦time¦ ¦is¦ ¦the¦ ¦least¦ ¦da ma ging¦ .
𐋇¦the¦ ¦ac r on y m¦ ¦f ast¦ ¦has¦ ¦been¦ ¦developed¦ ¦to¦ ¦help¦ ¦you¦ ¦th ink¦ ¦about¦ ¦the¦ ¦ma in¦ ¦w ar ning¦ ¦signs¦ ¦of¦ ¦a¦ ¦st ro ke¦ .
𐋇¦if¦ ¦you¦ ¦se e¦ ¦them¦ ¦call¦ ¦1 1 2¦ ¦or¦ ¦9 9 9¦ ¦imm ed ia tely¦ ¦f ast¦ ¦st an ds¦ ¦for¦ :
𐋇 ¦face¦ ▁-▁ ¦this¦ ¦is¦ ¦the¦ ¦person¦ ' ¦s¦ ¦face¦ ¦fa lling¦ ¦to¦ ¦one¦ ¦ side¦ .
𐋇 ¦can¦ ¦h e¦ ¦la u gh ¦ ?
𐋇¦w ings¦ ▁-▁ ¦can¦ ¦l if t¦ ¦both¦ ¦hands¦ ¦and¦ ¦ho ld¦ ¦them¦ ¦up¦
𐋇 ¦sp ee ch¦ ▁-▁ ¦is¦ ¦hi s¦ ¦sp ee ch¦ ¦c ho ked¦ ?
𐋇 ¦time¦ ▁( ¦time¦ ▁ ~ ) ▁-▁ ¦call¦ ¦1 1 2¦ ¦or¦ ¦9 9 9¦ ¦if¦ ¦you¦ ¦se e¦ ¦any¦ ¦of¦ ¦these¦ ¦signs¦
𐋇 ¦cance r¦ ¦symptoms¦
𐋇 ¦tre ating¦ ¦cance r¦ ¦bet ter¦ ¦if¦ ¦it¦ ¦is¦ ¦detected¦ ¦on¦ ¦time¦ .
𐋇 ¦call¦ ¦your¦ ¦gp¦ ¦if¦ ¦you¦ ¦n ot ice¦ ¦any¦ ¦of¦ ¦them¦ :
𐋇¦a¦ ¦new¦ ¦l um p¦ ¦or¦ ¦t um or¦
𐋇¦a¦ ¦no de¦ ¦or¦ ¦t um or¦ ¦that¦ ¦has¦ ¦chan ged¦
𐋇 ¦ab n ormal¦ ¦ bl ee ding¦
𐋇 ¦chan ges¦ ¦in¦ ¦your¦ ¦s k in¦
𐋇¦l os ing¦ ¦we ight¦ ¦for¦ ¦no¦ ¦re as on¦
𐋇¦you¦ ¦are¦ ¦cons ta ntly¦ ¦t ir ed¦
𐋇 ¦be¦ ¦rea dy¦
𐋇 ¦pre p are¦ ¦for¦ ¦the¦ ¦c om ing¦ ¦mon ths¦ :
𐋇 ¦keep¦ ¦an¦ ¦ey e¦ ¦on¦ ¦your¦ ¦medic ations¦
𐋇 ¦get¦ ¦your¦ ¦pr esc ri ption¦ ¦on¦ ¦time¦
𐋇 ¦know¦ ¦how¦ ¦to¦ ¦f ind¦ ¦any¦ ¦health¦ ¦service¦ ¦you¦ ¦need¦
𐋇 ¦pr esc r ip tions¦ ¦and¦ ¦coll ecting¦ ¦medic ines¦
𐋇 ¦pr esc r ip tions¦ ¦and¦ ¦coll ecting¦ ¦medic ines¦
𐋇¦the¦ ¦temp or ary¦ ¦chan ges¦ ¦made¦ ¦during¦ ¦the¦ ¦covid¦ - ¦19¦ ¦outbreak¦ ¦me an¦ ¦that¦ ¦your¦ ¦gp¦ ¦can¦ ¦s end¦ ¦your¦ ¦pr esc ri ption¦ ¦to¦ ¦your¦ ¦ph arm ac ist¦ .
𐋇¦a¦ ¦p ap er¦ ¦c op y¦ ¦is¦ ¦not¦ ¦required¦ .
𐋇¦there¦ ¦may¦ ¦be¦ ¦a¦ ¦sh ort¦ ¦del ay¦ ¦in¦ ¦s ending¦ ¦the¦ ¦pr esc ri ption¦ ¦to¦ ¦the¦ ¦ph arm acy¦ .
𐋇¦it¦ ¦may¦ ¦be¦ ¦la un ched¦ ¦later¦ ¦in¦ ¦the¦ ¦day¦ .
𐋇 ¦call¦ ¦the¦ ¦ph arm acy¦ ¦to¦ ¦make¦ ¦sure¦ ¦it¦ ¦is¦ ¦rea dy¦ ¦for¦ ¦colle ction¦ ¦before¦ ¦you¦ ¦lea ve¦ ¦the¦ ¦house¦ .
𐋇¦do¦ ¦not¦ ¦go¦ ¦to¦ ¦the¦ ¦ph arm acy¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦covid¦ - ¦19¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦covid¦ - ¦19¦ ¦symptoms¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦wai ting¦ ¦for¦ ¦a¦ ¦test¦ ¦or¦ ¦covid¦ - ¦19¦ ¦test¦ ¦results¦
𐋇¦if¦ ¦close¦ ¦contact¦ ¦with¦ ¦covid¦ - ¦19¦ ¦case¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦re stric ting¦ ¦your¦ ¦movements¦
𐋇 ¦call¦ ¦your¦ ¦ph arm ac ist¦ ¦and¦ ¦t ell¦ ¦one¦ ¦of¦ ¦your¦ ¦family¦ ¦to¦ ¦coll ect¦ ¦the¦ ¦pr esc ri ption¦ .
𐋇 ¦medical¦ ¦supp l ies¦
𐋇¦there¦ ¦is¦ ¦no¦ ¦dis ru ption¦ ¦to¦ ¦the¦ ¦supp ly¦ ¦of¦ ¦medic ation¦ .
𐋇 ¦no¦ ¦need¦ ¦to¦ ¦pr esc rib e¦ ¦more¦ ¦medic ation¦ ¦than¦ ¦you¦ ¦need¦ .
𐋇¦if¦ ¦you¦ ¦do¦ ¦this¦ ,▁ ¦it¦ ¦will¦ ¦aff ect¦ ¦the¦ ¦supp ly¦ ¦of¦ ¦medic ation¦ ¦to¦ ¦others¦ .
𐋇¦stay¦ ¦safe¦ .
𐋇 ¦keep¦ ¦each¦ ¦other¦ ¦safe¦
𐋇¦the¦ ¦covid¦ ¦tracker¦ ¦is¦ ¦a¦ ¦fre e¦ ¦app¦ ¦for¦ ¦your¦ ¦m ob i le¦ ¦phone¦ .
𐋇¦it¦ ¦will¦ ¦help¦ ¦us¦ ¦protect¦ ¦each¦ ¦other¦ ¦and¦ ¦cur b ¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦coronavirus¦ ▁( ¦covid¦ - ¦19¦ )▁ ¦in¦ ¦ireland¦ .
𐋇¦the¦ ¦covid¦ ¦tracking¦ ¦app¦ ¦co mb ined¦ ¦with¦ ¦ex is ting¦ ¦public¦ ¦health¦ ¦measures¦ ,▁ ¦h el ps¦ ¦us¦ ¦stay¦ ¦safe¦ ¦when¦ ¦we¦ ¦me et¦ ,▁ ¦s oc ially¦ ,▁ ¦at¦ ¦work¦ ¦or¦ ¦tra ve lling¦ .
𐋇 ¦direct¦ ¦contact¦ ¦alert¦
𐋇¦if¦ ¦you¦ ¦use¦ ¦the¦ ¦app¦ :
𐋇¦you¦ ¦will¦ ¦receive¦ ¦an¦ ¦alert¦ ¦when¦ ¦you¦ ¦make¦ ¦close¦ ¦contact¦ ¦with¦ ¦another¦ ¦app¦ ¦us er¦ ¦who¦ ¦has¦ ¦tested¦ ¦positive¦ ¦for¦ ¦the¦ ¦cr own¦ ¦virus¦ ¦test¦
𐋇¦you¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦tr ack¦ ¦any¦ ¦s ign¦ ¦and¦ ¦get¦ ¦advice¦ ¦on¦ ¦how¦ ¦to¦ ¦protect¦ ¦yourself¦ ¦and¦ ¦others¦
𐋇¦if¦ ¦you¦ ¦get¦ ¦a¦ ¦positive¦ ¦test¦ ¦result¦ ¦for¦ ¦the¦ ¦cr own¦ ¦virus¦ ,▁ ¦you¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦s end¦ ¦an¦ ¦an on y mo us¦ ¦alert¦ ¦to¦ ¦other¦ ¦app¦ ¦us ers¦ ¦you¦ ¦have¦ ¦come¦ ¦into¦ ¦the¦ ¦close¦ ¦with¦ ¦their¦ ¦contact¦ .
𐋇 ¦immediate¦ ¦contact¦ ¦alert¦ ▁-▁ ¦this¦ ¦is¦ ¦how¦ ¦it¦ ¦l oo ks¦ ¦and¦ ¦how¦ ¦to¦ ¦contact¦ ¦tracking¦ ¦wor ks¦
𐋇 ¦ch eck¦ ¦into¦ ¦covid¦
𐋇 ¦tr ack¦ ¦how¦ ¦you¦ ¦feel¦ ¦every¦ ¦day¦ ,▁ ¦f ind¦ ¦out¦ ¦if¦ ¦you¦ ¦have¦ ¦symptoms¦ ¦of¦ ¦coronavirus¦ ¦and¦ ¦get¦ ¦re li able¦ ¦information¦ .
𐋇 ¦wh y¦ ¦would¦ ¦you¦ ¦use¦ ¦the¦ ¦app¦
𐋇 ¦priv acy¦ ¦prot ected¦
𐋇¦the¦ ¦covid¦ ¦tracker¦ ¦app¦ ¦prot ects¦ ¦the¦ ¦priv acy¦ ¦of¦ ¦all¦ ¦us ers¦ .
𐋇¦it¦ ¦is¦ ¦d es ig ned¦ ¦to¦ ¦protect¦ ¦your¦ ¦priv acy¦ .
𐋇¦how¦ ¦your¦ ¦data¦ ¦will¦ ¦be¦ ¦used¦
𐋇¦the¦ ¦techn ology¦ ¦in¦ ¦use¦
𐋇¦the¦ ¦app¦ ¦u ses¦ ¦b lu et oo th¦ ¦and¦ ¦an on y mo us¦ ¦to¦ ¦coll ect¦ ¦contact¦ ¦information¦ ¦on¦ ¦any¦ ¦phone¦ ¦using¦ ¦the¦ ¦app¦ .
𐋇¦the¦ ¦techn ology¦ ¦used¦ ¦in¦ ¦the¦ ¦app¦
𐋇¦d ow n lo ad¦ ¦the¦ ¦app¦ ¦to day¦
𐋇 ¦get¦ ¦the¦ ¦app¦ ¦from¦ ¦your¦ ¦normal¦ ¦app¦ ¦st ore¦
𐋇¦s el ect¦ ¦the¦ ¦information¦ ¦you¦ ¦w ant¦ ¦to¦ ¦share¦ ¦or¦ ¦not¦ ¦share¦
𐋇 ¦get¦ ¦invol v ed¦ ¦in¦ ¦this¦ ¦work¦ ¦and¦ ¦control¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦cr own¦ ¦virus¦ ¦and¦ ¦keep¦ ¦each¦ ¦other¦ ¦safe¦ .
𐋇¦you¦ ¦may¦ ¦be¦ ¦in¦ ¦immediate¦ ¦contact¦ ¦if¦ ¦you¦ ¦come¦ ¦into¦ ¦close¦ ¦contact¦ ¦with¦ ¦someone¦ ¦who¦ ¦has¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ ) :
𐋇 ¦direct¦ ¦contact¦
𐋇 ¦immediate¦ ¦contact¦ ¦me ans¦ :
𐋇 ¦contact¦ ¦about¦ ¦2¦ ¦meters¦ ¦with¦ ¦an¦ ¦infected¦ ¦person¦ ¦for¦ ¦more¦ ¦than¦ ¦15¦ ¦min u tes¦ ,▁ ¦ind o ors¦ ¦or¦ ¦out d o ors¦
𐋇 ¦li ving¦ ¦in¦ ¦the¦ ¦same¦ ¦house¦ ¦or¦ ¦acc om mo d ation¦ ¦as¦ ¦an¦ ¦infected¦ ¦person¦
𐋇¦s it ting¦ ¦in¦ ¦the¦ ¦v ic in ity¦ ¦of¦ ¦an¦ ¦infected¦ ¦person¦ ¦on¦ ¦two¦ ¦s ea ts¦ ¦on¦ ¦public¦ ¦transport¦ ¦or¦ ¦an¦ ¦air pl an e¦
𐋇¦you¦ ¦may¦ ¦also¦ ¦be¦ ¦your¦ ¦immediate¦ ¦or¦ ¦c as ual¦ ¦contact¦ ¦if¦ ¦you¦ ¦sp end¦ ¦more¦ ¦than¦ ¦2¦ ¦hours¦ ¦ind o ors¦ ¦in¦ ¦an¦ ¦off ice¦ ¦or¦ ¦c la ss ro om¦ ¦with¦ ¦an¦ ¦infected¦ ¦person¦ .
𐋇¦this¦ ¦will¦ ¦dep end¦ ¦on¦ ¦the¦ ¦s iz e¦ ¦of¦ ¦the¦ ¦ro om¦ ¦and¦ ¦other¦ ¦c ir c um st an ces¦ .
𐋇¦the¦ ¦health¦ ¦off ici als¦ ¦or¦ ¦contact¦ ¦admin i str at or¦ ¦will¦ ¦t ell¦ ¦you¦ ¦if¦ ¦you¦ ¦are¦ ¦at¦ ¦risk¦ .
𐋇 ¦advice¦ ¦for¦ ¦healthcare¦ ¦workers¦
𐋇 ¦healthcare¦ ¦workers¦ ¦should¦ ¦follow¦ ¦specific¦ ¦advice¦ :
𐋇 ¦healthcare¦ ¦workers¦ ¦who¦ ¦are¦ ¦w earing¦ ¦ pp e¦ ¦when¦ ¦al er ted¦ ¦through¦ ¦the¦ ¦covid¦ ¦tracker¦ ¦app¦
𐋇¦how¦ ¦to¦ ¦f ind¦ ¦out¦ ¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦
𐋇¦you¦ ¦will¦ ¦us ually¦ ¦f ind¦ ¦out¦ ¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦ :
𐋇 ¦our¦ ¦contact¦ ¦tracking¦ ¦team¦
𐋇¦on¦ ¦the¦ ¦covid¦ ¦tracker¦ ¦app¦
𐋇 ¦from¦ ¦the¦ ¦public¦ ¦health¦ ¦team¦ ¦in ve st ig ating¦ ¦a¦ ¦ce rt if ied¦ ¦case¦ ¦in¦ ¦a¦ ¦specific¦ ¦s etting¦ .
𐋇¦for¦ ¦example¦ ¦nu rs ing¦ ¦home¦ ¦or¦ ¦work pl ace¦ ¦or¦ ¦school¦ .
𐋇¦when¦ ¦you¦ ¦are¦ ¦in¦ ¦your¦ ¦immediate¦ ¦contact¦
𐋇¦you¦ ¦will¦ ¦be¦ ¦your¦ ¦immediate¦ ¦contact¦ ¦if¦ ¦you¦ ¦have¦ ¦been¦ ¦in¦ ¦contact¦ ¦with¦ :
𐋇¦a¦ ¦person¦ ¦who¦ ¦developed¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ¦and¦ ¦star ted¦ ¦self¦ - ¦isolation¦ ¦within¦ ¦4 8¦ ¦hours¦ ¦of¦ ¦being¦ ¦contac ted¦
𐋇¦a¦ ¦person¦ ¦who¦ ¦had¦ ¦no¦ ¦symptoms¦ ¦but¦ ¦tested¦ ¦positive¦ ¦for¦ ¦the¦ ¦virus¦ ¦within¦ ¦24¦ ¦hours¦ ¦of¦ ¦being¦ ¦contac ted¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦ ¦but¦ ¦no¦ ¦contact¦ ¦has¦ ¦been¦ ¦made¦
𐋇¦if¦ ¦you¦ ¦th ink¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦ ¦but¦ ¦have¦ ¦not¦ ¦he ard¦ ¦from¦ ¦the¦ ¦contact¦ ¦tracking¦ ¦team¦ :
𐋇 ¦restrict¦ ¦your¦ ¦movements¦ ▁( ¦stay¦ ¦at¦ ¦home¦ )
𐋇 ¦call¦ ¦the¦ ¦covid¦ - ¦19¦ ¦h el p line¦ ¦and¦ ¦t ell¦ ¦them¦ ¦that¦ ¦you¦ ¦have¦ ¦been¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ ¦someone¦ ¦who¦ ¦has¦ ¦tested¦ ¦positive¦ ▁( ¦covid¦ - ¦19¦ )
𐋇 ¦what¦ ¦to¦ ¦do¦ ¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦
𐋇 ¦fi x¦ ¦covid¦ - ¦19¦ ¦test¦
𐋇 ¦restrict¦ ¦your¦ ¦movements¦ ▁( ¦stay¦ ¦at¦ ¦home¦ ).
𐋇¦read¦ ¦about¦ ¦what¦ ¦to¦ ¦do¦ ¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦
𐋇 ¦li ving¦ ¦with¦ ¦someone¦ ¦who¦ ¦is¦ ¦a¦ ¦positive¦ ¦close¦ ¦contact¦
𐋇¦you¦ ¦do¦ ¦not¦ ¦have¦ ¦to¦ ¦restrict¦ ¦your¦ ¦movements¦ ¦if¦ ¦you¦ ¦live¦ ¦with¦ ,▁ ¦or¦ ¦have¦ ¦been¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ ,▁ ¦someone¦ ¦who¦ ¦has¦ ¦been¦ ¦to ld¦ ¦to¦ ¦be¦ ¦a¦ ¦close¦ ¦contact¦ .
𐋇¦you¦ ¦can¦ ¦go¦ ¦to¦ ¦work¦ ,▁ ¦school¦ ,▁ ¦pres ch oo l¦ ¦or¦ ¦ch ild c are¦ ¦if¦ ¦you¦ ¦have¦ ¦no¦ ¦symptoms¦ .
𐋇¦if¦ ¦the¦ ¦immediate¦ ¦contact¦ ¦has¦ ¦symptoms¦ ,▁ ¦they¦ ¦will¦ ¦need¦ ¦to¦ ¦self¦ - ¦isol ate¦ ¦and¦ ¦call¦ ¦the¦ ¦gp¦ .
𐋇¦you¦ ¦will¦ ¦need¦ ¦to¦ ¦restrict¦ ¦your¦ ¦movements¦ .
𐋇 ¦ra nd om¦ ¦contact¦
𐋇¦you¦ ¦may¦ ¦have¦ ¦been¦ ¦in¦ ¦contact¦ ¦with¦ ¦someone¦ ¦with¦ ¦covid¦ - ¦19¦ ,▁ ¦but¦ ¦you¦ ¦are¦ ¦not¦ ¦a¦ ¦close¦ ¦contact¦ ¦by¦ ¦def in ition¦ .
𐋇¦this¦ ¦is¦ ¦a¦ ¦tr iv ial¦ ¦tou ch¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦c as ual¦ ¦contact¦ ,▁ ¦you¦ ¦do¦ ¦not¦ ¦need¦ ¦to¦ ¦restrict¦ ¦your¦ ¦movements¦ .
𐋇 ¦follow¦ ¦the¦ ¦health¦ ¦advice¦ ¦on¦ ¦how¦ ¦to¦ ¦protect¦ ¦yourself¦ ¦and¦ ¦others¦ ,▁ ¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦c as ual¦ ¦contact¦ ,▁ ¦there¦ ¦is¦ ¦no¦ ¦need¦ ¦to¦ ¦take¦ ¦the¦ ¦test¦ .
𐋇 ¦inv it ations¦ ¦are¦ ¦n ow¦ ¦being¦ ¦s ent¦ ¦to¦ ¦el ig i ble¦ ¦people¦ ¦on¦ ¦a¦ ¦ph a sed¦ ¦ba sis¦ .
𐋇¦b ow el s c re en¦ ¦is¦ ¦ser ving¦ ¦those¦ ¦wh ose¦ ¦app oi nt ments¦ ¦have¦ ¦been¦ ¦po st p o ned¦ ¦due¦ ¦to¦ ¦cov id 1 9¦ .
𐋇 ¦home¦ ¦scre ening¦ ¦equipment¦ ¦and¦ ¦laboratory¦ ¦rep orts¦ ¦will¦ ¦be¦ ¦proc es sed¦ .
𐋇¦we¦ ¦will¦ ¦continue¦ ¦to¦ ¦monit or¦ ¦public¦ ¦health¦ ¦advice¦ ¦to¦ ¦e ns ure¦ ¦that¦ ¦the¦ ¦proc ess¦ ¦is¦ ¦safe¦ ¦for¦ ¦you¦ ¦and¦ ¦our¦ ¦staff¦ .
𐋇¦you¦ ¦can¦ ¦call¦ ¦b ow el s c re en¦ ¦on¦ ¦fre e ph one¦
𐋇¦ end os c op ic¦ ¦app oi nt ments¦
𐋇¦a¦ ¦n ur se¦ ¦will¦ ¦contact¦ ¦you¦ ¦to¦ ¦arr ange¦ ¦your¦ ¦ end os c op y¦ ¦and¦ ¦to¦ ¦ad v ise¦ ¦you¦ ¦about¦ ¦the¦ ¦covid¦ - ¦19¦ ¦measures¦ ¦in¦ ¦the¦ ¦hospital¦ .
𐋇¦these¦ ¦chan ges¦ ¦may¦ ¦include¦ :
𐋇¦your¦ ¦n ur se¦ ¦or¦ ¦doctor¦ ¦w earing¦ ¦personal¦ ¦prot ective¦ ¦equipment¦ ▁( ¦ pp e¦ )
𐋇¦you¦ ¦would¦ ¦have¦ ¦to¦ ¦stay¦ ¦outside¦ ¦until¦ ¦it¦ ¦is¦ ¦time¦ ¦for¦ ¦your¦ ¦appointment¦
𐋇 ¦have¦ ¦fe w er¦ ¦people¦ ¦in¦ ¦your¦ ¦healthcare¦ ¦bu il ding¦
𐋇¦you¦ ¦may¦ ¦have¦ ¦to¦ ¦wai t¦ ¦lo nger¦ ¦for¦ ¦your¦ ¦appointment¦ ¦follow¦ ¦hospital¦ ¦and¦ ¦public¦ ¦health¦ ¦advice¦ ¦on¦ ¦att ending¦ ¦hospital¦ ¦app oi nt ments¦ .
𐋇 ¦ex os c op y¦ ¦after¦ ¦ bo we l¦ ¦scre ening¦
𐋇 ¦signs¦ ¦of¦ ¦illness¦ ▁-▁ ¦call¦ ¦your¦ ¦gp¦
𐋇¦it¦ ¦is¦ ¦important¦ ¦to¦ ¦re me mber¦ ¦that¦ ¦9¦ ¦out¦ ¦of¦ ¦10¦ ¦people¦ ¦who¦ ¦have¦ ¦blood¦ ¦in¦ ¦their¦ ¦ bo we l¦ ¦movements¦ ▁( ¦s hi t¦ )▁ ¦will¦ ¦not¦ ¦have¦ ¦cance r¦ .
𐋇¦a¦ ¦sm all¦ ¦gr ow th¦ ¦called¦ ¦pol y ps¦ ¦or¦ ¦other¦ ¦i ll n es ses¦ ¦such¦ ¦as¦ ¦f ic us¦ ▁( ¦he m or r h oi ds¦ )▁ ¦can¦ ¦cause¦ ¦blood¦ ¦in¦ ¦your¦ ¦s hi t¦ .
𐋇¦it¦ ¦is¦ ¦very¦ ¦important¦ ¦to¦ ¦be¦ ¦a w are¦ ¦of¦ ¦the¦ ¦symptoms¦ ¦of¦ ¦ bo we l¦ ¦cance r¦ .
𐋇 ¦signs¦ ¦include¦ :
𐋇¦the¦ ¦con st ant¦ ¦ch ange¦ ¦in¦ ¦normal¦ ¦ bo we l¦ ¦movements¦ .
𐋇 ¦go ing¦ ¦more¦ ¦often¦ ,▁ ¦with¦ ¦di arr ho e a¦ ¦with¦ ¦pain¦ ¦in¦ ¦the¦ ¦sto ma ch¦ ¦s om et im es¦
𐋇 ¦blood¦ ¦in¦ ¦your¦ ¦s hi t¦ ,▁ ¦especially¦ ¦if¦ ¦it¦ ¦is¦ ¦mi x ed¦ ¦through¦ ¦the¦ ¦s hi t¦ .
𐋇¦this¦ ¦ma k es¦ ¦it¦ ¦un li k ely¦ ¦that¦ ¦he m or r h oi ds¦ ¦are¦ ¦the¦ ¦cause¦
𐋇 ¦sto ma ch¦ ¦pain¦ ,▁ ¦disc om f ort¦ ,▁ ¦or¦ ¦ab d om en¦ ¦that¦ ¦is¦ ¦con st ant¦ ¦after¦ ¦e ating¦ .
𐋇¦s om et im es¦ ¦you¦ ¦d on¦ ' ¦t¦ ¦e at¦ ¦as¦ ¦much¦ ,▁ ¦or¦ ¦you¦ ¦l ose¦ ¦we ight¦
𐋇 ¦symptoms¦ ¦of¦ ¦ bo we l¦ ¦cance r¦ ¦are¦ ¦also¦ ¦prev al ent¦ ,▁ ¦and¦ ¦most¦ ¦people¦ ¦who¦ ¦have¦ ¦these¦ ¦symptoms¦ ¦do¦ ¦not¦ ¦have¦ ¦cance r¦ .▁ 𐋇¦for¦ ¦example¦ :
𐋇¦a¦ ¦ch ange¦ ¦in¦ ¦normal¦ ¦ bo we l¦ ¦movements¦ ¦is¦ ¦us ually¦ ¦caused¦ ¦by¦ ¦so me thing¦ ¦e at en¦ ¦by¦ ¦a¦ ¦person¦
𐋇¦you¦ ¦prob ab ly¦ ¦d on¦ ' ¦t¦ ¦have¦ ¦a¦ ¦lo us y¦ ¦illness¦ ¦if¦ ¦you¦ ¦d on¦ ' ¦t¦ ¦go¦ ¦to¦ ¦the¦ ¦to il et¦ ¦as¦ ¦often¦ ,▁ ¦or¦ ¦if¦ ¦the¦ ¦s hi t¦ ¦g ets¦ ¦h ar der¦ .
𐋇¦it¦ ¦may¦ ¦be¦ ¦wor th¦ ¦tr ying¦ ¦la x at ives¦ ¦before¦ ¦go ing¦ ¦to¦ ¦the¦ ¦doctor¦ .
𐋇 ¦r ar ely¦ ¦h ard¦ ¦and¦ ¦s hi t¦
𐋇¦f r es h ¦ ¦blood¦ ¦not¦ ¦in¦ ¦the¦ ¦s hi t¦ ¦ it s el f¦ ¦or¦ ¦cov ering¦ ¦the¦ ¦s hi t¦ .
𐋇¦this¦ ¦is¦ ¦often¦ ¦se en¦ ¦in¦ ¦pain¦ ¦due¦ ¦to¦ ¦he m or r h oi ds¦ ¦or¦ ¦min or¦ ¦c u ts¦
𐋇¦you¦ ¦should¦ ¦be¦ ¦more¦ ¦ca re ful¦ ¦about¦ ¦these¦ ¦symptoms¦ ¦as¦ ¦you¦ ¦age¦ ¦and¦ ¦if¦ ¦they¦ ¦pers ist¦ ¦d esp ite¦ ¦si mp le¦ ¦tre at ments¦ .
𐋇¦if¦ ¦you¦ ¦n ot ice¦ ¦any¦ ¦of¦ ¦them¦ ,▁ ¦p le ase¦ ¦contact¦ ¦your¦ ¦gp¦ .
𐋇 ¦signs¦ ¦of¦ ¦ bo we l¦ ¦cance r¦
𐋇 ¦scre ening¦ ¦will¦ ¦res u me¦ ¦according¦ ¦to¦ ¦public¦ ¦health¦ ¦advice¦ ¦as¦ ¦corona ry¦ ¦virus¦ ¦restrictions¦ ¦are¦ ¦m it ig ated¦ .
𐋇¦we¦ ¦will¦ ¦continue¦ ¦to¦ ¦keep¦ ¦a¦ ¦close¦ ¦ey e¦ ¦on¦ ¦this¦ ¦gu ide¦ ¦to¦ ¦e ns ure¦ ¦that¦ ¦you¦ ¦and¦ ¦our¦ ¦staff¦ ¦are¦ ¦safe¦ .
𐋇¦if¦ ¦you¦ ¦would¦ ¦like¦ ¦to¦ ¦contact¦ ¦us¦ ,▁ ¦p le ase¦ ¦call¦ ¦fre e ph one¦ .
𐋇¦the¦ ¦people¦ ¦who¦ ¦will¦ ¦be¦ ¦tested¦ ¦first¦
𐋇¦we¦ ¦will¦ ¦star t¦ ¦with¦ ¦the¦ ¦lo ng est¦ ¦wai ting¦ ¦for¦ ¦b re ast¦ ¦scre ening¦ .
𐋇¦these¦ ¦l et t ers¦ ¦will¦ ¦be¦ ¦s ent¦ ¦out¦ ¦during¦ ¦se p te mber¦ ▁/▁ ¦o ct ob er¦ .
𐋇 ¦following¦ ¦this¦ ,▁ ¦we¦ ¦will¦ ¦s end¦ ¦out¦ ¦inv it ations¦ ¦to¦ ¦people¦ ¦for¦ ¦ro ut ine¦ ¦scre ening¦ .
𐋇¦it¦ ¦will¦ ¦take¦ ¦us¦ ¦several¦ ¦mon ths¦ ¦to¦ ¦c at ch¦ ¦up¦ ¦on¦ ¦the¦ ¦wai ting¦ ¦l ist¦ ¦as¦ ¦the¦ ¦tests¦ ¦were¦ ¦disc o nt in u ed¦ ¦in¦ ¦march¦ .
𐋇¦we¦ ¦will¦ ¦not¦ ¦be¦ ¦able¦ ¦to¦ ¦do¦ ¦the¦ ¦same¦ ¦number¦ ¦of¦ ¦tests¦ ¦every¦ ¦day¦ ¦because¦ ¦social¦ ¦separ ation¦ ¦has¦ ¦to¦ ¦be¦ ¦practi sed¦ .
𐋇¦p le ase¦ ¦be¦ ¦pa ti ent¦ ¦and¦ ¦wai t¦ ¦for¦ ¦your¦ ¦l et ter¦ ¦as king¦ ¦you¦ ¦to¦ ¦b ook¦ ¦your¦ ¦test¦ ¦ag a in¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦a ged¦ ¦between¦ ¦50¦ ¦and¦ ¦5 2¦ ¦and¦ ¦c om ing¦ ¦for¦ ¦your¦ ¦test¦ ¦for¦ ¦the¦ ¦first¦ ¦time¦ ,▁ ¦p le ase¦ ¦ch eck¦ ¦the¦ ¦reg is ter¦ ¦h er e¦ ¦to¦ ¦make¦ ¦sure¦ ¦we¦ ¦have¦ ¦all¦ ¦the¦ ¦detail s¦ ¦we¦ ¦need¦ ¦to¦ ¦arr ange¦ ¦your¦ ¦test¦ ¦appointment¦ .
𐋇 ¦go ing¦ ¦for¦ ¦a¦ ¦scre ening¦
𐋇 ¦while¦ ¦your¦ ¦b re ast¦ ¦test¦ ¦will¦ ¦be¦ ¦the¦ ¦same¦ ,▁ ¦there¦ ¦may¦ ¦be¦ ¦some¦ ¦chan ges¦ ¦when¦ ¦you¦ ¦go¦ ¦to¦ ¦your¦ ¦cl in ic¦ ¦or¦ ¦m ob i le¦ ¦uni t¦ ¦for¦ ¦your¦ ¦ne xt¦ ¦scre ening¦ ¦appointment¦ .
𐋇 ¦our¦ ¦cl in ics¦ ¦and¦ ¦m ob i le¦ ¦uni ts¦ ¦are¦ ¦wor king¦ ¦h ard¦ ¦to¦ ¦make¦ ¦chan ges¦ ¦to¦ ¦keep¦ ¦you¦ ¦safe¦ ¦when¦ ¦you¦ ¦go¦ ¦for¦ ¦your¦ ¦appointment¦ .
𐋇¦these¦ ¦chan ges¦ ¦may¦ ¦include¦ :
𐋇¦t al king¦ ¦on¦ ¦the¦ ¦phone¦ ¦with¦ ¦the¦ ¦brea st ch eck¦ ¦team¦ ¦before¦ ¦your¦ ¦appointment¦
𐋇¦your¦ ¦ra di ogra p her¦ ¦or¦ ¦doctor¦ ¦w earing¦ ¦personal¦ ¦prot ective¦ ¦equipment¦ ▁( ¦ pp e¦ )
𐋇¦w earing¦ ¦a¦ ¦mask¦ ¦during¦ ¦your¦ ¦appointment¦
𐋇 ¦wai ting¦ ¦outside¦ ¦until¦ ¦it¦ ' ¦s¦ ¦time¦ ¦to¦ ¦go¦ ¦to¦ ¦your¦ ¦appointment¦
𐋇 ¦fe w er¦ ¦people¦ ¦in¦ ¦the¦ ¦healthcare¦ ¦bu il ding¦ ¦or¦ ¦m ob i le¦ ¦uni t¦
𐋇 ¦wai ting¦ ¦a¦ ¦l it t le¦ ¦lo nger¦ ¦for¦ ¦your¦ ¦appointment¦ ¦because¦ ¦the¦ ¦uni t¦ ¦must¦ ¦be¦ ¦comp le tely¦ ¦disinf ected¦ ¦between¦ ¦each¦ ¦scre ening¦
𐋇¦c om ing¦ ¦into¦ ¦the¦ ¦uni t¦ ¦or¦ ¦cl in ic¦ ¦without¦ ¦someone¦ ¦from¦ ¦your¦ ¦family¦ ¦with¦ ¦you¦
𐋇 ¦ent ering¦ ¦and¦ ¦e xi ting¦ ¦your¦ ¦cl in ic¦ ¦through¦ ¦v ar ious¦ ¦do ors¦ .
𐋇¦for¦ ¦this¦ ¦re as on¦ ,▁ ¦you¦ ¦are¦ ¦ad vi sed¦ ¦to¦ :
𐋇 ¦make¦ ¦sure¦ ¦you¦ ¦have¦ ¦en ough¦ ¦time¦ ¦to¦ ¦par k¦ ¦if¦ ¦you¦ ¦are¦ ¦d ri ving¦
𐋇 ¦be¦ ¦pre p ared¦ ¦to¦ ¦sp end¦ ¦more¦ ¦time¦ ¦at¦ ¦the¦ ¦test¦
𐋇 ¦ch eck¦ ¦your¦ ¦transport¦ ¦op tions¦ ¦for¦ ¦retur ning¦ ¦home¦
𐋇 ¦br ing¦ ¦prop er¦ ¦c lo thing¦ ¦and¦ ¦a¦ ¦r ai nc o at¦ ¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦arr ive¦ ¦by¦ ¦ca r¦
𐋇 ¦br ing¦ ¦your¦ ¦ own¦ ¦p en¦ ¦to¦ ¦s ign¦ ¦the¦ ¦required¦ ¦for ms¦
𐋇¦stay¦ ¦in¦ ¦tou ch¦ ¦with¦ ¦your¦ ¦cl in ic¦ ¦before¦ ¦your¦ ¦visit¦ ¦and¦ ¦follow¦ ¦their¦ ¦advice¦
𐋇 ¦to il ets¦ ¦may¦ ¦not¦ ¦be¦ ¦available¦ ¦in¦ ¦some¦ ¦test¦ ¦centr es¦
𐋇 ¦due¦ ¦to¦ ¦covid¦ - ¦19¦ ¦restrictions¦ ,▁ ¦it¦ ¦is¦ ¦ta king¦ ¦us¦ ¦lo nger¦ ¦to¦ ¦do¦ ¦the¦ ¦tests¦ .
𐋇¦it¦ ¦is¦ ¦the re f ore¦ ¦important¦ ¦to¦ ¦come¦ ¦to¦ ¦your¦ ¦appointment¦ ¦when¦ ¦you¦ ¦are¦ ¦called¦ .
𐋇¦you¦ ¦will¦ ¦receive¦ ¦one¦ ¦brea st ch eck¦ ¦appointment¦ ¦l et ter¦ ¦during¦ ¦this¦ ¦scre ening¦ ¦ro un d¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦un able¦ ¦to¦ ¦att end¦ ¦your¦ ¦appointment¦ ,▁ ¦p le ase¦ ¦contact¦ ¦us¦ ¦to¦ ¦ch ange¦ ¦your¦ ¦appointment¦ .
𐋇¦you¦ ¦will¦ ¦not¦ ¦receive¦ ¦a¦ ¦re min der¦ ¦l et ter¦ .
𐋇 ¦follow¦ - ¦up¦ ¦treatment¦
𐋇 ¦hospital¦ ¦cl in ics¦ ¦are¦ ¦available¦ ¦for¦ ¦people¦ ¦if¦ ¦the¦ ¦results¦ ¦of¦ ¦scre ening¦ ¦and¦ ¦follow¦ - ¦up¦ ¦tests¦ ¦sh ow¦ ¦that¦ ¦they¦ ¦need¦ ¦hospital¦ ¦treatment¦ .
𐋇¦there¦ ¦may¦ ¦be¦ ¦chan ges¦ ¦when¦ ¦you¦ ¦go¦ ¦to¦ ¦your¦ ¦hospital¦ ¦cl in ic¦ ¦for¦ ¦your¦ ¦ne xt¦ ¦appointment¦ .
𐋇¦do¦ ¦your¦ ¦b est¦ ¦to¦ ¦make¦ ¦chan ges¦ ¦to¦ ¦keep¦ ¦you¦ ¦safe¦ ¦during¦ ¦your¦ ¦appointment¦ .
𐋇¦these¦ ¦chan ges¦ ¦may¦ ¦include¦ :
𐋇¦your¦ ¦n ur se¦ ¦or¦ ¦doctor¦ ¦w earing¦ ¦personal¦ ¦prot ective¦ ¦equipment¦ ▁( ¦ pp e¦ )
𐋇 ¦wai ting¦ ¦outside¦ ¦until¦ ¦it¦ ▁’▁ ¦s¦ ¦time¦ ¦for¦ ¦your¦ ¦appointment¦
𐋇 ¦fe w er¦ ¦people¦ ¦in¦ ¦your¦ ¦healthcare¦ ¦bu il ding¦
𐋇 ¦wai ting¦ ¦lo nger¦ ¦for¦ ¦your¦ ¦appointment¦ ¦while¦ ¦the¦ ¦treatment¦ ¦r oo ms¦ ¦are¦ ¦being¦ ¦disinf ected¦
𐋇¦your¦ ¦hospital¦ ¦cl in ic¦ ¦will¦ ¦contact¦ ¦you¦ ¦before¦ ¦your¦ ¦appointment¦ ¦to¦ ¦t ell¦ ¦you¦ ¦what¦ ¦to¦ ¦exp ect¦ ¦when¦ ¦you¦ ¦come¦ ¦to¦ ¦the¦ ¦cl in ic¦ .
𐋇¦you¦ ¦can¦ ¦contact¦ ¦brea st ch eck¦ ¦on¦ ¦fre e ph one¦ .
𐋇 ¦as k¦ ¦to¦ ¦sp ea k¦ ¦to¦ ¦one¦ ¦of¦ ¦our¦ ¦h ead¦ ¦n ur ses¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦ ill¦ ¦or¦ ¦wai ting¦ ¦on¦ ¦your¦ ¦ own¦
𐋇¦we¦ ¦as k¦ ¦that¦ ¦you¦ ¦do¦ ¦not¦ ¦come¦ ¦to¦ ¦your¦ ¦appointment¦ ¦if¦ ¦you¦ ¦are¦ ¦ ill¦ ¦or¦ ¦wai ting¦ ¦on¦ ¦your¦ ¦ own¦ ¦because¦ ¦you¦ ¦have¦ ¦symptoms¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇 ¦follow¦ ¦the¦ ¦l at est¦ ¦gu id el ines¦ ¦for¦ ¦sta ying¦ ¦al one¦ ¦after¦ ¦tra v el ing¦ ¦ab ro ad¦ ¦before¦ ¦att ending¦ ¦your¦ ¦appointment¦ .
𐋇 ¦star ting¦ ¦ag a in¦ ¦sa f ely¦
𐋇 ¦brea st ch eck¦ ¦p erm an ent¦ ¦uni ts¦ ¦continue¦ ¦to¦ ¦help¦ ¦their¦ ¦host¦ ¦hosp it als¦ ¦ass ess¦ ¦and¦ ¦tre at¦ ¦women¦ ¦with¦ ¦cance r¦ ¦symptoms¦ ¦and¦ ¦pri or itiz e¦ ¦patients¦ ¦with¦ ¦ad v a nc ed¦ ¦or¦ ¦a gg re ss ive¦ ¦cance r¦ .
𐋇 ¦during¦ ¦this¦ ¦work¦ ,▁ ¦all¦ ¦brea st ch eck¦ ¦m ob i le¦ ¦uni ts¦ ¦are¦ ¦being¦ ¦ad ap ted¦ ¦so¦ ¦that¦ ¦they¦ ¦can¦ ¦provide¦ ¦a¦ ¦safe¦ ¦en vir on ment¦ ¦for¦ ¦patients¦ ¦and¦ ¦staff¦ ¦when¦ ¦b re ast¦ ¦scre ening¦ ¦res um es¦ .
𐋇¦the¦ ¦res um ption¦ ¦of¦ ¦scre ening¦ ¦will¦ ¦dep end¦ ¦on¦ ¦the¦ ¦state¦ ¦of¦ ¦covid¦ - ¦19¦ ¦and¦ ¦the¦ ¦e as ing¦ ¦of¦ ¦government¦ ¦restrictions¦ .
𐋇¦we¦ ¦will¦ ¦continue¦ ¦to¦ ¦ch eck¦ ¦that¦ ¦the¦ ¦scre ening¦ ¦system¦ ¦is¦ ¦f u nc tion ing¦ ¦well¦ ¦during¦ ¦the¦ ¦re st ar t¦ ¦period¦ ¦in¦ ¦the¦ ¦inter e sts¦ ¦of¦ ¦your¦ ¦safety¦ ¦and¦ ¦the¦ ¦safety¦ ¦of¦ ¦our¦ ¦staff¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦symptoms¦ ▁-▁ ¦call¦ ¦your¦ ¦gp¦
𐋇 ¦contact¦ ¦your¦ ¦gp¦ ¦imm ed ia tely¦ ¦if¦ ¦you¦ ¦have¦ ¦any¦ ¦signs¦ ¦of¦ ¦b re ast¦ ¦cance r¦ .
𐋇 ¦ne ver¦ ¦i gn ore¦ ¦the¦ ¦symptoms¦ .
𐋇 ¦symptoms¦ ¦of¦ ¦b re ast¦ ¦cance r¦ ¦include¦ :
𐋇¦l um p¦ ¦in¦ ¦the¦ ¦b re ast¦
𐋇 ¦lea k age¦ ¦from¦ ¦your¦ ¦n i pp les¦ ▁( ¦this¦ ¦may¦ ¦con tain¦ ¦blood¦ )
𐋇¦a¦ ¦l um p¦ ¦under¦ ¦your¦ ¦ar mp i t¦
𐋇 ¦ch ange¦ ¦in¦ ¦s iz e¦ ¦or¦ ¦sh ap e¦ ¦in¦ ¦e it her¦ ¦b re ast¦
𐋇¦p at ches¦ ¦on¦ ¦the¦ ¦s k in¦ ¦of¦ ¦your¦ ¦brea sts¦
𐋇 ¦r as h ¦ ¦on¦ ¦or¦ ¦around¦ ¦your¦ ¦sh in¦
𐋇 ¦ch ange¦ ¦the¦ ¦app ear ance¦ ¦of¦ ¦your¦ ¦sh ine¦ ,▁ ¦or¦ ¦s qu ee z e¦ ¦it¦ ¦into¦ ¦your¦ ¦b re ast¦
𐋇 ¦att end¦ ¦an y w h er e¦ ¦is¦ ¦an¦ ¦online¦ ¦facil ity¦ ¦for¦ ¦patients¦ ¦to¦ ¦get¦ ¦a¦ ¦v ide o¦ ¦cons ult ation¦ ¦with¦ ¦a¦ ¦pr e¦ - ¦arr an ged¦ ¦appointment¦ .
𐋇¦it¦ ¦can¦ ¦be¦ ¦used¦ ¦on¦ ¦any¦ ¦comp u ter¦ ,▁ ¦ta bl et¦ ¦or¦ ¦s ma rt ph one¦ ¦with¦ ¦the¦ ¦l at est¦ ¦ ve rs ion¦ ¦of¦ ¦the¦ ¦go og le¦ ¦ch r ome¦ ¦or¦ ¦sa f ar i¦ ¦we b ¦ ¦br ow s er¦
𐋇¦it¦ ¦will¦ ¦not¦ ¦work¦ ¦with¦ ¦inter n et¦ ¦ex pl or er¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦go¦ ¦to¦ ¦a¦ ¦vir t ual¦ ¦wai ting¦ ¦a rea¦ ¦on¦ ¦time¦ ¦and¦ ¦the¦ ¦day¦ ¦of¦ ¦your¦ ¦appointment¦ ¦with¦ ¦an¦ ¦inter n et¦ ¦con ne ction¦ .
𐋇¦your¦ ¦hospital¦ ¦or¦ ¦out pa ti ent¦ ¦cl in ic¦ ¦will¦ ¦give¦ ¦you¦ ¦an¦ ¦inter n et¦ ¦con ne ction¦ .
𐋇¦b í ¦ ¦in¦ ¦the¦ ¦wai ting¦ ¦ro om¦ ¦t en¦ ¦min u tes¦ ¦before¦ ¦your¦ ¦appointment¦ .
𐋇 ¦only¦ ¦people¦ ¦with¦ ¦arr an ged¦ ¦app oi nt ments¦ ¦can¦ ¦be¦ ¦in¦ ¦the¦ ¦wai ting¦ ¦a rea¦ .
𐋇¦you¦ ¦will¦ ¦not¦ ¦be¦ ¦se en¦ ¦u ne x p ect ed ly¦ .
𐋇 ¦make¦ ¦sure¦ ¦you¦ ¦give¦ ¦all¦ ¦the¦ ¦detail s¦ ,▁ ¦including¦ ¦your¦ ¦date¦ ¦of¦ ¦b ir th¦ ¦and¦ ¦phone¦ ¦number¦ .
𐋇¦we¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦call¦ ¦you¦ ¦if¦ ¦there¦ ¦is¦ ¦any¦ ¦diffic ult y¦ .
𐋇¦we¦ ¦will¦ ¦not¦ ¦re tain¦ ¦the¦ ¦detail s¦ ¦you¦ ¦provide¦ ¦after¦ ¦the¦ ¦call¦ .
𐋇¦how¦ ¦to¦ ¦use¦ ¦att end¦ ¦an y w h er e¦
𐋇¦it¦ ¦is¦ ¦recommended¦ ¦that¦ ¦you¦ ¦v ie w¦ ¦this¦ ¦v ide o¦ ¦before¦ ¦using¦ ¦att end¦ ¦an y w h er e¦ ¦for¦ ¦the¦ ¦first¦ ¦time¦ .
𐋇¦this¦ ¦will¦ ¦give¦ ¦you¦ ¦an¦ ¦i ns ight¦ ¦into¦ ¦the¦ ¦la y o ut¦ ¦of¦ ¦your¦ ¦v ide o¦ ¦cons ult ation¦
𐋇¦this¦ ¦information¦ ¦is¦ ¦for¦ ¦people¦ ¦li ving¦ ¦in¦ ¦dublin¦ ¦city¦ ¦and¦ ¦county¦ .
𐋇¦this¦ ¦is¦ ¦being¦ ¦d one¦ ¦to¦ ¦prevent¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦coronavirus¦ .
𐋇¦if¦ ¦you¦ ¦live¦ ¦outside¦ ¦dublin¦ ,▁ ¦you¦ ¦should¦ ¦only¦ ¦travel¦ ¦for¦ ¦education¦ ,▁ ¦work¦ ¦and¦ ¦other¦ ¦b as ic¦ ¦needs¦ .
𐋇¦you¦ ¦can¦ ¦travel¦ ¦through¦ ¦dublin¦ ¦to¦ ¦another¦ ¦county¦ .
𐋇 ¦level¦ ¦of¦ ¦con str ai nts¦
𐋇 ¦dublin¦ ¦is¦ ¦at¦ ¦level¦ ¦3¦ ¦of¦ ¦the¦ ¦restrictions¦ .
𐋇¦p ub s¦ ¦that¦ ¦do¦ ¦not¦ ¦provide¦ ¦food¦ ¦in¦ ¦dublin¦ ¦will¦ ¦remain¦ ¦closed¦ .
𐋇¦e ating¦ ¦within¦ ¦res ta u ra nts¦ ¦and¦ ¦ca f es¦ ¦will¦ ¦also¦ ¦be¦ ¦pro hi b i ted¦ .
𐋇¦the¦ ¦r est¦ ¦of¦ ¦ireland¦ ¦is¦ ¦at¦ ¦level¦ ¦2¦ ¦of¦ ¦the¦ ¦restrictions¦ .
𐋇¦read¦ ¦more¦ ¦about¦ ¦the¦ ¦le v els¦ ¦of¦ ¦restrictions¦ ¦on¦ ¦w w w¦ . ¦g ov ¦ . ¦i e¦
𐋇 ¦travel¦
𐋇¦you¦ ¦should¦ ¦only¦ ¦travel¦ ¦within¦ ¦county¦ ¦dublin¦ .
𐋇¦stay¦ ¦in¦ ¦dublin¦ ¦un less¦ ¦you¦ ¦have¦ ¦to¦ ¦lea ve¦ ¦for¦ ¦e duc a tional¦ ,▁ ¦work¦ ¦and¦ ¦other¦ ¦b as ic¦ ¦needs¦ .
𐋇 ¦where¦ ¦possible¦ ,▁ ¦do¦ ¦not¦ ¦share¦ ¦your¦ ¦ca r¦ ¦or¦ ¦other¦ ¦priv ate¦ ¦ ve h ic les¦ ¦with¦ ¦people¦ ¦from¦ ¦outside¦ ¦your¦ ¦family¦ .
𐋇¦do¦ ¦not¦ ¦use¦ ¦public¦ ¦transport¦ ¦un less¦ ¦ab s o lu tely¦ ¦ne cess ary¦ ▁-▁ ¦w alk¦ ¦or¦ ¦c y c le¦ ¦inst ead¦ ¦if¦ ¦possible¦ .
𐋇¦by¦ ¦la w¦ ,▁ ¦you¦ ¦must¦ ¦wear¦ ¦a¦ ¦face¦ ¦cover¦ ¦on¦ ¦public¦ ¦transport¦ .
𐋇¦h ot els¦ ¦and¦ ¦gu est¦ ¦hou ses¦
𐋇¦h ot els¦ ,▁ ¦gu est¦ ¦hou ses¦ ¦and¦ ¦b ed¦ ¦and¦ ¦brea k fa sts¦ ▁( ¦b ¦ ▁ & ▁ ¦b s¦ )▁ ¦will¦ ¦remain¦ ¦open¦ .
𐋇 ¦only¦ ¦res id ents¦ ¦can¦ ¦use¦ ¦their¦ ¦services¦ .
𐋇 ¦work¦
𐋇¦do¦ ¦your¦ ¦work¦ ¦from¦ ¦home¦ ¦un less¦ ¦it¦ ¦is¦ ¦ne cess ary¦ ¦to¦ ¦go¦ ¦to¦ ¦your¦ ¦work pl ace¦ ¦in¦ ¦person¦ .
𐋇 ¦social¦ ¦me et ings¦
𐋇¦a¦ ¦ma x im um¦ ¦of¦ ¦6¦ ¦people¦ ¦from¦ ¦1¦ ¦other¦ ¦family¦ ¦can¦ ¦visit¦ ¦your¦ ¦home¦ .
𐋇¦this¦ ¦inclu des¦ ¦in door¦ ¦and¦ ¦out door¦ ¦s pa ces¦ ¦in¦ ¦your¦ ¦home¦ .
𐋇 ¦keep¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦people¦ ¦you¦ ¦do¦ ¦not¦ ¦live¦ ¦with¦ ¦those¦ .
𐋇 ¦social¦ ¦or¦ ¦family¦ ¦ga ther ings¦ ¦should¦ ¦not¦ ¦take¦ ¦place¦ ¦in¦ ¦other¦ ¦s et t ings¦ .
𐋇 ¦over¦ ¦7 0¦ ¦or¦ ¦medic ally¦ ¦v ul n er able¦
𐋇 ¦people¦ ¦li ving¦ ¦in¦ ¦dublin¦ ¦who¦ ¦are¦ ¦over¦ ¦7 0¦ ¦or¦ ¦medic ally¦ ¦v ul n er able¦ ¦should¦ ¦take¦ ¦ext r a¦ ¦care¦ ¦to¦ ¦protect¦ ¦the m s el ves¦ .
𐋇¦this¦ ¦is¦ ¦due¦ ¦to¦ ¦the¦ ¦high¦ ¦level¦ ¦of¦ ¦the¦ ¦virus¦ ¦in¦ ¦the¦ ¦county¦ .
𐋇¦stay¦ ¦home¦ ¦as¦ ¦much¦ ¦as¦ ¦possible¦ ¦and¦ ¦limi t¦ ¦social¦ ¦contact¦ .
𐋇 ¦use¦ ¦your¦ ¦b est¦ ¦j ud g ment¦ ¦to¦ ¦stay¦ ¦safe¦ ¦when¦ ¦m ee ting¦ ¦others¦ ¦and¦ ¦to¦ ¦lea ve¦ ¦your¦ ¦home¦ .
𐋇¦read¦ ¦about¦ ¦how¦ ¦to¦ ¦protect¦ ¦yourself¦ ¦if¦ ¦you¦ ¦c ook¦ .
𐋇 ¦schools¦ ,▁ ¦colle ges¦ ¦and¦ ¦ch ild c are¦
𐋇 ¦pla yg r ou ps¦ ,▁ ¦schools¦ ¦and¦ ¦colle ges¦ ¦in¦ ¦dublin¦ ¦can¦ ¦remain¦ ¦open¦ ¦to¦ ¦prot ective¦ ¦measures¦ .
𐋇 ¦staff¦ ¦and¦ ¦students¦ ¦can¦ ¦mo ve¦ ¦in¦ ¦and¦ ¦out¦ ¦of¦ ¦dublin¦ ¦to¦ ¦att end¦ ¦these¦ ¦places¦ .
𐋇 ¦out door¦ ¦pla yg ro un ds¦ ,▁ ¦pla yg ro un ds¦ ¦and¦ ¦par ks¦
𐋇 ¦out door¦ ¦pla yg ro un ds¦ ,▁ ¦pla yg ro un ds¦ ¦and¦ ¦par ks¦ ¦can¦ ¦stay¦ ¦open¦ .
𐋇 ¦be¦ ¦sure¦ ¦to¦ ¦follow¦ ¦advice¦ ¦on¦ ¦social¦ ¦separ ation¦ .
𐋇¦read¦ ¦about¦ ¦prot ecting¦ ¦your¦ ¦baby¦ ¦from¦ ¦the¦ ¦coronavirus¦ .
𐋇 ¦ca f es¦ ¦and¦ ¦res ta u ra nts¦ ,▁ ¦including¦ ¦food¦ ¦service¦ ¦b ar s¦
𐋇 ¦all¦ ¦ca f es¦ ¦and¦ ¦res ta u ra nts¦ ,▁ ¦including¦ ¦c at ering¦ ¦b ar s¦ ,▁ ¦can¦ ¦stay¦ ¦open¦ ¦for¦ :
𐋇 ¦br ing¦ ¦food¦
𐋇 ¦de li ver ies¦
𐋇 ¦out door¦ ¦di ning¦ ¦for¦ ¦a¦ ¦ma x im um¦ ¦of¦ ¦15¦ ¦people¦ ▁-▁ ¦with¦ ¦social¦ ¦separ ation¦
𐋇¦a¦ ¦b an¦ ¦on¦ ¦in door¦ ¦food¦ ¦is¦ ¦cur re ntly¦ ¦in¦ ¦place¦ .
𐋇¦p ub s¦ ¦that¦ ¦do¦ ¦not¦ ¦s ell¦ ¦food¦ ▁( ¦w et¦ ¦p ub s¦ )
𐋇¦b ar s¦ ¦that¦ ¦d on¦ ' ¦t¦ ¦ser ve¦ ¦food¦ ▁( ¦w et¦ ¦p ub s¦ )▁ ¦remain¦ ¦closed¦ ¦in¦ ¦dublin¦ .
𐋇¦p ub s¦ ¦in¦ ¦dublin¦ ¦that¦ ¦do¦ ¦not¦ ¦s ell¦ ¦food¦ ▁( ¦w et¦ ¦p ub s¦ )▁ ¦must¦ ¦remain¦ ¦closed¦ .
𐋇 ¦sho ps¦ ¦and¦ ¦services¦
𐋇 ¦sho ps¦ ,▁ ¦shopping¦ ¦ma lls¦ ¦and¦ ¦services¦ ¦like¦ ¦ha ir d re ss ers¦ ¦can¦ ¦stay¦ ¦open¦ ¦with¦ ¦prot ective¦ ¦measures¦ .
𐋇¦by¦ ¦la w¦ ,▁ ¦you¦ ¦must¦ ¦wear¦ ¦face¦ ¦cover¦ ¦in¦ ¦these¦ ¦places¦ .
𐋇¦read¦ ¦about¦ ¦safe¦ ¦shopping¦ ¦during¦ ¦the¦ ¦cr own¦ ¦virus¦ ¦outbreak¦ .
𐋇 ¦organiz ed¦ ¦events¦
𐋇¦these¦ ¦are¦ ¦a¦ ¦cont ro lled¦ ¦v en ue¦ ¦with¦ ¦a¦ ¦de si gn ated¦ ¦ev ent¦ ¦organiz er¦ ,▁ ¦ ow n er¦ ¦or¦ ¦mana g er¦ .
𐋇¦c i ne ma s¦ ¦and¦ ¦th ea ter¦ ¦events¦
𐋇 ¦ar ts¦ ¦events¦
𐋇 ¦bu si ness¦ ¦and¦ ¦tr aining¦ ¦events¦ ▁( ¦other¦ ¦than¦ ¦sp ort¦ )
𐋇 ¦conf er ence¦
𐋇 ¦in door¦ ¦events¦
𐋇 ¦no¦ ¦in door¦ ¦ev ent¦ ¦should¦ ¦take¦ ¦place¦ .
𐋇 ¦out door¦ ¦events¦
𐋇 ¦out door¦ ¦events¦ ¦for¦ ¦up¦ ¦to¦ ¦15¦ ¦people¦ ¦can¦ ¦be¦ ¦he ld¦ .
𐋇¦this¦ ¦does¦ ¦not¦ ¦include¦ ¦social¦ ¦ga ther ings¦ .
𐋇 ¦social¦ ¦or¦ ¦family¦ ¦ga ther ings¦ ¦should¦ ¦not¦ ¦take¦ ¦place¦ .
𐋇¦m u se u ms¦ ,▁ ¦ga ll er ies¦ ¦and¦ ¦other¦ ¦c ult ural¦ ¦att r ac tions¦
𐋇 ¦all¦ ¦in door¦ ¦c ult ural¦ ¦centr es¦ ¦are¦ ¦closed¦ .
𐋇 ¦li b r ar ies¦
𐋇 ¦li b r ar ies¦ ¦will¦ ¦be¦ ¦available¦ ¦for¦ ¦ e¦ - ¦services¦ ¦and¦ ¦call¦ ¦and¦ ¦colle ction¦ .
𐋇 ¦sp ort¦
𐋇 ¦no¦ ¦sp orting¦ ¦events¦ ¦or¦ ¦ga m es¦ ¦can¦ ¦be¦ ¦ ru n¦ .
𐋇¦the¦ ¦ex cep tions¦ ¦are¦ :
𐋇 ¦non¦ - ¦contact¦ ¦tr aining¦ ,▁ ¦but¦ ¦outside¦ ¦only¦ ¦with¦ ¦a¦ ¦ma x im um¦ ¦group¦ ¦of¦ ¦15¦ ¦people¦
𐋇 ¦pro f es si on al¦ ¦and¦ ¦el ite¦ ¦sp orts¦ ,▁ ¦in ter¦ - ¦county¦ ¦and¦ ¦cl ub ¦ ¦cha mp i o ns hi ps¦ ,▁ ¦and¦ ¦h or se¦ ¦r ac ing¦ ¦can¦ ¦continue¦ ¦be h ind¦ ¦closed¦ ¦do ors¦
𐋇 ¦g y ms¦ ,▁ ¦le is ure¦ ¦centr es¦ ¦and¦ ¦sw i mm ing¦ ¦po ols¦
𐋇¦these¦ ¦will¦ ¦remain¦ ¦open¦ ¦for¦ ¦ind iv id ual¦ ¦tr aining¦ ¦only¦ ¦and¦ ¦with¦ ¦prot ective¦ ¦measures¦ .
𐋇 ¦no¦ ¦f it ness¦ ¦or¦ ¦d ance¦ ¦cl as ses¦ ¦should¦ ¦be¦ ¦d one¦ ¦ind o ors¦ .
𐋇¦m arr ia ges¦
𐋇 ¦up¦ ¦to¦ ¦50¦ ¦people¦ ¦can¦ ¦att end¦ ¦a¦ ¦w ed ding¦ ¦ce re m on y¦ ¦and¦ ¦rece ption¦ .
𐋇 ¦from¦ ¦mon day¦ ¦ 21¦ ¦se p te mber¦ ,▁ ¦up¦ ¦to¦ ¦2 5¦ ¦people¦ ¦can¦ ¦att end¦ ¦a¦ ¦w ed ding¦ ¦ce re m on y¦ ¦and¦ ¦rece ption¦ .
𐋇¦f un er als¦
𐋇¦a¦ ¦ma x im um¦ ¦of¦ ¦2 5¦ ¦mo ur n ers¦ ¦may¦ ¦att end¦ ¦a¦ ¦f un er al¦ ¦service¦ ,▁ ¦b ur ial¦ ¦or¦ ¦cre m ation¦ ¦ce re m on y¦ .
𐋇 ¦long¦ - ¦ter m¦ ¦res ide ntial¦ ¦care¦ ¦facil ities¦ ▁-▁ ¦nu rs ing¦ ¦and¦ ¦care¦ ¦h omes¦
𐋇 ¦visi ting¦ ¦is¦ ¦susp e nded¦ .
𐋇¦the¦ ¦only¦ ¦ex cep tions¦ ¦to¦ ¦this¦ ¦are¦ ¦crit ical¦ ¦and¦ ¦comp as si on ate¦ ¦c ir c um st an ces¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦the¦ ¦end¦ ¦of¦ ¦ her¦ ¦l ife¦ .
𐋇 ¦ch ur ches¦ ¦and¦ ¦other¦ ¦places¦ ¦of¦ ¦wor s hi p¦
𐋇 ¦ch ur ches¦ ¦and¦ ¦other¦ ¦places¦ ¦of¦ ¦wor s hi p¦ ¦can¦ ¦only¦ ¦remain¦ ¦open¦ ¦for¦ ¦priv ate¦ ¦p ra y er¦ .
𐋇 ¦services¦ ¦will¦ ¦be¦ ¦available¦ ¦online¦ .
𐋇 ¦advice¦ ¦for¦ ¦e veryone¦ ¦across¦ ¦the¦ ¦country¦
𐋇¦e veryone¦ ¦across¦ ¦the¦ ¦country¦ ¦should¦ ¦continue¦ ¦to¦ :
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦properly¦ ¦and¦ ¦often¦
𐋇¦to¦ ¦cover¦ ¦cough¦ ¦and¦ ¦sneezing¦
𐋇 ¦avoid¦ ¦contact¦ ¦with¦ ¦ey es¦ ,▁ ¦nose¦ ¦and¦ ¦mouth¦
𐋇 ¦regul arly¦ ¦clean¦ ¦and¦ ¦disinf ect¦ ¦sur fa ces¦
𐋇 ¦keep¦ ¦a¦ ¦safe¦ ¦dista nce¦ ¦of¦ ¦2¦ ¦meters¦ ¦from¦ ¦others¦
𐋇 ¦wear¦ ¦face¦ ¦cover¦ ¦when¦ ¦using¦ ¦public¦ ¦transport¦ ,▁ ¦in¦ ¦sho ps¦ ,▁ ¦shopping¦ ¦centr es¦ ¦or¦ ¦any¦ ¦in door¦ ¦loc ation¦ ¦that¦ ¦cannot¦ ¦s us tain¦ ¦social¦ ¦ex tens ion¦
𐋇 ¦ga in¦ ¦k n ow l ed ge¦ ¦and¦ ¦self¦ - ¦monit or¦ ¦the¦ ¦signs¦ ¦of¦ ¦coronavirus¦
𐋇 ¦self¦ - ¦isolation¦ ¦and¦ ¦call¦ ¦your¦ ¦gp¦ ¦imm ed ia tely¦ ¦for¦ ¦a¦ ¦coronavirus¦ ¦test¦ ¦if¦ ¦you¦ ¦have¦ ¦symptoms¦ ¦of¦ ¦coronavirus¦
𐋇¦d ow n lo ad¦ ¦the¦ ¦covid¦ ¦tracking¦ ¦app¦
𐋇 ¦min im iz e¦ ¦the¦ ¦number¦ ¦of¦ ¦close¦ ¦contac ts¦ ¦as¦ ¦much¦ ¦as¦ ¦possible¦
𐋇 ¦keep¦ ¦a¦ ¦recor d¦ ¦of¦ ¦your¦ ¦daily¦ ¦contac ts¦ ¦to¦ ¦help¦ ¦tr ack¦ ¦contact¦ ¦if¦ ¦you¦ ¦are¦ ¦diagn osed¦ ¦with¦ ¦a¦ ¦corona ry¦ ¦virus¦
𐋇¦the¦ ¦outbreak¦ ¦of¦ ¦covid¦ ¦19¦ ▁( ¦coronavirus¦ )▁ ¦p u ts¦ ¦ext r a¦ ¦ str ess¦ ¦on¦ ¦people¦ ¦with¦ ¦spec ial¦ ¦needs¦ ,▁ ¦people¦ ¦with¦ ¦dis ab il ities¦ ¦and¦ ¦family¦ ¦car ers¦ .
𐋇¦this¦ ¦advice¦ ¦may¦ ¦help¦ ¦car ers¦ ¦and¦ ¦fa m il ies¦ ¦care¦ ¦for¦ ¦someone¦ ¦with¦ ¦spec ial¦ ¦needs¦ ¦during¦ ¦this¦ ¦period¦ .
𐋇 ¦ex pl aining¦ ¦what¦ ¦is¦ ¦in¦ ¦the¦ ¦covid¦ - ¦19¦
𐋇 ¦make¦ ¦sure¦ ¦the¦ ¦person¦ ¦under st an ds¦ ¦what¦ ¦is¦ ¦happ ening¦ ¦at¦ ¦the¦ ¦mo ment¦ .
𐋇 ¦use¦ ¦these¦ ¦to¦ ¦help¦ ¦exp la in¦ ¦the¦ ¦coronavirus¦ :
𐋇¦covid¦ - ¦19¦ ¦test¦
𐋇¦t alk¦ ¦about¦ ¦the¦ ¦test¦ ¦for¦ ¦covid¦ ¦19¦ ¦and¦ ¦exp la in¦ ¦what¦ ¦happ ens¦ ¦if¦ ¦they¦ ¦need¦ ¦to¦ ¦be¦ ¦tested¦ .
𐋇¦if¦ ¦h e¦ ¦or¦ ¦sh e¦ ¦has¦ ¦to¦ ¦go¦ ¦to¦ ¦a¦ ¦test¦ ¦center¦ ,▁ ¦the¦ ¦ro le¦ ¦of¦ ¦activ ity¦ ¦may¦ ¦help¦ ¦exp la in¦ ¦the¦ ¦testing¦ ¦proc ess¦ ¦in¦ ¦ad v ance¦ .
𐋇¦this¦ ¦will¦ ¦e ns ure¦ ¦that¦ ¦no thing¦ ¦u ne x p ected¦ ¦happ ens¦ ¦on¦ ¦the¦ ¦day¦ ¦of¦ ¦the¦ ¦test¦ .
𐋇 ¦supp orts¦ ¦available¦ ¦to¦ ¦you¦
𐋇 ¦contact¦ ¦your¦ ¦service¦ ¦provid er¦ ¦for¦ ¦information¦ ¦on¦ ¦how¦ ¦they¦ ¦can¦ ¦help¦ ¦you¦ .
𐋇¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦have¦ ¦a¦ ¦service¦ ¦provid er¦ ,▁ ¦call¦ ¦your¦ ¦local¦ ¦public¦ ¦health¦ ¦n ur se¦ ¦or¦ ¦hse¦ ¦dis a bility¦ ¦mana g er¦ .
𐋇 ¦contact¦ ¦detail s¦ ¦for¦ ¦the¦ ¦hse¦ ¦service¦ ¦for¦ ¦people¦ ¦with¦ ¦dis ab il ities¦ ¦by¦ ¦county¦
𐋇¦your¦ ¦county¦ ¦cou nc il¦ ¦may¦ ¦be¦ ¦able¦ ¦to¦ ¦help¦ ¦you¦ ¦if¦ ¦you¦ ¦need¦ ¦food¦ ¦or¦ ¦medical¦ ¦supp l ies¦ .
𐋇 ¦under st and¦ ¦the¦ ¦da nger¦ ¦to¦ ¦the¦ ¦person¦ ¦you¦ ¦are¦ ¦supp orting¦
𐋇¦the¦ ¦person¦ ¦you¦ ¦are¦ ¦car ing¦ ¦for¦ ¦may¦ ¦be¦ ¦at¦ ¦g rea ter¦ ¦risk¦ ¦of¦ ¦ser ious¦ ¦illness¦ ¦if¦ ¦they¦ ¦get¦ ¦covid¦ ¦19¦ .
𐋇¦they¦ ¦may¦ ¦have¦ ¦a¦ ¦long¦ - ¦ter m¦ ¦illness¦ ¦or¦ ¦a¦ ¦w ea k e ned¦ ¦immune¦ ¦system¦ .
𐋇 ¦advice¦ ¦for¦ ¦people¦ ¦at¦ ¦g rea ter¦ ¦risk¦ ¦from¦ ¦covid¦ - ¦19¦
𐋇¦f ind¦ ¦out¦ ¦what¦ ¦their¦ ¦needs¦ ¦are¦ ¦other¦ ¦than¦ ¦medical¦ ¦needs¦ .
𐋇¦if¦ ¦they¦ ¦are¦ ¦wor r ied¦ ¦about¦ ¦an y thing¦ ,▁ ¦th ink¦ ¦of¦ ¦w ays¦ ¦to¦ ¦support¦ ¦them¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦having¦ ¦reg ular¦ ¦v ide o¦ ¦cha ts¦ ¦with¦ ¦people¦ ¦if¦ ¦it¦ ¦is¦ ¦not¦ ¦possible¦ ¦to¦ ¦me et¦ ¦them¦ ¦in¦ ¦person¦ .
𐋇¦you¦ ¦may¦ ¦have¦ ¦al rea dy¦ ¦received¦ ¦a¦ ¦call¦ ¦from¦ ¦your¦ ¦sta nd ard¦ ¦service¦ ¦if¦ ¦the¦ ¦person¦ ¦you¦ ¦are¦ ¦car ing¦ ¦for¦ ¦is¦ ¦at¦ ¦high¦ ¦risk¦ .
𐋇¦if¦ ¦not¦ ,▁ ¦you¦ ¦should¦ ¦call¦ ¦your¦ ¦service¦ ¦provid er¦ ¦to¦ ¦disc us s¦ ¦an¦ ¦emergency¦ ¦pl an¦ .
𐋇¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦have¦ ¦a¦ ¦service¦ ¦provid er¦ ,▁ ¦call¦ ¦your¦ ¦public¦ ¦health¦ ¦n ur se¦ ¦or¦ ¦the¦ ¦dis a bility¦ ¦mana g er¦ ¦at¦ ¦local¦ ¦hse¦ ¦dis a bility¦ ¦services¦ .
𐋇 ¦contact¦ ¦detail s¦ ¦for¦ ¦the¦ ¦hse¦ ¦service¦ ¦for¦ ¦people¦ ¦with¦ ¦dis ab il ities¦ ¦by¦ ¦county¦
𐋇 ¦children¦ ¦with¦ ¦dis ab il ities¦
𐋇 ¦pre par ations¦ ¦and¦ ¦the¦ ¦normal¦ ¦co ur se¦ ¦of¦ ¦the¦ ¦day¦
𐋇¦do¦ ¦as¦ ¦much¦ ¦pre par ation¦ ¦as¦ ¦you¦ ¦can¦ ¦when¦ ¦ma king¦ ¦chan ges¦ ¦to¦ ¦the¦ ¦normal¦ ¦co ur se¦ ¦of¦ ¦the¦ ¦day¦
𐋇 ¦use¦ ¦v is ual¦ ¦ ai ds¦ ¦where¦ ¦possible¦ ,▁ ¦such¦ ¦as¦ :
" 𐋇 ¦first¦ ¦and¦ ¦then¦ "▁ ¦ch ar ts¦ ▁-▁ ¦a¦ ¦way¦ ¦to¦ ¦sh ow¦ ¦the¦ ¦child¦ ¦that¦ ¦they¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦do¦ ¦their¦ ¦fa v o ur ite¦ ¦activ ity¦ ¦if¦ ¦they¦ ¦co mpl et e¦ ¦the¦ ¦first¦ ¦activ ity¦
𐋇¦a¦ ¦c al end a r¦ ¦with¦ ¦p i ct ures¦ ¦ex pl aining¦ ¦what¦ ¦will¦ ¦be¦ ¦happ ening¦
𐋇¦a¦ ¦pers o na li zed¦ ¦b ook¦ ¦with¦ ¦a¦ ¦su mm ary¦ ¦of¦ ¦what¦ ¦will¦ ¦be¦ ¦happ ening¦
𐋇 ¦v is ual¦ ¦a id¦ ¦with¦ ¦a¦ ¦s ch ed u le¦ ¦of¦ ¦the¦ ¦child¦ ' ¦s¦ ¦daily¦ ¦activ ities¦
𐋇¦the¦ ¦normal¦ ¦co ur se¦ ¦of¦ ¦the¦ ¦day¦ ¦h el ps¦ ¦your¦ ¦child¦ ¦feel¦ ¦safe¦ .
𐋇¦the¦ ¦normal¦ ¦co ur se¦ ¦of¦ ¦the¦ ¦day¦ ¦can¦ ¦help¦ ¦them¦ ¦feel¦ ¦more¦ ¦in¦ ¦control¦ ¦of¦ ¦th ings¦ .
𐋇¦the¦ ¦normal¦ ¦co ur se¦ ¦of¦ ¦the¦ ¦day¦ ¦can¦ ¦give¦ ¦your¦ ¦child¦ ¦conf idence¦ ¦that¦ ¦no thing¦ ¦b ad¦ ¦will¦ ¦happ en¦ ¦to¦ ¦hi m¦ ▁/▁ ¦ her¦ .
𐋇 ¦follow¦ ¦the¦ ¦normal¦ ¦co ur se¦ ¦of¦ ¦the¦ ¦day¦ ¦as¦ ¦much¦ ¦as¦ ¦you¦ ¦can¦ .
𐋇¦you¦ ¦should¦ ¦continue¦ ¦with¦ :
𐋇¦the¦ ¦same¦ ¦sl ee p¦ ¦and¦ ¦w a ke¦ ¦time¦
𐋇¦the¦ ¦same¦ ¦me al¦ ¦times¦
𐋇¦the¦ ¦out door¦ ¦times¦ ¦if¦ ¦appr op ri ate¦
𐋇¦the¦ ¦times¦ ¦to¦ ¦re la x¦ ¦and¦ ¦have¦ ¦f u n¦
𐋇¦d on¦ ' ¦t¦ ¦e nc o ur age¦ ¦them¦ ¦to o¦ ¦much¦ ¦if¦ ¦possible¦ .
𐋇 ¦give¦ ¦the¦ ¦child¦ ¦one¦ ¦ thing¦ ¦to¦ ¦do¦ ¦at¦ ¦a¦ ¦time¦ ,▁ ¦such¦ ¦as¦ ¦st ick ers¦ ,▁ ¦c ol or ing¦ ¦or¦ ¦p i ct ure¦ ¦b oo ks¦ .
𐋇¦s ort¦ ¦th ings¦ ¦up¦ ¦at¦ ¦home¦
𐋇 ¦health¦ ¦pa ss p ort¦
𐋇 ¦ch eck¦ ¦that¦ ¦the¦ ¦health¦ ¦pa ss p ort¦ ¦of¦ ¦the¦ ¦person¦ ¦you¦ ¦care¦ ¦for¦ ¦is¦ ¦up¦ ¦to¦ ¦date¦ .
𐋇¦this¦ ¦is¦ ¦a¦ ¦ph ys ical¦ ¦d oc u ment¦ ¦that¦ ¦sh ow s¦ ¦the¦ ¦supp orts¦ ¦a¦ ¦person¦ ¦needs¦ ¦if¦ ¦they¦ ¦have¦ ¦to¦ ¦att end¦ ¦a¦ ¦test¦ ¦or¦ ¦go¦ ¦into¦ ¦hospital¦ .
𐋇¦h er e¦ ¦may¦ ¦be¦ ¦a¦ ¦spec ial¦ ¦gu ide¦ ¦to¦ ¦help¦
𐋇 ¦mo ve ment¦
𐋇¦the¦
𐋇¦d re ss ing¦
𐋇 ¦go¦ ¦to¦ ¦the¦ ¦to il et¦
𐋇 ¦chec king¦ ¦supp l ies¦
𐋇 ¦have¦ ¦a¦ ¦pl an¦ ¦for¦ ¦who¦ ¦you¦ ¦can¦ ¦call¦ ¦if¦ ¦you¦ ¦need¦ ¦e ss en ti als¦ .
𐋇 ¦pre p are¦ ¦what¦ ¦you¦ ¦will¦ ¦need¦ ¦for¦ ¦this¦ ¦period¦ .
𐋇 ¦essential¦ ¦supp l ies¦ ¦for¦ ¦a¦ ¦week¦ ¦or¦ ¦two¦ ,▁ ¦including¦ ¦gr oc er ies¦ ¦and¦ ¦cl ea ning¦ ¦supp l ies¦
𐋇 ¦over¦ - ¦the¦ - ¦co un ter¦ ¦medic ines¦ ¦and¦ ¦medic ines¦
𐋇 ¦contin ence¦ ¦ ai ds¦ ,▁ ¦f l ies¦ ,▁ ¦ca th et ers¦ ,▁ ¦f ee ding¦ ¦t ub es¦ ¦l as ting¦ ¦one¦ ¦mon th¦ .
𐋇¦if¦ ¦you¦ ¦n orm ally¦ ¦receive¦ ¦de te nt ion¦ ¦produc ts¦ ¦from¦ ¦the¦ ¦health¦ ¦service¦ ¦ex ecu tive¦ ,▁ ¦this¦ ¦should¦ ¦continue¦ .
𐋇 ¦contact¦ ¦your¦ ¦de te nt ion¦ ¦offic er¦ ¦if¦ ¦you¦ ¦have¦ ¦any¦ ¦qu es tions¦ .
𐋇 ¦hospital¦ ¦app oi nt ments¦
𐋇¦the¦ ¦number¦ ¦of¦ ¦hospital¦ ¦app oi nt ments¦ ¦for¦ ¦patients¦ ¦have¦ ¦chan ged¦ ¦due¦ ¦to¦ ¦the¦ ¦outbreak¦ ¦of¦ ¦covid¦ ¦19¦ .
𐋇¦the¦ ¦normal¦ ¦co ur se¦ ¦of¦ ¦the¦ ¦day¦
𐋇 ¦pre p are¦ ¦a¦ ¦ro ut ine¦ ¦co ur se¦ ¦of¦ ¦the¦ ¦day¦ .
𐋇¦w r ite¦ ¦down¦ ¦the¦ ¦normal¦ ¦events¦ ¦that¦ ¦take¦ ¦place¦ ¦each¦ ¦day¦ ¦and¦ ¦make¦ ¦sure¦ ¦the¦ ¦person¦ ¦under st an ds¦ ¦them¦ .
𐋇¦this¦ ¦advice¦ ¦will¦ ¦help¦ ¦your¦ ¦pl an¦ :
𐋇¦w r ite¦ ¦the¦ ¦normal¦ ¦co ur se¦ ¦of¦ ¦the¦ ¦day¦ ¦for¦ ¦each¦ ¦day¦ ¦of¦ ¦the¦ ¦week¦
𐋇 ¦al w ays¦ ¦ad h ering¦ ¦to¦ ¦the¦ ¦same¦ ¦sl ee p¦ ¦and¦ ¦w a ke¦ ¦time¦
𐋇 ¦ph ys ical¦ ¦activ ity¦ ¦and¦ ¦r est¦ ¦time¦ ¦during¦ ¦the¦ ¦day¦
𐋇 ¦healthy¦ ¦food¦ ,▁ ¦s n ac ks¦ ¦and¦ ¦h y dr ation¦
𐋇 ¦activ ities¦ ¦that¦ ¦they¦ ¦can¦ ¦do¦ ¦on¦ ¦their¦ ¦ own¦ ¦if¦ ¦possible¦ ▁-▁ ¦for¦ ¦example¦ ,▁ ¦y og a¦ ¦or¦ ¦pa in ting¦
𐋇 ¦any¦ ¦activ ities¦ ¦you¦ ¦include¦ ¦must¦ ¦ad h er e¦ ¦to¦ ¦the¦ ¦social¦ ¦separ ation¦ ¦gu id el ines¦ .
𐋇 ¦take¦ ¦care¦ ¦of¦ ¦yourself¦
𐋇¦you¦ ¦need¦ ¦to¦ ¦take¦ ¦care¦ ¦of¦ ¦yourself¦ ¦so¦ ¦that¦ ¦you¦ ¦can¦ ¦take¦ ¦care¦ ¦of¦ ¦others¦ .
𐋇¦stay¦ ¦fi t¦ ¦and¦ ¦take¦ ¦care¦ ¦of¦ ¦your¦ ¦me ntal¦ ¦health¦ ¦and¦ ¦ac cep t¦ ¦any¦ ¦help¦ ¦that¦ ¦is¦ ¦off ered¦ ¦to¦ ¦you¦ .
𐋇 ¦prot ecting¦ ¦your¦ ¦child¦ ¦from¦ ¦covid¦ - ¦19¦
𐋇¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ )▁ ¦can¦ ¦aff ect¦ ¦children¦ ¦as¦ ¦well¦ ¦as¦ ¦ad ul ts¦ .
𐋇¦but¦ ¦fe w¦ ¦cases¦ ¦have¦ ¦been¦ ¦reported¦ ¦in¦ ¦children¦ ¦worldwide¦ .
𐋇 ¦children¦ ¦also¦ ¦app ear¦ ¦to¦ ¦get¦ ¦a¦ ¦m il der¦ ¦infection¦ ¦than¦ ¦ad ul ts¦ ¦or¦ ¦the¦ ¦el d erly¦ .
𐋇¦they¦ ¦often¦ ¦have¦ ¦no¦ ¦symptoms¦ .
𐋇 ¦children¦ ¦do¦ ¦not¦ ¦spread¦ ¦the¦ ¦virus¦ ¦more¦ ¦than¦ ¦ad ul ts¦ ,▁ ¦and¦ ¦they¦ ¦r ar ely¦ ¦cause¦ ¦the¦ ¦virus¦ ¦to¦ ¦spread¦ ¦in¦ ¦fa m il ies¦ .
𐋇¦read¦ ¦h er e¦ ¦what¦ ¦to¦ ¦do¦ ¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦covid¦ - ¦19¦ ¦symptoms¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦wor r ied¦ ¦about¦ ¦your¦ ¦child¦ ' ¦s¦ ¦health¦ ,▁ ¦call¦ ¦your¦ ¦gp¦ .
𐋇 ¦prot ecting¦ ¦your¦ ¦child¦
𐋇¦the¦ ¦most¦ ¦important¦ ¦th ings¦ ¦you¦ ¦can¦ ¦do¦ ¦to¦ ¦protect¦ ¦your¦ ¦child¦ ¦are¦ :
𐋇 ¦follow¦ ¦the¦ ¦advice¦ ¦on¦ ¦how¦ ¦to¦ ¦protect¦ ¦yourself¦ ¦and¦ ¦others¦ ¦from¦ ¦covid¦ - ¦19¦
𐋇¦w at ch¦ ¦out¦ ¦for¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ▁-▁ ¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ,▁ ¦they¦ ¦will¦ ¦need¦ ¦to¦ ¦isol ate¦ ¦the m s el ves¦ ¦and¦ ¦call¦ ¦their¦ ¦gp¦
𐋇¦e nc o ur age¦ ¦your¦ ¦child¦ ¦to¦ ¦wash¦ ¦their¦ ¦hands¦ ¦regul arly¦ ¦and¦ ¦properly¦
𐋇 ¦clean¦ ¦and¦ ¦disinf ect¦ ¦all¦ ¦sur fa ces¦ ¦in¦ ¦your¦ ¦home¦ ¦and¦ ¦all¦ ¦areas¦ ¦where¦ ¦people¦ ¦tou ch¦ ¦them¦ .
𐋇¦do¦ ¦not¦ ¦for g et¦ ¦the¦ ¦hands¦ ¦of¦ ¦the¦ ¦do ors¦ ,▁ ¦the¦ ¦rem ot e¦ ¦control¦ ¦and¦ ¦the¦ ¦to il et¦ .
𐋇 ¦follow¦ ¦the¦ ¦advice¦ ¦to¦ ¦prevent¦ ¦your¦ ¦child¦ ¦from¦ ¦getting¦ ¦or¦ ¦sprea ding¦ ¦viral¦ ¦infections¦
𐋇 ¦face¦ ¦and¦ ¦child¦ ¦cov ers¦
𐋇 ¦face¦ ¦cov ers¦ ¦are¦ ¦not¦ ¦recommended¦ ¦for¦ ¦children¦ ¦under¦ ¦13¦ .
𐋇 ¦y ou ng¦ ¦children¦ ¦may¦ ¦not¦ ¦be¦ ¦able¦ ¦to¦ ¦follow¦ ¦the¦ ¦advice¦ ¦of¦ ¦w earing¦ ¦a¦ ¦mask¦ ¦properly¦ .
𐋇¦they¦ ¦should¦ ¦wear¦ ¦a¦ ¦face¦ ¦mask¦ ¦if¦ ¦ad vi sed¦ ¦to¦ ¦do¦ ¦so¦ ¦by¦ ¦a¦ ¦doctor¦ ¦or¦ ¦healthcare¦ ¦work er¦ ,▁ ¦for¦ ¦example¦ ,▁ ¦when¦ ¦att ending¦ ¦a¦ ¦hospital¦ ¦cl in ic¦ .
𐋇 ¦children¦ ¦over¦ ¦13¦ ¦should¦ ¦follow¦ ¦the¦ ¦advice¦ ¦giv en¦ ¦to¦ ¦ad ul ts¦ ¦about¦ ¦w earing¦ ¦face¦ ¦masks¦ .
𐋇¦they¦ ¦must¦ ¦wear¦ ¦face¦ ¦cov ers¦ ¦when¦ ¦ent ering¦ ¦a¦ ¦sho p¦ ¦or¦ ¦when¦ ¦tra ve lling¦ ¦on¦ ¦public¦ ¦transport¦ ¦and¦ ¦should¦ ¦wear¦ ¦a¦ ¦face¦ ¦cover¦ ¦w he ne ver¦ ¦it¦ ¦is¦ ¦diffic ul t¦ ¦to¦ ¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦others¦ .
𐋇 ¦all¦ ¦sec ond ary¦ ¦school¦ ¦children¦ ¦should¦ ¦wear¦ ¦face¦ ¦cover¦ ¦in¦ ¦sec ond ary¦ ¦school¦ ,▁ ¦even¦ ¦if¦ ¦they¦ ¦are¦ ¦under¦ ¦13¦ .
𐋇¦it¦ ¦is¦ ¦because¦ ¦they¦ ¦are¦ ¦at¦ ¦the¦ ¦same¦ ¦st age¦ ¦of¦ ¦development¦ ¦as¦ ¦their¦ ¦p e ers¦ ¦and¦ ¦can¦ ¦follow¦ ¦the¦ ¦advice¦ ¦on¦ ¦face¦ ¦cover¦ ¦properly¦ .
𐋇 ¦se e¦ ¦how¦ ¦your¦ ¦children¦ ¦should¦ ¦wash¦ ¦their¦ ¦hands¦
𐋇¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦symptoms¦ ¦of¦ ¦coronavirus¦
𐋇¦this¦ ¦advice¦ ¦is¦ ¦us ually¦ ¦for¦ ¦in fa nts¦ ¦and¦ ¦children¦ ¦under¦ ¦12¦ ¦or¦ ¦13¦ ¦years¦ ¦of¦ ¦age¦ ¦att ending¦ ¦pr imary¦ ¦school¦ .
𐋇 ¦sec ond ary¦ ¦school¦ ¦children¦ ¦with¦ ¦symptoms¦ ¦should¦ ¦follow¦ ¦the¦ ¦ad ul ts¦ ' ▁ ¦advice¦ ¦on¦ ¦when¦ ¦to¦ ¦contact¦ ¦their¦ ¦gp¦ ¦for¦ ¦a¦ ¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ )▁ ¦test¦ .
𐋇 ¦keep¦ ¦your¦ ¦child¦ ¦at¦ ¦home¦
𐋇¦do¦ ¦not¦ ¦all ow¦ ¦your¦ ¦child¦ ¦to¦ ¦go¦ ¦to¦ ¦school¦ ¦or¦ ¦att end¦ ¦a¦ ¦ch ild c are¦ ¦centre¦ ¦if¦ ¦they¦ ¦have¦ ¦covid¦ - ¦19¦ ¦symptoms¦ .
𐋇¦h e¦ ¦may¦ ¦have¦ ¦to¦ ¦stay¦ ¦away¦ ¦from¦ ¦others¦ .
𐋇¦this¦ ¦will¦ ¦dep end¦ ¦on¦ ¦the¦ ¦symptoms¦ .
𐋇¦read¦ ¦more¦ ¦about¦ ¦when¦ ¦a¦ ¦child¦ ¦should¦ ¦be¦ ¦k e p t¦ ¦home¦ ¦from¦ ¦school¦ ¦or¦ ¦a¦ ¦ch ild c are¦ ¦centre¦ .
𐋇¦when¦ ¦to¦ ¦s ee k¦ ¦emergency¦ ¦medical¦ ¦help¦
𐋇¦read¦ ¦more¦ ¦about¦ ¦the¦ ¦symptoms¦ ¦in¦ ¦children¦ ¦and¦ ¦in fa nts¦ ¦who¦ ¦need¦ ¦emergency¦ ¦medical¦ ¦help¦ .
𐋇¦if¦ ¦your¦ ¦child¦ ¦s ud d en ly¦ ¦bec omes¦ ¦very¦ ¦ ill¦ ,▁ ¦it¦ ¦is¦ ¦un li k ely¦ ¦to¦ ¦be¦ ¦a¦ ¦corona ry¦ ¦virus¦ . ,
𐋇¦the¦ ¦symptoms¦ ¦may¦ ¦be¦ ¦caused¦ ¦by¦ ¦another¦ ¦illness¦ .
𐋇¦if¦ ¦your¦ ¦baby¦ ¦is¦ ¦under¦ ¦three¦ ¦mon ths¦ ¦o ld¦ ¦and¦ ¦has¦ ¦a¦ ¦high¦ ¦temp erat ure¦ ▁( ¦3 8¦ ¦de g re es¦ ¦c el si us¦ ¦or¦ ¦more¦ ),▁ ¦call¦ ¦9 9 9¦ ¦or¦ ¦1 1 2¦ .
𐋇¦if¦ ¦your¦ ¦baby¦ ¦is¦ ¦between¦ ¦3¦ ¦and¦ ¦6¦ ¦mon ths¦ ¦o ld¦ ¦and¦ ¦has¦ ¦a¦ ¦high¦ ¦temp erat ure¦ ,▁ ¦contact¦ ¦your¦ ¦gp¦ ¦imm ed ia tely¦ .
𐋇¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦common¦ ¦symptoms¦ ¦of¦ ¦covid¦ - ¦19¦
𐋇 ¦common¦ ¦symptoms¦ ¦of¦ ¦covid¦ - ¦19¦ ¦are¦ :
𐋇 ¦temp erat ure¦ ¦3 8¦ ¦de g re es¦ ¦c el si us¦ ¦or¦ ¦more¦
𐋇 ¦new¦ ¦cough¦ ▁-▁ ¦they¦ ¦can¦ ¦be¦ ¦cou gh s¦ ¦of¦ ¦any¦ ¦k ind¦ ,▁ ¦not¦ ¦j ust¦ ¦d ry¦
𐋇¦l os s¦ ¦or¦ ¦ch ange¦ ¦in¦ ¦ta st e¦ ¦or¦ ¦sm ell¦
𐋇 ¦sh ort ness¦ ¦of¦ ¦brea th¦
𐋇¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦common¦ ¦symptoms¦ ¦of¦ ¦covid¦ - ¦19¦ :
𐋇 ¦keep¦ ¦your¦ ¦child¦ ¦away¦ ¦from¦ ¦others¦ ▁-▁ ¦this¦ ¦me ans¦ ¦you¦ ¦have¦ ¦to¦ ¦keep¦ ¦them¦ ¦in¦ ¦a¦ ¦ro om¦ ¦by¦ ¦the m s el ves¦ ¦without¦ ¦any¦ ¦contact¦ ¦with¦ ¦others¦ ¦as¦ ¦much¦ ¦as¦ ¦possible¦ .
𐋇 ¦call¦ ¦a¦ ¦gp¦ ▁-▁ ¦they¦ ¦will¦ ¦t ell¦ ¦you¦ ¦if¦ ¦your¦ ¦child¦ ¦needs¦ ¦a¦ ¦covid¦ - ¦19¦ ¦test¦ .
𐋇¦e veryone¦ ¦li ving¦ ¦with¦ ¦your¦ ¦child¦ ¦should¦ ¦restrict¦ ¦their¦ ¦movements¦ .
𐋇¦this¦ ¦me ans¦ ¦they¦ ¦cannot¦ ¦go¦ ¦to¦ ¦school¦ ,▁ ¦ch ild c are¦ ¦or¦ ¦work¦ ¦until¦ ¦it¦ ¦is¦ ¦safe¦ .
𐋇 ¦test¦ ¦your¦ ¦child¦ ' ¦s¦ ¦symptoms¦ ¦at¦ ¦home¦ .
𐋇¦the¦ ¦child¦ ¦should¦ ¦only¦ ¦lea ve¦ ¦the¦ ¦house¦ ¦to¦ ¦be¦ ¦tested¦ ¦or¦ ¦to¦ ¦se e¦ ¦a¦ ¦doctor¦ .
𐋇 ¦call¦ ¦your¦ ¦gp¦ ¦first¦ .
𐋇¦do¦ ¦not¦ ¦take¦ ¦your¦ ¦child¦ ¦to¦ ¦the¦ ¦doctor¦ ¦un less¦ ¦the¦ ¦doctor¦ ¦s ays¦ ¦so¦ .
𐋇¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦other¦ ¦symptoms¦ ¦that¦ ¦a¦ ¦person¦ ¦with¦ ¦covid¦ - ¦19¦ ¦does¦ ¦not¦ ¦n orm ally¦ ¦have¦
𐋇 ¦less¦ ¦common¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ¦include¦ :
𐋇¦s ore¦ ¦th ro at¦
𐋇¦h ea d a ch e¦
𐋇 ¦fe el ing¦ ¦sick¦ ¦or¦ ¦v o mi ting¦
𐋇¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦any¦ ¦of¦ ¦these¦ ¦symptoms¦ ,▁ ¦keep¦ ¦them¦ ¦at¦ ¦home¦ ¦for¦ ¦at¦ ¦least¦ ¦4 8¦ ¦hours¦ .
𐋇¦it¦ ¦is¦ ¦un li k ely¦ ¦to¦ ¦con tain¦ ¦covid¦ - ¦19¦ ,▁ ¦but¦ ¦ma y b e¦ ¦a¦ ¦s ign¦ ¦of¦ ¦another¦ ¦infectious¦ ¦infection¦ .
𐋇¦the¦ ¦people¦ ¦li ving¦ ¦with¦ ¦your¦ ¦child¦ ¦do¦ ¦not¦ ¦need¦ ¦to¦ ¦restrict¦ ¦their¦ ¦movements¦ ¦un less¦ ¦they¦ ¦are¦ ¦sick¦ .
𐋇 ¦after¦ ¦4 8¦ ¦hours¦ ,▁ ¦your¦ ¦child¦ ¦can¦ ¦retur n¦ ¦to¦ ¦school¦ ¦or¦ ¦a¦ ¦ch ild c are¦ ¦centre¦ ¦as¦ ¦long¦ ¦as¦ :
𐋇 ¦hi s¦ ¦symptoms¦ ¦do¦ ¦not¦ ¦get¦ ¦wor se¦
𐋇¦it¦ ¦does¦ ¦not¦ ¦come¦ ¦with¦ ¦new¦ ¦signs¦
𐋇 ¦does¦ ¦not¦ ¦requir e¦ ¦p ara ce ta mo l¦ ¦or¦ ¦i b u p ro fen¦ ¦for¦ ¦4 8¦ ¦hours¦ ▁-▁ ¦this¦ ¦may¦ ¦mask¦ ¦a¦ ¦fever¦ ¦if¦ ¦it¦ ¦is¦
𐋇 ¦no¦ ¦one¦ ¦el se¦ ¦li ving¦ ¦with¦ ¦it¦ ¦has¦ ¦been¦ ¦ ill¦ ¦or¦ ¦has¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦
𐋇 ¦th or n y¦ ¦or¦ ¦sneezing¦ ¦nose¦
𐋇¦if¦ ¦your¦ ¦child¦ ¦only¦ ¦has¦ ¦a¦ ¦r un n y¦ ¦nose¦ ¦or¦ ¦s n ee z es¦ ,▁ ¦it¦ ' ¦s¦ ¦o k ay¦ ¦to¦ ¦l et¦ ¦them¦ ¦go¦ ¦to¦ ¦school¦ .
𐋇¦read¦ ¦more¦ ¦advice¦ ¦on¦ ¦sneezing¦ ¦or¦ ¦sneezing¦ ¦and¦ ¦wh y¦ ¦it¦ ' ¦s¦ ¦o k ay¦ ¦to¦ ¦l et¦ ¦your¦ ¦child¦ ¦go¦ ¦to¦ ¦school¦ ¦or¦ ¦a¦ ¦ch ild c are¦ ¦centre¦
𐋇¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦di arr ho e a¦
𐋇¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦di arr ho e a¦ ,▁ ¦they¦ ¦should¦ ¦stay¦ ¦home¦ .
𐋇¦h e¦ ¦should¦ ¦not¦ ¦go¦ ¦to¦ ¦school¦ ¦until¦ ¦the¦ ¦di arr ho e a¦ ¦has¦ ¦g one¦ ¦4 8¦ ¦hours¦ .
𐋇 ¦people¦ ¦li ving¦ ¦with¦ ¦your¦ ¦child¦ ¦do¦ ¦not¦ ¦need¦ ¦to¦ ¦restrict¦ ¦their¦ ¦movements¦ ¦as¦ ¦long¦ ¦as¦ ¦they¦ ¦feel¦ ¦o k¦ .
𐋇 ¦di arr ho e a¦ ¦is¦ ¦not¦ ¦a¦ ¦common¦ ¦covid¦ - ¦19¦ ¦s y m pt om¦ .
𐋇¦but¦ ¦it¦ ¦is¦ ¦a¦ ¦s ign¦ ¦of¦ ¦infection¦ .
𐋇¦it¦ ¦may¦ ¦p ass¦ ¦this¦ ¦infection¦ ¦to¦ ¦other¦ ¦children¦ .
𐋇¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦a¦ ¦long¦ - ¦ter m¦ ¦brea thing¦ ¦illness¦ ¦getting¦ ¦wor se¦
𐋇¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦a¦ ¦long¦ - ¦ter m¦ ¦brea thing¦ ¦illness¦ ¦that¦ ¦has¦ ¦br ou gh t¦ ¦wor se¦ :
𐋇 ¦keep¦ ¦your¦ ¦child¦ ¦away¦ ¦from¦ ¦others¦
𐋇¦e veryone¦ ¦li ving¦ ¦with¦ ¦your¦ ¦child¦ ¦should¦ ¦restrict¦ ¦their¦ ¦movements¦
𐋇¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦u nd ia gn osed¦ ¦symptoms¦ ¦but¦ ¦does¦ ¦not¦ ¦need¦ ¦a¦ ¦covid¦ - ¦19¦ ¦test¦
𐋇¦s om et im es¦ ¦your¦ ¦gp¦ ¦may¦ ¦not¦ ¦know¦ ¦wh y¦ ¦your¦ ¦child¦ ¦is¦ ¦ ill¦ .
𐋇¦h e¦ ¦may¦ ¦not¦ ¦be¦ ¦able¦ ¦to¦ ¦diagn ose¦ ¦hi s¦ ¦symptoms¦ .
𐋇¦h e¦ ¦may¦ ¦dec ide¦ ¦based¦ ¦on¦ ¦hi s¦ ¦symptoms¦ ¦that¦ ¦your¦ ¦child¦ ¦does¦ ¦not¦ ¦need¦ ¦to¦ ¦take¦ ¦the¦ ¦covid¦ - ¦19¦ ¦test¦ .
𐋇¦if¦ ¦this¦ ¦happ ens¦ ,▁ ¦your¦ ¦child¦ ¦should¦ ¦be h a ve¦ ¦as¦ ¦if¦ ¦they¦ ¦have¦ ¦covid¦ - ¦19¦ .
𐋇¦this¦ ¦is¦ ¦d one¦ ¦to¦ ¦keep¦ ¦others¦ ¦safe¦ .
𐋇¦it¦ ¦is¦ ¦not¦ ¦possible¦ ¦to¦ ¦be¦ ¦sure¦ ¦that¦ ¦your¦ ¦child¦ ¦does¦ ¦not¦ ¦have¦ ¦the¦ ¦virus¦ .
𐋇¦h e¦ ¦will¦ ¦have¦ ¦to¦ ¦continue¦ ¦to¦ ¦stay¦ ¦away¦ ¦from¦ ¦others¦ .
𐋇¦h e¦ ¦will¦ ¦have¦ ¦to¦ ¦remain¦ ¦al one¦ ¦until¦ ¦h e¦ ¦me ets¦ ¦both¦ ¦of¦ ¦these¦ ¦conditions¦ :
𐋇 ¦without¦ ¦high¦ ¦temp erat ure¦ ▁( ¦3 8¦ ¦de g re es¦ ¦c el si us¦ ¦or¦ ¦more¦ )▁ ¦for¦ ¦five¦ ¦days¦
𐋇¦it¦ ¦has¦ ¦been¦ ¦t en¦ ¦days¦ ¦since¦ ¦symptoms¦ ¦first¦ ¦app e ared¦
𐋇 ¦community¦ ¦as se ss ment¦ ¦hub s¦ ¦for¦ ¦coronavirus¦
𐋇 ¦community¦ ¦as se ss ment¦ ¦hub s¦ ¦help¦ ¦mana ge¦ ¦the¦ ¦increase¦ ¦in¦ ¦corona ry¦ ¦virus¦ ¦cases¦ ¦in¦ ¦the¦ ¦community¦ .
𐋇 ¦who¦ ¦are¦ ¦for¦ ¦these¦ ¦hub s¦ ? ▁ 𐋇¦these¦ ¦hub s¦ ¦are¦ ¦for¦ ¦people¦ :
𐋇 ¦who¦ ¦is¦ ¦very¦ ¦ ill¦
𐋇 ¦that¦ ¦they¦ ¦have¦ ¦tested¦ ¦positive¦ ¦for¦ ¦the¦ ¦coronavirus¦
𐋇 ¦likely¦ ¦to¦ ¦car ry¦ ¦a¦ ¦coronavirus¦
𐋇¦they¦ ¦need¦ ¦a¦ ¦face¦ - ¦to¦ - ¦face¦ ¦appointment¦ ¦with¦ ¦a¦ ¦gp¦
𐋇¦your¦ ¦gp¦ ¦may¦ ¦ref er¦ ¦you¦ ¦to¦ ¦a¦ ¦hub ¦ ¦for¦ ¦face¦ - ¦to¦ - ¦face¦ ¦as se ss ment¦ ¦if¦ :
𐋇¦you¦ ¦feel¦ ¦your¦ ¦symptoms¦ ¦are¦ ¦getting¦ ¦wor se¦
𐋇¦you¦ ¦th ink¦ ¦that¦ ¦you¦ ¦cannot¦ ¦mana ge¦ ¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦at¦ ¦home¦
𐋇¦you¦ ¦are¦ ¦wor r ied¦ ¦about¦ ¦your¦ ¦brea thing¦ ▁-▁ ¦such¦ ¦as¦ ¦sh ort ness¦ ¦of¦ ¦brea th¦ ¦or¦ ¦pain¦ ¦or¦ ¦di str ess¦
𐋇¦you¦ ¦are¦ ¦concer ned¦ ¦about¦ ¦other¦ ¦diseases¦ ¦you¦ ¦al rea dy¦ ¦have¦
𐋇¦the¦ ¦hub s¦ ¦are¦ ¦for¦ ¦people¦ ¦a ged¦ ¦16¦ ¦and¦ ¦over¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦wor r ied¦ ¦about¦ ¦your¦ ¦child¦ ¦or¦ ¦the¦ ¦symptoms¦ ¦of¦ ¦their¦ ¦illness¦ ,▁ ¦call¦ ¦your¦ ¦gp¦ .
𐋇¦the¦ ¦community¦ ¦as se ss ment¦ ¦hub s¦ ¦help¦ ¦to¦ ¦mana ge¦ ¦an¦ ¦incre as ing¦ ¦number¦ ¦of¦ ¦cases¦ ¦of¦ ¦coronavirus¦ ¦in¦ ¦the¦ ¦community¦ .
𐋇¦when¦ ¦to¦ ¦call¦ ¦your¦ ¦gp¦
𐋇¦your¦ ¦gp¦ ¦or¦ ¦out¦ - ¦of¦ - ¦hours¦ ¦gp¦ ¦will¦ ¦dec ide¦ ¦if¦ ¦you¦ ¦need¦ ¦a¦ ¦face¦ - ¦to¦ - ¦face¦ ¦cons ult ation¦ ¦at¦ ¦a¦ ¦hub ¦ .
𐋇 ¦call¦ ¦your¦ ¦gp¦ :
𐋇¦if¦ ¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦get¦ ¦wor se¦ ▁-▁ ¦especially¦ ¦if¦ ¦your¦ ¦brea thing¦ ¦is¦ ¦h ar der¦ ¦or¦ ¦f as ter¦
𐋇¦if¦ ¦you¦ ¦feel¦ ¦you¦ ¦cannot¦ ¦mana ge¦ ¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦yourself¦
𐋇¦as¦ ¦so on¦ ¦as¦ ¦your¦ ¦gp¦ ¦ref ers¦ ¦to¦ ¦a¦ ¦hub ¦ ,▁ ¦we¦ ¦will¦ ¦s end¦ ¦you¦ ¦a¦ ¦te xt¦ ¦with¦ ¦detail s¦ ¦of¦ ¦your¦ ¦appointment¦ ¦as¦ ¦so on¦ ¦as¦ ¦possible¦ .
𐋇 ¦make¦ ¦sure¦ ¦your¦ ¦gp¦ ¦has¦ ¦an¦ ¦up¦ - ¦to¦ - ¦date¦ ¦te le ph one¦ ¦number¦ .
𐋇¦m ed ications¦
𐋇 ¦br ing¦ ¦a¦ ¦l ist¦ ¦of¦ ¦your¦ ¦medic ations¦ ¦to¦ ¦your¦ ¦as se ss ment¦ ¦appointment¦ .
𐋇 ¦what¦ ¦happ ens¦ ¦at¦ ¦a¦ ¦hub ¦
𐋇¦a¦ ¦gp¦ ¦will¦ ¦ex a m ine¦ ¦you¦ ¦and¦ ¦dec ide¦ ¦on¦ ¦a¦ ¦treatment¦ ¦pl an¦ .
𐋇¦a¦ ¦ref er r al¦ ¦must¦ ¦be¦ ¦ob ta ined¦ ¦from¦ ¦a¦ ¦gp¦ .
𐋇¦we¦ ¦cannot¦ ¦ac cep t¦ ¦people¦ ¦who¦ ¦do¦ ▁' ¦w alk¦ - ¦in¦ ' .
𐋇 ¦coronavirus¦ ¦test¦
𐋇 ¦hub s¦ ¦do¦ ¦not¦ ¦provide¦ ¦cr own¦ ¦virus¦ ¦testing¦ .
𐋇 ¦op ening¦ ¦hours¦
𐋇¦the¦ ¦hub s¦ ¦will¦ ¦be¦ ¦open¦ ¦from¦ ¦8¦ ¦ am¦ ¦to¦ ¦8¦ ¦p m¦ ,▁ ¦se v en¦ ¦days¦ ¦a¦ ¦week¦ .
𐋇¦they¦ ¦will¦ ¦be¦ ¦contin u ed¦ ¦for¦ ¦as¦ ¦long¦ ¦as¦ ¦they¦ ¦are¦ ¦nee ded¦ .
𐋇¦your¦ ¦as se ss ment¦
𐋇¦we¦ ¦will¦ ¦take¦ ¦your¦ ¦contact¦ ¦detail s¦ ,▁ ¦then¦ ¦a¦ ¦n ur se¦ ¦and¦ ¦gp¦ ¦will¦ ¦make¦ ¦a¦ ¦f ul l¦ ¦as se ss ment¦ .
𐋇 ¦each¦ ¦appointment¦ ¦la sts¦ ¦about¦ ¦an¦ ¦hou r¦ .
𐋇¦the¦ ¦team¦ ¦will¦ ¦dec ide¦ ¦if¦ :
𐋇 ¦that¦ ¦you¦ ¦need¦ ¦to¦ ¦go¦ ¦to¦ ¦the¦ ¦hospital¦ ¦for¦ ¦ext r a¦ ¦support¦ ¦and¦ ¦treatment¦
𐋇 ¦that¦ ¦you¦ ¦are¦ ¦able¦ ¦to¦ ¦reco ver¦ ¦at¦ ¦home¦
𐋇¦it¦ ¦would¦ ¦help¦ ¦if¦ ¦you¦ ¦had¦ ¦ext r a¦ ¦support¦ ¦to¦ ¦help¦ ¦you¦ ¦reco ver¦ ¦in¦ ¦the¦ ¦community¦ ¦or¦ ¦sp end¦ ¦some¦ ¦time¦ ¦in¦ ¦an¦ ¦isolation¦ ¦facil ity¦ .
𐋇¦read¦ ¦more¦ ¦about¦ ¦coronavirus¦ ¦isolation¦ ¦facil ities¦ .
𐋇¦you¦ ¦and¦ ¦your¦ ¦gp¦ ¦will¦ ¦be¦ ¦giv en¦ ¦a¦ ¦c op y¦ ¦of¦ ¦the¦ ¦as se ss ment¦ ¦report¦ .
𐋇 ¦re stric ted¦ ¦movements¦ ▁( ¦stay¦ ¦at¦ ¦home¦ )
𐋇 ¦re stric ting¦ ¦your¦ ¦movements¦ ¦me ans¦ ¦not¦ ¦having¦ ¦as¦ ¦much¦ ¦contact¦ ¦with¦ ¦others¦ ¦as¦ ¦possible¦ .
𐋇¦this¦ ¦is¦ ¦d one¦ ¦to¦ ¦prevent¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ ).
𐋇¦when¦ ¦you¦ ¦should¦ ¦restrict¦ ¦your¦ ¦movements¦
𐋇¦you¦ ¦will¦ ¦need¦ ¦to¦ ¦restrict¦ ¦your¦ ¦movements¦ ¦for¦ ¦14¦ ¦days¦ ¦if¦ :
𐋇¦you¦ ¦have¦ ¦had¦ ¦direct¦ ¦contact¦ ¦with¦ ¦someone¦ ¦who¦ ¦has¦ ¦been¦ ¦diagn osed¦ ¦with¦ ¦covid¦ ▁ - ¦19¦
𐋇¦you¦ ¦live¦ ¦with¦ ¦someone¦ ¦who¦ ¦has¦ ¦symptoms¦ ¦of¦ ¦covid¦ ▁ - ¦19¦ ¦illness¦ ¦even¦ ¦th ough¦ ¦you¦ ¦feel¦ ¦well¦
𐋇¦if¦ ¦you¦ ¦ca me¦ ¦to¦ ¦ireland¦ ¦from¦ ¦another¦ ¦country¦ ,▁ ¦in¦ ¦most¦ ¦cases¦
𐋇¦there¦ ¦is¦ ¦spec ial¦ ¦advice¦ ¦for¦ ¦people¦ ¦c om ing¦ ¦to¦ ¦ireland¦ ¦from¦ ¦high¦ - ¦risk¦ ¦countries¦ ▁-▁ ¦se e¦ ¦the¦ ¦l ist¦ ¦on¦ ¦g ov ¦ . ¦i e¦
𐋇¦you¦ ¦should¦ ¦restrict¦ ¦your¦ ¦movements¦ ¦as¦ ¦you¦ ¦may¦ ¦have¦ ¦covid¦ - ¦19¦ .
𐋇¦you¦ ¦can¦ ¦spread¦ ¦the¦ ¦virus¦ ¦even¦ ¦if¦ ¦you¦ ¦have¦ ¦no¦ ¦symptoms¦ .
𐋇¦if¦ ¦you¦ ¦follow¦ ¦this¦ ¦advice¦ ,▁ ¦you¦ ¦will¦ ¦keep¦ ¦others¦ ¦safe¦ .
𐋇¦how¦ ¦to¦ ¦restrict¦ ¦your¦ ¦movements¦ :
𐋇¦stay¦ ¦away¦ ¦from¦ ¦others¦ ¦and¦ ¦other¦ ¦social¦ ¦occ a si ons¦ ¦as¦ ¦much¦ ¦as¦ ¦possible¦ .
𐋇¦stay¦ ¦at¦ ¦home¦ ¦or¦ ¦in¦ ¦your¦ ¦acc om mo d ation¦ ¦as¦ ¦much¦ ¦as¦ ¦possible¦ .
𐋇¦you¦ ¦can¦ ¦exerc ise¦ ¦out d o ors¦ ¦as¦ ¦long¦ ¦as¦ ¦you¦ ¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦others¦ .
𐋇¦d on¦ ' ¦t¦
𐋇¦do¦ ¦not¦ ¦go¦ ¦to¦ ¦the¦ ¦work pl ace¦ ¦un less¦ ¦you¦ ¦are¦ ¦wor king¦ ¦al one¦ ¦and¦ ¦can¦ ¦avoid¦ ¦others¦ ¦al t og ether¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦an¦ ¦essential¦ ¦work er¦ ¦and¦ ¦have¦ ¦no¦ ¦signs¦ ¦of¦ ¦illness¦ ,▁ ¦t alk¦ ¦to¦ ¦your¦ ¦e mploy er¦ .
𐋇¦do¦ ¦not¦ ¦att end¦ ¦school¦ ¦or¦ ¦colle ge¦
𐋇¦do¦ ¦not¦ ¦use¦ ¦a¦ ¦public¦ ¦transport¦ ¦system¦
𐋇¦do¦ ¦not¦ ¦inv ite¦ ¦others¦ ¦home¦
𐋇¦do¦ ¦not¦ ¦visit¦ ¦others¦ ,▁ ¦even¦ ¦if¦ ¦you¦ ¦us ually¦ ¦care¦ ¦for¦ ¦them¦ .
𐋇¦d on¦ ' ¦t¦ ¦go¦ ¦to¦ ¦the¦ ¦sho ps¦ ¦or¦ ¦the¦ ¦ph arm acy¦ ▁-▁ ¦if¦ ¦possible¦ ,▁ ¦order¦ ¦your¦ ¦gr oc er ies¦ ¦online¦ ¦or¦ ¦as k¦ ¦your¦ ¦family¦ ¦or¦ ¦f ri ends¦ ¦to¦ ¦coll ect¦ ¦them¦ ¦for¦ ¦you¦ .
𐋇¦do¦ ¦not¦ ¦go¦ ¦to¦ ¦schools¦ ¦to¦ ¦coll ect¦ ¦your¦ ¦children¦ ¦un less¦ ¦ne cess ary¦ .
𐋇 ¦as k¦ ¦your¦ ¦family¦ ¦or¦ ¦f ri ends¦ ¦to¦ ¦coll ect¦ ¦the¦ ¦children¦ ¦from¦ ¦school¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦to¦ ¦coll ect¦ ¦them¦ ,▁ ¦stay¦ ¦away¦ ¦from¦ ¦others¦ ¦and¦ ¦stay¦ ¦in¦ ¦your¦ ¦ca r¦ .
𐋇¦d on¦ ' ¦t¦ ¦go¦ ¦to¦ ¦a¦ ¦f un er al¦ ¦or¦ ¦w ed ding¦ ▁ -
𐋇¦read¦ ¦more¦ ¦about¦ ¦gr ief¦ ¦and¦ ¦death¦ ¦during¦ ¦covid¦ - ¦19¦
𐋇 ¦keep¦ ¦away¦ ¦from¦ ¦the¦ ¦el d erly¦ ,▁ ¦an yone¦ ¦with¦ ¦a¦ ¦long¦ - ¦ter m¦ ¦illness¦ ¦and¦ ¦pre gnant¦ ¦women¦ .
𐋇¦when¦ ¦can¦ ¦you¦ ¦sto p¦ ¦re stric ting¦ ¦your¦ ¦movements¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦ ¦for¦ ¦someone¦ ¦who¦ ¦has¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ ¦19¦ ,▁ ¦you¦ ¦must¦ ¦restrict¦ ¦your¦ ¦movements¦ ¦for¦ ¦14¦ ¦days¦ .
𐋇¦do¦ ¦this¦ ¦from¦ ¦the¦ ¦date¦ ¦you¦ ¦were¦ ¦last¦ ¦in¦ ¦contact¦ ¦with¦ ¦that¦ ¦person¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦u ns ure¦ ¦of¦ ¦the¦ ¦date¦ ,▁ ¦restrict¦ ¦your¦ ¦movements¦ ¦to¦ ¦the¦ ¦date¦ ¦giv en¦ ¦to¦ ¦you¦ ¦by¦ ¦the¦ ¦contact¦ ¦tracker¦ .
𐋇¦you¦ ¦can¦ ¦sto p¦ ¦re stric ting¦ ¦your¦ ¦movements¦ ¦when¦ ¦you¦ ¦me et¦ ¦the¦ ¦following¦ ¦conditions¦ :
𐋇¦you¦ ¦have¦ ¦tested¦ ¦negative¦ ▁( ¦covid¦ - ¦19¦ ¦was¦ ¦not¦ ¦detected¦ ),▁ ¦and¦ ¦10¦ ¦days¦ ¦have¦ ¦p as sed¦ ¦since¦ ¦you¦ ¦were¦ ¦in¦ ¦contact¦ ¦with¦ ¦someone¦ ¦who¦ ¦tested¦ ¦positive¦ .
𐋇¦you¦ ¦have¦ ¦no¦ ¦signs¦ ¦of¦ ¦illness¦
𐋇 ¦car ing¦ ¦for¦ ¦someone¦ ¦who¦ ¦is¦ ¦not¦ ¦c ap able¦ ¦of¦ ¦self¦ - ¦isolation¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦car ing¦ ¦for¦ ¦someone¦ ¦who¦ ¦is¦ ¦un able¦ ¦to¦ ¦self¦ - ¦isol ate¦ ¦the m s el ves¦ ,▁ ¦you¦ ¦and¦ ¦the¦ ¦others¦ ¦in¦ ¦the¦ ¦house¦ ¦must¦ ¦restrict¦ ¦your¦ ¦movements¦ ¦for¦ ¦1 7¦ ¦days¦ .
𐋇¦read¦ ¦about¦ ¦the¦ ¦di ff er ence¦ ¦between¦ ¦self¦ - ¦isolation¦ ¦and¦ ¦re stric ting¦ ¦movements¦
𐋇¦if¦ ¦you¦ ¦live¦ ¦with¦ ¦someone¦ ¦who¦ ¦is¦ ¦re stric ting¦ ¦their¦ ¦movements¦
𐋇¦if¦ ¦you¦ ¦live¦ ¦with¦ ¦someone¦ ¦who¦ ¦is¦ ¦re stric ting¦ ¦their¦ ¦movements¦ ,▁ ¦you¦ ¦do¦ ¦not¦ ¦need¦ ¦to¦ ¦restrict¦ ¦your¦ ¦movements¦ ¦as¦ ¦long¦ ¦as¦ ¦that¦ ¦person¦ ¦has¦ ¦no¦ ¦symptoms¦ .
𐋇¦if¦ ¦you¦ ¦live¦ ¦with¦ ¦someone¦ ¦who¦ ¦has¦ ¦covid¦ - ¦19¦ ¦symptoms¦
𐋇 ¦restrict¦ ¦your¦ ¦movements¦ ,▁ ¦even¦ ¦if¦ ¦you¦ ¦are¦ ¦not¦ ¦sick¦ .
𐋇¦the¦ ¦person¦ ¦with¦ ¦the¦ ¦symptoms¦ ¦should¦ ¦be h a ve¦ ¦as¦ ¦if¦ ¦they¦ ¦have¦ ¦the¦ ¦corona ry¦ ¦virus¦ ¦and¦ :
𐋇 ¦immediate¦ ¦self¦ - ¦isolation¦
𐋇 ¦call¦ ¦your¦ ¦gp¦ ¦for¦ ¦advice¦
𐋇¦a¦ ¦covid¦ - ¦19¦ ¦test¦ ¦may¦ ¦be¦ ¦arr an ged¦ ¦for¦ ¦the¦ ¦person¦ ¦you¦ ¦live¦ ¦with¦
𐋇¦if¦ ¦that¦ ¦test¦ ¦is¦ ¦positive¦ ,▁ ¦you¦ ¦will¦ ¦be¦ ¦in¦ ¦close¦ ¦contact¦ ¦and¦ ¦need¦ ¦to¦ ¦restrict¦ ¦your¦ ¦movements¦ .
𐋇¦if¦ ¦the¦ ¦virus¦ ¦is¦ ¦not¦ ¦detected¦ ▁( ¦negative¦ ¦result¦ ),▁ ¦you¦ ¦no¦ ¦lo nger¦ ¦need¦ ¦to¦ ¦restrict¦ ¦your¦ ¦movements¦ .
𐋇 ¦continue¦ ¦to¦ ¦ad h er e¦ ¦to¦ ¦the¦ ¦advice¦ ¦on¦ ¦prot ecting¦ ¦yourself¦ ¦and¦ ¦others¦
𐋇¦if¦ ¦someone¦ ¦li ving¦ ¦with¦ ¦you¦ ¦is¦ ¦wai ting¦ ¦for¦ ¦a¦ ¦test¦ ¦result¦
𐋇¦read¦ ¦advice¦ ¦on¦ ¦what¦ ¦to¦ ¦do¦ ¦if¦ ¦you¦ ¦live¦ ¦with¦ ¦someone¦ ¦who¦ ¦is¦ ¦wai ting¦ ¦for¦ ¦a¦ ¦test¦ ¦result¦ .
𐋇 ¦travel¦ ¦to¦ ¦ireland¦ ¦from¦ ¦another¦ ¦country¦
𐋇 ¦restrict¦ ¦your¦ ¦movements¦ ¦for¦ ¦14¦ ¦days¦ ¦if¦ ¦you¦ ¦come¦ ¦from¦ ¦a¦ ¦non¦ - ¦high¦ - ¦risk¦ ¦country¦ .
𐋇¦this¦ ¦me ans¦ ¦sta ying¦ ¦at¦ ¦home¦ ¦or¦ ¦in¦ ¦your¦ ¦acc om mo d ation¦ .
𐋇¦do¦ ¦not¦ ¦att end¦ ¦events¦ ¦such¦ ¦as¦ ¦f un er als¦ ,▁ ¦part ies¦ ¦or¦ ¦w ed d ings¦ .
𐋇 ¦those¦ ¦from¦ ¦the¦ ¦g re en¦ ▁/▁ ¦or ange¦ ¦regi ons¦ ¦of¦ ¦n or ther n¦ ¦ireland¦ ¦do¦ ¦not¦ ¦have¦ ¦to¦ ¦restrict¦ ¦their¦ ¦movements¦ .
𐋇 ¦visit¦ ¦g ov ¦ . ¦i e¦ ¦for¦ ¦more¦ ¦information¦ ¦on¦ ¦travel¦ ¦and¦ ¦testing¦ ¦before¦ ¦c om ing¦ ¦to¦ ¦ireland¦ .
𐋇¦there¦ ¦is¦ ¦different¦ ¦advice¦ ¦for¦ ¦people¦ ¦c om ing¦ ¦to¦ ¦ireland¦ ¦from¦ ¦high¦ - ¦risk¦ ¦countries¦ .▁ –
𐋇 ¦se e¦ ¦the¦ ¦l ist¦ ¦on¦ ¦g ov ¦ . ¦i e¦ .
𐋇 ¦tre at¦ ¦the¦ ¦symptoms¦ ¦of¦ ¦coronavirus¦ ¦at¦ ¦home¦
𐋇 ¦no¦ ¦vaccine¦ ¦is¦ ¦y et¦ ¦available¦ ,▁ ¦and¦ ¦no¦ ¦specific¦ ¦treatment¦ ¦is¦ ¦available¦ ¦for¦ ¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ ).
𐋇¦but¦ ¦many¦ ¦of¦ ¦the¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦can¦ ¦be¦ ¦tre ated¦ ¦at¦ ¦home¦ .
¦8 0¦ %▁ ¦of¦ ¦people¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦reco ver¦ ¦from¦ ¦the¦ ¦corona ry¦ ¦virus¦ ¦at¦ ¦home¦ ¦and¦ ¦will¦ ¦not¦ ¦need¦ ¦to¦ ¦go¦ ¦to¦ ¦the¦ ¦hospital¦ .
𐋇¦the¦ ¦vaccines¦ ¦will¦ ¦be¦ ¦made¦ ¦available¦ ¦g rad ually¦ ¦to¦ ¦the¦ ¦w ho le¦ ¦community¦ .
𐋇¦f ind¦ ¦out¦ ¦more¦ ¦about¦ ¦the¦ ¦covid¦ - ¦19¦ ¦vaccine¦
𐋇¦you¦ ¦should¦ ¦stay¦ ¦away¦ ¦if¦ ¦you¦ ¦develop ¦ ¦symptoms¦ ¦to¦ ¦control¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇 ¦call¦ ¦your¦ ¦gp¦ ¦or¦ ¦out¦ - ¦of¦ - ¦hours¦ ¦doctor¦ ¦and¦ ¦t alk¦ ¦to¦ ¦them¦ ¦about¦ ¦getting¦ ¦a¦ ¦covid¦ - ¦19¦ ¦test¦ .
𐋇 ¦most¦ ¦imp or ta ntly¦ ,▁ ¦protect¦ ¦others¦ ¦from¦ ¦covid¦ - ¦19¦ .
𐋇 ¦prot ecting¦ ¦those¦ ¦in¦ ¦v ul n er able¦ ¦grou ps¦ ¦from¦ ¦the¦ ¦coronavirus¦ ¦is¦ ¦very¦ ¦important¦ .
𐋇¦you¦ ¦should¦ :
𐋇 ¦self¦ - ¦isolation¦
𐋇 ¦get¦ ¦en ough¦ ¦sl ee p¦ ¦and¦ ¦r est¦ ¦time¦
𐋇 ¦dr ink¦ ¦p le nt y¦ ¦of¦ ¦water¦ ¦to¦ ¦avoid¦ ¦de h y dr ation¦ .
𐋇¦your¦ ¦ ur ine¦ ¦should¦ ¦be¦ ¦br ight¦ ¦y e ll ow¦ ¦or¦ ¦br ight¦
𐋇¦e at¦ ¦he al t hi ly¦
𐋇¦do¦ ¦not¦ ¦s mo ke¦
𐋇¦f an¦ ¦you¦
𐋇 ¦keep¦ ¦an¦ ¦ey e¦ ¦out¦ ¦for¦ ¦signs¦ ¦of¦ ¦illness¦ ¦and¦ ¦tre at¦ ¦them¦ .
𐋇 ¦more¦ ¦information¦ ¦about¦ ¦the¦ ¦signs¦ ¦of¦ ¦the¦ ¦coronavirus¦ :
𐋇 ¦fever¦
𐋇 ¦cough¦
𐋇 ¦sh ort ness¦ ¦of¦ ¦brea th¦
𐋇¦l ost¦ ¦or¦ ¦al t ered¦ ¦sm ell¦
𐋇¦if¦ ¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦get¦ ¦wor se¦
𐋇 ¦call¦ ¦your¦ ¦gp¦ ¦if¦ ¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦do¦ ¦not¦ ¦imp ro ve¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦over¦ ¦6 0¦ ¦or¦ ¦have¦ ¦a¦ ¦disease¦ ¦that¦ ¦p u ts¦ ¦you¦ ¦at¦ ¦g rea ter¦ ¦risk¦ ¦for¦ ¦coronavirus¦ ,▁ ¦you¦ ¦should¦ ¦keep¦ ¦a¦ ¦close¦ ¦ey e¦ ¦on¦ ¦your¦ ¦signs¦ ¦of¦ ¦illness¦ . .
𐋇 ¦call¦ ¦your¦ ¦gp¦ ¦if¦ ¦the¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦get¦ ¦wor se¦ .
𐋇 ¦medic ation¦ ¦for¦ ¦treatment¦
𐋇¦the¦ ¦b est¦ ¦medic ine¦ ¦dep ends¦ ¦on¦ ¦your¦ ¦s y mp ot o ms¦ :
𐋇 ¦symptoms¦ ¦of¦ ¦illness¦
𐋇 ¦other¦ ¦health¦ ¦co mpl ications¦
𐋇 ¦any¦ ¦other¦ ¦medical¦ ¦treatment¦ ¦you¦ ¦are¦ ¦rece i ving¦
𐋇¦p ara ce ta mo l¦ ¦or¦ ¦i b u p ro fen¦ ¦may¦ ¦help¦ ¦lower¦ ¦your¦ ¦temp erat ure¦ ¦and¦ ¦give¦ ¦you¦ ¦rel ief¦ ¦from¦ ¦your¦ ¦pa ins¦ .
𐋇¦p ara ce ta mo l¦ ¦is¦ ¦recommended¦ ¦as¦ ¦the¦ ¦first¦ ¦ line¦ ¦of¦ ¦treatment¦ ¦for¦ ¦most¦ ¦people¦ .
𐋇¦read¦ ¦all¦ ¦the¦ ¦gu id el ines¦ ¦in¦ ¦the¦ ¦p ac k age¦ ¦before¦ ¦ta king¦ ¦any¦ ¦medic ation¦ .
𐋇 ¦take¦ ¦advice¦ ¦from¦ ¦any¦ ¦health¦ ¦pro f es si on al¦ .
𐋇 ¦anti b i ot ics¦
𐋇 ¦anti b i ot ics¦ ¦do¦ ¦not¦ ¦work¦ ¦against¦ ¦coronavirus¦ ¦or¦ ¦any¦ ¦other¦ ¦viruses¦ .
𐋇¦they¦ ¦will¦ ¦not¦ ¦give¦ ¦you¦ ¦rel ief¦ ¦from¦ ¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦or¦ ¦help¦ ¦you¦ ¦to¦ ¦reco ver¦ .
𐋇 ¦coronavirus¦ ¦is¦ ¦a¦ ¦virus¦ ¦that¦ ¦is¦ ¦not¦ ¦h el p ed¦ ¦by¦ ¦anti b i ot ics¦ .
𐋇 ¦i b u p ro fen¦
𐋇¦it¦ ¦is¦ ¦o k ay¦ ¦to¦ ¦take¦ ¦anti ¦ - ¦inf la mm atory¦ ¦medic ations¦ ▁( ¦ ns ai ds¦ )▁ ¦if¦ ¦you¦ ¦have¦ ¦a¦ ¦corona ry¦ ¦virus¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦evidence¦ ¦that¦ ¦it¦ ¦is¦ ¦d an ge ro us¦ .
𐋇 ¦only¦ ¦take¦ ¦one¦ ¦anti ¦ - ¦inf la mm atory¦ ¦medic ation¦ ¦at¦ ¦a¦ ¦time¦ .
𐋇¦it¦ ¦is¦ ¦o k ay¦ ¦to¦ ¦take¦ ¦p ara ce ta mo l¦ ¦and¦ ¦anti ¦ - ¦inf la mm atory¦ ¦d ru g s¦ ¦such¦ ¦as¦ ¦i b u p ro fen¦ ¦t og ether¦ .
𐋇 ¦anti ¦ - ¦inf la mm atory¦ ¦medic ations¦ ¦include¦ :
𐋇 ¦i b u p ro fen¦ ▁-▁ ¦br and¦ ¦na m es¦ :▁ 𐋇 ¦nu ro fen¦ ,▁ ¦a ct ip ro fen¦ ,▁ ¦ad v il¦ ,▁ ¦b ru fen¦ ,▁ ¦b ru p r o¦ ,▁ ¦bu p le x¦ ,▁ ¦e as o fen¦ ,▁ ¦and¦ ¦f en op ine¦ .
𐋇 ¦i b u p ro fen¦ ¦ ge l¦ ¦may¦ ¦con tain¦ ¦the¦ ¦na m es¦ :▁ 𐋇 ¦nu ro fen¦ ,▁ ¦m el fen¦ ,▁ ¦ph or pa in¦ ,▁ ¦i b u ge l¦ ¦and¦ ¦i b u le ve¦
𐋇¦n ap ro x en¦ ▁-▁ ¦a in m¦ ¦b ra nd a¦ :▁ 𐋇¦n ap r os y n¦
𐋇¦d ic lo f e na c¦ ▁-▁ ¦br and¦ ¦na m es¦ :▁ 𐋇 ¦v ol ta ro l¦ ,▁ ¦d ic l o¦ ,▁ ¦d ic la c¦ ,▁ ¦ca ta f l am¦ ,▁ ¦d if en e¦ ¦and¦ ¦f l ector¦
𐋇 ¦visi ting¦ ¦nu rs ing¦ ¦h omes¦ ¦and¦ ¦res ide ntial¦ ¦care¦ ¦centr es¦
𐋇 ¦people¦ ¦li ving¦ ¦in¦ ¦nu rs ing¦ ¦h omes¦ ¦and¦ ¦res ide ntial¦ ¦care¦ ¦facil ities¦ ¦can¦ ¦have¦ ¦two¦ ¦of¦ ¦your¦ ¦ le¦ ¦4¦ ¦have¦ ¦a¦ ¦w ee k ly¦ ¦visit¦ ,▁ ¦provid ed¦ ¦the¦ ¦facil ity¦ ¦has¦ ¦a¦ ¦high¦ ¦level¦ ¦of¦ ¦vacc ination¦ .
𐋇¦this¦ ¦is¦ ¦d one¦ ¦in¦ ¦comp as si on ate¦ ¦c ir c um st an ces¦ ¦under¦ ¦level¦ ¦5¦ ¦restrictions¦ .
𐋇¦covid¦ - ¦19¦ ¦can¦ ¦spread¦ ¦qu ick ly¦ ¦and¦ ¦can¦ ¦do¦ ¦a¦ ¦l ot¦ ¦of¦ ¦h ar m¦ ¦if¦ ¦received¦ ¦in¦ ¦a¦ ¦nu rs ing¦ ¦home¦ ¦or¦ ¦res ide ntial¦ ¦care¦ ¦centre¦ ▁( ¦sc f¦ ).
𐋇¦you¦ ¦can¦ ¦spread¦ ¦the¦ ¦virus¦ ,▁ ¦even¦ ¦if¦ ¦you¦ ¦only¦ ¦have¦ ¦mild¦ ¦symptoms¦ ,▁ ¦or¦ ¦if¦ ¦you¦ ¦have¦ ¦no¦ ¦symptoms¦ ¦or¦ ¦even¦ ¦if¦ ¦you¦ ¦feel¦ ¦well¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦rece ntly¦ ¦arr iv ed¦ ¦in¦ ¦ireland¦ ¦from¦ ¦b ri tain¦ ¦or¦ ¦south¦ ¦afr ica¦ ,▁ ¦stay¦ ¦al one¦ ¦for¦ ¦14¦ ¦days¦ ¦and¦ ¦not¦ ¦visit¦ ¦a¦ ¦nu rs ing¦ ¦home¦ ¦or¦ ¦res ide ntial¦ ¦care¦ ¦centre¦ .
𐋇 ¦visi ts¦
𐋇¦the¦ ¦arr an ge ments¦ ¦for¦ ¦visi ting¦ ¦res id ents¦ ¦in¦ ¦nu rs ing¦ ¦h omes¦ ¦and¦ ¦res ide ntial¦ ¦care¦ ¦centr es¦ ¦are¦ ¦as¦ ¦fo ll ow s¦ :
𐋇 ¦one¦ ¦visit¦ ¦per¦ ¦week¦ ¦from¦ ¦one¦ ¦person¦ ¦under¦ ¦level¦ ¦3¦ ¦and¦ ¦level¦ ¦4¦ ¦restrictions¦
𐋇 ¦one¦ ¦f ort n i gh t ly¦ ¦visit¦ ¦from¦ ¦one¦ ¦person¦ ¦under¦ ¦level¦ ¦5¦ ▁-▁ ¦for¦ ¦crit ical¦ ¦and¦ ¦comp as si on ate¦ ¦re as ons¦ ¦only¦
𐋇 ¦level¦ ¦5¦ ¦restrictions¦ ¦app ly¦ ¦in¦ ¦the¦ ¦state¦ .
𐋇¦the¦ ¦visit¦ ¦should¦ ¦only¦ ¦last¦ ¦an¦ ¦hou r¦ .
𐋇¦it¦ ¦is¦ ¦not¦ ¦ne cess ary¦ ¦to¦ ¦visit¦ ¦the¦ ¦same¦ ¦person¦ ¦every¦ ¦time¦ .
𐋇¦it¦ ¦is¦ ¦the¦ ¦res ident¦ ▁' ¦s¦ ¦c ho ice¦ ¦wh ether¦ ¦or¦ ¦not¦ ¦to¦ ¦ad mi t¦ ¦a¦ ¦visi t or¦ .
𐋇¦t alk¦ ¦to¦ ¦staff¦ ¦if¦ ¦a¦ ¦more¦ ¦ex te nded¦ ¦visit¦ ¦is¦ ¦required¦ ,▁ ¦for¦ ¦example¦ ,▁ ¦at¦ ¦the¦ ¦end¦ ¦of¦ ¦l ife¦ .
𐋇¦in¦ ¦cases¦ ¦like¦ ¦this¦ ,▁ ¦more¦ ¦than¦ ¦one¦ ¦visi t or¦ ¦may¦ ¦arr ive¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦to¦ ¦visit¦ ¦in¦ ¦crit ical¦ ¦and¦ ¦comp as si on ate¦ ¦c ir c um st an ces¦ ,▁ ¦you¦ ¦should¦ ¦follow¦ ¦the¦ ¦advice¦ ¦b el ow¦ ¦in¦ ¦the¦ ¦inter e sts¦ ¦of¦ ¦k ee p ing¦ ¦e veryone¦ ¦safe¦ .
𐋇 ¦crit ical¦ ¦and¦ ¦comp as si on ate¦ ¦visi ts¦
𐋇 ¦ad di tional¦ ¦visi ts¦ ¦for¦ ¦crit ical¦ ¦and¦ ¦comp as si on ate¦ ¦c ir c um st an ces¦ ¦may¦ ¦be¦ ¦p erm it ted¦ ¦in¦ ¦cases¦ ¦such¦ ¦as¦ :
𐋇 ¦end¦ ¦of¦ ¦l ife¦
𐋇¦if¦ ¦a¦ ¦res ident¦ ¦is¦ ¦very¦ ¦wor r ied¦ ¦or¦ ¦up s et¦ ¦and¦ ¦a¦ ¦visit¦ ¦from¦ ¦someone¦ ¦close¦ ¦to¦ ¦them¦ ¦may¦ ¦p ut¦ ¦them¦ ¦at¦ ¦e ase¦
𐋇¦if¦ ¦there¦ ¦is¦ ¦an¦ ¦important¦ ¦ev ent¦ ¦in¦ ¦the¦ ¦l ife¦ ¦of¦ ¦the¦ ¦res ident¦
𐋇¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦have¦ ¦the¦ ¦o pp ort un ity¦ ¦to¦ ¦visit¦ ¦ag a in¦ ¦for¦ ¦a¦ ¦fe w¦ ¦mon ths¦ ¦or¦ ¦years¦ ,▁ ¦for¦ ¦example¦ ,▁ ¦if¦ ¦you¦ ¦are¦ ¦lea ving¦ ¦the¦ ¦country¦ ¦or¦ ¦n earing¦ ¦the¦ ¦end¦ ¦of¦ ¦your¦ ¦l ife¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦to¦ ¦make¦ ¦fi na nc ial¦ ¦or¦ ¦other¦ ¦arr an ge ments¦ ¦or¦ ¦to¦ ¦ad v oc ate¦ ¦on¦ ¦be h al f¦ ¦of¦ ¦the¦ ¦res ident¦
𐋇 ¦out door¦ ¦visi ts¦
𐋇 ¦out door¦ ¦visi ts¦ ¦are¦ ¦p erm it ted¦ ,▁ ¦as¦ ¦long¦ ¦as¦ ¦people¦ ¦stay¦ ¦two¦ ¦meters¦ ¦a par t¦ ▁( ¦social¦ ¦separ ation¦ )▁ ¦at¦ ¦all¦ ¦times¦ ¦and¦ ¦if¦ ¦the¦ ¦res ident¦ ¦is¦ ¦able¦ ¦to¦ ¦get¦ ¦out d o ors¦ .
𐋇 ¦such¦ ¦visi ts¦ ¦must¦ ¦be¦ ¦arr an ged¦ ¦in¦ ¦ad v ance¦ .
𐋇 ¦visi ts¦ ¦at¦ ¦the¦ ¦w i nd ow¦
𐋇¦it¦ ¦is¦ ¦al w ays¦ ¦possible¦ ¦to¦ ¦t alk¦ ¦to¦ ¦res id ents¦ ¦outside¦ ¦of¦ ¦their¦ ¦open¦ ¦w i nd ow s¦ ¦or¦ ¦on¦ ¦the¦ ¦phone¦ ¦but¦ ¦stay¦ ¦a¦ ¦safe¦ ¦dista nce¦ ¦from¦ ¦each¦ ¦other¦ .
𐋇 ¦such¦ ¦visi ts¦ ¦must¦ ¦be¦ ¦arr an ged¦ ¦in¦ ¦ad v ance¦ .
𐋇 ¦before¦ ¦you¦ ¦visit¦
𐋇¦the¦ ¦nu rs ing¦ ¦home¦ ¦will¦ ¦us ually¦ ¦s ee k¦ ¦the¦ ¦contact¦ ¦detail s¦ ¦of¦ ¦na med¦ ¦visi t ors¦ ¦in¦ ¦ad v ance¦ .
𐋇 ¦ch eck¦ ¦in¦ ¦ad v ance¦ ¦if¦ ¦it¦ ¦is¦ ¦o k¦ ¦to¦ ¦visit¦ .
𐋇¦the¦ ¦staff¦ ¦will¦ ¦prob ab ly¦ ¦give¦ ¦you¦ ¦a¦ ¦specific¦ ¦time¦ .
𐋇¦you¦ ¦will¦ ¦have¦ ¦to¦ ¦come¦ ¦and¦ ¦go¦ ¦at¦ ¦the¦ ¦ag re ed¦ ¦times¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦as ked¦ ¦a¦ ¦number¦ ¦of¦ ¦qu es tions¦ ¦before¦ ¦you¦ ¦visit¦ ¦to¦ ¦make¦ ¦sure¦ ¦you¦ ¦have¦ ¦no¦ ¦covid¦ ¦19¦ ¦s ign¦ .
𐋇¦your¦ ¦temp erat ure¦ ¦may¦ ¦be¦ ¦r ai sed¦ ¦before¦ ¦you¦ ¦en ter¦ ¦the¦ ¦centre¦ .
𐋇¦the¦ ¦mana ge ment¦ ¦of¦ ¦the¦ ¦centre¦ ¦has¦ ¦the¦ ¦r ight¦ ¦to¦ ¦dec ide¦ ¦wh ether¦ ¦or¦ ¦not¦ ¦you¦ ¦can¦ ¦visit¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦un able¦ ¦to¦ ¦visit¦ ¦your¦ ¦rel ative¦ ,▁ ¦it¦ ¦may¦ ¦wor ry¦ ¦you¦ .
𐋇¦the¦ ¦restrictions¦ ¦are¦ ¦in¦ ¦place¦ ¦to¦ ¦keep¦ ¦you¦ ,▁ ¦your¦ ¦family¦ ¦me mber¦ ¦and¦ ¦the¦ ¦healthcare¦ ¦staff¦ ¦safe¦ .
𐋇¦s om et im es¦ ¦a¦ ¦res ident¦ ¦may¦ ¦have¦ ¦to¦ ¦lea ve¦ ¦with¦ ¦the¦ ¦visi t or¦ ¦to¦ ¦de al¦ ¦with¦ ¦so me thing¦ ¦very¦ ¦important¦ ¦such¦ ¦as¦ ¦some¦ ¦personal¦ ¦need¦ ,▁ ¦the¦ ¦death¦ ¦of¦ ¦a¦ ¦family¦ ¦me mber¦ ¦or¦ ¦a¦ ¦visit¦ ¦to¦ ¦a¦ ¦family¦ ¦g ra ve¦ .
𐋇¦a¦ ¦pl an¦ ¦will¦ ¦be¦ ¦pre p ared¦ ¦to¦ ¦keep¦ ¦the¦ ¦res ident¦ ¦as¦ ¦safe¦ ¦as¦ ¦possible¦ ¦for¦ ¦the m s el ves¦ ¦and¦ ¦other¦ ¦res id ents¦ .
𐋇¦read¦ ¦about¦ ¦how¦ ¦to¦ ¦take¦ ¦care¦ ¦of¦ ¦your¦ ¦me ntal¦ ¦health¦ ¦during¦ ¦a¦ ¦corona ry¦ ¦virus¦ ¦outbreak¦ .
𐋇 ¦during¦ ¦your¦ ¦visit¦
𐋇¦you¦ ¦will¦ ¦need¦ ¦to¦ ¦wear¦ ¦a¦ ¦face¦ ¦cover¦ ¦or¦ ¦medical¦ ¦mask¦ ¦during¦ ¦your¦ ¦visit¦ .
𐋇¦the¦ ¦cover¦ ¦should¦ ¦be¦ ¦le f t¦ ¦on¦ ¦you¦ ¦even¦ ¦if¦ ¦you¦ ¦are¦ ¦al one¦ ¦and¦ ¦2¦ ¦meters¦ ¦a par t¦ .
𐋇¦in¦ ¦some¦ ¦cases¦ ,▁ ¦it¦ ¦is¦ ¦b est¦ ¦to¦ ¦re mo ve¦ ¦the¦ ¦mask¦ :
𐋇¦if¦ ¦it¦ ¦is¦ ¦to o¦ ¦diffic ul t¦ ¦to¦ ¦comm un ic ate¦ ¦with¦ ¦your¦ ¦family¦ ¦and¦ ¦wear¦ ¦the¦ ¦mask¦
𐋇¦if¦ ¦your¦ ¦rel ative¦ ¦is¦ ¦un able¦ ¦to¦ ¦ident if y¦ ¦you¦ ¦with¦ ¦the¦ ¦mask¦ ¦on¦ ¦you¦
𐋇¦if¦ ¦the¦ ¦mask¦ ¦off ends¦ ¦your¦ ¦l oved¦ ¦one¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦tr ou ble¦ ¦w earing¦ ¦a¦ ¦face¦ ¦mask¦ ,▁ ¦you¦ ¦can¦ ¦wear¦ ¦face¦ ¦masks¦ .
𐋇 ¦ce lls¦ ¦are¦ ¦not¦ ¦as¦ ¦g ood¦ ¦as¦ ¦face¦ ¦cover¦ ¦and¦ ¦may¦ ¦not¦ ¦give¦ ¦you¦ ¦or¦ ¦your¦ ¦family¦ ¦the¦ ¦same¦ ¦prote ction¦ ,▁ ¦but¦ ¦they¦ ¦will¦ ¦give¦ ¦you¦ ¦some¦ ¦prote ction¦ .
𐋇¦you¦ ¦may¦ ¦also¦ ¦be¦ ¦as ked¦ ¦to¦ ¦wear¦ ¦a¦ ¦prot ective¦ ¦ ap r on¦ .
𐋇¦you¦ ¦must¦ ¦ad h er e¦ ¦to¦ ¦the¦ ¦advice¦ ¦on¦ ¦prot ecting¦ ¦yourself¦ ¦and¦ ¦others¦ ¦against¦ ¦covid¦ - ¦19¦
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦properly¦ ¦when¦ ¦ent ering¦ ¦and¦ ¦lea ving¦ ¦patients¦
𐋇¦you¦ ¦can¦ ¦br ing¦ ¦a¦ ¦g if t¦ ¦or¦ ¦an y thing¦ ¦el se¦ ¦they¦ ¦w ant¦ .
𐋇 ¦each¦ ¦visit¦ ¦us ually¦ ¦la sts¦ ¦1¦ ¦hou r¦ .
𐋇¦if¦ ¦you¦ ¦need¦ ¦a¦ ¦more¦ ¦ex te nded¦ ¦visit¦ ¦for¦ ¦comp as si on ate¦ ¦c ir c um st an ces¦ ,▁ ¦t alk¦ ¦to¦ ¦staff¦ ¦about¦ ¦it¦ .
𐋇¦if¦ ¦an¦ ¦outbreak¦ ¦of¦ ¦the¦ ¦cr own¦ ¦virus¦ ¦brea ks¦ ¦out¦
𐋇¦if¦ ¦a¦ ¦covid¦ - ¦19¦ ¦outbreak¦ ¦brea ks¦ ¦out¦ ¦at¦ ¦the¦ ¦centre¦ ¦or¦ ¦facil ity¦ ,▁ ¦visi ts¦ ¦will¦ ¦be¦ ¦susp e nded¦ ¦for¦ ¦some¦ ¦time¦ .
𐋇 ¦one¦ ¦person¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦make¦ ¦one¦ ¦f ort n i gh t ly¦ ¦visit¦ ¦to¦ ¦res id ents¦ ¦under¦ ¦level¦ ¦5¦ ¦restrictions¦ .
𐋇 ¦ex cep tions¦ ¦will¦ ¦be¦ ¦made¦ ¦in¦ ¦spec ial¦ ¦cases¦ ,▁ ¦for¦ ¦example¦ ,▁ ¦if¦ ¦a¦ ¦person¦ ¦is¦ ¦in¦ ¦da nger¦ ¦of¦ ¦death¦ ¦or¦ ¦if¦ ¦the¦ ¦outbreak¦ ¦is¦ ¦in¦ ¦a¦ ¦partic ular¦ ¦place¦ .
𐋇¦you¦ ¦can¦ ¦disc us s¦ ¦this¦ ¦with¦ ¦the¦ ¦team¦ .
𐋇 ¦times¦ ¦you¦ ¦should¦ ¦not¦ ¦visit¦
𐋇¦do¦ ¦not¦ ¦visit¦ ¦if¦ :
𐋇¦you¦ ¦have¦ ¦been¦ ¦to ld¦ ¦that¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦ ¦with¦ ¦someone¦ ¦with¦ ¦the¦ ¦coronavirus¦
𐋇¦you¦ ¦have¦ ¦any¦ ¦signs¦ ¦of¦ ¦coronavirus¦ ¦or¦ ¦any¦ ¦other¦ ¦infection¦ ¦such¦ ¦as¦ ¦a¦ ¦cold¦ ¦or¦ ¦flu¦
𐋇¦you¦ ¦have¦ ¦signs¦ ¦of¦ ¦ga st ro e nt er itis¦ ,▁ ¦such¦ ¦as¦ ¦di arr he a¦ ¦and¦ ¦v o mi ting¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦any¦ ¦of¦ ¦these¦ ¦i ll n es ses¦ ,▁ ¦you¦ ¦should¦ ¦wai t¦ ¦at¦ ¦least¦ ¦2¦ ¦days¦ ¦after¦ ¦the¦ ¦sign al¦ ¦has¦ ¦g one¦ ¦before¦ ¦you¦ ¦visit¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦ ,▁ ¦you¦ ¦will¦ ¦need¦ ¦to¦ ¦stay¦ ¦al one¦ ¦for¦ ¦14¦ ¦days¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦been¦ ¦tested¦ ¦for¦ ¦covid¦ - ¦19¦ ,▁ ¦do¦ ¦not¦ ¦visit¦ ¦until¦ ¦you¦ ¦have¦ ¦been¦ ¦to ld¦ ¦that¦ ¦it¦ ¦is¦ ¦safe¦ ¦to¦ ¦do¦ ¦so¦ .
𐋇 ¦last¦ ¦re v ie w ed¦ ¦on¦ :▁ ¦0 7¦ ▁/▁ ¦0 1¦ ▁/▁ ¦2021¦
𐋇 ¦ne xt¦ ¦re v ie w¦ :▁ ¦30¦ ▁/▁ ¦11¦ ▁/▁ ¦20 2 3¦
𐋇 ¦travel¦ ¦and¦ ¦the¦ ¦coronavirus¦
𐋇 ¦travel¦ ¦in¦ ¦ireland¦
𐋇¦the¦ ¦l at est¦ ¦travel¦ ¦gu ide¦ ¦is¦ ¦available¦ ¦on¦ ¦g ov ¦ . ¦i e¦
𐋇¦how¦ ¦to¦ ¦s et¦ ¦up¦ ¦a¦ ¦test¦
𐋇¦stay¦ ¦at¦ ¦home¦ ▁-▁ ¦level¦ ¦5¦ ¦restrictions¦ ¦app ly¦ ¦in¦ ¦ireland¦ .
𐋇¦read¦ ¦about¦ ¦the¦ ¦restrictions¦ ¦at¦ ¦g ov ¦ . ¦i e¦
𐋇¦you¦ ¦can¦ ¦get¦ ¦a¦ ¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ )▁ ¦test¦ ,▁ ¦fre e¦ ¦of¦ ¦ch ar ge¦ ,▁ ¦if¦ ¦you¦ ¦have¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ¦and¦ ¦your¦ ¦gp¦ ¦th in ks¦ ¦it¦ ¦is¦ ¦nee ded¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦ ,▁ ¦you¦ ¦will¦ ¦receive¦ ¦a¦ ¦te xt¦ ¦me ss age¦ ¦with¦ ¦a¦ ¦l ink¦ ¦to¦ ¦b ook¦ ¦a¦ ¦test¦ ¦online¦ .
𐋇¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦arr ange¦ ¦an¦ ¦online¦ ¦test¦ ¦appointment¦ ,▁ ¦the¦ ¦contact¦ ¦tracking¦ ¦team¦ ¦will¦ ¦call¦ ¦you¦ ¦to¦ ¦arr ange¦ ¦one¦ .
𐋇 ¦fre e¦ ¦gp¦ ¦as se ss ment¦
𐋇¦there¦ ¦will¦ ¦be¦ ¦no¦ ¦ch ar ge¦ ¦for¦ ¦the¦ ¦test¦ ¦or¦ ¦as se ss ment¦ ¦by¦ ¦the¦ ¦gp¦ ¦or¦ ¦the¦ ¦out¦ - ¦of¦ - ¦hours¦ ¦gp¦ ¦service¦ .
𐋇 ¦call¦ ¦your¦ ¦gp¦ .
𐋇¦do¦ ¦not¦ ¦go¦ ¦to¦ ¦a¦ ¦gp¦ ¦cl in ic¦ ,▁ ¦ph arm acy¦ ,▁ ¦or¦ ¦hospital¦ .
𐋇¦the¦ ¦gp¦ ¦will¦ ¦ass ess¦ ¦you¦ ¦over¦ ¦the¦ ¦phone¦ .
𐋇¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦have¦ ¦a¦ ¦gp¦ ,▁ ¦any¦ ¦gp¦ ¦can¦ ¦arr ange¦ ¦the¦ ¦test¦ ¦for¦ ¦you¦ .
𐋇¦the¦ ¦gp¦ ¦out¦ - ¦of¦ - ¦hours¦ ¦service¦ ¦can¦ ¦also¦ ¦arr ange¦ ¦a¦ ¦test¦ .
𐋇¦h s el ive¦ ¦cannot¦ ¦order¦ ¦tests¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇¦this¦ ¦is¦ ¦one¦ ¦ line¦ ¦of¦ ¦information¦ .
𐋇¦if¦ ¦you¦ ¦need¦ ¦to¦ ¦have¦ ¦a¦ ¦covid¦ - ¦19¦ ¦test¦
𐋇¦if¦ ¦your¦ ¦gp¦ ¦dec i des¦ ¦you¦ ¦need¦ ¦to¦ ¦be¦ ¦tested¦ ,▁ ¦they¦ ¦will¦ ¦arr ange¦ ¦a¦ ¦test¦ ¦appointment¦ ¦for¦ ¦you¦ .
𐋇¦you¦ ¦will¦ ¦need¦ ¦to¦ ¦self¦ - ¦isol ate¦ ¦while¦ ¦wai ting¦ ¦for¦ ¦your¦ ¦test¦ .
𐋇¦the¦ ¦people¦ ¦in¦ ¦your¦ ¦family¦ ¦will¦ ¦have¦ ¦to¦ ¦restrict¦ ¦their¦ ¦movements¦ ¦and¦ ¦not¦ ¦go¦ ¦to¦ ¦school¦ ¦or¦ ¦work¦ .
𐋇¦you¦ ¦should¦ ¦have¦ ¦the¦ ¦test¦ ¦if¦ ¦your¦ ¦doctor¦ ¦dec i des¦ ¦that¦ ¦one¦ ¦is¦ ¦nee ded¦ .
𐋇¦you¦ ¦will¦ ¦know¦ ¦if¦ ¦you¦ ¦have¦ ¦covid¦ - ¦19¦ ¦and¦ ¦the¦ ¦ste ps¦ ¦you¦ ¦should¦ ¦take¦ ¦to¦ ¦make¦ ¦sure¦ ¦you¦ ¦do¦ ¦not¦ ¦spread¦ ¦the¦ ¦virus¦ .
𐋇¦it¦ ¦will¦ ¦help¦ ¦us¦ ¦f ind¦ ¦out¦ ¦how¦ ¦wid esp r ead¦ ¦the¦ ¦virus¦ ¦is¦ ¦sprea ding¦ ¦and¦ ¦make¦ ¦arr an ge ments¦ ¦to¦ ¦co mb at¦ ¦the¦ ¦ad ded¦ ¦pre ss ure¦ ¦in¦ ¦the¦ ¦health¦ ¦system¦ .
𐋇 ¦direct¦ ¦contac ts¦
𐋇¦we¦ ¦are¦ ¦not¦ ¦cur re ntly¦ ¦arr an ging¦ ¦tests¦ ¦for¦ ¦g ar ter¦ ¦contac ts¦ .
𐋇 ¦pri or ity¦ ¦is¦ ¦being¦ ¦giv en¦ ¦to¦ ¦people¦ ¦with¦ ¦symptoms¦ ¦of¦ ¦coronavirus¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦ ,▁ ¦you¦ ¦need¦ ¦to¦ ¦restrict¦ ¦your¦ ¦movements¦ ▁( ¦stay¦ ¦at¦ ¦home¦ ),▁ ¦even¦ ¦if¦ ¦you¦ ¦feel¦ ¦well¦ .
𐋇¦if¦ ¦you¦ ¦exp eri ence¦ ¦symptoms¦ ¦of¦ ¦covid¦ - ¦19¦ ,▁ ¦you¦ ¦need¦ ¦to¦ ¦self¦ - ¦isol ate¦ ▁( ¦stay¦ ¦in¦ ¦your¦ ¦ro om¦ )▁ ¦and¦ ¦call¦ ¦your¦ ¦doctor¦ ¦for¦ ¦advice¦ .
𐋇 ¦detail s¦ ¦of¦ ¦your¦ ¦test¦ ¦appointment¦
𐋇¦you¦ ¦will¦ ¦receive¦ ¦a¦ ¦te xt¦ ¦me ss age¦ ¦with¦ ¦the¦ ¦time¦ ¦and¦ ¦test¦ ¦centre¦ ¦detail s¦ .
𐋇¦the¦ ¦te xt¦ ¦will¦ ¦con tain¦ ¦your¦ ¦ref er ence¦ ¦number¦ .
𐋇¦you¦ ¦will¦ ¦need¦ ¦to¦ ¦br ing¦ ¦this¦ ¦with¦ ¦you¦ ¦to¦ ¦your¦ ¦appointment¦ .
𐋇 ¦most¦ ¦people¦ ¦will¦ ¦be¦ ¦tested¦ ¦in¦ ¦a¦ ¦public¦ ¦test¦ ¦centre¦ ▁-▁ ¦some¦ ¦are¦ ¦ca r¦ ¦service¦ ¦test¦ ¦centr es¦ .
𐋇 ¦testing¦ ¦is¦ ¦by¦ ¦appointment¦ ¦only¦ .
𐋇¦d on¦ ' ¦t¦ ¦go¦ ¦to¦ ¦an¦ ¦u ne x p ected¦ ¦test¦ ¦centre¦ ▁-▁ ¦you¦ ¦will¦ ¦not¦ ¦be¦ ¦tested¦ .
𐋇 ¦ne it her¦ ¦your¦ ¦doctor¦ ¦n or¦ ¦h s el ive¦ ¦has¦ ¦acc ess¦ ¦to¦ ¦your¦ ¦ref er ence¦ ¦number¦ .
𐋇 ¦br ing¦ ¦your¦ ¦phone¦
𐋇 ¦br ing¦ ¦your¦ ¦phone¦ ¦to¦ ¦the¦ ¦test¦ ¦centre¦ ¦or¦ ¦ca r¦ ¦service¦ ¦centre¦ .
𐋇¦if¦ ¦a¦ ¦gard a¦ ¦sto ps¦ ¦you¦ ¦on¦ ¦your¦ ¦way¦ ¦to¦ ¦a¦ ¦test¦ ¦centre¦ ,▁ ¦dis pl ay¦ ¦the¦ ¦te xt¦ ¦me ss age¦ ¦about¦ ¦your¦ ¦appointment¦ .
𐋇¦do¦ ¦not¦ ¦open¦ ¦your¦ ¦ca r¦ ¦w i nd ow¦ .
𐋇 ¦ho ld¦ ¦your¦ ¦phone¦ ¦by¦ ¦the¦ ¦w i nd ow¦ ¦to¦ ¦sh ow¦ ¦the¦ ¦detail s¦ ¦of¦ ¦your¦ ¦appointment¦ ¦to¦ ¦the¦ ¦gard a¦ .
𐋇¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦receive¦ ¦a¦ ¦te xt¦ ¦with¦ ¦test¦ ¦data¦
𐋇¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦receive¦ ¦a¦ ¦te xt¦ ¦within¦ ¦a¦ ¦day¦ ¦of¦ ¦go ing¦ ¦to¦ ¦your¦ ¦gp¦ ,▁ ¦call¦ ¦your¦ ¦gp¦ .
𐋇 ¦make¦ ¦sure¦ ¦your¦ ¦m ob i le¦ ¦number¦ ¦is¦ ¦cor r ect¦ .
𐋇 ¦chan ging¦ ¦a¦ ¦test¦ ¦appointment¦
𐋇¦the¦ ¦date¦ ¦or¦ ¦loc ation¦ ¦of¦ ¦your¦ ¦test¦ ¦appointment¦ ¦can¦ ¦be¦ ¦chan ged¦ ¦using¦ ¦the¦ ¦te xt¦ ¦me ss age¦ ¦you¦ ¦received¦ ¦with¦ ¦the¦ ¦detail s¦ ¦of¦ ¦your¦ ¦test¦ ¦appointment¦ .
𐋇¦you¦ ¦can¦ ¦also¦ ¦cance l¦ ¦your¦ ¦appointment¦ .
𐋇¦to¦ ¦ch ange¦ ¦or¦ ¦cance l¦ ¦your¦ ¦test¦ ¦appointment¦ :
𐋇¦open¦ ¦the¦ ¦te xt¦ ¦me ss age¦ .
𐋇 ¦cl ick¦ ¦on¦ ¦the¦ ¦l ink¦ ▁' ¦for¦ ¦more¦ ¦information¦ . . . '
𐋇¦a¦ ¦we b ¦ ¦p age¦ ¦with¦ ¦detail s¦ ¦of¦ ¦your¦ ¦test¦ ¦appointment¦ ¦will¦ ¦open¦ .
𐋇 ¦cl ick¦ ¦on¦ ¦the¦ ¦appr op ri ate¦ ¦l ink¦ ¦to¦ ¦ch ange¦ ¦or¦ ¦cance l¦ ¦your¦ ¦appointment¦ .
𐋇¦if¦ ¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦get¦ ¦wor se¦
𐋇¦if¦ ¦you¦ ¦get¦ ¦wor se¦ ¦while¦ ¦wai ting¦ ¦for¦ ¦your¦ ¦test¦ ,▁ ¦call¦ ¦your¦ ¦gp¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦diffic ult y¦ ¦brea thing¦ ¦or¦ ¦are¦ ¦not¦ ¦fe el ing¦ ¦well¦ ,▁ ¦call¦ ¦1 1 2¦ ¦or¦ ¦9 9 9¦ ¦and¦ ¦t ell¦ ¦them¦ ¦about¦ ¦your¦ ¦symptoms¦ .
𐋇¦if¦ ¦your¦ ¦gp¦ ¦dec i des¦ ¦you¦ ¦do¦ ¦not¦ ¦need¦ ¦to¦ ¦be¦ ¦tested¦
𐋇¦if¦ ¦your¦ ¦gp¦ ¦dec i des¦ ¦that¦ ¦you¦ ¦do¦ ¦not¦ ¦need¦ ¦a¦ ¦test¦ ,▁ ¦you¦ ¦will¦ ¦be¦ ¦as ked¦ ¦to¦ ¦stay¦ ¦home¦ ¦until¦ ¦you¦ ¦are¦ ¦fre e¦ ¦of¦ ¦symptoms¦ ¦for¦ ¦4 8¦ ¦hours¦ .
𐋇¦however¦ ,▁ ¦if¦ ¦you¦ ¦are¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ ¦someone¦ ¦with¦ ¦covid¦ - ¦19¦ ,▁ ¦you¦ ¦should¦ ¦follow¦ ¦the¦ ¦advice¦ ¦on¦ ¦re stric ting¦ ¦your¦ ¦movements¦ .
𐋇¦stay¦ ¦home¦ ¦for¦ ¦two¦ ¦weeks¦ ,▁ ¦even¦ ¦if¦ ¦your¦ ¦test¦ ¦was¦ ¦negative¦ ¦or¦ ¦the¦ ¦doctor¦ ¦th in ks¦ ¦another¦ ¦test¦ ¦is¦ ¦not¦ ¦nee ded¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦not¦ ¦a¦ ¦close¦ ¦contact¦ ,▁ ¦you¦ ¦can¦ ¦retur n¦ ¦to¦ ¦your¦ ¦normal¦ ¦daily¦ ¦activ ities¦ :
𐋇 ¦un less¦ ¦you¦ ¦have¦ ¦a¦ ¦temp erat ure¦ ¦of¦ ¦3 8¦ ¦de g re es¦ ¦c el si us¦ ¦or¦ ¦more¦ ▁( ¦as¦ ¦long¦ ¦as¦ ¦the¦ ¦temp erat ure¦ ¦is¦ ¦not¦ ¦l ow ered¦ ¦by¦ ¦p ara ce ta mo l¦ ¦or¦ ¦i b u p ro fen¦ )
𐋇 ¦un less¦ ¦you¦ ¦have¦ ¦a¦ ¦new¦ ¦cough¦
𐋇 ¦un less¦ ¦you¦ ¦live¦ ¦with¦ ¦someone¦ ¦who¦ ¦is¦ ¦ ill¦ ¦and¦ ¦may¦ ¦have¦ ¦covid¦ - ¦19¦
𐋇¦if¦ ¦your¦ ¦gp¦ ¦has¦ ¦to ld¦ ¦you¦ ¦that¦ ¦your¦ ¦illness¦ ¦is¦ ¦caused¦ ¦by¦ ¦so me thing¦ ¦other¦ ¦than¦ ¦covid¦ - ¦19¦ ,
𐋇¦if¦ ¦you¦ ¦tested¦ ¦negative¦ ¦for¦ ¦covid¦ - ¦19¦ ¦and¦ ¦have¦ ¦not¦ ¦had¦ ¦symptoms¦ ¦for¦ ¦4 8¦ ¦hours¦
𐋇 ¦un less¦ ¦you¦ ¦have¦ ¦had¦ ¦di arr he a¦ ¦for¦ ¦4 8¦ ¦hours¦
𐋇¦there¦ ¦is¦ ¦a¦ ¦limi t¦ ¦to¦ ¦what¦ ¦the¦ ¦test¦ ¦for¦ ¦covid¦ - ¦19¦ ¦can¦ ¦do¦
𐋇 ¦no¦ ¦co mpl et e¦ ¦test¦ ¦is¦ ¦acc ur ate¦ .
𐋇¦there¦ ¦is¦ ¦a¦ ¦limi t¦ ¦to¦ ¦what¦ ¦any¦ ¦test¦ ¦can¦ ¦do¦ ,▁ ¦including¦ ¦the¦ ¦test¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇¦the¦ ¦test¦ ¦will¦ ¦det ect¦ ¦the¦ ¦virus¦ ¦in¦ ¦most¦ ¦people¦ ¦with¦ ¦symptoms¦ ¦of¦ ¦illness¦ .
𐋇¦however¦ ,▁ ¦in¦ ¦some¦ ¦cases¦ ,▁ ¦the¦ ¦test¦ ¦will¦ ¦not¦ ¦det ect¦ ¦the¦ ¦virus¦ .
𐋇 ¦not¦ ¦all¦ ¦cases¦ ¦of¦ ¦coronavirus¦ ¦are¦ ¦detected¦ .
𐋇¦some¦ ¦samples¦ ¦may¦ ¦be¦ ¦m is pl ac ed¦ ,▁ ¦or¦ ¦the¦ ¦pa ti ent¦ ¦may¦ ¦not¦ ¦be¦ ¦ident if i able¦ .
𐋇¦this¦ ¦can¦ ¦happ en¦ ¦due¦ ¦to¦ ¦human¦ ¦ er r or¦ .
𐋇¦e ver y thing¦ ¦is¦ ¦d one¦ ¦to¦ ¦e ns ure¦ ¦that¦ ¦this¦ ¦does¦ ¦not¦ ¦happ en¦ ¦and¦ ¦every¦ ¦eff ort¦ ¦is¦ ¦made¦ ¦to¦ ¦con n ect¦ ¦the¦ ¦samples¦ ¦to¦ ¦the¦ ¦cor r ect¦ ¦pa ti ent¦ .
𐋇 ¦before¦ ¦you¦ ¦are¦ ¦tested¦
𐋇 ¦while¦ ¦you¦ ¦are¦ ¦wai ting¦ ¦for¦ ¦your¦ ¦test¦ ¦appointment¦ ,▁ ¦you¦ ¦should¦ ¦be h a ve¦ ¦as¦ ¦if¦ ¦you¦ ¦have¦ ¦the¦ ¦virus¦ ¦and¦ ¦stay¦ ¦al one¦ ¦for¦ ¦14¦ ¦days¦ .
𐋇 ¦people¦ ¦in¦ ¦your¦ ¦family¦ ¦will¦ ¦have¦ ¦to¦ ¦restrict¦ ¦their¦ ¦movements¦ .
𐋇 ¦tre at¦ ¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦at¦ ¦home¦ .
𐋇 ¦dr ink¦ ¦p le nt y¦ ¦of¦ ¦water¦ ¦to¦ ¦avoid¦ ¦de h y dr ation¦ ▁-▁ ¦your¦ ¦ ur ine¦ ¦should¦ ¦be¦ ¦l ight¦ ¦or¦ ¦clean¦ ¦y e ll ow¦ .
𐋇¦p ara ce ta mo l¦ ¦or¦ ¦i b u p ro fen¦ ¦may¦ ¦help¦ ¦with¦ ¦symptoms¦ ¦such¦ ¦as¦ ¦pain¦ ¦or¦ ¦fever¦ .
𐋇 ¦ser ies¦ ¦tests¦
𐋇¦covid¦ - ¦19¦ ¦ser ial¦ ¦tests¦ ¦are¦ ¦per for med¦ ¦on¦ ¦several¦ ¦grou ps¦ ¦of¦ ¦un in f ected¦ ¦people¦ .
𐋇¦the¦ ¦ser ies¦ ¦tests¦ ¦are¦ ¦c arr ied¦ ¦out¦ ¦on¦ ¦a¦ ¦v o lu nt ary¦ ¦ba sis¦ ,▁ ¦s om et im es¦ ¦perio d ically¦ ¦and¦ ¦w ee k ly¦ ,
𐋇¦the¦ ¦ser ies¦ ¦test¦ ¦is¦ ¦provid ed¦ ¦to¦ ¦people¦ ¦in¦ ¦specific¦ ¦loc ations¦ ¦where¦ ¦infection¦ ¦may¦ ¦occur ¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦work p la ces¦ ▁( ¦me at¦ ¦fa ct ory¦ )▁ ¦or¦ ¦other¦ ¦ es ta bl is h ments¦ ¦such¦ ¦as¦ ¦a¦ ¦res ide ntial¦ ¦care¦ ¦centre¦ ¦or¦ ¦direct¦ ¦pr ov is ion¦ ¦centre¦ ).
𐋇¦if¦ ¦you¦ ¦have¦ ¦a¦ ¦ser ies¦ ¦test¦ ,▁ ¦you¦ ¦can¦ ¦go¦ ¦to¦ ¦school¦ ¦or¦ ¦work¦ ¦as¦ ¦us ual¦ ¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦have¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ¦or¦ ¦if¦ ¦you¦ ¦test¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇¦if¦ ¦this¦ ¦is¦ ¦the¦ ¦case¦ ,▁ ¦you¦ ¦will¦ ¦need¦ ¦to¦ ¦be¦ ¦self¦ - ¦isol ated¦ ,▁ ¦and¦ ¦your¦ ¦close¦ ¦contac ts¦ ¦will¦ ¦need¦ ¦to¦ ¦restrict¦ ¦their¦ ¦movements¦ .
𐋇 ¦wh y¦ ¦di et¦ ¦and¦ ¦n ut r ition¦ ¦help¦ ¦your¦ ¦health¦
𐋇¦it¦ ¦is¦ ¦important¦ ¦for¦ ¦all¦ ¦of¦ ¦us¦ ¦to¦ ¦e at¦ ¦healthy¦ ¦food¦ .
𐋇¦it¦ ¦h el ps¦ ¦us¦ ¦stay¦ ¦as¦ ¦healthy¦ ¦as¦ ¦we¦ ¦can¦ .
𐋇¦but¦ ¦e ating¦ ¦healthy¦ ¦food¦ ¦is¦ ¦s om et im es¦ ¦not¦ ¦e as y¦ .
𐋇 ¦only¦ ¦a¦ ¦thir d¦ ¦of¦ ¦the¦ ¦ir ish¦ ¦population¦ ¦e at¦ ¦the¦ ¦recommended¦ ¦a mo un t¦ ¦of¦ ¦ ve g et ab les¦ ,▁ ¦sa la ds¦ ¦and¦ ¦f ru i t¦ ¦every¦ ¦day¦ .
𐋇 ¦many¦ ¦people¦ ¦e at¦ ¦un he al th y¦ ¦food¦ ,▁ ¦such¦ ¦as¦ ¦ch oc ol ate¦ ,▁ ¦ca k es¦ ¦and¦ ¦b is c u i ts¦ ,▁ ¦every¦ ¦day¦ .
𐋇¦in¦ ¦ireland¦ ,▁ ¦6 2¦ %▁ ¦of¦ ¦the¦ ¦ad ul t¦ ¦population¦ ¦is¦ ¦over we ight¦ ¦or¦ ¦ob e se¦ .
𐋇 ¦one¦ ¦in¦ ¦four¦ ¦children¦ ¦is¦ ¦se v en¦ ¦years¦ ¦o ld¦ ,▁ ¦over we ight¦ ¦or¦ ¦ob e se¦ .
𐋇 ¦be ne f i ts¦ ¦of¦ ¦healthy¦ ¦e ating¦
𐋇 ¦healthy¦ ¦e ating¦ ¦will¦ ¦help¦ ¦you¦ ¦avoid¦ ¦c er tain¦ ¦diseases¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦ki ds¦ ,▁ ¦they¦ ¦will¦ ¦follow¦ ¦your¦ ¦g ood¦ ¦example¦ ¦of¦ ¦e ating¦ ¦healthy¦ ¦food¦ .
𐋇¦e ating¦ ¦healthy¦ ¦food¦ ¦can¦ ¦l ead¦ ¦to¦ ¦the¦ ¦following¦ .
𐋇 ¦healthy¦ ¦we ight¦
𐋇 ¦healthy¦ ¦we i gh t less¦ ¦risk¦ ¦of¦ ¦develop ing¦ ¦typ e¦ ¦2¦ ¦di ab e tes¦ ,▁ ¦h ear t¦ ¦disease¦ ¦and¦ ¦cance r¦
𐋇 ¦healthy¦ ¦ch ol es te ro l¦ ¦level¦
𐋇¦a¦ ¦bet ter¦ ¦under st an ding¦ ¦of¦ ¦well¦ - ¦being¦
𐋇 ¦di et¦ ,▁ ¦n ut r ition¦ ¦and¦ ¦your¦ ¦body¦
𐋇 ¦food¦ ¦conta ins¦ ¦n ut ri ents¦ ¦such¦ ¦as¦ ¦protein¦ ,▁ ¦f at¦ ¦and¦ ¦ vi ta m ins¦ .
𐋇¦your¦ ¦body¦ ¦needs¦ ¦the¦ ¦r ight¦ ¦mi x¦ ¦of¦ ¦n ut ri ents¦ ¦to¦ ¦be¦ ¦healthy¦ ¦and¦ ¦wh ol es ome¦ .
𐋇 ¦different¦ ¦f oo ds¦ ¦con tain¦ ¦different¦ ¦n ut ri ents¦ .
𐋇¦if¦ ¦you¦ ¦c ho ose¦ ¦a¦ ¦co mb ination¦ ¦of¦ ¦f oo ds¦ ¦every¦ ¦day¦ ,▁ ¦you¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦get¦ ¦all¦ ¦the¦ ¦n ut ri ents¦ ¦you¦ ¦need¦ ¦to¦ ¦gr ow¦ ¦and¦ ¦be¦ ¦healthy¦ .
𐋇 ¦that¦ ▁’▁ ¦s¦ ¦what¦ ¦a¦ ¦ba la nc ed¦ ¦di et¦ ¦me ans¦ .
𐋇¦the¦ ¦same¦ ¦typ es¦ ¦of¦ ¦n ut ri ents¦ ¦are¦ ¦grou p ed¦ ¦as¦ ¦fo ll ow s¦ :
𐋇¦ ve g et ab les¦ ,▁ ¦sa la ds¦ ¦and¦ ¦f ru i t¦
𐋇¦w ho le g ra in¦ ¦ce re als¦ ¦and¦ ¦br ead¦ ,▁ ¦p ot at o es¦ ,▁ ¦pa st a¦ ¦and¦ ¦r ice¦
𐋇 ¦low¦ - ¦f at¦ ¦m il k¦ ,▁ ¦y o gh ur t¦ ¦and¦ ¦ch ee se¦
𐋇¦f at¦ - ¦fre e¦ ¦me at¦ ,▁ ¦po ult ry¦ ,▁ ¦f ish¦ ,▁ ¦e gg s¦ ,▁ ¦be ans¦ ¦and¦ ¦nu ts¦
𐋇 ¦fa ts¦ ,▁ ¦sprea ds¦ ¦and¦ ¦o il s¦
𐋇¦the¦ ¦body¦ ¦g ets¦ ¦en er g y¦ ▁( ¦c al or ies¦ )▁ ¦from¦ ¦the¦ ¦food¦ ¦you¦ ¦e at¦ .
𐋇¦if¦ ¦you¦ ¦take¦ ¦in¦ ¦more¦ ¦c al or ies¦ ¦than¦ ¦you¦ ¦use¦ ,▁ ¦you¦ ¦will¦ ¦ga in¦ ¦we ight¦ ¦and¦ ¦bec ome¦ ¦over we ight¦ .
𐋇¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦take¦ ¦in¦ ¦en ough¦ ¦c al or ies¦ ,▁ ¦you¦ ¦will¦ ¦be¦ ¦b el ow¦ ¦normal¦ ¦we ight¦ .
𐋇¦e it her¦ ¦of¦ ¦these¦ ¦is¦ ¦b ad¦ ¦for¦ ¦your¦ ¦health¦ .
𐋇¦e at¦ ¦healthy¦ ¦food¦
𐋇 ¦ma king¦ ¦sm all¦ ¦chan ges¦ ¦to¦ ¦your¦ ¦di et¦ ¦can¦ ¦make¦ ¦a¦ ¦bi g¦ ¦di ff er ence¦ ¦to¦ ¦your¦ ¦health¦ ¦n ow¦ ¦and¦ ¦in¦ ¦the¦ ¦f ut ure¦ .
𐋇 ¦tre at¦ ¦the¦ ¦symptoms¦ ¦of¦ ¦coronavirus¦ ¦at¦ ¦home¦
𐋇¦there¦ ¦is¦ ¦no¦ ¦specific¦ ¦treatment¦ ¦for¦ ¦covid¦ - ¦19¦ ,▁ ¦but¦ ¦some¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ¦can¦ ¦be¦ ¦tre ated¦ ¦at¦ ¦home¦ .
¦8 0¦ %▁ ¦of¦ ¦people¦ ¦will¦ ¦reco ver¦ ¦at¦ ¦home¦ ▁-▁ ¦they¦ ¦will¦ ¦not¦ ¦have¦ ¦to¦ ¦go¦ ¦to¦ ¦the¦ ¦hospital¦ .
𐋇¦the¦ ¦vaccines¦ ¦will¦ ¦be¦ ¦del iv ered¦ ¦in¦ ¦sta ges¦ ,▁ ¦and¦ ¦the re f ore¦ ,▁ ¦it¦ ¦will¦ ¦take¦ ¦some¦ ¦time¦ ¦to¦ ¦vacc in ate¦ ¦the¦ ¦ent ir e¦ ¦population¦ .
𐋇¦if¦ ¦you¦ ¦exp eri ence¦ ¦symptoms¦ ¦of¦ ¦illness¦ ,▁ ¦you¦ ¦should¦ ¦self¦ - ¦isol ate¦ ¦to¦ ¦prevent¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇 ¦call¦ ¦your¦ ¦gp¦ ¦or¦ ¦gp¦ ¦out¦ ¦of¦ ¦hours¦ ¦to¦ ¦disc us s¦ ¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦and¦ ¦f ind¦ ¦out¦ ¦if¦ ¦a¦ ¦covid¦ - ¦19¦ ¦test¦ ¦is¦ ¦nee ded¦ .
𐋇¦the¦ ¦most¦ ¦important¦ ¦ thing¦ ¦you¦ ¦can¦ ¦do¦ ¦is¦ ¦make¦ ¦sure¦ ¦you¦ ¦do¦ ¦not¦ ¦spread¦ ¦the¦ ¦coronavirus¦ ¦to¦ ¦others¦ .
𐋇¦it¦ ¦is¦ ¦ext re m ely¦ ¦important¦ ¦to¦ ¦protect¦ ¦people¦ ¦at¦ ¦the¦ ¦g re at est¦ ¦risk¦ .
𐋇¦you¦ ¦should¦ :
𐋇 ¦rem aining¦ ¦in¦ ¦self¦ - ¦isolation¦
𐋇¦p le nt y¦ ¦of¦ ¦sl ee p¦
𐋇 ¦dr ink¦ ¦p le nt y¦ ¦of¦ ¦water¦ ¦to¦ ¦avoid¦ ¦de h y dr ation¦ .
𐋇¦the¦ ¦c ol or¦ ¦of¦ ¦your¦ ¦ ur ine¦ ¦should¦ ¦be¦ ¦l ight¦ ¦y e ll ow¦ ¦or¦ ¦clean¦
𐋇¦e at¦ ¦healthy¦
𐋇¦do¦ ¦not¦ ¦s mo ke¦
𐋇 ¦keep¦ ¦w ar m¦
𐋇 ¦keep¦ ¦an¦ ¦ey e¦ ¦on¦ ¦and¦ ¦tre at¦ ¦your¦ ¦symptoms¦
𐋇¦read¦ ¦more¦ ¦about¦ :
𐋇 ¦fever¦
𐋇 ¦cough¦ ▁-▁ ¦any¦ ¦cough¦ ¦is¦ ¦not¦ ¦j ust¦ ¦a¦ ¦d ry¦ ¦cough¦
𐋇 ¦sh ort ness¦ ¦of¦ ¦brea th¦
𐋇 ¦al t ered¦ ¦or¦ ¦l ost¦ ¦sm ell¦
𐋇¦if¦ ¦your¦ ¦symptoms¦ ¦get¦ ¦wor se¦
𐋇 ¦call¦ ¦your¦ ¦gp¦ ¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦feel¦ ¦well¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦over¦ ¦6 0¦ ¦or¦ ¦have¦ ¦a¦ ¦c ond ition¦ ¦that¦ ¦p u ts¦ ¦you¦ ¦at¦ ¦g rea ter¦ ¦risk¦ ¦from¦ ¦coronavirus¦ ,▁ ¦keep¦ ¦a¦ ¦close¦ ¦ey e¦ ¦on¦ ¦your¦ ¦symptoms¦ .
𐋇 ¦call¦ ¦your¦ ¦gp¦ ¦imm ed ia tely¦ ¦if¦ ¦they¦ ¦do¦ ¦not¦ ¦get¦ ¦wor se¦ .
𐋇¦m ed ications¦ ¦to¦ ¦tre at¦ ¦symptoms¦ ¦of¦ ¦illness¦
𐋇¦the¦ ¦medic ines¦ ¦used¦ ¦will¦ ¦dep end¦ ¦on¦ :
𐋇¦the¦ ¦symptoms¦ ¦of¦ ¦illness¦
𐋇¦you¦ ¦have¦ ¦another¦ ¦medical¦ ¦c ond ition¦
𐋇 ¦any¦ ¦other¦ ¦medic ations¦ ¦you¦ ¦are¦ ¦ta king¦
𐋇¦p ara ce ta mo l¦ ¦or¦ ¦i b u p ro fen¦ ¦will¦ ¦help¦ ¦to¦ ¦lower¦ ¦your¦ ¦temp erat ure¦ ¦and¦ ¦tre at¦ ¦your¦ ¦pa ins¦ .
𐋇¦p ara ce ta mo l¦ ¦is¦ ¦the¦ ¦ma in¦ ¦medic ation¦ ¦recommended¦ ¦as¦ ¦a¦ ¦medical¦ ¦treatment¦ ¦for¦ ¦most¦ ¦people¦ .
𐋇 ¦before¦ ¦ta king¦ ¦any¦ ¦medic ation¦ ,▁ ¦be¦ ¦sure¦ ¦to¦ ¦r ead¦ ¦the¦ ¦information¦ ¦on¦ ¦the¦ ¦acc o mp an ying¦ ¦lea f l et¦ .
𐋇 ¦follow¦ ¦the¦ ¦advice¦ ¦giv en¦ ¦to¦ ¦you¦ ¦by¦ ¦a¦ ¦health¦ ¦pro f es si on al¦ .
𐋇 ¦anti b i ot ics¦
𐋇 ¦anti b i ot ics¦ ¦do¦ ¦not¦ ¦k ill¦ ¦the¦ ¦cr own¦ ¦virus¦ ¦or¦ ¦any¦ ¦other¦ ¦virus¦ .
𐋇¦they¦ ¦will¦ ¦not¦ ¦help¦ ¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦and¦ ¦will¦ ¦not¦ ¦sp e ed¦ ¦up¦ ¦your¦ ¦reco ve ry¦ .
𐋇 ¦coronavirus¦ ¦is¦ ¦a¦ ¦virus¦ ,▁ ¦and¦ ¦anti b i ot ics¦ ¦cannot¦ ¦tre at¦ ¦viruses¦ .
𐋇 ¦i ob ú p ro if e in¦
𐋇¦it¦ ¦is¦ ¦o k ay¦ ¦to¦ ¦take¦ ¦i b u p ro fen¦ ¦or¦ ¦other¦ ¦anti ¦ - ¦inf la mm atory¦ ¦d ru g s¦ ▁( ¦ ns ai ds¦ )▁ ¦if¦ ¦you¦ ¦have¦ ¦the¦ ¦corona ry¦ ¦virus¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦evidence¦ ¦that¦ ¦they¦ ¦are¦ ¦u ns a f e¦ .
𐋇 ¦only¦ ¦take¦ ¦one¦ ¦of¦ ¦the¦ ¦anti ¦ - ¦inf la mm atory¦ ¦d ru g s¦ ¦at¦ ¦a¦ ¦time¦ .
𐋇¦it¦ ¦is¦ ¦o k ay¦ ¦to¦ ¦take¦ ¦p ara ce ta mo l¦ ¦and¦ ¦an¦ ¦anti ¦ - ¦inf la mm atory¦ ¦drug¦ ¦at¦ ¦the¦ ¦same¦ ¦time¦ .
𐋇 ¦anti ¦ - ¦inf la mm atory¦ ¦d ru g s¦ ¦include¦ :
𐋇 ¦i ob ú p ro if e in¦ ▁-▁ ¦br and¦ ¦na m es¦ :▁ 𐋇 ¦nu ro fen¦ ,▁ ¦a ct ip ro fen¦ ,▁ ¦ad v il¦ ,▁ ¦b ru fen¦ ,▁ ¦b ru p r o¦ ,▁ ¦bu p le x¦ ,▁ ¦e as o fen¦ ,▁ ¦and¦ ¦f en op ine¦ .
𐋇 ¦i b u p ro fen¦ ¦ ge l¦ ¦is¦ ¦called¦ ¦nu ro fen¦ ,▁ ¦m el fen¦ ,▁ ¦p or pa in¦ ,▁ ¦i b u ge l¦ ¦and¦ ¦i b u le ve¦
𐋇¦n ap ro x en¦ ▁-▁ ¦a in m¦ ¦b ra nd a¦ :▁ 𐋇¦n ap r os y n¦
𐋇¦d ic lo f e na c¦ ▁-▁ ¦br and¦ ¦na me¦ :▁ 𐋇 ¦v ol ta ro l¦ ,▁ ¦d ic l o¦ ,▁ ¦d ic la c¦ ,▁ ¦ca ta f l am¦ ,▁ ¦d if en e¦ ¦and¦ ¦f l ector¦
𐋇 ¦healthy¦ ¦food¦ ¦for¦ ¦fa m il ies¦
𐋇 ¦children¦ ¦gr ow¦ ¦f ast¦ ,▁ ¦so¦ ¦they¦ ¦need¦ ¦food¦ ¦to¦ ¦get¦ ¦the¦ ¦r ight¦ ¦a mo un t¦ ¦of¦ ¦en er g y¦ ,▁ ¦protein¦ ¦and¦ ¦other¦ ¦n ut ri ents¦ .
𐋇¦e ating¦ ¦healthy¦ ¦food¦ ¦will¦ ¦help¦ ¦children¦ ¦gr ow¦ ,▁ ¦lear n¦ ¦and¦ ¦pl ay¦ .
𐋇¦it¦ ¦will¦ ¦also¦ ¦help¦ ¦prevent¦ ¦v ar ious¦ ¦i ll n es ses¦ ,▁ ¦such¦ ¦as¦ ¦h ear t¦ ¦disease¦ ,▁ ¦typ e¦ ¦2¦ ¦di ab e tes¦ ¦and¦ ¦cance r¦ ¦when¦ ¦they¦ ¦gr ow¦ ¦up¦ .
𐋇¦you¦ ¦can¦ ¦use¦ ¦the¦ ¦food¦ ¦p y ra m id¦ ¦to¦ ¦pl an¦ ¦me als¦ ¦and¦ ¦s n ac ks¦ ¦for¦ ¦children¦ ¦over¦ ¦5¦ ¦years¦ ¦o ld¦ .
𐋇¦how¦ ¦to¦ ¦e at¦ ¦well¦
𐋇 ¦typ es¦ ¦of¦ ¦healthy¦ ¦food¦
𐋇¦s om et im es¦ ¦it¦ ¦is¦ ¦diffic ul t¦ ¦for¦ ¦b us y¦ ¦fa m il ies¦ ¦to¦ ¦e at¦ ¦g ood¦ ¦food¦ ¦every¦ ¦day¦ .
𐋇¦but¦ ¦g ood¦ ¦h ab i ts¦ ¦that¦ ¦children¦ ¦lear n¦ ¦at¦ ¦home¦ ¦will¦ ¦stay¦ ¦with¦ ¦them¦ ¦for¦ ¦the¦ ¦r est¦ ¦of¦ ¦their¦ ¦l ives¦ .
𐋇 ¦what¦ ¦children¦ ¦are¦ ¦ad vi sed¦ ¦to¦ ¦e at¦ ¦according¦ ¦to¦ ¦the¦ ¦food¦ ¦p y ra m id¦ :
𐋇 ¦healthy¦ ¦food¦ ¦for¦ ¦children¦
𐋇 ¦every¦ ¦par ent¦ ¦w a nts¦ ¦the¦ ¦b est¦ ¦for¦ ¦their¦ ¦child¦ ¦as¦ ¦they¦ ¦gr ow¦ ¦up¦ .
𐋇 ¦what¦ ¦y ou ng¦ ¦children¦ ¦e at¦ ¦and¦ ¦dr ink¦ ¦is¦ ¦important¦ ¦for¦ ¦their¦ ¦health¦ ¦n ow¦ ¦and¦ ¦in¦ ¦the¦ ¦f ut ure¦ .
𐋇 ¦healthy¦ ¦school¦ ¦l un ch¦
𐋇¦it¦ ¦is¦ ¦s om et im es¦ ¦diffic ul t¦ ¦to¦ ¦provide¦ ¦a¦ ¦healthy¦ ,▁ ¦inter es ting¦ ¦l un ch¦ ¦that¦ ¦school¦ ¦children¦ ¦would¦ ¦en j o y¦ .▁ 𐋇 ¦children¦ ¦get¦ ¦one¦ - ¦thir d¦ ¦of¦ ¦their¦ ¦daily¦ ¦n ut ri tional¦ ¦needs¦ ¦from¦ ¦their¦ ¦l un ch¦ ,▁ ¦so¦ ¦it¦ ▁’▁ ¦s¦ ¦important¦ ¦to¦ ¦do¦ ¦some¦ ¦th in king¦ ¦and¦ ¦pl an ning¦ ¦about¦ ¦it¦ .
𐋇¦how¦ ¦to¦ ¦make¦ ¦he al t hi er¦ ¦ch oi ces¦
𐋇 ¦ma king¦ ¦healthy¦ ¦ch oi ces¦ ¦is¦ ¦often¦ ¦not¦ ¦e as y¦ .
𐋇¦it¦ ¦do es n¦ ▁’▁ ¦t¦ ¦have¦ ¦to¦ ¦be¦ ¦per f ect¦ .
𐋇¦it¦ ¦invol ves¦ ¦ma king¦ ¦chan ges¦ .
𐋇 ¦st ick¦ ¦with¦ ¦them¦ ,▁ ¦and¦ ¦you¦ ¦will¦ ¦s uc ce ed¦ .
𐋇 ¦g ood¦ ¦h ab i ts¦ ¦that¦ ¦our¦ ¦children¦ ¦lear n¦ ¦at¦ ¦home¦ ¦will¦ ¦stay¦ ¦with¦ ¦them¦ ¦for¦ ¦a¦ ¦l if e ti me¦ .
𐋇 ¦sm all¦ ¦chan ges¦ ¦in¦ ¦di et¦ ¦and¦ ¦activ ity¦ ¦for¦ ¦children¦ ¦can¦ ¦make¦ ¦a¦ ¦bi g¦ ¦di ff er ence¦ ¦to¦ ¦their¦ ¦f ut ure¦ ¦health¦ .
𐋇¦if¦ ¦your¦ ¦ki ds¦ ¦se e¦ ¦that¦ ¦you¦ ¦are¦ ¦ac tive¦ ¦and¦ ¦e ating¦ ¦healthy¦ ¦food¦ ¦at¦ ¦all¦ ¦times¦ ,▁ ¦they¦ ¦are¦ ¦more¦ ¦likely¦ ¦to¦ ¦do¦ ¦the¦ ¦same¦ .
𐋇¦the¦ ¦r ight¦ ¦we ight¦ ¦for¦ ¦your¦ ¦child¦
𐋇 ¦many¦ ¦children¦ ¦in¦ ¦ireland¦ ▁( ¦about¦ ¦one¦ ¦in¦ ¦five¦ )▁ ¦are¦ ¦over we ight¦ .
𐋇 ¦many¦ ¦par ents¦ ¦are¦ ¦u na w are¦ ¦that¦ ¦their¦ ¦children¦ ¦are¦ ¦c arr ying¦ ¦to o¦ ¦much¦ ¦we ight¦ .
𐋇¦for¦ ¦the¦ ¦most¦ ¦par t¦ ,▁ ¦e ating¦ ¦more¦ ¦food¦ ¦than¦ ¦they¦ ¦need¦ ¦to¦ ¦gr ow¦ ¦and¦ ¦activ ity¦ ¦will¦ ¦ad d¦ ¦up¦ ¦we ight¦ .
𐋇¦if¦ ¦children¦ ¦are¦ ¦over we ight¦ ,▁ ¦it¦ ¦can¦ ¦cre ate¦ ¦health¦ ¦prob le ms¦ ¦for¦ ¦them¦ ¦in¦ ¦the¦ ¦f ut ure¦ .
𐋇 ¦as k¦ ¦your¦ ¦gp¦ ¦or¦ ¦n ur se¦ ¦to¦ ¦me as ure¦ ¦your¦ ¦child¦ ' ¦s¦ ¦we ight¦ ¦and¦ ¦he ight¦ ¦during¦ ¦your¦ ¦ne xt¦ ¦visit¦ .
𐋇¦they¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦t ell¦ ¦you¦ ¦if¦ ¦your¦ ¦child¦ ¦is¦ ¦over we ight¦ ¦or¦ ¦ob e se¦ .
𐋇¦they¦ ¦will¦ ¦use¦ ¦a¦ ¦gr ow th¦ ¦ch ar t¦ ¦to¦ ¦f ind¦ ¦out¦ ¦if¦ ¦your¦ ¦child¦ ¦is¦ ¦cur re ntly¦ ¦over we ight¦ ¦or¦ ¦over we ight¦ .
𐋇¦if¦ ¦your¦ ¦child¦ ¦is¦ ¦over we ight¦ ¦if¦ ¦they¦ ¦reduce¦ ¦the¦ ¦a mo un t¦ ¦of¦ ¦food¦ ¦they¦ ¦e at¦ ¦and¦ ¦bec ome¦ ¦more¦ ¦ac tive¦ ,▁ ¦they¦ ¦will¦ ¦a ch ie ve¦ ¦the¦ ¦r ight¦ ¦we ight¦ .
𐋇 ¦ch eck¦ ¦your¦ ¦child¦ ' ¦s¦ ¦body¦ ¦m ass¦ ¦in de x¦ ▁( ¦b m i¦ )▁ ¦on¦ ¦the¦ ¦n h s¦ ¦healthy¦ ¦we ight¦ ¦c al c ul at or¦ .
𐋇¦you¦ ¦can¦ ¦also¦ ¦use¦ ¦this¦ ¦c al c ul at or¦ ¦to¦ ¦ch eck¦ ¦your¦ ¦ own¦ ¦b m i¦ ¦to¦ ¦se e¦ ¦if¦ ¦you¦ ¦have¦ ¦a¦ ¦healthy¦ ¦we ight¦ .
𐋇¦it¦ ¦bec omes¦ ¦diffic ul t¦ ¦to¦ ¦t alk¦ ¦to¦ ¦your¦ ¦child¦ ¦about¦ ¦we ight¦ .
𐋇¦when¦ ¦t al king¦ ¦about¦ ¦we ight¦ ¦with¦ ¦your¦ ¦child¦ ,▁ ¦it¦ ¦is¦ ¦important¦ ¦to¦ ¦e m ph as iz e¦ ¦health¦ .
𐋇¦b al ance¦ ¦exerc i ses¦
𐋇¦these¦ ¦b al ance¦ ¦exerc i ses¦ ¦can¦ ¦be¦ ¦d one¦ ¦at¦ ¦home¦ ¦to¦ ¦help¦ ¦your¦ ¦health¦ ¦and¦ ¦to¦ ¦imp ro ve¦ ¦your¦ ¦mo bility¦ .
𐋇¦d on¦ ' ¦t¦ ¦wor ry¦ ¦if¦ ¦you¦ ¦ha v en¦ ' ¦t¦ ¦d one¦ ¦much¦ ¦in¦ ¦a¦ ¦while¦ - ▁ ¦this¦ ¦exerc ise¦ ¦is¦ ¦e as y¦ .
𐋇 ¦wear¦ ¦lo ose¦ ,▁ ¦c om f ort able¦ ¦c lo thing¦ ¦and¦ ¦keep¦ ¦a¦ ¦water¦ ¦b ot t le¦ ¦n ear¦ ¦you¦ .
𐋇 ¦take¦ ¦it¦ ¦e as y¦ ¦at¦ ¦first¦ ¦and¦ ¦g rad ually¦ ¦increase¦ ¦the¦ ¦a mo un t¦ ¦of¦ ¦exerc ise¦ ¦you¦ ¦do¦ .
𐋇¦t ry¦ ¦to¦ ¦do¦ ¦this¦ ¦exerc ise¦ ¦at¦ ¦least¦ ¦t w ice¦ ¦a¦ ¦week¦ ¦and¦ ¦do¦ ¦it¦ ¦with¦ :
𐋇 ¦exerc i ses¦ ¦in¦ ¦your¦ ¦s it ting¦
𐋇¦f le xi bility¦ ¦exerc i ses¦
𐋇 ¦ag il ity¦ ¦to¦ ¦st re ng th en¦ ¦you¦
𐋇¦w al king¦ ¦a side¦
𐋇 ¦st and¦ ¦with¦ ¦your¦ ¦le g s¦ ¦t og ether¦ ¦and¦ ¦your¦ ¦k ne es¦ ¦s li gh t ly¦ ¦b ent¦ .
𐋇 ¦take¦ ¦a¦ ¦sl ow¦ ,▁ ¦sl ow¦ ¦ste p¦ ¦a side¦ ,▁ ¦mo ve¦ ¦one¦ ¦le g¦ ¦a side¦ ¦at¦ ¦first¦ .
𐋇 ¦mo ve¦ ¦your¦ ¦other¦ ¦fo ot¦ ¦as¦ ¦fa r¦ ¦as¦ ¦ her¦
𐋇¦do¦ ¦not¦ ¦lower¦ ¦your¦ ¦hi ps¦ ¦while¦ ¦do ing¦ ¦this¦ .
𐋇 ¦take¦ ¦10¦ ¦ste ps¦ ¦in¦ ¦each¦ ¦di re ction¦ ¦or¦ ¦mo ve¦ ¦from¦ ¦one¦ ¦ side¦ ¦of¦ ¦the¦ ¦ro om¦ ¦to¦ ¦the¦ ¦other¦
𐋇 ¦si mp le¦ ¦fines¦
𐋇¦this¦ ¦invol ves¦ ¦w al king¦ ¦a side¦ ¦while¦ ¦p ut ting¦ ¦one¦ ¦fo ot¦ ¦over¦ ¦your¦ ¦other¦ .
𐋇 ¦first¦ ,▁ ¦place¦ ¦your¦ ¦r ight¦ ¦fo ot¦ ¦over¦ ¦your¦ ¦le f t¦ ¦fo ot¦
𐋇 ¦then¦ ¦place¦ ¦your¦ ¦le f t¦ ¦fo ot¦ ¦over¦ ¦your¦ ¦r ight¦ ¦fo ot¦
𐋇 ¦make¦ ¦five¦ ¦c ross¦ - ¦ste ps¦ ¦on¦ ¦each¦ ¦ side¦ .
𐋇¦if¦ ¦ne cess ary¦ ,▁ ¦place¦ ¦your¦ ¦fi ng ers¦ ¦against¦ ¦the¦ ¦w all¦ ¦to¦ ¦keep¦ ¦you¦ ¦in¦ ¦your¦ ¦p os ition¦ .
𐋇¦it¦ ¦is¦ ¦b est¦ ¦to¦ ¦take¦ ¦sm all¦ ¦ste ps¦ ,▁ ¦as¦ ¦you¦ ¦will¦ ¦work¦ ¦more¦ ¦on¦ ¦your¦ ¦b al ance¦ ¦this¦ ¦way¦ .
𐋇¦h ee l¦ - ¦to¦ - ¦to e¦ ¦w alk¦
𐋇 ¦st and¦ ¦up¦ ¦stra ight¦ ,▁ ¦place¦ ¦your¦ ¦r ight¦ ¦h ee l¦ ¦on¦ ¦the¦ ¦f lo or¦ ¦j ust¦ ¦in¦ ¦f r on t¦ ¦of¦ ¦your¦ ¦le f t¦ ¦to e¦ .
𐋇 ¦then¦ ¦do¦ ¦the¦ ¦same¦ ¦with¦ ¦your¦ ¦le f t¦ ¦h ee l¦ .
𐋇 ¦make¦ ¦sure¦ ¦you¦ ¦are¦ ¦l oo king¦ ¦stra ight¦ ¦a h ead¦ .
𐋇¦if¦ ¦ne cess ary¦ ,▁ ¦place¦ ¦your¦ ¦fi ng ers¦ ¦against¦ ¦the¦ ¦w all¦ ¦to¦ ¦keep¦ ¦you¦ ¦in¦ ¦your¦ ¦p os ition¦ .
𐋇 ¦take¦ ¦at¦ ¦least¦ ¦five¦ ¦ste ps¦ .
𐋇 ¦mo ve¦ ¦away¦ ¦from¦ ¦the¦ ¦w all¦ ¦as¦ ¦you¦ ¦get¦ ¦bet ter¦ .
𐋇 ¦st an ding¦ ¦on¦ ¦one¦ ¦le g¦
𐋇 ¦first¦ ,▁ ¦st and¦ ¦in¦ ¦f r on t¦ ¦of¦ ¦the¦ ¦w all¦ ,▁ ¦with¦ ¦your¦ ¦hands¦ ¦out str et ched¦ ¦and¦ ¦your¦ ¦fi ng ers¦ ¦h it ting¦ ¦the¦ ¦w all¦ .
𐋇¦l if t¦ ¦your¦ ¦le f t¦ ¦le g¦ ,▁ ¦keep¦ ¦your¦ ¦hi ps¦ ¦f l at¦ ¦and¦ ¦b end¦ ¦the¦ ¦other¦ ¦le g¦ ¦s li gh t ly¦ .
𐋇¦ ge ntly¦ ¦place¦ ¦your¦ ¦fo ot¦ ¦b ack¦ ¦on¦ ¦the¦ ¦f lo or¦ .
𐋇 ¦ho ld¦ ¦your¦ ¦fo ot¦ ¦up¦ ¦for¦ ¦5¦ ¦to¦ ¦10¦ ¦sec on ds¦ ¦and¦ ¦do¦ ¦three¦ ¦exerc i ses¦ ¦on¦ ¦each¦ ¦ side¦ .
𐋇 ¦ste p¦ - ¦up¦
𐋇 ¦use¦ ¦a¦ ¦ste p¦ ¦with¦ ¦a¦ ¦ra il ing¦ ¦or¦ ¦stay¦ ¦n ear¦ ¦a¦ ¦w all¦ ¦if¦ ¦possible¦ .
𐋇 ¦st and¦ ¦up¦ ¦on¦ ¦the¦ ¦ste p¦ ¦with¦ ¦your¦ ¦r ight¦ ¦fo ot¦ .
𐋇 ¦st and¦ ¦up¦ ¦there¦ ¦with¦ ¦your¦ ¦le f t¦ ¦fo ot¦
𐋇 ¦st and¦ ¦down¦ ¦ag a in¦ ¦and¦ ¦rep e at¦
𐋇¦to¦ ¦imp ro ve¦ ¦your¦ ¦b al ance¦ ,▁ ¦the¦ ¦ste ps¦ ¦need¦ ¦to¦ ¦be¦ ¦ta k en¦ ¦sl ow ly¦ ¦and¦ ¦in¦ ¦a¦ ¦cont ro lled¦ ¦m an n er¦ .
𐋇 ¦rep e at¦ ¦up¦ ¦to¦ ¦5¦ ¦ste ps¦ ¦on¦ ¦each¦ ¦le g¦ .
𐋇¦the¦ ¦death¦ ¦of¦ ¦a¦ ¦person¦ ¦and¦ ¦the¦ ¦gr ief¦ ¦that¦ ¦fo ll ow s¦ ¦during¦ ¦the¦ ¦outbreak¦ ¦of¦ ¦the¦ ¦coronavirus¦
𐋇¦we¦ ¦need¦ ¦to¦ ¦ad h er e¦ ¦to¦ ¦the¦ ¦social¦ ¦separ ation¦ ¦and¦ ¦other¦ ¦measures¦ ¦caused¦ ¦by¦ ¦the¦ ¦outbreak¦ ¦of¦ ¦the¦ ¦coronavirus¦ ▁( ¦covid¦ - ¦19¦ ) .▁ 𐋇 ¦th ings¦ ¦have¦ ¦to¦ ¦be¦ ¦d one¦ ¦di ff e re ntly¦ ¦n ow¦ ¦that¦ ¦someone¦ ¦related¦ ¦to¦ ¦us¦ ¦ dies¦ .
𐋇¦a¦ ¦conf ide ntial¦ ¦support¦ ¦ line¦ ¦is¦ ¦available¦ ¦from¦ ¦the¦ ¦ir ish¦ ¦hosp ice¦ ¦f ou nd ation¦ ¦and¦ ¦the¦ ¦hse¦ .
𐋇¦if¦ ¦you¦ ¦need¦ ¦more¦ ¦support¦ ,▁ ¦use¦ ¦one¦ ¦of¦ ¦the¦ ¦te le ph one¦ ¦or¦ ¦online¦ ¦me ntal¦ ¦health¦ ¦support¦ ¦services¦ ¦available¦ ¦to¦ ¦you¦ .
𐋇¦if¦ ¦your¦ ¦gr ief¦ ¦is¦ ¦getting¦ ¦wor se¦ ,▁ ¦or¦ ¦you¦ ¦are¦ ¦having¦ ¦tr ou ble¦ ¦sl ee p ing¦ ,▁ ¦t alk¦ ¦to¦ ¦your¦ ¦gp¦ .
𐋇¦t alk¦ ¦to¦ ¦your¦ ¦gp¦ ,▁ ¦if¦ ¦you¦ ¦are¦ ¦s eri o us ly¦ ¦wor r ied¦ ¦or¦ ¦have¦ ¦diffic ult y¦ ¦sl ee p ing¦ .
𐋇¦f un er al¦ ▁/▁ ¦f un er al¦
𐋇¦we¦ ¦cannot¦ ¦sp end¦ ¦time¦ ¦t og ether¦ ¦in¦ ¦grou ps¦ ¦during¦ ¦the¦ ¦outbreak¦ .
𐋇¦this¦ ¦me ans¦ ¦that¦ ¦we¦ ¦cannot¦ ¦have¦ ¦a¦ ¦gr and¦ ¦f un er al¦ ▁/▁ ¦f un er al¦ .
𐋇 ¦those¦ ¦at¦ ¦the¦ ¦f un er al¦ ¦must¦ ¦also¦ ¦follow¦ ¦the¦ ¦gu id el ines¦ ¦for¦ ¦social¦ ¦separ ation¦ .
𐋇¦this¦ ¦me ans¦ ¦that¦ ¦people¦ ¦have¦ ¦to¦ ¦wai t¦ ¦for¦ ¦two¦ ¦meters¦ ▁( ¦6¦ . ¦5¦ ¦fe et¦ )▁ ¦a par t¦ .
𐋇¦you¦ ¦should¦ ¦not¦ ¦go¦ ¦to¦ ¦a¦ ¦f un er al¦ ¦if¦ ¦you¦ ¦are¦ ¦self¦ - ¦isol ated¦ ¦or¦ ¦need¦ ¦to¦ ¦restrict¦ ¦your¦ ¦movements¦ .
𐋇 ¦death¦ ¦aff ects¦ ¦every¦ ¦family¦ .
𐋇¦we¦ ¦know¦ ¦that¦ ¦these¦ ¦arr an ge ments¦ ¦make¦ ¦m at t ers¦ ¦even¦ ¦more¦ ¦diffic ul t¦ ,▁ ¦but¦ ¦we¦ ¦are¦ ¦tr ying¦ ¦to¦ ¦protect¦ ¦e veryone¦ .
𐋇¦the¦ ¦f un er al¦ ¦dir ector¦ ¦and¦ ¦your¦ ¦pri est¦ ,▁ ¦minister¦ ¦ et c¦ ,▁ ¦will¦ ¦know¦ ¦what¦ ¦to¦ ¦do¦ .
𐋇 ¦advice¦ ¦for¦ ¦those¦ ¦who¦ ¦are¦ ¦s ad¦ ¦at¦ ¦this¦ ¦time¦
𐋇¦the¦ ¦death¦ ¦of¦ ¦someone¦ ¦close¦ ¦to¦ ¦us¦ ¦h ur ts¦ ¦us¦ ¦all¦ .
𐋇¦it¦ ¦can¦ ¦aff ect¦ ¦your¦ ¦me ntal¦ ¦health¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦r ight¦ ¦or¦ ¦w ro ng¦ ¦way¦ ¦to¦ ¦de al¦ ¦with¦ ¦death¦ .
𐋇¦you¦ ¦may¦ ¦feel¦ ¦many¦ ¦different¦ ¦e mo tions¦ .
𐋇 ¦re le ase¦ ¦your¦ ¦fe el ings¦ ¦and¦ ¦hand le¦ ¦them¦ ¦in¦ ¦a¦ ¦way¦ ¦that¦ ¦su i ts¦ ¦you¦ ¦b est¦ .
𐋇¦this¦ ¦is¦ ¦par t¦ ¦of¦ ¦the¦ ¦way¦ ¦we¦ ¦de al¦ ¦with¦ ¦death¦ .
𐋇¦stay¦ ¦in¦ ¦tou ch¦ ¦with¦ ¦others¦ .
𐋇¦we¦ ¦cannot¦ ¦be¦ ¦t og ether¦ ¦in¦ ¦grou ps¦ ¦at¦ ¦this¦ ¦time¦ .
𐋇 ¦because¦ ¦of¦ ¦this¦ ,▁ ¦you¦ ¦may¦ ¦not¦ ¦be¦ ¦able¦ ¦to¦ ¦me et¦ ¦people¦ ¦who¦ ¦w ant¦ ¦to¦ ¦s y m pa th iz e¦ ¦with¦ ¦you¦ .
𐋇 ¦while¦ ¦you¦ ¦may¦ ¦be¦ ¦ph ys ically¦ ¦separ ated¦ ¦from¦ ¦your¦ ¦normal¦ ¦support¦ ¦n et w or k¦ ,▁ ¦do¦ ¦not¦ ¦c ut¦ ¦yourself¦ ¦off ¦ ¦from¦ ¦them¦ .
𐋇¦l et¦ ¦people¦ ¦exp r ess¦ ¦their¦ ¦s y m pa th y¦ ¦and¦ ¦l et¦ ¦them¦ ¦support¦ ¦you¦ ¦in¦ ¦different¦ ¦w ays¦ .
𐋇 ¦phone¦ ¦ca lls¦ ,▁ ¦te x ts¦ ,▁ ¦e ma il s¦ ,▁ ¦and¦ ¦support¦ ¦me ss a ges¦ ¦on¦ ¦social¦ ¦m ed ia¦ ¦from¦ ¦the¦ ¦people¦ ¦clos est¦ ¦to¦ ¦you¦ ¦can¦ ¦c om f ort¦ ¦you¦ .
𐋇 ¦contact¦ ¦them¦ ¦and¦ ¦make¦ ¦sure¦ ¦to¦ ¦contact¦ ¦someone¦ ¦every¦ ¦day¦ .
𐋇 ¦a ns w er¦ ¦their¦ ¦ca lls¦ ¦and¦ ¦a ns w er¦ ¦their¦ ¦me ss a ges¦ .
𐋇¦stay¦ ¦in¦ ¦tou ch¦ ¦with¦ ¦the¦ ¦people¦ ¦who¦ ¦off end¦ ¦you¦ ,▁ ¦but¦ ¦if¦ ¦the¦ ¦me ss a ges¦ ¦of¦ ¦support¦ ¦are¦ ¦ex cess ive¦ ¦for¦ ¦you¦ ,▁ ¦there¦ ¦is¦ ¦no¦ ¦need¦ ¦to¦ ¦rep ly¦ ¦to¦ ¦them¦ .
𐋇 ¦while¦ ¦it¦ ¦is¦ ¦important¦ ¦to¦ ¦stay¦ ¦in¦ ¦tou ch¦ ,▁ ¦do¦ ¦not¦ ¦do¦ ¦so¦ ¦until¦ ¦you¦ ¦are¦ ¦rea dy¦ .
𐋇¦e at¦ ¦healthy¦ ¦food¦
𐋇¦t ry¦ ¦not¦ ¦to¦ ¦ne g l ect¦ ¦what¦ ¦is¦ ¦ne cess ary¦ .
𐋇 ¦even¦ ¦if¦ ¦your¦ ¦sto ma ch¦ ¦is¦ ¦not¦ ¦g ood¦ ,▁ ¦t ry¦ ¦to¦ ¦e at¦ ¦healthy¦ ¦food¦ ¦and¦ ¦dr ink¦ ¦p le nt y¦ ¦of¦ ¦water¦ .
𐋇¦this¦ ¦will¦ ¦help¦ ¦you¦ ¦stay¦ ¦ph ys ically¦ ¦fi t¦ ¦while¦ ¦you¦ ¦are¦ ¦s ad¦ .
𐋇¦do¦ ¦the¦ ¦daily¦ ¦ro ut ines¦
𐋇¦it¦ ¦may¦ ¦help¦ ¦you¦ ¦to¦ ¦main tain¦ ¦normal¦ ¦h ab i ts¦ .
𐋇¦t ry¦ ¦to¦ ¦do¦ ¦the¦ ¦th ings¦ ¦you¦ ¦n orm ally¦ ¦do¦ ¦every¦ ¦day¦ ,▁ ¦as¦ ¦much¦ ¦as¦ ¦you¦ ¦can¦ .
𐋇¦it¦ ¦is¦ ¦important¦ ¦that¦ ¦you¦ ¦do¦ ¦these¦ ¦th ings¦ ¦at¦ ¦the¦ ¦same¦ ¦times¦ ,▁ ¦e at¦ ¦a¦ ¦me al¦ ,▁ ¦get¦ ¦up¦ ¦and¦ ¦go¦ ¦to¦ ¦b ed¦ ¦and¦ ¦so¦ ¦on¦ .
𐋇 ¦go¦ ¦out¦ ¦in¦ ¦the¦ ¦gard en¦ ¦or¦ ¦on¦ ¦your¦ ¦b al c on y¦ ¦to¦ ¦get¦ ¦some¦ ¦fre s h ¦ ¦air ¦ ,▁ ¦if¦ ¦you¦ ¦can¦ .
𐋇 ¦live¦ ¦day¦ ¦to day¦
𐋇¦you¦ ¦may¦ ¦feel¦ ¦o k ay¦ ¦on¦ ¦c er tain¦ ¦days¦ ,▁ ¦and¦ ¦the¦ ¦sa d ness¦ ¦may¦ ¦not¦ ¦be¦ ¦as¦ ¦b ad¦ ¦as¦ ¦on¦ ¦other¦ ¦days¦ ▁-▁ ¦that¦ ' ¦s¦ ¦normal¦ .
𐋇¦some¦ ¦people¦ ¦may¦ ¦feel¦ ¦gu il t y¦ ¦when¦ ¦this¦ ¦happ ens¦ ,▁ ¦but¦ ¦there¦ ¦is¦ ¦no¦ ¦need¦ ¦for¦ ¦that¦ .
𐋇¦t ry¦ ¦to¦ ¦be¦ ¦n ice¦ ¦to¦ ¦yourself¦ ¦and¦ ¦under st and¦ ¦your¦ ¦fe el ings¦ ¦every¦ ¦day¦ .
𐋇¦this¦ ¦happ ens¦ ¦nat ur ally¦ ¦when¦ ¦a¦ ¦person¦ ¦is¦ ¦gr ie ving¦ ¦a¦ ¦death¦ .
𐋇 ¦car ing¦ ¦for¦ ¦be rea v ed¦ ¦children¦
𐋇¦if¦ ¦children¦ ¦in¦ ¦your¦ ¦family¦ ¦are¦ ¦s ad¦ ,▁ ¦keep¦ ¦an¦ ¦ey e¦ ¦on¦ ¦them¦ .
𐋇 ¦a ns w er¦ ¦their¦ ¦qu es tions¦ ¦ho ne st ly¦ .
𐋇 ¦children¦ ¦are¦ ¦bet ter¦ ¦able¦ ¦to¦ ¦hand le¦ ¦a¦ ¦s ad¦ ¦st ory¦ ¦when¦ ¦they¦ ¦are¦ ¦to ld¦ ¦the¦ ¦t ru th¦ .
𐋇 ¦children¦ ¦may¦ ¦be¦ ¦s ad¦ ¦one¦ ¦min ute¦ ¦and¦ ¦happ y¦ ¦the¦ ¦ne xt¦ .
𐋇¦l et¦ ¦them¦ ¦follow¦ ¦their¦ ¦ own¦ ¦co ur se¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦r ight¦ ¦or¦ ¦w ro ng¦ ¦way¦ ¦to¦ ¦sh ow¦ ¦their¦ ¦sa d ness¦ .
𐋇¦t ry¦ ¦to¦ ¦give¦ ¦h on est¦ ,▁ ¦age¦ - ¦appr op ri ate¦ ¦information¦ ¦about¦ ¦death¦ .
𐋇¦l et¦ ¦the¦ ¦ki ds¦ ¦gu ide¦ ¦you¦ .
𐋇¦l et¦ ¦their¦ ¦qu es tions¦ ¦gu ide¦ ¦the¦ ¦con ve rs ation¦ .
𐋇¦d on¦ ▁’▁ ¦t¦ ¦wor ry¦ ¦if¦ ¦you¦ ¦can¦ ▁’▁ ¦t¦ ¦a ns w er¦ ¦every¦ ¦qu e st ion¦ ¦they¦ ¦as k¦ .
𐋇¦t ell¦ ¦them¦ ¦you¦ ¦will¦ ¦get¦ ¦the¦ ¦information¦ ¦for¦ ¦them¦ ¦and¦ ¦t ry¦ ¦to¦ ¦star t¦ ¦the¦ ¦con ve rs ation¦ ¦ag a in¦ ¦when¦ ¦you¦ ¦have¦ ¦the¦ ¦a ns w ers¦ .
𐋇¦if¦ ¦you¦ ¦th ink¦ ¦it¦ ' ¦s¦ ¦t im ely¦ ,▁ ¦star t¦ ¦t al king¦ ¦about¦ ¦the¦ ¦person¦ ¦who¦ ¦d ied¦ ¦and¦ ¦their¦ ¦me m or ies¦ ¦of¦ ¦that¦ ¦person¦ .
𐋇 ¦limi t¦ ¦new s¦ ¦and¦ ¦social¦ ¦m ed ia¦
𐋇¦t ry¦ ¦to¦ ¦limi t¦ ¦the¦ ¦a mo un t¦ ¦of¦ ¦new s¦ ¦and¦ ¦social¦ ¦m ed ia¦ ¦you¦ ¦w at ch¦ .
𐋇¦when¦ ¦you¦ ¦are¦ ¦s ad¦ ,▁ ¦the¦ ¦new s¦ ¦may¦ ¦up s et¦ ¦you¦ ¦and¦ ¦make¦ ¦you¦ ¦or¦ ¦your¦ ¦family¦ ¦even¦ ¦sa d der¦ .
𐋇¦w ays¦ ¦to¦ ¦help¦ ¦others¦ ¦who¦ ¦are¦ ¦gr ie ving¦
𐋇¦to¦ ¦help¦ ¦a¦ ¦f ri end¦ ¦or¦ ¦family¦ ¦me mber¦ ¦of¦ ¦you¦ ¦who¦ ¦is¦ ¦gr ie ving¦ ,▁ ¦th ink¦ ¦about¦ ¦how¦ ¦you¦ ¦can¦ ¦ext end¦ ¦your¦ ¦c ond ol en ces¦ ¦to¦ ¦them¦ ¦at¦ ¦this¦ ¦time¦ .
𐋇¦there¦ ¦are¦ ¦other¦ ¦w ays¦ ¦you¦ ¦can¦ ¦c om f ort¦ ¦them¦ ¦if¦ ¦you¦ ¦are¦ ¦not¦ ¦in¦ ¦their¦ ¦comp an y¦ .
𐋇 ¦te xt¦ ¦or¦ ¦call¦ ▁-▁ ¦as k¦ ¦your¦ ¦f ri end¦ ¦how¦ ¦they¦ ¦are¦ ,▁ ¦as k¦ ¦them¦ ¦what¦ ¦could¦ ¦help¦ ¦them¦ ¦and¦ ¦l ist en¦ ¦ca re f ul ly¦
𐋇 ¦lea ve¦ ¦food¦ ¦or¦ ¦a¦ ¦g if t¦ ¦at¦ ¦the¦ ¦ door¦ ¦as¦ ¦a¦ ¦s ign¦ ¦of¦ ¦cons ol ation¦
𐋇 ¦off er¦ ¦pract ical¦ ¦help¦ ,▁ ¦for¦ ¦example¦ ,▁ ¦shopping¦
𐋇 ¦off er¦ ¦ass ist ance¦ ¦with¦ ¦techn ology¦ ¦such¦ ¦as¦ ¦v ide o¦ ¦ca lls¦ ,▁ ¦wh at s ap p¦ ¦or¦ ¦other¦ ¦w ays¦ ¦to¦ ¦keep¦ ¦in¦ ¦tou ch¦
𐋇 ¦exp r ess¦ ¦your¦ ¦c ond ol en ces¦ ¦online¦ ¦on¦ ¦ ri p¦ . ¦i e¦ ¦or¦ ¦similar¦
𐋇¦w r ite¦ ¦a¦ ¦c ard¦
𐋇¦w hi che ver¦ ¦way¦ ¦you¦ ¦c ho ose¦ ¦to¦ ¦exp r ess¦ ¦your¦ ¦s y m pa th y¦ ,▁ ¦be¦ ¦sure¦ ¦to¦ ¦contact¦ ¦them¦ .
𐋇¦l et¦ ¦them¦ ¦know¦ ¦that¦ ¦you¦ ¦are¦ ¦available¦ ¦not¦ ¦only¦ ¦in¦ ¦the¦ ¦sh ort¦ ¦ter m¦ ¦but¦ ¦in¦ ¦the¦ ¦c om ing¦ ¦weeks¦ ¦and¦ ¦mon ths¦ .
𐋇 ¦re me mber¦ ¦that¦ ¦the¦ ¦person¦ ¦may¦ ¦not¦ ¦al w ays¦ ¦w ant¦ ¦to¦ ¦t alk¦ ¦to¦ ¦you¦ .
𐋇 ¦that¦ ' ¦s¦ ¦o k ay¦ ¦to o¦ ▁-▁ ¦it¦ ' ¦s¦ ¦important¦ ¦to¦ ¦give¦ ¦them¦ ¦sp ace¦ .
𐋇¦it¦ ¦is¦ ¦also¦ ¦important¦ ¦for¦ ¦them¦ ¦to¦ ¦know¦ ¦that¦ ¦you¦ ¦are¦ ¦there¦ ¦when¦ ¦they¦ ¦need¦ ¦you¦ ¦most¦ .
𐋇 ¦in door¦ ¦f it ness¦ ¦for¦ ¦the¦ ¦el d erly¦
𐋇¦it¦ ¦is¦ ¦important¦ ¦to¦ ¦stay¦ ¦ac tive¦ ¦while¦ ¦sta ying¦ ¦home¦ ¦or¦ ¦sta ying¦ ¦al one¦ ¦during¦ ¦the¦ ¦corona ry¦ ¦virus¦ ¦outbreak¦ .
𐋇 ¦an yone¦ ¦can¦ ¦be¦ ¦ac tive¦ ,▁ ¦it¦ ▁’▁ ¦s¦ ¦e as y¦ ¦to¦ ¦get¦ ¦star ted¦ ,▁ ¦and¦ ¦it¦ ▁’▁ ¦s¦ ¦ne ver¦ ¦to o¦ ¦l ate¦ .
𐋇 ¦an y thing¦ ¦that¦ ¦e nc ou ra ges¦ ¦you¦ ¦to¦ ¦mo ve¦ ¦is¦ ¦ph ys ical¦ ¦activ ity¦ ¦and¦ ¦will¦ ¦be ne f i t¦ ¦you¦ ¦no¦ ¦m at ter¦ ¦what¦ ¦age¦ ¦you¦ ¦are¦ .
𐋇¦e nc o ur age¦ ¦yourself¦ ¦to¦ ¦be¦ ¦more¦ ¦ag i le¦ .
𐋇¦it¦ ¦may¦ ¦be¦ ¦cha ll en ging¦ ¦to¦ ¦m ot iv ate¦ ¦yourself¦ ,▁ ¦especially¦ ¦if¦ ¦it¦ ¦is¦ ¦cold¦ ¦and¦ ¦r aining¦ .
𐋇¦but¦ ,▁ ¦you¦ ¦can¦ ¦exerc ise¦ ¦and¦ ¦be¦ ¦ac tive¦ ¦an y w h er e¦ ▁-▁ ¦at¦ ¦home¦ ¦or¦ ¦in¦ ¦your¦ ¦gard en¦ .
𐋇 ¦activ ities¦ ¦for¦ ¦ ol der¦ ¦people¦
𐋇 ¦all¦ ¦ad ul ts¦ ¦should¦ ¦be¦ ¦as¦ ¦ac tive¦ ¦as¦ ¦they¦ ¦can¦ ¦be¦ ¦every¦ ¦day¦ .
𐋇¦for¦ ¦example¦ :
𐋇 ¦at¦ ¦least¦ ¦1 5 0¦ ¦min u tes¦ ¦of¦ ¦mod er ate¦ ¦a er ob ic¦ ¦activ ity¦ ¦each¦ ¦week¦ ,▁ ¦such¦ ¦as¦ :▁ 𐋇¦w al king¦ ,▁ ¦da ncing¦ ¦or¦ ¦even¦ ¦m owing¦ ¦the¦ ¦gr ass¦ .
𐋇 ¦exerc i ses¦ ¦to¦ ¦st re ng th en¦ ¦the¦ ¦m us c les¦ ▁ - ¦2¦ ¦days¦ ¦or¦ ¦more¦ ¦a¦ ¦week¦ ▁-▁ ¦for¦ ¦example¦ ,▁ ¦d ig ging¦ ¦in¦ ¦the¦ ¦gard en¦ ,▁ ¦ste p¦ ¦a er ob ics¦ ,▁ ¦exerc i ses¦ ¦with¦ ¦hand¦ ¦we i gh ts¦ ¦or¦ ¦y og a¦
𐋇 ¦even¦ ¦hou se w or k¦ ¦like¦ ¦c oo king¦ ¦and¦ ¦not¦ ¦s it ting¦ ¦down¦ ¦all¦ ¦the¦ ¦time¦ .
𐋇¦you¦ ¦are¦ ¦more¦ ¦at¦ ¦risk¦ ¦of¦ ¦fa lling¦ ¦if¦ ¦you¦ ¦are¦ ¦an¦ ¦ ol der¦ ¦person¦ .
𐋇¦t ry¦ ¦to¦ ¦do¦ ¦one¦ ¦of¦ ¦these¦ ¦every¦ ¦day¦ :
𐋇¦t ry¦ ¦these¦ :
𐋇 ¦exerc i ses¦ ¦for¦ ¦b al ance¦
𐋇 ¦exerc i ses¦ ¦to¦ ¦st re ng th en¦ ¦you¦
𐋇 ¦exerc i ses¦ ¦for¦ ¦f le xi bility¦
𐋇 ¦exerc i ses¦ ¦while¦ ¦you¦ ¦are¦ ¦s it ting¦
𐋇¦f le xi bility¦ ¦exerc i ses¦
𐋇¦these¦ ¦f le xi bility¦ ¦exerc i ses¦ ¦can¦ ¦be¦ ¦d one¦ ¦at¦ ¦home¦ ¦to¦ ¦help¦ ¦your¦ ¦health¦ ¦and¦ ¦imp ro ve¦ ¦your¦ ¦mo bility¦ .
𐋇¦d on¦ ' ¦t¦ ¦wor ry¦ ¦if¦ ¦you¦ ¦ha v en¦ ' ¦t¦ ¦d one¦ ¦much¦ ¦in¦ ¦a¦ ¦while¦ - ▁ ¦this¦ ¦exerc ise¦ ¦is¦ ¦e as y¦ .
𐋇 ¦wear¦ ¦lo ose¦ ,▁ ¦c om f ort able¦ ¦c lo thing¦ ¦and¦ ¦keep¦ ¦a¦ ¦water¦ ¦b ot t le¦ ¦n ear¦ ¦you¦ .
𐋇 ¦take¦ ¦it¦ ¦e as y¦ ¦at¦ ¦first¦ ¦and¦ ¦g rad ually¦ ¦increase¦ ¦the¦ ¦a mo un t¦ ¦of¦ ¦exerc ise¦ ¦you¦ ¦do¦ .
𐋇¦t ry¦ ¦to¦ ¦do¦ ¦this¦ ¦exerc ise¦ ¦at¦ ¦least¦ ¦t w ice¦ ¦a¦ ¦week¦ ¦and¦ ¦do¦ ¦it¦ ¦with¦ :
𐋇 ¦exerc i ses¦ ¦for¦ ¦b al ance¦
𐋇 ¦exerc i ses¦ ¦in¦ ¦your¦ ¦s it ting¦
𐋇 ¦ag il ity¦ ¦to¦ ¦st re ng th en¦ ¦you¦
𐋇¦n eck¦ ¦r ot ation¦
𐋇¦this¦ ¦h el ps¦ ¦with¦ ¦the¦ ¦r ot ation¦ ¦and¦ ¦f le xi bility¦ ¦of¦ ¦the¦ ¦n eck¦ .
𐋇 ¦si t¦ ¦up¦ ¦stra ight¦ ¦and¦ ¦keep¦ ¦your¦ ¦sho ul d ers¦ ¦down¦ .
𐋇¦l ook¦ ¦stra ight¦ ¦a h ead¦ .
𐋇¦t ur n¦ ¦your¦ ¦h ead¦ ¦sl ow ly¦ ¦t ow ards¦ ¦your¦ ¦le f t¦ ¦sho ul der¦ ¦as¦ ¦fa r¦ ¦as¦ ¦you¦ ¦can¦ .
𐋇 ¦rep e at¦ ¦for¦ ¦5¦ ¦sec on ds¦ ¦and¦ ¦star t¦ ¦ag a in¦ .
𐋇¦t ur n¦ ¦your¦ ¦h ead¦ ¦sl ow ly¦ ¦t ow ards¦ ¦your¦ ¦r ight¦ ¦sho ul der¦ ,▁ ¦then¦ .
𐋇 ¦make¦ ¦3¦ ¦r ot ations¦ ¦on¦ ¦each¦ ¦ side¦ .
𐋇¦n eck¦ ¦ex tens ion¦
𐋇¦it¦ ¦h el ps¦ ¦to¦ ¦re le ase¦ ¦st if f¦ ¦m us c les¦ ¦in¦ ¦the¦ ¦n eck¦ .
𐋇 ¦si t¦ ¦up¦ ¦stra ight¦ ,▁ ¦l ook¦ ¦stra ight¦ ¦a h ead¦ ¦and¦ ¦keep¦ ¦your¦ ¦le f t¦ ¦sho ul der¦ ¦down¦ ¦with¦ ¦your¦ ¦r ight¦ ¦hand¦ .
𐋇 ¦sl ow ly¦ ¦t il t¦ ¦your¦ ¦h ead¦ ¦to¦ ¦the¦ ¦r ight¦ ¦and¦ ¦your¦ ¦sho ul d ers¦ ¦down¦ .
𐋇¦do¦ ¦the¦ ¦same¦ ¦on¦ ¦the¦ ¦other¦ ¦ side¦ .
𐋇 ¦ho ld¦ ¦each¦ ¦ str et ch¦ ¦for¦ ¦5¦ ¦sec on ds¦ ¦and¦ ¦do¦ ¦it¦ ▁-▁ ¦3¦ ¦times¦ ¦on¦ ¦each¦ ¦ side¦ .
𐋇¦c ro uc hing¦ ¦a side¦
𐋇¦it¦ ¦h el ps¦ ¦with¦ ¦f le xi bility¦ ¦in¦ ¦the¦ ¦lower¦ ¦b ack¦
𐋇 ¦st and¦ ¦up¦ ¦stra ight¦ ¦with¦ ¦your¦ ¦fe et¦ ¦hi p¦ - ¦wid th¦ ¦a par t¦ ¦and¦ ¦your¦ ¦hands¦ ¦down¦ ¦to¦ ¦your¦ ¦si des¦ .
𐋇 ¦sl ide¦ ¦your¦ ¦le f t¦ ¦hand¦ ¦down¦ ¦to¦ ¦your¦ ¦ side¦ ¦as¦ ¦fa r¦ ¦as¦ ¦you¦ ¦can¦ .
𐋇¦as¦ ¦you¦ ¦lower¦ ¦your¦ ¦ar m¦ ,▁ ¦you¦ ¦should¦ ¦feel¦ ¦a¦ ¦ti gh t ness¦ ¦in¦ ¦the¦ ¦hi p¦ ¦on¦ ¦the¦ ¦other¦ ¦ side¦ .
𐋇¦do¦ ¦the¦ ¦same¦ ¦with¦ ¦your¦ ¦r ight¦ ¦hand¦ .
𐋇 ¦rep e at¦ ¦each¦ ¦ex tens ion¦ ¦for¦ ¦2¦ ¦sec on ds¦ ,▁ ¦3¦ ¦times¦ ¦on¦ ¦both¦ ¦si des¦ .
𐋇¦ str et c hing¦ ¦your¦ ¦b ut t oc ks¦
𐋇¦it¦ ¦is¦ ¦g ood¦ ¦for¦ ¦m us c les¦ ¦that¦ ¦are¦ ¦st if f¦ ¦in¦ ¦the¦ ¦b ut t oc ks¦ .
𐋇 ¦place¦ ¦your¦ ¦hands¦ ¦against¦ ¦a¦ ¦w all¦ ,▁ ¦so¦ ¦you¦ ¦d on¦ ' ¦t¦ ¦f all¦ .
𐋇¦b end¦ ¦the¦ ¦r ight¦ ¦fo ot¦ ¦and¦ ¦take¦ ¦a¦ ¦ste p¦ ¦b ack¦ ¦with¦ ¦your¦ ¦le f t¦ ¦fo ot¦ ,▁ ¦about¦ ¦one¦ ¦fo ot¦ ,▁ ¦and¦ ¦keep¦ ¦it¦ ¦stra ight¦ .
𐋇 ¦both¦ ¦fe et¦ ¦should¦ ¦be¦ ¦f l at¦ ¦on¦ ¦the¦ ¦f lo or¦ .
𐋇¦the¦ ¦m us c le¦ ¦of¦ ¦the¦ ¦le f t¦ ¦h ee l¦ ¦is¦ ¦ str et ched¦ ¦if¦ ¦the¦ ¦le f t¦ ¦fo ot¦ ¦is¦ ¦k e p t¦ ¦as¦ ¦stra ight¦ ¦as¦ ¦possible¦ ¦with¦ ¦the¦ ¦le f t¦ ¦h ee l¦ ¦on¦ ¦the¦ ¦f lo or¦ .
𐋇¦do¦ ¦the¦ ¦same¦ ¦with¦ ¦the¦ ¦other¦ ¦le g¦ .
𐋇¦e ating¦ ¦healthy¦ ¦food¦
𐋇¦e ating¦ ¦a¦ ¦w ide¦ ¦r ange¦ ¦of¦ ¦healthy¦ ¦f oo ds¦ ¦will¦ ¦give¦ ¦you¦ ¦the¦ ¦en er g y¦ ¦and¦ ¦n ut ri ents¦ ¦you¦ ¦need¦ ¦to¦ ¦be¦ ¦healthy¦ .
𐋇 ¦pl an ning¦ ¦and¦ ¦pre par ation¦
𐋇¦h er e¦ ¦are¦ ¦some¦ ¦ti ps¦ ¦for¦ ¦e ating¦ ¦healthy¦ ¦food¦ :
𐋇 ¦pl an¦ ¦your¦ ¦me als¦ ▁-▁ ¦this¦ ¦will¦ ¦help¦ ¦you¦ ¦e at¦ ¦different¦ ¦and¦ ¦n ut r it ious¦ ¦f oo ds¦ .
𐋇¦it¦ ¦will¦ ¦also¦ ¦sa ve¦ ¦you¦ ¦mo ne y¦ ¦and¦ ¦reduce¦ ¦your¦ ¦re li ance¦ ¦on¦ ¦con v en i ence¦ ¦or¦ ¦proc es sed¦ ¦food¦ .
𐋇 ¦pre p are¦ ¦your¦ ¦me als¦ ¦main ly¦ ¦using¦ ¦fre s h ¦ ¦i ng re di ents¦ ¦and¦ ¦c ho ose¦ ¦f ru i ts¦ ,▁ ¦sa la ds¦ ¦and¦ ¦ ve g et ab les¦ ¦as¦ ¦s n ac ks¦ .
𐋇 ¦use¦ ¦he al t hi er¦ ¦c oo king¦ ¦met ho ds¦ ¦such¦ ¦as¦ ¦g ri lling¦ ¦or¦ ¦ev ap or ating¦ ¦r at her¦ ¦than¦ ¦f r ying¦ ¦or¦ ¦ro as ting¦ ¦with¦ ¦o il¦ ¦or¦ ¦f at¦ .
𐋇 ¦use¦ ¦the¦ ¦food¦ ¦p y ra m id¦ ¦as¦ ¦a¦ ¦gu ide¦ ¦to¦ ¦what¦ ¦you¦ ¦p ut¦ ¦on¦ ¦your¦ ¦pl ate¦ .
𐋇 ¦si t¦ ¦at¦ ¦the¦ ¦t able¦ ¦and¦ ¦en j o y¦ ¦your¦ ¦me als¦ .
𐋇¦t ry¦ ¦not¦ ¦to¦ ¦e at¦ ¦in¦ ¦f r on t¦ ¦of¦ ¦the¦ ¦t v ¦ ¦or¦ ¦comp u ter¦ .
𐋇 ¦make¦ ¦healthy¦ ¦ch oi ces¦
𐋇 ¦use¦ ¦the¦ ¦food¦ ¦p y ra m id¦ ¦as¦ ¦a¦ ¦gu ide¦ ¦to¦ ¦the¦ ¦typ es¦ ¦and¦ ¦a mo un t¦ ¦of¦ ¦food¦ ¦you¦ ¦need¦ ¦each¦ ¦day¦ .
𐋇¦e at¦ ¦p le nt y¦ ¦of¦ ¦ ve g et ab les¦ ,▁ ¦sa la ds¦ ¦and¦ ¦f ru i t¦ ▁-▁ ¦up¦ ¦to¦ ¦h al f¦ ¦of¦ ¦your¦ ¦pl ate¦ ¦or¦ ¦b ow l¦ ¦at¦ ¦each¦ ¦me al¦ .
𐋇¦c ho ose¦ ¦food¦ ¦in¦ ¦different¦ ¦c ol ors¦ .
𐋇¦c ho ose¦ ¦w ho le me al¦ ¦and¦ ¦w ho le g ra in¦ ¦p ie ces¦ ¦of¦ ¦br ead¦ ,▁ ¦ce re als¦ ,▁ ¦pa st a¦ ¦and¦ ¦br own¦ ¦r ice¦ .
𐋇 ¦be¦ ¦a w are¦ ¦of¦ ¦the¦ ¦di ff er ence¦ ¦in¦ ¦c al or ies¦ ▁-▁ ¦different¦ ¦typ es¦ ¦have¦ ¦more¦ ¦c al or ies¦ ¦than¦ ¦others¦ .
𐋇¦c ho ose¦ ¦low¦ - ¦f at¦ ¦m il k¦ ,▁ ¦y o gh ur t¦ ¦or¦ ¦ch ee se¦ .
𐋇¦c ho ose¦ ¦m il k¦ ¦and¦ ¦y og ur t¦ ¦more¦ ¦often¦ ¦than¦ ¦ch ee se¦ .
𐋇¦read¦ ¦more¦ ¦about¦ ¦that¦ ¦h er e¦ :
𐋇¦e at¦ ¦a¦ ¦fe w¦ ¦of¦ ¦the¦ ¦following¦ ¦t w ice¦ ¦a¦ ¦day¦ :▁ 𐋇 ¦po ult ry¦ ,▁ ¦f ish¦ ,▁ ¦e gg s¦ ,▁ ¦nu ts¦ ,▁ ¦be ans¦ ¦or¦ ¦me at¦ .
𐋇¦c ho ose¦ ¦f ish¦ ¦t w ice¦ ¦a¦ ¦week¦ ▁-▁ ¦ oi ly¦ ¦f ish¦ ¦is¦ ¦b est¦ .
𐋇¦c ut¦ ¦b ack¦ ¦on¦ ¦the¦ ¦c hi ps¦ ¦and¦ ¦f ast¦ ¦food¦ ¦as¦ ¦much¦ ¦as¦ ¦possible¦ .
𐋇¦they¦ ¦are¦ ¦high¦ ¦in¦ ¦f at¦ ,▁ ¦s al t¦ ¦and¦ ¦c al or ies¦ .
𐋇¦d on¦ ' ¦t¦ ¦e at¦ ¦the¦ ¦following¦ ¦every¦ ¦day¦ :
𐋇¦s we et¦ ¦dr in ks¦
𐋇¦b is c u i ts¦ ,▁ ¦ca k es¦ ,▁ ¦de ss er ts¦ ,▁ ¦ch oc ol ate¦ ,▁ ¦s we ets¦ .
𐋇 ¦proc es sed¦ ¦s al ted¦ ¦m ea ts¦ ¦such¦ ¦as¦ ¦sa us a ges¦ ,▁ ¦b ac on¦ ¦and¦ ¦h am¦ .
𐋇¦s al t y¦ ¦s n ac ks¦ ¦like¦ ¦cr is ps¦ .
𐋇¦how¦ ¦much¦ ¦food¦ ¦do¦ ¦you¦ ¦need¦ ?
𐋇 ¦use¦ ¦the¦ ¦food¦ ¦p y ra m id¦ ¦as¦ ¦a¦ ¦gu ide¦ ¦to¦ ¦the¦ ¦typ es¦ ¦and¦ ¦a mo un t¦ ¦of¦ ¦food¦ ¦you¦ ¦need¦ ¦each¦ ¦day¦ .
𐋇¦the¦ ¦a mo un t¦ ¦of¦ ¦food¦ ¦you¦ ¦need¦ ¦to¦ ¦e at¦ ¦dep ends¦ ¦on¦ ¦your¦ ¦age¦ ¦and¦ ¦activ ity¦ ¦level¦ .
𐋇 ¦healthy¦ ¦food¦
𐋇 ¦se e¦ ¦how¦ ¦these¦ ¦people¦ ¦used¦ ¦the¦ ¦food¦ ¦p y ra m id¦ ¦as¦ ¦a¦ ¦gu ide¦ ¦to¦ ¦under st an ding¦ ¦healthy¦ ¦e ating¦ .
𐋇 ¦healthy¦ ¦food¦ ¦for¦ ¦l ife¦
𐋇 ¦int ro duc t ory¦ ¦si x¦ - ¦week¦ ¦c oo k e ry¦ ¦co ur ses¦ ¦on¦ ¦n ut r ition¦ ¦and¦ ¦n ut r ition¦ ¦are¦ ¦ ru n¦ ¦th r ou g ho ut¦ ¦the¦ ¦country¦ .
𐋇¦f it ness¦ ¦to¦ ¦st re ng th en¦ ¦you¦
𐋇¦this¦ ¦typ e¦ ¦of¦ ¦exerc ise¦ ¦can¦ ¦be¦ ¦d one¦ ¦at¦ ¦home¦ ¦to¦ ¦st re ng th en¦ ¦you¦ ¦and¦ ¦imp ro ve¦ ¦your¦ ¦health¦ ¦and¦ ¦mo bility¦ .
𐋇¦d on¦ ' ¦t¦ ¦wor ry¦ ¦if¦ ¦you¦ ¦ha v en¦ ' ¦t¦ ¦d one¦ ¦much¦ ¦in¦ ¦a¦ ¦while¦ - ▁ ¦this¦ ¦exerc ise¦ ¦is¦ ¦e as y¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦se ated¦ ,▁ ¦do¦ ¦the¦ ¦exerc ise¦ ¦on¦ ¦a¦ ¦st ur dy¦ ,▁ ¦st ur dy¦ ,▁ ¦w he el less¦ ¦ch ai r¦ .
𐋇¦you¦ ¦should¦ ¦be¦ ¦able¦ ¦to¦ ¦si t¦ ¦with¦ ¦your¦ ¦fe et¦ ¦on¦ ¦the¦ ¦f lo or¦ ¦and¦ ¦your¦ ¦k ne es¦ ¦b ent¦ ¦at¦ ¦a¦ ¦9 0¦ ¦de g re e¦ ¦a ng le¦ .
𐋇 ¦avoid¦ ¦an¦ ¦a ng l ed¦ ¦ch ai r¦ ,▁ ¦as¦ ¦this¦ ¦will¦ ¦restrict¦ ¦your¦ ¦mo ve ment¦ .
𐋇 ¦wear¦ ¦lo ose¦ ,▁ ¦c om f ort able¦ ¦c lo thing¦ ¦and¦ ¦keep¦ ¦a¦ ¦water¦ ¦b ot t le¦ ¦n ear¦ ¦you¦ .
𐋇 ¦take¦ ¦it¦ ¦e as y¦ ¦at¦ ¦first¦ ¦and¦ ¦g rad ually¦ ¦increase¦ ¦the¦ ¦a mo un t¦ ¦of¦ ¦exerc ise¦ ¦you¦ ¦do¦ .
𐋇¦t ry¦ ¦to¦ ¦do¦ ¦this¦ ¦exerc ise¦ ¦at¦ ¦least¦ ¦t w ice¦ ¦a¦ ¦week¦ ¦and¦ ¦do¦ ¦it¦ ¦with¦ :
𐋇 ¦exerc i ses¦ ¦for¦ ¦b al ance¦
𐋇 ¦exerc i ses¦ ¦in¦ ¦your¦ ¦s it ting¦
𐋇¦f le xi bility¦ ¦exerc i ses¦
𐋇 ¦getting¦ ¦in¦ ¦your¦ ¦p os ition¦
𐋇 ¦si t¦ ¦on¦ ¦the¦ ¦ ed ge¦ ¦of¦ ¦the¦ ¦ch ai r¦ ¦with¦ ¦your¦ ¦fe et¦ ¦hi p¦ - ¦wid th¦ ¦a par t¦ .
𐋇¦ str et ch¦ ¦for w ard¦ ¦s li gh t ly¦ .
𐋇 ¦st and¦ ¦up¦ ¦sl ow ly¦ ¦p ut ting¦ ¦your¦ ¦fe et¦ ¦in¦ ¦contact¦ .
𐋇¦l ook¦ ¦stra ight¦ ¦a h ead¦ ¦and¦ ¦d on¦ ▁’▁ ¦t¦ ¦l ook¦ ¦down¦ .
𐋇 ¦st and¦ ¦up¦ ¦stra ight¦ ¦and¦ ¦then¦ ¦si t¦ ¦down¦ ¦sl ow ly¦ ¦on¦ ¦your¦ ¦ ass¦ .
𐋇¦do¦ ¦this¦ ¦5¦ ¦times¦ ¦in¦ ¦a¦ ¦r ow¦ - ▁ ¦the¦ ¦so on er¦ ¦you¦ ¦do¦ ¦it¦ ,▁ ¦the¦ ¦bet ter¦ .
𐋇 ¦go ing¦ ¦down¦ ¦on¦ ¦your¦ ¦go gg les¦
𐋇 ¦place¦ ¦your¦ ¦hands¦ ¦on¦ ¦the¦ ¦b ack¦ ¦of¦ ¦the¦ ¦ch ai r¦ ¦to¦ ¦keep¦ ¦it¦ ¦st ea dy¦ ¦and¦ ¦st and¦ ¦with¦ ¦your¦ ¦fe et¦ ¦hi p¦ - ¦wid th¦ ¦a par t¦ .
𐋇¦b end¦ ¦your¦ ¦k ne es¦ ¦sl ow ly¦ ¦as¦ ¦fa r¦ ¦as¦ ¦you¦ ¦can¦ ,▁ ¦and¦ ¦keep¦ ¦them¦ ¦f oc u sed¦ ¦for w ard¦ .
𐋇¦t ry¦ ¦b ending¦ ¦them¦ ¦over¦ ¦your¦ ¦bi g¦ ¦to e¦ .
𐋇 ¦al w ays¦ ¦keep¦ ¦your¦ ¦b ack¦ ¦stra ight¦ .
𐋇 ¦st and¦ ¦up¦ ¦n ice¦ ¦and¦ ¦sm oo th¦ ,▁ ¦s qu ee z ing¦ ¦your¦ ¦b ut t oc ks¦ ¦all¦ ¦the¦ ¦time¦ .
𐋇 ¦rep e at¦ ¦5¦ ¦times¦ .
𐋇 ¦ra ising¦ ¦the¦ ¦c la w s¦ ¦when¦ ¦you¦ ¦are¦ ¦s it ting¦
𐋇 ¦place¦ ¦your¦ ¦hands¦ ¦on¦ ¦the¦ ¦b ack¦ ¦of¦ ¦the¦ ¦ch ai r¦ ¦for¦ ¦sta bility¦ .
𐋇¦l if t¦ ¦your¦ ¦he els¦ ¦off ¦ ¦the¦ ¦f lo or¦ ¦for¦ ¦as¦ ¦long¦ ¦as¦ ¦you¦ ¦can¦ .
𐋇¦do¦ ¦this¦ ¦sl ow ly¦ ,▁ ¦ ge ntly¦ .
𐋇 ¦rep e at¦ ¦5¦ ¦times¦ .
𐋇¦to¦ ¦make¦ ¦this¦ ¦more¦ ¦diffic ul t¦ ,▁ ¦do¦ ¦this¦ ¦exerc ise¦ ¦without¦ ¦the¦ ¦ch ai r¦ .
𐋇 ¦ra ising¦ ¦your¦ ¦fo ot¦ ¦out¦ ¦to¦ ¦the¦ ¦ side¦ .
𐋇 ¦place¦ ¦your¦ ¦hands¦ ¦on¦ ¦the¦ ¦b ack¦ ¦of¦ ¦the¦ ¦ch ai r¦ ¦for¦ ¦sta bility¦
𐋇 ¦ra ise¦ ¦your¦ ¦le f t¦ ¦le g¦ ¦and¦ ¦ str et ch¦ ¦it¦ ¦a side¦ ¦as¦ ¦fa r¦ ¦as¦ ¦you¦ ¦can¦ ,▁ ¦k ee p ing¦ ¦your¦ ¦b ack¦ ¦and¦ ¦hi ps¦ ¦stra ight¦ .
𐋇¦do¦ ¦not¦ ¦l oo p¦ ¦to¦ ¦the¦ ¦r ight¦ .
𐋇 ¦retur n¦ ¦to¦ ¦where¦ ¦you¦ ¦star ted¦ .
𐋇¦n ow¦ ¦ra ise¦ ¦your¦ ¦r ight¦ ¦fo ot¦ ¦and¦ ¦ str et ch¦ ¦it¦ ¦a side¦ ¦as¦ ¦fa r¦ ¦as¦ ¦you¦ ¦can¦ .
𐋇 ¦ra ise¦ ¦and¦ ¦lower¦ ¦both¦ ¦le g s¦ ¦5¦ ¦times¦ .
𐋇¦ str et c hing¦ ¦your¦ ¦le g s¦
𐋇 ¦place¦ ¦your¦ ¦hands¦ ¦on¦ ¦the¦ ¦b ack¦ ¦of¦ ¦the¦ ¦ch ai r¦ ¦for¦ ¦sta bility¦ .
𐋇 ¦st and¦ ¦up¦ ¦stra ight¦ ,▁ ¦ str et ch¦ ¦your¦ ¦le f t¦ ¦le g¦ ¦out¦ ¦be h ind¦ ,▁ ¦and¦ ¦keep¦ ¦it¦ ¦stra ight¦ .
𐋇 ¦keep¦ ¦your¦ ¦b ack¦ ¦stra ight¦ ¦when¦ ¦ str et c hing¦ ¦your¦ ¦le g¦ .
𐋇 ¦keep¦ ¦your¦ ¦b ack¦ ¦stra ight¦ ¦as¦ ¦you¦ ¦lower¦ ¦your¦ ¦le g¦ ¦ag a in¦ .
𐋇¦you¦ ¦should¦ ¦feel¦ ¦the¦ ¦pre ss ure¦ ¦in¦ ¦the¦ ¦b ack¦ ¦of¦ ¦your¦ ¦qu a rt ers¦ ¦and¦ ¦b ut t oc ks¦ .
𐋇¦do¦ ¦the¦ ¦same¦ ¦with¦ ¦the¦ ¦r ight¦ ¦le g¦ .
𐋇 ¦ho ld¦ ¦the¦ ¦le g¦ ¦up¦ ¦for¦ ¦5¦ ¦sec on ds¦ ¦and¦ ¦do¦ ¦it¦ ¦5¦ ¦times¦ ¦with¦ ¦both¦ ¦fe et¦ .
𐋇¦p us h ¦ - ¦up¦ ¦from¦ ¦the¦ ¦w all¦
𐋇 ¦keep¦ ¦the¦ ¦le ng th¦ ¦of¦ ¦your¦ ¦w ings¦ ¦away¦ ¦from¦ ¦the¦ ¦w all¦ .
𐋇 ¦place¦ ¦your¦ ¦hands¦ ¦against¦ ¦the¦ ¦f l at¦ ¦w all¦ ¦of¦ ¦your¦ ¦chest¦ ,▁ ¦with¦ ¦your¦ ¦fi ng ers¦ ¦ str et ched¦ ¦stra ight¦ ¦up¦ .
𐋇¦b end¦ ¦your¦ ¦w ings¦ ¦sl ow ly¦ ,▁ ¦with¦ ¦your¦ ¦el b ow s¦ ¦to¦ ¦your¦ ¦si des¦ ¦and¦ ¦your¦ ¦b ack¦ ¦stra ight¦ .
𐋇 ¦li e¦ ¦down¦ ¦to¦ ¦the¦ ¦w all¦ ¦as¦ ¦fa r¦ ¦as¦ ¦you¦ ¦can¦ .
𐋇 ¦retur n¦ ¦sl ow ly¦ ¦to¦ ¦where¦ ¦you¦ ¦star ted¦ .
𐋇¦do¦ ¦these¦ ¦3¦ ¦exerc i ses¦ ¦between¦ ¦5¦ ¦and¦ ¦10¦ ¦times¦ .
𐋇 ¦cur l ing¦ ¦the¦ ¦bi ce ps¦
𐋇 ¦keep¦ ¦a¦ ¦fe w¦ ¦l ight¦ ¦we i gh ts¦ ¦n ear¦ ¦you¦ ▁( ¦ e¦ . ¦ g¦ .▁ ¦b ot t les¦ ¦f ul l¦ ¦of¦ ¦water¦ )▁ ¦and¦ ¦st and¦ ¦with¦ ¦your¦ ¦fe et¦ ¦hi p¦ - ¦wid th¦ ¦a par t¦ .
𐋇 ¦keep¦ ¦your¦ ¦w ings¦ ¦by¦ ¦your¦ ¦ side¦ ,▁ ¦l if t¦ ¦the¦ ¦we i gh ts¦ ¦up¦ ¦to¦ ¦your¦ ¦sho ul d ers¦ .
𐋇 ¦sl ow ly¦ ¦lower¦ ¦ag a in¦ .
𐋇¦this¦ ¦can¦ ¦also¦ ¦be¦ ¦d one¦ ¦while¦ ¦you¦ ¦are¦ ¦s it ting¦ .
𐋇 ¦rep e at¦ ¦these¦ ¦3¦ ¦exerc i ses¦ ¦5¦ ¦times¦ ¦with¦ ¦both¦ ¦hands¦ .
𐋇 ¦what¦ ¦happ ens¦ ¦during¦ ¦a¦ ¦test¦ ¦for¦ ¦the¦ ¦coronavirus¦
𐋇¦there¦ ¦are¦ ¦2 8¦ ¦test¦ ¦ce nt ers¦ ¦na tion w ide¦ .
𐋇 ¦most¦ ¦ce nt ers¦ ¦are¦ ¦in¦ ¦a¦ ¦bu il ding¦ ¦or¦ ¦cl in ic¦ .
𐋇¦some¦ ¦have¦ ¦a¦ ¦dr ive¦ - ¦in¦ ¦service¦ .
𐋇¦the¦ ¦test¦ ¦ta k es¦ ¦about¦ ¦15¦ ¦min u tes¦ .
𐋇¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦feel¦ ¦well¦ ¦en ough¦ ¦to¦ ¦dr ive¦ ¦to¦ ¦the¦ ¦test¦ ¦centre¦ ,▁ ¦someone¦ ¦in¦ ¦your¦ ¦family¦ ¦can¦ ¦dr ive¦ ¦you¦ ¦there¦ .
𐋇¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦a¦ ¦test¦ ¦appointment¦ ,▁ ¦you¦ ¦can¦ ¦dr ive¦ ¦them¦ ¦to¦ ¦the¦ ¦test¦ ¦centre¦ .
𐋇 ¦follow¦ ¦the¦ ¦advice¦ ¦on¦ ¦respiratory¦ ¦h yg ien e¦ ¦and¦ ¦social¦ ¦separ ation¦ ¦and¦ ¦wear¦ ¦a¦ ¦face¦ ¦mask¦ ¦in¦ ¦the¦ ¦test¦ ¦centre¦ ¦and¦ ¦on¦ ¦your¦ ¦way¦ ¦to¦ ¦the¦ ¦test¦ ¦center¦ ¦and¦ ¦home¦ .
𐋇 ¦test¦ ¦centre¦
𐋇¦d on¦ ' ¦t¦ ¦go¦ ¦to¦ ¦a¦ ¦test¦ ¦centre¦ ¦un less¦ ¦you¦ ¦have¦ ¦an¦ ¦appointment¦ ▁-▁ ¦you¦ ¦will¦ ¦not¦ ¦be¦ ¦tested¦ .
𐋇 ¦par k¦ ¦and¦ ¦stay¦ ¦in¦ ¦your¦ ¦ca r¦ .
𐋇¦a¦ ¦healthcare¦ ¦work er¦ ¦will¦ ¦come¦ ¦to¦ ¦you¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦giv en¦ ¦a¦ ¦mask¦ ¦to¦ ¦p ut¦ ¦on¦ ,▁ ¦they¦ ¦will¦ ¦exp la in¦ ¦to¦ ¦you¦ ¦what¦ ¦will¦ ¦happ en¦ ,▁ ¦they¦ ¦will¦ ¦as k¦ ¦you¦ ¦some¦ ¦qu es tions¦ ,▁ ¦and¦ ¦you¦ ¦will¦ ¦be¦ ¦ta k en¦ ¦to¦ ¦the¦ ¦test¦ ¦centre¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦as ked¦ ¦to¦ ¦wash¦ ¦your¦ ¦hands¦ ¦properly¦ .
𐋇 ¦healthcare¦ ¦staff¦ ¦will¦ ¦take¦ ¦some¦ ¦personal¦ ¦detail s¦ ¦from¦ ¦you¦ ,▁ ¦including¦ ¦your¦ ¦te le ph one¦ ¦number¦ .
𐋇¦this¦ ¦will¦ ¦be¦ ¦d one¦ ¦to¦ ¦contact¦ ¦you¦ ¦with¦ ¦your¦ ¦results¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦as ked¦ ¦to¦ ¦ bl ow¦ ¦your¦ ¦nose¦ ¦into¦ ¦a¦ ¦ti ss ue¦ ¦and¦ ¦then¦ ¦place¦ ¦the¦ ¦ti ss ue¦ ¦in¦ ¦a¦ ¦b in¦ .
𐋇¦a¦ ¦healthcare¦ ¦work er¦ ¦will¦ ¦take¦ ¦a¦ ¦sampl e¦ ¦in side¦ ¦your¦ ¦mouth¦ ¦and¦ ¦from¦ ¦your¦ ¦nose¦ ¦with¦ ¦a¦ ¦sw ab ¦ .
𐋇¦this¦ ¦will¦ ¦be¦ ¦s ent¦ ¦to¦ ¦a¦ ¦laboratory¦ ¦for¦ ¦testing¦ .
𐋇¦you¦ ¦will¦ ¦then¦ ¦have¦ ¦to¦ ¦dr ive¦ ¦home¦ ¦and¦ ¦stay¦ ¦al one¦ .
𐋇 ¦ca r¦ ¦service¦ ¦test¦ ¦centre¦
𐋇¦some¦ ¦have¦ ¦a¦ ¦dr ive¦ - ¦in¦ ¦service¦ .
𐋇¦you¦ ¦can¦ ¦dr ive¦ ¦yourself¦ ¦if¦ ¦you¦ ¦feel¦ ¦g ood¦ ¦en ough¦ .
𐋇¦if¦ ¦not¦ ,▁ ¦you¦ ¦can¦ ¦be¦ ¦dr iv en¦ ¦by¦ ¦someone¦ ¦el se¦ ,▁ ¦ma y b e¦ ¦someone¦ ¦in¦ ¦your¦ ¦family¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦a¦ ¦child¦ ¦who¦ ¦has¦ ¦a¦ ¦test¦ ¦appointment¦ ,▁ ¦you¦ ¦can¦ ¦dr ive¦ ¦them¦ ¦to¦ ¦the¦ ¦test¦ ¦center¦ .
𐋇¦do¦ ¦not¦ ¦go¦ ¦to¦ ¦a¦ ¦ca r¦ ¦service¦ ¦test¦ ¦centre¦ ¦un less¦ ¦you¦ ¦are¦ ¦in¦ ¦a¦ ¦ca r¦ ¦with¦ ¦an¦ ¦appointment¦ ▁-▁ ¦you¦ ¦will¦ ¦not¦ ¦be¦ ¦tested¦ ¦u ne x p ect ed ly¦ .
𐋇¦stay¦ ¦in¦ ¦your¦ ¦ca r¦ ¦at¦ ¦all¦ ¦times¦ .
𐋇 ¦follow¦ ¦staff¦ ¦signs¦ ¦and¦ ¦in str uc tions¦ .
𐋇¦a¦ ¦healthcare¦ ¦work er¦ ¦will¦ ¦as k¦ ¦you¦ ¦to¦ ¦open¦ ¦your¦ ¦w i nd ow¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦giv en¦ ¦a¦ ¦mask¦ ¦to¦ ¦p ut¦ ¦on¦ ¦your¦ ¦face¦ ▁-▁ ¦cov ering¦ ¦your¦ ¦nose¦ ¦and¦ ¦mouth¦ .
𐋇¦they¦ ¦will¦ ¦direct¦ ¦you¦ ¦to¦ ¦a¦ ¦test¦ ¦b ay¦ ¦to¦ ¦take¦ ¦your¦ ¦test¦ ¦sampl e¦ ▁-▁ ¦stay¦ ¦in¦ ¦your¦ ¦ca r¦ .
𐋇 ¦one¦ ¦healthcare¦ ¦work er¦ ¦will¦ ¦take¦ ¦your¦ ¦personal¦ ¦data¦ ▁-▁ ¦these¦ ¦will¦ ¦be¦ ¦required¦ ¦so¦ ¦that¦ ¦we¦ ¦can¦ ¦s end¦ ¦you¦ ¦your¦ ¦results¦ .
𐋇 ¦another¦ ¦will¦ ¦take¦ ¦two¦ ¦sw ab s¦ ¦in side¦ ¦your¦ ¦mouth¦ ¦and¦ ¦nose¦ .
𐋇 ¦then¦ ¦you¦ ¦will¦ ¦have¦ ¦to¦ ¦dr ive¦ ¦home¦ ¦and¦ ¦stay¦ ¦al one¦ .
𐋇 ¦home¦ ¦testing¦
𐋇¦if¦ ¦you¦ ¦cannot¦ ¦att end¦ ¦a¦ ¦test¦ ¦centre¦ ,▁ ¦you¦ ¦can¦ ¦be¦ ¦tested¦ ¦at¦ ¦home¦ .
𐋇¦a¦ ¦healthcare¦ ¦work er¦ ¦will¦ ¦come¦ ¦to¦ ¦your¦ ¦home¦ ¦with¦ ¦test¦ ¦ki ts¦ .
𐋇¦they¦ ¦will¦ ¦use¦ ¦a¦ ¦sw ab ¦ ¦to¦ ¦take¦ ¦a¦ ¦sampl e¦ ¦in side¦ ¦your¦ ¦mouth¦ ¦and¦ ¦nose¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦as ked¦ ¦to¦ ¦provide¦ ¦them¦ ¦with¦ ¦some¦ ¦personal¦ ¦detail s¦ ▁-▁ ¦these¦ ¦will¦ ¦be¦ ¦required¦ ¦so¦ ¦that¦ ¦we¦ ¦can¦ ¦s end¦ ¦you¦ ¦your¦ ¦results¦ .
𐋇 ¦test¦ ¦results¦
𐋇¦you¦ ¦will¦ ¦receive¦ ¦your¦ ¦test¦ ¦results¦ ¦on¦ ¦te xt¦ ,▁ ¦but¦ ¦if¦ ¦you¦ ¦get¦ ¦a¦ ¦positive¦ ¦result¦ ,▁ ¦you¦ ¦will¦ ¦also¦ ¦be¦ ¦called¦ .
𐋇¦when¦ ¦you¦ ¦get¦ ¦your¦ ¦results¦
𐋇 ¦most¦ ¦people¦ ¦get¦ ¦test¦ ¦results¦ ¦within¦ ¦2¦ ¦days¦ ¦but¦ ¦s om et im es¦ ¦it¦ ¦ta k es¦ ¦lo nger¦ .
𐋇 ¦people¦ ¦who¦ ¦are¦ ¦s eri o us ly¦ ¦ ill¦ ¦in¦ ¦hospital¦ ¦will¦ ¦get¦ ¦their¦ ¦results¦ ¦first¦ .
𐋇¦do¦ ¦not¦ ¦call¦ ¦your¦ ¦gp¦ ¦to¦ ¦get¦ ¦the¦ ¦test¦ ¦results¦ .
𐋇¦it¦ ¦is¦ ¦important¦ ¦to¦ ¦keep¦ ¦the¦ ¦phone¦ ¦l ines¦ ¦fre e¦ ¦for¦ ¦people¦ ¦s ee king¦ ¦advice¦ ¦on¦ ¦symptoms¦ ¦of¦ ¦illness¦ .
𐋇¦if¦ ¦you¦ ¦d id¦ ¦the¦ ¦test¦ ¦because¦ ¦you¦ ¦had¦ ¦symptoms¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦not¦ ¦received¦ ¦your¦ ¦test¦ ¦results¦ ,▁ ¦you¦ ¦can¦ ¦sto p¦ ¦self¦ - ¦isolation¦ ¦if¦ ¦you¦ ¦me et¦ ¦both¦ ¦of¦ ¦these¦ ¦conditions¦ :
𐋇 ¦have¦ ¦you¦ ¦not¦ ¦had¦ ¦a¦ ¦fever¦ ▁( ¦3 8¦ ¦de g re es¦ ¦c el si us¦ ¦or¦ ¦a bo ve¦ )▁ ¦in¦ ¦the¦ ¦last¦ ¦5¦ ¦days¦
𐋇 ¦that¦ ¦10¦ ¦days¦ ¦have¦ ¦p as sed¦ ¦since¦ ¦the¦ ¦symptoms¦ ¦first¦ ¦ca me¦ ¦to¦ ¦you¦
𐋇¦if¦ ¦you¦ ¦t ook¦ ¦the¦ ¦test¦ ¦because¦ ¦you¦ ¦were¦ ¦a¦ ¦close¦ ¦contact¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦close¦ ¦contact¦ ¦and¦ ¦have¦ ¦no¦ ¦symptoms¦ ¦continue¦ ¦to¦ ¦restrict¦ ¦your¦ ¦movements¦ ▁( ¦stay¦ ¦at¦ ¦home¦ )▁ ¦for¦ ¦14¦ ¦days¦ .
𐋇¦do¦ ¦this¦ ¦from¦ ¦the¦ ¦last¦ ¦date¦ ¦you¦ ¦were¦ ¦in¦ ¦contact¦ ¦with¦ ¦the¦ ¦person¦ ¦who¦ ¦tested¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦u ns ure¦ ¦of¦ ¦the¦ ¦date¦ ,▁ ¦restrict¦ ¦your¦ ¦movements¦ ¦to¦ ¦the¦ ¦date¦ ¦the¦ ¦contact¦ ¦tracking¦ ¦team¦ ¦to ld¦ ¦you¦ ¦to¦ ¦do¦ ¦so¦ .
𐋇¦you¦ ¦can¦ ¦sto p¦ ¦re stric ting¦ ¦your¦ ¦movements¦ ¦when¦ ¦both¦ ¦of¦ ¦these¦ ¦conditions¦ ¦app ly¦ :
𐋇¦you¦ ¦tested¦ ¦negative¦ ¦for¦ ¦your¦ ¦test¦ ▁( ¦covid¦ - ¦19¦ ¦was¦ ¦not¦ ¦detected¦ )▁ ¦10¦ ¦days¦ ¦after¦ ¦you¦ ¦last¦ ¦contac ted¦ ¦the¦ ¦person¦ ¦who¦ ¦tested¦ ¦positive¦ .
𐋇¦you¦ ¦do¦ ¦not¦ ¦have¦ ¦covid¦ - ¦19¦ ¦symptoms¦
𐋇 ¦li ving¦ ¦with¦ ¦a¦ ¦close¦ ¦contact¦
𐋇¦if¦ ¦you¦ ¦live¦ ¦with¦ ¦a¦ ¦close¦ ¦contact¦ ,▁ ¦you¦ ¦do¦ ¦not¦ ¦have¦ ¦to¦ ¦restrict¦ ¦your¦ ¦movements¦ ¦while¦ ¦wai ting¦ ¦for¦ ¦their¦ ¦test¦ ¦or¦ ¦test¦ ¦results¦ .
𐋇 ¦pregn a ncy¦ ¦and¦ ¦covid¦ - ¦19¦
𐋇¦we¦ ¦are¦ ¦still¦ ¦learning¦ ¦about¦ ¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ ).
𐋇¦we¦ ¦d on¦ ▁’▁ ¦t¦ ¦re ally¦ ¦under st and¦ ¦how¦ ¦it¦ ¦h ur ts¦ ¦pre gnant¦ ¦women¦ ¦and¦ ¦their¦ ¦bab ies¦ .
𐋇 ¦our¦ ¦k n ow l ed ge¦ ¦to¦ ¦date¦ ¦indic ates¦ ¦that¦ ¦pre gnant¦ ¦women¦ ¦are¦ ¦not¦ ¦at¦ ¦risk¦ ¦if¦ ¦they¦ ¦receive¦ ¦covid¦ - ¦19¦ .
𐋇 ¦our¦ ¦k n ow l ed ge¦ ¦to¦ ¦date¦ ¦sh ow s¦ ¦that¦ ¦the¦ ¦risk¦ ¦of¦ ¦getting¦ ¦the¦ ¦virus¦ ¦during¦ ¦pregn a ncy¦ ¦is¦ ¦no¦ ¦g rea ter¦ ¦than¦ ¦for¦ ¦women¦ ¦of¦ ¦the¦ ¦same¦ ¦age¦ ¦who¦ ¦are¦ ¦not¦ ¦pre gnant¦ .
𐋇 ¦contact¦ ¦your¦ ¦local¦ ¦hospital¦ ¦if¦ ¦you¦ ¦are¦ ¦wor r ied¦ ¦that¦ ¦your¦ ¦baby¦ ¦is¦ ¦not¦ ¦mo ving¦ ¦as¦ ¦much¦ ¦as¦ ¦us ual¦ ¦or¦ ¦if¦ ¦you¦ ¦are¦ ¦wor r ied¦ ¦about¦ ¦their¦ ¦well¦ - ¦being¦ .
𐋇¦the¦ ¦hospital¦ ¦will¦ ¦per for m¦ ¦tests¦ ¦to¦ ¦conf ir m¦ ¦that¦ ¦your¦ ¦baby¦ ¦is¦ ¦o k¦ .
𐋇 ¦prot ecting¦ ¦yourself¦ ¦and¦ ¦your¦ ¦baby¦
𐋇¦to¦ ¦protect¦ ¦yourself¦ ¦and¦ ¦your¦ ¦baby¦ ,▁ ¦you¦ ¦should¦ ¦ca re f ul ly¦ ¦follow¦ ¦the¦ ¦advice¦ ¦b el ow¦ :
𐋇 ¦wash¦ ¦hands¦ ¦properly¦
𐋇 ¦social¦ ¦separ ation¦
𐋇¦stay¦ ¦at¦ ¦home¦
𐋇 ¦call¦ ¦your¦ ¦gp¦ ¦for¦ ¦advice¦ ¦if¦ ¦you¦ ¦have¦ ¦any¦ ¦of¦ ¦the¦ ¦symptoms¦ ¦of¦ ¦the¦ ¦coronavirus¦ .
𐋇¦if¦ ¦you¦ ¦get¦ ¦covid¦ - ¦19¦
𐋇¦if¦ ¦you¦ ¦test¦ ¦positive¦ ¦for¦ ¦covid¦ - ¦19¦ ,▁ ¦contact¦ ¦your¦ ¦m at er n ity¦ ¦uni t¦ ¦or¦ ¦hospital¦ .
𐋇¦the¦ ¦hospital¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦monit or¦ ¦your¦ ¦pregn a ncy¦ ¦if¦ ¦you¦ ¦get¦ ¦the¦ ¦virus¦ ¦properly¦ .
𐋇 ¦pre gnant¦ ¦women¦ ¦us ually¦ ¦have¦ ¦mild¦ ¦symptoms¦ ¦when¦ ¦they¦ ¦receive¦ ¦covid¦ - ¦19¦ .
𐋇¦they¦ ¦have¦ ¦a¦ ¦normal¦ ¦b ir th¦ ¦and¦ ¦are¦ ¦at¦ ¦low¦ ¦risk¦ ¦of¦ ¦giv ing¦ ¦their¦ ¦in fa nts¦ ¦covid¦ - ¦19¦ .
𐋇 ¦contact¦ ¦your¦ ¦local¦ ¦hospital¦ ¦if¦ ¦you¦ ¦are¦ ¦wor r ied¦ ¦that¦ ¦your¦ ¦baby¦ ¦is¦ ¦not¦ ¦mo ving¦ ¦as¦ ¦much¦ ¦as¦ ¦us ual¦ ¦or¦ ¦if¦ ¦you¦ ¦are¦ ¦wor r ied¦ ¦about¦ ¦their¦ ¦well¦ - ¦being¦ .
𐋇¦the¦ ¦hospital¦ ¦will¦ ¦per for m¦ ¦tests¦ ¦to¦ ¦conf ir m¦ ¦that¦ ¦your¦ ¦baby¦ ¦is¦ ¦o k¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦covid¦ - ¦19¦ ¦symptoms¦ ,▁ ¦you¦ ¦will¦ ¦most¦ ¦likely¦ ¦need¦ ¦to¦ ¦go¦ ¦into¦ ¦hospital¦ ¦and¦ ¦the¦ ¦in tens ive¦ ¦care¦ ¦uni t¦ .
𐋇¦you¦ ¦may¦ ¦be¦ ¦at¦ ¦g rea ter¦ ¦risk¦ ¦of¦ ¦bec om ing¦ ¦pre m at ur ely¦ ¦or¦ ¦having¦ ¦a¦ ¦s ti ll b ir th¦ ,▁ ¦if¦ ¦you¦ ¦have¦ ¦symptoms¦ ¦than¦ ¦if¦ ¦you¦ ¦have¦ ¦no¦ ¦symptoms¦ .
𐋇¦covid¦ ¦pl ai nt itis¦ ¦and¦ ¦s ti ll b ir th¦
𐋇¦there¦ ¦is¦ ¦a¦ ¦l ink¦ ¦between¦ ¦a¦ ¦t in y¦ ¦number¦ ¦of¦ ¦s ti ll b ir ths¦ ¦and¦ ¦an¦ ¦illness¦ ¦known¦ ¦as¦ ¦covid¦ ¦pla st ic itis¦ .
𐋇¦covid¦ ¦pla st ic itis¦ ¦occur s¦ ¦when¦ ¦the¦ ¦pla q ue¦ ¦is¦ ¦infected¦ ¦with¦ ¦covid¦ - ¦19¦ .
𐋇¦this¦ ¦inter f er es¦ ¦with¦ ¦the¦ ¦pla ce nt a¦ ' ¦s¦ ¦a bility¦ ¦to¦ ¦give¦ ¦the¦ ¦baby¦ ¦o x yg en¦ ¦and¦ ¦n ut ri ents¦ .
𐋇¦s ti ll b ir th¦ ¦is¦ ¦mo st ly¦ ¦l in ked¦ ¦to¦ ¦covid¦ ¦pla qu e p o x¦ ¦when¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦r ates¦ ¦are¦ ¦very¦ ¦high¦ .
𐋇¦as¦ ¦the¦ ¦covid¦ - ¦19¦ ¦infection¦ ¦rate¦ ¦fa lls¦ ,▁ ¦this¦ ¦will¦ ¦not¦ ¦be¦ ¦a¦ ¦concer n¦ .
𐋇 ¦contact¦ ¦your¦ ¦m at er n ity¦ ¦uni t¦ ¦or¦ ¦hospital¦ ¦imm ed ia tely¦ ¦if¦ ¦you¦ ¦n ot ice¦ ¦that¦ ¦your¦ ¦baby¦ ¦is¦ ¦not¦ ¦mo ving¦ ¦n orm ally¦ .
𐋇¦a¦ ¦high¦ ¦fever¦ ¦during¦ ¦pregn a ncy¦
𐋇 ¦symptoms¦ ¦of¦ ¦coronavirus¦ ¦include¦ ¦fever¦ ▁( ¦high¦ ¦temp erat ure¦ ).
𐋇¦this¦ ¦may¦ ¦cre ate¦ ¦diffic ult ies¦ ¦for¦ ¦you¦ ¦during¦ ¦the¦ ¦first¦ ¦tr im es ter¦ ▁( ¦weeks¦ ¦ 0¦ ¦to¦ ¦13¦ ).
𐋇¦if¦ ¦you¦ ¦exp eri ence¦ ¦a¦ ¦high¦ ¦temp erat ure¦ ¦during¦ ¦your¦ ¦pregn a ncy¦ ,▁ ¦call¦ ¦your¦ ¦gp¦ ¦or¦ ¦m id w ife¦ .
𐋇¦when¦ ¦you¦ ¦bec ome¦ ¦pre gnant¦ ,▁ ¦your¦ ¦body¦ ' ¦s¦ ¦immune¦ ¦system¦ ¦g rad ually¦ ¦chan ges¦ .
𐋇¦this¦ ¦happ ens¦ ¦in¦ ¦order¦ ¦for¦ ¦your¦ ¦pregn a ncy¦ ¦to¦ ¦have¦ ¦a¦ ¦s uc cess ful¦ ¦out c ome¦ .
𐋇¦you¦ ¦could¦ ¦get¦ ¦more¦ ¦infections¦ ¦more¦ ¦qu ick ly¦ ¦because¦ ¦you¦ ¦are¦ ¦pre gnant¦ .
𐋇 ¦all¦ ¦pre gnant¦ ¦women¦ ¦should¦ ¦get¦ ¦the¦ ¦following¦ ¦vaccines¦ :
𐋇¦w ho op ing¦ ¦cough¦ ¦vaccine¦
𐋇 ¦flu¦ ¦vaccine¦
𐋇¦covid¦ - ¦19¦ ¦vaccine¦ ▁-▁ ¦when¦ ¦you¦ ¦get¦ ¦the¦ ¦off er¦
𐋇 ¦before¦ ¦your¦ ¦child¦ ¦is¦ ¦ bor n¦
𐋇¦the¦ ¦staff¦ ¦car ing¦ ¦for¦ ¦you¦ ¦should¦ ¦make¦ ¦sure¦ ¦that¦ ¦you¦ ¦are¦ ¦invol v ed¦ ¦in¦ ¦all¦ ¦dec i si ons¦ ¦that¦ ¦are¦ ¦made¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦wor r ied¦ ¦about¦ ¦your¦ ¦pregn a ncy¦ ,▁ ¦call¦ ¦your¦ ¦hospital¦ ¦for¦ ¦advice¦ .
𐋇¦m at er n ity¦ ¦hosp it als¦ ¦have¦ ¦h el pl ines¦ ¦open¦ ¦to¦ ¦ad v ise¦ ¦you¦ ¦at¦ ¦any¦ ¦time¦ .
𐋇 ¦that¦ ¦said¦ ,▁ ¦you¦ ¦should¦ ¦go¦ ¦to¦ ¦the¦ ¦hospital¦ ¦if¦ ¦you¦ ¦have¦ ¦any¦ ¦concer ns¦ ¦about¦ ¦the¦ ¦mo ve ment¦ ¦of¦ ¦your¦ ¦un bor n¦ ¦baby¦ .
𐋇 ¦more¦ ¦information¦ ¦on¦ :▁ 𐋇¦m y c hi ld¦ . ¦i e¦
𐋇 ¦app oi nt ments¦ ¦and¦ ¦sc an ning¦
𐋇 ¦a nt en at al¦ ¦care¦ ¦contin ues¦ ¦to¦ ¦be¦ ¦provid ed¦ ¦in¦ ¦hosp it als¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦rece i ving¦ ¦care¦ ¦in¦ ¦the¦ ¦hospital¦ ¦and¦ ¦from¦ ¦your¦ ¦gp¦ ,▁ ¦continue¦ ¦with¦ ¦this¦ .
𐋇¦a¦ ¦number¦ ¦of¦ ¦app oi nt ments¦ ¦are¦ ¦made¦ ¦over¦ ¦the¦ ¦phone¦ ,▁ ¦fo ll owed¦ ¦by¦ ¦a¦ ¦sh ort¦ ¦hospital¦ ¦visit¦ .
𐋇¦you¦ ¦will¦ ¦need¦ ¦to¦ ¦go¦ ¦to¦ ¦the¦ ¦hospital¦ ¦for¦ ¦ex a min ations¦ ,▁ ¦a¦ ¦blood¦ ¦test¦ ¦and¦ ¦an¦ ¦ ult r as o un d¦ ¦sc an¦ .
𐋇¦you¦ ¦should¦ ¦go¦ ¦it¦ ¦al one¦ ¦to¦ ¦reduce¦ ¦the¦ ¦number¦ ¦of¦ ¦people¦ ¦in¦ ¦the¦ ¦hospital¦ .
𐋇¦f et al¦ ¦an at om y¦ ¦sc an¦ ▁-▁ ¦sc an ned¦ ¦at¦ ¦20¦ ¦weeks¦
𐋇¦the¦ ¦f et al¦ ¦an at om ical¦ ¦sc an¦ ¦is¦ ¦us ually¦ ¦per for med¦ ¦between¦ ¦18¦ ¦and¦ ¦2 2¦ ¦weeks¦ ¦of¦ ¦pregn a ncy¦ .
𐋇¦it¦ ¦is¦ ¦also¦ ¦called¦ ¦an¦ ¦a no ma ly¦ ¦sc an¦ .
𐋇¦a¦ ¦b ir th¦ ¦part n er¦ ¦is¦ ¦us ually¦ ¦able¦ ¦to¦ ¦att end¦ ¦the¦ ¦f et al¦ ¦an at om y¦ ¦sc an¦ ¦with¦ ¦you¦ .
𐋇¦this¦ ¦will¦ ¦dep end¦ ¦on¦ ¦the¦ ¦hospital¦ ¦and¦ ¦current¦ ¦government¦ ¦restrictions¦ .
𐋇¦a¦ ¦pri or¦ ¦ch eck¦ ¦with¦ ¦the¦ ¦hospital¦ ¦is¦ ¦required¦ .
𐋇¦if¦ ¦your¦ ¦b ir th¦ ¦part n er¦ ¦is¦ ¦un able¦ ¦to¦ ¦att end¦ ,▁ ¦you¦ ¦will¦ ¦be¦ ¦exp la ined¦ ¦wh y¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦a¦ ¦corona ry¦ ¦virus¦ ¦before¦ ¦your¦ ¦baby¦ ¦is¦ ¦ bor n¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦a¦ ¦corona ry¦ ¦virus¦ ,▁ ¦your¦ ¦healthcare¦ ¦team¦ ¦will¦ ¦be¦ ¦much¦ ¦more¦ ¦ca re ful¦ .
𐋇¦this¦ ¦will¦ ¦continue¦ ¦before¦ ,▁ ¦during¦ ¦and¦ ¦after¦ ¦the¦ ¦b ir th¦ ¦of¦ ¦your¦ ¦baby¦ .
𐋇¦your¦ ¦ob st et r ici an¦ ¦or¦ ¦m id w ife¦ ¦will¦ ¦t alk¦ ¦to¦ ¦you¦ ¦about¦ ¦the¦ ¦sa f est¦ ¦way¦ ¦and¦ ¦time¦ ¦to¦ ¦give¦ ¦b ir th¦ .
𐋇 ¦other¦ ¦do ctors¦ ¦with¦ ¦exp e rt ise¦ ¦may¦ ¦be¦ ¦invol v ed¦ ¦in¦ ¦your¦ ¦care¦ .
𐋇¦this¦ ¦could¦ ¦be¦ ¦a¦ ¦doctor¦ ¦de al ing¦ ¦with¦ ¦infectious¦ ¦diseases¦ ¦and¦ ¦a¦ ¦ne on at al¦ ¦doctor¦ ▁-▁ ¦that¦ ¦is¦ ,▁ ¦a¦ ¦doctor¦ ¦who¦ ¦de als¦ ¦with¦ ¦new bor n¦ ¦bab ies¦ .
𐋇¦you¦ ¦may¦ ¦be¦ ¦c ared¦ ¦for¦ ¦in¦ ¦an¦ ¦isolation¦ ¦ro om¦ ¦with¦ ¦an¦ ¦ en¦ - ¦su ite¦ ¦during¦ ¦your¦ ¦l ab ou r¦ .
𐋇¦you¦ ¦may¦ ¦have¦ ¦to¦ ¦stay¦ ¦in¦ ¦this¦ ¦ro om¦ ¦while¦ ¦you¦ ¦are¦ ¦in¦ ¦hospital¦ .
𐋇 ¦during¦ ¦the¦ ¦b ir th¦ ¦of¦ ¦your¦ ¦baby¦ ¦and¦ ¦the¦ ¦ch ild b ir th¦
𐋇¦in¦ ¦most¦ ¦cases¦ ,▁ ¦your¦ ¦part n er¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦be¦ ¦pres ent¦ ¦during¦ ¦the¦ ¦b ir th¦ ¦of¦ ¦your¦ ¦child¦ .
𐋇 ¦every¦ ¦eff ort¦ ¦will¦ ¦be¦ ¦made¦ ¦to¦ ¦e ns ure¦ ¦that¦ ¦your¦ ¦part n er¦ ¦is¦ ¦pres ent¦ ¦at¦ ¦the¦ ¦b ir th¦ ,▁ ¦but¦ ¦in¦ ¦some¦ ¦hosp it als¦ ,▁ ¦your¦ ¦part n er¦ ¦may¦ ¦not¦ ¦be¦ ¦able¦ ¦to¦ ¦att end¦ .
𐋇¦there¦ ¦are¦ ¦restrictions¦ ¦to¦ ¦keep¦ ¦e veryone¦ ¦safe¦ .
𐋇¦if¦ ¦your¦ ¦part n er¦ ¦can¦ ¦be¦ ¦with¦ ¦you¦ ,▁ ¦they¦ ¦will¦ ¦need¦ ¦to¦ ¦wear¦ ¦personal¦ ¦prot ective¦ ¦c lo thing¦ ¦to¦ ¦reduce¦ ¦the¦ ¦risk¦ ¦of¦ ¦infection¦ .
𐋇¦you¦ ¦will¦ ¦not¦ ¦need¦ ¦to¦ ¦wear¦ ¦a¦ ¦face¦ ¦mask¦ ¦during¦ ¦ch ild b ir th¦ ¦and¦ ¦b ir th¦ .
𐋇¦but¦ ,▁ ¦you¦ ¦will¦ ¦need¦ ¦to¦ ¦wear¦ ¦a¦ ¦mask¦ ¦when¦ ¦you¦ ¦are¦ ¦outside¦ ¦your¦ ¦ro om¦ .
𐋇 ¦after¦ ¦the¦ ¦b ir th¦ ¦of¦ ¦your¦ ¦child¦
𐋇 ¦visi t ors¦ ¦to¦ ¦the¦ ¦hospital¦
𐋇 ¦no¦ ¦visi t or¦ ¦is¦ ¦all owed¦ ¦in¦ ¦any¦ ¦m at er n ity¦ ¦uni t¦ .
𐋇¦these¦ ¦restrictions¦ ¦are¦ ¦in¦ ¦the¦ ¦inter e sts¦ ¦of¦ ¦your¦ ¦safety¦ ¦and¦ ¦the¦ ¦safety¦ ¦of¦ ¦your¦ ¦child¦ .
𐋇¦these¦ ¦restrictions¦ ¦will¦ ¦be¦ ¦l if ted¦ ¦as¦ ¦so on¦ ¦as¦ ¦possible¦ .
𐋇 ¦go ing¦ ¦home¦ ¦early¦
𐋇 ¦many¦ ¦women¦ ¦c ho ose¦ ¦to¦ ¦go¦ ¦home¦ ¦early¦ ¦because¦ ¦of¦ ¦the¦ ¦restrictions¦ ¦on¦ ¦hospital¦ ¦visi t ors¦ .
𐋇 ¦phone¦ ¦support¦ ¦from¦ ¦po st pa rt um¦ ¦m id w ives¦ ¦is¦ ¦available¦ ¦from¦ ¦some¦ ¦hosp it als¦ .
𐋇 ¦community¦ ¦m id w ives¦ ¦will¦ ¦be¦ ¦ma king¦ ¦home¦ ¦visi ts¦ ¦w he re ver¦ ¦this¦ ¦is¦ ¦available¦ .
𐋇 ¦ne on at al¦ ¦care¦ ¦in¦ ¦the¦ ¦ne on at al¦ ¦in tens ive¦ ¦care¦ ¦uni t¦
𐋇¦in¦ ¦most¦ ¦ne on at al¦ ¦in tens ive¦ ¦care¦ ¦uni ts¦ ▁( ¦n ic us¦ ),▁ ¦only¦ ¦a¦ ¦15¦ - ¦min ute¦ ¦visit¦ ¦is¦ ¦n ow¦ ¦all owed¦ .
𐋇¦this¦ ¦is¦ ¦being¦ ¦d one¦ ¦to¦ ¦protect¦ ¦v ul n er able¦ ¦in fa nts¦ .
𐋇¦these¦ ¦restrictions¦ ¦will¦ ¦be¦ ¦l if ted¦ ¦when¦ ¦it¦ ¦is¦ ¦safe¦ ¦to¦ ¦do¦ ¦so¦ .
𐋇¦some¦ ¦uni ts¦ ¦have¦ ¦the¦ ¦techn ology¦ ¦to¦ ¦en able¦ ¦par ents¦ ¦to¦ ¦have¦ ¦contact¦ ¦with¦ ¦their¦ ¦in fa nts¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦a¦ ¦corona ry¦ ¦virus¦ ¦after¦ ¦the¦ ¦b ir th¦ ¦of¦ ¦your¦ ¦baby¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦covid¦ - ¦19¦ ,▁ ¦your¦ ¦doctor¦ ¦or¦ ¦m id w ife¦ ¦will¦ ¦disc us s¦ ¦your¦ ¦op tions¦ ¦after¦ ¦giv ing¦ ¦b ir th¦ .
𐋇 ¦one¦ ¦o ption¦ ¦is¦ ¦for¦ ¦someone¦ ¦el se¦ ¦to¦ ¦take¦ ¦care¦ ¦of¦ ¦your¦ ¦baby¦ ¦until¦ ¦the¦ ¦covid¦ - ¦19¦ ¦is¦ ¦g one¦ .
𐋇¦this¦ ¦is¦ ¦recommended¦ ¦to¦ ¦protect¦ ¦your¦ ¦baby¦ ¦from¦ ¦covid¦ - ¦19¦ .
𐋇¦this¦ ¦care¦ ¦could¦ ¦be¦ ¦provid ed¦ ¦by¦ ¦a¦ ¦family¦ ¦me mber¦ ¦or¦ ¦healthcare¦ ¦work er¦ .
𐋇¦this¦ ¦could¦ ¦be¦ ¦provid ed¦ ¦at¦ ¦home¦ ¦or¦ ¦in¦ ¦hospital¦ .
𐋇¦it¦ ¦is¦ ¦not¦ ¦known¦ ¦how¦ ¦long¦ ¦this¦ ¦will¦ ¦last¦ .
𐋇¦the¦ ¦advice¦ ¦will¦ ¦dep end¦ ¦on¦ ¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦and¦ ¦the¦ ¦results¦ ¦of¦ ¦the¦ ¦test¦ ¦you¦ ¦will¦ ¦have¦ .
𐋇 ¦ta king¦ ¦care¦ ¦of¦ ¦your¦ ¦baby¦ ¦if¦ ¦you¦ ¦have¦ ¦covid¦ - ¦19¦
𐋇¦if¦ ¦you¦ ¦c ho ose¦ ¦to¦ ¦take¦ ¦care¦ ¦of¦ ¦your¦ ¦baby¦ ,▁ ¦the¦ ¦doctor¦ ¦or¦ ¦m id w ife¦ ¦will¦ ¦exp la in¦ ¦the¦ ¦da nger¦ ¦to¦ ¦you¦ .
𐋇¦you¦ ¦and¦ ¦your¦ ¦baby¦ ¦will¦ ¦be¦ ¦pl ac ed¦ ¦in¦ ¦an¦ ¦isolation¦ ¦ro om¦ ¦with¦ ¦an¦ ¦ en¦ - ¦su ite¦ ¦ba th ro om¦ .
𐋇¦your¦ ¦baby¦ ¦will¦ ¦be¦ ¦in side¦ ¦an¦ ¦inc ub at or¦ ¦in¦ ¦your¦ ¦ro om¦ .
𐋇¦this¦ ¦is¦ ¦a¦ ¦uni q ue¦ ¦c rad le¦ ¦made¦ ¦of¦ ¦pla st ic¦ .
𐋇¦it¦ ¦k ee ps¦ ¦the¦ ¦l ov ely¦ ¦inf ant¦ ¦w ar m¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦se e¦ ¦your¦ ¦baby¦ ¦in side¦ ¦the¦ ¦inc ub at or¦ .
𐋇¦when¦ ¦you¦ ¦take¦ ¦your¦ ¦baby¦ ¦out¦ ¦of¦ ¦the¦ ¦inc ub at or¦ ¦to¦ ¦be¦ ¦f ed¦ ,▁ ¦w as h ed¦ ,▁ ¦or¦ ¦o ther w ise¦ ¦c ared¦ ¦for¦ ,▁ ¦you¦ ¦must¦ :
𐋇 ¦dr ess¦ ¦with¦ ¦long¦ ¦sl ee ves¦ ¦and¦ ¦wear¦ ¦a¦ ¦sur g ical¦ ¦mask¦
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦properly¦ ¦and¦ ¦often¦ ¦with¦ ¦so a p¦ ¦and¦ ¦water¦ ¦or¦ ¦r ub b ing¦ ¦al c o ho l¦ ▁-▁ ¦before¦ ¦and¦ ¦after¦ ¦hand l ing¦ ¦your¦ ¦baby¦
𐋇¦your¦ ¦child¦ ¦should¦ ¦be¦ ¦monit or ed¦ ¦for¦ ¦signs¦ ¦of¦ ¦infection¦ .
𐋇¦this¦ ¦will¦ ¦continue¦ ¦for¦ ¦14¦ ¦days¦ ¦from¦ ¦the¦ ¦last¦ ¦time¦ ¦you¦ ¦had¦ ¦contact¦ ¦with¦ ¦your¦ ¦baby¦ .
𐋇¦if¦ ¦your¦ ¦child¦ ¦sh ow s¦ ¦any¦ ¦signs¦ ¦of¦ ¦infection¦ ,▁ ¦they¦ ¦will¦ ¦need¦ ¦to¦ ¦be¦ ¦tested¦ .
𐋇 ¦me ntal¦ ¦health¦
𐋇 ¦per in at al¦ ¦me ntal¦ ¦health¦ ¦services¦ ¦are¦ ¦available¦ ¦for¦ ¦women¦ ¦with¦ ¦me ntal¦ ¦health¦ ¦prob le ms¦ ¦and¦ :
𐋇 ¦pl an ning¦ ¦a¦ ¦pregn a ncy¦
𐋇 ¦who¦ ¦is¦ ¦pre gnant¦
𐋇 ¦having¦ ¦a¦ ¦child¦ ¦under¦ ¦one¦ ¦year¦ ¦of¦ ¦age¦
𐋇 ¦signs¦ ¦of¦ ¦the¦ ¦cr own¦ ¦virus¦
𐋇 ¦restrictions¦ ¦remain¦ ¦in¦ ¦place¦ ¦to¦ ¦protect¦ ¦us¦ ¦from¦ ¦covid¦ - ¦19¦ .
𐋇¦read¦ ¦about¦ ¦current¦ ¦government¦ ¦restrictions¦ ¦on¦ ¦g ov ¦ . ¦i e¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦any¦ ¦signs¦ ¦of¦ ¦covid¦ - ¦19¦ ▁( ¦coronavirus¦ )▁ ¦you¦ ¦should¦ ¦stay¦ ¦al one¦ ¦and¦ ¦call¦ ¦your¦ ¦gp¦ ¦imm ed ia tely¦ .
𐋇¦your¦ ¦doctor¦ ¦will¦ ¦t ell¦ ¦you¦ ¦if¦ ¦a¦ ¦covid¦ ▁ - ¦19¦ ¦test¦ ¦needs¦ ¦to¦ ¦be¦ ¦fi x ed¦ .
𐋇¦read¦ ¦about¦ ¦how¦ ¦to¦ ¦s et¦ ¦up¦ ¦a¦ ¦test¦ .
𐋇¦the¦ ¦others¦ ¦in¦ ¦the¦ ¦house¦ ¦will¦ ¦have¦ ¦to¦ ¦restrict¦ ¦their¦ ¦movements¦ ▁( ¦stay¦ ¦at¦ ¦home¦ ).
𐋇 ¦common¦ ¦signs¦
𐋇¦the¦ ¦most¦ ¦common¦ ¦symptoms¦ ¦of¦ ¦coronavirus¦ ¦are¦ :
𐋇 ¦fever¦ ▁( ¦high¦ ¦temp erat ure¦ ¦3 8¦ ¦de g re es¦ ¦c el si us¦ ¦or¦ ¦more¦ )
𐋇 ¦cough¦ ▁-▁ ¦any¦ ¦k ind¦ ¦of¦ ¦cough¦ ,▁ ¦it¦ ¦does¦ ¦not¦ ¦have¦ ¦to¦ ¦be¦ ¦d ry¦
𐋇 ¦sh ort ness¦ ¦of¦ ¦brea th¦ ¦or¦ ¦diffic ult y¦ ¦brea thing¦
𐋇 ¦th ings¦ ¦are¦ ¦not¦ ¦the¦ ¦same¦ ¦ta st e¦ ¦or¦ ¦sm ell¦ ▁–▁ ¦this¦ ¦me ans¦ ¦that¦ ¦you¦ ¦have¦ ¦n ot ic ed¦ ¦that¦ ¦you¦ ¦are¦ ¦not¦ ¦getting¦ ¦the¦ ¦sm ell¦ ¦or¦ ¦ta st e¦ ¦of¦ ¦an y thing¦ ¦or¦ ¦that¦ ¦you¦ ¦are¦ ¦not¦ ¦getting¦ ¦a¦ ¦normal¦ ¦sm ell¦ ¦or¦ ¦ta st e¦
𐋇¦you¦ ¦may¦ ¦have¦ ¦no¦ ¦symptoms¦ ¦for¦ ¦14¦ ¦days¦ .
𐋇¦the¦ ¦symptoms¦ ¦are¦ ¦very¦ ¦similar¦ ¦to¦ ¦those¦ ¦of¦ ¦a¦ ¦cold¦ ¦or¦ ¦flu¦ .
𐋇¦if¦ ¦your¦ ¦gp¦ ¦det ects¦ ¦the¦ ¦virus¦ ¦in¦ ¦time¦ ,▁ ¦you¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦take¦ ¦ste ps¦ ¦to¦ ¦control¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇 ¦call¦ ¦the¦ ¦emergency¦ ¦services¦ ¦at¦ ¦1 1 2¦ ¦or¦ ¦9 9 9¦ ¦if¦ ¦you¦ ¦have¦ ¦sh ort ness¦ ¦of¦ ¦brea th¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦if¦ ¦your¦ ¦brea th¦ ¦is¦ ¦so¦ ¦b ad¦ ,▁ ¦you¦ ¦can¦ ' ¦t¦ ¦f in ish¦ ¦a¦ ¦se nt ence¦ .
𐋇¦m ea d ow¦ ¦fever¦
𐋇¦m ea d ow¦ ¦fever¦ ¦is¦ ¦an¦ ¦all er g ic¦ ¦rea ction¦ ¦caused¦ ¦by¦ ¦po ll en¦ ¦c om ing¦ ¦into¦ ¦contact¦ ¦with¦ ¦your¦ ¦mouth¦ ,▁ ¦nose¦ ,▁ ¦ey es¦ ¦and¦ ¦th ro at¦ .
𐋇 ¦po ll en¦ ¦is¦ ¦a¦ ¦del ic ate¦ ¦pl ant¦ ¦p ow der¦ .
𐋇¦m ea d ow¦ ¦fever¦ ¦wor s ens¦ ¦between¦ ¦march¦ ¦and¦ ¦se p te mber¦ ,▁ ¦and¦ ¦especially¦ ¦when¦ ¦it¦ ¦is¦ ¦h ot¦ ,▁ ¦h um id¦ ¦and¦ ¦w in dy¦ .
𐋇¦this¦ ¦r ange¦ ¦has¦ ¦the¦ ¦high est¦ ¦po ll en¦ ¦co un t¦ .
𐋇 ¦symptoms¦ ¦of¦ ¦m ea d ow¦ ¦fever¦
𐋇 ¦symptoms¦ ¦of¦ ¦fever¦ ¦include¦ :
𐋇 ¦sneezing¦ ¦and¦ ¦cou g hing¦
𐋇¦s mo k y¦ ¦or¦ ¦st u ff y¦ ¦nose¦
𐋇¦ it ch y¦ ¦ey es¦ ,▁ ¦r ed¦ ¦or¦ ¦w a te ry¦
𐋇¦ it ch y¦ ¦th ro at¦ ,▁ ¦mouth¦ ,▁ ¦nose¦ ¦and¦ ¦ ear s¦
𐋇 ¦not¦ ¦to¦ ¦sm ell¦ ¦o d h ar h ra th¦
𐋇 ¦pain¦ ¦around¦ ¦your¦ ¦fo re h ead¦ ¦and¦ ¦fo re h ead¦ ▁( ¦fo re h ead¦ )
𐋇¦h ea d a ch e¦
𐋇¦ ear¦ ¦pain¦
𐋇¦t ir ed ness¦
𐋇 ¦as th m a¦ ¦and¦ ¦h ay¦ ¦fever¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦as th m a¦ ,▁ ¦you¦ ¦may¦ ¦have¦ :
𐋇¦ tens ion¦ ¦in¦ ¦the¦ ¦chest¦ ¦on¦ ¦you¦
𐋇 ¦sh ort ness¦ ¦of¦ ¦brea th¦
𐋇 ¦cough¦ ¦and¦ ¦cough¦
𐋇¦h ay¦ ¦fever¦ ¦can¦ ¦last¦ ¦for¦ ¦weeks¦ ¦and¦ ¦mon ths¦ .
𐋇¦a¦ ¦cold¦ ¦dis a pp ear s¦ ¦after¦ ¦1¦ ¦to¦ ¦2¦ ¦weeks¦ .
𐋇 ¦treatment¦ ¦for¦ ¦m ea d ow¦ ¦fever¦
𐋇¦there¦ ¦is¦ ¦cur re ntly¦ ¦no¦ ¦c ure¦ ¦for¦ ¦h ay¦ ¦fever¦ ,▁ ¦and¦ ¦you¦ ¦cannot¦ ¦avoid¦ ¦it¦ .
𐋇 ¦v ar ious¦ ¦th ings¦ ¦can¦ ¦be¦ ¦d one¦ ¦to¦ ¦ta me¦ ¦the¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦during¦ ¦a¦ ¦period¦ ¦of¦ ¦high¦ ¦po ll en¦ ¦co un t¦ .
𐋇¦to¦ ¦ta me¦ ¦the¦ ¦symptoms¦ ¦of¦ ¦h ay¦ ¦fever¦ :
𐋇 ¦v a se line¦ ¦around¦ ¦your¦ ¦p or es¦ ¦to¦ ¦c at ch¦ ¦the¦ ¦po ll en¦
𐋇 ¦wear¦ ¦w ra pp ed¦ ¦su ng l as ses¦ ¦to¦ ¦protect¦ ¦the¦ ¦ey es¦ ¦from¦ ¦po ll en¦
𐋇 ¦have¦ ¦a¦ ¦sh ower¦ ¦after¦ ¦being¦ ¦out d o ors¦ ,▁ ¦and¦ ¦ch ange¦ ¦your¦ ¦c lo th es¦ ¦to¦ ¦get¦ ¦r id¦ ¦of¦ ¦po ll en¦
𐋇¦stay¦ ¦in side¦ ¦if¦ ¦possible¦
𐋇 ¦keep¦ ¦w i nd ow s¦ ¦and¦ ¦do ors¦ ¦closed¦ ¦if¦ ¦possible¦
𐋇 ¦v ac u um¦ ¦clean¦ ¦fre qu e ntly¦
𐋇¦d us ting¦ ¦with¦ ¦a¦ ¦da m p¦ ¦c lo th¦
𐋇 ¦bu y¦ ¦a¦ ¦po ll en¦ ¦f il ter¦ ¦for¦ ¦ca r¦ ¦v ents¦
𐋇 ¦bu y¦ ¦a¦ ¦v ac u um¦ ¦c le an er¦ ¦with¦ ¦a¦ ¦he p a¦ ¦f il ter¦ ▁( ¦high¦ - ¦eff ic ie ncy¦ ¦air ¦ ¦partic ul ate¦ ¦f il ter¦ ) ▁( ¦these¦ ¦can¦ ¦c at ch¦ ¦the¦ ¦pol lu ta nts¦ )
𐋇¦to¦ ¦ta me¦ ¦the¦ ¦symptoms¦ ¦of¦ ¦h ay¦ ¦fever¦ :
𐋇¦do¦ ¦not¦ ¦c ut¦ ¦gr ass¦ ¦or¦ ¦w alk¦ ¦on¦ ¦gr ass¦
𐋇¦d on¦ ' ¦t¦ ¦sp end¦ ¦to o¦ ¦much¦ ¦time¦ ¦outside¦
𐋇¦do¦ ¦not¦ ¦keep¦ ¦in¦ ¦the¦ ¦house¦
𐋇¦d on¦ ' ¦t¦ ¦s mo ke¦ ¦and¦ ¦stay¦ ¦away¦ ¦from¦ ¦s mo k ers¦ ▁-▁ ¦it¦ ¦ma k es¦ ¦the¦ ¦symptoms¦ ¦wor se¦
𐋇¦do¦ ¦not¦ ¦d ry¦ ¦your¦ ¦c lo th es¦ ¦out d o ors¦ ▁-▁ ¦for¦ ¦f ear¦ ¦of¦ ¦fa lling¦ ¦into¦ ¦po ll en¦
𐋇¦do¦ ¦not¦ ¦l et¦ ¦p ets¦ ¦into¦ ¦the¦ ¦house¦ ¦if¦ ¦possible¦ ▁-▁ ¦they¦ ¦may¦ ¦br ing¦ ¦po ll en¦ ¦into¦ ¦the¦ ¦house¦
𐋇¦when¦ ¦to¦ ¦go¦ ¦to¦ ¦a¦ ¦ph arm acy¦
𐋇¦t alk¦ ¦to¦ ¦your¦ ¦ph arm ac ist¦ ¦if¦ ¦you¦ ¦have¦ ¦h ay¦ ¦fever¦ .
𐋇¦they¦ ¦can¦ ¦ad v ise¦ ¦you¦ ¦and¦ ¦recomm end¦ ¦the¦ ¦b est¦ ¦treatment¦ ¦ e¦ . ¦ g¦ .▁ ¦anti h is ta m ine¦ ¦dro pl ets¦ ,▁ ¦ta bl ets¦ ¦or¦ ¦n as al¦ ¦sp r ay¦ .
𐋇¦they¦ ¦can¦ ¦help¦ ¦with¦ :
𐋇¦ it ch y¦ ¦and¦ ¦w a te ry¦ ¦ey es¦ ¦and¦ ¦sneezing¦
𐋇¦a¦ ¦st u ff y¦ ¦nose¦
𐋇¦when¦ ¦to¦ ¦go¦ ¦to¦ ¦your¦ ¦gp¦
𐋇¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦get¦ ¦bet ter¦ ¦after¦ ¦ta king¦ ¦the¦ ¦ph arm acy¦ ¦treatment¦ ,▁ ¦your¦ ¦gp¦ ¦may¦ ¦be¦ ¦able¦ ¦to¦ ¦help¦ .
𐋇 ¦visit¦ ¦your¦ ¦gp¦ :
𐋇¦if¦ ¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦get¦ ¦wor se¦
𐋇¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦get¦ ¦bet ter¦ ¦after¦ ¦ta king¦ ¦medic ines¦ ¦from¦ ¦the¦ ¦ph arm acy¦
𐋇 ¦treatment¦ ¦from¦ ¦your¦ ¦gp¦
𐋇¦your¦ ¦gp¦ ¦may¦ ¦pr esc rib e¦ ¦st er oi ds¦ ¦for¦ ¦you¦ .
𐋇¦if¦ ¦st er oi ds¦ ¦and¦ ¦other¦ ¦medic ations¦ ¦for¦ ¦h ay¦ ¦fever¦ ¦do¦ ¦not¦ ¦work¦ ¦for¦ ¦you¦ ,▁ ¦your¦ ¦gp¦ ¦may¦ ¦ref er¦ ¦you¦ ¦for¦ ¦immun o ther ap y¦ .
𐋇¦you¦ ¦will¦ ¦be¦ ¦giv en¦ ¦sm all¦ ¦doses¦ ¦of¦ ¦po ll en¦ ¦by¦ ¦in j e ction¦ ¦or¦ ¦in¦ ¦ta bl ets¦ .
𐋇¦you¦ ¦will¦ ¦g rad ually¦ ¦ga in¦ ¦immun ity¦ ¦from¦ ¦the¦ ¦po ll en¦ . .
𐋇¦this¦ ¦treatment¦ ¦is¦ ¦us ually¦ ¦d one¦ ¦in¦ ¦the¦ ¦w in ter¦ ¦about¦ ¦3¦ ¦mon ths¦ ¦before¦ ¦the¦ ¦star t¦ ¦of¦ ¦the¦ ¦h ay¦ ¦fever¦ ¦se as on¦ .
𐋇 ¦protect¦ ¦yourself¦ ¦and¦ ¦others¦ ¦from¦ ¦the¦ ¦coronavirus¦
𐋇¦there¦ ¦is¦ ¦no¦ ¦vaccine¦ ¦for¦ ¦the¦ ¦coronavirus¦ .
𐋇 ¦th ink¦ ¦about¦ ¦the¦ ¦way¦ ¦the¦ ¦cr own¦ ¦virus¦ ¦sprea ds¦ ¦to¦ ¦protect¦ ¦you¦ ¦and¦ ¦others¦ ▁( ¦covid¦ - ¦19¦ ).
𐋇 ¦coronavirus¦ ¦is¦ ¦spread¦ ¦by¦ ¦sneezing¦ ¦or¦ ¦cou g hing¦ .
𐋇¦it¦ ¦must¦ ¦p ass¦ ¦from¦ ¦the¦ ¦nose¦ ¦or¦ ¦mouth¦ ¦of¦ ¦an¦ ¦infected¦ ¦person¦ ¦into¦ ¦your¦ ¦ey es¦ ,▁ ¦nose¦ ¦or¦ ¦mouth¦ ¦to¦ ¦get¦ ¦the¦ ¦virus¦ .
𐋇¦this¦ ¦can¦ ¦happ en¦ ¦dir ect ly¦ ¦or¦ ¦ind ir ect ly¦ ▁( ¦on¦ ¦hands¦ ,▁ ¦ob j ects¦ ,▁ ¦sur fa ces¦ ).
𐋇 ¦re me mber¦ ¦this¦ .
𐋇¦it¦ ¦will¦ ¦help¦ ¦you¦ ¦re me mber¦ ¦all¦ ¦the¦ ¦th ings¦ ¦you¦ ¦need¦ ¦to¦ ¦do¦ ¦to¦ ¦protect¦ ¦yourself¦ ¦and¦ ¦others¦ ¦from¦ ¦the¦ ¦virus¦ .
𐋇 ¦level¦ ¦3¦ ¦restrictions¦ ¦app ly¦ ¦in¦ ¦every¦ ¦county¦ ¦in¦ ¦the¦ ¦state¦ .
𐋇¦there¦ ¦is¦ ¦more¦ ¦information¦ ¦on¦ ¦g ov ¦ . ¦i e¦ ¦reg ar ding¦ ¦the¦ ¦re st ri ction¦ ¦le v els¦ ¦th r ou g ho ut¦ ¦the¦ ¦state¦ .
𐋇 ¦take¦ ¦resp on si bility¦ ,▁ ¦stay¦ ¦a¦ ¦safe¦
𐋇¦as¦ ¦public¦ ¦health¦ ¦restrictions¦ ¦are¦ ¦ ea sed¦ ,▁ ¦hand¦ ¦washing¦ ¦and¦ ¦respiratory¦ ¦h yg ien e¦ ¦and¦ ¦social¦ ¦separ ation¦ ¦are¦ ¦of¦ ¦p ara mo un t¦ ¦imp ort ance¦ .
𐋇¦there¦ ¦is¦ ¦a¦ ¦risk¦ ¦of¦ ¦another¦ ¦outbreak¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦e veryone¦ ¦should¦ ¦be¦ ¦sen si ble¦ ¦and¦ ¦follow¦ ¦the¦ ¦advice¦ ¦b el ow¦ ¦to¦ ¦cur b ¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦coronavirus¦ .
𐋇¦t ry¦ ¦not¦ ¦to¦ ¦me et¦ ¦so¦ ¦many¦ ¦people¦ ¦outside¦ ¦your¦ ¦home¦ ¦and¦ ¦d on¦ ' ¦t¦ ¦sp end¦ ¦to o¦ ¦much¦ ¦time¦ ¦with¦ ¦them¦ .
𐋇¦you¦ ¦should¦ :
𐋇¦w earing¦ ¦a¦ ¦face¦ ¦mask¦ ¦on¦ ¦public¦ ¦transport¦ ▁-▁ ¦this¦ ¦is¦ ¦the¦ ¦la w¦ ,▁ ¦and¦ ¦you¦ ¦can¦ ¦be¦ ¦f ined¦ ¦or¦ ¦ref u sed¦ ¦ent ry¦ ¦if¦ ¦you¦ ¦d on¦ ' ¦t¦ ¦wear¦ ¦a¦ ¦mask¦
𐋇 ¦work¦ ¦away¦ ¦from¦ ¦home¦ ¦if¦ ¦possible¦ ▁-▁ ¦if¦ ¦you¦ ¦can¦ ' ¦t¦ ¦work¦ ¦from¦ ¦home¦ ,▁ ¦stay¦ ¦2¦ ¦mon ths¦ ¦away¦ ¦from¦ ¦others¦
𐋇 ¦avoid¦ ¦cr ow ded¦ ¦places¦ ¦as¦ ¦much¦ ¦as¦ ¦possible¦ ▁-▁ ¦lea ve¦ ¦if¦ ¦social¦ ¦separ ation¦ ¦is¦ ¦not¦ ¦possible¦ .
𐋇 ¦not¦ ¦use¦ ¦public¦ ¦transport¦ ¦un less¦ ¦ne cess ary¦ ▁-▁ ¦w alk¦ ¦or¦ ¦c y c le¦ ¦if¦ ¦you¦ ¦can¦
𐋇¦stay¦ ¦cl ear¦ ¦of¦ ¦places¦ ¦where¦ ¦you¦ ¦cannot¦ ¦stay¦ ¦2¦ ¦mon ths¦ ¦away¦ ¦from¦ ¦others¦ ¦if¦ ¦possible¦
𐋇 ¦wear¦ ¦face¦ ¦cover¦ ¦when¦ ¦visi ting¦ ¦people¦ ¦over¦ ¦7 0¦ ¦or¦ ¦other¦ ¦v ul n er able¦ ¦people¦ - ▁ ¦pract ice¦ ¦social¦ ¦separ ation¦ ¦for¦ ¦safety¦ .
𐋇 ¦can¦ :
𐋇 ¦me et¦ ¦people¦ ¦ind o ors¦ ¦and¦ ¦out d o ors¦ ¦on¦ ¦social¦ ¦occ a si ons¦ ¦but¦ ¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦others¦
𐋇¦to¦ ¦att end¦ ¦medical¦ ¦app oi nt ments¦ ¦and¦ ¦coll ect¦ ¦medic ines¦ ¦and¦ ¦medical¦ ¦produc ts¦
𐋇 ¦exerc ise¦ ¦out d o ors¦ ¦and¦ ¦ind o ors¦ ¦in¦ ¦f it ness¦ ¦centr es¦ ¦and¦ ¦sp orts¦ ¦cl ub s¦ ¦as¦ ¦long¦ ¦as¦ ¦public¦ ¦health¦ ¦advice¦ ¦is¦ ¦ad h ered¦ ¦to¦
𐋇 ¦visit¦ ¦out door¦ ¦areas¦ ,▁ ¦pla yg ro un ds¦ ¦and¦ ¦si tes¦ ,▁ ¦if¦ ¦you¦ ¦can¦ ¦stay¦ ¦at¦ ¦least¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦others¦
𐋇¦do¦ ¦not¦ ¦i gn ore¦ ¦any¦ ¦del ays¦ ¦in¦ ¦s ee king¦ ¦treatment¦ ¦if¦ ¦you¦ ¦have¦ ¦un us ual¦ ¦signs¦ ¦or¦ ¦symptoms¦
𐋇 ¦social¦ ¦separ ation¦
𐋇 ¦social¦ ¦separ ation¦ ¦is¦ ¦important¦ ¦to¦ ¦del ay¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦coronavirus¦ .
𐋇 ¦contact¦ ¦between¦ ¦infected¦ ¦and¦ ¦healthy¦ ¦people¦ ¦will¦ ¦be¦ ¦reduc ed¦ .
𐋇¦stay¦ ¦away¦ ¦2¦ ¦meters¦ ▁( ¦6¦ ¦fe et¦ )▁ ¦from¦ ¦others¦
𐋇 ¦avoid¦ ¦sh ared¦ ¦sl ee p ing¦ ¦areas¦
𐋇 ¦avoid¦ ¦cr ow ded¦ ¦places¦
𐋇¦do¦ ¦not¦ ¦sh a ke¦ ¦hands¦ ¦or¦ ¦have¦ ¦close¦ ¦contact¦ ¦with¦ ¦others¦ ,▁ ¦if¦ ¦possible¦
𐋇¦there¦ ¦is¦ ¦l it t le¦ ¦da nger¦ ¦if¦ ¦you¦ ¦are¦ ¦j ust¦ ¦pa ss ing¦ ¦someone¦ .
𐋇¦but¦ ¦t ry¦ ¦to¦ ¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ¦as¦ ¦much¦ ¦as¦ ¦possible¦ .
𐋇 ¦social¦ ¦separ ation¦ ¦at¦ ¦work¦
𐋇 ¦follow¦ ¦the¦ ¦advice¦ ¦on¦ ¦social¦ ¦se g re g ation¦ ¦e ver y w h er e¦ ¦outside¦ ¦your¦ ¦home¦ ,▁ ¦including¦ ¦your¦ ¦work pl ace¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦retur ning¦ ¦to¦ ¦work¦ ,▁ ¦r ead¦ ¦about¦ ¦the¦ ¦safe¦ ¦retur n¦ ¦to¦ ¦work¦ .
𐋇 ¦contact¦ ¦the¦ ¦health¦ ¦and¦ ¦safety¦ ¦author ity¦ ▁( ¦h s a¦ )▁ ¦by¦ ¦e ma il¦ ¦w c u¦ ▁ @ ▁ ¦h s a¦ . ¦i e¦ ¦or¦ ¦te le ph one¦ ¦1 8 9 0¦ ¦2 8 9¦ ¦3 8 9¦ ¦if¦ :
𐋇¦you¦ ¦are¦ ¦concer ned¦ ¦about¦ ¦the¦ ¦imp le me nt ation¦ ¦of¦ ¦social¦ ¦se g re g ation¦ ¦measures¦ ¦in¦ ¦the¦ ¦work pl ace¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦the¦ ¦e mploy er¦ ¦and¦ ¦need¦ ¦advice¦ ¦on¦ ¦prev en ting¦ ¦cr own¦ ¦virus¦ ¦in¦ ¦the¦ ¦work pl ace¦
𐋇 ¦isol ate¦ ¦yourself¦ ¦if¦ ¦you¦ ¦have¦ ¦symptoms¦ ¦of¦ ¦coronavirus¦
𐋇 ¦be¦ ¦very¦ ¦ca re ful¦ ¦if¦ ¦you¦ ¦are¦ ¦in¦ ¦a¦ ¦group¦ ¦at¦ ¦risk¦ ¦from¦ ¦coronavirus¦
𐋇¦c oc oo ning¦ ¦of¦ ¦people¦ ¦at¦ ¦high¦ ¦risk¦ ▁( ¦ext re m ely¦ ¦v ul n er able¦ )
𐋇 ¦what¦ ¦to¦ ¦do¦ ¦if¦ ¦you¦ ¦live¦ ¦with¦ ¦someone¦ ¦who¦ ¦has¦ ¦the¦ ¦symptoms¦ ¦of¦ ¦coronavirus¦
𐋇 ¦travel¦ ¦and¦ ¦coronavirus¦
𐋇 ¦g ood¦ ¦h yg ien e¦ ¦and¦ ¦hand¦ ¦washing¦
𐋇 ¦g ood¦ ¦h yg ien e¦ ¦and¦ ¦prop er¦ ¦hand w as hing¦ ¦will¦ ¦help¦ ¦cur b ¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦coronavirus¦ .▁ 𐋇 ¦follow¦ ¦this¦ ¦advice¦ ¦as¦ ¦much¦ ¦as¦ ¦possible¦ ¦and¦ ¦e nc o ur age¦ ¦others¦ ¦to¦ ¦do¦ ¦the¦ ¦same¦ .
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦often¦ ¦and¦ ¦a de qu a tely¦ .
𐋇 ¦cover¦ ¦your¦ ¦mouth¦ ¦and¦ ¦nose¦ ¦with¦ ¦a¦ ¦hand k er ch ief¦ ¦or¦ ¦sl ee ve¦ ¦when¦ ¦cou g hing¦ ¦and¦ ¦sneezing¦ .
𐋇¦p ut¦ ¦the¦ ¦hand k er ch ief¦ ¦in¦ ¦a¦ ¦b in¦ ¦and¦ ¦wash¦ ¦your¦ ¦hands¦ .
𐋇 ¦clean¦ ¦and¦ ¦disinf ect¦ ¦an y thing¦ ¦or¦ ¦sur f ace¦ ¦that¦ ¦you¦ ¦tou ch¦ ¦fre qu e ntly¦
𐋇¦d on¦ ' ¦t¦
𐋇¦do¦ ¦not¦ ¦place¦ ¦your¦ ¦hands¦ ¦n ear¦ ¦your¦ ¦ey es¦ ,▁ ¦nose¦ ¦or¦ ¦mouth¦ ¦un less¦ ¦they¦ ¦are¦ ¦clean¦ .
𐋇¦do¦ ¦not¦ ¦share¦ ¦th ings¦ ¦that¦ ¦come¦ ¦in¦ ¦contact¦ ¦with¦ ¦your¦ ¦mouth¦ ▁-▁ ¦b ot t les¦ ,▁ ¦c u ps¦ ¦for¦ ¦example¦
𐋇¦when¦ ¦you¦ ¦should¦ ¦wash¦ ¦your¦ ¦hands¦
𐋇¦you¦ ¦should¦ ¦wash¦ ¦your¦ ¦hands¦ :
𐋇 ¦after¦ ¦cou g hing¦ ¦or¦ ¦sneezing¦
𐋇 ¦before¦ ¦and¦ ¦after¦ ¦e ating¦
𐋇 ¦before¦ ¦and¦ ¦after¦ ¦pre par ing¦ ¦food¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦been¦ ¦in¦ ¦contact¦ ¦with¦ ¦someone¦ ¦who¦ ¦has¦ ¦a¦ ¦fever¦ ¦or¦ ¦respiratory¦ ¦symptoms¦ ▁( ¦cough¦ ,▁ ¦sh ort ness¦ ¦of¦ ¦brea th¦ ,▁ ¦diffic ult y¦ ¦brea thing¦ )
𐋇 ¦before¦ ¦and¦ ¦after¦ ¦you¦ ¦are¦ ¦on¦ ¦public¦ ¦transport¦
𐋇 ¦before¦ ¦and¦ ¦after¦ ¦being¦ ¦in¦ ¦a¦ ¦cr ow d¦ ▁( ¦especially¦ ¦an¦ ¦in door¦ ¦cr ow d¦ )
𐋇¦when¦ ¦you¦ ¦en ter¦ ¦and¦ ¦lea ve¦ ¦bu ild ings¦ ,▁ ¦your¦ ¦ own¦ ¦home¦ ¦or¦ ¦an yone¦ ¦el se¦ ▁’▁ ¦s¦ ¦house¦
𐋇¦if¦ ¦you¦ ¦were¦ ¦de al ing¦ ¦with¦ ¦anim als¦ ¦or¦ ¦anim al¦ ¦w a st e¦
𐋇 ¦before¦ ¦you¦ ¦s mo ke¦ ¦a¦ ¦c ig ar et t e¦ ¦or¦ ¦a¦ ¦c ig ar et t e¦
𐋇¦if¦ ¦your¦ ¦hands¦ ¦are¦ ¦di rt y¦
𐋇 ¦after¦ ¦using¦ ¦the¦ ¦to il et¦
𐋇 ¦take¦ ¦care¦ ¦of¦ ¦your¦ ¦hands¦ .
𐋇 ¦app ly¦ ¦mo ist ur iz er¦ ¦often¦ .
𐋇 ¦any¦ ¦produc t¦ ¦will¦ ¦make¦ ¦a¦ ¦re as on¦ ,▁ ¦a¦ ¦b as ic¦ ¦one¦ ¦without¦ ¦per f u me¦ ¦or¦ ¦c ol or¦ .
𐋇 ¦use¦ ¦the¦ ¦covid¦ ¦tracker¦
𐋇¦the¦ ¦covid¦ ¦tracker¦ ¦is¦ ¦a¦ ¦fre e¦ ¦and¦ ¦e as y¦ ¦to¦ ¦use¦ ¦app¦ ¦and¦ :
𐋇 ¦will¦ ¦alert¦ ¦you¦ ¦to¦ ¦close¦ ¦contact¦ ¦if¦ ¦someone¦ ¦you¦ ¦have¦ ¦had¦ ¦close¦ ¦contact¦ ¦with¦ ¦g ets¦ ¦a¦ ¦positive¦ ¦result¦ ¦for¦ ¦covid¦ ▁ - ¦19¦
𐋇¦it¦ ¦will¦ ¦give¦ ¦you¦ ¦advice¦ ¦on¦ ¦how¦ ¦to¦ ¦protect¦ ¦yourself¦ ¦and¦ ¦others¦
𐋇¦it¦ ¦will¦ ¦alert¦ ¦other¦ ¦us ers¦ ¦of¦ ¦the¦ ¦app¦ ¦with¦ ¦wh om¦ ¦you¦ ¦have¦ ¦had¦ ¦close¦ ¦contact¦ ¦if¦ ¦you¦ ¦get¦ ¦a¦ ¦positive¦ ¦result¦ ¦for¦ ¦the¦ ¦coronavirus¦
𐋇¦the¦ ¦app¦ ¦is¦ ¦par t¦ ¦of¦ ¦our¦ ¦contact¦ ¦tracking¦ .
𐋇 ¦contact¦ ¦tracking¦ ¦is¦ ¦very¦ ¦important¦ ¦to¦ ¦cur b ¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦coronavirus¦ .
𐋇¦the¦ ¦more¦ ¦people¦ ¦who¦ ¦f ind¦ ¦and¦ ¦u ses¦ ¦the¦ ¦app¦ ,▁ ¦the¦ ¦bet ter¦ ¦the¦ ¦contact¦ ¦tracking¦ .
𐋇¦it¦ ¦will¦ ¦help¦ ¦us¦ ¦stay¦ ¦safe¦ ¦when¦ ¦we¦ ¦me et¦ ¦people¦ ¦s oc ially¦ ,▁ ¦at¦ ¦work¦ ¦or¦ ¦while¦ ¦tra v el ing¦ ,▁ ¦if¦ ¦we¦ ¦use¦ ¦the¦ ¦app¦ ¦and¦ ¦follow¦ ¦the¦ ¦public¦ ¦health¦ ¦advice¦ ¦on¦ ¦this¦ ¦p age¦ .
𐋇 ¦visi t ors¦
𐋇¦d on¦ ' ¦t¦ ¦me et¦ ¦to o¦ ¦many¦ ¦people¦ ¦outside¦ ¦your¦ ¦home¦ ¦and¦ ¦sp end¦ ¦to o¦ ¦much¦ ¦time¦ ¦with¦ ¦them¦ .
𐋇 ¦no¦ ¦house¦ ¦should¦ ¦have¦ ¦more¦ ¦than¦ ¦t en¦ ¦visi t ors¦ ▁( ¦from¦ ¦a¦ ¦ma x im um¦ ¦of¦ ¦4¦ ¦n ets¦ ).
𐋇¦the¦ ¦house¦ ¦should¦ ¦be¦ ¦large¦ ¦en ough¦ ¦to¦ ¦have¦ ¦a¦ ¦dista nce¦ ¦of¦ ¦2¦ ¦meters¦ ¦between¦ ¦each¦ ¦person¦ ¦and¦ ¦p le nt y¦ ¦of¦ ¦air ¦ ¦in side¦ .
𐋇 ¦keep¦ ¦yourself¦ ¦and¦ ¦your¦ ¦visi t ors¦ ¦safe¦ .
𐋇¦do¦ ¦not¦ ¦visit¦ ¦others¦ ¦if¦ :
𐋇¦you¦ ¦would¦ ¦have¦ ¦any¦ ¦s ign¦ ¦of¦ ¦the¦ ¦cr own¦ ¦virus¦
𐋇¦if¦ ¦the¦ ¦contact¦ ¦trac k ers¦ ¦to ld¦ ¦you¦ ¦that¦ ¦you¦ ¦had¦ ¦close¦ ¦contact¦ ¦with¦ ¦someone¦ ¦who¦ ¦had¦ ¦the¦ ¦virus¦
𐋇 ¦ch eck¦ ¦with¦ ¦people¦ ¦in¦ ¦ad v ance¦ ¦before¦ ¦you¦ ¦visit¦ ¦that¦ ¦they¦ ¦have¦ ¦no¦ ¦signs¦ ¦and¦ ¦are¦ ¦fe el ing¦ ¦well¦ .
𐋇¦if¦ ¦visi t ors¦ ¦are¦ ¦able¦ ¦to¦ ¦stay¦ ¦2¦ ¦meters¦ ¦a par t¦ ,▁ ¦it¦ ¦is¦ ¦not¦ ¦ne cess ary¦ ¦to¦ ¦wear¦ ¦a¦ ¦face¦ ¦cover¦ .
𐋇¦if¦ ¦people¦ ¦cannot¦ ¦remain¦ ¦2¦ ¦meters¦ ¦a par t¦ ,▁ ¦e veryone¦ ¦should¦ ¦wear¦ ¦a¦ ¦face¦ ¦cover¦ .
𐋇 ¦wear¦ ¦a¦ ¦face¦ ¦mask¦ ¦every¦ ¦time¦ ¦you¦ ¦visit¦ ¦people¦ ¦over¦ ¦7 0¦ ¦or¦ ¦others¦ ¦who¦ ¦are¦ ¦he al t hi ly¦ ¦v ul n er able¦ .
𐋇 ¦clean¦ ¦your¦ ¦hands¦ ¦regul arly¦ ¦and¦ ¦t ell¦ ¦visi t ors¦ ¦to¦ ¦wash¦ ¦their¦ ¦hands¦ ¦when¦ ¦they¦ ¦en ter¦ .
𐋇¦do¦ ¦not¦ ¦wear¦ ¦dis p os able¦ ¦g lo ves¦ ¦inst ead¦ ¦of¦ ¦cl ea ning¦ ¦your¦ ¦hands¦ .
𐋇¦the¦ ¦virus¦ ¦aff ects¦ ¦them¦ ¦the¦ ¦same¦ ¦way¦ ¦it¦ ¦g ets¦ ¦on¦ ¦your¦ ¦hands¦ .
𐋇 ¦cor ru ption¦ ¦can¦ ¦get¦ ¦on¦ ¦the¦ ¦hands¦ ¦when¦ ¦you¦ ¦re mo ve¦ ¦them¦ .
𐋇¦when¦ ¦your¦ ¦visi t ors¦ ¦dis a pp ear¦ ,▁ ¦clean¦ ¦all¦ ¦sur fa ces¦ ¦they¦ ¦have¦ ¦been¦ ¦in¦ ¦contact¦ ¦with¦ .
𐋇 ¦use¦ ¦for¦ ¦ro ut ine¦ ¦hou se ho ld¦ ¦cl ea ning¦ ¦and¦ ¦disinf ec ta nts¦ .
𐋇 ¦comp as si on ate¦ ¦visi ts¦
𐋇 ¦retur ning¦ ¦to¦ ¦work¦ ¦sa f ely¦
𐋇¦do¦ ¦your¦ ¦work¦ ¦from¦ ¦home¦ .
𐋇 ¦only¦ ¦essential¦ ¦workers¦ ¦should¦ ¦go¦ ¦to¦ ¦work p la ces¦ .
𐋇 ¦only¦ ¦essential¦ ¦workers¦ ,▁ ¦con st ru ction¦ ¦workers¦ ¦and¦ ¦people¦ ¦who¦ ¦work¦ ¦outside¦ ¦should¦ ¦go¦ ¦to¦ ¦their¦ ¦work pl ace¦ .
𐋇¦the¦ ¦use¦ ¦of¦ ¦face¦ ¦masks¦ ¦is¦ ¦recommended¦ ¦in¦ ¦cr ow ded¦ ¦work p la ces¦ .
𐋇 ¦before¦ ¦you¦ ¦retur n¦ ¦to¦ ¦work¦
𐋇 ¦before¦ ¦you¦ ¦retur n¦ ¦to¦ ¦work¦ ,▁ ¦you¦ ¦must¦ :
𐋇¦f ill¦ ¦in¦ ¦a¦ ¦retur n¦ ¦to¦ ¦work¦ ¦for m¦
𐋇¦t ell¦ ¦your¦ ¦e mploy er¦ ¦about¦ ¦any¦ ¦re le v ant¦ ¦covid¦ - ¦19¦ ¦c ir c um st an ces¦ ¦they¦ ¦should¦ ¦be¦ ¦a w are¦ ¦of¦
𐋇 ¦partic ip ate¦ ¦in¦ ¦any¦ ¦tr aining¦ ¦provid ed¦ ¦by¦ ¦your¦ ¦e mploy er¦
𐋇 ¦pr e¦ - ¦retur n¦ ¦to¦ ¦work¦ ¦for m¦
𐋇¦you¦ ¦will¦ ¦need¦ ¦to¦ ¦co mpl et e¦ ¦this¦ ¦for m¦ ¦at¦ ¦least¦ ¦3¦ ¦days¦ ¦before¦ ¦your¦ ¦retur n¦ ¦to¦ ¦work¦ .
𐋇¦this¦ ¦for m¦ ¦app l ies¦ ¦to¦ ¦your¦ ¦j ob ¦ ¦and¦ ¦is¦ ¦only¦ ¦available¦ ¦from¦ ¦your¦ ¦e mploy er¦ .
𐋇¦the¦ ¦for m¦ ¦decl ar es¦ :
𐋇¦you¦ ¦do¦ ¦not¦ ¦have¦ ¦covid¦ - ¦19¦ ¦symptoms¦
𐋇 ¦not¦ ¦sta ying¦ ¦al one¦ ▁( ¦self¦ - ¦isol ating¦ )
𐋇¦you¦ ¦are¦ ¦not¦ ¦wai ting¦ ¦for¦ ¦covid¦ - ¦19¦ ¦test¦ ¦results¦
𐋇¦you¦ ¦are¦ ¦not¦ ¦retur ning¦ ¦from¦ ¦some¦ ¦other¦ ¦country¦
𐋇¦your¦ ¦e mploy er¦ ¦may¦ ¦as k¦ ¦you¦ ¦to¦ ¦conf ir m¦ ¦these¦ ¦detail s¦ ¦in¦ ¦the¦ ¦f ut ure¦ .
𐋇¦this¦ ¦may¦ ¦be¦ ¦because¦ ¦you¦ ¦are¦ ¦only¦ ¦occ a si on ally¦ ¦at¦ ¦work¦ ¦or¦ ¦you¦ ¦have¦ ¦not¦ ¦been¦ ¦at¦ ¦work¦ ¦for¦ ¦a¦ ¦period¦ ¦of¦ ¦time¦ ,▁ ¦ e¦ . ¦ g¦ ¦on¦ ¦an n ual¦ ¦lea ve¦ .
𐋇 ¦protect¦ ¦yourself¦ ¦in¦ ¦the¦ ¦work pl ace¦
𐋇 ¦ad h er e¦ ¦to¦ ¦the¦ ¦measures¦ ¦la id¦ ¦down¦ ¦by¦ ¦your¦ ¦e mploy er¦ ¦to¦ ¦e ns ure¦ ¦social¦ ¦isolation¦
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦properly¦ ¦regul arly¦
𐋇 ¦ad h er e¦ ¦to¦ ¦h yg ien e¦ ¦advice¦ ¦for¦ ¦cou g hing¦ ¦and¦ ¦sneezing¦
𐋇¦stay¦ ¦al one¦ ¦when¦ ¦tra v el ing¦ ¦to¦ ¦work¦
𐋇 ¦use¦ ¦your¦ ¦ own¦ ¦p en¦ ¦to¦ ¦s ign¦ ¦in¦
𐋇 ¦wear¦ ¦a¦ ¦face¦ ¦mask¦ ¦if¦ ¦there¦ ¦are¦ ¦many¦ ¦people¦ ¦in¦ ¦your¦ ¦work pl ace¦
𐋇 ¦get¦ ¦and¦ ¦use¦ ¦the¦ ¦contact¦ ¦tracker¦ ¦app¦ ▁-▁ - ¦you¦ ¦will¦ ¦be¦ ¦al er ted¦ ¦for¦ ¦immediate¦ ¦contact¦ ¦if¦ ¦someone¦ ¦close¦ ¦to¦ ¦you¦ ¦f in ds¦ ¦a¦ ¦positive¦ ¦result¦ ¦for¦ ¦covid¦ ▁ - ¦19¦
𐋇¦do¦ ¦not¦ ¦tou ch¦ ¦your¦ ¦ey es¦ ,▁ ¦mouth¦ ¦or¦ ¦nose¦
𐋇¦do¦ ¦not¦ ¦share¦ ¦an y thing¦ ¦that¦ ¦c omes¦ ¦in¦ ¦contact¦ ¦with¦ ¦your¦ ¦m ou ths¦ ,▁ ¦such¦ ¦as¦ ¦b ot t les¦ ¦or¦ ¦c u ps¦
𐋇¦do¦ ¦not¦ ¦sh a ke¦ ¦hands¦ ¦with¦ ¦an yone¦
𐋇¦do¦ ¦not¦ ¦have¦ ¦face¦ - ¦to¦ - ¦face¦ ¦me et ings¦ ¦and¦ ¦go¦ ¦on¦ ¦bu si ness¦ ¦t ri ps¦ ¦if¦ ¦possible¦ ▁-▁ ¦use¦ ¦te le ph one¦ ¦or¦ ¦v ide o¦ ¦conf e re ncing¦
𐋇¦you¦ ¦may¦ ¦be¦ ¦wor r ied¦ ¦about¦ ¦how¦ ¦your¦ ¦work pl ace¦ ¦is¦ ¦hand l ing¦ ¦a¦ ¦covid¦ - ¦19¦ ¦outbreak¦ .
𐋇¦if¦ ¦so¦ ,▁ ¦contact¦ ¦the¦ ¦health¦ ¦and¦ ¦safety¦ ¦author ity¦ .
𐋇¦if¦ ¦you¦ ¦get¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦at¦ ¦work¦
𐋇¦t ell¦ ¦the¦ ¦mana g er¦ ¦imm ed ia tely¦ .
𐋇¦your¦ ¦e mploy er¦ ¦will¦ ¦have¦ ¦a¦ ¦proc ess¦ ¦in¦ ¦place¦ .
𐋇 ¦follow¦ ¦the¦ ¦gu id el ines¦ ¦and¦ ¦advice¦ ¦available¦ ¦to¦ ¦you¦ .
𐋇¦stay¦ ¦away¦ ¦from¦ ¦other¦ ¦staff¦ ¦imm ed ia tely¦
𐋇 ¦wear¦ ¦a¦ ¦face¦ ¦cover¦ ¦if¦ ¦one¦ ¦is¦ ¦available¦
𐋇¦stay¦ ¦at¦ ¦least¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦others¦
𐋇 ¦call¦ ¦your¦ ¦gp¦ ¦to¦ ¦arr ange¦ ¦a¦ ¦covid¦ - ¦19¦ ¦test¦
𐋇 ¦go¦ ¦home¦ ¦as¦ ¦so on¦ ¦as¦ ¦it¦ ¦is¦ ¦safe¦ ¦to¦ ¦do¦ ¦so¦ .
𐋇¦stay¦ ¦al one¦ ¦at¦ ¦home¦ ¦and¦ ¦call¦ ¦your¦ ¦gp¦ .
𐋇¦do¦ ¦not¦ ¦use¦ ¦public¦ ¦transport¦ ¦of¦ ¦any¦ ¦k ind¦ ¦to¦ ¦get¦ ¦home¦ .
𐋇¦if¦ ¦you¦ ¦can¦ ' ¦t¦ ¦go¦ ¦home¦ ¦stra ight¦ ¦away¦ :
𐋇¦stay¦ ¦al one¦ ¦in¦ ¦the¦ ¦bu il ding¦ ¦and¦ ¦call¦ ¦your¦ ¦gp¦
𐋇¦do¦ ¦not¦ ¦tou ch¦ ¦an yone¦ ,▁ ¦sur f ace¦ ¦or¦ ¦an y thing¦ ¦el se¦
𐋇 ¦cover¦ ¦your¦ ¦mouth¦ ¦and¦ ¦nose¦ ¦with¦ ¦a¦ ¦ti ss ue¦ ¦when¦ ¦you¦ ¦cough¦ ¦or¦ ¦s n ee z e¦ .
𐋇¦p ut¦ ¦the¦ ¦di rt y¦ ¦p ap er¦ ¦to we l¦ ¦in¦ ¦a¦ ¦tr as h ¦ ¦ba g¦ .
𐋇 ¦people¦ ¦at¦ ¦g rea ter¦ ¦risk¦ ¦from¦ ¦coronavirus¦
𐋇 ¦work¦ ¦from¦ ¦home¦ ¦if¦ ¦you¦ ¦are¦ ¦at¦ ¦g rea ter¦ ¦risk¦ ¦from¦ ¦coronavirus¦ .
𐋇¦if¦ ¦you¦ ¦can¦ ' ¦t¦ ¦work¦ ¦from¦ ¦home¦ ,▁ ¦t alk¦ ¦to¦ ¦your¦ ¦gp¦ ¦or¦ ¦e mploy er¦ .
𐋇¦your¦ ¦e mploy er¦ ¦may¦ ¦s ee k¦ ¦occ u pa tional¦ ¦health¦ ¦advice¦ .
𐋇 ¦make¦ ¦sure¦ ¦your¦ ¦e mploy er¦ ¦has¦ ¦sa f e g u ards¦ ¦in¦ ¦place¦ ¦where¦ ¦possible¦ .
𐋇 ¦advice¦ ¦for¦ ¦e mploy ers¦
𐋇¦e mploy ers¦ ¦should¦ ¦ad h er e¦ ¦to¦ ¦work¦ ¦sa f ely¦ ¦prot oc o l¦
𐋇¦these¦ ¦gu id el ines¦ ¦con tain¦ ¦advice¦ :
𐋇 ¦sto p¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦the¦ ¦work pl ace¦
𐋇 ¦ste ps¦ ¦to¦ ¦reduce¦ ¦the¦ ¦risk¦ ¦of¦ ¦covid¦ - ¦19¦
𐋇 ¦what¦ ¦to¦ ¦do¦ ¦if¦ ¦an¦ ¦e mploy e e¦ ¦sh ow s¦ ¦signs¦ ¦of¦ ¦the¦ ¦virus¦
𐋇¦the¦ ¦health¦ ¦and¦ ¦safety¦ ¦author ity¦ ▁( ¦h s a¦ )▁ ¦provid es¦ ¦advice¦ ¦to¦ ¦e mploy ers¦ ¦and¦ ¦e mploy e es¦ ¦on¦ ¦work pl ace¦ ¦prote ction¦ ¦measures¦ .
𐋇 ¦chec k li sts¦ ¦and¦ ¦te mpl ates¦ ¦from¦ ¦the¦ ¦h s a¦ ¦are¦ ¦available¦ ¦to¦ ¦help¦ ¦e mploy ers¦ ,▁ ¦bu si ness¦ ¦ ow n ers¦ ¦and¦ ¦mana g ers¦ ¦prevent¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ ¦in¦ ¦the¦ ¦work pl ace¦ .
𐋇 ¦advice¦ ¦for¦ ¦healthcare¦ ¦workers¦
𐋇 ¦gu id el ines¦ ¦and¦ ¦advice¦ ¦for¦ ¦healthcare¦ ¦staff¦ ,▁ ¦mana g ers¦ ¦and¦ ¦staff¦ ¦retur ning¦ ¦to¦ ¦work¦ ¦during¦ ¦the¦ ¦covid¦ - ¦19¦ ¦outbreak¦ ¦are¦ ¦available¦ ¦on¦ ¦he al th s erv ice¦ . ¦hse¦ . ¦i e¦
𐋇¦read¦ ¦gu id el ines¦ ¦for¦ ¦retur ning¦ ¦healthcare¦ ¦mana g ers¦ ¦and¦ ¦healthcare¦ ¦staff¦ ¦on¦ ¦how¦ ¦to¦ ¦work¦ ¦sa f ely¦
𐋇 ¦water¦ ¦sys tems¦
𐋇¦read¦ ¦the¦ ¦en vir on me ntal¦ ¦health¦ ¦advice¦ ¦for¦ ¦mana ging¦ ¦water¦ ¦sys tems¦ ¦in¦ ¦the¦ ¦ev ent¦ ¦of¦ ¦a¦ ¦sh ut d own¦
𐋇 ¦that¦ ¦advice¦ ¦has¦ ¦inclu ded¦ :
𐋇¦h ot els¦
𐋇 ¦food¦ ¦pre mi ses¦
𐋇 ¦water¦ ¦rec rea tional¦ ¦facil ities¦
𐋇 ¦organiz ations¦ ¦that¦ ¦provide¦ ¦advice¦ ¦to¦ ¦e mploy ers¦ ¦and¦ ¦e mploy e es¦
𐋇 ¦shopping¦ ¦sa f ely¦ ¦during¦ ¦the¦ ¦corona ry¦ ¦virus¦ ¦outbreak¦
𐋇¦the¦ ¦bi gg est¦ ¦da nger¦ ¦of¦ ¦shopping¦ ¦is¦ ¦being¦ ¦in¦ ¦contact¦ ¦with¦ ¦an¦ ¦infected¦ ¦person¦ .
𐋇¦when¦ ¦shopping¦ ,▁ ¦you¦ ¦should¦ :
𐋇 ¦wear¦ ¦a¦ ¦face¦ ¦cover¦
𐋇 ¦pract ice¦ ¦b est¦ ¦h yg ien e¦ ¦practi ces¦
𐋇 ¦pract ice¦ ¦social¦ ¦separ ation¦
𐋇 ¦without¦ ¦contact¦ ¦with¦ ¦people¦ ¦outside¦ ¦of¦ ¦those¦ ¦who¦ ¦live¦ ¦with¦ ¦you¦
𐋇 ¦someone¦ ¦who¦ ¦p as ses¦ ¦by¦ ¦in¦ ¦the¦ ¦st ore¦ ¦is¦ ¦not¦ ¦much¦ ¦of¦ ¦a¦ ¦da nger¦ ¦to¦ ¦you¦ .
𐋇¦but¦ ¦stay¦ ¦away¦ ¦from¦ ¦2¦ ¦meters¦ ¦away¦ ¦as¦ ¦much¦ ¦as¦ ¦possible¦ .
𐋇 ¦face¦ ¦cover¦
𐋇¦by¦ ¦la w¦ ,▁ ¦you¦ ¦must¦ ¦wear¦ ¦a¦ ¦face¦ ¦cover¦ ¦while¦ ¦shopping¦ ¦because¦ ¦it¦ ¦can¦ ¦be¦ ¦diffic ul t¦ ¦to¦ ¦pract ice¦ ¦social¦ ¦separ ation¦ ¦while¦ ¦in¦ ¦a¦ ¦st ore¦ .
𐋇 ¦face¦ ¦cov ers¦ ¦should¦ ¦also¦ ¦be¦ ¦wor n¦ ¦in¦ ¦b us y¦ ¦or¦ ¦cr ow ded¦ ¦out door¦ ¦s pa ces¦ ,▁ ¦such¦ ¦as¦ ¦a¦ ¦shopping¦ ¦st re et¦ .
𐋇¦however¦ ,▁ ¦face¦ ¦co ver age¦ ¦is¦ ¦not¦ ¦su it able¦ ¦for¦ ¦e veryone¦ .
𐋇¦it¦ ▁’▁ ¦s¦ ¦o k ay¦ ¦if¦ ¦c er tain¦ ¦people¦ ¦c ho ose¦ ¦not¦ ¦to¦ ¦wear¦ ¦them¦ .
𐋇¦f ac ial¦ ¦cover¦ ¦is¦ ¦not¦ ¦su it able¦ ¦for¦ ¦children¦ ¦under¦ ¦13¦ ¦or¦ ¦for¦ ¦people¦ ¦with¦ ¦spec ial¦ ¦needs¦ ¦as¦ ¦they¦ ¦may¦ ¦be¦ ¦up s et¦ ¦or¦ ¦very¦ ¦u nc om f ort able¦ ¦to¦ ¦wear¦ .
𐋇¦when¦ ¦you¦ ¦should¦ ¦stay¦ ¦home¦
𐋇¦d on¦ ▁’▁ ¦t¦ ¦go¦ ¦out¦ ¦shopping¦ ¦if¦ ¦you¦ ▁’▁ ¦r e¦ ¦fe el ing¦ ¦sick¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦at¦ ¦g rea ter¦ ¦risk¦ ¦from¦ ¦covid¦ - ¦19¦ ,▁ ¦consid er¦ ¦do ing¦ ¦your¦ ¦shopping¦ ¦online¦ ¦or¦ ¦as k¦ ¦someone¦ ¦to¦ ¦sho p¦ ¦for¦ ¦you¦ .
𐋇¦if¦ ¦you¦ ¦need¦ ¦help¦ ,▁ ¦you¦ ¦can¦ ¦also¦ ¦contact¦ ¦your¦ ¦local¦ ¦county¦ ¦cou nc il¦ .
𐋇¦they¦ ¦have¦ ¦community¦ ¦support¦ ¦in¦ ¦place¦ ¦to¦ ¦de li ver¦ ¦essential¦ ¦g oo ds¦ .
𐋇¦read¦ ¦more¦ ¦about¦ ¦how¦ ¦local¦ ¦author ities¦ ¦can¦ ¦help¦ ¦you¦ ¦during¦ ¦the¦ ¦corona ry¦ ¦virus¦ ¦outbreak¦ .
𐋇 ¦reduce¦ ¦the¦ ¦risk¦ ¦while¦ ¦shopping¦
𐋇 ¦only¦ ¦go¦ ¦shopping¦ ¦when¦ ¦ne cess ary¦ .
𐋇¦this¦ ¦reduc es¦ ¦the¦ ¦risk¦ ¦of¦ ¦contr ac ting¦ ¦or¦ ¦sprea ding¦ ¦covid¦ - ¦19¦ .
𐋇¦when¦ ¦you¦ ¦are¦ ¦shopping¦
𐋇 ¦use¦ ¦the¦ ¦disinf ect ant¦ ¦provid ed¦ ,▁ ¦on¦ ¦your¦ ¦hands¦ ,▁ ¦the¦ ¦tr ol le y¦ ¦or¦ ¦b as k et¦ .
𐋇 ¦re me mber¦ ¦to¦ ¦make¦ ¦no¦ ¦contact¦ ¦with¦ ¦your¦ ¦face¦ .
𐋇 ¦wear¦ ¦a¦ ¦face¦ ¦mask¦ ¦if¦ ¦you¦ ' ¦r e¦ ¦over¦ ¦13¦ ▁-▁ ¦but¦ ¦d on¦ ' ¦t¦ ¦wear¦ ¦it¦ ¦if¦ ¦you¦ ¦feel¦ ¦u nc om f ort able¦ ¦w earing¦ ¦it¦
𐋇¦if¦ ¦you¦ ¦cough¦ ¦or¦ ¦s n ee z e¦ ,▁ ¦cover¦ ¦your¦ ¦mouth¦ ¦and¦ ¦nose¦ ¦with¦ ¦a¦ ¦ti ss ue¦ ¦or¦ ¦your¦ ¦sl ee ve¦ .
𐋇 ¦follow¦ ¦the¦ ¦gu id el ines¦ ¦for¦ ¦social¦ ¦separ ation¦ ▁-▁ ¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦others¦ ¦in¦ ¦qu e ues¦ ¦when¦ ¦shopping¦ .
𐋇¦p ay¦ ¦by¦ ¦c ard¦ ¦r at her¦ ¦than¦ ¦c as h ¦ ▁-▁ ¦a¦ ¦conta ct less¦ ¦pa y ment¦ ¦met ho d¦ ¦may¦ ¦reduce¦ ¦the¦ ¦risk¦ ¦of¦ ¦infection¦ .
𐋇¦if¦ ¦you¦ ¦use¦ ¦c as h ¦ ,▁ ¦the¦ ¦risk¦ ¦is¦ ¦low¦ ,▁ ¦especially¦ ¦if¦ ¦you¦ ¦clean¦ ¦your¦ ¦hands¦ ¦regul arly¦ ¦after¦ ¦hand l ing¦ ¦c as h ¦ .
𐋇 ¦after¦ ¦shopping¦
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦properly¦
𐋇 ¦sa ve¦ ¦your¦ ¦shopping¦
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦ag a in¦
𐋇 ¦sh ow¦ ¦resp ect¦ ¦for¦ ¦others¦
𐋇 ¦only¦ ¦bu y¦ ¦what¦ ¦you¦ ¦need¦ ▁-▁ ¦it¦ ¦is¦ ¦re st oc ked¦ ¦in¦ ¦st or es¦ ¦daily¦ .
𐋇¦do¦ ¦not¦ ¦go¦ ¦shopping¦ ¦during¦ ¦the¦ ¦hours¦ ¦s et¦ ¦for¦ ¦healthcare¦ ¦workers¦ ¦and¦ ¦car ers¦ .
𐋇 ¦de li ve ry¦ ¦and¦ ¦colle ction¦ ¦services¦ ¦are¦ ¦very¦ ¦important¦ ¦for¦ ¦people¦ ¦who¦ ¦are¦ ¦c oc oo ning¦ ¦and¦ ¦are¦ ¦un able¦ ¦to¦ ¦lea ve¦ ¦their¦ ¦h omes¦ .
𐋇 ¦only¦ ¦res er ve¦ ¦de li ve ry¦ ¦times¦ ¦if¦ ¦ne cess ary¦ .
𐋇 ¦shopping¦ ¦for¦ ¦a¦ ¦v ul n er able¦ ¦person¦
𐋇¦how¦ ¦covid¦ - ¦19¦ ¦is¦ ¦spread¦
𐋇 ¦direct¦ ¦contact¦
𐋇 ¦local¦ ¦restrictions¦ ¦to¦ ¦sto p¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦coronavirus¦
𐋇¦you¦ ¦could¦ ¦get¦ ¦the¦ ¦virus¦ ¦from¦ ¦someone¦ ¦who¦ ¦has¦ ¦the¦ ¦virus¦ ¦if¦ ¦you¦ ¦have¦ ¦close¦ ¦contact¦ ¦with¦ ¦it¦ .
𐋇¦it¦ ¦is¦ ¦spread¦ ¦in¦ ¦dro pl ets¦ ¦from¦ ¦your¦ ¦nose¦ ¦and¦ ¦mouth¦ ,▁ ¦ e¦ . ¦ g¦ .▁ ¦when¦ ¦someone¦ ¦is¦ ¦t al king¦ ¦lo ud ly¦ ,▁ ¦s in ging¦ ,▁ ¦sh ou ting¦ ,▁ ¦cou g hing¦ ¦or¦ ¦sneezing¦ .
𐋇¦this¦ ¦happ ens¦ ¦when¦ ¦people¦ ¦are¦ ¦1¦ ¦to¦ ¦2¦ ¦meters¦ ¦a par t¦ .
𐋇¦this¦ ¦is¦ ¦wh y¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ ¦is¦ ¦reduc ed¦ ¦when¦ ¦you¦ ¦keep¦ ¦a¦ ¦dista nce¦ ¦of¦ ¦2¦ ¦meters¦ ¦from¦ ¦others¦ .
𐋇 ¦infected¦ ¦sur fa ces¦
𐋇¦the¦ ¦virus¦ ¦can¦ ¦be¦ ¦found¦ ¦from¦ ¦a¦ ¦sur f ace¦ ¦that¦ ¦has¦ ¦been¦ ¦infected¦ ¦or¦ ¦s n ee zed¦ ¦by¦ ¦a¦ ¦person¦ ¦with¦ ¦the¦ ¦virus¦ .
𐋇¦the¦ ¦virus¦ ¦can¦ ¦be¦ ¦pres ent¦ ¦in¦ ¦dro pl ets¦ ¦that¦ ¦f all¦ ¦on¦ ¦sur ro un ding¦ ¦sur fa ces¦ .
𐋇¦if¦ ¦you¦ ¦l ay¦ ¦your¦ ¦hand¦ ¦on¦ ¦your¦ ¦ey es¦ ,▁ ¦nose¦ ¦or¦ ¦mouth¦ ,▁ ¦you¦ ¦could¦ ¦also¦ ¦get¦ ¦the¦ ¦virus¦ .
𐋇¦this¦ ¦is¦ ¦wh y¦ ¦it¦ ¦is¦ ¦important¦ ¦to¦ ¦wash¦ ¦your¦ ¦hands¦ ¦properly¦ ¦and¦ ¦often¦ .
𐋇¦how¦ ¦long¦ ¦the¦ ¦virus¦ ¦can¦ ¦sur v ive¦
𐋇 ¦si mp le¦ ¦hou se ho ld¦ ¦disinf ec ta nts¦ ¦can¦ ¦k ill¦ ¦the¦ ¦virus¦ ¦on¦ ¦sur fa ces¦ .
𐋇 ¦clean¦ ¦the¦ ¦sur f ace¦ ¦first¦ ,▁ ¦and¦ ¦then¦ ¦use¦ ¦a¦ ¦disinf ect ant¦ .
𐋇¦the¦ ¦cr own¦ ¦virus¦ ¦can¦ ¦sur v ive¦ ¦for¦ :
𐋇 ¦up¦ ¦to¦ ¦7 2¦ ¦hours¦ ¦on¦ ¦pla st ic¦ ¦and¦ ¦sta in less¦ ¦st ee l¦ .
𐋇 ¦less¦ ¦than¦ ¦4¦ ¦hours¦ ¦on¦ ¦co pp er¦
𐋇 ¦less¦ ¦than¦ ¦24¦ ¦hours¦ ¦on¦ ¦car d bo ard¦
𐋇 ¦air bor n e¦ ¦transmission¦
𐋇 ¦air bor n e¦ ¦transmission¦ ¦is¦ ¦the¦ ¦spread¦ ¦of¦ ¦viruses¦ ¦in¦ ¦very¦ ¦sm all¦ ¦water¦ ¦partic les¦ .
𐋇¦this¦ ¦can¦ ¦happ en¦ ¦over¦ ¦a¦ ¦dista nce¦ ¦lo nger¦ ¦than¦ ¦dro pl ets¦ ,▁ ¦such¦ ¦as¦ ¦across¦ ¦a¦ ¦ro om¦ .
𐋇 ¦air bor n e¦ ¦transmission¦ ¦does¦ ¦not¦ ¦app ear¦ ¦to¦ ¦pl ay¦ ¦a¦ ¦major¦ ¦ro le¦ ¦in¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇¦but¦ ¦it¦ ¦can¦ ¦happ en¦ ¦in¦ ¦some¦ ¦cases¦ .
𐋇¦to¦ ¦protect¦ ¦yourself¦ ,▁ ¦keep¦ ¦in door¦ ¦s pa ces¦ ¦well¦ ¦ ventil ated¦ ▁( ¦all owing¦ ¦fre s h ¦ ¦air ¦ ¦in¦ )▁ ¦by¦ ¦op ening¦ ¦w i nd ow s¦ ¦and¦ ¦do ors¦ ¦if¦ ¦possible¦ .
𐋇¦how¦ ¦to¦ ¦protect¦ ¦yourself¦
𐋇¦a¦ ¦face¦ ¦mask¦ ¦can¦ ¦protect¦ ¦you¦ ,▁ ¦but¦ ¦you¦ ¦should¦ ¦al w ays¦ ¦do¦ ¦what¦ ¦is¦ ¦ne cess ary¦ ¦to¦ ¦prevent¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ .
𐋇¦these¦ ¦include¦ :
𐋇 ¦social¦ ¦separ ation¦
𐋇 ¦cover¦ ¦your¦ ¦cough¦ ¦and¦ ¦s n ee z e¦ .
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦properly¦
𐋇¦do¦ ¦not¦ ¦place¦ ¦your¦ ¦hands¦ ¦n ear¦ ¦your¦ ¦ey es¦ ,▁ ¦nose¦ ¦or¦ ¦mouth¦ ¦un less¦ ¦they¦ ¦are¦ ¦clean¦
𐋇¦the¦ ¦virus¦ ¦can¦ ¦qu ick ly¦ ¦spread¦ ¦in¦ ¦a¦ ¦cr ow ded¦ ¦en vir on ment¦ .
𐋇 ¦avoid¦ ¦cr ow ded¦ ¦places¦ ¦as¦ ¦much¦ ¦as¦ ¦possible¦ .
𐋇 ¦lea ve¦ ¦a¦ ¦place¦ ¦if¦ ¦it¦ ¦is¦ ¦cr ow ded¦ ¦and¦ ¦you¦ ¦cannot¦ ¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦others¦ .
𐋇¦p ets¦ ¦and¦ ¦the¦ ¦cr own¦ ¦virus¦
𐋇¦there¦ ¦is¦ ¦no¦ ¦evidence¦ ¦that¦ ¦p ets¦ ¦such¦ ¦as¦ ¦ca ts¦ ¦and¦ ¦d og s¦ ¦can¦ ¦spread¦ ¦the¦ ¦coronavirus¦ ¦among¦ ¦humans¦ .
𐋇¦to¦ ¦give¦ ¦yourself¦ ¦bet ter¦ ¦prote ction¦ ,▁ ¦wash¦ ¦your¦ ¦hands¦ ¦often¦ ¦and¦ ¦a de qu a tely¦ ¦when¦ ¦in¦ ¦contact¦ ¦with¦ ¦p ets¦ .
𐋇 ¦face¦ ¦mask¦ ,▁ ¦medical¦ ¦mask¦ ¦and¦ ¦dis p os able¦ ¦g lo ves¦
𐋇¦you¦ ¦are¦ ¦required¦ ¦by¦ ¦la w¦ ¦to¦ ¦wear¦ ¦face¦ ¦cover¦
𐋇 ¦public¦ ¦transport¦ .
𐋇¦in¦ ¦sho ps¦ ,▁ ¦shopping¦ ¦centr es¦ ¦ et c¦ ▁-▁ ¦se e¦ ¦co mpl et e¦ ¦l ist¦
𐋇 ¦face¦ ¦cover¦ ¦should¦ ¦also¦ ¦be¦ ¦wor n¦ :
𐋇¦when¦ ¦it¦ ¦is¦ ¦not¦ ¦possible¦ ¦to¦ ¦stay¦ ¦away¦ ¦2¦ ¦meters¦ ¦from¦ ¦others¦
𐋇¦in¦ ¦hosp it als¦ ,▁ ¦doctor¦ ' ¦s¦ ¦dis p e ns ary¦ ,▁ ¦nu rs ing¦ ¦h omes¦ ¦and¦ ¦at¦ ¦the¦ ¦de nt ist¦ ¦and¦ ¦other¦ ¦health¦ ¦ce nt ers¦
𐋇¦when¦ ¦people¦ ¦are¦ ¦at¦ ¦risk¦ ¦from¦ ¦people¦ ¦who¦ ¦are¦ ¦at¦ ¦g rea ter¦ ¦risk¦ ¦from¦ ¦the¦ ¦corona ry¦ ¦virus¦ ▁-▁ ¦e g¦ ¦people¦ ¦over¦ ¦7 0¦ ¦years¦ ¦of¦ ¦age¦ ¦or¦ ¦people¦ ¦who¦ ¦are¦ ¦v ul n er able¦ ¦to¦ ¦health¦
𐋇¦there¦ ¦are¦ ¦people¦ ¦who¦ ¦should¦ ¦not¦ ▁/▁ ¦cannot¦ ¦wear¦ ¦face¦ ¦cover¦ .
𐋇¦h er e¦ ¦is¦ ¦a¦ ¦p ie ce¦ ¦of¦ ¦c lo th¦ ¦that¦ ¦cov ers¦ ¦your¦ ¦nose¦ ¦and¦ ¦mouth¦ .
𐋇¦this¦ ¦co ver age¦ ¦may¦ ¦restrict¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦coronavirus¦ ¦in¦ ¦the¦ ¦community¦ .
𐋇¦it¦ ¦may¦ ¦help¦ ¦to¦ ¦prevent¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦coronavirus¦ ¦from¦ ¦sneezing¦ ¦or¦ ¦cou g hing¦ ¦in¦ ¦people¦ ¦with¦ ¦the¦ ¦virus¦ .
𐋇¦they¦ ¦may¦ ¦help¦ ¦people¦ ¦who¦ ¦do¦ ¦not¦ ¦know¦ ¦they¦ ¦have¦ ¦the¦ ¦virus¦ ¦to¦ ¦p ass¦ ¦on¦ ¦the¦ ¦virus¦ ¦to¦ ¦others¦ .
𐋇 ¦social¦ ¦separ ation¦
𐋇 ¦cover¦ ¦your¦ ¦mouth¦ ¦and¦ ¦nose¦ ¦with¦ ¦a¦ ¦hand k er ch ief¦ ¦or¦ ¦sl ee ve¦ ¦when¦ ¦cou g hing¦ ¦and¦ ¦sneezing¦ .
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦often¦ ¦and¦ ¦a de qu a tely¦
𐋇¦do¦ ¦not¦ ¦place¦ ¦your¦ ¦hands¦ ¦n ear¦ ¦your¦ ¦ey es¦ ,▁ ¦nose¦ ¦or¦ ¦mouth¦ ¦un less¦ ¦they¦ ¦are¦ ¦clean¦ .
𐋇 ¦people¦ ¦who¦ ¦should¦ ¦not¦ ¦wear¦ ¦face¦ ¦cover¦
𐋇¦you¦ ¦do¦ ¦not¦ ¦need¦ ¦to¦ ¦wear¦ ¦a¦ ¦mask¦ ¦if¦ ¦you¦ ¦have¦ ¦an¦ ¦illness¦ ¦or¦ ¦partic ular¦ ¦needs¦ ¦and¦ ¦a¦ ¦f ac ial¦ ¦cov ering¦ ¦may¦ ¦up s et¦ ¦or¦ ¦make¦ ¦you¦ ¦u nc om f ort able¦ .
𐋇¦f ac ial¦ ¦co ver age¦ ¦is¦ ¦also¦ ¦not¦ ¦recommended¦ ¦for¦ ¦people¦ ¦with¦ :
𐋇¦they¦ ¦have¦ ¦tr ou ble¦ ¦brea thing¦
𐋇 ¦u nc o ns c ious¦ ¦person¦ ¦or¦ ¦sp ee ch¦
𐋇¦a¦ ¦person¦ ¦who¦ ¦is¦ ¦un able¦ ¦to¦ ¦re mo ve¦ ¦the¦ ¦face¦ ¦cover¦ ¦without¦ ¦ass ist ance¦ ,
𐋇¦a¦ ¦person¦ ¦with¦ ¦spec ial¦ ¦needs¦ ¦or¦ ¦h earing¦ ¦diffic ult ies¦ ,▁ ¦or¦ ¦who¦ ¦is¦ ¦d ea f¦
𐋇¦in¦ ¦such¦ ¦cases¦ ,▁ ¦the¦ ¦person¦ ¦will¦ ¦receive¦ ¦some¦ ¦prote ction¦ ¦from¦ ¦the¦ ¦ch ea ter¦ ¦if¦ ¦h e¦ ¦is¦ ¦able¦ ¦to¦ ¦th r ow¦ ¦ che at ers¦ .
𐋇¦but¦ ¦this¦ ¦is¦ ¦the¦ ¦only¦ ¦time¦ ¦you¦ ¦should¦ ¦sp end¦ ¦on¦ ¦ce lls¦ .
𐋇¦you¦ ¦will¦ ¦get¦ ¦bet ter¦ ¦prote ction¦ ¦against¦ ¦covid¦ - ¦19¦ ¦if¦ ¦you¦ ¦wear¦ ¦a¦ ¦c lo th¦ - ¦ covered¦ ¦face¦ ¦cover¦ .
𐋇 ¦children¦ ¦under¦ ¦the¦ ¦age¦ ¦of¦ ¦13¦ ¦are¦ ¦not¦ ¦ad vi sed¦ ¦to¦ ¦wear¦ ¦face¦ ¦masks¦ ,▁ ¦but¦ ¦some¦ ¦children¦ ¦may¦ ¦c ho ose¦ ¦to¦ ¦wear¦ ¦one¦ .
𐋇¦there¦ ¦is¦ ¦a¦ ¦g ood¦ ¦ch ance¦ ¦that¦ ¦y ou ng¦ ¦children¦ ¦will¦ ¦not¦ ¦follow¦ ¦the¦ ¦advice¦ ¦on¦ ¦how¦ ¦to¦ ¦wear¦ ¦face¦ ¦masks¦ ¦properly¦ .
𐋇¦there¦ ¦is¦ ¦also¦ ¦a¦ ¦risk¦ ¦that¦ ¦they¦ ¦may¦ ¦not¦ ¦under st and¦ ¦the¦ ¦imp ort ance¦ ¦of¦ ¦a v oi ding¦ ¦to uc hing¦ ¦the¦ ¦cover¦ .
𐋇 ¦children¦ ¦under¦ ¦13¦ ¦should¦ ¦wear¦ ¦a¦ ¦mask¦ ¦if¦ ¦recommended¦ ¦by¦ ¦their¦ ¦doctor¦ ¦or¦ ¦health¦ ¦work er¦ .
𐋇 ¦children¦ ¦may¦ ¦be¦ ¦ad vi sed¦ ¦to¦ ¦wear¦ ¦a¦ ¦mask¦ ¦while¦ ¦att ending¦ ¦a¦ ¦hospital¦ ¦cl in ic¦ ¦for¦ ¦example¦ .
𐋇 ¦children¦ ¦under¦ ¦13¦ ¦only¦ ¦in¦ ¦the¦ ¦first¦ ¦year¦ ¦of¦ ¦sec ond ary¦ ¦school¦ ¦should¦ ¦wear¦ ¦face¦ ¦cover¦ ¦while¦ ¦att ending¦ ¦school¦ .
𐋇¦this¦ ¦is¦ ¦recommended¦ ¦because¦ ¦they¦ ¦are¦ ¦at¦ ¦the¦ ¦same¦ ¦st age¦ ¦of¦ ¦development¦ ¦as¦ ¦their¦ ¦p e ers¦ ¦and¦ ¦can¦ ¦properly¦ ¦follow¦ ¦the¦ ¦advice¦ ¦on¦ ¦face¦ ¦co ver ings¦ .
𐋇¦when¦ ¦one¦ ¦should¦ ¦wear¦
𐋇¦you¦ ¦must¦ ¦wear¦ ¦face¦ ¦cover¦ ¦on¦ ¦public¦ ¦transport¦ ,▁ ¦by¦ ¦la w¦ ¦and¦ ¦in¦ :
𐋇 ¦sho ps¦ ¦and¦ ¦ph arm acy¦
𐋇 ¦shopping¦ ¦ce nt ers¦
𐋇 ¦li b r ar ies¦
𐋇¦c i ne ma s¦
𐋇 ¦the at ers¦
𐋇 ¦concer t¦ ¦ha lls¦
𐋇 ¦bi ng o¦ ¦ha lls¦
𐋇¦m u se u ms¦
𐋇 ¦na il¦ ¦s al on¦
𐋇 ¦ha ir d re ss ers¦ ¦and¦ ¦b ar b ers¦
𐋇¦t at t o o¦ ¦sho p¦ ¦and¦ ¦p i erc ing¦
𐋇 ¦travel¦ ¦ag ents¦ ¦and¦ ¦tou r¦ ¦op erat ors¦
𐋇 ¦la u nd ry¦ ¦ce nt ers¦ ¦and¦ ¦d ry¦ ¦c le an ers¦
𐋇¦b oo k ma k ers¦
𐋇 ¦many¦ ¦of¦ ¦these¦ ¦places¦ ¦are¦ ¦temp o ra ri ly¦ ¦closed¦ ¦due¦ ¦to¦ ¦health¦ ¦risk¦ ¦to¦ ¦the¦ ¦public¦ .
𐋇¦when¦ ¦you¦ ¦can¦ ¦re mo ve¦ ¦the¦ ¦face¦ ¦cover¦
𐋇¦you¦ ¦can¦ ¦re mo ve¦ ¦the¦ ¦face¦ ¦cover¦ ¦to¦
𐋇¦t alk¦ ¦to¦ ¦someone¦ ¦who¦ ¦has¦ ¦comm un ic ation¦ ¦diffic ult ies¦
𐋇 ¦provid ing¦ ¦emergency¦ ¦ass ist ance¦ ¦or¦ ¦care¦ ¦to¦ ¦a¦ ¦v ul n er able¦ ¦person¦
𐋇 ¦ta king¦ ¦medic ation¦
𐋇¦you¦ ¦may¦ ¦be¦ ¦as ked¦ ¦to¦ ¦re mo ve¦ ¦the¦ ¦face¦ ¦cover¦ ¦to¦ ¦conf ir m¦ ¦your¦ ¦age¦ ¦or¦ ¦ident ity¦
𐋇¦you¦ ¦can¦ ¦also¦ ¦re mo ve¦ ¦the¦ ¦face¦ ¦cover¦ :
𐋇 ¦at¦ ¦a¦ ¦p ost¦ ¦off ice¦ ,▁ ¦cre di t¦ ¦un ion¦ ¦or¦ ¦b an k¦
𐋇¦in¦ ¦a¦ ¦res ta ur ant¦ ¦or¦ ¦ca f e¦ ¦while¦ ¦e ating¦ ¦and¦ ¦dr in king¦
𐋇¦when¦ ¦you¦ ¦are¦ ¦rece i ving¦ ¦medical¦ ¦or¦ ¦de ntal¦ ¦treatment¦
𐋇 ¦where¦ ¦it¦ ¦is¦ ¦made¦ ¦from¦
𐋇¦a¦ ¦face¦ ¦cover¦ ¦is¦ ¦made¦ ¦of¦ ¦c lo th¦ ¦such¦ ¦as¦ ¦c ot t on¦ ¦or¦ ¦s il k¦ .
𐋇¦you¦ ¦can¦ ¦bu y¦ ¦them¦ ¦or¦ ¦make¦ ¦them¦ ¦at¦ ¦home¦ ¦from¦ ¦i tems¦ ¦like¦ ¦sc ar ves¦ ,▁ ¦t¦ - ¦sh ir ts¦ ,▁ ¦f it ness¦ ¦sh ir ts¦ ,▁ ¦or¦ ¦t ow els¦ .
𐋇¦how¦ ¦you¦ ¦wear¦ ¦a¦ ¦face¦ ¦cover¦
𐋇¦it¦ ¦should¦ ¦cover¦ ¦the¦ ¦nose¦ ¦and¦ ¦be¦ ¦under¦ ¦the¦ ¦ch in¦ ¦and¦ :
𐋇 ¦that¦ ¦it¦ ¦l ies¦ ¦qu i et ly¦ ¦and¦ ¦c om f ort ab ly¦ ¦on¦ ¦the¦ ¦ch ee k¦
𐋇 ¦be¦ ¦sec ur ed¦ ¦with¦ ¦an¦ ¦ ear¦ ¦stra p¦ ¦or¦ ¦l oo p¦
𐋇¦there¦ ¦should¦ ¦be¦ ¦at¦ ¦least¦ ¦2¦ ¦p ie ces¦ ¦of¦ ¦c lo th¦
𐋇 ¦be¦ ¦able¦ ¦to¦ ¦c at ch¦ ¦your¦ ¦brea th¦ ¦with¦ ¦e ase¦
𐋇¦how¦ ¦to¦ ¦st ore¦ ¦and¦ ¦wash¦ ¦face¦ ¦cov ers¦
𐋇 ¦st ore¦ ¦your¦ ¦face¦ ¦cover¦ ¦made¦ ¦of¦ ¦c lo th¦ ¦properly¦ ¦and¦ ¦wash¦ ¦it¦ ¦regul arly¦ ¦to¦ ¦keep¦ ¦it¦ ¦clean¦ .
𐋇 ¦have¦ ¦more¦ ¦than¦ ¦one¦ ¦face¦ ¦cover¦ ,▁ ¦so¦ ¦you¦ ¦have¦ ¦a¦ ¦clean¦ ¦one¦ ¦if¦ ¦nee ded¦ .
𐋇 ¦re mo ve¦ ¦it¦ ¦properly¦ ¦and¦ ¦clean¦ ¦or¦ ¦disinf ect¦ ¦your¦ ¦hands¦ ¦after¦ ¦hand l ing¦ ¦the¦ ¦face¦ ¦cover¦ ▁'
𐋇 ¦st or ing¦ ¦your¦ ¦face¦ ¦cover¦
𐋇 ¦st or ing¦ ¦w et¦ ¦or¦ ¦di rt y¦ ¦face¦ ¦cover¦
𐋇¦if¦ ¦your¦ ¦face¦ ¦g ets¦ ¦w et¦ ¦or¦ ¦di rt y¦ ¦due¦ ¦to¦ ¦s we at¦ ,▁ ¦s al iv a¦ ,▁ ¦make¦ - ¦up¦ ¦or¦ ¦an y thing¦ ¦el se¦ ,▁ ¦p ut¦ ¦the¦ ¦face¦ ¦cover¦ ¦in¦ ¦a¦ ¦ti gh t ly¦ ¦closed¦ ¦ba g¦ ,▁ ¦and¦ ¦then¦ ¦wash¦ ¦it¦ .
𐋇 ¦wash¦ ¦the¦ ¦w et¦ ¦or¦ ¦di rt y¦ ¦face¦ ¦cover¦ ¦as¦ ¦so on¦ ¦as¦ ¦possible¦ ¦before¦ ¦it¦ ¦bec omes¦ ¦r ot t en¦ .
𐋇 ¦brea thing¦ ¦through¦ ¦a¦ ¦w et¦ ¦face¦ ¦cover¦ ¦is¦ ¦not¦ ¦e as y¦ ¦to¦ ¦brea th e¦ ¦and¦ ¦is¦ ¦not¦ ¦as¦ ¦effective¦ ¦as¦ ¦a¦ ¦d ry¦ ¦cover¦ .
𐋇 ¦st or ing¦ ¦d ry¦ ¦face¦ ¦cover¦
𐋇¦a¦ ¦clean¦ ¦face¦ ¦cover¦ ¦can¦ ¦be¦ ¦pl ac ed¦ ¦sa f ely¦ ¦until¦ ¦you¦ ¦have¦ ¦to¦ ¦p ut¦ ¦it¦ ¦on¦ ¦ag a in¦ .
𐋇 ¦re mo ve¦ ¦it¦ ¦properly¦ ¦and¦ ¦clean¦ ¦or¦ ¦disinf ect¦ ¦your¦ ¦hands¦ ¦after¦ ¦hand l ing¦ ¦it¦ .
𐋇 ¦keep¦ ¦it¦ ¦in¦ ¦a¦ ¦d ry¦ ¦ba g¦ ¦to¦ ¦l et¦ ¦air ¦ ¦through¦ ▁( ¦ba g¦ ¦made¦ ¦of¦ ¦p ap er¦ ¦or¦ ¦c lo th¦ )▁ ¦to¦ ¦keep¦ ¦it¦ ¦clean¦ .
𐋇¦when¦ ¦you¦ ¦p ut¦ ¦it¦ ¦on¦ ¦ag a in¦ ,▁ ¦keep¦ ¦the¦ ¦same¦ ¦ side¦ ¦outside¦ .
𐋇¦the¦ ¦more¦ ¦fre qu ent¦ ¦hand l ing¦ ¦of¦ ¦the¦ ¦face¦ ¦cover¦ ¦without¦ ¦washing¦ ¦it¦ ,▁ ¦the¦ ¦g rea ter¦ ¦the¦ ¦risk¦ ¦of¦ ¦conta m ination¦ .
𐋇¦when¦ ¦you¦ ¦re mo ve¦ ¦the¦ ¦face¦ ¦cover¦ ¦to¦ ¦e at¦ ¦or¦ ¦dr ink¦ ¦so me thing¦ ¦in¦ ¦a¦ ¦safe¦ ¦place¦ ¦such¦ ¦as¦ ¦your¦ ¦p oc k et¦ ,▁ ¦p ur se¦ ¦or¦ ¦p ap er¦ ¦ba g¦ .
𐋇 ¦clean¦ ¦and¦ ¦disinf ect¦ ¦your¦ ¦hands¦ ¦after¦ ¦re mo ving¦ ¦the¦ ¦face¦ ¦mask¦ .
𐋇¦p ut¦ ¦on¦ ¦the¦ ¦face¦ ¦cover¦ ¦ag a in¦ ¦after¦ ¦e ating¦ ¦and¦ ¦keep¦ ¦the¦ ¦same¦ ¦outside¦ .
𐋇 ¦clean¦ ¦and¦ ¦disinf ect¦ ¦your¦ ¦hands¦ ¦ag a in¦ ¦after¦ ¦app l ying¦ ¦the¦ ¦face¦ ¦mask¦ .
𐋇 ¦washing¦ ¦your¦ ¦face¦ ¦cover¦
𐋇¦you¦ ¦should¦ ¦wash¦ ¦your¦ ¦face¦ ¦cover¦ ¦when¦ ¦it¦ ¦is¦ ¦di rt y¦ ¦or¦ ¦at¦ ¦least¦ ¦daily¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦a¦ ¦one¦ - ¦time¦ ¦face¦ ¦cover¦ ,▁ ¦th r ow¦ ¦it¦ ¦away¦ ¦after¦ ¦you¦ ¦have¦ ¦used¦ ¦it¦ ¦o nce¦ .
𐋇¦you¦ ¦do¦ ¦not¦ ¦need¦ ¦to¦ ¦st er il iz e¦ ¦face¦ ¦masks¦ .
𐋇 ¦wash¦ ¦it¦ ¦in¦ ¦a¦ ¦washing¦ ¦ma ch ine¦ ¦or¦ ¦by¦ ¦hand¦ ¦as¦ ¦you¦ ¦would¦ ¦with¦ ¦other¦ ¦c lo th es¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦using¦ ¦a¦ ¦washing¦ ¦ma ch ine¦ .
𐋇 ¦ad d¦ ¦your¦ ¦face¦ ¦cov ers¦ ¦to¦ ¦your¦ ¦reg ular¦ ¦wash¦
𐋇 ¦use¦ ¦a¦ ¦reg ular¦ ¦la u nd ry¦ ¦det er g ent¦ ¦and¦ ¦s et¦ ¦the¦ ¦temp erat ure¦ ¦for¦ ¦the¦ ¦typ e¦ ¦of¦ ¦f ab r ic¦ ¦pres ent¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦washing¦ ¦by¦ ¦hand¦
𐋇 ¦wash¦ ¦your¦ ¦face¦ ¦cover¦ ¦with¦ ¦water¦ ¦and¦ ¦f ab r ic¦ ¦det er g ent¦ ¦or¦ ¦so a p¦
𐋇 ¦r in se¦ ¦th or ou gh ly¦ ¦with¦ ¦clean¦ ¦water¦ ¦to¦ ¦re mo ve¦ ¦the¦ ¦det er g ent¦ ¦or¦ ¦so a p¦ ¦ag a in¦
𐋇 ¦fo g¦ ¦on¦ ¦your¦ ¦gl as ses¦
𐋇¦there¦ ¦may¦ ¦be¦ ¦fo g¦ ¦on¦ ¦your¦ ¦gl as ses¦ ¦when¦ ¦you¦ ¦wear¦ ¦the¦ ¦face¦ ¦cover¦ .
𐋇¦the¦ ¦w ar m¦ ¦air ¦ ¦from¦ ¦your¦ ¦brea th¦ ¦p as ses¦ ¦out¦ ¦through¦ ¦the¦ ¦sur f ace¦ ¦of¦ ¦the¦ ¦face¦ ¦cover¦ .
𐋇¦this¦ ¦can¦ ¦cause¦ ¦fo g¦ ¦on¦ ¦your¦ ¦gl as ses¦ ¦and¦ ¦make¦ ¦you¦ ¦un able¦ ¦to¦ ¦se e¦ ¦cor r ect ly¦ .
𐋇 ¦cl ea ning¦ ¦your¦ ¦gl as ses¦ ¦will¦ ¦not¦ ¦cause¦ ¦as¦ ¦much¦ ¦fo g¦ .
𐋇 ¦before¦ ¦you¦ ¦p ut¦ ¦on¦ ¦the¦ ¦face¦ ¦cover¦ :
𐋇 ¦clean¦ ¦your¦ ¦gl as ses¦ ¦with¦ ¦water¦ ¦and¦ ¦so a p¦ .
𐋇 ¦sh a ke¦ ¦them¦ ¦to¦ ¦re mo ve¦ ¦the¦ ¦water¦ ¦from¦ ¦them¦ .
𐋇 ¦lea ve¦ ¦the¦ ¦gl as ses¦ ¦to¦ ¦air ¦ ¦d ry¦ ¦or¦ ¦d ry¦ ¦them¦ ¦with¦ ¦a¦ ¦clean¦ ¦c lo th¦ .
𐋇 ¦make¦ ¦sure¦ ¦the¦ ¦face¦ ¦cover¦ ¦is¦ ¦well¦ ¦comp r es sed¦
𐋇¦the¦ ¦face¦ ¦cover¦ ¦will¦ ¦sto p¦ ¦the¦ ¦fo g¦ ¦on¦ ¦your¦ ¦gl as ses¦ ¦if¦ ¦you¦ ¦p ut¦ ¦them¦ ¦on¦ ¦cor r ect ly¦ .
𐋇¦it¦ ¦do es n¦ ▁’▁ ¦t¦ ¦have¦ ¦to¦ ¦be¦ ¦u nc om f ort able¦ ¦but¦ ¦be¦ ¦per f ect ly¦ ¦s qu ee zed¦ ¦with¦ ¦no¦ ¦ga p¦ ¦around¦ ¦your¦ ¦nose¦ .
𐋇 ¦place¦ ¦your¦ ¦gl as ses¦ ¦over¦ ¦the¦ ¦face¦ ¦cover¦ ¦se al¦ ¦to¦ ¦keep¦ ¦your¦ ¦brea th¦ ¦away¦ ¦from¦ ¦your¦ ¦gl as ses¦ .
𐋇¦you¦ ¦may¦ ¦not¦ ¦be¦ ¦able¦ ¦to¦ ¦s et¦ ¦your¦ ¦face¦ ¦cover¦ ¦long¦ ¦up¦ ¦en ough¦ ¦on¦ ¦your¦ ¦face¦ ¦to¦ ¦do¦ ¦this¦ . .
𐋇¦if¦ ¦not¦ ,▁ ¦t ry¦ ¦st ic king¦ ¦the¦ ¦face¦ ¦cover¦ ¦under¦ ¦your¦ ¦gl as ses¦ ¦with¦ ¦t ap e¦ .
𐋇¦how¦ ¦to¦ ¦make¦ ¦one¦
𐋇¦to¦ ¦make¦ ¦a¦ ¦c lo th¦ ¦cover¦ ¦at¦ ¦home¦ :
𐋇¦c ut¦ ¦two¦ ¦ti gh t ly¦ ¦w ov en¦ ¦c ot t on¦ ¦rec ta ng les¦ ,▁ ¦about¦ ¦2 5 c m¦ ¦ x¦ ¦1 5 c m¦ .
𐋇 ¦fo ld¦ ¦and¦ ¦se w¦ ¦u pp er¦ ¦and¦ ¦lower¦ ¦ ed ges¦ .
𐋇 ¦fo ld¦ ¦and¦ ¦se w¦ ¦the¦ ¦ ed ges¦ ¦to¦ ¦the¦ ¦ side¦ ,▁ ¦lea ving¦ ¦a¦ ¦ga p¦ ¦large¦ ¦en ough¦ ¦to¦ ¦p ass¦ ¦e la st ic¦ .
𐋇 ¦i ns er t¦ ¦e la st ic¦ ¦1 5 c m¦ ¦long¦ ¦through¦ ¦the¦ ¦ side¦ ¦ ed ges¦ ¦and¦ ¦ti e¦ ¦them¦ ¦ti gh t ly¦ .
𐋇¦a¦ ¦h ai r¦ ¦ rib b on¦ ¦or¦ ¦t w ine¦ ¦c ut¦ ¦long¦ ¦en ough¦ ¦to¦ ¦ti e¦ ¦be h ind¦ ¦the¦ ¦h ead¦ ¦will¦ ¦work¦ .
𐋇 ¦fi x¦ ¦the¦ ¦e la st ic¦ ¦k no ts¦ ¦in side¦ ¦the¦ ¦ ed ges¦ ¦of¦ ¦the¦ ¦mask¦ ¦and¦ ¦g ri p¦ ¦if¦ ¦you¦ ¦need¦ ¦a¦ ¦ne at¦ ¦f in ish¦ .
𐋇¦how¦ ¦long¦ ¦will¦ ¦it¦ ¦last¦
𐋇¦f ac ial¦ ¦co ver age¦ ¦should¦ ¦be¦ ¦rem oved¦ ¦when¦ :
𐋇¦it¦ ¦no¦ ¦lo nger¦ ¦cov ers¦ ¦the¦ ¦nose¦ ¦and¦ ¦mouth¦
𐋇 ¦which¦ ¦are¦ ¦ rib b on¦ ,▁ ¦e la st ic¦ ,▁ ¦or¦ ¦stra ps¦ ¦ str et ched¦ ¦or¦ ¦da ma ged¦
𐋇¦h e¦ ¦can¦ ' ¦t¦ ¦stay¦ ¦on¦ ¦the¦ ¦f r on t¦
𐋇 ¦ho les¦ ¦in¦ ¦the¦ ¦c lo th¦ ¦or¦ ¦if¦ ¦it¦ ¦is¦ ¦t or n¦
𐋇¦how¦ ¦to¦ ¦use¦ ¦the¦ ¦face¦ ¦cover¦ ¦properly¦
𐋇 ¦clean¦ ¦your¦ ¦hands¦ ¦properly¦ ¦before¦ ¦app l ying¦ ¦it¦ .
𐋇 ¦pract ice¦ ¦using¦ ¦it¦ ¦so¦ ¦that¦ ¦you¦ ¦are¦ ¦c om f ort able¦ ¦w earing¦ ¦and¦ ¦re mo ving¦ ¦it¦ .
𐋇 ¦make¦ ¦sure¦ ¦it¦ ¦is¦ ¦made¦ ¦of¦ ¦a¦ ¦c lo th¦ ¦that¦ ¦you¦ ¦are¦ ¦c om f ort able¦ ¦with¦
𐋇 ¦cover¦ ¦your¦ ¦mouth¦ ¦and¦ ¦nose¦ ¦and¦ ¦make¦ ¦sure¦ ¦there¦ ¦are¦ ¦no¦ ¦ga ps¦ .
𐋇 ¦ti e¦ ¦it¦ ¦sec ur ely¦ .
𐋇 ¦car ry¦ ¦clean¦ ¦face¦ ¦cov ers¦ ¦in¦ ¦a¦ ¦se al ed¦ ¦ba g¦ ¦that¦ ¦is¦ ¦w at er p r oo f¦ .
𐋇 ¦car ry¦ ¦another¦ ¦similar¦ ¦ba g¦ ¦to¦ ¦p ut¦ ¦used¦ ¦cov ers¦ .
𐋇¦do¦ ¦not¦ ¦tou ch¦ ¦your¦ ¦face¦ ¦cover¦ ¦when¦ ¦w earing¦ ¦it¦ ▁-▁ ¦if¦ ¦it¦ ¦does¦ ,▁ ¦clean¦ ¦your¦ ¦hands¦ ¦properly¦ .
𐋇¦do¦ ¦not¦ ¦use¦ ¦a¦ ¦w et¦ ¦or¦ ¦di rt y¦ ¦face¦ ¦cover¦ .
𐋇¦do¦ ¦not¦ ¦share¦ ¦your¦ ¦face¦ ¦cover¦ ¦with¦ ¦others¦ .
𐋇¦d on¦ ' ¦t¦ ¦take¦ ¦off ¦ ¦your¦ ¦face¦ ¦cover¦ ¦for¦ ¦t al king¦ ,▁ ¦e ating¦ ¦and¦ ▁/▁ ¦or¦ ¦w a ving¦ ▁-▁ ¦if¦ ¦you¦ ¦need¦ ¦to¦ ¦exp ose¦ ¦your¦ ¦nose¦ ¦or¦ ¦mouth¦ ,▁ ¦take¦ ¦off ¦ ¦the¦ ¦cover¦ ¦and¦ ¦p ut¦ ¦it¦ ¦in¦ ¦your¦ ¦used¦ ¦cover¦ ¦ba g¦ .
𐋇¦do¦ ¦not¦ ¦th r ow¦ ¦away¦ ¦your¦ ¦face¦ ¦cov ers¦ ¦in¦ ¦public¦ ¦places¦ .
𐋇 ¦re mo ving¦ ¦your¦ ¦re us able¦ ¦face¦ ¦cover¦
𐋇¦to¦ ¦properly¦ ¦re mo ve¦ ¦the¦ ¦face¦ ¦cover¦ :
𐋇 ¦re mo ve¦ ¦it¦ ¦from¦ ¦the¦ ¦b ack¦ ¦of¦ ¦your¦ ¦h ead¦ ▁-▁ ¦do¦ ¦not¦ ¦l ay¦ ¦your¦ ¦hand¦ ¦on¦ ¦the¦ ¦p ie ce¦ ¦in¦ ¦f r on t¦ ¦of¦ ¦your¦ ¦face¦
𐋇¦p ut¦ ¦it¦ ¦in¦ ¦a¦ ¦se al ed¦ ¦ba g¦ ¦that¦ ¦is¦ ¦w a te rt ight¦ ¦or¦ ¦wash¦ ¦it¦ ¦imm ed ia tely¦ ▁-▁ ¦p ut¦ ¦dis p os able¦ ¦masks¦ ¦in¦ ¦a¦ ¦b in¦ ¦imm ed ia tely¦
𐋇 ¦clean¦ ¦your¦ ¦hands¦ ¦properly¦
𐋇 ¦masks¦ ¦of¦ ¦any¦ ¦use¦
𐋇¦how¦ ¦to¦ ¦sa f ely¦ ¦dis p ose¦ ¦of¦ ¦a¦ ¦dis p os able¦ ¦mask¦ :
𐋇 ¦re mo ve¦ ¦it¦ ¦from¦ ¦the¦ ¦b ack¦ ¦of¦ ¦your¦ ¦h ead¦ ▁-▁ ¦do¦ ¦not¦ ¦tou ch¦ ¦the¦ ¦f r on t¦ ¦of¦ ¦the¦ ¦mask¦
𐋇 ¦th r ow¦ ¦it¦ ¦away¦ ¦imm ed ia tely¦ ¦in¦ ¦a¦ ¦closed¦ ¦b in¦
𐋇 ¦clean¦ ¦your¦ ¦hands¦ ¦with¦ ¦an¦ ¦al c o ho l¦ - ¦based¦ ¦disinf ect ant¦ ¦or¦ ¦so a p¦ ¦and¦ ¦water¦
𐋇 ¦th r ow¦ ¦in¦ ¦the¦ ¦general¦ ¦b in¦ ¦at¦ ¦home¦ ¦or¦ ¦work¦ ,▁ ¦or¦ ¦in¦ ¦a¦ ¦b in¦ ¦if¦ ¦you¦ ¦are¦ ¦out¦
𐋇¦do¦ ¦not¦ ¦th r ow¦ ¦them¦ ¦in¦ ¦the¦ ¦rec y c l ing¦ ¦b in¦ ¦as¦ ¦they¦ ¦cannot¦ ¦be¦ ¦rec y c l ed¦
𐋇 ¦take¦ ¦them¦ ¦home¦ ¦if¦ ¦you¦ ¦d on¦ ' ¦t¦ ¦have¦ ¦a¦ ¦b in¦ ▁-▁ ¦d on¦ ' ¦t¦ ¦th r ow¦ ¦them¦ ¦away¦ ¦on¦ ¦the¦ ¦st re et¦ .
𐋇¦ che at¦ ¦and¦ ¦face¦ ¦sh ie ld¦
𐋇 ¦ce lls¦ ¦are¦ ¦not¦ ¦the¦ ¦b est¦ ¦o ption¦ ¦for¦ ¦prot ecting¦ ¦you¦ ¦and¦ ¦others¦ ¦from¦ ¦covid¦ - ¦19¦ .
𐋇¦they¦ ¦can¦ ¦sto p¦ ¦some¦ ¦of¦ ¦the¦ ¦dro pl ets¦ ¦from¦ ¦your¦ ¦mouth¦ ¦or¦ ¦nose¦ ¦from¦ ¦sprea ding¦ ¦and¦ ¦it¦ ¦is¦ ¦bet ter¦ ¦not¦ ¦to¦ ¦th r ow¦ ¦an y thing¦ ¦away¦ .
𐋇¦but¦ ¦you¦ ¦should¦ ¦only¦ ¦wear¦ ¦ che at ers¦ ¦if¦ ¦you¦ ¦are¦ ¦ ill¦ ¦or¦ ¦w ea k e ned¦ ¦and¦ ¦have¦ ¦diffic ult y¦ ¦w earing¦ ¦a¦ ¦face¦ ¦mask¦ .
𐋇¦the¦ ¦ce ll ul ite¦ ¦should¦ ¦cover¦ ¦the¦ ¦si des¦ ¦of¦ ¦your¦ ¦face¦ ▁( ¦from¦ ¦ ear¦ ¦to¦ ¦ ear¦ )▁ ¦and¦ ¦down¦ ¦under¦ ¦your¦ ¦ch in¦ .
𐋇 ¦re us able¦ ¦ce lls¦ ¦should¦ ¦al w ays¦ ¦be¦ ¦cl ea ned¦ ¦after¦ ¦wear¦ ¦and¦ ¦k e p t¦ ¦in¦ ¦a¦ ¦clean¦ ¦place¦ ¦until¦ ¦you¦ ¦need¦ ¦them¦ ¦ag a in¦ .
𐋇¦you¦ ¦should¦ ¦wear¦ ¦a¦ ¦mask¦ ¦if¦
𐋇¦you¦ ¦have¦ ¦the¦ ¦coronavirus¦ ,▁ ¦if¦ ¦you¦ ¦th ink¦ ¦you¦ ¦have¦ ¦the¦ ¦virus¦ ¦or¦ ¦are¦ ¦wai ting¦ ¦for¦ ¦a¦ ¦test¦ ¦result¦
𐋇¦you¦ ¦are¦ ¦car ing¦ ¦for¦ ¦someone¦ ¦who¦ ¦has¦ ¦or¦ ¦is¦ ¦suspected¦ ¦of¦ ¦having¦ ¦the¦ ¦cr own¦ ¦virus¦
𐋇¦you¦ ¦are¦ ¦wai ting¦ ¦for¦ ¦yourself¦ ¦and¦ ¦if¦ ¦you¦ ¦can¦ ' ¦t¦ ¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦other¦ ¦people¦ ¦in¦ ¦the¦ ¦house¦
𐋇¦f ac ial¦ ¦cover¦ ¦with¦ ¦v al ve¦ ¦or¦ ¦ ventil at or¦
𐋇¦a¦ ¦face¦ ¦cover¦ ¦with¦ ¦a¦ ¦v al ve¦ ¦or¦ ¦v ent¦ ¦does¦ ¦not¦ ¦protect¦ ¦you¦ ¦from¦ ¦covid¦ - ¦19¦
𐋇¦do¦ ¦not¦ ¦wear¦ ¦a¦ ¦face¦ ¦cover¦ ¦with¦ ¦v al ves¦ ¦or¦ ¦a¦ ¦f an¦ .
𐋇¦the¦ ¦face¦ ¦cov ers¦ ¦are¦ ¦not¦ ¦g ood¦ ¦en ough¦ ¦to¦ ¦sto p¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦virus¦ ¦as¦ ¦you¦ ¦could¦ ¦brea th e¦ ¦in¦ ¦or¦ ¦out¦ ¦of¦ ¦the¦ ¦virus¦ ¦through¦ ¦the¦ ¦v al ve¦ ¦or¦ ¦through¦ ¦the¦ ¦ ventil at or¦ .
𐋇¦they¦ ¦are¦ ¦us ually¦ ¦used¦ ¦by¦ ¦con st ru ction¦ ¦workers¦ ¦or¦ ¦a rt is ans¦ ¦for¦ ¦d ust¦ ¦prote ction¦ .
𐋇¦they¦ ¦are¦ ¦not¦ ¦d es ig ned¦ ¦to¦ ¦prevent¦ ¦the¦ ¦spread¦ ¦of¦ ¦viruses¦ .
𐋇 ¦medical¦ ¦mask¦
𐋇¦the¦ ¦medical¦ ¦mask¦ ¦is¦ ¦for¦ ¦these¦ ¦people¦ ;
𐋇 ¦health¦ ¦care¦ ¦workers¦
𐋇 ¦people¦ ¦who¦ ¦are¦ ¦self¦ - ¦isol ated¦ ¦and¦ ¦cannot¦ ¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦others¦ ¦in¦ ¦their¦ ¦ own¦ ¦home¦
𐋇¦they¦ ¦are¦ ¦also¦ ¦used¦ ¦by¦ ¦other¦ ¦workers¦ ¦in¦ ¦specific¦ ¦po si tions¦ .
𐋇¦these¦ ¦masks¦ ¦are¦ ¦very¦ ¦important¦ ¦and¦ ¦are¦ ¦not¦ ¦for¦ ¦the¦ ¦general¦ ¦public¦ ¦un less¦ ¦a¦ ¦person¦ ¦is¦ ¦self¦ - ¦isol ated¦ ¦and¦ ¦cannot¦ ¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦others¦ ¦in¦ ¦their¦ ¦home¦ .
𐋇 ¦wear¦ ¦a¦ ¦c lo th¦ - ¦ covered¦ ¦face¦ ¦mask¦ ¦when¦ ¦shopping¦ ¦and¦ ¦on¦ ¦public¦ ¦transport¦ .
𐋇¦this¦ ¦will¦ ¦e ns ure¦ ¦that¦ ¦the¦ ¦medical¦ ¦masks¦ ¦are¦ ¦available¦ ¦to¦ ¦those¦ ¦who¦ ¦need¦ ¦them¦ .
𐋇 ¦dis p os able¦ ¦g lo ves¦
𐋇¦do¦ ¦not¦ ¦wear¦ ¦dis p os able¦ ¦g lo ves¦ ¦inst ead¦ ¦of¦ ¦washing¦ ¦your¦ ¦hands¦ .
𐋇¦the¦ ¦virus¦ ¦st ays¦ ¦on¦ ¦them¦ ¦in¦ ¦the¦ ¦same¦ ¦way¦ ¦it¦ ¦st ays¦ ¦on¦ ¦your¦ ¦hands¦ .
𐋇 ¦also¦ ,▁ ¦the¦ ¦virus¦ ¦can¦ ¦spread¦ ¦to¦ ¦your¦ ¦hands¦ ¦when¦ ¦you¦ ¦tou ch¦ ¦them¦ .
𐋇 ¦dis p os able¦ ¦g lo ves¦ ¦are¦ ¦wor n¦ ¦in¦ ¦medical¦ ¦s et t ings¦ .
𐋇¦they¦ ¦are¦ ¦not¦ ¦as¦ ¦effective¦ ¦in¦ ¦e ver y day¦ ¦l ife¦ .
𐋇¦w earing¦ ¦dis p os able¦ ¦g lo ves¦ ¦may¦ ¦make¦ ¦you¦ ¦feel¦ ¦safe¦ ¦but¦ ¦this¦ ¦is¦ ¦not¦ ¦the¦ ¦case¦
𐋇 ¦sneezing¦ ¦or¦ ¦cou g hing¦ ¦into¦ ¦g lo ves¦ ▁-▁ ¦this¦ ¦cre ates¦ ¦a¦ ¦new¦ ¦sur f ace¦ ¦on¦ ¦which¦ ¦the¦ ¦virus¦ ¦can¦ ¦sur v ive¦
𐋇 ¦give¦ ¦yourself¦ ¦the¦ ¦virus¦ ¦when¦ ¦you¦ ¦take¦ ¦off ¦ ¦your¦ ¦g lo ves¦ ¦or¦ ¦l ay¦ ¦a¦ ¦hand¦ ¦on¦ ¦some¦ ¦sur f ace¦
𐋇 ¦not¦ ¦washing¦ ¦your¦ ¦hands¦ ¦as¦ ¦often¦ ¦as¦ ¦ne cess ary¦ ¦and¦ ¦p ut ting¦ ¦the¦ ¦conta min ated¦ ¦g lo ves¦ ¦on¦ ¦your¦ ¦face¦ ¦how¦ ¦to¦ ¦wash¦ ¦your¦ ¦hands¦ ¦properly¦ ¦and¦ ¦avoid¦ ¦infection¦
𐋇¦how¦ ¦to¦ ¦clean¦ ¦your¦ ¦hands¦
𐋇 ¦cl ea ning¦ ¦your¦ ¦hands¦ ¦will¦ ¦help¦ ¦control¦ ¦the¦ ¦spread¦ ¦of¦ ¦ba ct er ia¦ ¦and¦ ¦viruses¦ ¦that¦ ¦cause¦ ¦infections¦ .
𐋇¦h u nd re ds¦ ¦of¦ ¦people¦ ¦bec ome¦ ¦ ill¦ ¦every¦ ¦day¦ ¦in¦ ¦ireland¦ ¦from¦ ¦associated¦ ¦healthcare¦ ¦infections¦ .
𐋇¦you¦ ¦could¦ ¦get¦ ¦a¦ ¦ser ious¦ ¦illness¦ ,▁ ¦even¦ ¦death¦ ,▁ ¦with¦ ¦these¦ ¦infections¦ .
𐋇¦the¦ ¦b est¦ ¦way¦ ¦to¦ ¦sto p¦ ¦h arm ful¦ ¦g er ms¦ ¦from¦ ¦sprea ding¦ ¦is¦ ¦by¦ ¦cl ea ning¦ ¦your¦ ¦hands¦ .
𐋇 ¦about¦ ¦30¦ %▁ ¦to¦ ¦50¦ %▁ ¦of¦ ¦infections¦ ¦that¦ ¦star t¦ ¦in¦ ¦hosp it als¦ ¦can¦ ¦be¦ ¦a v oi ded¦ .
𐋇 ¦clean¦ ¦your¦ ¦hands¦
𐋇 ¦use¦ ¦so a p¦ ¦and¦ ¦water¦ ¦or¦ ¦al c o ho l¦ ¦hand¦ ¦ ge l¦ ¦to¦ ¦clean¦ ¦your¦ ¦hands¦ ¦regul arly¦ .
𐋇 ¦hand¦ ¦disinf ec ta nts¦ ¦con tain¦ ¦al c o ho l¦ ¦and¦ ¦are¦ ¦ext re m ely¦ ¦f la mm able¦ .
𐋇¦do¦ ¦not¦ ¦use¦ ¦them¦ ¦n ear¦ ¦he at¦ ¦or¦ ¦f ir e¦ .
𐋇¦how¦ ¦to¦ ¦wash¦ ¦your¦ ¦hands¦ ¦with¦ ¦so a p¦ ¦and¦ ¦water¦
𐋇¦w et¦ ¦your¦ ¦hands¦ ¦with¦ ¦w ar m¦ ¦water¦ ¦and¦ ¦so a p¦ .
𐋇 ¦r ub ¦ ¦your¦ ¦hands¦ ¦t og ether¦ ¦until¦ ¦fo am¦ ¦is¦ ¦for med¦ .
𐋇 ¦r ub ¦ ¦the¦ ¦to p¦ ¦of¦ ¦your¦ ¦hands¦ ,▁ ¦between¦ ¦your¦ ¦fi ng ers¦ ¦and¦ ¦under¦ ¦your¦ ¦fi ng ers¦ .
𐋇¦do¦ ¦this¦ ¦for¦ ¦about¦ ¦20¦ ¦sec on ds¦ .
𐋇 ¦clean¦ ¦your¦ ¦hands¦ ¦under¦ ¦r un ning¦ ¦water¦ .
𐋇¦d ry¦ ¦your¦ ¦hands¦ ¦with¦ ¦a¦ ¦clean¦ ¦to we l¦ ¦or¦ ¦p ap er¦ ¦to we l¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦d ry¦ ¦s k in¦ ¦or¦ ¦a¦ ¦prob le m¦ ¦with¦ ¦your¦ ¦s k in¦ ,▁ ¦use¦ ¦a¦ ¦mo ist ur iz er¦ ¦after¦ ¦washing¦ ¦your¦ ¦hands¦ ¦and¦ ¦at¦ ¦n ight¦ .
𐋇 ¦hand¦ ¦h yg ien e¦ ¦at¦ ¦home¦
𐋇 ¦make¦ ¦sure¦ ¦you¦ ¦wash¦ ¦your¦ ¦hands¦ ¦when¦ ¦you¦ ¦are¦ ¦at¦ ¦home¦ ¦and¦ ¦not¦ ¦in¦ ¦hospital¦ :
𐋇 ¦after¦ ¦you¦ ¦use¦ ¦the¦ ¦to il et¦
𐋇¦when¦ ¦you¦ ¦clean¦ ¦up¦ ¦after¦ ¦your¦ ¦p et¦
𐋇 ¦before¦ ¦pre par ing¦ ¦food¦ ,▁ ¦before¦ ¦hand l ing¦ ¦food¦ ¦or¦ ¦before¦ ¦a¦ ¦me al¦
𐋇 ¦after¦ ¦de al ing¦ ¦with¦ ¦ra w¦ ¦me at¦
𐋇 ¦after¦ ¦using¦ ¦public¦ ¦transport¦
𐋇¦when¦ ¦you¦ ¦retur n¦ ¦home¦ ¦after¦ ¦m ee ting¦ ¦a¦ ¦l ot¦ ¦of¦ ¦people¦
𐋇 ¦cl ea ning¦ ¦your¦ ¦hands¦ ¦will¦ ¦help¦ ¦you¦ ¦avoid¦ :
𐋇¦c ol ds¦ ¦and¦ ¦flu¦
𐋇 ¦sto ma ch¦ ¦a ches¦ ¦such¦ ¦as¦ ¦no ro vir us¦ ¦di arr he a¦
𐋇 ¦ey e¦ ¦infections¦ ¦such¦ ¦as¦ ¦con j un ct iv itis¦
𐋇 ¦bu ll f r og s¦ ¦such¦ ¦as¦ ¦m rs a¦ ¦and¦ ¦v r e¦
𐋇 ¦children¦ ¦often¦ ¦have¦ ¦these¦ ¦infections¦ ,▁ ¦par ents¦ ¦and¦ ¦ch ild c are¦ ¦workers¦ ¦should¦ ¦al w ays¦ ¦make¦ ¦sure¦ ¦that¦ ¦children¦ ¦clean¦ ¦their¦ ¦hands¦ ¦regul arly¦ .
𐋇 ¦hand¦ ¦h yg ien e¦ ¦in¦ ¦health¦ ¦care¦ ¦centr es¦
𐋇 ¦patients¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦pa ti ent¦ ¦with¦ ¦an¦ ¦infection¦ ,▁ ¦the¦ ¦staff¦ ¦will¦ ¦support¦ ¦you¦ ¦and¦ ¦t ell¦ ¦you¦ ¦how¦ ¦to¦ ¦control¦ ¦the¦ ¦spread¦ ¦of¦ ¦ba ct er ia¦ ▁( ¦g er ms¦ ).
𐋇 ¦follow¦ ¦all¦ ¦the¦ ¦in str uc tions¦ ¦giv en¦ ¦to¦ ¦you¦ ¦by¦ ¦your¦ ¦doctor¦ ¦or¦ ¦n ur se¦ ¦to¦ ¦help¦ ¦keep¦ ¦your¦ ¦infection¦ ¦under¦ ¦control¦ .
𐋇¦the¦ ¦b est¦ ¦way¦ ¦to¦ ¦avoid¦ ¦and¦ ¦prevent¦ ¦infection¦ ¦is¦ ¦to¦ :
𐋇 ¦clean¦ ¦your¦ ¦hands¦ ¦often¦
𐋇¦do¦ ¦not¦ ¦for g et¦ ¦to¦ ¦clean¦ ¦your¦ ¦hands¦ ¦properly¦ ¦after¦ ¦go ing¦ ¦to¦ ¦the¦ ¦to il et¦ ¦and¦ ¦before¦ ¦a¦ ¦me al¦
𐋇 ¦use¦ ¦your¦ ¦ own¦ ¦so a p¦ ,▁ ¦f l an ne l¦ ,▁ ¦sp on ge¦ ¦and¦ ¦ra z or¦
𐋇¦do¦ ¦not¦ ¦share¦ ¦new s p ap ers¦ ¦or¦ ¦an y thing¦ ¦personal¦ ¦with¦ ¦other¦ ¦patients¦
𐋇 ¦restrict¦ ¦any¦ ¦contact¦ ¦with¦ ¦patients¦ ¦and¦ ¦stay¦ ¦out¦ ¦of¦ ¦b ed¦
𐋇¦t ell¦ ¦staff¦ ¦if¦ ¦the¦ ¦facil ities¦ ¦at¦ ¦the¦ ¦hospital¦ ¦or¦ ¦cl in ic¦ ¦are¦ ¦not¦ ¦clean¦
𐋇¦you¦ ¦are¦ ¦less¦ ¦likely¦ ¦to¦ ¦spread¦ ▁' ¦g er ms¦ ' ▁ ¦at¦ ¦home¦ .
𐋇¦but¦ ¦you¦ ¦should¦ ¦al w ays¦ ¦keep¦ ¦your¦ ¦hands¦ ¦and¦ ¦to il et¦ ¦clean¦ .
𐋇 ¦visi t ors¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦visi ting¦ ¦a¦ ¦pa ti ent¦ ,▁ ¦clean¦ ¦your¦ ¦hands¦ ¦when¦ ¦you¦ ¦en ter¦ ¦and¦ ¦lea ve¦ ¦the¦ ¦w ard¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦ma king¦ ¦a¦ ¦long¦ ¦visit¦ ¦or¦ ¦h el p ing¦ ¦a¦ ¦pa ti ent¦ ,▁ ¦clean¦ ¦your¦ ¦hands¦ ¦regul arly¦ ¦while¦ ¦you¦ ¦are¦ ¦there¦ .
𐋇¦you¦ ¦can¦ ¦use¦ ¦so a p¦ ¦and¦ ¦water¦ ¦or¦ ¦al c o ho l¦ ¦ ge l¦ ¦available¦ ¦at¦ ¦the¦ ¦hospital¦ ▁/▁ ¦health¦ ¦center¦ .
𐋇¦if¦ ¦there¦ ¦is¦ ¦any¦ ¦dir t¦ ¦on¦ ¦your¦ ¦hands¦ ¦or¦ ¦under¦ ¦your¦ ¦fi ng ers¦ ,▁ ¦you¦ ¦will¦ ¦need¦ ¦to¦ ¦use¦ ¦so a p¦ ¦and¦ ¦water¦ .
𐋇¦you¦ ¦can¦ ¦then¦ ¦e ns ure¦ ¦that¦ ¦they¦ ¦are¦ ¦properly¦ ¦cl ea ned¦ ¦by¦ ¦using¦ ¦al c o ho l¦ ¦ ge l¦ .
𐋇 ¦vaccine¦
𐋇¦a¦ ¦vaccine¦ ¦reduc es¦ ¦infections¦ ¦and¦ ¦prot ects¦ ¦you¦ ¦and¦ ¦your¦ ¦family¦ .
𐋇 ¦as k¦ ¦your¦ ¦doctor¦ ¦or¦ ¦ph arm ac ist¦ ¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦had¦ ¦all¦ ¦the¦ ¦appr op ri ate¦ ¦in j ec tions¦ .
𐋇 ¦as k¦ ¦your¦ ¦doctor¦ ¦or¦ ¦ph arm ac ist¦ ¦if¦ ¦you¦ ¦should¦ ¦get¦ ¦this¦ ¦year¦ ' ¦s¦ ¦flu¦ ¦vaccine¦ ¦or¦ ¦a¦ ¦vaccine¦ ¦to¦ ¦protect¦ ¦you¦ ¦from¦ ¦pneumonia¦ .
𐋇¦this¦ ¦is¦ ¦especially¦ ¦important¦ ¦for¦ ¦the¦ ¦el d erly¦ ¦or¦ ¦those¦ ¦with¦ ¦long¦ - ¦ter m¦ ¦health¦ ¦i ll n es ses¦ .
𐋇 ¦sto p¦ ¦s mo king¦ ¦during¦ ¦the¦ ¦corona ry¦ ¦virus¦ ¦outbreak¦
𐋇¦do¦ ¦you¦ ¦al rea dy¦ ¦have¦ ¦a¦ ¦sto p¦ ¦pl an¦ ▁( ¦qu i t¦ ) ? ▁ 𐋇¦s ign¦ ¦in¦
𐋇¦if¦ ¦you¦ ¦s mo ke¦ ,▁ ¦you¦ ¦are¦ ¦at¦ ¦g rea ter¦ ¦risk¦ ¦of¦ ¦develop ing¦ ¦an¦ ¦acute¦ ¦respiratory¦ ¦infection¦ ¦such¦ ¦as¦ ¦the¦ ¦flu¦ .
𐋇¦s mo k ers¦ ¦are¦ ¦at¦ ¦g rea ter¦ ¦risk¦ ¦of¦ ¦getting¦ ¦the¦ ¦flu¦ ¦and¦ ¦getting¦ ¦a¦ ¦wor se¦ ¦infection¦ ¦than¦ ¦non¦ ▁-▁ ¦s mo k ers¦ .
𐋇 ¦al th ough¦ ¦it¦ ¦is¦ ¦a¦ ¦new¦ ¦virus¦ ,▁ ¦it¦ ¦is¦ ¦n ow¦ ¦cl ear¦ ¦that¦ ¦people¦ ¦are¦ ¦also¦ ¦at¦ ¦risk¦ ¦from¦ ¦the¦ ¦coronavirus¦ ,▁ ¦because¦ ¦they¦ ¦s mo ke¦ .
𐋇 ¦like¦ ¦the¦ ¦flu¦ ,▁ ¦corona ry¦ ¦virus¦ ¦may¦ ¦be¦ ¦wor se¦ ¦for¦ ¦s mo k ers¦ ,
𐋇¦if¦ ¦you¦ ¦s mo ke¦ ,▁ ¦you¦ ¦do¦ ¦not¦ ¦need¦ ¦self¦ - ¦isolation¦ ¦un less¦ ¦you¦ ¦have¦ ¦symptoms¦ .
𐋇¦but¦ ¦you¦ ¦should¦ ¦follow¦ ¦the¦ ¦same¦ ¦advice¦ ¦as¦ ¦e veryone¦ ¦el se¦ :▁ 𐋇¦stay¦ ¦home¦ ¦and¦ ¦protect¦ ¦yourself¦ ¦from¦ ¦the¦ ¦cr own¦ ¦virus¦ .
𐋇¦this¦ ¦is¦ ¦a¦ ¦g ood¦ ¦time¦ ¦to¦ ¦qu i t¦ ¦s mo king¦ .
𐋇 ¦sto pping¦ ¦s mo king¦ ¦will¦ ¦st re ng th en¦ ¦your¦ ¦nat ural¦ ¦def en ses¦ ¦against¦ ¦all¦ ¦typ es¦ ¦of¦ ¦infections¦ ,▁ ¦including¦ ¦the¦ ¦coronavirus¦ .
𐋇¦when¦ ¦you¦ ¦sto p¦ ,▁ ¦the¦ ¦ha ir s¦ ¦in¦ ¦your¦ ¦air w ays¦ ▁( ¦c il ia¦ )▁ ¦will¦ ¦star t¦ ¦wor king¦ ¦ag a in¦ .
𐋇 ¦within¦ ¦a¦ ¦day¦ ¦or¦ ¦two¦ ,▁ ¦the¦ ¦o x yg en¦ ¦le v els¦ ¦in¦ ¦your¦ ¦body¦ ¦will¦ ¦imp ro ve¦ .
𐋇¦your¦ ¦blood¦ ¦pre ss ure¦ ¦and¦ ¦p ul se¦ ¦will¦ ¦dec re ase¦ ,▁ ¦which¦ ¦will¦ ¦reduce¦ ¦the¦ ¦ str ess¦ ¦on¦ ¦your¦ ¦body¦ .
𐋇 ¦each¦ ¦of¦ ¦these¦ ¦will¦ ¦give¦ ¦you¦ ¦prote ction¦ ¦against¦ ¦the¦ ¦coronavirus¦ .
𐋇¦how¦ ¦t ob ac c o¦ ¦h ar ms¦ ¦you¦
𐋇¦w ea k er¦ ¦h ear t¦ ¦and¦ ¦lu ng s¦
𐋇¦s mo king¦ ¦aff ects¦ ¦the¦ ¦way¦ ¦your¦ ¦h ear t¦ ¦and¦ ¦lu ng s¦ ¦work¦ ,▁ ¦ma king¦ ¦it¦ ¦less¦ ¦e as y¦ ¦for¦ ¦you¦ ¦to¦ ¦f ight¦ ¦off ¦ ¦an¦ ¦acute¦ ¦infection¦ ,▁ ¦such¦ ¦as¦ ¦the¦ ¦flu¦ ¦or¦ ¦the¦ ¦corona ry¦ ¦virus¦ .
𐋇¦c ig ar et t e¦ ¦s mo ke¦ ¦da ma ges¦ ¦the¦ ¦nat ural¦ ¦b ar ri ers¦ ¦to¦ ¦infection¦ ¦in¦ ¦the¦ ¦lu ng s¦ ,▁ ¦ma king¦ ¦it¦ ¦ ea si er¦ ¦for¦ ¦the¦ ¦virus¦ ¦to¦ ¦att a ch¦ ¦to¦ ¦the¦ ¦sur f ace¦ ¦of¦ ¦your¦ ¦lu ng¦ ¦and¦ ¦cause¦ ¦infection¦ ¦of¦ ¦the¦ ¦lu ng¦ ¦ti ss ues¦ .
𐋇 ¦la ying¦ ¦a¦ ¦hand¦ ¦on¦ ¦your¦ ¦face¦
𐋇¦the¦ ¦corona ry¦ ¦virus¦ ¦is¦ ¦spread¦ ¦in¦ ¦sneezing¦ ¦or¦ ¦cou g hing¦ ¦dro ps¦ ,▁ ¦it¦ ¦has¦ ¦to¦ ¦go¦ ¦from¦ ¦the¦ ¦infected¦ ¦nose¦ ¦or¦ ¦mouth¦ ¦and¦ ¦into¦ ¦your¦ ¦ own¦ ¦ey es¦ ,▁ ¦nose¦ ¦or¦ ¦mouth¦ ¦to¦ ¦inf ect¦ ¦you¦ .
𐋇¦this¦ ¦can¦ ¦happ en¦ ¦dir ect ly¦ ¦or¦ ¦ind ir ect ly¦ ▁( ¦on¦ ¦hands¦ ,▁ ¦ob j ects¦ ,▁ ¦sur fa ces¦ ).
𐋇¦e veryone¦ ¦is¦ ¦ad vi sed¦ ¦not¦ ¦to¦ ¦l ay¦ ¦a¦ ¦hand¦ ¦on¦ ¦their¦ ¦face¦ .
𐋇¦but¦ ¦when¦ ¦you¦ ¦s mo ke¦ ,▁ ¦chan ces¦ ¦are¦ ¦you¦ ¦p ut¦ ¦your¦ ¦hands¦ ¦on¦ ¦your¦ ¦face¦ ,▁ ¦especially¦ ¦your¦ ¦mouth¦ .
𐋇¦this¦ ¦inc rea ses¦ ¦the¦ ¦risk¦ ¦of¦ ¦infection¦ .
𐋇 ¦protect¦ ¦yourself¦ ¦and¦ ¦others¦ ¦from¦ ¦coronavirus¦
𐋇¦d on¦ ▁’▁ ¦t¦ ¦be¦ ¦to o¦ ¦close¦ ¦to¦ ¦others¦
𐋇 ¦social¦ ¦separ ation¦ ¦is¦ ¦important¦ ¦to¦ ¦help¦ ¦cur b ¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦coronavirus¦ .
𐋇¦this¦ ¦is¦ ¦d one¦ ¦by¦ ¦re stric ting¦ ¦contact¦ ¦between¦ ¦pote nt ially¦ ¦infected¦ ¦people¦ ¦and¦ ¦healthy¦ ¦people¦ .
𐋇¦you¦ ¦should¦ ¦stay¦ ¦2¦ ¦meters¦ ▁( ¦6¦ . ¦5¦ ¦fe et¦ )▁ ¦away¦ ¦from¦ ¦others¦ .
𐋇 ¦people¦ ¦t end¦ ¦to¦ ¦be¦ ¦close¦ ¦to¦ ¦others¦ ¦when¦ ¦they¦ ¦are¦ ¦s mo king¦ .
𐋇 ¦qu it ting¦ ¦s mo king¦ ¦will¦ ¦reduce¦ ¦the¦ ¦risk¦ ¦of¦ ¦infection¦ .
𐋇 ¦social¦ ¦separ ation¦
𐋇 ¦sh ar ing¦ ¦c ig ar et tes¦
𐋇 ¦g ood¦ ¦h yg ien e¦ ¦and¦ ¦hand w as hing¦ ¦are¦ ¦very¦ ¦important¦ ¦at¦ ¦the¦ ¦pres ent¦ ¦time¦ .
𐋇¦the¦ ¦advice¦ ¦of¦ ¦public¦ ¦health¦ ¦do ctors¦ ¦is¦ ¦that¦ ¦we¦ ¦should¦ ¦not¦ ¦share¦ ¦th ings¦ ¦that¦ ¦come¦ ¦into¦ ¦our¦ ¦m ou ths¦ ,▁ ¦such¦ ¦as¦ ¦b ot t les¦ ¦or¦ ¦c u ps¦ .
𐋇¦c ig ar et tes¦ ¦should¦ ¦the re f ore¦ ¦not¦ ¦be¦ ¦sh ared¦ ¦with¦ ¦others¦ .
𐋇 ¦g ood¦ ¦h yg ien e¦ ¦and¦ ¦hand¦ ¦washing¦ .
𐋇¦s mo ke¦ ¦from¦ ¦other¦ ¦people¦ ' ¦s¦ ¦c ig ar et tes¦
𐋇¦s mo king¦ ¦ind o ors¦ ¦p u ts¦ ¦your¦ ¦clos est¦ ¦people¦ ¦at¦ ¦risk¦ ¦because¦ ¦your¦ ¦second¦ - ¦hand¦ ¦s mo ke¦ ¦inter f er es¦ ¦with¦ ¦the¦ ¦body¦ ' ¦s¦ ¦nat ural¦ ¦def en ces¦ ¦to¦ ¦f ight¦ ¦infections¦ ¦such¦ ¦as¦ ¦coronavirus¦ .
𐋇 ¦children¦ ¦in¦ ¦partic ular¦ ¦are¦ ¦at¦ ¦risk¦ ¦of¦ ¦second¦ - ¦hand¦ ¦s mo ke¦ ¦because¦ ¦they¦ ¦brea th e¦ ¦f as ter¦ ,▁ ¦and¦ ¦their¦ ¦lu ng s¦ ,▁ ¦air w ays¦ ¦and¦ ¦immune¦ ¦system¦ ¦are¦ ¦still¦ ¦develop ing¦ .
𐋇¦the¦ ¦b est¦ ¦way¦ ¦to¦ ¦avoid¦ ¦this¦ ¦and¦ ¦to¦ ¦protect¦ ¦others¦ ¦is¦ ¦to¦ ¦qu i t¦ ¦s mo king¦ .
𐋇 ¦get¦ ¦advice¦ ¦on¦ ¦how¦ ¦to¦ ¦do¦ ¦this¦ ¦from¦ ¦the¦ ¦online¦ ¦qu i t¦ ¦supp orts¦ ,▁ ¦get¦ ¦star ted¦ ¦on¦ ¦a¦ ¦personal¦ ¦qu it pl an¦ ¦pl an¦ ¦or¦ ¦jo in¦ ¦us¦ ¦on¦ ¦fa ce b ook¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦al rea dy¦ ¦reg ist ered¦ ¦for¦ ¦support¦ ¦from¦ ¦the¦ ▁' ¦sto p¦ ' ▁ ¦team¦
𐋇 ¦or d in ary¦ ¦cold¦
𐋇 ¦signs¦ ¦of¦ ¦the¦ ¦cold¦
𐋇¦the¦ ¦first¦ ¦s ign¦ ¦of¦ ¦a¦ ¦cold¦ ¦is¦ ¦a¦ ¦s ore¦ ¦th ro at¦ .
𐋇 ¦then¦ ¦c omes¦ ¦a¦ ¦sneezing¦ ¦or¦ ¦st u ff y¦ ,▁ ¦sick¦ ¦or¦ ¦th ou gh t ful¦ ¦nose¦ .
𐋇 ¦one¦ ¦in¦ ¦three¦ ¦people¦ ¦who¦ ¦c at ch¦ ¦a¦ ¦cold¦ ¦us ually¦ ¦have¦ ¦a¦ ¦cough¦ ¦and¦ ¦feel¦ ¦sick¦ .
𐋇¦a¦ ¦cold¦ ¦is¦ ¦caused¦ ¦by¦ ¦a¦ ¦virus¦ .
𐋇 ¦anti b i ot ics¦ ¦will¦ ¦not¦ ¦c ure¦ ¦viruses¦ .
𐋇 ¦water¦ ¦dis a pp ear s¦ ¦from¦ ¦the¦ ¦body¦ ¦when¦ ¦a¦ ¦person¦ ¦sw ea ts¦ ¦or¦ ¦s n ee z es¦ .
𐋇 ¦the re f ore¦ ,▁ ¦it¦ ¦is¦ ¦important¦ ¦to¦ ¦dr ink¦ ¦p le nt y¦ ¦of¦ ¦f lu i ds¦ .
𐋇 ¦take¦ ¦a¦ ¦brea k¦ ¦and¦ ¦e at¦ ¦he al t hi ly¦ .
𐋇¦do¦ ¦not¦ ¦as k¦ ¦your¦ ¦doctor¦ ¦for¦ ¦anti b i ot ics¦ ¦when¦ ¦you¦ ¦have¦ ¦a¦ ¦cold¦ .
𐋇¦you¦ ¦us ually¦ ¦feel¦ ¦wor se¦ ¦for¦ ¦2¦ - ¦3¦ ¦days¦ ¦before¦ ¦you¦ ¦g rad ually¦ ¦star t¦ ¦to¦ ¦reco ver¦ .
𐋇¦the¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦us ually¦ ¦last¦ ¦for¦ ¦a¦ ¦week¦ .
𐋇 ¦cold¦ ¦symptoms¦ ¦are¦ ¦very¦ ¦similar¦ ¦to¦ ¦the¦ ¦symptoms¦ ¦of¦ ¦the¦ ¦flu¦ ,▁ ¦but¦ ¦the¦ ¦flu¦ ¦is¦ ¦much¦ ¦more¦ ¦ser ious¦ .
𐋇 ¦cold¦
𐋇¦it¦ ¦c omes¦ ¦to¦ ¦you¦ ¦g rad ually¦
𐋇¦you¦ ¦us ually¦ ¦feel¦ ¦it¦ ¦in¦ ¦your¦ ¦nose¦ ¦and¦ ¦th ro at¦
𐋇¦you¦ ¦feel¦ ¦sick¦ ¦but¦ ¦you¦ ¦are¦ ¦able¦ ¦to¦ ¦continue¦ ¦as¦ ¦normal¦ ▁-▁ ¦for¦ ¦example¦ ,▁ ¦go ing¦ ¦to¦ ¦work¦
𐋇 ¦flu¦
𐋇¦it¦ ¦c omes¦ ¦to¦ ¦you¦ ¦qu ick ly¦ ¦within¦ ¦a¦ ¦fe w¦ ¦hours¦
𐋇¦you¦ ¦us ually¦ ¦feel¦ ¦it¦ ¦in¦ ¦your¦ ¦nose¦ ¦and¦ ¦th ro at¦
𐋇¦you¦ ¦get¦ ¦t ir ed¦ ¦and¦ ¦un able¦ ¦to¦ ¦continue¦ ¦as¦ ¦us ual¦
𐋇 ¦signs¦ ¦of¦ ¦the¦ ¦cold¦ :
𐋇¦a¦ ¦st u ff y¦ ¦or¦ ¦s mo k y¦ ¦nose¦
𐋇¦s ore¦ ¦th ro at¦
𐋇¦h ea d a ch e¦
𐋇¦m us c le¦ ¦pa ins¦
𐋇 ¦cough¦
𐋇 ¦sneezing¦
𐋇 ¦high¦ ¦temp erat ure¦
𐋇 ¦pre ss ure¦ ¦in¦ ¦your¦ ¦ ear s¦ ¦and¦ ¦face¦
𐋇¦you¦ ¦get¦ ¦no¦ ¦ta st e¦ ¦or¦ ¦sm ell¦ ¦of¦ ¦an y thing¦
𐋇 ¦ad ul ts¦ ¦and¦ ¦children¦ ¦have¦ ¦the¦ ¦same¦ ¦symptoms¦ .
𐋇¦s om et im es¦ ¦the¦ ¦symptoms¦ ¦last¦ ¦lo nger¦ ¦in¦ ¦children¦ .
𐋇 ¦ca u ses¦ ¦of¦ ¦the¦ ¦cold¦
𐋇¦a¦ ¦cold¦ ¦is¦ ¦caused¦ ¦by¦ ¦a¦ ¦virus¦ .
𐋇¦they¦ ¦spread¦ ¦ ea si ly¦ ¦among¦ ¦people¦ .
𐋇¦you¦ ¦bec ome¦ ¦conta g ious¦ ¦until¦ ¦all¦ ¦the¦ ¦symptoms¦ ¦are¦ ¦g one¦ .
𐋇¦this¦ ¦us ually¦ ¦ta k es¦ ¦about¦ ¦a¦ ¦week¦ .
𐋇 ¦cou g hing¦ ¦and¦ ¦sneezing¦ ¦sprea ds¦ ¦g er ms¦ ¦that¦ ¦can¦ ¦live¦ ¦on¦ ¦hands¦ ¦and¦ ¦sur fa ces¦ ¦for¦ ¦24¦ ¦hours¦ .
𐋇¦to¦ ¦reduce¦ ¦the¦ ¦spread¦ ¦of¦ ¦a¦ ¦cold¦ ,▁ ¦do¦ ¦the¦ ¦following¦ :
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦with¦ ¦w ar m¦ ¦water¦ ¦and¦ ¦so a p¦
𐋇 ¦cough¦ ¦into¦ ¦your¦ ¦el b ow¦ ¦to¦ ¦make¦ ¦sure¦ ¦you¦ ¦d on¦ ' ¦t¦ ¦spread¦ ¦g er ms¦ ¦on¦ ¦your¦ ¦hands¦ ¦or¦ ¦others¦
𐋇 ¦use¦ ¦a¦ ¦ti ss ue¦ ¦to¦ ¦c at ch¦ ¦the¦ ¦g er ms¦ ¦when¦ ¦you¦ ¦cough¦ ¦or¦ ¦s n ee z e¦
𐋇 ¦th r ow¦ ¦the¦ ¦p ap er¦ ¦to we l¦ ¦in¦ ¦the¦ ¦b in¦ ¦as¦ ¦so on¦ ¦as¦ ¦possible¦
𐋇¦how¦ ¦to¦ ¦avoid¦ ¦c ol ds¦
𐋇¦the¦ ¦b est¦ ¦w ays¦ ¦to¦ ¦avoid¦ ¦c ol ds¦ ¦are¦ :
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦with¦ ¦w ar m¦ ¦water¦ ¦and¦ ¦so a p¦ ,▁ ¦especially¦ ¦before¦ ¦me als¦ .
𐋇¦do¦ ¦not¦ ¦share¦ ¦t ow els¦ ¦or¦ ¦c u ps¦ ¦with¦ ¦a¦ ¦cold¦
𐋇¦do¦ ¦not¦ ¦tou ch¦ ¦your¦ ¦ey es¦ ¦or¦ ¦nose¦ .
𐋇¦you¦ ¦could¦ ¦get¦ ¦yourself¦ ¦infected¦ ¦if¦ ¦you¦ ¦have¦ ¦the¦ ¦virus¦ .
𐋇 ¦keep¦ ¦exerc ising¦ ¦and¦ ¦stay¦ ¦healthy¦
𐋇¦the¦ ¦flu¦ ¦vaccine¦ ¦prot ects¦ ¦against¦ ¦the¦ ¦flu¦ ¦but¦ ¦not¦ ¦the¦ ¦cold¦ .
𐋇 ¦treatment¦
𐋇 ¦most¦ ¦c ol ds¦ ¦can¦ ¦be¦ ¦tre ated¦ ¦at¦ ¦home¦ .
𐋇¦you¦ ¦will¦ ¦reco ver¦ ¦without¦ ¦any¦ ¦spec ial¦ ¦treatment¦ .
𐋇 ¦dr ink¦ ¦p le nt y¦ ¦of¦ ¦f lu i ds¦ ,▁ ¦take¦ ¦a¦ ¦brea k¦ ¦and¦ ¦e at¦ ¦healthy¦ ¦food¦ .
𐋇 ¦continue¦ ¦as¦ ¦us ual¦ ¦when¦ ¦you¦ ¦reco ver¦ .
𐋇¦t alk¦ ¦to¦ ¦your¦ ¦ph arm ac ist¦ ¦about¦ ¦the¦ ¦produc ts¦ ¦and¦ ¦medic ines¦ ¦that¦ ¦will¦ ¦help¦ ¦you¦ .
𐋇¦p ara ce ta mo l¦ ¦or¦ ¦i b u p ro fen¦ ¦can¦ ¦be¦ ¦ta k en¦ ¦to¦ ¦rel ie ve¦ ¦pain¦ ¦or¦ ¦fever¦ .
𐋇¦a¦ ¦n as al¦ ¦sp r ay¦ ¦h el ps¦ ¦to¦ ¦open¦ ¦a¦ ¦st u ff y¦ ¦nose¦ .
𐋇¦you¦ ¦may¦ ¦also¦ ¦f ind¦ ¦rel ief¦ ¦with¦ ¦th ro at¦ ¦sp r ays¦ ,▁ ¦lo tions¦ ¦and¦ ¦cough¦ ¦tre at ments¦ .
𐋇 ¦be¦ ¦ca re ful¦ ¦about¦ ¦ta king¦ ¦medic ines¦ ¦for¦ ¦cou gh s¦ ¦and¦ ¦c ol ds¦ ¦if¦ ¦you¦ ¦are¦ ¦also¦ ¦ta king¦ ¦p ara ce ta mo l¦ ¦or¦ ¦i b u p ro fen¦ .
𐋇 ¦that¦ ¦way¦ ,▁ ¦you¦ ¦could¦ ¦take¦ ¦more¦ ¦than¦ ¦the¦ ¦recommended¦ ¦d ose¦ .
𐋇¦there¦ ¦are¦ ¦some¦ ¦medic ations¦ ¦that¦ ¦are¦ ¦not¦ ¦su it able¦ ¦for¦ ¦children¦ ,▁ ¦in fa nts¦ ¦and¦ ¦pre gnant¦ ¦women¦ .
𐋇 ¦get¦ ¦advice¦ ¦from¦ ¦your¦ ¦ph arm ac ist¦ .
𐋇¦there¦ ¦is¦ ¦l it t le¦ ¦evidence¦ ¦that¦ ¦n ut ri tional¦ ¦supp le ments¦ ¦such¦ ¦as¦ ¦ vi ta m in¦ ¦ c¦ ,▁ ¦z in c¦ ,▁ ¦ec hi na ce a¦ ¦or¦ ¦g ar l ic¦ ¦help¦ ¦to¦ ¦he al¦ .
𐋇 ¦visit¦ ¦your¦ ¦gp¦ :
𐋇¦if¦ ¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦do¦ ¦not¦ ¦imp ro ve¦ ¦after¦ ¦3¦ ¦weeks¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦diffic ult y¦ ¦brea thing¦ ¦or¦ ¦have¦ ¦chest¦ ¦pain¦
𐋇¦if¦ ¦your¦ ¦illness¦ ¦symptoms¦ ¦s ud d en ly¦ ¦get¦ ¦wor se¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦a¦ ¦very¦ ¦high¦ ¦temp erat ure¦ ¦or¦ ¦you¦ ¦feel¦ ¦very¦ ¦h ot¦ ,▁ ¦and¦ ¦you¦ ¦are¦ ¦sh a king¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦wor r ied¦ ¦about¦ ¦your¦ ¦child¦ ' ¦s¦ ¦symptoms¦ ¦of¦ ¦illness¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦a¦ ¦long¦ - ¦ter m¦ ¦illness¦ ▁-▁ ¦for¦ ¦example¦ ,▁ ¦if¦ ¦you¦ ¦have¦ ¦di ab e tes¦ ,▁ ¦h ear t¦ ,▁ ¦lu ng¦ ,▁ ¦k id ne y¦ ¦or¦ ¦ne ur ological¦ ¦disease¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦a¦ ¦w ea k e ned¦ ¦immune¦ ¦system¦ ▁-▁ ¦for¦ ¦inst ance¦ ,▁ ¦if¦ ¦you¦ ¦have¦ ¦di ab e tes¦ ¦or¦ ¦are¦ ¦rece i ving¦ ¦ che mo ther ap y¦
𐋇 ¦anti b i ot ics¦
𐋇 ¦anti b i ot ics¦ ¦will¦ ¦not¦ ¦do¦ ¦you¦ ¦any¦ ¦g ood¦ ¦for¦ ¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦ ,▁ ¦and¦ ¦you¦ ¦will¦ ¦not¦ ¦reco ver¦ ¦f as ter¦ .
𐋇 ¦anti b i ot ics¦ ¦are¦ ¦effective¦ ¦against¦ ¦ba ct er ial¦ ¦infections¦ .
𐋇¦c ol ds¦ ¦are¦ ¦a¦ ¦virus¦ .
𐋇 ¦sh ort ness¦ ¦of¦ ¦brea th¦
𐋇 ¦sh ort ness¦ ¦of¦ ¦brea th¦ ¦may¦ ¦not¦ ¦be¦ ¦a¦ ¦concer n¦ ¦but¦ ¦s om et im es¦ ¦it¦ ¦can¦ ¦be¦ ¦ser ious¦ ¦and¦ ¦may¦ ¦requir e¦ ¦treatment¦ .
𐋇¦you¦ ¦may¦ ¦have¦ ¦a¦ ¦h ear t¦ ¦att ack¦ ¦or¦ ¦a¦ ¦prob le m¦ ¦with¦ ¦your¦ ¦lu ng s¦ ¦or¦ ¦air w ays¦ .
𐋇 ¦call¦ ¦a¦ ¦gp¦ ¦if¦ ¦you¦ ¦have¦ ¦sh ort ness¦ ¦of¦ ¦brea th¦ :
𐋇 ¦which¦ ¦l as ted¦ ¦lo nger¦ ¦than¦ ¦a¦ ¦mon th¦
𐋇 ¦which¦ ¦g ets¦ ¦wor se¦ ¦when¦ ¦you¦ ¦are¦ ¦ac tive¦
𐋇 ¦which¦ ¦g ets¦ ¦wor se¦ ¦when¦ ¦you¦ ¦li e¦ ¦down¦
𐋇¦you¦ ¦have¦ ¦been¦ ¦cou g hing¦ ¦for¦ ¦3¦ ¦weeks¦ ¦or¦ ¦more¦
𐋇 ¦that¦ ¦your¦ ¦an k les¦ ¦are¦ ¦sw o ll en¦
𐋇 ¦sh ort ness¦ ¦of¦ ¦brea th¦ ¦co mb ined¦ ¦with¦ ¦high¦ ¦temp erat ure¦ ¦may¦ ¦be¦ ¦a¦ ¦s ign¦ ¦of¦ ¦the¦ ¦corona ry¦ ¦virus¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦these¦ ¦symptoms¦ ¦you¦ ¦should¦ ¦call¦ ¦your¦ ¦gp¦ .
𐋇¦it¦ ¦is¦ ¦important¦ ¦to¦ ¦s ee k¦ ¦medical¦ ¦advice¦ ¦to¦ ¦e ns ure¦ ¦that¦ ¦it¦ ¦is¦ ¦not¦ ¦ser ious¦ .
𐋇¦you¦ ¦are¦ ¦not¦ ¦w as ting¦ ¦an yone¦ ▁' ¦s¦ ¦time¦ ¦chec king¦ ¦it¦ ¦out¦ .
𐋇 ¦ca u ses¦ ¦sh ort ness¦ ¦of¦ ¦brea th¦
𐋇¦there¦ ¦are¦ ¦many¦ ¦different¦ ¦ca u ses¦ ¦of¦ ¦sh ort ness¦ ¦of¦ ¦brea th¦ .
𐋇¦the¦ ¦most¦ ¦common¦ ¦ca u ses¦ ¦include¦ ¦a¦ ¦common¦ ¦cold¦ ¦or¦ ¦chest¦ ,▁ ¦as th m a¦ ,▁ ¦being¦ ¦over we ight¦ ¦or¦ ¦a¦ ¦s mo k er¦ .
𐋇¦it¦ ¦can¦ ¦also¦ ¦be¦ ¦a¦ ¦s ign¦ ¦of¦ ¦a¦ ¦p an ic¦ ¦att ack¦ .
𐋇¦but¦ ¦s om et im es¦ ¦it¦ ¦can¦ ¦be¦ ¦a¦ ¦s ign¦ ¦of¦ ¦so me thing¦ ¦more¦ ¦ser ious¦ ,▁ ¦such¦ ¦as¦ ¦lu ng¦ ¦cance r¦ ¦or¦ ¦the¦ ¦lu ng¦ ¦disease¦ ¦known¦ ¦as¦ ¦ch r on ic¦ ¦ob str uc tive¦ ¦p ul m on ary¦ ¦disease¦ ▁( ¦c op d¦ ).
𐋇 ¦any¦ ¦treatment¦ ¦you¦ ¦need¦ ¦will¦ ¦dep end¦ ¦on¦ ¦what¦ ¦is¦ ¦ca us ing¦ ¦your¦ ¦symptoms¦ .
𐋇¦d on¦ ' ¦t¦ ¦t ry¦ ¦to¦ ¦self¦ - ¦diagn ose¦ ▁-▁ ¦al w ays¦ ¦cons ul t¦ ¦a¦ ¦gp¦ .
𐋇 ¦contact¦ ¦tracking¦
𐋇 ¦contact¦ ¦tracking¦ ¦ident if ies¦ ¦people¦ ¦who¦ ¦have¦ ¦had¦ ¦close¦ ¦contact¦ ¦with¦ ¦someone¦ ¦with¦ ¦the¦ ¦corona ry¦ ¦virus¦ .
𐋇¦this¦ ¦is¦ ¦being¦ ¦d one¦ ¦to¦ ¦reduce¦ ¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦coronavirus¦ ¦in¦ ¦the¦ ¦community¦ .
𐋇¦the¦ ¦people¦ ¦who¦ ¦do¦ ¦this¦ ¦work¦ ¦are¦ ¦called¦ ▁ “ ¦contact¦ ¦trac k ers¦ ▁ ” .
𐋇¦if¦ ¦you¦ ¦get¦ ¦a¦ ¦positive¦ ¦result¦
𐋇¦if¦ ¦you¦ ¦get¦ ¦a¦ ¦positive¦ ¦result¦ ¦the¦ ¦contact¦ ¦tracker¦ ¦will¦ ¦call¦ ¦you¦ ¦to¦ ¦f ind¦ ¦the¦ ¦contact¦ ¦detail s¦ ¦of¦ ¦an yone¦ ¦you¦ ¦have¦ ¦been¦ ¦in¦ ¦close¦ ¦contact¦ ¦with¦ .
𐋇¦if¦ ¦you¦ ¦test¦ ¦positive¦ ¦only¦ ¦covid¦ - ¦19¦ ¦sign als¦ ¦you¦
𐋇¦they¦ ¦will¦ ¦as k¦ ¦you¦ ¦about¦ ¦the¦ ¦people¦ ¦and¦ ¦places¦ ¦you¦ ¦visi ted¦ ¦4 8¦ ¦hours¦ ¦before¦ ¦your¦ ¦illness¦ ¦cou nt er par ts¦ ¦beg an¦ ¦and¦ ¦you¦ ¦beg an¦ ¦to¦ ¦self¦ - ¦isol ate¦ .
𐋇¦if¦ ¦you¦ ¦test¦ ¦positive¦ ¦but¦ ¦do¦ ¦not¦ ¦have¦ ¦covid¦ - ¦19¦ ¦symptoms¦
𐋇¦the¦ ¦contact¦ ¦tracker¦ ¦will¦ ¦only¦ ¦as k¦ ¦you¦ ¦about¦ ¦people¦ ¦and¦ ¦places¦ ¦you¦ ¦visi ted¦ ¦24¦ ¦hours¦ ¦before¦ ¦your¦ ¦test¦ ¦and¦ ¦until¦ ¦you¦ ¦star ted¦ ¦self¦ - ¦isolation¦ .
𐋇¦they¦ ¦w on¦ ▁’▁ ¦t¦ ¦as k¦ ¦you¦ ¦about¦ ¦people¦ ¦who¦ ¦p as sed¦ ¦by¦ ¦on¦ ¦the¦ ¦st re et¦ ¦or¦ ¦in¦ ¦sho ps¦ .
𐋇¦there¦ ¦is¦ ¦l it t le¦ ¦da nger¦ ¦in¦ ¦such¦ ¦s itu ations¦ ,▁ ¦especially¦ ¦if¦ ¦you¦ ¦are¦ ¦pract ising¦ ¦social¦ ¦separ ation¦ .
𐋇 ¦contact¦ ¦tracking¦ ¦is¦ ¦conf ide ntial¦ .
𐋇 ¦no¦ - ¦one¦ ¦who¦ ¦ca lls¦ ¦the¦ ¦contact¦ ¦admin i str at or¦ ¦will¦ ¦know¦ ¦that¦ ¦you¦ ¦provid ed¦ ¦their¦ ¦contact¦ ¦detail s¦ .
𐋇¦covid¦ ¦tracker¦ ¦app¦
𐋇¦the¦ ¦contact¦ ¦tracker¦ ¦will¦ ¦also¦ ¦as k¦ ¦you¦ ¦if¦ ¦you¦ ¦have¦ ¦used¦ ¦the¦ ¦covid¦ ¦tracker¦ ¦app¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦been¦ ¦using¦ ¦it¦ ,▁ ¦they¦ ¦will¦ ¦as k¦ ¦you¦ ¦to¦ ¦use¦ ¦the¦ ¦up lo ad¦ ¦f un ction¦ ¦ag a in¦ ¦to¦ ¦s end¦ ¦an¦ ¦alert¦ ¦to¦ ¦your¦ ¦immediate¦ ¦contac ts¦ .
𐋇¦you¦ ¦do¦ ¦this¦ ¦with¦ ¦the¦ ¦app¦ .
𐋇¦it¦ ¦is¦ ¦your¦ ¦c ho ice¦ ¦to¦ ¦do¦ ¦this¦ .
𐋇¦if¦ ¦you¦ ¦cons ent¦ ,▁ ¦a¦ ¦separ ate¦ ¦up lo ad¦ ¦co de¦ ¦will¦ ¦be¦ ¦s ent¦ ¦to¦ ¦you¦ ¦with¦ ¦a¦ ¦te xt¦ ¦me ss age¦ .
𐋇¦this¦ ¦co de¦ ¦will¦ ¦re le ase¦ ¦the¦ ¦loc k¦ ¦on¦ ¦the¦ ¦app¦ ' ¦s¦ ¦up lo ad¦ ¦f un ction¦ .
𐋇 ¦de h y dr ation¦
𐋇¦your¦ ¦body¦ ¦lo ses¦ ¦more¦ ¦f lu id¦ ¦than¦ ¦it¦ ¦ab s or b s¦ ¦when¦ ¦you¦ ¦are¦ ¦de h y dr ated¦ .
𐋇¦this¦ ¦can¦ ¦be¦ ¦ser ious¦ ¦for¦ ¦you¦ ¦if¦ ¦you¦ ¦do¦ ¦not¦ ¦get¦ ¦medical¦ ¦treatment¦ .
𐋇 ¦children¦ ¦and¦ ¦people¦ ¦over¦ ¦6 5¦ ¦are¦ ¦at¦ ¦g rea ter¦ ¦risk¦ ¦of¦ ¦de h y dr ation¦ .
𐋇¦you¦ ¦are¦ ¦more¦ ¦likely¦ ¦to¦ ¦bec ome¦ ¦de h y dr ated¦ ¦if¦ ¦you¦ ¦have¦ ¦symptoms¦ ¦of¦ ¦flu¦ ¦or¦ ¦coronavirus¦ .
𐋇 ¦signs¦ ¦of¦ ¦de h y dr ation¦
𐋇 ¦symptoms¦ ¦of¦ ¦de h y dr ation¦ ¦in¦ ¦ad ul ts¦ ¦and¦ ¦children¦ ¦include¦ :
𐋇¦t ar t¦
𐋇¦d ar k¦ ¦y e ll ow¦ ¦ ur ine¦ ¦with¦ ¦a¦ ¦st ro ng¦ ¦o d or¦
𐋇¦d iz z i ness¦ ¦or¦ ¦conf us ion¦
𐋇 ¦fe el ing¦ ¦t ir ed¦
𐋇¦d ry¦ ¦mouth¦ ,▁ ¦li ps¦ ¦and¦ ¦ey es¦
𐋇¦l it t le¦ ¦ ur ine¦ ,▁ ¦and¦ ¦less¦ ¦than¦ ¦four¦ ¦times¦ ¦a¦ ¦day¦
𐋇 ¦de h y dr ation¦ ¦can¦ ¦occur ¦ ¦more¦ ¦ ea si ly¦ ¦in¦ ¦the¦ ¦following¦ ¦s itu ations¦ :
𐋇 ¦high¦ ¦temp erat ures¦ ¦of¦ ¦3 8¦ ¦de g re es¦ ¦c el si us¦ ¦or¦ ¦a bo ve¦ ¦you¦
𐋇 ¦di ab e tes¦
𐋇 ¦v o mi ting¦ ¦or¦ ¦di arr he a¦
𐋇 ¦sp ending¦ ¦to o¦ ¦much¦ ¦time¦ ¦in¦ ¦the¦ ¦su n¦ ▁( ¦he at¦ ¦st ro ke¦ )
𐋇¦if¦ ¦you¦ ¦dr ink¦ ¦to o¦ ¦much¦ ¦al c o ho l¦
𐋇¦s we ating¦ ¦a¦ ¦l ot¦ ¦after¦ ¦exerc ise¦
𐋇¦ ur in ating¦ ¦more¦ ¦often¦ ¦due¦ ¦to¦ ¦medic ation¦ ¦you¦ ¦are¦ ¦ta king¦ ▁( ¦di ur et ics¦ )
𐋇 ¦reduce¦ ¦the¦ ¦risk¦ ¦of¦ ¦de h y dr ation¦
𐋇 ¦dr ink¦ ¦li qu i ds¦ ¦when¦ ¦you¦ ¦feel¦ ¦any¦ ¦s ign¦ ¦of¦ ¦de h y dr ation¦ .
𐋇¦if¦ ¦you¦ ¦can¦ ▁’▁ ¦t¦ ¦dr ink¦ ¦ ea si ly¦ ¦because¦ ¦you¦ ¦feel¦ ¦sick¦ ¦or¦ ¦if¦ ¦you¦ ¦were¦ ¦sick¦ ,▁ ¦star t¦ ¦with¦ ¦sm all¦ ¦b ub b les¦ ¦and¦ ¦then¦ ¦dr ink¦ ¦more¦ ¦b ul b s¦ ,▁ ¦g rad ually¦ .
𐋇¦you¦ ¦can¦ ¦use¦ ¦a¦ ¦sp o on¦ ¦to¦ ¦help¦ ¦your¦ ¦child¦ ¦sw a ll ow¦ ¦the¦ ¦li qu id¦ .
𐋇¦you¦ ¦should¦ ¦dr ink¦ ¦en ough¦ ¦th r ou g ho ut¦ ¦the¦ ¦day¦ ¦so¦ ¦that¦ ¦your¦ ¦ ur ine¦ ¦has¦ ¦a¦ ¦cl ear¦ ¦l ight¦ ¦c ol or¦ .
𐋇 ¦dr ink¦ ¦a¦ ¦dr ink¦ ¦if¦ ¦you¦ ¦are¦ ¦at¦ ¦risk¦ ¦of¦ ¦de h y dr ation¦ .
𐋇¦for¦ ¦example¦ ,▁ ¦if¦ ¦you¦ ¦are¦ ¦sneezing¦ ,▁ ¦s we ating¦ ¦or¦ ¦have¦ ¦di arr he a¦ .
𐋇 ¦ca re g iv ers¦ :▁ 𐋇 ¦make¦ ¦sure¦ ¦the¦ ¦person¦ ¦in¦ ¦your¦ ¦care¦ ¦dr in ks¦ ¦en ough¦
𐋇¦the¦ ¦person¦ ¦you¦ ¦care¦ ¦for¦ ¦may¦ ¦not¦ ¦re al iz e¦ ¦that¦ ¦h e¦ ▁/▁ ¦sh e¦ ¦is¦ ¦not¦ ¦dr in king¦ ¦en ough¦ ¦f lu i ds¦ .
𐋇¦to¦ ¦help¦ ¦them¦ :
𐋇 ¦make¦ ¦sure¦ ¦they¦ ¦dr ink¦ ¦during¦ ¦me al¦ ¦time¦
𐋇 ¦make¦ ¦it¦ ¦a¦ ¦social¦ ¦h ab i t¦ ,▁ ¦like¦ ▁" ¦dr in king¦ ¦a¦ ¦c u p¦ ¦of¦ ¦te a¦ "
𐋇 ¦give¦ ¦them¦ ¦p le nt y¦ ¦of¦ ¦water¦ ▁-▁ ¦such¦ ¦as¦ ¦s ou p¦ ,▁ ¦ ice¦ ¦cre am¦ ¦or¦ ¦j el ly¦ ,▁ ¦or¦ ¦f ru i t¦ ¦like¦ ¦m el ons¦
𐋇¦a¦ ¦ph arm ac ist¦ ¦can¦ ¦help¦ ¦with¦ ¦de h y dr ation¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦v o mi ting¦ ¦or¦ ¦have¦ ¦di arr he a¦ ¦and¦ ¦are¦ ¦l os ing¦ ¦to o¦ ¦much¦ ¦f lu id¦ ,▁ ¦you¦ ¦need¦ ¦to¦ ¦re pl ace¦ ¦the¦ ¦su g a r¦ ,▁ ¦s al ts¦ ¦and¦ ¦min er als¦ ¦l ost¦ ¦by¦ ¦your¦ ¦body¦ .
𐋇¦your¦ ¦ph arm ac ist¦ ¦may¦ ¦recomm end¦ ¦or al¦ ¦re h y dr ation¦ ¦p ou ches¦ .
𐋇¦this¦ ¦is¦ ¦a¦ ¦p ow der¦ ¦that¦ ¦you¦ ¦mi x¦ ¦with¦ ¦water¦ ¦and¦ ¦then¦ ¦dr ink¦ ¦it¦ .
𐋇 ¦as k¦ ¦your¦ ¦ph arm ac ist¦ ¦which¦ ¦ on es¦ ¦are¦ ¦b est¦ ¦for¦ ¦you¦ ¦or¦ ¦your¦ ¦child¦ .
𐋇¦when¦ ¦to¦ ¦s ee k¦ ¦medical¦ ¦help¦
𐋇 ¦contact¦ ¦your¦ ¦gp¦ ¦if¦ ¦your¦ ¦symptoms¦ ¦do¦ ¦not¦ ¦imp ro ve¦ ¦with¦ ¦treatment¦ ¦and¦ :
𐋇¦you¦ ¦are¦ ¦fe el ing¦ ¦more¦ ¦t ir ed¦ ¦than¦ ¦us ual¦
𐋇¦you¦ ¦are¦ ¦conf u sed¦ ¦and¦ ¦up s et¦
𐋇¦you¦ ¦have¦ ¦d iz z i ness¦ ¦that¦ ¦does¦ ¦not¦ ¦go¦ ¦away¦ ¦when¦ ¦you¦ ¦st and¦ ¦up¦
𐋇¦you¦ ¦d id¦ ¦not¦ ¦ ur in ate¦ ¦during¦ ¦the¦ ¦day¦
𐋇¦your¦ ¦p ul se¦ ¦is¦ ¦w ea k¦ ¦or¦ ¦f ast¦
𐋇¦you¦ ¦have¦ ¦se iz ures¦
𐋇¦these¦ ¦are¦ ¦signs¦ ¦of¦ ¦severe¦ ¦de h y dr ation¦ ¦that¦ ¦ ur ge ntly¦ ¦requir e¦ ¦medical¦ ¦treatment¦ .
𐋇 ¦de h y dr ation¦ ¦in¦ ¦children¦
𐋇 ¦children¦ ¦under¦ ¦five¦ ¦with¦ ¦de h y dr ation¦
𐋇 ¦children¦ ¦under¦ ¦5¦ ¦should¦ ¦dr ink¦ ¦p le nt y¦ ¦of¦ ¦f lu i ds¦ ¦to¦ ¦avoid¦ ¦de h y dr ation¦ .
𐋇 ¦de h y dr ation¦ ¦is¦ ¦common¦ ¦in¦ ¦y ou ng¦ ¦children¦ .
𐋇¦this¦ ¦can¦ ¦be¦ ¦ser ious¦ ¦if¦ ¦not¦ ¦de al t¦ ¦with¦ ¦qu ick ly¦ .
𐋇 ¦contact¦ ¦your¦ ¦gp¦ ¦ ur ge ntly¦ ¦if¦ ¦your¦ ¦child¦ :
𐋇 ¦sl ee p y¦
𐋇 ¦brea thing¦ ¦f ast¦
𐋇¦when¦ ¦your¦ ¦child¦ ¦is¦ ¦cr ying¦ ¦they¦ ¦have¦ ¦no¦ ¦t ear s¦ ¦or¦ ¦a¦ ¦fe w¦ ¦t ear s¦
𐋇 ¦fo nt an el le¦ ¦pres sed¦ ¦in¦ ▁( ¦the¦ ¦so f t¦ ¦sp ot¦ ¦on¦ ¦the¦ ¦child¦ ' ¦s¦ ¦h ead¦ )
𐋇¦d ry¦ ¦mouth¦
𐋇¦d ar k¦ ¦y e ll ow¦ ¦ ur ine¦ ¦or¦ ¦no¦ ¦ ur ine¦ ¦for¦ ¦the¦ ¦last¦ ¦12¦ ¦hours¦
𐋇 ¦cold¦ ¦hands¦ ¦and¦ ¦fe et¦ ¦or¦ ¦a¦ ¦sta ined¦ ¦app ear ance¦
𐋇 ¦o nce¦ ¦the¦ ¦de h y dr ation¦ ¦has¦ ¦been¦ ¦tre ated¦ ,▁ ¦your¦ ¦baby¦ ¦will¦ ¦need¦ ¦to¦ ¦dr ink¦ ¦p le nt y¦ ¦of¦ ¦f lu i ds¦ .
𐋇 ¦continue¦ ¦brea st f ee ding¦ ¦or¦ ¦using¦ ¦f orm ul a¦ ¦m il k¦ ▁-▁ ¦t ry¦ ¦to¦ ¦fe ed¦ ¦a¦ ¦l it t le¦ ¦more¦ ¦often¦ ¦than¦ ¦us ual¦
𐋇 ¦give¦ ¦sm all¦ ¦b ub b les¦ ¦of¦ ¦water¦ ¦to¦ ¦children¦ ¦who¦ ¦are¦ ¦on¦ ¦f orm ul a¦ ¦or¦ ¦d ry¦ ¦food¦
𐋇 ¦give¦ ¦sm all¦ ¦children¦ ¦the¦ ¦normal¦ ¦di et¦
𐋇 ¦give¦ ¦a¦ ¦sm all¦ ¦dro p¦ ¦of¦ ¦the¦ ¦re h y dr ated¦ ¦s ol ution¦ ¦regul arly¦ ¦to¦ ¦make¦ ¦sure¦ ¦they¦ ¦get¦ ¦the¦ ¦l ost¦ ¦li qu id¦ ,▁ ¦s al ts¦ ¦and¦ ¦su g ar s¦ , ▁-▁ ¦as k¦ ¦your¦ ¦ph arm ac ist¦ ¦to¦ ¦su gg est¦ ¦one¦
𐋇¦d on¦ ' ¦t¦
𐋇¦do¦ ¦not¦ ¦make¦ ¦the¦ ¦f orm ul a¦ ¦w ea k er¦ .
𐋇¦d on¦ ' ¦t¦ ¦give¦ ¦y ou ng¦ ¦children¦ ¦f ru i t¦ ¦j u ice¦ ¦or¦ ¦f iz z y¦ ¦dr in ks¦ ▁-▁ ¦it¦ ¦ma k es¦ ¦di arr he a¦ ¦or¦ ¦di arr he a¦ ¦wor se¦ .
𐋇 ¦coronavirus¦ ▁-▁ ¦treatment¦
𐋇¦there¦ ¦is¦ ¦no¦ ¦specific¦ ¦treatment¦ ¦available¦ ¦for¦ ¦coronavirus¦ .
𐋇¦but¦ ¦8 0¦ %▁ ¦of¦ ¦people¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦reco ver¦ ¦from¦ ¦the¦ ¦corona ry¦ ¦virus¦ ¦at¦ ¦home¦ ¦and¦ ¦will¦ ¦not¦ ¦need¦ ¦to¦ ¦go¦ ¦into¦ ¦hospital¦ .
𐋇¦the¦ ¦vaccines¦ ¦will¦ ¦be¦ ¦available¦ ¦in¦ ¦sta ges¦ ¦and¦ ¦as¦ ¦a¦ ¦result¦ ¦it¦ ¦will¦ ¦take¦ ¦some¦ ¦time¦ ¦to¦ ¦vacc in ate¦ ¦the¦ ¦population¦ .
𐋇¦if¦ ¦you¦ ¦exp eri ence¦ ¦symptoms¦ ,▁ ¦you¦ ¦should¦ ¦self¦ - ¦isol ated¦ ¦to¦ ¦prevent¦ ¦the¦ ¦spread¦ ¦of¦ ¦covid¦ - ¦19¦ .
𐋇 ¦call¦ ¦your¦ ¦gp¦ ¦or¦ ¦out¦ ¦of¦ ¦hours¦ ¦service¦ ¦imm ed ia tely¦ ¦to¦ ¦disc us s¦ ¦your¦ ¦symptoms¦ ¦and¦ ¦to¦ ¦det erm ine¦ ¦if¦ ¦you¦ ¦need¦ ¦to¦ ¦have¦ ¦a¦ ¦covid¦ - ¦19¦ ¦test¦ .
𐋇¦the¦ ¦most¦ ¦important¦ ¦ thing¦ ¦is¦ ¦to¦ ¦protect¦ ¦others¦ ¦from¦ ¦the¦ ¦virus¦ .
𐋇 ¦prot ecting¦ ¦those¦ ¦in¦ ¦at¦ - ¦risk¦ ¦grou ps¦ ¦from¦ ¦covid¦ - ¦19¦ ¦is¦ ¦cr uc ial¦ .
𐋇 ¦self¦ - ¦isolation¦
𐋇 ¦get¦ ¦en ough¦ ¦sl ee p¦ ¦and¦ ¦r est¦ ¦time¦
𐋇 ¦dr ink¦ ¦p le nt y¦ ¦of¦ ¦water¦ ¦to¦ ¦avoid¦ ¦de h y dr ation¦ .
𐋇¦your¦ ¦ ur ine¦ ¦should¦ ¦be¦ ¦br ight¦ ¦y e ll ow¦ ¦or¦ ¦br ight¦
𐋇¦e at¦ ¦he al t hi ly¦
𐋇¦do¦ ¦not¦ ¦s mo ke¦
𐋇¦f an¦ ¦you¦
𐋇 ¦keep¦ ¦an¦ ¦ey e¦ ¦out¦ ¦for¦ ¦signs¦ ¦of¦ ¦illness¦ ¦and¦ ¦tre at¦ ¦them¦
𐋇¦read¦ ¦more¦ ¦about¦ ¦signs¦
𐋇 ¦fever¦
𐋇 ¦cough¦ ▁-▁ ¦any¦ ¦k ind¦ ,▁ ¦not¦ ¦j ust¦ ¦d ry¦ ¦cough¦ .
𐋇 ¦sh ort ness¦ ¦of¦ ¦brea th¦
𐋇 ¦al t ered¦ ¦or¦ ¦l ost¦ ¦sm ell¦
𐋇¦if¦ ¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦get¦ ¦wor se¦
𐋇 ¦contact¦ ¦your¦ ¦gp¦ ¦if¦ ¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦do¦ ¦not¦ ¦imp ro ve¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦in¦ ¦an¦ ¦at¦ - ¦risk¦ ¦group¦ ¦over¦ ¦6 0¦ ,▁ ¦you¦ ¦should¦ ¦keep¦ ¦a¦ ¦close¦ ¦ey e¦ ¦on¦ ¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦ .
𐋇 ¦contact¦ ¦your¦ ¦gp¦ ¦if¦ ¦the¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦get¦ ¦wor se¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦in¦ ¦an¦ ¦at¦ - ¦risk¦ ¦group¦ ,▁ ¦you¦ ¦should¦ ¦keep¦ ¦a¦ ¦close¦ ¦ey e¦ ¦on¦ ¦your¦ ¦signs¦ ¦of¦ ¦illness¦ .
𐋇 ¦contact¦ ¦your¦ ¦gp¦ ¦if¦ ¦the¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦get¦ ¦wor se¦ .
𐋇 ¦medic ation¦ ¦for¦ ¦treatment¦
𐋇¦the¦ ¦b est¦ ¦medic ation¦ ¦dep ends¦ ¦on¦ ¦your¦ ¦symptoms¦ :
𐋇 ¦symptoms¦ ¦of¦ ¦illness¦
𐋇 ¦other¦ ¦health¦ ¦co mpl ications¦
𐋇 ¦any¦ ¦other¦ ¦medical¦ ¦treatment¦ ¦you¦ ¦are¦ ¦rece i ving¦
𐋇¦p ara ce ta mo l¦ ¦or¦ ¦i b u p ro fen¦ ¦may¦ ¦help¦ ¦lower¦ ¦your¦ ¦temp erat ure¦ ¦and¦ ¦give¦ ¦you¦ ¦rel ief¦ ¦from¦ ¦your¦ ¦pa ins¦ .
𐋇¦p ara ce ta mo l¦ ¦is¦ ¦recommended¦ ¦as¦ ¦the¦ ¦first¦ ¦ line¦ ¦of¦ ¦treatment¦ ¦for¦ ¦most¦ ¦people¦ .
𐋇¦read¦ ¦all¦ ¦the¦ ¦gu id el ines¦ ¦in¦ ¦the¦ ¦p ac k age¦ ¦before¦ ¦ta king¦ ¦any¦ ¦medic ation¦ .
𐋇 ¦take¦ ¦advice¦ ¦from¦ ¦any¦ ¦health¦ ¦pro f es si on al¦ .
𐋇 ¦anti b i ot ics¦
𐋇 ¦anti b i ot ics¦ ¦do¦ ¦not¦ ¦work¦ ¦against¦ ¦covid¦ - ¦19¦ ¦or¦ ¦any¦ ¦other¦ ¦viruses¦ .
𐋇¦they¦ ¦will¦ ¦not¦ ¦give¦ ¦you¦ ¦rel ief¦ ¦from¦ ¦your¦ ¦symptoms¦ ¦of¦ ¦illness¦ ¦or¦ ¦help¦ ¦you¦ ¦to¦ ¦reco ver¦ .
𐋇¦covid¦ - ¦19¦ ¦is¦ ¦a¦ ¦virus¦ ¦that¦ ¦is¦ ¦not¦ ¦h el p ed¦ ¦by¦ ¦anti b i ot ics¦ .
𐋇 ¦i ob u p ro fen¦
𐋇¦it¦ ¦is¦ ¦o k ay¦ ¦to¦ ¦take¦ ¦anti ¦ - ¦inf la mm atory¦ ¦medic ations¦ ▁( ¦ ns ai ds¦ )▁ ¦if¦ ¦you¦ ¦have¦ ¦covid¦ - ¦19¦ .
𐋇¦there¦ ¦is¦ ¦no¦ ¦evidence¦ ¦that¦ ¦it¦ ¦is¦ ¦d an ge ro us¦ .
𐋇 ¦only¦ ¦take¦ ¦one¦ ¦anti ¦ - ¦inf la mm atory¦ ¦medic ation¦ ¦at¦ ¦a¦ ¦time¦ .
𐋇¦it¦ ¦is¦ ¦o k ay¦ ¦to¦ ¦take¦ ¦p ara ce ta mo l¦ ¦and¦ ¦anti ¦ - ¦inf la mm atory¦ ¦medic ations¦ ¦such¦ ¦as¦ ¦i ob u p ro fen¦ ¦t og ether¦ .
𐋇 ¦anti ¦ - ¦inf la mm atory¦ ¦medic ations¦ ¦include¦ :
𐋇 ¦i ob u p ro fen¦ ▁-▁ ¦br and¦ ¦na m es¦ :▁ 𐋇 ¦nu ro fen¦ ,▁ ¦a ct ip ro fen¦ ,▁ ¦ad v il¦ ,▁ ¦b ru fen¦ ,▁ ¦b ru p r o¦ ,▁ ¦bu p le x¦ ,▁ ¦e as o fen¦ ,▁ ¦and¦ ¦f en op ine¦ .
𐋇 ¦i ob u p ro fen¦ ¦ ge l¦ ¦may¦ ¦con tain¦ ¦the¦ ¦na m es¦ :▁ 𐋇 ¦nu ro fen¦ ,▁ ¦m el fen¦ ,▁ ¦p or pa in¦ ,▁ ¦i b u ge l¦ ¦and¦ ¦i b u le ve¦
𐋇¦n ap k i ns on¦ ▁-▁ ¦br and¦ ¦na me¦ :▁ 𐋇¦n ap r os y n¦
𐋇 ¦di ch lo ro ph en ics¦ ▁-▁ ¦br and¦ ¦na m es¦ :▁ 𐋇 ¦v ol ta ro l¦ ,▁ ¦d ic l o¦ ,▁ ¦d ic la c¦ ,▁ ¦ca ta f l am¦ ,▁ ¦d if en e¦ ¦and¦ ¦f l ector¦
𐋇 ¦ta king¦ ¦care¦ ¦of¦ ¦your¦ ¦me ntal¦ ¦health¦ ¦during¦ ¦the¦ ¦corona ry¦ ¦virus¦ ¦outbreak¦
𐋇 ¦out b rea ks¦ ¦of¦ ¦infectious¦ ¦diseases¦ ¦such¦ ¦as¦ ¦coronavirus¦ ▁( ¦covid¦ - ¦19¦ )▁ ¦can¦ ¦be¦ ¦of¦ ¦concer n¦ ¦to¦ ¦us¦ .
𐋇¦this¦ ¦can¦ ¦aff ect¦ ¦your¦ ¦me ntal¦ ¦health¦ .
𐋇¦but¦ ¦you¦ ¦can¦ ¦do¦ ¦many¦ ¦th ings¦ ¦to¦ ¦take¦ ¦care¦ ¦of¦ ¦your¦ ¦me ntal¦ ¦health¦ ¦during¦ ¦this¦ ¦time¦ .
𐋇¦how¦ ¦this¦ ¦can¦ ¦aff ect¦ ¦your¦ ¦me ntal¦ ¦health¦
𐋇¦the¦ ¦spread¦ ¦of¦ ¦the¦ ¦coronavirus¦ ¦is¦ ¦a¦ ¦cha ll en ging¦ ¦new¦ ¦ev ent¦ .
𐋇¦it¦ ¦may¦ ¦cause¦ ¦some¦ ¦people¦ ¦more¦ ¦an xi et y¦ ¦than¦ ¦others¦ .
𐋇 ¦re me mber¦ ¦that¦ ¦medical¦ ,▁ ¦sc ie nt if ic¦ ¦and¦ ¦community¦ ¦health¦ ¦exp er ts¦ ¦are¦ ¦do ing¦ ¦their¦ ¦b est¦ ¦to¦ ¦br ing¦ ¦the¦ ¦virus¦ ¦under¦ ¦control¦ .
𐋇 ¦re me mber¦ ¦this¦ ¦when¦ ¦you¦ ¦are¦ ¦wor r ied¦ .
𐋇¦t ry¦ ¦to¦ ¦re me mber¦ ¦this¦ ¦when¦ ¦you¦ ¦feel¦ ¦wor r ied¦ .
𐋇¦it¦ ¦has¦ ¦affected¦ ¦all¦ ¦our¦ ¦l ives¦ ¦in¦ ¦some¦ ¦w ays¦ .
𐋇¦but¦ ¦in¦ ¦time¦ ,▁ ¦it¦ ¦will¦ ¦p ass¦ .
𐋇¦e veryone¦ ' ¦s¦ ¦l ife¦ ¦has¦ ¦chan ged¦ ¦in¦ ¦many¦ ¦w ays¦ ¦but¦ ¦over¦ ¦time¦ ¦it¦ ¦will¦ ¦come¦ ¦to¦ ¦an¦ ¦end¦ .
𐋇¦you¦ ¦may¦ ¦n ot ice¦ :
𐋇 ¦more¦ ¦an xi et y¦
𐋇 ¦under¦ ¦pre ss ure¦
𐋇 ¦cons ta ntly¦ ¦l oo king¦ ¦for¦ ¦signs¦ ¦of¦ ¦illness¦ ¦in¦ ¦yourself¦ ¦or¦ ¦others¦
𐋇 ¦more¦ ¦c an ta il¦ ¦on¦ ¦you¦
𐋇¦d ist ru st ful¦ ¦or¦ ¦re st less¦
𐋇 ¦that¦ ¦your¦ ¦normal¦ ¦pa ins¦ ¦are¦ ¦the¦ ¦same¦ ¦as¦ ¦having¦ ¦the¦ ¦virus¦
𐋇 ¦diffic ult y¦ ¦sl ee p ing¦
𐋇 ¦that¦ ¦you¦ ¦can¦ ¦do¦ ¦no thing¦ ¦or¦ ¦that¦ ¦th ings¦ ¦are¦ ¦sp ir al ing¦ ¦out¦ ¦of¦ ¦control¦
𐋇 ¦that¦ ¦you¦ ¦have¦ ¦fo ol ish¦ ¦ id ea s¦
𐋇¦how¦ ¦to¦ ¦take¦ ¦care¦ ¦of¦ ¦your¦ ¦me ntal¦ ¦health¦ ¦at¦ ¦this¦ ¦time¦
𐋇¦you¦ ¦need¦ ¦to¦ ¦be¦ ¦pr ud ent¦ ¦about¦ ¦this¦ ¦and¦ ¦get¦ ¦acc ur ate¦ ¦information¦ .
𐋇¦h er e¦ ¦are¦ ¦some¦ ¦w ays¦ ¦you¦ ¦can¦ ¦do¦ ¦this¦ .
𐋇 ¦get¦ ¦the¦ ¦l at est¦ ¦information¦ ¦but¦ ¦d on¦ ' ¦t¦ ¦sp end¦ ¦to o¦ ¦much¦ ¦time¦ ¦l oo king¦ ¦at¦ ¦the¦ ¦new s¦ ¦or¦ ¦social¦ ¦m ed ia¦
𐋇 ¦all¦ ¦the¦ ¦k n ow l ed ge¦ ¦about¦ ¦covid¦ - ¦19¦ ¦can¦ ¦be¦ ¦r ed u nd ant¦ ¦for¦ ¦us¦ .
𐋇¦it¦ ¦may¦ ¦wor ry¦ ¦you¦ ¦for¦ ¦no¦ ¦re as on¦ .
𐋇¦if¦ ¦so¦ ,▁ ¦c ho ose¦ ¦a¦ ¦specific¦ ¦time¦ ¦each¦ ¦day¦ ¦or¦ ¦every¦ ¦second¦ ¦day¦ ¦to¦ ¦get¦ ¦the¦ ¦most¦ ¦important¦ ¦information¦ .
𐋇¦s om et im es¦ ¦it¦ ¦is¦ ¦not¦ ¦e as y¦ ¦to¦ ¦dis ti ng u ish¦ ¦between¦ ¦f ac ts¦ ¦and¦ ¦r um ors¦ .
𐋇 ¦get¦ ¦your¦ ¦information¦ ¦from¦ ¦re li able¦ ¦and¦ ¦re li able¦ ¦sour ces¦ .
𐋇 ¦people¦ ¦t alk¦ ¦about¦ ¦their¦ ¦wor r ies¦ ¦or¦ ¦exp r ess¦ ¦personal¦ ¦op in i ons¦ ¦about¦ ¦covid¦ - ¦19¦ ¦on¦ ¦social¦ ¦m ed ia¦ .
𐋇¦this¦ ¦may¦ ¦ad d¦ ¦to¦ ¦your¦ ¦an xi et y¦ ¦and¦ ¦wor ry¦ .
𐋇¦it¦ ¦is¦ ¦important¦ ¦to¦ ¦make¦ ¦a¦ ¦ca re ful¦ ¦c ho ice¦ ¦about¦ ¦who¦ ¦you¦ ¦contact¦ ¦on¦ ¦social¦ ¦m ed ia¦ ¦and¦ ¦how¦ ¦much¦ ¦time¦ ¦you¦ ¦sp end¦ ¦on¦ ¦social¦ ¦m ed ia¦ .
𐋇¦if¦ ¦you¦ ¦feel¦ ¦that¦ ¦all¦ ¦the¦ ¦t alk¦ ¦about¦ ¦the¦ ¦coronavirus¦ ¦is¦ ¦to o¦ ¦much¦ ¦for¦ ¦you¦ ,▁ ¦t alk¦ ¦to¦ ¦someone¦ ¦close¦ ¦to¦ ¦you¦ ¦about¦ ¦it¦ ¦or¦ ¦get¦ ¦help¦ .
𐋇 ¦keep¦ ¦do ing¦ ¦the¦ ¦us ual¦ ¦th ings¦
𐋇¦the¦ ¦corona ry¦ ¦virus¦ ¦outbreak¦ ¦can¦ ¦aff ect¦ ¦what¦ ¦you¦ ¦do¦ ¦every¦ ¦day¦ ¦in¦ ¦different¦ ¦w ays¦ .
𐋇¦but¦ ¦it¦ ¦would¦ ¦be¦ ¦bet ter¦ ¦for¦ ¦you¦ ¦if¦ ¦you¦ ¦could¦ ¦have¦ ¦some¦ ¦k ind¦ ¦of¦ ¦st ru ct ure¦ ¦to¦ ¦your¦ ¦day¦ ¦in¦ ¦these¦ ¦t ur b ul ent¦ ¦wor l ds¦ .
𐋇¦it¦ ¦is¦ ¦important¦ ¦to¦ ¦p ay¦ ¦att e nt ion¦ ¦to¦ ¦your¦ ¦ own¦ ¦needs¦ ¦and¦ ¦fe el ings¦ ¦in¦ ¦this¦ ¦st re ss ful¦ ¦time¦ ,▁ ¦especially¦ .
𐋇¦you¦ ¦may¦ ¦still¦ ¦be¦ ¦able¦ ¦to¦ ¦do¦ ¦th ings¦ ¦that¦ ¦you¦ ¦en j o y¦ ¦and¦ ¦that¦ ¦make¦ ¦you¦ ¦feel¦ ¦at¦ ¦e ase¦ .
𐋇¦you¦ ¦could¦ ,▁ ¦for¦ ¦example¦ :
𐋇 ¦reg ular¦ ¦exerc ise¦ ,▁ ¦and¦ ¦go ing¦ ¦for¦ ¦a¦ ¦w alk¦
𐋇 ¦go¦ ¦to¦ ¦b ed¦ ¦at¦ ¦your¦ ¦normal¦ ¦b ed ti me¦
𐋇¦e at¦ ¦healthy¦ ¦food¦
𐋇¦do¦ ¦not¦ ¦dr ink¦ ¦to o¦ ¦much¦ ¦al c o ho l¦
𐋇 ¦pract ice¦ ¦re la x ation¦ ¦techn i q ues¦ ¦such¦ ¦as¦ ¦brea thing¦ ¦exerc i ses¦
𐋇¦read¦ ¦a¦ ¦b ook¦
𐋇¦s ear ch¦ ¦f it ness¦ ¦or¦ ¦y og a¦ ¦cl as ses¦ ,▁ ¦concer ts¦ ,▁ ¦ch ur ch¦ ¦services¦ ¦or¦ ¦gu i ded¦ ¦to ur s¦ ¦online¦
𐋇 ¦go¦ ¦to¦ ¦cl as ses¦ ¦if¦ ¦you¦ ¦can¦ ¦stay¦ ¦away¦ ¦2¦ ¦m h ¦ ¦from¦ ¦others¦
𐋇¦you¦ ¦will¦ ¦feel¦ ¦bet ter¦ ¦if¦ ¦you¦ ¦do¦ ¦so me thing¦ ¦cre ative¦ .
𐋇 ¦keep¦ ¦in¦ ¦tou ch¦ ¦with¦ ¦others¦
𐋇¦your¦ ¦f ri ends¦ ¦and¦ ¦family¦ ¦can¦ ¦help¦ ¦you¦ ¦when¦ ¦you¦ ¦are¦ ¦under¦ ¦pre ss ure¦ .
𐋇 ¦keep¦ ¦in¦ ¦tou ch¦ ¦with¦ ¦them¦ ¦at¦ ¦this¦ ¦time¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦to¦ ¦sto p¦ ¦mo ving¦ ¦around¦ ¦or¦ ¦if¦ ¦you¦ ¦have¦ ¦to¦ ¦stay¦ ¦al one¦ ,▁ ¦t ry¦ ¦to¦ ¦keep¦ ¦in¦ ¦tou ch¦ ¦with¦ ¦people¦ ¦in¦ ¦other¦ ¦w ays¦ ,▁ ¦for¦ ¦example¦ :
𐋇 ¦r ph ost¦
𐋇 ¦social¦ ¦m ed ia¦
𐋇 ¦v ide o¦ ¦ca lls¦
𐋇 ¦phone¦ ¦ca lls¦
𐋇 ¦te xt¦ ¦me ss a ging¦
𐋇 ¦v ide o¦ ¦ca lls¦ ¦can¦ ¦be¦ ¦made¦ ¦to¦ ¦many¦ ¦people¦ ¦at¦ ¦the¦ ¦same¦ ¦time¦ ¦on¦ ¦different¦ ¦v ide o¦ ¦app s¦ .
𐋇¦t al king¦ ¦to¦ ¦others¦ ¦will¦ ¦reduce¦ ¦your¦ ¦an xi et y¦ ¦and¦ ¦wor ry¦ .
𐋇¦you¦ ¦d on¦ ▁’▁ ¦t¦ ¦have¦ ¦to¦ ¦pr et end¦ ¦to¦ ¦be¦ ¦st ro ng¦ ¦or¦ ¦be¦ ¦able¦ ¦to¦ ¦hand le¦ ¦e ver y thing¦ ¦al one¦
𐋇¦t ry¦ ¦to¦ ¦come¦ ¦before¦ ¦the¦ ¦h ara ss ment¦ ¦and¦ ¦support¦ ¦each¦ ¦other¦
𐋇¦it¦ ¦is¦ ¦under s ta nd able¦ ¦that¦ ¦you¦ ¦would¦ ¦feel¦ ¦v ul n er able¦ ¦or¦ ¦under¦ ¦pre ss ure¦ ¦after¦ ¦rea ding¦ ¦or¦ ¦h earing¦ ¦new s¦ ¦about¦ ¦the¦ ¦outbreak¦ .
𐋇 ¦ident if y¦ ¦these¦ ¦fe el ings¦ .
𐋇 ¦rem ind¦ ¦yourself¦ ¦and¦ ¦others¦ ¦to¦ ¦take¦ ¦care¦ ¦of¦ ¦their¦ ¦ph ys ical¦ ¦and¦ ¦me ntal¦ ¦health¦ .
𐋇 ¦getting¦ ¦rel ief¦ ¦from¦ ¦s mo king¦ ,▁ ¦dr in king¦ ¦and¦ ¦food¦
𐋇¦if¦ ¦you¦ ¦s mo ke¦ ¦or¦ ¦dr ink¦ ,▁ ¦t ry¦ ¦not¦ ¦to¦ ¦s mo ke¦ ¦or¦ ¦dr ink¦ ¦more¦ ¦than¦ ¦us ual¦ .
𐋇¦this¦ ¦will¦ ¦not¦ ¦help¦ ¦you¦ ¦in¦ ¦the¦ ¦long¦ ¦ ru n¦ .
𐋇¦e ating¦ ¦h ab i ts¦ ¦are¦ ¦often¦ ¦related¦ ¦to¦ ¦your¦ ¦e mo tions¦ .
𐋇¦you¦ ¦may¦ ¦e at¦ ¦food¦ ¦to¦ ¦get¦ ¦rel ief¦ ¦during¦ ¦a¦ ¦corona ry¦ ¦virus¦ ¦outbreak¦ .
𐋇¦e ating¦ ¦for¦ ¦rel ief¦ ¦can¦ ¦cause¦ ¦you¦ ¦to¦ ¦ga in¦ ¦we ight¦ ¦and¦ ¦imp ai r¦ ¦your¦ ¦health¦ .
𐋇¦it¦ ¦is¦ ¦important¦ ¦to¦ ¦dis ti ng u ish¦ ¦between¦ ¦your¦ ¦m ood¦ ¦and¦ ¦the¦ ¦a mo un t¦ ¦of¦ ¦food¦ ¦you¦ ¦e at¦ .
𐋇¦if¦ ¦you¦ ¦al rea dy¦ ¦have¦ ¦me ntal¦ ¦health¦ ¦diffic ult ies¦ ¦and¦ ¦are¦ ¦using¦ ¦the¦ ¦me ntal¦ ¦health¦ ¦services¦
𐋇¦if¦ ¦the¦ ¦ho rs es ho e¦ ¦fa lls¦ ¦on¦ ¦the¦ ¦na il¦ ,▁ ¦it¦ ¦will¦ ¦help¦ ¦you¦ ¦if¦ ¦you¦ ¦have¦ ¦a¦ ¦pl an¦ ¦in¦ ¦place¦ .
𐋇 ¦th ings¦ ¦you¦ ¦could¦ ¦do¦ :
𐋇 ¦pre p are¦ ¦a¦ ¦l ist¦ ¦of¦ ¦phone¦ ¦nu mbers¦ ¦for¦ ¦me ntal¦ ¦health¦ ¦services¦ ,▁ ¦rel at ives¦ ¦and¦ ¦f ri ends¦ ¦that¦ ¦you¦ ¦can¦ ¦call¦ ¦if¦ ¦you¦ ¦need¦ ¦help¦
𐋇 ¦keep¦ ¦ta king¦ ¦any¦ ¦medic ines¦ ¦and¦ ¦coll ect¦ ¦your¦ ¦pr esc ri ption¦ ¦with¦ ¦the¦ ¦help¦ ¦of¦ ¦your¦ ¦doctor¦ ¦or¦ ¦p s y c hi at r ist¦
𐋇 ¦continue¦ ¦with¦ ¦any¦ ¦cou ns el ing¦ ¦or¦ ¦p s y c ho ther ap y¦ ¦s es si ons¦ ¦you¦ ¦have¦
𐋇¦c ut¦ ¦b ack¦ ¦on¦ ¦the¦ ¦time¦ ¦you¦ ¦sp end¦ ¦l ist ening¦ ¦to¦ ¦the¦ ¦new s¦ ¦and¦ ¦use¦ ¦no¦ ¦phone¦ ¦but¦ ¦a¦ ¦re li able¦ ¦sour ce¦
𐋇 ¦pract ice¦ ¦re la x ation¦ ¦techn i q ues¦ ¦and¦ ¦brea thing¦ ¦exerc i ses¦
𐋇¦if¦ ¦th ings¦ ¦get¦ ¦wor se¦ ,▁ ¦contact¦ ¦your¦ ¦me ntal¦ ¦health¦ ¦team¦ ¦or¦ ¦gp¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦an¦ ¦in te ll ect ual¦ ¦dis a bility¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦an¦ ¦in te ll ect ual¦ ¦dis a bility¦ ,▁ ¦you¦ ¦may¦ ¦feel¦ ¦more¦ ¦an x ious¦ ¦or¦ ¦s ad¦ ¦about¦ ¦the¦ ¦covid¦ - ¦19¦ .
𐋇¦you¦ ¦may¦ ¦also¦ ¦be¦ ¦wor r ied¦ ¦about¦ ¦your¦ ¦family¦ ¦or¦ ¦those¦ ¦close¦ ¦to¦ ¦you¦ .
𐋇¦it¦ ¦is¦ ¦important¦ ¦to¦ ¦take¦ ¦care¦ ¦of¦ ¦yourself¦ .
𐋇¦t ry¦ ¦to¦ ¦keep¦ ¦up¦ ¦with¦ ¦the¦ ¦normal¦ ¦th ings¦ ¦in¦ ¦your¦ ¦l ife¦ ,▁ ¦take¦ ¦a¦ ¦ba th¦ ¦every¦ ¦day¦ ¦and¦ ¦e at¦ ¦healthy¦ ¦food¦ .
𐋇 ¦keep¦ ¦in¦ ¦tou ch¦ ¦with¦ ¦people¦ ¦you¦ ¦tr ust¦ ¦over¦ ¦the¦ ¦phone¦ ¦or¦ ¦the¦ ¦inter n et¦ .
𐋇¦read¦ ¦the¦ ¦advice¦ ¦on¦ ¦how¦ ¦to¦ ¦help¦ ¦someone¦ ¦with¦ ¦spec ial¦ ¦needs¦ ¦during¦ ¦the¦ ¦corona ry¦ ¦virus¦ ¦outbreak¦ .
𐋇 ¦ob se ss ive¦ ¦comp ul s ive¦ ¦dis or der¦ ▁( ¦ oc d¦ )▁ ¦and¦ ¦the¦ ¦corona ry¦ ¦virus¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦ob se ss ive¦ ¦comp ul s ive¦ ¦dis or der¦ ▁( ¦ oc d¦ ),▁ ¦you¦ ¦may¦ ¦be¦ ¦very¦ ¦sc ared¦ :
𐋇 ¦that¦ ¦you¦ ¦get¦ ¦the¦ ¦coronavirus¦
𐋇 ¦that¦ ¦you¦ ¦would¦ ¦h ar m¦ ¦others¦
𐋇 ¦th ings¦ ¦are¦ ¦not¦ ¦in¦ ¦the¦ ¦r ight¦ ¦order¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦wor r ied¦ ¦about¦ ¦getting¦ ¦the¦ ¦coronavirus¦ ,▁ ¦you¦ ¦will¦ ¦be¦ ¦ca u gh t¦ ¦by¦ :
𐋇¦c le an li ness¦ ¦hands¦
𐋇¦c le an li ness¦
𐋇 ¦a v oi ding¦ ¦th ings¦ ¦like¦ ¦public¦ ¦transport¦ ¦system¦
𐋇 ¦washing¦ ¦your¦ ¦hands¦
𐋇¦you¦ ¦may¦ ¦cons ta ntly¦ ¦be¦ ¦washing¦ ¦or¦ ¦cl ea ning¦ ¦your¦ ¦hands¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦previously¦ ¦sub d u ed¦ ¦a¦ ¦dis or der¦ ¦like¦ ¦this¦ ,▁ ¦it¦ ¦may¦ ¦come¦ ¦b ack¦ ¦on¦ .
𐋇 ¦follow¦ ¦the¦ ¦advice¦ ¦a bo ve¦ .
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦properly¦ ¦and¦ ¦often¦ ,▁ ¦but¦ ¦you¦ ¦do¦ ¦not¦ ¦need¦ ¦to¦ ¦do¦ ¦more¦ ¦than¦ ¦recommended¦ .
𐋇 ¦co king¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦at¦ ¦high¦ ¦risk¦ ¦from¦ ¦the¦ ¦coronavirus¦ ▁( ¦covid¦ - ¦19¦ ,▁ ¦it¦ ¦is¦ ¦recommended¦ ¦that¦ ¦you¦ ¦c ook¦ .
𐋇¦you¦ ¦should¦ ¦stay¦ ¦home¦ ¦as¦ ¦much¦ ¦as¦ ¦possible¦ ¦and¦ ¦stay¦ ¦away¦ ¦from¦ ¦others¦ .
𐋇¦as¦ ¦restrictions¦ ¦are¦ ¦l if ted¦ ,▁ ¦people¦ ¦will¦ ¦be¦ ¦at¦ ¦g rea ter¦ ¦risk¦ ¦of¦ ¦contr ac ting¦ ¦the¦ ¦virus¦ ¦due¦ ¦to¦ ¦activ ities¦ ¦such¦ ¦as¦ :
𐋇 ¦an¦ ¦ev ent¦ ¦such¦ ¦as¦ ¦a¦ ¦w ed ding¦ ¦and¦ ¦f un er al¦
𐋇 ¦cr ow ded¦ ¦places¦ ¦that¦ ¦cannot¦ ¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦others¦
𐋇¦the¦ ¦more¦ ¦people¦ ¦who¦ ¦att end¦ ,▁ ¦the¦ ¦g rea ter¦ ¦the¦ ¦risk¦ .
𐋇¦you¦ ¦have¦ ¦to¦ ¦dec ide¦ ¦what¦ ¦is¦ ¦b est¦ ¦for¦ ¦your¦ ¦ own¦ ¦health¦ .
𐋇¦but¦ ¦c er tain¦ ¦th ings¦ ¦should¦ ¦continue¦ ¦to¦ ¦protect¦ ¦you¦ ¦from¦ ¦the¦ ¦cr own¦ ¦virus¦ ¦and¦ ¦stay¦ ¦safe¦ .
𐋇¦the¦ ¦people¦ ¦that¦ ¦need¦ ¦c oc oo ning¦
𐋇¦you¦ ¦must¦ ¦c oc o on¦ ¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦person¦ ¦who¦ ¦is¦ ¦at¦ ¦high¦ ¦risk¦ ▁( ¦very¦ ¦v ul n er able¦ )▁ ¦from¦ ¦the¦ ¦coronavirus¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦u ns ure¦ ¦wh ether¦ ¦or¦ ¦not¦ ¦to¦ ¦c ook¦ ,▁ ¦t alk¦ ¦to¦ ¦your¦ ¦doctor¦ .
𐋇¦if¦ ¦you¦ ¦are¦ ¦an¦ ¦essential¦ ¦work er¦ ,▁ ¦get¦ ¦advice¦ ¦from¦ ¦occ u pa tional¦ ¦health¦ .
𐋇¦t alk¦ ¦to¦ ¦your¦ ¦gp¦ ¦if¦ ¦your¦ ¦child¦ ¦has¦ ¦a¦ ¦long¦ - ¦ter m¦ ¦illness¦ ¦and¦ ¦needs¦ ¦advice¦ ¦on¦ ¦how¦ ¦to¦ ¦protect¦ ¦them¦ .
𐋇 ¦call¦ ¦your¦ ¦doctor¦ ¦if¦ ¦you¦ ¦have¦ ¦any¦ ¦signs¦ ¦of¦ ¦the¦ ¦coronavirus¦ .
𐋇¦m ee ting¦ ¦people¦ ¦from¦ ¦other¦ ¦h omes¦
𐋇 ¦me et¦ ¦the¦ ¦sm all¦ ¦group¦ ¦of¦ ¦the¦ ¦same¦ ¦si x¦ .
𐋇¦this¦ ¦will¦ ¦help¦ ¦you¦ ¦stay¦ ¦safe¦ ¦from¦ ¦the¦ ¦coronavirus¦ .
𐋇¦if¦ ¦you¦ ¦have¦ ¦a¦ ¦long¦ - ¦ter m¦ ¦illness¦ ¦and¦ ¦your¦ ¦gp¦ ¦has¦ ¦ad vi sed¦ ¦you¦ ¦not¦ ¦to¦ ¦me et¦ ¦others¦ ¦you¦ ¦should¦ ¦al w ays¦ ¦follow¦ ¦your¦ ¦doctor¦ ' ¦s¦ ¦advice¦ .
𐋇¦m ee ting¦ ¦people¦ ¦in side¦
𐋇 ¦visi t ors¦ ¦can¦ ¦come¦ ¦to¦ ¦your¦ ¦house¦ ¦and¦ ¦you¦ ¦can¦ ¦visit¦ ¦another¦ ¦house¦ .
𐋇 ¦wear¦ ¦a¦ ¦face¦ ¦mask¦ ¦when¦ ¦you¦ ¦me et¦ ¦other¦ ¦people¦ ¦in side¦ ¦or¦ ¦when¦ ¦there¦ ¦are¦ ¦visi t ors¦ ¦in¦ ¦your¦ ¦house¦ ¦and¦ ¦when¦ ¦you¦ ¦visit¦ .
𐋇¦the¦ ¦people¦ ¦you¦ ¦me et¦ ¦should¦ :
𐋇¦stay¦ ¦out¦ ¦of¦ ¦2¦ ¦meters¦ ¦if¦ ¦possible¦
𐋇 ¦wear¦ ¦a¦ ¦face¦ ¦cover¦ ¦if¦ ¦they¦ ¦can¦ ' ¦t¦ ¦stay¦ ¦out¦ ¦2¦ ¦meters¦ ¦away¦
𐋇 ¦wash¦ ¦their¦ ¦hands¦ ¦and¦ ¦pract ice¦ ¦g ood¦ ¦h yg ien e¦
𐋇¦if¦ ¦you¦ ¦dec ide¦ ¦to¦ ¦visit¦ ¦another¦ ¦house¦ ,▁ ¦l et¦ ¦them¦ ¦know¦ ¦in¦ ¦ad v ance¦ ¦that¦ ¦you¦ ¦are¦ ¦go ing¦ .
𐋇 ¦make¦ ¦sure¦ ¦no¦ ¦one¦ ¦is¦ ¦fe el ing¦ ¦sick¦ ¦with¦ ¦the¦ ¦symptoms¦ ¦of¦ ¦coronavirus¦ .
𐋇¦you¦ ¦should¦ ¦stay¦ ¦away¦ ¦2¦ ¦meters¦ ¦from¦ ¦others¦ ¦and¦ ¦wash¦ ¦your¦ ¦hands¦ ¦when¦ ¦you¦ ¦retur n¦ ¦to¦ ¦your¦ ¦ own¦ ¦home¦ .
𐋇¦you¦ ¦should¦ ¦wear¦ ¦a¦ ¦face¦ ¦mask¦ ¦un less¦ ¦you¦ ¦can¦ ¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦others¦ ¦and¦ ¦wash¦ ¦your¦ ¦hands¦ ¦when¦ ¦you¦ ¦go¦ ¦home¦ .
𐋇 ¦people¦ ¦with¦ ¦symptoms¦ ¦of¦ ¦coronavirus¦ ¦should¦ ¦not¦ ¦visit¦ ¦you¦ .
𐋇¦when¦ ¦the¦ ¦visi t ors¦ ¦dis a pp ear¦ ,▁ ¦you¦ ¦should¦ ¦clean¦ ¦the¦ ¦sur fa ces¦ ¦they¦ ¦have¦ ¦been¦ ¦in¦ ¦contact¦ ¦with¦ ¦them¦ .
𐋇 ¦use¦ ¦for¦ ¦ro ut ine¦ ¦hou se ho ld¦ ¦cl ea ning¦ ¦and¦ ¦disinf ec ta nts¦ .
𐋇¦m ee ting¦ ¦people¦ ¦outside¦
𐋇¦if¦ ¦you¦ ¦dec ide¦ ¦to¦ ¦me et¦ ¦people¦ :
𐋇 ¦me et¦ ¦one¦ ¦sm all¦ ¦group¦ ¦of¦ ¦people¦
𐋇 ¦only¦ ¦me et¦ ¦them¦ ¦for¦ ¦a¦ ¦sh ort¦ ¦time¦
𐋇¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦others¦ ¦in¦ ¦the¦ ¦group¦
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦when¦ ¦you¦ ¦get¦ ¦home¦
𐋇 ¦go ing¦ ¦for¦ ¦a¦ ¦w alk¦
𐋇¦if¦ ¦you¦ ¦go¦ ¦for¦ ¦a¦ ¦w alk¦ ,▁ ¦you¦ ¦should¦ :
𐋇¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦others¦
𐋇¦stay¦ ¦away¦ ¦from¦ ¦others¦ ¦as¦ ¦much¦ ¦as¦ ¦possible¦
𐋇¦stay¦ ¦away¦ ¦from¦ ¦sur fa ces¦
𐋇 ¦not¦ ¦to¦ ¦sh a ke¦ ¦hands¦ ¦with¦ ¦people¦
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦when¦ ¦you¦ ¦en ter¦ ¦your¦ ¦ own¦ ¦home¦
𐋇 ¦go ing¦ ¦on¦ ¦a¦ ¦ca r¦ ¦t ri p¦
𐋇¦if¦ ¦you¦ ¦go¦ ¦on¦ ¦a¦ ¦ca r¦ ¦jo ur ne y¦ ,▁ ¦you¦ ¦should¦ :
𐋇 ¦travel¦ ¦on¦ ¦your¦ ¦jo ur ne y¦ ¦with¦ ¦someone¦ ¦who¦ ¦l ives¦ ¦with¦ ¦you¦ ¦or¦ ¦someone¦ ¦from¦ ¦your¦ ¦social¦ ¦group¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦in¦ ¦a¦ ¦ta x i¦ ¦e veryone¦ ¦should¦ ¦wear¦ ¦a¦ ¦face¦ ¦mask¦ .
𐋇¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦others¦ ¦when¦ ¦you¦ ¦are¦ ¦out¦
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦when¦ ¦you¦ ¦get¦ ¦home¦
𐋇 ¦travel¦
𐋇¦you¦ ¦should¦ ¦stay¦ ¦home¦ ¦as¦ ¦much¦ ¦as¦ ¦possible¦ ¦and¦ ¦stay¦ ¦away¦ ¦from¦ ¦others¦ .
𐋇¦but¦ ¦if¦ ¦you¦ ¦are¦ ¦go ing¦ ¦to¦ ¦travel¦ ¦in¦ ¦your¦ ¦ own¦ ¦county¦ ¦or¦ ¦to¦ ¦another¦ ¦county¦ ,▁ ¦f ind¦ ¦out¦ ¦how¦ ¦the¦ ¦virus¦ ¦is¦ ¦sprea ding¦ ¦in¦ ¦that¦ ¦a rea¦ .
𐋇 ¦th ink¦ ¦about¦ ¦the¦ ¦b est¦ ¦way¦ ¦to¦ ¦protect¦ ¦yourself¦ ¦before¦ ¦you¦ ¦hi t¦ ¦the¦ ¦ro ad¦ .
𐋇 ¦public¦ ¦transport¦
𐋇¦if¦ ¦you¦ ¦have¦ ¦to¦ ¦travel¦ ¦by¦ ¦public¦ ¦transport¦ :
𐋇 ¦go¦ ¦at¦ ¦times¦ ¦that¦ ¦are¦ ¦not¦ ¦b us y¦ ,▁ ¦if¦ ¦possible¦
𐋇¦you¦ ¦have¦ ¦to¦ ¦wear¦ ¦face¦ ¦cover¦ ¦on¦ ¦public¦ ¦transport¦ ▁-▁ ¦that¦ ' ¦s¦ ¦the¦ ¦la w¦ .
𐋇¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦others¦
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦when¦ ¦you¦ ¦are¦ ¦at¦ ¦home¦
𐋇 ¦res ta u ra nts¦
𐋇 ¦before¦ ¦you¦ ¦go¦ ¦to¦ ¦a¦ ¦res ta ur ant¦ ,▁ ¦th ink¦ ¦ca re f ul ly¦ ¦about¦ ¦the¦ ¦da ng ers¦ .
𐋇¦it¦ ¦should¦ ¦be¦ :
𐋇¦the¦ ¦res ta ur ant¦ ¦is¦ ¦large¦ ¦en ough¦ ¦to¦ ¦lea ve¦ ¦a¦ ¦2¦ ¦me ter¦ ¦sp ace¦ ¦between¦ ¦the¦ ¦t ab les¦
𐋇 ¦safe¦ ¦ent r ance¦ ¦and¦ ¦e xi t¦ ¦so¦ ¦you¦ ¦can¦ ¦stay¦ ¦away¦ ¦2¦ ¦meters¦ ¦from¦ ¦others¦
𐋇¦ stric t¦ ¦h yg ien e¦ ¦measures¦ ¦are¦ ¦imp le m ented¦
𐋇 ¦reduce¦ ¦the¦ ¦risk¦ :
𐋇 ¦j ust¦ ¦wai t¦ ¦a¦ ¦sh ort¦ ¦dista nce¦
𐋇¦t ell¦ ¦the¦ ¦ser ver¦ ¦that¦ ¦you¦ ¦are¦ ¦co king¦
𐋇 ¦wear¦ ¦a¦ ¦face¦ ¦mask¦ ¦in¦ ¦the¦ ¦res ta ur ant¦
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦when¦ ¦you¦ ¦go¦ ¦home¦
𐋇 ¦shopping¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦a¦ ¦c ook¦ ,▁ ¦you¦ ¦may¦ ¦w ant¦ ¦to¦ ¦as k¦ ¦your¦ ¦f ri ends¦ ¦or¦ ¦rel at ives¦ ¦to¦ ¦do¦ ¦the¦ ¦shopping¦ ¦for¦ ¦you¦ .
𐋇 ¦because¦ ¦it¦ ¦is¦ ¦not¦ ¦e as y¦ ¦to¦ ¦stay¦ ¦away¦ ¦2¦ ¦meters¦ ¦from¦ ¦others¦ ¦in¦ ¦the¦ ¦sho ps¦ .
𐋇¦if¦ ¦you¦ ¦go¦ ¦shopping¦ ,▁ ¦you¦ ¦should¦ :
𐋇¦p ut¦ ¦on¦ ¦face¦ ¦cover¦ ▁-▁ ¦this¦ ¦is¦ ¦the¦ ¦la w¦ ¦in¦ ¦sho ps¦ ,▁ ¦shopping¦ ¦centr es¦ ¦and¦ ¦other¦ ¦re ta il¦ ¦out l ets¦ ¦such¦ ¦as¦ ¦ha ir d re ss ers¦ ¦and¦ ¦c i ne ma s¦
𐋇 ¦go¦ ¦at¦ ¦the¦ ¦times¦ ¦s et¦ ¦a side¦ ¦for¦ ¦people¦ ¦c oo king¦ ▁-▁ ¦ch eck¦ ¦these¦ ¦times¦ ¦at¦ ¦your¦ ¦local¦ ¦su p erm ar k et¦
𐋇 ¦ad h er e¦ ¦to¦ ¦the¦ ¦gu id el ines¦ ¦for¦ ¦social¦ ¦separ ation¦ ,▁ ¦and¦ ¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦others¦
𐋇 ¦using¦ ¦services¦ ¦when¦ ¦social¦ ¦separ ation¦ ¦cannot¦ ¦be¦ ¦pract ic ed¦
𐋇¦s om et im es¦ ¦it¦ ¦will¦ ¦not¦ ¦be¦ ¦possible¦ ¦to¦ ¦pract ice¦ ¦social¦ ¦separ ation¦ ¦e g¦ ¦ha ir d re ss er¦ .
𐋇¦you¦ ¦must¦ ¦ass ess¦ ¦the¦ ¦risk¦ ¦before¦ ¦using¦ ¦these¦ ¦services¦ .
𐋇¦to¦ ¦reduce¦ ¦the¦ ¦risk¦ :
𐋇¦t ell¦ ¦the¦ ¦service¦ ¦provid er¦ ¦that¦ ¦you¦ ¦are¦ ¦co a x ing¦ ¦when¦ ¦b oo king¦ ¦your¦ ¦appointment¦
𐋇¦d on¦ ' ¦t¦ ¦go¦ ¦to¦ ¦places¦ ¦like¦ ¦this¦ ¦to o¦ ¦often¦
𐋇 ¦sp end¦ ¦as¦ ¦l it t le¦ ¦time¦ ¦as¦ ¦possible¦ ¦in¦ ¦these¦ ¦places¦
𐋇 ¦arr ange¦ ¦your¦ ¦appointment¦ ¦at¦ ¦a¦ ¦time¦ ¦and¦ ¦day¦ ¦when¦ ¦there¦ ¦will¦ ¦be¦ ¦fe w¦ ¦people¦
𐋇 ¦make¦ ¦sure¦ ¦the¦ ¦bu si ness¦ ¦fo ll ow s¦ ¦national¦ ¦h yg ien e¦ ¦gu id el ines¦ ¦and¦ ¦under st an ds¦ ¦your¦ ¦needs¦
𐋇 ¦wear¦ ¦a¦ ¦face¦ ¦cover¦
𐋇 ¦wash¦ ¦your¦ ¦hands¦ ¦when¦ ¦you¦ ¦go¦ ¦home¦
𐋇 ¦get¦ ¦help¦ ¦while¦ ¦c oo king¦
𐋇¦there¦ ¦are¦ ¦community¦ ¦supp orts¦ ¦for¦ ¦people¦ ¦who¦ ¦are¦ ¦c oc oo ning¦ .
𐋇 ¦ass ist ance¦ ¦is¦ ¦also¦ ¦available¦ ¦to¦ ¦coll ect¦ ¦these¦ ¦i tems¦
𐋇 ¦gr oc er ies¦ ,
𐋇 ¦medic ation¦
𐋇 ¦other¦ ¦e ss en ti als¦ :
𐋇¦in¦ ¦some¦ ¦cases¦ ¦help¦ ¦is¦ ¦also¦ ¦available¦ ¦to¦ ¦get¦ ¦rel ief¦ ¦from¦ ¦social¦ ¦separ ation¦ .
𐋇¦m ed ications¦ ¦and¦ ¦pr esc r ip tions¦
𐋇 ¦chan ges¦ ¦have¦ ¦been¦ ¦made¦ ¦to¦ ¦make¦ ¦it¦ ¦ ea si er¦ ¦for¦ ¦you¦ ¦to¦ ¦f ind¦ ¦your¦ ¦medic ines¦ ¦and¦ ¦pr esc r ip tions¦ .
𐋇 ¦long¦ ¦ter m¦ ¦res ide ntial¦ ¦care¦
𐋇¦if¦ ¦you¦ ¦live¦ ¦in¦ ¦a¦ ¦long¦ - ¦ter m¦ ¦res ide ntial¦ ¦center¦ ,▁ ¦t alk¦ ¦to¦ ¦your¦ ¦ca re g i ver¦ ¦about¦ ¦sh ort¦ ¦w al ks¦ ¦or¦ ¦f it ness¦ .
𐋇¦they¦ ¦will¦ ¦be¦ ¦able¦ ¦to¦ ¦help¦ ¦you¦ ¦dec ide¦ ¦which¦ ¦o ption¦ ¦is¦ ¦safe¦ ¦for¦ ¦you¦
𐋇¦if¦ ¦your¦ ¦car er¦ ¦c omes¦ ¦to¦ ¦visit¦ ¦you¦ .
𐋇 ¦continue¦ ¦with¦ ¦visi ts¦ ¦from¦ ¦people¦ ¦who¦ ¦help¦ ¦you¦ ¦with¦ ¦your¦ ¦daily¦ ¦needs¦ .
𐋇¦these¦ ¦include¦ :
𐋇 ¦health¦ ¦care¦ ¦workers¦
𐋇 ¦personal¦ ¦car ers¦ ¦and¦
𐋇 ¦social¦ ¦car ers¦ .
𐋇¦these¦ ¦people¦ ¦can¦ ¦visit¦ ¦you¦ ¦if¦ ¦they¦ ¦have¦ ¦no¦ ¦symptoms¦ ¦of¦ ¦the¦ ¦disease¦
𐋇¦when¦ ¦car ers¦ ¦visit¦ ,▁ ¦they¦ ¦should¦ :
𐋇 ¦wash¦ ¦hi s¦ ¦hands¦ ¦first¦ .
𐋇 ¦wash¦ ¦their¦ ¦hands¦ ¦often¦ ¦while¦ ¦in¦ ¦your¦ ¦house¦ .
𐋇¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ,▁ ¦if¦ ¦possible¦ .
𐋇¦if¦ ¦your¦ ¦car er¦ ¦develop s¦ ¦symptoms¦ ¦of¦ ¦the¦ ¦disease¦
𐋇¦if¦ ¦a¦ ¦car er¦ ¦develop s¦ ¦symptoms¦ ¦of¦ ¦the¦ ¦disease¦ ,▁ ¦they¦ ¦will¦ ¦not¦ ¦be¦ ¦able¦ ¦to¦ ¦l ook¦ ¦after¦ ¦you¦ ¦if¦ ¦they¦ ¦bec ome¦ ¦ ill¦ .
𐋇¦they¦ ¦should¦ ¦stay¦ ¦away¦ ¦from¦ ¦you¦ ¦until¦ :
¦5¦ ¦days¦ ¦without¦ ¦fever¦
¦14¦ ¦days¦ ¦without¦ ¦symptoms¦ ¦of¦ ¦the¦ ¦disease¦
𐋇 ¦contact¦ ¦your¦ ¦car er¦ ' ¦s¦ ¦organiz er¦ ¦to¦ ¦f ind¦ ¦you¦ ¦another¦ ¦car er¦ .
𐋇¦you¦ ¦should¦ ¦have¦ ¦a¦ ¦l ist¦ ¦of¦ ¦other¦ ¦people¦ ¦who¦ ¦would¦ ¦l ook¦ ¦after¦ ¦you¦ ¦if¦ ¦your¦ ¦pr imary¦ ¦car er¦ ¦bec a me¦ ¦ ill¦
𐋇¦if¦ ¦you¦ ¦are¦ ¦c oo king¦ ¦and¦ ¦others¦ ¦in¦ ¦the¦ ¦house¦ ¦with¦ ¦you¦
𐋇 ¦al th ough¦ ¦diffic ul t¦ ,▁ ¦you¦ ¦should¦ ¦avoid¦ ¦all¦ ¦un ne cess ary¦ ¦contact¦ ¦with¦ ¦people¦ ¦in¦ ¦the¦ ¦house¦ ¦when¦ ¦c oo king¦ .
𐋇 ¦an yone¦ ¦in¦ ¦the¦ ¦house¦ ¦must¦ ¦c ook¦ ¦if¦ :
𐋇¦they¦ ¦are¦ ¦over¦ ¦7 0¦ ¦years¦ ¦o ld¦
𐋇¦they¦ ¦have¦ ¦any¦ ¦of¦ ¦the¦ ¦diseases¦ ¦that¦ ¦could¦ ¦p ut¦ ¦them¦ ¦at¦ ¦high¦ ¦risk¦ ¦from¦ ¦the¦ ¦coronavirus¦
𐋇¦if¦ ¦someone¦ ¦el se¦ ¦in¦ ¦the¦ ¦house¦ ¦is¦ ¦under¦ ¦7 0¦ ¦and¦ ¦they¦ ¦d on¦ ▁’▁ ¦t¦ ¦have¦ ¦any¦ ¦illness¦ ¦that¦ ¦would¦ ¦ end a nger¦ ¦them¦ ,▁ ¦they¦ ¦d on¦ ▁’▁ ¦t¦ ¦need¦ ¦to¦ ¦c oc o on¦ .
𐋇¦they¦ ¦can¦ ¦help¦ ¦you¦ ¦stay¦ ¦safe¦ ¦if¦ :
𐋇¦they¦ ¦follow¦ ¦the¦ ¦advice¦ ¦on¦ ¦social¦ ¦separ ation¦ ¦and¦ ¦hand¦ ¦h yg ien e¦ ¦at¦ ¦home¦ .
𐋇¦they¦ ¦sp end¦ ¦as¦ ¦l it t le¦ ¦time¦ ¦as¦ ¦possible¦ ¦in¦ ¦r oo ms¦ ¦with¦ ¦others¦ ,▁ ¦for¦ ¦example¦ ,▁ ¦in¦ ¦the¦ ¦k it ch en¦ ¦and¦ ¦se ating¦ ¦areas¦
𐋇¦w i nd ow s¦ ¦are¦ ¦op e ned¦ ¦to¦ ¦re le ase¦ ¦fre s h ¦ ¦air ¦ ¦into¦ ¦the¦ ¦sh ared¦ ¦s pa ces¦
𐋇¦they¦ ¦use¦ ¦their¦ ¦ own¦ ¦to we l¦ ¦to¦ ¦d ry¦ ¦their¦ ¦hands¦ ¦and¦ ¦cr oc k e ry¦
𐋇¦c ut le ry¦ ,▁ ¦u tens il s¦ ,▁ ¦po ts¦ ¦and¦ ¦s k i ll ets¦ ¦are¦ ¦th or ou gh ly¦ ¦cl ea ned¦
𐋇¦a¦ ¦ba th ro om¦ ¦is¦ ¦well¦ ¦cl ea ned¦ ¦by¦ ¦others¦ ¦every¦ ¦time¦ ¦it¦ ¦is¦ ¦used¦ ,▁ ¦for¦ ¦example¦ ,▁ ¦all¦ ¦sur fa ces¦ ¦on¦ ¦which¦ ¦you¦ ¦have¦ ¦pl ac ed¦ ¦your¦ ¦hand¦
𐋇 ¦clean¦ ¦e ver y thing¦ ¦and¦ ¦hand¦ - ¦pa in ted¦ ¦sur fa ces¦ ▁( ¦e g¦ ¦ door¦ ¦hand les¦ ,▁ ¦k et t les¦ ¦and¦ ¦ph on es¦ )▁ ¦with¦ ¦your¦ ¦normal¦ ¦cl ea ning¦ ¦produc ts¦
𐋇 ¦sta ying¦ ¦safe¦ ¦and¦ ¦so un d¦
𐋇 ¦sta ying¦ ¦at¦ ¦home¦ ¦and¦ ¦having¦ ¦l it t le¦ ¦contact¦ ¦with¦ ¦others¦ ¦is¦ ¦diffic ul t¦ .
𐋇¦it¦ ¦can¦ ¦aff ect¦ ¦your¦ ¦m ood¦ ¦or¦ ¦e mo tions¦ .
𐋇¦you¦ ¦may¦ ¦have¦ ¦low¦ ¦m ood¦ ,▁ ¦an xi et y¦ ¦or¦ ¦diffic ult y¦ ¦sl ee p ing¦ .
𐋇 ¦th ings¦ ¦you¦ ¦can¦ ¦do¦ ¦to¦ ¦stay¦ ¦healthy¦ :
𐋇 ¦mo ve¦ ¦around¦ ▁-▁ ¦get¦ ¦up¦ ¦and¦ ¦mo ve¦ ¦around¦ ¦as¦ ¦much¦ ¦as¦ ¦possible¦
𐋇 ¦go¦ ¦for¦ ¦a¦ ¦w alk¦ ¦or¦ ¦me et¦ ¦out d o ors¦ ¦but¦ ¦stay¦ ¦2¦ ¦meters¦ ¦away¦ ¦from¦ ¦others¦
𐋇 ¦follow¦ ¦our¦ ¦advice¦ ¦on¦ ¦f it ness¦ ¦at¦ ¦home¦
𐋇 ¦continue¦ ¦with¦ ¦your¦ ¦daily¦ ¦activ ities¦ ,▁ ¦as¦ ¦us ual¦ .
𐋇¦stay¦ ¦in¦ ¦tou ch¦ ¦with¦ ¦your¦ ¦f ri ends¦ ¦or¦ ¦rel at ives¦ ¦over¦ ¦the¦ ¦phone¦ ¦or¦ ¦on¦ ¦social¦ ¦m ed ia¦
